OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	superficial_relationship

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]
PMC4910734	6/2015	S135-PMC4910734	['MANY of the Micronutrients STUDIES HAVE BEEN BASED ON Plasma and Urinary clinical results, which SUGGEST the elevation of Lipid Peroxide-generated Aldehydes (Hne, mda)84–86as well as deficiencies in antioxidants, such as Vitamin E, Sulfur-containing Compounds, such as cysteine, methionine, and Gsh,119carnitine,120biotin,121and ( n -3) pufas.122given the depressed levels of Sulfur-containing Compounds in asd Individuals, it is NOT SURPRISING that these children are more sensitive than neurotypicals to the exposure of mercury and other heavy metals.78the antioxidant supplements, which SHOW symptom improvements include, but are not limited to Ubiquinol,123nac,124carnosine, and Vitamin C.125other Micronutrients, including b1,126B6-Mg2+,127Folate, Vitamin E, Retinol, and Zn2+, HAVE BEEN selected for a variety of reasons RELATING to the INVOLVEMENT in abnormal Metabolic pathways IMPLICATED in asd,1even THOUGH the clinical assays do not always show a deficiency in asd Individuals compared to neurotypical controls.119with all of the single Micronutrient STUDIES, there are CONFLICTING results regarding efficacy.119there are a FEW STUDIES, which utilize broad-spectrum Micronutrient supplementation and report improvements in clinical BIOMARKERS and/or various autism-rating scales.76,121,128the broad-spectrum Micronutrient STUDIES are very PROMISING BECAUSE all DEMONSTRATE a significant CORRELATION between nutritional deficiencies and severity of autistic symptoms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 430), ('ANOMALY_CURIOUS_FINDING', 434), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 783), ('SUPERFICIAL_RELATIONSHIP', 827), ('SUPERFICIAL_RELATIONSHIP', 843), ('SUPERFICIAL_RELATIONSHIP', 886), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 910), ('ANOMALY_CURIOUS_FINDING', 910), ('INCOMPLETE_EVIDENCE', 1062), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('INCOMPLETE_EVIDENCE', 1135), ('SUPERFICIAL_RELATIONSHIP', 1243), ('INCOMPLETE_EVIDENCE', 1333), ('PROBABLE_UNDERSTANDING', 1350), ('PROBABLE_UNDERSTANDING', 1360), ('INCOMPLETE_EVIDENCE', 1372), ('SUPERFICIAL_RELATIONSHIP', 1398)]	23	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_48107', 'nitric acid', 122, 'lipid peroxide'), ('CHEBI_17478', 'aldehyde', 147, 'aldehydes'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 158, 'HNE'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin E'), ('CHEBI_36933', 'oxygen-19 atom', 232, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 250, 'compounds'), ('CHEBI_16856', 'glutathione', 295, 'GSH'), ('CHEBI_36933', 'oxygen-19 atom', 376, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 394, 'compounds'), ('NCBITaxon_1', 'root', 411, 'individuals'), ('CHEBI_17976', 'ubiquinol', 648, 'ubiquinol'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin C'), ('CHEBI_33839', 'macromolecule', 702, 'micronutrients'), ('CHEBI_73173', '2,4-DB', 731, '126B6'), ('CHEBI_6636', 'magnesium dichloride', 737, 'Mg2+,'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 742, '127folate'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin E'), ('CHEBI_26536', 'retinoic acid', 764, 'retinol'), ('CHEBI_29105', 'zinc(2+)', 777, 'Zn2+,'), ('GO_0008152', 'metabolic process', 867, 'metabolic'), ('NCBITaxon_1', 'root', 976, 'individuals'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1048, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1177, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1319, 'micronutrient')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3417531	7/2012	S66-PMC3417531	["(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?"]	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC3888066	12/2012	S12-PMC3888066	['this NOTION is BASED ON the KNOWN Teratogenic EFFECTS of Retinoic Acids on the Central Nervous System,1–3the CALCULATED dose of Retinol and Beta Carotene Ingested by the mother during early Pregnancy, and STRONG EVIDENCE that the fetus Metabolizes Beta Carotene to Retinoids and has LIMITED ability to store Beta Carotene in Fat Cells.4–7\nin 1995, rothman et al DEMONSTRATED that high maternal dietary intake of Vitamin A in the form of Retinol, ie, >10,000 iu/day, particularly in the first Trimester, MAY BE ASSOCIATED with Cranial-Neural-Crest Birth defects.8using a smooth regression curve, THIS study of 22,748 Pregnant women and their offspring IDENTIFIED 1 infant in 57 with malformations that COULD BE ATTRIBUTED to the intake of supplements of Preformed Vitamin A at a dose >10,000 iu/day.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 283), ('INCOMPLETE_EVIDENCE', 362), ('INCOMPLETE_EVIDENCE', 503), ('SUPERFICIAL_RELATIONSHIP', 510), ('QUESTION_ANSWERED_BY_THIS_WORK', 595), ('INCOMPLETE_EVIDENCE', 651), ('INCOMPLETE_EVIDENCE', 701), ('SUPERFICIAL_RELATIONSHIP', 710)]	16	[('CHEBI_50905', 'teratogenic agent', 34, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 57, 'retinoic acids'), ('UBERON_0001017', 'central nervous system', 79, 'central nervous system'), ('CHEBI_26536', 'retinoic acid', 128, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 140, 'beta carotene'), ('GO_0007631', 'feeding behavior', 154, 'ingested'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0008152', 'metabolic process', 236, 'metabolizes'), ('CHEBI_51438', 'D-isoascorbic acid', 248, 'beta carotene'), ('CHEBI_26537', 'retinoid', 265, 'retinoids'), ('CHEBI_51438', 'D-isoascorbic acid', 308, 'beta carotene'), ('CL_0000136', 'fat cell', 325, 'fat cells'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 437, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 492, 'trimester'), ('UBERON_0001456', 'face', 526, 'cranial'), ('UBERON_0002342', 'neural crest', 534, 'neural-crest'), ('GO_0007567', 'parturition', 547, 'birth'), ('GO_0007565', 'female pregnancy', 616, 'pregnant'), ('GO_0007565', 'female pregnancy', 753, 'preformed'), ('CHEBI_27300', 'vitamin D', 763, 'vitamin A')]
PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
PMC4490503	6/2015	S137-PMC4490503	['gdm develops when beta cell dysfunction coexists, and MAY BE characterised by further abnormalities in adipokine and cytokine profiles, increased Free Fatty Acids (ffa), Triglycerides (tg), low Vitamin D and Endothelial dysfunction.ijms-16-13442-t001_table 1\n\ncaption (table-wrap): table 1\n\nlongitudinal studies of inflammatory markers in prediction of gdm.inflammatory markerfirst author (year)study designgdm statusgdm diagnostic criteriagestational age at testing (weeks)EFFECT in gdmmatching or adjustment for confounderstnf-αkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weekstnf-Α ↑ 34–36 weeks in gdm inversely CORRELATED with Insulin sensitivityfat massgao (2008) [65]nested case-control22 gdm 10 igt 20 ngtunknown12–20 weeks 24–32 weekstnf-Α ↑ in gdm positively CORRELATED with bmi 14–20 weeksn/ageorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmisaucedo (2011) [67]prospective60 gdm 60 ngt24–28 weeks ada criteria 2010 [68]30 weeks 6 weeks 6 months Postpartumtnf-Α ↑ in both groups at 6 weeks Tnf-Α ↑ 6months Postpartum in gdmage weightlopez-tinoco (2012) [69]case-control63 gdm 63 ngt24–28 weeks nddg criteria [70]mean ~29 weekstnf-Α ↑ in gdmbmiguillemette (2014) [71]prospective61 gdm 695 ngt24–28 weeks iadpsg criteria [44]5–16 weeks 24–28 weekstnf-Α ↑ in both groups and ASSOCIATED with Insulin resistanceage bmi tg adiponectin.il-6morrisett (2011) [72]case-control20 gdm 27 ngt26.1 ± 3.7 weeks cda criteria [73]26.1 ± 3.7 weeks 8 weeks post-partumil-6 ↑ in gdm and post-Partum, CORRELATED with Insulin sensitivity and bmibmihassiakos (2015) [74]case-control40 gdm 94 ngt24–28 weeks iadpsg criteria [44]11–14 weekil-6 ↑ in gdm and inversely RELATED to Birth weightmaternal weightleptinkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weeksleptin ↑ across Pregnancy inverse CORRELATION with Insulin sensitivity, BUT non-significant when adjusted for fat massfat massgeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmiqiu (2004) [75]prospective47 gdm 776 ngt26–28 weeks carpenter and coustan criteria [64]13 weeks10-ng/ml ↑ in leptin ASSOCIATED with 20% ↑ gdmparity bmi family history of non-Insulin dependent diabetesadiponectingeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksage ethnicity gravidity parity bmimcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weekadiponectin ↓ gdm and offspringage maternal weightwilliams (2004) [77]nested case-control41 gdm 70 ngt26–28 weeks carpenter and coustan criteria [64]13 week4.6-fold ↑ risk of gdm if adiponectin < 6.4 mcg/ml, overweight women 11-fold ↑ risk of gdmbmilain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksadiponectin < 25th 11-fold ↑ risk gdmbmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or random Glucose ≥ 8.9 mmol/l24–32 weeks↓ adiponectin ASSOCIATED with ↑ Glucose and bmibmi c-peptide Gestation genderlacroix (2013) [79]prospective38 gdm 407 ngt24–28 weeks iadpsg criteria [44]6–13 week↓ adiponectin ASSOCIATED with ↑ risk gdm (or1.12 per 1 µg/ml ↓ of adiponectin) and ASSOCIATED with Insulin sensitivitybmi hba1cianniello (2013) [39]prospective16 gdm 32 ngt24–28 weeks carpenter and coustan criteria [64]all trimesters↓ adiponectin PREDICTIVE of gdm in overweight/obesen/aweerakiet (2006) [80]prospective60 gdm 299 ngt24–28 weeks carpenter and coustan criteria [64]21–27 weekadiponectin 10 µg/ml has sensitivity of 91% and specificity of 31% for gdmbmirbp-4krzyzanovska (2008) [81]nested case-control20 gdm 22 ngt24–28 weeks carpenter and coustan criteria [64]30 weekrbp-4 ↓ in gdmn/ananda (2013) [82]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/aabetew (2013) [84]nested case-control173 gdm 187 ngt24–28 weeks carpenter and coustan criteria [64]16 weeksrbp-4 ↑ in gdm BUT NOT significant after adjustmentmaternal age ethnicityresistinlain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksno differencebmigeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or Random Glucose ≥ 8.9 mmol/l24–32 weeksnot ASSOCIATED with Glucose or Birth weightbmi c-peptide Gestation gendernanda (2012) [85]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/amcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weeksresistin ↓ in gdm and offspringage maternal weightvisfatinkrzyzanovska (2006) [86]nested case-control64 gdm 30 ngt24–28 weeks carpenter and coustan criteria [64]28–30 weeks 38–40 weeks 2 weeks post-Partumvisfatin ↑ in gdmbmiferreira (2011) [87]case-control100 gdm 300 ngt24–28 weeks who criteria 2006 [83]11–13 weekvisfatin ↑ in gdmn/a\nngt = normal Glucose tolerance; igt = impaired Glucose tolerance; fpg = fasting plasma Glucose; homa-ir = homeostasis model assessment for Insulin resistance; matsuda index = measure of Insulin sensitivity; bmi = body mass index; tg = Triglycerides; n/a = not available; ↓ = decreased levels; ↑ = increased levels; adips = australasian diabetes in Pregnancy society; ada = american diabetes association; nddg = national diabetes data group; iadpsg = international association of diabetes and Pregnancy study group; cda = canadian diabetes association; who = world health organisation.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 474), ('SUPERFICIAL_RELATIONSHIP', 689), ('SUPERFICIAL_RELATIONSHIP', 842), ('SUPERFICIAL_RELATIONSHIP', 1457), ('SUPERFICIAL_RELATIONSHIP', 1665), ('SUPERFICIAL_RELATIONSHIP', 1827), ('SUPERFICIAL_RELATIONSHIP', 2027), ('ANOMALY_CURIOUS_FINDING', 2065), ('SUPERFICIAL_RELATIONSHIP', 2387), ('SUPERFICIAL_RELATIONSHIP', 3275), ('SUPERFICIAL_RELATIONSHIP', 3437), ('SUPERFICIAL_RELATIONSHIP', 3506), ('SUPERFICIAL_RELATIONSHIP', 3670), ('ANOMALY_CURIOUS_FINDING', 4255), ('SUPERFICIAL_RELATIONSHIP', 4764)]	16	[('CHEBI_37958', 'dye', 146, 'free'), ('CHEBI_35366', 'fatty acid', 151, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 170, 'triglycerides'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0001986', 'endothelium', 208, 'endothelial'), ('PR_000000034', 'BMP', 655, '-α'), ('PR_000045358', 'insulin family protein', 705, 'insulin'), ('PR_000000034', 'BMP', 819, '-α'), ('GO_0030254', 'protein secretion by the type III secretion system', 1131, 'postpartumTNF'), ('PR_000000034', 'BMP', 1144, '-α'), ('PR_000000134', 'tumor necrosis factor alpha', 1175, 'TNF-α'), ('GO_0007565', 'female pregnancy', 1191, 'postpartum'), ('PR_000000034', 'BMP', 1314, '-α'), ('PR_000000034', 'BMP', 1433, '-α'), ('PR_000045358', 'insulin family protein', 1473, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1636, '-6'), ('GO_0007567', 'parturition', 1657, 'partum'), ('PR_000045358', 'insulin family protein', 1681, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1801, '-6'), ('GO_0007567', 'parturition', 1838, 'birth'), ('GO_0007565', 'female pregnancy', 2009, 'pregnancy'), ('PR_000045358', 'insulin family protein', 2044, 'insulin'), ('PR_000045358', 'insulin family protein', 2445, 'insulin'), ('GO_0007565', 'female pregnancy', 3132, 'pregnant'), ('CHEBI_17234', 'glucose', 3230, 'glucose'), ('CHEBI_17234', 'glucose', 3293, 'glucose'), ('GO_0007565', 'female pregnancy', 3322, 'gestation'), ('PR_000045358', 'insulin family protein', 3522, 'insulin'), ('GO_0007565', 'female pregnancy', 4631, 'pregnant'), ('CHEBI_45267', 'praziquantel', 4722, 'random'), ('CHEBI_17234', 'glucose', 4729, 'glucose'), ('CHEBI_17234', 'glucose', 4780, 'glucose'), ('GO_0007567', 'parturition', 4791, 'birth'), ('GO_0007565', 'female pregnancy', 4817, 'gestation'), ('GO_0030164', 'protein denaturation', 5223, 'partumVisfatin'), ('CHEBI_17234', 'glucose', 5374, 'glucose'), ('CHEBI_17234', 'glucose', 5408, 'glucose'), ('CHEBI_17234', 'glucose', 5448, 'glucose'), ('PR_000045358', 'insulin family protein', 5500, 'insulin'), ('PR_000045358', 'insulin family protein', 5547, 'insulin'), ('CHEBI_17855', 'triglyceride', 5596, 'triglycerides'), ('GO_0007565', 'female pregnancy', 5709, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 5853, 'Pregnancy')]
PMC4600246	10/2015	S14-PMC4600246	['the benefit of Vitamin K on bone IS THOUGHT TO be UNRELATED to increasing bmd BUT RATHER increasing bone strength.19a RECENT meta-analysis HAS SHOWN that vitamin K2(45\u2005mg/day) significantly reduces Hip (77% reduction), vertebral (60% reduction) and all non-vertebral fractures (81% reduction).20whether the results of vitamin K2At a dose of 45\u2005mg CAN be translated to over the counter doses of Vitamin K1(such as 1–5\u2005mg) is STILL a matter of DEBATE, BUT Vitamin K1On its own HAS already BEEN SHOWN to reduce fractures and cancer in a clinical TRIAL, ALTHOUGH more DATA ARE NEEDED TO CONFIRM these benefits.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 347), ('IMPORTANT_CONSIDERATION', 424), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 442), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 450), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 543), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 550), ('FUTURE_WORK', 564), ('INCOMPLETE_EVIDENCE', 583)]	16	[('CHEBI_27300', 'vitamin D', 15, 'vitamin K'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 162, 'K2'), ('UBERON_0001464', 'hip', 198, 'hip'), ('CHEBI_34810', 'Lactitol dihydrate', 326, 'K2at'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 326, 'K2at'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 394, 'vitamin K1'), ('CHEBI_33227', '(E)-cinnamyl alcohol', 454, 'vitamin K1on'), ('PR_000009495', 'keratin, type II cytoskeletal 8', 462, 'K1on')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC4874157	5/2016	S115-PMC4874157	['several other STUDIES SUGGEST that, WHENEVER POSSIBLE, Interferon Β treatment SHOULD BE discontinued prior to Conception.21–28HOWEVER, SIMILAR women in OTHER STUDIES continued to receive treatment modalities throughout Pregnancy.1015–19\ninitially, Vitamin D was given as a supplement to address the paucity women MAY SUFFER from during Pregnancy,29and to attend to the Vitamin D deficiency in the general lebanese population.30more RECENT STUDIES have also SHOWN that maintaining adequate levels of Vitamin D during Pregnancy MIGHT have a PROTECTIVE EFFECT and lower the risk of developing Postpartum relapses.31\npsychological support was CRUCIAL in maintaining the mental well-Being of the mother.32some women exhibited signs of anxiety and depression.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 45), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 313), ('IMPORTANT_CONSIDERATION', 317), ('INCOMPLETE_EVIDENCE', 432), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 550), ('IMPORTANT_CONSIDERATION', 639)]	16	[('CHEBI_76163', 'isoxicam', 55, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 55, 'interferon β'), ('GO_0007620', 'copulation', 110, 'conception'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 590, 'postpartum'), ('GO_0016441', 'posttranscriptional gene silencing', 677, '-being')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
PMC4973215	8/2016	S80-PMC4973215	['ALTHOUGH Cord Blood 25(Oh)D levels do CORRELATE to maternal levels, FACTORS that AFFECT fetal growth MAY not be uniform throughout Pregnancy and this DIFFERENCE in timing COULD AFFECT study FINDINGS.1,3,4,5,6in addition, maternal characteristics such as obesity or pre-eclampsia COULD also AFFECT results that MAY NOT HAVE BEEN SEEN IF Vitamin D samples were obtained during early Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 290), ('INCOMPLETE_EVIDENCE', 310), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 333)]	15	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 22, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 381, 'pregnancy')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5385921	4/2017	S123-PMC5385921	['Rodent MODELS BASED ON transient Prenatal exposure to Vitamin D deficiency have FOUND a range of persistent molecular, neurochemical and behavioural changes of interest to neuropsychiatry.32a number OF STUDIES have LINKED asd with Neuronal Migration.33migration-ASSOCIATED phenotypes such as changes in Neuronal density and volume, aberrant Minicolumns and heterotopias HAVE BEEN detected in patients with asd.34,35as Neuronal Migration starts at 6 weeks Gestation and USUALLY ends around 24 weeks Gestation, the OBSERVED ASSOCIATION between our mid-Gestation samples, which were drawn at ~20 weeks Gestation, and risk of asd CORROBORATES our PREVIOUS FINDINGS LINKING Vitamin D deficiency with abnormal Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 215), ('SUPERFICIAL_RELATIONSHIP', 262), ('INCOMPLETE_EVIDENCE', 370), ('INCOMPLETE_EVIDENCE', 469), ('INCOMPLETE_EVIDENCE', 513), ('SUPERFICIAL_RELATIONSHIP', 522), ('INCOMPLETE_EVIDENCE', 626), ('INCOMPLETE_EVIDENCE', 643), ('SUPERFICIAL_RELATIONSHIP', 661)]	15	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0000540', 'neuron', 231, 'neuronal'), ('GO_0001764', 'neuron migration', 231, 'neuronal migration'), ('CL_0000540', 'neuron', 303, 'neuronal'), ('UBERON_0016512', 'lumen of duodenum', 341, 'minicolumns'), ('CL_0000540', 'neuron', 418, 'neuronal'), ('GO_0001764', 'neuron migration', 418, 'neuronal migration'), ('GO_0007565', 'female pregnancy', 455, 'gestation'), ('GO_0007565', 'female pregnancy', 498, 'gestation'), ('GO_0007565', 'female pregnancy', 550, 'gestation'), ('GO_0007565', 'female pregnancy', 599, 'gestation'), ('CHEBI_27300', 'vitamin D', 669, 'vitamin D'), ('GO_0007420', 'brain development', 704, 'brain development'), ('UBERON_0000955', 'brain', 704, 'brain')]
PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3659910	1/2013	S141-PMC3659910	['Vitamin D-deficiency in mothers have significantly INCREASED RISK of infantile rickets DUE TO INADEQUATE Maternal–fetal transfer of 25-Hydroxyvitamin D.[32] RECENT retrospective STUDIES FOUND a significant and PREVIOUSLY UNDETECTED ASSOCIATION of maternal Vitamin D deficiency with rickets-ASSOCIATED infant Heart Failure and with acute Lower Respiratory Tract infection,[33] a SERIOUS COMPLICATION OFTEN ASSOCIATED with sepsis without clinical signs of rickets.']	[('IMPORTANT_CONSIDERATION', 51), ('PROBABLE_UNDERSTANDING', 87), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 221), ('SUPERFICIAL_RELATIONSHIP', 232), ('SUPERFICIAL_RELATIONSHIP', 290), ('IMPORTANT_CONSIDERATION', 378), ('IMPORTANT_CONSIDERATION', 386), ('PROBABLE_UNDERSTANDING', 399), ('SUPERFICIAL_RELATIONSHIP', 405)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007618', 'mating', 105, 'maternal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0002081', 'cardiac atrium', 308, 'heart failure'), ('UBERON_0004905', 'articulation', 337, 'lower respiratory tract')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5659607	10/2017	S21-PMC5659607	['a recent meta-analysis SUGGESTED that INSUFFICIENT power DUE TO an OVERESTIMATION of the treatment effect MAY HAVE BEEN one of the ISSUES for the non-significance of the FINDINGS[11], BUT we HYPOTHESIZED that maternal 25(Oh)D level at trial entry MAY also have INFLUENCED the EFFECT of the Vitamin D supplementation[12].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 38), ('PROBLEM_COMPLICATION', 57), ('PROBLEM_COMPLICATION', 67), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 131), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 276)]	14	[('CHEBI_71657', 'versiconol acetate', 218, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 224, 'D'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC2889879	5/2010	S146-PMC2889879	['our results of the PROTECTIVE EFFECT of fatty fish COULD IN PART be due to the content of Vitamin D. WHILE the epidemiological EVIDENCE LINKING low Prenatal Vitamin D and schizophrenia REMAINS INCONCLUSIVE, Rodent MODELS have provided COMPELLING EVIDENCE about the ROLE of Vitamin D deficiency for Brain Development like larger lateral volumes [36], subtle Memory dysfunction and altered attention processing [37] which have IMPLICATIONS for neuropsychiatric disorders.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 235), ('SUPERFICIAL_RELATIONSHIP', 265), ('IMPORTANT_CONSIDERATION', 425)]	13	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'prenatal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 207, 'rodent'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('GO_0007420', 'brain development', 298, 'brain development'), ('UBERON_0000955', 'brain', 298, 'brain'), ('GO_0007613', 'memory', 357, 'memory')]
PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
PMC3717170	5/2013	S18-PMC3717170	['IN ORDER TO DETERMINE mechanisms INVOLVED in inhibition of Breast tumor growth, christakos’ lab SHOWED that C/Ebpα, a transcription factor that HAS BEEN SHOWN to play a CRITICAL ROLE in growth arrest of other cell types, is induced by 1,25(Oh)2D3In mcf-7 Human Breast cancer cells.2c/Ebpα was found to induce transcription of the Vitamin D receptor in mcf-7 cells.2since the levels of the vdr CORRELATE with the antiproliferative effects of 1,25(Oh)2D3, and since it HAS BEEN SUGGESTED that C/Ebpα CAN be considered a POTENTIAL tumor suppressor, these FINDINGS SUGGEST mechanisms whereby 1,25(Oh)2D3May act to inhibit Growth Of Breast cancer Cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 169), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 393), ('INCOMPLETE_EVIDENCE', 467), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 552), ('INCOMPLETE_EVIDENCE', 561)]	13	[('UBERON_0000310', 'breast', 59, 'breast'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 108, 'C/EBPα'), ('CHEBI_37958', 'dye', 235, '1,'), ('CHEBI_45409', 'ritonavir', 237, '25(OH)2D3in'), ('NCBITaxon_9606', 'Homo sapiens', 255, 'human'), ('UBERON_0000310', 'breast', 261, 'breast'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 284, 'EBPα'), ('CHEBI_27300', 'vitamin D', 330, 'vitamin D'), ('CHEBI_37983', 'sulfur-35 atom', 441, '1'), ('CHEBI_17996', 'chloride', 442, ','), ('CHEBI_73394', 'Ala-Ser', 443, '25(OH)2D3'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 491, 'C/EBPα'), ('CHEBI_37958', 'dye', 588, '1,'), ('CHEBI_83462', 'metolachlor OXA', 590, '25(OH)2D3may'), ('GO_0048468', 'cell development', 618, 'growth of ... cells'), ('UBERON_0000310', 'breast', 628, 'breast')]
PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4684854	12/2015	S57-PMC4684854	['LIMITATIONS of Vitamin D research as RELATED to Gestational outcomes\nALTHOUGH maternal-fetal outcomes in the presence of adequate Gestational Vitamin D are GENERALLY favorable as REPORTED in the medical literature, SOME reports HAVE BEEN INCONSISTENT and CAST DOUBT on the LINK between Gestational Vitamin D sufficiency and health.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 156), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 273)]	13	[('CHEBI_28384', 'vitamin K', 15, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'Gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 286, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4949006	7/2016	S136-PMC4949006	['Vitamin B6Supplementation HAS BEEN shown in 3 SMALL STUDIES to give a modest gain in Birth weight.99Vitamin C supplementation has not been shown to be of value in improving Pregnancy outcomes,99but HAS SHOWN value for PREVENTION of wheezing and asthma in the children of smokers.100\n\nVitamin E\nONE STUDY CORRELATED risk of wheeze inversely to the level of Vitamin E as well as a linear RELATIONSHIP between the level and the forced Expiratory volume at 1 minute.101NO OTHER STUDIES APPEAR to support OR REFUTE this.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 294), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 468), ('ANOMALY_CURIOUS_FINDING', 482), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 503)]	13	[('CHEBI_10122', 'Zizyphine F', 0, 'Vitamin B6supplementation'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin B6supplementation'), ('GO_0007567', 'parturition', 85, 'birth'), ('CHEBI_65430', 'ardisiphenol A', 98, '99Vitamin C'), ('PR_000004900', 'complement C3', 108, 'C'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 284, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin E'), ('GO_0010467', 'gene expression', 432, 'expiratory')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC5045784	10/2016	S74-PMC5045784	['fetal and newborn concentrations of 25(Oh)D DEPEND ON and CORRELATE with maternal Serum levels AS the fetus has no endogenous production of 25(Oh)d and DEPENDS on transplacental transfer.28THIS occurs MAINLY in the third trimester and THEREFORE, as we and others PREVIOUSLY REPORTED, preterm infants are at INCREASED RISK of Vitamin D deficiency.10,29our PRIOR STUDY DEMONSTRATED that Birth before 32 completed weeks of Gestation is an INDEPENDENT RISK FACTOR for low 25(Oh)d levels at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 235), ('INCOMPLETE_EVIDENCE', 263), ('IMPORTANT_CONSIDERATION', 307), ('INCOMPLETE_EVIDENCE', 355), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 436), ('SUPERFICIAL_RELATIONSHIP', 448)]	13	[('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_63056', 'zinc cation', 140, '25(OH'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('GO_0007567', 'parturition', 385, 'birth'), ('GO_0007565', 'female pregnancy', 420, 'gestation'), ('CHEBI_30778', 'gallic acid', 468, '25(OH)'), ('GO_0007567', 'parturition', 486, 'birth')]
PMC5129897	10/2016	S118-PMC5129897	["“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment."]	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
PMC5474873	6/2017	S145-PMC5474873	['the CONFLICTING FINDING of the PRESENT STUDY COULD POSSIBLY BE ATTRIBUTED to any of the following: (1) DIFFERENT measures were used as PROXIES for Vitamin D—the present study ONLY CONSIDERED the sun exposure variables (and not diet) as a main source for Vitamin D levels (9,13,14); (2) the FOCUS of the PRESENT STUDY was detailed assessment of the entire distribution of the cape scale WHEREAS hedelin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 290), ('QUESTION_ANSWERED_BY_THIS_WORK', 303), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386)]	13	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC2821652	2/2010	S77-PMC2821652	["in developing a definition of adherence by Serum 25(Oh)D levels, SEVERAL ASSUMPTIONS were made a priori about WHAT types of PATTERNS of 25(Oh)D levels would be exhibited by adherent and nonadherent patients BASED ON CURRENT KNOWLEDGE about the Metabolism Of Vitamin D.\nassumption 1\nBASED ON KNOWN pharmacokinetics of Vitamin D [64], adherent patients' 25(Oh)D levels would be expected to rise over time, eventually reaching a steady state after 2 months of therapy; nonadherent patients' 25(Oh)D levels would be expected to be erratic and to exhibit variable PATTERNS that would differ significantly from adherent patients' 25(Oh)D levels over the same dosing interval."]	[('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('EXPLICIT_QUESTION', 110), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 207), ('PROBABLE_UNDERSTANDING', 207), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 216), ('PROBABLE_UNDERSTANDING', 282), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 559)]	12	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 244, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 317, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 325, 'D'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 358, 'D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 488, '25'), ('PR_000011614', 'opioid growth factor receptor', 491, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 494, 'D'), ('CHEBI_71657', 'versiconol acetate', 624, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 624, '25(OH ... D')]
PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]
PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
PMC3695234	7/2013	S17-PMC3695234	['ANOTHER STUDY REPORTED regional DIFFERENCES in the number of prescriptions of epipens within the united states; the highest rates were FOUND in new england, and the lowest in the southern states.2THESE results MAY provide IMPORTANT etiologic CLUES and INDICATE the POTENTIAL ROLE of Vitamin D in atopic disease susceptibility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 135), ('PROBABLE_UNDERSTANDING', 195), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 210), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 275)]	12	[('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]
PMC3814422	10/2013	S47-PMC3814422	['potential confounders and mediators\nwe considered the following as POTENTIAL CONFOUNDERS BECAUSE of their KNOWN or POTENTIAL PLAUSIBLE ASSOCIATION with both maternal concentrations of Vitamin D and with childhood atopic and Lung function outcomes21,22: maternal FACTORS during Pregnancy [smoking, infections, anxiety score, Antibiotic use, Paracetamol use, body mass index (bmi) and Alcohol intake], OTHER maternal factors (educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine) and Postnatal FACTORS that MAY reflect a background socio-economic CONFOUNDING pathway originating prior to Birth (breastfeeding, day care, pets, exposure to damp/mould in home, environmental tobacco smoke exposure and number of younger siblings).']	[('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('PROBLEM_COMPLICATION', 89), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 135), ('SUPERFICIAL_RELATIONSHIP', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 400), ('SUPERFICIAL_RELATIONSHIP', 579), ('INCOMPLETE_EVIDENCE', 592), ('PROBLEM_COMPLICATION', 632)]	12	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0002048', 'lung', 224, 'lung'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 324, 'antibiotic'), ('CHEBI_46195', 'paracetamol', 340, 'paracetamol'), ('CHEBI_30879', 'alcohol', 383, 'alcohol'), ('GO_0007567', 'parturition', 569, 'postnatal'), ('GO_0007567', 'parturition', 673, 'birth')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4689556	12/2015	S151-PMC4689556	['the FINDINGS from our trial, the FIRST Prenatal Vitamin D intervention trial to report child health outcomes, SUGGEST that either the dosing regimen used in this study was INADEQUATE, OR that the RELATIONSHIP between Cord Blood 25(Oh) Vitamin D and child health SEEN in OBSERVATIONAL studies MAY BE RELATED to hidden CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 172), ('PROBLEM_COMPLICATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 196), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBLEM_COMPLICATION', 317)]	12	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0009472', 'axilla', 217, 'cord blood'), ('CHEBI_30778', 'gallic acid', 228, '25(OH)'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4770602	1/2016	S75-PMC4770602	['[22] IN CONTRAST WITH our results OTHER study SHOWED that low Birth weight is NOTED in infants of mothers supplemented with Vitamin D.\nwe THINKS that some POSSIBLE LIMITATIONS of the present study that SHOULD BE addressed and noted in FUTURE STUDIES are included; unmeasured sun exposure, maternal baseline 25-Oh-D and Preconception, physical activity, local area and early Pregnancy dietary Intake to HELP realize the EFFECT of these FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 202), ('FUTURE_WORK', 235), ('FUTURE_WORK', 402), ('SUPERFICIAL_RELATIONSHIP', 419), ('SUPERFICIAL_RELATIONSHIP', 435)]	12	[('GO_0007567', 'parturition', 62, 'birth'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 307, '25-OH-D'), ('PR_000000164', 'BMP2', 309, '-OH'), ('PR_000006444', 'diacylglycerol kinase delta', 313, 'D'), ('GO_0007565', 'female pregnancy', 319, 'preconception'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy'), ('GO_0007631', 'feeding behavior', 392, 'intake')]
PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]
PMC4832516	10/2015	S139-PMC4832516	['WHILE the ASSOCIATIONS between season of Birth, or ESTIMATED Antenatal sunshine exposure, with Birth weight are CONSISTENT with experimental EFFECTS of in utero Vitamin D exposure on fetal growth, differing patterns of seasonality and INDEPENDENT ASSOCIATIONS SUGGEST that OTHER mechanisms MAY LINK season of Birth to Adult height and also puberty timing in women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 247), ('INCOMPLETE_EVIDENCE', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 290), ('SUPERFICIAL_RELATIONSHIP', 294)]	12	[('GO_0007567', 'parturition', 41, 'birth'), ('GO_0007567', 'parturition', 61, 'antenatal'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007567', 'parturition', 309, 'birth'), ('UBERON_0007023', 'adult organism', 318, 'adult')]
PMC4989298	8/2016	S375-PMC4989298	['conclusions\nALTHOUGH the AVAILABLE literature data SUGGEST the existence of a RELATIONSHIP between latitude and its consequent degree of ultraviolet radiation exposure, Vitamin D levels and the prevalence and severity of allergic diseases, the data of OBSERVATIONAL studies are encouraging, BUT CONTROVERSIAL and the ONLY available rct FAILS to SHOW an EFFECT on allergic disease prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 252), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 317), ('PROBLEM_COMPLICATION', 336), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 353)]	12	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]
PMC5405075	4/2017	S5-PMC5405075	['ALTHOUGH, the results of rcts SHOWED a POTENTIAL ASSOCIATION with asthma-RELATED phenotypes RATHER than asthma per se , the low toxicity of Vitamin D supplements make it TEMPTING to SPECULATE that Pregnant women at a high RISK of obtaining a child with asthma MAY BE benefited, ESPECIALLY if they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 260), ('ANOMALY_CURIOUS_FINDING', 278)]	12	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnant'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S106-PMC2963768	['HOWEVER, these age-DEPENDENT DIFFERENCES MAY HAVE BEEN CONFOUNDED by seasonal timing of Gestation—a younger age IMPLIED that the third trimester COINCIDED with the expected seasonal nadir of Vitamin D Synthesis, when maternal Vitamin D stores MIGHT be relatively depleted and, THUS, when transfer of Vitamin D Metabolites to the foetus MAY have been minimized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 45), ('DIFFICULT_TASK', 55), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 277), ('INCOMPLETE_EVIDENCE', 336)]	11	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('CHEBI_25212', 'metabolite', 310, 'metabolites')]
PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3277098	12/2011	S184-PMC3277098	['this data has the advantage of focussing on the Early Life Period and MAY THEREFORE provide INSIGHT into the aetiological ROLE of Vitamin D. DESPITE the OBSERVED PROTECTIVE ASSOCIATION of Serum 25(Oh)D and allergy, it has been NOTED that the widespread practice of supplementation COINCIDED with the rise in allergic disease [35].']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('ANOMALY_CURIOUS_FINDING', 141), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 281)]	11	[('UBERON_0019248', 'early embryo', 48, 'early life period'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D')]
PMC3319623	4/2012	S63-PMC3319623	['SIMILAR mechanisms MAY apply to bad and rdd, BUT the EVIDENCE for Vitamin D in these disorders is much LESS STRONG and OTHER FACTORS such as maternal infections and fluctuations in diet MAY also play an IMPORTANT ROLE.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 203), ('SUPERFICIAL_RELATIONSHIP', 213)]	11	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]
PMC3427192	4/2012	S18-PMC3427192	['1,25(Oh)2D3, also referred to as Calcitriol, is then transported throughout the body via the Blood to various cells types that Express vdrs, where Gene Expression is induced.24,39BECAUSE the MAJORITY of Vitamin D Metabolism occurs in this skin, several FACTORS ARE THOUGHT TO INFLUENCE Vitamin D skin Metabolism, including age, body fat, the level of skin Melanin, and OTHER variables such as latitude, the amount and degree of sun exposure, and use of sunscreen products with uv protection.40these FACTORS HAVE BEEN PREVIOUSLY ASSOCIATED with Vitamin D deficiency in epidemiologic studies.41-43\n\ncaption (fig): figure 2.']	[('PROBABLE_UNDERSTANDING', 177), ('PROBABLE_UNDERSTANDING', 191), ('SUPERFICIAL_RELATIONSHIP', 253), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 276), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('SUPERFICIAL_RELATIONSHIP', 499), ('INCOMPLETE_EVIDENCE', 507), ('INCOMPLETE_EVIDENCE', 517), ('SUPERFICIAL_RELATIONSHIP', 528)]	11	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_73394', 'Ala-Ser', 2, '25(OH)2D3'), ('CHEBI_17823', 'calcitriol', 33, 'calcitriol'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0010467', 'gene expression', 127, 'express'), ('GO_0010467', 'gene expression', 147, 'gene expression'), ('SO_0000704', 'gene', 147, 'gene'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 203, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 301, 'metabolism'), ('CHEBI_25179', 'melanins', 356, 'melanin'), ('CHEBI_27300', 'vitamin D', 544, 'vitamin D')]
PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
PMC3470091	9/2012	S19-PMC3470091	['such a RELATION HAS BEEN ATTRIBUTED to special receptors for Vitamin D in Pancreatic Betacells.9moreover, Vitamin D WAS SHOWN to have positive EFFECTS on Insulin sensitivity, and its deficiency to have negative EFFECTS on the function of Betacells.11IN AGREEMENT with this, cohort studies REVEALED that Vitamin D had a PROTECTIVE EFFECT against diabetes type Ii.8,11also, Serum concentration of Vitamin D during 24-29thweek of Pregnancy in women suffering from Gestational diabetes mellitus (gdm) was lower than that in women without the disease.12\nthe study of Vitamin D status and improving it in the Lactating mothers with previous gdm is of CONSPICUOUS VALUE.4,13\ndue to the limited exposure to sunshine and inadequate Intake, the level of Vitamin D is reduced in the milk of Lactating mothers.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 319), ('SUPERFICIAL_RELATIONSHIP', 330), ('IMPORTANT_CONSIDERATION', 645)]	11	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000169', 'type B pancreatic cell', 74, 'pancreatic betacells'), ('UBERON_0001264', 'pancreas', 74, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000045358', 'insulin family protein', 154, 'insulin'), ('CL_0000365', 'animal zygote', 238, 'betacells'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CL_0002212', 'type II muscle cell', 359, 'II'), ('UBERON_0001977', 'blood serum', 372, 'serum'), ('CHEBI_27300', 'vitamin D', 395, 'vitamin D'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'gestational'), ('CHEBI_27300', 'vitamin D', 562, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 603, 'lactating'), ('GO_0007631', 'feeding behavior', 723, 'intake'), ('CHEBI_27300', 'vitamin D', 744, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 780, 'lactating')]
PMC3613945	2/2013	S184-PMC3613945	['ecological studies INDICATE that Vitamin D deficiency is ASSOCIATED with asthma and asthma RELATED phenotypes101–105, BUT SOME STUDIES CONTRADICT these FINDINGS reporting a positive ASSOCIATION106,107, WHEREAS others SHOW no association108.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 217)]	11	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S94-PMC3702245	['BASED ON BIOMARKERS AFFECTED by Vitamin D status, and FINDINGS from observational studies and recent randomized trials, FUTURE STUDIES SHOULD include trial arms to achieve Serum 25(Oh)D concentrations that HAVE BEEN ASSOCIATED with POTENTIAL Extraskeletal benefits8,82,84,94–96of Vitamin D to understand BETTER both the benefits and risks of Vitamin D supplementation to mother and offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 54), ('FUTURE_WORK', 120), ('FUTURE_WORK', 135), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 304)]	11	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D')]
PMC3717170	5/2013	S136-PMC3717170	['in Humans, the ROLE of Vitamin D in type 2 diabetes is SUGGESTED by a large NUMBER OF cross-sectional STUDIES that have CONSISTENTLY FOUND an inverse ASSOCIATION between Vitamin D status and prevalent hyperglycemia, including a REPORTED seasonal variation in the Control Of Glycemia in patients with diabetes, being worse in the winter when hypovitaminosis d is more prevalent.35in the MAJORITY of longitudinal OBSERVATIONAL studies, lower Vitamin D status is also ASSOCIATED with INCREASED RISK of incident type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 228), ('PROBABLE_UNDERSTANDING', 386), ('INCOMPLETE_EVIDENCE', 411), ('SUPERFICIAL_RELATIONSHIP', 465), ('IMPORTANT_CONSIDERATION', 481)]	11	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0006936', 'muscle contraction', 263, 'control of glycemia'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D')]
PMC3760821	9/2013	S28-PMC3760821	['this APPARENT rise in 1,25(Oh)2D has LED TO the SUGGESTION that Pregnant women MAY REQUIRE higher cellular exposure to active Vitamin D during the second and third trimesters, and HAS BEEN interpreted by SOME as PROVIDING EVIDENCE for its POTENTIAL ROLE in obstetric well-Being[8].']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 249)]	11	[('CHEBI_17996', 'chloride', 23, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 24, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 271, '-being')]
PMC3760821	9/2013	S39-PMC3760821	['WHILE it HAS BEEN SPECULATED that Vitamin D deficiency MAY BE causal in the development of adiposity and, POTENTIALLY, its co-morbidities, a RECENT STUDY using Genetic Markers AS instrumental VARIABLES in bi-directional mendelian randomization analysis has PROVIDED EVIDENCE that a higher bmi leads to lower 25ohd and that the LIKELIHOOD of lower 25ohd increasing bmi is small[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 176), ('SUPERFICIAL_RELATIONSHIP', 192), ('PROBABLE_UNDERSTANDING', 257), ('INCOMPLETE_EVIDENCE', 266), ('PROBABLE_UNDERSTANDING', 327)]	11	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0001645', 'genetic_marker', 160, 'genetic markers')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
PMC4113768	7/2014	S1038-PMC4113768	['these data SUGGEST that the RELATED EFFECTS are strong and CONSISTENT across DIFFERENT types of infections, HIGHLIGHTING THE NEED to PREVENT Vitamin D deficiency in Pregnant mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('FUTURE_WORK', 125), ('SUPERFICIAL_RELATIONSHIP', 133)]	11	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnant')]
PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4466139	6/2015	S119-PMC4466139	['it is THEREFORE IMPORTANT to correct the deficiency in utero with higher doses in those AT RISK of SERIOUS deficiency and to closely follow these infants re the early detection of diseases RELATED to lack of Vitamin D.\nknowledge of a generalized Vitamin D deficiency and of RELATED RISK FACTORS MAY LEAD TO IMPROVING education and to more effective PUBLIC HEALTH initiatives.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 99), ('SUPERFICIAL_RELATIONSHIP', 189), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 299), ('FUTURE_WORK', 307), ('IMPORTANT_CONSIDERATION', 349)]	11	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]
PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
PMC4595656	10/2015	S10-PMC4595656	['HOWEVER in RECENT YEARS, myriad OTHER functions and ROLES for Vitamin D HAVE BEEN gradually POSTULATED and VERIFIED, and its pleiotropic EFFECTS are now BEYOND DISPUTE (kalueff and tuohimaa,2007; mccann and ames,2008; lai and fang,2013; schlogl and holick,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 137), ('IMPORTANT_CONSIDERATION', 153), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]
PMC4770602	1/2016	S23-PMC4770602	['[518]\nbased ON the ROLE of maternal Vitamin D deficiency, AS a POTENTIAL in DEPENDENT RISK FACTOR for Preeclampsia, Vitamin D supplementation in early Pregnancy REMAINS a POSSIBLE intervention and POSSIBLE improved Pregnancy outcomes through PREVENTION or delay of Preeclampsia.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 242)]	11	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 265, 'preeclampsia')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4897157	5/2016	S13-PMC4897157	['among such FACTORS, there is GROWING RECOGNITION of the INFLUENCE of sunlight exposure and Vitamin D. since its immunomodulatory EFFECT was FIRST CONFIRMED, Vitamin D has emerged as a variable of interest in the pathogenesis of Allergic diseases; accordingly, there is also interest in sunlight exposure because of its ASSOCIATION with the generation of vitamin D. SEVERAL STUDIES HAVE SHOWN that Vitamin D has an EFFECT on the pathogenesis of allergic diseases56).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 365), ('INCOMPLETE_EVIDENCE', 381), ('SUPERFICIAL_RELATIONSHIP', 414)]	11	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0040011', 'locomotion', 228, 'allergic'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 362, 'D'), ('CHEBI_27300', 'vitamin D', 397, 'vitamin D')]
PMC4973215	8/2016	S10-PMC4973215	['THUS, levels of neonates at Birth depend entirely on that of the mother and, ACCORDINGLY, SEVERAL STUDIES have CONSISTENTLY CORRELATED Cord Blood 25(Oh)D levels to those of their mothers.1,2,3,4,5,6in addition, maternal Vitamin D deficiency HAS BEEN LINKED to decreased fetal growth and Birth size in OBSERVATIONAL studies.7,8,9\nmaternal Vitamin D deficiency is PREVALENT, the extent of which CAN be INFLUENCED by many variables including skin pigmentation, sun exposure, season, age, Vitamin supplementation and obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 301), ('IMPORTANT_CONSIDERATION', 362), ('INCOMPLETE_EVIDENCE', 393), ('SUPERFICIAL_RELATIONSHIP', 400)]	11	[('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007567', 'parturition', 287, 'birth'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 485, 'vitamin')]
PMC5028238	10/2016	S202-PMC5028238	['studies involving moderate Prenatal Vitamin D supplementation HAVE REPORTED no adverse EFFECTS.89THEREFORE, we would not expect Vitamin D to result in slos-RELATED Teratogenic EFFECTS, ALTHOUGH ADDITIONAL STUDIES would BE NEEDED to ascertain the EFFECTS of large doses of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 87), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 156), ('SUPERFICIAL_RELATIONSHIP', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('FUTURE_WORK', 194), ('FUTURE_WORK', 205), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 246)]	11	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_50905', 'teratogenic agent', 164, 'teratogenic'), ('GO_0007565', 'female pregnancy', 272, 'prenatal'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D')]
PMC5035678	4/2016	S132-PMC5035678	['they FOUND that high dose supplementation for a mean of 14 weeks during Pregnancy was not beneficial to the patients’ plasma Glucose level or Insulin resistance during Pregnancy, BUT that their babies BENEFITTED from the supplementation with decreased neonatal hypovitaminosis D. the authors CONCLUDED that the commencement of Vitamin D supplementation MAY HAVE been too late to cause any observable EFFECTS on Β-Cell function, and they SUGGESTED that earlier supplementation, EVEN before Pregnancy, MIGHT be EFFECTIVE.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('IMPORTANT_CONSIDERATION', 201), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 353), ('IMPORTANT_CONSIDERATION', 357), ('SUPERFICIAL_RELATIONSHIP', 400), ('INCOMPLETE_EVIDENCE', 437), ('ANOMALY_CURIOUS_FINDING', 477), ('INCOMPLETE_EVIDENCE', 500), ('SUPERFICIAL_RELATIONSHIP', 509)]	11	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_17234', 'glucose', 125, 'glucose'), ('PR_000045358', 'insulin family protein', 142, 'insulin'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CL_0000623', 'natural killer cell', 411, 'β-cell'), ('GO_0007565', 'female pregnancy', 489, 'pregnancy')]
PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5045784	10/2016	S86-PMC5045784	['mccarthy et al.29REPORTED that in a cohort of 274 preterm infants (<32 weeks) in ireland, levels of 25(Oh)D REMAINED under 20\u2009ng\u2009ml−1in 78% of subjects DESPITE 18 days on average of enteral Feeding and Vitamin D supplementation.29a RECENT intervention TRIAL by fort et al.17DEMONSTRATED that biochemical Vitamin D deficiency among EXTREMELY preterm infants CAN be reduced by additional supplementation with 200 units of Vitamin D daily, and PREVENTED by additional supplementation with 800 units of Vitamin D daily17and these two regimens were FOUND TO BE SAFE.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 232), ('PROBABLE_UNDERSTANDING', 272), ('PROBABLE_UNDERSTANDING', 272), ('IMPORTANT_CONSIDERATION', 331), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 441), ('ANOMALY_CURIOUS_FINDING', 544), ('IMPORTANT_CONSIDERATION', 556)]	11	[('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 106, 'D'), ('GO_0007631', 'feeding behavior', 190, 'feeding'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC5051327	9/2016	S54-PMC5051327	['IN FACT, the ONLY study PREVIOUSLY addressing THIS topic was performed in southern china, where Vitamin D deficiency is relatively UNCOMMON and no RELATION to Birth asphyxia was FOUND.19two randomised controlled studies of Antenatal Vitamin D supplementation REPORTED lower apgar score at 1 and 5\u2005min, respectively.2021in addition, in the latter study REPORTED, 13% of Vitamin D deficient newborn had apgar score at 5\u2005min <7, as compared TO 1.1% among those who were sufficient.21our observational study design disables us from investigating a causal RELATION between Vitamin D levels and fetal distress/Birth asphyxia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 259), ('INCOMPLETE_EVIDENCE', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 438), ('SUPERFICIAL_RELATIONSHIP', 551)]	11	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 159, 'birth'), ('GO_0007567', 'parturition', 223, 'antenatal'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('GO_0007567', 'parturition', 604, 'birth')]
PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5129897	10/2016	S187-PMC5129897	['the institute FOUND no EVIDENCE of adverse health EFFECTS for the general population for intakes as high as 10,000 iu/d.96given the latitudes of canada, sun exposure is a good source of Vitamin D primarily in the summer and then best near solar noon.97\nmore than12 million canadians do not meet the minimum Vitamin D GUIDELINES of 50\xa0nmol/l put forth by health canada.98sun exposure HAS BEEN RECOGNIZED AS a KEY FACTOR INFLUENCING Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 317), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 383), ('PROBABLE_UNDERSTANDING', 392), ('PROBABLE_UNDERSTANDING', 403), ('IMPORTANT_CONSIDERATION', 408), ('SUPERFICIAL_RELATIONSHIP', 412), ('SUPERFICIAL_RELATIONSHIP', 419)]	11	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 307, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC5318550	2/2017	S21-PMC5318550	['the MAJORITY of studies focused on maternal influenza as the primary cause for a higher prevalence of schizophrenia ASSOCIATED with certain Birth months.3poor Prenatal nutrition HAS BEEN PROPOSED to be RELATED to the Birth seasonality of Individuals who develop schizophrenia.4\nadverse Birth outcomes are RISK FACTORS for impaired Cognitive Development.56PREVIOUS STUDIES have repeatedly described RELATIONSHIPS between season of Birth and Birth weight, and duration of Gestation.7\nRECENTLY, a strong INTEREST in the EFFECTS of Vitamin D on development of the Brain emerged.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 398), ('INCOMPLETE_EVIDENCE', 482), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 517)]	11	[('GO_0007567', 'parturition', 140, 'birth'), ('GO_0007565', 'female pregnancy', 159, 'prenatal'), ('GO_0007567', 'parturition', 217, 'birth'), ('NCBITaxon_1', 'root', 238, 'individuals'), ('GO_0007567', 'parturition', 286, 'birth'), ('GO_0050787', 'detoxification of mercury ion', 331, 'cognitive development'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007567', 'parturition', 440, 'birth'), ('GO_0007565', 'female pregnancy', 470, 'gestation'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('UBERON_0000955', 'brain', 560, 'brain')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]
PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
PMC2889879	5/2010	S191-PMC2889879	['MISCLASSIFICATION of fish and Pufa or Vitamin D Intake due to measurement ERROR ASSOCIATED with the Food frequency questionnaire is UNAVOIDABLE, BUT GIVEN the study design LIKELY non-differential, and THUS attenuating any TRUE ASSOCIATION.']	[('PROBLEM_COMPLICATION', 0), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 222), ('SUPERFICIAL_RELATIONSHIP', 227)]	10	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 30, 'PUFA'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_33290', 'food', 100, 'food')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3004407	12/2010	S159-PMC3004407	["TAKING INTO account Vitamin D's EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70]."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
PMC3075531	7/2010	S40-PMC3075531	['discussion\nwe FOUND the same results as studies in europe and north america, which IMPLICATES lower Serum Vitamin D level in ms patients than in normal population, IN SPITE of sufficient sun exposure in isfahan region.23815the HYPOTHESIS that Vitamin D deficiency is a RISK FACTOR for ms was first PROPOSED over 30 years ago4and GAINED CREDIBILITY after the discovery of the immunomodulatory EFFECTS of Vitamin D.5moreover, in the past few years, the epidemiological EVIDENCE of an increased ms risk among Individuals with low Vitamin D concentrations has ACHIEVED SUBSTANTIAL STRENGTH.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 83), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 298), ('PROBABLE_UNDERSTANDING', 329), ('SUPERFICIAL_RELATIONSHIP', 392), ('INCOMPLETE_EVIDENCE', 467), ('PROBABLE_UNDERSTANDING', 556)]	10	[('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 403, 'vitamin D'), ('NCBITaxon_1', 'root', 506, 'individuals'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D')]
PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]
PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]
PMC3515553	12/2012	S169-PMC3515553	['the differences in CONFOUNDERS between sample subsets and the overall alspac sample are UNLIKELY to AFFECT the ASSOCIATION between genotypes and Cord Blood Vitamin B-12 or genotypes and iq because, as EXPECTED, there was no association between genotypes and POTENTIAL CONFOUNDERS, OTHER than what MAY have arisen by chance DUE TO performing a large number of tests on the data.']	[('PROBLEM_COMPLICATION', 19), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('PROBLEM_COMPLICATION', 268), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('INCOMPLETE_EVIDENCE', 297), ('PROBLEM_COMPLICATION', 323)]	10	[('UBERON_0002240', 'spinal cord', 145, 'cord'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 156, 'vitamin B-12')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3613945	2/2013	S227-PMC3613945	['explored PREVIOUS epidemiological EVIDENCE SUGGESTING a reduced risk ASSOCIATED with Vitamin D. NO EVIDENCE for ASSOCIATION between dbp genotype and risk of Colorectal cancer was FOUND, ALTHOUGH ASSOCIATIONS between dbp Snps and microsatellite-unstable Colorectal cancer were REPORTED168.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 276)]	10	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0012652', 'colorectum', 157, 'colorectal'), ('SO_0000694', 'SNP', 220, 'SNPs'), ('UBERON_0012652', 'colorectum', 253, 'colorectal')]
PMC3659910	1/2013	S65-PMC3659910	['methods are CURRENTLY available to quantify the CONTRIBUTION of Endogenous Vitamin D Synthesis resulting from sun exposure, BUT SERIOUS LIMITATIONS REMAIN in ACCURATELY ESTIMATING dietary Vitamin D intake BECAUSE of the INCOMPLETENESS of Nutrient databases for both Vitamin D-fortified Food and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 124), ('IMPORTANT_CONSIDERATION', 128), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 205), ('INCOMPLETE_EVIDENCE', 220)]	10	[('GO_0009790', 'embryo development', 64, 'endogenous'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 75, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33284', 'nutrient', 238, 'nutrient'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
PMC3702245	6/2013	S26-PMC3702245	['from Animal studies and SOME Human data, it is SUGGESTED that mineralization of the Fetal Skeleton is independent of Vitamin D and, THEREFORE, maternal Vitamin D deficiency has little EFFECT on fetal Skeletal Development.59IN CONTRAST, SOME recent OBSERVATIONAL STUDIES SUGGEST that Vitamin D nutrition during Pregnancy MAY AFFECT fetal Bone Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 324)]	10	[('NCBITaxon_33208', 'Metazoa', 5, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 29, 'human'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0004288', 'skeleton', 90, 'skeleton'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0001501', 'skeletal system development', 200, 'skeletal development'), ('UBERON_0004288', 'skeleton', 200, 'skeletal'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0048539', 'bone marrow development', 337, 'bone development')]
PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]
PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]
PMC3717170	5/2013	S10-PMC3717170	['WHILE it was LONG HELD that Vitamin D ACTED only at the Intestine, Kidney, and Skeleton, and that its function was LIMITED to calcium Homeostasis, the POSSIBILITY of Extraskeletal EFFECTS HAS BEEN CONSIDERED for decades AS a result of the discovery of the vdr in Tissues that have no involvement in Calcium Homeostasis (e.g., skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('PROBABLE_UNDERSTANDING', 220)]	10	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000160', 'intestine', 56, 'intestine'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004288', 'skeleton', 79, 'skeleton'), ('GO_0042592', 'homeostatic process', 134, 'homeostasis'), ('UBERON_0001431', 'distal carpal bone 2', 166, 'extraskeletal'), ('UBERON_0000479', 'tissue', 263, 'tissues'), ('GO_0055073', 'cadmium ion homeostasis', 299, 'calcium homeostasis'), ('UBERON_0001987', 'placenta', 332, 'placenta'), ('UBERON_0001264', 'pancreas', 342, 'pancreas'), ('UBERON_0000310', 'breast', 352, 'breast'), ('UBERON_0002367', 'prostate gland', 360, 'prostate'), ('UBERON_0001155', 'colon', 373, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 397, 'activated T cells')]
PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC3991049	11/2013	S24-PMC3991049	["a RECENT STUDY SHOWED that a daily supplement of 4000 iu of Vitamin D was REQUIRED to sustain normal Metabolism in Pregnancy and this dose was EFFECTIVE and SAFE.9\nin THIS STUDY we EVALUATED the prevalence of Vitamin D deficiency in Pregnant women and EVALUATED the EFFECT of weekly Oral 50,000 iu of Vitamin D on mothers' and newborn's level of Vitamin D.\n\nmethods\nTHIS is a prospective observational study conducted at a single center at hamad medical corporation in doha, qatar."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 143), ('IMPORTANT_CONSIDERATION', 157), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('SUPERFICIAL_RELATIONSHIP', 266), ('QUESTION_ANSWERED_BY_THIS_WORK', 366)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0008152', 'metabolic process', 101, 'metabolism'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'pregnant'), ('UBERON_0000165', 'mouth', 283, 'oral'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4380518	9/2014	S52-PMC4380518	['shea et al studied 2500 elderly Adults and FOUND that lack of pnv use was ASSOCIATED with higher odds of Vitamin D insufficiency (<75 nmol/l) in both black (5.2 (95% ci: 3.5, 7.7)) and white participants (or 2.6, 95% ci: 2.0, 3.2), HOWEVER these subjects were much older and not Pregnant.26a SMALL turkish STUDY of 79 Pregnant women SHOWED significantly higher 25(Oh)D levels among women reporting pnv use in the third trimester,27BUT this study DID NOT include women of african descent and DID NOT have the power to address POTENTIAL INTERACTION by bmi.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 333), ('PROBLEM_COMPLICATION', 431), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 491), ('INCOMPLETE_EVIDENCE', 525), ('SUPERFICIAL_RELATIONSHIP', 535)]	10	[('UBERON_0007023', 'adult organism', 32, 'adults'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnant'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 361, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 361, '25(OH)D')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
PMC4600246	10/2015	S74-PMC4600246	['combining Vitamin K2With an Ace Inhibitor (Perindopril) HAS SHOWN synergistic EFFECTS on hcc recurrence and survival, and THUS this combination SHOULD also BE FURTHER explored.60moreover, ADDITIONAL STUDIES SHOULD BE explored combining Vitamin K2With Acyclic Retinoids, AS this combination HAS also SHOWN positive results on Human Hcc cell lines.69the health benefits of Vitamin K have been summarised inbox 1.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 78), ('PROBABLE_UNDERSTANDING', 122), ('FUTURE_WORK', 144), ('ANOMALY_CURIOUS_FINDING', 156), ('FUTURE_WORK', 159), ('FUTURE_WORK', 188), ('FUTURE_WORK', 207), ('PROBABLE_UNDERSTANDING', 270), ('INCOMPLETE_EVIDENCE', 290)]	10	[('CHEBI_77570', 'tropisetron hydrochloride', 10, 'vitamin K2with'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 28, 'ACE inhibitor'), ('CHEBI_8024', 'perindopril', 43, 'perindopril'), ('CHEBI_77570', 'tropisetron hydrochloride', 236, 'vitamin K2with'), ('CHEBI_33333', 'alkylidene group', 251, 'acyclic retinoids'), ('NCBITaxon_9606', 'Homo sapiens', 325, 'human'), ('CL_0000745', 'retina horizontal cell', 331, 'HCC'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin K')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]
PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
PMC4864049	1/2016	S350-PMC4864049	['this is PARTICULARLY INTERESTING because it LINKS FINDINGS SHOWING decreased levels of Serotonin in asd patients\xa0[160] and reduced levels of Vitamin D. HOWEVER, a previous study FOUND LITTLE EVIDENCE that maternal Gestational Vitamin D levels are RELATED to the asd phenotype among offspring\xa0[161].']	[('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 184), ('SUPERFICIAL_RELATIONSHIP', 247)]	10	[('CHEBI_28790', 'serotonin', 87, 'serotonin'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestational'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4908484	6/2016	S0-PMC4908484	['protective EFFECTS of 1 Α ,25‐Dihydroxyvitamin D3 on Cultured Neural Cells exposed to catalytic iron\n\nabstractabstract\nRECENT STUDIES have POSTULATED a ROLE for Vitamin D and its receptor on Cerebral function, and anti‐inflammatory, immunomodulatory and Neuroprotective EFFECTS HAVE BEEN DESCRIBED; Vitamin D can inhibit proinflammatory cytokines and Nitric Oxide synthesis during various neurodegenerative insults, and MAY BE CONSIDERED as a POTENTIAL Drug for the treatment of these disorders.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 288), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 427), ('INCOMPLETE_EVIDENCE', 443)]	10	[('CHEBI_37983', 'sulfur-35 atom', 22, '1'), ('CHEBI_63991', '15-epi-lipoxin B4', 24, 'α ,25‐Dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 47, 'D3'), ('CL_0000010', 'cultured cell', 53, 'cultured'), ('CL_0002319', 'neural cell', 62, 'neural cells'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0001893', 'telencephalon', 191, 'cerebral'), ('GO_0019234', 'sensory perception of fast pain', 254, 'neuroprotective'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('CHEBI_16480', 'nitric oxide', 351, 'nitric oxide'), ('GO_0000740', 'nuclear membrane fusion', 351, 'nitric oxide'), ('CHEBI_23888', 'drug', 453, 'drug')]
PMC4930210	7/2016	S142-PMC4930210	['ALTHOUGH PREVIOUS STUDIES HAVE SHOWN FACTORS like age, season, and Vitamin D supplementation AFFECT 3-Epi-25(Oh)D3[29,30], in OUR STUDY the ONLY FACTOR positively CORRELATED with level of the 3-Epi-25(Oh)D3Was Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 163)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_76629', '2-lysophosphatidic acid', 100, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 112, 'D3'), ('CHEBI_73839', 'D-Leu-D-Leu', 192, '3-epi-25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 204, 'D3was'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S305-PMC4934634	['OTHER CONCERNS are the INSUFFICIENT EVIDENCE to determine the EFFECTS of Vitamin D supplementation/fortification on bone health and fracture incidence and that fda RECOMMENDATIONS to include Vitamin D on Food labels MAY ENCOURAGE fortification of Vitamin D in products that would not otherwise necessarily be RECOMMENDED, and lastly, that there is SOME EVIDENCE for POSSIBLE adverse consequences to Vitamin D fortification [107].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 62), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 216), ('FUTURE_WORK', 220), ('FUTURE_WORK', 309), ('INCOMPLETE_EVIDENCE', 348), ('INCOMPLETE_EVIDENCE', 366)]	10	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33290', 'food', 204, 'food'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC4949006	7/2016	S147-PMC4949006	['it HAS BEEN IDENTIFIED as a Nutrient of PUBLIC HEALTH CONCERN by the us department of health and Human services.104\nNUMEROUS STUDIES HAVE SHOWN a prevalence of vitamin d levels of less than 50 nmol/l in 30% to 96% of Pregnant women, increasing with latitude and with nonwhite race.105–111a study done using archived samples of Cord Blood in denmark SHOWED an increased risk of developing schizophrenia with either elevated or low levels of Vitamin D. it was HYPOTHESIZED that IF all the infants COULD have been Born with normal levels there would have been a reduction of 43% in the incidence of schizophrenia among the Adults.112there is also an ASSOCIATION of Vitamin D deficiency and Insulin resistance,113which was reversed with a single injection of the vitamin114(not approved in the united states).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 458), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('INCOMPLETE_EVIDENCE', 495), ('SUPERFICIAL_RELATIONSHIP', 647)]	10	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'Human'), ('GO_0007565', 'female pregnancy', 217, 'pregnant'), ('UBERON_0002240', 'spinal cord', 327, 'cord'), ('UBERON_0000178', 'blood', 332, 'blood'), ('CHEBI_28384', 'vitamin K', 440, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 440, 'Vitamin D'), ('GO_0007567', 'parturition', 511, 'born'), ('UBERON_0007023', 'adult organism', 620, 'adults'), ('CHEBI_27300', 'vitamin D', 662, 'vitamin D'), ('PR_000045358', 'insulin family protein', 687, 'insulin')]
PMC4973215	8/2016	S14-PMC4973215	['THUS, sufficient EVIDENCE is LACKING at this time to RECOMMEND routine Vitamin D supplementation during Pregnancy.12HOWEVER, identification of specific RISK FACTORS for Vitamin D deficiency and the additive EFFECTS of these RISK FACTORS MAY LEAD TO OPPORTUNITIES for targeted supplementation with improved outcomes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 207), ('SUPERFICIAL_RELATIONSHIP', 224), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 241), ('FUTURE_WORK', 249)]	10	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]
PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]
PMC5085625	9/2016	S169-PMC5085625	['conclusions\nin CONCLUSION, both the results of PREVIOUS STUDIES and OUR FINDINGS PRESENTED HERE, documenting the LINK between Maternal deficiency of Vitamin D and the INCREASED RISK of Preeclampsia, POINT TO the IMPORTANT ROLE of an appropriate level and adequate Metabolism Of this Vitamin in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 91), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 212), ('SUPERFICIAL_RELATIONSHIP', 222)]	10	[('GO_0007618', 'mating', 126, 'maternal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 185, 'preeclampsia'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 264, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 283, 'vitamin'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy')]
PMC5351212	3/2017	S262-PMC5351212	['HOWEVER, the fact that mia with poly(I:c) has induced abnormalities in Social Interaction and Cognition at a more translationally RELEVANT age, i.e., juveniles, together with the presence of behavioral abnormalities not normally associated with schizophrenia such as altered digging behavior SUGGEST to us that this Animal MODEL MAY have greater relevance to asd\n\nvitddoes not alter maternal or fetal inflammatory Cytokine Production\nin VIEW OF the KNOWN immunomodulatory EFFECTS of Vitamin D, an obvious neuroprotective mechanism explored HERE was the POSSIBILITY that vitdameliorates the inflammatory response induced by Poly(I:c).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 329), ('INCOMPLETE_EVIDENCE', 437), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 472), ('QUESTION_ANSWERED_BY_THIS_WORK', 540), ('INCOMPLETE_EVIDENCE', 553)]	10	[('CHEBI_51686', 'haematoxylin', 37, 'I'), ('GO_0019417', 'sulfur oxidation', 71, 'social interaction'), ('GO_0050890', 'cognition', 94, 'cognition'), ('NCBITaxon_33208', 'Metazoa', 316, 'animal'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 414, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 483, 'vitamin D'), ('CHEBI_37311', 'einsteinium molecular entity', 623, 'poly'), ('CHEBI_51686', 'haematoxylin', 628, 'I')]
PMC5510234	7/2017	S78-PMC5510234	['the authors REPORTED that EVEN in regions where Vitamin A deficiency is a PUBLIC HEALTH CONCERN, Vitamin A supplementation for PREVENTION of Prenatal mtct is not RECOMMENDED.58finally a RECENT REVIEW done on the vitamin a supplementation for the reduction of the RISK of mother-to-child transmission of hiv, REPORTED that early observational studies FOUND an ASSOCIATION between Vitamin A deficiency and increased rates of mtct of hiv.']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 127), ('FUTURE_WORK', 162), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 263), ('INCOMPLETE_EVIDENCE', 308), ('INCOMPLETE_EVIDENCE', 350), ('SUPERFICIAL_RELATIONSHIP', 359)]	10	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin A')]
PMC5706533	11/2017	S20-PMC5706533	['we SPECIFICALLY AIMED to estimate the EFFECTS of Vitamin D supplementation during Pregnancy on maternal, neonatal, and infant outcomes, taking into consideration the quality of AVAILABLE evidence and heterogeneity across studies; determine frequencies at which relevant outcome variable data were missing, unreported, or inconsistently reported among trials that were otherwise eligible for inclusion; and IDENTIFY ONGOING or PLANNED STUDIES of Vitamin D supplementation during Pregnancy to project the state of EVIDENCE that COULD accrue in the next decade.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 177), ('FUTURE_WORK', 406), ('IMPORTANT_CONSIDERATION', 415), ('FUTURE_WORK', 426), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 526)]	10	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 478, 'pregnancy')]
PMC5706533	11/2017	S163-PMC5706533	['MANY of the REPORTED doses, HOWEVER, DID NOT yield EFFECTS on maternal 25(Oh)D that would be expected BASED ON Vitamin D pharmacokinetics.3637the muted dose-25(Oh)D RELATION COULD BE ATTRIBUTED to high baseline 25(Oh)D, low precision of 25(Oh)D assays, low rates of adherence to supplementation regimens, or lower than labeled Vitamin D content of the Supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 183)]	10	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 73, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 352, 'supplements')]
PMC5812027	2/2018	S136-PMC5812027	['supplementation CAN THEREFORE ONLY PARTLY EXPLAIN the large proportion with high Vitamin D status, and OTHER LIKELY CONTRIBUTORS are Pregnancy associated Endocrine changes and POSSIBLY lifestyle FACTORS.']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 195)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0006397', 'mRNA processing', 154, 'endocrine')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S87-BMJ_2010_Apr_29_340_c1640	['RECENT work by sayers et al also INDICATES that ambient erythemal ultraviolet radiation levels during Pregnancy, EVEN in a single location, CAN be used to INDICATE Vitamin D status.29further work COULD CONFIRM the timing of the OBSERVED EFFECT of Prenatal ultraviolet radiation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 113), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 237)]	9	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 247, 'prenatal')]
PMC1888711	5/2007	S46-PMC1888711	['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation"further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs"Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]
PMC2582131	11/2008	S100-PMC2582131	['OUR FINDINGS are also GENERALLY CONSISTENT with a relatively large body of LITERATURE documenting a significant and inverse ASSOCIATION of circulating Vitamin D concentrations with measurements of glycemia or presence of type 2 dm among non-Pregnant women, ALTHOUGH the majority of THESE FINDINGS are based ON cross-sectional/RETROSPECTIVE data.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 257), ('INCOMPLETE_EVIDENCE', 282), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC2872349	4/2010	S146-PMC2872349	['this is an IDEAL platform on which TO INVESTIGATE epigenetic Modulation Of Placental Calcium Transport, PARTICULARLY the ROLE of Vitamin D. this SHOULD improve our understanding of the processes INVOLVED in developing osteoporosis, and POTENTIALLY provide a focus for interventions to avert DETRIMENTAL processes by INFLUENCING maternal dietary habits.']	[('IMPORTANT_CONSIDERATION', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 121), ('FUTURE_WORK', 145), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 291), ('SUPERFICIAL_RELATIONSHIP', 316)]	9	[('GO_0061724', 'lipophagy', 61, 'modulation of'), ('GO_0006813', 'potassium ion transport', 75, 'placental calcium transport'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2874518	6/2010	S111-PMC2874518	['women in our cohort were receiving adequate amounts of these Micronutrients from their diet alone, as assessed by the 24-hour dietary Recall (table 2), confirming the inverse Supplement HYPOTHESIS, that women who least NEED Supplements are most LIKELY to take them.22\nOTHER STUDIES have SUGGESTED POTENTIAL adverse EFFECTS of SOME Supplements, specifically those containing antioxidant Vitamins such as Vitamins C and E, on Pregnancy outcome when taken by women with adequate dietary Micronutrient intake.']	[('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 219), ('PROBABLE_UNDERSTANDING', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 268), ('INCOMPLETE_EVIDENCE', 268), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('SUPERFICIAL_RELATIONSHIP', 315), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('GO_0060033', 'anatomical structure regression', 134, 'recall'), ('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_33341', 'titanium atom', 224, 'supplements'), ('CHEBI_33341', 'titanium atom', 331, 'supplements'), ('CHEBI_33277', 'gamma-tocotrienol', 386, 'vitamins'), ('CHEBI_27300', 'vitamin D', 403, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 418, 'E'), ('GO_0007565', 'female pregnancy', 424, 'pregnancy'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 484, 'micronutrient')]
PMC2963768	10/2010	S83-PMC2963768	["cement, brick, or tin)\xa0\xa0floor03 (6)0.221\xa0\xa0walls6 (25)16 (32)0.537\xa0\xa0roof20 (83)45 (90)0.411child is/was usually swaddled during the first 6 months of Life24 (100)46 (92)0.154child was deliberately exposed to sunlight before Learning to crawl/walk18 (75)36 (72)0.786mother's clothing practices when outdoors\xa0\xa0head usually covered23 (96)50 (100)0.146\xa0\xa0Face usually covered00-\xa0\xa0Arms usually covered24 (100)48 (96)0.321\xa0\xa0usually wears burka in public21 (91)47 (94)0.672number of meals at which mother reportedly Consumed Food items from Animal source during the past week (median±iqr)any type of fish13.0±514.5±120.158\xa0\xa0small fish with Bones6.0±76±80.561\xa0\xa0milk0±00±70.119\xa0\xa0meat0±0.50±20.415\xa0\xa0Eggs0±1.50±20.247\xa0\xa0Liver0±00±00.324\nfigures in parentheses indicate percentages;\niqr=interquartile range;\nsd=standard deviation\n\ndiscussion\nTHIS PRELIMINARY STUDY in sylhet during the winter dry season REVEALED that the Vitamin d status of young infants in rural bangladesh MIGHT be POOR enough to put many AT RISK of rickets and other POTENTIAL Vitamin D-RELATED health consequences."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 827), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('INCOMPLETE_EVIDENCE', 889), ('INCOMPLETE_EVIDENCE', 961), ('IMPORTANT_CONSIDERATION', 970), ('IMPORTANT_CONSIDERATION', 994), ('INCOMPLETE_EVIDENCE', 1023), ('SUPERFICIAL_RELATIONSHIP', 1043)]	9	[('UBERON_0008878', 'palmar part of manus', 149, 'life24'), ('GO_0007612', 'learning', 223, 'learning'), ('UBERON_0001456', 'face', 349, 'Face'), ('UBERON_0001460', 'arm', 374, 'Arms'), ('GO_0007631', 'feeding behavior', 507, 'consumed'), ('CHEBI_33290', 'food', 516, 'food'), ('NCBITaxon_33208', 'Metazoa', 532, 'animal'), ('UBERON_0001474', 'bone element', 631, 'bones6'), ('CL_0000059', 'ameloblast', 687, 'Eggs0'), ('UBERON_0001773', 'sclera', 706, 'Liver0'), ('CHEBI_33229', 'vitamin (role)', 907, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1033, 'vitamin D')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC2963768	10/2010	S137-PMC2963768	["a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual's 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]
PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]
PMC2996405	11/2010	S59-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATION with Vitamin D, which had been PREVIOUSLY ASSOCIATED, separately, to both of them.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 163)]	9	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2996405	11/2010	S155-PMC2996405	['this result MAY SUGGEST that Vitamin D related Genes COULD have been subject, AT LEAST IN PART, to a latitude-DEPENDENT adaptation, SUPPORTING the HYPOTHESIS that selection also ACTED on OTHER mechanisms different from depigmentation.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187)]	9	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 47, 'genes')]
PMC3032617	5/2010	S102-PMC3032617	['INTERESTINGLY, ALTHOUGH the average weight gain was normal in the two groups during Pregnancy without any significant statistical difference, this was FOUND lower in the Vitamin C group COMPARED TO controls, and this COULD SUGGEST the POSSIBILITY of a better Fatty Acid Catabolism provided by high dose Vitamin C intake which IS KNOWN to enhance Carnitine synthesis, a fundamental long chain Fatty Acid transporter to the Mitochondrial site for energy production in form of atp, also, Ascorbic Acid is INVOLVED in the biosynthetic pathway of Thyroid hormones which are known regulators of the basal Metabolism.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 186), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 235), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 502)]	9	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('CHEBI_35366', 'fatty acid', 259, 'fatty acid'), ('GO_0009062', 'fatty acid catabolic process', 259, 'fatty acid catabolism'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin C'), ('CHEBI_17126', 'carnitine', 346, 'carnitine'), ('GO_0015915', 'fatty-acyl group transport', 392, 'fatty acid'), ('GO_0005739', 'mitochondrion', 422, 'mitochondrial'), ('CHEBI_22652', 'ascorbic acid', 485, 'ascorbic acid'), ('CHEBI_9437', 'temoporfin', 542, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 542, 'thyroid'), ('GO_0008152', 'metabolic process', 599, 'metabolism')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
PMC3278486	1/2012	S137-PMC3278486	["comparison with other studies\nour finding of no benefit, BUT a POSSIBLE adverse EFFECT from Folic Acid supplementation on cancer incidence is IN LINE WITH REPORTED results of studies on other Nutrient supplements, including Vitamin E, Β-Carotene (Vitamin-A precursor) or Selenium; all SHOWING no or an adverse EFFECT of supplementation in controlled clinical trials on cancer development.4243a RECENT meta-analysis of Folic Acid supplements by clarke and coworkers, in the ‘b-Vitamin treatment trialists' collaboration’3with individual patient data, FOUND no increased cancer risk in any subgroups."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 310), ('INCOMPLETE_EVIDENCE', 394), ('INCOMPLETE_EVIDENCE', 550)]	9	[('CHEBI_30751', 'formic acid', 92, 'folic acid'), ('CHEBI_33284', 'nutrient', 192, 'nutrient'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin E'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 235, 'β-carotene'), ('CHEBI_83326', 'tedizolid phosphate', 247, 'vitamin-A'), ('CHEBI_27568', 'selenium atom', 271, 'selenium'), ('CHEBI_30751', 'formic acid', 418, 'folic acid'), ('CHEBI_33229', 'vitamin (role)', 476, 'Vitamin')]
PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3338544	4/2012	S161-PMC3338544	['there are AS YET no epidemiological studies DEMONSTRATING a direct ASSOCIATION between autistic spectrum disorders and developmental Vitamin D levels, YET there are EFFECTS of season of Birth, latitude of Birth, and migrant status that MAY INDICATE a POSSIBLE ASSOCIATION (for review,[39]).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 67), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 251), ('SUPERFICIAL_RELATIONSHIP', 260)]	9	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC3338544	4/2012	S162-PMC3338544	['if FURTHER EVIDENCE CONTINUES to SUPPORT this ASSOCIATION, the Dvd-deficient Mouse MODEL MAY BE utilized to FURTHER EXAMINE the ROLE Vitamin D plays in Brain Development with RELEVANCE to autism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 108), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 175)]	9	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 63, 'DVD'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007420', 'brain development', 152, 'brain development'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3501517	11/2012	S194-PMC3501517	['these data SUGGEST that SOME PROTECTIVE BENEFIT MAY BE derived from Vitamin D supplementation in the setting of radiation-induced Lung injury; HOWEVER, the POTENTIAL physiological relevance of these differences is DIFFICULT to ascertain given the absence of systematic sampling or the LACK OF DATA on the magnitude of the differences.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 156), ('DIFFICULT_TASK', 214), ('INCOMPLETE_EVIDENCE', 285)]	9	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002048', 'lung', 130, 'lung')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3613945	2/2013	S8-PMC3613945	['in VIEW of the HEIGHTENED INTEREST in Vitamin D as a PUBLIC HEALTH TARGET, well-DESIGNED STUDIES that look simultaneously at Vitamin D and its carrier in RELATION to genotypes and adverse health outcome SHOULD BE ENCOURAGED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 53), ('FUTURE_WORK', 67), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 154), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	9	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3651971	5/2013	S139-PMC3651971	['the lack of EFFECT is UNLIKELY to be DUE TO a lack of Vitamin A deficiency among Pregnant women; ∼20% of mothers were NOTED to have a Serum Retinol concentration below 0.70\u2005µmol/l, a prevalence that fell to ∼3% with supplementation.20gestational night blindness of ∼10% also responded to Vitamin A supplementation,37and the risk of Maternal death was reduced by ∼40% through supplementation.20there was no lack of Cognitive or motor effect, which is LIKELY to be OWING TO the POOR response to supplementation among the offspring; infants Born to supplemented women had a higher Serum Retinol than infants Born to Placebo mothers by 3\u2005months of age.24the children Born to supplemented women also had better Lung function (as measured by the forced Expiratory volume at 1\u2005s and forced vital capacity)25and raised natural Antibody levels26in childhood, FURTHER EVIDENCE of a physiological EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 22), ('PROBLEM_COMPLICATION', 37), ('ANOMALY_CURIOUS_FINDING', 118), ('PROBABLE_UNDERSTANDING', 450), ('PROBLEM_COMPLICATION', 463), ('PROBLEM_COMPLICATION', 476), ('INCOMPLETE_EVIDENCE', 850), ('SUPERFICIAL_RELATIONSHIP', 886)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_26536', 'retinoic acid', 140, 'retinol'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A'), ('GO_0007618', 'mating', 332, 'maternal'), ('GO_0050890', 'cognition', 414, 'cognitive'), ('GO_0007567', 'parturition', 538, 'born'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_26536', 'retinoic acid', 584, 'retinol'), ('GO_0007567', 'parturition', 605, 'born'), ('CHEBI_26130', 'biological pigment', 613, 'placebo'), ('GO_0007567', 'parturition', 663, 'born'), ('UBERON_0002048', 'lung', 706, 'lung'), ('GO_0010467', 'gene expression', 747, 'expiratory'), ('GO_0042571', 'immunoglobulin complex, circulating', 819, 'antibody')]
PMC3668200	5/2013	S0-PMC3668200	['comparison of the Serum Vitamin D level between breastfed and formula-Fed infants: several FACTORS which CAN AFFECT Serum Vitamin D concentration\nit is COMMON KNOWLEDGE among pediatricians that exclusively breastfed infants SHOULD BE supplemented with Vitamin D (400 iu/day) BECAUSE Human Breast Milk contains an INADEQUATE amount of Vitamin D. accordingly, choi et al.1)REPORTED a vitamin deficiency in early infants in a comparative study between Breastfed and formula-Fed infants in this issue.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('FUTURE_WORK', 159), ('FUTURE_WORK', 224), ('PROBABLE_UNDERSTANDING', 275), ('IMPORTANT_CONSIDERATION', 313), ('INCOMPLETE_EVIDENCE', 371)]	9	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 70, 'fed'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 283, 'human'), ('UBERON_0001348', 'brown adipose tissue', 289, 'breast milk'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0007567', 'parturition', 449, 'breastfed'), ('GO_0007631', 'feeding behavior', 471, 'fed')]
PMC3702245	6/2013	S24-PMC3702245	['further, a RECENT STUDY of the RELATIONSHIP between Serum 25(Oh)D and bone turnover in Pregnant women in istanbul, turkey, FOUND a negative CORRELATION between the second and third trimester and Postpartum 25(Oh)D concentrations and Serum cross-linked c-terminal telopeptide of Type 1 Collagen, which is a MARKER of Bone Resorption.58THESE studies SEEM to INDICATE a LINK between very low Vitamin D status and subclinical osteomalacia in the mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 306), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 348), ('INCOMPLETE_EVIDENCE', 356), ('SUPERFICIAL_RELATIONSHIP', 367)]	9	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 58, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('GO_0007565', 'female pregnancy', 195, 'postpartum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('UBERON_0001977', 'blood serum', 233, 'serum'), ('PR_000002123', 'C-C motif chemokine 3', 278, 'type 1 collagen'), ('GO_0045453', 'bone resorption', 316, 'bone resorption'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D')]
PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S102-PMC3717170	['in RELATION to the systemic pathology of copd the ROLE of Vitamin D has generated interest, AS Vitamin D deficiency is OFTEN present in patients with copd,24dependent on the severity of copd.25indeed, the prevalence of Vitamin D deficiency, defined as Plasma 25(Oh) D3Concentrations below 20 ng/ml (50 nmol/l), was 58% in a cross-sectional study of 151 copd patients entering Pulmonary rehabilitation during summer.26in the bergen copd cohort study, the prevalence of Vitamin D deficiency was INDEED higher in the copd patients than in the control subjects, INDEPENDENT of season, age, smoking, comorbidity, and body mass index.27several POTENTIAL EXPLANATIONS for the increased risk of Vitamin D deficiency in patients with copd include poor diet, less outdoor activity and THUS less exposure to sunlight, accelerated Skin Aging due to smoking, Renal dysfunction, and treatment with Corticosteroids.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 119), ('ANOMALY_CURIOUS_FINDING', 493), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 638), ('PROBABLE_UNDERSTANDING', 648), ('PROBABLE_UNDERSTANDING', 775)]	9	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('CHEBI_73735', 'gadoterate', 259, '25(OH) D3concentrations'), ('PR_000016555', 'thymocyte selection-associated high mobility group box protein TOX', 259, '25(OH) D3concentrations'), ('UBERON_0002048', 'lung', 376, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 468, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 687, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 819, 'skin'), ('GO_0007568', 'aging', 824, 'aging'), ('UBERON_0002113', 'kidney', 846, 'renal'), ('CHEBI_50850', 'etabonate ester', 884, 'corticosteroids')]
PMC3717170	5/2013	S163-PMC3717170	['in large population-based studies, low levels of Vitamin D PREDICT loss of mobility and disability in Basic activities Of daily living, independent of age and other POTENTIAL CONFOUNDERS.47BASED on THESE FINDINGS, SOME gerontologists CLAIM that Vitamin D has antiaging EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 175), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 187), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 269)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'basic'), ('UBERON_0002828', 'ventral cochlear nucleus', 119, 'of'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3717170	5/2013	S176-PMC3717170	['CONSISTENTLY, in the longitudinal Aging study amsterdam, low Vitamin D and high Parathyroid hormone were strong, INDEPENDENT RISK FACTORS for loss of muscle strength and muscle mass (sarcopenia).49low Vitamin D levels also APPEAR TO BE CORRELATED with collagen deposition and are RELATED to Arterial stiffness.50the ROLE of Vitamin D in energetics has BEEN LESS THOROUGHLY INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 113), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 223), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 280), ('SUPERFICIAL_RELATIONSHIP', 316), ('ANOMALY_CURIOUS_FINDING', 352), ('INCOMPLETE_EVIDENCE', 357)]	9	[('GO_0007568', 'aging', 34, 'Aging'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 80, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('UBERON_0001637', 'artery', 291, 'arterial'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
PMC3760821	9/2013	S172-PMC3760821	['WHILE josefson et al ., REPORTED an IMPACT of maternal age and neonatal adiposity, directly measured by air displacement plethysmography, on Cord Vitamin D levels, in the CURRENT STUDY, ALTHOUGH neonatal bmi sds was significantly negatively CORRELATED with Cord 25Ohd in subjects with t1dm, regression analysis INDICATED that maternal age at Delivery and SURROGATE measures of neonatal adiposity (Subscapular Skinfold, Triceps Skinfold, and sds bmi) did not impact significantly on Cord Blood 25Ohd.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 171), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 241), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 355)]	9	[('UBERON_0002240', 'spinal cord', 141, 'cord'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('GO_0007567', 'parturition', 342, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 397, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 419, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 482, 'cord'), ('UBERON_0000178', 'blood', 487, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 493, '25OHD')]
PMC3798907	8/2013	S107-PMC3798907	['this is an IMPORTANT differential result because, together with the between-subject variation and the COMPLEX EFFECTS on Cytokine Production, it INDICATES that the observed in vivo epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses and childhood asthma/wheeze cannot be EXPLAINED by a direct and CONSISTENT EFFECT on overall th-cell responsiveness, as originally HYPOTHESISED [22].']	[('IMPORTANT_CONSIDERATION', 11), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 197), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 343), ('SUPERFICIAL_RELATIONSHIP', 354), ('INCOMPLETE_EVIDENCE', 410)]	9	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 121, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin E'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3798907	8/2013	S111-PMC3798907	['the DIFFERENTIAL EFFECTS of supplementation on hdm and tg responses EXCLUDES the POSSIBILITY that any suppressive EFFECTS of Vitamin E supplementation REPRESENT toxicity, which was also avoided by adding physiological concentrations representative of those measured in Cord Blood at Birth in the epidemiological study DEMONSTRATING an ASSOCIATION between Vitamin E and cbmc responses [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 68), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 151), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 335)]	9	[('CHEBI_27300', 'vitamin D', 125, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('GO_0007567', 'parturition', 283, 'birth'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC3814422	10/2013	S130-PMC3814422	['ALTHOUGH we COULD NOT directly investigate the ASSOCIATION of maternal 25(Oh)D with Early Life Respiratory infections, the LACK OF ASSOCIATION with transient early wheezing phenotype ARGUES AGAINST a PROTECTIVE EFFECT of Prenatal Vitamin D on Respiratory Viral infections in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 12), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 211)]	9	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('UBERON_0001847', 'lobule of pinna', 84, 'early life'), ('UBERON_0001004', 'respiratory system', 95, 'respiratory'), ('GO_0007565', 'female pregnancy', 221, 'prenatal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 243, 'respiratory'), ('NCBITaxon_1', 'root', 255, 'viral')]
PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3829803	11/2013	S175-PMC3829803	['in aggregate, these OBSERVATIONS SUGGEST that Vitamin A and its derivatives MAY play an IMPORTANT ROLE in Antiviral Responses BUT demonstrate clearly that mechanistic studies are ESSENTIAL to fully UNDERSTAND and exploit this POTENTIAL.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 179), ('FUTURE_WORK', 198), ('INCOMPLETE_EVIDENCE', 226)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('GO_0002901', 'mature B cell apoptotic process', 106, 'antiviral responses')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]
PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
PMC4113768	7/2014	S1203-PMC4113768	['conclusions: pth is the MOST LIKELY MARKER to be outside the reference range (raised) IF the patient is Vitamin D deficient BUT the literature SUGGESTS the RELATIONSHIP between 25Ohd and pth MAY BE COMPLICATED by Glomerular filtration rate.']	[('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 191), ('DIFFICULT_TASK', 198)]	9	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('UBERON_0000074', 'renal glomerulus', 213, 'glomerular')]
PMC4113768	7/2014	S1301-PMC4113768	['; wood, a.d.\nbackground: variation in Vitamin D binding protein (Vdbp) MAY EXPLAIN the INCONSISTENCIES between studies of Vitamin D; EITHER ( a ) through a mechanism by which the circulating half-life of 25-Hydroxy Vitamin D [25(Oh)D] MAY BE extended or ( b ) BECAUSE non-Vdbp bound or free Metabolites of Vitamin D MAY BETTER REFLECT biological activity.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133), ('INCOMPLETE_EVIDENCE', 235), ('PROBABLE_UNDERSTANDING', 260), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 327)]	9	[('CHEBI_28384', 'vitamin K', 38, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin D'), ('PR_000017279', 'testis-specific basic protein Y 1', 65, 'VDBP'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 204, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 226, '25(OH)D'), ('PR_000017279', 'testis-specific basic protein Y 1', 272, 'VDBP'), ('CHEBI_25212', 'metabolite', 291, 'metabolites'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC4113768	7/2014	S1803-PMC4113768	['ACCORDING to ASSOCIATIONS with allergic outcomes we COULD SHOW comparable EFFECTS SEEN earlier within the lina cohort: there was NO EVIDENCE that Vitamin D has allergy-PROTECTIVE EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 179)]	9	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4113768	7/2014	S3136-PMC4113768	['DEPENDING ON the cutoff chosen, dietary intakes of Vitamin D MAY OR MAY NOT provide sufficient IMPACT upon Vitamin D status, in improving levels of 25(Oh)d. purpose: we SOUGHT TO EXAMINE WHETHER a supplemental dose of 10 mcg (400 iu) as found in fortified foods OR as a supplement, has a measurable IMPACT on Vitamin D status, as defined by improving status from below to above 50 nmol/l, or from less than 30 nmol/l to above 30 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('SUPERFICIAL_RELATIONSHIP', 299)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 148, '25(OH'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4377870	3/2015	S87-PMC4377870	['[22] also reported CONFLICTING EVIDENCE for EFFECTS of Vitamin C intake in Adults, with epidemiological STUDIES SHOWING a positive ASSOCIATION between Vitamin C intake and Lung function in SOME [65], but NOT ALL studies [23,66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204)]	9	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('UBERON_0007023', 'adult organism', 75, 'adults'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin C'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4377879	3/2015	S89-PMC4377879	['a cochrane review FOUND a significant RELATIONSHIP between an increase in Serum Vitamin D concentrations at term and borderline reduction in low Birthweight [42] but there is yet NOT ENOUGH EVIDENCE for policy AS the NUMBER OF high-quality trials IS THOUGHT TO be currently too SMALL to draw conclusions on its usefulness and SAFETY [18].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 179), ('PROBABLE_UNDERSTANDING', 210), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 278), ('IMPORTANT_CONSIDERATION', 326)]	9	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007596', 'blood coagulation', 145, 'birthweight')]
PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC4516377	6/2015	S74-PMC4516377	['ON THE OTHER HAND, this gender DIFFERENCE was NOT FOUND in ANOTHER study.20\nthe mechanism by which Vitamin D INFLUENCES adiposity is not COMPLETELY understood, but there are LINES OF RESEARCH that try to explain this phenomenon.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109), ('PROBABLE_UNDERSTANDING', 137), ('INCOMPLETE_EVIDENCE', 174)]	9	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4600246	10/2015	S24-PMC4600246	['Coronary Heart disease (chd)\nMAY reduce the RISK of chd, chd mortality and all-cause mortality52676\nInsulin sensitivity\nMAY help improve Insulin sensitivity40\nwarfarin international normalised ratio (inr)\nMAY help to stabilise inr in patients on warfarin41\nlow Vitamin K status (indicated by undercarboxylated mgp) is ASSOCIATED with increased vascular calcifications, and these levels CAN be improved by effective Vitamin K supplementation28–32it was long BELIEVED that Vitamin K was ONLY INVOLVED in forming Coagulation factors (ie, maintaining Haemostasis).']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 44), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 318), ('INCOMPLETE_EVIDENCE', 386), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 485), ('SUPERFICIAL_RELATIONSHIP', 490)]	9	[('UBERON_0002949', 'tectospinal tract', 0, 'Coronary heart'), ('PR_000045358', 'insulin family protein', 100, 'Insulin'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin K'), ('GO_0050817', 'coagulation', 510, 'coagulation'), ('GO_0007599', 'hemostasis', 547, 'haemostasis')]
PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
PMC4897157	5/2016	S126-PMC4897157	['BECAUSE SEVERAL STUDIES SHOWED that winter Birth COULD BE a risk factor for fa718), and Vitamin D IS CONSIDERED AS the factor that MEDIATES the ASSOCIATION between Birth season and allergic diseases, we expected that insufficient sun exposure during infancy would exert a same INFLUENCE on the presence of Fa.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('GO_0007567', 'parturition', 43, 'birth'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth'), ('CHEBI_30751', 'formic acid', 306, 'FA')]
PMC4930210	7/2016	S144-PMC4930210	['ALTHOUGH the physiological ROLE of the c3-epimerization pathway has NOT YET BEEN ELUCIDATED, there are INDICATIONS that it has SOME anti-proliferative activity and differentiation activity ONLY at levels of APPROXIMATELY 10%-30%, respectively, COMPARED TO non-epimeric Vitamin D Metabolites [11,12].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('FULL_UNKNOWN', 68), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 244)]	9	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_25212', 'metabolite', 279, 'metabolites')]
PMC4930210	7/2016	S165-PMC4930210	['ANOTHER RECENT canadian STUDY [35] SHOWED summer sun exposure was a PREDICTOR of 25(Oh)D3Concentration BUT fall sun exposure was NOT, which MAY BE RELATED to lower Vitamin D-weighted climatological uv in toronto during the fall.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ANOMALY_CURIOUS_FINDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 81, '25(OH)D3concentration'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 81, '25('), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 86, ')D3concentration'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4971719	8/2016	S169-PMC4971719	['this ASSOCIATION MAY BE ATTRIBUTED to a true EFFECT of nutritional deficiency OR ALTERNATELY MIGHT be RELATED to DIFFERENCES in Vitamin D Metabolism between women who are predisposed to depression and those who are not.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	9	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 128, 'vitamin D metabolism')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4973215	8/2016	S94-PMC4973215	['Vitamin D supplementation during Pregnancy HAS BEEN SHOWN to positively AFFECT Cord Blood Vitamin D levels at Birth.43,44studies of Vitamin D supplementation during Pregnancy THUS FAR HAVE SHOWN CONFLICTING results with respect to Birth weight and reduction of sga.43,45,46,47,48adequately powered and randomized controlled trials of vitamin d supplementation during Pregnancy ARE NEEDED TO ASSESS the IMPACT of supplementation on sga as well as the APPROPRIATE dose and timing of supplementation.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('FUTURE_WORK', 377), ('FUTURE_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 402), ('IMPORTANT_CONSIDERATION', 450)]	9	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007567', 'parturition', 231, 'birth'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy')]
PMC4989298	8/2016	S337-PMC4989298	['in RECENT YEARS a POSSIBLE ROLE in PREVENTION HAS BEEN ATTRIBUTED to Vitamin D. indeed, OBSERVATIONAL and cohort studies have DOCUMENTED the existence of a CORRELATION between vitamin d intake (from dietary sources or supplementation) in Pregnant women and children and the risk of wheezing, asthma or Food allergy later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 156)]	9	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 238, 'pregnant'), ('CHEBI_33290', 'food', 302, 'food'), ('UBERON_0000104', 'life cycle', 324, 'life')]
PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC5129897	10/2016	S14-PMC5129897	['FEW well-designed clinical TRIALS SHOW beneficial EFFECTS of Vitamin D MAINLY BECAUSE many such trials were BASED ON GUIDELINES for Pharmaceutical Drugs.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 108), ('ANOMALY_CURIOUS_FINDING', 114), ('ANOMALY_CURIOUS_FINDING', 114), ('PROBABLE_UNDERSTANDING', 117)]	9	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 132, 'pharmaceutical drugs')]
PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
PMC5474873	6/2017	S25-PMC5474873	['reviewed seven STUDIES on Vitamin D and psychosis and CONCLUDED that Individuals with psychosis showed lower Vitamin D levels than healthy controls (16), and a COMPREHENSIVE meta-analysis of observation studies SUGGESTED a strong RELATIONSHIP between Vitamin D deficiency and schizophrenia (17) Vitamin D HAS BEEN FOUND to Modulate Dopamine Neurotransmission (5), and SEVERAL STUDIES REPORTED an ASSOCIATION between early Life Vitamin D deficiency and later psychotic disorder.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 368), ('INCOMPLETE_EVIDENCE', 384), ('SUPERFICIAL_RELATIONSHIP', 396)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 69, 'individuals'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 295, 'Vitamin D'), ('GO_0065007', 'biological regulation', 323, 'modulate'), ('CHEBI_18243', 'dopamine', 332, 'dopamine'), ('GO_0061527', 'dopamine secretion, neurotransmission', 332, 'dopamine neurotransmission'), ('UBERON_0000104', 'life cycle', 422, 'life'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D')]
PMC5513133	7/2017	S170-PMC5513133	['caption (table-wrap): table 4\n\nASSOCIATION of Vitamin D supplementation and Pregnancy-induced hypertension (pih) outcomes in clinical trialsauthor, location, yearstudy designsubjectsinterventionkey findingsresultsolsen and secher, denmark, 1990 [91]randomized controlled clinical trial5644 Pregnant women2500\xa0iu Vitamin D supplement versus no Supplement at week 20 of Pregnancy↓ pe31.5% reduction in the odds ( p \xa0<\xa00.005)olsen et al., europe, 2000 [98]randomized placebo controlled clinical trial386 women who previously experienced pih2.7\xa0g N-3 Fatty Acids/day given from 33\xa0weeks until Delivery vs Olive Oil placebo↔ pih recurrence riskor\xa0=\xa00.9895% ci: 0.63–1.53\n\nevidence that SUGGESTS no association between maternal Vitamin D deficiency and pe\nWHILE the PRECEDING STUDIES SUPPORT a LINK between Vitamin D deficiency during Pregnancy and risk of pe, SOME STUDIES present CONFLICTING EVIDENCE (tables2and3).']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 681), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('INCOMPLETE_EVIDENCE', 760), ('INCOMPLETE_EVIDENCE', 778), ('SUPERFICIAL_RELATIONSHIP', 788), ('INCOMPLETE_EVIDENCE', 855), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 876), ('INCOMPLETE_EVIDENCE', 888)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 290, 'pregnant'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 343, 'supplement'), ('GO_0007565', 'female pregnancy', 368, 'pregnancy'), ('GO_0007567', 'parturition', 377, '↓'), ('CHEBI_30256', 'thiocarbonyl group', 543, 'n-3'), ('CHEBI_35366', 'fatty acid', 547, 'fatty acids'), ('GO_0007567', 'parturition', 589, 'delivery'), ('CHEBI_50695', 'monobactam', 601, 'olive oil'), ('CHEBI_27300', 'vitamin D', 722, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 801, 'vitamin D'), ('GO_0007565', 'female pregnancy', 829, 'pregnancy')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S241-PMC5513133	['ALTHOUGH CURRENT EVIDENCE SUPPORTS an ASSOCIATION between Angiogenic factors and pe, these STUDIES have NOT FOUND an ASSOCIATION between Vitamin D levels and Angiogenic factors [14,15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 117)]	9	[('GO_0001525', 'angiogenesis', 58, 'angiogenic'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0001525', 'angiogenesis', 158, 'angiogenic')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]
PMC5664622	9/2017	S121-PMC5664622	['the ASSOCIATION between Vitamin D consumption and financial status WAS NOT INVESTIGATED, which is one of the LIMITATIONS of OUR STUDY BECAUSE that FACTOR MIGHT have AFFECTED the diet of the investigated population.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 124), ('PROBLEM_COMPLICATION', 134), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 165)]	9	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5706533	11/2017	S160-PMC5706533	['populations without Vitamin D deficiency MIGHT have little to gain from any dose, BUT deficient populations MIGHT require relatively high doses to raise Vitamin D status to an optimal range ASSOCIATED with clinical BENEFITS.35in this FRAMEWORK, the DISTINCTION between placebo versus active control trials is ONLY INFORMATIVE insofar as an active control dose increases the baseline status to which the intervention dose is compared (as such, we considered a “modified” baseline status to be reflected by the mean 25(Oh)d at Delivery in the control group).']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 190), ('IMPORTANT_CONSIDERATION', 215), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('INCOMPLETE_EVIDENCE', 309), ('INCOMPLETE_EVIDENCE', 314)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 514, '25(OH)'), ('GO_0007567', 'parturition', 525, 'delivery')]
PMC5706533	11/2017	S167-PMC5706533	['for example, for the EFFECT of Vitamin D on pre-eclampsia, de-regil and colleagues REPORTED a pooled risk ratio of 0.52 (95% confidence interval 0.25 to 1.05) based on two trials that we included in our review, but neither of which met our minimum criteria for case definitions and methods of ascertainment: one trial ONLY mentioned the exclusion of a participant for “severe pre-eclampsia,”38AND the other REPORTED frequencies of pre-eclampsia but DID NOT mention any screening or diagnostic procedures.39de-regil and colleagues also REPORTED that Vitamin D reduced the RISK of Preterm Birth based on thee trials,6but the current meta-analysis based on 15 comparisons produced REASONABLY strong evidence of a null effect.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 407), ('INCOMPLETE_EVIDENCE', 449), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 571), ('PROBABLE_UNDERSTANDING', 678)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 579, 'preterm birth')]
PMC5732505	12/2017	S152-PMC5732505	['maternal Vitamin D status ASSOCIATED with Birth size: Pregnancy 25(Oh)D SHOWED a positive ASSOCIATION towards Birth weight, BUT ucb 25(Oh)D an inverse ASSOCIATION with Head circumference, WHILE ONLY the inverse ASSOCIATION with Head circumference was VERIFIED with linear model.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 90), ('ANOMALY_CURIOUS_FINDING', 124), ('SUPERFICIAL_RELATIONSHIP', 151), ('ANOMALY_CURIOUS_FINDING', 188), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 251)]	9	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('UBERON_0000033', 'head', 168, 'head'), ('UBERON_0000033', 'head', 228, 'head')]
PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5956785	5/2018	S210-PMC5956785	['additionally, IMPROVED UNDERSTANDING of Vitamin D NEEDS in children with chronic arthritis will HELP TO CLARIFY the ROLE of Vitamin D in the UNDERLYING disease processes so that therapies that target specific Vitamin D responsive Immune pathways CAN be developed.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 23), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 141), ('FUTURE_WORK', 246), ('INCOMPLETE_EVIDENCE', 246)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0002405', 'immune system', 230, 'immune')]
BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S100-BMJ_2010_Apr_29_340_c1640	['the first trimester is also a sensitive period with regard to Prenatal Thymocyte differentiation, with Animal STUDIES SHOWING that chemicals such as Dioxin CAN alter this process, disrupt the development of central tolerance, and LEAD TO increased auto-reactive Peripheral T Cells.49FURTHERMORE, indirect EFFECTS of Vitamin D SHOULD BE CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 230), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('FUTURE_WORK', 326), ('FUTURE_WORK', 336)]	8	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CL_0000893', 'thymocyte', 71, 'thymocyte'), ('NCBITaxon_33208', 'Metazoa', 103, 'animal'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 149, 'dioxin'), ('CL_0000111', 'peripheral neuron', 262, 'peripheral T cells'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin D')]
PMC2151954	10/2007	S175-PMC2151954	['for example, low maternal Vitamin D levels HAVE BEEN ASSOCIATED with altered Birth anthropometry, with SOME STUDIES FINDING an ASSOCIATION between Vitamin D deficiency and larger Birth weight and length [29], WHILE others HAVE SHOWN an ASSOCIATION between lower maternal Vitamin D levels and shorter Gestation and smaller Knee-Heel length (a component of Birth length) [22].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 236)]	8	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'gestation'), ('UBERON_0001485', 'knee joint', 322, 'knee-heel'), ('GO_0007567', 'parturition', 355, 'birth')]
PMC2290997	4/2008	S160-PMC2290997	['OTHER sun-dependent pathways\nthe sun MAY BE BEST KNOWN for boosting Production Of Vitamin D, BUT there are many OTHER uvr-MEDIATED EFFECTS independent of this pathway.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	8	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 68, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC2396486	6/2008	S11-PMC2396486	['disruptions in pathways RELATED to calcium-binding proteins and Mitochondrial function MAY underlie SOME of the behavioural features ASSOCIATED with Animal MODELS of developmental Vitamin D deficiency\n\nintroduction\nbased on CLUES from epidemiology, we have PROPOSED that low Prenatal Vitamin D MAY BE a risk factor for later development of schizophrenia[1].']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 294)]	8	[('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('NCBITaxon_33208', 'Metazoa', 149, 'animal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]
PMC2582131	11/2008	S127-PMC2582131	['IF CONFIRMED, our data RAISE the POSSIBILITY that treating Vitamin D deficiency in Pregnancy, via supplementation OR lifestyle measures, CAN CONTRIBUTE to the PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('EXPLICIT_QUESTION', 23), ('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC2679409	5/2009	S500-PMC2679409	['ANY FUTURE STUDIES of Vitamin A supplementation MUST FOCUS on HIGH-RISK women, assess the most APPROPRIATE Vitamin type and dosage, and show that the intervention is both SAFE for the mother and fetus, and EFFECTIVE.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 62), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 171), ('SUPERFICIAL_RELATIONSHIP', 206)]	8	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
PMC2685863	5/2009	S1-PMC2685863	['dietary Vitamin D intake HAS BEEN ASSOCIATED with lower ms risk, and Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED RISK, BUT direct LINKS between Vitamin D and ms have NOT BEEN IDENTIFIED.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 178)]	8	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC2722583	1/2009	S122-PMC2722583	['for example, the fact that Prenatal Folate supplementation substantially reduces the risk of Neural Tube defect ONLY IF it is taken Preconceptually is WELL KNOWN BUT improving Vitamin A status before Pregnancy HAS also BEEN SHOWN to have a dramatic and AS YET UNEXPLAINED EFFECT on maternal morbidity and mortality (west et al 1999).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 253), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 272)]	8	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 36, 'folate'), ('UBERON_0001049', 'neural tube', 93, 'neural tube'), ('GO_0007608', 'sensory perception of smell', 132, 'preconceptually'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin A'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy')]
PMC2798111	12/2010	S95-PMC2798111	['WHILE not powered to assess SAFETY at this juncture, it is IMPORTANT TO NOTE that, thus FAR, there HAVE BEEN no increased rates of infection in the infants or adverse health EFFECTS that COULD BE ATTRIBUTED to Vitamin D supplementation in this cohort.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 88), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	8	[('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC2821652	2/2010	S119-PMC2821652	['in THIS TRIAL, we SOUGHT TO DETERMINE WHETHER there was a significant ASSOCIATION between adherence to Vitamin D supplementation as measured by pill count and assessment of a NOVEL measure of adherence BASED UPON Serum levels of Vitamin D Metabolites in a Pregnant population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 70), ('FULL_UNKNOWN', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_25212', 'metabolite', 239, 'metabolites'), ('GO_0007565', 'female pregnancy', 256, 'pregnant')]
PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
PMC2963768	10/2010	S139-PMC2963768	['the Vitamin D receptor HAS BEEN FOUND within VIRTUALLY every Organ-System (55), and the active Metabolite of Vitamin D is WELL-DESCRIBED as a potent mediator of Cell Proliferation and Differentiation, PARTICULARLY NOTED for its range of EFFECTS on Immune function in laboratory MODELS (56).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 45), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 214), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 278)]	8	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000062', 'organ', 61, 'organ'), ('UBERON_0000467', 'anatomical system', 67, 'system'), ('CHEBI_39382', 'flufenoxuron', 95, 'metabolite'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D'), ('GO_0030154', 'cell differentiation', 161, 'cell proliferation ... differentiation'), ('UBERON_0002405', 'immune system', 248, 'immune')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
PMC3075531	7/2010	S48-PMC3075531	['the ONLY study satisfying this condition used a nested case-control design to sample an underlying prospective cohort comprising over 7 million Individuals who served in the us military and had at least two Serum samples stored in the us department of defense Serum repository.18the study CONCLUDED that Serum concentration of 25 Hydroxyvitamin D in healthy young white Adults is an IMPORTANT PREDICTOR of their risk of developing ms, INDEPENDENTLY from their place of Birth and latitude of residence during childhood.18in a prospective investigation comprising approximately 200,000 women in the usa, Vitamin D intake was measured every 4 years by a comprehensive semi-quantitative Food frequency questionnaire.37the incidence of ms during the 30-year follow-up decreased with increasing Vitamin D intake (p=0.03 for trend) and was 33% lower among women in the highest quintile of Vitamin D intake versus those in the lowest quintile.17furthermore, ms incidence was 41% lower among women taking 400 iu per day or more from Supplements compared with non-users.17ATTEMPTS to RELATE Vitamin D intake to ms risk HAVE also BEEN made in casecontrol studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 435), ('INCOMPLETE_EVIDENCE', 1062), ('SUPERFICIAL_RELATIONSHIP', 1074), ('INCOMPLETE_EVIDENCE', 1109)]	8	[('NCBITaxon_1', 'root', 144, 'individuals'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('UBERON_0001977', 'blood serum', 260, 'Serum'), ('UBERON_0001977', 'blood serum', 304, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 327, '25'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 330, 'hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 370, 'adults'), ('GO_0007567', 'parturition', 469, 'birth'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_33290', 'food', 683, 'food'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 882, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 1024, 'supplements'), ('CHEBI_27300', 'vitamin D', 1081, 'vitamin D')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
PMC3277098	12/2011	S3-PMC3277098	['there is a GROWING BODY of LITERATURE LINKING Vitamin D (Serum 25(Oh)D, Oral Intake and SURROGATE indicators such as latitude) to various immune-RELATED conditions, including allergy, ALTHOUGH the nature of this RELATIONSHIP is STILL UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 184), ('SUPERFICIAL_RELATIONSHIP', 212), ('FULL_UNKNOWN', 228)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 57, 'serum'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 63, '25 ... OH ... D'), ('UBERON_0000165', 'mouth', 72, 'oral'), ('GO_0007631', 'feeding behavior', 77, 'intake')]
PMC3277098	12/2011	S185-PMC3277098	['SUPPORTING this observation are SEVERAL STUDIES which FOUND Vitamin D supplementation to be ASSOCIATED with an INCREASED RISK of atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and Food allergy [70], HOWEVER NONE of these papers are SUPPORTED by biological measures of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 233), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 266)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 214, 'food'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
PMC3296991	2/2012	S21-PMC3296991	['HOWEVER, there are gaps in the understanding of WHETHER AND HOW Vitamin D INFLUENCES fetal Bone Development and WHETHER markers of bone turnover in Cord Blood PREDICT bone Mineral content.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('EXPLICIT_QUESTION', 48), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('EXPLICIT_QUESTION', 112), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0048539', 'bone marrow development', 91, 'bone development'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_46662', 'mineral', 172, 'mineral')]
PMC3347007	4/2012	S166-PMC3347007	['it is QUESTIONABLE WHETHER this ASSOCIATION is random OR IF it REFLECTS a seasonal variation in dietary Vitamin D intake OR in the AWARENESS of the IMPORTANCE of Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 148)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3347028	3/2012	S70-PMC3347028	['[23], SHOWED that Ifn-Γ-mediated Antimicrobial activity of Human Macrophages, especially IMPORTANT in hiv and tuberculosis patients, is DEPENDENT on Vitamin D. BOTH STUDY findings have IMPLICATIONS for the Pregnant woman and her developing fetus, BUT our understanding of such processes following maternal exposure to a pathogen or maternal infection REMAINS SCANT.']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 185), ('ANOMALY_CURIOUS_FINDING', 247), ('INCOMPLETE_EVIDENCE', 351), ('INCOMPLETE_EVIDENCE', 359)]	8	[('PR_000008920', 'interferon alpha-7', 18, 'IFN-γ'), ('CHEBI_65381', 'albizoside C', 33, 'antimicrobial'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_0000235', 'macrophage', 65, 'macrophages'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnant')]
PMC3348565	4/2012	S130-PMC3348565	['these SPECULATIONS RELATE two studies in which supplementation of a single large dose (300\u200800033or 500\u200800023iu) of Vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar DISCREPANCIES in Prostate cancer research with Vitamin D.22our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin d group COULD BE DUE TO such fluctuations IF the HYPOTHESIS is TRUE.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('INCOMPLETE_EVIDENCE', 372), ('PROBLEM_COMPLICATION', 381), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 406), ('INCOMPLETE_EVIDENCE', 413), ('PROBABLE_UNDERSTANDING', 427)]	8	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 228, 'prostate'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3356951	4/2012	S15-PMC3356951	['black People Absorb more uvb in the Melanin of their skin than do white People and, THEREFORE, require more sun exposure to produce the same amount of vitamin D.[4]\nthe high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('PROBABLE_UNDERSTANDING', 84), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 230), ('IMPORTANT_CONSIDERATION', 240), ('PROBLEM_COMPLICATION', 254), ('PROBABLE_UNDERSTANDING', 260), ('SUPERFICIAL_RELATIONSHIP', 292), ('SUPERFICIAL_RELATIONSHIP', 304)]	8	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('GO_0040011', 'locomotion', 13, 'absorb'), ('CHEBI_25179', 'melanins', 36, 'melanin'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'people'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 159, 'D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3407995	7/2012	S436-PMC3407995	['a RECENT cochrane review ASSESSED the EFFECTS and SAFETY of Vitamin D supplementation in Pregnancy and EXAMINED WHETHER supplementation with Vitamin D alone OR in combination with Calcium and other Vitamins and Minerals given to women during Pregnancy COULD SAFELY improve Pregnancy outcomes [175].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 252), ('IMPORTANT_CONSIDERATION', 258)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 180, 'calcium'), ('CHEBI_33277', 'gamma-tocotrienol', 198, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 211, 'minerals'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]
PMC3427192	4/2012	S42-PMC3427192	['studies of Vitamin D status in school-age children with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe persistent asthmaasthma exacerbationsincreased 25(Oh)D ASSOCIATED with reduced hospitalization, reduced Anti-Inflammatory Medication use and reduced Airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate persistent asthmahospitalization or emergency Department visitbaseline 25(Oh)D levels < 30 ng/ml ASSOCIATED with higher odds of hospitalization or emergency department over 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled and POORLY controlled asthmaspirometry, asthma controlpositive CORRELATIONS NOTED between 25(Oh)d and asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung function and Airway hyperresponsivenesslower Serum 25(Oh)D ASSOCIATED with decreased Lung function and increased Airway hyperresponsiveness with exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans with and without asthmaphysician-diagnosed asthmadecreased 25(Oh)D in asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, parallel arm clinical trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations in children with Vitamin D3Supplementation added to inhaled Budesonidesearing742010100 (64)7cross-sectionalmoderate to severe persistent asthmacorticosteroid use and Airflow limitationdecreased 25(Oh)D ASSOCIATED with lower Lung function and higher Corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind clinical trialschoolchildren (allcomers), subgroup with physician-diagnosed asthmaasthma exacerbationsreduced risk of asthma exacerbations in the subgroup with asthma after Vitamin D3Supplementation\nother cross-sectional studies of Vitamin D status have also examined the ASSOCIATIONS between 25(Oh)D concentrations and asthma Control in school-age children.']	[('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 516), ('PROBLEM_COMPLICATION', 656), ('SUPERFICIAL_RELATIONSHIP', 715), ('ANOMALY_CURIOUS_FINDING', 728), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1476), ('SUPERFICIAL_RELATIONSHIP', 1873)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH)D'), ('CHEBI_60426', 'dioleoyl phosphatidylglycerol', 290, 'anti-inflammatory medication'), ('UBERON_0001005', 'respiratory airway', 335, 'airway'), ('UBERON_0008247', 'tube foot', 465, 'department'), ('CHEBI_71657', 'versiconol acetate', 490, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 490, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 742, '25(OH'), ('UBERON_0001005', 'respiratory airway', 845, 'airway'), ('UBERON_0001977', 'blood serum', 877, 'serum'), ('CHEBI_71657', 'versiconol acetate', 883, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 885, '(OH ... D'), ('UBERON_0002048', 'lung', 917, 'lung'), ('UBERON_0001005', 'respiratory airway', 945, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1103, '25(OH)D'), ('CHEBI_52915', 'phosphatediyl group', 1291, 'vitamin D3supplementation'), ('CHEBI_72362', 'phosphatidylethanolamine 44:1-OH', 1334, 'budesonideSearing742010100'), ('UBERON_0001005', 'respiratory airway', 1440, 'airflow'), ('CHEBI_71657', 'versiconol acetate', 1468, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1468, '25(OH)D'), ('UBERON_0002048', 'lung', 1498, 'lung'), ('CHEBI_36916', 'cation', 1523, 'corticosteroid'), ('CHEBI_52915', 'phosphatediyl group', 1774, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 1833, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1894, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1900, 'D'), ('GO_0065007', 'biological regulation', 1928, 'control')]
PMC3427192	4/2012	S52-PMC3427192	['in these sub-analyses, Vitamin D3Supplementation was ASSOCIATED with a decreased risk of exacerbations compared with Placebo, with a relative risk of 0.17.75similarly, in a more RECENT randomized, double-blind 6-mo trial where 800 µg of inhaled Budesonide was administered daily to a small group of 48 children with asthma in the presence or absence of 500 iu/day of Vitamin D3, children receiving supplemental Vitamin D did not have a reduction in 25(Oh)D during the winter months and also had a reduced risk of asthma exacerbations triggered by acute Respiratory Viral infections.73these INITIAL FINDINGS SUGGEST that Vitamin D supplementation MAY have therapeutic benefit children with asthma, ALTHOUGH ADDITIONAL randomized, double-blind, placebo-controlled STUDIES ARE NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 607), ('INCOMPLETE_EVIDENCE', 646), ('ANOMALY_CURIOUS_FINDING', 697), ('FUTURE_WORK', 706), ('FUTURE_WORK', 762)]	8	[('CHEBI_52915', 'phosphatediyl group', 23, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D3supplementation'), ('CHEBI_26130', 'biological pigment', 117, 'placebo'), ('CHEBI_3219', 'bupropion', 245, 'budesonide'), ('CHEBI_33279', 'vitamin D5', 367, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 367, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 449, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 455, 'D'), ('UBERON_0001004', 'respiratory system', 553, 'respiratory'), ('NCBITaxon_1', 'root', 565, 'viral'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D')]
PMC3427192	4/2012	S65-PMC3427192	['Haplotype analysis of the vdr polymorphisms SHOWED a significant ASSOCIATION with asthmavollmert90200432munich, germany/ germansnps in the vdr and Integrin Β7None of the Snps were ASSOCIATED with asthmawjst912005951munich, germany/ germany and sweden13 Snps in the vdrin unaffected siblings, Allele in the 5′ region was undertransmitted while two other Alleles in the 3′ terminal region were overtransmittedwjst922006947munich, germany/ germany and swedenserum levels of Vitamin D and genotyping of dna Single Base variantsat least one positive Snp with a transmission disequilibrium of for asthma or total Ige and Vitamin D was FOUND in several Genes\nONLY a HANDFUL OF STUDIES have evaluated the LINK between asthma and polymorphisms in other Genes INVOLVED in Vitamin d synthesis, bioavailability and Metabolism.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 629), ('INCOMPLETE_EVIDENCE', 652), ('INCOMPLETE_EVIDENCE', 659), ('SUPERFICIAL_RELATIONSHIP', 697), ('SUPERFICIAL_RELATIONSHIP', 750)]	8	[('SO_0001024', 'haplotype', 0, 'Haplotype'), ('PR_000009070', 'integrator complex subunit 3', 147, 'integrin β7None'), ('SO_0000694', 'SNP', 170, 'SNPs'), ('SO_0000694', 'SNP', 253, 'SNPs'), ('SO_0001023', 'allele', 292, 'allele'), ('SO_0001023', 'allele', 353, 'alleles'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D'), ('SO_0000984', 'single', 503, 'single base'), ('SO_0000694', 'SNP', 545, 'SNP'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 607, 'IgE'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('SO_0000704', 'gene', 646, 'genes'), ('SO_0000704', 'gene', 744, 'genes'), ('CHEBI_33229', 'vitamin (role)', 762, 'vitamin'), ('GO_0008152', 'metabolic process', 803, 'metabolism')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3470091	9/2012	S94-PMC3470091	['conclusion\nthe FINDINGS of the study INDICATE that intramuscular administration of a single dose of 300,000 iu of Vitamin D is EFFECTIVE and SAFE to improve Vitamin D status, and to ameliorate the FACTORS RELATED to the health of mothers and infants, PARTICULARLY in the regions with SEVERE Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 197), ('SUPERFICIAL_RELATIONSHIP', 205), ('ANOMALY_CURIOUS_FINDING', 251), ('IMPORTANT_CONSIDERATION', 284)]	8	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC3472720	8/2012	S11-PMC3472720	['this season of Birth EFFECT, combined with an OBSERVED latitude gradient in incidence (higher risk at higher latitude) [10], SUGGEST that an environmental FACTOR, POSSIBLY Vitamin D exposure, MAY BE IMPORTANT in PREDICTING ms risk.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 192), ('IMPORTANT_CONSIDERATION', 199), ('SUPERFICIAL_RELATIONSHIP', 212)]	8	[('GO_0007567', 'parturition', 15, 'birth'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC3476426	8/2012	S128-PMC3476426	['Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders SUGGESTING that Vitamin D MIGHT play a ROLE in Regulating auto-Antibody production [5,6].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001442', 'skeleton of manus', 93, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulating'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
PMC3488410	10/2012	S5-PMC3488410	['we will specifically discuss the Vitamin D deficiency MODEL, the poly i:c MODEL, the Ketamine MODEL, and the Postnatal Ventral Hippocampal lesion MODEL, all of which REFLECT core Neurodevelopmental ISSUES UNDERLYING schizophrenia onset.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 166), ('IMPORTANT_CONSIDERATION', 198), ('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_6121', 'ketamine', 85, 'ketamine'), ('GO_0007567', 'parturition', 109, 'postnatal'), ('UBERON_0000218', 'vertebral arch of axis', 119, 'ventral hippocampal'), ('GO_0007399', 'nervous system development', 179, 'neurodevelopmental')]
PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
PMC3488410	10/2012	S136-PMC3488410	['AS hippocampal Neurogenesis plays an IMPORTANT ROLE in Learning and Memory processes [74], we SPECULATE that the PREVIOUSLY DEMONSTRATED normalization of a Vitamin D deficiency-induced Habituation deficit in the hole board by Haloperidol [136] COULD result from an AT LEAST partially restored mitotic activity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 244), ('PROBABLE_UNDERSTANDING', 265)]	8	[('GO_0022008', 'neurogenesis', 15, 'neurogenesis'), ('GO_0007612', 'learning', 55, 'learning'), ('GO_0007613', 'memory', 68, 'memory'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0046959', 'habituation', 185, 'habituation'), ('CHEBI_5613', 'haloperidol', 226, 'haloperidol')]
PMC3509518	11/2012	S116-PMC3509518	['the POTENTIAL PROTECTIVE EFFECTS of Vitamin C and antioxidant rich foods on allergic disease HAVE BEEN NOTED in a NUMBER OF PREVIOUS STUDIES, including LINKS between higher intakes of antioxidant rich Foods, better Pulmonary function and reduced risk of wheeze [21].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 152)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_33290', 'food', 201, 'foods'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC3515553	12/2012	S21-PMC3515553	['the AIM of THIS STUDY was TO EXAMINE the ASSOCIATION of maternal dietary Intake of Vitamin B-12 and also of Snps in Fut2 and tcn2 with offspring iq assessed at age 8 in a population of european origin.figure 1shows the framework for the HYPOTHESIS that we have EXAMINED HERE concerning the LINKS between maternal Vitamin B-12 during Pregnancy with offspring iq.10.1371/journal.pone.0051084.g001\n\ncaption (fig): figure 1\ndiagram showing the framework of the mendelian randomization approach used in this study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 237), ('QUESTION_ANSWERED_BY_THIS_WORK', 261), ('QUESTION_ANSWERED_BY_THIS_WORK', 270), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 83, 'vitamin B-12'), ('SO_0000694', 'SNP', 108, 'SNPs'), ('PR_000007719', 'frizzled-2', 116, 'FUT2'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin B'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy')]
PMC3515553	12/2012	S134-PMC3515553	['conditioning on offspring genotype made this ASSOCIATION SOMEWHAT stronger, giving SUPPORT to the HYPOTHESIS that offspring iq score MAY BE INFLUENCED by maternal Vitamin B-12 status during the Intra-Uterine or Perinatal Period RATHER than REFLECT post-Natal offspring exposure to dietary Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('SUPERFICIAL_RELATIONSHIP', 240)]	8	[('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 163, 'vitamin B-12'), ('UBERON_0001273', 'ilium', 194, 'intra'), ('UBERON_0000995', 'uterus', 200, 'uterine'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal period'), ('GO_0007567', 'parturition', 253, 'natal'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 289, 'vitamin B-12')]
PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC3582478	2/2013	S10-PMC3582478	['changes in Fatty Acid composition during Pregnancy quickly return to the normal range following Parturition HOWEVER, an increase in the Omega-6/3 ratio increases the risk of Ppd11,12low maternal Omega-3 Polyunsaturated Fatty Acid Intake is SUGGESTED to CONTRIBUTE to decreased maternal and fetal health, INTERACTING with the Serotonin transporter Alleles to CONTRIBUTE TO ppd.13\ndecreased Pregnancy Vitamin D ASSOCIATES with many RISK FACTORS for ppd, including Preeclampsia,14SUGGESTING that it will indirectly Modulate ppd susceptibility.']	[('ANOMALY_CURIOUS_FINDING', 108), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 358), ('SUPERFICIAL_RELATIONSHIP', 409), ('SUPERFICIAL_RELATIONSHIP', 430), ('INCOMPLETE_EVIDENCE', 475)]	8	[('CHEBI_35366', 'fatty acid', 11, 'fatty acid'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0019230', 'proprioception', 96, 'parturition'), ('CHEBI_30823', 'oleate', 136, 'omega'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 174, 'PPD11'), ('CHEBI_79370', 'ibho#10', 195, 'omega-3'), ('GO_0033576', 'protein glycosylation in cytosol', 203, 'polyunsaturated fatty acid intake'), ('CHEBI_35366', 'fatty acid', 219, 'fatty acid'), ('CHEBI_28790', 'serotonin', 325, 'serotonin'), ('SO_0001023', 'allele', 347, 'alleles'), ('GO_0007565', 'female pregnancy', 389, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 462, 'preeclampsia'), ('GO_0065007', 'biological regulation', 512, 'modulate')]
PMC3613945	2/2013	S63-PMC3613945	['IN CONTRAST, the ROLE of Vitamin D and dbp in Innate Immunity HAS BEEN appreciated ONLY more RECENTLY, EITHER through its INVOLVEMENT in the Vitamin D transport pathway OR by independent mechanisms51.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0045087', 'innate immune response', 46, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3613945	2/2013	S188-PMC3613945	['overall EVIDENCE SUGGESTS that Vitamin D PROTECTS against asthma, BUT the precise nature of this RELATIONSHIP is AMBIGUOUS and INCONSISTENT findings are LIKELY a function of epidemiological context.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('PROBABLE_UNDERSTANDING', 153)]	8	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3641012	4/2013	S21-PMC3641012	['determination of the Vitamin D intake level (and corresponding Serum 25(Oh)D concentration) that SAFELY optimizes Vitamin D-responsive maternal-infant health outcomes would have GLOBAL IMPLICATIONS, but MAY be particularly RELEVANT to resource-poor communities in south asia, where a relatively low Prenatal Vitamin D status OVERLAPS with a HIGH BURDEN of morbidity and mortality ASSOCIATED with adverse Birth and early infant health outcomes [15].']	[('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 185), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 325), ('IMPORTANT_CONSIDERATION', 341), ('SUPERFICIAL_RELATIONSHIP', 380)]	8	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 69, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 299, 'prenatal'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('GO_0007567', 'parturition', 404, 'birth')]
PMC3641012	4/2013	S163-PMC3641012	['ALTHOUGH δ25(Oh)D was inversely ASSOCIATED with baseline Vitamin D status, and ABOUT 24% of the variance in δ25(Oh)D in the Vitamin D group was EXPLAINED by baseline 25(Oh)D, this ASSOCIATION APPEARED TO BE due to regression to the mean, SINCE similar TRENDS were observed in both the Vitamin D and placebo groups.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 79), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 180), ('ANOMALY_CURIOUS_FINDING', 192), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 252)]	8	[('CHEBI_33010', 'chromide(1-)', 12, '(OH)D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 111, '(OH)D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 166, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3651971	5/2013	S142-PMC3651971	['the Human studies that have SUGGESTED a ROLE for Vitamin A in Cognitive and Motor Development are LIMITED to much younger children.1718another POSSIBLE EXPLANATION for our results is that differences between groups were attenuated by routine supplementation from the national Vitamin A programme started in 1995.30given the wide cis for experimental measures of Cognitive and motor development, and the POTENTIAL for Brain plasticity, the supplementation programme MIGHT have attenuated a treatment EFFECT, allowing placebo group children to regain the nutritional losses of their early Life.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 152), ('INCOMPLETE_EVIDENCE', 403), ('INCOMPLETE_EVIDENCE', 465), ('SUPERFICIAL_RELATIONSHIP', 499)]	8	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('GO_0050890', 'cognition', 62, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 76, 'motor development'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A'), ('GO_0050890', 'cognition', 362, 'cognitive'), ('UBERON_0000955', 'brain', 417, 'brain'), ('UBERON_0000104', 'life cycle', 587, 'life')]
PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC3668200	5/2013	S1-PMC3668200	['ALTHOUGH the authors STATED SOME exclusion criteria, the study lacks SOME guidelines for CONSIDERATIONS in the evaluation of Vitamin D deficiency, especially those pertaining to FACTORS that can AFFECT the Vitamin concentration in the body.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69), ('FUTURE_WORK', 89), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 206, 'vitamin')]
PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3672018	5/2013	S44-PMC3672018	['BOTH STUDIES SUGGEST that Prenatal malnutrition strongly IMPACTS Adult health, ALTHOUGH neither INDICATES specific EFFECTS from the lack of Vitamin D. the EFFECT of Vitamin D levels during Gestation, THUS, has never previously been followed in large populations.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 155), ('PROBABLE_UNDERSTANDING', 200)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('UBERON_0007023', 'adult organism', 65, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'gestation')]
PMC3691177	6/2013	S109-PMC3691177	['our results SUGGEST that the MOST LIKELY EXPLANATION for the FINDING of decreased wheezing risk in offspring of mothers with a higher Vitamin D intake during Pregnancy in observational studies[1]–[4], is CONFOUNDING by OTHER dietary or lifestyle factors ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 29), ('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 219), ('SUPERFICIAL_RELATIONSHIP', 254)]	8	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3695234	7/2013	S67-PMC3695234	['in that study, a significant INTERACTION between Il4 Gene polymorphism and Vitamin D deficiency was OBSERVED.17THESE data INDICATE that Vitamin D deficiency MAY increase the risk of Food sensitization in certain genotypes, PROVIDING EVIDENCE of Gene-Vitamin D INTERACTION in Food sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 157), ('PROBABLE_UNDERSTANDING', 223), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 260)]	8	[('PR_000008989', 'interleukin-1 family member 7', 49, 'IL4'), ('SO_0000704', 'gene', 53, 'gene'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('SO_0000704', 'gene', 245, 'gene'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_33290', 'food', 275, 'food')]
PMC3702245	6/2013	S2-PMC3702245	['CONSISTENT with the expanded ROLE of Vitamin D, RECENT OBSERVATIONAL STUDIES have DEMONSTRATED that low Vitamin D status in Pregnancy is ASSOCIATED with multiple POTENTIAL adverse maternal, fetal, and infant outcomes and CONTRIBUTES to low Vitamin D status in infants at Birth.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 137), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 221)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007567', 'parturition', 271, 'birth')]
PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
PMC3702245	6/2013	S60-PMC3702245	['HOWEVER, a committee of Vitamin D EXPERTS99AND the Endocrine society8recommend a target Serum concentration >75 nmol/l BASED ON the AVAILABLE EVIDENCE in order to achieve optimal benefits for Skeletal health as well as POTENTIAL nonskeletal BENEFITS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 241)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 51, 'Endocrine'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]
PMC3717170	5/2013	S0-PMC3717170	['Vitamin D: beyond bone\n\nabstract\nin RECENT YEARS, Vitamin D HAS BEEN received INCREASED ATTENTION due TO the resurgence of Vitamin D deficiency and rickets in developed countries and the IDENTIFICATION of Extraskeletal EFFECTS of Vitamin D, SUGGESTING UNEXPECTED benefits of Vitamin D in health and disease, beyond bone health.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 241), ('ANOMALY_CURIOUS_FINDING', 252)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 205, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]
PMC3717170	5/2013	S73-PMC3717170	['YET, before such FINDINGS are fully EMBRACED, the mechanism(s) of action of Vitamin D and its PROTECTIVE EFFECT during Pregnancy MUST BE BETTER delineated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 137)]	8	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3717170	5/2013	S208-PMC3717170	['CONTINUING RESEARCH IS NEEDED to BETTER UNDERSTAND the RELATIONSHIPS between Vitamin D and Extraskeletal health and to determine the OPTIMAL dose of Vitamin D for Individuals BASED ON age, health conditions, and other FACTORS.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 133), ('SUPERFICIAL_RELATIONSHIP', 175), ('SUPERFICIAL_RELATIONSHIP', 218)]	8	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 91, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC3728489	7/2013	S312-PMC3728489	['it HAS BEEN PROPOSED, THOUGH NOT PROVEN, that low levels of Vitamin D during Pregnancy and infancy COULD increase the RISK of Neurodevelopmental disorders, and that supplementation COULD play a ROLE in prevention.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 126, 'neurodevelopmental')]
PMC3739737	8/2013	S163-PMC3739737	['RECENTLY, EVIDENCE has EMERGED from Animal MODELS to SUGGEST that Vitamin D insufficiency or deficiency MAY exacerbate the progression of an UNDERLYING Brain disorder.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('NCBITaxon_33208', 'Metazoa', 36, 'animal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3739737	8/2013	S176-PMC3739737	['FURTHER REFINEMENTS to the MODEL, such as combined with second hit exposures, MAY BE NECESSARY to MORE adequately MODEL the EFFECTS of Vitamin D deficiency in Human populations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 85), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC3760821	9/2013	S174-PMC3760821	['POTENTIAL mechanisms by which Vitamin D MIGHT INFLUENCE Glycaemic Control in t1dm include, the IMPACT of this Vitamin on Intracellular Calcium Regulation and, THUS, Glucose transport in target Tissues, INFLUENCES on Insulin receptor Expression and the EFFECT of Vitamin D on systemic inflammation ASSOCIATED with Insulin resistance[31],[32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 252), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 56, 'glycaemic control'), ('CHEBI_33229', 'vitamin (role)', 110, 'vitamin'), ('GO_0005622', 'intracellular anatomical structure', 121, 'intracellular'), ('GO_0006260', 'DNA replication', 121, 'intracellular'), ('GO_0051303', 'establishment of chromosome localization', 135, 'calcium regulation'), ('CHEBI_17234', 'glucose', 165, 'glucose'), ('UBERON_0000479', 'tissue', 193, 'tissues'), ('PR_000045358', 'insulin family protein', 216, 'insulin'), ('GO_0010467', 'gene expression', 233, 'expression'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('PR_000045358', 'insulin family protein', 313, 'insulin')]
PMC3760821	9/2013	S184-PMC3760821	['in conclusion, the FINDING that Vitamin D DEPENDENT processes MAY BE negatively IMPACTED by maternal nutritional status and obesity in a t1dm cohort is a significant one and provides FURTHER EVIDENCE that population-based INTERVENTIONS aimed at reducing obesity and improving pre-Pregnancy and Gestational Vitamin D status ARE NEEDED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 80), ('FUTURE_WORK', 183), ('INCOMPLETE_EVIDENCE', 183), ('FUTURE_WORK', 222), ('FUTURE_WORK', 323)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 280, 'pregnancy'), ('GO_0007565', 'female pregnancy', 294, 'gestational'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC3773018	4/2013	S79-PMC3773018	['furthermore, OUR FINDINGS REMAINED SIMILAR after controlling for season of Birth or stratification by season of Birth, INDICATING that Birth season is UNLIKELY to MEDIATE the ASSOCIATIONS between persistently low Vitamin D and risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 151), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 175)]	8	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 135, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3798907	8/2013	S16-PMC3798907	['BASED ON these FINDINGS, there HAVE BEEN CALLS FOR trials of Vitamin E based intervention during Pregnancy [14].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC3798907	8/2013	S136-PMC3798907	['the original ASSOCIATION between maternal Vitamin E and cbmc responses was INDEPENDENT of many POTENTIALLY CONFOUNDING FACTORS (Birth order, maternal atopy, maternal smoking, sex [12], and maternal bmi [27], MAKING IT UNLIKELY that any EFFECT of in vitro Vitamin E supplementation was being negated by extraneous factors, moreover the EFFECT of supplementation was compared with an unsupplemented control for each subject.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 75), ('INCOMPLETE_EVIDENCE', 95), ('PROBLEM_COMPLICATION', 107), ('PROBABLE_UNDERSTANDING', 208), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 335)]	8	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('GO_0007567', 'parturition', 128, 'birth'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin E')]
PMC3809191	1/2013	S53-PMC3809191	['THIS EVIDENCE is CONSISTENT with low Vitamin D levels in either Pregnant or non-Pregnant Individuals in our country as in the rest of the world.11,12HOWEVER we did not FIND significant association of low levels of Serum 25 (Oh) D with elevated RISK for gdm EVEN after adjustment for conventional risk FACTORS for diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('IMPORTANT_CONSIDERATION', 244), ('ANOMALY_CURIOUS_FINDING', 257), ('SUPERFICIAL_RELATIONSHIP', 301)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('UBERON_0001977', 'blood serum', 214, 'serum'), ('CHEBI_71657', 'versiconol acetate', 220, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25 (OH) D')]
PMC3814422	10/2013	S11-PMC3814422	['it HAS BEEN ARGUED that maternal Vitamin D deficiency MIGHT, AT LEAST IN PART, EXPLAIN the rising PREVALENCE of asthma and allergic disease in SOME countries2.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 98), ('INCOMPLETE_EVIDENCE', 143)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC3829803	11/2013	S256-PMC3829803	['THIS is the FIRST work to DEMONSTRATE the antiviral EFFECT of Vitamin A on Muv and MAY CONTRIBUTE to better treatment OPTIONS for Muv.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87), ('FUTURE_WORK', 118)]	8	[('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'MuV'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'MuV')]
PMC3873449	12/2013	S44-PMC3873449	['the results SHOULD provide a BETTER UNDERSTANDING of the maternal FACTORS that INFLUENCE Vitamin D status during Pregnancy and help in raising AWARENESS as well as SUGGESTING STRATEGIES to prevent Vitamin D deficiency in china.']	[('FUTURE_WORK', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 143), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 175)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]
PMC4113768	7/2014	S17-PMC4113768	['sex-specific ASSOCIATIONS between 25-Hydroxy Vitamin D3And Serum Lipids in elderly german subjects without intake of Lipid-modifying Drugs\n\njungert, a.; neuhäuser-berthold, m.\nbackground: ALTHOUGH EMERGING EVIDENCE INDICATES an ASSOCIATION between Vitamin D and Serum Lipids, the data are STILL INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 289), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	8	[('CHEBI_668', '1-Phenyl-5-heptene-1,3-diyne', 34, '25-Hydroxy Vitamin D3and'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'Vitamin D3and'), ('UBERON_0001977', 'blood serum', 59, 'Serum'), ('CHEBI_18059', 'lipid', 65, 'Lipids'), ('CHEBI_18059', 'lipid', 117, 'Lipid'), ('CHEBI_23888', 'drug', 133, 'Drugs'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_18059', 'lipid', 268, 'lipids')]
PMC4113768	7/2014	S817-PMC4113768	['the CORRELATIONS between dbp levels and several amino acid transporters SUGGEST that Vitamin D Delivery MAY BE IMPORTANT for Placental function, but FURTHER WORK is now REQUIRED to establish WHETHER these ASSOCIATIONS are causal.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 111), ('FUTURE_WORK', 149), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 125, 'placental')]
PMC4113768	7/2014	S1173-PMC4113768	['THIS STUDY has two AIMS: (1) TO EXAMINE the ASSOCIATION between Vitamin D status and qus and bmd; and (2) TO EXAMINE WHETHER gender, age, physical activity or body mass index (bmi) MODIFY these ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4113768	7/2014	S1783-PMC4113768	['the epidemiological data INDICATE that Vitamin D deficiency is relatively COMMON, AT LEAST in SOME parts of the united states and europe, and that INADEQUATE Serum levels of the Vitamin D are ASSOCIATED with an INCREASED RISK and POOR prognosis of several types of cancer.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 74), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 211), ('IMPORTANT_CONSIDERATION', 230)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_28384', 'vitamin K', 178, 'Vitamin D')]
PMC4113768	7/2014	S1793-PMC4113768	['the AIM of the PRESENT STUDY was to follow up the study participants INVESTIGATING WHETHER the EFFECT of Vitamin D is restricted to the Prenatal period OR can also be SEEN in one or two year old infants INDEPENDENTLY from the maternal status during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 203)]	8	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('GO_0007565', 'female pregnancy', 249, 'pregnancy')]
PMC4113768	7/2014	S2071-PMC4113768	['a WIDE RANGE of non-Skeletal conditions HAVE BEEN ASSOCIATED with Vitamin D deficiency, BUT EVIDENCE for a causal LINK is INCONCLUSIVE and INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('UBERON_0004288', 'skeleton', 20, 'skeletal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4113768	7/2014	S2517-PMC4113768	['THESE FINDINGS SUGGEST that; (1) there is no additional BENEFIT to calcium absorption or bone mineralisation from a Blood level for 25(Oh)D above ~75 nmol/l; (2)DESPITE adequate Vitamin D and regular physical activity lower dietary Calcium intake is STILL a PREDICTOR of lower total body bmd and bmc; and (3) in certain population groups with baseline 25(Oh)D > 75 nmol/l, Vitamin D supplementation of 50,000 iu/month does not significantly increase 25(Oh)D concentrations over a 12 month period, but POSSIBLY PREVENTS seasonal decline.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 258), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 510)]	8	[('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 352, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 450, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 450, '25(OH)D')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4231606	10/2013	S113-PMC4231606	['WHILE HISTORICAL EVIDENCE SUGGESTS that Vitamin D supplementation CAN PREVENT caries onset and progression, much of this RESEARCH has been OVERLOOKED [18,29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4231606	10/2013	S117-PMC4231606	['RECENTLY, a meta-analysis REPORTED that Vitamin D supplementation in childhood CAN help PREVENT caries [30], and it HAS also BEEN SUGGESTED that concentrations of 25(Oh)D between 75–100\xa0nmol/l MAY reduce the RISK for Caries [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 193), ('IMPORTANT_CONSIDERATION', 208)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 165, '(OH)D'), ('CHEBI_23042', 'carotene', 217, 'caries')]
PMC4251419	12/2014	S1-PMC4251419	['the active form of Vitamin D has an IMPORTANT ROLE in Calcium Metabolism and in bone mineralisation, BUT the EVIDENCE for OTHER health outcomes is MIXED, with the strongest EFFECTS SEEN in the weakest epidemiological study designs.']	[('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 181)]	8	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 54, 'calcium metabolism')]
PMC4251419	12/2014	S27-PMC4251419	['DESPITE these relatively COHERENT FINDINGS from ecologic and OBSERVATIONAL studies, and PLAUSIBLE biological mechanisms, trials of Vitamin D supplementation for the PREVENTION of Immune-related diseases have LARGELY returned null results [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 208)]	8	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0002405', 'immune system', 179, 'immune')]
PMC4251419	12/2014	S145-PMC4251419	['TRADITIONALLY the level of total 25(Oh)D HAS BEEN CONSIDERED the best ESTIMATE of Vitamin D status, BUT RECENT STUDIES have SUGGESTED that the “bioavailable” (albumin-bound and free) 25(Oh)D concentration MAY BE more RELEVANT to health and disease [83].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 217)]	8	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC4251419	12/2014	S161-PMC4251419	['EFFECTS MAY not be direct, but COULD work through alterations in the microbiome, OR be ONLY PARTLY Vitamin D-MEDIATED, with exposure to uvr itself also IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 152)]	8	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4256222	12/2014	S18-PMC4256222	['DIFFERENT LINES of EVIDENCE also SUGGEST that maternal Vitamin D status MAY IMPACT offspring bone health in the short as well as the long term, BUT the studies have shown CONFLICTING results[5]–[9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	8	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S103-PMC4383226	['it is UNCLEAR HOW Vitamin A COULD INTERACT with G6Pd to INFLUENCE the risk of malaria infection; the ONLY literature discussion regarding Vitamin A and G6Pd is LIMITED to Animal FINDINGS on Adipose and Lipogenic activities (higueret et al., 1989;arana et al., 2008).']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 14), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 178)]	8	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 48, 'G6PD'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 152, 'G6PD'), ('NCBITaxon_33208', 'Metazoa', 171, 'animal'), ('UBERON_2000251', 'adipose fin', 190, 'adipose'), ('GO_0008610', 'lipid biosynthetic process', 202, 'lipogenic')]
PMC4383575	1/2015	S196-PMC4383575	['1997), BUT these two SMALL STUDIES DID NOT estimate fruits rich in Vitamin C. LIKEWISE, the inverse ASSOCIATION between dried fruits (rich in Flavonoids) and adduct levels COULD SUGGEST a POTENTIAL inhibition of adduct formation by these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 188)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin C'), ('CHEBI_72544', 'flavonoids', 142, 'flavonoids'), ('CHEBI_33284', 'nutrient', 238, 'nutrients')]
PMC4405493	4/2015	S24-PMC4405493	['THUS, we SOUGHT TO DETERMINE IF Vitamin D deficiency in the first trimester of nulliparous patients is ASSOCIATED with clinical outcomes MOST ASSOCIATED with SIGNIFICANT maternal and fetal morbidity and mortality: Preeclampsia, Gestational diabetes, Preterm Delivery, spontaneous abortion, and growth restriction.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 103), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 158)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 214, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007565', 'female pregnancy', 250, 'preterm'), ('GO_0007567', 'parturition', 258, 'delivery')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4417995	4/2015	S79-PMC4417995	['SINCE sun/uvb exposure increases Vitamin D Serum levels, SOME authors have logically HYPOTHESIZED that ad clinical improvement by sun/uvb MIGHT be MEDIATED at a molecular level by Vitamin D.\nthis is SUPPORTED by the observation that Vitamin D deficiency is ASSOCIATED with more SEVERE skin lesions localized on body sites that are not exposed to sun [37].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 257), ('IMPORTANT_CONSIDERATION', 278)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC4448820	5/2015	S162-PMC4448820	['the case study Nutrients covered in this review are Vitamin A, iron, zinc, Vitamin D, Folic Acid, and Selenium and were chosen on the basis of their PUBLIC HEALTH IMPORTANCE and BECAUSE they provide the MOST RELEVANT EVIDENCE with regard to their KNOWN EFFECT on Immunity.']	[('IMPORTANT_CONSIDERATION', 149), ('IMPORTANT_CONSIDERATION', 163), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 203), ('IMPORTANT_CONSIDERATION', 208), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 253)]	8	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_30751', 'formic acid', 86, 'folic acid'), ('CHEBI_27568', 'selenium atom', 102, 'selenium'), ('GO_0007566', 'embryo implantation', 263, 'immunity')]
PMC4448820	5/2015	S212-PMC4448820	['INTERESTINGLY, this RELATION and its correction are PROPOSED as a POTENTIAL BIOMARKER for znd in a manner ANALOGOUS TO SOME of the classic enzyme stimulation assay for Vitamins (Vitamin B-6, Thiamin, and riboflavin).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 119)]	8	[('CHEBI_33277', 'gamma-tocotrienol', 168, 'vitamins'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('CHEBI_26948', 'vitamin B1', 191, 'thiamin')]
PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4448820	5/2015	S1471-PMC4448820	['BECAUSE Human Milk HAS BEEN SUGGESTED as a POTENTIALLY useful BIOMARKER of Vitamin A status of women and, by extrapolation, of their children and POTENTIALLY OTHER groups within the population (324), it is useful to explore the POTENTIAL IMPACT of inflammation on the use of Breast-Milk Vitamin A concentrations and interpretation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 238)]	8	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('UBERON_0001913', 'milk', 14, 'milk'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('UBERON_0000310', 'breast', 275, 'breast'), ('UBERON_0001913', 'milk', 282, 'milk'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A')]
PMC4488777	5/2015	S31-PMC4488777	['research on the ROLE of Vitamin D in Reproduction Process Modulation SEEMS ESPECIALLY INTERESTING; their CONCLUSIONS PRESUMABLY have a significant practical meaning in infertility treatment, a SERIOUS medical PROBLEM affecting up to 53 million people worldwide [8].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 75), ('ANOMALY_CURIOUS_FINDING', 86), ('PROBABLE_UNDERSTANDING', 105), ('PROBABLE_UNDERSTANDING', 117), ('IMPORTANT_CONSIDERATION', 193), ('IMPORTANT_CONSIDERATION', 209)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0003301', 'physiological cardiac muscle hypertrophy', 37, 'reproduction process modulation')]
PMC4499946	7/2015	S98-PMC4499946	['our PREVIOUS pharmacokinetic FINDINGS among Pregnant women in dhaka [16,40] HAVE GENERALLY BEEN CONSISTENT with published ESTIMATES of the Vitamin D-to-25(Oh)D dose–response RELATIONSHIP in non-Pregnant Adults (i.e., an APPROXIMATELY 0.7 nmol/l increase in 25(Oh)D at steady state for each 1 μg/day of Vitamin D3[41,42]).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 220)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnant'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'OH)D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant'), ('UBERON_0007023', 'adult organism', 203, 'adults'), ('CHEBI_63056', 'zinc cation', 257, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_33279', 'vitamin D5', 302, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 302, 'vitamin D3')]
PMC4499946	7/2015	S296-PMC4499946	['the trial is primarily DESIGNED and powered TO EVALUATE the dose–response EFFECTS of Vitamin D on infant length, an outcome that is directly ALIGNED with the classical ROLE of Vitamin D in Mineral Metabolism and bone health BUT MAY also be interpreted as a SURROGATE marker for Organ (including Brain) Growth and Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 257)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_46662', 'mineral', 189, 'mineral'), ('GO_0008152', 'metabolic process', 197, 'metabolism'), ('UBERON_0000062', 'organ', 278, 'organ'), ('GO_0007420', 'brain development', 295, 'brain ... growth ... development'), ('UBERON_0000955', 'brain', 295, 'brain')]
PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
PMC4516377	6/2015	S72-PMC4516377	['webb, kline & holick36have already EXPLAINED this phenomenon, SHOWING that latitude and seasons AFFECT the quality and quantity of solar radiation that reach earth, especially uvb spectrum, drastically INFLUENCING the cutaneous Synthesis Of Vitamin D. it is also BELIEVED that Vitamin D deficiency MAY BE RELATED to lack of sun exposure in obese Individuals, as they become more sedentary and remain more sheltered from the sun.']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 298), ('SUPERFICIAL_RELATIONSHIP', 305)]	8	[('GO_0030474', 'spindle pole body duplication', 228, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_1', 'root', 346, 'individuals')]
PMC4586450	10/2015	S445-PMC4586450	['both Iron and Vitamin C intakes were lower and calcium intakes higher in the highest compared with the lowest fat intake quartiles ( p< 0.001), and these DIFFERENCES MAY ACCOUNT FOR the lower ferritin concentration FOUND.60because the strongest ASSOCIATION between Nutrient intake and ferritin at age 1.5 years was a negative one with Calcium Intake ( p< 0.001), IT IS POSSIBLE that this is due to the presence of Calcium in the Gut adversely AFFECTING the absorption of iron from the diet.114cows’ Milk is the main source of calcium in the diet at this age (61% of calcium), and the amount of Cows’ Milk consumed was negatively ASSOCIATED with ferritin ( p< 0.001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 170), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 245), ('INCOMPLETE_EVIDENCE', 363), ('SUPERFICIAL_RELATIONSHIP', 443), ('SUPERFICIAL_RELATIONSHIP', 629)]	8	[('CHEBI_24870', 'ion', 5, 'iron'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin C'), ('CHEBI_33284', 'nutrient', 265, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 335, 'calcium'), ('GO_0007631', 'feeding behavior', 343, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 414, 'calcium'), ('UBERON_0001555', 'digestive tract', 429, 'gut'), ('UBERON_0001913', 'milk', 499, 'milk'), ('NCBITaxon_33208', 'Metazoa', 594, 'cows'), ('UBERON_0001913', 'milk', 600, 'milk')]
PMC4586451	10/2015	S18-PMC4586451	['this has LED to dietary RECOMMENDATIONS for Pregnancy that limit concentrated sources of Vitamin A and stress the IMPORTANCE of periconceptional Folic Acid supplementation, which HAS BEEN SHOWN to be PROTECTIVE against Neural Tube defects.4\nTHERE IS EVIDENCE that optimal fetal Neurodevelopment is DEPENDENT on specific Nutrients supplied by the mother mainly from dietary sources; these MAY include Long-Chain polyunsaturated Fatty Acids (lc-pufas) such as Docosahexaenoic Acid (Dha), an N-3 Fatty Acid, and arachidonic acid, an N-6 Fatty Acid.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 388)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('UBERON_0001049', 'neural tube', 219, 'neural tube'), ('GO_0007399', 'nervous system development', 278, 'neurodevelopment'), ('CHEBI_33284', 'nutrient', 320, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 400, 'long-chain'), ('CHEBI_35366', 'fatty acid', 427, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 458, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 480, 'DHA'), ('CHEBI_35245', 'GDP-galactose', 489, 'n-3 fatty acid'), ('CHEBI_18320', '1,4-dithiothreitol', 530, 'n-6'), ('CHEBI_35366', 'fatty acid', 534, 'fatty acid')]
PMC4600246	10/2015	S50-PMC4600246	['it HAS BEEN PRESUMED that Prenatal Vitamin K deficiency induced by warfarin MAY BE the UNDERLYING cause of these calcifications.4344indeed, SEVERAL STUDIES INDICATE a CONNECTION between warfarin and Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 167)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin K'), ('UBERON_0001637', 'artery', 199, 'arterial')]
PMC4600246	10/2015	S68-PMC4600246	['IN SUMMARY, Vitamin K MAY improve Insulin sensitivity in men with diabetes.40\n\nVitamin K and cancer\nVitamin K2Has BEEN SHOWN to inhibit the growth of Human cancer cell lines, including Hepatoma lines, as well as to treat myelodysplastic syndrome.50–53two trials SEEM to INDICATE that Vitamin K245\u2005mg/day reduces the Development Of Hepatocellular Carcinoma (Hcc) in patients with Liver cirrhosis and that Vitamin K2Significantly reduces the recurrence of hcc in patients following the curative treatment of hcc with an ASSOCIATED reduction in all-cause mortality in these patients.54–61the POSSIBLE reduction in mortality with Vitamin K2May be EXPLAINED by multiple mechanisms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 262), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 518), ('INCOMPLETE_EVIDENCE', 589), ('PROBABLE_UNDERSTANDING', 643)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin K'), ('PR_000045358', 'insulin family protein', 34, 'insulin'), ('CHEBI_28384', 'vitamin K', 79, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 100, 'Vitamin'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 108, 'K2has'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0004705', 'fenestra', 185, 'hepatoma'), ('CHEBI_86324', 'quinolone antibiotic', 284, 'vitamin K245'), ('GO_0002234', 'detection of endoplasmic reticulum overloading', 316, 'development of hepatocellular carcinoma'), ('UBERON_0012474', 'hepatic cecum', 331, 'hepatocellular'), ('GO_0000724', 'double-strand break repair via homologous recombination', 357, 'HCC'), ('UBERON_0002107', 'liver', 379, 'liver'), ('CHEBI_64387', 'thiosultap(1-)', 404, 'vitamin K2significantly'), ('CHEBI_27325', 'xanthophyll', 626, 'vitamin K2may'), ('PR_000017209', 'utrophin', 626, 'vitamin K2may')]
PMC4684854	12/2015	S119-PMC4684854	['economic burden of Gestational Vitamin D deficiency\nthe economic IMPACT of Vitamin D deficiency as it RELATES to maternal-fetal health is DIFFICULT to objectively quantify AS INSUFFICIENT evidence has ACCUMULATED THUS FAR on the totality of short- and long-term sequelae of Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 102), ('DIFFICULT_TASK', 138), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 175), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 213)]	8	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4689556	12/2015	S20-PMC4689556	['thus FAR there HAS BEEN a LACK OF randomised controlled trial evidence to definitively confirm OR REFUTE the RELATIONSHIP between Prenatal Vitamin D and childhood health outcomes FOUND in OBSERVATIONAL studies.']	[('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 130, 'prenatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
PMC4764019	1/2016	S39-PMC4764019	['the OBSERVED ASSOCIATION is so strong that mcgrath et al ESTIMATED that 50% of the BURDEN of schizophrenia in the entire country of denmark COULD PERHAPS be ATTRIBUTED to PROBLEMS produced by low Perinatal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 157), ('IMPORTANT_CONSIDERATION', 171)]	8	[('GO_0036268', 'swimming', 196, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 196, 'perinatal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4785305	3/2016	S31-PMC4785305	['in the middle east and north africa region, there are FEW RECENT rcts that attempted to determine the OPTIMAL regimen of Vitamin D replacement in healthy Pregnant women.38–41WITH the exception of soheilykhah et al 40who ASSESSED the EFFECT of Vitamin D supplementation on Insulin resistance, the primary outcomes in THESE studies were MOSTLY maternal and neonatal 25(Oh)D levels (seeonline supplementary appendix1).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 233), ('INCOMPLETE_EVIDENCE', 316), ('PROBABLE_UNDERSTANDING', 335)]	8	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('PR_000045358', 'insulin family protein', 272, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 364, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 364, '25 ... OH ... D')]
PMC4832516	10/2015	S10-PMC4832516	['WHILST OTHER mechanisms MAY contribute to these ASSOCIATIONS, these FINDINGS are CONSISTENT with a POSSIBLE ROLE of in utero Vitamin D exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4889866	5/2016	S89-PMC4889866	['TO OUR KNOWLEDGE, THIS is the FIRST cohort STUDY TO simultaneously ASSESS the EFFECT of both maternal and Cord Blood Vitamin D status on tlr-RELATED immune response and various infectious diseases during Infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'infancy')]
PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5051327	9/2016	S19-PMC5051327	['SEVERAL STUDIES HAVE REPORTED increased frequency of emergency caesarean Delivery in RELATION to low Vitamin D,1415but NO PREVIOUS STUDY HAS BEEN particularly designed to study the RELATION between low Vitamin D levels, measured as 25-Hydroxy\xa0(Oh) Vitamin D, in early Pregnancy and the RISK for fetal distress/Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 85), ('FULL_UNKNOWN', 119), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 181), ('IMPORTANT_CONSIDERATION', 286)]	8	[('GO_0007567', 'parturition', 73, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_29991', 'L-aspartate(1-)', 232, '25-hydroxy (OH)'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 268, 'pregnancy'), ('GO_0007567', 'parturition', 310, 'birth')]
PMC5051327	9/2016	S59-PMC5051327	['this was CONNECTED to the Cyclic Adenosine Monophosphate (Camp) pathway and RELATED to accelerated relaxation.2829this EFFECT was not seen in Vitamin D Receptor knockout Mice, which IMPLIES that the EFFECT is MEDIATED by the Vitamin D receptor which SEEMS IMPORTANT for Cardiac muscle function.2830using a state Cardiac diagram, asphyxia is slowing the Relaxation phase in the fetal Heart.3132pregnancy is a condition with increased Oestrogen levels.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 119), ('PROBABLE_UNDERSTANDING', 182), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 209), ('ANOMALY_CURIOUS_FINDING', 250), ('IMPORTANT_CONSIDERATION', 256)]	8	[('CHEBI_23447', 'cyclic nucleotide', 26, 'cyclic adenosine monophosphate'), ('CHEBI_17489', "3',5'-cyclic AMP", 58, 'cAMP'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 142, 'vitamin D receptor'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000948', 'heart', 270, 'cardiac'), ('UBERON_0000948', 'heart', 312, 'cardiac'), ('GO_0032809', 'neuronal cell body membrane', 353, 'relaxation'), ('UBERON_0000948', 'heart', 383, 'heart'), ('CHEBI_50114', 'estrogen', 433, 'oestrogen')]
PMC5062906	10/2016	S47-PMC5062906	['THESE FINDINGS IMPLICATE a ROLE for Vitamin D in determining epigenetic state and HIGHLIGHT the NEED FOR FURTHER STUDY to determine the mechanism and POTENTIAL LINKS to health and disease.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 96), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]
PMC5129897	10/2016	S151-PMC5129897	['as with all ESTIMATES, these have uncertainties, including the 25(Oh)D concentration–health outcome RELATIONS used; the ESTIMATES of economic BURDENS; whether reducing risk of specific diseases would translate into the same fraction of economic BURDEN; the extent to which changing risk-modifying risk factors such as smoking, alcohol Consumption, diet, and obesity modify the relative reduction due to higher 25(Oh)D concentration; and that the analysis omitted several Vitamin D–sensitive diseases and conditions BECAUSE of LIMITED UNDERSTANDING of the EFFECTS.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 245), ('PROBLEM_COMPLICATION', 515), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 555)]	8	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007631', 'feeding behavior', 335, 'consumption'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5129897	10/2016	S158-PMC5129897	['the ESTIMATES intable\xa09SHOW a POTENTIAL large BENEFIT of improving Vitamin D status in terms of reduction in economic BURDEN ($12.5billion) and premature deaths (23,000/yr) ON THE BASIS OF the types of disease for which EVIDENCE IS STRONG that higher 25(Oh)D concentrations have beneficial EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
PMC5387760	11/2016	S188-PMC5387760	['the advantage of Ca Intake to the Human body also DEPENDS ON OPTIMAL levels of Vitamin D. OUR STUDY’s ability TO DETERMINE multiple INTERACTION EFFECTS among different Micronutrients and Vitamins in RELATION to Birth outcomes and early child survival was LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('QUESTION_ANSWERED_BY_THIS_WORK', 110), ('SUPERFICIAL_RELATIONSHIP', 132), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 255)]	8	[('CHEBI_32588', 'potassium chloride', 17, 'Ca'), ('GO_0007631', 'feeding behavior', 20, 'intake'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33839', 'macromolecule', 168, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 187, 'vitamins'), ('GO_0007567', 'parturition', 211, 'birth')]
PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
PMC5405075	4/2017	S44-PMC5405075	['OF NOTE, Food base approaches MAY BE ASSUMED AS a better representative of long-term Vitamin D Intake, which MIGHT INFLUENCE the fetus during all stages of Gestation and EVEN ex utero .']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('ANOMALY_CURIOUS_FINDING', 170)]	8	[('CHEBI_33290', 'food', 9, 'food'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('GO_0007565', 'female pregnancy', 156, 'gestation')]
PMC5405075	4/2017	S84-PMC5405075	['THEREFORE, it remains to be answered IF a real cause-effect RELATIONSHIP exists OR Vitamin D exerts a PROTECTIVE ROLE via OTHER UNDERLYING mechanisms of this MULTIFACTORIAL disease, such as Lung function or protection against Viral infections.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 128), ('DIFFICULT_TASK', 158)]	8	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'lung'), ('NCBITaxon_1', 'root', 226, 'viral')]
PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5426325	4/2017	S119-PMC5426325	['THUS, we CANNOT RULE OUT WHETHER the Birth cohort results REFLECT a TRUE adverse EFFECT of Vitamin D on bone; one PREVIOUS STUDY did indeed report borderline significant inverse ASSOCIATIONS between maternal late Pregnancy 25(Oh)D concentrations and offspring Forearm fractures(12).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 178)]	8	[('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 223, '25(OH)D'), ('UBERON_0002386', 'forelimb zeugopod', 260, 'forearm')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5513133	7/2017	S145-PMC5513133	['ALTHOUGH these STUDIES FIND an inverse ASSOCIATION between Vitamin D levels and pe, this ASSOCIATION MAY BE CONFOUNDED by the Gestational age at Serum collection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 101), ('DIFFICULT_TASK', 108)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestational'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC5513133	7/2017	S254-PMC5513133	['BUT this Vitamin D level was maintained in ONLY 74% of Pregnancies in the supplementation group by weeks 32 to 38 of Gestation, SUGGESTING that supplementation at EVEN earlier time-points or before Pregnancy MAY BE NECESSARY to maintain sufficient Vitamin D levels that are PROTECTIVE against pe.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 208), ('IMPORTANT_CONSIDERATION', 215), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5537904	7/2017	S17-PMC5537904	['WHILE NUMEROUS STUDIES HAVE REPORTED that higher maternal Vitamin D intake (from Food and/or dietary supplements) is ASSOCIATED with increased Prenatal and/or cord Blood 25(Oh)D levels [14,15,16,17], it is NOT CLEAR WHETHER this TRANSLATES TO an EFFECT on neonatal adiposity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('SUPERFICIAL_RELATIONSHIP', 229), ('SUPERFICIAL_RELATIONSHIP', 246)]	8	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 81, 'food'), ('GO_0007565', 'female pregnancy', 143, 'prenatal'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 176, 'D')]
PMC5546866	8/2017	S127-PMC5546866	['the published gwas (8,22) DID NOT stratify Individuals by Vitamin D supplement usage, which COULD ACCOUNT FOR differing ASSOCIATIONS before and after supplementation in our cohort, or the differing FINDINGS MIGHT REFLECT the LOWER POWER in our study.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 207), ('SUPERFICIAL_RELATIONSHIP', 213), ('INCOMPLETE_EVIDENCE', 225)]	8	[('NCBITaxon_1', 'root', 43, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5638722	8/2017	S101-PMC5638722	['BECAUSE of this, it is NOT SURPRISING that the results of OUR STUDY DID not SHOW Vitamin D level AS an INDEPENDENT risk FACTOR for neonatal sepsis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 120)]	8	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5706533	11/2017	S148-PMC5706533	['THOUGH SOME OBSERVATIONAL STUDIES HAVE SHOWN ASSOCIATIONS between maternal Vitamin D deficiency and Gestational diabetes and pre-eclampsia,22we DID NOT FIND ROBUST corroborating evidence from randomised controlled trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 157)]	8	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
PMC5732505	12/2017	S27-PMC5732505	['MANY of the FINDINGS regarding the RELATIONSHIP between Vitamin D deficiency and gdm are BASED ON case-control STUDIES, which MAY include a POTENTIAL selection BIAS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 140), ('PROBLEM_COMPLICATION', 160)]	8	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5732505	12/2017	S148-PMC5732505	['furthermore, SOME of these FACTORS are RELATED to or CO-EXIST with POOR Vitamin D status [24,25], which further increases the CHALLENGE when dissecting INDEPENDENT EFFECT.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 67), ('DIFFICULT_TASK', 126), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 164)]	8	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5732505	12/2017	S151-PMC5732505	['ALTHOUGH a biological mechanism between low Vitamin D status and diabetes is PLAUSIBLE [29], ONLY a FEW INTERVENTIONS have been conducted, and these HAVE NOT proved an EFFECT of Vitamin D supplementation on RISK of gdm [30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 149), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 207)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5838372	3/2018	S78-PMC5838372	['discussion\nvitamin D deficiency LEADS TO IMPORTANT health PROBLEMS, NOT ONLY in mothers BUT ALSO in their infants, BECAUSE the Vitamin D store of the mother is the MAJOR source of Vitamin D for the fetus (9).']	[('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('ANOMALY_CURIOUS_FINDING', 88), ('PROBABLE_UNDERSTANDING', 115), ('IMPORTANT_CONSIDERATION', 164)]	8	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 19, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC5941617	5/2018	S119-PMC5941617	['ONLY FEW STUDIES evaluated the EFFICACY and SAFETY of intermittent Vitamin D supplementation during the first year of Life, particularly in cases with low compliance [109–111], THUS AT PRESENT daily supplementation REMAINS PREFERRED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 177), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 215), ('PROBABLE_UNDERSTANDING', 223)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC5941617	5/2018	S199-PMC5941617	['particularly, Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING vitamin D Metabolism (table\xa07) (see “Extraskeletal actions of Vitamin D” for specific RECOMMENDATIONS).']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 84), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 195), ('FUTURE_WORK', 291)]	8	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_23888', 'drug', 189, 'drugs'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 213, 'D metabolism'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC5941617	5/2018	S319-PMC5941617	['HOWEVER, it is UNCLEAR WHETHER the OBSERVED Vitamin D deficiency/insufficiency is TO BE CONSIDERED a consequence of the infection itself OR IF it plays a ROLE in determining susceptibility to infections or the severity of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('SUPERFICIAL_RELATIONSHIP', 154)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S386-PMC5941617	['two STUDIES in vitro SHOWED the IMPORTANCE of Vitamin D supplementation in patients affected by Corticosteroid-resistant asthma [315,343] BUT two other STUDIES DEMONSTRATED in vivo that lower 25(Oh)D levels were ASSOCIATED with an increase in Corticosteroids use and an IMPAIRED Lung function [344,345].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 212), ('IMPORTANT_CONSIDERATION', 270)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_36916', 'cation', 96, 'corticosteroid'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_50850', 'etabonate ester', 243, 'corticosteroids'), ('UBERON_0002048', 'lung', 279, 'lung')]
PMC5941617	5/2018	S405-PMC5941617	['furthermore, the use of Vitamin D supplementation for primary PREVENTION of allergic diseases REMAINS an attractive AREA OF STUDY, BUT CURRENT KNOWLEDGE and EVIDENCE DOES NOT ALLOW to RECOMMEND it in routine use.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 157), ('DIFFICULT_TASK', 166), ('FUTURE_WORK', 184)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC6043562	7/2018	S15-PMC6043562	['OTHER STUDIES have FOUND PROTECTIVE ASSOCIATIONS of maternal Antenatal Vitamin D or antioxidant Nutrient intake with later allergic or Respiratory outcomes8–12, THOUGH their findings have NOT always been reproducible13–16.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('ANOMALY_CURIOUS_FINDING', 161), ('ANOMALY_CURIOUS_FINDING', 188)]	8	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_33284', 'nutrient', 96, 'nutrient'), ('UBERON_0001004', 'respiratory system', 135, 'respiratory')]
BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S94-BMJ_2010_Apr_29_340_c1640	['in this setting, there is STRONG a priori EVIDENCE that sun exposure or Vitamin D, or both, is LIKELY to be the central exposure6and LITTLE a priori evidence for any other strong DETERMINANT of multiple sclerosis LIKELY to be LINKED to maternal ambient Ultraviolet radiation exposure during the first Trimester.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 42), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 179), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 253, 'ultraviolet'), ('GO_0009294', 'DNA mediated transformation', 301, 'trimester')]
PMC2290997	4/2008	S83-PMC2290997	['SOME STUDIES have DEMONSTRATED high prevalence of low Vitamin D levels in People with type 2 diabetes, ALTHOUGH it is NOT CLEAR WHETHER this is a cause of the disease or an EFFECT of another causative FACTOR—for example, lower levels of physical activity (in this case, outdoor activity in particular).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ANOMALY_CURIOUS_FINDING', 103), ('FULL_UNKNOWN', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 201)]	7	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'people')]
PMC2581757	11/2008	S14-PMC2581757	['in preeclampsia, an inverse CORRELATION between Vitamin E levels and Lipid peroxidation HAS BEEN FOUND [10] SUGGESTING that Vitamin E content in Plasma MAY BE used as a prognostic MARKER of the LIKELY development of Preeclampsia [11].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 180), ('PROBABLE_UNDERSTANDING', 194)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006266', 'DNA ligation', 69, 'lipid'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 145, 'plasma'), ('GO_0007128', 'meiotic prophase I', 216, 'preeclampsia')]
PMC2581757	11/2008	S16-PMC2581757	['THUS, decreased Plasma levels of Vitamin E COULD BE a CONTRIBUTORY FACTOR of hypertension in preeclampsia, BUT OTHER STUDIES have not demonstrated significant differences in Plasma Vitamin E levels between normal and Preeclamptic women [13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 117)]	7	[('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin E'), ('GO_0007565', 'female pregnancy', 217, 'preeclamptic')]
PMC2581757	11/2008	S198-PMC2581757	['the activities of antioxidant enzymes were also INFLUENCED by the use of Vitamins C and E. the reduction of sod activity during the development of Preeclampsia was controlled as a CONSEQUENCE of Vitamin consumption: the decrease was FOUND TO BE 14% WHEREAS it was 23% in patients who had not used Vitamins C and E. the most prominent EFFECT of the use of these Vitamins was FOUND TO BE ASSOCIATED with the activity of Glutathione reductase.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('SUPERFICIAL_RELATIONSHIP', 334), ('ANOMALY_CURIOUS_FINDING', 374), ('SUPERFICIAL_RELATIONSHIP', 386)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamins C'), ('PR_000004900', 'complement C3', 82, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 88, 'E'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia'), ('CHEBI_33229', 'vitamin (role)', 195, 'vitamin'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('PR_000004900', 'complement C3', 306, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 312, 'E'), ('CHEBI_33277', 'gamma-tocotrienol', 361, 'vitamins'), ('CHEBI_16856', 'glutathione', 418, 'glutathione')]
PMC2582131	11/2008	S85-PMC2582131	['the biologically active form of Vitamin D is 1,25-[Oh] D. HOWEVER, 25-[Oh] D is REGARDED AS the BEST INDICATOR of Vitamin D status in the body because it is the substrate for the Renal and Nonrenal Production Of 1,25-[Oh] D and has a longer biological half-life and higher concentrations in circulation than 1,25-[Oh] D. Plasma 25-[Oh] D REFLECTS Vitamin D from both endogenous and exogenous sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('PROBABLE_UNDERSTANDING', 80), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 96), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 338), ('SUPERFICIAL_RELATIONSHIP', 338)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 47, '25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 67, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006260', 'DNA replication', 179, 'renal ...'), ('UBERON_0002113', 'kidney', 179, 'renal'), ('UBERON_0000970', 'eye', 189, 'nonrenal'), ('GO_0030164', 'protein denaturation', 198, 'production of ... OH] D'), ('CHEBI_84441', '13(S)-HOTrE', 212, '1,25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 310, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 321, 'Plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 328, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
PMC2889879	5/2010	S95-PMC2889879	['we DECIDED not to include dietary Vitamin D ESTIMATES in the final multivariate MODELS AS fish is a rich source of Vitamin D and COULD account for SOME of the EFFECT of fish on our outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 159)]	7	[('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3032617	5/2010	S8-PMC3032617	['conclusion\nthe results of THIS STUDY SUGGEST including Vitamin C in the GUIDELINES of multivitamin PREVENTION for Pregnant women, ESPECIALLY in developing countries where seasonal availability of fruits and Vegetables COULD result in adverse clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_33267', 'elemental nitrogen', 207, 'vegetables')]
PMC3107676	4/2011	S39-PMC3107676	['the PURPOSE of OUR STUDY was (1) TO describe the prevalence and PATTERNS of Nitrosatable Drug use among u.s. women during the first Trimester of Pregnancy, including type of Drug (secondary or tertiary Amine, amide) and indication of use; (2) TO EXAMINE maternal factors ASSOCIATED with Nitrosatable Drug use; and (3) TO INVESTIGATE the prevalence of supplemental Vitamin C use among women who took Nitrosatable Drugs in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 318)]	7	[('CHEBI_75872', '(R)-sarin', 76, 'nitrosatable drug'), ('GO_0009294', 'DNA mediated transformation', 132, 'trimester'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_23888', 'drug', 174, 'drug'), ('CHEBI_32952', 'amine', 202, 'amine'), ('CHEBI_7587', 'nitroalkane', 287, 'nitrosatable'), ('CHEBI_23888', 'drug', 300, 'drug'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin C'), ('CHEBI_7496', 'nelfinavir', 399, 'nitrosatable drugs'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy')]
PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
PMC3257641	3/2010	S6-PMC3257641	['in THIS REVIEW, we OUTLINE the RESEARCH EVIDENCE TO DATE RELATING to Vitamin D status and Pregnancy, including a range of POSSIBLE health outcomes from pre-Conception to later Life (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 122)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007620', 'copulation', 156, 'conception'), ('UBERON_0000104', 'life cycle', 176, 'life')]
PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC3257641	3/2010	S141-PMC3257641	['a TENTATIVE LINK between Vitamin D status and autism HAS BEEN POSTULATED, arising MAINLY from the FINDINGS of population level studies [117,118].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 98)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3277098	12/2011	S43-PMC3277098	['HOWEVER, just as with the epidemiological ASSOCIATIONS, the EFFECTS of Vitamin D on Th2 Cells HAVE also BEEN CONTRADICTORY, with REPORTS of both enhancement and inhibition [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CL_0000546', 'T-helper 2 cell', 84, 'Th2 cells')]
PMC3277098	12/2011	S59-PMC3277098	['the “Vitamin D/microbiome HYPOTHESIS” has PROPONENTS on BOTH SIDES, with vassallo and camargo [35] ARGUING that deficiency is causative, WHILE wjst [17] SUGGESTS that the introduction of Vitamin D supplementation COINCIDES with the rise in allergic disease.']	[('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3277098	12/2011	S113-PMC3277098	['WHILE Vitamin D MAY BE ASSOCIATED with the development of wheeze through OTHER mechanisms (seesection 4.3) these REPORTS of wheeze are NOT NECESSARILY RELATED to a true th2-dominant allergic response.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC3277098	12/2011	S199-PMC3277098	['most of these OBSERVATIONAL studies DID NOT have direct serological measures of 25(Oh)D levels to ACCURATELY CONFIRM Vitamin D status and cross sectional study designs involving older children and Adults fail TO provide EVIDENCE on aetiological FACTORS.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('UBERON_0007023', 'adult organism', 197, 'adults')]
PMC3277098	12/2011	S207-PMC3277098	['RANDOMIZED control TRIALS are ultimately REQUIRED to determine the EFFECTS of Vitamin D supplementation on the developing Immune System, and any POTENTIAL ROLE in preventing allergic disease.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune system')]
PMC3338544	4/2012	S12-PMC3338544	['moreover, there is now CONVINCING EXPERIMENTAL EVIDENCE BASED ON a MODEL in sprague-dawley Rats that developmental Vitamin D (Dvd) deficiency is ASSOCIATED with a range of schizophrenia-related neurochemical, neuroanatomical, and behavioural phenotypes[4],[5].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 145)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD')]
PMC3347007	4/2012	S30-PMC3347007	['the AIMS of the PRESENT STUDY, conducted within the danish national Birth cohort, were: (1) to ESTIMATE the Vitamin D intake among danish Pregnant women; (2) TO INVESTIGATE the sources of Vitamin D; and (3) TO EXAMINE POTENTIAL DETERMINANTS of sufficient total Vitamin D intake among danish Pregnant women, including Gestational, lifestyle, and dietary factors.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('QUESTION_ANSWERED_BY_THIS_WORK', 207), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 228)]	7	[('GO_0007567', 'parturition', 68, 'Birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('GO_0007565', 'female pregnancy', 317, 'gestational')]
PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3347028	3/2012	S154-PMC3347028	['beyond growth, RECENT REPORTS of neonates followed prospectively for acute Viral infections and bronchiolitis from Respiratory syncytial Virus (Rsv) SUPPORT the PREMISE that these states of deficiency do IMPACT on the health of the young infant and SUGGEST a greater ROLE of Vitamin D beyond bone health [103,104,105].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 204), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 267)]	7	[('NCBITaxon_1', 'root', 75, 'viral'), ('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('NCBITaxon_1', 'root', 137, 'virus'), ('NCBITaxon_10088', 'Mus <genus>', 144, 'RSV'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3347028	3/2012	S216-PMC3347028	['having a higher 25(Oh)D concentration was ASSOCIATED with improved health outcomes in both studies, BUT WHETHER improved Vitamin D status is a MARKER of some OTHER parameter or a direct EFFECT of Vitamin D supplementation REMAINS UNCLEAR at this time.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 186), ('FULL_UNKNOWN', 222)]	7	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3348565	4/2012	S110-PMC3348565	['THUS the LACK OF a PROTECTIVE EFFECT of Vitamin D against pneumonia is PROBABLY not due to MISCLASSIFICATION of outcomes or INADEQUATE supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 71), ('PROBLEM_COMPLICATION', 91), ('PROBLEM_COMPLICATION', 124)]	7	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3348565	4/2012	S139-PMC3348565	['the SPECULATIVE negative ROLE of fluctuations is Vitamin D NEEDS to be CONSIDERED with CAUTION UNTIL FURTHER EVIDENCE is available.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 25), ('FUTURE_WORK', 59), ('FUTURE_WORK', 71), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 95), ('INCOMPLETE_EVIDENCE', 101)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC3356951	4/2012	S3-PMC3356951	['high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('ANOMALY_CURIOUS_FINDING', 48), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 85), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 135)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'D')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3356951	4/2012	S151-PMC3356951	['primary hyperparathyroidism and vdd NEED treatment with Vitamin D.[103]\n\ncaption (table-wrap): table 2\n\ntreatment and prevention STRATEGIES[103]\n\nnoncalcemic benefits of Vitamin D\nescp RECOMMENDS prescribing Vitamin D supplementation for fall PREVENTION and do not RECOMMEND supplementation beyond RECOMMENDED daily NEEDS for the purpose of preventing Cardiovascular disease or death or improving quality of life.']	[('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 129), ('FUTURE_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 243), ('FUTURE_WORK', 265), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 316)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 352, 'cardiovascular')]
PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3407995	7/2012	S261-PMC3407995	['maternal Vitamin D status early in Pregnancy was ASSOCIATED with risk of low Birth weight and small-for-Gestational age infants in ONE STUDY, WHEREAS another study FOUND this RELATION ONLY among white women [141].']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 184), ('INCOMPLETE_EVIDENCE', 184)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007567', 'parturition', 77, 'birth'), ('GO_0007565', 'female pregnancy', 104, 'gestational')]
PMC3407995	7/2012	S449-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation of 4000 iu/day for Pregnant women is SAFE and MOST EFFECTIVE in achieving sufficiency in all women and their neonates regardless of race, WHEREAS the current ESTIMATED average REQUIREMENT is comparatively ineffective at achieving adequate circulating 25(Oh)D concentrations, especially in african americans [179].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 99), ('SUPERFICIAL_RELATIONSHIP', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 229)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 304, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 304, '25(OH)D')]
PMC3407995	7/2012	S480-PMC3407995	['HOWEVER, common dietary DEFICIENCIES within many populations of particular Nutrients including dha, Vitamin D, Folic Acid, and Iodine, that all play CRITICAL ROLES at various developmental stages, HAVE BEEN SHOWN to CONTRIBUTE to functional abnormalities, many of which have lasting EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24), ('IMPORTANT_CONSIDERATION', 149), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33284', 'nutrient', 75, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30751', 'formic acid', 111, 'folic acid'), ('CHEBI_24859', 'iodine atom', 127, 'iodine')]
PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3424155	8/2012	S172-PMC3424155	['Vitamin D deficiency during the third Trimester of Pregnancy in Humans HAS BEEN ASSOCIATED with Cardiovascular disease, diabetes and obesity in offspring[23], which COULD BE LINKED to the POTENTIAL ROLE of Vitamin D in the Regulation Of Adiposity[24],[25].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 223)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009294', 'DNA mediated transformation', 38, 'trimester'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'humans'), ('UBERON_0004535', 'cardiovascular system', 96, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0045752', 'positive regulation of Toll signaling pathway', 223, 'regulation of adiposity')]
PMC3424155	8/2012	S210-PMC3424155	['furthermore, the literature SHOWS SOME RELATIONSHIP between Vitamin D deficiency and Adipose Tissue Development, and OTHER STUDIES SHOULD evaluate such EFFECTS, and the transgenerational EFFECTS.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 39), ('FUTURE_WORK', 117), ('FUTURE_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 187)]	7	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 85, 'adipose tissue development'), ('UBERON_0001013', 'adipose tissue', 85, 'adipose tissue')]
PMC3427192	4/2012	S23-PMC3427192	['SEVERAL of THESE STUDIES NOTED an inverse RELATIONSHIP between maternal Vitamin D intake and the RISK of subsequent wheezing in young infants and preschool children.58,61,62,64HOWEVER, Vitamin D intakes varied CONSIDERABLY between geographic locations, from 548 iu/day in the united states58and 260 iu/day in finland62to 248 and 137 iu/day in japan64and scotland,61respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 210)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3470091	9/2012	S18-PMC3470091	['these CAN cause Vitamin D deficiency in mothers’ Milk as the only source of Vitamin D for babies.6\nthere are EVIDENCES SHOWING the ROLE of Vitamin D in keeping normal Glucose Homeostasis.7-10resistance to Insulin and destruction of Insulin secretion in Human and Animal MODELS has CONSIDERABLY been RELATED to Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 270), ('ANOMALY_CURIOUS_FINDING', 281), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001913', 'milk', 49, 'milk'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_17234', 'glucose', 167, 'glucose'), ('GO_0042593', 'glucose homeostasis', 167, 'glucose homeostasis'), ('PR_000045358', 'insulin family protein', 205, 'insulin'), ('PR_000045358', 'insulin family protein', 232, 'insulin'), ('NCBITaxon_9606', 'Homo sapiens', 253, 'human'), ('NCBITaxon_33208', 'Metazoa', 263, 'animal'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D')]
PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC3509518	11/2012	S24-PMC3509518	['THEREFORE, the AIM of THIS STUDY was TO PROSPECTIVELY ASSESS the EFFECTS of Maternal intakes of selected Antioxidants (Β-Carotene, Vitamin C, Vitamin E, copper and zinc) in Pregnancy on early infant allergic outcomes, namely eczema, Immunoglobulin e (Ige)-mediated Food allergy, allergic sensitisation and wheeze in a population at high risk of developing allergic disease BASED ON familial ASSOCIATION.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 373), ('SUPERFICIAL_RELATIONSHIP', 391)]	7	[('GO_0007618', 'mating', 76, 'maternal'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 119, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin E'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('GO_0019815', 'B cell receptor complex', 233, 'Immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 251, 'IgE'), ('CHEBI_33290', 'food', 265, 'food')]
PMC3509518	11/2012	S103-PMC3509518	['discussion\nin this study, there were SOME inverse (“PROTECTIVE”) RELATIONSHIPS between antioxidant intakes in Pregnancy and infant allergic outcomes, but this was ONLY evident for selected antioxidant factors (Vitamin C and copper) and ONLY SEEN in RELATION to dietary Nutrients and not for dietary supplements per se .']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 249)]	7	[('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin C'), ('CHEBI_33284', 'nutrient', 269, 'nutrients')]
PMC3515553	12/2012	S127-PMC3515553	['discussion\n\nmain findings\nTO THE BEST OF OUR KNOWLEDGE THIS is the FIRST STUDY to EXAMINE the IMPACT of differential concentrations of circulating Vitamin B-12 on offspring iq through the use of records of Maternal Pregnancy Vitamin B-12 intake, as well as Vitamin B-12 RELATED Genetic variants.']	[('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 147, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 147, 'vitamin B-12'), ('GO_0007618', 'mating', 206, 'maternal'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 225, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 235, '12'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 257, 'vitamin B-12'), ('SO_0000704', 'gene', 278, 'genetic')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3613945	2/2013	S238-PMC3613945	['moreover, SEVERAL STUDIES HAVE SHOWN an inverse CORRELATION between Serum levels of Vitamin D and ms173,174, SUGGESTING that polymorphisms INFLUENCING Vitamin D status MIGHT CONTRIBUTE to the initiation or progression of disease.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 139), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 174)]	7	[('UBERON_0001977', 'blood serum', 68, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
PMC3616124	4/2013	S139-PMC3616124	['hp phenotype, Prenatal/multivitamin use at randomization, and Plasma Ascorbate\nhp phenotype INFLUENCES Plasma Ascorbate concentration[35], PROVIDING a POTENTIAL mechanism by which hp phenotype MIGHT INFLUENCE treatment response to Vitamin C and E. we EXAMINED the RELATIONSHIP between hp phenotype and Plasma Ascorbate in a pre-planned analysis.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 251), ('SUPERFICIAL_RELATIONSHIP', 264)]	7	[('GO_0007565', 'female pregnancy', 14, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 62, 'Plasma'), ('CHEBI_2874', 'Asimicin', 69, 'Ascorbate'), ('UBERON_0001969', 'blood plasma', 103, 'plasma'), ('CHEBI_22651', 'ascorbate', 110, 'ascorbate'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 245, 'E'), ('UBERON_0001969', 'blood plasma', 302, 'plasma'), ('CHEBI_22651', 'ascorbate', 309, 'ascorbate')]
PMC3629265	4/2013	S8-PMC3629265	["while these infants had several RISK FACTORS for Vitamin D deficiency, they were all receiving Cow's milk based formula supplemented with 400 iu/l of vitamin D.\n\nconclusion\nTHIS report SUGGESTS that CURRENT practice with regards to Vitamin D supplementation MAY BE INADEQUATE, especially for high-risk infants."]	[('SUPERFICIAL_RELATIONSHIP', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 173), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 199), ('INCOMPLETE_EVIDENCE', 258), ('IMPORTANT_CONSIDERATION', 265), ('PROBLEM_COMPLICATION', 265)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 95, 'cow'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3659910	1/2013	S101-PMC3659910	['a NEW STUDY FINDS that women who develop SEVERE Preeclampsia TEND to have lower Blood levels of Vitamin D than healthy Pregnant women raising the POSSIBILITY that the vitamin plays a ROLE in the COMPLICATION.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 183), ('IMPORTANT_CONSIDERATION', 195)]	7	[('GO_0007128', 'meiotic prophase I', 48, 'preeclampsia'), ('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC3659910	1/2013	S194-PMC3659910	['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]
PMC3691177	6/2013	S14-PMC3691177	['dietary intake of Vitamin D makes a relatively small CONTRIBUTION to overall Vitamin D status, and APPARENT EFFECTS of Vitamin D intake MAY BE CONFOUNDED by OTHER CORRELATED nutrients.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 136), ('DIFFICULT_TASK', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('SUPERFICIAL_RELATIONSHIP', 163)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC3691177	6/2013	S137-PMC3691177	['ALTHOUGH THESE FINDINGS cannot automatically be generalised to OTHER populations of Pregnant women, one MIGHT expect Prenatal Vitamin D supplementation to SHOW its clearest clinical EFFECTS in a deficient population such as this.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 117, 'prenatal'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3702245	6/2013	S34-PMC3702245	['Fetal growth\nthe ASSOCIATION between Birth weight and maternal Vitamin D status or intake REMAINS INCONCLUSIVE.5while SOME OBSERVATIONAL68–71and interventional53,72,73studies FOUND improvement in Birth weight with maternal Vitamin D supplementation or improved Vitamin D status, several other observational studies31,74–76and SOME interventional studies18,33,77,78showed no improvement with higher Vitamin D status or supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 398, 'vitamin D')]
PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC3705146	5/2013	S37-PMC3705146	['clearly, the relative lack of sunlight had an evolutionary IMPACT on Genes AFFECTING Vitamin D generation from sunlight, BUT WHAT EVIDENCE is there that it MIGHT also have selected for a change in the prevalence of a disease such as schizophrenia?']	[('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('EXPLICIT_QUESTION', 125), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 156), ('EXPLICIT_QUESTION', 246)]	7	[('SO_0000704', 'gene', 69, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3705146	5/2013	S160-PMC3705146	['furthermore, a RECENT report DEMONSTRATES an equivalently strong season-of-Birth EFFECT in multiple sclerosis with peaks in april and may and in PARALLEL with schizophrenia (torrey et al.,1997; davies et al.,2003), deficits in births of future multiple sclerosis patients during october and november (dobson et al.,2013), a FINDING the authors ATTRIBUTE to VARIATIONS in sunlight during Gestation and to the resulting variations in Vitamin D availability.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 324), ('SUPERFICIAL_RELATIONSHIP', 344), ('DIFFICULT_TASK', 357)]	7	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007565', 'female pregnancy', 387, 'gestation'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D')]
PMC3705146	5/2013	S208-PMC3705146	['with respect to the POSSIBLE ROLE of sunlight intensity in behavioral phenotypes, it HAS BEEN PROPOSED that cutaneous Vitamin D generation MAY BE INVOLVED in Gestational EFFECTS that Modulate the eventual development of schizophrenia (mcgrath and welham,1999).']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'gestational'), ('GO_0065007', 'biological regulation', 183, 'modulate')]
PMC3705320	3/2013	S173-PMC3705320	['(2008) [24], as well the RECENT iom REPORT (2010) [1], have DEMONSTRATED that the ∆[25(Oh)D] per mcg is a curvilinear inverse FUNCTION of Vitamin D Intake at doses <50 mcg/day, but nearly proportional to Intake at >50 mcg/day [24], which MAY EXPLAIN the greater OBSERVED efficiency of the lower dose.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 238), ('PROBABLE_UNDERSTANDING', 242), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007631', 'feeding behavior', 148, 'intake'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC3705320	3/2013	S201-PMC3705320	['NONETHELESS, increases in the mean calcium concentration (within the normal range) and suppression of pth secretion among Pregnant women receiving the higher-dose regimen (70,000 iu initial dose followed by weekly doses of 35,000 iu) HIGHLIGHTED the physiological IMPACT of the intervention and the NEED to cautiously address POTENTIAL Pregnancy-specific sensitivities to Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 264), ('FUTURE_WORK', 299), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3713405	7/2013	S49-PMC3713405	['most RECENTLY, and most IMPORTANTLY, a danish population-based case-control study (423 cases and 423 control) that directly assessed Vitamin D levels in Blood Spots from NEW born infants provided SOLID EVIDENCE SHOWING that low Prenatal Vitamin D levels are ASSOCIATED with an INCREASED RISK of schizophrenia (mcgrath et al., 2010).']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 24), ('FULL_UNKNOWN', 170), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 258), ('IMPORTANT_CONSIDERATION', 277)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 153, 'blood spots'), ('GO_0007565', 'female pregnancy', 228, 'prenatal'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3717170	5/2013	S140-PMC3717170	['THEREFORE, EVIDENCE from intervention studies—which is the most DIRECT EVIDENCE—is CRITICALLY IMPORTANT before one can conclude that Vitamin D has a ROLE in the prevention or treatment of diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 149)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3739737	8/2013	S160-PMC3739737	['the lack of a marked behavioural phenotype in the avd MODEL in the male sprague-dawley Rat MAY have IMPORTANT IMPLICATIONS for FUTURE Animal models exploring the biological mechanisms that MAY underpin the epidemiological ASSOCIATIONS between low Vitamin D and adverse Brain outcomes.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 127), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 222)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rat'), ('NCBITaxon_33208', 'Metazoa', 134, 'animal'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0000955', 'brain', 269, 'brain')]
PMC3739737	8/2013	S168-PMC3739737	['THUS, we SPECULATE that the epidemiological CLUES LINKING low Vitamin D and adverse Neurocognitive outcomes MAY BE MEDIATED by ‘two hits’ – in other words low vitamin d MAY exacerbate a separate Neurobiological stressor.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 169)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 84, 'neurocognitive'), ('UBERON_0002906', 'anterior occipital sulcus', 195, 'neurobiological')]
PMC3760821	9/2013	S44-PMC3760821	['there are numerous REPORTS SUPPORTING a ROLE for Vitamin D in promoting Insulin sensitivity and maintaining Glycaemic Control in t2dm, WHILE the EVIDENCE for a similar ROLE in t1dm is more LIMITED.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 168), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0051162', 'L-arabitol metabolic process', 108, 'glycaemic control')]
PMC3798907	8/2013	S1-PMC3798907	['we INVESTIGATED WHETHER these ASSOCIATIONS REFLECT direct EFFECTS of Vitamin E by INVESTIGATING the EFFECTS of supplementing cbmc cultures with physiological concentrations of Vitamin E. cbmc from seventy neonates were cultured supplemented with either nothing, Α-Tocopherol or Ascorbic Acid.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 100)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin E'), ('CHEBI_27725', 'butin', 262, 'α-tocopherol'), ('CHEBI_22652', 'ascorbic acid', 278, 'ascorbic acid')]
PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S63-PMC3814422	['additional analyses\nTO TEST WHETHER ASSOCIATIONS were driven by a threshold effect of greater risk in those whose mothers had insufficient levels of Vitamin D, we EXAMINED ASSOCIATIONS of categories of 25(Oh)D levels (≥ 50 nmol/l; 27.5–49.99 nmol/l and < 27.5 nmol/l) with outcomes, we also repeated analyses using 75 nmol/l as a higher THRESHOLD for sufficiency as recommended in a more RECENT REVIEW23.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('SUPERFICIAL_RELATIONSHIP', 172), ('PROBABLE_UNDERSTANDING', 337), ('INCOMPLETE_EVIDENCE', 388)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 208, 'D')]
PMC3827489	10/2013	S83-PMC3827489	['studies have SUGGESTED that Vitamin D MAY directly Regulate Insulin secretion by binding to Pancreatic Β-Cell vdrs59), and MAY indirectly AFFECT Pancreatic Β-Cell function by Regulating Extracellular calcium concentrations59); these data SUGGEST that low Vitamin D levels MAY BE ASSOCIATED with Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 138), ('INCOMPLETE_EVIDENCE', 238), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 279)]	7	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 51, 'regulate'), ('PR_000045358', 'insulin family protein', 60, 'insulin'), ('CL_0000173', 'pancreatic D cell', 92, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 92, 'pancreatic β-'), ('CL_0000173', 'pancreatic D cell', 145, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 145, 'pancreatic β-'), ('GO_0065007', 'biological regulation', 175, 'regulating'), ('GO_0005576', 'extracellular region', 186, 'extracellular'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('PR_000045358', 'insulin family protein', 295, 'insulin')]
PMC3827489	10/2013	S92-PMC3827489	['this FINDING MAY BE EXPLAINED BY PREVIOUS STUDIES SUGGESTING that higher Vitamin D levels or appropriate Vitamin D intake in Pregnant women is ASSOCIATED with increased infant Birth weight66,67).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 17), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC3888066	12/2012	S45-PMC3888066	['examples of non-fortified Foods that are high in Vitamin A or beta Carotene are listed intable 5.37\n\ncalculation of Vitamin A and beta Carotene intake during Pregnancy\nthe absorption, Metabolism, storage, and Excretion Of Beta Carotene and Retinol in the mother are NOT COMPLETELY UNDERSTOOD; HOWEVER, most investigators agree that consumption of these forms of Vitamin A is RELATED to maternal Serum levels.38–40in ONE STUDY, maternal diet INFLUENCED Cord levels of Beta Carotene, but not Vitamin A.41absorption Of Beta Carotene from raw carrots and a low fat diet is very low compared to carrot juice.42according to current literature, 6 μg of Ingested Beta Carotene convert to 1 Retinol equivalent, or 1 μg Retinol, but ratios have ranged from 3.3:1 to 26:1.43,44\nbased on the discussion above, it MAY BE apparent that Maternal Ingestion of non-Beta Carotene sources of Vitamin A in foods + fortified foods + nutritional supplements would not LIKELY elevate Retinoic Acid levels in the fetus to Teratogenic levels.']	[('INCOMPLETE_EVIDENCE', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('SUPERFICIAL_RELATIONSHIP', 375), ('INCOMPLETE_EVIDENCE', 416), ('SUPERFICIAL_RELATIONSHIP', 441), ('INCOMPLETE_EVIDENCE', 801), ('PROBABLE_UNDERSTANDING', 946)]	7	[('CHEBI_33290', 'food', 26, 'foods'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_23042', 'carotene', 67, 'carotene'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin A'), ('CHEBI_23042', 'carotene', 135, 'carotene'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('GO_0008152', 'metabolic process', 184, 'metabolism'), ('GO_0007530', 'sex determination', 209, 'excretion of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 222, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 240, 'retinol'), ('GO_0060033', 'anatomical structure regression', 240, 'retinol'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin A'), ('UBERON_0001977', 'blood serum', 395, 'serum'), ('UBERON_0002240', 'spinal cord', 452, 'cord'), ('CHEBI_51438', 'D-isoascorbic acid', 467, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin A'), ('GO_0046311', 'prenylcysteine biosynthetic process', 513, 'of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 516, 'beta carotene'), ('GO_0007631', 'feeding behavior', 646, 'ingested'), ('CHEBI_51438', 'D-isoascorbic acid', 655, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 682, 'retinol'), ('CHEBI_26536', 'retinoic acid', 710, 'retinol'), ('GO_0007618', 'mating', 822, 'maternal'), ('GO_0007631', 'feeding behavior', 831, 'ingestion'), ('CHEBI_51438', 'D-isoascorbic acid', 848, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 961, 'retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 998, 'teratogenic'), ('GO_0031649', 'heat generation', 998, 'teratogenic')]
PMC4045304	2/2014	S1-PMC4045304	['though both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 182), ('INCOMPLETE_EVIDENCE', 254)]	7	[('SO_0000704', 'gene', 12, 'genetic'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_30751', 'formic acid', 214, 'folic acid'), ('GO_0008152', 'metabolic process', 230, 'metabolic')]
PMC4045304	2/2014	S5-PMC4045304	['in this communication, CONTROVERSIES regarding increase in ESTIMATE of prevalence, IMPLICATIONS of changes in definition, and POSSIBLE ASSOCIATION between SOME modifiable nutritional risk factors such as Folic Acid and Vitamin D and asd will be discussed.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 155)]	7	[('CHEBI_5054', 'Fibrin', 204, 'folic'), ('CHEBI_37527', 'acid', 210, 'acid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4045304	2/2014	S191-PMC4045304	['investigators have ADVANCED the HYPOTHESIS that ASSOCIATION between Vitamin D and autism COULD BE EXPLAINED by the RELATIONSHIP between seasonality and low maternal Serum 25-Hydroxyvitamin D concentration (a valid INDICATOR of Vitamin D status) [73].']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 214)]	7	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 171, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4072587	6/2014	S127-PMC4072587	['SEVERAL STUDIES have FOUND an ASSOCIATION between maternal Vitamin D status and post-Natal growth, BUT results are INCONSISTENT and the majority are OBSERVATIONAL studies that HAVE been carried out in developed countries.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 149), ('IMPORTANT_CONSIDERATION', 176)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 85, 'natal')]
PMC4072587	6/2014	S156-PMC4072587	['our results STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy and HIGHLIGHT the NEED FOR FURTHER RESEARCH to explore the IMPACT of supplementation on longer term child growth and developmental outcomes, PARTICULARLY with regard to language.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 108), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 149), ('IMPORTANT_CONSIDERATION', 231)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4113768	7/2014	S162-PMC4113768	['ALTHOUGH there is SOME SUGGESTION that SELF-REPORTED sleep quality and sleep latency MIGHT be ASSOCIATED with Vitamin D status, results APPEAR TO vary by ethnicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 94), ('ANOMALY_CURIOUS_FINDING', 136)]	7	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC4113768	7/2014	S912-PMC4113768	['studies carried out in a number of types of Dogs by may mellanby SHOWED that Vitamin D deficiency damaged the Development Of Teeth at the same time as Bones and that this COULD BE reversed with a diet high in Vitamin D. she conducted a series of early randomized controlled trials in orphanages too that SHOWED lower rates of caries in children under 12 who were given diets higher in Vitamin D. RECENT RESEARCH in children with specific syndromes and in Gene knockout Mice have CONFIRMED a central ROLE for Vitamin D in Tooth mineralization with EFFECTS on Tooth structure, as described by may mellanby.']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 396), ('INCOMPLETE_EVIDENCE', 479), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 547)]	7	[('NCBITaxon_33208', 'Metazoa', 44, 'dogs'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0042466', 'chemokinesis', 110, 'development of teeth'), ('UBERON_0001091', 'calcareous tooth', 125, 'teeth'), ('UBERON_0001474', 'bone element', 151, 'bones'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin D'), ('SO_0000704', 'gene', 455, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 469, 'mice'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 521, 'tooth'), ('UBERON_0001091', 'calcareous tooth', 558, 'tooth')]
PMC4113768	7/2014	S1393-PMC4113768	['the AIM of THIS STUDY was THEREFORE TO INVESTIGATE the EFFECTS of Vitamin D on the Gene Expression of IMPORTANT enzymes INVOLVED in Brain Steroidogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 120)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0010467', 'gene expression', 83, 'gene expression'), ('SO_0000704', 'gene', 83, 'gene'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0001501', 'skeletal system development', 138, 'steroidogenesis')]
PMC4113768	7/2014	S1400-PMC4113768	['the EFFECTS on Cyp17A1 as well as Cyp19A1 SUGGEST that the levels of Estrogens MAY BE AFFECTED by Vitamin D.\nconclusions: the results INDICATE that Vitamin D has a suppressive EFFECT on some of the Genes for enzymes in the Brain Steroidogenesis implicating that the products of these enzymes MAY BE decreased.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 292)]	7	[('PR_000006101', 'cytochrome P450 1A1', 15, 'CYP17A1'), ('PR_000006101', 'cytochrome P450 1A1', 34, 'CYP19A1'), ('CHEBI_50114', 'estrogen', 69, 'estrogens'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('SO_0000704', 'gene', 198, 'genes'), ('UBERON_0000955', 'brain', 223, 'brain'), ('GO_0001501', 'skeletal system development', 229, 'steroidogenesis')]
PMC4113768	7/2014	S1641-PMC4113768	['background: meta-analysis of clinical trials of Vitamin D supplementation for the PREVENTION of acute Respiratory infection (ari) SHOWS a PROTECTIVE EFFECT in the general population, BUT there is CONTROVERSY regarding the OPTIMAL dosing regimen.']	[('SUPERFICIAL_RELATIONSHIP', 82), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 222)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 102, 'respiratory')]
PMC4113768	7/2014	S1828-PMC4113768	['in SOME of the elderly subjects lower Plasma 25(Oh)D levels coexisting with high alkaline phosphatase activity MAY INDICATE developing osteomalacia.taking INTO ACCOUNT lower Plasma 25(Oh)D, 1,25(Oh)D and calcium levels among the MAJORITY of centenarians, the sufficient Vitamin D and calcium supplementation SHOULD be systematically APPLIED also in the oldest old.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 155), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 308), ('SUPERFICIAL_RELATIONSHIP', 333)]	7	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 45, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC4113768	7/2014	S2097-PMC4113768	['background: ACCUMULATING EVIDENCE SUGGESTS that Vitamin D deficiency MAY BE a risk FACTOR for Cardiovascular disease BUT its ASSOCIATION with the risk of stroke is UNCERTAIN.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 164)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular')]
PMC4113768	7/2014	S2159-PMC4113768	['IN CONTRAST, a GROWING NUMBER OF SMALL randomised trials testing the EFFECT of Vitamin D supplementation on Blood pressure have REPORTED MIXED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	7	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC4113768	7/2014	S2257-PMC4113768	['it is THUS CONCEIVABLE that polymorphisms in the Gene encoding this protein, the Vitamin D Receptor Gene (Vdr), MAY alter both its structure and functions and HENCE, MAY INFLUENCE one’s susceptibility to various debilitating diseases.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 81, 'vitamin D receptor'), ('SO_0000704', 'gene', 100, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 106, 'VDR')]
PMC4113768	7/2014	S2295-PMC4113768	['IT IS CLEAR that general female public FACES an IMMINENT THREAT of Vitamin D deficiency-RELATED diseases UNLESS aggressive public AWARENESS is conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 39), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 130)]	7	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4113768	7/2014	S3066-PMC4113768	['RISK FACTORS for Cardiovascular disease HAVE also BEEN ASSOCIATED with low Serum (25(Oh)D. we AIMED TO INVESTIGATE WHETHER high-dose Vitamin D supplementation CAN improve Glucose Metabolism in a population with impaired fasting Glucose and/or impaired Glucose tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 55), ('QUESTION_ANSWERED_BY_THIS_WORK', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 159)]	7	[('UBERON_0004535', 'cardiovascular system', 17, 'cardiovascular'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_17234', 'glucose', 171, 'glucose'), ('GO_0006006', 'glucose metabolic process', 171, 'glucose metabolism'), ('CHEBI_17234', 'glucose', 228, 'glucose'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4113768	7/2014	S3122-PMC4113768	['the OBJECTIVE of THIS RETROSPECTIVE case-CONTROL STUDY was TO FURTHER INVESTIGATE the POSSIBLE LINK between type i hypersensitivity and Vitamin D status in an inner-city population KNOWN to have a high prevalence of Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 181)]	7	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4113768	7/2014	S3248-PMC4113768	['Prenatal Vitamin D deficiency in a Rat pup MODEL HAS BEEN ASSOCIATED with Ventriculomegaly and Brain overgrowth and abnormal behaviour WHILE a FEW STUDIES have DEMONSTRATED an ASSOCIATION between Prenatal Vitamin D deficiency and lower Birthweight.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 176)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 35, 'rat'), ('UBERON_0001137', 'dorsum', 74, 'ventriculomegaly'), ('UBERON_0000955', 'brain', 95, 'brain'), ('GO_0007565', 'female pregnancy', 196, 'prenatal'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0007596', 'blood coagulation', 236, 'birthweight')]
PMC4113768	7/2014	S3303-PMC4113768	['HOWEVER, rcts in iran, where the mean Serum 25(Oh)D levels TEND to be low, IN PART DUE TO sun avoidance during the hot summers, have FOUND beneficial EFFECTS of Vitamin D supplementation on cvd RISK FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 83), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('SUPERFICIAL_RELATIONSHIP', 194)]	7	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 44, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4251419	12/2014	S6-PMC4251419	['over the last 10-15 years, INCREASED RISK of a WIDE RANGE of health outcomes HAS BEEN LINKED to Vitamin D deficiency, ALTHOUGH in many cases the LINKS REMAIN rather weak.']	[('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('ANOMALY_CURIOUS_FINDING', 118), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 151)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4251419	12/2014	S73-PMC4251419	['LIMITED SUCCESS in Vitamin D supplementation trials SUGGESTS that Vitamin D-INDEPENDENT EFFECTS MAY CONTRIBUTE more strongly to disease RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 136)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4289064	1/2015	S133-PMC4289064	['“other” refers to oils, flavorings, drinks, candy, honey, and other items that do not fit into other Food groups.10.1371/journal.pone.0114805.t001\n\ncaption (table-wrap): table 1\naverage proportion of total Nutrient Intake by percent yield due to pollinators and country for children 1 to 3 years old.% yield due to pollinatorsenergyvitamin acalciumfolateironzinc bangladesh 00.740.380.550.480.620.6850.050.190.080.140.080.07250.080.100.130.170.110.10650.040.090.090.120.070.04950.080.250.160.100.120.12total1.001.001.001.001.001.00 mozambique 00.570.290.540.300.370.4950.140.130.190.290.200.16250.130.020.160.240.250.19650.140.270.080.150.120.13950.020.300.040.020.050.03total1.001.001.001.001.001.00 uganda 00.680.490.530.400.520.5550.140.090.140.300.130.16250.100.090.240.140.210.17650.040.020.010.080.020.05950.040.320.070.080.120.07total1.001.001.001.001.001.00 zambia 00.480.380.410.300.510.5150.170.110.170.350.210.24250.060.020.140.100.080.10650.120.210.130.180.070.03950.070.270.110.050.110.101000.090.000.040.020.030.02total1.001.001.001.001.001.00\nBASED ON these results, we HYPOTHESIZED that pollinators would be most IMPORTANT for nutritional health ASSOCIATED with Vitamin A, BUT less IMPORTANT for nutritional health ASSOCIATED with all other Nutrients.']	[('PROBABLE_UNDERSTANDING', 1058), ('INCOMPLETE_EVIDENCE', 1085), ('IMPORTANT_CONSIDERATION', 1129), ('SUPERFICIAL_RELATIONSHIP', 1162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1189), ('IMPORTANT_CONSIDERATION', 1198), ('SUPERFICIAL_RELATIONSHIP', 1231)]	7	[('CHEBI_33290', 'food', 101, 'food'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('GO_0007631', 'feeding behavior', 215, 'intake'), ('CHEBI_27300', 'vitamin D', 1178, 'vitamin A'), ('CHEBI_33284', 'nutrient', 1257, 'nutrients')]
PMC4329404	10/2014	S185-PMC4329404	['THEREFORE, ALTHOUGH it does not SEEM LIKELY that Vitamin D deficiency per se causes asthma in early Life, it is LIKELY that Vitamin D deficiency CONTRIBUTES to increased disease severity in children with asthma and that supplementation MAY reduce severity.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 236)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC4377870	3/2015	S88-PMC4377870	['DESPITE the OBSERVATIONAL data LINKING Vitamin C to Lung health, supplementation with Vitamin C has not been shown to reduce the RISK of asthma [66] which MAY be RELATED to the interdependence of Nutrients found in Foods, resulting in lack OF efficacy when supplementing with isolated Nutrients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('ANOMALY_CURIOUS_FINDING', 240)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin C'), ('UBERON_0002048', 'lung', 52, 'lung'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_33284', 'nutrient', 196, 'nutrients'), ('CHEBI_33290', 'food', 215, 'foods'), ('CHEBI_33284', 'nutrient', 285, 'nutrients')]
PMC4377870	3/2015	S139-PMC4377870	['WHILE Vitamin D has beneficial EFFECTS INDEPENDENT of uv exposure [109], it can be DIFFICULT to separate this POTENTIAL CONFOUNDER from direct EFFECTS of Vitamin D on Lung health [110].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 39), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 120), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC4377870	3/2015	S146-PMC4377870	['epidemiological EVIDENCE LINKS low levels of Vitamin D with wheeze and Respiratory infections, THOUGH EVIDENCE for the LINK with asthma onset is weak and INCONSISTENT [111].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 71, 'respiratory')]
PMC4377888	3/2015	S69-PMC4377888	['ALTHOUGH the ROLE of Vitamin A is well ESTABLISHED, OTHER maternal Micronutrient deficiencies are ASSOCIATED with abnormal Kidney structure or function in her offspring; BUT with LESS clear mechanisms lisle et al.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('INCOMPLETE_EVIDENCE', 179)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC4380518	9/2014	S68-PMC4380518	['IN LIGHT OF two RECENT meta-analyses/systematic reviews CONCLUDING that low 25(Oh)D levels during Pregnancy are ASSOCIATED with SEVERAL morbidities in Pregnancy15,16, optimizing Vitamin D status during Pregnancy MAY BE IMPORTANT.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 76, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy15'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4383226	2/2015	S31-PMC4383226	['SEVERAL STUDIES have SUGGESTED that childhood immunization MAY confer non-specific health EFFECTS beyond targeted diseases, BUT the IMPACT of standard vaccination and Vitamin A supplementation on malaria Infection is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 132), ('FULL_UNKNOWN', 217)]	7	[('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('GO_0007586', 'digestion', 204, 'infection')]
PMC4383226	2/2015	S108-PMC4383226	["Placental malaria and Vitamin A\ndifferences in the IMPACT of Vitamin A on malaria infection by Birth weight, and having a mother who used Antimalarials during the child's Gestational period SUGGESTS exposure to Placental malaria MAY play a CRITICAL ROLE in Vitamin A's PROTECTIVE EFFECT mechanisms later on in childhood."]	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 280)]	7	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_22580', 'anthraquinone', 138, 'antimalarials'), ('GO_0007565', 'female pregnancy', 171, 'gestational'), ('UBERON_0001987', 'placenta', 211, 'placental'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin A')]
PMC4396835	1/2015	S129-PMC4396835	['seasonal EFFECTS\nOUR FINDING that more children with asd of swedish or other non-african/non-middle east background were Born in the spring than during other seasons - COULD POSSIBLY implicate OTHER aetiological FACTORS THAN Vitamin D levels, such as, for instance, infections.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220)]	7	[('GO_0007567', 'parturition', 121, 'born'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4405493	4/2015	S157-PMC4405493	['HOWEVER, WHETHER Vitamin D deficiency is a RISK FACTOR for Gestational diabetes in itself OR IF Vitamin D supplementation CAN PREVENT gdm is YET UNKNOWN [72].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('FULL_UNKNOWN', 141)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4417995	4/2015	S2-PMC4417995	['HOWEVER, OBSERVATIONS LINKING high Vitamin D levels to an INCREASED RISK of developing ad HAVE also BEEN published, EFFECTIVELY creating a CONTROVERSY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4417995	4/2015	S12-PMC4417995	['the function of Vitamin D, traditionally ASSOCIATED with calcium and Phosphate Homeostasis, IS THOUGHT TO be highly COMPLEX, and its POTENTIAL ROLES in Cardiovascular, neoplastic, and Microbial infections and Autoimmune diseases HAVE BEEN investigated in RECENT STUDIES [5].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 92), ('DIFFICULT_TASK', 116), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 255)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0051320', 'S phase', 69, 'phosphate'), ('GO_0042592', 'homeostatic process', 79, 'homeostasis'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
PMC4417995	4/2015	S68-PMC4417995	['in CONCLUSION, ALTHOUGH there is a predominance of PAPERS POINTING TO Vitamin D as a PROTECTIVE FACTOR, VARIOUS STUDIES actually IDENTIFY it as a risk factor for ad.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]
PMC4448820	5/2015	S185-PMC4448820	['AS a result of increased INTEREST in the activities of Vitamin D beyond the traditional FOCUS on bone/calcium, an IMPORTANT NEW UNDERSTANDING of Vitamin D’s ROLE in Immune function has EMERGED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 185)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0002405', 'immune system', 165, 'immune')]
PMC4448820	5/2015	S291-PMC4448820	['ALTHOUGH SOME EFFECTS of Vitamin D are MEDIATED independently of vdr, the large MAJORITY of the activity of Vitamin D CAN be EXPLAINED via binding of the Vitamin D Metabolite [1,25(Oh)2D] to a single, zinc-finger containing, ligand-activated transcription factor, vdr.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 125)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 164, 'metabolite'), ('CHEBI_17996', 'chloride', 177, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 178, '25(OH)2D')]
PMC4448820	5/2015	S347-PMC4448820	['cell culture MODELS and a very SMALL NUMBER OF Human clinical STUDIES INDICATE that nutritional factors including Vitamins A and D AFFECT numerous Genes INVOLVED in Chromatin Remodeling or processes that are INVOLVED in epigenetic Regulation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 114, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 129, 'D'), ('SO_0000704', 'gene', 147, 'genes'), ('GO_0000785', 'chromatin', 165, 'chromatin'), ('GO_0006338', 'chromatin remodeling', 165, 'chromatin remodeling'), ('GO_0065007', 'biological regulation', 231, 'regulation')]
PMC4448820	5/2015	S574-PMC4448820	['the IMPORTANT EFFECTS of Vitamin A on Immune function are REFLECTED in the MANY community and clinical STUDIES that SHOWED that Vitamin A AFFECTS mortality and morbidity.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 138)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]
PMC4448820	5/2015	S586-PMC4448820	['also, ALTHOUGH it IS CLEAR that inflammation is ASSOCIATED with decreased Serum Retinol and rbp concentrations, the ROLE of Vitamin A supplementation on inflammation and its MARKERS is LESS CLEAR.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 174), ('FULL_UNKNOWN', 185), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_26536', 'retinoic acid', 80, 'retinol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]
PMC4448820	5/2015	S1518-PMC4448820	['caption (boxed-text): text box 52\u2003\nCURRENTLY available Vitamin D BIOMARKERS/indicators\n\n● 25(Oh)D:\n○ GENERALLY RECOGNIZED AS the best currently available biomarker\n○ reflects Intake\n○ functional relevance not clearly established\n● functional biomarkers:\n○ Parathyroid hormone\n○ calcium absorption\n○ Bone Resorption\n○ bone Mineral density\n\nINFLUENCE of inflammation on Vitamin D assessment.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 111), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 339)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 90, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 175, 'intake'), ('GO_0007567', 'parturition', 182, '○'), ('UBERON_0001132', 'parathyroid gland', 256, 'parathyroid'), ('GO_0008218', 'bioluminescence', 299, 'bone resorption ○'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D')]
PMC4452099	6/2015	S100-PMC4452099	['all of these FACTORS, which in DIFFERENT ways MAY BE RELATED to either Vitamin D intake and/or t1d risk, can be ASSUMED to be balanced between the Individuals from the various exposure groups, and THEREFORE CONFOUNDING is not to be expected.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 197), ('PROBLEM_COMPLICATION', 207)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4488777	5/2015	S150-PMC4488777	['this very clever approach gave the authors of these, and of other SIMILAR STUDIES from both europe and the usa, REASONS to state that their data STRONGLY SUGGEST that the EFFECTS of Vitamin D MAY BE MEDIATED through the Endometrium, not the follicle or Oocyte [56,57].']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 145), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 199)]	7	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001852', 'endolymph', 220, 'endometrium'), ('CL_0000023', 'oocyte', 253, 'oocyte')]
PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]
PMC4516377	6/2015	S50-PMC4516377	['these mechanisms are not yet FULLY ELUCIDATED; HOWEVER, SOME STUDIES have provided a FEW PLAUSIBLE explanations.24,25one EXPLANATION is that low Calcium intake increases serum Calcitriol levels, which can stimulate the flow of calcium from Adipocytes by Vitamin D Membrane receptors, identified as ASSOCIATED with rapid Membrane response to Steroids.']	[('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 298)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 145, 'calcium'), ('CHEBI_17823', 'calcitriol', 176, 'calcitriol'), ('CL_0000136', 'fat cell', 240, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0016020', 'membrane', 264, 'membrane'), ('GO_0016020', 'membrane', 320, 'membrane'), ('CHEBI_35341', 'steroid', 341, 'steroids')]
PMC4595656	10/2015	S1-PMC4595656	['the pleiotropic EFFECTS of Vitamin D are now BEYOND DISPUTE and a GROWING NUMBER OF STUDIES provide ACCUMULATING EVIDENCE of a ROLE for Vitamin D in Brain Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007420', 'brain development', 149, 'brain development'), ('UBERON_0000955', 'brain', 149, 'brain')]
PMC4595656	10/2015	S119-PMC4595656	['FUTURE DIRECTIONS and conclusions\nin LIGHT of the ACCUMULATING Animal and in vitro EVIDENCE to DATE, it is LIKELY that Vitamin D plays a ROLE in hippocampal development in vivo .']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 107), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('NCBITaxon_33208', 'Metazoa', 63, 'animal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4598849	10/2015	S56-PMC4598849	['in THIS STUDY with a large sample, adjustment for more confounders and using non-linear models, we FOUND that there was an inverted u-shaped RELATIONSHIP between Cord Blood 25(Oh)D and Birth weight, SUGGESTING that the newborn with low or high levels of fetal Vitamin D are both in INCREASED risk of growth restriction and higher levels of fetal Vitamin D HAVE not been shown to confer greater BENEFITS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 356), ('IMPORTANT_CONSIDERATION', 394)]	7	[('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_71657', 'versiconol acetate', 173, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 173, '25(OH)D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC4598849	10/2015	S61-PMC4598849	['THEREFORE, the inverted u shaped RELATIONSHIP in THIS STUDY MAYBE SUGGESTED that Gestational Vitamin D MAY have dual biological EFFECTS on the fetal growth.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 128)]	7	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4600246	10/2015	S9-PMC4600246	['HOWEVER, the RECENTLY updated usa preventive services task force (uspstf) has RECENTLY STATED that there is INSUFFICIENT EVIDENCE that Calcium and Vitamin D PREVENT a fracture in Premenopausal women or in men who have not experienced a fracture and now RECOMMENDS against daily supplementation with 400\u2005iu or less of Vitamin D3 and 1000\u2005mg or less of calcium for the primary prevention of fractures in non-institutionalised Postmenopausal women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 157), ('FUTURE_WORK', 253)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 135, 'calcium'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 179, 'premenopausal'), ('CHEBI_33279', 'vitamin D5', 317, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 317, 'vitamin D3'), ('GO_0007595', 'lactation', 424, 'postmenopausal')]
PMC4600246	10/2015	S35-PMC4600246	["THUS, the EFFECT of Vitamin K on cac MIGHT be independent of changes in Serum cytokine levels (BUT NOT NECESSARILY RULING out Vitamin K's benefit on the blunting of the EFFECTS of these cytokines)."]	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 20, 'vitamin K'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin K')]
PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4624803	10/2015	S107-PMC4624803	['such lifestyle FACTORS COULD lead to lower levels of Vitamin D.\n\nlimitations\nTHIS is a medium- sized STUDY and a WEAK ASSOCIATION with the risk of developing adhd with Vitamin D deficiency COULD NOT BE EXCLUDED.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4632418	10/2015	S129-PMC4632418	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and gdm STILL REMAINS (or = 1.67; 95% ci, 1.31, 2.13; i2= 25.6%, p = 0.251) EVEN after adjusting for maternal age, bmi and ethnicity (supplementary figure s4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 62), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 68), ('ANOMALY_CURIOUS_FINDING', 130)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4632418	10/2015	S132-PMC4632418	['conclusions\nin CONCLUSION, the EVIDENCE from THIS ARTICLE INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational')]
PMC4684854	12/2015	S3-PMC4684854	['ALTHOUGH immediate costs for obstetric COMPLICATIONS RELATED to Gestational Vitamin D insufficiency MAY BE modest, the short- and long-term costs for pediatric healthcare resulting from such Gestational COMPLICATIONS MAY BE enormous and present an enduring BURDEN on Healthcare systems.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 217), ('IMPORTANT_CONSIDERATION', 257)]	7	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'gestational'), ('UBERON_0004151', 'cardiac chamber', 267, 'healthcare')]
PMC4684854	12/2015	S4-PMC4684854	['with INCREASING EVIDENCE POINTING TO fetal origins of SOME later Life disease, securing Vitamin D sufficiency in Pregnancy APPEARS TO BE a simple, SAFE, and cost-EFFECTIVE measure that CAN be incorporated into routine Preconception and Prenatal Care in the offices of primary care clinicians.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 123), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 162), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0000104', 'life cycle', 65, 'life'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 218, 'preconception'), ('GO_0008283', 'cell proliferation', 236, 'prenatal care')]
PMC4684854	12/2015	S60-PMC4684854	['FOUND that Gestational Vitamin D supplementation was ASSOCIATED with increased Birth weight and Birth length BUT, UNLIKE SOME OTHER RESEARCH, was not associated with other beneficial maternal and neonatal outcomes such as reductions in preeclampsia, Gestational diabetes, small for Gestational age infants, Preterm Birth, or rates of cesarean Delivery [44].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('ANOMALY_CURIOUS_FINDING', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	7	[('GO_0007565', 'female pregnancy', 11, 'gestational'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'birth'), ('GO_0007567', 'parturition', 96, 'birth'), ('GO_0007565', 'female pregnancy', 250, 'gestational'), ('GO_0007565', 'female pregnancy', 282, 'gestational'), ('GO_0007565', 'female pregnancy', 307, 'preterm birth'), ('GO_0007567', 'parturition', 343, 'delivery')]
PMC4684854	12/2015	S103-PMC4684854	['there is escalating EVIDENCE in general that low Vitamin D levels are CORRELATED with higher RISK for a variety of mental health PROBLEMS including depressive illness [70], as Vitamin D IS KNOWN to play an IMPORTANT ROLE in activating Genes that release Neurotransmitters such as Dopamine and Serotonin [70,71].']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('SO_0000704', 'gene', 235, 'genes'), ('CHEBI_25512', 'neurotransmitter', 254, 'neurotransmitters'), ('CHEBI_18243', 'dopamine', 280, 'dopamine'), ('CHEBI_28790', 'serotonin', 293, 'serotonin')]
PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]
PMC4684854	12/2015	S127-PMC4684854	['with regard to economic challenges ASSOCIATED with Vitamin D insufficiency, SUFFICE it to say that there are CONSIDERABLE costs POTENTIALLY ASSOCIATED with Gestational Vitamin D insufficiency [99] as well as corresponding BENEFITS and cost savings resulting from inexpensive supplementation with this ESSENTIAL Nutrient [99].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 140), ('IMPORTANT_CONSIDERATION', 222), ('IMPORTANT_CONSIDERATION', 301)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_33284', 'nutrient', 311, 'nutrient')]
PMC4689556	12/2015	S143-PMC4689556	['we FOUND NO EVIDENCE that Prenatal Vitamin D status is RELATED to healthcare utilisation, HOWEVER one MIGHT argue that the very SMALL number of subjects with adequate Vitamin D status LIMITED the power of this analysis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 184)]	7	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4690051	12/2015	S12-PMC4690051	['WHILE THRESHOLDS for Vitamin D sufficiency HAVE BEEN DEBATED RECENTLY [10,11], low circulating levels of 25(Oh)D HAVE BEEN ASSOCIATED with increased mortality in black and white older adults dwelling in north america [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 123)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D')]
PMC4719746	1/2016	S21-PMC4719746	['the AIMS of THIS PAPER were TO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, ASSESS RISK FACTORS for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women identified with low values during early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 161)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 171, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 179, 'D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC4719746	1/2016	S132-PMC4719746	['RECENT STUDIES from the same part of oslo MAY have increased AWARENESS of Vitamin D deficiency among health personnel [26–28], which MAY have CONTRIBUTED to the SOMEWHAT lower prevalence of Vitamin D deficiency in ethnic minorities in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 61), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 235)]	7	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4764019	1/2016	S45-PMC4764019	['BECAUSE OTHER FACTORS, such as socioeconomic status and ethnic background, COULD EXPLAIN both the low Vitamin D status and the poor performance in school in this group of children, this ASSOCIATION CANNOT BE CONSIDERED causal.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 198)]	7	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4770602	1/2016	S76-PMC4770602	['level of calcium in studied women was an IMPORTANT unmeasured covariate in OUR STUDY, WHEREAS, low calcium intake MAY BE ASSOCIATED with Vitamin D deficiency and MAY be a RISK FACTOR for Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 171)]	7	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 187, 'preeclampsia')]
PMC4800340	5/2016	S23-PMC4800340	['Vitamin D\nthe POSSIBLE ROLE of Vitamin D in Food allergy HAS BEEN HYPOTHESIZED BECAUSE several observational studies REPORTED varying Food allergy incidence ASSOCIATED with geographic or seasonal variation (sun exposure).']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 157)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_33290', 'food', 44, 'food'), ('CHEBI_33290', 'food', 134, 'food')]
PMC4829940	5/2016	S118-PMC4829940	['epigenetic EFFECTS of maternal Vitamin D levels on offspring methylomes can NEVERTHELESS not be excluded; the cpg’s in the neighborhood of the CANDIDATE Genes, as mapped by the illumina humanmethylation450 beadchip, MAY not be the same as the ones REPORTED from OTHER studies.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('SO_0000704', 'gene', 153, 'genes')]
PMC4848664	4/2016	S131-PMC4848664	['development of the Folic Acid ul was BASED ON EVIDENCE of masking of Vitamin B-12 deficiency anemia, and THUS, CONCERNS about the Folic Acid ul are ONLY applicable to those with a Vitamin B-12 deficiency and not to the general population.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 105), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 148)]	7	[('CHEBI_30751', 'formic acid', 19, 'folic acid'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 69, 'vitamin B-12'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 180, 'vitamin B-12')]
PMC4859539	5/2016	S97-PMC4859539	["in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
PMC4889866	5/2016	S19-PMC4889866	['THUS, DESPITE a WIDE VARIETY of studies that acknowledged the immunomodulatory ROLE of Vitamin D, the results HAVE BEEN CONFLICTING.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	7	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
PMC4889866	5/2016	S108-PMC4889866	['SINCE one POTENTIAL source of Il-10 is Treg, it was SPECULATED that higher Vitamin D level would be ASSOCIATED with less Treg Cells to respond to tlr stimulation, THUS resulting in lower Il-10 response as SEEN in OUR STUDY.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 100), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	7	[('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000901', 'Tr1 cell', 39, 'Treg'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CL_0000960', 'T3 B cell', 121, 'Treg cells'), ('PR_000001470', 'interleukin-28B', 187, 'IL-10')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4896250	4/2016	S3695-PMC4896250	['a259 ASSOCIATION of vdr and Cyp2R1 polymorphisms with persistent allergic rhinitis in a han chinese population\n\nhui-qin tian, lei cheng, xin-yuan chen\n\nthe first affiliated hospital of nanjing medical university, china\n\ncorrespondence: hui-qin tian – the first affiliated hospital of nanjing medical university china\na) background: as recent STUDIES have DESCRIBED an ASSOCIATION between Vitamin D and allergic rhinitis, we HYPOTHESIZED that Genes encoding components of the Vitamin D pathway MAY BE CANDIDATE Genes for susceptibility to allergic rhinitis.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 368), ('INCOMPLETE_EVIDENCE', 424), ('INCOMPLETE_EVIDENCE', 493), ('INCOMPLETE_EVIDENCE', 500)]	7	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 28, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 388, 'vitamin D'), ('SO_0000704', 'gene', 442, 'genes'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('GO_0007601', 'visual perception', 475, 'vitamin D'), ('SO_0000704', 'gene', 510, 'genes')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4897157	5/2016	S93-PMC4897157	['following CONFIRMATION of the Immunomodulatory EFFECTS of Vitamin D and formulation of the HYPOTHESIS that Vitamin D MAY BE ASSOCIATED with allergic disease prevalence, numerous studies pertaining to the RELATIONSHIP between Vitamin D and allergic diseases HAVE BEEN conducted.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 204), ('INCOMPLETE_EVIDENCE', 257)]	7	[('GO_0007566', 'embryo implantation', 30, 'immunomodulatory'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4930210	7/2016	S19-PMC4930210	['a combined analysis of two randomized clinical trials of 494 Pregnant women taking 400, 2000, and 4000 iu/day Vitamin D during Pregnancy SHOWED that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥ 80 nmol/l than 400 and 2000 iu/day in all women and their neonates REGARDLESS OF race, SUGGESTING that the current dietary RECOMMENDATION in the absence of supplementation in Pregnancy MAY not be OPTIMAL [9].']	[('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 332), ('FUTURE_WORK', 368), ('INCOMPLETE_EVIDENCE', 430), ('IMPORTANT_CONSIDERATION', 441)]	7	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy')]
PMC4930210	7/2016	S164-PMC4930210	['THUS, it APPEARS that ALTHOUGH winter uvr exposure MAY BE insufficient, VARIATIONS in summer sun exposure will alter fall 25(Oh)D concentration and THUS indirectly INFLUENCE winter Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 51), ('DIFFICULT_TASK', 72), ('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4944244	7/2016	S230-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care staff to assess the level of knowledge RELATED to Vitamin D. in addition, THIS RESEARCH AIMED to create the AWARENESS on the IMPORTANCE of Vitamin D to patient.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('IMPORTANT_CONSIDERATION', 163), ('IMPORTANT_CONSIDERATION', 180)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4971719	8/2016	S137-PMC4971719	['BECAUSE our study participants were drawn from a parent study looking at Omega-3 Fatty Acids (Dha and Epa) and their RELATIONSHIP to depression, and to adjust for other POTENTIAL CONFOUNDERS, we CONDUCTED a stepwise linear regression to BETTER UNDERSTAND the ASSOCIATION of Vitamin D with the bdi score.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 179), ('QUESTION_ANSWERED_BY_THIS_WORK', 195), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 259)]	7	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 73, 'omega-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 94, 'DHA'), ('CHEBI_34733', 'EPN', 102, 'EPA'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4971719	8/2016	S162-PMC4971719	['in the PUBLISHED LITERATURE, both low and high Vitamin D levels HAVE BEEN ASSOCIATED with Perinatal depression, a FINDING that others HAVE HYPOTHESIZED MAY BE due to a 24-hydroxylase-based degradation mechanism responding to abnormally high concentrations of Vitamin D [29].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 152)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0036268', 'swimming', 90, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 90, 'perinatal'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4973215	8/2016	S81-PMC4973215	['concurrently, we also EXAMINED maternal variables KNOWN to POTENTIALLY AFFECT Vitamin D levels and sga in an effort to BETTER UNDERSTAND the ROLE of these RISK FACTORS in vitamin d levels and risk of sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4973215	8/2016	S83-PMC4973215	['obesity is WELL KNOWN to be a RISK FACTOR for Vitamin D deficiency BECAUSE of a Sequestering Of Vitamin D in Adipose Tissue.35maternal obesity during Pregnancy HAS also BEEN ASSOCIATED with lower Vitamin D levels in neonates at Delivery.24,36,37,38our data are CONSISTENT and illustrate the inverse RELATIONSHIP between maternal bmi at Delivery and Vitamin D status after adjusting for confounding variables.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051208', 'sequestering of calcium ion', 80, 'sequestering of vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007567', 'parturition', 336, 'delivery'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
PMC4973215	8/2016	S87-PMC4973215	['IMPORTANTLY, OUR STUDY ILLUSTRATES the ADDITIVE EFFECT of maternal RISK FACTORS and their PREDICTIVE probabilities for Vitamin D deficiency and sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 90)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4989298	8/2016	S376-PMC4989298	['the use of Vitamin D supplementation for the primary PREVENTION of allergic diseases REMAINS an attractive TOPIC of study, BUT CURRENT KNOWLEDGE and AVAILABLE EVIDENCE does not warrant its RECOMMENDATION [129].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 149), ('FUTURE_WORK', 189)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4998950	4/2016	S5-PMC4998950	['conclusions\nif REFLECTING ASSOCIATIONS for Prenatal hypovitaminosis, THESE FINDINGS IMPLY Gestational Vitamin D substitution AS a means of asd PREVENTION.']	[('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('GO_0007565', 'female pregnancy', 90, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5045784	10/2016	S69-PMC5045784	['a variety of host FACTORS MAY confer altered susceptibility to bpd in preterm infants and SOME of these MAY BE Genetic and RELATED to Vitamin D bioavailability that is not REFLECTED in 25(Oh)D levels.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 172)]	7	[('SO_0000704', 'gene', 111, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 185, '25(OH)D')]
PMC5051327	9/2016	S68-PMC5051327	['in the logistic regression analysis of Vitamin D levels in women who underwent caesarean section due to suspected fetal distress/Birth asphyxia, we DID NOT adjust for maternal bmi SINCE it SEEMS to be INVOLVED in a causal pathway.35HOWEVER, SIMILAR results were FOUND in stratified analysis of lean women (≤25 in bmi).']	[('INCOMPLETE_EVIDENCE', 148), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('SUPERFICIAL_RELATIONSHIP', 201), ('ANOMALY_CURIOUS_FINDING', 230), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5051327	9/2016	S70-PMC5051327	['SINCE PRIOR STUDIES had REPORTED on INCREASED RISK of emergency caesarean Delivery in RELATION to low Vitamin D, we used caesarean Delivery DUE TO suspected fetal distress AS a main outcome and Birth asphyxia as a secondary outcome.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('PROBLEM_COMPLICATION', 140), ('PROBABLE_UNDERSTANDING', 172)]	7	[('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 131, 'delivery'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC5051327	9/2016	S83-PMC5051327	['IF OTHER groups REPRODUCE our FINDINGS and a causal RELATIONSHIP CAN be established, we MIGHT be in a position to lower the risk of fetal distress/Birth asphyxia with Vitamin D supplementation/sun exposure in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 88)]	7	[('GO_0007567', 'parturition', 147, 'birth'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy')]
PMC5062906	10/2016	S89-PMC5062906	['panel above the graph lists all statistically significant ( p value <0.05) comparisons determined by regression analysis for overall diet-dependent effects (diet) and diet\u2009×\u2009strain INTERACTIVE EFFECTS (diet\u2009×\u2009strain)\n\nmaternal Vitamin D depletion alters g1and g2offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner\nwe next ASSESSED WHETHER maternal Vitamin D depletion AFFECTS offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner across multiple generations.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 193), ('SUPERFICIAL_RELATIONSHIP', 333), ('QUESTION_ANSWERED_BY_THIS_WORK', 358), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('SUPERFICIAL_RELATIONSHIP', 404), ('SUPERFICIAL_RELATIONSHIP', 483)]	7	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
PMC5062906	10/2016	S232-PMC5062906	['ONE LIKELY EXPLANATION for the sporadic methylation changes OBSERVED in response to Vitamin D depletion is perturbation of global epigenetic Programming AS an indirect EFFECT of Dysregulation of master epigenetic REGULATORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 4), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 153), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'programming'), ('GO_0060233', 'oenocyte delamination', 178, 'dysregulation')]
PMC5062906	10/2016	S268-PMC5062906	['HOWEVER, we CANNOT COMPLETELY RULE OUT the POSSIBILITY that cis -acting Allelic DIFFERENCES in g1and g2animals somehow INFLUENCES the Vitamin D-DEPENDENT parent of origin epigenetic EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('SO_0001023', 'allele', 72, 'allelic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5062906	10/2016	S283-PMC5062906	['these observations SUGGEST that Vitamin D-induced changes in methylation are MOST LIKELY the result of sporadic epimutations due TO global dysregulation of epigenetic maintenance and that disruption of epigenetic Regulatory mechanisms is MOST LIKELY the causal FACTOR.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 77), ('PROBABLE_UNDERSTANDING', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('PROBABLE_UNDERSTANDING', 238), ('PROBABLE_UNDERSTANDING', 243), ('SUPERFICIAL_RELATIONSHIP', 261)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 213, 'regulatory')]
PMC5064894	10/2016	S28-PMC5064894	['DESPITE these SUGGESTIVE results from observational studies, there HAVE BEEN FEW prospective randomized controlled trials examining the IMPACT of Vitamin D supplementation on RISK of ari in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 175)]	7	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5085625	9/2016	S109-PMC5085625	['ALTHOUGH preeclampsia HAS BEEN LINKED to maternal Vitamin D insufficiency/deficiency, STILL LITTLE IS KNOWN on POTENTIAL differences in Placental Metabolism Of this Vitamin in uncomplicated and preeclamptic Pregnancies [32].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 86), ('IMPORTANT_CONSIDERATION', 86), ('FULL_UNKNOWN', 92), ('INCOMPLETE_EVIDENCE', 111)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'placental'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 146, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 165, 'vitamin'), ('GO_0007565', 'female pregnancy', 207, 'pregnancies')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S70-PMC5129897	['a meta-analysis of Lung cancer incidence versus 25(Oh)D concentration at the time of enrollment FOUND that relative risk decreased from 1.0 at 20\xa0nmol/l to 0.86 at 40\xa0nmol/l and 0.84 at 50\xa0nmol/l, after which the 95% confidence intervals became very large.47most of the 13 studies were prospective studies with long follow-up times, and ONE STUDY involved smokers who had taken large doses of Vitamin A, which MAY have AFFECTED cancer risk since it competes with Vitamin D.50thus, doubling the calculated change in relative risk to 0.72 at 40\xa0nmol/l and 0.68 at 50\xa0nmol/l and higher SEEMS REASONABLE.']	[('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 337), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 419), ('ANOMALY_CURIOUS_FINDING', 583), ('PROBABLE_UNDERSTANDING', 583), ('PROBABLE_UNDERSTANDING', 589)]	7	[('UBERON_0002048', 'lung', 19, 'lung'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D')]
PMC5129897	10/2016	S93-PMC5129897	['a RECENT PAPER by EXPERTS in ms ESTIMATED that Vitamin D supplementation COULD PREVENT 40% of ms cases.63using that value, the total economic BURDEN of ms in canada could eventually be reduced by $1.5\xa0billion.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 142)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S117-PMC5129897	["the annual economic BURDEN of crohn's disease in canada is $1.7\xa0billion, WHEREAS that of ulcerative colitis is $1.2\xa0billion.78several papers HAVE REPORTED inverse CORRELATIONS between Vitamin D status and incidence, prevalence, and/or severity of Inflammatory Bowel disease.79,80\nEVIDENCE is mounting that higher 25(Oh)D concentrations are ASSOCIATED with BETTER Pregnancy and Birth outcomes."]	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 280), ('SUPERFICIAL_RELATIONSHIP', 340), ('IMPORTANT_CONSIDERATION', 356)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001782', 'pigmented layer of retina', 247, 'inflammatory bowel'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 319, 'D'), ('GO_0007565', 'female pregnancy', 363, 'pregnancy'), ('GO_0007567', 'parturition', 377, 'birth')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5146866	12/2016	S85-PMC5146866	['moreover, the internal VALIDITY of the EXISTING STUDIES is a subject for discussion because the INDEPENDENT EFFECT of maternal race/ethnicity on the Vitamin D status was not controlled for and other maternal FACTORS MAY also have an ASSOCIATION with the development of Vitamin D deficiency/insufficiency in infants at Birth.']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 216), ('SUPERFICIAL_RELATIONSHIP', 233)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0007567', 'parturition', 318, 'birth')]
PMC5155676	12/2016	S108-PMC5155676	['weight gain in Pregnancy REPRESENTS NOT ONLY increased fat mass BUT ALSO Feto-Placental Tissues and hemodilution (16); our data, THEREFORE, SUGGEST that overall volume of dilution, and not just adiposity, MAY BE IMPORTANT for response to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 36), ('ANOMALY_CURIOUS_FINDING', 64), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 212)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000981', 'femur', 73, 'feto'), ('UBERON_0002483', 'trabecular bone tissue', 78, 'placental tissues'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
PMC5167470	12/2016	S44-PMC5167470	['HOWEVER, daily ingestion of multivitamin tablets that include around 6,000–8,000 u/d of Vitamin A do not SEEM to increase the rate of malformations RELATED to Isotretinoine (13-Cis Retinoic) exposure, and this result is from SEVERAL long-term case-control STUDIES.25,26for Vitamin D, exposure to high doses increased the rate of fetal Cardiac malformations, especially Aortic stenosis, which HAS BEEN ASSOCIATED with an intake of 4,000 iu/d.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 256), ('INCOMPLETE_EVIDENCE', 392), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A'), ('CHEBI_31719', 'ipriflavone', 159, 'isotretinoine'), ('CHEBI_33804', 'gluconates', 174, '13-cis'), ('CHEBI_26537', 'retinoid', 181, 'retinoic'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('UBERON_0000948', 'heart', 335, 'cardiac'), ('UBERON_0000947', 'aorta', 369, 'aortic')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5351212	3/2017	S39-PMC5351212	['(b) GIVEN the anti-inflammatory properties of Vitamin D, the PRESENT STUDY was DESIGNED TO INVESTIGATE WHETHER use of Calcitriol, [1α, 25-Dihydroxy Vitamin D3 (1,25Ohd)], the hormonally active form of Vitamin D, COULD prevent Poly(I:C)-induced behavioral dysfunctions RELEVANT TO asd, including deficits in Social Interaction, stereotyped behavior, innate anxiety, and Emotional Learning.']	[('PROBABLE_UNDERSTANDING', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 268)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 118, 'calcitriol'), ('CHEBI_43176', 'hydroxy group', 138, 'dihydroxy'), ('CHEBI_33279', 'vitamin D5', 148, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 148, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 162, '25OHD'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 226, 'poly(I:C'), ('GO_0019417', 'sulfur oxidation', 307, 'social interaction'), ('GO_0050959', 'echolocation', 369, 'emotional learning')]
PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC5359891	3/2017	S110-PMC5359891	['lactis ncc 2818 (cncm i-3446) also known as bl818control groupfolic Acid400\xa0μgstandard Preconception recommendationiron12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, though WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose Iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard Preconception recommendationhttp://www.cdc.gov/Preconception/documents/clinical-content_womensnutritionfactsheet3.pdfβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictions\n\noutcome measurements\nthe primary analysis will adjust for site, ethnicity and Preconception glycaemia to account for POTENTIAL imbalance between treatment arms amongst Pregnancies which reach 28\xa0weeks’ Gestation, examining for differences in means between the control and intervention groups for the primary endpoint, specifically the fasting and/or 60-min and/or 2-h Glucose concentrations following a 75-g ogtt at 28\xa0weeks’ Gestation.']	[('INCOMPLETE_EVIDENCE', 195), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 341), ('PROBABLE_UNDERSTANDING', 496), ('IMPORTANT_CONSIDERATION', 714), ('INCOMPLETE_EVIDENCE', 913)]	7	[('CHEBI_82451', "3,3'-Dimethoxybenzidine-4,4'-diisocyanate", 68, 'acid400'), ('GO_0007565', 'female pregnancy', 87, 'preconception'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('CHEBI_24870', 'ion', 312, 'iron'), ('CHEBI_17234', 'glucose', 353, 'glucose'), ('GO_0006006', 'glucose metabolic process', 353, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 375, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 411, 'calcium'), ('GO_0007565', 'female pregnancy', 451, 'pregnancy'), ('GO_0007565', 'female pregnancy', 562, 'preconception'), ('GO_0007565', 'female pregnancy', 609, 'preconception'), ('CHEBI_52743', 'bromine-79 atom', 681, 'carotene720'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 731, 'retinol'), ('GO_0007565', 'female pregnancy', 763, 'pregnancy'), ('GO_0007565', 'female pregnancy', 874, 'preconception'), ('GO_0007565', 'female pregnancy', 964, 'pregnancies'), ('GO_0007565', 'female pregnancy', 998, 'gestation'), ('CHEBI_17234', 'glucose', 1164, 'glucose'), ('GO_0007565', 'female pregnancy', 1222, 'gestation')]
PMC5368580	4/2017	S183-PMC5368580	['Water-soluble Vitamins are THOUGHT TO be actively Secreted involving members of the solute carrier (slc) and atp-binding Cassette (abc) family; breast Cancer–Resistant Protein (Bcrp) is ASSOCIATED with riboflavin secretion, Vitamin B-12 uptake MIGHT be PARTLY DEPENDENT on a receptor-mediated system, and Thiamin transporters Thtr1 and Thtr2 MAY BE INVOLVED in Thiamin secretion.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 244), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 260), ('INCOMPLETE_EVIDENCE', 342), ('SUPERFICIAL_RELATIONSHIP', 349)]	7	[('CHEBI_15377', 'water', 0, 'Water'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('GO_0046903', 'secretion', 50, 'secreted'), ('SO_0005853', 'gene_cassette', 121, 'cassette'), ('PR_000005005', 'calnexin', 151, 'cancer–resistant protein'), ('PR_000004760', 'bleomycin hydrolase', 177, 'BCRP'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 224, 'vitamin B-12'), ('CHEBI_26948', 'vitamin B1', 305, 'thiamin'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 326, 'THTR1'), ('PR_000001155', 'Toll-like receptor 4', 336, 'THTR2'), ('CHEBI_26948', 'vitamin B1', 361, 'thiamin')]
PMC5385921	4/2017	S15-PMC5385921	['THIS STUDY REPORTED lower 25-Hydroxyvitamin D (25Ohd) concentrations in neonatal samples from the asd cases compared with their unaffected siblings.6RECENTLY, a chinese asd case–control study ( n =68 cases) compared first trimester (11–13 weeks) maternal 25Ohd concentrations and REPORTED significantly lower concentrations of 25Ohd in the asd cases compared with their gender- and age-matched controls.12\nwe RECENTLY REPORTED an ASSOCIATION between developmental Vitamin D deficiency and a measure of social impairment within the autism spectrum, based on a large dutch Birth cohort.13in this study, Vitamin D was measured at two occasions: at mid-Gestation and at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 280), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 430)]	7	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 26, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 47, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 255, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 327, '25OHD'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('GO_0007567', 'parturition', 571, 'birth'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0007565', 'female pregnancy', 649, 'gestation'), ('GO_0007567', 'parturition', 666, 'birth')]
PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]
PMC5385921	4/2017	S142-PMC5385921	['it is FEASIBLE that a SAFE, inexpensive and PUBLICALLY acceptable Vitamin D supplementation in AT-RISK groups MAY reduce the PREVALENCE of this RISK FACTOR.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 144)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5405075	4/2017	S14-PMC5405075	['in THIS mini-REVIEW ARTICLE, we AIM to present the CURRENT KNOWLEDGE as it EMERGES from studies FOCUSED on the IMPACT of maternal Vitamin D status and Vitamin d supplementation on the Development Of Asthma in early childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 111)]	7	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 151, 'vitamin'), ('GO_0009602', 'detection of symbiont', 184, 'development of asthma')]
PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC5405075	4/2017	S38-PMC5405075	['CONSEQUENTLY, longitudinal studies measuring 25(Oh)D levels, a POSSIBLE more objective INDICATOR of Vitamin D status, were DESIGNED TO explore the POSSIBLE IMPACT of Vitamin D on asthma-like symptoms or asthma.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	7	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 47, '('), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5410409	4/2017	S62-PMC5410409	['SOME REPORTED that high maternal Vitamin D intake during Pregnancy was ASSOCIATED with reduced RISK of wheezing in the child, WHILE SOME SHOWED no effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 137)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC5418719	5/2017	S138-PMC5418719	['CONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu per day MAY optimize Vitamin D levels during early hospitalization in vlbw infants.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5426325	4/2017	S16-PMC5426325	['until 1 june 1985, Vitamin D fortification of Margarine was MANDATORY in denmark, BUT fortification was abolished, RELATED to an UNSUPPORTED ASSUMPTION that the amounts added to Margarine were too small to IMPACT the dietary NEEDS of Vitamin D in the danish population(3).']	[('IMPORTANT_CONSIDERATION', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 206), ('IMPORTANT_CONSIDERATION', 225)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_6784', 'mestranol', 46, 'margarine'), ('CHEBI_6784', 'mestranol', 178, 'margarine'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC5426325	4/2017	S19-PMC5426325	['the EVIDENCE for LINKING maternal Vitamin D insufficiency to offspring fracture rates is SPARSE and is BASED ON results from Animal studies(5), as well as observational studies SUGGESTING that maternal Vitamin D status INFLUENCES fetal bone growth and mineralisation(6), and PERHAPS also long-term bone health among offspring(7–12).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 275)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animal'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5452160	4/2017	S237-PMC5452160	['CONSIDERING the high prevalence of iron, zinc, Vitamin A, b12, and Folate deficiencies, and PREVIOUSLY presented results on Iodine deficiency in this study population [63], INTERVENTIONS to promote the strengthening of anc, and access and adherence to nutrition and health interventions are URGENTLY NEEDED [64,65].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 173), ('IMPORTANT_CONSIDERATION', 291), ('FUTURE_WORK', 300)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_24859', 'iodine atom', 124, 'iodine')]
PMC5474873	6/2017	S40-PMC5474873	['given the LIMITED RESEARCH, the AIM of THIS STUDY is TO INVESTIGATE the ASSOCIATION between Adult Life sun exposure (AS a PROXY for Vitamin D status) and later pes.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 122)]	7	[('UBERON_0000113', 'post-juvenile adult stage', 92, 'adult life'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5474873	6/2017	S165-PMC5474873	['THE CURRENT STUDY was BASED ON multiple exposure factors (several sun exposure VARIABLES) AS PROXIES for Vitamin D level and their RELATIONSHIP with pes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 79), ('PROBABLE_UNDERSTANDING', 90), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 131)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 113, 'D')]
PMC5487839	3/2016	S131-PMC5487839	['an increased risk of malformations events has NOT been OBSERVED in Humans (LIMITED DATA) [360]cvitamin dthe ROLE for Vitamin D supplementation in Pregnancy is CONTROVERSIAL, BUT there is NO EVIDENCE of a reduction in adverse Pregnancy outcomes (e.g., Preeclampsia, Stillbirth, neonatal death) [361] or improvement in bone Mineral content in children in studies in which supplementation was given INDEPENDENTLY from Blood levels [362].']	[('FULL_UNKNOWN', 46), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 396)]	7	[('NCBITaxon_9606', 'Homo sapiens', 67, 'humans'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 251, 'preeclampsia'), ('GO_0001966', 'thigmotaxis', 265, 'stillbirth'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('UBERON_0000178', 'blood', 415, 'blood')]
PMC5513133	7/2017	S0-PMC5513133	['the ROLE of Vitamin D in pre-eclampsia: a systematic review\n\nabstract\n\nbackground\nthe etiology of pre-eclampsia (pe) is not YET FULLY UNDERSTOOD, THOUGH CURRENT LITERATURE INDICATES an upregulation of Inflammatory Mediators produced by the Placenta AS a POTENTIAL causal mechanism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 146), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 254)]	7	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 201, 'inflammatory mediators'), ('UBERON_0001987', 'placenta', 240, 'placenta')]
PMC5513133	7/2017	S4-PMC5513133	['these sources were retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D.\n\nresults\nseveral case-control studies and cross-sectional studies HAVE SHOWN an ASSOCIATION between Vitamin D status and pe, ALTHOUGH EVIDENCE HAS BEEN INCONSISTENT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279)]	7	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5513133	7/2017	S30-PMC5513133	['WHILE the pathogenesis of pe INVOLVES a number of biological Processes, there are several HYPOTHESES to SUGGEST HOW Vitamin D levels MAY AFFECT these processes (table1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 112), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('GO_0007565', 'female pregnancy', 61, 'processes'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5524288	7/2017	S111-PMC5524288	['THESE FINDINGS SHOW that higher Vitamin D status is significantly ASSOCIATED with lower ptb RISK for both ptb subtypes and that Vitamin D plays an IMPORTANT ROLE in the UNDERLYING causes of indicated ptb including maternal hypertension, pre-existing diabetes, and non-reassuring fetal status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5539754	8/2017	S30-PMC5539754	['due to the seasonal nature of 25Ohd concentrations in many parts of the world [32], and the OBSERVED ASSOCIATIONS between Vitamin D and Insulin resistance, it WOULD seem PRUDENT to HYPOTHESISE that seasonal variation of Glucose Homeostasis MAY BE MEDIATED through 25Ohd.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_PREDICTION', 159), ('IMPORTANT_CONSIDERATION', 170), ('FUTURE_WORK', 181), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 247)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 30, '25OHD'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000045358', 'insulin family protein', 136, 'insulin'), ('CHEBI_17234', 'glucose', 220, 'glucose'), ('GO_0042593', 'glucose homeostasis', 220, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 264, '25OHD')]
PMC5539754	8/2017	S105-PMC5539754	['GIVEN that the ASSOCIATION between early Gestation through extended winter and Insulin resistance is INDEPENDENT of Serum 25Ohd <30\xa0nmol/l, our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 144), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 228)]	7	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 122, '25OHD'), ('PR_000045358', 'insulin family protein', 192, 'insulin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]
PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
PMC5664622	9/2017	S9-PMC5664622	['the FIRST REPORTS on Vitamin D insufficiency appeared in the 80s of the previous century but it was not until recently that the PROBLEM gained significant ATTENTION DUE TO the GROWING TENDENCY to stay indoors, avoid sun exposure, and use of sunscreen [2,3].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 165), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 184)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5679631	11/2017	S159-PMC5679631	['TO OUR KNOWLEDGE, THIS is the FIRST report of a large scale observational study INDICATING that Prenatal Vitamin D exposure, AS measured either by maternal use of multivitamin supplements containing Vitamin D, or 25(Oh)D quintiles, INFLUENCES several IMPORTANT bacterial taxa within the infant Gut.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 251)]	7	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('UBERON_0001555', 'digestive tract', 294, 'gut')]
PMC5706533	11/2017	S151-PMC5706533	['this COULD BE EVIDENCE of the biological responsiveness of fetal growth to Vitamin D, CONSISTENT with OBSERVATIONAL epidemiological STUDIES2223AND SOME Animal research.2425yet this is also an example of an intangible meta-analysis result that frustrates as much as it illuminates as the EFFECT cannot be attributed to a specific dose or target 25(Oh)d threshold.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 287)]	7	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 152, 'animal'), ('CHEBI_30778', 'gallic acid', 344, '25(OH)')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5732505	12/2017	S155-PMC5732505	['SOME earlier STUDIES HAVE SHOWN that SEVERE maternal Vitamin D deficiency ASSOCIATES with smaller Head circumference at Birth [32,33], YET SOME HAVE NOT [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 144)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000033', 'head', 98, 'head'), ('GO_0007567', 'parturition', 120, 'birth')]
PMC5732505	12/2017	S168-PMC5732505	['the threshold for DEFINING Vitamin D deficiency and the diagnostic criteria for gdm VARY between STUDIES, which MIGHT AFFECT the results and COMPLICATE the comparison of STUDIES.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 84), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 118), ('DIFFICULT_TASK', 141), ('INCOMPLETE_EVIDENCE', 170)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5758521	1/2018	S20-PMC5758521	['HOWEVER, there is a LACK OF DATA on WHETHER Vitamin A and E nutritional status MAY BE ASSOCIATED with Metabolic health BIOMARKERS in early Life in Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 119)]	7	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0008152', 'metabolic process', 102, 'metabolic'), ('UBERON_0000104', 'life cycle', 139, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'humans')]
PMC5758521	1/2018	S21-PMC5758521	['to fill this IMPORTANT research data gap, we SOUGHT TO EVALUATE WHETHER Vitamin A and e nutritional status in neonates are ASSOCIATED with circulating concentrations of leptin, adiponectin, Igf-I and Igf-Ii which are IMPORTANT BIOMARKERS of fetal growth and Metabolic health15,16.']	[('IMPORTANT_CONSIDERATION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 227)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000008919', 'interferon alpha-6', 190, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 200, 'IGF-II'), ('GO_0008152', 'metabolic process', 258, 'metabolic')]
PMC5784894	1/2018	S20-PMC5784894	['[14]\nconsidered TOGETHER, THESE FINDINGS IMPLY that early Life Vitamin D exposure has EFFECTS that persist into childhood, MAY IMPACT on peak bone mass accrual and INFLUENCE subsequent bone loss, the development of osteoporosis and the risk of Life-limiting fracture.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC5784894	1/2018	S173-PMC5784894	['we BELIEVE that our data are ROBUST and that our INFERENCES of a reduced EFFECT of loading in offspring of Vitamin D deplete Animals stand BECAUSE the increased compliance of the Bones in the deplete group MEANS that the strain stimulus induced by the load of 10.5n was greater than in the replete group.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 49), ('PROBABLE_UNDERSTANDING', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 139), ('PROBABLE_UNDERSTANDING', 206)]	7	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animals'), ('UBERON_0001474', 'bone element', 179, 'bones')]
PMC5941617	5/2018	S20-PMC5941617	['the main OBJECTIVE is to give RECOMMENDATIONS regarding the PREVENTION and treatment of Vitamin D deficiency in italian children and adolescents (0–18\xa0years), CONSIDERING both the Skeletal and Extra-Skeletal EFFECTS of Vitamin D and POTENTIAL RISK FACTORS in specific subgroups of children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 243)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0004288', 'skeleton', 180, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 193, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5941617	5/2018	S471-PMC5941617	['strict adherence to gluten free diet itself MAY REPRESENTS a DETERMINANT of Vitamin D status, BECAUSE it HAS BEEN DEMONSTRATED that sweden cd children on gluten free diet had low Vitamin D intake compared with nordic nutrition recommendation and lower Nutrient density of Vitamin D than healthy children [431].']	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114)]	7	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S648-PMC5941617	['Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING Vitamin D Metabolism (table\xa07).']	[('FUTURE_WORK', 17), ('IMPORTANT_CONSIDERATION', 17), ('PROBABLE_UNDERSTANDING', 37), ('IMPORTANT_CONSIDERATION', 70), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 181)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_23888', 'drug', 175, 'drugs'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0008152', 'metabolic process', 201, 'metabolism')]
PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
PMC5941617	5/2018	S720-PMC5941617	['we SUGGEST to CONSIDER serum 25(Oh)D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation, and/or with specific conditions POSSIBLY AFFECTING Pregnancy course (table\xa09).']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 68), ('ANOMALY_CURIOUS_FINDING', 107), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 205)]	7	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
PMC5952272	5/2018	S147-PMC5952272	['experiment on Animal models SHOWED that 1,25 Dihydroxyvitamin D3 Prenatal supplementations were PROTECTIVE for offsprings against induced Maternal Immune Activation (mia).42maternal Immune Activation in experimental Animals Reproduces asd-like symptoms via significant increase of proinflammatory cytokines; however, administration of Vitamin D has blocked the emergence of asd-relevant deficits in social INTERACTION, stereotyped behaviour, and emotional Learning and Memory.42RECENTLY, sotodehasl et al43have reviewed 80 articles LINKING autism and Vitamin D. the authors found no significant DIFFERENCES between children with asd and neurotypical developed children.43this was also SUPPORTED by a canadian prospective cohort study that included 3852 children.44forty-one children were diagnosed with asd, who have no difference in the level of Vitamin D in their Serum compared with non-asd children.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 406), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('SUPERFICIAL_RELATIONSHIP', 532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 685)]	7	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 40, '1,25 dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 62, 'D3'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007618', 'mating', 138, 'maternal'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 147, 'immune activation'), ('UBERON_0002405', 'immune system', 147, 'immune'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 182, 'immune activation'), ('UBERON_0002405', 'immune system', 182, 'immune'), ('NCBITaxon_33208', 'Metazoa', 216, 'animals'), ('GO_0000003', 'reproduction', 224, 'reproduces'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('GO_0007612', 'learning', 456, 'learning'), ('GO_0007613', 'memory', 469, 'memory'), ('CHEBI_27300', 'vitamin D', 551, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 847, 'vitamin D'), ('UBERON_0001977', 'blood serum', 866, 'serum')]
PMC5956785	5/2018	S24-PMC5956785	['an updated, systematic analysis of pertinent literature SHOULD help to FURTHER REFINE understanding of the RELATIONSHIPS between Vitamin D and juvenile arthritis, contribute to optimizing management of vitamin d status in children with arthritis, and CLARIFY Vitamin D’s POTENTIAL ROLE in MEDIATING disease pathogenesis.']	[('FUTURE_WORK', 56), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 107), ('FUTURE_WORK', 251), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 281), ('SUPERFICIAL_RELATIONSHIP', 289)]	7	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC5956785	5/2018	S62-PMC5956785	['defining Vitamin D status\nvitamin D deficiency is DEFINED AS a Serum 25(Oh)D concentration less than 30\xa0nmol/l, a 25(Oh)D concentration between 30 and 50\xa0nmol/l IS CONSIDERED insufficient, greater than 50\xa0nmol/l IS CONSIDERED sufficient and a 25(Oh)D status greater than 125\xa0nmol/l IS CONSIDERED AT RISK of adverse EFFECTS [19].']	[('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 212), ('INCOMPLETE_EVIDENCE', 282), ('IMPORTANT_CONSIDERATION', 296), ('SUPERFICIAL_RELATIONSHIP', 315)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 34, 'D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 114, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC6011374	6/2018	S15-PMC6011374	['this MAY BE explained, IN PART, by INADEQUATE control of RELATED risk factors and CONFOUNDERS in statistical analyses, VARIATIONS between assays that measure Vitamin D and significant HETEROGENEITY between studied populations [6].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 23), ('PROBLEM_COMPLICATION', 35), ('SUPERFICIAL_RELATIONSHIP', 57), ('PROBLEM_COMPLICATION', 82), ('DIFFICULT_TASK', 119), ('DIFFICULT_TASK', 184)]	7	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
PMC6043562	7/2018	S161-PMC6043562	['Prenatal exposure INTERACTIONS MAY play an IMPORTANT ROLE, AS EVIDENCED by the POTENTIAL synergy between Vitamin E and Pm2.5.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 59), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 79)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin E'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 119, 'PM2')]
BMJ_2010_Apr_29_340_c1640	4/2010	S101-BMJ_2010_Apr_29_340_c1640	['for example, Vitamin D can down-regulate Interleukin 6, an IMPORTANT mediator of the adverse EFFECT of maternal infection during Pregnancy on neural development in the fetus.505152\n\nPrenatal and Postnatal timing\nour results do not INDICATE that the POSSIBLE beneficial EFFECT of Ultraviolet radiation exposure is confined ONLY to the Prenatal period.']	[('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000008988', 'interleukin-1 family member 5', 41, 'interleukin 6'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'Prenatal'), ('GO_0007567', 'parturition', 195, 'postnatal'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 279, 'ultraviolet'), ('GO_0007565', 'female pregnancy', 334, 'prenatal')]
PMC1168874	7/2005	S68-PMC1168874	['OUR FINDING is IN AGREEMENT with the CONCLUSION of the european network of the teratology information services, whose data set DID NOT PROVIDE EVIDENCE for an INCREASED RISK of major cas ASSOCIATED with high Vitamin A intake (10,000 iu per day or more) during the Organogenetic period of Embryo26.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_27300', 'vitamin D', 208, 'vitamin A'), ('GO_0048513', 'animal organ development', 264, 'organogenetic'), ('UBERON_0000922', 'embryo', 288, 'embryo26')]
PMC2151954	10/2007	S171-PMC2151954	['with respect to seasonally-fluctuating exposures that MAY UNDERLIE THESE FINDINGS, we SPECULATE that low Prenatal Vitamin D is a CANDIDATE that WARRANTS closer inspection [4].']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 129), ('FUTURE_WORK', 144)]	6	[('GO_0007565', 'female pregnancy', 105, 'prenatal'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC2290997	4/2008	S80-PMC2290997	['researchers are now seeking to understand HOW much uvr/Vitamin D is NEEDED to lower the risk of diabetes and WHETHER this is a FACTOR ONLY in high-risk groups.']	[('EXPLICIT_QUESTION', 42), ('FUTURE_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('EXPLICIT_QUESTION', 109), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 134)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2290997	4/2008	S86-PMC2290997	['“moreover, there is an inflammatory component to atherosclerosis, and Vascular Smooth Muscle Cells have a Vitamin D receptor and relax in the presence of 1,25(Oh)D, SUGGESTING a multitude of mechanisms by which Vitamin D MAY BE cardioprotective.”\nTO DETERMINE the POTENTIAL LINK betwen sun exposure and the PROTECTIVE effect in preventing hypertension, rolfdieter krause of the free university of berlin department of natural medicine and colleagues exposed a group of hypertensive Adults to a Tanning Bed that emitted full-spectrum uvr similar to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 221), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 307)]	6	[('CL_0000359', 'vascular associated smooth muscle cell', 70, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 70, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 158, '(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('UBERON_0007023', 'adult organism', 482, 'adults'), ('UBERON_0002544', 'digit', 494, 'tanning'), ('UBERON_0002531', 'paired fin bud', 502, 'bed')]
PMC2290997	4/2008	S95-PMC2290997	['in addition, 25(Oh)D levels are inversely ASSOCIATED with the clinical status of ra patients, and greater intake of Vitamin D HAS BEEN LINKED with lower ra RISK, AS REPORTED in january 2004 in arthritis & rheumatism .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 156), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 165)]	6	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2396486	6/2008	S102-PMC2396486	['Calbindin is strongly induced by Vitamin D[29], and THUS it is FEASIBLE that the reduction in this protein MAY BE a consequence of the Early Life reduction in Vitamin D. the POTENTIAL LINKS between Vitamin D and Neuronal calcium binding proteins HAS BEEN NOTED in a recent review article[30]\ntwo members of the dynamin family (Dynamin 1 and Dynamin 1-Like proteins) were also significantly down-regulated.']	[('PROBABLE_UNDERSTANDING', 52), ('PROBABLE_UNDERSTANDING', 63), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 184), ('ANOMALY_CURIOUS_FINDING', 246)]	6	[('PR_000004967', 'calbindin', 0, 'Calbindin'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 135, 'early life'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CL_0000540', 'neuron', 212, 'neuronal'), ('PR_000006501', 'dickkopf-related protein 3', 327, 'dynamin 1'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 341, 'dynamin 1-like')]
PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
PMC2582131	11/2008	S92-PMC2582131	['lastly, IT IS POSSIBLE that the OBSERVED inverse ASSOCIATION of Plasma 25-[Oh] D with gdm risk REFLECTS the IMPACT of other components of major endogenous and exogenous sources of Vitamin D on Glucose Homeostasis through OTHER pathways.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	6	[('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 71, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_17234', 'glucose', 193, 'glucose'), ('GO_0042593', 'glucose homeostasis', 193, 'glucose homeostasis')]
PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2679409	5/2009	S477-PMC2679409	['given the POTENTIAL Teratogenic EFFECT and toxicity of high-dose Vitamin A, a variety of Vitamin A INTERVENTIONS (daily supplementation with either low-dose Vitamin A or Β-Carotene) HAVE BEEN evaluated with assessment of SAFETY and IMPACT on maternal, newborn and infant outcomes.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 221), ('SUPERFICIAL_RELATIONSHIP', 232)]	6	[('CHEBI_50905', 'teratogenic agent', 20, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 170, 'β-carotene')]
PMC2679409	5/2009	S499-PMC2679409	['the largest rct reporting the IMPACT of Vitamin A on stillbirths [101] also INDICATES no benefit of vitamin a for fetal or early infant survival, ALTHOUGH vitamin a does APPEAR TO BE of benefit to maternal health and survival, and Vitamin A deficiencies are KNOWN to CO-exist with iron deficiency [98].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 146), ('ANOMALY_CURIOUS_FINDING', 170), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin A')]
PMC2685863	5/2009	S2-PMC2685863	['a team of canadian and british researchers has now REPORTED EVIDENCE that Vitamin D INTERACTS with a variant form of the Hla-Drb1 Gene, which HAS BEEN ASSOCIATED with ms.\nas REPORTED in the 6 february 2009 issue of the online journal plos genetics , study leader george ebers, a clinical neurologist at the university of oxford, united kingdom, and colleagues examined cells with two copies of the Hla-Drb*15 form of Hla-Drb1 .']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151), ('INCOMPLETE_EVIDENCE', 174)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 121, 'HLA-DRB1'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 398, 'HLA-DRB'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 417, 'HLA-DRB1')]
PMC2779500	11/2009	S46-PMC2779500	['[31] maintain that Prenatal supplementation of Vitamins B, C, and e SHOULD BE continued DUE TO their MANY REPORTED positive EFFECTS on maternal and fetal health.']	[('FUTURE_WORK', 68), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamins B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 47, 'vitamins B'), ('CHEBI_18245', 'carboxylato group', 59, 'C'), ('PR_000004900', 'complement C3', 59, 'C')]
PMC2841444	2/2010	S499-PMC2841444	['although the quality of the trials is variable and FURTHER STUDIES ARE NEEDED, these data SUGGEST a POSSIBLE ROLE for Antenatal maternal Vitamin K administration as a means of reducing RISKS of pvh and mortality in preterm infants.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007567', 'parturition', 118, 'antenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K')]
PMC2889879	5/2010	S125-PMC2889879	['HOWEVER, NONE of these covariates change the ESTIMATES substantially, and was THEREFORE not included in the final multivariate MODEL\ncsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha) and Docosapentaenoic Acid\ndadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of fat other than Eicosapentaenoic Acid, Docosahexaenoic Acid and Docosapentaenoic Acid\nesum of Arachidonic And Linoleic Acids\nfadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of other than Omega-6 Fatty Acids\ngsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha), Docosapentaenoic Acid and Α-Linolenic Acid\nhadjusted for age, total energy intake and dietary Intake of Vitamin B12, Alcohol and dietary intake of other than Omega-3 Fatty Acids\nthe intake of Vitamin D was significantly ASSOCIATED with a decreased relative risk of both the middle and high levels of psychotic-like symptoms (table4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 78), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 871)]	6	[('CHEBI_36003', 'decenoic acid', 141, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 164, 'EPA'), ('CHEBI_36003', 'decenoic acid', 170, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 192, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 201, 'docosapentaenoic acid'), ('CHEBI_33279', 'vitamin D5', 284, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 284, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 297, 'alcohol'), ('CHEBI_36003', 'decenoic acid', 342, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 365, 'docosahexaenoic acid'), ('CHEBI_61205', 'docosatetraenoic acid', 390, 'docosapentaenoic acid'), ('CHEBI_36431', 'angelic acid', 420, 'arachidonic and'), ('CHEBI_25048', 'linolenic acid', 436, 'linoleic acids'), ('CHEBI_33279', 'vitamin D5', 512, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 512, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 525, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 566, 'omega-6 fatty acids'), ('CHEBI_36003', 'decenoic acid', 594, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 617, 'EPA'), ('CHEBI_36003', 'decenoic acid', 623, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 645, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 651, 'docosapentaenoic acid'), ('CHEBI_86354', '2-hydroxyacrylic acid', 677, 'α-linolenic acid'), ('GO_0007631', 'feeding behavior', 745, 'intake'), ('CHEBI_33279', 'vitamin D5', 755, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 755, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 768, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 809, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 843, 'vitamin D')]
PMC2913107	8/2010	S10-PMC2913107	['FOR THIS REASON, in 2007, the canadian paediatric society CAUTIONED Pregnant women they MAY REQUIRE NOT 400 iu/day BUT 2000 iu/day, or more, to PREVENT Gestational Vitamin D deficiency (9).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
PMC2996405	11/2010	S11-PMC2996405	['in addition we CONFIRM, at a molecular level, the LINK between schizophrenia and Vitamin D. finally, we discuss a MODEL in which schizophrenia is, at LEAST PARTLY, a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 201)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 231, 'vitamin D metabolism')]
PMC2996405	11/2010	S103-PMC2996405	['an IMPORTANT factor HYPOTHESIZED to be both latitude DEPENDENT and Neural Development-RELATED is Vitamin D. we checked for an enrichment of lrgs in Vitamin D related (vdr) Genes by manually creating a list of 943 Genes that broadly comprised the most IMPORTANT processes in which it is INVOLVED, since a comprehensive list is not yet present in the literature (additional file4).']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 286)]	6	[('GO_0007399', 'nervous system development', 67, 'neural development'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 148, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'Vitamin'), ('SO_0000704', 'gene', 172, 'genes'), ('SO_0000704', 'gene', 213, 'genes')]
PMC2996405	11/2010	S168-PMC2996405	['ACCORDING TO our HYPOTHESIS that Vitamin D COULD BE the LINK between latitude and schizophrenia, we FOCUSED on the 9 lrgs present in both the lists of Vitamin D and schizophrenia RELATED Genes (figure1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0000704', 'gene', 187, 'genes')]
PMC2996405	11/2010	S250-PMC2996405	['we also FOUND a molecular RELATIONSHIP of schizophrenia with both latitude and Vitamin D. AT LEAST in one case, our results SUGGEST that schizophrenia COULD BE a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 197)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 227, 'vitamin D metabolism')]
PMC3004407	12/2010	S146-PMC3004407	['using both circulating 25(Oh)D and pth as MARKERS of Vitamin D deficiency, THESE FINDINGS UNDERSCORE RECENT REPORTS of widespread Vitamin D deficiency among Pregnant women, EVEN in areas of the world with ample sunlight.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant')]
PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC3075531	7/2010	S46-PMC3075531	['the REASONS WHY Vitamin D deficiency is THOUGHT TO be a RISK FACTOR for ms are as follows: first, ms frequency increases with increasing latitude, which is strongly inversely CORRELATED with duration and intensity of uvb from sunlight and Vitamin D concentrations.2830–35second, prevalence of ms is lower than EXPECTED at high latitudes in populations with high Consumption of Vitamin-D-rich Fatty fish43536.']	[('PROBABLE_UNDERSTANDING', 4), ('EXPLICIT_QUESTION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 310)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0007631', 'feeding behavior', 362, 'consumption'), ('CHEBI_83326', 'tedizolid phosphate', 377, 'vitamin-D'), ('CHEBI_33250', 'atom', 392, 'fatty')]
PMC3099599	5/2011	S211-PMC3099599	['HOWEVER, Vitamin D deficiency (vdd) and its bony manifestation, rickets, CAN lead to deformation of the weakened Skull during Birth resulting in psdh, and CONTRIBUTE to bony FINDINGS that SEEMINGLY CONFIRM the child abuse etiology.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 174), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 198)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0003129', 'skull', 113, 'skull'), ('GO_0007567', 'parturition', 126, 'birth')]
PMC3235789	12/2011	S99-PMC3235789	['in the case of Vitamin D deficiency, OUR FINDINGS are CONSISTENT with a RECENT cohort of Pregnant women, which FOUND a dose-response RELATIONSHIP between 25-Oh-D and the PREVALENCE of Bv during Pregnancy [29], and a nationally representative cross-sectional study of women in the united states, which found that 25-Oh-D <30\u2009ng/ml significantly increased the odds of bv during Pregnancy (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 133), ('IMPORTANT_CONSIDERATION', 170)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_17808', 'IDP', 157, 'OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 184, 'BV'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 312, '25-OH-D'), ('GO_0007565', 'female pregnancy', 376, 'pregnancy')]
PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
PMC3257641	3/2010	S56-PMC3257641	['a RECENT meta-analysis of Vitamin D supplementation in RELATION to bone health in Adults, SHOWED that for every 1 iu increase in oral Vitamin D3, the 25(Oh)D level COULD BE expected to increase by 0.016 nmol/l, with a relatively linear RELATIONSHIP AT LEAST up to 2000 iu/day [45].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 236), ('PROBABLE_UNDERSTANDING', 249)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0007023', 'adult organism', 82, 'adults'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC3257641	3/2010	S63-PMC3257641	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and defective Reproduction MAY BE the result of hypocalcaemia RATHER than a Vitamin D EFFECT per se , AS the infertile female Vdr null Mice developed normal fertility when Fed a Calcium rich diet [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 140), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0000003', 'reproduction', 68, 'reproduction'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 180, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('GO_0007631', 'feeding behavior', 226, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium')]
PMC3257641	3/2010	S119-PMC3257641	['a norwegian case control study FOUND cod Liver oil use during Pregnancy was ASSOCIATED with lower risk of type 1 diabetes in the offspring, INDICATING Vitamin D or the N-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid in the cod Liver oil, or both, MAY have a PROTECTIVE EFFECT against type i diabetes [89].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 262), ('SUPERFICIAL_RELATIONSHIP', 273), ('SUPERFICIAL_RELATIONSHIP', 284)]	6	[('UBERON_0002107', 'liver', 41, 'liver'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_35418', 'N-acetylneuraminate', 168, 'n-3 fatty acids'), ('CHEBI_36003', 'decenoic acid', 184, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 210, 'docosahexaenoic acid'), ('UBERON_0002107', 'liver', 242, 'liver')]
PMC3257641	3/2010	S160-PMC3257641	['to examine the POTENTIAL long term EFFECTS of low Vitamin D on offspring health, randomized controlled trials STUDIES MAY NOT BE feasible, particularly for RARE diseases with later onset such as schizophrenia.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35), ('FUTURE_WORK', 110), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 156)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3277098	12/2011	S57-PMC3277098	['weiss [33] PROPOSES in his editorial on Vitamin D and the Gut microbiome that Vitamin D COULD POTENTIALLY INTERACT directly with both the galt and the microflora, to INFLUENCE Immune function and allergy outcomes, a THEORY also explored by vassallo and camargo [35].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 216)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 58, 'gut'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 176, 'immune')]
PMC3277098	12/2011	S60-PMC3277098	['this line of argument HIGHLIGHTS that the potency and pharmacokinetics of endogenous and exogenous Vitamin D MAY BE DIFFERENT and that Serum 25(Oh)D, sun exposure and oral Intake SHOULD BE CONSIDERED INDEPENDENTLY of one another.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('FUTURE_WORK', 179), ('FUTURE_WORK', 189), ('SUPERFICIAL_RELATIONSHIP', 200)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 141, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 172, 'intake')]
PMC3277098	12/2011	S181-PMC3277098	['[64] FOUND that lower Serum 25(Oh)D (of ≤37.5 nmol/l) was ASSOCIATED with both Peanut (or 2.39; 95% ci 1.29–4.45, p = 0.005) and shrimp (or 3.08; 95% ci 1.16–8.19, p = 0.02) sensitization, HOWEVER, OTHER studies of Food allergy are LARGELY LIMITED TO epidemiological data without serological measures of Vitamin D [69,70,71,72].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 28, '25(OH)D'), ('NCBITaxon_10088', 'Mus <genus>', 79, 'peanut'), ('CHEBI_33290', 'food', 215, 'food'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3277098	12/2011	S194-PMC3277098	['there is also SOME EVIDENCE that the EFFECT of supplementation MAY depend ON WHETHER Vitamin D is administered in a fat- OR Water-soluble form.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_15377', 'water', 124, 'water')]
PMC3277098	12/2011	S197-PMC3277098	['these CONTRASTING results HIGHLIGHT THE NEED for randomised controlled trials (rct) to provide clearer picture of ROLE of Vitamin D during infancy in Regulation of Allergic disease, including uptake, Metabolism and Immunomodulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 150)]	6	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0065007', 'biological regulation', 150, 'regulation'), ('GO_0040011', 'locomotion', 164, 'allergic'), ('GO_0008152', 'metabolic process', 200, 'metabolism'), ('GO_0050900', 'leukocyte migration', 215, 'immunomodulation')]
PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
PMC3347007	4/2012	S1-PMC3347007	['the AIMS of the PRESENT STUDY were to ESTIMATE the intake and sources of Vitamin D in danish Pregnant women and TO EXAMINE POTENTIAL DETERMINANTS of Vitamin D intake of the recommended level (10 µg per day).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3347007	4/2012	S19-PMC3347007	['Animal studies SHOW a POSSIBLE ASSOCIATION between maternal Vitamin D status and Brain Development in pups, which COULD POSSIBLY play a ROLE in Cognitive and Neurological Development [4].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 136)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007420', 'brain development', 81, 'brain development'), ('UBERON_0000955', 'brain', 81, 'brain'), ('GO_0050890', 'cognition', 144, 'cognitive ...'), ('GO_0007399', 'nervous system development', 158, 'neurological development'), ('UBERON_0001016', 'nervous system', 158, 'neurological')]
PMC3347007	4/2012	S183-PMC3347007	['HOWEVER, we BELIEVE that the DETERMINANTS of Vitamin D intake SEEN in THIS STUDY MAY adequately reflect the ones of the background population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 81)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347028	3/2012	S58-PMC3347028	['DESPITE these OBSERVATIONS, it was CONCLUDED that the condition of Vitamin D deficiency LED TO weakness and malnutrition and was not a direct EFFECT of Vitamin D on the Immune System.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC3347028	3/2012	S157-PMC3347028	['the FEW STUDIES that HAVE BEEN conducted have FOCUSED more on discernible neonatal EFFECTS of Vitamin D during Pregnancy, RATHER than the long-latency and later health EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 168)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC3347028	3/2012	S158-PMC3347028	['reports of neonatal seizures due to SEVERE hypocalcemia or rickets in utero that is manifested at Birth from SEVERE maternal and THUS fetal Vitamin D deficiency are RARE and do not further our understanding of POTENTIAL epigenetic EFFECTS of Vitamin D [122,123].']	[('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 231)]	6	[('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC3347028	3/2012	S233-PMC3347028	['looking carefully at the INCREASING NUMBER OF epidemiological STUDIES involving women with Preeclampsia: is there a LINK with Vitamin D deficiency where PERHAPS in certain women, there is loss of the Vitamin D-mediated Suppression Of T Cells that leads to a profound inflammatory reaction REMINISCENT of graft- vs. -host disease?']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 289), ('EXPLICIT_QUESTION', 328)]	6	[('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0048469', 'cell maturation', 219, 'suppression of T cells'), ('CL_0000084', 'T cell', 234, 'T cells')]
PMC3347028	3/2012	S240-PMC3347028	['WHILE there REMAINS much to be DISCOVERED and learned about Vitamin D’s EFFECT on the mother and her developing fetus, there is enough EVIDENCE TO SUPPORT the PREMISE that deficiency is not healthful for either the mother or fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3347028	3/2012	S242-PMC3347028	['a RECENT randomized controlled TRIAL with 350 women of diverse racial and ethnic backgrounds SHOWED that 4000 iu Vitamin D/day is MOST EFFECTIVE in improving the Vitamin D status of Pregnant women, attaining circulating levels of at least 40 ng/ml (100 nmol/l) for 25(Oh)D, and was NECESSARY to achieve OPTIMAL 1,25(Oh)2D production.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 303)]	6	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 267, '(OH ... D'), ('CHEBI_37983', 'sulfur-35 atom', 311, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 313, '25(OH)2D')]
PMC3348565	4/2012	S133-PMC3348565	['FURTHER QUESTIONS arise with respect to the previous treatment trial in the same region of kabul, which showed that a single high-dose supplementation with 100\u2008000 iu Vitamin D3Given orally to young children, along with Antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months.3the INCONSISTENT results COULD BE RELATED to the evidence that stimulation of toll-like receptors on Macrophages and Monocytes by Bacterial Antigens is IMPORTANT in up-regulation of Cyp27B1 and the Vitamin D receptor,5which are CRUCIAL in Production Of Cathelicidins in Vitamin-D-depleted Individuals.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 336), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 366), ('IMPORTANT_CONSIDERATION', 484), ('IMPORTANT_CONSIDERATION', 560)]	6	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 167, 'vitamin D3given'), ('PR_000001177', 'D(2) dopamine receptor', 175, 'D3given'), ('CHEBI_33282', 'antibacterial agent', 220, 'antibiotic'), ('CL_0000235', 'macrophage', 433, 'macrophages'), ('CL_0000576', 'monocyte', 449, 'monocytes'), ('CHEBI_22695', 'base', 462, 'bacterial'), ('CHEBI_59132', 'antigen', 472, 'antigens'), ('PR_000006101', 'cytochrome P450 1A1', 514, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0030154', 'cell differentiation', 571, 'production of cathelicidins'), ('CHEBI_83326', 'tedizolid phosphate', 602, 'vitamin-D'), ('NCBITaxon_1', 'root', 621, 'individuals')]
PMC3355895	1/2011	S87-PMC3355895	['FINDINGS from the avon longitudinal study of parents and children (sayers and tobias,2009) FURTHER REINFORCED the IMPORTANCE of maternal 25(Oh)-Vitamin D levels, DEMONSTRATING a positive ASSOCIATION between ambient ultraviolet b radiation in Pregnancy and offspring bmc at 9 years old.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_63056', 'zinc cation', 137, '25(OH'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy')]
PMC3356951	4/2012	S14-PMC3356951	['[1–3] this PANDEMIC of hypovitaminosis d CAN MAINLY be ATTRIBUTED to lifestyle and environmental FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 197, 'D production')]
PMC3356951	4/2012	S104-PMC3356951	['Heart disease\nSEVERAL STUDIES are PROVIDING EVIDENCE that the PROTECTIVE EFFECT of Vitamin D on the Heart COULD BE via the Renin–angiotensin hormone system, through the suppression of inflammation, or directly on the cells of the Heart and Blood-Vessel Walls.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 106)]	6	[('UBERON_0000948', 'heart', 0, 'Heart'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000948', 'heart', 100, 'heart'), ('PR_000014368', 'RuvB-like 1', 123, 'renin'), ('UBERON_0000948', 'heart', 230, 'heart'), ('UBERON_0003512', 'lung blood vessel', 240, 'blood-vessel walls')]
PMC3395583	7/2012	S1-PMC3395583	["we AIMED TO INVESTIGATE WHETHER season of Birth INFLUENCES the risk of rheumatoid arthritis, crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and TO EXPLORE the CORRELATION between the risk of id and predicted ultraviolet b (uvb) light exposure and Vitamin D status during Gestation."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('GO_0007567', 'parturition', 42, 'birth'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'gestation')]
PMC3407995	7/2012	S11-PMC3407995	['RECENT RESEARCH HAS SHOWN that maternal dietary deficiencies of Docosahexaenoic Acid (Dha), Vitamin D, Folic Acid and Iodine are ASSOCIATED with a variety of poor foetal and/or infant health outcomes MOSTLY IMPACTING Brain Development and/or function in infancy and OFTEN throughout Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 129), ('PROBABLE_UNDERSTANDING', 200), ('SUPERFICIAL_RELATIONSHIP', 207), ('PROBABLE_UNDERSTANDING', 266)]	6	[('CHEBI_36003', 'decenoic acid', 64, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_30751', 'formic acid', 103, 'folic acid'), ('CHEBI_24859', 'iodine atom', 118, 'iodine'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
PMC3407995	7/2012	S259-PMC3407995	['SEVERAL STUDIES have DEMONSTRATED an ASSOCIATION between POOR maternal Vitamin D status and SEVERE Preeclampsia that CAN result in Miscarriage [141].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 92), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 131, 'miscarriage')]
PMC3424155	8/2012	S10-PMC3424155	['conclusion\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D deficiency accompanies changes in the Renal Expression of IMPORTANT FACTORS that MAY retard the Maturation Of Glomeruli by EXTENDING the period of Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('IMPORTANT_CONSIDERATION', 120), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002113', 'kidney', 100, 'renal'), ('GO_0010467', 'gene expression', 106, 'expression'), ('GO_0009902', 'chloroplast relocation', 158, 'maturation of glomeruli'), ('UBERON_0000074', 'renal glomerulus', 172, 'glomeruli'), ('GO_0001822', 'kidney development', 209, 'nephrogenesis')]
PMC3427192	4/2012	S34-PMC3427192	['this finding is SIMILAR TO OTHER STUDIES where an INCREASED risk of allergic sensitization was NOTED in infants who received Vitamin D supplementation.67,68likewise, gale et al.63NOTED that maternal 25(Oh)D concentrations greater than 75\u2009nmol/l (30 ng/ml) were ASSOCIATED with 5-fold increased odds of asthma at 9 y of age in the exposed children.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D')]
PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]
PMC3427192	4/2012	S64-PMC3427192	['Genetic studies of Vitamin D and asthmaauthoryearnlocation/ populationoutcome measuresfindingsbossé8620091,064québec, canada/ french-canadian familiesgenotype of Genes INVOLVED in the Vitamin D pathwaysnps in Il10, Cyp24A1, Cyp2R1, Il1Rl1 and Cd86 were ASSOCIATED with asthma and atopypoon8720041,139quebecvdr Genetic variants in family-based cohortssix Allelic varients were ASSOCIATED with asthma, while four varients were ASSOCIATED with atopyraby882004582united states/ multi-centertwenty-eight loci in 7 positional candidates were genotypedvdr polymorphism DEMONSTRATED significant transmission distortionsaadi8920091,090jinan china/ han Populationsnps in the vdronly one marker showed a significant ASSOCIATION with asthma.']	[('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 376), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 562), ('SUPERFICIAL_RELATIONSHIP', 705)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('SO_0000704', 'gene', 162, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007601', 'visual perception', 184, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 209, 'IL10'), ('PR_000006101', 'cytochrome P450 1A1', 215, 'CYP24A1'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 224, 'CYP2R1'), ('PR_000008998', 'interleukin-21 receptor', 232, 'IL1RL1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 243, 'CD86'), ('SO_0000704', 'gene', 310, 'genetic'), ('SO_0001023', 'allele', 354, 'allelic'), ('SO_0000751', 'proviral_location', 643, 'populationSNPs')]
PMC3472720	8/2012	S12-PMC3472720	['IN ORDER TO TEST the HYPOTHESIS that low Vitamin D status during Gestation is a RISK FACTOR for ms, we explored a well-DESCRIBED developmental Vitamin D (dvd) deficiency Rodent MODEL, [11,12].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 177)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestation'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 170, 'rodent')]
PMC3472720	8/2012	S105-PMC3472720	['conclusions\nwe SHOW HERE for the FIRST TIME that a maternal Vitamin D deficiency induces inverted transgenerational EFFECTS on the Immune System of offspring: the f2generation is more sensitive to Myelin peptide immunization WHILE, as PREVIOUSLY DEMONSTRATED, the f1generation is less sensitive.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('INCOMPLETE_EVIDENCE', 235)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune system'), ('UBERON_0000345', 'myelin', 197, 'myelin')]
PMC3476426	8/2012	S0-PMC3476426	['reduced Serum concentrations of 25-Hydroxy Vitamin D in children with autism: RELATION to autoimmunity\n\nabstract\n\nbackground\naside from the Skeletal health affection, Vitamin D deficiency has BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering for SOME Autoimmune disorders.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 192), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 259)]	6	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 32, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0004288', 'skeleton', 140, 'skeletal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 264, 'autoimmune')]
PMC3476426	8/2012	S22-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders, including multiple sclerosis (ms) and systemic lupus erythematosus (sle) [5-7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
PMC3476426	8/2012	S91-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders [5,6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
PMC3501517	11/2012	S190-PMC3501517	['these data CONTRAST WITH OTHER published STUDIES that demonstrate a POSSIBLE PROTECTIVE ROLE of Vitamin D supplementation during Lung injury.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 88)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002048', 'lung', 129, 'lung')]
PMC3509518	11/2012	S11-PMC3509518	['IN SUMMARY, THIS STUDY SUGGESTS that maternal diet of fresh Foods rich in Vitamin C is ASSOCIATED with reduced risk of infant wheeze, and that copper intake is ASSOCIATED with reduced RISK of several allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 160), ('IMPORTANT_CONSIDERATION', 184)]	6	[('CHEBI_33290', 'food', 60, 'foods'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin C')]
PMC3509518	11/2012	S131-PMC3509518	['we could not confirm PREVIOUS FINDINGS that reduced maternal Vitamin E intakes were ASSOCIATED with increased risk of developing childhood wheeze [9,10,11,12] DESPITE the fact that almost 50% of Pregnant mothers did not meet the rdi when intakes from diet alone were TAKEN INTO ACCOUNT, and 20% of the mothers did not meet the rdi when total Vitamin E intakes were analysed [18].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ANOMALY_CURIOUS_FINDING', 159), ('IMPORTANT_CONSIDERATION', 267)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin E')]
PMC3509518	11/2012	S148-PMC3509518	['conclusions\nIN SUMMARY, THIS STUDY SUGGESTS an ASSOCIATION between Maternal Consumption of Foods rich in SOME antioxidant factors, namely Vitamin C and copper, and reduced risk of allergic outcomes in infancy in a population PREDISPOSED to allergic disease.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 225)]	6	[('GO_0007618', 'mating', 67, 'maternal'), ('GO_0007631', 'feeding behavior', 76, 'consumption'), ('CHEBI_33290', 'food', 91, 'foods'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin C')]
PMC3515553	12/2012	S94-PMC3515553	['all three maternal Snps SHOWED a SIMILAR magnitude of EFFECT on Cord Blood Vitamin B-12 concentration, but statistical EVIDENCE for the EFFECT of the Fut2 Snp and tcn2 rs9606756 was absent in this SMALL sample (table 3).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 197)]	6	[('SO_0000694', 'SNP', 19, 'SNPs'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 75, 'vitamin B-12'), ('PR_000007719', 'frizzled-2', 150, 'FUT2'), ('SO_0000694', 'SNP', 155, 'SNP')]
PMC3521768	12/2012	S30-PMC3521768	['the PURPOSE of THE CURRENT STUDY is TO INVESTIGATE the INDEPENDENT and INTERACTION EFFECTS of Prenatal zinc and Vitamin A deficiencies on Birthweight in rural sidama, southern ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 83)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin A'), ('GO_0007596', 'blood coagulation', 138, 'birthweight')]
PMC3552819	12/2012	S189-PMC3552819	['MANY participants DEMONSTRATED a rapid rise in [25(Oh)D] during the first week, which is SIMILAR TO the response to an acute dose of ultraviolet radiation exposure [25]; BUT distinct from the more gradual EFFECTS of OTHER forms of exogenous Vitamin D Intake (e.g., oral D2 Ingestion [10]).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	6	[('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007631', 'feeding behavior', 251, 'intake'), ('CHEBI_37987', 'Cy3 dye', 270, 'D2'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 270, 'D2'), ('GO_0007631', 'feeding behavior', 273, 'ingestion')]
PMC3616124	4/2013	S173-PMC3616124	['THEREFORE, we EXAMINED the POTENTIAL for hp phenotype to INFLUENCE the effectiveness of Vitamin C and E in preventing Preeclampsia and SERIOUS COMPLICATIONS of pah.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 102, 'E'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia')]
PMC3641012	4/2013	S132-PMC3641012	['AS EVIDENCE that this plateau was not an artifact of diminishing supplement adherence over time, a sensitivity analysis in which 25(Oh)D was MODELED as a function of cumulative Vitamin D dose REVEALED the same PATTERN (figure\xa03), and fit the data well (table\xa05).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210)]	6	[('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3641012	4/2013	S243-PMC3641012	['third, a positive ASSOCIATION between adj-ca and 25(Oh)D was apparent in the range of 25(Oh)D below 100\xa0nmol/l BUT not above 100\xa0nmol/l; evidence of POSSIBLE harm would be more CONSISTENT with the OPPOSITE FINDING of a Serum calcium that was tightly Controlled (i.e., unassociated with 25(Oh)D) within the lower range of 25(Oh)D, but deflected upward at higher 25(Oh)D. all maternal uncorrected and adj-ca values were below the threshold for hypercalcemia used by the iom in the 1997 Vitamin D dris (2.75\xa0mmol/l) [10] and the 2010 revision (2.63\xa0mmol/l) [7].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 206)]	6	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('GO_0065007', 'biological regulation', 250, 'controlled'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 321, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 364, 'OH)D'), ('CHEBI_27300', 'vitamin D', 484, 'vitamin D')]
PMC3659910	1/2013	S105-PMC3659910	['STUDIES by other groups HAVE REPORTED abnormal Expression of 1α-hydroxylase, a Vitamin D—activating enzyme in Preeclamptic Pregnancies, REVEALING a POTENTIAL ROLE for 1,25(Oh) 2D3 as a REGULATOR of Placentation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('GO_0010467', 'gene expression', 47, 'expression'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'preeclamptic'), ('GO_0007565', 'female pregnancy', 123, 'pregnancies'), ('CHEBI_73394', 'Ala-Ser', 169, '25(OH) 2D3'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 169, '25(OH) 2D3'), ('GO_0001890', 'placenta development', 198, 'placentation')]
PMC3659910	1/2013	S124-PMC3659910	['the cochrane review CONCLUDED that there is NOT ENOUGH EVIDENCE TO EVALUATE the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnancy')]
PMC3659910	1/2013	S133-PMC3659910	['BECAUSE the POOR Vitamin D stores of the mother MAY impair Vitamin D state in the infant, it is IMPORTANT to know WHETHER rickets can be PREVENTED in breast Fed infants by supplementation of the mother.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 96), ('EXPLICIT_QUESTION', 114), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'fed')]
PMC3659910	1/2013	S175-PMC3659910	['a RECENT systematic review CONCLUDED that Antenatal Vitamin D supplementation is EFFECTIVE in improving the Vitamin D status of asian and white women, improves growth in the first year of Life in south asian babies and THEREFORE MAY CONTRIBUTE to reducing the incidence of rickets in this latter group, without evidence of harm.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 81), ('PROBABLE_UNDERSTANDING', 219), ('FUTURE_PREDICTION', 229), ('SUPERFICIAL_RELATIONSHIP', 233)]	6	[('GO_0007567', 'parturition', 42, 'antenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3668200	5/2013	S41-PMC3668200	['THEREFORE, daily supplementation with 400 iu of Vitamin D during the last Trimester of Pregnancy HAS BEEN practiced, ALBEIT with MINIMAL EFFECT on circulating 25(Oh)D concentrations in the mother and infant at term.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 159, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D')]
PMC3668200	5/2013	S51-PMC3668200	['MANY RESEARCH REPORTS on Vitamin D, which is IMPORTANT for Bony Metabolism and immunity, and has beneficial EFFECTS on diverse Organs, HAVE BEEN published RECENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001461', 'elbow', 59, 'bony'), ('GO_0008152', 'metabolic process', 64, 'metabolism'), ('UBERON_0000062', 'organ', 127, 'organs')]
PMC3672018	5/2013	S35-PMC3672018	['obesity MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third Trimester when Adipose Tissue is formed; fractures MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third and/or second trimester [13]; and t1d with low Vitamin D during the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 126), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 146)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001013', 'adipose tissue', 90, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC3672018	5/2013	S47-PMC3672018	['to study the INFLUENCE of seasonal variation and timing of fetal exposure in RELATION to later EFFECTS of Vitamin D on health outcomes, one REQUIRES EVEN larger numbers of subjects to be followed over long time.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 140), ('ANOMALY_CURIOUS_FINDING', 149)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3685533	6/2013	S124-PMC3685533	['after Birth ONLY fs newborns unsupplemented SHOWED Vitamin D levels higher than lob and mbb; no differences were found in case of maternal supplementation in Pregnancy, MOST LIKELY DUE TO a specific ROLE of supplementation in neonates.']	[('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 169), ('PROBABLE_UNDERSTANDING', 181), ('PROBLEM_COMPLICATION', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC3695234	7/2013	S20-PMC3695234	['a GROWING body of LITERATURE has LINKED decreased Serum Vitamin D levels with allergic diseases, PARTICULARLY ad.2-4HOWEVER, large-scale prospective and randomized studies are LACKING.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('FULL_UNKNOWN', 176)]	6	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3695234	7/2013	S21-PMC3695234	['THUS, the available data highlights the NEED FOR FURTHER ANALYSIS of the ASSOCIATIONS between Vitamin D and atopic diseases in DIFFERENT populations.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3695234	7/2013	S54-PMC3695234	['THEREFORE, the RELATIONSHIP between Vitamin D and ad HAS been INVESTIGATED both HERE and in PREVIOUS STUDIES.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('INCOMPLETE_EVIDENCE', 92)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S60-PMC3695234	['supplementation with oral Vitamin D in 14 atopic subjects with moderate-to-severe atopic dermatitis for 21 days resulted in a significant increase in Cathelicidin Expression in ad-lesional skin.11ANOTHER pilot STUDY of winter-time onset or exacerbation of ad also SHOWED a favorable IMPACT of Vitamin D supplementation.12HOWEVER, there are CONFLICTING data surrounding the EFFECT of Vitamin D on the development of allergic Skin disease.']	[('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 283), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 319), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 373)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 150, 'cathelicidin'), ('GO_0010467', 'gene expression', 163, 'expression'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 424, 'skin')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3695234	7/2013	S76-PMC3695234	['these EFFORTS TO CLARIFY the RELATIONSHIP between Vitamin D and ad COULD lead to the IDENTIFICATION of POTENTIAL TARGETS for therapeutic intervention in ad.']	[('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 113)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC3702245	6/2013	S49-PMC3702245	['in SUPPORT of this premise is the FINDING that Vitamin D deficiency is an INDEPENDENT RISK FACTOR for bacterial vaginosis in Pregnant women.88a study from pittsburgh SHOWED an inverse dose-response RELATIONSHIP between Serum 25(Oh)D concentrations and the prevalence of bacterial vaginosis.88compared with a Serum concentration of 75 nmol/l, the prevalence of bacterial vaginosis increased 1.65-fold (ci 1.01–2.69) and 1.26-fold (ci 1.01–1.57) at Serum concentrations of 20 nmol/l and 50 nmol/l, respectively.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 198)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_71657', 'versiconol acetate', 225, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 225, '25(OH ... D'), ('UBERON_0001977', 'blood serum', 308, 'serum'), ('UBERON_0001977', 'blood serum', 447, 'serum')]
PMC3702245	6/2013	S74-PMC3702245	['in studies of Adults and nonpregnant women, a Vitamin D intake of up to 10,000 iu/day is ASSOCIATED with achievement of a Serum 25(Oh)D concentration ≥80 nmol/l without Vitamin D toxicity.103,104from a review of PREVIOUS STUDIES, an additional daily intake of 100 iu of Vitamin D increases the Serum 25(Oh)D concentration by 1–2 nmol/l.7,105THEREFORE, knowing the population baseline Serum 25(Oh)D concentration, IT IS POSSIBLE to ESTIMATE the Vitamin D intake REQUIRED to replete body stores and achieve an expected target Serum 25(Oh)d concentration.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 212), ('PROBABLE_UNDERSTANDING', 338), ('INCOMPLETE_EVIDENCE', 413), ('INCOMPLETE_EVIDENCE', 431), ('IMPORTANT_CONSIDERATION', 461)]	6	[('UBERON_0007023', 'adult organism', 14, 'adults'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 122, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 131, 'OH)D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('CHEBI_71657', 'versiconol acetate', 300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 300, '25(OH)D'), ('UBERON_0001977', 'blood serum', 384, 'serum'), ('CHEBI_33010', 'chromide(1-)', 392, '(OH)D'), ('CHEBI_27300', 'vitamin D', 444, 'vitamin D'), ('UBERON_0001977', 'blood serum', 524, 'serum'), ('CHEBI_30778', 'gallic acid', 530, '25(OH)')]
PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC3705146	5/2013	S226-PMC3705146	['HOWEVER, mcgrath and colleagues have ALSO SHOWN that the RELATIONSHIP between Vitamin D in Gestation and subsequent schizophrenia MAY BE COMPLEX, in that those with low maternal vitamin d are at INCREASED RISK of bearing offspring who become schizophrenic as are those with overly high Vitamin D (mcgrath et al.,2010a).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 137), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestation'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
PMC3705320	3/2013	S15-PMC3705320	['Serum 25-Hydroxyvitamin D concentration ([25(Oh)D]) ≥ 50 nmol/l is ASSOCIATED with Skeletal health benefits [1], BUT SOME data SUGGEST that IMPROVING Vitamin D status to attain Serum [25(Oh)D] ≥ 80 nmol/l MAY enhance a range of Vitamin D-related functions [6,7,8].']	[('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 140), ('INCOMPLETE_EVIDENCE', 205)]	6	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3705320	3/2013	S17-PMC3705320	['the POSSIBLE ASSOCIATION between maternal-fetal Vitamin D status and infant health outcomes MAY be particularly relevant to south asian countries such as bangladesh, where adverse Perinatal outcomes and infant mortality are PUBLIC HEALTH PRIORITIES [10], and where Vitamin D deficiency HAS BEEN observed among women of Reproductive age [11] and young infants [12].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 224), ('IMPORTANT_CONSIDERATION', 238), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0000003', 'reproduction', 319, 'reproductive')]
PMC3713405	7/2013	S29-PMC3713405	['EVIDENCE CONTINUES to mount from both epidemiological and pre-clinical studies to INDICATE that developmental Vitamin D (Dvd) deficiency MAY BE also an IMPORTANT developmental RISK factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 137), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 121, 'DVD')]
PMC3717170	5/2013	S44-PMC3717170	['as with antibacterial Responses to infection, it HAS BEEN PROPOSED that Adaptive Immune Responses MAY BE compromised in patients with low Serum concentrations of 25(Oh)D3, and ASSOCIATION studies HAVE SHOWN LINKS between Autoimmune disease and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 207)]	6	[('GO_0060033', 'anatomical structure regression', 22, 'responses'), ('GO_0051866', 'general adaptation syndrome', 72, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 81, 'immune'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('CHEBI_62946', 'ammonium sulfate', 162, '25(OH)D3'), ('UBERON_0001442', 'skeleton of manus', 221, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC3717170	5/2013	S47-PMC3717170	['moreover, IT IS POSSIBLE that SOME diseases, such as leprosy and hiv infection, MAY BE ASSOCIATED with dysregulation of the core Vitamin D intracrine Immune mechanism, and MAY THEREFORE require higher circulating levels of 25(Oh)D3To reestablish normal Immune Responses.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 176)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0002405', 'immune system', 150, 'immune'), ('CHEBI_63755', 'o-nitrophenyl group', 223, '25(OH)D3to'), ('GO_0006955', 'immune response', 253, 'immune responses'), ('UBERON_0002405', 'immune system', 253, 'immune')]
PMC3717170	5/2013	S104-PMC3717170	['and WHILE Vitamin D concentration HAS BEEN RELATED to Lung function in the general population, the RELATION between Lung function and Vitamin D concentration has YET to be investigated in copd patients ONLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 99), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 202)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung'), ('UBERON_0002048', 'lung', 116, 'lung'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3717170	5/2013	S134-PMC3717170	['from a biological perspective, the HYPOTHESIS that Vitamin D MAY BE a DETERMINANT of diabetes risk is PLAUSIBLE, AS both impaired Insulin secretion and action HAVE BEEN reported with Vitamin D insufficiency.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000045358', 'insulin family protein', 130, 'insulin'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3717170	5/2013	S182-PMC3717170	["low Vitamin D levels HAVE BEEN ASSOCIATED with accelerated Cognitive decline in epidemiological studies, and low Vitamin D dietary intake is ASSOCIATED with INCREASED risk of alzheimer's disease and depression.53,54mechanisms SUGGESTED for this ASSOCIATION include β-Amyloid formation/aggregation, Dysregulation of Gabaergic activity and nmda receptor, and increased calcium Entry Into Neurons."]	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 245)]	6	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0050890', 'cognition', 59, 'cognitive'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_60425', 'amyloid fibril', 267, 'amyloid'), ('GO_0060233', 'oenocyte delamination', 298, 'dysregulation'), ('CHEBI_86629', 'G b H', 315, 'GABAergic'), ('GO_0046897', 'N-terminal peptidyl-tyrosine methylation', 375, 'entry into neurons'), ('CL_0000540', 'neuron', 386, 'neurons')]
PMC3717170	5/2013	S184-PMC3717170	['WHETHER Vitamin D supplementation MAY positively IMPACT the Aging process REMAINS UNKNOWN and will REQUIRE FURTHER long-term intervention STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 49), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 99), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007568', 'aging', 60, 'aging')]
PMC3717170	5/2013	S185-PMC3717170	['Vitamin D dietary reference intakes\ndaniel bikle (university of california and va medical center, san francisco) addressed the RECENT institute of medicine (iom) RECOMMENDATIONS for dietary Intake of Vitamin D and EVALUATED WHETHER they were sufficient in the context of EMERGING DATA about the ROLES of Vitamin D and the prevalence of deficiency.']	[('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 162), ('QUESTION_ANSWERED_BY_THIS_WORK', 214), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 190, 'intake'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3739737	8/2013	S145-PMC3739737	['FUTURE RESEARCH SHOULD investigate the POTENTIAL ROLE of Vitamin D-deficiency on Gaba, and POSSIBLE IMPLICATIONS on Cognition.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_16865', 'gamma-aminobutyric acid', 81, 'GABA'), ('GO_0050890', 'cognition', 116, 'cognition')]
PMC3760821	9/2013	S173-PMC3760821	['a KEY FINDING of THE CURRENT STUDY is that in t1dm Pregnancy, maternal Vitamin D levels EXHIBIT an INDEPENDENT inverse RELATIONSHIP with hba1clevels.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ANOMALY_CURIOUS_FINDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 119)]	6	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3773018	4/2013	S61-PMC3773018	['discussion\nTHIS is the FIRST STUDY TO EXAMINE the EFFECTS of longitudinal trajectory Vitamin D status, by measurement of Plasma 25(Oh)D concentrations from Birth to early childhood, on the development of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 128, '25(OH ... D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3773018	4/2013	S86-PMC3773018	['it SHOULD BE NOTED that four Snps SHOWED significant INTERACTION EFFECTS with Vitamin D deficiency at Birth on fs in our PREVIOUS report (18).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 121)]	6	[('SO_0000694', 'SNP', 29, 'SNPs'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'birth')]
PMC3798907	8/2013	S15-PMC3798907	['moreover, two of these cohorts have DEMONSTRATED that low maternal Vitamin E intake during Pregnancy is ASSOCIATED with increased in vitro proliferative responses by Cord Blood Mononuclear Cells (cbmc) and that this ASSOCIATION is independent of the POTENTIALLY CONFOUNDING EFFECTS of Birth order, sex, maternal atopy and maternal smoking [12,13].']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 250), ('PROBLEM_COMPLICATION', 262), ('SUPERFICIAL_RELATIONSHIP', 274)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CL_0000752', 'cone retinal bipolar cell', 166, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('GO_0031097', 'medial cortex', 177, 'mononuclear'), ('GO_0007567', 'parturition', 285, 'birth')]
PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]
PMC3798907	8/2013	S100-PMC3798907	['discussion\nTHIS STUDY was BASED ON our novel OBSERVATION in a general population study, that low maternal Vitamin E intake during Pregnancy is INDEPENDENTLY ASSOCIATED with increased in vitro Proliferative Responses by cbmc and an increased LIKELIHOOD of asthma in children aged 5 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('PROBABLE_UNDERSTANDING', 241)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0001780', 'neutrophil homeostasis', 192, 'proliferative responses')]
PMC3798907	8/2013	S106-PMC3798907	['HOWEVER, ALTHOUGH direct supplementation of cbmc with Vitamin E was ASSOCIATED with decreased proliferative responses to ppd, klh and hdm, there was an OPPOSITE EFFECT on Proliferation to the allergen tg.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('GO_0008283', 'cell proliferation', 171, 'proliferation')]
PMC3798907	8/2013	S108-PMC3798907	['it is LIKELY that the OBSERVED in vivo epidemiological ASSOCIATIONS with Vitamin E intake REFLECT the EFFECTS of overall Nutrient/dietary patterns ASSOCIATED with higher Vitamin E intake.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 147)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin E'), ('CHEBI_33284', 'nutrient', 121, 'nutrient'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin E')]
PMC3798907	8/2013	S114-PMC3798907	['this SEEMS an UNLIKELY EXPLANATION for the DIFFERENTIAL EFFECTS of Vitamin E supplementation on tg and hdm responses SEEN in the current work because, as in our original observational study, cbmc samples were collected throughout the year [12].']	[('ANOMALY_CURIOUS_FINDING', 5), ('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E')]
PMC3798907	8/2013	S148-PMC3798907	['in THE CURRENT STUDY, the EFFECTS of in vitro Vitamin E supplementation on cbmc and pbmc Effector cytokine responses did DIFFER, BUT the EFFECTS of in vitro Vitamin C supplementation were broadly SIMILAR in neonates and Adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('CHEBI_35224', 'effector', 89, 'effector'), ('CHEBI_33229', 'vitamin (role)', 157, 'vitamin'), ('CHEBI_18245', 'carboxylato group', 165, 'C'), ('UBERON_0007023', 'adult organism', 220, 'adults')]
PMC3798907	8/2013	S151-PMC3798907	['conclusions\noverall, THIS WORK DEMONSTRATES that in vitro supplementation of cbmc with Vitamins E or C CAN INFLUENCE their Immune function but NOT in the simple and consistent manner predicted by models arising from observational epidemiological studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107), ('ANOMALY_CURIOUS_FINDING', 143)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 101, 'C'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3814422	10/2013	S119-PMC3814422	['furthermore, from a PUBLIC HEALTH perspective Maternal Pregnancy Vitamin D as a risk FACTOR for future offspring atopy or Respiratory health would only be of MAJOR IMPORTANCE IF it was relevant to most of the population and not ONLY those members at the extremes.']	[('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 228)]	6	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 122, 'respiratory')]
PMC3814422	10/2013	S134-PMC3814422	['by way of analogy, in a study of Vitamin D and Adult Lung function we FOUND that, WHILST there were APPARENT ASSOCIATIONS with dietary Vitamin D intake, there was NO EVIDENCE for an association with Blood 25(Oh)D concentrations29.']	[('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 82), ('ANOMALY_CURIOUS_FINDING', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002048', 'lung', 53, 'lung'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH)D')]
PMC3820434	12/2012	S379-PMC3820434	['THEREFORE, it was HYPOTHESIZED that a Mixture of dietary products (Resveratrol, green tea extract, Α -Tocopherol, Vitamin C, N-3 ( ω -3) polyunsaturated Fatty Acids, and tomato extract) selected for their EVIDENCE-BASED antioxidant and anti-inflammatory EFFECTS MAY yield more healthy EFFECTS than any single Molecule.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 254), ('INCOMPLETE_EVIDENCE', 262), ('SUPERFICIAL_RELATIONSHIP', 285)]	6	[('CHEBI_60004', 'mixture', 38, 'mixture'), ('CHEBI_27881', 'resveratrol', 67, 'resveratrol'), ('CHEBI_27725', 'butin', 99, 'α -tocopherol'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin C'), ('CHEBI_30256', 'thiocarbonyl group', 125, 'n-3'), ('CHEBI_35366', 'fatty acid', 153, 'fatty acids'), ('CHEBI_36357', 'polyatomic entity', 309, 'molecule')]
PMC3827489	10/2013	S25-PMC3827489	['THUS, given the IMPORTANT ROLE of Vitamin D in childhood health, THIS REVIEW will FOCUS on the IMPACT of Vitamin D on health and disease in childhood and Adolescence.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 154, 'adolescence')]
PMC3829803	11/2013	S32-PMC3829803	['a SURPRISING spin-OFF from these Vitamin A supplementation STUDIES was the re-discovery that Vitamin A ‘treatment’ CAN significantly decrease the morbidity and mortality ASSOCIATED with acute Mev infection [16]–[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('ANOMALY_CURIOUS_FINDING', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'MeV')]
PMC3873449	12/2013	S197-PMC3873449	['this SUGGESTS that education levels are MOST LIKELY to INFLUENCE women’s health awareness RATHER than directly AFFECT Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3882256	1/2014	S25-PMC3882256	['we EXAMINED WHETHER any observed ASSOCIATIONS were MEDIATED by Cord Blood ferritin levels, Gestational age, offspring’s birthweight, and dietary iron intake and explored WHETHER offspring sex and maternal Vitamin C intake moderate any ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 235)]	6	[('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007565', 'female pregnancy', 91, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC4034700	5/2014	S6-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4034700	5/2014	S258-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4045304	2/2014	S243-PMC4045304	['these studies INDICATE that maternal mcs, particularly diabetes, MAY BE ASSOCIATED with Neurodevelopmental PROBLEMS in children and Vitamin D supplementation early in childhood SHOULD BE given further CONSIDERATION in treatment of asd [103–105].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 177), ('FUTURE_WORK', 201)]	6	[('GO_0007399', 'nervous system development', 88, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4072587	6/2014	S12-PMC4072587	['IMPORTANT biological functions involving growth and developmental outcomes HAVE BEEN ATTRIBUTED to Vitamin D, and deficiency during Pregnancy MAY result in IMPORTANT health CONSEQUENCES for both mother and child[3],[4],[5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 156), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy')]
PMC4072587	6/2014	S121-PMC4072587	['our finding of an ASSOCIATION between maternal Vitamin D and infant Language composite scores, that was ONLY observed when maternal Vitamin D levels fell below 37.5 nmol/l in late Pregnancy, RAISES the POSSIBILITY that there is a threshold EFFECT, and that Language impairment is a feature of more marked Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 191), ('INCOMPLETE_EVIDENCE', 202), ('SUPERFICIAL_RELATIONSHIP', 240)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0006266', 'DNA ligation', 68, 'language'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('GO_0006266', 'DNA ligation', 257, 'language'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]
PMC4072587	6/2014	S126-PMC4072587	['we OBSERVED an inverse RELATIONSHIP between length-for-age z scores at 6 months of age and overall maternal Vitamin D concentration, ALTHOUGH the ESTIMATED magnitude of change ASSOCIATED with an increase in Vitamin D of 25 nmol/l was SMALL.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ANOMALY_CURIOUS_FINDING', 133), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 234)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4113768	7/2014	S12-PMC4113768	['a third EMERGING theme, also RELATING to Vitamin D dose–response RELATIONSHIPS, was the POTENTIAL DIFFERENTIAL EFFECT of daily vs. intermittent bolus dosing on biological outcomes.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S55-PMC4113768	['conclusions: the PRESENT INVESTIGATION INDICATES that the Vitamin D status MAY function AS an INDEPENDENT positive PREDICTOR of sod, especially in non-obese, non-smoking elderly women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S170-PMC4113768	['the OBJECTIVE of THIS SYSTEMATIC REVIEW was TO ASSESS the ASSOCIATION between Vitamin D RELATED MARKERS and Colorectal cancer prognosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 96)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0012652', 'colorectum', 108, 'colorectal')]
PMC4113768	7/2014	S377-PMC4113768	['background: INTERACTIONS between dietary Calcium and Vitamin D MAY have IMPLICATIONS for the Regulation of Serum 25-Hydroxy Vitamin D (25(Oh)D) and its Catabolism, and CONSEQUENTLY for the dietary REQUIREMENT for Vitamin D ((iom) institute of medicine.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 63), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 168), ('IMPORTANT_CONSIDERATION', 197)]	6	[('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0065007', 'biological regulation', 93, 'regulation'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 113, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('GO_0009056', 'catabolic process', 152, 'catabolism'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4113768	7/2014	S485-PMC4113768	['in addition, an ASSOCIATION between INADEQUATE Vitamin D levels and impaired Lung function COULD BE EXPLAINED by an INCREASED RISK of Respiratory infections or a negative INFLUENCE on muscle function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 100), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0001004', 'respiratory system', 134, 'respiratory')]
PMC4113768	7/2014	S599-PMC4113768	['this NOVEL FINDING SUPPORTED an A priori HYPOTHESIS that low uvb exposure and low Vitamin D status have an etiologic ROLE in Food allergy.']	[('FULL_UNKNOWN', 5), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 32), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 117)]	6	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_33290', 'food', 125, 'food')]
PMC4113768	7/2014	S808-PMC4113768	['we THEREFORE AIMED TO ESTABLISH WHETHER maternal Vitamin D and Vitamin D-binding protein (dbp) levels MIGHT RELATE to the Expression of amino acid transporters in Human Placenta.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 122, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 163, 'human'), ('UBERON_0001987', 'placenta', 169, 'placenta')]
PMC4113768	7/2014	S1118-PMC4113768	['background: approximately one billion People worldwide have low Serum levels of Vitamin D. the AIM of THIS STUDY was TO EVALUATE the dose-response EFFECT in order TO DETERMINE the level of supplementation of Vitamin D REQUIRED in patients with deficiency in Vitamin D concentration (≤20 ng/ml).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('IMPORTANT_CONSIDERATION', 218)]	6	[('NCBITaxon_10088', 'Mus <genus>', 38, 'people'), ('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4113768	7/2014	S1176-PMC4113768	['multiple linear regression was used TO ASSESS WHETHER Vitamin D status was RELATED to qus and bmd and WHETHER age (below vs. above the median age), gender, bmi (≤26.5 vs.>26.5 kg/m2) or physical activity (low vs. high) MODIFIED these RELATIONSHIPS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 234)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1288-PMC4113768	['for the present divids-2 study we followed up the children, now aged 3–6 years, to measure bone structure and strength by quantitative ultrasound (qus).the PURPOSE of THE STUDY was (1) TO DETERMINE the EFFECT of Vitamin D supplementation in infancy on bone structure and strength of children aged 3–6 years; (2) TO EVALUATE the ASSOCIATION of current Vitamin D status with bone structure and strength.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 156), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 202), ('QUESTION_ANSWERED_BY_THIS_WORK', 312), ('SUPERFICIAL_RELATIONSHIP', 328)]	6	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin D')]
PMC4113768	7/2014	S1448-PMC4113768	['THIS STUDY INVESTIGATED WHETHER Vitamin D status PREDICTS ed and OTHER cvd MARKERS in Ageing men.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007568', 'aging', 86, 'ageing')]
PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]
PMC4113768	7/2014	S1560-PMC4113768	['conclusions: upon bivariate analysis, we OBSERVED a CORRELATION between Vitamin D and Cmv Antibody titre, SIMILAR in magnitude to a PREVIOUSLY PUBLISHED CORRELATION between Vitamin D and Ebna1 titres (salzer j, nystrom m, hallmans g, stenlund h, wadell g, sundstrom p. epstein-barr virus Antibodies and Vitamin D in prospective multiple sclerosis biobank samples.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibody'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 187, 'EBNA1'), ('GO_0042571', 'immunoglobulin complex, circulating', 288, 'antibodies'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC4113768	7/2014	S1578-PMC4113768	['AS MOST studies examining Vitamin D status and disease progression to date have included Individuals receiving art, the AIMS of THIS STUDY are TO EVALUATE the EFFECT of vitamin d status over time on immunological outcomes, such as cd4+ cell count and cd4+ percentage in hiv-infected Individuals with hiv viraemia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('NCBITaxon_1', 'root', 283, 'individuals')]
PMC4113768	7/2014	S1695-PMC4113768	['THIS STUDY was AIMED TO INVESTIGATE the prevalence of Vitamin D deficiency in Adult female of local population in pakistan and TO find out social and Genetic FACTORS that may CONTRIBUTE in hypovitaminosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 175)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 78, 'adult'), ('SO_0000704', 'gene', 150, 'genetic')]
PMC4113768	7/2014	S1702-PMC4113768	['conclusion: subjects that had Vitamin D deficiency not showed any significant clinical sign of any disease so this situation of Vitamin D deficiency COULD BE ignore at early stage that MAY lead to SOME drastic health EFFECTS in later stages that MAY BE OTHER then bone disorders.']	[('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 217), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4113768	7/2014	S1806-PMC4113768	['HOWEVER, according TO allergic outcomes our data RATHER POINT to a promoting THAN a protecting EFFECT of Vitamin D.\n\n2.82.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1983-PMC4113768	['RECENT EVIDENCE SUGGESTS that Vitamin D MAY have a WIDE RANGE of PROTECTIVE EFFECT on Human health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 76)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 86, 'human')]
PMC4113768	7/2014	S2073-PMC4113768	['the 2011 iom report CONCLUDED (i) that the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is 10 µg (400 iu) daily in those with minimal sunlight exposure, corresponding to a median Serum 25Ohd level of 40 nmol/l; (ii) that a 25Ohd level below 30 nmol/l indicated risk of deficiency; (iii) that a 25ohd level above 50 nmol/l INDICATED sufficiency in 97.5%; and (iv) that 25ohd levels in excess of 125 nmol/l COULD BE ASSOCIATED with harm.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 425), ('SUPERFICIAL_RELATIONSHIP', 434)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 205, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 243, '25OHD')]
PMC4113768	7/2014	S2135-PMC4113768	['the IDENTIFIED DETERMINANTS of Serum 25(Oh)D MAY CONTRIBUTE to tailor EVIDENCE-BASED RECOMMENDATIONS for optimizing Vitamin D status to specific target groups.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 70), ('FUTURE_WORK', 85)]	6	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4113768	7/2014	S2303-PMC4113768	['in THIS cross-SECTIONAL case-CONTROL STUDY, we DESCRIBED the differences and ASSOCIATIONS in the Metabolic patterns of Adult saudis with and without hypothyroid dysfunction in RELATION to their Vitamin D status, pth, calcium and Lipid profile.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0008152', 'metabolic process', 97, 'metabolic'), ('UBERON_0007023', 'adult organism', 119, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_18059', 'lipid', 229, 'lipid')]
PMC4113768	7/2014	S2469-PMC4113768	['Vitamin D and tuberculosis in Adults in selected districts in the provinces baghlan, bamyan and badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground: EVIDENCE for an ASSOCIATION between Vitamin D and tuberculosis (tb) is INCONSISTENT and NO previous STUDIES HAVE BEEN conducted in afghanistan.']	[('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('FULL_UNKNOWN', 266), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0007023', 'adult organism', 30, 'Adults'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4113768	7/2014	S2470-PMC4113768	['THIS STUDY AIMS to explore an ASSOCIATION between tb and Vitamin D levels in a rural afghan population and TO EXAMINE POSSIBLE factors RELATED to tb and Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 107), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4113768	7/2014	S2663-PMC4113768	['HOWEVER, there is uncertainty as to WHETHER low Vitamin D status is a TRUE cause of these outcomes, OR simply a MARKER of OTHER lifestyle VARIABLES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 138)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4113768	7/2014	S3130-PMC4113768	['conclusions: THESE FINDINGS CONTRAST WITH OTHER RECENT STUDIES which SHOWED clear ASSOCIATIONS between Ige levels and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 82)]	6	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 103, 'IgE'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
PMC4169453	9/2014	S12-PMC4169453	['trial registration\nclinicaltrials.govnct01506557\n\nintroduction\nGROWING EVIDENCE SUGGESTS that Vitamin D deficiency has a negative IMPACT on the Skeletal System and MAY BE a POTENTIAL RISK FACTOR for a wide range of diseases, including cancer, Cardiovascular disease, hypertension, diabetes, Autoimmune diseases, and allergies[1].']	[('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 183)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001434', 'skeletal system', 144, 'skeletal system'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 291, 'autoimmune')]
PMC4169453	9/2014	S135-PMC4169453	['the EFFECT of group (Vitamin D dose) x time INTERACTION ( p \u200a=\u200a0.12) and the EFFECT of group ( p \u200a=\u200a0.45) on infants’ Serum 25(Oh)D levels was not statistically significant, WHILE the EFFECT of time was statistically significant ( p<0.0001) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 174), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 124, '25(OH)D')]
PMC4169453	9/2014	S142-PMC4169453	['a CORRELATION between maternal and breastfed infants’ 25(Oh)D levels was STILL significant after 3 and 6 months of Vitamin D supplementation BUT APPEARED weaker than the Postpartum CORRELATION: in the 400 iu/d group at v3 r\u200a=\u200a0.35 ( p \u200a=\u200a0.003) and at v6 r\u200a=\u200a0.4 ( p \u200a=\u200a0.0009), and in the 1200 iu/d group at v3 r\u200a=\u200a0.3 ( p \u200a=\u200a0.01) and at v6 r\u200a=\u200a0.39 ( p \u200a=\u200a0.0007), respectively.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('ANOMALY_CURIOUS_FINDING', 73), ('IMPORTANT_CONSIDERATION', 73), ('ANOMALY_CURIOUS_FINDING', 141), ('ANOMALY_CURIOUS_FINDING', 145), ('SUPERFICIAL_RELATIONSHIP', 181)]	6	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 60, 'D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'postpartum')]
PMC4169453	9/2014	S184-PMC4169453	['there is GROWING EVIDENCE SHOWING Serum 25(Oh)D levels higher than 30 ng/ml, or EVEN higher than 40 ng/ml as EFFECTIVE for expression of Extra-Skeletal EFFECTS RELATED to proper Vitamin D status[1],[34],[35].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 160)]	6	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 40, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 137, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC4171568	9/2014	S141-PMC4171568	['HOWEVER, THERE IS EVIDENCE that high doses of Vitamin D are NOT NECESSARILY PROTECTIVE; in 424 matched pairs from a population-based cohort, a bi-modal RELATIONSHIP APPEARED in which the participants with the lowest and highest levels of Vitamin D had increased risk of schizophrenia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 152), ('ANOMALY_CURIOUS_FINDING', 165)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4231606	10/2013	S121-PMC4231606	['regular milk drinkers had BETTER Vitamin D concentrations, a FINDING SUPPORTED by A large-scale clinical STUDY OBSERVING an ASSOCIATION between frequent Milk Consumption and increased 25(Oh)D [33].']	[('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001913', 'milk', 153, 'milk'), ('GO_0007631', 'feeding behavior', 158, 'consumption'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 187, 'OH)D')]
PMC4231606	10/2013	S132-PMC4231606	['a DEFICIENCY in this protein IN CONJUNCTION WITH UNDESIRABLE Vitamin D, pth, and calcium levels MAY SUGGEST that children with s-ecc have nutritional DEFICIENCIES.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4251419	12/2014	S7-PMC4251419	['after the UNDISPUTED IMPORTANCE of Vitamin D for bone health, the STRONGEST EVIDENCE is PROBABLY for an increased RISK of Immune disorders in ASSOCIATION with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 10), ('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 88), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4251419	12/2014	S138-PMC4251419	['the LACK OF any PROTECTIVE EFFECT of Vitamin D supplementation in Adulthood MAY BE BECAUSE the processes necessary for disease have already been put in place much earlier in life.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 83), ('PROBLEM_COMPLICATION', 83)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 66, 'adulthood')]
PMC4256222	12/2014	S103-PMC4256222	['HOWEVER, IF our results are reliable, there MIGHT be OTHER aspects UNDERLYING a seasonal variation during Pregnancy on bone fracture risk later in Life INDEPENDENTLY of Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
PMC4292819	1/2015	S277-PMC4292819	['HOWEVER, as fish and shellfish are IMPORTANT CONTRIBUTORS of Fatty Acids, Vitamin D, proteins, and minerals, it is ADVISABLE that women of child-Bearing age receive proper GUIDANCE to choose the right types of fish from nonpolluted waters.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 115), ('IMPORTANT_CONSIDERATION', 115), ('FUTURE_WORK', 172)]	6	[('CHEBI_35366', 'fatty acid', 61, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 145, 'bearing')]
PMC4303849	1/2015	S0-PMC4303849	['Regulation Of Calcitriol Biosynthesis and activity: focus on Gestational Vitamin D deficiency and adverse Pregnancy outcomes\n\nabstract\nVitamin D has garnered a great deal of ATTENTION in RECENT years DUE TO a GLOBAL prevalence of Vitamin D deficiency ASSOCIATED with an INCREASED RISK of a variety of Human diseases.']	[('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 187), ('PROBABLE_UNDERSTANDING', 200), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 270)]	6	[('GO_1900952', 'positive regulation of 18-methylnonadec-1-ene biosynthetic process', 0, 'Regulation of Calcitriol Biosynthesis'), ('CHEBI_17823', 'calcitriol', 14, 'Calcitriol'), ('PR_000004909', 'complement component C8 beta chain', 14, 'Calcitriol'), ('GO_0007565', 'female pregnancy', 61, 'Gestational'), ('CHEBI_28384', 'vitamin K', 73, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 73, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 301, 'human')]
PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 291, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', "Deiter's cell", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', "Deiter's cell", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]
PMC4329404	10/2014	S14-PMC4329404	['an ASSOCIATION between Vitamin D Receptor (Vdr) Gene polymorphisms and asthma susceptibility is REPORTED (3,4); HOWEVER, the RELATIONSHIP between Serum Vitamin D levels and asthma REMAINS CONTROVERSIAL (5).']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 23, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 43, 'VDR'), ('SO_0000704', 'gene', 48, 'gene'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4329404	10/2014	S18-PMC4329404	['a RECENT unselected cohort of over 2000 children OBSERVED no association between Serum Vitamin D and asthma or Lung function; HOWEVER, higher Serum Vitamin D was ASSOCIATED with a greater RISK of wheeze (11).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('ANOMALY_CURIOUS_FINDING', 126), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 188)]	6	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4377870	3/2015	S85-PMC4377870	['OBSERVATIONAL studies in children SHOWED Consumption of fruit, a rich source of Vitamin C, was RELATED to reduced wheezing [62] and Vitamin C intake was negatively ASSOCIATED with wheezing [63], WHILE ANOTHER STUDY reported no relationship between Vitamin C intake and Lung function [64].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('INCOMPLETE_EVIDENCE', 201)]	6	[('GO_0007631', 'feeding behavior', 41, 'consumption'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin C'), ('UBERON_0002048', 'lung', 269, 'lung')]
PMC4377870	3/2015	S137-PMC4377870	['Vitamin D\nepidemiological studies SHOW PROMISING ASSOCIATIONS between Vitamin D and Lung health; HOWEVER the mechanisms responsible for these EFFECTS are POORLY UNDERSTOOD.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 154)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC4377870	3/2015	S153-PMC4377870	['the ROLE for Vitamin D in enhancing Steroid responsiveness SUGGESTED by observational studies [120] is SUPPORTED by mechanistic studies [121], and in concert with the actions of Vitamin D in infection, MAY EXPLAIN the EFFECT of Vitamin D in reducing asthma exacerbations [111].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 206), ('SUPERFICIAL_RELATIONSHIP', 218)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_35341', 'steroid', 36, 'steroid'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4377870	3/2015	S155-PMC4377870	['data for the ROLE of Vitamin D in copd onset is LIMITED, THOUGH SEVERAL cross-sectional STUDIES HAVE REPORTED an ASSOCIATION between low Vitamin D levels, or deficiency, with copd incidence [123].']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4377870	3/2015	S178-PMC4377870	['a SMALL STUDY in sweden FOUND that in older subjects with SEVERE copd, Intakes of Folic Acid and Selenium were below recommended levels, and although intake of calcium was adequate, Serum calcium levels were low, LIKELY RELATED to their Vitamin D status AS Intake was lower than recommended [141].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 220), ('PROBABLE_UNDERSTANDING', 254)]	6	[('GO_0007631', 'feeding behavior', 71, 'intakes'), ('CHEBI_30751', 'formic acid', 82, 'folic acid'), ('CHEBI_27568', 'selenium atom', 97, 'selenium'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('GO_0007631', 'feeding behavior', 257, 'intake')]
PMC4377870	3/2015	S251-PMC4377870	['it APPEARS that Vitamin D is IMPORTANT in Respiratory diseases and infections, HOWEVER the temporal ROLE of Vitamin D deficiency in disease onset, pathogenesis and exacerbations and WHETHER supplementation is indicated is yet to be clarified.']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 42, 'respiratory'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4380518	9/2014	S0-PMC4380518	['Prenatal Vitamin use and Vitamin D status during Pregnancy, differences by race and overweight status\n\nabstract\n\nobjective\nwe AIMED TO STUDY WHETHER Prenatal Vitamin (pnv) use PROTECTS against low 25(Oh)D levels in all women and PARTICULARLY in obese and black women who are both AT RISK of Vitamin D deficiency and poor pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 176), ('IMPORTANT_CONSIDERATION', 229), ('IMPORTANT_CONSIDERATION', 280)]	6	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_33229', 'vitamin (role)', 9, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 158, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC4380518	9/2014	S51-PMC4380518	['in ANOTHER STUDY of massachusetts women, black women REPORTED taking periconceptional multivitamins half as often as white women.19additionally, our prevalence of Vitamin D deficiency is SIMILAR TO that REPORTED in nhanes24and in another boston cohort, project viva.13,25others have ANALYZED the ASSOCIATION between pnv use and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 283), ('SUPERFICIAL_RELATIONSHIP', 296)]	6	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
PMC4380518	9/2014	S62-PMC4380518	['we also LACKED DATA on Vitamin D binding protein which MAY DIFFER by race/ethnicity and COULD AFFECT the ASSOCIATION between pnv use and 25(Oh)D measured in the Plasma.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 161, 'plasma')]
PMC4383226	2/2015	S99-PMC4383226	['Vitamin A, dtp and gender\nOUR STUDY EXTENDS PREVIOUS randomized clinical TRIAL EVIDENCE from burkina faso (zeba et al., 2008), papua new guinea (shankar et al., 1999), tanzania (villamor et al., 2002), and uganda (nankabirwa et al., 2011) SHOWING consistent reductions in malaria-induced morbidity and Mortality from Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 239)]	6	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('GO_0065007', 'biological regulation', 302, 'mortality'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 325, 'A')]
PMC4383226	2/2015	S101-PMC4383226	["NOT ONLY did we identify a PROTECTIVE ASSOCIATION between Vitamin A and malaria in a study population with high immunization coverage for bcg, dtp, and poliomyelitis, we also FOUND in unadjusted MODELS that dtp did not modify Vitamin A's ASSOCIATION with malaria."]	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('SUPERFICIAL_RELATIONSHIP', 238)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4396835	1/2015	S0-PMC4396835	['autism spectrum disorder and low Vitamin D at Birth: a sibling control study\n\nabstract\n\nbackground\ninsufficient Vitamin D activity has attracted increasing INTEREST AS a POSSIBLE UNDERLYING RISK factor in disorders of the Central Nervous System, including autism.']	[('IMPORTANT_CONSIDERATION', 156), ('INCOMPLETE_EVIDENCE', 156), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 222, 'central nervous system')]
PMC4396835	1/2015	S168-PMC4396835	['conclusion\nOUR FINDINGS of a low Vitamin D level in a group of newborn children, who later developed asd, provide SUPPORT for the HYPOTHESIS that developmental Vitamin D deficiency during late Pregnancy MAY carry an INCREASED risk of asd in the child, along with several other RISK FACTORS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 216), ('SUPERFICIAL_RELATIONSHIP', 277)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC4405493	4/2015	S158-PMC4405493	['although Vitamin D has a biologically POSSIBLE ROLE in all the aforementioned disorders, this WAS NOT DEMONSTRATED in our population AS Vitamin D deficiency did not increase the odds for adverse Pregnancy outcome in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 133), ('QUESTION_ANSWERED_BY_THIS_WORK', 216)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC4427001	4/2015	S40-PMC4427001	['THEREFORE, the AIMS of the PRESENT STUDY were (1) TO DETERMINE Midgestational and early Postpartum Vitamin D status by measuring 25(Oh)D Plasma levels in Pregnant women with and without gdm to CONFIRM the hypothetical deficiency in gdm in central european population and (2) to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of parameters characterising Glucose tolerance.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 291)]	6	[('GO_0007507', 'heart development', 63, 'midgestational'), ('GO_0007565', 'female pregnancy', 88, 'postpartum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 132, 'OH ... D'), ('UBERON_0001969', 'blood plasma', 137, 'plasma'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007507', 'heart development', 312, 'midgestational'), ('GO_0007565', 'female pregnancy', 331, 'postpartum'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_17234', 'glucose', 409, 'glucose')]
PMC4427001	4/2015	S118-PMC4427001	['[26] FOUND an inverse ASSOCIATION between second trimester 25(Oh)D levels < 25\u2009nmol/l and 1\u2009hr after load Glucose (50\u2009g) levels; HOWEVER, ONLY 5% of studied women developed gdm and as mentioned above THRESHOLD for Vitamin D deficiency DIFFERED from our study.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235)]	6	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25(OH ... D'), ('CHEBI_17234', 'glucose', 106, 'glucose'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S521-PMC4448820	['a LIMITED NUMBER of other STUDIES also SUGGEST that Vitamin A (286), selenium (287), iron (288), and zinc deficiencies (289) MAY AFFECT the microbiome.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A')]
PMC4448820	5/2015	S581-PMC4448820	['ALTHOUGH Vitamin A MAY have a preventive EFFECT on the incidence or severity of diarrhea and measles in community trials, it has had LITTLE or the OPPOSITE EFFECT on Respiratory infections (105).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory')]
PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
PMC4448820	5/2015	S1046-PMC4448820	['● five ONGOING clinical trials MAY provide FURTHER INSIGHTS into the ROLE of Vitamin D in the chronic inflammation RELATED to asthma (596).']	[('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4448820	5/2015	S1135-PMC4448820	['in SOME conditions, supplementation with Vitamins A, d, and e and copper and Selenium was PROTECTIVE against mastitis (652), BUT others REPORTED in hiv-infected women that antioxidant Micronutrient supplementation did not lower (660), and MIGHT EVEN increase the risk of scm (661).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 239), ('ANOMALY_CURIOUS_FINDING', 245)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamins A'), ('CHEBI_27568', 'selenium atom', 77, 'selenium'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 184, 'micronutrient')]
PMC4448820	5/2015	S1473-PMC4448820	['HOWEVER, recent data from a subset of women recruited as part of a national survey in cameroon INDICATE that Human-milk Vitamin A concentrations (casual samples at ≥1 mo Postpartum) were ASSOCIATED with crp, and this ASSOCIATION SEEMED TO BE EXPLAINED by a decrease in Plasma rbp (776).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 217), ('ANOMALY_CURIOUS_FINDING', 229), ('PROBABLE_UNDERSTANDING', 242)]	6	[('NCBITaxon_9606', 'Homo sapiens', 109, 'human'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 170, 'postpartum'), ('UBERON_0001969', 'blood plasma', 269, 'plasma')]
PMC4452099	6/2015	S18-PMC4452099	['SEVERAL epidemiological STUDIES also FOUND that the risk of t1d was decreased in Individuals supplemented with Vitamin D during Gestation or infancy, and that the PROTECTIVE EFFECT was directly DEPENDENT ON the supplementation dose: the larger the dose, the smaller t1d risk [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('NCBITaxon_1', 'root', 81, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'gestation')]
PMC4452099	6/2015	S83-PMC4452099	['this study CONFIRMED the linear increasing TREND in the incidence of childhood t1d in Individuals Born in denmark from 1983 to 1988, and we FOUND NO EVIDENCE to support that the Early Life exposure to small extra doses of Vitamin D from the danish mandatory Margarine fortification programme AFFECTED this TREND.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 292), ('INCOMPLETE_EVIDENCE', 306)]	6	[('NCBITaxon_1', 'root', 86, 'individuals'), ('GO_0007567', 'parturition', 98, 'born'), ('UBERON_0001847', 'lobule of pinna', 178, 'early life'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('CHEBI_6784', 'mestranol', 258, 'margarine')]
PMC4466139	6/2015	S89-PMC4466139	['in OUR STUDY, north african mothers and newborns had the lowest 25Ohd values; this FINDING is IN LINE WITH PREVIOUS DATA SUGGESTING that ethnic origin is a risk FACTOR for Vitamin D deficiency [23–24].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4466139	6/2015	S115-PMC4466139	['moreover, SOME STUDIES HAVE SHOWN a large inter-Individual difference in response to treatment with identical doses of Vitamin D SUGGESTING that common Genetic variants IMPLICATED in Vitamin d Homeostasis MAY AFFECT the response to sun exposure or to Vitamin D supplementation [39].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 209)]	6	[('NCBITaxon_1', 'root', 48, 'individual'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('SO_0000704', 'gene', 152, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 183, 'vitamin'), ('GO_0042592', 'homeostatic process', 193, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC4488777	5/2015	S14-PMC4488777	['introduction\nthe ROLE of Vitamin D in fertility treatment has been RECENTLY DESCRIBED in SOME COMPREHENSIVE REPORTS [1,2].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 108)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]
PMC4490503	6/2015	S308-PMC4490503	['FURTHER rcts are CRUCIAL to determining WHETHER Vitamin D has a ROLE in pathophysiology of gdm and WHETHER supplementation has a ROLE in preventing gdm [129].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
PMC4499946	7/2015	S42-PMC4499946	['the primary AIM is TO INVESTIGATE the EFFECT of maternal Vitamin D supplementation on infant length at 1 year of age, but the trial also provides an OPPORTUNITY to study a range of OTHER POTENTIAL Vitamin D–responsive outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('INCOMPLETE_EVIDENCE', 187)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]
PMC4516377	6/2015	S14-PMC4516377	['GIVEN the above, THIS integrative REVIEW AIMED TO EVALUATE the ASSOCIATION between calcium intake and Serum Vitamin D levels with body fat (bf) accumulation in children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	6	[('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4516377	6/2015	S65-PMC4516377	['THUS, the active transport becomes the main mechanism of calcium absorption when its Ingestion is low.34\nit can be OBSERVED that many of the mechanisms that explain adiposity and its ASSOCIATION with the assessed Micronutrients DEMONSTRATE the close ASSOCIATION between Calcium and the Vitamin D present in the Metabolic events of Adipogenesis, and the fact that the presence or absence of one of them CAN bring damage not only to bone, but health as a whole.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 228), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 402)]	6	[('GO_0007631', 'feeding behavior', 85, 'ingestion'), ('CHEBI_33839', 'macromolecule', 213, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 270, 'calcium'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 311, 'metabolic'), ('GO_0060612', 'adipose tissue development', 331, 'adipogenesis')]
PMC4586450	10/2015	S245-PMC4586450	['these results SUGGEST that within the range of fat intakes normally consumed by united kingdom preschool children, there is no EVIDENCE of an EFFECT on growth or obesity development of increasing the proportion of ei coming from fat in the diet.vitamin a\nthe sources of Vitamin A (Retinol equivalents) in the diet and changes in Intake between age 1.5 years and age 3.5 years were examined longitudinally (n = 755 with Food records at both ages).23the diet was categorized by core and noncore Foods, and THERE was EVIDENCE that the quality of the diet deteriorated with age.23between age 1.5 years and age 3.5 years, the dietary Intake of Vitamin A decreased by 56 µg/day (95% ci, −17 to −95 µg/d; p = 0.005) MAINLY due to decreased Intake of whole milk (390 g/d at age 1.5 y; 261 g/d at age 3.5 y) and increased Intake of energy-dense, Nutrient-poor Foods such as puddings, cakes, biscuits, confectionery, and crisps.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 514), ('PROBABLE_UNDERSTANDING', 709)]	6	[('CHEBI_27300', 'vitamin D', 270, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 281, 'retinol'), ('GO_0007631', 'feeding behavior', 329, 'intake'), ('CHEBI_33290', 'food', 419, 'food'), ('CHEBI_33290', 'food', 493, 'foods'), ('GO_0007631', 'feeding behavior', 629, 'intake'), ('CHEBI_27300', 'vitamin D', 639, 'vitamin A'), ('GO_0007631', 'feeding behavior', 733, 'intake'), ('GO_0007631', 'feeding behavior', 813, 'intake'), ('CHEBI_33284', 'nutrient', 837, 'nutrient'), ('CHEBI_33290', 'food', 851, 'foods')]
PMC4595656	10/2015	S4-PMC4595656	['HOWEVER, a SMALL NUMBER OF STUDIES, MOSTLY in vitro , POINT to a ROLE for Vitamin D in Differentiation and Development Of Hippocampal Neurons.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 65)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 87, 'differentiation ...'), ('GO_0048513', 'animal organ development', 107, 'development of ... neurons'), ('CL_0002608', 'hippocampal neuron', 122, 'hippocampal neurons')]
PMC4595656	10/2015	S85-PMC4595656	['HOWEVER the FINDING of increased numbers of Apoptotic Cells in the hippocampus is IN CONTRAST TO the FINDINGS of decreased numbers of Apoptotic Cells at Birth in the developing Cortex (ko et al.,2004) and with the KNOWN overall EFFECTS of Vitamin D on Apoptosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 228)]	6	[('CL_0000445', 'apoptosis fated cell', 44, 'apoptotic cells'), ('CL_0000445', 'apoptosis fated cell', 134, 'apoptotic cells'), ('GO_0007567', 'parturition', 153, 'birth'), ('UBERON_0001851', 'cortex', 177, 'cortex'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0006915', 'apoptotic process', 252, 'apoptosis')]
PMC4598849	10/2015	S10-PMC4598849	['maternal Vitamin D deficiency during Pregnancy is a SIGNIFICANT PUBLIC HEALTH PROBLEM GLOBALLY78DUE to the combined EFFECTS of limited sunlight exposure, INADEQUATE intake, and additional growth NEEDS of the fetus.']	[('IMPORTANT_CONSIDERATION', 52), ('PROBLEM_COMPLICATION', 78), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 116), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy')]
PMC4598849	10/2015	S11-PMC4598849	['the LINK between maternal Vitamin D status and fetal growth, AS measured most frequently by infant Birth weight and small for Gestational age (sga), HAS BEEN explored by a NUMBER OF observational STUDIES9101112131415AND randomized supplementation trials1617181920worldwide with MIXED results.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 196), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 278)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'gestational')]
PMC4598849	10/2015	S13-PMC4598849	['EVIDENCES from SOME STUDIES SUPPORT the HYPOTHESIS that lower Vitamin D status causes adverse fetal growth in a linear way, more SEVERE deficiency would be expected to have a stronger EFFECT than less severe deficiency or sufficiency91012131416.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4598849	10/2015	S79-PMC4598849	['in CONCLUSION, THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4600246	10/2015	S15-PMC4600246	['Vitamin K and vascular calcifications\nCoronary Artery calcium (cac) HAS BEEN SHOWN to have increasing prevalence as Kidney function declines.3indeed, cac prevalence HAS BEEN reported in 13% of ‘healthy’ patients without Renal disease,2140% of patients with chronic Kidney disease patients not on dialysis,2157% of patients starting dialysis22and 83% of patients on long-term dialysis.23diets lacking Vitamin K can PRECIPITATE the development of Vitamin K deficiency in as little as 7\u2005days.24additionally, subclinical Vitamin K deficiency is not UNCOMMON, especially in patients receiving warfarin.25cross-sectional and cohort data HAVE SHOWN a lower risk of Coronary Heart disease (chd), chd mortality, all-cause mortality and SEVERE Aortic calcifications with higher Vitamin K2(Menaquinone) intake526(box 1).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 414), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 631), ('IMPORTANT_CONSIDERATION', 727)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001621', 'coronary artery', 38, 'Coronary artery'), ('UBERON_0002113', 'kidney', 116, 'kidney'), ('UBERON_0002113', 'kidney', 220, 'renal'), ('UBERON_0002113', 'kidney', 265, 'kidney'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 517, 'vitamin K'), ('UBERON_0004151', 'cardiac chamber', 658, 'coronary heart'), ('UBERON_0000947', 'aorta', 734, 'aortic'), ('CHEBI_28934', 'vitamin D2', 768, 'vitamin K2'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 776, 'K2'), ('CHEBI_18154', 'polysaccharide', 779, 'menaquinone')]
PMC4600246	10/2015	S36-PMC4600246	['DESPITE the fact that Vitamin K1Has a beneficial EFFECT on cac in older men and women, LARGER STUDIES powered for clinical end points (stroke, Myocardial infarction and death) ARE NEEDED TO ASSESS the risks and benefits of Vitamin K therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('FUTURE_WORK', 87), ('FUTURE_WORK', 176), ('FUTURE_WORK', 187)]	6	[('CHEBI_26871', 'terpene alkaloid', 22, 'vitamin K1has'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 30, 'K1has'), ('UBERON_0002349', 'myocardium', 143, 'myocardial'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin K')]
PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', "2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]
PMC4624803	10/2015	S19-PMC4624803	['AIM\nthe AIM of the STUDY was TO TEST the HYPOTHESIS that low levels of Vitamin D in the child during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC4624803	10/2015	S94-PMC4624803	['[17] reviewed the Animal research literature and CONCLUDED that there are INDICATIONS of behavioural EFFECTS of Vitamin D inadequacy, BUT that the EVIDENCE is WEAK.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 159)]	6	[('NCBITaxon_33208', 'Metazoa', 18, 'animal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4624803	10/2015	S116-PMC4624803	['AS a CONSEQUENCE of the LIMITED statistical power, we cannot exclude that the MAY BE a small to medium sized ASSOCIATION between Vitamin D levels at Birth and a later diagnosis of adhd.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 109)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth')]
PMC4627942	10/2015	S221-PMC4627942	["caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards."]	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
PMC4632418	10/2015	S7-PMC4632418	['IN SUMMARY, the EVIDENCE from this meta-analysis INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	6	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4632418	10/2015	S14-PMC4632418	['HOWEVER, it is NOT CLEAR WHETHER a POOR Vitamin D status is ASSOCIATED with the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 80)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4632418	10/2015	S98-PMC4632418	['SIMILARLY, our meta-analysis of 20 independent observational studies provided STRONG EVIDENCE that Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational')]
PMC4632418	10/2015	S115-PMC4632418	['in words, there is a CONNECTION between Glucose Metabolism and Vitamin D pathways, EVEN IF FURTHER STUDIES based on larger population ARE NEEDED to get more evidence about the topic.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('FUTURE_WORK', 91), ('FUTURE_WORK', 99), ('FUTURE_WORK', 134)]	6	[('CHEBI_17234', 'glucose', 40, 'glucose'), ('GO_0006006', 'glucose metabolic process', 40, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4632418	10/2015	S119-PMC4632418	['besides, EARLIER STUDIES have IDENTIFIED a NUMBER OF FACTORS that INFLUENCE Serum levels of 25(Oh)D, including obesity, fat malabsorption syndrome which is UNABLE TO absorb the fat-soluble Vitamin D, medications enhancing the Catabolism of 25(Oh)D and 1,25(Oh)2D3, and so on [5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 66), ('DIFFICULT_TASK', 156)]	6	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0009056', 'catabolic process', 226, 'catabolism'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('CHEBI_73394', 'Ala-Ser', 254, '25(OH)2D3')]
PMC4632418	10/2015	S126-PMC4632418	['thirdly, there is one more POINT that the OBSERVED ASSOCIATIONS between maternal Vitamin D status and the risk of adverse Pregnancy outcomes COULD BE AFFECTED by CONFOUNDING FACTORS, such as bmi and skin tone.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 150), ('PROBLEM_COMPLICATION', 162)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4676908	12/2015	S111-PMC4676908	['the content of each anc visit is also IMPORTANT, AS SOME anc INTERVENTIONS MAY not be beneficial, such as high does concomitant supplementation with Vitamin C and Vitamin e to PREVENT pre-eclampsia in high-risk women (poston2006).']	[('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 149, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin')]
PMC4684854	12/2015	S62-PMC4684854	['studies on Reproductive outcomes RELATED to Vitamin D supplementation, HOWEVER, are inherently PLAGUED by a NUMBER OF common CONFOUNDERS which CLOUD the picture.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 125), ('INCOMPLETE_EVIDENCE', 143)]	6	[('GO_0000003', 'reproduction', 11, 'reproductive'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4684854	12/2015	S66-PMC4684854	['many of the RECENT publications CHALLENGING the efficacy of Gestational Vitamin D sufficiency HAVE BEEN meta-analyses which ATTEMPT to synthesize diverse data from numerous observational and supplementation studies which do NOT NECESSARILY incorporate individual differences in these central DETERMINANTS.']	[('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 94), ('DIFFICULT_TASK', 124), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 292)]	6	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4684854	12/2015	S137-PMC4684854	["as discussed, individual Vitamin D indices CAN be INFLUENCED by various DETERMINANTS DESPITE specific levels of supplementation; it is THUS the author's RECOMMENDATION that a personalized medical approach be taken via individual screening for 25(Oh)D as a routine part of Preconception and Prenatal care."]	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 85), ('PROBABLE_UNDERSTANDING', 135), ('FUTURE_WORK', 153)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('GO_0007565', 'female pregnancy', 272, 'preconception'), ('GO_0007565', 'female pregnancy', 290, 'prenatal')]
PMC4684854	12/2015	S140-PMC4684854	['the ONGOING personal health BURDEN ASSOCIATED with Gestational Vitamin D insufficiency throughout many parts of the world has the POTENTIAL to be ameliorated CONSIDERABLY by straightforward educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Pregnancy.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 28), ('PROBLEM_COMPLICATION', 28), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 130), ('ANOMALY_CURIOUS_FINDING', 158)]	6	[('GO_0007565', 'female pregnancy', 51, 'gestational'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'preconception'), ('GO_0007565', 'female pregnancy', 251, 'prenatal'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy')]
PMC4689556	12/2015	S137-PMC4689556	['to further investigate the WEAK EVIDENCE for a LINK between Cord Blood 25(Oh) Vitamin D concentration and eczema cost (table 9), we analysed WHETHER there was a RELATIONSHIP between Cord 25(Oh) Vitamin D level and prescription of a medicated cream (aor 2.52, p = 0.10, 95% ci 0.85–7.47) and WHETHER cord 25(Oh) Vitamin D was ASSOCIATED with the number of eczema Medications prescribed (r = 0.07, p = 0.91, 95% ci -0.72–7.80).']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('SUPERFICIAL_RELATIONSHIP', 325)]	6	[('UBERON_0002240', 'spinal cord', 60, 'cord'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_30778', 'gallic acid', 71, '25(OH)'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 182, 'cord'), ('CHEBI_30778', 'gallic acid', 187, '25(OH)'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D'), ('CHEBI_25441', 'mycothiols', 362, 'medications')]
PMC4689556	12/2015	S167-PMC4689556	['given that SOME observational studies SUGGEST adverse child Respiratory health outcomes are ASSOCIATED with very high maternal Vitamin D level during Pregnancy, empiric data ARE NEEDED before high dose Prenatal Vitamin D supplementation CAN be routinely RECOMMENDED [44].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 174), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 254)]	6	[('UBERON_0001004', 'respiratory system', 60, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4689556	12/2015	S171-PMC4689556	['a further LIMITATION of the study is its SMALL size and wide confidence intervals, SO that a small EFFECT of Prenatal Vitamin D on child healthcare utilization in the first 3 years CANNOT BE confidently EXCLUDED.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 83), ('SUPERFICIAL_RELATIONSHIP', 99), ('DIFFICULT_TASK', 181), ('INCOMPLETE_EVIDENCE', 203)]	6	[('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4691762	12/2015	S120-PMC4691762	['the vitality trial will also enable a FUTURE evaluation of WHETHER Postnatal Vitamin D supplementation is ASSOCIATED with IMPROVED bone health in later childhood—the historical basis of widespread Postnatal Vitamin D supplementation, which REMAINS essentially UNTESTED.']	[('FUTURE_WORK', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 260)]	6	[('GO_0007567', 'parturition', 67, 'postnatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'postnatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4764019	1/2016	S51-PMC4764019	['CAN it be that Vitamin D inadequacy CONTRIBUTES to the disease BURDEN of so many otherwise UNRELATED disorders?']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 91), ('EXPLICIT_QUESTION', 110)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4770602	1/2016	S26-PMC4770602	['THUS, THIS STUDY was AIMED TO EXAMINE the IMPACT of Vitamin D supplementation in reduction of RISK of Preeclampsia in nulliparous women in a randomized controlled trial.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 94)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia')]
PMC4770602	1/2016	S66-PMC4770602	['[20] also, ROLE of Vitamin D in the PREVENTION of Preeclampsia is SUPPORTED by two clinical TRIALS, HOWEVER, in one of these STUDIES as an uncontrolled trial, supplementation with a multivitamin/Mineral supplement and halibut Liver oil provided at 20 week Gestation reduced the odds of Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 125)]	6	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 50, 'preeclampsia'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002107', 'liver', 226, 'liver'), ('GO_0007565', 'female pregnancy', 256, 'gestation'), ('GO_0007128', 'meiotic prophase I', 286, 'preeclampsia')]
PMC4770602	1/2016	S78-PMC4770602	['THEREFORE, ADDITIONAL well-designed, prospective, randomized TRIALS of supplementation with good sample size that control for dietary exposure will BE NECESSARY to determine a POTENTIAL ROLE for Vitamin D in the PREVENTION of Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 186), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 226, 'preeclampsia')]
PMC4778858	3/2016	S124-PMC4778858	['a MAJOR strength of THIS PLANNED STUDY was its design to reduce POTENTIAL CONFOUNDERS of ASSOCIATIONS between maternal and Cord Blood Vitamin D levels and maternal bmi.']	[('IMPORTANT_CONSIDERATION', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 64), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 89)]	6	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4785305	3/2016	S22-PMC4785305	['WHILE the total Calcitriol levels double in the first trimester, free Calcitriol levels do not increase until the third trimester and remain so until Lactation.24conversely, Parathyroid hormone (pth) levels decrease early on and increase back to mid-normal range by term.2the total calcium level decreases during Pregnancy, due to haemodilution, WHILE the ionised calcium level remains stable.2vitamin D binding proteins also increase during Pregnancy secondary to high Oestrogen levels,45but the 25-Hydroxyvitamin D (25(Oh)D) level, the single best nutritional INDICATOR of Vitamin D status,6remains stable.7the changes in Calcitriol levels led to the description of Pregnancy as a state of ‘absorptive hypercalciuria’.12the above Adaptive physiology is KEY to SAFETY CONSIDERATIONS when using Vitamin D supplementation during Pregnancy, as well as to determining key biochemical and hormonal parameters to be monitored.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 346), ('SUPERFICIAL_RELATIONSHIP', 562), ('IMPORTANT_CONSIDERATION', 755), ('IMPORTANT_CONSIDERATION', 762), ('IMPORTANT_CONSIDERATION', 769)]	6	[('CHEBI_17823', 'calcitriol', 16, 'calcitriol'), ('CHEBI_17823', 'calcitriol', 70, 'calcitriol'), ('GO_0007595', 'lactation', 150, 'lactation'), ('UBERON_0001132', 'parathyroid gland', 174, 'parathyroid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('PR_000006444', 'diacylglycerol kinase delta', 402, 'D'), ('GO_0007565', 'female pregnancy', 442, 'pregnancy'), ('CHEBI_50114', 'estrogen', 470, 'oestrogen'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 497, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 518, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 575, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 624, 'calcitriol'), ('GO_0007565', 'female pregnancy', 668, 'pregnancy'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 732, 'adaptive'), ('CHEBI_27300', 'vitamin D', 795, 'vitamin D'), ('GO_0007565', 'female pregnancy', 828, 'pregnancy')]
PMC4800340	5/2016	S40-PMC4800340	['in the boston Birth cohort study, Cord Blood Vitamin D deficiency [25(Oh)D concentration <11 ng/ml] was not FOUND TO be ASSOCIATED with Food sensitization to eight common Food Allergen in children.67HOWEVER, when individual Genetic variant of 4 CANDIDATE Genes INVOLVED in Ige synthesis and Vitamin D Metabolism were jointly considered, there is a statistically strong Gene-Vitamin D INTERACTION (pinteraction=9×10-6) on Food sensitization.']	[('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 120), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 384)]	6	[('GO_0007567', 'parturition', 14, 'birth'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_33290', 'food', 136, 'food'), ('CHEBI_33290', 'food', 171, 'food'), ('CHEBI_50904', 'allergen', 176, 'allergen'), ('SO_0000704', 'gene', 224, 'genetic'), ('SO_0000704', 'gene', 255, 'genes'), ('GO_0007630', 'jump response', 273, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 273, 'IgE'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 299, 'D metabolism'), ('SO_0000704', 'gene', 369, 'gene'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33290', 'food', 421, 'food')]
PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]
PMC4811107	3/2016	S109-PMC4811107	["NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus."]	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
PMC4846845	4/2016	S156-PMC4846845	['a RECENT meta-analysis did NOT see a positive change in ptb, lbw, pre-eclampsia, and Gestational diabetes rates with Vitamin D supplementation, THOUGH they did CONCLUDE that Vitamin D has “PLAUSIBLE EFFECTS” on many Perinatal outcomes [119].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007565', 'female pregnancy', 85, 'gestational'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0036268', 'swimming', 216, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 216, 'perinatal')]
PMC4846845	4/2016	S174-PMC4846845	['a RECENT STUDY REPORTED that methylation of a subset of Cpg Sites identified through a network analysis is AFFECTED by both ancestry and maternal Vitamin D concentrations, SUGGESTING that both of these factors MAY IMPACT the methylome of the neonate [135].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 214)]	6	[('SO_0000036', 'matrix_attachment_site', 56, 'CpG sites'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4859539	5/2016	S15-PMC4859539	['to address this GAP in the literature, the AIM of THIS follow-up STUDY was TO DETERMINE IF maternal Vitamin D status during Pregnancy and/or a child’s current Vitamin D status AFFECT the circulating concentration of Cathelicidin in healthy children years after Delivery.']	[('FULL_UNKNOWN', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0007567', 'parturition', 261, 'delivery')]
PMC4889866	5/2016	S1-PMC4889866	['the AIM of THIS STUDY was TO INVESTIGATE the ROLE of maternal and Cord Blood Vitamin D level in tlr-RELATED Innate Immunity and its EFFECT on infectious outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('UBERON_0002240', 'spinal cord', 66, 'cord'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0045087', 'innate immune response', 108, 'innate immunity')]
PMC4889866	5/2016	S15-PMC4889866	['GIVEN the IMPORTANT Immune Modulatory ROLE of Vitamin D, the LINK between toll-like receptors- (tlrs-) mediated Innate Immunity and Vitamin D DESERVES in-depth INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 160)]	6	[('GO_0051452', 'intracellular pH reduction', 20, 'immune modulatory'), ('UBERON_0002405', 'immune system', 20, 'immune'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0045087', 'innate immune response', 112, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4889866	5/2016	S23-PMC4889866	['in addition, we SOUGHT TO INVESTIGATE WHETHER maternal Blood and Cord Blood Vitamin D CORRESPOND in their ASSOCIATION with tlr-related Innate Immunity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('EXPLICIT_QUESTION', 38), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0045087', 'innate immune response', 135, 'innate immunity')]
PMC4896250	4/2016	S4160-PMC4896250	['FURTHER ELUCIDATION of the ROLE of Vitamin D in hdm sensitization MAY hold PROFOUND IMPLICATIONS for the prevention and treatment of ad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4896250	4/2016	S7522-PMC4896250	['a531 the ASSOCIATION between Serum Vitamin D levels and allergic diseases in elementary schoolchildren\n\nhea-kyoung yang1, ji young lee1, minji kim1, kangmo ahn2, jihyun kim1, young-min kim1, hye-young kim3, yong mean park4, woo kyung kim5, so-yeon lee6\n\n1samsung medical center, south korea;2samsung;3medical research institute of pusan national university hospital;4konkuk university school of medicine;5seoul paik hospital/inje university college of medicine;6department of pediatrics, hallym sacred Heart hospital, hallym university college of medicine\n\ncorrespondence: hea-kyoung yang – samsung medical center, south korea\npurpose: there are CONTROVERSIES about the RELATIONSHIP between Vitamin D and allergic diseases, ALTHOUGH there HAS BEEN GROWING INTEREST in Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 646), ('SUPERFICIAL_RELATIONSHIP', 670), ('ANOMALY_CURIOUS_FINDING', 724), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 748)]	6	[('UBERON_0001977', 'blood serum', 29, 'Serum'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('UBERON_0000948', 'heart', 502, 'Heart'), ('CHEBI_27300', 'vitamin D', 691, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 768, 'vitamin D')]
PMC4896250	4/2016	S9520-PMC4896250	['Epidermal barrier injury and Dysregulatory of Immune System COULD BE induced by Vitamin D. the AIM of STUDY was TO REVEAL RELATION in between of Serum level of 25-hydroxyvitamin d with atopic dermatitis occurrence and severity in children.']	[('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('UBERON_0007376', 'outer epithelium', 0, 'Epidermal'), ('GO_0007631', 'feeding behavior', 29, 'dysregulatory'), ('UBERON_0002405', 'immune system', 46, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 53, 'system'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC4897157	5/2016	S15-PMC4897157	['RECENT report REPORTED that fa was MORE COMMON in children Born in boston, during the autumn and winter seasons, SUGGESTING that seasonal fluctuations in sunlight, and perhaps also Vitamin D levels, MAY BE INVOLVED in the pathogenesis of fa7).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 206)]	6	[('GO_0007567', 'parturition', 59, 'born'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4897157	5/2016	S92-PMC4897157	['ALTHOUGH results are EQUIVOCAL, a CONSIDERABLE body of EVIDENCE SUGGESTS that Vitamin D has an IMPORTANT IMPACT on the progression of allergic diseases11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4897157	5/2016	S106-PMC4897157	['ALTHOUGH the UNDERLYING mechanism REMAINS TO BE CLEARLY ESTABLISHED, seasonal differences in Ultraviolet B exposure, and PERHAPS also Vitamin D levels, MAY BE INVOLVED in the development of allergic diseases718).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 34), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_72754', 'bisphenol AF', 93, 'ultraviolet B'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]
PMC4923982	5/2016	S114-PMC4923982	['IN LIGHT OF this PROPOSED oxidative pathway, we EXAMINED the POSSIBILITY that the antioxidant Vitamin C modified the ASSOCIATION between iron and gdm, but we FOUND that dietary Intake of Vitamin C above the median had no measurable effect on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 158)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin C')]
PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
PMC4934634	11/2015	S40-PMC4934634	['ILLUSTRATIVE of this, Vitamin D Nuclear receptors (vdr) HAVE BEEN IDENTIFIED in numerous Tissues including Organs INVOLVED in Reproduction and infant growth such as the Ovary, Testis, Placenta and Mammary Gland [14,15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0005634', 'nucleus', 32, 'nuclear'), ('UBERON_0000479', 'tissue', 89, 'tissues'), ('UBERON_0000062', 'organ', 107, 'organs'), ('GO_0000003', 'reproduction', 126, 'reproduction'), ('UBERON_0000992', 'ovary', 169, 'ovary'), ('UBERON_0000473', 'testis', 176, 'testis'), ('UBERON_0001987', 'placenta', 184, 'placenta'), ('UBERON_0001911', 'mammary gland', 197, 'mammary gland')]
PMC4934634	11/2015	S79-PMC4934634	['this INDICATES Vitamin D CAN have a positive IMPACT on the Endometrium and subsequent Embryo Implantation, an IDEA SUPPORTED BY Animal MODELS [32].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 135)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001852', 'endolymph', 59, 'endometrium'), ('GO_0007601', 'visual perception', 86, 'embryo'), ('UBERON_0000922', 'embryo', 86, 'embryo'), ('GO_0007566', 'embryo implantation', 93, 'implantation'), ('NCBITaxon_33208', 'Metazoa', 128, 'animal')]
PMC4934634	11/2015	S80-PMC4934634	['the positive RELATIONSHIP between maternal Vitamin D status and post-Ivf Pregnancy in non-hispanic white, BUT NOT in asian women, SUGGESTS that genetics play a ROLE in the RELATIONSHIP between Vitamin D and fertility.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ANOMALY_CURIOUS_FINDING', 106), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 160), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 69, 'IVF'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4934634	11/2015	S81-PMC4934634	['this FINDING COULD IMPACT doctor’s RECOMMENDATION of what are CONSIDERED OPTIMAL Vitamin D levels when women of different ethnic groups undergo ivf.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 19), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S109-PMC4934634	['Gestational diabetes\nthe IMPACT of Vitamin D on vascular health and Glucose Control CAN LIKEWISE TRANSLATE to adverse EFFECTS of Vitamin D deficiency on Pregnancy outcomes including an INCREASED risk for Gestational diabetes and Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('GO_0046323', 'glucose import', 68, 'glucose control'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'gestational'), ('GO_0007128', 'meiotic prophase I', 229, 'preeclampsia')]
PMC4944244	7/2016	S28-PMC4944244	['THEREFORE, it is NECESSARY to determine the PREVALENCE of hypovitaminosis D among Pregnant women and assess its risk FACTORS to overcome the PROBLEMS caused by lack of Vitamin D.\n\nmethods\n\nsubjects and sampling\na cross-sectional study was conducted in petaling district, selangor.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 141), ('PROBLEM_COMPLICATION', 141)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4944244	7/2016	S171-PMC4944244	['HOWEVER, this ASSUMPTION would not be EFFECTIVE for countries with less exposure to the sun, where low education was ASSOCIATED with lower Serum 25(Oh)D, PERHAPS AS a result of less dietary intake of Vitamin D and less opportunity for sunbathing leisure and vacation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 154), ('PROBABLE_UNDERSTANDING', 162)]	6	[('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 145, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4944244	7/2016	S225-PMC4944244	['finally, AWARENESS of high PREVALENCE and DANGERS of hypovitaminosis d during Pregnancy NEEDS TO be highlighted to health care workers so that they are better informed of FACTORS INFLUENCING Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 9), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 42), ('FUTURE_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4971719	8/2016	S37-PMC4971719	['BY CONTRAST, the RECENT nielsen case-control danish national Birth cohort FOUND that high levels of Vitamin D in mid Pregnancy were ASSOCIATED with antidepressant use in the Postpartum Period, an UNEXPECTED FINDING [29].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 132), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 207)]	6	[('GO_0007567', 'parturition', 61, 'Birth'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('GO_0007565', 'female pregnancy', 174, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 185, 'period')]
PMC4973215	8/2016	S29-PMC4973215	['to explore RELATIONSHIPS between race, Vitamin D levels and sga, we first EVALUATED race as a PREDICTOR of Vitamin D levels (sufficient or deficient) in cord Blood and ASSESSED for POTENTIAL CONFOUNDERS: medicaid status, bmi at Delivery, hypertension, maternal age and Prenatal Vitamin use.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 168), ('INCOMPLETE_EVIDENCE', 181), ('PROBLEM_COMPLICATION', 191)]	6	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 278, 'vitamin')]
PMC4973215	8/2016	S45-PMC4973215	['SIMILARLY, infants on medicaid, a MARKER of socioeconomic status, had higher odds of Vitamin D deficiency (odds ratio (or) 2.3, 95% ci: 1.4, 3.8), WHEREAS Prenatal Vitamin use SHOWED a PROTECTIVE EFFECT (or 0.24, 95% ci: 0.09, 0.62).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 185), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 164, 'vitamin')]
PMC4973215	8/2016	S92-PMC4973215	['this corresponds to the WELL-KNOWN ASSOCIATION that women with higher bmi TEND to Deliver infants with higher Birth weights.40,41,42\nfurthermore, identification and recognition of women and infants at high risk of Vitamin D deficiency and sga CAN LEAD TO OPPORTUNITIES for risk modification and reduction in adverse outcomes.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 247), ('FUTURE_WORK', 255)]	6	[('GO_0007567', 'parturition', 82, 'deliver'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4976416	7/2016	S23-PMC4976416	['[16]\nheadache is a RECOGNIZED EFFECT of methemoglobinemia, and reduction of previously elevated methemoglobin concentration is PRESUMABLY the mechanism by which Vitamin E improves this symptom, AS improved methemoglobin concentration SEEMS to be the most CONSISTENT laboratory parameter in studies of Vitamin E for protection against dapsone side effects.']	[('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 194), ('ANOMALY_CURIOUS_FINDING', 234), ('INCOMPLETE_EVIDENCE', 255)]	6	[('CHEBI_27300', 'vitamin D', 161, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin E')]
PMC4979151	8/2016	S10-PMC4979151	['introduction\nthe IMPORTANCE of adequate Vitamin D status during Pregnancy HAS BEEN SUGGESTED by OBSERVATIONAL studies DEMONSTRATING ASSOCIATIONS between low 25(Oh)D3And adverse Birth outcomes, childhood infections, and atopy [1,2].']	[('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_76945', 'manool', 157, '25(OH)D3and'), ('PR_000036846', 'class II olfactory receptor', 157, '25(OH)D3and'), ('GO_0007567', 'parturition', 177, 'birth')]
PMC4982007	8/2016	S280-PMC4982007	['THUS, based ON a LIMITED NUMBER OF observational studies evidence LINKING maternal Vitamin D deficiency with reduced offspring Cognitive function is NOT CONCLUSIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC4990268	8/2016	S39-PMC4990268	['the interventions considered by this review are outlined intable 1(numbered to correspond to the sections of the paper where they are addressed).10.1371/journal.pone.0160562.t001\n\ncaption (table-wrap): table 1\ninterventions addressed in THIS review.Nutritioninfectionobstetrical and other• immediate & exclusive breastfeeding• deworming• advance distribution of Misoprostol for use immediately after Childbirth for preventing post-Partum hemorrhage• antenatal Iron supplementation & anemia screening & treatment• intermittent presumptive treatment of malaria & use of Insecticide-treated nets• pre-eclampsia screening & treatment• multi-Micronutrient supplementation• Tetanus Toxoid• clean Delivery practices• Calcium supplementation• advance distribution of Chlorhexidine for application to the Umbilical Cord Stump• thermal care• antenatal Vitamin A supplementation• syphilis screening & treatment• Birth preparedness & complication readiness• advance distribution of Vitamin A for administration to the newborn• hiv screening/ pmtct• tobacco, alcohol use• Iodized Salt use• Family Planning• balanced protein-energy supplementation\n\neffects modified by context\nfor each of these INTERVENTIONS, the review addresses: 1) EVIDENCE on EFFECTS with regard to mortality and other IMPORTANT endpoints and 2) variation in expected EFFECTS by context.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 237), ('SUPERFICIAL_RELATIONSHIP', 1181), ('INCOMPLETE_EVIDENCE', 1221), ('SUPERFICIAL_RELATIONSHIP', 1233), ('IMPORTANT_CONSIDERATION', 1276), ('SUPERFICIAL_RELATIONSHIP', 1325)]	6	[('GO_0012501', 'programmed cell death', 249, 'NutritionInfectionObstetrical'), ('CHEBI_63610', 'misoprostol', 362, 'misoprostol'), ('GO_0007623', 'circadian rhythm', 400, 'childbirth'), ('GO_0007567', 'parturition', 431, 'partum'), ('UBERON_0001013', 'adipose tissue', 431, 'partum'), ('CHEBI_24870', 'ion', 460, 'iron'), ('CHEBI_24852', 'insecticide', 568, 'insecticide'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 637, 'micronutrient'), ('CHEBI_32848', 'serine residue', 668, 'Tetanus'), ('CHEBI_29238', 'tritium atom', 676, 'toxoid'), ('GO_0007567', 'parturition', 690, 'delivery'), ('CHEBI_31341', 'calcium dihydroxide', 710, 'Calcium'), ('CHEBI_3647', 'chlorpromazine', 759, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 796, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 850, 'A'), ('GO_0007567', 'parturition', 901, 'Birth'), ('CHEBI_27300', 'vitamin D', 970, 'vitamin A'), ('CHEBI_31721', 'Irsogladine maleate', 1059, 'Iodized salt'), ('GO_0006437', 'tyrosyl-tRNA aminoacylation', 1077, 'Family Planning')]
PMC4990268	8/2016	S295-PMC4990268	['as with all supplementation STRATEGIES to prevent the COMPLICATIONS ASSOCIATED with Micronutrient deficiencies, the IMPACT of supplementation in the Antenatal Period will DEPEND ON the overall Vitamin A status of the population and the special demands that Pregnancy makes on Vitamin A reserves.']	[('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('GO_0007567', 'parturition', 149, 'antenatal'), ('UBERON_0006721', 'alisphenoid bone', 149, 'antenatal period'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin A'), ('GO_0007565', 'female pregnancy', 257, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A')]
PMC4992225	8/2016	S260-PMC4992225	['it is also POSSIBLE that AS a result of vascular changes in Pregnancy the maternal Cerebral environment is more vulnerable to inflammation PERHAPS, EXPLAINING IN PART the LINK between Vitamin D and depression in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 139), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0001893', 'telencephalon', 83, 'cerebral'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4992225	8/2016	S261-PMC4992225	['IN LIGHT OF the inflammatory nature of depression and the strong ROLE of Vitamin D AS an anti-inflammatory and immunomodulator, inflammation MAY MEDIATE the RELATIONSHIP between vitamin d deficiency and depression during Pregnancy [73,74].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 83), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 157)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]
PMC4997421	8/2016	S93-PMC4997421	['FOUND a significantly increased RISK of spontaneous Preterm Delivery, maternal anemia, and Pregnancy-induced hypertension when Retinol levels were below 0.70 µmol/l, and BASED ON those functional EFFECTS RECOMMEND a level of 0.70 µmol/l to define Vitamin A deficiency in Pregnancy [3].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 170), ('QUESTION_ANSWERED_BY_THIS_WORK', 170), ('SUPERFICIAL_RELATIONSHIP', 196), ('FUTURE_WORK', 204)]	6	[('GO_0007565', 'female pregnancy', 52, 'preterm'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin A'), ('GO_0007565', 'female pregnancy', 271, 'pregnancy')]
PMC4997421	8/2016	S139-PMC4997421	['MORE RESEARCH IS NEEDED to determine WHAT type of INTERVENTIONS will be best for specific populations, ESPECIALLY the low-income and minority populations that bear a greater BURDEN of Vitamin A inadequacy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('EXPLICIT_QUESTION', 37), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 174)]	6	[('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 192, 'A')]
PMC4998950	4/2016	S33-PMC4998950	['discussion\nTHIS STUDY is, TO OUR KNOWLEDGE, the FIRST population-based study to ESTIMATE the RELATIONSHIP between maternal Vitamin D deficiency and the RISK of asd in a child.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 152)]	6	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4998950	4/2016	S46-PMC4998950	['AS Vitamin D deficiency in Pregnancy is both PREVALENT and treatable, FURTHER INVESTIGATION of this ASSOCIATION IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 45), ('FUTURE_WORK', 70), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('FUTURE_WORK', 112)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC5024513	9/2016	S71-PMC5024513	['caption (table-wrap): table 2\n\ncharacteristics of included studiesstudy informationparticipantssupplementsmeasurementqualitystudycountrystudy designstudy groupsnumberageinclusion criteriaexclusion criteriasupplement type and dosenumber with available dataestimated compliance: n (%)data collection method (s)time period(s)quality ratingbaker et.al (2009) [23]ukcross-sectional studyna50014–18singleton Pregnancy, age 14–18, Gestational age\u2009<\u2009=20\xa0weeksinability to provide informed consent, preeclampsia, Clotting disorders, hiv/aids, haemoglobinopathies, diabetes, Renal disease, hypertension, multiple Gestations, history of 3=\u2009>\u2009previous Miscarriagespreconception folic acid49834 (6.9)24\xa0h recall (multiple)third Trimester+Folic Acid in early pregnancy498220 (44.2)Iron in early pregnancy49839 (7.8)multivitamins in early pregnancy49819 (3.8)Folic Acid only in 3rd trimester2905 (1.7)Iron and Folic Acid in 3rd trimester29013 (4.5)Iron only in 3rd trimester29042 (14.5)multivitamins in 3rd trimester2907 (2.4)castillo-duran et.al (2001) [43]chilerctzinc supplemented24916.4 (mean)beginning Prenatal visits before 20\xa0weeks Gestation, aged <19 at estimated due dateadolescents whose background included chronic diseases, Drug abuse, mental retardation, illiteracy or Pregnancy due to incest or rape20\xa0mg Zinc Sulphate dailyintervention group - 249at least 50\xa0% compliance24\xa0h Recall (multiple)second and third Trimester+placebo25840\xa0mg Iron Sulphateall participants - 507chan et.al (2006) [24]usarctcontrol group, 2 intervention groups excluded from review*2315–17enrolled before 20\xa0weeks Gestationhypertension, diabetes, Renal or Liver disease, alcohol or tobacco use, using medicines effecting Ca Metabolismno additional supplements reportedfood diary (weighing not mentioned)second and third Trimester−/+chang et.al (2003) [37]usaretrospective chart reviewna91812–17self-reported racial group as african-american; singleton Pregnancybirth results not AVAILABLE DUE TO abortion, Miscarriage or transfer of care90\xa0mg Carbonyl Iron daily plus additional up to 120\xa0mg for those classified as anaemic918not reportednot reportedsecond and third Trimester+dawson et.al (2000) [35]usarctone-a-day without iron2016–20aged 16–20, less than 16\xa0weeks Gestation, no Iron supplementation for previous 30\xa0dayshypertension; diabetes; other medical problems; haemoglobin <11\xa0g/dl; haematocrit <30\xa0%vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, Pantothenic Acid 10\xa0mg20not reportedvenous Blood samplesecond and third Trimester and Delivery−/+one-a-day with iron2018\xa0mg iron, vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, Niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, pantothenic Acid 10\xa0mg20derbyshire (2009) [39]ukcross-sectional studyna2015–19attending Antenatal classes or community clinicsincomplete diarynone reportedfood diary unweighedthird Trimester+gadowsky et.al (1995) [42]canadacross-sectional studyna5814–19not reportednot reportedfolic Acid mean 479\xa0μg/day5882\xa0%Venous Blood samplethird trimester+Elemental Iron mean 31.5\xa0mg/daycyanocobalamin (B12) mean 2.24\xa0μg/dgiddens et.al (2000) [27]usarct (subset from a larger study)na5913–18singleton Pregnancies, between 13 and 19\xa0weeks Gestationnot REPORTEDREPORTED that any contribution from Supplements was not included in analysisfood diary weighedmean over Pregnancy−/+ginde et.al (2010) [32]usasecondary analysis of cross sectional surveyna8413–19not reportednot reportedsome participants taking Vitamin D Supplementsnot reportednot reportedvenous Blood samplemean over Pregnancy+gutierrez et.al (1999) [28]usacross-sectional studyna4613–18self-identified ethnicity as mexican american, primigravida, 13–18 years of agehistory of Miscarriage or health problems, involved in competitive athletic performances or heavy exercise, planned to move away during study periodnone reported24\xa0h recall (single)second and third Trimester+iannotti et.al (2005) [36]usacross-sectional studyna8013–18self-reported racial group as african-american; singleton Pregnancynot reportednone reported10\xa0ml Venous Blood samplesecond and third trimesters+job et.al (1995) [41]australiacross-sectional studyna3513–19not reportednot reportednone REPORTED24\xa0h recallmean over Pregnancy+lee et.al (2013) [25]usacross-sectional studyna15613–18age 18 or under, carrying a single fetus, 12–30 weeks Gestation at recruitmentnot REPORTEDREPORTED that any CONTRIBUTION from Supplements was not included in analysis24\xa0h recall (multiple)<23\xa0weeks Gestation, 23–30 weeks Gestation and mean over Pregnancy+mcguire et.al.']	[('INCOMPLETE_EVIDENCE', 1954), ('PROBLEM_COMPLICATION', 1964), ('INCOMPLETE_EVIDENCE', 3401), ('INCOMPLETE_EVIDENCE', 4377), ('INCOMPLETE_EVIDENCE', 4553), ('SUPERFICIAL_RELATIONSHIP', 4579)]	6	[('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007565', 'female pregnancy', 424, 'gestational'), ('GO_0050817', 'coagulation', 504, 'clotting'), ('UBERON_0002113', 'kidney', 565, 'renal'), ('GO_0007565', 'female pregnancy', 603, 'gestations'), ('GO_0050788', 'sequestering of mercury', 640, 'miscarriagesPreconception'), ('GO_0009294', 'DNA mediated transformation', 715, 'trimester'), ('CHEBI_30751', 'formic acid', 725, 'Folic acid'), ('CHEBI_24870', 'ion', 767, 'Iron'), ('CHEBI_30751', 'formic acid', 844, 'Folic acid'), ('CHEBI_24870', 'ion', 886, 'Iron'), ('CHEBI_30751', 'formic acid', 895, 'folic acid'), ('CHEBI_24870', 'ion', 933, 'Iron'), ('GO_0007565', 'female pregnancy', 1092, 'prenatal'), ('GO_0007565', 'female pregnancy', 1124, 'gestation'), ('CHEBI_23888', 'drug', 1221, 'drug'), ('GO_0007565', 'female pregnancy', 1267, 'pregnancy'), ('CHEBI_10127', 'zonisamide', 1304, 'Zinc sulphate'), ('GO_0060033', 'anatomical structure regression', 1376, 'recall'), ('GO_0009294', 'DNA mediated transformation', 1410, 'trimester'), ('CHEBI_83530', 'atenolol-desisopropyl', 1436, 'iron sulphateAll'), ('GO_0051866', 'general adaptation syndrome', 1589, 'gestationHypertension'), ('UBERON_0002113', 'kidney', 1622, 'renal'), ('UBERON_0002107', 'liver', 1631, 'liver'), ('CHEBI_32588', 'potassium chloride', 1696, 'Ca'), ('GO_0008152', 'metabolic process', 1699, 'metabolismNo'), ('GO_0009294', 'DNA mediated transformation', 1795, 'trimester'), ('GO_0007605', 'sensory perception of sound', 1927, 'pregnancyBirth'), ('GO_0046660', 'female sex differentiation', 1981, 'miscarriage'), ('CHEBI_30255', 'sulfidocarbonate(.1-)', 2018, 'carbonyl iron'), ('GO_0009294', 'DNA mediated transformation', 2142, 'trimester'), ('GO_0007565', 'female pregnancy', 2242, 'gestation'), ('CHEBI_24870', 'ion', 2256, 'iron'), ('CHEBI_27300', 'vitamin D', 2403, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2421, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2438, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2455, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2474, 'thiamine'), ('CHEBI_16410', 'pyridoxamine', 2524, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2541, 'vitamin B'), ('CHEBI_7916', 'pantothenic acid', 2558, 'pantothenic acid'), ('UBERON_0000178', 'blood', 2601, 'blood'), ('GO_0009294', 'DNA mediated transformation', 2630, 'trimester'), ('GO_0007567', 'parturition', 2644, 'delivery'), ('CHEBI_27300', 'vitamin D', 2707, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2725, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2742, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2759, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2778, 'thiamine'), ('CHEBI_7542', 'neurotensin', 2814, 'niacin'), ('CHEBI_16410', 'pyridoxamine', 2828, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2845, 'vitamin B'), ('CHEBI_37527', 'acid', 2874, 'acid'), ('GO_0007567', 'parturition', 2950, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 3043, 'trimester'), ('CHEBI_37527', 'acid', 3145, 'Acid'), ('UBERON_0001638', 'vein', 3171, 'Venous'), ('UBERON_0000178', 'blood', 3178, 'blood'), ('CHEBI_4779', 'emedastine', 3206, 'Elemental'), ('CHEBI_24870', 'ion', 3216, 'Iron'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 3253, 'B12'), ('GO_0007565', 'female pregnancy', 3351, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3388, 'gestationNot'), ('CHEBI_33341', 'titanium atom', 3445, 'supplements'), ('GO_0007565', 'female pregnancy', 3513, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 3653, 'vitamin D'), ('CHEBI_46978', 'thiazinemonocarboxylic acid', 3663, 'supplementsNot'), ('UBERON_0000178', 'blood', 3705, 'blood'), ('GO_0007565', 'female pregnancy', 3727, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3887, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 4074, 'trimester'), ('GO_0006915', 'apoptotic process', 4201, 'pregnancyNot'), ('UBERON_0001638', 'vein', 4241, 'Venous'), ('UBERON_0000178', 'blood', 4248, 'blood'), ('GO_0007565', 'female pregnancy', 4406, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4525, 'gestation'), ('CHEBI_33341', 'titanium atom', 4597, 'supplements'), ('GO_0007565', 'female pregnancy', 4669, 'gestation'), ('GO_0007565', 'female pregnancy', 4692, 'gestation'), ('GO_0007565', 'female pregnancy', 4716, 'pregnancy')]
PMC5028238	10/2016	S83-PMC5028238	['in addition, BENEFITS from Prenatal Vitamin D supplementation are also Modulated by geographic location and OTHER FACTORS.47THEREFORE biological mechanisms that maximize Vitamin D production and absorption would be selected for in the north.']	[('IMPORTANT_CONSIDERATION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('SUPERFICIAL_RELATIONSHIP', 114), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122)]	6	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0065007', 'biological regulation', 71, 'modulated'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5028238	10/2016	S85-PMC5028238	['this HAS BEEN used TO EXPLAIN WHY northern populations have a higher prevalence of slos.11\ncarriers also are HYPOTHESIZED to have a Reproductive advantage because of the reduced fetal death due to Rachitic Cephalopelvic disproportion.11,35this is again RELATED to increased Vitamin D Production causing improved bone formation.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('PROBABLE_UNDERSTANDING', 22), ('EXPLICIT_QUESTION', 30), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('GO_0000003', 'reproduction', 132, 'reproductive'), ('UBERON_0001286', "Bowman's space", 197, 'rachitic cephalopelvic'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 284, 'production')]
PMC5035678	4/2016	S109-PMC5035678	['discussion\nTO OUR KNOWLEDGE, THIS is the FIRST STUDY TO EVALUATE the EFFECTS of Vitamin D supplementation during Pregnancy on Glucose Metabolism shortly after Delivery.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 69)]	6	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0006006', 'glucose metabolic process', 126, 'glucose metabolism'), ('GO_0007567', 'parturition', 159, 'delivery')]
PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]
PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]
PMC5051327	9/2016	S20-PMC5051327	['the primary AIM of this PILOT STUDY was TO INVESTIGATE 25-Oh Vitamin D, the main MARKER of Vitamin D status, in women who underwent caesarean section DUE to suspected fetal distress COMPARED TO those who did not.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]
PMC5062906	10/2016	S243-PMC5062906	['WHILE maternal Vitamin D deficiency resulted in both phenotypic and epigenetic changes in both generations, it REMAINS UNCLEAR WHETHER the Dna Methylation changes are causally LINKED to the phenotypic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('EXPLICIT_QUESTION', 127), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0006306', 'DNA methylation', 139, 'DNA methylation')]
PMC5062906	10/2016	S250-PMC5062906	['ALTHOUGH Vitamin D deficiency HAS BEEN LINKED to adverse Pregnancy/Birth outcomes [14,46–52], there is currently NO STANDARD practice of screening women for Vitamin D deficiency during Pregnancy nor are there standard RECOMMENDATIONS beyond Prenatal Vitamins for supplementation during this CRITICAL time [53,54].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 218), ('IMPORTANT_CONSIDERATION', 291)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 57, 'pregnancy ...'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 250, 'vitamins')]
PMC5062906	10/2016	S251-PMC5062906	['our data HIGHLIGHT two mechanisms that CONTRIBUTE to interindividual DIFFERENCES in response to Vitamin D deficiency: the Genetic INFLUENCE on maternal Plasma depletion of 25(Oh)D and the INFLUENCE of parent and grandparent of origin in the extent of Vitamin D-DEPENDENT developmental and epigenetic outcomes.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('SO_0000704', 'gene', 122, 'genetic'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC5062906	10/2016	S256-PMC5062906	['Genetic INFLUENCES on adiposity MAY also indirectly explain DIFFERENCES in Vitamin D depletion SINCE adiposity HAS BEEN LINKED to Vitamin D levels [55].']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 120)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5064894	10/2016	S11-PMC5064894	['discussion\nIF SHOWN to reduce the RISK of viral ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia may be a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-ASSOCIATED morbidity and mortality in young infants.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 186), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0007565', 'female pregnancy', 97, 'postpartum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 139, 'antenatal care')]
PMC5084041	10/2016	S31-PMC5084041	['population-representative data on Vitamin D status during Pregnancy IS NEEDED to evaluate the POTENTIAL NEED for new PUBLIC-HEALTH policies and to provide reliable data on potential RISK groups for Vitamin D deficiency.']	[('FUTURE_WORK', 68), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 104), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 182)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5085625	9/2016	S105-PMC5085625	['SOME EVIDENCE SUGGESTS that Preeclampsia MAY BE ASSOCIATED with a decrease in Placental and fetal concentrations of Vitamin D, and Placental dysfunction plays an IMPORTANT ROLE in the pathogenesis of pe [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('GO_0007128', 'meiotic prophase I', 28, 'preeclampsia'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0001987', 'placenta', 131, 'placental')]
PMC5085625	9/2016	S174-PMC5085625	['AVAILABLE EVIDENCE is STILL INSUFFICIENT to CONFIRM a causative LINK between Vitamin D and Pregnancy disorders IN LINE WITH hill’s criteria.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC5095257	11/2016	S83-PMC5095257	['TO EXPLORE the POSSIBLE EFFECT of uvb radiation exposure, which IS KNOWN to INFLUENCE Vitamin D status, on the seasonality pattern OBSERVED in aad, we compared monthly ors (supplemental figure 1) dividing the cohort into 2 groups according to geographical latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 131)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5129897	10/2016	S20-PMC5129897	['the criteria most RELEVANT for Vitamin D are strength of ASSOCIATION, CONSISTENT findings in DIFFERENT populations, temporality, biological gradient, plausibility (e.g., mechanisms), coherence with known facts, and experiments (e.g., clinical trials).5not all criteria NEED be satisfied, BUT the more that are, the stronger the case.']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 269), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 288)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
PMC5129897	10/2016	S159-PMC5129897	['the uncertainty in the numbers is ABOUT 50% AS a result of omitting other diseases with LESS EVIDENCE FOR Vitamin D EFFECTS as well as the POSSIBILITY that the ESTIMATES are too high.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC5129897	10/2016	S168-PMC5129897	['for some intermediate situations, such as cancer, survival rates are better with higher 25(Oh)D concentrations.12,93thus, EVEN IF all canadians achieved concentrations of > 100\xa0nmol/l immediately, the beneficial EFFECTS would accrue slowly, PERHAPS over 10–20\xa0y because for many health outcomes, the beneficial EFFECTS of Vitamin D are much stronger for PREVENTION than for treatment.']	[('ANOMALY_CURIOUS_FINDING', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('SUPERFICIAL_RELATIONSHIP', 212), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 311), ('SUPERFICIAL_RELATIONSHIP', 354)]	6	[('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 94, 'D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5129897	10/2016	S180-PMC5129897	['BUT SOME STUDIES FOUND that Vitamin D AFFECTS mortality rates more than incidence rates.94our ESTIMATES also do NOT take into account prevalence rates for the various diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 112)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5133057	10/2016	S17-PMC5133057	['its occurrence is classically ASSOCIATED with low Intake of Vitamin A from Food sources [5,12], BUT it MAY also be ASSOCIATED with OTHER FACTORS such as socioeconomic status, and inadequate sanitation and the presence of infection [13,14,15].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('GO_0007631', 'feeding behavior', 50, 'intake'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_33290', 'food', 75, 'food')]
PMC5146866	12/2016	S0-PMC5146866	['prevalence and RISK factors for Vitamin D insufficiency and deficiency at Birth and ASSOCIATED outcome\n\nabstract\n\nbackground\noccurrence and consequence of Cord Blood (Cb) Vitamin D insufficiency/deficiency has not BEEN ADEQUATELY explored DESPITE rising CONCERN regarding THIS topic in pediatrics.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 214), ('ANOMALY_CURIOUS_FINDING', 239), ('PROBLEM_COMPLICATION', 254), ('QUESTION_ANSWERED_BY_THIS_WORK', 272)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('UBERON_0002240', 'spinal cord', 155, 'cord'), ('UBERON_0000178', 'blood', 160, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 167, 'CB'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5146866	12/2016	S11-PMC5146866	['background\ncharacterization of the Vitamin D status in the maternal-fetal-neonatal interface is clinically IMPORTANT BECAUSE of the increased rates of detection of Vitamin D insufficiency in Cord Blood (Cb) and the ASSOCIATED RISK for health COMPLICATIONS in infants and children [1,2], including but not limited to rickets [3], infectious and allergic diseases, and type 1 diabetes [4–6].']	[('IMPORTANT_CONSIDERATION', 107), ('PROBABLE_UNDERSTANDING', 117), ('PROBLEM_COMPLICATION', 117), ('SUPERFICIAL_RELATIONSHIP', 215), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 242)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0009472', 'axilla', 191, 'cord blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 203, 'CB')]
PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
PMC5223368	12/2016	S144-PMC5223368	['THEREFORE, the positive ASSOCIATION between high temperature at the third Trimester and increased Birth length in THIS STUDY MIGHT be PARTLY EXPLAINED by Vitamin D status of mothers [31].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 141)]	6	[('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5223368	12/2016	S185-PMC5223368	['one of the LIMITATIONS of THIS STUDY was that FACTORS which COULD AFFECT Birth size such as maternal dietary information and maternal Vitamin D status during Pregnancy were NOT available.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC5318550	2/2017	S22-PMC5318550	['owing to its RELATIONSHIP with the duration of the photoperiod, low Vitamin D levels are put forward AS a POTENTIAL mechanism between season of Birth and Neurological outcomes.8\nanother CANDIDATE mechanism for the seasonal PATTERNS in intellectual ability are the educational policies regarding school entry.9age at school entrance and the relative age compared with peers are considered to AFFECT the youngest in class.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 391)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('UBERON_0001016', 'nervous system', 154, 'neurological')]
PMC5340372	3/2017	S103-PMC5340372	['HOWEVER, in CONTRARY to these REPORTS, a survey in canadian children SHOWED that both low and high Vitamin D levels were RELATED to INCREASED RISK of wheeze and reduced performance of Lung function [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 121), ('IMPORTANT_CONSIDERATION', 132)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0002048', 'lung', 184, 'lung')]
PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
PMC5340372	3/2017	S136-PMC5340372	['second, our PREVIOUS report CONCLUDED that relatively low Vitamin D levels were COMMON in the patch population sample of children and young Adults with an inverse CORRELATION between 25(Oh)D level and age being SHOWN HERE [51].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 211), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 140, 'adults'), ('CHEBI_33010', 'chromide(1-)', 185, '(OH)D')]
PMC5359891	3/2017	S92-PMC5359891	['the intervention\nthe nutritional intervention Preconception and during Pregnancy to maintain healthy Glucose Metabolism and offspring health (nipper) intervention comprises: (1) a Micronutrient-enriched nutritional drink containing myo-inositol, Vitamin D, riboflavin, Vitamin B6, Vitamin B12And zinc together with standard Folic Acid, Iodine, calcium, β-Carotene and iron; the quantities PROPOSED are either standard amounts (Myo-Inositol [54]), enhanced amounts that are available in over-the-counter products (Vitamins b6, b12, riboflavin), RECOMMENDED daily allowance amounts in uk for Pregnant women (Vitamin D, zinc, Folic Acid, Iodine) or minimal amounts for Micronutrients LINKED with POTENTIAL DETRIMENTAL EFFECTS at higher doses (Iron, Β-Carotene, Calcium) and (2) Probiotics (containing lactobacillus rhamnosus ncc 4007 (cgmcc 1.3724) also known as lpr and bifidobacterium animalis Sp.']	[('INCOMPLETE_EVIDENCE', 389), ('FUTURE_WORK', 544), ('SUPERFICIAL_RELATIONSHIP', 681), ('INCOMPLETE_EVIDENCE', 693), ('IMPORTANT_CONSIDERATION', 703), ('SUPERFICIAL_RELATIONSHIP', 715)]	6	[('GO_0007565', 'female pregnancy', 46, 'Preconception'), ('GO_0007565', 'female pregnancy', 71, 'Pregnancy'), ('CHEBI_17234', 'glucose', 101, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 101, 'Glucose Metabolism'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 180, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 269, 'vitamin B6'), ('CHEBI_10124', 'zolmitriptan', 281, 'vitamin B12and'), ('CHEBI_30751', 'formic acid', 324, 'folic acid'), ('CHEBI_24859', 'iodine atom', 336, 'iodine'), ('CHEBI_23042', 'carotene', 355, 'carotene'), ('CHEBI_25435', 'mutagen', 427, 'myo-inositol'), ('CHEBI_33277', 'gamma-tocotrienol', 513, 'vitamins'), ('GO_0007565', 'female pregnancy', 590, 'pregnant'), ('CHEBI_27300', 'vitamin D', 606, 'vitamin D'), ('CHEBI_30751', 'formic acid', 623, 'folic acid'), ('CHEBI_24859', 'iodine atom', 635, 'iodine'), ('CHEBI_33839', 'macromolecule', 666, 'micronutrients'), ('CHEBI_24870', 'ion', 740, 'iron'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 746, 'β-carotene'), ('CHEBI_22313', 'alkaline earth metal atom', 758, 'calcium'), ('CHEBI_26346', 'prostaglandins J', 775, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 893, 'sp')]
PMC5372327	3/2017	S39-PMC5372327	['THEREFORE, Vitamin D does NOT ONLY have a ROLE in Modulating Host Defence To Infections, BUT is LIKELY to Control FACTORS in autoimmunity, also in allergic disease.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 89), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulating'), ('GO_0030989', 'dynein-driven meiotic oscillatory nuclear movement', 61, 'host defence to infections'), ('GO_0065007', 'biological regulation', 106, 'control')]
PMC5372327	3/2017	S122-PMC5372327	['discussion\nTO THE BEST OF OUR KNOWLEDGE, THIS is the largest and MOST COMPREHENSIVE randomised intervention STUDY TO ASSESS the EFFECTS of Vitamin D supplementation on Skeletal and extra Skeletal outcomes in infants.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('PROBABLE_UNDERSTANDING', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 108), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('SUPERFICIAL_RELATIONSHIP', 128)]	6	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0004288', 'skeleton', 168, 'skeletal'), ('UBERON_0004288', 'skeleton', 187, 'skeletal')]
PMC5385921	4/2017	S120-PMC5385921	['ASSUMING that the variables of interest are causally RELATED and that other VARIABLES remain unchanged), optimising Vitamin D status of this sample COULD BE ASSOCIATED with a reduction in the prevalence of asd of APPROXIMATELY 10%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 213)]	6	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5385921	4/2017	S121-PMC5385921	['the FINDING from THIS STUDY LENDS weight to the GROWING BODY of epidemiological and Animal MODEL-based research LINKING Gestational Vitamin D deficiency and altered Brain Development.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 112)]	6	[('NCBITaxon_33208', 'Metazoa', 84, 'animal'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007420', 'brain development', 165, 'brain development'), ('UBERON_0000955', 'brain', 165, 'brain')]
PMC5405075	4/2017	S2-PMC5405075	['SINCE asthma is presented with high incidence in childhood and neonatal Vitamin D stores DEPEND on maternal Vitamin levels, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation was SUGGESTED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 108, 'vitamin'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'gestation')]
PMC5405075	4/2017	S9-PMC5405075	['SINCE asthma is presented with high incidence in childhood, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation HAS BEEN PROPOSED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC5405075	4/2017	S11-PMC5405075	['several OBSERVATIONAL STUDIES explored THIS issue and SUGGESTED a PUTATIVE PROTECTIVE ROLE of Prenatal Vitamin D sufficiency in the development Of Wheezing and Asthma in the offspring [reviewed in ref.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0001503', 'ossification', 144, 'of wheezing'), ('GO_0006953', 'acute-phase response', 160, 'asthma')]
PMC5405075	4/2017	S82-PMC5405075	['taken all TOGETHER, Vitamin D SHOWS a POTENTIAL ASSOCIATION RATHER with asthma-RELATED phenotypes than with asthma per se .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 79)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC5405075	4/2017	S98-PMC5405075	['moreover, any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up, SINCE a u -curve ASSOCIATION between Vitamin D circulating levels and IMPACT on allergy and Human health HAS BEEN also PROPOSED (83,84).']	[('FUTURE_WORK', 27), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 126), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 228)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human')]
PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
PMC5418719	5/2017	S19-PMC5418719	['the AIM of THIS STUDY was TO DETERMINE WHETHER daily Vitamin D supplementation with a high dose of 800\xa0iu is SAFE and EFFECTIVE to increase the proportion of vlbw infants with 25(Oh)D\u2009>\u200930\xa0ng/ml, from 2\xa0weeks of age until hospital discharge.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('IMPORTANT_CONSIDERATION', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 176, '25(OH)D')]
PMC5418719	5/2017	S89-PMC5418719	['discussion\nTHIS PROSPECTIVE STUDY was PLANNED TO DETERMINE WHETHER 800\xa0iu Vitamin D supplementation from 2\xa0weeks of age is SAFE and EFFECTIVE to reach sufficient Vitamin D levels at 36\xa0weeks pma in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5418719	5/2017	S103-PMC5418719	['CONSISTENT with PREVIOUS reports about a dose-response EFFECT of Vitamin D supplementation [2,23], we OBSERVED that early supplementation with 800\xa0iu Vitamin D safely achieved an 88% PROBABILITY of Vitamin D sufficiency at 36 pma in the MAJORITY of infants with Cord-Blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 183), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 262, 'cord'), ('UBERON_0000178', 'blood', 267, 'blood'), ('CHEBI_71657', 'versiconol acetate', 283, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 283, '25(OH ... D')]
PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5426325	4/2017	S27-PMC5426325	['we DID NOT identify OTHER abrupt societal changes during 1983–1988 that POTENTIALLY COULD INFLUENCE our results, neither in relation to fortification practices in other Food products for Consumption(31,32), nor in relation to Margarine intake in the danish population(33)or in relation to national RECOMMENDATIONS for Vitamin D supplementation to Pregnant women or infants.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('FUTURE_WORK', 298)]	6	[('CHEBI_33290', 'food', 169, 'food'), ('GO_0007631', 'feeding behavior', 187, 'consumption'), ('CHEBI_6784', 'mestranol', 226, 'margarine'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 347, 'pregnant')]
PMC5426325	4/2017	S121-PMC5426325	['nonetheless, the decreasing TREND MAY have been AFFECTED by INFLUENCES more powerful than the LIKELY IMPACT of Vitamin D in the modest amounts of 1·25 µg vitamin d/100 g Margarine(31).']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 101)]	6	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_6784', 'mestranol', 170, 'margarine')]
PMC5474873	6/2017	S27-PMC5474873	['mcgrath and colleagues REPORTED that “both low and high concentrations of neonatal Vitamin D were ASSOCIATED with INCREASED RISK of schizophrenia.” SIMILARLY, absence of supplementation with Vitamin d before the age of one was FOUND TO BE ASSOCIATED with later schizophrenia in males (19).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 148), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC5474873	6/2017	S29-PMC5474873	['WHILE there are MANY STUDIES reporting the ASSOCIATION between Vitamin D levels in the Blood samples (18,19), there is STILL a LACK OF STUDIES on sun exposure, the main source of Vitamin D in most countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 127)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC5489519	6/2017	S115-PMC5489519	['THUS, our results SUGGEST that the Vitamin D modulation of Trail expression in Mammary Epithelial Cells MAY CONTRIBUTE to Trail protein levels in Human Milk, which MAY have IMPLICATIONS for both mother and infant health under Vitamin D deficient and sufficient conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 59, 'TRAIL'), ('CL_0002327', 'mammary gland epithelial cell', 79, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 79, 'mammary epithelial'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 122, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0001913', 'milk', 152, 'milk'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5510234	7/2017	S79-PMC5510234	['HOWEVER, another DID NOT FIND a benefit for Vitamin A in decreasing mtct rates.59\nlow maternal Vitamin D level (<32 ng/ml) HAS BEEN SHOWN to be ASSOCIATED with a 50% higher risk of mtct of hiv at 6 weeks in tanzanian women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S91-PMC5513133	['given the ROLE of Vitamin D in Modulation of inflammation and Immune function, Placental Implantation, Angiogenesis and adverse Birth outcomes such as low Birth weight and sga, we EXAMINED the EVIDENCE that Vitamin D MAY play a ROLE in the etiology and PREVENTION of pe in this manuscript.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 217), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0065007', 'biological regulation', 31, 'modulation'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 79, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('GO_0007566', 'embryo implantation', 89, 'implantation'), ('GO_0001525', 'angiogenesis', 103, 'angiogenesis'), ('GO_0007567', 'parturition', 128, 'birth'), ('GO_0007567', 'parturition', 155, 'birth'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5513133	7/2017	S116-PMC5513133	['EVIDENCE to SUPPORT the ROLE of Vitamin D in pe\nSEVERAL cohort and case control studies measuring Vitamin D before the development of pe SHOW an ASSOCIATION between Vitamin D and pe (tables2and3).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 145)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC5513133	7/2017	S199-PMC5513133	['discussion\nOBSERVATIONAL studies evaluating the ASSOCIATION between Vitamin D and pe HAVE SHOWN INCONSISTENT results and MUST BE interpreted CAUTIOUSLY.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 141)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S210-PMC5513133	['smoking MAY BE an IMPORTANT CONFOUNDER and SHOULD BE CONSIDERED in studies LINKING Vitamin D to pe.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 18), ('PROBLEM_COMPLICATION', 28), ('FUTURE_WORK', 43), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5513133	7/2017	S269-PMC5513133	['FUTURE STUDIES SHOULD include follow up from the pre-Conception period until Delivery to ELUCIDATE the mechanisms and INTERACTIONS which DRIVE Vitamin D status, response, and onset of pe to inform population-specific dose RECOMMENDATIONS.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('FUTURE_WORK', 89), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 137), ('FUTURE_WORK', 222)]	6	[('GO_0007620', 'copulation', 53, 'conception'), ('GO_0007567', 'parturition', 77, 'delivery'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5524288	7/2017	S0-PMC5524288	['maternal 25(Oh)D concentrations ≥40 ng/ml ASSOCIATED with 60% lower Preterm Birth RISK among general obstetrical patients at an urban medical center\n\nabstract\n\nbackground\nGIVEN the HIGH RATE of Preterm Birth (ptb) nationwide and data from rcts DEMONSTRATING risk reduction with Vitamin D supplementation, the medical university of south carolina (musc) implemented a NEW standard of care for Pregnant women to receive Vitamin D testing and supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 181), ('INCOMPLETE_EVIDENCE', 244), ('FULL_UNKNOWN', 367)]	6	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 68, 'preterm birth'), ('GO_0007565', 'female pregnancy', 194, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('GO_0007565', 'female pregnancy', 392, 'pregnant'), ('CHEBI_27300', 'vitamin D', 418, 'vitamin D')]
PMC5537904	7/2017	S180-PMC5537904	['we used season of Birth as a crude measurement of sun exposure because we DID NOT have direct measures of uvb-synthesized Vitamin D, and THUS our results for the relative CONTRIBUTION of Oral Intake versus sun exposure SHOULD BE INTERPRETED with CAUTION.']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 171), ('FUTURE_WORK', 219), ('FULL_UNKNOWN', 229), ('INCOMPLETE_EVIDENCE', 246)]	6	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('UBERON_0000165', 'mouth', 187, 'oral'), ('GO_0007631', 'feeding behavior', 192, 'intake')]
PMC5539754	8/2017	S0-PMC5539754	['season and Vitamin D status are INDEPENDENTLY ASSOCIATED with Glucose Homeostasis in Pregnancy\n\nabstract\n\nbackground\nVitamin D status and season are intrinsically LINKED, and both have been PROPOSED to be ASSOCIATED with Glucose Homeostasis in Pregnancy, with CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_17234', 'glucose', 62, 'glucose'), ('GO_0042593', 'glucose homeostasis', 62, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 117, 'Vitamin D'), ('CHEBI_17234', 'glucose', 221, 'glucose'), ('GO_0042593', 'glucose homeostasis', 221, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy')]
PMC5539754	8/2017	S17-PMC5539754	['in Pregnancy, the ASSOCIATION between low Vitamin D levels and abnormalities in Glucose tolerance is the subject of scientific DEBATE, with SOME STUDIES reporting that maternal Insulin sensitivity, fasting Glucose and Gestational diabetes are not associated with 25ohd [7], WHILE others have FOUND inverse ASSOCIATIONS between 25ohd, fasting Glucose [8] and risk of Gestational diabetes [9].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 274), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 306)]	6	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17234', 'glucose', 80, 'glucose'), ('PR_000045358', 'insulin family protein', 177, 'insulin'), ('CHEBI_17234', 'glucose', 206, 'glucose'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('CHEBI_17234', 'glucose', 342, 'glucose'), ('GO_0007565', 'female pregnancy', 366, 'gestational')]
PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]
PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
PMC5546866	8/2017	S118-PMC5546866	['discussion\nTHIS STUDY ASSESSED the RELATIONSHIPS between common Genetic variants and the response to Vitamin D supplementation in Pregnancy; rs12785878 in dhcr7 was ASSOCIATED with 25(Oh)D status in early Pregnancy prior to Vitamin D supplementation, WHEREAS rs10741657 in Cyp2R1 and rs2282679 in gc were ASSOCIATED with both the achieved and change in 25(Oh)D concentration following supplementation with 1000 iu/d Cholecalciferol.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251), ('SUPERFICIAL_RELATIONSHIP', 305)]	6	[('SO_0000704', 'gene', 64, 'genetic'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 181, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 187, 'D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 273, 'CYP2R1'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 356, 'OH)D'), ('CHEBI_52550', 'theopalauamide', 416, 'cholecalciferol')]
PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
PMC5579643	8/2017	S65-PMC5579643	['a systematic review of Vitamin D supplementation for the PREVENTION of allergic diseases FOUND NO EVIDENCES about the PROTECTIVE ROLE of this Nutrient in children, but the CURRENTLY available data are poor [24].']	[('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 172)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_33284', 'nutrient', 142, 'nutrient')]
PMC5623264	9/2017	S73-PMC5623264	['twenty-two studies ASSESSED the EFFECT of the INTERVENTIONS on ptb.24–43 45 46all systematic reviews included individually\xa0rcts,24–469 cluster-rcts24 30–32 35 36 38 42 45and 10\xa0both rcts and quasi-rcts.24 26 29–32 43–46the number of included trials per review ranged from 241to 61 trials.30the number of included participants in the reviews ranged from 603 participants41to over 310\u2009000 participants.24supplementation with Vitamins was reported in five reviews,24–26 45 46supplementation with Minerals in eight reviews27–34and mmn supplementation was assessed in three reviews.35–37there was one review on protein supplementation and nutritional education38and two reviews REPORTED on marine oil and Fatty Acid supplementation.39 40one review evaluated reduced Salt intake,41one deworming42and two reviews preventive Antimalarial drugs.43 44\n\nmethodological quality of the included reviews\nsixteen reviews were of high quality.24–26 28–33 36 38 39 42 43 45 46six reviews were assessed to be of moderate quality.27 34 37 40 41 44only one included review had a score of three and, therefore, was judged to be of low methodological quality (table 1).35\n\neffects of interventions\n\noral supplementation with Vitamins alone or in combination\nfive systematic reviews INVESTIGATED the EFFECT of oral supplementation with Vitamin A,24vitamin C45Or Vitamin E during Pregnancy46And oral Folic Acid supplementation25 26during the Periconceptional period and Pregnancy (see\xa0onlinesupplementary table 6).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 673), ('QUESTION_ANSWERED_BY_THIS_WORK', 1260), ('SUPERFICIAL_RELATIONSHIP', 1277)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 423, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 493, 'minerals'), ('CHEBI_35366', 'fatty acid', 700, 'fatty acid'), ('CHEBI_24866', 'salt', 761, 'salt'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 817, 'antimalarial'), ('CHEBI_33277', 'gamma-tocotrienol', 1203, 'vitamins'), ('CHEBI_27300', 'vitamin D', 1313, 'vitamin A'), ('CHEBI_528968', '1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine', 1333, 'C45or'), ('PR_000001309', 'CD70 molecule', 1333, 'C45or'), ('CHEBI_27300', 'vitamin D', 1339, 'vitamin E'), ('GO_0006412', 'translation', 1356, 'pregnancy46and'), ('CHEBI_30751', 'formic acid', 1376, 'folic acid'), ('UBERON_0001844', 'cochlea', 1418, 'periconceptional'), ('GO_0007565', 'female pregnancy', 1446, 'pregnancy')]
PMC5634437	10/2017	S228-PMC5634437	['THEREFORE, the harmful EFFECTS we OBSERVED for Haloperidol COULD BE due to the elevated 7-Dehydrocholesterol levels and not a reduction in Vitamin D. further mechanism-based STUDIES ARE REQUIRED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 174), ('FUTURE_WORK', 182)]	6	[('CHEBI_5613', 'haloperidol', 47, 'haloperidol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 88, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5638722	8/2017	S88-PMC5638722	['discussion\nthe AIM of OUR STUDY was TO BETTER EVALUATE the EFFECT of Cord-Blood Vitamin D levels on sepsis, by excluding the babies with known RISK factors for infection and who underwent resuscitation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 143)]	6	[('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5638722	8/2017	S91-PMC5638722	['this FINDING has led to the common HYPOTHESIS that Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections, and low levels of circulating Vitamin D have BEEN SHOWN to be strongly ASSOCIATED with infectious diseases816).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5638722	8/2017	S105-PMC5638722	['BUT we PROPOSE that, MORE prospective STUDIES regarding to the RELATIONSHIP of Vitamin D and sepsis in premature infants ARE NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 21), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 63), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5638722	8/2017	S114-PMC5638722	['DUE TO the absence of Serum Vitamin D levels of the mothers who have premature Deliveries, the results obtained give ONLY INDIRECT DATA about maternal morbidities and Vitamin D. epidemiologic STUDIES ARE NEEDED for investigating the POSSIBLE maternal EFFECTS of low Vitamin D levels during Pregnancy.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 122), ('FUTURE_WORK', 192), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'deliveries'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC5659607	10/2017	S135-PMC5659607	['to explore that ISSUE, we performed the combined analyses stratified for the women’s 25(Oh)D level at trial entry, which SHOWED that the Vitamin D supplement resulted in a significantly reduced RISK of asthma/recurrent wheeze in the offspring of women with 25(Oh)D ≥ 30 ng/ml, BUT a much SMALLER and statistically non-significant EFFECT among women with 25(Oh)D < 30 ng/ml.']	[('PROBLEM_COMPLICATION', 16), ('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('INCOMPLETE_EVIDENCE', 288), ('SUPERFICIAL_RELATIONSHIP', 330)]	6	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 257, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 257, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5706533	11/2017	S107-PMC5706533	['biochemical safety outcomes (hypercalcaemia, hypercalciuria, hypocalcaemia) were RARE; ONLY four trials met our minimum criteria for case definitions and methods of ascertainment based on routine monitoring of maternal Serum calcium (table 2; tables s9-s11in appendix 10), YET ignoring the these criteria did not change the inference that there was no significant EFFECT of Vitamin D supplementation on the RISK of hypercalcaemia, which is a primary INDICATOR of toxicity of Vitamin D supplementation (table s9 and fig s18 in Appendix 10).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 273), ('SUPERFICIAL_RELATIONSHIP', 364), ('IMPORTANT_CONSIDERATION', 407), ('SUPERFICIAL_RELATIONSHIP', 450)]	6	[('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 526, 'appendix')]
PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC5707701	11/2017	S164-PMC5707701	['ACCORDING TO the recommendations of the institute of medicine (iom) [62], we ESTIMATED the supply of Vitamin E for infants in the PRESENT STUDY using the average quantity of milk consumed by infants aged 0–6 m (780 ml), and FOUND that the POSSIBLE EFFECT of these milks offered to the infants was 5.0, 3.0, 1.9, 1.6, 1.7, 1.6 mg/day of Vitamin E, respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 248)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin E')]
PMC5732505	12/2017	S178-PMC5732505	['HOWEVER, randomised controlled TRIALS ARE REQUIRED in specific RISK groups of Vitamin D deficiency TO CLARIFY if Vitamin D supplementation AFFECTS the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 151)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
PMC5758521	1/2018	S140-PMC5758521	['MOST STUDIES on Vitamins A and E in Pregnancy HAVE BEEN focused on the ASSOCIATION with fetal growth, and the FINDINGS HAVE BEEN INCONSISTENT33–35.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 25, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 31, 'E'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy')]
PMC5758521	1/2018	S144-PMC5758521	['REPORTED that maternal Α-Tocopherol concentrations were positively ASSOCIATED with Birth weight, BUT poston and colleagues FOUND that Prenatal supplementation with Α-Tocopherol and Vitamin C was ASSOCIATED with elevated risk of low Birth weight8.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 195)]	6	[('CHEBI_27725', 'butin', 23, 'α-tocopherol'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27725', 'butin', 164, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin C'), ('GO_0007567', 'parturition', 232, 'birth')]
PMC5758521	1/2018	S155-PMC5758521	['it SHOULD be NOTED that the normal reference values for Vitamins A and E in Cord Blood are NOT AVAILABLE, and our OBSERVED ASSOCIATIONS were MOSTLY moderate.']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 141)]	6	[('CHEBI_27300', 'vitamin D', 56, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 56, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 71, 'E'), ('UBERON_0009472', 'axilla', 76, 'cord blood')]
PMC5784894	1/2018	S189-PMC5784894	['identification of specific pathways is being pursued with a VIEW to BETTER UNDERSTANDING the CONTRIBUTION of early Life Vitamin D to bone health in later Life and to identify new pathways that COULD IMPACT on osteoporosis PREVENTION and treatment.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 222)]	6	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0000104', 'life cycle', 154, 'life')]
PMC5827025	2/2018	S0-PMC5827025	['INFLUENT FACTORS of Gestational Vitamin D deficiency and its RELATION to an INCREASED RISK of Preterm Delivery in chinese population\n\nabstract\nGestational Vitamin D deficiency (vdd) HAS BEEN LINKED with adverse Pregnant outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 76), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 191)]	6	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'preterm'), ('GO_0007567', 'parturition', 102, 'delivery'), ('GO_0007565', 'female pregnancy', 143, 'Gestational'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 211, 'pregnant')]
PMC5841533	2/2018	S19-PMC5841533	['supplementation with single Micronutrients during Pregnancy APPEARS TO have little influence on children’s Cognitive outcomes: 10 trials conducted in high-income, middle-income and low-income settings FOUND no effects of Antenatal iron, zinc, Vitamin A or Choline supplementation on Cognitive functions.13–20supplementation with mmn, on the OTHER HAND, COULD AFFECT children’s Cognitive functions via three RELATED pathways.']	[('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 201), ('ANOMALY_CURIOUS_FINDING', 341), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 359), ('SUPERFICIAL_RELATIONSHIP', 407)]	6	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0050890', 'cognition', 107, 'cognitive'), ('GO_0007567', 'parturition', 221, 'antenatal'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin A'), ('CHEBI_15354', 'choline', 256, 'choline'), ('GO_0050890', 'cognition', 283, 'cognitive'), ('GO_0050890', 'cognition', 377, 'cognitive')]
PMC5941617	5/2018	S3-PMC5941617	['THUS, Vitamin D deficiency MAY AFFECT NOT ONLY Musculoskeletal health BUT ALSO a POTENTIALLY WIDE range of acute and chronic conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 38), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	6	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 47, 'musculoskeletal')]
PMC5941617	5/2018	S103-PMC5941617	['in 2016 the united kingdom scientific advisory committee on nutrition (sacn) reviewed THE EVIDENCE on Vitamin D and health and RECOMMENDED that Serum 25(Oh)D levels of all children and adolescents in the united kingdom SHOULD NOT fall below 10\xa0ng/ml (a so-CALLED “population PROTECTIVE level”) at any time of the year to protect Musculoskeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 90), ('FUTURE_WORK', 127), ('FUTURE_WORK', 219), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 275)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('UBERON_0002204', 'musculoskeletal system', 329, 'musculoskeletal')]
PMC5941617	5/2018	S117-PMC5941617	['ON THE CONTRARY, Vitamin D supplementation at higher dosages SEEMED TO BE ASSOCIATED with increased RISK of hypervitaminosis D with hypercalciuria and hypercalcemia [62].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 7), ('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 125, 'D')]
PMC5941617	5/2018	S257-PMC5941617	['results of these studies are HETEROGENEOUS, because SOME DEMONSTRATED that Vitamin D status was significantly RELATED to bone mass [41,42,54,206–208] WHILE others DID NOT FIND any association [44,209–211].']	[('DIFFICULT_TASK', 29), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]
PMC5941617	5/2018	S472-PMC5941617	['AS Vitamin D is an IMPORTANT KEY DETERMINANT of bone mass acquisition, SOME authors RECOMMENDED Vitamin D supplementation during winter and spring in all cd children and adolescents to optimize bone recovery [432].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 71), ('FUTURE_WORK', 84)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S613-PMC5941617	['MORE STUDIES, particularly rcts, ARE NEEDED to confirm the PROMISING ROLE of Vitamin D in the promotion of the GLOBAL health of children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5952272	5/2018	S107-PMC5952272	['anaemia and intellectual abilities\niron, Folate, Vitamin B12, Vitamin A, zinc, and other Micronutrient deficiencies CAN CONTRIBUTE to anaemia.5iron-deficiency anaemia is a MAJOR PUBLIC HEALTH nutritional PROBLEM AFFECTING People of all ages.']	[('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_30863', '5-azaorotic acid', 41, 'folate'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 89, 'micronutrient'), ('NCBITaxon_10088', 'Mus <genus>', 222, 'people')]
PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
PMC5952272	5/2018	S151-PMC5952272	['on the community level, it was NOTICED that diet plays a MAJOR ROLE in the manifestation of anaemia and Vitamin E and D deficiency; HOWEVER, OTHER factors MAY interfere to make such a deficiency multifactorial.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 118, 'D')]
PMC5956785	5/2018	S14-PMC5956785	['Vitamin D status is POTENTIALLY GOVERNED by these same FACTORS; Vitamin D receptor genotype, ethnically RELATED skin tone and clothing, environmental variations in exposure to ultraviolet b radiation RELATING to the latitude of residence and season, and Vitamin D nutritional intake are FACTORS that Modulate Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 287)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0065007', 'biological regulation', 300, 'modulate'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
PMC5956785	5/2018	S250-PMC5956785	['certain vdr Gene polymorphisms MAY BE ASSOCIATED with different biologic response to Vitamin D. the cdx2 polymorphism of the Vdr Gene specifically the gg genotype, HAVE BEEN SUGGESTED to be more represented in patients with jia COMPARED TO healthy controls who more OFTEN have the ga genotype [82].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('PROBABLE_UNDERSTANDING', 266)]	6	[('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 125, 'VDR'), ('SO_0000704', 'gene', 129, 'gene')]
PMC5956785	5/2018	S251-PMC5956785	['RECENTLY THE IDEA of investigating epistasis (Gene-Gene interactions) amongst Genes in the inflammatory and Vitamin D pathway and HOW their INTERACTIONS CONTRIBUTE to jia risk was explored by ellis et al.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 130), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('SO_0000704', 'gene', 46, 'gene'), ('SO_0000704', 'gene', 51, 'gene'), ('SO_0000704', 'gene', 78, 'genes'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC6011374	6/2018	S10-PMC6011374	['a POSSIBLE ASSOCIATION between fetal sex, Vitamin D status and gdm provides FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 76), ('EXPLICIT_QUESTION', 84), ('FUTURE_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC6011374	6/2018	S122-PMC6011374	['a POSSIBLE CONNECTION between fetal sex, Vitamin D status and Pregnancy complications REVEALS FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 86), ('FUTURE_WORK', 94), ('FUTURE_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC6043562	7/2018	S106-PMC6043562	['IN KEEPING WITH our HYPOTHESIS, we OBSERVED that higher Prenatal intakes of N-3 polyunsaturated Fatty Acids (a POTENTIAL immunomodulatory agent), Vitamin D (an antioxidant and Immunomodulatory Agent) and Folate were ASSOCIATED with lower levels of allergic disease BIOMARKERS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 265)]	6	[('GO_0007565', 'female pregnancy', 56, 'prenatal'), ('CHEBI_30256', 'thiocarbonyl group', 76, 'n-3'), ('CHEBI_35366', 'fatty acid', 96, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_35476', 'antipsychotic agent', 176, 'immunomodulatory agent'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC6043562	7/2018	S107-PMC6043562	['IN CONTRAST with OTHER Nutrients, total Vitamin E intake in Pregnancy APPEARED TO amplify the adverse EFFECT of Prenatal exposure to Pm2.5on Feno measured in adolescence, SUGGESTING a synergy between these two exposures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 171)]	6	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 133, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
PMC1448690	4/2006	S301-PMC1448690	['in an investigation of WHETHER reduction in childhood infections OR change in diet COULD explain increases in asthma and atopic disease, seaton and devereux [178] FOUND that low intake of Vitamin C was ASSOCIATED with a sevenfold increase in the risk of bronchial hyper-reactivity; by CONTRAST, those with the lowest intake of saturated fats had a tenfold lower risk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 202), ('ANOMALY_CURIOUS_FINDING', 285)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin C')]
PMC2290997	4/2008	S26-PMC2290997	['more RECENTLY, there HAS BEEN a GROWING APPRECIATION for Vitamin D’s IMPACT on bone health in Adults.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adults')]
PMC2290997	4/2008	S71-PMC2290997	['other health LINKS\nVARIOUS STUDIES have LINKED low 25(Oh)D levels to diseases other than cancer, raising the POSSIBILITY that Vitamin D insufficiency is CONTRIBUTING to many major illnesses.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 153)]	5	[('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 57, 'D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2290997	4/2008	S138-PMC2290997	['“current OBSERVATIONS of widespread Vitamin D insufficiency SHOULD NOT BE ATTRIBUTED ONLY to sun protection STRATEGIES,” says lucas.']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 85), ('FUTURE_WORK', 108)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC2396486	6/2008	S133-PMC2396486	['combined with OTHER experimental findings, THE CURRENT STUDY LENDS FURTHER CREDIBILITY to the NOTION that developmental Vitamin D deficiency IMPACTS adversely on normal Brain Development[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007420', 'brain development', 169, 'brain development'), ('UBERON_0000955', 'brain', 169, 'brain')]
PMC2582131	11/2008	S12-PMC2582131	['conclusions\nFINDINGS from the PRESENT STUDY SUGGEST that maternal Vitamin D deficiency in early Pregnancy is significantly ASSOCIATED with an elevated RISK for gdm.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 151)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC2679409	5/2009	S497-PMC2679409	['conclusion\nthe existence of a cochrane review on the subject and several strong rcts allow us to rate the level of evidence as grade c [96], BUT the AVAILABLE EVIDENCE SUGGESTS no ROLE of Vitamin A in PREVENTING stillbirths.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 180), ('SUPERFICIAL_RELATIONSHIP', 201)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin A')]
PMC2779500	11/2009	S327-PMC2779500	['this outcome is ANECDOTAL and highly DEPENDENT upon the amount of Vitamin C absorbed; HOWEVER, it ILLUSTRATES the POTENTIAL sensitivity of clinical results to the details of measurement timing.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin C')]
PMC2798111	12/2010	S16-PMC2798111	["Human Milk's total Vitamin D or its antirachitic activity obtained from mothers receiving 400\u2009iu/day TYPICALLY contains 33–68\u2009iu/l, far below the ESTIMATED daily infant REQUIREMENT of 400\u2009iu/l [3–5], the NECESSARY level for the PREVENTION of rickets [1]."]	[('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 228)]	5	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2798111	12/2010	S97-PMC2798111	['infant Vitamin D levels in exclusively breastfed infants REFLECT maternal Vitamin D status, and GIVEN that the majority of the mothers in this cohort present with circulating 25(Oh)D levels <30\u2009ng/ml, it is NOT SURPRISING that the infants who are almost solely DEPENDENT on the mother for their Vitamin D have corresponding deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('PROBABLE_UNDERSTANDING', 96), ('PROBABLE_UNDERSTANDING', 207), ('ANOMALY_CURIOUS_FINDING', 211), ('SUPERFICIAL_RELATIONSHIP', 261)]	5	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 178, 'OH)D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC2821652	2/2010	S19-PMC2821652	['at the time of Birth, Cord Blood AS a direct reflection of fetal Vitamin D status will contain APPROXIMATELY 50–60% of the maternal circulating levels of 25(Oh)D. this RELATIONSHIP APPEARS TO BE linear EVEN at Pharmacological intakes of Vitamin D [12].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 181), ('ANOMALY_CURIOUS_FINDING', 202)]	5	[('GO_0007567', 'parturition', 15, 'birth'), ('UBERON_0009472', 'axilla', 22, 'cord blood'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_52217', 'pharmaceutical', 210, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC2821652	2/2010	S20-PMC2821652	['with respect to the more Polar Metabolites of Vitamin D, a SIMILAR (BUT lesser) RELATIONSHIP is OBSERVED between mother and fetus [11].']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 96)]	5	[('CHEBI_37173', 'silanol', 25, 'polar'), ('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2821652	2/2010	S21-PMC2821652	['INTERESTINGLY, there APPEARS TO BE LITTLE, if ANY, RELATIONSHIP with respect to the parent Vitamin, Vitamin D [11].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 51)]	5	[('CHEBI_33229', 'vitamin (role)', 91, 'vitamin'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2821652	2/2010	S23-PMC2821652	['THUS, in the Human fetus, Vitamin D Metabolism in all LIKELIHOOD begins with 25(Oh)D. as a result, the nutritional Vitamin D status of the Human fetus/neonate is totally DEPENDENT on the Vitamin D stores of the mother [11]; THUS, IF the mother is hypovitaminotic D, her fetus will experience depleted Vitamin D exposure throughout Gestation [14].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 170), ('PROBABLE_UNDERSTANDING', 224), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230)]	5	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 26, 'vitamin D metabolism'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 331, 'gestation')]
PMC2872349	4/2010	S42-PMC2872349	['the RELATIONSHIPS REMAINED after adjustment for KNOWN Genetic markers of osteoporosis risk, such as polymorphisms in the Gene for the Vitamin D Receptor (vdr), and after adjustment for lifestyle characteristics in Adulthood that MIGHT have INFLUENCED bone mass (physical activity, dietary calcium intake, cigarette smoking, and alcohol consumption).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 229), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('SO_0000704', 'gene', 54, 'genetic'), ('SO_0000704', 'gene', 121, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0000113', 'post-juvenile adult stage', 214, 'adulthood')]
PMC2874518	6/2010	S114-PMC2874518	['ANOTHER STUDY FOUND that use of supplements for Vitamins C and E was ASSOCIATED with an INCREASED RISK of premature rupture of membranes.24unfortunately, this information was NOT RECORDED in our study.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 88), ('FULL_UNKNOWN', 175)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins C'), ('PR_000004900', 'complement C3', 57, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E')]
PMC2874518	6/2010	S117-PMC2874518	['a RECENT-meta-analysis of seven studies CONCLUDED that combined Vitamin C and e supplementation had no potential benefit in the improvement of maternal and neonatal outcome and increased the risk of Gestational Hypertension in women at risk of pre-eclampsia.26\nit is WELL ESTABLISHED that there are significant INTERACTIONS between Micronutrients and their Metabolism.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 267), ('PROBABLE_UNDERSTANDING', 267), ('SUPERFICIAL_RELATIONSHIP', 311)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin C'), ('GO_0007549', 'dosage compensation', 199, 'gestational hypertension'), ('CHEBI_33839', 'macromolecule', 332, 'micronutrients'), ('GO_0008152', 'metabolic process', 357, 'metabolism')]
PMC2889879	5/2010	S128-PMC2889879	['we FOUND SUPPORT for a PROTECTIVE EFFECT regarding the risk of positive psychotic-like symptoms with high dietary Intake of fish, Omega-3 and omega-6 Pufa, as well as of Vitamin D. the ASSOCIATIONS were j-shaped with the strongest reduced risk for an intermediate intake of Fish or Pufa.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 185)]	5	[('GO_0007631', 'feeding behavior', 114, 'intake'), ('CHEBI_30823', 'oleate', 130, 'omega'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 150, 'PUFA'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 274, 'fish'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 282, 'PUFA')]
PMC2913107	8/2010	S6-PMC2913107	['even more INTERESTING, SOME of the patients SEEMED to IMPROVE when treated with an average dose of ABOUT 4000 iu of Vitamin D/day.']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 99)]	5	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2913107	8/2010	S9-PMC2913107	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING the current EPIDEMIC of Gestational Vitamin D deficiency (8).']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 127, 'gestational'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC2913107	8/2010	S11-PMC2913107	['IF adequate amounts of Vitamin D PREVENT autism, one WOULD EXPECT children with rickets to have an INCREASED RISK of autism.']	[('FUTURE_PREDICTION', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('FUTURE_PREDICTION', 53), ('FUTURE_PREDICTION', 59), ('IMPORTANT_CONSIDERATION', 99)]	5	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC2913107	8/2010	S41-PMC2913107	['a comment to the authors (20) DETAILED the EVIDENCE that Antiepileptic Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism, lowering 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('CHEBI_35218', 'anthocyanin cation', 57, 'antiepileptic'), ('CHEBI_23888', 'drug', 71, 'drugs'), ('CHEBI_23888', 'drug', 107, 'drugs'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0008152', 'metabolic process', 174, 'metabolism'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2913107	8/2010	S42-PMC2913107	['i AGREE WITH dr eyles’ comment that the Vitamin D THEORY is ‘HIGHLY PARSIMONIOUS.’ indeed, it was love of parsimony that led me to first HYPOTHESIZE that Vitamin D is intimately INVOLVED in the pathology and epidemiology of both autism and influenza (21).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2913107	8/2010	S44-PMC2913107	['OBVIOUSLY, ANOTHER, and more PARSIMONIOUS EXPLANATION, is that Vitamin D is INVOLVED in all three.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC2963768	10/2010	S108-PMC2963768	['young infants DEPEND ALMOST ENTIRELY on the transplacental transfer of Vitamin D and 25(Oh)D, which EXPLAINS the CONSISTENT ASSOCIATION between maternal and Cord-blood 25(Oh)D (25) and the observation that maternal Antenatal Vitamin D supplementation augments both maternal and Cord-Blood 25(Oh)D (26).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 21), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 168, '25(OH ... D'), ('GO_0007567', 'parturition', 215, 'antenatal'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 278, 'cord'), ('UBERON_0000178', 'blood', 283, 'blood'), ('CHEBI_71657', 'versiconol acetate', 289, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 289, '25 ... OH ... D')]
PMC2963768	10/2010	S111-PMC2963768	['RECENTLY STUDIED female workers in a garment factory in dhaka and SPECULATED that their long day-time hours in indoors, brief exposure to low-intensity sunlight in the early morning, outdoor air pollution, and widespread sunscreen use, in combination with darkly-Pigmented skin, MAY CONTRIBUTE to their POOR Vitamin D status (mean 25(Oh)D of 37 nmol/l, and 15% of the participants had 25(Oh)D <25 nmol/l) (28).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 283), ('IMPORTANT_CONSIDERATION', 303)]	5	[('CHEBI_26130', 'biological pigment', 263, 'pigmented'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 331, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 385, '25(OH)D')]
PMC2963768	10/2010	S113-PMC2963768	['inferences regarding the DETERMINANTS of infant/toddlers’ Vitamin D status in THIS STUDY were LIMITED, largely BECAUSE of the SMALL sample-size and substantial uniformity with respect to selected maternal clothing and dietary practices.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 94), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 126)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]
PMC2996405	11/2010	S212-PMC2996405	['as STATED, latitude acts directly OR indirectly, on a WIDE VARIETY of phenomena, THEREFORE it is expected that its EFFECTS are not limited just to Vitamin D and Neural Development.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007399', 'nervous system development', 161, 'neural development')]
PMC2996405	11/2010	S213-PMC2996405	['for similar REASONS, we expected that also the LINK between latitude and schizophrenia cannot be completely EXPLAINED by Vitamin D. for example, in the intersection between lrgs and Genes RELATED with schizophrenia (additional file3) there is a Gene INVOLVED in the Circadian Rhythms, timeless .']	[('PROBABLE_UNDERSTANDING', 12), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('SO_0000704', 'gene', 182, 'genes'), ('SO_0000704', 'gene', 245, 'gene'), ('GO_0007623', 'circadian rhythm', 266, 'circadian rhythms')]
PMC3004407	12/2010	S143-PMC3004407	['after accounting for the EFFECT of Gestational age through multivariable regression, 25(Oh)D status retained a significant negative ASSOCIATION with pth, CONFIRMING that EVEN during Pregnancy, pth is a PREDICTOR of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 132), ('PROBABLE_UNDERSTANDING', 154), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 87, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC3032617	5/2010	S117-PMC3032617	['ALTHOUGH we DID not achieve the expected 50% of patients not hospitalized in the Vitamin C group, the difference between the Vitamin C group and controls, 42% vs. 28% was FOUND significant, also is to note the higher amount of drop-outs in the Vitamin C group which MIGHT have INFLUENCED the results (13 vs. 3).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin C')]
PMC3034879	12/2010	S10-PMC3034879	['DESPITE DISCREPANT S-25-Ohd at baseline (median 36.3 vs. 52.5\xa0nmol/l, p \u2009<\u20090.001), the values at 14\xa0months were SIMILAR (63 vs. 66\xa0nmol/l, p \u2009=\u20090.58) in low d and high d. Serum 25-ohd increased more in low D ( p \u2009<\u20090.001) DESPITE SIMILAR total intake of Vitamin D (mean 12.3\xa0μg/day).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 222), ('SUPERFICIAL_RELATIONSHIP', 230)]	5	[('CHEBI_16786', 'vestitone', 19, 'S-'), ('1', 'A1BG (human)', 20, '-'), ('CHEBI_72765', 'verruculogen', 21, '25-OHD'), ('UBERON_0001977', 'blood serum', 171, 'Serum'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 206, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC3034879	12/2010	S28-PMC3034879	['BASED ON these results, it was CONCLUDED that maternal Vitamin D status AFFECTS bone Mineral accrual and INFLUENCES bone size during the Intrauterine Period [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_46662', 'mineral', 85, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 137, 'intrauterine period')]
PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC3034879	12/2010	S186-PMC3034879	['ON THE OTHER HAND, S-25-Ohd REFLECTS relatively short-term accumulation of dietary Vitamin D and solar exposure [41], WHEREAS observing DIFFERENCES in bone VARIABLES takes more time.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 19, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3061267	2/2011	S50-PMC3061267	['LATER trials within less Vitamin A deficient populations in bangladesh [23] and ghana [24] FAILED TO FIND any IMPACT.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC3075531	7/2010	S49-PMC3075531	['in norway, a study comprising 119 ms cases and 251 controls living above the arctic circle, where Fatty Fish is a MAJOR CONTRIBUTOR to Vitamin D intake, REPORTED a lower risk of ms for Individuals who Ate fish three or more times per week at 16–20 years of age compared with those with a lower Consumption (odds ratio=0.57 [95%ci 0.33-0.93]; p=0.024).19supplementation with codliver oil was also ASSOCIATED with lower risk of ms, BUT ONLY among Individuals with low summer outdoor activity.']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 396), ('ANOMALY_CURIOUS_FINDING', 430)]	5	[('CHEBI_38677', 'famphur', 98, 'fatty fish'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_1', 'root', 185, 'individuals'), ('GO_0009636', 'response to toxic substance', 201, 'ate'), ('GO_0007631', 'feeding behavior', 294, 'consumption'), ('NCBITaxon_1', 'root', 445, 'individuals')]
PMC3107676	4/2011	S37-PMC3107676	['PREVIOUS STUDIES have NOT REPORTED prevalence of Vitamin C supplementation among women who took Drugs classified as Nitrosatable or INDICATED the EFFECTS of Vitamin C intake on any ASSOCIATIONS between Nitrosatable Drug use and adverse Pregnancy outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 181)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin C'), ('CHEBI_23888', 'drug', 96, 'drugs'), ('CHEBI_7587', 'nitroalkane', 116, 'nitrosatable'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_75872', '(R)-sarin', 202, 'nitrosatable drug'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3235789	12/2011	S22-PMC3235789	['ONE us cohort STUDY has EXAMINED the ASSOCIATION between maternal Vitamin D status and bv in Pregnancy, FINDING a dose-response RELATIONSHIP between the mean unadjusted Serum 25-Oh-D concentration and the prevalence of Bv per gram stain of Vaginal smears obtained in early Pregnancy [29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_65350', 'lorcaserin hydrochloride', 177, '-OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 219, 'BV'), ('UBERON_0001987', 'placenta', 240, 'vaginal'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3257641	3/2010	S5-PMC3257641	['1. review\nthe high PREVALENCE of Vitamin D insufficiency during Pregnancy is increasingly RECOGNIZED, amid GROWING EVIDENCE that the Intrauterine environment CAN have both immediate and long-lasting EFFECTS on health of the offspring.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 199)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
PMC3257641	3/2010	S78-PMC3257641	['HOWEVER, it is NOT CLEAR that the Vitamin D REQUIREMENTS of these largely nocturnal Animals REFLECT Human NEEDS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 84, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 100, 'human')]
PMC3257641	3/2010	S121-PMC3257641	['low Vitamin D intake during Pregnancy HAS BEEN ASSOCIATED with an increased risk of asthma, eczema or hay fever [92,93], WHILE winter Birth was ASSOCIATED with higher Ige levels and lower Il-10 than summer Birth [57].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 167, 'IgE'), ('PR_000001470', 'interleukin-28B', 188, 'IL-10'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]
PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3271033	1/2012	S131-PMC3271033	['it HAS BEEN SUGGESTED BUT is NOT PROVEN that early Life calcium absorption is PRIMARILY non-Vitamin D DEPENDENT [2].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('UBERON_0000104', 'life cycle', 51, 'life'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3271033	1/2012	S132-PMC3271033	['HOWEVER, it is LIKELY that by three months of age, Vitamin D has a KEY ROLE in calcium absorption, especially in Breast-Fed infants with a relatively low Calcium Intake COMPARED TO formula-Fed infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'breast'), ('UBERON_0000310', 'breast', 113, 'breast'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 154, 'calcium'), ('GO_0007631', 'feeding behavior', 162, 'intake'), ('GO_0007631', 'feeding behavior', 189, 'fed')]
PMC3271033	1/2012	S148-PMC3271033	['the EFFECTS of maternal Vitamin D deficiency are COMPLEX and MAY EXTEND beyond bone health EFFECTS in infants.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('DIFFICULT_TASK', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3277098	12/2011	S4-PMC3277098	['THIS REVIEW explores the FINDINGS of epidemiological, clinical and laboratory research, and the POTENTIAL ROLE of Vitamin D in promoting the inappropriate Immune Responses which UNDERPIN the rise in a broad range of Immune diseases.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006955', 'immune response', 155, 'immune responses'), ('UBERON_0002405', 'immune system', 155, 'immune'), ('UBERON_0002405', 'immune system', 216, 'immune')]
PMC3277098	12/2011	S11-PMC3277098	['we AIM to review the CURRENT EVIDENCE on Vitamin D in RELATION to Immune mechanisms and FOCUS on the EFFECT of Pregnancy and Early Life exposure on Allergy Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002405', 'immune system', 66, 'immune'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001847', 'lobule of pinna', 125, 'early life'), ('GO_0060021', 'roof of mouth development', 148, 'allergy development')]
PMC3277098	12/2011	S31-PMC3277098	['this ASSOCIATION persists after adjusting for physical activity and dietary intake SUGGESTING obesity is an INDEPENDENT risk factor for reduced Serum 25(Oh)D and SUPPORTS the notion that Vitamin D deficiency MAY follow from modern lifestyle change.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 208)]	5	[('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 150, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3277098	12/2011	S204-PMC3277098	['there is MUCH EVIDENCE to SHOW Vitamin D AFFECTS Differentiation and Proliferation Of Immune Cells [2,24,25] and that Genetic polymorphisms, including of vdr and Vdbp , MAY CONTRIBUTE to disease susceptibility [42,78,79,80,81].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 49, 'differentiation ...'), ('GO_0008283', 'cell proliferation', 69, 'proliferation of ... cells'), ('CL_0000738', 'leukocyte', 86, 'immune cells'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('SO_0000704', 'gene', 118, 'genetic'), ('PR_000017279', 'testis-specific basic protein Y 1', 162, 'VDBP')]
PMC3296991	2/2012	S0-PMC3296991	['EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, Cord Parathyroid Hormone and bone-specific alkaline phosphatase, and newborn Whole body bone Mineral content\n\nabstract\nin SPITE of a high prevalence of Vitamin D inadequacy in Pregnant women and neonates, RELATIONSHIPS among Vitamin D status (25(Oh)D), Parathyroid hormone (pth), bone specific alkaline phosphatase (balp), and Whole body bone Mineral content (wbbmc) in the newborn are POORLY characterized.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('ANOMALY_CURIOUS_FINDING', 187), ('SUPERFICIAL_RELATIONSHIP', 270), ('PROBLEM_COMPLICATION', 451)]	5	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('UBERON_0000948', 'heart', 65, 'Cord'), ('UBERON_0001132', 'parathyroid gland', 70, 'Parathyroid'), ('CHEBI_5762', 'hordatine A', 82, 'Hormone'), ('UBERON_0004043', 'semicircular canal ampulla', 142, 'Whole'), ('CHEBI_46662', 'mineral', 158, 'Mineral'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 308, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 318, 'parathyroid'), ('UBERON_0007688', 'anlage', 392, 'whole'), ('CHEBI_46662', 'mineral', 408, 'mineral')]
PMC3296991	2/2012	S22-PMC3296991	['the PURPOSE of the PRESENT STUDY was TO INVESTIGATE the RELATIONSHIPS among maternal and Cord Vitamin D status, pth, balp, and Whole Body bmc (wbbmc) in newborns in a multiethnic population in oakland, california and TO EVALUATE the predictive value of the biochemical indices as indicators of neonatal wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	5	[('UBERON_0002240', 'spinal cord', 89, 'cord'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 127, 'whole body')]
PMC3296991	2/2012	S83-PMC3296991	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to racial DISPARITIES in fetal growth and bone mineralization [20,21], although ADDITIONAL RESEARCH IS WARRANTED in this area.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 140), ('FUTURE_WORK', 151)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene')]
PMC3309463	6/2011	S44-PMC3309463	['we SPECULATE that (a) developmental Vitamin D deficiency MAY underlie KEY features of the epidemiology of schizophrenia, (b) the Vitamin D deficiency during development decanalizes Brain Development and (c) schizophrenia is a behavioral phenotype ASSOCIATED with increased variance ASSOCIATED with this decanalization of Brain Development.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 247), ('SUPERFICIAL_RELATIONSHIP', 282)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007420', 'brain development', 181, 'brain development'), ('UBERON_0000955', 'brain', 181, 'brain'), ('GO_0007420', 'brain development', 321, 'brain development'), ('UBERON_0000955', 'brain', 321, 'brain')]
PMC3309463	6/2011	S89-PMC3309463	['with respect to the epidemiology of schizophrenia, we OUTLINE HOW one CANDIDATE environmental RISK FACTOR, low Prenatal Vitamin D, CAN result in environmental editing of Brain Development.']	[('INCOMPLETE_EVIDENCE', 54), ('EXPLICIT_QUESTION', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 131)]	5	[('GO_0007565', 'female pregnancy', 111, 'prenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007420', 'brain development', 170, 'brain development'), ('UBERON_0000955', 'brain', 170, 'brain')]
PMC3347007	4/2012	S27-PMC3347007	['the danish national Birth cohort (dnbc) offers information on Vitamin D intake in danish Pregnant women as well as information on socio-demographic and lifestyle factors, and is THEREBY an excellent OPPORTUNITY TO investigate POTENTIAL DETERMINANTS of Vitamin D intake.']	[('PROBABLE_UNDERSTANDING', 178), ('FUTURE_WORK', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 211), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 236)]	5	[('GO_0007567', 'parturition', 20, 'Birth'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC3347007	4/2012	S148-PMC3347007	['in OTHER studies, maternal age was also FOUND TO BE inversely ASSOCIATED with Vitamin D intake and the use of Supplements, SUGGESTING that younger Individuals MAY BE less conscious about health matters [17,18,27,28,29].']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 40), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 159)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 110, 'supplements'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC3347028	3/2012	S2-PMC3347028	['there are clear indicators from in vitro and Animal in vivo studies that POINT to Vitamin D’s INDISPUTABLE ROLE in both Innate and Adaptive Immunity; HOWEVER, the translation of THESE FINDINGS to clinical practice, including the Care of the Pregnant woman, has not occurred.']	[('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 178)]	5	[('NCBITaxon_33208', 'Metazoa', 45, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007631', 'feeding behavior', 120, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 131, 'adaptive immunity'), ('GO_0007567', 'parturition', 229, 'care'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]
PMC3347028	3/2012	S143-PMC3347028	['from the prior sections, IT IS CLEAR that Vitamin D deficiency during Pregnancy is common throughout the world YET WHAT EFFECT does deficiency have on the mother and her developing fetus?']	[('PROBABLE_UNDERSTANDING', 25), ('ANOMALY_CURIOUS_FINDING', 111), ('EXPLICIT_QUESTION', 115), ('SUPERFICIAL_RELATIONSHIP', 120), ('EXPLICIT_QUESTION', 186)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3347028	3/2012	S196-PMC3347028	['secondary analysis INDICATED that Preterm Birth and labor were inversely RELATED to pre-Delivery Vitamin D status (Preterm Birth or = 0.50 per 10 ng/ml, p = 0.002; Preterm Labor or Birth or = 0.72 per 10 ng/ml, p = 0.012), an EFFECT that PERSISTED EVEN after controlling for race.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 226), ('INCOMPLETE_EVIDENCE', 238), ('ANOMALY_CURIOUS_FINDING', 248)]	5	[('GO_0007565', 'female pregnancy', 34, 'preterm'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007567', 'parturition', 88, 'delivery'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'preterm'), ('GO_0007567', 'parturition', 123, 'birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 164, 'preterm labor'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC3347028	3/2012	S217-PMC3347028	['studies specifically designed and powered to answer the QUESTION of WHETHER OR NOT Vitamin D supplementation LEADS TO improved health outcomes—lower RISK of Preterm Birth, preeclampsia, and infection REMAIN to be done.']	[('EXPLICIT_QUESTION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 200)]	5	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'preterm birth')]
PMC3347028	3/2012	S218-PMC3347028	['we can conservatively say that WHILE we do not understand completely the ROLE of 1,25(Oh)2D during Pregnancy, achieving OPTIMAL production can be done SAFELY with 4000 iu Vitamin D3/day, which APPEARS TO BE the amount of Vitamin D that would be conservatively generated by the body with adequate sunlight exposure over the duration of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 151), ('ANOMALY_CURIOUS_FINDING', 193)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 83, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 171, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 171, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'gestation')]
PMC3347028	3/2012	S220-PMC3347028	['unanswered questions and direction of FUTURE RESEARCH endeavors\nthere are many UNANSWERED QUESTIONS about Vitamin D’s “true” ROLE during Pregnancy: at no other time during the Lifecycle is 25(Oh)D so closely LINKED with 1,25(Oh)2D [6].']	[('FUTURE_WORK', 38), ('ANOMALY_CURIOUS_FINDING', 79), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0000104', 'life cycle', 176, 'lifecycle'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 222, '25(OH)2D')]
PMC3348565	4/2012	S129-PMC3348565	['an ASSOCIATED ISSUE is that, after the start of our trial, SPECULATIONS arose that high fluctuations of natural or supplemented Vitamin D intake MIGHT be LINKED to negative outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('PROBLEM_COMPLICATION', 14), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3355895	1/2011	S52-PMC3355895	['these OBSERVATIONS MAY SUGGEST a POSSIBLE mechanism for the INFLUENCE of maternal Vitamin D status on Placental Calcium Transport and Intrauterine bone Mineral accrual.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 60)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'placental'), ('UBERON_0001987', 'placenta', 102, 'placental'), ('GO_0006816', 'calcium ion transport', 112, 'calcium transport'), ('UBERON_0022293', 'reproductive gland secretion', 134, 'intrauterine'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
PMC3356951	4/2012	S2-PMC3356951	['this PANDEMIC of hypovitaminosis d can MAINLY be ATTRIBUTED to lifestyle (for example, reduced outdoor activities) and environmental (for example, air pollution) FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 5), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 213)]	5	[('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 254, 'vitamin D production')]
PMC3356951	4/2012	S19-PMC3356951	['[7] in THIS REVIEW, we will FOCUS on the biology of Vitamin D and summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and its clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('PROBABLE_UNDERSTANDING', 100), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 173)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3356951	4/2012	S99-PMC3356951	['[7172] MANY STUDIES have SUGGESTED a LINK between low Vitamin D levels and an INCREASED RISK of cancer, with the STRONGEST EVIDENCE for Colorectal cancer.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 78), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0012652', 'colorectum', 136, 'colorectal')]
PMC3356951	4/2012	S123-PMC3356951	["RECENTLY, it HAS BEEN SUGGESTED that chronically INADEQUATE Vitamin D intake MAY play a significant ROLE in the pathogenesis of parkinson's disease."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3366611	4/2012	S155-PMC3366611	['a modest negative ASSOCIATION between maternal bmi and diet quality HAS BEEN IDENTIFIED [131], and obesity is ASSOCIATED with lower levels of Vitamin D [132] and Folic Acid levels during the Childbearing years [133], which MAY increase the risk of Insulin resistance and Neural Tube defects, respectively [134].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 223)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30751', 'formic acid', 162, 'folic acid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 191, 'childbearing'), ('PR_000045358', 'insulin family protein', 248, 'insulin'), ('UBERON_0001049', 'neural tube', 271, 'neural tube')]
PMC3395583	7/2012	S86-PMC3395583	['THESE FINDINGS are INTERESTING since SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of id [23,24].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3395583	7/2012	S92-PMC3395583	['NOTABLY, schizophrenia is also INFLUENCED by the season of Birth and a RECENT STUDY HAS SHOWN that neonatal Vitamin D levels are significantly ASSOCIATED with risk of schizophrenia later in Life [49,50].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 143)]	5	[('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 190, 'life')]
PMC3424155	8/2012	S173-PMC3424155	['maternal Nutrient restriction causes adiposity in offspring[26], and RECENT DATA SUGGEST that maternal Vitamin D deficiency AFFECTS adiposity, ALTHOUGH the mechanisms are NOT yet FULLY UNDERSTOOD[23].']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 143), ('INCOMPLETE_EVIDENCE', 171)]	5	[('CHEBI_33284', 'nutrient', 9, 'nutrient'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3424155	8/2012	S179-PMC3424155	['in Rats, it has been OBSERVED that maternal Vitamin D deficiency LEADS to a significant increase in the number of Glomeruli, which is a UNIQUE and IMPORTANT EFFECT of Vitamin D restriction during fetal development[13].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 65), ('ANOMALY_CURIOUS_FINDING', 136), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomeruli'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC3427192	4/2012	S45-PMC3427192	['WHILE these studies SHOW INTRIGUING ASSOCIATIONS between Vitamin D insufficiency (or deficiency) and asthma Control, the cross-sectional nature of the 25(Oh)D measurement and outcome assessment prevents causal INTERPRETATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 210)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0065007', 'biological regulation', 108, 'control'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D')]
PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]
PMC3427250	8/2012	S18-PMC3427250	['HOWEVER there is so far NO CONCLUSIVE EVIDENCE about the causality of these RELATIONSHIPS, as NO randomised controlled TRIALS of Vitamin D supplementation with an appropriate assessment of a VARIETY of health outcomes have been carried out to date[21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 94), ('DIFFICULT_TASK', 191)]	5	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3427250	8/2012	S133-PMC3427250	['WHILE several observational studies POINT to CORRELATIONS between Vitamin D insufficiency and maternal and neonatal ill health, EXPERIMENTAL EVIDENCE from supplementation clinical trials IS NEEDED to inform health policy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 128), ('FUTURE_WORK', 187)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3470091	9/2012	S77-PMC3470091	['such a change results in the inhibition of pth secretion from Parathyroid Cells.27\nthe increase of Serum calcium in the ig in the PRESENT STUDY is SIMILAR TO that REPORTED in the OTHER STUDIES.15,17-20,22-25,27,28the mechanism of increasing Serum Calcium by Vitamin D is that Vitamin D attaches optionally to receptors X Of Retinoic Acid (rxr), and composes a heteromeric Complex with a certain sequence on the dna, known as reacting elements to Vitamin D. this LEADS to the transcription of a special mrna, which results in the Translation Of several Proteins such as Epithelial calcium channels and the proteins attached to calcium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 462)]	5	[('CL_0000512', 'paracrine cell', 62, 'parathyroid cells'), ('UBERON_0001132', 'parathyroid gland', 62, 'parathyroid'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 247, 'calcium'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_30341', 'silver monochloride', 319, 'X of'), ('GO_0000805', 'X chromosome', 319, 'X'), ('CHEBI_26536', 'retinoic acid', 324, 'retinoic acid'), ('GO_0032991', 'protein-containing complex', 372, 'complex'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('GO_0006415', 'translational termination', 529, 'translation of ... proteins'), ('UBERON_0000483', 'epithelium', 569, 'epithelial')]
PMC3470091	9/2012	S87-PMC3470091	['moreover, ANOTHER STUDY,18SHOWED that a single dose of 200,000 iu of Vitamin D in the healthy youths was ASSOCIATED with a peak in Vitamin D concentration after two weeks of treatment, BUT lower than that of OUR STUDY at three months after treatment.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 208)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3470091	9/2012	S93-PMC3470091	['moreover, additional clinical trial STUDIES will HAVE TO BE CONDUCTED to determine the EFFECT of mega doses of Vitamin D on other health-related parameters such as the FACTORS RELATED to Metabolic syndrome as well as inflammatory MARKERS.']	[('FUTURE_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 230)]	5	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0008152', 'metabolic process', 187, 'metabolic')]
PMC3471827	10/2012	S111-PMC3471827	['in SUPPORT of this NOTION, PREVIOUS STUDIES HAVE SHOWN a clear ASSOCIATION between maternal Vitamin E status during Gestation and Cognitive function of the offspring[21]–[23].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin E'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0050890', 'cognition', 130, 'cognitive')]
PMC3472720	8/2012	S0-PMC3472720	['Prenatal Vitamin D deficiency INDUCES an early and more SEVERE experimental Autoimmune encephalomyelitis in the second generation\n\nabstract\nin a PREVIOUS STUDY, we DEMONSTRATED that Mouse Adult f1offspring, exposed to a Vitamin D deficiency during Pregnancy, developed a less SEVERE and delayed experimental Autoimmune encephalomyelitis (eae), when compared with control offspring.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 276)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0005445', 'segment of pes', 76, 'Autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('UBERON_0005445', 'segment of pes', 308, 'Autoimmune')]
PMC3472720	8/2012	S53-PMC3472720	['NONETHELESS, to date, NOT a single study has yet DEMONSTRATED a Pirna- or a Mirna-ASSOCIATED action of Vitamin D on the Immune or the Nervous system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('SO_0001035', 'piRNA', 64, 'piRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('UBERON_0001016', 'nervous system', 134, 'nervous')]
PMC3476426	8/2012	S11-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3476426	8/2012	S106-PMC3476426	['THUS, Vitamin D deficiency MAY CONTRIBUTE to higher mutation rates and impaired Repair Of Dna [35] AS a result of increased oxidative stress which was REPORTED in some autistic children [22].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 151)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0006281', 'DNA repair', 80, 'repair of DNA')]
PMC3476426	8/2012	S109-PMC3476426	['autism was MORE COMMON among children of the mothers who took Antiepileptic Drugs AS these Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism [39].']	[('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 138), ('IMPORTANT_CONSIDERATION', 155), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('CHEBI_35218', 'anthocyanin cation', 62, 'antiepileptic'), ('CHEBI_23888', 'drug', 76, 'drugs'), ('CHEBI_23888', 'drug', 91, 'drugs'), ('CHEBI_23888', 'drug', 127, 'drugs'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 184, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 192, 'D')]
PMC3476426	8/2012	S150-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3501517	11/2012	S232-PMC3501517	['HOWEVER, the IMPACT of these DIFFERENCES on overall clinical RELEVANCE of Vitamin D deficiency is LIKELY minimal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('IMPORTANT_CONSIDERATION', 61), ('PROBABLE_UNDERSTANDING', 98)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3509518	11/2012	S150-PMC3509518	['the PROTECTIVE EFFECTS of fresh Foods rich in Vitamin C on wheeze is CONSISTENT with PREVIOUS STUDIES, and it is notable that we DID NOT observe any effect of Vitamin supplements on any allergic outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 129)]	5	[('CHEBI_33290', 'food', 32, 'foods'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 159, 'vitamin')]
PMC3515553	12/2012	S7-PMC3515553	['OUR FINDINGS SUGGEST that maternal Vitamin B-12 MAY not have an IMPORTANT EFFECT on offspring Cognitive ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin B'), ('PR_000004770', 'Polycomb complex protein BMI-1', 43, 'B-12'), ('GO_0050890', 'cognition', 94, 'cognitive')]
PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
PMC3515553	12/2012	S49-PMC3515553	['potential confounders and mediators\nwe TESTED for the ASSOCIATION of POTENTIAL CONFOUNDERS with offspring iq, maternal dietary Vitamin B-12 intake and genotypes of Vitamin B-12 RELATED variants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 69), ('PROBLEM_COMPLICATION', 79), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 164, 'vitamin B-12')]
PMC3515887	11/2012	S218-PMC3515887	['Ascorbic Acid\nthe RATIONALE for Ascorbic Acid (Vitamin C) supplementation in large doses is that it blocks binding to da receptors and POSSIBLY corrects redox balance, leading to correction of Metabolic stress that MAY CONTRIBUTE to autism symptoms.']	[('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_2878', 'Aspecioside', 0, 'Ascorbic Acid'), ('CHEBI_22652', 'ascorbic acid', 32, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('GO_0008152', 'metabolic process', 193, 'metabolic')]
PMC3552819	12/2012	S208-PMC3552819	['THEREFORE, upward deflections in the Serum and Urine BIOMARKERS of Calcium Homeostasis signaled a NEED TO BE cautious about the transient EFFECTS of large sudden influxes of Vitamin D, and the risk of dose-dependent toxicity.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('FUTURE_WORK', 98), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 138)]	5	[('UBERON_0001977', 'blood serum', 37, 'serum'), ('UBERON_0001088', 'urine', 47, 'urine'), ('GO_0055073', 'cadmium ion homeostasis', 67, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3586494	2/2013	S261-PMC3586494	['as discussed in the section on epigenetics, experimental studies on the IMPACT of methyl-supplemented diets containing added Folate and Vitamin B-12 REVEALED the POTENTIAL ROLE of these Micronutrients in inducing major changes in offspring phenotype, including the ability to IMPACT the development of chronic diseases.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 276)]	5	[('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 136, 'vitamin B-12'), ('CHEBI_33839', 'macromolecule', 186, 'micronutrients')]
PMC3613945	2/2013	S3-PMC3613945	['WHETHER these variants also INFLUENCE the ROLE of Vitamin D in an Immunologic milieu is NOT KNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 88)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000913', 'interstitial fluid', 66, 'immunologic')]
PMC3613945	2/2013	S5-PMC3613945	['indeed, dbp and Vitamin D MAY JOINTLY OR INDEPENDENTLY CONTRIBUTE to a variety of adverse health outcomes unrelated to classical notions of their function in bone and Mineral Metabolism.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_46662', 'mineral', 167, 'mineral'), ('GO_0008152', 'metabolic process', 175, 'metabolism')]
PMC3613945	2/2013	S56-PMC3613945	['OF more immediate clinical INTEREST, PERHAPS, was our OBSERVATION that this Allele was also CORRELATED with the response of Serum 25(Oh)D levels to long-term Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 27), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('SO_0001023', 'allele', 76, 'allele'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 130, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3613945	2/2013	S189-PMC3613945	['a molecular mechanism by which Vitamin D MAY AFFECT asthma is UNKNOWN and its RELATIONSHIP to atopy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45), ('FULL_UNKNOWN', 62), ('SUPERFICIAL_RELATIONSHIP', 78), ('FULL_UNKNOWN', 103)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3629265	4/2013	S86-PMC3629265	['WHILE our 6 infants had numerous RISK FACTORS for Vitamin D deficiency, they were not Breast Fed, which was the most CONSISTENT FINDING in PREVIOUS reports (13,15–19).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007567', 'parturition', 86, 'breast'), ('GO_0007631', 'feeding behavior', 93, 'fed')]
PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
PMC3641012	4/2013	S18-PMC3641012	['uncertainty surrounding Vitamin D REQUIREMENTS in Pregnancy has LED TO DIVERGENT dose RECOMMENDATIONS; for example, the unicef Antenatal Micronutrient formulation contains 200\xa0iu/day [11], the canadian paediatric society has SUGGESTED 2000\xa0iu/day [12], and hollis et al.']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 86), ('INCOMPLETE_EVIDENCE', 225)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 137, 'micronutrient')]
PMC3641012	4/2013	S161-PMC3641012	['given the substantial inter-Individual VARIABILITY in the response to Vitamin D supplementation (figure\xa03), we EXPLORED the ROLE of the following POTENTIAL MODIFIERS of the magnitude of the change in 25(Oh)D (δ25(Oh)D) from baseline to Delivery (selected a priori ): maternal weight at baseline, maternal age, Gestational age, maternal body mass index at baseline (bmi), gravidity, parity, baseline Pth status, season and baseline Vitamin D status.']	[('DIFFICULT_TASK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('NCBITaxon_1', 'root', 28, 'individual'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('CHEBI_33010', 'chromide(1-)', 212, '(OH)D'), ('GO_0007567', 'parturition', 236, 'delivery'), ('GO_0007565', 'female pregnancy', 310, 'gestational'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 399, 'PTH'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC3651971	5/2013	S19-PMC3651971	['this research SUGGESTS that Central Nervous System Development MAY BE PROTECTED in Vitamin A deficiency, POSSIBLY BECAUSE Vitamin A is preferentially allocated to the developing fetus.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 105), ('PROBABLE_UNDERSTANDING', 114)]	5	[('GO_0003204', 'cardiac skeleton development', 28, 'central nervous system development'), ('UBERON_0001017', 'central nervous system', 28, 'central nervous system'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
PMC3651971	5/2013	S27-PMC3651971	['THIS STUDY is the FIRST TO EXAMINE EFFECTS of routine, maternal Vitamin A supplementation before, during and following Pregnancy, provided via a randomised, placebo-controlled trial, on child Cognitive and motor ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0050890', 'cognition', 192, 'cognitive')]
PMC3651971	5/2013	S140-PMC3651971	['the HYPOTHESISED EFFECT of Gestational Vitamin A supplementation on Cognition and Motor Development is BASED ON sound THEORY.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 103), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 118)]	5	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('GO_0050890', 'cognition', 68, 'cognition'), ('GO_0009653', 'anatomical structure morphogenesis', 82, 'motor development')]
PMC3651971	5/2013	S143-PMC3651971	['there are also a host of OTHER nutritional INFLUENCES on Cognitive Development, SOME of which MIGHT obscure the RELATIONSHIP between early Vitamin A deficiency and developmental outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('GO_0050787', 'detoxification of mercury ion', 57, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A')]
PMC3659910	1/2013	S16-PMC3659910	['[1] the QUESTION scientists HAVE BEEN working on for almost a decade is WHY and HOW Vitamin D is AFFECTING Conception, Pregnancy and the health of the newborn.']	[('EXPLICIT_QUESTION', 8), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 72), ('EXPLICIT_QUESTION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	5	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007620', 'copulation', 107, 'conception'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3659910	1/2013	S97-PMC3659910	['RECENT work EMPHASIZES the IMPORTANCE of NON-CLASSICAL ROLES of Vitamin D in Pregnancy and the Placenta.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('UBERON_0001987', 'placenta', 95, 'placenta')]
PMC3659910	1/2013	S107-PMC3659910	['two clinical trials SUPPORT a POTENTIAL ROLE of Vitamin D in the PREVENTION of Preeclampsia, ALTHOUGH neither of these treated with Vitamin D supplements alone.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 93)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 79, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3668200	5/2013	S28-PMC3668200	['Breast Milk ALONE can meet the Nutrient REQUIREMENT during the first 6 months of Life, with the POSSIBLE EXCEPTION of Vitamin D. the Vitamin A and Vitamin E contents of the Breast Milk are CORRELATED with the amount of the Vitamins in the dietary intake of Lactating mothers.']	[('ANOMALY_CURIOUS_FINDING', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 189)]	5	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33284', 'nutrient', 31, 'nutrient'), ('UBERON_0000104', 'life cycle', 81, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin E'), ('UBERON_0001348', 'brown adipose tissue', 173, 'breast milk'), ('CHEBI_33277', 'gamma-tocotrienol', 223, 'vitamins'), ('GO_0007594', 'puparial adhesion', 257, 'lactating')]
PMC3668200	5/2013	S45-PMC3668200	['the authors DID NOT TAKE into CONSIDERATION the height profiles of the newborns EVEN IF Minerals and Vitamin D are key FACTORS of bony growth.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_46751', 'quinolizidine', 88, 'minerals'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3672018	5/2013	S12-PMC3672018	['THE PRESENT STUDY addresses these ISSUES in RELATION to Vitamin D.\n\nVitamin D\nvitamin D is a fat-soluble Vitamin that is NECESSARY for the Human body.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBLEM_COMPLICATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 68, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'D'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human')]
PMC3672018	5/2013	S42-PMC3672018	['furthermore, there are studies SHOWING that low fetal Vitamin D MAY lead to persistent changes in the Immune System, THUS POSSIBLY INFLUENCING the risk of developing Autoimmune diseases such as t1d [14,19,20].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 102, 'immune system'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune')]
PMC3672018	5/2013	S54-PMC3672018	['the main HYPOTHESIS is that low levels of Vitamin D during CRITICAL phases of development have adverse EFFECTS on the long term risk of developing the above mentioned disease outcomes, and that exposure to extra Vitamin D from Food fortification has beneficial EFFECTS PREVENTING the mentioned diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 269)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'food')]
PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
PMC3672018	5/2013	S162-PMC3672018	['AS diet is USUALLY different between families with higher socioeconomic status and those with lower status [31], maternal socioeconomic status MAY have AFFECTED Margarine/milk Intake and THUS exposure to Vitamin D. information on socioeconomic position, education and ethnicity is available from statistics denmark and can be controlled for.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187)]	5	[('CHEBI_6784', 'mestranol', 161, 'margarine'), ('GO_0007631', 'feeding behavior', 176, 'intake'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 212, 'D')]
PMC3679329	6/2013	S8-PMC3679329	['these results SUGGEST that among Pregnant and Lactating women, those who do not use dietary supplements TEND to have a lower intake of healthy Foods, such as beans and vegetables, as well as a lower intake of dietary fiber and Β-Carotene, which are abundant in these Foods, and non-users are more LIKELY than users to have INADEQUATE Intake of micro-Nutrient such as Vitamin C and iron.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 104), ('PROBABLE_UNDERSTANDING', 297), ('IMPORTANT_CONSIDERATION', 323), ('PROBLEM_COMPLICATION', 323)]	5	[('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('GO_0007594', 'puparial adhesion', 46, 'lactating'), ('CHEBI_33290', 'food', 143, 'foods'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 227, 'β-carotene'), ('CHEBI_33290', 'food', 267, 'foods'), ('GO_0007631', 'feeding behavior', 334, 'intake'), ('CHEBI_33284', 'nutrient', 350, 'nutrient'), ('CHEBI_27300', 'vitamin D', 367, 'vitamin C')]
PMC3691177	6/2013	S21-PMC3691177	['Vitamin D insufficiency is NEVERTHELESS very common during Pregnancy[15]–[17], and it HAS BEEN PROPOSED that Prenatal Vitamin D supplementation MAY PREVENT childhood wheezing and asthma[18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3691177	6/2013	S127-PMC3691177	['it HAS RECENTLY BEEN SHOWN that doses of 4000 iu of Vitamin D daily are SAFE and effective for short term treatment of Vitamin D deficiency during Pregnancy[30], ALTHOUGH the long term EFFECTS on child health have NOT BEEN STUDIED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 162), ('SUPERFICIAL_RELATIONSHIP', 185), ('FULL_UNKNOWN', 214)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3691177	6/2013	S129-PMC3691177	['two RECENT OBSERVATIONAL STUDIES that DOCUMENTED Prenatal Vitamin D status by measuring Cord Blood 25(Oh)D concentration, FOUND RELATIONSHIPS with allergic sensitisation and/or wheezing in early childhood[8],[31].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 99, '25(OH ... D')]
PMC3691177	6/2013	S139-PMC3691177	['given the modest EFFECTS on Cord Blood Vitamin D achieved by these INTERVENTIONS, the SAFETY and efficacy of higher dose Prenatal Vitamin D supplementation STRATEGIES NEED TO BE explored.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 156), ('FUTURE_WORK', 167)]	5	[('UBERON_0002240', 'spinal cord', 28, 'cord'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'prenatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3695234	7/2013	S0-PMC3695234	['CORRELATION between Serum Vitamin D level and the severity of atopic dermatitis ASSOCIATED with Food sensitization\n\nabstract\n\npurpose\na GROWING BODY of LITERATURE has LINKED Vitamin D deficiency with allergic diseases, particularly atopic dermatitis (ad).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 136), ('SUPERFICIAL_RELATIONSHIP', 167)]	5	[('UBERON_0001977', 'blood serum', 20, 'Serum'), ('CHEBI_28384', 'vitamin K', 26, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 26, 'Vitamin'), ('CHEBI_33290', 'food', 96, 'Food'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3695234	7/2013	S51-PMC3695234	['ALTHOUGH there was no healthy control group, OUR FINDINGS SHOWED lower normal levels of Serum Vitamin D (15.61±5.67 ng/ml) irrespective of ad severity, which SUGGESTS a CORRELATION between ad and the absorption and Metabolism Of Vitamin D.\nthis Metabolism begins with two processes: absorption into the skin as Vitamin D3And via the Gut as either Vitamin D2Or Vitamin D3.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 215, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0008152', 'metabolic process', 245, 'metabolism'), ('CHEBI_61991', 'maltotriose trisaccharide', 311, 'vitamin D3and'), ('PR_000027594', 'histone H3', 311, 'vitamin D3and'), ('UBERON_0001555', 'digestive tract', 333, 'gut'), ('CHEBI_27329', 'xanthosine phosphate', 347, 'vitamin D2or'), ('PR_000017209', 'utrophin', 347, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 360, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 360, 'vitamin D3')]
PMC3695234	7/2013	S57-PMC3695234	['the 1,25(Oh)2D3Molecule induces Antimicrobial peptide Gene Expression in isolated Human Keratinocytes, Monocytes, Neutrophils, and Human cell lines.9tlr activation of Human Macrophages up-regulates the Expression of the Vitamin D receptor and Vitamin D-1-hydroxylase Genes, leading to the induction of the Cathelicidin.10these data SUGGEST a LINK between tlrs and Vitamin D-mediated Innate Immunity, INDICATING that a DIFFERENCE in the ability of Human populations to produce Vitamin D MAY contributes to susceptibility to Microbial infection.']	[('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 342), ('INCOMPLETE_EVIDENCE', 400), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('INCOMPLETE_EVIDENCE', 486)]	5	[('CHEBI_84221', '1-ethyl-2-propylcyclohexane', 4, '1,25(OH)2D3molecule'), ('CHEBI_65381', 'albizoside C', 32, 'antimicrobial'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 82, 'human'), ('CL_0000312', 'keratinocyte', 88, 'keratinocytes'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000775', 'neutrophil', 114, 'neutrophils'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 167, 'human'), ('CL_0000235', 'macrophage', 173, 'macrophages'), ('GO_0010467', 'gene expression', 202, 'expression'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('SO_0000704', 'gene', 267, 'genes'), ('PR_000006009', 'alpha-catulin', 306, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('GO_0045087', 'innate immune response', 383, 'innate immunity'), ('NCBITaxon_9606', 'Homo sapiens', 447, 'human'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 523, 'microbial')]
PMC3695234	7/2013	S61-PMC3695234	['camargo et al.13found no decreased risk of ad in the children of mothers with higher intakes of Vitamin D. a northern finland Birth cohort INDICATED the ASSOCIATION between Vitamin D supplementation in the first year of Life and an increased risk of atopy at age 31 years.14a FURTHER prospective study REPORTED that an increased concentration of 25(Oh)D3In maternal Serum predisposed infants to ad at 9 months of age.15these variable results MAY BE secondary to the differences in the absolute amount of Vitamin D exposure, the baseline Vitamin D status, and the timing of exposure.']	[('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 302), ('INCOMPLETE_EVIDENCE', 442)]	5	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('UBERON_0000104', 'life cycle', 220, 'life'), ('PR_000001883', 'lysosome-associated membrane protein', 346, '25(OH)D3in'), ('UBERON_0001977', 'blood serum', 366, 'serum'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 537, 'vitamin D')]
PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]
PMC3695234	7/2013	S77-PMC3695234	['in conclusion, the results of THIS STUDY SUGGEST that Vitamin D deficiency MIGHT be RELATED to the severity of ad that is ASSOCIATED with Food sensitization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_33290', 'food', 138, 'food')]
PMC3702245	6/2013	S1-PMC3702245	['WHILE Vitamin D is IMPORTANT for Calcium and Phosphorus Homeostasis and for bone health, it also plays IMPORTANT ROLES in many OTHER physiologic functions in the body.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 33, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 45, 'phosphorus'), ('GO_0042592', 'homeostatic process', 56, 'homeostasis')]
PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC3702245	6/2013	S44-PMC3702245	['with INCREASING INTEREST in the ROLE of Vitamin D in Glucose Homeostasis, the ASSOCIATION between maternal Serum 25(Oh)D concentration in early Pregnancy and the risk of Gestational diabetes mellitus was investigated in a study from the national institutes of health, bethesda, md.85the authors FOUND that maternal Vitamin D deficiency [serum 25(Oh)D < 50 nmol/l] was ASSOCIATED with a higher risk of Gestational diabetes mellitus (adjusted odds ratio 2.66; ci 1.01–7.02).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 295), ('SUPERFICIAL_RELATIONSHIP', 368)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('GO_0042593', 'glucose homeostasis', 53, 'glucose homeostasis'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 113, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 343, '25(OH)D'), ('GO_0007565', 'female pregnancy', 401, 'gestational')]
PMC3702245	6/2013	S61-PMC3702245	['a target concentration of 75 nmol/l is CONSISTENT with the Cord Blood 25(Oh)D level REPORTED in SOME STUDIES as being PROTECTIVE against lower respiratory infection, wheezing, and eczema in infants.94–96to achieve a target Serum concentration >75 nmol/l, the society RECOMMENDS a daily Vitamin D Intake of 1500–2000 iu.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 118), ('FUTURE_WORK', 267)]	5	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 70, '25(OH ... D'), ('UBERON_0001977', 'blood serum', 223, 'serum'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007631', 'feeding behavior', 296, 'intake')]
PMC3704911	7/2013	S24-PMC3704911	['additionally, Prenatal DEFICIENCIES in Vitamins D and E HAVE BEEN ASSOCIATED with increased incidences of Respiratory difficulties, including wheezing and asthma, in the offspring [7], and maternal Vitamin D deficiencies HAVE BEEN RELATED to observed hyper-Locomotion in the Adult Rat [8].']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamins D'), ('PR_000006444', 'diacylglycerol kinase delta', 48, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 54, 'E'), ('UBERON_0001004', 'respiratory system', 106, 'respiratory'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0040011', 'locomotion', 257, 'locomotion'), ('UBERON_0007023', 'adult organism', 275, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 281, 'rat')]
PMC3705146	5/2013	S31-PMC3705146	['(2009) have EXTENDED that THEORY to PROPOSE the risk for schizophrenia around the world is RELATED to levels of Vitamin D from fish in their current diet.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3705320	3/2013	S178-PMC3705320	['in Pregnant participants, the higher-dose Vitamin D regimen had a significant suppressive EFFECT on maternal pth secretion, relative to the lower dose, as INDICATED by the change in average Pth concentrations from baseline to delivery, SIMILAR TO PREVIOUS OBSERVATIONS by wagner et al.']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 256)]	5	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 190, 'PTH')]
PMC3713405	7/2013	S46-PMC3713405	['GIVEN that Vitamin D deficiency is common (1) during winter and spring, (2) at high latitudes (holick et al., 1995), (3) in urban environments (mcgrath et al., 2001) and (4) in dark skinned Individuals (clemens et al., 1982;holick et al., 1995), these ecological data led TO the HYPOTHESIS that low maternal Vitamin D COULD BE a modified risk FACTOR for schizophrenia.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 272), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 343)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC3717170	5/2013	S2-PMC3717170	['HOWEVER, the biological significance of the Expression of the vdr in different Tissues is not FULLY understood, and the ROLE of Vitamin D in Extraskeletal health HAS been a matter of DEBATE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('GO_0010467', 'gene expression', 44, 'expression'), ('UBERON_0000479', 'tissue', 79, 'tissues'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 141, 'extraskeletal')]
PMC3717170	5/2013	S85-PMC3717170	['the 1,25(Oh)2D3-induced increase in cellular Ca2+is also ASSOCIATED with reduced Lipid accumulation in mature Adipocytes.23in prelimary BUT ongoing STUDIES, a Murine diet-induced obesity (dio) MODEL is being used to evaluate the ROLE of Vitamin D in adiposity.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72779', '11-trans-LTE4', 4, '1,25(OH)2D3'), ('CHEBI_29108', 'calcium(2+)', 45, 'Ca2+'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('CL_0000136', 'fat cell', 110, 'adipocytes'), ('NCBITaxon_39107', 'Murinae', 159, 'murine'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3717170	5/2013	S111-PMC3717170	['multivariate regression analyses REVEALED that, after correction for age, gender, and bmi, Vitamin D concentration REMAINED INDEPENDENTLY ASSOCIATED with fev1 ( β = 0.26, p< 0.01) and dlco ( β = 0.25, p< 0.01), and there was a TREND for fvc ( β = 0.15, p< 0.08) in the subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 138), ('INCOMPLETE_EVIDENCE', 227)]	5	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3717170	5/2013	S125-PMC3717170	['they have INITIATED a randomized controlled trial of 25(Oh)D3Repletion in Vitamin D–deficient hemodialysis patients TO EVALUATE efficacy and SAFETY and the EFFECTS on inflammation and esa REQUIREMENTS.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 156), ('IMPORTANT_CONSIDERATION', 188)]	5	[('CHEBI_76706', 'EC 6.1.* (C-O bond-forming ligase) inhibitor', 53, '25(OH)D3repletion'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH'), ('PR_000006494', 'disrupted in schizophrenia 1 protein', 59, 'D3repletion'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3717170	5/2013	S133-PMC3717170	['to systemically appraise the AVAILABLE EVIDENCE on the ROLE of Vitamin D in diabetes, pittas reviewed the original bradford hill criteria, which have been subsequently modified to include three general categories (mechanistic STUDIES, direct EVIDENCE, and parallel evidence),34and then applied these criteria to the AVAILABLE evidence.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 226), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 316)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3717170	5/2013	S135-PMC3717170	['the EFFECT of Vitamin D MAY BE direct, as SUPPORTED by the Expression of the vdr and the local Production Of 1,25(Oh)2D3In Pancreatic Β Cells, OR indirect via its ROLE in Regulating Calcium Homeostasis and calcium Flux through Cell Membranes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('SUPERFICIAL_RELATIONSHIP', 163)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0010467', 'gene expression', 59, 'expression'), ('GO_0008283', 'cell proliferation', 95, 'production of ...'), ('CHEBI_84175', '2-methylhexadecanoate', 109, '1,25(OH)2D3in'), ('GO_0006306', 'DNA methylation', 117, '2D3in'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic'), ('CL_0000015', 'male germ cell', 134, 'β cells'), ('GO_0065007', 'biological regulation', 171, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 182, 'calcium homeostasis'), ('GO_0006457', 'protein folding', 214, 'flux'), ('GO_0005886', 'plasma membrane', 227, 'cell membranes'), ('GO_0007613', 'memory', 232, 'membranes')]
PMC3717170	5/2013	S165-PMC3717170	['UNFORTUNATELY, the QUESTION of WHETHER Vitamin D PREVENTS OR slows Aging cannot be easily tested.']	[('IMPORTANT_CONSIDERATION', 0), ('EXPLICIT_QUESTION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007568', 'aging', 67, 'aging')]
PMC3717170	5/2013	S178-PMC3717170	['INTERESTINGLY, a RECENT STUDY FOUND that vdrs are highly concentrated in the Cristae of the Mitochondria Inner Membrane.51the ROLE of Vitamin D in Homeostatic Signaling is COMPLEX and pervasive.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126), ('DIFFICULT_TASK', 172)]	5	[('UBERON_0004721', 'crista ampullaris', 77, 'cristae'), ('GO_0005743', 'mitochondrial inner membrane', 92, 'mitochondria inner membrane'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0038128', 'ERBB2 signaling pathway', 147, 'homeostatic signaling')]
PMC3717170	5/2013	S179-PMC3717170	['Vitamin D AFFECTS several pathways RELATED to inflammation and Cell Proliferation, including inhibition of aromatase (conversion from Testosterone to Estrogens), Cox2, prostaglandin receptor, Nf-κb, Hif-1 and Vegf, and stimulation of Igfbp-3 and E-Cadherin.52in addition, poor Vitamin D status is a RISK factor for several Autoimmune diseases, CONFIRMING the ROLE of this Vitamin in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBABLE_UNDERSTANDING', 344), ('SUPERFICIAL_RELATIONSHIP', 359)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 63, 'cell proliferation'), ('CHEBI_17347', 'testosterone', 134, 'testosterone'), ('CHEBI_50114', 'estrogen', 150, 'estrogens'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 162, 'COX2'), ('GO_0005883', 'neurofilament', 192, 'NF'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 199, 'HIF-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 209, 'VEGF'), ('PR_000008940', 'intraflagellar transport protein 88', 234, 'IGFBP-3'), ('PR_000001447', 'cadherin-1', 246, 'E-cadherin'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 323, 'autoimmune'), ('CHEBI_33229', 'vitamin (role)', 372, 'vitamin'), ('UBERON_0002405', 'immune system', 383, 'immune')]
PMC3728489	7/2013	S169-PMC3728489	['it HAS also BEEN SUGGESTED that maternal Intake of Vitamin E and polyunsaturated Fatty Acids during Pregnancy MAY INFLUENCE Development Of the Immune System and be IMPLICATED in childhood asthma and allergy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 164)]	5	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_35366', 'fatty acid', 81, 'fatty acids'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0002020', 'protease binding', 124, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC3760821	9/2013	S15-PMC3760821	['maternal Vitamin D levels EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a POTENTIAL ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 125, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 148, 'glycaemic control')]
PMC3760821	9/2013	S158-PMC3760821	['the present analysis FURTHER determined that, Cord Blood Vitamin D levels CORRELATED with those of the mother, and were, THUS, PREDOMINANTLY deficient/insufficient and, in women with t1dm, low Vitamin D levels PERSISTED post-Delivery.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 74), ('PROBABLE_UNDERSTANDING', 121), ('PROBABLE_UNDERSTANDING', 127), ('INCOMPLETE_EVIDENCE', 210)]	5	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007567', 'parturition', 225, 'delivery')]
PMC3760821	9/2013	S160-PMC3760821	['EVEN given the LACK OF EVIDENCE SUPPORTING a causal LINK between low Vitamin D and a range of non-bone health outcomes, assessment and supplementation are ESSENTIAL with respect to the optimal bone health of both mother and off-spring.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('IMPORTANT_CONSIDERATION', 155)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3760821	9/2013	S181-PMC3760821	['clearly, prospective clinical randomised controlled trials of Vitamin D supplementation ARE REQUIRED TO evaluate and CLARIFY the ASSOCIATION between Vitamin D status and Glycaemic Control in t1dm Pregnancy.']	[('FUTURE_WORK', 88), ('IMPORTANT_CONSIDERATION', 92), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('FUTURE_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 129)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 170, 'glycaemic control'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
PMC3773018	4/2013	S21-PMC3773018	['THIS STUDY FURTHER extends and strengthens our PREVIOUS work by EXAMINING the risk of fs in RELATION to the longitudinal trajectory of Vitamin D status from Birth to early childhood in the same Birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007567', 'parturition', 157, 'birth'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC3798907	8/2013	S7-PMC3798907	['the OBSERVED ASSOCIATIONS between Vitamin E and childhood Respiratory disease are COMPLEX, and the nature and form of nutritional intervention NEED TO BE carefully CONSIDERED before inclusion in trials.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('DIFFICULT_TASK', 82), ('FUTURE_WORK', 143), ('FUTURE_WORK', 164)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]
PMC3798907	8/2013	S85-PMC3798907	['HOWEVER, as was the case for cbmc, in general, Vitamin C supplementation was ASSOCIATED with a TREND for an increase in cytokines characteristic of Th Effector Cells; Ifn-Γ and Il-4, which was significant for the Il-4 response to klh, (10 of 16 cultures) ALTHOUGH this trend was not universal and there was decreased Ifn-Γ after stimulation with con a (figure 4andtable 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 95), ('ANOMALY_CURIOUS_FINDING', 255)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('CL_0000635', "Deiter's cell", 148, 'Th effector cells'), ('CHEBI_35224', 'effector', 151, 'effector'), ('PR_000008920', 'interferon alpha-7', 167, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 177, 'IL-4'), ('PR_000001470', 'interleukin-28B', 213, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 317, 'IFN-γ')]
PMC3798907	8/2013	S110-PMC3798907	['this CONCERN is SUPPORTED by the RECENT report that high-dose Antenatal Vitamin C and E supplementation is ASSOCIATED with increased infant healthcare utilisation and cost of care [23].']	[('IMPORTANT_CONSIDERATION', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 107)]	5	[('GO_0007567', 'parturition', 62, 'antenatal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC3798907	8/2013	S143-PMC3798907	['the mechanisms by which Vitamins E and C MEDIATED their COMPLEX EFFECTS on cbmc responses in THE CURRENT STUDY are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 56), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('FULL_UNKNOWN', 115)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 39, 'C'), ('PR_000004900', 'complement C3', 39, 'C')]
PMC3814422	10/2013	S118-PMC3814422	['HOWEVER, given the large sample size, and the range of Vitamin D values, we would have expected to see SOME EVIDENCE of qualitative TRENDS IF this were the case and none was present.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3827489	10/2013	S44-PMC3827489	['girls are at particular RISK for low Vitamin D status, which HAS BEEN ASCRIBED to lifestyle factors such as frequent use of sunscreen or coverage of skin by clothing that COULD AFFECT cutaneous Synthesis Of Vitamin D6).']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 194, 'synthesis of ... D6'), ('CHEBI_33237', 'vitamin D4', 207, 'vitamin D6'), ('PR_000017299', 'VIP peptides', 207, 'vitamin D6')]
PMC3827489	10/2013	S68-PMC3827489	['SEVERAL STUDIES conducted in DIFFERENT ethnic groups have FOUND a close ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of tuberculosis43-45).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S82-PMC3827489	['OTHER EVIDENCE SUGGESTS that low dietary Vitamin D and decreased sun exposure DUE to fewer outdoor activities are RISK FACTORS for the low Vitamin D levels OBSERVED in obese subjects4,20).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 156)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3827489	10/2013	S96-PMC3827489	['IN GENERAL, the OBSERVATIONAL EVIDENCE LINKING low maternal Vitamin D status during Pregnancy to an increase in the risk of allergic diseases in the offspring SEEMS more convincing.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 159)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy')]
PMC3873449	12/2013	S2-PMC3873449	['the PURPOSE of THIS STUDY was TO ASSESS the Vitamin D status of Pregnant women residing in beijing in winter AND EVALUATE the IMPACT of maternal factors on Serum 25-hydroxyvitamin d [25(Oh)D] levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 109), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC3873449	12/2013	S183-PMC3873449	['ANOTHER STUDY SHOWED that Vitamin D supplementation of 4000 iu/day for Pregnant women is MOST EFFECTIVE in achieving sufficiency in all women REGARDLESS OF race [43].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 142)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnant')]
PMC3873449	12/2013	S188-PMC3873449	['HOWEVER, SINCE there is INSUFFICIENT DATA to evaluate the EFFECTIVENESS of Vitamin D supplementation during Pregnancy Vitamin D supplementation as routine Antenatal care is YET TO BE DETERMINED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 58), ('FULL_UNKNOWN', 173)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 155, 'antenatal')]
PMC3873449	12/2013	S210-PMC3873449	['TO OUR KNOWLEDGE, THIS STUDY is the FIRST to report the INFLUENCE of maternal FACTORS on Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 78)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnant')]
PMC3901983	1/2013	S107-PMC3901983	['it is the FIRST well-DOCUMENTED REPORT RELATING to maternal Vitamin K deficiency and following COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 95)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin K')]
PMC3904479	1/2014	S32-PMC3904479	['this CONCEPT was FURTHER PROMOTED by DESCRIBING the RELATIONSHIP between maternal diet, Birth weight, and Vitamin D Receptor genotype alteration, all as a programmer of osteopenia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 52)]	5	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 106, 'vitamin D receptor')]
PMC3926113	1/2014	S125-PMC3926113	['INTERACTION between Cytosolic Vitc and Membrane bound Vitamin E regenerates oxidized Vitamin E and results in an efficient antioxidant mechanism[9], which SUGGESTS that Vitc deficiency MAY alter Vitamin E levels HEREBY POSSIBLY disrupting Membrane integrity.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('INCOMPLETE_EVIDENCE', 219)]	5	[('GO_0005829', 'cytosol', 20, 'cytosolic'), ('PR_000017299', 'VIP peptides', 30, 'VitC'), ('GO_0016020', 'membrane', 39, 'membrane'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin E'), ('PR_000017299', 'VIP peptides', 169, 'VitC'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin E'), ('GO_0016020', 'membrane', 239, 'membrane')]
PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
PMC3991049	11/2013	S3-PMC3991049	['we CONDUCTED THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency among Pregnant women and TO EVALUATE the EFFECTIVENESS and level of weekly Oral 50,000 iu of Vitamin D supplementation for the mother and the newborn.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('SUPERFICIAL_RELATIONSHIP', 117)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('UBERON_0000165', 'mouth', 151, 'oral'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3991049	11/2013	S20-PMC3991049	['BECAUSE 25-Hydroxyvitamin D crosses the Placenta,1and Fetal and Cord Blood levels of the new born Vitamin D status CORRELATE with the mother levels of Vitamin D,2,3a higher level of Vitamin D in the fetus MAY raise the concern of POSSIBLE POTENTIAL fetal harm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 230), ('INCOMPLETE_EVIDENCE', 239)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 8, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0000922', 'embryo', 54, 'fetal'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4045304	2/2014	S2-PMC4045304	['several RECENT STUDIES have PUT FORWARD HYPOTHESES to EXPLAIN the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_30751', 'formic acid', 104, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4045304	2/2014	S133-PMC4045304	['a GROWING body of LITERATURE SUGGESTS that certain modifiable RISK FACTORS such as maternal Metabolic syndrome and certain Vitamins such as Vitamin D and Folic Acid either in utero or early Life, MAY BE ASSOCIATED with increased risk of autism [43–45].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('GO_0008152', 'metabolic process', 92, 'metabolic'), ('CHEBI_33277', 'gamma-tocotrienol', 123, 'vitamins'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('UBERON_0000104', 'life cycle', 190, 'life')]
PMC4045304	2/2014	S190-PMC4045304	['Vitamin D and autism hypotheses\nseveral HYPOTHESES HAVE BEEN PROPOSED and tested to EXPLAIN the ASSOCIATION between Vitamin D status of mother and/or autistic child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4045304	2/2014	S193-PMC4045304	['OTHER mechanisms which MAY EXPLAIN the EFFECT of Vitamin D on autism symptoms are that Vitamin D MAY reduce the severity of autism through its anti-inflammatory actions, increasing T-Regulatory Cells, antiautoimmune effects, and upregulating Glutathione, a scavenger of oxidative byproducts [81–84].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 181, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 183, 'regulatory'), ('CHEBI_16856', 'glutathione', 242, 'glutathione')]
PMC4045304	2/2014	S219-PMC4045304	["ANOTHER PROPOSED HYPOTHESIS for the ROLE of Vitamin D in development of autism HAS TO do with Vitamin D's function in the Dna Repair and maintenance [95]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 79)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0006281', 'DNA repair', 122, 'DNA repair')]
PMC4045304	2/2014	S224-PMC4045304	['the EFFECT of a Genetically impaired Vitamin D system combined with INADEQUATE amounts of Vitamin D MAY BE ASSOCIATED with de novo mutations REPORTED in autism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 68), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 141)]	5	[('SO_0000704', 'gene', 16, 'genetically'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4045304	2/2014	S266-PMC4045304	['furthermore, OTHER modifiable, nutrition related RISK factors such as Folic Acid, Vitamin D, and maternal Metabolic syndrome MAY ACCOUNT FOR SOME proportion of increase in asd prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_30751', 'formic acid', 70, 'folic acid'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0008152', 'metabolic process', 106, 'metabolic')]
PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]
PMC4051754	6/2014	S35-PMC4051754	['Calcium, gamma-Glutamyl transpeptidase (ggt), Bilirubin, and Creatinine concentrations had a significant diet × time INTERACTION WHILE Vitamin A and Vitamin E concentrations TENDED to have a significant INTERACTION.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_24322', 'glutamoyl group', 15, 'glutamyl'), ('CHEBI_16990', 'bilirubin IXalpha', 46, 'bilirubin'), ('CHEBI_16737', 'creatinine', 61, 'creatinine'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin E')]
PMC4071151	6/2014	S64-PMC4071151	['RISK factors MAY include preoperative malnutrition (e.g., Vitamin D, iron), decreased Food Intake (dumping syndrome, reduced hunger and increased satiety, Food intolerances), inadequate Nutrient supplementation (POOR compliance with multivitamin/multimineral regimen, insufficient amounts of Vitamins and/or Minerals in supplements) and/or nutritional support (lack of follow-up, INSUFFICIENT monitoring, DIFFICULTY in recognizing symptoms of deficiency), Nutrient malabsorption (reduced absorptive Gastro-Intestinal area) [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 212), ('PROBLEM_COMPLICATION', 380), ('DIFFICULT_TASK', 405)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 86, 'food intake'), ('CHEBI_33290', 'food', 155, 'food'), ('CHEBI_33284', 'nutrient', 186, 'nutrient'), ('CHEBI_33277', 'gamma-tocotrienol', 292, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 308, 'minerals'), ('CHEBI_33284', 'nutrient', 456, 'nutrient'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 499, 'gastro-intestinal')]
PMC4072587	6/2014	S99-PMC4072587	['HOWEVER, lower language composite scores were SEEN in infants Born to women with Vitamin D deficiency (<37.5 nmol/l) compared to those Born to women who were Vitamin D replete (≥75 nmol/l) (md −3.48, 95% ci −5.52 to −1.44) (table 5).10.1371/journal.pone.0099005.t004\n\ncaption (table-wrap): table 4\ndevelopmental composite scores at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted model 1adjusted model 2domainmean developmental composite score [sd]mean difference1,2(95% ci)p valuemean difference1,3(95% ci)p valuemean difference1,4(95% ci)p valuecognitive104.5 [10.1]−0.47 (−1.22 to 0.27)0.21−0.39 (−1.19 to 0.40)0.30−0.43 (−1.23 to 0.370.29language97.8 [7.6]−0.02 (−0.58 to 0.55)0.960.04 (−0.51 to 0.59)0.890.08 (−0.47 to 0.63)0.77motor110.9 [13.4]0.03 (−0.97 to 1.03)0.950.25 (−0.71 to 1.21)0.610.05 (−0.92 to 0.64)0.92socio-emotional79.6 [9.8]−0.12 (−0.85 to 0.61)0.75−0.06 (−0.81 to 0.70)0.88−0.14 (−0.92 to 0.64)0.71\nvalues are ESTIMATED mean difference for each outcome associated with a 25 nmol/l increase in Vitamin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 348), ('INCOMPLETE_EVIDENCE', 1010)]	5	[('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001977', 'blood serum', 373, 'serum'), ('CHEBI_72765', 'verruculogen', 379, '25-OHD'), ('GO_0007565', 'female pregnancy', 421, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 1093, 'vitamin')]
PMC4072587	6/2014	S138-PMC4072587	['an inverse ASSOCIATION between Birth Head circumference and maternal Vitamin D was OBSERVED, HOWEVER this FINDING DID NOT persist at 6 months of age.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 83), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007567', 'parturition', 31, 'birth'), ('UBERON_0000033', 'head', 37, 'head'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S161-PMC4113768	['conclusion: THIS research PROVIDES PRELIMINARY EVIDENCE that Vitamin D MIGHT be ASSOCIATED with Sleep quality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0030431', 'sleep', 96, 'sleep')]
PMC4113768	7/2014	S179-PMC4113768	['FURTHER STUDIES assessing the EFFECT of Vitamin D supplementation, and RELATED molecular and Genetic FACTORS, on Colorectal cancer survival ARE WARRANTED.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_WORK', 140)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('SO_0000704', 'gene', 93, 'genetic'), ('UBERON_0012652', 'colorectum', 113, 'colorectal')]
PMC4113768	7/2014	S228-PMC4113768	['current EVIDENCE SUGGESTS that immunomodulatory properties of Vitamin D MAY INFLUENCE lrti RISK.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('IMPORTANT_CONSIDERATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S244-PMC4113768	['conclusions: OUR FINDINGS SUGGEST that Vitamin D deficiency at Birth is ASSOCIATED with INCREASED RISK of lrti PARTICULARLY in infants Born to mothers without allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 88), ('ANOMALY_CURIOUS_FINDING', 111)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007567', 'parturition', 135, 'born')]
PMC4113768	7/2014	S253-PMC4113768	['hiv progression, which is ASSOCIATED with excessive Immune Activation and impaired T-Cell Immunity, is also ASSOCIATED with low Serum Vitamin D level ALTHOUGH biological PLAUSIBILITY and causality have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('ANOMALY_CURIOUS_FINDING', 150), ('INCOMPLETE_EVIDENCE', 170)]	5	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 52, 'immune activation'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0002456', 'T cell mediated immunity', 83, 'T-cell immunity'), ('GO_0005622', 'intracellular anatomical structure', 84, '-cell'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4113768	7/2014	S286-PMC4113768	['BASED ON the Skeletal and non Skeletal EFFECTS of Vitamin D (vd), it SEEMS REASONABLE to optimize their vd status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 75)]	5	[('UBERON_0004288', 'skeleton', 13, 'skeletal'), ('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4113768	7/2014	S378-PMC4113768	['the national academies press : washington, dc, usa, 2011).we INVESTIGATED WHETHER DIFFERENT levels of habitual Calcium Intake INFLUENCED Serum 25(Oh)D and indices of Vitamin D activation and Catabolism during winter and in the context of both adequate and inadequate Vitamin D intakes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('EXPLICIT_QUESTION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007631', 'feeding behavior', 119, 'intake'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 143, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009056', 'catabolic process', 191, 'catabolism'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4113768	7/2014	S441-PMC4113768	['background: there is GROWING EVIDENCE from OBSERVATIONAL epidemiological and Animal studies that foetal Vitamin D deficiency MAY BE a risk factor for the development of neuropsychiatric disorders in adulthood, and that this MAY BE ASSOCIATED with increased Lateral Ventricle diameter (ventriculomegaly) in the foetal Brain.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('NCBITaxon_33208', 'Metazoa', 77, 'animal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0002285', 'telencephalic ventricle', 257, 'lateral ventricle'), ('UBERON_0000955', 'brain', 317, 'brain')]
PMC4113768	7/2014	S484-PMC4113768	['background: Vitamin D MAY INFLUENCE Tissue Modelling and Repair in the Lungs throughout Life and THUS low levels of Vitamin D MAY have a negative IMPACT on Lung function.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 146)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0048771', 'tissue remodeling', 36, 'tissue modelling'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('GO_0006281', 'DNA repair', 57, 'repair'), ('UBERON_0002048', 'lung', 71, 'lungs'), ('UBERON_0000104', 'life cycle', 88, 'life'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002048', 'lung', 156, 'lung')]
PMC4113768	7/2014	S502-PMC4113768	['RANDOMIZED controlled TRIALS ARE NEEDED to fully ELUCIDATE the POTENTIAL RELATIONS of Vitamin D with measures of Lung function.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 49), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 73)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002048', 'lung', 113, 'lung')]
PMC4113768	7/2014	S580-PMC4113768	['AIM: the PRESENT STUDY EXAMINED IF exposure to Vitamin D from fortified Margarine and milk during Prenatal Life INFLUENCED Birth weight.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_6784', 'mestranol', 72, 'margarine'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000104', 'life cycle', 107, 'life'), ('GO_0007567', 'parturition', 123, 'birth')]
PMC4113768	7/2014	S843-PMC4113768	['knowledge levels APPEAR TO CORRELATE with use of Vitamin D supplementation, SUGGESTING that APPROPRIATE information provision is VITAL.']	[('ANOMALY_CURIOUS_FINDING', 17), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 129)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S917-PMC4113768	['what is LESS CLEAR is the RELEVANT SIGNIFICANCE of Vitamin D deficiency to Tooth Development, at a population level, in the uk at present.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0048538', 'thymus development', 75, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 75, 'tooth')]
PMC4113768	7/2014	S983-PMC4113768	['apart from its well-DOCUMENTED ROLE in Bone mineralisation, Vitamin D is IMPLICATED in muscle strength and SEVERE Vitamin D deficiency CAN delay gross motor Development, such as walking in children (agarwal, a., et al .']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 135)]	5	[('GO_0007567', 'parturition', 39, 'bone'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0008289', 'lipid binding', 157, 'development')]
PMC4113768	7/2014	S1027-PMC4113768	['THIS STUDY was done TO EVALUATE the ASSOCIATION between maternal Vitamin D supplementation during Pregnancy, the risk of bacterial and Viral infections, and their POSSIBLE CONTRIBUTION to the risk of pre-term Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('NCBITaxon_1', 'root', 135, 'viral'), ('GO_0007567', 'parturition', 209, 'birth')]
PMC4113768	7/2014	S1046-PMC4113768	['THEREFORE, we AIMED TO INVESTIGATE the ASSOCIATION between Serum levels of 25(Oh) Vitamin D and bone turnover MARKERS in a population-based sample of children with Serum calcium levels.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('UBERON_0001977', 'blood serum', 59, 'serum'), ('CHEBI_30778', 'gallic acid', 75, '25(OH)'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 164, 'serum')]
PMC4113768	7/2014	S1053-PMC4113768	['conclusions: THIS STUDY SHOWED ASSOCIATIONS between MARKERS of bone turnover and 25(Oh) Vitamin D which are DEPENDENT on Serum calcium level in school-aged children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 108)]	5	[('CHEBI_30778', 'gallic acid', 81, '25(OH)'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum')]
PMC4113768	7/2014	S1386-PMC4113768	['robust randomised controlled TRIALS ARE NEEDED to determine WHETHER improving Vitamin D status has a positive EFFECT on Insulin resistance OR OTHER pathophysiological indicators of dm including Beta-Cell function.']	[('FUTURE_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000045358', 'insulin family protein', 120, 'insulin'), ('CL_0000349', 'extraembryonic cell', 194, 'beta-cell')]
PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1536-PMC4113768	['in the FUTURE, Genetic FACTORS MIGHT be taken into ACCOUNT when RECOMMENDING Vitamin D supplementation or Food fortification.']	[('FUTURE_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 51), ('FUTURE_WORK', 64)]	5	[('SO_0000704', 'gene', 15, 'genetic'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_33290', 'food', 106, 'food')]
PMC4113768	7/2014	S1541-PMC4113768	['OBSERVATIONAL STUDIES SHOW that Vitamin D deficiency MAY increase the LIKELIHOOD of Ebv reactivation, and that there is a weak negative CORRELATION between Vitamin D and anti-Ebna1 titre.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'EBV'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 175, 'EBNA1')]
PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]
PMC4113768	7/2014	S1691-PMC4113768	['background: MANY epidemiological STUDIES in RECENT years SUGGEST that Vitamin D is ASSOCIATED with a high RISK of osteoporotic fractures, malignancy of Breast, Colon, Prostate and many Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000310', 'breast', 152, 'breast'), ('UBERON_0001155', 'colon', 160, 'colon'), ('UBERON_0002367', 'prostate gland', 167, 'prostate'), ('GO_0045333', 'cellular respiration', 185, 'respiratory'), ('UBERON_0001004', 'respiratory system', 185, 'respiratory')]
PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4113768	7/2014	S1748-PMC4113768	['MANY STUDIES HAVE SHOWN an inverse ASSOCIATION between 25Ohd levels and a wide range of disorders, THUS Vitamin D supplementation HAS BEEN promoted to support good health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 55, '25OHD'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1801-PMC4113768	['HOWEVER, 25(Oh)D3Levels at year one SHOWED an INDEPENDENT TREND: due to the general rickets prophylaxis within the first year (87% of the children were supplemented with Vitamin D at least during the first 3 months), absolute 25(Oh)D3Was generally higher with almost no variations due to seasonal sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 58)]	5	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 9, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 15, 'D3levels'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 226, '25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 232, 'D3was')]
PMC4113768	7/2014	S1810-PMC4113768	['DUE to pleiotropic Vitamin D EFFECTS it INFLUENCES NOT ONLY physical and mental health status BUT ALSO the quality of Life.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 51), ('ANOMALY_CURIOUS_FINDING', 94)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC4113768	7/2014	S1835-PMC4113768	['methods: IN ORDER TO ASSESS the POTENTIAL health EFFECTS of Consuming Vitamin D fortified Foods, we performed a registry based study, taking advantage of the extensive danish PUBLIC HEALTH registries.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 175)]	5	[('GO_0007631', 'feeding behavior', 60, 'consuming'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_33290', 'food', 90, 'foods')]
PMC4113768	7/2014	S1866-PMC4113768	['; lanham-new, s.\nbackground: maintaining a healthy Vitamin D status is PROBLEMATIC within the uk, largely DUE TO a combination of two FACTORS: required uv exposure for dermal Production Of Vitamin D is limited by seasonality and there are few Vitamin D-rich foods readily available within the diet.']	[('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 175, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4113768	7/2014	S1868-PMC4113768	['WHILST Food fortification is a sustainable solution for the PREVENTION of Vitamin D deficiency, the Food industry NEEDS to determine SUITABLE means of carriage IF it is to maximise the effectiveness of fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('FUTURE_WORK', 114), ('IMPORTANT_CONSIDERATION', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	5	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 100, 'food')]
PMC4113768	7/2014	S1901-PMC4113768	['THIS simulation STUDY AIMED TO ASSESS the IMPACT of replacing non fortified Cow’s Milk with Vitamin D fortified gum in the diets of young uk children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	5	[('NCBITaxon_33208', 'Metazoa', 76, 'cow'), ('UBERON_0001913', 'milk', 82, 'milk'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4113768	7/2014	S1984-PMC4113768	['the PRESENT STUDY AIMS TO EXAMINE the ASSOCIATIONS of Serum 25-Hydroxy Vitamin D levels [25(Oh)D, a BIOMARKER of Vitamin D in blood] with clrd and outcomes using data from a large-scale prospective cohort study in the u.s.\nmethods: a total of 15,772 (m: 7,414, f: 8,358) subjects aged ≥20 year old who participated in the u.s. third national health and nutrition examination survey, had measures of serum 25(Oh)D at baseline (1988–1994), and had been followed up through december of 2006 were analyzed.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 60, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 405, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 405, '25(OH)D')]
PMC4113768	7/2014	S2053-PMC4113768	['the AIM of THIS STUDY was TO ASSESS Vitamin D status in a group of children and adolescents with Lower Respiratory Tract infections and TO EVALUATE the RELATIONSHIP between 25-hydroxy vitamin d (25-Oh-D) levels and the severity of infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 136), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004905', 'articulation', 97, 'lower respiratory tract'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 195, '25-OH-D')]
PMC4113768	7/2014	S2272-PMC4113768	['background: ACCUMULATING EVIDENCE has stipulated a strong CORRELATION between Vitamin D (vitd) deficiency and Cardiovascular disease (cvd) HOWEVER a mechanistic LINK is missing.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ANOMALY_CURIOUS_FINDING', 139), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 110, 'cardiovascular')]
PMC4113768	7/2014	S2288-PMC4113768	['the PRESENT cross-sectional STUDY AIMS TO DETERMINE the prevalence and RISK FACTORS of Vitamin D deficiency among Premenopausal women visiting commercial centers in riyadh city.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 71)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 114, 'premenopausal')]
PMC4113768	7/2014	S2393-PMC4113768	['background: we performed a systematic review TO EXPLORE WHETHER (1) low maternal circulating 25(Oh)-Vitamin D (25(Oh)D) during Pregnancy is ASSOCIATED with impairment of offspring health; and (2) maternal supplementation with Vitamin D in Pregnancy MIGHT ameliorate these EFFECTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 272)]	5	[('CHEBI_63056', 'zinc cation', 93, '25(OH'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4113768	7/2014	S2421-PMC4113768	['conclusions: in addition to the mechanistic INSIGHTS afforded by ASSOCIATIONS between maternal free 25(oh)-Vitamin D index, rxra methylation in Umbilical Cord dna, and childhood bmc, such epigenetic marks in early Life MIGHT represent NOVEL BIOMARKERS for adverse bone outcomes in the offspring.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 219), ('FULL_UNKNOWN', 235), ('SUPERFICIAL_RELATIONSHIP', 241)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 144, 'umbilical cord'), ('UBERON_0000104', 'life cycle', 214, 'life')]
PMC4113768	7/2014	S2424-PMC4113768	['contemporary and historical EVIDENCE INDICATES the VALUE of Vitamin D in treating tb and Genetic variation in Vitamin D receptors HAS BEEN LINKED to ethnic variations in tb.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S2443-PMC4113768	['FURTHER STUDIES to identify the UNDERLYING mechanisms RELATING to the very high levels of Vitamin D deficiency in tb patients from the horn of africa and indian subcontinent will have IMPLICATIONS for understanding the ROLE of Vitamin D in tb aetiology as well as for the prevention and treatment of active tuberculous disease in these patients.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 184), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4113768	7/2014	S2638-PMC4113768	['THERE IS EVIDENCE TO SUPPORT a ROLE for Vitamin D in muscle function, YET LITTLE IS KNOWN about the ROLE of Antenatal 25(Oh)D exposure in programming muscle development.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 70), ('FULL_UNKNOWN', 74), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC4113768	7/2014	S3079-PMC4113768	['; boyle, r.j.\nbackground: OBSERVATIONAL STUDIES SUGGEST high Prenatal Vitamin D intake MAY BE ASSOCIATED with reduced childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('GO_0007565', 'female pregnancy', 61, 'prenatal'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4113768	7/2014	S3097-PMC4113768	['THE CURRENT STUDY was DESIGNED TO IDENTIFY the EFFECT of Vitamin D insufficiency and deficiency (vdid) and host Genetic Single Nucleotide Polymorphisms (Snps) that alter Vitamin d receptor Expression on the RISK for tb in hiv-infected and –exposed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 207)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('SO_0000704', 'gene', 112, 'genetic'), ('SO_0000694', 'SNP', 120, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 153, 'SNPs'), ('CHEBI_33229', 'vitamin (role)', 170, 'Vitamin'), ('GO_0010467', 'gene expression', 189, 'expression')]
PMC4113768	7/2014	S3328-PMC4113768	['when ADDITIONAL EVIDENCE on EFFECTS RELATED to Vitamin D from OBSERVATIONAL studies with respect to Serum 25(Oh)D level or personal uvb irradiance, the ROLE of skin pigmentation, and laboratory studies of mechanisms, hill’s criteria for causality in a biological system (hill ab.']	[('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D')]
PMC4169453	9/2014	S11-PMC4169453	['conclusions\nVitamin D supplementation at a dose of 400 iu/d was not sufficient to maintain 25(Oh)D >20 ng/ml in nursing women, WHILE 1200 iu/d APPEARED more EFFECTIVE, but had no effect on Breastfed offspring Vitamin D status, or changes in the bone mass and the body composition OBSERVED in both during breastfeeding.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('ANOMALY_CURIOUS_FINDING', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 280)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('GO_0007567', 'parturition', 189, 'breastfed'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4169453	9/2014	S126-PMC4169453	['the EFFECT of group (Vitamin D dose) x time INTERACTION ( p \u200a=\u200a0.0004) and the EFFECT of time (p<0.0001) on maternal Serum 25(Oh)D level were statistically significant, BUT the EFFECT of group (Vitamin D dose) was not ( p \u200a=\u200a0.25).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 123, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4169453	9/2014	S197-PMC4169453	['taking into account the maternal REQUIREMENT, 1200 iu/d of Vitamin D MAY PROTECT against Vitamin D deficiency, but SEEMS TOO low TO fully replenish Vitamin D insufficiency (20 ng/ml<25(Oh)D <30 ng/ml).']	[('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 73), ('ANOMALY_CURIOUS_FINDING', 115), ('DIFFICULT_TASK', 121)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 182, '25 ... OH ... D')]
PMC4169453	9/2014	S212-PMC4169453	['ANOTHER INTERESTING OBSERVATION RELATES to pth as a functional MARKER of Vitamin D status in Adults, children and infants but not necessarily in neonates[44]–[47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults')]
PMC4169453	9/2014	S241-PMC4169453	['Vitamin D3 supplementation at a dose of 1200 iu/d is more EFFECTIVE at improving Vitamin D status of nursing women, but STILL SEEMS TOO low TO fully replenish Vitamin D deficiency/insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 120), ('IMPORTANT_CONSIDERATION', 120), ('ANOMALY_CURIOUS_FINDING', 126), ('DIFFICULT_TASK', 132)]	5	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4188019	1/2010	S66-PMC4188019	['with NEW date on the ROLE of Vitamin D besides bone Metabolism, SOME authors are PLEADING for higher cut-off values to determine deficiency (norman et al., 2007; sachan et al., 2005; wagner et al., 2008).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0008152', 'metabolic process', 52, 'metabolism')]
PMC4193194	10/2014	S190-PMC4193194	['ALIGNED with this FINDINGS, the cochrane collaboration initiative have CONCLUDED on its latest review on Antioxidants for preventing pe that evidence from trials reviewed does NOT SUPPORT the use of Vitamin C and E during Pregnancy for the PREVENTION of Preeclampsia and other outcomes (rumbold et al.,2008; salles et al.,2012).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'E'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 254, 'preeclampsia')]
PMC4210909	10/2014	S91-PMC4210909	['iron status CAN also be AFFECTED by the intake of OTHER Nutrients that MAY inhibit (e.g., calcium, phytates) OR promote (e.g., Vitamin C) iron absorption [43].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin C')]
PMC4251419	12/2014	S9-PMC4251419	['clues from epidemiology\nindications that Vitamin D MAY BE ASSOCIATED with disorders of Human Immune function OFTEN originate from OBSERVATIONS of geographic VARIATION in disease occurrence.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 109), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 157)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 87, 'human'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4251419	12/2014	S23-PMC4251419	['HOWEVER, for AT LEAST some of the Immune-RELATED diseases, it is DIFFICULT to determine WHETHER low sun exposure OR Vitamin D cause, OR are caused by, the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	5	[('UBERON_0002405', 'immune system', 34, 'immune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4251419	12/2014	S26-PMC4251419	['lower Vitamin D status HAS BEEN LINKED to increased risk of multiple sclerosis (see case study [14]) and to type 1 diabetes [15], although not all studies SHOW a PROTECTIVE ASSOCIATION [16].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4251419	12/2014	S72-PMC4251419	['it is CHALLENGING to DIFFERENTIATE between Vitamin D-DEPENDENT and INDEPENDENT pathways in the EFFECT of sun exposure on disease risk.']	[('DIFFICULT_TASK', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4251419	12/2014	S117-PMC4251419	['other studies SUGGEST that the microbiome MAY modify the capacity of Tissue Regulation by Vitamin D. in Rodent MODELS, Probiotics CAN upregulate Expression of the vdr in the Colon, reducing inflammation and delaying the transition to dysplasia and cancer [75].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 130)]	5	[('UBERON_0000479', 'tissue', 69, 'tissue'), ('GO_0065007', 'biological regulation', 76, 'regulation'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 104, 'rodent'), ('CHEBI_26346', 'prostaglandins J', 119, 'probiotics'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0001155', 'colon', 174, 'colon')]
PMC4256222	12/2014	S10-PMC4256222	['adjustment for Vitamin D status strengthened this ASSOCIATION (1.82, 1.12–2.97), which INDICATED a POTENTIAL seasonal IMPACT on offspring fractures INDEPENDENT of maternal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4258799	11/2014	S307-PMC4258799	['BASED ON their findings, it SEEMS that a combination of Vitamin E and Selenium had a more significant IMPACT on motility compared to morphology.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 70, 'selenium')]
PMC4289064	1/2015	S26-PMC4289064	['we FOCUSED our analyses on children and women in developing countries, where high rates of malnutrition and limited access to Nutrient Supplements MAY make Individuals more susceptible to the EFFECTS of pollinator declines, and analyzed five of the most IMPORTANT Nutrients to global nutrition: Vitamin A, zinc, iron, Folate, and Calcium[14],[15](data on Iodine, another globally IMPORTANT Nutrient, were not available in the datasets we analyzed).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 254), ('IMPORTANT_CONSIDERATION', 380)]	5	[('CHEBI_33284', 'nutrient', 126, 'nutrient'), ('CHEBI_33341', 'titanium atom', 135, 'supplements'), ('NCBITaxon_1', 'root', 156, 'individuals'), ('CHEBI_33284', 'nutrient', 264, 'nutrients'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 318, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 330, 'calcium'), ('CHEBI_24859', 'iodine atom', 355, 'iodine'), ('CHEBI_33284', 'nutrient', 390, 'nutrient')]
PMC4289064	1/2015	S88-PMC4289064	['we also TESTED the INFLUENCE of uncertainty in the CONTRIBUTION of pollinators to crop yields on our results for Vitamin A Intake in children and FOUND that WHILE the specific values for the proportion of the population at risk of Nutrient deficiency changed slightly if we used the minimum, midpoint, or maximum percent yield due to pollinators of the categories defined by klein et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin A'), ('GO_0007631', 'feeding behavior', 123, 'intake'), ('CHEBI_33284', 'nutrient', 231, 'nutrient')]
PMC4302429	1/2015	S34-PMC4302429	['the AIMS of THIS STUDY were (i) TO INVESTIGATE the immunomodulatory capacity of Vitamin D and (ii) TO EXAMINE the IMPACT of Vitamin D3 supplementation as a preventive or adjuvant therapeutic intervention on the course and mortality of experimental E. Coli meningoencephalitis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('CHEBI_33279', 'vitamin D5', 124, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 124, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 248, 'E. coli')]
PMC4302429	1/2015	S125-PMC4302429	['high Vitamin D3 concentrations inhibited the Production of proinflammatory cytokine Il-6 and increased production of anti-inflammatory cytokine Il-10, WHILE Ifn-Γ production in the Cns stayed unaffected\nPREVIOUS investigations REVEALED that Vitamin D plays IMPORTANT ROLES in signaling in both the Adaptive and Innate Immune Response To Viral and bacterial Infection [16,25].']	[('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 227), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267)]	5	[('CHEBI_33279', 'vitamin D5', 5, 'vitamin D3'), ('GO_0007128', 'meiotic prophase I', 45, 'production'), ('PR_000001470', 'interleukin-28B', 84, 'IL-6'), ('PR_000001470', 'interleukin-28B', 144, 'IL-10'), ('PR_000008920', 'interferon alpha-7', 157, 'IFN-γ'), ('UBERON_0001017', 'central nervous system', 181, 'CNS'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0051886', 'negative regulation of timing of anagen', 298, 'adaptive ...'), ('GO_0045048', 'protein insertion into ER membrane', 311, 'innate immune response to ... infection'), ('UBERON_0002405', 'immune system', 318, 'immune'), ('NCBITaxon_1', 'root', 337, 'viral')]
PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]
PMC4329404	10/2014	S0-PMC4329404	['Vitamin D deficiency induces th2 skewing and Eosinophilia in neonatal allergic Airways disease\n\nabstract\n\nbackground\nASSOCIATIONS between Vitamin D status and childhood asthma are increasingly REPORTED, but direct causation and mechanisms UNDERLYING an EFFECT remain UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 239), ('SUPERFICIAL_RELATIONSHIP', 253), ('FULL_UNKNOWN', 267)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000771', 'eosinophil', 45, 'eosinophilia'), ('UBERON_0001005', 'respiratory airway', 79, 'airways'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4329404	10/2014	S23-PMC4329404	['Cord Blood Vitamin D levels inversely CORRELATED with wheeze (17), WHILE a u-shaped RELATIONSHIP with total and Antigen-specific Ige HAS BEEN OBSERVED in a population of children in arizona (18).']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 142)]	5	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_59132', 'antigen', 112, 'antigen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE')]
PMC4329404	10/2014	S150-PMC4329404	['studies in asthmatic children HAVE SHOWN ASSOCIATIONS between low Vitamin D status and increased use of inhaled Steroids (34), SUGGESTING the immunomodulatory EFFECTS of Vitamin D MAY impact on efficacy of Steroids.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 180)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_35341', 'steroid', 112, 'steroids'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_35341', 'steroid', 206, 'steroids')]
PMC4329404	10/2014	S157-PMC4329404	['our data SUGGEST Vitamin D is playing a widespread ROLE in Immunomodulation, and further SUGGESTS that supplementation MAY BE beneficial and MAY reduce disease severity.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 59, 'immunomodulation')]
PMC4329745	10/2014	S1-PMC4329745	['objectives:\nthe AIM of THIS STUDY was TO DETERMINE the prevalence and ASSESS some risk FACTORS of Vitamin D deficiency among women attending our clinics in tehran, the capital of iran.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 87)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4329745	10/2014	S15-PMC4329745	['objectives\nthe AIM of THIS STUDY was TO DETERMINE the prevalence and ASSESS some risk FACTORS of Vitamin D deficiency among women aged 20-80 attending our clinics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('SUPERFICIAL_RELATIONSHIP', 86)]	5	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4329745	10/2014	S94-PMC4329745	['OTHER POSSIBLE causes of reduced Vitamin D Synthesis in the skin in our area COULD BE dark skin color, indoor lifestyle and air pollution (2); lack of dietary fortification with Vitamin D multivitamin supplements MIGHT as well AGGRAVATE the situation in iranian women (18).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 227)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 33, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4329745	10/2014	S96-PMC4329745	['ON THE OTHER HAND, Blood samples were taken REGARDLESS OF season or weather conditions WHEREAS this COULD INFLUENCE the Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4340999	3/2015	S98-PMC4340999	['up to now, a FEW STUDIES have EXAMINED the ASSOCIATION between lower maternal Vitamin D levels in later Pregnancy and offspring adiposity at age 6 years34; at birth, age 9 months and age 9 years35; at ages 5 and 9.5 years36; and at age 35 years,37and shown INCONSISTENT results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy')]
PMC4377870	3/2015	S93-PMC4377870	['indeed an epidemiological study in the united kingdom of over 7000 Adults aged 45–74 years FOUND that increased Plasma Vitamin C concentration was ASSOCIATED with a decreased risk of obstructive Airways disease, SUGGESTIVE of a PROTECTIVE EFFECT [69].']	[('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0007023', 'adult organism', 67, 'adults'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin C'), ('UBERON_0001005', 'respiratory airway', 195, 'airways')]
PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
PMC4377870	3/2015	S134-PMC4377870	['THOUGH like Vitamin C, it MAY BE DIFFICULT to disentangle the EFFECTS of Flavonoids from OTHER Nutrients in Flavonoid-rich foods.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin C'), ('PR_000004900', 'complement C3', 20, 'C'), ('CHEBI_72544', 'flavonoids', 73, 'flavonoids'), ('CHEBI_33284', 'nutrient', 95, 'nutrients'), ('CHEBI_47916', 'flavonoid', 108, 'flavonoid')]
PMC4377870	3/2015	S163-PMC4377870	['copd exacerbations are GENERALLY caused by Viral or bacterial Lung infections, and THOUGH Vitamin D has a positive ROLE in reducing infection, there is NO EVIDENCE to support that Vitamin D is ASSOCIATED with ameliorating exacerbations in copd patients [129].']	[('PROBABLE_UNDERSTANDING', 23), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('NCBITaxon_1', 'root', 43, 'viral'), ('UBERON_0002048', 'lung', 62, 'lung'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC4377879	3/2015	S93-PMC4377879	['observational or experimental data LINKING Water-soluble Vitamins to any risk of maternal mortality are APPARENTLY unavailable [21]; these Vitamins, such as Vitamin C, Thiamin, niacin and riboflavin and others, do HOWEVER APPEAR to decline in Serum or Plasma levels, LIKELY due to extra uptake by the foetus or haemodilution, or in the case of niacin also increased Urinary Excretion [21].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('ANOMALY_CURIOUS_FINDING', 222), ('PROBABLE_UNDERSTANDING', 267)]	5	[('CHEBI_15377', 'water', 43, 'water'), ('CHEBI_33277', 'gamma-tocotrienol', 57, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 139, 'vitamins'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 168, 'thiamin'), ('UBERON_0001977', 'blood serum', 243, 'serum'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('GO_0046802', 'exit of virus from host cell nucleus by nuclear egress', 366, 'urinary excretion'), ('UBERON_0001088', 'urine', 366, 'urinary')]
PMC4380518	9/2014	S47-PMC4380518	['discussion\nour data SUGGEST that WHILE Prenatal pnv use is ASSOCIATED with lower odds of Vitamin D deficiency, the ASSOCIATION is NOT UNIFORM.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 115), ('DIFFICULT_TASK', 130)]	5	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4383226	2/2015	S102-PMC4383226	['we FOUND no indication of an elevated gender EFFECT for either dtp or Vitamin A, ALTHOUGH the latter SEEMED TO BE more PROTECTIVE among children living in communities with higher Allele frequencies for x-linked g6pdd.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 81), ('ANOMALY_CURIOUS_FINDING', 101), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('SO_0001023', 'allele', 179, 'allele')]
PMC4383226	2/2015	S106-PMC4383226	['all of the epidemiological EVIDENCE TO SUPPORT the DETRIMENTAL gender-BASED EFFECTS from Vitamin A and dtp on child mortality comes from guinea bissau (benn et al., 2009a,b2009b;fisker et al., 2013).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S122-PMC4383226	['this analysis SHOWED that when mozambique data were EXCLUDED from Blood film analysis, the magnitude of PROTECTIVE Vitamin A EFFECTS in both Blood film and antigenemia MODELS were nearly identical.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 168)]	5	[('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4383226	2/2015	S134-PMC4383226	['given that Vitamin A is fat soluble and CAN be stored in the Liver for long periods of time (blomhoff, 1994;tanumihardjo, 2011), ADDITIONAL RESEARCH IS NEEDED to examine WHETHER regular supplementation has an IMPACT on increased protection.']	[('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 129), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0002107', 'liver', 61, 'liver')]
PMC4383575	1/2015	S187-PMC4383575	['maternal Intake of fruits rich in Vitamin C was ASSOCIATED with lower adduct levels in Cord Blood, which is IN LINE WITH PREVIOUS FINDINGS; inverse ASSOCIATIONS with vitamin c HAVE BEEN REPORTED in Adults (palli et al.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 176)]	5	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin C'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0007023', 'adult organism', 198, 'adults')]
PMC4383575	1/2015	S254-PMC4383575	['several POTENTIAL modifiable FACTORS (e.g., higher maternal pre-Pregnancy bmi, low maternal Intake of healthy Foods, and low Intake of fruits rich in Vitamin C) were IDENTIFIED as POTENTIAL RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 190)]	5	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007631', 'feeding behavior', 92, 'intake'), ('CHEBI_33290', 'food', 110, 'foods'), ('GO_0007631', 'feeding behavior', 125, 'intake'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin C')]
PMC4396835	1/2015	S128-PMC4396835	['ACCORDINGLY, the swedish somali women and women from the middle east SEEM PARTICULARLY vulnerable to low Vitamin D levels, AFFECTING the Vitamin D status of the offspring, PRESUMABLY due to both dark skin [32] and covered clothing.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 172)]	5	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4396835	1/2015	S131-PMC4396835	['in conjunction with the elevated incidence of asd in these populations, this MAY SUPPORT a ROLE of Vitamin D deficiency - RATHER than OTHER seasonal factors - in the Development Of Autism.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	5	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 166, 'development of autism')]
PMC4396835	1/2015	S136-PMC4396835	['PREVIOUS FINDINGS of low levels of Vitamin D COULD REFLECT the CONSEQUENCES of asd per se, that is, the IMPACT of a Person’s indoor lifestyle and circumscribed diet.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBLEM_COMPLICATION', 63), ('SUPERFICIAL_RELATIONSHIP', 104)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'person')]
PMC4396835	1/2015	S167-PMC4396835	['HOWEVER, as low Vitamin D is SUGGESTED to CONTRIBUTE to the pathogenesis of autoimmunity [69], OUR FINDINGS COULD BE relevant in this context as well.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 108)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4405493	4/2015	S126-PMC4405493	['BECAUSE Vitamin D deficiency is so widespread, determining WHETHER Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes is an area of MAJOR PUBLIC HEALTH CONCERN.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4405493	4/2015	S147-PMC4405493	['the ROLE Vitamin D plays in adverse clinical outcomes such as Preeclampsia, Gestational diabetes, Preterm Labor, growth restriction, and spontaneous Abortion is SPECULATIVE, but MAY INVOLVE Vitamin D’s Regulation Of Placental Trophoblast Invasion and Angiogenesis, in addition to its anti-inflammatory properties [5].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 182), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 62, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 76, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 98, 'preterm labor'), ('GO_0007569', 'cell aging', 149, 'abortion'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_1900101', 'regulation of endoplasmic reticulum unfolded protein response', 202, 'regulation of ... invasion ...'), ('UBERON_0001987', 'placenta', 216, 'placental'), ('UBERON_0000088', 'trophoblast', 226, 'trophoblast'), ('GO_0001525', 'angiogenesis', 251, 'angiogenesis')]
PMC4405493	4/2015	S155-PMC4405493	['THUS, in combination with its immunomodulatory and anti-inflammatory properties, Vitamin D MAY play a POTENTIAL ROLE in the PREVENTION of Preterm Birth and small-for-Gestational-age neonates.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'preterm birth'), ('GO_0007565', 'female pregnancy', 166, 'gestational')]
PMC4417995	4/2015	S80-PMC4417995	['this would be a CONSEQUENCE of Vitamin D decreased production in covered skin areas, THUS INDICATING a local PROTECTIVE EFFECT of Vitamin D against the development of ad lesions.']	[('PROBABLE_UNDERSTANDING', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4417995	4/2015	S110-PMC4417995	['[30] also EVIDENCED that breastfeeding is GENERALLY ASSOCIATED with low Vitamin D intake, AS OPPOSED TO replacement formulas and dairy drinks fortified with Vitamin D, which provide a CONSIDERABLY higher Intake.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC4427001	4/2015	S95-PMC4427001	['finally, SEVERAL STUDIES SUGGEST that Vitamin D COULD play a ROLE in the pathogenesis of diabetes mellitus type 2 by AFFECTING Insulin sensitivity of Β Cell function [36,37].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 117)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('PR_000045358', 'insulin family protein', 127, 'insulin'), ('CL_0000570', 'parafollicular cell', 150, 'β cell')]
PMC4448820	5/2015	S68-PMC4448820	['phase i of the bond program included an evaluation of 6 Nutrients— zinc, iron, Folic Acid, Vitamin B-12, Vitamin A, and Iodine—chosen for their PUBLIC HEALTH IMPORTANCE and BECAUSE they represent the range of ISSUES confronting those who are addressing the ROLE of nutrition in research, clinical care, or program development/evaluation.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158), ('PROBABLE_UNDERSTANDING', 173), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 257)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_30751', 'formic acid', 79, 'folic acid'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 120, 'iodine')]
PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]
PMC4448820	5/2015	S572-PMC4448820	['an Animal study INDICATED that a high Vitamin A intake MAY BE LINKED to asthma (164), an ASSOCIATION that REMAINS TO BE STUDIED in Humans.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 89), ('FULL_UNKNOWN', 106)]	5	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'humans')]
PMC4448820	5/2015	S578-PMC4448820	['one POSSIBLE EXPLANATION for the APPARENT lack of benefit of Vitamin A supplementation below 6 mo of age is that infants in SUCH studies are PROTECTED from infection by maternally derived Immune factors (e.g., Serum Igg, factors in Breast Milk) to a greater degree than are older infants.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 33), ('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('UBERON_0002405', 'immune system', 188, 'immune'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('UBERON_0001348', 'brown adipose tissue', 232, 'breast milk')]
PMC4448820	5/2015	S1447-PMC4448820	['text box 47 provides a summary of currently available BIOMARKERS of Vitamin A.\n\ncaption (boxed-text): text box 47\u2003\nCURRENTLY available indicators of Vitamin A\n\n● night blindness: primary functional BIOMARKER\n● Serum Retinol:\n○ Retinol in Serum measured by hplc is the most widely used and ACCEPTED INDICATOR for Vitamin A status.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 298)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('UBERON_0001977', 'blood serum', 210, 'Serum'), ('CHEBI_26536', 'retinoic acid', 216, 'retinol'), ('CHEBI_27810', 'resorcinol', 227, 'Retinol'), ('UBERON_0001977', 'blood serum', 238, 'serum'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin A')]
PMC4452099	6/2015	S14-PMC4452099	['there are several REASONS to SUGGEST that Vitamin D supplementation early in Life MAY CONTRIBUTE to PREVENTING t1d.']	[('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000104', 'life cycle', 77, 'life')]
PMC4452099	6/2015	S28-PMC4452099	['the AIM of THIS STUDY was TO ASSESS WHETHER Gestational and early Infancy exposure to small extra doses of Vitamin D coming from fortified Margarine INFLUENCED the risk of developing t1d later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0000023', 'wing', 66, 'infancy'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_6784', 'mestranol', 139, 'margarine'), ('UBERON_0000104', 'life cycle', 196, 'life')]
PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
PMC4466139	6/2015	S88-PMC4466139	['these two classifications of Vitamin D status are significantly DIVERGENT and the issue of DESIRABLE Vitamin D levels for a given age is a matter of great DEBATE, especially in the light of the Skeletal and Extraskeletal EFFECTS of Vitamin D (these were NOT BEEN INVESTIGATED in this study).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 221), ('FULL_UNKNOWN', 254)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004288', 'skeleton', 194, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 207, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC4466139	6/2015	S98-PMC4466139	['the mechanisms INVOLVED in this reduction of neonatal 25Ohd levels are NOT YET KNOWN; it MAY BE the result of DIFFERENT Vitamin D binding proteins concentrations OR a different 25Ohd half-life in the neonatal age [23,32].']	[('SUPERFICIAL_RELATIONSHIP', 15), ('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 54, '25OHD'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD')]
PMC4466139	6/2015	S112-PMC4466139	['RECENTLY, an increasing NUMBER OF STUDIES HAVE SHOWN that higher doses of Vitamin D supplementation are SAFE and EFFECTIVE in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnant')]
PMC4466139	6/2015	S118-PMC4466139	['furthermore, AS maternal Vitamin D deficiency status AFFECTS the newborn, it MAY BE CONSIDERED as a risk FACTOR for other Vitamin D-related disorders in these newborns.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4488777	5/2015	S187-PMC4488777	['conclusions\nCURRENT RESEARCH on the ROLE of Vitamin D in Fertility impairments, such as polycystic Ovary syndrome, Uterine fibroids, improper Semen parameters and in the case of in vitro treatments and Pregnancy failure, SUGGESTS it plays an IMPORTANT ROLE in Human Reproduction processes.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 242), ('SUPERFICIAL_RELATIONSHIP', 252)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0009566', 'fertilization', 57, 'fertility'), ('UBERON_0000992', 'ovary', 99, 'ovary'), ('UBERON_0000995', 'uterus', 115, 'uterine'), ('UBERON_0001968', 'semen', 142, 'semen'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('GO_0000003', 'reproduction', 266, 'reproduction')]
PMC4488777	5/2015	S191-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health since there were no adverse EFFECTS REPORTED for Vitamin D intake of up to 10,000 iu/d [66], BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS still REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 197)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4499946	7/2015	S23-PMC4499946	['Vitamin D status is THEREFORE a logical CANDIDATE AS a modifiable nutritional DETERMINANT of linear growth in communities where stunting is prevalent and Vitamin D status is commonly SUBOPTIMAL.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 183)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4499946	7/2015	S41-PMC4499946	['BUILDING ON our EARLIER FINDINGS of a beneficial EFFECT of Prenatal Vitamin D supplementation on infant length in a PRELIMINARY TRIAL [26], we are conducting a larger dose-ranging trial of maternal Vitamin D3Supplementation in dhaka, bangladesh.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 116)]	5	[('GO_0007565', 'female pregnancy', 59, 'prenatal'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_52915', 'phosphatediyl group', 198, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'vitamin D3supplementation')]
PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]
PMC4516377	6/2015	S8-PMC4516377	['inverse RELATIONSHIP between Serum Vitamin D and measures of adiposity in children HAS BEEN OBSERVED and this ASSOCIATION was INFLUENCED by the sex of the patient and by the seasons of the year.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 110), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4516377	6/2015	S66-PMC4516377	['the mechanisms INVOLVED in the ASSOCIATION between obesity and Serum levels of Vitamin D have not been described specifically for children.figure 3shows the POSSIBLE mechanisms INVOLVED in the ASSOCIATION between Vitamin D and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4595656	10/2015	S2-PMC4595656	['a NUMBER OF STUDIES to date have investigated the EFFECTS of early-Life Vitamin D deprivation on Adult hippocampus in Animals and Humans, and there is a growing BODY OF EVIDENCE to SUGGEST a ROLE for this hormone in the development of selected hippocampal functions such as latent inhibition and hole board Habituation in Rats.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 191)]	5	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0007023', 'adult organism', 97, 'adult'), ('NCBITaxon_33208', 'Metazoa', 118, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('GO_0046959', 'habituation', 307, 'habituation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 322, 'rats')]
PMC4595656	10/2015	S8-PMC4595656	['IN LIGHT OF the IMPORTANCE of the hippocampus in ltp and spatial Learning, FURTHER INVESTIGATIONS on the early EFFECTS of Vitamin D deprivation on hippocampal development ARE WARRANTED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('FUTURE_WORK', 75), ('SUPERFICIAL_RELATIONSHIP', 111), ('FUTURE_WORK', 171)]	5	[('GO_0007612', 'learning', 65, 'learning'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4595656	10/2015	S9-PMC4595656	['introduction\nuntil a little over 30 years ago, the ROLE of hormonal Vitamin D was classically ASSOCIATED with Calcium Homeostasis, bone formation and maintenance, its up-Regulation by Parathyroid hormone being KNOWN for MANY YEARS.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 220)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 110, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 170, 'regulation'), ('UBERON_0001132', 'parathyroid gland', 184, 'parathyroid')]
PMC4595656	10/2015	S25-PMC4595656	['since then the investigation of a neural ROLE for Vitamin D has gained SIGNIFICANT traction and a PLETHORA OF Animal STUDIES have SHED LIGHT both on its presence and its biological activity within the Cns independent of Transport via the Blood-Brain Barrier.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 110, 'animal'), ('UBERON_0001017', 'central nervous system', 201, 'CNS'), ('GO_0006809', 'nitric oxide biosynthetic process', 220, 'transport'), ('UBERON_0000178', 'blood', 238, 'blood'), ('UBERON_0000052', 'fornix of brain', 244, 'brain barrier')]
PMC4595656	10/2015	S91-PMC4595656	['two STUDIES have investigated the EFFECT of a single treatment of 50 μg of Vitamin D on Neurotransmitter concentrations in offspring of Rats, and FOUND that within the hippocampus, levels of Serotonin and 5h1aa, BUT NOT Dopamine or hva, were negatively AFFECTED by the single treatment, which the authors referred to as Hormonal Imprinting (tekes et al.,2009a,b).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 146), ('ANOMALY_CURIOUS_FINDING', 212), ('SUPERFICIAL_RELATIONSHIP', 253)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 88, 'neurotransmitter'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 136, 'rats'), ('CHEBI_28790', 'serotonin', 191, 'serotonin'), ('CHEBI_18243', 'dopamine', 220, 'dopamine'), ('GO_0007601', 'visual perception', 320, 'hormonal'), ('GO_0071514', 'genetic imprinting', 329, 'imprinting')]
PMC4595656	10/2015	S106-PMC4595656	['this FINDING POINTS to DIFFERENTIAL EFFECTS of varying concentrations of Vitamin D on Cellular Hippocampal Development and WARRANT FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 123)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0045168', 'cell-cell signaling involved in cell fate commitment', 86, 'cellular hippocampal development')]
PMC4595656	10/2015	S121-PMC4595656	['this constitutes a MAJOR lacuna in our overall understanding of the ROLE of Vitamin D in the early development of the hippocampus and is an AVENUE RIPE for EXPLORATION.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 68), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4598849	10/2015	S6-PMC4598849	['THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth, and the risk of sga reduced at moderate concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4598849	10/2015	S9-PMC4598849	['WHETHER the common Vitamin D deficiency during Pregnancy CONTRIBUTES to any of the GLOBAL adverse fetal growth epidemic REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 83), ('FULL_UNKNOWN', 120)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC4600246	10/2015	S27-PMC4600246	['low levels of Vitamin K impair activation of Osteocalcin and decrease the activity of Osteoblasts (cells IMPORTANT for building bone).3334thus, Vitamin K is VITAL to the functionality of proteins such as Osteocalcin (IMPORTANT for building bone), (mgp, the most potent Arterial Calcification Inhibitor known) and the growth-arrest sequence-6 protein (Gas6, INVOLVED in Cell Growth Regulation35\nVitamin K HAS BEEN SHOWN to significantly delay the development of cac in a 3-year, double-blind, randomised controlled trial of 452 patients (229 patients on Vitamin K1And 223 patients in the control group).36all patients were assigned to a multivitamin (containing 1.6\u2005mg Thiamine, 1.8\u2005mg riboflavin, 2.1\u2005mg Vitamin B-6, 3\u2005µg Vitamin B12, 75\u2005mg Vitamin C, 12\u2005mg Vitamin E, 6\u2005mg Pantothenic Acid, 20\u2005mg niacin, 160\u2005µg Folate and 30\u2005µg of Biotin) as well as calcium (600\u2005mg Calcium Carbonate) and Vitamin D (Cholecalciferol 400\u2005iu).']	[('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 357), ('INCOMPLETE_EVIDENCE', 404)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 45, 'osteocalcin'), ('CL_0000062', 'osteoblast', 86, 'osteoblasts'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 204, 'osteocalcin'), ('UBERON_0001637', 'artery', 269, 'arterial'), ('GO_0051301', 'cell division', 278, 'calcification'), ('CHEBI_35222', 'inhibitor', 292, 'inhibitor'), ('PR_000008000', 'gap junction beta-4 protein', 351, 'Gas6'), ('GO_0071475', 'cellular hyperosmotic salinity response', 369, 'cell growth regulation35'), ('CHEBI_28384', 'vitamin K', 394, 'Vitamin K'), ('CHEBI_10124', 'zolmitriptan', 553, 'vitamin K1and'), ('PR_000017209', 'utrophin', 553, 'vitamin K1and'), ('CHEBI_26948', 'vitamin B1', 668, 'thiamine'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin B'), ('CHEBI_33279', 'vitamin D5', 722, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 741, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 758, 'vitamin E'), ('CHEBI_7916', 'pantothenic acid', 774, 'pantothenic acid'), ('CHEBI_30863', '5-azaorotic acid', 813, 'folate'), ('CHEBI_15956', 'biotin', 833, 'biotin'), ('CHEBI_3311', 'calcium carbonate', 868, 'calcium carbonate'), ('CHEBI_27300', 'vitamin D', 891, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 902, 'cholecalciferol')]
PMC4624803	10/2015	S85-PMC4624803	['adjustment was made for the covariates age of mother, smoking of mother, season of Birth january to march and season of Birth july to september.all childrenchildren with mothers Born in swedenestimate95% confidence limitsp-valueestimate95% confidence limitsp-valuemodel 1-0.77-2.32, 0.770.32-1.11-2.76, 0.530.18model 2-0.77-2.25, 0.700.30-1.08-2.77, 0.620.21model 3-1.00-2.40, 0.390.16-1.00-2.47, 0.460.18model 4-0.99-2.34, 0.360.15-1.11-2.66, 0.440.16\n\ndiscussion\nOUR STUDY FAILS to SUPPORT the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 465), ('PROBLEM_COMPLICATION', 475), ('INCOMPLETE_EVIDENCE', 484), ('INCOMPLETE_EVIDENCE', 496), ('SUPERFICIAL_RELATIONSHIP', 564)]	5	[('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 120, 'birth'), ('GO_0007567', 'parturition', 178, 'born'), ('CHEBI_27300', 'vitamin D', 526, 'vitamin D'), ('GO_0007565', 'female pregnancy', 543, 'pregnancy')]
PMC4632418	10/2015	S21-PMC4632418	['the scientific EVIDENCE LINKING Vitamin D deficiency with diabetes is GROWING large, but data investigating the RELATIONSHIP between Vitamin D levels and gdm are INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4632418	10/2015	S118-PMC4632418	['apart from diet and Supplements, ANOTHER way of keeping OPTIMAL level of body Vitamin D is from skin exposure to sunlight, which is REMARKABLY INFLUENCED by geographical location, season, dark skin tone, sunscreen use and EVEN the air pollution [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 132), ('SUPERFICIAL_RELATIONSHIP', 143), ('ANOMALY_CURIOUS_FINDING', 222)]	5	[('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4645901	8/2014	S14-PMC4645901	['WHILE an increase in government advertising would have CONTRIBUTED to the rise in uptake of Vitamin D supplementation, a leaflet proved to be a simple YET EFFECTIVE INTERVENTION in improving Vitamin uptake in babies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 55), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 155), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC4684854	12/2015	S70-PMC4684854	['(ii) commencement of supplementation at differing times during the Gestation MAY miss CRITICAL periods when Vitamin D MAY play a PIVOTAL ROLE.']	[('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 86), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('GO_0007565', 'female pregnancy', 67, 'gestation'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4684854	12/2015	S84-PMC4684854	['obesity presents a CONFOUNDING INFLUENCE in THIS discussion, however, AS a greater bmi is ASSOCIATED with lower Vitamin D levels as well as greater Insulin resistance and risk for Gestational diabetes.']	[('PROBLEM_COMPLICATION', 19), ('SUPERFICIAL_RELATIONSHIP', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0007565', 'female pregnancy', 180, 'gestational')]
PMC4684854	12/2015	S94-PMC4684854	['a systematic review and meta-analysis of 24 studies SUGGESTED that low maternal Vitamin D levels in Pregnancy MAY BE ASSOCIATED with an INCREASED RISK of small for Gestational age infants, as well as being LINKED to preeclampsia, Gestational diabetes, and Preterm Birth [66].']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 136), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('GO_0007565', 'female pregnancy', 230, 'gestational'), ('GO_0007565', 'female pregnancy', 256, 'preterm birth')]
PMC4684854	12/2015	S110-PMC4684854	['a RECENT body of work has begun TO SUGGEST that lower Gestational Vitamin D levels MAY also be ASSOCIATED with higher rates of pediatric atopic disease [77], food sensitivities [78], atopic dermatitis [79], eczema [80], asthma [81], impaired Lung function [82], allergic disease [83], and other conditions frequently characterized by a hypersensitive Immune state.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('GO_0007565', 'female pregnancy', 54, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002048', 'lung', 242, 'lung'), ('UBERON_0002405', 'immune system', 351, 'immune')]
PMC4689556	12/2015	S16-PMC4689556	['SEVERAL STUDIES have LINKED low Vitamin D status to a number of resource intensive childhood health PROBLEMS including allergy and infection [2–7], in addition to the WELL-ESTABLISHED EFFECTS on bone Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 100), ('PROBABLE_UNDERSTANDING', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0008152', 'metabolic process', 200, 'metabolism')]
PMC4689556	12/2015	S149-PMC4689556	['[39]\nstudies in OTHER populations, USUALLY with higher Prenatal Vitamin D status THAN ours, have FOUND an inverse RELATIONSHIP between Cord Blood 25(Oh) Vitamin D level and child health outcomes [4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_30778', 'gallic acid', 146, '25(OH)'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4689556	12/2015	S185-PMC4689556	['outcomes of a subsequent intervention trial SUGGEST that higher dose Vitamin D, and POSSIBLY combined mother/infant supplementation MAY BE NEEDED for positive health EFFECTS on the child [38].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4690051	12/2015	S74-PMC4690051	['BASED ON supplemental studies of Vitamin D during Pregnancy, a 10 ng/ml increase in 25(Oh)D has resulted in a PROTECTIVE odds ratio for healthy Pregnancy outcomes [37]; THUS, we ASSESSED such EFFECTS on Cognitive and language scaled scores.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 110), ('PROBABLE_UNDERSTANDING', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 192)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0050890', 'cognition', 203, 'cognitive')]
PMC4690051	12/2015	S136-PMC4690051	['THESE FINDINGS SUGGEST that SOME compensatory mechanisms MAY exist to minimize EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]
PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
PMC4719746	1/2016	S20-PMC4719746	['DESPITE the CONTROVERSIES RELATED to adverse outcomes, and LACK OF EVIDENCE of clear benefits of routine supplementation, most western countries RECOMMEND Vitamin D supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 145)]	5	[('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy')]
PMC4719746	1/2016	S139-PMC4719746	['our data also INDICATED that low SELF-REPORTED Intake of Vitamin D supplements was an INDEPENDENT RISK FACTOR for Vitamin D deficiency, also FOUND in an irish study [3].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 141)]	5	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4719746	1/2016	S152-PMC4719746	['the SMALL increase of 25(Oh)D OBSERVED among women with a slight deficiency at baseline who did not receive the recommendation, MAY BE RELATED to usual practices in norway of routinely RECOMMENDING a daily intake of 10\xa0μg Vitamin D as part of Antenatal Care [21].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 135), ('FUTURE_WORK', 185)]	5	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 22, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 243, 'antenatal care')]
PMC4729160	1/2016	S132-PMC4729160	['so in the FUTURE health public policy on Vitamin A SHOULD BE paid more ATTENTION on Pregnant women with pertinent INFLUENCE FACTORS of vad, accordingly, eliminate vad improve the nutritional status of chinese Pregnant women.']	[('FUTURE_WORK', 10), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 49, 'A'), ('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 209, 'pregnant')]
PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]
PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4765528	12/2015	S117-PMC4765528	['one of the MODELS that HAS BEEN POSTULATED is the ROLE of maternal Vitamin D status and Postnatal calcium transfer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 50)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 88, 'postnatal')]
PMC4765528	12/2015	S124-PMC4765528	['FINDINGS from the southampton women’ survey also CORROBORATE the ROLE of low maternal Vitamin D levels on offspring bone mass and SUGGESTS that the mechanism is RELATED to Umbilical Venous calcium concentrations [56,58].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0007118', 'umbilicus', 172, 'umbilical'), ('UBERON_0001638', 'vein', 182, 'venous')]
PMC4770602	1/2016	S63-PMC4770602	['Preeclampsia is one of the LEADING CAUSES of Maternal and Perinatal Morbidity and mortality which, Vitamin D HAS BEEN HYPOTHESIZED to INFLUENCE Preeclampsia RISK.']	[('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 157)]	5	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('GO_0007618', 'mating', 45, 'maternal ...'), ('GO_0019230', 'proprioception', 58, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 58, 'perinatal'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 144, 'preeclampsia')]
PMC4770602	1/2016	S71-PMC4770602	['this result is in SIMILAR with OTHER FINDINGS which REPORTED that Intake of milk, and THEREFORE Vitamin D and Calcium, during Pregnancy is ASSOCIATED with increased infant birth weight.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 86), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('GO_0007631', 'feeding behavior', 66, 'intake'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 110, 'calcium'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC4770602	1/2016	S77-PMC4770602	['THEREFORE, Calcium intake MAY CONFOUND an ASSOCIATION between maternal Vitamin D deficiency and preeclampsia RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 11, 'calcium'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4778858	3/2016	S108-PMC4778858	['these results are IN CONTRAST TO OTHER reports SUGGESTING that Vitamin D levels INFLUENCE the RISK of gdm [15,32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
PMC4785305	3/2016	S30-PMC4785305	['ONE STUDY from india, comparing non-intervention to Vitamin D supplementation groups, with the dose being DEPENDENT on 25(Oh)D levels at 20\u2005weeks Gestation, SHOWED that Vitamin D supplementation resulted in a significant difference in the achieved 25(Oh)D level at Delivery (43.1 (81.3) nmol/l in the former group versus 56.8 (47.5) nmol/l in the latter group).37hollis et al 36and sablok et al 37SHOWED that Vitamin D supplementation decreased the RISK of Preterm labour, Gestational diabetes and hypertensive complications (all combined).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 395), ('IMPORTANT_CONSIDERATION', 449)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 125, 'D'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 248, '25(OH)D'), ('GO_0007567', 'parturition', 265, 'delivery'), ('CHEBI_27300', 'vitamin D', 409, 'vitamin D'), ('GO_0007565', 'female pregnancy', 457, 'preterm'), ('GO_0007565', 'female pregnancy', 473, 'gestational')]
PMC4811107	3/2016	S20-PMC4811107	['these analyses COULD identify Pregnant women who NEED a Prenatal Vitamin D intervention tailored to them BASED ON the various characteristics, as well as identifying children who MAY have a lower level of 25(Oh)D at Birth and MAY BE prioritized for Vitamin D screening.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 226)]	5	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('GO_0007565', 'female pregnancy', 56, 'prenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('GO_0007567', 'parturition', 216, 'birth'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4811107	3/2016	S99-PMC4811107	['this DIFFERENCE LIKELY LED to the result in which women who were obese before Pregnancy were more LIKELY to have Delivered a child with Vitamin D deficiency COMPARED TO women who had a normal bmi (odds ratio = or = 2.1, 95% confidence interval = ci 1.2, 3.6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007567', 'parturition', 113, 'delivered'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4811441	3/2016	S136-PMC4811441	['also, an increase in 25(Oh)D ≥30 nmol/l was not associated with Pregnancy-induced hypertension.10.1371/journal.pone.0152198.t004\n\ncaption (table-wrap): table 4\nbivariable and multivariable logistic regression analysis of the DETERMINANTS of Pregnancy-induced hypertension.bivariablemultivariableabor95% cipbor95% ciplowerupperlowerupper25(Oh)D t10.0081.0081.0011.0140.0240.0021.0020.9931.0100.709obesity t10.3661.4430.8972.3210.131-0.1690.8440.4641.5380.844nulliparity0.3611.4351.0391.9830.0290.2051.2280.8541.7650.269excessive gwg0.4731.6041.1462.2460.0060.3631.4380.9952.0780.054preexisting medical condition t10.6321.8810.8764.0400.1050.0891.0930.4542.6290.842assisted reproduction0.1821.2000.7881.8280.3950.0841.0880.6561.8030.745tobacco use t1-0.6330.5310.2161.3080.169-0.4470.6400.2621.5630.327height0.0541.0551.0291.083<0.0010.0351.0351.0051.0660.021age ≥40 years t1-0.1410.8680.3732.0240.744-0.1920.8250.3122.1840.699dbp t10.0871.0911.0691.114<0.0010.0881.0921.0671.117<0.001\n25(Oh)d = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure,\ndichotomous: age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition and assisted reproduction\na.adjusted for multifetal Pregnancy, baseline employment status, Gestational age at t1, month of Conception and northern european country of Birth\n\ndiscussion\nthese results are the primary outcome of the gravid study–TO OUR KNOWLEDGE the FIRST STUDY reporting on the RELATIONSHIP between longitudinal Vitamin D status and its RELATION to pe and Gestational bp trajectory.']	[('SUPERFICIAL_RELATIONSHIP', 225), ('PROBABLE_UNDERSTANDING', 1438), ('INCOMPLETE_EVIDENCE', 1459), ('SUPERFICIAL_RELATIONSHIP', 1488), ('SUPERFICIAL_RELATIONSHIP', 1547)]	5	[('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_33010', 'chromide(1-)', 338, '(OH)D'), ('CHEBI_63056', 'zinc cation', 984, '25(OH'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 994, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1043, 'gestational'), ('UBERON_0000178', 'blood', 1084, 'blood'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1286, 'gestational'), ('GO_0007620', 'copulation', 1318, 'conception'), ('GO_0007567', 'parturition', 1362, 'birth'), ('CHEBI_27300', 'vitamin D', 1522, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1566, 'gestational')]
PMC4843009	4/2016	S120-PMC4843009	['the present OBSERVATIONS underscore the powerful direct or indirect INFLUENCE of 1,25(Oh)2D3On the Brain, which PRESUMABLY accounts FOR the various Cerebral EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 112), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_35448', '1,2-phenylene group', 83, '25(OH)2D3on'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0001893', 'telencephalon', 148, 'cerebral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4859539	5/2016	S1-PMC4859539	['THIS STUDY SOUGHT TO DETERMINE IF circulating Cathelicidin concentrations in healthy children are RELATED to the age of the child, body composition and Vitamin D status at Birth and at the time of the study visit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('PR_000006009', 'alpha-catulin', 46, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC4864049	1/2016	S351-PMC4864049	['in addition, WHILE THERE IS EVIDENCE that Vitamin D MAY increase Dna Demethylation of selected Gene Promoters, the mechanisms behind this EFFECT are NOT CLEAR\xa0[162].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 138), ('FULL_UNKNOWN', 149)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0006306', 'DNA methylation', 65, 'DNA demethylation'), ('SO_0000704', 'gene', 95, 'gene'), ('SO_0000167', 'promoter', 100, 'promoters')]
PMC4889866	5/2016	S9-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D, BUT NOT cord Vitamin D level, was ASSOCIATED with Viral tlr-triggered Il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('NCBITaxon_1', 'root', 110, 'viral'), ('PR_000001470', 'interleukin-28B', 130, 'IL-10')]
PMC4889866	5/2016	S14-PMC4889866	['in addition to allergic diseases, Vitamin D also partakes a POTENTIAL ROLE in Airway inflammation, THUS, STRONGLY LINKED with acute infectious illness such as upper or lower Respiratory Tract infections, sepsis, and hospitalization [7–10].']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 99), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 78, 'airway'), ('UBERON_0000065', 'respiratory tract', 174, 'respiratory tract')]
PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]
PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]
PMC4889866	5/2016	S96-PMC4889866	["ANOTHER RECENT publication had DEMONSTRATED that ALTHOUGH low levels of Vitamin D in the Cord Blood were ASSOCIATED with higher Airway resistance in childhood, maternal Vitamin D level was not related to the children's Airway resistance [20]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 49), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood'), ('UBERON_0001005', 'respiratory airway', 128, 'airway'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 219, 'airway')]
PMC4889866	5/2016	S109-PMC4889866	['FURTHER RESEARCH IS WARRANTED to investigate the mechanism in which maternal Vitamin D status AFFECTS neonatal tlr-RELATED Il-10 response.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 123, 'IL-10')]
PMC4889866	5/2016	S111-PMC4889866	['HOWEVER, in present analyses, ALBEIT an ASSOCIATION between maternal Vitamin D level and Viral Tlr-Triggered Il-10 Response, there was no effect on the PREVALENCE of infectious diseases during the first 12 months of Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('IMPORTANT_CONSIDERATION', 152)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'viral'), ('GO_0033153', 'T cell receptor V(D)J recombination', 95, 'TLR-triggered ... -10 response'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('UBERON_0000104', 'life cycle', 216, 'life')]
PMC4889866	5/2016	S112-PMC4889866	['our OBSERVATIONS are AT ODDS with SEVERAL STUDIES that SHOWED lower Vitamin D status to be ASSOCIATED with increased incidence or severity of infection during early childhood.']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4889866	5/2016	S113-PMC4889866	['HOWEVER, most studies that SHOWED PROTECTIVE EFFECT of Vitamin D against Respiratory diseases were of interventional studies that used supplementary Vitamin D and DID NOT measure Serum Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 73, 'respiratory'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4889866	5/2016	S115-PMC4889866	['DEMONSTRATED an ASSOCIATION between low Cord Blood Vitamin D level and increased Respiratory syncytial Virus infections in infancy, HOWEVER, UNLIKE our participants, around 50% of their neonates were Vitamin D sufficient [27–29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141)]	5	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 81, 'respiratory'), ('NCBITaxon_1', 'root', 103, 'virus'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4889866	5/2016	S118-PMC4889866	['these INCONSISTENT OBSERVATIONS POINT to the COMPLICATED ROLE of Vitamin D in the Immune modulation and disease process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 57)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC4889866	5/2016	S121-PMC4889866	['first, the predominantly low Serum level of 25(Oh)D in THIS STUDY has LIMITED our ability TO DETERMINE WHETHER there is an ASSOCIATION between higher concentration of Vitamin D and infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 70), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4889866	5/2016	S124-PMC4889866	['THUS, FUTURE STUDIES RELATED to the EFFECT of Prenatal Vitamin D level on neonatal Innate Immunity and subsequent health outcomes will NEED to focus on populations with more Vitamin d sufficient Pregnant mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 135)]	5	[('GO_0007565', 'female pregnancy', 46, 'prenatal'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0045087', 'innate immune response', 83, 'innate immunity'), ('CHEBI_33229', 'vitamin (role)', 174, 'vitamin'), ('GO_0007565', 'female pregnancy', 195, 'pregnant')]
PMC4889866	5/2016	S130-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D level, BUT NOT cord Vitamin D, was ASSOCIATED with Tlr3 and Tlr7-8 triggered il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 110, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 119, 'TLR7')]
PMC4896250	4/2016	S3551-PMC4896250	['objectives\nTHIS STUDY AIMED TO DETERMINE the prevalence of Vitamin D deficiency in exclusively Breastfed infants and TO EVALUATE its RELATIONSHIP between pth in this population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 133)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'breastfed')]
PMC4896250	4/2016	S3696-PMC4896250	['THIS STUDY SOUGHT TO EVALUATE WHETHER Genetic variants in the Vitamin D pathway-related Genes are ASSOCIATED with allergic rhinitis in a han chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('SO_0000704', 'gene', 38, 'genetic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007601', 'visual perception', 62, 'vitamin D'), ('SO_0000704', 'gene', 88, 'genes')]
PMC4896250	4/2016	S4149-PMC4896250	['emerging EVIDENCE has IMPLICATED Vitamin D as a CRITICAL REGULATOR of Immunity, playing a ROLE in both the innate and cell-Mediated Immune Systems.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007566', 'embryo implantation', 70, 'immunity'), ('GO_0007127', 'meiosis I', 123, 'mediated immune'), ('UBERON_0002405', 'immune system', 132, 'immune systems')]
PMC4896250	4/2016	S6528-PMC4896250	['we SOUGHT TO DETERMINE WHETHER the immunomodulatory properties of Vitamin D MIGHT have beneficial EFFECTS on crs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4897157	5/2016	S123-PMC4897157	['THEREFORE, we SUGGEST that sun exposure and Vitamin D status during infancy MAY have an IMPACT on the LIKELIHOOD of developing allergic diseases.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('PROBABLE_UNDERSTANDING', 102)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4897157	5/2016	S153-PMC4897157	['to CONFIRM the EFFECT of sun exposure during infancy on the development of Allergic Diseases, FURTHER prospective INVESTIGATIONS that measure Serum Vitamin D levels ARE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 94), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 169)]	5	[('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 75, 'allergic diseases'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4903143	5/2016	S157-PMC4903143	['AS operative Delivery via caesarean Section MAY result in deficiency or disruption of a healthy biome, steps to diminish the need for operative Delivery by addressing POTENTIALLY modifiable DETERMINANTS such as elevated bmi [159] and Vitamin D deficiency [94] in Pregnancy MAY BE in order.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 190), ('INCOMPLETE_EVIDENCE', 273)]	5	[('GO_0007567', 'parturition', 13, 'delivery'), ('GO_0007601', 'visual perception', 36, 'section'), ('GO_0007567', 'parturition', 144, 'delivery'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 263, 'pregnancy')]
PMC4923982	5/2016	S64-PMC4923982	['we also ASSESSED the POSSIBILITY that bmi (<25 = referent vs. ≥25), smoking (never = referent vs. ever), dietary Vitamin C intake (below median = referent vs. median or above) and dietary Calcium Intake (below median = referent vs. median or above) MAY have synergistic or antagonistic EFFECTS on the ASSOCIATION between dietary iron intake and gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 286), ('SUPERFICIAL_RELATIONSHIP', 301)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin C'), ('CHEBI_22313', 'alkaline earth metal atom', 188, 'calcium'), ('GO_0007631', 'feeding behavior', 196, 'intake')]
PMC4930210	7/2016	S9-PMC4930210	['introduction\nVitamin D plays an IMPORTANT ROLE in promoting healthy Pregnancy and Fetal Development, and POOR Vitamin D status HAS BEEN ASSOCIATED with adverse maternal and infant health [1].']	[('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007608', 'sensory perception of smell', 68, 'pregnancy ...'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 82, 'fetal development'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4930210	7/2016	S20-PMC4930210	['HOWEVER, THESE STUDIES used sub-optimal quantification methods (radio-immunoassays) and DID NOT CONSIDER the POTENTIAL CONTRIBUTION of dietary Vitamin D to total intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4930210	7/2016	S139-PMC4930210	['one STRENGTH of THE CURRENT STUDY is its use of a quantification method capable of ACCURATELY measuring 25(Oh)D (separating epimer) and adding the potential CONTRIBUTION of dietary Vitamin D to the total intake ESTIMATE.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 211)]	5	[('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4930210	7/2016	S143-PMC4930210	['the fact that season significantly AFFECTED 25(Oh)D concentration BUT NOT 3-epi-25(oh)d3suggests that Vitamin D supplements COULD BE a source for 3-Epi-25(Oh)D3As SHOWN in a PREVIOUS STUDY [30].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 174)]	5	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 50, 'D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_63219', "alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer", 146, '3-epi-25(OH)D3as'), ('PR_000006270', 'triokinase/FMN cyclase', 158, 'D3as')]
PMC4930210	7/2016	S170-PMC4930210	['this FINDING EXTENDS the literature SUGGESTING that 600 iu/day MAY not be enough to achieve Vitamin D status >75 nmol/l in Pregnant women residing in higher latitudes with limited sun exposure.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant')]
PMC4934634	11/2015	S1-PMC4934634	['RECENT RESEARCH has SUGGESTED that Vitamin D MAY exert a broad RANGE of ROLES throughout the Human Life Cycle starting from Reproduction to Adult chronic disease risk.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('SUPERFICIAL_RELATIONSHIP', 72)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('UBERON_0000104', 'life cycle', 99, 'life cycle'), ('GO_0007049', 'cell cycle', 104, 'cycle'), ('GO_0000003', 'reproduction', 124, 'reproduction'), ('UBERON_0007023', 'adult organism', 140, 'adult')]
PMC4934634	11/2015	S53-PMC4934634	['vdr and enzymes NECESSARY for Vitamin D Metabolism HAVE BEEN FOUND in male Testis, mature Spermatozoa, and the Ejaculatory Tract SUGGESTING an IMPORTANT ROLE of this Vitamin in Male Fertility [19].']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 143), ('SUPERFICIAL_RELATIONSHIP', 153)]	5	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 30, 'vitamin D metabolism'), ('UBERON_0000473', 'testis', 75, 'testis'), ('CL_0000019', 'sperm', 90, 'spermatozoa'), ('UBERON_0002649', 'dorsolateral fasciculus of medulla', 111, 'ejaculatory tract'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin'), ('GO_0007141', 'male meiosis I', 177, 'male fertility')]
PMC4934634	11/2015	S62-PMC4934634	[', restored fertility and litter size by Feeding a high calcium diet to female Vdr null Mice SUGGESTING a PLAUSIBLE ROLE of Vitamin D in Calcium Homeostasis RATHER than a direct EFFECT on vdr [17].']	[('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('GO_0007631', 'feeding behavior', 40, 'feeding'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 78, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mice'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 136, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 136, 'calcium homeostasis')]
PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4944244	7/2016	S100-PMC4944244	['this is IN LINE WITH OUR STUDY, where the PREVALENCE of hypovitaminosis D (25 (Oh) D Serum <50\xa0nmol/l) in the first trimester was high (90.4\xa0%) and only 11.1\xa0% took supplements containing Vitamin D. moreover, most of them had just started the Supplements and the results MAY not have AFFECTED their Vitamin D status yet.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 284)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 72, 'D'), ('CHEBI_71657', 'versiconol acetate', 75, '25 (OH) D'), ('PR_000003010', 'moesin isoform 1', 78, '(OH ... D'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 243, 'supplements'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC4944244	7/2016	S203-PMC4944244	['OUR STUDY SHOWED SIMILAR results where fair skin such as chinese had a higher level of Serum 25(Oh) D. initially, by using simple logistic regression analysis, the skin color type, Melanin index measurement and sun protection score SHOWED CORRELATION with Vitamin D status ( p \u2009<\u20090.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_71657', 'versiconol acetate', 93, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 93, '25(OH) D'), ('CHEBI_25179', 'melanins', 181, 'melanin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4944244	7/2016	S212-PMC4944244	['certain Dress code and sun block had limited the ability of the skin to synthesize Vitamin D.\nVitamin D Intake from Food is one of the MODIFIABLE FACTORS that CAN reduce the RISK of hypovitaminosis d. a total of 55.1\xa0% of respondents have met the malaysian recommended Nutrient intakes (rni) for Vitamin D in Pregnant women which REQUIRE Intake of 5\xa0μg (200\xa0iu) per day [38,39] (table\xa01).']	[('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 174), ('IMPORTANT_CONSIDERATION', 330)]	5	[('UBERON_0001348', 'brown adipose tissue', 8, 'dress'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 104, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_33284', 'nutrient', 269, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('GO_0007631', 'feeding behavior', 338, 'intake')]
PMC4969253	8/2016	S80-PMC4969253	['the IMPACT of Prenatal disruption of ra signaling in Adult Airway structure and function HAS BEEN WELL DEMONSTRATED using a MODEL of Vitamin A deficiency in Mice [14].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 124)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('UBERON_0007023', 'adult organism', 53, 'adult'), ('UBERON_0001005', 'respiratory airway', 59, 'airway'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mice')]
PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
PMC4971719	8/2016	S13-PMC4971719	['FUTURE INVESTIGATIONS SHOULD study WHETHER Vitamin D supplementation in early Pregnancy MAY PREVENT Perinatal depressive symptoms.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0036268', 'swimming', 100, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 100, 'perinatal')]
PMC4971719	8/2016	S31-PMC4971719	['the more RECENT huang et al., STUDY EXAMINED the ASSOCIATION 25 Oh Vitamin D levels measured at 15\xa0weeks Gestation with depression and anxiety symptoms measured at that same time point [25].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_63058', '(2R,3S)-EHNA', 61, '25 OH'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC4971719	8/2016	S38-PMC4971719	['we CONDUCTED THIS STUDY TO EVALUATE WHETHER Plasma Vitamin D levels, measured in early and late Pregnancy were ASSOCIATED with depression symptom scores at 3 time points during Pregnancy and at 6–8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'postpartum')]
PMC4971719	8/2016	S45-PMC4971719	['as a secondary AIM of THIS STUDY, we EVALUATED WHETHER Vitamin D levels were ASSOCIATED with mini international neuropsychiatric interview diagnoses of major depressive disorder (mdd), generalized anxiety disorder (gad), or anxiety symptoms (mini anxiety subtest, question 1a) [34].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4971719	8/2016	S146-PMC4971719	['CONVERSELY, we FOUND that ALTHOUGH there was a TREND toward an ASSOCIATION of most recent Vitamin D levels with the bdi score in later Pregnancy and Postpartum, this trend was not significant and largely disappeared after adjustment for the baseline Bdi score.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'postpartum'), ('PR_000004717', "transcription factor TFIIIB component B''", 250, 'BDI')]
PMC4971719	8/2016	S160-PMC4971719	['an additional LIMITATION of OUR STUDY was that we were unable to explore the POTENTIALLY modulatory EFFECTS of inflammatory cytokines on the RELATIONSHIP between Vitamin D and depressive symptoms [23].']	[('INCOMPLETE_EVIDENCE', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4973215	8/2016	S0-PMC4973215	['racial DISPARITIES in Cord Blood Vitamin D levels and its ASSOCIATION with small-for-Gestational-age infants\n\nabstract\n\nobjective:\nTO EXAMINE the RELATIONSHIP of race and maternal characteristics and their ASSOCIATION with Cord Blood Vitamin D levels and small-for-Gestational-age (sga) status.']	[('IMPORTANT_CONSIDERATION', 7), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'gestational'), ('UBERON_0002240', 'spinal cord', 223, 'cord'), ('UBERON_0000178', 'blood', 228, 'blood'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 265, 'gestational')]
PMC4973215	8/2016	S15-PMC4973215	['THUS, the primary PURPOSE of THIS STUDY was to EXAMINE the RELATIONSHIP between race, maternal characteristics, Cord Blood Vitamin D levels and sga status among infants during one winter season in a midwestern us population.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4973215	8/2016	S63-PMC4973215	['we FOUND that black race was ASSOCIATED with a significantly greater incidence of sga, and that black race and Vitamin D deficiency TOGETHER were ASSOCIATED with EVEN greater odds of sga.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 146), ('ANOMALY_CURIOUS_FINDING', 162)]	5	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4973215	8/2016	S66-PMC4973215	['ONLY a SMALL proportion of white infants were sga, and this MAY have LIMITED our ability to detect significant ASSOCIATIONS between Vitamin D and sga among white infants.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4973215	8/2016	S75-PMC4973215	['IN CONTRAST TO the above-mentioned studies, our results SHOW that the combination of black race and Vitamin D deficiency was ASSOCIATED with increased odds of sga, BUT this RELATIONSHIP was not preserved for white infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 164), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4973215	8/2016	S85-PMC4973215	['furthermore, the PROTECTIVE EFFECT against Vitamin D deficiency was SEEN in both blacks and whites in our study, IN CONTRAST TO a RECENTLY PUBLISHED STUDY by burris et al.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4973215	8/2016	S104-PMC4973215	['we IDENTIFIED additive and modifiable maternal RISK FACTORS that WOULD BENEFIT MOST from risk reduction and targeted Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_PREDICTION', 65), ('IMPORTANT_CONSIDERATION', 71), ('PROBABLE_UNDERSTANDING', 79)]	5	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4973215	8/2016	S105-PMC4973215	['a GREATER UNDERSTANDING of the variables that INFLUENCE Vitamin D status during Pregnancy CAN have an immense PUBLIC HEALTH IMPACT in the reduction of adverse Perinatal outcomes such as sga.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0036268', 'swimming', 159, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 159, 'perinatal')]
PMC4976416	7/2016	S16-PMC4976416	['[8]\nALTHOUGH many cosmeceuticals contain Vitamins C and e, VERY FEW are actually EFFECTIVE in topical application because the stability is COMPROMISED as soon as the product is opened and exposed to air and light.']	[('ANOMALY_CURIOUS_FINDING', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 139)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamins C')]
PMC4976416	7/2016	S77-PMC4976416	['[58]\n\nvitamin e intake during pregnancy and childhood\nVitamin E supplements in Pregnancy USUALLY contain only small doses of Vitamin E, ALTHOUGH adverse EFFECTS have not been OBSERVED EVEN at higher doses.']	[('INCOMPLETE_EVIDENCE', 89), ('ANOMALY_CURIOUS_FINDING', 136), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 175), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin E'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin E')]
PMC4982007	8/2016	S69-PMC4982007	['n \u2009=\u20095832: age 4\xa0years \u2003n \u2009=\u20095191; age 8\xa0years \u2003n \u2009=\u20097339; age 16\xa0yearsmaternal Gestational weight gain (kg)3 categories of weight gain1: less than recommended2: as recommended3: more than recommendedpre-Pregnancy weight (kg)school entry assessment score-4\xa0yearsiq- wechsler intelligence scale for children -iii-8\xa0yearsadequate final exam results-16\xa0yearschildren of women gained weight\u2009<\u2009expected-↓ school entry assessment score (-0.075 sd) and adequate final-exam results (or\u2009=\u20090.88); ↑weight gain - early and mid Pregnancy -↑school entry assessment score (0.072 and 0.077 sd)↑ weight gain in all three periods of Pregnancy-↑ iq at 8\xa0years (0.070 to 0.078 sd) and ↑pre-Pregnancy weight-↓ school entry assessment score (-0.004 sd/kg), iq (-0.004 sd) and the odds (or\u2009=\u20090.99) of achieving adequate final exam resultsconfounders adjusted for: the child’s sex, current age, ma; me, parity, pre-Pregnancy bmi, smoking and mode of Delivery16 medium\nbmi body mass index, qs quality score, rb risk of bias, ga Gestational age, ma maternal age, bwt Birthweight, ses socio-economic status, me maternal education, pe paternal education, miq maternal intelligence, he home environment, ms maternal smoking, bf breast-feeding, dm maternal diabetes, pih Pregnancy induced hypertension\n\ncaption (table-wrap): table 3\n\nsummary of the studies examining ASSOCIATIONS of maternal Vitamin D status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb20gale c; 2008 \u2003n \u2009=\u2009178\u2003age 9\xa0years\u2003uk\u2003prospective longitudinalserum Vitamin D concentrations assessed at 28-42 weeks Gestation21.2\xa0% had <27.5\xa0nmol/l28.3\xa0% had 27.5-50\xa0nmol/lwechsler abbreviated scale of intelligencefull-scale, verbal or performance iqno association between Vitamin D concentrations and offspring iq (full-scale, verbal or performance)confounders adjusted for: unadjusted16 medium21whitehouse ajo; 2012\u2003age 5\xa0years ( n \u2009=\u2009534)\u2003age 10\xa0years ( n \u2009=\u2009474)\u2003australia\u2003prospective longitudinalserum Vitamin D concentrations assessed at 18\xa0weeks Gestation25.2\xa0% mothers had insufficiency (≤46\xa0nmol/l)(lowest quartile)peabody picture vocabulary test Receptive Languagechildren of mothers with Vitamin D insufficiency (lowest quartile (≤46\xa0nmol/l) were at INCREASED RISK (or\u2009=\u20091.97) of Language impairment compared to children of mothers without insufficiency (highest quartile (≥72\xa0nmol/l; or\u2009=\u20091.00)confounders adjusted for: ma, ms, parity, family income, season of maternal Blood sampling13 medium22morales\xa0e; 2012 \u2003n \u2009=\u20091820\u2003age 11-23 months\u2003spain\u2003prospective population based\u2003cohort studyplasma Vitamin D concentrations assessed during 12-23 weeks Gestation19.5\xa0% mothers had deficiency (<20\xa0ng/ml)31.5\xa0% had insufficiency (20-30\xa0ng/ml)bayley scales of infant development (mental (mdi) and psychomotor (pdi) developmental score)a positive linear ASSOCIATION between Vitamin D concentrations and mdi and pdiper 10\xa0ng/ml increase in Vitamin D concentrations mdi and pdi score increased by β\u2009=\u20090.79 and β\u2009=\u20090.88 points respectivelycompared to infants of deficient mothers, infants of mothers with normal level scored higher mdi (β\u2009=\u20092.60) and pdi (β\u2009=\u20092.32) points respectivelyconfounders adjusted for: the child’s sex, bwt, area of study, maternal country of origin, ma, parity, Pre-Pregnancy bmi, ses, me, ms, Alcohol and season15 medium\nqs quality score, rb risk of bias, ma maternal age, bwt Birthweight, me Maternal education, ms maternal smoking, bmi body mass index, ses socio-economic status\n\ncaption (table-wrap): table 4\n\nsummary of the studies examining ASSOCIATIONS of maternal Folate status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb23wu btf; 2012 \u2003n \u2009=\u2009154\u2003age 18 months\u2003canada\u2003prospectiveplasma Folate and thcy concentrations assessed at 16 and 36\xa0weeks Gestationno Folate deficiency (plasma Folate <6.8\xa0nmol/l)high thcy not reportedbayley scales of infant developmentreceptive language, expressive language, Cognitive skills, fine motor and gross motorno ASSOCIATION of Folate and thcy with Cognitive functionconfounders adjusted for: the child’s sex, bf, ethnicity, ma, miq, maternal Fatty Acid level13 medium24tamura t; 2005 \u2003n \u2009=\u2009355\u2003age 5\xa0years\u2003usa\u2003prospective\u2003mothers participated in zinc supplementation trial during Pregnancyred cell and Plasma Folate concentrations – 19, 26 and 37\xa0weeks Gestation and thcy concentrations-26 and 37\xa0weekslow Folate-(Plasma Folate <11\xa0nmol/l)19\xa0weeks- 7.4\xa0%; 26\xa0weeks- 8.2\xa0%; 37\xa0weeks- 14.0\xa0%Red Cell Folate <430\xa0nmol/l)19\xa0weeks- 7.2\xa0%; 26\xa0weeks- 3.8\xa0%; 37\xa0weeks- 3.3\xa0%high thcy (thcy\u2009>\u20097\xa0μmol/l)26\xa0weeks- 8.4\xa0%; 37\xa0weeks- 22.1\xa0%differential ability scale (verbal, nonverbal and general iq), Visual and Auditory sequential Memory (Visual and Auditory Memory span)knox cube (attention span and Short-Term Memory)gross motor scale (gross Motor Development and grooved pegboard (manipulative dexterity)no difference in the mental and psychomotor developmental scores between children of mothers with normal and deficient Folate and thcy groups.']	[('SUPERFICIAL_RELATIONSHIP', 1338), ('IMPORTANT_CONSIDERATION', 2306), ('SUPERFICIAL_RELATIONSHIP', 2901), ('SUPERFICIAL_RELATIONSHIP', 3617), ('SUPERFICIAL_RELATIONSHIP', 4142)]	5	[('GO_0007565', 'female pregnancy', 80, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 616, 'pregnancy'), ('GO_0007565', 'female pregnancy', 671, 'pregnancy'), ('GO_0007565', 'female pregnancy', 892, 'pregnancy'), ('GO_0007567', 'parturition', 927, 'delivery16'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('GO_0007596', 'blood coagulation', 1042, 'birthweight'), ('GO_0007565', 'female pregnancy', 1242, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1363, 'vitamin D'), ('GO_0050890', 'cognition', 1395, 'cognitive'), ('CHEBI_27300', 'vitamin D', 1611, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1660, 'gestation21'), ('CHEBI_27300', 'vitamin D', 1818, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2052, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2098, 'gestation25'), ('GO_0000724', 'double-strand break repair via homologous recombination', 2201, 'Receptive languageChildren'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin D'), ('GO_0006266', 'DNA ligation', 2336, 'language'), ('UBERON_0000178', 'blood', 2527, 'blood'), ('CHEBI_27300', 'vitamin D', 2650, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2703, 'gestation19'), ('CHEBI_27300', 'vitamin D', 2921, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2986, 'vitamin D'), ('GO_0007568', 'aging', 3332, 'pre'), ('GO_0007565', 'female pregnancy', 3336, 'pregnancy'), ('CHEBI_30879', 'alcohol', 3364, 'alcohol'), ('GO_0007596', 'blood coagulation', 3448, 'birthweight'), ('GO_0007618', 'mating', 3464, 'maternal'), ('CHEBI_30863', '5-azaorotic acid', 3642, 'folate'), ('GO_0050890', 'cognition', 3671, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 3881, 'folate'), ('GO_0007565', 'female pregnancy', 3940, 'gestationNo'), ('CHEBI_30863', '5-azaorotic acid', 3952, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 3978, 'folate'), ('GO_0050890', 'cognition', 4095, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 4157, 'folate'), ('GO_0050890', 'cognition', 4178, 'cognitive'), ('CHEBI_35366', 'fatty acid', 4272, 'fatty acid'), ('GO_0007605', 'sensory perception of sound', 4410, 'pregnancyRed'), ('UBERON_0001969', 'blood plasma', 4432, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4439, 'folate'), ('GO_0007565', 'female pregnancy', 4483, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 4536, 'folate'), ('UBERON_0001969', 'blood plasma', 4544, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4551, 'folate'), ('CL_0000232', 'erythrocyte', 4619, 'Red cell'), ('CHEBI_30863', '5-azaorotic acid', 4628, 'folate'), ('GO_0007601', 'visual perception', 4819, 'Visual'), ('GO_0006754', 'ATP biosynthetic process', 4830, 'Auditory ...'), ('GO_0007613', 'memory', 4850, 'Memory'), ('GO_0007601', 'visual perception', 4858, 'visual'), ('GO_0007605', 'sensory perception of sound', 4869, 'auditory'), ('GO_0007613', 'memory', 4878, 'memory'), ('GO_0007608', 'sensory perception of smell', 4920, 'short-term memory'), ('GO_0009653', 'anatomical structure morphogenesis', 4963, 'motor development'), ('CHEBI_30863', '5-azaorotic acid', 5145, 'folate')]
PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
PMC4989298	8/2016	S370-PMC4989298	['published an exhaustive review CONCLUDING that there were NO conclusive DATA identifying a POSSIBLE dose of Vitamin D resulting in PREVENTION of Food allergy [126].']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 31), ('FULL_UNKNOWN', 58), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_33290', 'food', 145, 'food')]
PMC4990268	8/2016	S297-PMC4990268	['IN FACT, the CURRENT EVIDENCE provides SOME SUPPORT for this RELATED to Vitamin A supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy')]
PMC4992225	8/2016	S1-PMC4992225	['researchers have studied the RELATIONSHIP between low Serum Vitamin D concentration and Perinatal depression, ALTHOUGH NO clinical trial HAS BEEN CONDUCTED on Vitamin D’s EFFECTS on depression RELATED to Childbirth.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 110), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0036268', 'swimming', 88, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 88, 'perinatal'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 204, 'childbirth')]
PMC4998950	4/2016	S14-PMC4998950	['we considered other parental characteristics described below (also seetable 1) as POTENTIAL CONFOUNDERS or mediators BASED ON their ASSOCIATIONS with asd and Vitamin D deficiency.5,8,9\n\ncaption (table-wrap): table 1\nstudy population characteristics in relation to lifetime maternal history of diagnosed Vitamin D deficiencymaternal history of Vitamin D deficiencycharacteristicnoyes p allindividuals, n (%)509 092 (99.9)547 (0.1)509 639 (100.0)cases of asd with intellectual disability, n (%)2463 (0.5)13 (2.4)<0.00012476 (0.5)cases of asd without intellectual disability, n (%)7396 (1.4)10 (1.8)0.467406 (1.4)male (%)51.352.60.5151.3maternal age, years: mean29.928.5<0.000129.9paternal age, years: mean32.834.0<0.000132.8maternal country of Birth (%)\u2003sweden76.319.2<0.000176.2\u2003europe8.34.60.0028.3\u2003outside europe12.838.9<0.000112.9\u2003sub-saharan africa2.637.3<0.00012.6lowest quintile of disposable family income (%)14.835.6<0.000114.8elementary maternal education (%)15.643.1<0.000115.6elementary paternal education (%)16.832.7<0.000116.8born small for Gestational age (%)2.53.70.092.5premature Birth (<37 weeks, %)5.96.20.075.9maternal history of neuropsychiatric disorder (%)a2.49.3<0.00012.4paternal history of neuropsychiatric disorder (%)a2.02.00.982.0maternal history of affective disorder (%)b15.436.8<0.000115.4paternal history of affective disorder (%)b8.110.80.028.1maternal history of epilepsy (%)1.01.50.251.0paternal history of epilepsy (%)1.00.70.521.0\nparental histories of neuropsychiatric disorder include any in-patient or secondary care out-patient record of diagnosed non-affective psychosis, bipolar disorder, attention-deficit hyperactivity disorder, asd, or intellectual disability.']	[('INCOMPLETE_EVIDENCE', 82), ('PROBLEM_COMPLICATION', 92), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 132)]	5	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D'), ('GO_0007567', 'parturition', 742, 'birth'), ('GO_0007565', 'female pregnancy', 1053, 'gestational'), ('GO_0007567', 'parturition', 1095, 'birth')]
PMC4998950	4/2016	S37-PMC4998950	['second, maternal Vitamin D status was IDENTIFIED from secondary care records, and THEREFORE under-ascertained and PERHAPS DIFFERENTIALLY so with regard to asd RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5014971	8/2016	S29-PMC5014971	['OBSERVATIONAL studies have CONSISTENTLY FOUND an ASSOCIATION with low maternal Vitamin D status and INCREASED risk of neonatal infectious disease and later inflammatory and atopic disease in offspring [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 27), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 100)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5028238	10/2016	S78-PMC5028238	['pathway LINKS Dhcr7, Vitamin D Synthesis and Cholesterol Synthesis\n\nevolutionary advantage for Dhcr7 mutations\nheterozygote advantage among carriers HAS BEEN PROPOSED PREVIOUSLY17BASED on the RELATIONSHIP between Dhcr7 and Vitamin d. heterozygote carriers have lower amounts of functional dhcr7 resulting from their carrier state.8this would lower the amount of available 7-Dehydrocholesterol that is converted to Cholesterol.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 192)]	5	[('PR_000006474', 'ATP-dependent RNA helicase A', 14, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 21, 'vitamin D synthesis'), ('CHEBI_16113', 'cholesterol', 45, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 45, 'cholesterol synthesis'), ('PR_000006474', 'ATP-dependent RNA helicase A', 95, 'DHCR7'), ('PR_000006474', 'ATP-dependent RNA helicase A', 213, 'DHCR7'), ('CHEBI_33229', 'vitamin (role)', 223, 'vitamin'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 372, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 414, 'cholesterol')]
PMC5028238	10/2016	S81-PMC5028238	['researchers FOUND certain Dhcr7 variants were ASSOCIATED with lower Vitamin D levels in the general population45and among Individuals with polycystic Ovary syndrome.46this FURTHER LINKS Vitamin D levels with Dhcr7 variants.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 180)]	5	[('PR_000006474', 'ATP-dependent RNA helicase A', 26, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_1', 'root', 122, 'individuals'), ('UBERON_0000992', 'ovary', 150, 'ovary'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('PR_000006474', 'ATP-dependent RNA helicase A', 208, 'DHCR7')]
PMC5028238	10/2016	S146-PMC5028238	["SEVERAL clinical trials were performed in the 1970s for Nafoxidine.69,70,71,72the major reaction to the Drug consisted of dermatitis (55% of patients) exacerbated by sunlight.72this INDICATES that the Drug EFFECTED patients' dermal response to sunlight exposure (which COULD BE RELATED to its inhibition of Dhcr7 and Dysregulation of Vitamin D Synthesis pathways)."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 206), ('INCOMPLETE_EVIDENCE', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	5	[('CHEBI_7447', 'nafcillin', 56, 'nafoxidine'), ('CHEBI_23888', 'drug', 104, 'drug'), ('CHEBI_23888', 'drug', 201, 'drug'), ('PR_000006474', 'ATP-dependent RNA helicase A', 307, 'DHCR7'), ('GO_0060233', 'oenocyte delamination', 317, 'dysregulation'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 334, 'vitamin D synthesis')]
PMC5035678	4/2016	S148-PMC5035678	['CONSISTENT with our results, THESE STUDIES have FOUND that Vitamin D is ineffective or has UNCERTAIN EFFECTS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 48), ('FULL_UNKNOWN', 91), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5035678	4/2016	S160-PMC5035678	['IN SPITE of these LIMITATIONS, THIS is currently the ONLY study in the literature that evaluates the INFLUENCE of Vitamin D supplementation during Pregnancy on Postpartum dysglycemia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'postpartum')]
PMC5045784	10/2016	S60-PMC5045784	['finally, interventional Animal and Human studies provide STRONG EVIDENCE for a beneficial ROLE of Vitamin D supplementation in Pulmonary outcomes.7,20\nthe ROLE of Vitamin D status in the development of bpd REMAINS incompletely understood.']	[('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 206)]	5	[('NCBITaxon_33208', 'Metazoa', 24, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0002048', 'lung', 127, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5045784	10/2016	S70-PMC5045784	['for example, common Vitamin D-related polymorphisms, in Vitamin D-binding protein or vdr LIKELY alter the bioavailable levels of 25(Oh)D.24A STUDY by koroglu et al.25EXAMINED the ROLE of the vdr variant Fok 1 in bpd risk among 109 preterm neonates but DID NOT FIND a significant change in the odds ratio.']	[('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 252)]	5	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 129, '25(OH ... D'), ('PR_000007593', 'glutamate carboxypeptidase 2', 203, 'Fok 1')]
PMC5062906	10/2016	S63-PMC5062906	['HERE, we ASSESS (1) overall dietary EFFECTS (diet, maternal, or grandmaternal Vitamin D-deficient diet compared to control diet); (2) diet-independent parent/grandparent of origin EFFECTS (po/gpo, cross 1 compared to cross 2, samples from different diets combined); and (3) diet-dependent parent/grandparent of origin EFFECTS (diet\u2009×\u2009po/gpo, both diet and cross differences assessed in an interactive model).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 180), ('SUPERFICIAL_RELATIONSHIP', 318)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5062906	10/2016	S242-PMC5062906	['we also FIND that parent and grandparent of origin plays in an IMPORTANT ROLE in the direction and extent of Vitamin D-DEPENDENT developmental and epigenetic EFFECTS in the offspring.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 158)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5064894	10/2016	S39-PMC5064894	['third, THERE HAVE BEEN NO STUDIES assessing the ASSOCIATION between Vitamin D supplementation and quantitative Nasal carriage of streptococcus pneumoniae (pneumococcus), the most IMPORTANT cause of bacterial lrti in young children worldwide.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000004', 'nose', 111, 'nasal')]
PMC5084016	10/2016	S135-PMC5084016	['GIVEN the INFLUENCE of sunlight exposure on Vitamin D Metabolism, ATTENTION to ethnic groups with hyper-Pigmented skin or with little exposure to sunlight SHOULD BE paid also during Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_WORK', 155)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 44, 'vitamin D metabolism'), ('CHEBI_26130', 'biological pigment', 104, 'pigmented'), ('GO_0007595', 'lactation', 182, 'lactation')]
PMC5084016	10/2016	S170-PMC5084016	['a systematic review of the literature HIGHLIGHTED an INCREASED RISK of iron and Vitamin B 12 deficiency and low Birth weight in ASSOCIATION with vegetarian or strictly vegan diets, DESPITE the absence of adverse EFFECTS for the fetus [79].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 128), ('ANOMALY_CURIOUS_FINDING', 181), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 80, 'vitamin B 12'), ('GO_0007567', 'parturition', 112, 'birth')]
PMC5084041	10/2016	S10-PMC5084041	['the DETERMINANTS of season-corrected change in 25(Oh)D were origin, sun-Seeking behaviour, clothing style, dietary Vitamin D intake, Vitamin D supplementation and recent travel <35° n. in CONCLUSION, season-corrected 25(Oh)D concentration increased during Pregnancy and DEPENDED PARTLY on lifestyle FACTORS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 299)]	5	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('GO_0007601', 'visual perception', 72, 'seeking'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 133, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 141, 'D'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D'), ('GO_0007565', 'female pregnancy', 256, 'pregnancy')]
PMC5084041	10/2016	S14-PMC5084041	['introduction\nduring the past decade, Vitamin D has received INCREASING ATTENTION and has been ASSOCIATED with health BENEFITS in addition to its RECOGNIZED EFFECTS on bone health.']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 145), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5085625	9/2016	S38-PMC5085625	['ALTHOUGH the biological ROLE of Vitamin D HAS BEEN studied extensively, the consequences of its deficiency for maternal, fetal and neonatal health are STILL UNCLEAR [4,22,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 151)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S95-PMC5085625	['CONSEQUENTLY, Vitamin D level in early Pregnancy is less LIKELY to play a MAJOR ROLE in Placental Development, and it is later increased in this parameter which may PREVENT the development of pe [13].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 57), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0001890', 'placenta development', 88, 'placental development'), ('UBERON_0001987', 'placenta', 88, 'placental')]
PMC5085625	9/2016	S100-PMC5085625	['both a RECENT meta-analysis and several OBSERVATIONAL studies SHOWED a significant ASSOCIATION between Vitamin D deficiency and INCREASED RISK for Preeclampsia [39,40,41].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia')]
PMC5085625	9/2016	S120-PMC5085625	['HOWEVER, PUBLISHED EVIDENCE regarding the RELATIONSHIP between Vitamin D level and occurrence of gdm is INCONCLUSIVE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5095257	11/2016	S80-PMC5095257	['one of the POSTULATED mechanisms EXPLAINING a month-of-Birth EFFECT in Autoimmune disease is the ROLE that Vitamin D deficiency MIGHT play in the pathophysiology of such diseases (31).']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 128)]	5	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0001442', 'skeleton of manus', 71, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC5095257	11/2016	S82-PMC5095257	['this HYPOTHESIS is PARTICULARLY PLAUSIBLE in the case of aad because of the KNOWN ASSOCIATION of the disease with polymorphisms in both the Vitamin D Receptor ( Vdr ) Gene and the Cyp27B1 Gene encoding 1-α-hydroxylase converting 25-Hydroxyvitamin D into its active form 1,25-Dihydroxyvitamin D (8,27,33).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 140, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 161, 'VDR'), ('SO_0000704', 'gene', 167, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 180, 'CYP27B1'), ('SO_0000704', 'gene', 188, 'gene'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 229, '25-hydroxyvitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 270, '1,25-dihydroxyvitamin D')]
PMC5095257	11/2016	S85-PMC5095257	['FURTHER STUDIES ARE REQUIRED to investigate the ASSOCIATION of Perinatal Vitamin D status and the RISK for aad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 98)]	5	[('GO_0036268', 'swimming', 63, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 63, 'perinatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5118763	12/2016	S203-PMC5118763	['in conclusion, women assigned to the mmn regimen had a higher concentration of Plasma Vitamin B-12, ALTHOUGH the PUBLIC HEALTH SIGNIFICANCE of the size of the EFFECT is UNCERTAIN.']	[('ANOMALY_CURIOUS_FINDING', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 169)]	5	[('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 86, 'vitamin B-12')]
PMC5129897	10/2016	S74-PMC5129897	["based on data from the us for 2004–2013, using the national cancer institute's surveillance, epidemiology, and end results (seer) program, cancer incidence rates for those aged 20–49\xa0y is 2% of that for those aged >50\xa0y.53\n\nrespiratory infections\ninfluenza and pneumonia accounted for 5,694 deaths of canadians in 2012.54the total economic impact for Respiratory infections was $5.4\xa0billion in 2008.55the ESTIMATED economic BURDEN in 2016 is$5.4\xa0billion\u2009×\u2009(1.033)2\u2009×\u2009(0.994)6\u2009×\u2009(36.3\xa0million/33.3\xa0million)\xa0=\xa0$6.1\xa0billion\nclinical trials SUPPORT the ROLE of Vitamin D in reducing RISK of influenza."]	[('INCOMPLETE_EVIDENCE', 405), ('IMPORTANT_CONSIDERATION', 424), ('INCOMPLETE_EVIDENCE', 537), ('SUPERFICIAL_RELATIONSHIP', 549), ('IMPORTANT_CONSIDERATION', 579)]	5	[('UBERON_0001004', 'respiratory system', 351, 'respiratory'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D')]
PMC5129897	10/2016	S86-PMC5129897	['OBSERVATIONAL STUDIES offer GOOD EVIDENCE that Vitamin D AFFECTS RISK of dm.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 65)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5146866	12/2016	S1-PMC5146866	['THIS STUDY was DESIGNED TO DETERMINE the rate, maternal RISK FACTORS, and clinical outcomes in infants in ASSOCIATION with Vitamin D insufficient/deficient status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'birth')]
PMC5146866	12/2016	S26-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, OUR STUDY is the FIRST that in addition to identifying the rate, also ESTIMATES the risk of Vitamin D deficiency/insufficiency in the cb and ASSOCIATED outcome in a diverse population of infants.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]
PMC5146866	12/2016	S102-PMC5146866	['HOWEVER, it is UNLIKELY that these limitations will AFFECT the OBSERVED rate of Vitamin D deficiency and insufficiency SEEN at Birth in the studied infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5155676	12/2016	S14-PMC5155676	['maternal Vitamin D INSUFFICIENCY during Pregnancy is common (1,2), and THERE IS EVIDENCE that this MIGHT have DETRIMENTAL EFFECTS on maternal health, Fetal Development (3,4) and the long-term Skeletal health of children (1,3).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 150, 'fetal development'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC5155676	12/2016	S22-PMC5155676	['during Pregnancy, maternal hemodilution is ACCOMPANIED by a number OF physiological changes to both Vitamin D Metabolism (15) and maternal body composition (16); such adaptations MIGHT lead to DIFFERENCES in the DETERMINANTS of response to Vitamin D supplementation between Pregnant and nonpregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 67), ('INCOMPLETE_EVIDENCE', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007601', 'visual perception', 100, 'vitamin D'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007565', 'female pregnancy', 274, 'pregnant')]
PMC5155676	12/2016	S99-PMC5155676	['THUS, those women who are AT RISK of Vitamin D insufficiency in early Pregnancy, gain greater weight, and Deliver in winter MIGHT NEED supplementation with a higher dose of Cholecalciferol to achieve SIMILAR 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 130), ('SUPERFICIAL_RELATIONSHIP', 200)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007567', 'parturition', 106, 'deliver'), ('CHEBI_52550', 'theopalauamide', 173, 'cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 214, 'D')]
PMC5155676	12/2016	S103-PMC5155676	['it is WELL RECOGNIZED that Individuals who are overweight or obese are at higher RISK of Vitamin D insufficiency, and this is SIMILARLY OBSERVED in Pregnancy (2,22).']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 11), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 136)]	5	[('NCBITaxon_1', 'root', 27, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC5155676	12/2016	S113-PMC5155676	['IMPORTANTLY, the difference between the 25(Oh)D achieved at 34 weeks of Gestation in women randomized to Placebo compared with Cholecalciferol decreased with increasing baseline 25(Oh)D. this is CONSISTENT with PREVIOUS STUDIES in Adults, which HAVE SHOWN that the incremental response to Vitamin D supplementation is higher in Vitamin D insufficient than replete subjects (13,14) and that the increase in 25(Oh)D relative to supplementation dose is negatively ASSOCIATED with dose of vitamin D supplement (26).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 461)]	5	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007565', 'female pregnancy', 72, 'gestation'), ('CHEBI_26130', 'biological pigment', 105, 'placebo'), ('CHEBI_52550', 'theopalauamide', 127, 'cholecalciferol'), ('CHEBI_33010', 'chromide(1-)', 180, '(OH)D'), ('UBERON_0007023', 'adult organism', 231, 'adults'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 493, 'D')]
PMC5240436	1/2017	S114-PMC5240436	['a PREVIOUS STUDY that provided combined Vitamin A and zinc supplementation to children in ghana LED TO a reduction in the RISK of clinical malaria episodes [46] possibly DUE TO the synergistic EFFECTS of Vitamin A and zinc on Immune function [47].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 170), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A'), ('UBERON_0002405', 'immune system', 226, 'immune')]
PMC5318550	2/2017	S28-PMC5318550	['next, we determined in additional models WHETHER this ASSOCIATION COULD BE explained by specific variables—thereby testing DIFFERENT HYPOTHESES; (2) sociodemographic factors and maternal iq; (3) child Birth weight and Gestational duration; (4) Pregnancy Vitamin D plasma status; (5) maternal nutritional intake; (6) maternal exposure to fever during Pregnancy; and (7) child age relative to peers at school.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	5	[('GO_0007567', 'parturition', 201, 'birth'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0007565', 'female pregnancy', 350, 'pregnancy')]
PMC5340372	3/2017	S131-PMC5340372	['more INVESTIGATION is REQUIRED to FURTHER understand the ROLE of Vitamin D for the PREVENTION of Respiratory Tract infection in infancy.']	[('FUTURE_WORK', 5), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 83)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 97, 'respiratory tract')]
PMC5340372	3/2017	S147-PMC5340372	['ALTHOUGH Cord Vitamin D levels are STRONGLY CORRELATED with maternal Vitamin D levels, the extent of the IMPACT on later Respiratory function is DISTINCTIVE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 145)]	5	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0045333', 'cellular respiration', 121, 'respiratory'), ('UBERON_0001004', 'respiratory system', 121, 'respiratory')]
PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5351212	3/2017	S4-PMC5351212	['in addition, given the KNOWN immunomodulatory and neuroprotective EFFECTS of Vitamin D, we also INVESTIGATED WHETHER the co-administration of Vitamin D COULD block mia-induced asd-related behaviors.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
PMC5359891	3/2017	S42-PMC5359891	['meta-analysis of observational studies STRONGLY POINTS to a ROLE for maternal Vitamin D deficiency in gdm [37], and additional Vitamin D in Pregnant women with gdm HAS BEEN SHOWN to have beneficial EFFECTS on glycaemia and total and low-density lipoprotein Cholesterol (ldl)-Cholesterol concentrations [38].']	[('PROBABLE_UNDERSTANDING', 39), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 198)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_16113', 'cholesterol', 257, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 275, 'cholesterol')]
PMC5359891	3/2017	S112-PMC5359891	['secondary maternal outcomes of the initial phase of the nipper study are:\nmaintenance of a healthy Pregnancy, including normal duration of Gestation (at least 37\xa0weeks’ Gestation), absence of gdm (defined using the international association of the diabetes and Pregnancy study groups criteria: Glucose cut-off values of ≥5.1\xa0mmol/l for fasting Plasma Glucose, and/or ≥10.0\xa0mmol/l for 1-h and/or ≥8.5\xa0mmol/l for 2-h post load), change in fasting Glucose and ogtt Glucose area under the curve from Preconception baseline to 28\xa0weeks’ Gestation, maternal wellbeing/mood, absence of excessive nausea and vomiting, adequate Pregnancy weight gain (institute of medicine criteria) and Vaginal Delivery rates\nreduction in maternal Micronutrient insufficiency, specifically less riboflavin, Vitamin B6, Vitamin B12, zinc and Vitamin D insufficiency, before and during Pregnancy\nalteration in Gut microbiota CONSISTENT with enhanced wellbeing\nalteration in maternal metabolomic and epigenetic biomarkers CONSISTENT with improved maternal and/or offspring wellbeing\nenhancement of Breast Milk Micronutrient content, altered Immunological factors, epigenetic and metabolomic profiles (subsample) and maintenance of healthy Lactogenesis\nsecondary offspring outcomes of the initial phase of the nipper study are:\nneonatal adiposity measured by pea pod\nBirthweight 2500–4000\xa0g, size for Gestational age at Birth and customised birthweight centile\nreduced adiposity gain during Infancy, analysed taking account of infant Feeding\nreduction in Cord Blood c-peptide as a marker of overall glycaemia during Gestation\npromotion of offspring wellbeing and healthy Cardiometabolic RISK FACTORS, including Visceral adiposity and markers of Insulin resistance, during infancy\nalteration in offspring metabolomic and epigenetic biomarkers in Perinatal samples, CONSISTENT with improved infant Metabolic and allergic Wellbeing\nalteration in Gut microbiota to a microbiota ASSOCIATED with infant Metabolic and allergic Wellbeing\n\ndata and biosample collection\nstudy data will be collected by trained research staff using an access-controlled, web-based database (medscinet, stockholm) managed with support from the data management staff of the mrc Lifecourse epidemiology unit and the singapore institute for clinical sciences.']	[('INCOMPLETE_EVIDENCE', 898), ('INCOMPLETE_EVIDENCE', 994), ('SUPERFICIAL_RELATIONSHIP', 1658), ('INCOMPLETE_EVIDENCE', 1835), ('SUPERFICIAL_RELATIONSHIP', 1945)]	5	[('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('GO_0007565', 'female pregnancy', 139, 'gestation'), ('GO_0007565', 'female pregnancy', 169, 'gestation'), ('GO_0007565', 'female pregnancy', 261, 'Pregnancy'), ('CHEBI_17234', 'glucose', 294, 'glucose'), ('UBERON_0001969', 'blood plasma', 344, 'plasma'), ('CHEBI_17234', 'glucose', 351, 'glucose'), ('CHEBI_17234', 'glucose', 445, 'glucose'), ('CHEBI_17234', 'glucose', 462, 'glucose'), ('GO_0007565', 'female pregnancy', 496, 'preconception'), ('GO_0007565', 'female pregnancy', 532, 'gestation'), ('GO_0007565', 'female pregnancy', 619, 'pregnancy'), ('UBERON_0001987', 'placenta', 678, 'vaginal'), ('GO_0007567', 'parturition', 686, 'delivery'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 723, 'micronutrient'), ('CHEBI_33237', 'vitamin D4', 782, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 794, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 816, 'vitamin D'), ('GO_0007565', 'female pregnancy', 859, 'pregnancy'), ('UBERON_0001555', 'digestive tract', 883, 'gut'), ('UBERON_0001348', 'brown adipose tissue', 1070, 'breast milk'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1082, 'micronutrient'), ('UBERON_0003222', 'flexor digitorum superficialis', 1113, 'immunological'), ('GO_0001554', 'luteolysis', 1211, 'lactogenesis'), ('GO_0007608', 'sensory perception of smell', 1338, 'Birthweight'), ('GO_0007565', 'female pregnancy', 1372, 'gestational'), ('GO_0007567', 'parturition', 1391, 'birth'), ('UBERON_0000023', 'wing', 1462, 'infancy'), ('GO_0007631', 'feeding behavior', 1505, 'feeding'), ('UBERON_0002240', 'spinal cord', 1526, 'cord'), ('UBERON_0000178', 'blood', 1531, 'blood'), ('GO_0007565', 'female pregnancy', 1587, 'gestation'), ('GO_0007599', 'hemostasis', 1642, 'cardiometabolic'), ('UBERON_0002075', 'viscus', 1682, 'visceral'), ('PR_000045358', 'insulin family protein', 1716, 'insulin'), ('GO_0036268', 'swimming', 1816, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1816, 'perinatal'), ('GO_0051238', 'sequestering of metal ion', 1867, 'metabolic ... wellbeing'), ('UBERON_0001555', 'digestive tract', 1914, 'gut'), ('GO_0051238', 'sequestering of metal ion', 1968, 'metabolic ... wellbeing'), ('UBERON_0001281', 'hepatic sinusoid', 2220, 'Lifecourse')]
PMC5372327	3/2017	S2-PMC5372327	['MANY countries apply Vitamin D supplementation STRATEGIES in infants, but the guidelines are NOT BASED ON scientific EVIDENCE and AIM at PREVENTION of rickets.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 47), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5372327	3/2017	S29-PMC5372327	['HOWEVER, data on the RELATIONSHIP between Vitamin D and bmd in children are SOMEWHAT CONTRADICTORY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5372327	3/2017	S48-PMC5372327	['HOWEVER, findings have NOT been CONSISTENT [39] and RECENT STUDIES on Prenatal Vitamin D supplementation have not demonstrated an EFFECT on wheezing at 3\xa0years of age [40,41].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 130)]	5	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5385921	4/2017	S56-PMC5385921	['ancestry information and Genetic relatedness derived from observed common Genetic variants\nethnicity is strongly ASSOCIATED with Vitamin D status (darker skinned Individuals are more PRONE to Vitamin D deficiency and insufficiency).19genome-wide genotype data for the children allow us to build models that are BETTER able to account for variation in ethnic background (compared with register-based or self-ascribed ethnicity) and for Genetic relatedness between cohort members that MAY inflate an association statistic when Genes AFFECT the exposure or outcome variable.']	[('SUPERFICIAL_RELATIONSHIP', 113), ('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 311), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 531)]	5	[('SO_0000704', 'gene', 25, 'genetic'), ('SO_0000704', 'gene', 74, 'genetic'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('NCBITaxon_1', 'root', 162, 'individuals'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('SO_0000704', 'gene', 435, 'genetic'), ('SO_0000704', 'gene', 525, 'genes')]
PMC5385921	4/2017	S141-PMC5385921	['the ASSOCIATION between developmental Vitamin D deficiency and asd MAY have IMPORTANT IMPLICATIONS from a PUBLIC HEALTH perspective.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 86), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5405075	4/2017	S32-PMC5405075	['IN THE LIGHT of the POSSIBLE parallel-asthma epidemic, cellular molecular studies along with epidemiological data SUGGEST that Vitamin D deficiency MAY have a programming EFFECT in utero and promote a trajectory to develop asthma in childhood and later in Life (2,37–39).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0000104', 'life cycle', 256, 'life')]
PMC5405075	4/2017	S56-PMC5405075	['still, the ASSOCIATION of Vitamin D with asthma, AMBIGUOUSLY emerged from observational studies, COULD NOT be confirmed and established AS a causative FACTOR.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('DIFFICULT_TASK', 97), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5410409	4/2017	S57-PMC5410409	['three large Birth cohort studies SHOWED CONSISTENT positive ASSOCIATIONS between maternal Intake of Vitamin E in Pregnancy and PREVENTION of childhood asthma or wheeze at 2 years of age [5].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 127)]	5	[('GO_0007567', 'parturition', 12, 'birth'), ('GO_0007631', 'feeding behavior', 90, 'intake'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin E'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]
PMC5418719	5/2017	S104-PMC5418719	['ALTHOUGH a number of Vitamin D deficiency was significantly lower after supplementation than before supplementation in the PRESENT STUDY, supplementation with 800\xa0iu MIGHT not be sufficient to achieve optimal Vitamin D levels in preterm infants with UNDERLYING level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5426325	4/2017	S13-PMC5426325	['BASED ON Serum 25-Hydroxy Vitamin D3(25(Oh)D3) measurements, STUDIES HAVE SHOWN a pronounced seasonal variation in Vitamin D status in denmark and other countries with latitudes above 35° north and south(1,2), MOST LIKELY RELATED to insufficient actinic Vitamin D Synthesis during the darker part of the year in such countries.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 222)]	5	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 15, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 26, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 26, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 37, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 254, 'vitamin D synthesis')]
PMC5474873	6/2017	S0-PMC5474873	['sun exposure and psychotic experiences\n\nabstract:executive-summary\n\nobjective\nsun exposure IS CONSIDERED the single most IMPORTANT source of Vitamin D. Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the etiology of psychotic disorders.']	[('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 152, 'Vitamin D')]
PMC5474873	6/2017	S170-PMC5474873	['another LIMITATION is that there is ONLY a SMALL NUMBER of published studies reporting the ASSOCIATION between questionnaires-based sun exposure and Vitamin D. for example, glanz et al.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5474873	6/2017	S185-PMC5474873	['PREVIOUS STUDIES HAVE REPORTED ASSOCIATIONS between Vitamin D and INCREASED RISK for health PROBLEMS, such as schizophrenia, as well as clinical symptoms in patients with mental health problems.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5474873	6/2017	S186-PMC5474873	['HOWEVER, there is a LACK OF PREVIOUS STUDIES on HOW sun exposure, the main source of Vitamin D, INFLUENCES psychotic experiences in the general population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 48), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]
PMC5513133	7/2017	S5-PMC5513133	['clinical trials TO DATE HAVE BEEN unable to show an INDEPENDENT EFFECT of Vitamin D supplementation in PREVENTING pe.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5513133	7/2017	S6-PMC5513133	['conclusions\nthe included clinical trials do not show an independent effect of Vitamin D supplementation in PREVENTING pe; HOWEVER, ISSUES with dose, timing, and duration of supplementation HAVE NOT BEEN COMPLETELY ADDRESSED.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('PROBLEM_COMPLICATION', 131), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5513133	7/2017	S52-PMC5513133	['additionally, Vitamin D LIKELY plays a KEY ROLE in the pathology of pre-eclamptic conditions by AFFECTING Blood pressure through Calcium Homeostasis and/or Modulating inflammation and Immunity, which are examined further in THIS review.']	[('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 96), ('QUESTION_ANSWERED_BY_THIS_WORK', 224)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0055073', 'cadmium ion homeostasis', 129, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 156, 'modulating'), ('GO_0007566', 'embryo implantation', 184, 'immunity')]
PMC5513133	7/2017	S70-PMC5513133	['FOUND that the EFFECT of 1,25(Oh)2D on Vsmc Proliferation is MEDIATED by increased vegf Expression, WHILE others FIND no relation between Vitamin D and pro-Angiogenic factors [15].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_82784', 'PVP38-Ag NP', 25, '1,25(OH)2D'), ('CL_0000359', 'vascular associated smooth muscle cell', 39, 'VSMC'), ('GO_0008283', 'cell proliferation', 44, 'proliferation'), ('GO_0010467', 'gene expression', 88, 'expression'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0001525', 'angiogenesis', 156, 'angiogenic')]
PMC5513133	7/2017	S71-PMC5513133	['there is currently NOT enough data to strongly SUPPORT the HYPOTHESIS that impaired Angiogenesis EXPLAINS the ASSOCIATION between Vitamin D deficiency and pe [60].']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('GO_0001525', 'angiogenesis', 84, 'angiogenesis'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5513133	7/2017	S132-PMC5513133	['germany, 2–14 [85]↓ 25(Oh)D levels in pe in summer compared to controls, 1,25(Oh)2D ↓ only in winter25(Oh)D: pe:18.2\xa0±\xa017.1; control: 49.2\xa0±\xa029.2\xa0ng/ml, ( p \xa0<\xa00.001); 1,25(Oh)2D: 291\xa0±\xa0217 vs 612.3\xa0±\xa0455\xa0pmol/ml ( p \xa0<\xa00.05)mohaghegh et al., iran, 2015 [89]↓ mean 25(Oh)D in pe compared to Pregnant controls without pe25(Oh)D:Pe: 37.9\xa0±\xa033.9\xa0nmol/lcontrols: 58.2\xa0±\xa038.2\xa0nmol/l( p \xa0=\xa00.001)powe, usa, 2010 [86]↔ women with pe and controls with 25(Oh)D\xa0<\xa015.0\xa0nmol/ladjusted or: 1.3595% ci: 0.40 to 4.50robinson et al., usa, 2010 [25]↑ eospe in women with maternal 25(Oh)D levels <=19.6\xa0nmol/l compared to levels >19.6\xa0nmol/lor: 3.6095% ci: 1.71–7.58( p \xa0<\xa00.001)schneuer et al., australia, 2014 [114]↔ pe or eospe and low 25(Oh)D (< 25\xa0nmol/l)adjusted or- all pe: 0.4695% ci: 0.19–1.10adjusted or- eospe: 1.4095% ci: 0.20 to 9.89singla et al., india, 2015 [87]↓ mean Serum Vitamin D in women with pe vs controlspe: 24.2\xa0±\xa012.4\xa0nmol/l controls: 36.9\xa0±\xa016.7\xa0nmol/l;( p \xa0=\xa00.0001)ullah et al., bangladesh, 2013 [82]↑ pe per 25\xa0nmol/l decrease in 25(Oh)D leveladjusted or: 1.6695% ci: 1.05–3.02wetta et al., uk, 2013 [96]↔ between pe and 25-Oh D\xa0<\xa030\xa0ng/ml and <37.4\xa0nmol/l<30\xa0ng/ml adjusted or: 1.195% ci: 0.6–2.0adjusted or: 1.4 (<37.4\xa0nmol/l)95% ci: 0.7–3.0woodham et al., usa, 2011 [15]↓ severe pe in women with 10\xa0nmol/l increase in maternal 25(Oh)D leveladjusted or: 0.6295% ci: 0.51–0.76xu et al., usa, 2014 [53]↑ pe in women with Vitamin D deficiency (<37.5\xa0nmol/l)or: 4.495% ci: 1.8–10.8yu et al., uk, 2012 [115]↔ Serum Vitamin D raw values in pe and controls25(Oh)D levels: controls: 46.8\xa0nmol/l (27.8–70.0;)early pe: 32.2\xa0nmol/l (22.7–50.4); late pe: 39.2\xa0nmol/l (22.1–63.0) ( p \xa0=\xa00.231)alvarez-fernandez et al., spain, 2014 [90]↑ pe in women with 25(Oh)D levels <50\xa0nmol/l compared TO levels >50\xa0nmol/l after 20\xa0weeks of Gestationor: 4.695% ci:1.4–15( p \xa0=\xa00.010)scholl et al., usa, 2013 [78]↑ pe in women with 25(Oh)D\xa0<\xa049.9\xa0nmol/l and hyperparathyroidismadjusted or: 2.8695% ci: 1.28–6.41burris et al., usa, 2014 [94]↔ Pe and 25(Oh)D levels compared at each 25\xa0nmol/l increase in 25 (Oh)Dadjusted or: 1.1495% ci: 0.77–1.67haugen et al., norway, 2000 [77]↓ pe in women taking 10–15 mcg/d as compared with no supplementsadjusted or: 0.7395% ci: 0.58–0.92shand et al., canada, 2010 [37]↔ pe and 25(Oh)D levels <37.5\xa0nmol/ladjusted or: 0.9195% ci: 0.31–2.62wei et al., canda 2012 [60]↔ Pe and 25(Oh)D\xa0<\xa050\xa0nmol/ladjusted or: 1.2495% ci: 0.58–2.67( p \xa0=\xa00.58)wei, canada, 2013 [14]↑ pe and women with ↓ pigf levels and maternal 25(Oh)d\xa0<\xa050\xa0nmol/ladjusted or: 2.9795% ci: 1.23–7.20zhou, china, 2014 [116]↔ pe and 25(Oh)D levels25(Oh)D levelsgroup a ( n \xa0=\xa013): 41.4\xa0±\xa06.5\xa0nmol/l; group b ( n \xa0=\xa036): 62.1\xa0±\xa07.0\xa0nmol/l; group c ( n \xa0=\xa025): 89.6\xa0±\xa013.0\xa0nmol/l; ( p \xa0=\xa00.900)\na case-cohort study of women from 12 different united states (us) sites whose vitamin D levels were measured at ≤26\xa0weeks of Gestation SHOWED that 25(Oh)D levels greater than 50\xa0nmol/l were ASSOCIATED with a 40% reduction in risk for severe pe (0.65 [95% ci 0.43 to 0.98]), although there was no reduction in absolute and relative risk for the milder clinical subtypes of pe when 25(Oh)D levels were greater than 50\xa0nmol/l [79].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 1791), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2293), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2609), ('INCOMPLETE_EVIDENCE', 2914), ('SUPERFICIAL_RELATIONSHIP', 2969)]	5	[('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 75, '25(OH)2D ↓'), ('CHEBI_33010', 'chromide(1-)', 102, '(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 168, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 265, '25'), ('PR_000011614', 'opioid growth factor receptor', 268, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 271, 'D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 322, 'OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 327, 'PE'), ('CHEBI_71657', 'versiconol acetate', 444, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 444, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 725, 'OH)D'), ('UBERON_0001977', 'blood serum', 867, 'serum'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1043, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1043, '25(OH ... D'), ('CHEBI_72765', 'verruculogen', 1134, '25-OH D'), ('CHEBI_71657', 'versiconol acetate', 1343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1343, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1434, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1519, 'serum'), ('CHEBI_27300', 'vitamin D', 1525, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 1566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1759, 'OH)D'), ('GO_0007565', 'female pregnancy', 1830, 'gestationOR'), ('CHEBI_71657', 'versiconol acetate', 1920, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2030, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2037, '25(OH)D'), ('CHEBI_982', '2-Aceto-2-hydroxybutanoate', 2091, '25 (OH)DAdjusted'), ('CHEBI_71657', 'versiconol acetate', 2303, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2303, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2393, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2400, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 2534, '25(OH'), ('CHEBI_71657', 'versiconol acetate', 2619, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 2635, '(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2865, 'D'), ('GO_0007565', 'female pregnancy', 2904, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 2926, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 3159, '25(OH)D')]
PMC5513133	7/2017	S169-PMC5513133	['OF NOTE, Omega-3 Fatty Acids found along with Vitamin D in cod Liver oil are LIKELY to play an INDEPENDENT ROLE in PREVENTING pe [92,93].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 9, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC5513133	7/2017	S236-PMC5513133	['FUTURE INVESTIGATIONS SHOULD CONSIDER concurrently measuring Vdbp levels and calculated free Vitamin D levels when CONSIDERING the ROLE of Vitamin D in pe [18].']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('PR_000017279', 'testis-specific basic protein Y 1', 61, 'VDBP'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5513133	7/2017	S242-PMC5513133	['STUDIES with longitudinal study design carefully controlling for temporal sequences of changes in Vitamin D levels in women with pe ARE NEEDED to identify the ROLE of Vitamin D and any POTENTIAL Mediators in the pathway LINKING Vitamin D to pe.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 220)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_35222', 'inhibitor', 195, 'mediators'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC5524288	7/2017	S118-PMC5524288	['among women with initial 25(Oh)D concentrations <40 ng/ml, the significantly lower ptb rate (60%) for those who achieved ≥40 ng/ml COMPARED TO those who did not reach the target concentration on a follow-up test SUGGESTS that maternal Vitamin D status is a MODIFIABLE RISK FACTOR that CAN be addressed during the Prenatal period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 268), ('INCOMPLETE_EVIDENCE', 285)]	5	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'prenatal')]
PMC5524288	7/2017	S126-PMC5524288	['additionally, using Serum 25(Oh)D concentration is a BETTER INDICATOR of Vitamin D status and statistically more powerful than using reported Intake BECAUSE it ACCOUNTS FOR all Vitamin D input sources (sun exposure, Food, and Supplements) and makes provision for inter-Individual VARIABILITY in Vitamin D dose response.']	[('PROBABLE_UNDERSTANDING', 53), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 149), ('INCOMPLETE_EVIDENCE', 160), ('DIFFICULT_TASK', 280)]	5	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 28, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007631', 'feeding behavior', 142, 'intake'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_33290', 'food', 216, 'food'), ('CHEBI_33341', 'titanium atom', 226, 'supplements'), ('NCBITaxon_1', 'root', 269, 'individual'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5537904	7/2017	S25-PMC5537904	['THUS, the PURPOSE of THIS analysis was TO EXAMINE the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and early Life body composition.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54)]	5	[('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 139, 'life')]
PMC5546866	8/2017	S19-PMC5546866	['in a PREVIOUS Genome-wide association study (gwas), we DEMONSTRATED that a NUMBER OF Single-Nucleotide Polymorphisms (Snps) in or near to Genes encoding KEY components of the Vitamin D Metabolism pathway are ASSOCIATED with Serum 25(Oh)D level (8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('SO_0001026', 'genome', 14, 'genome'), ('SO_0000694', 'SNP', 85, 'single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 118, 'SNPs'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 175, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 233, 'OH ... D')]
PMC5579643	8/2017	S61-PMC5579643	['NEVERTHELESS, the POTENTIAL EFFECT of Vitamin D on Th1/Th2 Adaptive Immune Response is of INTEREST and RELATED to Food allergy [21,22,23].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0042639', 'telogen', 51, 'Th1 ...'), ('GO_0002290', 'gamma-delta T cell activation involved in immune response', 55, 'Th2 adaptive immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_33290', 'food', 114, 'food')]
PMC5579643	8/2017	S63-PMC5579643	['when specifically CONSIDERING a POTENTIAL ROLE for Vitamins in Food allergy, Vitamin D HAS BEEN SHOWN to AFFECT several mechanisms that promote immunologic tolerance, including T Regulatory Cell function and the induction of tolerogenic Dendritic Cells.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 177, 'T regulatory cell'), ('GO_0065007', 'biological regulation', 179, 'regulatory'), ('CL_0000451', 'dendritic cell', 237, 'dendritic cells')]
PMC5634602	10/2017	S115-PMC5634602	['this, coupled with the LACK OF dangerously high levels or clinical side EFFECTS REPORTED with dosing between 400–1600 iu in preterm infants, lead us to argue for CONSIDERATION of and ADDITIONAL EVALUATION of the 800 iu dose of Vitamin D in addition to Vitamin D from diet sources in this high-risk hospitalized patient population.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 80), ('FUTURE_WORK', 162), ('FUTURE_WORK', 183)]	5	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC5634602	10/2017	S137-PMC5634602	['HOWEVER, given that the MAJORITY of Prenatal Vitamins have 400 iu of Vitamin D and this has not been shown to increase levels in Pregnancy this LIKELY does not have any IMPACT on our DESCRIBED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 183)]	5	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 45, 'vitamins'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5634602	10/2017	S146-PMC5634602	['ALTERNATIVELY, the risks of RECOMMENDATION of too low a dose MAY have significant IMPACT on Individual and population health with disease outcomes ASSOCIATED with low Vitamin D status, including hypocalcemic seizures, growth restriction, fractures, and elevation of Serum Parathyroid hormone [53–55].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 28), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 82), ('SUPERFICIAL_RELATIONSHIP', 147)]	5	[('NCBITaxon_1', 'root', 92, 'individual'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001977', 'blood serum', 266, 'serum'), ('UBERON_0001132', 'parathyroid gland', 272, 'parathyroid')]
PMC5638722	8/2017	S132-PMC5638722	['as a CONCLUSION; OUR STUDY is the FIRST to INVESTIGATE the RELATIONSHIP between the Cord-Blood Vitamin D levels and neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 84, 'cord'), ('UBERON_0000178', 'blood', 89, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5659607	10/2017	S114-PMC5659607	['these results UNDERLINE that Vitamin D supplementation during Pregnancy MAY BE an IMPORTANT FACTOR in the PREVENTION of childhood asthma.']	[('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5659607	10/2017	S120-PMC5659607	['DESPITE these DIFFERENCES, the trials SIMILARLY SHOWED that the Vitamin D supplementation resulted in significantly increased post-interventional 25(Oh)D levels in the mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 48)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
PMC5659607	10/2017	S153-PMC5659607	['conclusion\nthis combined analysis SHOWS a significant and clinically IMPORTANT 26% PROTECTIVE EFFECT of Vitamin D supplementation during Pregnancy on the RISK of asthma/recurrent wheeze in the offspring, with a more pronounced risk reduction of 46% in women with 25(Oh)D level ≥ 30 ng/ml at trial entry.']	[('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 263, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 263, '25(OH)D')]
PMC5679631	11/2017	S115-PMC5679631	['discussion\nthe OBJECTIVE of THIS STUDY was TO INVESTIGATE the POTENTIAL of Vitamin D to INFLUENCE the presence and or abundance of several key bacterial taxa within the infant Intestinal microbiota.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 88)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000160', 'intestine', 176, 'intestinal')]
PMC5679631	11/2017	S116-PMC5679631	['we THEORIZED that Vitamin D COULD IMPACT Intestinal colonization due to its immunomodulatory EFFECTS [17,18]; namely, through its inhibition of Intestinal infections via stimulated Antimicrobial Peptide Production and promotion of anti-Inflammatory Responses by the Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 3), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 93)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000160', 'intestine', 41, 'intestinal'), ('UBERON_0000160', 'intestine', 144, 'intestinal'), ('CHEBI_65381', 'albizoside C', 181, 'antimicrobial'), ('GO_0001519', 'peptide amidation', 195, 'peptide production'), ('GO_0006888', 'endoplasmic reticulum to Golgi vesicle-mediated transport', 236, 'inflammatory responses'), ('UBERON_0002405', 'immune system', 266, 'immune system')]
PMC5679631	11/2017	S132-PMC5679631	['COMPATIBLE with our PRESENT STUDY, the results of these three investigations SUGGEST that Vitamin D MAY play a ROLE in shaping the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000160', 'intestine', 131, 'intestinal')]
PMC5685050	10/2014	S0-PMC5685050	['vitamin D deficiency in thailand☆\nvitamin D deficiency has received INCREASED ATTENTION over the past several years since Vitamin D MAY play an IMPORTANT ROLE not ONLY in bone Metabolism but also in a variety of non-Skeletal diseases such as diabetes mellitus, Autoimmune diseases, infectious diseases, Cardiovascular diseases and cancer1,2,3.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 144), ('SUPERFICIAL_RELATIONSHIP', 154), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 8, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0008152', 'metabolic process', 176, 'metabolism'), ('UBERON_0004288', 'skeleton', 216, 'skeletal'), ('UBERON_0001442', 'skeleton of manus', 261, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 303, 'cardiovascular')]
PMC5706533	11/2017	S0-PMC5706533	['Vitamin D supplementation during Pregnancy: state of the evidence from a systematic review of randomised trials\n\nabstract\nobjectives \xa0TO ESTIMATE the EFFECTS of Vitamin D supplementation during Pregnancy on 11 maternal and 27 neonatal/infant outcomes; TO DETERMINE frequencies at which trial outcome data were missing, unreported, or inconsistently reported; and to project the POTENTIAL contributions of registered ongoing or planned trials.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 134), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('INCOMPLETE_EVIDENCE', 378)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy')]
PMC5706533	11/2017	S164-PMC5706533	['we CONSIDERED the weak ASSOCIATION between dose and 25(Oh)D to reflect the overall low quality of many of the trials, which TEMPERED expectations of finding dose DEPENDENT EFFECTS of Vitamin D on clinical outcomes.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5707701	11/2017	S170-PMC5707701	['these inverse CORRELATIONS between SOME of the Carotenoids and current bmi MAY BE due TO the underlying mechanism that an excess of body fat increases the consumption of all antioxidant elements in the diet [63], SO that Lactating women with a higher bmi and more body fat consumed more Vitamins A and E than those with lower bmi, resulting in lower Carotenoids in Human Milk.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('PROBABLE_UNDERSTANDING', 213)]	5	[('CHEBI_50815', 'norgestimate', 47, 'carotenoids'), ('GO_0007594', 'puparial adhesion', 221, 'lactating'), ('CHEBI_27300', 'vitamin D', 287, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 296, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 302, 'E'), ('CHEBI_50815', 'norgestimate', 350, 'carotenoids'), ('NCBITaxon_9606', 'Homo sapiens', 365, 'human'), ('UBERON_0001913', 'milk', 371, 'milk')]
PMC5732505	12/2017	S0-PMC5732505	['maternal Vitamin D status, Gestational diabetes and infant Birth size\n\nabstract\n\nbackground\nmaternal Vitamin D status HAS BEEN ASSOCIATED with both Gestational diabetes mellitus (gdm) and fetal growth restriction, HOWEVER, the EVIDENCE is INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'gestational'), ('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5732505	12/2017	S28-PMC5732505	['case-control STUDIES OFTEN focus on HIGH-RISK groups, for example women who are overweight and sedentary, which are INDEPENDENT RISK FACTORS for Vitamin D deficiency as well (for example [16]).']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5732505	12/2017	S132-PMC5732505	['abbreviations: gwg, Gestational weight gain; gdm, Gestational diabetes mellitus; 25(Oh)D, 25-Hydroxy Vitamin D; suboptimal, ucb, Umbilical Cord Blood; 25(Oh)D\u2009<\u200980\xa0nmol/l; optimal 25(Oh)D\u2009≥\u200980\xa0nmol/l\n\ndiscussion\nthe primary FOCUS of this work was TO DETERMINE WHETHER 25(Oh)D concentration differs between mothers with AND without gdm, and WHETHER Vitamin D status AFFECTS Birth size in normal-Birth-weight infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 365)]	5	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 90, '25-hydroxy vitamin D'), ('UBERON_0002331', 'umbilical cord', 129, 'umbilical cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0007567', 'parturition', 373, 'birth'), ('GO_0007567', 'parturition', 394, 'birth')]
PMC5732505	12/2017	S136-PMC5732505	['INTERESTINGLY, Pregnancy Vitamin D status ASSOCIATED positively with Birth weight, BUT an inverse ASSOCIATION was OBSERVED between newborn Vitamin D status and Head circumference at Birth.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0000033', 'head', 160, 'head'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC5732505	12/2017	S144-PMC5732505	['IN ACCORDANCE with OTHER STUDIES, our results IMPLY that in a Vitamin D sufficient population, the ASSOCIATION between 25(Oh)D and gdm MAY NOT exist [8,21,22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 135)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D')]
PMC5732505	12/2017	S157-PMC5732505	['HOWEVER, the clinical RELEVANCE, if any, of the inverse RELATIONSHIP between maternal Vitamin D status and Head circumference at Birth REMAINS UNEXPLAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 143)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000033', 'head', 107, 'head'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5758521	1/2018	S19-PMC5758521	['taken TOGETHER, these OBSERVATIONS SUGGEST that Vitamins A and E MAY AFFECT Metabolic health.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E'), ('GO_0008152', 'metabolic process', 76, 'metabolic')]
PMC5784894	1/2018	S21-PMC5784894	['we HYPOTHESISE that Antenatal Vitamin D status MAY BE RESPONSIBLE for altered bone responsiveness to Postnatal mechanical loading, a major anabolic INFLUENCE on bone size, mass and strength, and thus act as a DETERMINANT of later Skeletal ill-health.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 148), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'postnatal'), ('UBERON_0004288', 'skeleton', 230, 'skeletal')]
PMC5784894	1/2018	S138-PMC5784894	['IMPORTANTLY, and for the FIRST TIME, we have DEMONSTRATED that for those with early Life Vitamin D deficiency, the Anabolic response of bone to mechanical loading is reduced in Growing bone, AFFECTING both Cortical and Trabecular Bone, with the EFFECT on Cortical bone persisting into “Adult” Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 191), ('SUPERFICIAL_RELATIONSHIP', 245)]	5	[('UBERON_0000104', 'life cycle', 84, 'life'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 115, 'anabolic'), ('GO_0040007', 'growth', 177, 'growing'), ('UBERON_0001851', 'cortex', 206, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 219, 'trabecular bone'), ('UBERON_0001851', 'cortex', 255, 'cortical'), ('UBERON_0007023', 'adult organism', 286, 'adult'), ('UBERON_0000104', 'life cycle', 293, 'life')]
PMC5804088	2/2018	S19-PMC5804088	['OTHER STUDIES have FOUND EVIDENCE of ASSOCIATIONS between acute malaria and deficiency of Thiamine [14] and antioxidants including Vitamin E [15], which SUGGESTS they have ROLES in protection against malaria.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_26948', 'vitamin B1', 90, 'thiamine'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin E')]
PMC5812027	2/2018	S118-PMC5812027	['AS the results between change in 25Ohd and neonatal Birth size and Preterm Delivery REMAINED after adjustment for season of Conception, origin and Vitamin D supplementation, Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 209), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 33, '25OHD'), ('GO_0007567', 'parturition', 52, 'birth'), ('GO_0007565', 'female pregnancy', 67, 'preterm'), ('GO_0007567', 'parturition', 75, 'delivery'), ('GO_0007620', 'copulation', 124, 'conception'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5812027	2/2018	S121-PMC5812027	['it is also POSSIBLE that the ASSOCIATIONS between fetal growth and maternal Vitamin D status are DUE TO residual CONFOUNDING or REVERSE CAUSATION.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBLEM_COMPLICATION', 97), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5812027	2/2018	S127-PMC5812027	['this COULD BE INTERPRETED AS SUPPORT of our finding that late RATHER than early Pregnancy Vitamin D status is the stronger PREDICTOR of fetal growth restriction.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5812027	2/2018	S145-PMC5812027	['DESPITE FEW cases of iufd in the gravid cohort, our results SUGGEST that Vitamin D deficiency in early Pregnancy MAY BE LINKED to iufd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC5827025	2/2018	S94-PMC5827025	['NUMEROUS STUDIES SHOWED that season is a MAJOR INFLUENT FACTOR for Vitamin D status31,32.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 56)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5827025	2/2018	S101-PMC5827025	['follow-up, SEVERAL randomized TRIAL of Vitamin D supplementation FOUND that the rate of Preterm Delivery is significant more lower in Pregnant women with Serum 25(Oh)D ≥40\u2009ng/ml COMPARED TO those with Serum 25(Oh)D ≤20\u2009ng/ml, SUGGESTING higher 25(Oh)D concentration was ASSOCIATED with an decreased risk of Preterm Delivery35–38.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 270)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'preterm'), ('GO_0007567', 'parturition', 96, 'delivery'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_63056', 'zinc cation', 160, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 166, 'D'), ('UBERON_0001977', 'blood serum', 201, 'serum'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 210, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 213, 'D'), ('CHEBI_71657', 'versiconol acetate', 244, '25(OH)D'), ('GO_0007565', 'female pregnancy', 307, 'preterm'), ('GO_0008219', 'cell death', 315, 'delivery35')]
PMC5838372	3/2018	S20-PMC5838372	['the lack of Vitamin D during Pregnancy is the MOST IMPORTANT RISK FACTOR for infantile rickets and MAY also result in POOR fetal growth and Neonatal Development (8,9,10,11).']	[('PROBABLE_UNDERSTANDING', 46), ('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0021985', 'neurohypophysis development', 140, 'neonatal development')]
PMC5838372	3/2018	S82-PMC5838372	['the SAFETY dose during Pregnancy is NOT CLEAR, but hollis et al (20) SHOWED that Vitamin D supplementation of 4000 iu/day for achieving adequate levels was SAFE and EFFECTIVE in Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FULL_UNKNOWN', 36), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 156), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC5941617	5/2018	S7-PMC5941617	['besides these classic Skeletal actions, RECENT STUDIES have DEMONSTRATED that Vitamin D exerts OTHER significant Extraskeletal actions, with a POSSIBLE ROLE in the pathogenesis of several pathological conditions, including infectious and Autoimmune diseases [1].']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('UBERON_0004288', 'skeleton', 22, 'skeletal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 113, 'extraskeletal'), ('UBERON_0001442', 'skeleton of manus', 238, 'autoimmune')]
PMC5941617	5/2018	S65-PMC5941617	['LIMITATIONS of the study include the fact that SOME of the studies mainly included children aged 7–11\xa0years, and that Vitamin D supplements, Food fortification or sun awareness campaigns COULD have INFLUENCED the ESTIMATES.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 213)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 141, 'food')]
PMC5941617	5/2018	S159-PMC5941617	['1–18\xa0years\nthe promotion of an adequate Vitamin D status is IMPORTANT for older children and adolescents, AS nutritional rickets MAY develop during the entire pediatric age [28] and Vitamin D deficiency MAY negatively AFFECT bone health [25,26].']	[('IMPORTANT_CONSIDERATION', 60), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 218)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC5941617	5/2018	S172-PMC5941617	['CONSIDERING the italian child health care system organization, family pediatricians MAY anamnestically evaluate Vitamin D intake of children and POSSIBLE RISK FACTORS for deficiency during periodic health check-ups [176].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC5941617	5/2018	S205-PMC5941617	['tuberculosis)xxxxamenorrheaxcancer (DIFFERENT types)xfxxxhepatitis cgxxrecurrent acute Lower Respiratory Tract infectionsgxxatopic dermatitisgxxatopic asthmagxxautoimmune diseaseshxxixcardiovascular diseases (especially hypertension)xxmetabolic syndrome, type 2 diabetesx\npes pediatric endocrine society, Es endocrine society, fcn federal commission for nutrition (switzerland), sahm society for adolescent health and medicine, aap american academy of pediatrics, eap european academy of pediatrics\nasuggested to guide Vitamin D prescription in Individuals with underlying RISKS requiring continuing supplementation all year long, if NECESSARY\nbgenetic conditions (Osteogenesis imperfecta, idiopathic juvenile osteoporosis, turner syndrome), Endocrine conditions (cushing syndrome, hypogonadism, hyperthyroidism, hyperparathyroidism, growth hormone deficiency, diabetes mellitus) ASSOCIATED with reduced bone mass\ncliving at higher latitudes in the winter and spring months\ndafrican-american and hispanic children\neobese children with additional RISK factors/symptoms for Vitamin D deficiency\nfsome lymphomas\ngpatients admitted to hospital\nhmultiple sclerosis, psoriasis, rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus\nisystemic lupus erythematosus, juvenile idiopathic arthritis, juvenile dermatomyositis as associated with reduced bone mass\n\nSkeletal actions of Vitamin D\n\nnutritional rickets\nrickets is characterized by defective Mineralization Of developing Bone Tissue and reduced or absent Endochondral Ossification of the growth plate, with subsequent deformation [183,184].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('IMPORTANT_CONSIDERATION', 573), ('IMPORTANT_CONSIDERATION', 634), ('SUPERFICIAL_RELATIONSHIP', 880), ('SUPERFICIAL_RELATIONSHIP', 1046)]	5	[('UBERON_0004905', 'articulation', 87, 'lower respiratory tract'), ('CL_0002322', 'embryonic stem cell', 305, 'ES'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('NCBITaxon_1', 'root', 545, 'individuals'), ('GO_0001503', 'ossification', 665, 'osteogenesis'), ('GO_0006397', 'mRNA processing', 742, 'endocrine'), ('CHEBI_27300', 'vitamin D', 1072, 'vitamin D'), ('UBERON_0004288', 'skeleton', 1365, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 1385, 'vitamin D'), ('GO_0051217', 'molybdenum incorporation via L-aspartyl molybdenum bis(molybdopterin guanine dinucleotide)', 1454, 'mineralization of ...'), ('UBERON_0002481', 'bone tissue', 1483, 'bone tissue'), ('GO_0042695', 'thelarche', 1488, 'tissue'), ('GO_0001958', 'endochondral ossification', 1517, 'endochondral ossification'), ('UBERON_0010363', 'endochondral element', 1517, 'endochondral')]
PMC5941617	5/2018	S256-PMC5941617	['SEVERAL STUDIES evaluated the ASSOCIATION between Vitamin D status and bone mass in children and adolescents, USUALLY SEARCHING for a CORRELATION between actual Serum 25(Oh)D levels and bone mass.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 161, 'serum'), ('CHEBI_71657', 'versiconol acetate', 167, '25(OH)D')]
PMC5941617	5/2018	S265-PMC5941617	['in 2016 the national osteoporosis foundation applied an EVIDENCE based grading system to describe the strength of AVAILABLE EVIDENCE on modifiable lifestyle factors that MAY INFLUENCE the acquisition of pbm, reporting MODERATE EVIDENCE (grade b) for Vitamin D [220].']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 218)]	5	[('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC5941617	5/2018	S301-PMC5941617	['a RECENT LITERATURE REVIEW SUPPORTS a ROLE for Vitamin D deficiency ONLY for tuberculosis, recurrent acute otitis media and SEVERE bronchiolitis [242].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 124)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5941617	5/2018	S306-PMC5941617	['all BUT two [259,261] of the aforementioned reviews concluded that published studies do not INDICATE a PROTECTIVE EFFECT of Vitamin D supplementation on the PREVENTION of acute Respiratory infections in healthy Individuals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 177, 'respiratory'), ('NCBITaxon_1', 'root', 211, 'individuals')]
PMC5941617	5/2018	S340-PMC5941617	['SEVERAL STUDIES investigated a POSSIBLE RELATIONSHIP between Vitamin D deficiency and tuberculosis infection in children [295], BUT literature results are DISCORDANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5941617	5/2018	S389-PMC5941617	['being Vitamin D INVOLVED in Innate Immunity and in skin barrier integrity, and BECAUSE both FACTORS are dysfunctional in ad, the ASSOCIATION is actively DEBATED.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 153)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0045087', 'innate immune response', 28, 'innate immunity')]
PMC5941617	5/2018	S391-PMC5941617	['HOWEVER, at LEAST two longitudinal STUDIES have CORRELATED the Vitamin D Cord Blood low levels to the development of ad in the offsprings, FINDING that low levels in the Cord Blood significantly increased the risk to develop the disease [347,348].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0009472', 'axilla', 170, 'cord blood')]
PMC5941617	5/2018	S411-PMC5941617	['negative results were obtained in term of primary PREVENTION by Vitamin D supplementation in a RECENT meta-analysis and conclusions were that the EFFECTS of Vitamin D supplementation REMAIN UNCERTAIN [353].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 183), ('FULL_UNKNOWN', 190)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5941617	5/2018	S423-PMC5941617	['CONVERSELY, neonatal Vitamin D status SEEMS TO BE ASSOCIATED to the RISK of t1dm in some [382] BUT NOT all the populations [383].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S683-PMC5941617	['Serum 25(Oh)D evaluation MAY BE CONSIDERED in children with SEVERE ad unresponsive to common therapy and multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5956785	5/2018	S1-PMC5956785	['WHILE the ROLES of Vitamin D in OTHER Autoimmune diseases HAVE BEEN investigated, less is known about the ROLE of Vitamin D in chronic childhood arthritis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 38, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5956785	5/2018	S21-PMC5956785	['CONSEQUENTLY, low Vitamin D concentrations are ASSOCIATED with an increase in pro-Inflammatory Mediators and more active disease [6,10] CONSISTENT, for example, with the OBSERVATION that low Serum 25(Oh)D is ASSOCIATED with increased disease activity in rheumatoid arthritis [11].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_64664', '(2-nitrophenyl)azo group', 81, '-inflammatory mediators'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D')]
PMC5956785	5/2018	S30-PMC5956785	['HERE we report the results of a Vitamin D- jia scoping review that summarizes, synthesizes, evaluates, and interprets pertinent EVIDENCE from the literature to address the following research questions: 1) WHAT is the RELATIONSHIP between Vitamin D status and the occurrence of jia?']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 128), ('EXPLICIT_QUESTION', 205), ('SUPERFICIAL_RELATIONSHIP', 217), ('EXPLICIT_QUESTION', 280)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5956785	5/2018	S140-PMC5956785	['the 2013, systematic literature review of 19 childhood arthritis STUDIES REPORTED Vitamin D status (14 reporting 25(Oh)D and 11 reporting 1,25(Oh)D) SUGGESTED that at that time there was NO CLEAR LINK between Vitamin D status and children with chronic arthritis [12].']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 149), ('FULL_UNKNOWN', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 116, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 143, 'OH)D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5956785	5/2018	S186-PMC5956785	['long-term cohort STUDIES CAN FURTHER CLARIFY the RELATIONSHIP between Vitamin D concentration and disease duration or frequency of relapse.']	[('FUTURE_WORK', 17), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5956785	5/2018	S280-PMC5956785	['we do not, HOWEVER, know the optimal Vitamin D status for children with jia, WHETHER reduced Vitamin D is caused by increased utilization OR reduced Vitamin D status in children with jia, the IMPACT of Vitamin D in disease activity or the ROLE of Vdr polymorphisms with jia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('EXPLICIT_QUESTION', 77), ('SUPERFICIAL_RELATIONSHIP', 192), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 247, 'VDR')]
PMC5956785	5/2018	S283-PMC5956785	['INVESTIGATING the Genetic and environmental ROLE that Vitamin D plays in the PREVENTION and Control of jia in the same children will HELP to tease out the multifaceted ROLE played by Vitamin D in this disease.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('FUTURE_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 168)]	5	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 92, 'control'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC6011374	6/2018	S30-PMC6011374	['we also AIMED TO EXAMINE the RELATIONSHIP between Serum 25(Oh)D at 15\u2009±\u20091\xa0weeks’ Gestation and the risk of an adverse Pregnancy outcome and included determining the EFFECT modification of fetal sex on the ASSOCIATION between maternal Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 165), ('SUPERFICIAL_RELATIONSHIP', 205)]	5	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 56, '25(OH)D'), ('GO_0007565', 'female pregnancy', 81, 'gestation'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy')]
PMC6011374	6/2018	S97-PMC6011374	['HOWEVER, after adjusting for factors shown to be ASSOCIATED with Vitamin D status including bmi and recreational walking, serum 25(Oh)D remained significantly lower in the women recruited in adelaide SUGGESTING the INFLUENCE of OTHER factors not measured as part of scope for example, hours spent outside in the sun.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 215), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 130, '(OH ... D')]
PMC6043562	7/2018	S160-PMC6043562	['IN SUMMARY, we FOUND that greater maternal intakes of Vitamin D, Folate, and N-3 Fatty Acids were ASSOCIATED with less Airway inflammation in adolescence, WHILE other Nutrients (Vitamin E), and air Pollutants were ASSOCIATED with higher inflammation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 214)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 65, 'folate'), ('CHEBI_35418', 'N-acetylneuraminate', 77, 'n-3 fatty acids'), ('UBERON_0001005', 'respiratory airway', 119, 'airway'), ('CHEBI_33284', 'nutrient', 167, 'nutrients'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E'), ('CHEBI_26199', 'polyprenol', 198, 'pollutants')]
PMC1888711	5/2007	S123-PMC1888711	['Albendazole HAS BEEN SHOWN to reduce the decline in haemoglobin during Pregnancy, but there is NO CONCLUSIVE EVIDENCE for an EFFECT of Vitamin A or other Micronutrients on anemia during Pregnancy, PARTICULARLY when compared with Iron and Folate supplementation [60,61].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 197)]	4	[('CHEBI_16664', 'albendazole', 0, 'Albendazole'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_33839', 'macromolecule', 154, 'micronutrients'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_24870', 'ion', 229, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
PMC2396486	6/2008	S2-PMC2396486	['because the Nucleus Accumbens HAS BEEN IMPLICATED in neuropsychiatric disorders, in THE CURRENT STUDY we EXAMINED protein Expression in this region in Adult Rats exposed to Dvd deficiency\n\nmethods\nfemale sprague dawley Rats were maintained on a Vitamin D deficient diet for 6 weeks, Mated and allowed to Give Birth, after which a diet containing Vitamin D was reintroduced.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 105)]	4	[('UBERON_0001882', 'nucleus accumbens', 12, 'nucleus accumbens'), ('GO_0010467', 'gene expression', 122, 'expression'), ('UBERON_0007023', 'adult organism', 151, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 157, 'rats'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 173, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 219, 'rats'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007618', 'mating', 283, 'mated'), ('GO_0007631', 'feeding behavior', 304, 'give'), ('GO_0007567', 'parturition', 309, 'birth'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC2396486	6/2008	S13-PMC2396486	['given that Vitamin D levels in the population fluctuate across the seasons and decrease across higher latitude[4], low Prenatal Vitamin D ‘FITS’ these key environmental features and is THEREFORE a PLAUSIBLE CANDIDATE risk factor for this disease.']	[('SUPERFICIAL_RELATIONSHIP', 139), ('PROBABLE_UNDERSTANDING', 185), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 207)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'prenatal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2581757	11/2008	S10-PMC2581757	['the functional consequence and the POSSIBLE ROLE of the decrease in Plasma Vitamin C reserves in Preeclampsia (pe) are CONSISTENT with the fact that women who Ingested less Vitamin C than the recommended daily allowance (8.5\xa0mg) were at a 2-fold INCREASED risk of developing pe [7].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 119), ('IMPORTANT_CONSIDERATION', 246)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin C'), ('GO_0007128', 'meiotic prophase I', 97, 'preeclampsia'), ('GO_0007631', 'feeding behavior', 159, 'ingested'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C')]
PMC2582131	11/2008	S26-PMC2582131	['in the PRESENT STUDY, we EVALUATED the ASSOCIATION between maternal Plasma Vitamin D concentrations in early Pregnancy and subsequent risk of gdm based ON a prospective cohort study of Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
PMC2582131	11/2008	S88-PMC2582131	['several mechanisms MAY EXPLAIN the OBSERVED ASSOCIATION between Vitamin D deficiency and gdm risk.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC2606998	6/2007	S86-PMC2606998	['both Folate and Vitamin\u2009D are CONSIDERED to have PROFOUND EFFECTS on Pregnancy outcome, as well as on maternal health.6,7.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC2646054	3/2009	S185-PMC2646054	['experiments in hypercholesterolemic Rabbits HAVE SHOWN that administration of the antioxidant Vitamin E during Pregnancy resulted in reduced atherosclerotic lesions in the offspring (16,17), INDICATING that maternal oxidative stress LIKELY plays a ROLE in maternal programming for atherosclerosis.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 191), ('PROBABLE_UNDERSTANDING', 233), ('SUPERFICIAL_RELATIONSHIP', 248)]	4	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rabbits'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]
PMC2779500	11/2009	S42-PMC2779500	['for example, ALTHOUGH reduced mortality HAS BEEN SHOWN in hiv-positive children receiving Vitamin A supplementation [30], the administration of Vitamin A supplements to women has BEEN IMPLICATED in increased Vaginal Viral shedding (no effect on risk was observed from Vitamins B, C, and E) [31], a heightened risk of Mother-To-Child Hiv Transmission [32], and hastened progression of child mortality [30].']	[('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 179), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin A'), ('UBERON_0001987', 'placenta', 208, 'vaginal'), ('NCBITaxon_1', 'root', 216, 'viral'), ('CHEBI_27300', 'vitamin D', 268, 'vitamins B'), ('PR_000000037', 'BMP receptor type-2', 277, 'B'), ('CHEBI_18245', 'carboxylato group', 280, 'C'), ('PR_000004900', 'complement C3', 280, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 287, 'E'), ('GO_0048870', 'cell motility', 317, 'mother-to-child'), ('GO_0007228', 'positive regulation of hh target transcription factor activity', 333, 'HIV transmission')]
PMC2798111	12/2010	S17-PMC2798111	['THEREFORE, Oral supplementation or sufficient sun exposure is NECESSARY to ensure adequate Vitamin D status for proper calcium absorption and bone mineralization [3–6].RECENT RESEARCH has also LINKED Vitamin D to Innate Immunity [7–9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 193)]	4	[('UBERON_0000165', 'mouth', 11, 'oral'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0045087', 'innate immune response', 213, 'innate immunity')]
PMC2798111	12/2010	S18-PMC2798111	["furthermore, Vitamin D deficiency HAS BEEN ASSOCIATED with a NUMBER OF disease states including but certainly not limited to rheumatoid arthritis [10], multiple sclerosis [11–14], type i and ii diabetes [15–19], crohn's disease [20], Cardiovascular disease [21,22], and a NUMBER of cancers [23,24]."]	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 272)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 234, 'cardiovascular')]
PMC2821652	2/2010	S29-PMC2821652	['DESPITE an expanding Intravascular volume during Pregnancy, maternal Vitamin D status SHOWS seasonal variation but beyond the typical FACTORS that INFLUENCE Vitamin D status in Adults (such as sunlight exposure and bmi), Vitamin D status does not fluctuate during Pregnancy and once supplemented, maternal Blood levels reach steady-state within 2 months [15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('GO_0005622', 'intracellular anatomical structure', 21, 'intravascular'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('UBERON_0000178', 'blood', 306, 'blood')]
PMC2821652	2/2010	S45-PMC2821652	["the PURPOSES of THIS STUDY were to define parameters for measuring adherence to Vitamin D supplementation by measures of Serum Metabolite, which could then be applied to other medication regimens, and TO EXAMINE the ASSOCIATION between adherence as determined by Serum Metabolites and adherence as determined by patients' pill counts."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_39382', 'flufenoxuron', 127, 'metabolite'), ('UBERON_0001977', 'blood serum', 263, 'serum'), ('CHEBI_25212', 'metabolite', 269, 'metabolites')]
PMC2872349	4/2010	S93-PMC2872349	['ADDITIONAL EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women’s survey, when maternal Vitamin D concentrations again CORRELATED with neonatal bone mass [41].']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2874518	6/2010	S121-PMC2874518	['the PATTERN of dietary supplement use in our cohort, with most women taking Supplements (mainly Folic Acid) in the first Trimester, is expected because there is no national RECOMMENDATION in england for routine Supplement-taking during Pregnancy apart from Folic Acid in the first trimester and Vitamin D for Pregnant women in ‘high-RISK’ groups.30there is no national RECOMMENDATION to take multivitamin and Mineral supplements at any stage during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 333), ('FUTURE_WORK', 369)]	4	[('CHEBI_33341', 'titanium atom', 76, 'supplements'), ('CHEBI_30751', 'formic acid', 96, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 121, 'trimester'), ('CHEBI_16158', 'steroid sulfate', 211, 'supplement'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('CHEBI_30751', 'formic acid', 257, 'folic acid'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('CHEBI_46662', 'mineral', 409, 'mineral'), ('GO_0007565', 'female pregnancy', 449, 'pregnancy')]
PMC2889879	5/2010	S35-PMC2889879	['furthermore, it HAS BEEN HYPOTHESIZED that Prenatal Vitamin D deficiency is a risk factor for schizophrenia, SUPPORTED by the ROLE of this Vitamin in Cell Growth and differentiation, the excess of winter births in schizophrenia (a period when Vitamin D levels are low), and increased Births of pre-schizophrenic subjects in urban areas, where Vitamin D deficiency is higher [12,18].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 139, 'vitamin'), ('GO_0016049', 'cell growth', 150, 'cell growth'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'births'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D')]
PMC2889879	5/2010	S36-PMC2889879	['HOWEVER, TO OUR KNOWLEDGE, NO STUDY has investigated the ASSOCIATION between dietary Intake of fish, Omega-3 and Omega-6 Pufa or Vitamin D and the risk of having positive psychotic symptoms in the general Adult population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('FULL_UNKNOWN', 27), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('GO_0007631', 'feeding behavior', 85, 'intake'), ('CHEBI_79370', 'ibho#10', 101, 'omega-3'), ('CHEBI_82670', 'ELQ-271', 113, 'omega-6 PUFA'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0007023', 'adult organism', 205, 'adult')]
PMC2889879	5/2010	S37-PMC2889879	['the main PURPOSE of the PRESENT STUDY was TO EVALUATE the ASSOCIATION between the dietary Intake of different fish species, the dietary Intake of Pufas (Omega-3 and Omega-6) and Vitamin D and the prevalence of positive psychotic-like symptoms in a population-based study among swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('GO_0007631', 'feeding behavior', 90, 'intake'), ('GO_0007631', 'feeding behavior', 136, 'intake'), ('CHEBI_86926', 'S a S b S', 146, 'PUFAs'), ('CHEBI_30823', 'oleate', 153, 'omega'), ('CHEBI_79370', 'ibho#10', 165, 'omega-6'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC2889879	5/2010	S135-PMC2889879	['OUR FINDINGS INDICATED a PROTECTIVE EFFECT of Vitamin D for the risk of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2889879	5/2010	S143-PMC2889879	['THUS, the CORRELATION between Vitamin D intake and Serum levels MAY VARY.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 64), ('DIFFICULT_TASK', 68)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum')]
PMC2898025	5/2010	S4-PMC2898025	['THIS PAPER reviews the PLAUSIBILITY of evidence FOCUSING on the seasonal INTERRELATION of farming, allergies, Viruses, Vitamin D, diet, Birth weight, and handedness.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('NCBITaxon_1', 'root', 110, 'viruses'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth')]
PMC2898025	5/2010	S36-PMC2898025	['thus far, the major evidence in SUPPORT of a seasonal EFFECT involves farming, allergies/immunity, Viruses, and Vitamin D. other POSSIBLE factors RELATED to Seasonal Birth are diet, Birth weight, and handedness.']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('NCBITaxon_1', 'root', 99, 'viruses'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 157, 'seasonal'), ('GO_0007567', 'parturition', 166, 'birth'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC2898025	5/2010	S113-PMC2898025	['seasonal variation in Vitamin D levels also HAS BEEN SUGGESTED as a factor differentially AFFECTING newborn Growth Plate width, and this MAY explain WHY babies Born in australia around october (spring) are relatively heavier than those Born at other times [156].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 137), ('EXPLICIT_QUESTION', 149)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002516', 'epiphyseal plate', 108, 'growth plate'), ('GO_0007567', 'parturition', 160, 'born'), ('GO_0007567', 'parturition', 236, 'born')]
PMC2913107	8/2010	S8-PMC2913107	['a 2008 REVIEW DETAILED the DEVASTATING EFFECT Gestational Vitamin D deficiency has on developing Mammalian Brains (7).']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_40674', 'Mammalia', 97, 'mammalian'), ('UBERON_0000955', 'brain', 107, 'brains')]
PMC2913107	8/2010	S46-PMC2913107	['indeed, without the Genetic TENDENCY for autism, i SUSPECT that SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities, as referenced above, with no evidence autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_PREDICTION', 120)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC2963768	10/2010	S12-PMC2963768	['introduction\nthroughout most of the previous century, Vitamin D deficiency and rickets were predominantly PERCEIVED as PROBLEMS of industrialized countries at northern latitudes, where insufficient exposure to sun and intake of Vitamin D were LINKED to INADEQUATE Intestinal absorption of Calcium and impaired Skeletal mineralization (1).']	[('PROBABLE_UNDERSTANDING', 106), ('IMPORTANT_CONSIDERATION', 119), ('SUPERFICIAL_RELATIONSHIP', 243), ('IMPORTANT_CONSIDERATION', 253)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0000160', 'intestine', 264, 'intestinal'), ('CHEBI_22313', 'alkaline earth metal atom', 289, 'calcium'), ('UBERON_0004288', 'skeleton', 310, 'skeletal')]
PMC2963768	10/2010	S14-PMC2963768	['THUS, Vitamin D deficiency has re-emerged as a GLOBAL PUBLIC-HEALTH CONCERN and is now presumptively LINKED to a range of infectious, inflammatory and neoplastic diseases throughout the Life Course and around the world (1).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 186, 'life course')]
PMC2963768	10/2010	S20-PMC2963768	['a case-control study on the ASSOCIATION between acute Lower Respiratory Tract infection (alri) and Vitamin D status in infants and young children conducted in zakiganj subdistrict of sylhet district in bangladesh, during january-february 2008, provided an OPPORTUNITY to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in northeastern rural bangladesh (4).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 256), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 288)]	4	[('UBERON_0004905', 'articulation', 54, 'lower respiratory tract'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC2963768	10/2010	S21-PMC2963768	['HERE, we AIMED to describe the Vitamin D status of the source population and briefly review the POTENTIAL DETERMINANTS of low infant 25(Oh)D in this setting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 133, '25 ... OH ... D')]
PMC2963768	10/2010	S72-PMC2963768	['in this group, age was the ONLY FACTOR that was significantly ASSOCIATED with Vitamin D deficiency DEFINED by 25(Oh)D <25 nmol/l (table 3).']	[('ANOMALY_CURIOUS_FINDING', 27), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 62), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
PMC2963768	10/2010	S76-PMC2963768	['results of analyses of ASSOCIATIONS of Vitamin D status with POTENTIAL RISK FACTORS were SIMILAR when repeated in a group restricted to participants aged less than six months (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC2963768	10/2010	S134-PMC2963768	['SOME investigators have played down the ROLE of Vitamin D in rickets in bangladesh (10,52), INSTEAD blaming dietary calcium deficits or OTHER Mineral deficiencies or excesses, e.g.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_46662', 'mineral', 142, 'mineral')]
PMC2963768	10/2010	S154-PMC2963768	['THEREFORE, RECOMMENDATIONS for universal Antenatal and/or infant Vitamin D supplementation in bangladesh BASED ON biochemical data ALONE would be premature.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 131)]	4	[('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC2996405	11/2010	S0-PMC2996405	['schizophrenia and Vitamin D RELATED Genes COULD have been subject to latitude-driven adaptation\n\nabstract\n\nbackground\nmany natural phenomena are directly OR indirectly RELATED to latitude.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 36, 'genes')]
PMC2996405	11/2010	S60-PMC2996405	['OUR FINDINGS SUGGEST a molecular LINK among latitude, schizophrenia and Vitamin D.\n\nresults\na set of Snps showing high levels of latitude-DEPENDENT population differentiation was selected by using a two-step approach.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('SO_0000694', 'SNP', 101, 'SNPs')]
PMC2996405	11/2010	S109-PMC2996405	['we checked WHETHER OR NOT in these 9 Genes belonged Snps, selected by our procedure, that were PREVIOUSLY studied in RELATIONSHIP to either schizophrenia or Vitamin D RELATED phenotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('SO_0000704', 'gene', 37, 'genes'), ('SO_0000694', 'SNP', 52, 'SNPs'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC2996405	11/2010	S147-PMC2996405	['searching for a mechanism that COULD CONNECT latitude and schizophrenia at a molecular level, we reasoned that a well-known phenomenon separately LINKED to both of them is Vitamin D. indeed, Vitamin D is ESSENTIAL for normal growth, calcium absorption and Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 146), ('IMPORTANT_CONSIDERATION', 204)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0001501', 'skeletal system development', 256, 'skeletal development'), ('UBERON_0004288', 'skeleton', 256, 'skeletal')]
PMC2996405	11/2010	S149-PMC2996405	['with the same dietary Intake, the most IMPORTANT DETERMINANT for Vitamin D levels IS CONSIDERED to be where Individuals live, because of the DEPENDENCE on geographical location of the availability of uv radiation for Vitamin D synthesis.']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('GO_0007631', 'feeding behavior', 22, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_1', 'root', 108, 'individuals'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC2996405	11/2010	S156-PMC2996405	['ON THE OTHER HAND, the RELATIONSHIP between Vitamin D and schizophrenia is WELL ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2996405	11/2010	S162-PMC2996405	['in addition, epidemiological data SUGGEST that Vitamin D deficiency MAY BE ASSOCIATED with INCREASED RISKS of mental health disorders such as schizophrenia [55].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 75), ('IMPORTANT_CONSIDERATION', 91)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC2996405	11/2010	S204-PMC2996405	['IT IS POSSIBLE to SPECULATE that a selective pressure COULD have favoured a Haplotype containing the t Allele in an environment with low Vitamin D availability, for its positive EFFECT on the bone phenotype.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('SO_0001024', 'haplotype', 76, 'haplotype'), ('SO_0001023', 'allele', 103, 'allele'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3004407	12/2010	S95-PMC3004407	['the odds of Vitamin D deficiency (AS measured by 25(Oh)D concentration) did NOT APPEAR TO change as a function of Gestational age; women in their later stages of Pregnancy had a SIMILAR odds of Vitamin D deficiency and insufficiency for a given race/ethnicity than women who had their 25(Oh)D concentrations measured earlier in Pregnancy ( p = .43).']	[('PROBABLE_UNDERSTANDING', 34), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 285, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 291, 'D'), ('GO_0007565', 'female pregnancy', 328, 'pregnancy')]
PMC3004407	12/2010	S150-PMC3004407	['what is MOST CONCERNING is that use of Prenatal Vitamins containing 400\u2009iu/tablet was IRRELEVANT in AFFECTING Vitamin D status: those who took their prescribed Prenatal vitamin containing Vitamin D did not differ from those who did not.']	[('PROBABLE_UNDERSTANDING', 8), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 48, 'vitamins'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC3032617	5/2010	S108-PMC3032617	['this data SUGGEST AT LEAST two considerations; first of all regular iron, Folic Acid and Vitamin B-Complex PROTECTED women from Blood and energy loss by stimulating Red Blood Cells and THEREFORE Hemoglobin Formation.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 107), ('PROBABLE_UNDERSTANDING', 185)]	4	[('CHEBI_30751', 'formic acid', 74, 'folic acid'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin B'), ('GO_0032991', 'protein-containing complex', 99, 'complex'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000232', 'erythrocyte', 165, 'red blood cells'), ('GO_0030154', 'cell differentiation', 165, 'red blood cells'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0042541', 'hemoglobin biosynthetic process', 195, 'hemoglobin formation')]
PMC3034879	12/2010	S145-PMC3034879	['we CONSIDER this as a random finding because it is UNLIKELY that higher maternal Vitamin D status would contribute to this and SEVERAL STUDIES have witnessed that Vitamin D deficiency is RELATED to delayed age of walking [24,25].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3034879	12/2010	S179-PMC3034879	['INTERESTINGLY, the use of d3supplements was ASSOCIATED with improved Vitamin D status to a greater extent than use of d2supplements, which is IN LINE WITH FINDINGS of houghton and vieth [38].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3075531	7/2010	S8-PMC3075531	['also, OUR STUDY SHOWED significant DISCREPANCY between the two groups ACCORDING TO the rate of deficiency, insufficiency and normal range of Vitamin D categories (p=0.021).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3075531	7/2010	S47-PMC3075531	['third, ms risk SEEMS to decrease with migration from high to low latitudes.15If Vitamin D had any EFFECT on ms risk, we WOULD EXPECT ms incidence to decrease with increasing 25-Hydroxyvitamin D concentrations.']	[('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_PREDICTION', 120), ('FUTURE_PREDICTION', 126)]	4	[('CHEBI_33995', '(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene', 75, '15If'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 174, '25-hydroxyvitamin D')]
PMC3075531	7/2010	S53-PMC3075531	['THUS, if Vitamin D was PROTECTIVE, these cancers WOULD BE EXPECTED to be RARE among Individuals with ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_PREDICTION', 49), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_1', 'root', 84, 'individuals')]
PMC3075531	7/2010	S56-PMC3075531	['Genes also CAN AFFECT Vitamin D Metabolism, skin color, and behavior, all of which CAN INFLUENCE circulating 25-Hydroxyvitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 109, '25-hydroxyvitamin D')]
PMC3075531	7/2010	S65-PMC3075531	['furthermore, screening of Serum 25-Hydroxyvitamin D concentrations is LIKELY to identify a large proportion of patients who are Vitamin D deficient or insufficient, and who MIGHT BENEFIT from Vitamin D supplementation for PREVENTION of osteoporosis and other complications, especially multiple sclerosis.']	[('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 222)]	4	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 32, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3099599	5/2011	S4-PMC3099599	['subdural hematoma MAY also be the result of common Birth trauma, COMPLICATED by Prenatal Vitamin D deficiency, which also CONTRIBUTES to the appearance of Long Bone fractures commonly ASSOCIATED with child abuse.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 65), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('GO_0007567', 'parturition', 51, 'birth'), ('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002495', 'long bone', 155, 'long bone')]
PMC3103150	3/2011	S2-PMC3103150	['THEREFORE, we undertook THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency and insufficiency [Serum 25 Hydroxyvitamin D (25Ohd) ≤ 15 ng/ml and 15-20 ng/ml, respectively] among healthy term Breastfed 3 month old infants and their mothers, evaluate for clinical and radiological rickets in those infants having 25Ohd < 10 ng/ml, and check for seasonal variation and PREDICTORS of infants’ Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 376)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 112, '25 hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 133, '25OHD'), ('GO_0007567', 'parturition', 201, 'breastfed'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 321, '25OHD'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC3103150	3/2011	S41-PMC3103150	['these definitions are based ON recent RECOMMENDATIONS regarding classification of Vitamin D status in children, developed after consideration of BIOMARKERS such as changes in alp, bone density and calcium absorption at varying concentrations of 25Ohd16.']	[('ANOMALY_CURIOUS_FINDING', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_63310', 'mycinamicin IV(1+)', 245, '25OHD16')]
PMC3103150	3/2011	S42-PMC3103150	['the cut-off for elevated pth was taken as 46 pg/ml BASED ON RECENT STUDIES in Vitamin D replete subjects17.']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 60)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3107676	4/2011	S38-PMC3107676	['accounting for Vitamin C use when assessing the EFFECTS of Nitrosatable Drugs on Pregnancy outcomes MAY prove to be CRITICALLY IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116), ('IMPORTANT_CONSIDERATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin C'), ('CHEBI_7496', 'nelfinavir', 59, 'nitrosatable drugs'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC3231892	4/2011	S21-PMC3231892	['women of Reproductive age, ESPECIALLY Pregnant women, in developing countries are recognized to be AT RISK of multiple Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, with the LIKELIHOOD of adverse EFFECTS on the mother and Pregnancy outcomes [1,6].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 99), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 260)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 119, 'micronutrient'), ('CHEBI_24870', 'ion', 155, 'iron'), ('CHEBI_30751', 'formic acid', 161, 'folic acid'), ('CHEBI_24859', 'iodine atom', 173, 'iodine'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins A'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy')]
PMC3257641	3/2010	S60-PMC3257641	['Conception\nSOME older STUDIES SHOWED that Vitamin D deficient Rats had reduced fertility and litter size, ASSOCIATED with impaired Ovarian function and Spermatogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('GO_0006936', 'muscle contraction', 0, 'Conception'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 62, 'rats'), ('UBERON_0000992', 'ovary', 131, 'ovarian'), ('GO_0007283', 'spermatogenesis', 152, 'spermatogenesis')]
PMC3257641	3/2010	S106-PMC3257641	['NEVERTHELESS, in two studies in Pigs, Vitamin D administration to two sows at doses that achieved Serum 25(Oh)D levels, APPROXIMATING RECOMMENDED Human levels, was ASSOCIATED with Coronary lesions in offspring at six weeks [74,75].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 134), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_10088', 'Mus <genus>', 32, 'pigs'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0005985', 'coronary vessel', 180, 'coronary')]
PMC3257641	3/2010	S120-PMC3257641	['THESE FINDINGS are also CONSISTENT with the FINDING of an inverse ASSOCIATION between Postnatal Vitamin D supplementation in early Life and type 1 diabetes risk [90,91].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 66)]	4	[('GO_0007567', 'parturition', 86, 'postnatal'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC3257641	3/2010	S131-PMC3257641	['seasonal and population level PATTERNS of schizophrenia incidence INDICATE the POSSIBLE ROLE of low Intrauterine Vitamin D in increasing later schizophrenia risk.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 88)]	4	[('UBERON_0022293', 'reproductive gland secretion', 100, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC3257641	3/2010	S150-PMC3257641	['EVEN with these trials (mostly of high risk women, many years ago) being systematically reviewed, it APPEARS that there is NOT ENOUGH EVIDENCE to evaluate the EFFECTS of Vitamin D supplementation in Pregnancy [124].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 101), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC3271033	1/2012	S17-PMC3271033	['THIS STUDY was CONDUCTED TO EVALUATE early Life bone Mineral content (bmc) and the EFFECTS of three months of Vitamin D supplementation in Breast-Fed hispanic and non-hispanic caucasian (henceforth, "caucasian") infants on Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_46662', 'mineral', 53, 'mineral'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0000310', 'breast', 139, 'breast'), ('GO_0007631', 'feeding behavior', 146, 'fed'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
PMC3271033	1/2012	S20-PMC3271033	['HOWEVER, the RELATIONSHIP between Vitamin D status and bone-related outcomes in supplemented infants provides INFORMATION about the EFFECTS of these Cord levels and Vitamin D supplementation in early Infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0000023', 'wing', 200, 'infancy')]
PMC3271033	1/2012	S160-PMC3271033	['LARGER STUDIES ARE NEEDED in diverse populations at various latitudes to FURTHER characterize the RELATIONSHIP between Vitamin D supplementation and bone Mineral content.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('FUTURE_WORK', 73), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_46662', 'mineral', 154, 'mineral')]
PMC3277098	12/2011	S1-PMC3277098	['abstract\na ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 77)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 37, 'regulation of immune'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_28384', 'vitamin K', 114, 'Vitamin D'), ('CL_0000542', 'lymphocyte', 137, 'lymphocytes')]
PMC3277098	12/2011	S9-PMC3277098	['aside from Skeletal health, Vitamin D HAS BEEN ASSOCIATED with various cancers and Autoimmune disorders [1] with EVIDENCE FOR a ROLE in development and maintenance of Lung structure and function [3,4,5].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('UBERON_0004288', 'skeleton', 11, 'skeletal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 83, 'autoimmune'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC3277098	12/2011	S10-PMC3277098	['it is this ASSOCIATION with Immune and Airway function that provides the basis for the HYPOTHESIS that Vitamin D MAY have direct LINKS with asthma and allergic disease [6,7].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001005', 'respiratory airway', 39, 'airway'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3277098	12/2011	S25-PMC3277098	['WHILE the incidence of rickets has been largely reduced in western countries through the use of dietary supplementation and uv exposure [12], the same societies continue to experience a high prevalence of sub-clinical Vitamin D deficiency or insufficiency [13] that is LIKELY RELATED to indoor lifestyle habits with limited sun exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 269), ('SUPERFICIAL_RELATIONSHIP', 276)]	4	[('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3277098	12/2011	S29-PMC3277098	['such populations are THEREFORE reliant on dietary or supplemental sources of Vitamin D; a FACTOR that MAY BE playing a ROLE in the current allergy epidemic [16,17].']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
PMC3277098	12/2011	S42-PMC3277098	['the resulting th2 relative dominance HAS BEEN used as an explanation for the earlier OBSERVATION (1990’s) that the rise in allergic disease COINCIDED with the introduction of routine Vitamin D fortification in high latitude regions [16,17].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3277098	12/2011	S45-PMC3277098	['in Human studies there is SOME EVIDENCE of a non-linear response to Vitamin D, in that both high and low levels HAVE BEEN ASSOCIATED with increased th2 activity, but also EVIDENCE of an increased Regulatory response.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('INCOMPLETE_EVIDENCE', 171)]	4	[('NCBITaxon_9606', 'Homo sapiens', 3, 'human'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0065007', 'biological regulation', 196, 'regulatory')]
PMC3277098	12/2011	S47-PMC3277098	['this MAY BE one POSSIBLE EXPLANATION for the epidemiological LINKS between both Autoimmune disease and allergy with Vitamin D deficiency [31].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('UBERON_0001442', 'skeleton of manus', 80, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3277098	12/2011	S56-PMC3277098	['given that B and T Cells are INFLUENCED by Vitamin D (section 4.1), there is SPECULATION that Orally Ingested Vitamin D COULD have the POTENTIAL to directly Modulate the function of Lymphocytes in the local Gut micro-environment.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CL_0000969', 'regulatory B cell', 11, 'B ...'), ('CL_0000084', 'T cell', 17, 'T cells'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 94, 'orally'), ('GO_0007631', 'feeding behavior', 101, 'ingested'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0065007', 'biological regulation', 157, 'modulate'), ('CL_0000542', 'lymphocyte', 182, 'lymphocytes'), ('UBERON_0001555', 'digestive tract', 207, 'gut')]
PMC3277098	12/2011	S64-PMC3277098	['they PROPOSED that, as reduced Lung volume is a RISK FACTOR for Lung function and Respiratory illness in Humans, Vitamin D deficiency COULD increase the risk of these conditions through EFFECTS on Lung Tissue growth.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0002048', 'lung', 64, 'lung'), ('UBERON_0001004', 'respiratory system', 82, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 105, 'humans'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 197, 'lung'), ('UBERON_0000479', 'tissue', 202, 'tissue')]
PMC3277098	12/2011	S70-PMC3277098	['the exact physiological mechanisms behind these OBSERVATIONS REMAINS unanswered, however there is GROWING EVIDENCE of Genetic variability that Modulates sensitivity to, and EFFECTS of, Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('SO_0000704', 'gene', 118, 'genetic'), ('GO_0065007', 'biological regulation', 143, 'modulates'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3277098	12/2011	S109-PMC3277098	['FOUND Vitamin D to BE inversely ASSOCIATED with wheeze in japanese children aged 16–24 months, an ASSOCIATION that was no longer significant when adjusted for Docosahexaenoic Acid Intake [51].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_36003', 'decenoic acid', 159, 'docosahexaenoic acid'), ('GO_0007631', 'feeding behavior', 180, 'intake')]
PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3296991	2/2012	S10-PMC3296991	['HOWEVER, the behavior of these BIOMARKERS in the fetus and their RELATIONSHIP with Vitamin D status and neonatal bone mineralization are POORLY characterized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBLEM_COMPLICATION', 137)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3319623	4/2012	S59-PMC3319623	['INTERESTINGLY, SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of psychiatric conditions, in particular schizophrenia[25].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3319623	4/2012	S60-PMC3319623	['Animal MODELS of Gestational Vitamin D deficiency HIGHLIGHT the IMPORTANT ROLE of Vitamin D for correct Neurodevelopment[25].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 17, 'gestational'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007399', 'nervous system development', 104, 'neurodevelopment')]
PMC3347028	3/2012	S3-PMC3347028	['until RECENTLY, there HAS BEEN a PAUCITY of data from randomized controlled trials to establish clear cut beneficial EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy')]
PMC3347028	3/2012	S16-PMC3347028	['it is with these CAUTIONS and confessions that we approach THIS review about Vitamin D’s ROLE during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC3347028	3/2012	S18-PMC3347028	['during this foray into the world of Vitamin D and the fetus, we MUST first define WHAT Vitamin D is, WHAT it is not, and review the Metabolic pathways LINKED with Vitamin D.\n\n2.']	[('IMPORTANT_CONSIDERATION', 64), ('EXPLICIT_QUESTION', 82), ('EXPLICIT_QUESTION', 101), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 132, 'metabolic'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3347028	3/2012	S36-PMC3347028	['general Vitamin D Metabolism\nIN ORDER TO understand the DIFFERENCES between the nonpregnant and Pregnant states and their EFFECTS on Vitamin D Metabolism, it is ESSENTIAL to understand the nonpregnant state first.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 122), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_28384', 'vitamin K', 8, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 8, 'Vitamin D Metabolism'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 133, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 141, 'D')]
PMC3347028	3/2012	S40-PMC3347028	['WHILE there APPEARS TO BE a DIFFERENTIAL conversion rate of the two forms of Vitamin D to 25(Oh)D [8], the conversion of either form is DEPENDENT on a functional Liver and the activity of 25-hydroxylase.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('UBERON_0002107', 'liver', 162, 'liver')]
PMC3347028	3/2012	S78-PMC3347028	['these in vitro FINDINGS HELP to EXPLAIN the significant ASSOCIATION between Vitamin D deficiency and Autoimmune diseases, such as systemic lupus erythematosus [25], multiple sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both types 1 [31,38,39,40,41,42] and 2 [43,44,45], and certain cancers, such as Colon [46,47,48,49], Breast [50,51,52,53,54,55], and Prostate [55,56,57,58,59].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('UBERON_0001155', 'colon', 339, 'colon'), ('UBERON_0000310', 'breast', 360, 'breast'), ('UBERON_0002367', 'prostate gland', 392, 'prostate')]
PMC3347028	3/2012	S82-PMC3347028	['in nonpregnant adolescents and Adults, increased pth is ASSOCIATED with lower circulating concentrations of ionized calcium, which is MOST OFTEN PRECIPITATED by Vitamin D deficiency and decreased Intestinal calcium absorption.']	[('SUPERFICIAL_RELATIONSHIP', 56), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('UBERON_0007023', 'adult organism', 31, 'adults'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0000160', 'intestine', 196, 'intestinal')]
PMC3347028	3/2012	S140-PMC3347028	['for those areas of the world with higher rates of deficiency, it APPEARS that a long-standing unawareness of HOW Vitamin D is made and of the short and long-term health CONSEQUENCES of Vitamin D insufficiency has LED TO widespread insufficiencies in most populations.']	[('ANOMALY_CURIOUS_FINDING', 65), ('EXPLICIT_QUESTION', 109), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 213)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3347028	3/2012	S146-PMC3347028	['such readily observable fetal and neonatal Skeletal EFFECTS of profound Vitamin D deficiency are easily understood in terms of cause and effect, BUT the more subtle EFFECTS of deficiency on the developing Immune System, for example, and subsequent infection risk or Immune dysfunction are more DIFFICULT to understand [19,84,97,98,99].']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 165), ('DIFFICULT_TASK', 294)]	4	[('UBERON_0004288', 'skeleton', 43, 'skeletal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002405', 'immune system', 205, 'immune system'), ('UBERON_0002405', 'immune system', 266, 'immune')]
PMC3347028	3/2012	S161-PMC3347028	['WHILE there are numerous epidemiological studies that bear EVIDENCE of the ASSOCIATION between Vitamin D deficiency and altered health, definitive proof in terms of randomized controlled trials is often LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('FULL_UNKNOWN', 203)]	4	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3347028	3/2012	S182-PMC3347028	['effectiveness of Vitamin D supplementation during Pregnancy\nthere HAS BEEN a PAUCITY OF studies evaluating the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_28384', 'vitamin K', 17, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC3347028	3/2012	S225-PMC3347028	['MORE WORK IS WARRANTED in this AREA to understand the POSSIBLE ROLE of Vitamin D deficiency in preeclampsia.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347028	3/2012	S231-PMC3347028	['IF so, does substrate sufficiency—EITHER through adequate sunlight exposure OR Vitamin D supplementation—saturate such EFFECTS, making them clinically irrelevant?']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 119), ('EXPLICIT_QUESTION', 161)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3347028	3/2012	S238-PMC3347028	['in the last five years, there has been an explosion of published data concerning the Immune EFFECTS of Vitamin D, YET LITTLE IS KNOWN in this regard about the specific Immune EFFECTS of Vitamin D during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('ANOMALY_CURIOUS_FINDING', 114), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('UBERON_0002405', 'immune system', 85, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 168, 'immune'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC3348565	4/2012	S115-PMC3348565	['AS WITH OTHER STUDIES, dietary calcium deficiency MIGHT have led to so-called wastage of body stores of Vitamin D in both groups, AFFECTING the maintenance of EVEN higher Vitamin D levels in the intervention group.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3355895	1/2011	S86-PMC3355895	["adjunctive EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women's survey, where maternal Vitamin D concentrations again CORRELATED with neonatal bone mass (harvey et al.,2008)."]	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3356951	4/2012	S11-PMC3356951	['in THIS REVIEW, we will summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and understand its biology and clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 154)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3356951	4/2012	S16-PMC3356951	['[5] emerging RESEARCH SUPPORTS the POSSIBLE ROLE of Vitamin D against cancer, Heart disease, fractures and falls, Autoimmune diseases, influenza, type-2 diabetes, and depression.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0001442', 'skeleton of manus', 114, 'autoimmune')]
PMC3356951	4/2012	S61-PMC3356951	['[5455] the SIGNIFICANCE of the ROLE that sunscreen MAY play in reducing Vitamin D Synthesis is STILL UNCLEAR.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 51), ('FULL_UNKNOWN', 95)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 72, 'vitamin D synthesis')]
PMC3356951	4/2012	S101-PMC3356951	['[71] a definitive conclusion cannot yet be made about the ASSOCIATION between Vitamin D concentration and cancer RISK, BUT results from MANY STUDIES are promising.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('INCOMPLETE_EVIDENCE', 136)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3356951	4/2012	S110-PMC3356951	['[79–87] the antihypertensive EFFECTS of Vitamin D are MEDIATED by renoprotective EFFECTS, suppression of the raas, by beneficial EFFECTS on Calcium Homeostasis, including the prevention of secondary hyperparathyroidism, and by vasculoprotection.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0050817', 'coagulation', 140, 'calcium'), ('GO_0042592', 'homeostatic process', 148, 'homeostasis')]
PMC3356951	4/2012	S127-PMC3356951	['[94] it is THEORIZED that Vitamin D MAY increase muscle strength, thereby PREVENTING falls.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC3356951	4/2012	S128-PMC3356951	['[6] MANY STUDIES HAVE SHOWN an ASSOCIATION between low Vitamin D concentrations and an INCREASED RISK of fractures and falls in older Adults.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3356951	4/2012	S143-PMC3356951	['[102] among women younger than 75 years, there is a lower RISK for early amd with higher Vitamin D levels, with a threshold EFFECT at 15.22 ng/l Serum 25 (Oh)D.\n\nrecommendation guidelines: endocrine society of clinical practice\n\ndiagnostic procedure\nescp RECOMMEND screening for vdd in Individuals at risk for deficiency and not for patients who are not AT RISK.']	[('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 124), ('FUTURE_WORK', 255), ('IMPORTANT_CONSIDERATION', 354)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25 (OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 151, '25 (OH)D'), ('NCBITaxon_1', 'root', 286, 'individuals')]
PMC3395583	7/2012	S0-PMC3395583	['month of Birth, Vitamin D and risk of Immune-mediated disease: a case control study\n\nabstract\n\nbackground\na season of Birth EFFECT in Immune-mediated diseases (id) such as multiple sclerosis and type 1 diabetes HAS BEEN CONSISTENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 220), ('INCOMPLETE_EVIDENCE', 233)]	4	[('GO_0007567', 'parturition', 9, 'birth'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0002405', 'immune system', 134, 'immune')]
PMC3395583	7/2012	S24-PMC3395583	['since all these conditions HAVE BEEN LINKED to Vitamin D deficiency [23,24], we also TESTED WHETHER the risk of disease by month of Birth follows the same seasonal distribution of predicted ultraviolet b (uvb) light radiation and 25-Hydroxyvitamin D (25-Oh-D) levels during Gestation.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 230, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 251, '25-OH-D'), ('GO_0007565', 'female pregnancy', 274, 'gestation')]
PMC3395583	7/2012	S56-PMC3395583	['we next INVESTIGATED WHETHER the monthly risk of id inversely CORRELATED with PREDICTED Gestational Uvb exposure and Vitamin D status during different Trimesters of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('GO_0007565', 'female pregnancy', 88, 'gestational'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 100, 'UVB'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 151, 'trimesters'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3407995	7/2012	S98-PMC3407995	['promote normal Brain Development—PRELIMINARY RESEARCH SUGGESTS that Gestational Vitamin D insufficiency HAS BEEN LINKED to altered Brain Development and Adult mental health [49], in particular schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007420', 'brain development', 15, 'brain development'), ('UBERON_0000955', 'brain', 15, 'brain'), ('GO_0007565', 'female pregnancy', 68, 'gestational'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007420', 'brain development', 131, 'brain development'), ('UBERON_0000955', 'brain', 131, 'brain'), ('UBERON_0007023', 'adult organism', 153, 'adult')]
PMC3407995	7/2012	S249-PMC3407995	['evidence of the POTENTIAL benefits of maternal Vitamin D supplementation for foetal/infant Brain health\npublished placebo-controlled intervention trials studying the IMPACT of Vitamin D supplementation in mothers with low Serum 25(Oh)D are RARE [45] because such trials are deemed UNACCEPTABLE by ethics committees.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 281)]	4	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 47, 'Vitamin D'), ('UBERON_0000955', 'brain', 91, 'Brain'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D')]
PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]
PMC3407995	7/2012	S262-PMC3407995	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to Vitamin D-RELATED DISPARITIES in foetal growth [141].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 81)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3407995	7/2012	S263-PMC3407995	['evidence from RECENT STUDIES SUGGESTS an early Prenatal INFLUENCE of maternal Vitamin D status on foetal Skeletal Development, with lasting Postnatal EFFECTS [141].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0001501', 'skeletal system development', 105, 'skeletal development'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007567', 'parturition', 140, 'postnatal')]
PMC3407995	7/2012	S290-PMC3407995	['HOWEVER, because Vitamin D intake is highly CORRELATED with the Intake of Long Chain N -3 Fatty Acids in the norwegian diet, the authors cautioned that further RESEARCH IS NEEDED to disentangle the separate EFFECTS of these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 207)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007631', 'feeding behavior', 64, 'intake'), ('CHEBI_25098', 'lyxoside', 74, 'long chain n -3 fatty acids'), ('CHEBI_33284', 'nutrient', 224, 'nutrients')]
PMC3407995	7/2012	S486-PMC3407995	['epidemiological studies have LINKED low maternal Vitamin D status to SEVERE Preeclampsia resulting in Miscarriage, risk of low Birth weight and small-for-Gestational age infants, neonatal hypocalcaemia with seizures and POSSIBLE INVOLVEMENT in the development of schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 229)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 102, 'miscarriage'), ('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
PMC3417531	7/2012	S87-PMC3417531	['more RECENTLY, FACTORS that HAVE BEEN ASSOCIATED with lrtis among inuit children are place of residence, lack of breast-feeding (39), reduced ventilation (40,41), neonatal Vitamin A deficiency (33) and above average levels of Organochlorines (42), and Pcbs (25).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 38)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin A'), ('CHEBI_25805', 'oxygen atom', 226, 'organochlorines'), ('CHEBI_26199', 'polyprenol', 252, 'PCBs')]
PMC3424155	8/2012	S209-PMC3424155	['FURTHER STUDIES are NECESSARY TO CLARIFY the IMPACT of maternal Vitamin D restriction on the Renal function of offspring.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002113', 'kidney', 93, 'renal')]
PMC3427192	4/2012	S36-PMC3427192	['Vitamin D in school-aged children with asthma\nseveral RECENT STUDIES HAVE SHOWN ASSOCIATIONS between Vitamin D status and asthma outcomes in school-age children (table 2), ALTHOUGH there is considerable variation between the study populations.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 80), ('ANOMALY_CURIOUS_FINDING', 172)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3427192	4/2012	S72-PMC3427192	['FURTHER mechanistic STUDIES ARE also NEEDED to understand the mechanisms by which Vitamin D exerts its EFFECTS both in healthy Individuals and subjects with chronic inflammatory disorders such as asthma.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 20), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('NCBITaxon_1', 'root', 127, 'individuals')]
PMC3427250	8/2012	S15-PMC3427250	['the ubiquitous presence of Vitamin D receptors in most Tissues, including the Placenta, SUGGESTS that Vitamin D MAY have OTHER ROLES as well.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000479', 'tissue', 55, 'tissues'), ('UBERON_0001987', 'placenta', 78, 'placenta'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3458940	9/2012	S20-PMC3458940	['EVEN mild Gestational Vitamin A deficiency LEADS to a deficit in Nephron number, which MAY predispose the Kidney to abnormal development or function when ASSOCIATED with other morbidities[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001285', 'nephron', 65, 'nephron'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC3465343	10/2012	S2-PMC3465343	['THE CURRENT STUDY SEEKS TO elucidate the EFFECT of maternal Vitamin A deficiency and the production of congenital Spinal deformities in the offsping.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 41)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('UBERON_0001130', 'vertebral column', 114, 'spinal')]
PMC3465343	10/2012	S190-PMC3465343	['moreover, EFFECTS of partial INSTEAD of absolute deprivation of Vitamin A on Spine malformation SHOULD also BE examined.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('UBERON_0001013', 'adipose tissue', 77, 'spine')]
PMC3470091	9/2012	S12-PMC3470091	['conclusions: the single 300,000 im dose of Vitamin D is REGARDED AS an EFFECTIVE and SAFE to promptly improve Vitamin D status in gdm.']	[('PROBABLE_UNDERSTANDING', 56), ('PROBABLE_UNDERSTANDING', 65), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 85)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3472720	8/2012	S3-PMC3472720	['UNEXPECTEDLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'mice')]
PMC3472720	8/2012	S29-PMC3472720	['PARADOXICALLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice')]
PMC3476426	8/2012	S2-PMC3476426	['immunomodulatory EFFECTS of Vitamin D MAY act NOT ONLY through Modulation of T-Helper Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 46), ('ANOMALY_CURIOUS_FINDING', 101)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 63, 'modulation'), ('CL_0000912', 'helper T cell', 77, 'T-helper cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 131, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 135, 'CD25highregulatory'), ('CL_0000084', 'T cell', 154, 'T-cells')]
PMC3476426	8/2012	S19-PMC3476426	['a ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 68)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 28, 'regulation of immune'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CL_0000542', 'lymphocyte', 128, 'lymphocytes')]
PMC3476426	8/2012	S102-PMC3476426	['in the PRESENT WORK, Serum 25-Hydroxy Vitamin D levels had significant negative CORRELATIONS with cars ( p< 0.001) which signifies the POSSIBLE LINK between the extent of Vitamin D deficiency and the degree of the severity of autism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('UBERON_0001977', 'blood serum', 21, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 27, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3476426	8/2012	S108-PMC3476426	['maternal Vitamin D deficiency MAY BE a risk factor for autism, POSSIBLY by AFFECTING fetal Brain Development as well as by AFFECTING maternal Immune System status during Pregnancy [37,38].']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 123)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007420', 'brain development', 91, 'brain development'), ('UBERON_0000955', 'brain', 91, 'brain'), ('UBERON_0002405', 'immune system', 142, 'immune system'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC3476426	8/2012	S110-PMC3476426	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING Gestational Vitamin D deficiency [40].']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3476426	8/2012	S131-PMC3476426	['we could NOT trace data in the literature concerning the POSSIBLE contributing ROLE of 25-Hydroxy Vitamin D deficiency in the induction of the production of Brain-specific auto-Antibodies in SOME autistic children to compare our results.']	[('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 191)]	4	[('CHEBI_43141', '3-hydroxypropoxy group', 87, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0000955', 'brain', 157, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibodies')]
PMC3476426	8/2012	S138-PMC3476426	['THUS, Vitamin D deficiency MAY BE a CONTRIBUTING FACTOR to the production of Brain-specific auto-Antibodies AS a result of deficiency of Tregs in some autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000955', 'brain', 77, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 97, 'antibodies'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 137, 'Tregs')]
PMC3476426	8/2012	S142-PMC3476426	['indeed, without the Genetic TENDENCY for autism, SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities with no EVIDENCE autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 142)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3501517	11/2012	S19-PMC3501517	['the EFFECTS of Vitamin D on Macrophage function HAVE BEEN WELL STUDIED in mycobacterium tuberculosis (mtb) , and clinical tuberculosis is ASSOCIATED with Vitamin D deficiency[17],[18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CL_0000235', 'macrophage', 28, 'macrophage'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3501517	11/2012	S23-PMC3501517	['MULTIPLE STUDIES have IDENTIFIED a CORRELATION between SEVERE Vitamin D deficiency in children and Lower Respiratory Tract infections such as influenza[23],[24],[25],[26],[27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 55)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0004905', 'articulation', 99, 'lower respiratory tract')]
PMC3501517	11/2012	S25-PMC3501517	['relatively FEW Animal STUDIES to date have evaluated the RELATIONSHIP between Vitamin D and acute Lung injury (ali), and those that HAVE BEEN published examine the EFFECT of Vitamin D supplementation above normal dietary intake[30],[31],[32].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002048', 'lung', 98, 'lung'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3501517	11/2012	S179-PMC3501517	['discussion\nour GOAL in THIS STUDY was TO INVESTIGATE the ROLE of Vitamin D in Lps-induced acute Lung injury and its resolution.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 78, 'LPS'), ('UBERON_0002048', 'lung', 96, 'lung')]
PMC3501517	11/2012	S214-PMC3501517	['we chose this MODEL because we were primarily interested in HOW Vitamin D level AFFECTED inflammatory response and resolution of inflammation RATHER than bacterial or Viral clearance.']	[('INCOMPLETE_EVIDENCE', 14), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_1', 'root', 167, 'viral')]
PMC3501517	11/2012	S223-PMC3501517	['the DIFFERENCES that the OTHER group saw MAY BE more the result of maternal and early Gestational Vitamin D deficiency and its EFFECTS on Fetal Lung Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007631', 'feeding behavior', 138, 'fetal'), ('GO_0030324', 'lung development', 144, 'lung development'), ('UBERON_0002048', 'lung', 144, 'lung')]
PMC3501517	11/2012	S224-PMC3501517	['this is SUPPORTED by Human data SUGGESTING that maternal Vitamin D MAY AFFECT fetal Lung Development[28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('NCBITaxon_9606', 'Homo sapiens', 21, 'human'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0030324', 'lung development', 84, 'lung development'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC3515553	12/2012	S6-PMC3515553	['the expected EFFECT of maternal Vitamin B-12 on offspring iq, GIVEN the RELATIONSHIPS between Snps and Vitamin B-12, and Snps and iq was consistent with the OBSERVATIONAL result.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 42, '12'), ('SO_0000694', 'SNP', 94, 'SNPs'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 103, 'vitamin B-12'), ('SO_0000694', 'SNP', 121, 'SNPs')]
PMC3515553	12/2012	S20-PMC3515553	['additionally, non-synonymous polymorphisms in the tcn2 Gene (rs1801198, 776c>g, p259r; rs9606756, 67a>g, i23v), that codes for the Transcobalamin Ii protein, HAVE BEEN ASSOCIATED with differences in the holotranscobalamin and total transcobalamin fractions of Vitamin B-12 and total Hcy concentration[3],[13]–[16], ALTHOUGH their EFFECTS are not fully established[16].']	[('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 315), ('SUPERFICIAL_RELATIONSHIP', 330)]	4	[('SO_0000704', 'gene', 55, 'gene'), ('PR_000016009', 'tumor-associated calcium signal transducer 2', 131, 'transcobalamin II'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 260, 'vitamin B-12'), ('CHEBI_37958', 'dye', 283, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 283, 'Hcy')]
PMC3515553	12/2012	S65-PMC3515553	['we INVESTIGATED the ASSOCIATION of POTENTIAL CONFOUNDING FACTORS with maternal Vitamin B-12 intake, offspring iq, and maternal and offspring genotype using linear regression and chi square tests.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 79, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 89, '12')]
PMC3515553	12/2012	S75-PMC3515553	['AS offspring genotype MAY INFLUENCE Cognitive ability per se , we adjusted for offspring genotype to estimate the EFFECT of maternal Vitamin B-12 status during Pregnancy on offspring iq.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 114)]	4	[('GO_0050890', 'cognition', 36, 'cognitive'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 133, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 143, '12'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC3515553	12/2012	S80-PMC3515553	['for example, POOR absorption COULD BE more RELEVANT for Individuals with reduced Vitamin B-12 intake.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('NCBITaxon_1', 'root', 56, 'individuals'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 81, 'vitamin B-12')]
PMC3515553	12/2012	S110-PMC3515553	['encoding aminoacids valine (v) at locus rs9606756 and arginine (r) at locus rs1801198) was ASSOCIATED with a considerable increase in iq scores (mean difference in iq per gg copy 4.2; 95%ci 1.2, 7.2).10.1371/journal.pone.0051084.t005\n\ncaption (table-wrap): table 5\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with offspring iq at age 8.Snpgenotypeniq mean (sd) Fut2 rs492602tt1009103.3 (16.8)tc1940104.2 (16.1)cc1012105.0 (16.7)mean difference in child iq per callelea(95% ci)39610.86 (0.14, 1.58)p-value0.02 tcn2 rs1801198gg784103.9 (16.6)cg1978104.1 (16.0)cc1208104.6 (17.0)mean difference in child iq per callelea(95% ci)39700.35 (−0.38, 1.08)p-value0.35 tcn2 rs9606756aa3673104.5 (16.1)ag1038104.7 (17.0)gg74108.0 (14.3)mean difference in child iq per gallelea(95% ci)47850.55 (−0.44, 1.54)p-value0.28\nAllele mentioned has been ASSOCIATED with higher Vitamin B-12 or lower Hcy levels.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 265), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 864)]	4	[('SO_0000694', 'SNP', 301, 'SNPs'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 317, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 317, 'vitamin B-12'), ('SO_0001627', 'intron_variant', 368, 'SNPgenotypeNIQ'), ('PR_000007719', 'frizzled-2', 393, 'FUT2'), ('SO_0001023', 'allele', 838, 'Allele'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 887, 'vitamin B-'), ('PR_000017269', 'ventral anterior homeobox 2', 887, 'vitamin B-12'), ('PR_000008443', 'huntingtin-associated protein 1', 909, 'Hcy')]
PMC3515553	12/2012	S119-PMC3515553	['maternal dietary intake of Vitamin B-12 was ASSOCIATED with the MAJORITY (7 out of 11 (64%)) of POTENTIAL CONFOUNDERS and with two of the three Mediators tested (table s7).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 96), ('PROBLEM_COMPLICATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 27, 'vitamin B-12'), ('CHEBI_35222', 'inhibitor', 144, 'mediators')]
PMC3515553	12/2012	S133-PMC3515553	['the effect size of this ASSOCIATION between genotypic variation and iq was of a magnitude expected given the RELATIONSHIPS between Genetic variation and Vitamin B-12 and the RELATIONSHIPS between Vitamin B-12 and iq OBSERVATIONALLY.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 216)]	4	[('SO_0000704', 'gene', 131, 'genetic'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 153, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 196, 'vitamin B-12')]
PMC3515553	12/2012	S143-PMC3515553	['PREVIOUS STUDIES of the EFFECT of Plasma Vitamin B-12 on Neurological Development in children SUGGEST that cobalamin deficiency has an adverse EFFECT on children’s Cognitive ability and motor skills.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('UBERON_0001969', 'blood plasma', 34, 'plasma'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 41, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 51, '12'), ('GO_0007399', 'nervous system development', 57, 'neurological development'), ('UBERON_0001016', 'nervous system', 57, 'neurological'), ('GO_0050890', 'cognition', 164, 'cognitive')]
PMC3515553	12/2012	S150-PMC3515553	['we DID NOT uncover any association between child’s genotype at Vitamin B-12 related variants and iq DESPITE FINDING an ASSOCIATION between offspring genotype and Cord Blood Vitamin B-12 concentration.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 100), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 63, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 173, 'vitamin B-12')]
PMC3515553	12/2012	S153-PMC3515553	['it HAS been PREVIOUSLY SHOWN that maternal cobalamin status is a strong PREDICTOR of Vitamin B-12 in breastfed infants up to AT LEAST 6 months of age[35].']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 125)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 85, 'vitamin B-12')]
PMC3515553	12/2012	S154-PMC3515553	['YET, LITTLE IS KNOWN about the INFLUENCE that low Plasma Vitamin B-12 during Pregnancy MAY have on the Cognitive ability of children later in Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 87)]	4	[('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0050890', 'cognition', 103, 'cognitive'), ('UBERON_0000104', 'life cycle', 142, 'life')]
PMC3515553	12/2012	S164-PMC3515553	['additionally, the Snps that we have used HERE as PROXIES for the unconfounded ASSOCIATION of maternal Vitamin B-12 with offspring iq explain ONLY a small proportion of the variance of Plasma Vitamin B-12[11],[39].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 141)]	4	[('SO_0000694', 'SNP', 18, 'SNPs'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 112, '12'), ('UBERON_0001969', 'blood plasma', 184, 'plasma'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 191, 'vitamin B-12')]
PMC3521768	12/2012	S1-PMC3521768	['objective\nTO ASSESS the INDEPENDENT and INTERACTION EFFECTS of Prenatal zinc and Vitamin A deficiencies on Birthweight in rural sidama, southern ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('GO_0007565', 'female pregnancy', 63, 'prenatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('GO_0007596', 'blood coagulation', 107, 'birthweight')]
PMC3534321	12/2012	S65-PMC3534321	['MANY STUDIES about PREVENTION of pe are BASED on primary INTERVENTIONS, when applied to whole population\u2009:\u2009bed rest, restriction of activity or regular exercise, nutritional measures as Reduced Salt intake, and antioxidants such as Vitamins C and e, garlic, marine oil.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26567', 'N-ribosyl-N(6)-isopentenyladenine', 186, 'reduced salt'), ('CHEBI_27300', 'vitamin D', 232, 'vitamins C')]
PMC3552819	12/2012	S16-PMC3552819	['the pharmacokinetics of oral Vitamin D3 are CONVENTIONALLY described with respect to its EFFECT on the Serum concentration of the predominant circulating Metabolite, 25-Hydroxyvitamin D ([25(Oh)D]), which is a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 227)]	4	[('CHEBI_33279', 'vitamin D5', 29, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 29, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_39382', 'flufenoxuron', 154, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 166, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 190, '(OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC3552819	12/2012	S221-PMC3552819	['LIKEWISE, we DID NOT document any NOTABLE Pregnancy-related hypersensitivity to a Vitamin D dose of 70,000 iu in terms of its EFFECTS on calcium Homeostasis.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0042592', 'homeostatic process', 145, 'homeostasis')]
PMC3586494	2/2013	S258-PMC3586494	['in RELATING maternal Micronutrient Intake with fetal Glucocorticoid exposure, a Mouse MODEL of maternal dietary restriction of copper, zinc, and Vitamin E DEMONSTRATED reduced activity level of Placental 11 Β -Hydroxysteroid dehydrogenase-2, an enzyme that PROTECTS the fetus from overexposure to maternal Glucocorticoids [113].']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 257)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 21, 'micronutrient'), ('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_24261', 'glucocorticoid', 53, 'glucocorticoid'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mouse'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin E'), ('UBERON_0001987', 'placenta', 194, 'placental'), ('CHEBI_36844', '7-hydroxy steroid', 207, 'β -hydroxysteroid'), ('CHEBI_36597', 'phthalazine', 306, 'glucocorticoids')]
PMC3599191	1/2013	S118-PMC3599191	['EVEN the lack of OTHER micro-Nutrients such as Selenium, Vitamins E, d and c, zinc and Folic Acid is RESPONSIBLE for the onset of disorders AFFECTING the Respiratory System in the offspring [46].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('CHEBI_27568', 'selenium atom', 47, 'selenium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamins E'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory system')]
PMC3613945	2/2013	S29-PMC3613945	['Genotype-phenotype ASSOCIATIONS and Vitamin D Metabolism\nmature Serum dbp concentration is a quantitative trait with a significant hereditable component (66%), AS ESTABLISHED by twin studies published AT LEAST a decade ago30,31.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 163), ('PROBABLE_UNDERSTANDING', 201)]	4	[('SO_0001026', 'genome', 0, 'Genotype'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 36, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 64, 'serum')]
PMC3613945	2/2013	S50-PMC3613945	['WHILE these common polymorphisms are ASSOCIATED with dbp status, others have DEMONSTRATED ASSOCIATION between genotype and Serum Vitamin D Metabolite levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('UBERON_0001977', 'blood serum', 123, 'serum'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 139, 'metabolite')]
PMC3613945	2/2013	S67-PMC3613945	['the ROLE of dbp as a C5A Adjuvant is APPARENTLY NOT strictly Vitamin D independent as 1,25(Oh)2D3Can mitigate the synergistic EFFECT of dbp and c5a60.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 37), ('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('PR_000002319', 'catenin beta-1 isoform 1', 21, 'C5a'), ('CHEBI_60809', 'adjuvant', 25, 'adjuvant'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_83135', '(S)-penflufen', 86, '1,25(OH)2D3can')]
PMC3613945	2/2013	S121-PMC3613945	['AS SUCH, polymorphisms in the dbp Gene MIGHT provide INSIGHT into the ROLE of Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('SO_0000704', 'gene', 34, 'gene'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3613945	2/2013	S185-PMC3613945	['FURTHER EVIDENCE SUGGESTING an inverse CORRELATION between Vitamin D and asthma is provided by Genetic109,110and epidemiologic (geospatial and solar radiation) STUDIES111.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('SO_0000704', 'gene', 95, 'genetic109')]
PMC3613945	2/2013	S187-PMC3613945	['REPORTED no association between ultraviolet radiation (uvr) or Vitamin D Serum levels; YET, cod Liver oil supplementation earlier in Life was ASSOCIATED with an INCREASED risk of asthma112.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0002107', 'liver', 96, 'liver'), ('UBERON_0000104', 'life cycle', 133, 'life')]
PMC3613945	2/2013	S207-PMC3613945	['cancer\nseveral OBSERVATIONAL STUDIES have DEMONSTRATED an inverse RELATIONSHIP between uvb irradiance (REQUIRED for the cutaneous Synthesis Of Vitamin D) or Vitamin D status [Serum 25(Oh)D concentrations] and the incidence of mortality from Endometrial126, Lung127,128, Breast127,129–133, Prostate134–137, Ovarian138,139and Colorectal cancer140–149.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 103)]	4	[('GO_0030474', 'spindle pole body duplication', 130, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0001977', 'blood serum', 175, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 184, 'OH)D'), ('UBERON_0004167', 'orbitofrontal cortex', 241, 'endometrial126'), ('UBERON_0002048', 'lung', 257, 'lung127'), ('UBERON_0013550', 'Brodmann (1909) area 19', 270, 'breast127'), ('UBERON_0003820', 'prostate bud', 289, 'prostate134'), ('UBERON_0008231', 'dorsal thoracic segment of trunk', 306, 'ovarian138'), ('UBERON_0012652', 'colorectum', 324, 'colorectal')]
PMC3613945	2/2013	S211-PMC3613945	['MUCH work HAS BEEN done to elucidate a Vitamin D-RELATED mechanistic ROLE in Breast cancer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000310', 'breast', 77, 'breast')]
PMC3613945	2/2013	S221-PMC3613945	['Prostate cancer\nstudies HAVE SHOWN that Vitamin D CAN inhibit Proliferation and Differentiation Of Human Prostatic Cells in vitro 162and 1,25(Oh)2D3Has marked anti-tumor EFFECTS in Animal MODELS163.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 188)]	4	[('UBERON_0002367', 'prostate gland', 0, 'Prostate'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 80, 'differentiation of ... cells'), ('NCBITaxon_9606', 'Homo sapiens', 99, 'human'), ('CL_0002492', 'strial marginal cell', 105, 'prostatic cells'), ('UBERON_0000054', 'macula', 105, 'prostatic'), ('CHEBI_17996', 'chloride', 138, ','), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 139, '25(OH)2D3has'), ('NCBITaxon_33208', 'Metazoa', 181, 'animal')]
PMC3613945	2/2013	S250-PMC3613945	['the UNDERLYING molecular mechanism governing this ASSOCIATION is NOT KNOWN, but Prenatal Vitamin D deficiency is ASSOCIATED with structural and functional deficits common to schizophrenic patients.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 50), ('FULL_UNKNOWN', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3613945	2/2013	S320-PMC3613945	['IT IS BECOMING CLEAR that dbp is indeed a multifunctional protein with an IMPORTANT auxiliary ROLE in the RELATIONSHIP between Vitamin D and Innate Immunity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0045087', 'innate immune response', 141, 'innate immunity')]
PMC3616124	4/2013	S189-PMC3616124	['HOWEVER, the pro-oxidant EFFECTS of Vitamin C[28]combined with the reduced antioxidant capacity of Hp 2-2 MAY have CONTRIBUTED to accelerated Coronary Artery narrowing in diabetic Hp 2-2 post-menopausal women taking Vitamins C and E[21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('PR_000008793', 'heat shock factor protein 4', 99, 'Hp 2-2'), ('UBERON_0005985', 'coronary vessel', 142, 'coronary'), ('UBERON_0001637', 'artery', 151, 'artery'), ('PR_000008443', 'huntingtin-associated protein 1', 180, 'Hp 2'), ('CHEBI_27300', 'vitamin D', 216, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'E')]
PMC3635901	4/2013	S38-PMC3635901	["[22], in their review, EMPHASIZED that patients AFFECTED with sjögren's syndrome (ss) who have low levels of Vitamin D are at a higher risk of developing SEVERE COMPLICATIONS such as lymphoma and peripheral neuropathy [23,24]."]	[('IMPORTANT_CONSIDERATION', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 154), ('PROBLEM_COMPLICATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3635901	4/2013	S41-PMC3635901	['finally, because (no-longer-just-a-)Vitamin D has several physiological properties INVOLVED with the Innate Immune Defense Against Tb, the ROLE of this Vitamin in the treatment of tb SHOULD BE evaluated, especially when ASSOCIATED with autoimmunity [18].']	[('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 139), ('FUTURE_WORK', 183), ('SUPERFICIAL_RELATIONSHIP', 220)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0048017', 'inositol lipid-mediated signaling', 101, 'innate immune defense against TB'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('CHEBI_33229', 'vitamin (role)', 152, 'vitamin')]
PMC3641012	4/2013	S13-PMC3641012	['HOWEVER, the EFFECTS of Vitamin D on maternal, Placental or Fetal Tissues are UNCERTAIN [2], and the extent to which health outcomes are responsive to changes in maternal-fetal Vitamin D status REMAINS UNKNOWN [2,6,7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 78), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0000922', 'embryo', 60, 'fetal'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3641012	4/2013	S25-PMC3641012	['these data MAY serve to design larger rcts to measure the EFFECTS of Antenatal Vitamin D supplementation on functional outcomes of clinical and PUBLIC HEALTH IMPORTANCE.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158)]	4	[('GO_0007567', 'parturition', 69, 'antenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3651971	5/2013	S17-PMC3651971	["DEFICIENCY of essential Nutrients CAN harm the fetus; NO RESEARCH to date has examined the long-term EFFECT of early Vitamin A deficiency on children's cognitive or motor skills."]	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_33284', 'nutrient', 24, 'nutrients'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
PMC3651971	5/2013	S25-PMC3651971	['there are SUGGESTIONS from SPARSE Human data that fetal Vitamin A deficiency MAY adversely AFFECT childhood development.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 91)]	4	[('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
PMC3659910	1/2013	S10-PMC3659910	['clearly, FURTHER INVESTIGATION is REQUIRED into the EFFECTS of Vitamin D, of Vitamin D supplementation, and of Vitamin D analogs for IMPROVEMENT in Human health generally and mothers and children specifically.']	[('FUTURE_WORK', 9), ('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 148, 'human')]
PMC3659910	1/2013	S13-PMC3659910	['CONCERNS about Vitamin D have RESURFACED in medical and scientific literature OWING TO its multiple EFFECTS on Human health.']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 111, 'human')]
PMC3659910	1/2013	S17-PMC3659910	['[2] also the media has been taking increasing INTEREST, and public EXPECTATIONS have been RAISED regarding the enhanced ROLES for Vitamin D in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('FUTURE_PREDICTION', 67), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC3659910	1/2013	S61-PMC3659910	['in the united states staple Foods like milk, breakfast cereals and margarines are artificially fortified with Vitamin D.[14] AT PRESENT, the number and variety of Vitamin D fortified foods available on the market DIFFERS significantly between countries and is ATTRIBUTED to the country-specific policies on Food fortification which are NOT YET unified.']	[('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('SUPERFICIAL_RELATIONSHIP', 260), ('FUTURE_WORK', 336)]	4	[('CHEBI_33290', 'food', 28, 'foods'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_33290', 'food', 307, 'food')]
PMC3659910	1/2013	S122-PMC3659910	['CONVERSELY, Vitamin D deficiency results in proximal muscle weakness and decreased Lower Extremity muscle function PERHAPS CONTRIBUTING TO the RISK for cesarean section.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 143)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0002103', 'hindlimb', 83, 'lower extremity')]
PMC3659910	1/2013	S138-PMC3659910	['OTHER SUGGESTS Vitamin D supplementation of 400 iu/day to Breast Fed infants is the MOST secure way of PREVENTING rickets in infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 58, 'breast fed')]
PMC3659910	1/2013	S146-PMC3659910	['[34] INTERESTINGLY, Vitamin D deficiency during Pregnancy is also ASSOCIATED with RISKS of health PROBLEMS later in childhood, including improper Bone Development at 9 yrs of age, asthma,[36] Dental Cavities, schizophrenia, and type i diabetes.']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0048539', 'bone marrow development', 146, 'bone development'), ('UBERON_0001076', 'neural spine', 192, 'dental cavities')]
PMC3659910	1/2013	S158-PMC3659910	['the BASIS for these RECOMMENDATIONS was made BEFORE IT WAS POSSIBLE to measure the circulating concentration of 25-Hydroxyvitamin D [25(Oh) D], the INDICATOR of nutritional Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 4), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 112, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3659910	1/2013	S186-PMC3659910	['also women are ENCOURAGED to continue to take Vitamin D supplements after Pregnancy to HELP PROTECT against health PROBLEMS such as osteoporosis.']	[('IMPORTANT_CONSIDERATION', 15), ('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC3659910	1/2013	S193-PMC3659910	["SENSIBLE sun exposure and education of the public about the beneficial EFFECTS of some limited sun exposure to satisfy their body's Vitamin D REQUIREMENTS SHOULD BE implemented."]	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 155)]	4	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3672018	5/2013	S19-PMC3672018	['furthermore, as PROPOSED in 2001, a CRITICAL window MAY exist during which Vitamin D levels have a persisting IMPACT on health outcomes [5].']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC3672018	5/2013	S34-PMC3672018	['adverse health EFFECTS of low Vitamin D MAY THEREFORE be MOST evident in Organs or Tissues whose development occurs in these trimesters, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 57)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000062', 'organ', 73, 'organs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
PMC3672018	5/2013	S107-PMC3672018	['25(Oh)D3 level from dbs cards\nBECAUSE the 25(Oh)D3 levels in the newborn Blood REFLECTS the Vitamin D status of the newborn as well as the mother at the end of Pregnancy [29], measurement of 25(Oh)D3 levels in dbs will serve as VALIDATION for the EFFECT of fortification for incident cases.']	[('PROBABLE_UNDERSTANDING', 30), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 247)]	4	[('CHEBI_62946', 'ammonium sulfate', 0, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 0, '25(OH)D3'), ('CHEBI_62946', 'ammonium sulfate', 42, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 42, '25(OH)D3'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('CHEBI_62946', 'ammonium sulfate', 191, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 191, '25(OH)D3')]
PMC3672018	5/2013	S148-PMC3672018	['the use of 50,000-100,000 Individuals from adjacent Birth years in the general population studies of events like fractures and diagnosis of t1d, a pivotal strength of THIS STUDY, makes it possible to detect EVEN minor EFFECTS of Vitamin D.\nFood disappearance statistics SHOW that Margarine Intake decreased and low fat milk slightly increased during the period covered.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('ANOMALY_CURIOUS_FINDING', 207), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 270)]	4	[('NCBITaxon_1', 'root', 26, 'individuals'), ('GO_0007567', 'parturition', 52, 'birth'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_33290', 'food', 240, 'Food'), ('CHEBI_6784', 'mestranol', 280, 'margarine'), ('GO_0007631', 'feeding behavior', 290, 'intake')]
PMC3672018	5/2013	S155-PMC3672018	['neither CONFOUNDING from external or internal factors, nor the LACK OF individual data on Vitamin D intake, is a prerequisite for the study, AS the INFLUENCES of lifestyle differences (e.g.']	[('PROBLEM_COMPLICATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 141), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3672018	5/2013	S175-PMC3672018	['Growth and Pubertal Development, POSSIBILITY RELATED to Vitamin D exposures in early Life, PERHAPS EVEN before Conception, in addition to the outcomes studied.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 91), ('ANOMALY_CURIOUS_FINDING', 99)]	4	[('GO_0040007', 'growth', 0, 'growth ...'), ('GO_0060021', 'roof of mouth development', 11, 'pubertal development'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000104', 'life cycle', 85, 'life'), ('GO_0007620', 'copulation', 111, 'conception')]
PMC3672018	5/2013	S179-PMC3672018	['results from this study are LIKELY to CONSIDERABLY increase our current understanding of the SIGNIFICANCE of early Vitamin D intake in RELATION to later health.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 93), ('SUPERFICIAL_RELATIONSHIP', 135)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3685533	6/2013	S15-PMC3685533	['circulating 25Ohd is the MAJOR circulating form of Vitamin D and is CONSIDERED AS the primary INDICATOR of Vitamin D status [1].']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 12, '25OHD'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3685533	6/2013	S27-PMC3685533	['moreover, SOME STUDIES INDICATE that ethnic DIFFERENCES play a ROLE in the circulating levels of Serum Vitamin D [13-15].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3691177	6/2013	S0-PMC3691177	['Prenatal Vitamin D supplementation and child Respiratory health: a randomised controlled trial\n\nabstract\n\nbackground\nOBSERVATIONAL studies SUGGEST high Prenatal Vitamin D intake MAY BE ASSOCIATED with reduced childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 45, 'Respiratory'), ('GO_0007565', 'female pregnancy', 152, 'prenatal'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC3691177	6/2013	S13-PMC3691177	['trial registration\ncontrolled-trials.comisrctn68645785\n\nintroduction\nseveral observational studies have SUGGESTED a PROTECTIVE EFFECT of higher maternal Vitamin D intake during Pregnancy on RISK of wheezing[1]–[3], asthma and allergic rhinitis[4], and eczema[3]in offspring.']	[('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC3691177	6/2013	S15-PMC3691177	['THESE STUDIES DID NOT REPORT outcomes in RELATION to maternal Serum 25-Hydroxyvitamin D (25(Oh)D) concentration, which takes account of skin synthesis, our primary source of Vitamin D, and is the gold STANDARD measure of Vitamin D status[5],[6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 201)]	4	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 68, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC3691177	6/2013	S19-PMC3691177	['the active Metabolite of Vitamin D, 1,25-Dihydroxyvitamin D, HAS BEEN SHOWN in Animal and in vitro MODELS to have potent Immune EFFECTS[12]and a ROLE in early Lung Development[13].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_39382', 'flufenoxuron', 11, 'metabolite'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 36, '1,25-dihydroxyvitamin D'), ('NCBITaxon_33208', 'Metazoa', 79, 'animal'), ('UBERON_0002405', 'immune system', 121, 'immune'), ('GO_0030324', 'lung development', 159, 'lung development'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC3695234	7/2013	S19-PMC3695234	['there has also been increasing AWARENESS of the IMPORTANCE of one POTENTIAL FACTOR-Vitamin D-in the development and progress of atopic Diseases.']	[('IMPORTANT_CONSIDERATION', 31), ('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007586', 'digestion', 135, 'diseases')]
PMC3695234	7/2013	S49-PMC3695234	['discussion\nACCORDING TO the results of the 2005-2006 national Health and nutrition examinations survey (nhanes), Vitamin D deficiency is ASSOCIATED with higher levels of Ige sensitization in children and adolescents.6to ASSESS the RELATIONSHIP between Vitamin D levels and Respiratory outcomes, other analyses were performed on the same survey data.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 137), ('QUESTION_ANSWERED_BY_THIS_WORK', 220), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('UBERON_0000925', 'endoderm', 62, 'Health'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 170, 'IgE'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 273, 'respiratory')]
PMC3695234	7/2013	S59-PMC3695234	['BASED ON the RELATIONSHIP between Vitamin D deficiency and ad, trials of Vitamin D supplementation in atopic populations or high-risk groups HAVE BEEN conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3695234	7/2013	S62-PMC3695234	['to DATE, most reports on this topic HAVE BEEN case-controlled or cross-sectional studies, and HAVE NOT ASCERTAINED any causal RELATIONSHIPS between Vitamin D deficiency and ad.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3695234	7/2013	S78-PMC3695234	['THUS, these data INDICATE the POTENTIAL ROLE of Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 40)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3702245	6/2013	S4-PMC3702245	['introduction\nVitamin D deficiency in Pregnancy is widespread in many parts of the world,1and there is an ASSOCIATION between low Vitamin D status and multiple POTENTIAL adverse outcomes of Pregnancy.2–5therefore, Vitamin D nutrition in Pregnancy SHOULD BE of GLOBAL HEALTH INTEREST.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 159), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 259)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3702245	6/2013	S31-PMC3702245	['RANDOMIZED controlled TRIALS with large sample sizes ARE NEEDED to assess the EFFECT of maternal Vitamin D supplementation on fetal Bone Development.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0048539', 'bone marrow development', 132, 'bone development')]
PMC3702245	6/2013	S35-PMC3702245	['a RECENT cochrane review79of five SMALL-sized intervention trials of Vitamin D supplementation CONCLUDED that mothers who were supplemented TENDED to have fewer babies weighing <2500 g (relative risk 0.48; 95% confidence interval [ci] 0.23–1.01).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3702245	6/2013	S91-PMC3702245	['based on this protocol, the authors CONCLUDED that 4000 iu/day of Vitamin D3Supplementation is SAFE and MOST EFFECTIVE in achieving Vitamin D sufficiency in mothers and adequate Vitamin D status in their offspring, irrespective of ethnicity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 95), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_52915', 'phosphatediyl group', 66, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 66, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3702339	6/2013	S0-PMC3702339	['prevalence and CORRELATES of Prenatal Vitamin A deficiency in rural sidama, southern ethiopia\n\nabstract\na cross-sectional study was CONDUCTED TO ASSESS the prevalence and CORRELATES of Prenatal Vitamin A deficiency (vad) in rural sidama, southern ethiopia.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('GO_0007565', 'female pregnancy', 29, 'Prenatal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin A'), ('GO_0007565', 'female pregnancy', 185, 'prenatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin A')]
PMC3705146	5/2013	S28-PMC3705146	['EVEN in the far reaches of populations in the arctic circle, the IMPACT of low light on skin type prevalence (karlsson et al.,2000) was not so extreme, MOST LIKELY BECAUSE a diet rich in Vitamin D from seafood helped to mitigate the lack of sun.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 152), ('PROBABLE_UNDERSTANDING', 164)]	4	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3705146	5/2013	S195-PMC3705146	['ALTHOUGH sunlight-induced Vitamin D is not an IMPORTANT source of Vitamin D for lower Animals, it HAS BEEN SHOWN that Prenatal dietary Vitamin D in sprague-dawley Rats has significant EFFECTS on Postnatal anxiety and social behaviors (pan et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 86, 'animals'), ('GO_0007565', 'female pregnancy', 118, 'prenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 163, 'rats'), ('GO_0007567', 'parturition', 195, 'postnatal')]
PMC3713405	7/2013	S91-PMC3713405	['in the developing Brain, levels of Vitamin D Receptor (Vdr) Expression COINCIDE with increasing levels of Apoptosis and decreasing levels of mitosis (burket et al., 2003) SUGGESTING similar actions TO that SEEN in peripheral Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 171), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000955', 'brain', 18, 'brain'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 35, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 55, 'VDR'), ('GO_0010467', 'gene expression', 60, 'expression'), ('GO_0006915', 'apoptotic process', 106, 'apoptosis'), ('UBERON_0000479', 'tissue', 225, 'tissue')]
PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
PMC3713405	7/2013	S141-PMC3713405	['HOWEVER, it is the COINCIDENT Expression of the vdr within developing Da Neurons (cui et al., 2013) and Projections in the Brain that SUGGEST an important ROLE for Vitamin D in the developing da system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0010467', 'gene expression', 30, 'expression'), ('CL_0000589', 'cochlear inner hair cell', 70, 'DA neurons'), ('GO_0042995', 'cell projection', 104, 'projections'), ('UBERON_0000955', 'brain', 123, 'brain'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC3713405	7/2013	S144-PMC3713405	['dvd-deficient e12 Embryos show decreased Gene Expression of nurr1, P57Kip2 and th (cui et al., 2010) SUGGESTING altered Vitamin D Signaling AFFECTS early Monoamine Cell Development, PERHAPS EVEN prior to e12.']	[('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 190)]	4	[('UBERON_0000922', 'embryo', 18, 'embryos'), ('GO_0010467', 'gene expression', 41, 'gene expression'), ('SO_0000704', 'gene', 41, 'gene'), ('PR_000004267', 'AT-rich interactive domain-containing protein 4A', 67, 'p57Kip2'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0043931', 'ossification involved in bone maturation', 120, 'vitamin D signaling'), ('CHEBI_17134', 'octopamine', 154, 'monoamine'), ('GO_0048468', 'cell development', 164, 'cell development')]
PMC3717170	5/2013	S1-PMC3717170	['the POSSIBILITY of Extraskeletal EFFECTS of Vitamin D was FIRST NOTED with the discovery of the Vitamin D Receptor (vdr) in Tissues and cells that are not involved in maintaining Mineral Homeostasis and bone health, including skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 64)]	4	[('UBERON_0001431', 'distal carpal bone 2', 19, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 96, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 124, 'tissues'), ('CHEBI_46662', 'mineral', 179, 'mineral'), ('GO_0055085', 'transmembrane transport', 179, 'mineral homeostasis'), ('UBERON_0001987', 'placenta', 232, 'placenta'), ('UBERON_0001264', 'pancreas', 242, 'pancreas'), ('UBERON_0000310', 'breast', 252, 'breast'), ('UBERON_0002367', 'prostate gland', 260, 'prostate'), ('UBERON_0001155', 'colon', 273, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 297, 'activated T cells')]
PMC3717170	5/2013	S13-PMC3717170	['nonclassical EFFECTS of Vitamin D\n\nVitamin D: beyond bone\nsylvia christakos (umdnj-new jersey medical school) began the meeting by summarizing the Metabolism and activity of Vitamin D and introducing the EMERGING AWARENESS of ROLES for Vitamin D beyond Calcium Homeostasis and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 204), ('IMPORTANT_CONSIDERATION', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('GO_0008152', 'metabolic process', 147, 'metabolism'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 253, 'calcium homeostasis'), ('GO_0006768', 'biotin metabolic process', 277, 'bone metabolism')]
PMC3717170	5/2013	S21-PMC3717170	['UNLIKE the ASSOCIATION between Vitamin D deficiency and rickets, causal LINKS between Vitamin D deficiency and specific Extraskeletal diseases have YET to be identified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 148)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 120, 'extraskeletal')]
PMC3717170	5/2013	S67-PMC3717170	['of equivalent IMPORTANCE, therapy with high potency Vitamin D Metabolites or their analogs MAY subserve an IMPORTANT ROLE in the management of these diseases.']	[('IMPORTANT_CONSIDERATION', 14), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites')]
PMC3717170	5/2013	S74-PMC3717170	['ADDITIONAL RESEARCH that addresses the IMPACT of Vitamin D on Immune Homeostasis during Pregnancy and its EFFECTS during early infancy and later childhood becomes ESSENTIAL.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 163)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 62, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC3717170	5/2013	S77-PMC3717170	['Vitamin D and obesity\nigor n. sergeev (south dakota state university) DISCUSSED the POSSIBILITY of integrating Vitamin D supplementation with current STRATEGIES in the PREVENTION and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 84), ('FUTURE_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3717170	5/2013	S103-PMC3717170	['Vitamin D is RELATED to Skeletal health in patients with copd, and Vitamin D deficiency is ASSOCIATED with low bone Mineral density.26,28additionally, low vitamin d HAS BEEN RELATED to decreased exercise performance26,29and exacerbation rate30in copd patients.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 24, 'skeletal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_46662', 'mineral', 116, 'mineral')]
PMC3717170	5/2013	S109-PMC3717170	['after stratification for Vitamin D deficiency, the CORRELATIONS PERSISTED ONLY in the patients with Vitamin D deficiency: fev1 ( r = 0.37, p< 0.01;fig.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 64), ('ANOMALY_CURIOUS_FINDING', 74), ('INCOMPLETE_EVIDENCE', 74)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3717170	5/2013	S112-PMC3717170	['from their unpublished secondary analysis, rutten and colleagues conclude that THERE IS EVIDENCE SUGGESTING that Vitamin D plays a ROLE in the Lung pathology of patients with copd, which requires FURTHER INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 196)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 143, 'lung')]
PMC3717170	5/2013	S132-PMC3717170	['translating epidemiological data into policy and clinical applications\n\nVitamin D for diabetes\nanastassios g. pittas (tufts medical center) HIGHLIGHTED the POTENTIALLY IMPORTANT ROLE of Vitamin D in a variety of non-Skeletal medical conditions, including type 2 diabetes.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 168), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0004288', 'skeleton', 216, 'skeletal')]
PMC3717170	5/2013	S155-PMC3717170	['alterations in these mechanisms during Vitamin D deficiency states MAY account for Skeletal muscle weakness, in VIEW of the KEY ROLE that Ca2+plays in the Regulation of Contractility.']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 112), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_29108', 'calcium(2+)', 138, 'Ca2+'), ('GO_0065007', 'biological regulation', 155, 'regulation'), ('GO_0006936', 'muscle contraction', 169, 'contractility')]
PMC3717170	5/2013	S164-PMC3717170	['indeed, beyond its ROLES in bone health and Calcium Homeostasis, Vitamin D AFFECTS many OTHER physiological domains that are CRITICALLY modified by Aging.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('IMPORTANT_CONSIDERATION', 125)]	4	[('GO_0055073', 'cadmium ion homeostasis', 44, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007568', 'aging', 148, 'aging')]
PMC3717170	5/2013	S168-PMC3717170	['shifting attention from Aging to the Aging phenotype, the QUESTION of WHETHER Vitamin D AFFECTS major Aging phenotypes becomes more approachable.']	[('EXPLICIT_QUESTION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 88)]	4	[('GO_0007568', 'aging', 24, 'aging'), ('GO_0007568', 'aging', 37, 'aging'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007568', 'aging', 102, 'aging')]
PMC3717170	5/2013	S171-PMC3717170	['there is STRONG EVIDENCE that obesity is ASSOCIATED with POOR Vitamin D status due to fat sequestration.48in fact, compared with the non-obese, higher doses of Vitamin D are REQUIRED in obese Individuals.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
PMC3717170	5/2013	S173-PMC3717170	['HOWEVER, some recent DATA SUGGEST that low Vitamin D PREDICTS an accelerated increase in fat mass and incident obesity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3728489	7/2013	S282-PMC3728489	['for illustration, we have selected three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL PREVENTIVE EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_33839', 'macromolecule', 41, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 56, 'folate'), ('CHEBI_24859', 'iodine atom', 64, 'iodine'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007399', 'nervous system development', 147, 'neurodevelopmental')]
PMC3728489	7/2013	S319-PMC3728489	['fish oil (that commonly contains Vitamin D) and OTHER omega 3 Fatty Acid supplements taken in infancy HAVE BEEN ASSOCIATED with improved Cognitive development, THOUGH this evidence is also far from definitive (auestad et al.,2003; karr et al.,2011; meldrum et al.,2012; luchtman and song,2013).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acid'), ('GO_0050890', 'cognition', 137, 'cognitive')]
PMC3728489	7/2013	S348-PMC3728489	['we REPORTED three examples of Micronutrients—Folate, Iodine, and Vitamin D—and discussed their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_33839', 'macromolecule', 30, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 45, 'folate'), ('CHEBI_24859', 'iodine atom', 53, 'iodine'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007399', 'nervous system development', 138, 'neurodevelopmental')]
PMC3734354	7/2013	S43-PMC3734354	['WHILE many Nutrients have a ROLE to play in Brain Development, certain ones SEEM TO BE of particular IMPORTANCE during fetal and neonatal life: protein, iron, zinc, Selenium, Iodine, Folate, Vitamin A, Choline, and Long-Chain polyunsaturated Fatty Acids (lcpufas) (georgieff,2007).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 76), ('IMPORTANT_CONSIDERATION', 101)]	4	[('CHEBI_33284', 'nutrient', 11, 'nutrients'), ('GO_0007420', 'brain development', 44, 'brain development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27568', 'selenium atom', 165, 'selenium'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_15354', 'choline', 202, 'choline'), ('CHEBI_28911', 'cob(III)alamin', 215, 'long-chain'), ('CHEBI_35366', 'fatty acid', 242, 'fatty acids')]
PMC3739737	8/2013	S1-PMC3739737	['the AIM of THIS STUDY was TO INVESTIGATE the EFFECTS of Adult Vitamin D (avd) deficiency on behavioural tasks of relevance to neuropsychiatric disorders in male sprague-dawley Rats.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0007023', 'adult organism', 56, 'adult'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 176, 'rats')]
PMC3739737	8/2013	S14-PMC3739737	['introduction\nVitamin D deficiency is PREVALENT in the Adult population[1]and there is a GROWING body of EVIDENCE SHOWING that Vitamin D has an IMPACT on Brain function[2],[3].']	[('IMPORTANT_CONSIDERATION', 37), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000955', 'brain', 153, 'brain')]
PMC3739737	8/2013	S20-PMC3739737	['WHILE there is now a considerable body of research examining the IMPACT of developmental Vitamin D (dvd) deficiency on Brain outcomes, there is relatively LITTLE KNOWN about the IMPACT of Adult Vitamin D (avd) deficiency on Rodent behaviour.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 155), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 224, 'rodent')]
PMC3760821	9/2013	S1-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal body mass index (bmi) and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3760821	9/2013	S16-PMC3760821	['introduction\nit is WELL ESTABLISHED that Vitamin D plays a primary ROLE in bone health, with SEVERE Vitamin D deficiency KNOWN to cause rickets in children and osteomalacia in Adults[1].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
PMC3760821	9/2013	S40-PMC3760821	['THESE FINDINGS led the study authors to CONCLUDE that population level INTERVENTIONS to reduce bmi would be expected to decrease the prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3760821	9/2013	S42-PMC3760821	['women with t1dm have an INCREASED RISK of Pregnancy complications including; Miscarriage, congenital malformations, macrosomia, still Birth, pre-term Birth and pre-eclampsia[22], SOME of which HAVE BEEN REPORTED to be ASSOCIATED with Vitamin D deficiency in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 77, 'miscarriage'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0007567', 'parturition', 150, 'birth'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3760821	9/2013	S43-PMC3760821	['further, it HAS BEEN SUGGESTED that Vitamin D CAN alter Glucose and Insulin Metabolism, and, THEREFORE, IMPACT on energy available to the foetus[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 93), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_17234', 'glucose', 56, 'glucose'), ('GO_0007369', 'gastrulation', 56, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 68, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 68, 'insulin')]
PMC3760821	9/2013	S46-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal bmi and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3760821	9/2013	S142-PMC3760821	['IMPACT of maternal bmi at booking on maternal and cord Vitamin D levels in women with t1dm\nin VIEW of the TREND towards a significant increase in bmi at booking in women with t1dm vs. controls ( table 1 ), the IMPACT of maternal bmi at booking (normal weight bmi <25 kg/m2vs.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 210)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3760821	9/2013	S154-PMC3760821	['maternal Vitamin D levels were also found to EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 134, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 157, 'glycaemic control')]
PMC3773018	4/2013	S12-PMC3773018	['PREVIOUS STUDIES (11–15) INDICATE that the immunomodulatory EFFECTS of Vitamin D, including its CONTRIBUTION to the development of allergic diseases, begin in utero .']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3773018	4/2013	S18-PMC3773018	['our study, conducted primarily in african american children in the u.s., was the FIRST to SHOW that Genetic polymorphisms MIGHT modify the EFFECTS of Vitamin D deficiency on the risk of fs (18).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('SO_0000704', 'gene', 100, 'genetic'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC3773018	4/2013	S54-PMC3773018	['SIMILAR ASSOCIATION PATTERNS between persistently low Vitamin D and high risk of fs were SEEN among children with 25(Oh)D measurements within 1 year of age and 1–3 years of age; among children Born in winter and non-winter; among children Born Preterm (< 37 weeks of Gestation) and children born term (>= 37 weeks) (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 89)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 114, '25(OH ... D'), ('GO_0007567', 'parturition', 193, 'born'), ('GO_0007567', 'parturition', 239, 'born'), ('GO_0007565', 'female pregnancy', 244, 'preterm'), ('GO_0007565', 'female pregnancy', 267, 'gestation')]
PMC3773018	4/2013	S56-PMC3773018	['DUE TO SMALL sample size after stratification, the significant ASSOCIATION between persistently low Vitamin D and risk of fs was ONLY observed in children with 25(Oh)d measurements within 1 year of age (or=2.99, 95%ci: 1.05–8.52).']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 160, '25(OH)')]
PMC3773018	4/2013	S70-PMC3773018	['another EXPLANATION is that BECAUSE these 460 children were predominantly black (>50%), and they TEND to be more LIKELY to have Vitamin D insufficiency (10).']	[('PROBABLE_UNDERSTANDING', 8), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 97), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3773018	4/2013	S71-PMC3773018	['insufficient Vitamin D status is UNDESIRABLE from many viewpoints, ESPECIALLY BECAUSE of its IMPACT on bone health and Immune function.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 78), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]
PMC3773018	4/2013	S83-PMC3773018	['furthermore, we OBSERVED significant INTERACTION EFFECTS between the Il4 Gene polymorphism and persistently low Vitamin D status on fs in this SMALLER sized study sample.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 143)]	4	[('PR_000008989', 'interleukin-1 family member 7', 69, 'IL4'), ('SO_0000704', 'gene', 73, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3798907	8/2013	S0-PMC3798907	['COMPLEX EFFECTS of Vitamin E and vitamin c supplementation on in vitro neonatal Mononuclear Cell responses to allergens\n\nabstract\nlow maternal dietary Vitamin E (but not Vitamin C) Intake during Pregnancy HAS BEEN ASSOCIATED with increased in vitro Cord Blood Mononuclear Cell (Cbmc) proliferative responses, childhood wheezing and asthma.']	[('DIFFICULT_TASK', 0), ('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin E'), ('CL_0000842', 'mononuclear cell', 80, 'Mononuclear Cell'), ('GO_0030061', 'mitochondrial crista', 80, 'Mononuclear'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CL_0002153', 'corneocyte', 249, 'cord'), ('UBERON_0002240', 'spinal cord', 249, 'cord'), ('CL_0000081', 'blood cell', 254, 'blood'), ('UBERON_0000178', 'blood', 254, 'blood'), ('CL_0000842', 'mononuclear cell', 260, 'mononuclear cell'), ('GO_0031097', 'medial cortex', 260, 'mononuclear'), ('CL_0002062', 'type I pneumocyte', 278, 'CBMC')]
PMC3798907	8/2013	S66-PMC3798907	['note that, EVEN where significant EFFECTS were seen, there was considerable Individual VARIATION in the EFFECTS of Vitamin E between different cbmc samples.']	[('ANOMALY_CURIOUS_FINDING', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('DIFFICULT_TASK', 87), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('NCBITaxon_1', 'root', 76, 'individual'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin E')]
PMC3798907	8/2013	S73-PMC3798907	['UNLIKE Vitamin E supplementation, addition of Vitamin C was ASSOCIATED with a general TREND for increases in the Effector cytokines Ifn-Γ and Il-4, which was significant for both cytokines after ppd stimulation (Ifn-Γ: 26 of 43 cultures DEMONSTRATING an increase in Ifn-Γ, Il-4: 20 of 42 cultures), and for Il-4 in cultures responding to klh (21 of 41 cultures) or tg (20 of 46 cultures).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 237)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_35224', 'effector', 113, 'effector'), ('PR_000008920', 'interferon alpha-7', 132, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 142, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 212, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 266, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 273, 'IL-4'), ('PR_000001470', 'interleukin-28B', 307, 'IL-4')]
PMC3798907	8/2013	S86-PMC3798907	['Production Of the Regulatory Cytokine Il-10 TENDED to be lower after Vitamin C supplementation of pbmc, significantly so for con a, WHEREAS, UNLIKE cbmc, there was a TREND for Tgf-Β secretion to be increased.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 166)]	4	[('GO_0008283', 'cell proliferation', 0, 'Production of ...'), ('GO_0090106', 'pancreatic E cell fate commitment', 18, 'regulatory cytokine IL-'), ('PR_000001470', 'interleukin-28B', 38, 'IL-10'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('PR_000000046', 'TGF-beta', 176, 'TGF-β')]
PMC3798907	8/2013	S93-PMC3798907	['it can be seen that the EFFECTS of Vitamin E supplementation on cbmc responses to these Allergens were GENERALLY inhibitory, with the NOTABLE EXCEPTIONS of stronger Proliferation to tg and increased secretion of the Regulatory cytokine Tgf-Β in cultures stimulated with either hdm or tg.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 103), ('ANOMALY_CURIOUS_FINDING', 134), ('ANOMALY_CURIOUS_FINDING', 142)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin E'), ('CHEBI_33663', 'cyclic hydrocarbon', 88, 'allergens'), ('GO_0008283', 'cell proliferation', 165, 'proliferation'), ('GO_0065007', 'biological regulation', 216, 'regulatory'), ('PR_000000046', 'TGF-beta', 236, 'TGF-β')]
PMC3798907	8/2013	S104-PMC3798907	['PREVIOUS work HAS REPORTED low maternal Vitamin E intake to be ASSOCIATED with increased Cbmc Proliferation to hdm and tg [13,16], encouraging the belief that the Nutrient has a direct EFFECT in Modulating neonatal T-Cell Responses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('CL_0002062', 'type I pneumocyte', 89, 'CBMC'), ('GO_0070343', 'white fat cell proliferation', 89, 'CBMC proliferation'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0065007', 'biological regulation', 195, 'modulating'), ('CL_0000084', 'T cell', 215, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 215, 'T-cell responses')]
PMC3798907	8/2013	S135-PMC3798907	['the population studied in the CURRENT study (children Born by elective caesarean section) DIFFERED from the general population from which the original ASSOCIATION between Vitamin E and cbmc responses was drawn [12], HOWEVER cbmc responses in a general population were not associated with mode of delivery (unpublished observations from [12]).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	4	[('GO_0007567', 'parturition', 54, 'born'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin E')]
PMC3798907	8/2013	S145-PMC3798907	['HOWEVER, such a shared property cannot provide an EXPLANATION where Vitamins E and C DIFFER in their EFFECTS on cbmc and pbmc responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 83, 'C'), ('PR_000004900', 'complement C3', 83, 'C')]
PMC3809191	1/2013	S54-PMC3809191	['data RELATING Vitamin D status to gdm RISK are INCONSISTENT and LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('IMPORTANT_CONSIDERATION', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC3814422	10/2013	S14-PMC3814422	['HOWEVER, a MAJOR LIMITATION of these studies is that diet makes a relatively minor CONTRIBUTION to total Vitamin D status, which is derived largely from Photosynthesis in the skin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 153, 'photosynthesis')]
PMC3814422	10/2013	S53-PMC3814422	['this variable incorporates the seasonal INFLUENCE on 25(Oh)D. to remove this seasonal INFLUENCE in an ATTEMPT to obtain a MARKER of habitual Vitamin D concentrations for each mother, we used the residuals from the sine–cosine regression model.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 86), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 149, 'D')]
PMC3814422	10/2013	S123-PMC3814422	['Serum 25(Oh)D HAS BEEN CRITICIZED as a PROXY for Vitamin D ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 59)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3814422	10/2013	S124-PMC3814422	['for instance, it HAS BEEN SUGGESTED that there is a NEED to DISTINGUISH between Serum 25(Oh)D and EFFECTS of Vitamin D supplementation, the former being a prohormone representing a physiological state that is only relevant at extremely high or low levels, and the latter representing the non-physiological action of interest4.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('UBERON_0001977', 'blood serum', 80, 'serum'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 86, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3814422	10/2013	S136-PMC3814422	["in SUPPORT of this, it is NOTABLE that analysis of the ASSOCIATION of maternal dietary Vitamin D with offspring asthma, wheeze and atopy in both the southampton women's survey13and alspac30failed to demonstrate an ASSOCIATION."]	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3821254	4/2013	S80-PMC3821254	['WHETHER a single ingredient of drakshavaleha such as Vitamin C, Vitamin P, Folic Acid, Minerals, etc., was EFFECTIVE in the current research OR the result was a collective outcome is such DIFFICULT to conclude at this level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('DIFFICULT_TASK', 188)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin P'), ('CHEBI_30751', 'formic acid', 75, 'folic acid'), ('CHEBI_46751', 'quinolizidine', 87, 'minerals')]
PMC3827489	10/2013	S5-PMC3827489	['it is RECOMMENDED that all infants, children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D. SINCE the vitamin d status of the newborn is highly RELATED to maternal Vitamin D levels, optimal Vitamin D levels in the mother during Pregnancy SHOULD BE maintained.']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('FUTURE_WORK', 268)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3827489	10/2013	S6-PMC3827489	['in conclusion, given the IMPORTANT ROLE of Vitamin D in childhood health, more time spent in outdoor activity (for sunlight exposure) and Vitamin D supplementation MAY be NECESSARY for optimal health in infants, children, and adolescents.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC3827489	10/2013	S23-PMC3827489	['RECENT STUDIES SUGGEST that Vitamin D insufficiency or deficiency MAY have a significant IMPACT on childhood health14,15).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC3827489	10/2013	S24-PMC3827489	['there are SEVERAL epidemiologic STUDIES SUGGESTING that Vitamin D plays an IMPORTANT ROLE in the prevention and management of various pediatric diseases.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3827489	10/2013	S39-PMC3827489	['seasonal variability has an IMPORTANT IMPACT on Vitamin D status24); the Vitamin D levels are lowest in winter, compared with spring, summer, and autumn20)BECAUSE MOST Vitamin D is produced following exposure to sunlight.']	[('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 38), ('PROBABLE_UNDERSTANDING', 155), ('PROBABLE_UNDERSTANDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3827489	10/2013	S50-PMC3827489	['Vitamin D insufficiency/deficiency and childhood bone health\nthe CRITICAL ROLE of Vitamin D in Skeletal mineralization was the FIRST of its physiological functions to be IDENTIFIED.']	[('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0001501', 'skeletal system development', 95, 'skeletal'), ('UBERON_0004288', 'skeleton', 95, 'skeletal')]
PMC3827489	10/2013	S57-PMC3827489	['ONE STUDY REPORTED that IF the Vitamin D level was 30 ng/ml or less, there was a significant decrease in Intestinal calcium absorption36), which CORRELATED to increased circulating Parathyroid hormone (pth)37).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000160', 'intestine', 105, 'intestinal'), ('UBERON_0001132', 'parathyroid gland', 181, 'parathyroid')]
PMC3827489	10/2013	S63-PMC3827489	['Vitamin D insufficiency/deficiency and Respiratory diseases\nemerging EVIDENCE SUGGESTS that Vitamin D plays an ESSENTIAL ROLE in the Modulation Of the Immune Responses.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 39, 'respiratory'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006880', 'intracellular sequestering of iron ion', 133, 'modulation of ... immune responses'), ('UBERON_0002405', 'immune system', 151, 'immune')]
PMC3827489	10/2013	S69-PMC3827489	['in addition, a RECENT meta-analysis FOUND that low Serum levels of Vitamin D were ASSOCIATED with a high RISK of active tuberculosis46).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 105)]	4	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3827489	10/2013	S73-PMC3827489	['another RECENT STUDY SHOWED that lower Vitamin D levels in 86 children with SEVERE, therapy-resistant asthma in the united kingdom were ASSOCIATED with worsened asthma Control and Lung function49).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'control'), ('UBERON_0002048', 'lung', 180, 'lung')]
PMC3827489	10/2013	S89-PMC3827489	['EFFECTS of maternal Vitamin D insufficiency/deficiency on infants and children\nstudies have SUGGESTED that Vitamin D concentrations in the fetus and newborn are highly DEPENDENT on and significantly RELATED to maternal Serum 25(Oh)D concentrations61-64).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_71657', 'versiconol acetate', 225, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 225, '25(OH ... D')]
PMC3829803	11/2013	S164-PMC3829803	['HOWEVER, the EFFECTS of Vitamin A on Viral infections have been highly VARIABLE and at times, completely CONTRADICTORY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('NCBITaxon_1', 'root', 37, 'viral')]
PMC3829803	11/2013	S165-PMC3829803	['ALTHOUGH reduced mortality from diarrheal disease is ASSOCIATED with Vitamin A supplements in children of the developing world this BENEFIT APPEARS TO BE due largely to milder bacterial infections [14,62,63].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 132), ('ANOMALY_CURIOUS_FINDING', 140)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A')]
PMC3873449	12/2013	S0-PMC3873449	['the high prevalence of Vitamin D deficiency and its RELATED maternal FACTORS in Pregnant women in beijing\n\nabstract\nmaternal Vitamin D deficiency HAS BEEN SUGGESTED to INFLUENCE fetal and neonatal health.']	[('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 23, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3873449	12/2013	S23-PMC3873449	['it is SUGGESTED that Vitamin D is LIKELY to have an EFFECT on several offspring outcomes such as a race-DEPENDENT lowering of Birthweight, type i diabetes and early childhood infections.']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007596', 'blood coagulation', 126, 'birthweight')]
PMC3873449	12/2013	S24-PMC3873449	['HOWEVER, data are CONFLICTED on the IMPACT of Vitamin D on the RISK of allergic conditions.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3873449	12/2013	S33-PMC3873449	['these FACTORS MAY LEAD TO an increase in the RISK of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3873449	12/2013	S39-PMC3873449	['there is considerable INTEREST in FACTORS that MAY INFLUENCE Vitamin D status in chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant')]
PMC3873449	12/2013	S144-PMC3873449	['this MAY SUGGEST that the ROLE of sun exposure is LIMITED in elevating Vitamin D concentration in Pregnant women residing in beijing in winter.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 50)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnant')]
PMC3882256	1/2014	S108-PMC3882256	['there was also no association between cord ferritin and either maternal dietary iron intake or hemoglobin.10.1371/journal.pone.0084684.t005\n\ncaption (table-wrap): table 5\nmultivariable linear regression estimates from stratified analyses for associations between Maternal Iron intake and hemoglobin in Pregnancy with offspring vascular indicators and body mass index with testing for EFFECT modification by maternal Vitamin C intake during Pregnancy and child sex (n\u200a=\u200a2958).offspring pulse wavevelocity (m/s)offspring Flow mediateddilatation (%)offspring systolic bloodpressure (mmhg)offspring diastolic bloodpressure (mmhg)offspring body massindex (kg/m2)b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p* Maternal Pregnancy dietary iron intake (continuous) (per 10 mg/d) in participants with Vitamin Cintake >50 mg/day0−0.3, 0.30.50.6−0.2, 1.50.5−0.3−2.4, 1.90.70.8−1.1, 2.70.80−.0.7, 0.60.3in participants with Vitamin Cintake ≤50 mg/day0.2−0.7, 1.1−0.3−2.7, 2.1−1.8−7.3, 3.71.2−4.0, 6.41.2−1.1, 3.5males0.2−0.2, 0.60.40.6−0.4, 1.60.20.4−2.3, 3.10.90.9−1.5, 3.20.70.2−0.7, 1.00.4females0−0.4, 0.40.5−0.7, 1.6−0.9−3.8, 2.00.7−1.9, 3.30.1−0.9, 1.0 maternal Pregnancy Iron supplement use in participants with Vitamin cintake >50 mg/day0−0.1, 0.20.20.30, 0.70.1−0.8−1.7, 0.10.9−0.4−1.2, 0.50.90.1−0.2, 0.30.9in participants with Vitamin Cintake ≤50 mg/day0.2−0.1, 0.5−0.3−1.1, 0.6−0.8−2.7, 1.2−0.1−2.0, 1.80−0.8, 0.8males0.1−0.1, 0.20.80.2−0.2, 0.60.9−0.9−2.1, 0.30.7−0.9−1.9, 0.10.06−0.1−0.4, 0.30.5females0.1−0.1, 0.20.3−0.3, 0.7−0.7−1.9, 0.50.2−0.8, 1.30.1−0.3, 0.5 maternal early Pregnancy anemia (<11 g/dl) males0−0.4, 0.40.90.2−0.9, 1.20.3−1.3−4.1, 1.40.80.3−2.1, 2.60.40.4−0.5, 1.20.2females−0.1−0.5, 0.4−0.5−1.7, 0.7−1.0−4.1, 2.1−0.9−3.7, 1.8−0.2−1.2, 0.8\n#adjusting for potential CONFOUNDING characteristics: maternal age, pre-Pregnancy bmi, smoking in Pregnancy, educational qualification (AS a PROXY for socioeconomic status), parity, and maternal total energy intake in the models with dietary iron intake as exposure).']	[('SUPERFICIAL_RELATIONSHIP', 384), ('PROBLEM_COMPLICATION', 1794), ('PROBABLE_UNDERSTANDING', 1905), ('SUPERFICIAL_RELATIONSHIP', 1910)]	4	[('GO_0007618', 'mating', 263, 'maternal'), ('CHEBI_24870', 'ion', 272, 'iron'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 416, 'vitamin C'), ('GO_0007565', 'female pregnancy', 440, 'pregnancy'), ('GO_0007601', 'visual perception', 519, 'flow'), ('GO_0007618', 'mating', 713, 'Maternal'), ('GO_0007565', 'female pregnancy', 722, 'pregnancy'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 800, 'vitamin Cintake'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 920, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1164, 'pregnancy'), ('CHEBI_24870', 'ion', 1174, 'iron'), ('CHEBI_33229', 'vitamin (role)', 1215, 'vitamin'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 1334, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1589, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1841, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1867, 'pregnancy')]
PMC3888066	12/2012	S52-PMC3888066	['conclusion and implications for care\nhigh levels of fetal Retinoic Acid, a Metabolite of Vitamin A, are KNOWN to be Teratogenic and MAY BE ASSOCIATED with developmental defects of the Central Nervous System, PARTICULARLY involving the Cerebellum, resulting in Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 208)]	4	[('CHEBI_26536', 'retinoic acid', 58, 'retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 75, 'metabolite'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_50905', 'teratogenic agent', 116, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 184, 'central nervous system'), ('UBERON_0002037', 'cerebellum', 235, 'cerebellum'), ('GO_0007399', 'nervous system development', 260, 'neurodevelopmental')]
PMC3973641	4/2014	S36-PMC3973641	['considering that exposure to suboptimal nutrition during early development LEADS TO a long-term, age-DEPENDENT Metabolic response[26], we INVESTIGATED the EFFECTS of a Vitamin B-deficient diet during Pregnancy or Pregnancy/Lactation in Mice offspring.']	[('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0008152', 'metabolic process', 111, 'metabolic'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin B'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('GO_0007595', 'lactation', 223, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'mice')]
PMC3991049	11/2013	S18-PMC3991049	['in RECENT YEARS there HAS BEEN an INCREASED UNDERSTANDING of the ROLE that Vitamin D plays in Regulation Of Cell Growth, immunity, and Cell Metabolism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0051900', 'regulation of mitochondrial depolarization', 94, 'regulation of cell growth ...'), ('GO_0044237', 'cellular metabolic process', 135, 'cell metabolism')]
PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]
PMC4045304	2/2014	S196-PMC4045304	['CANNALL used one of the inherited components of the Vitamin D system and Vitamin D RELATED disease, atherosclerosis, as a MODEL to illustrate the mechanism of ASSOCIATION between autism and the Vitamin D system.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4045304	2/2014	S207-PMC4045304	['a study conducted in saudi arabia FOUND that DESPITE the same amount of sun exposure, NOT ONLY was there much lower levels of 25-Hydroxy Vitamin D in autistic children as compared to controls (about half of those of controls), but also there was an extremely strong negative CORRELATION coefficient ( r = −0.84) between Vitamin D levels and autism severity on the autism severity scale [75].']	[('INCOMPLETE_EVIDENCE', 34), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 275)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 126, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 145, 'D'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
PMC4045304	2/2014	S227-PMC4045304	['the ROLE or ROLES Vitamin D MAY play in development of asd MAY BE resolved by randomized clinical trials of Prenatal Vitamin D supplementation or Vitamin D supplementation of newborns or in early childhood.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'prenatal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4072587	6/2014	S20-PMC4072587	['adverse maternal and neonatal outcomes HAVE previously BEEN DESCRIBED in ASSOCIATION with Antenatal Vitamin D deficiency, including INCREASED risk of pre-eclampsia, Gestational diabetes, caesarean section, as well as low Birth weight and small for Gestational age infants[15],[16],[17],[18],[19].']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 132)]	4	[('GO_0007567', 'parturition', 90, 'antenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 221, 'birth'), ('GO_0007565', 'female pregnancy', 248, 'gestational')]
PMC4072587	6/2014	S155-PMC4072587	['conclusions\nOUR STUDY INDICATES that low levels of Vitamin D during Pregnancy are of CONCERN in rural vietnam, and are ASSOCIATED with impaired Language Development at 6 months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('PROBLEM_COMPLICATION', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 144, 'language development')]
PMC4113768	7/2014	S27-PMC4113768	['conclusions: sex-specific ASSOCIATIONS of 25(Oh)D3With Serum Lipids MAY exist in elderly subjects, and an adequate Vitamin D status MAY have a beneficial IMPACT on dyslipidaemia in elderly women.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('CHEBI_86970', 'N-[(15Z)-tetracosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine', 42, '25(OH)D3with'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 42, '25(OH'), ('PR_000006480', 'type I iodothyronine deiodinase', 48, 'D3with'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_18059', 'lipid', 61, 'lipids'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4113768	7/2014	S29-PMC4113768	['ASSOCIATIONS between Vitamin D and biomarkers of Oxidative Stress in community-dwelling elderly subjects: a cross-sectional study\n\njungert, a.; neuhäuser-berthold, m.\nbackground: SOME STUDIES SUGGEST that Vitamin D MAY have anti-Oxidant and anti-inflammatory properties (asemi, z., et al.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 215)]	4	[('CHEBI_28384', 'vitamin K', 21, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 21, 'Vitamin D'), ('GO_0045733', 'acetate catabolic process', 49, 'Oxidative Stress'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_77969', 'food humectant', 229, 'oxidant')]
PMC4113768	7/2014	S136-PMC4113768	['FURTHER ANALYSIS is underway to assess POSSIBLE EXPLANATIONS for these varying RELATIONSHIPS between Vitamin D status and bone geometry by ethnicity and bone site.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S148-PMC4113768	['2012, 67 , 1139-1144), NO PUBLISHED research has specifically examined WHETHER there is a LINK between Vitamin D and Sleep.']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('EXPLICIT_QUESTION', 71), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0030431', 'sleep', 117, 'sleep')]
PMC4113768	7/2014	S149-PMC4113768	['THEREFORE, in THIS STUDY, ASSOCIATIONS between sleep quality and Vitamin D status in uk dwelling south asian (a) and caucasian (c) women were INVESTIGATED.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S168-PMC4113768	['background: RECENT experimental, ecological and epidemiological EVIDENCE LINKS Vitamin D with an anti-Carcinogenic EFFECT.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_76606', 'methyl carbamate', 102, 'carcinogenic')]
PMC4113768	7/2014	S356-PMC4113768	['DUE TO the unavailability of subsidized daily doses of Vitamin D and the unaffordability of Vitamin D testing in new zealand we have established a less than IDEAL process for treating and PREVENTING Vitamin D deficiency in our IDENTIFIED high risk women and children, using monthly doses of 50,000 iu Cal-D forte for women and Vitadol-c (multivitamin) for breast feeding babies.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 157), ('SUPERFICIAL_RELATIONSHIP', 188), ('INCOMPLETE_EVIDENCE', 227)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_17789', 'dihydrochelirubine', 301, 'Cal-D'), ('PR_000004968', 'calretinin', 301, 'Cal-D'), ('CHEBI_27355', 'xylulose phosphate', 327, 'vitadol')]
PMC4113768	7/2014	S357-PMC4113768	['we have decreased the incidence of rickets in our community but with limited subsidised treatment options in a poor and AT RISK community we are STILL CONCERNED about the IMPACT of Vitamin D deficiency on our vulnerable children.']	[('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 145), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4113768	7/2014	S389-PMC4113768	['background: RECENT STUDIES SUGGEST an ASSOCIATION between higher latitude, a PROXY of Vitamin D (vd) status, and allergic diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 77)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S456-PMC4113768	['THEREFORE, the larger mean foetal Lateral Ventricle size SEEN in october–december is LIKELY to RELATE to adverse exposure in june–september, when maternal Vitamin D status is highest.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 85), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('UBERON_0002285', 'telencephalic ventricle', 34, 'lateral ventricle'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4113768	7/2014	S473-PMC4113768	['high intakes (above RECOMMENDED daily amounts) of Vitamin A HAVE BEEN REPORTED to counteract the EFFECTS of Vitamin D (including EFFECTS in rcts).']	[('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4113768	7/2014	S625-PMC4113768	['these prospective data SUPPORT the HYPOTHESIS that maternal Vitamin D status and child season of Birth CONTRIBUTE to RISK of childhood p/tn allergy.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 103), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S631-PMC4113768	['; kiely, m.\nbackground: obesity is a RISK FACTOR for low circulating 25-Hydroxy Vitamin D (25(Oh)D), which is the BIOMARKER of Vitamin D status, and there are CONSISTENT negative ASSOCIATIONS between 25(Oh)D and measures of adiposity in Adults and children.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 179)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('UBERON_0007023', 'adult organism', 237, 'adults')]
PMC4113768	7/2014	S669-PMC4113768	['the PURPOSE of THIS STUDY was TO ASSESS Vitamin D status and its cross-sectional DETERMINANTS in this vulnerable population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S683-PMC4113768	['poorer Vitamin D status in māori MAY REFLECT darker skin tone or inequitable supply of oral Vitamin D. primary care practitioners SHOULD BE aware of the availability and common use of high-dose Vitamin D preparations, and SHOULD ask about over-the-counter Supplement use before prescribing Pharmaceutical Vitamin D in those of advanced aged.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('FUTURE_WORK', 130), ('FUTURE_WORK', 222)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 256, 'supplement'), ('CHEBI_52217', 'pharmaceutical', 290, 'pharmaceutical'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4113768	7/2014	S850-PMC4113768	['background: the ROLE of Vitamin D in bone Metabolism is WELL KNOWN BUT its’ actions on muscle are INCOMPLETELY understood.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('INCOMPLETE_EVIDENCE', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0008152', 'metabolic process', 42, 'metabolism')]
PMC4113768	7/2014	S877-PMC4113768	['the results of this review are at ODDS with findings from SOME observational studies, which have SUGGESTED that Vitamin D status AFFECTS Hand-grip strength.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0002398', 'manus', 137, 'hand')]
PMC4113768	7/2014	S898-PMC4113768	['such OBSERVATIONS from a relatively small clinic SUGGEST Vitamin D deficiency ACTS as a comorbid FACTOR in leading to changes in the Vertebral Bodies.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0002347', 'thoracic vertebra', 133, 'vertebral bodies')]
PMC4113768	7/2014	S914-PMC4113768	['conclusions: early work with dietary manipulations in a Dog MODEL together with trials in institutionalized children SUGGESTED that Vitamin D is an IMPORTANT PROTECTIVE factor against Dental decay.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 148), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('NCBITaxon_33208', 'Metazoa', 56, 'dog'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 184, 'dental')]
PMC4113768	7/2014	S1285-PMC4113768	['a RECENT meta-analysis SHOWED INCONSISTENT EFFECTS of Vitamin D supplementation on bone Mineral density of healthy children.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral')]
PMC4113768	7/2014	S1375-PMC4113768	['HOWEVER the mechanism is UNCLEAR, with studies examining the RELATIONSHIP between Vitamin D and Insulin resistance showing CONFLICTING results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 25), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000045358', 'insulin family protein', 96, 'insulin')]
PMC4113768	7/2014	S1415-PMC4113768	['conclusions: the vdr Snp rs7968585 PREDICTS the occurrence of t2dm, which MAY INDICATE a ROLE of Vitamin D in the pathogenesis of t2dm.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('SO_0000694', 'SNP', 21, 'SNP'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S1439-PMC4113768	['this is of CONCERN SINCE it MAY REFLECT undiagnosed levels of Vitamin D deficiency/insufficiency in the wider population.']	[('PROBLEM_COMPLICATION', 11), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 32)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S1571-PMC4113768	['there is also EVIDENCE that Vitamin D plays an IMPORTANT ROLE in OTHER aspects of health, including infection and immunity.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S1576-PMC4113768	['Vitamin D MAY aid in supporting the Innate and Adaptive Immune Responses, and henceforth Cd4 T-Cell preservation; STUDIES have FOUND that Vitamin D insufficiency was ASSOCIATED with cd4 changes after Antiretroviral Therapy (art) initiation (aziz, m., et al .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 36, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 47, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 56, 'immune'), ('CL_0000810', 'CD4-positive, alpha-beta thymocyte', 89, 'CD4 T-cell'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 200, 'antiretroviral'), ('GO_0003064', 'regulation of heart rate by hormone', 200, 'antiretroviral therapy')]
PMC4113768	7/2014	S1598-PMC4113768	['it is STILL UNCLEAR WHETHER the altered 25(Oh)D levels SEEN AFFECT the active Vitamin D Metabolite 1,25(Oh)2D and health outcomes (such as bone mineralization).']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 88, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D')]
PMC4113768	7/2014	S1599-PMC4113768	['the AIM of THIS STUDY is TO EVALUATE Vitamin D, Calcium and Phosphate Metabolites and their IMPACT on bone Mineral density in hiv-infected Antiretroviral-experienced adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 92)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 48, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 60, 'phosphate'), ('CHEBI_25212', 'metabolite', 70, 'metabolites'), ('CHEBI_46662', 'mineral', 107, 'mineral'), ('CHEBI_65417', '(+)-aplysinillin', 139, 'antiretroviral')]
PMC4113768	7/2014	S1678-PMC4113768	['it HAS BEEN PROVEN in MANY STUDIES that Vitamin D has a strong immunomodulator EFFECT and Vitamin D Receptor (Vdr) increases the Expression of certain anti-Mycobacterial Compound in Macrophages called cathecidilin.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_28384', 'vitamin K', 40, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 40, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 90, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 110, 'VDR'), ('GO_0010467', 'gene expression', 129, 'expression'), ('CHEBI_52217', 'pharmaceutical', 156, 'mycobacterial'), ('CHEBI_36357', 'polyatomic entity', 170, 'compound'), ('CL_0000235', 'macrophage', 182, 'macrophages')]
PMC4113768	7/2014	S1700-PMC4113768	['results: it HAS BEEN OBSERVED that in Adult female of pakistan most of them have Vitamin D insufficiency and SOME of them were deficient while Serum calcium is not a significant BIOMARKER to check the level of Vitamin D. in obese female Vitamin D insufficiency is more than non obese.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('UBERON_0007023', 'adult organism', 38, 'adult'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4113768	7/2014	S1713-PMC4113768	['multivariate logistic regression was performed TO IDENTIFY POTENTIAL DETERMINANTS of Vitamin D status and of six clinical MARKERS of asthma Control (asthma Control test score, british Thoracic society treatment step, number of exacerbations in preceding 12 months, % predicted fev1, exhaled Nitric Oxide concentration and degree of reversibility of Airway obstruction following administration of inhaled Salbutamol).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0065007', 'biological regulation', 140, 'control'), ('GO_0065007', 'biological regulation', 156, 'Control'), ('UBERON_0000915', 'thoracic segment of trunk', 184, 'Thoracic'), ('CHEBI_16480', 'nitric oxide', 291, 'nitric oxide'), ('UBERON_0001005', 'respiratory airway', 349, 'airway'), ('CHEBI_66163', 'samaderine Y', 404, 'salbutamol')]
PMC4113768	7/2014	S1726-PMC4113768	['we INVESTIGATED the EFFECT of dbp genotype on estimates of f25ohd (gc-f25ohd), and on their RELATIONSHIP with 25ohd3t1/2, a measure of 25ohd tissue usage, in populations KNOWN to differ in dbp genotype and Vitamin D supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4113768	7/2014	S1845-PMC4113768	['IN CONTRAST, there was NO EVIDENCE to SUGGEST a similar ASSOCIATION amongst the children Born while the Vitamin D fortification policy was in place.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('GO_0007567', 'parturition', 89, 'born'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1846-PMC4113768	['conclusion: the results of OUR STUDY SUGGEST that the Vitamin D fortification policy enacted in denmark until june 1st, 1985 had a PROTECTIVE EFFECT amongst children Born during the spring in regards to later development of schizophrenia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'born')]
PMC4113768	7/2014	S1850-PMC4113768	['HOWEVER, in RECENT YEARS, it HAS BEEN SHOWN that the ROLE of Vitamin D goes beyond Calcium Homeostasis and Skeletal health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0050817', 'coagulation', 83, 'calcium'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('UBERON_0004288', 'skeleton', 107, 'skeletal')]
PMC4113768	7/2014	S1851-PMC4113768	['NUMEROUS STUDIES have REPORTED that Vitamin D deficiency plays a significant ROLE in the Regulation Of Blood Pressure and Cardiovascular health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008217', 'regulation of blood pressure', 89, 'regulation of blood pressure'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0004535', 'cardiovascular system', 122, 'cardiovascular')]
PMC4113768	7/2014	S1970-PMC4113768	['SINCE Vitamin D is also obtained from dietary sources and Vitamin D supplements; THIS STUDY INVESTIGATED the INFLUENCE of Food and Vitamin D supplements on the Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration in children in the netherlands between october and april.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 92), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 160, 'serum'), ('CHEBI_43176', 'hydroxy group', 169, 'hydroxy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D')]
PMC4113768	7/2014	S1994-PMC4113768	['THIS STUDY adds NEW EVIDENCE to the research body of Vitamin D deficiency in RELATION to INCREASED RISKS of clrd, cvd and all-cause mortality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S1999-PMC4113768	['also, THERE IS EVIDENCE SUGGESTING that Vitamin D AFFECTS the Biosynthesis Of numerous Neurotransmitters and neurotrophic factors RELEVANT for mental health.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001507', 'acetylcholine catabolic process in synaptic cleft', 62, 'biosynthesis of ... neurotransmitters'), ('CHEBI_25512', 'neurotransmitter', 87, 'neurotransmitters')]
PMC4113768	7/2014	S2000-PMC4113768	['this RAISES the HYPOTHESIS that low Vitamin D is RELATED to POOR mental health in the Adult general population.']	[('EXPLICIT_QUESTION', 5), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 60)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adult')]
PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]
PMC4113768	7/2014	S2052-PMC4113768	['ONLY a LIMITED NUMBER OF studies EXAMINED the RELATIONSHIP between Vitamin D status and the prevalence and severity of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 119, 'respiratory')]
PMC4113768	7/2014	S2066-PMC4113768	['conclusions: the results of THIS STUDY SUGGEST an IMPORTANT ROLE for Vitamin D in the modulation of Immune response in children with Lower Respiratory Tract infections.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('UBERON_0004905', 'articulation', 133, 'lower respiratory tract')]
PMC4113768	7/2014	S2197-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD improve MARKERS of vascular health and fatigue in patients with chronic fatigue syndrome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S2244-PMC4113768	['background: DESPITE the identification of several Genetic polymorphisms in the Vitamin D Receptor Gene (Vdrg), the rs2228570 polymorphism, identified by the Fok1 restriction enzyme, APPEARS to be the ONLY one INFLUENCING the size of the Translated protein.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 182), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209)]	4	[('SO_0000704', 'gene', 50, 'genetic'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 79, 'vitamin D receptor'), ('SO_0000704', 'gene', 98, 'gene'), ('PR_000017279', 'testis-specific basic protein Y 1', 104, 'VDRG'), ('PR_000007593', 'glutamate carboxypeptidase 2', 157, 'Fok1'), ('GO_0006412', 'translation', 237, 'translated')]
PMC4113768	7/2014	S2311-PMC4113768	['the ASSOCIATION between pth and Cholesterol levels as well as the inverse ASSOCIATION between Vitamin D status and Ft3 NEEDS TO BE reassessed prospectively on a larger scale to confirm THESE FINDINGS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 185)]	4	[('CHEBI_16113', 'cholesterol', 32, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 115, 'FT3')]
PMC4113768	7/2014	S2334-PMC4113768	['in THIS PROSPECTIVE INTERVENTIONAL STUDY we INVESTIGATED the EFFECTS of Vitamin D3Supplementation on the Metabolic profiles of saudi t2dm subjects pre- and post-Vitamin D supplementation over an 18-month period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('CHEBI_52915', 'phosphatediyl group', 72, 'vitamin D3supplementation'), ('PR_000006649', 'zinc finger protein neuro-d4', 80, 'D3supplementation'), ('GO_0008152', 'metabolic process', 105, 'metabolic'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4113768	7/2014	S2449-PMC4113768	['the AIM of THIS STUDY was TO DETERMINE the CONTRIBUTION from sunlight and diet to total Vitamin D in a mixed ethnicity population living in north-east scotland.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4113768	7/2014	S2500-PMC4113768	['the AIM of THIS STUDY was TO INVESTIGATE the EFFECT of supplemental Vitamin D on bone Mineral accretion in adolescent female athletes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_46662', 'mineral', 86, 'mineral')]
PMC4113768	7/2014	S2523-PMC4113768	['the dose response RELATIONSHIP between Vitamin D supplementation and Plasma 25(Oh)D levels IS THOUGHT TO be biphasic (exponential at low intakes and linear at high), HOWEVER this is NOT WELL DOCUMENTED for supplementation levels that exceed 2000 iu per day for large populations of healthy Individuals.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 182)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 69, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 76, '25(OH ... D'), ('NCBITaxon_1', 'root', 290, 'individuals')]
PMC4113768	7/2014	S2544-PMC4113768	['our OBJECTIVE is TO EXAMINE the INFLUENCE of Vitamin D supplementation on Serum calcium levels and the RISK for hypercalcimia in healthy volunteers in the pure north health program.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4113768	7/2014	S2574-PMC4113768	['conclusion: THIS work SHOWS that Genetic FACTORS are ASSOCIATED with change in 25(Oh)D after Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('SO_0000704', 'gene', 33, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2662-PMC4113768	['there is ACCUMULATING EVIDENCE from meta-analyses of cohort studies that Vitamin D deficiency, AS measured by low Serum levels of 25-Hydroxy Vitamin D (25(Oh)D), PREDICTS INCREASED RISK of all-cause mortality, Cardiovascular disease and hypertension.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 130, '25-hydroxy vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('UBERON_0004535', 'cardiovascular system', 210, 'cardiovascular')]
PMC4113768	7/2014	S2828-PMC4113768	['REPORTED Vitamin D intakes, HOWEVER, were SIMILAR between the sexes after adjusting for energy intake.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S2878-PMC4113768	['RECENTLY, Vitamin D status during icu admission HAS BEEN shown to be ASSOCIATED with the RISK of short-term (30-, 60-, and 90-day) and long-term (1-year) mortality in critically ill patients.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4113768	7/2014	S3120-PMC4113768	['background: RECENT STUDIES have SUGGESTED POSSIBLE LINKS between Vitamin D deficiency and type i hypersensitivity and atopic disease.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S3147-PMC4113768	['Serum Vitamin D concentrations are ASSOCIATED with markers of Intestinal BUT NOT systemic inflammation in crohn’s disease in remission\n\nraftery, t.; smith, s.; o’morain, c.; mahmud, n.; healy, m.; cox, g.; mcnamara, d.; o’sullivan, m.\nbackground: there are ESTABLISHED ASSOCIATIONS between Vitamin D (vitd) status and crohn’s disease (cd).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 269)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_28384', 'vitamin K', 6, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 6, 'Vitamin D'), ('UBERON_0000160', 'intestine', 62, 'Intestinal'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC4113768	7/2014	S3195-PMC4113768	['the OBJECTIVE of the PRESENT STUDY was TO INVESTIGATE the prevalence and PREDICTORS of Vitamin D deficiency throughout the year among a large representative sample of 85 year-old men and women living in the north east of england (55°n).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4113768	7/2014	S3323-PMC4113768	['HOWEVER, cold temperature is also a risk FACTOR for seasonal diseases and outcome, making it DIFFICULT to separate the EFFECTS of solar uvb/Vitamin D from those of temperature.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 93), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4113768	7/2014	S3363-PMC4113768	['conclusion: the results SUGGESTED that quantitative ultrasound bmd COULD BE an INDICATOR for Vitamin D status in young children, and also provided FURTHER EVIDENCE to define Vitamin D deficiency for infants and children.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4113768	7/2014	S3367-PMC4113768	['our OBJECTIVES are (1) to conduct unbiased Genome-wide methylation profiling of Vitamin D in Human Peripheral Leukocytes; (2) to comprehensively search differential functional Methylation Sites UNDERLYING Vitamin D deficiency; (3) TO TEST the HYPOTHESIS that Vitamin D supplementation increases global Dna Methylation level by performing a randomized clinical trial (rct) in overweight/obese african americans with Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 194), ('QUESTION_ANSWERED_BY_THIS_WORK', 231), ('INCOMPLETE_EVIDENCE', 243)]	4	[('SO_0001026', 'genome', 43, 'genome'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('CL_0000118', 'basket cell', 99, 'peripheral leukocytes'), ('SO_0000134', 'genomically_imprinted', 176, 'methylation sites'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0006306', 'DNA methylation', 302, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin D')]
PMC4113768	7/2014	S3379-PMC4113768	['conclusion: SEVERE Vitamin D deficiency is ASSOCIATED with methylation changes in Leukocyte dna in young african americans, which MAY BE INVOLVED in systemic inflammation.']	[('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CL_0000738', 'leukocyte', 82, 'leukocyte')]
PMC4161853	8/2014	S219-PMC4161853	['HOWEVER, in Man, the ROLE of Vitamin A in malaria pathogenesis is multifaceted, and p. falciparum clearly BENEFITS from normal to high Vitamin A Hepatic stores, POSSIBLY depending on scavenged Vitamin A Metabolites to destabilize host Rbc Membranes facilitating invasion [123].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 161)]	4	[('NCBITaxon_40674', 'Mammalia', 12, 'man'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('CHEBI_26871', 'terpene alkaloid', 193, 'vitamin A metabolites'), ('CL_0000232', 'erythrocyte', 235, 'RBC'), ('GO_0016020', 'membrane', 239, 'membranes')]
PMC4169453	9/2014	S203-PMC4169453	['it is JUSTIFIED to RECOMMEND Vitamin D supplementation in breastfeeding women BASED ON their NEEDS and separately in Breastfed infants.']	[('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'breastfed')]
PMC4169453	9/2014	S221-PMC4169453	['keeping IN MIND the diminutive DIFFERENCES in 25(Oh)D levels among the study groups, we ASSUMED that the Vitamin D status in nursing women had no IMPACT on bone mass and body composition.']	[('IMPORTANT_CONSIDERATION', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 52, 'D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4171568	9/2014	S72-PMC4171568	['high levels of Serum Mda and low Plasma Ascorbic Acid were FOUND in the sample as a whole BUT at follow-up normalisation of these MARKERS were observed ONLY in the group receiving Vitamin C as an adjunct to anti-psychotic treatment.']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001977', 'blood serum', 15, 'serum'), ('CHEBI_34840', 'methyl methacrylate', 21, 'MDA'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('CHEBI_22652', 'ascorbic acid', 40, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin C')]
PMC4188019	1/2010	S83-PMC4188019	['in THIS PILOT STUDY, we FOUND that low Vitamin D levels in the antwerp population are frequent and that there is an EFFECT of the seasonal moment of the year and degree of sun exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 116)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4193194	10/2014	S188-PMC4193194	['results from this STUDY SHOWED that the supplementation with Vitamin C and E in a low-risk cohort of women DEMONSTRATED no significant differences in maternal or newborn complications RELATED to hypertension during Pregnancy (roberts et al.,2010; weissgerber et al.,2013).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 75, 'E'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC4221707	11/2014	S11-PMC4221707	['AS they also had a low intake (below the nordic nutritional recommendations) of Folate, Vitamin D, and Iron from foods, some of these women and their unborn children are POSSIBLY AT RISK for adverse EFFECTS on the Pregnancy and Birth outcome.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_24870', 'ion', 103, 'iron'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4221707	11/2014	S137-PMC4221707	['addition from Supplements LED TO significantly higher estimated intake of Vitamin D and Folate and borderline significantly higher intake of Calcium and Vitamin B12 in the Pregnant than referent women, WHEREAS ESTIMATED Intake of iron supplement EVENED out the difference in Intakes from Foods only (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 246)]	4	[('CHEBI_33341', 'titanium atom', 14, 'supplements'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 88, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium'), ('CHEBI_33279', 'vitamin D5', 153, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 153, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 172, 'pregnant'), ('GO_0007631', 'feeding behavior', 220, 'intake'), ('GO_0007631', 'feeding behavior', 275, 'intakes'), ('CHEBI_33290', 'food', 288, 'foods')]
PMC4231606	10/2013	S2-PMC4231606	['the PURPOSE of THIS STUDY was TO DETERMINE the ASSOCIATION between Vitamin D (25(Oh)D) levels and s-ecc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 47)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 78, '25(OH)D')]
PMC4231606	10/2013	S31-PMC4231606	['DEFICIENCY in Vitamin D during periods of Tooth Development MAY also result in developmental defects [17] including Enamel hypoplasia, a SIGNIFICANT RISK FACTOR for s-ecc.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 137), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0048538', 'thymus development', 42, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 42, 'tooth'), ('UBERON_0001752', 'enamel', 116, 'enamel')]
PMC4231606	10/2013	S106-PMC4231606	['multiple regression for 25(Oh)D concentrations REVEALED that levels were significantly and INDEPENDENTLY ASSOCIATED with s-ecc, regular Milk Consumption, and season of assessment BUT NOT household income and or the use of Vitamin D drops (table\xa03).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 179)]	4	[('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('UBERON_0001913', 'milk', 136, 'milk'), ('GO_0007631', 'feeding behavior', 141, 'consumption'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4231606	10/2013	S122-PMC4231606	['regression techniques were employed to determine WHETHER the ASSOCIATION between caries and Vitamin D status REMAINED after controlling for CONFOUNDERS.']	[('EXPLICIT_QUESTION', 49), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 140)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4231606	10/2013	S123-PMC4231606	['EVEN after controlling for seasonal INFLUENCE on Endogenous Synthesis, low household income, and infrequent Consumption of Vitamin D drops and milk, the significant ASSOCIATION REMAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 177)]	4	[('GO_0042400', 'ectoine catabolic process', 49, 'endogenous synthesis'), ('GO_0007631', 'feeding behavior', 108, 'consumption'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4231606	10/2013	S155-PMC4231606	['THIS STUDY SUGGESTS a CLEAR RELATIONSHIP between Vitamin D levels and the caries status of preschool children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 28)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4251419	12/2014	S12-PMC4251419	['THUS, higher latitude is OFTEN taken AS a PROXY for both lower levels of ultraviolet radiation (uvr) and lower Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4251419	12/2014	S15-PMC4251419	['both uvr and Vitamin D (in its active form 1,25(Oh)2D, seefigure 1) have immunomodulatory EFFECTS [8] that provide a PLAUSIBLE mechanism whereby higher levels COULD decrease the risk of Autoimmune diseases (see section on mechanisms, below) and, through the same pathways, COULD impair the Immune Response to vaccination or infection [9,10].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 273)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_17996', 'chloride', 44, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 45, '25(OH)2D'), ('UBERON_0001442', 'skeleton of manus', 186, 'autoimmune'), ('GO_0006955', 'immune response', 290, 'immune response'), ('UBERON_0002405', 'immune system', 290, 'immune')]
PMC4251419	12/2014	S137-PMC4251419	['HOWEVER, SEVERAL STUDIES SUGGEST that low Vitamin D status or low levels of ambient uvr during the in utero period [49], or during childhood [40], are ASSOCIATED with increased risk of Immune-related disorders.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002405', 'immune system', 185, 'immune')]
PMC4251419	12/2014	S159-PMC4251419	['this DISCREPANCY in timing MAY CONTRIBUTE to the failure of Vitamin D supplementation trials to decrease the RISK of disease onset.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4256222	12/2014	S14-PMC4256222	['introduction\nAdult bone mass MAY BE INFLUENCED by FACTORS operating as early as in fetal Life[1], and there has in particular been interest on the ROLE of maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0007023', 'adult organism', 13, 'Adult'), ('UBERON_0000104', 'life cycle', 89, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC4256222	12/2014	S17-PMC4256222	['Vitamin D plays a MAJOR ROLE in the REGULATION of calcium homeostasis[3],[4], and studies have FOUND that children Born to women with low Vitamin D status had lower Birth weight, Birth length, and lower bone Mineral content (bmc) at Birth[2].']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007567', 'parturition', 115, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007567', 'parturition', 165, 'birth'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_46662', 'mineral', 208, 'mineral'), ('GO_0007567', 'parturition', 233, 'birth')]
PMC4256222	12/2014	S99-PMC4256222	['adjustment for Vitamin D status did not attenuate this ASSOCIATION as would be expected if the ASSOCIATION were DUE TO seasonal variation in Vitamin D status, RATHER it was strengthened upon adjustment.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBLEM_COMPLICATION', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4256222	12/2014	S120-PMC4256222	['one POTENTIAL EXPLANATION for the null ASSOCIATION between maternal Vitamin D status and offspring bone fractures MAY BE the low prevalence of Vitamin D deficiency in our study population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 114)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4256222	12/2014	S124-PMC4256222	['CONSISTENT with temporal TRENDS, there were also fewer Vitamin D deficient mothers in our study sample COMPARED TO two later danish studies, which measured Vitamin D in pregnant women[32]and in a general population sample[33]approximately 10 years later.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4256222	12/2014	S135-PMC4256222	['weight and height MAY BE RELATED both to maternal Vitamin D status and offspring bone mass, and our results MAY BE CONFOUNDED when those data are missing.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 108), ('DIFFICULT_TASK', 115)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4256222	12/2014	S138-PMC4256222	['THUS, we cannot preclude that early Vitamin D supplementation IMPACTED offspring bone fracture RISK in our data and has blurred an ASSOCIATION with maternal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4258799	11/2014	S299-PMC4258799	['in women with unexplained infertility, oral Vitamin E intake improved the Endometrial response, POSSIBLY DUE TO its antioxidant and anticoagulant EFFECTS as well as by Modulating the anti-Estrogenic EFFECT of Clomiphene Citrate.']	[('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('UBERON_0001983', 'crypt of Lieberkuhn', 74, 'endometrial'), ('GO_0065007', 'biological regulation', 168, 'modulating'), ('CHEBI_59715', 'sodium squarate', 188, 'estrogenic'), ('CHEBI_3753', 'clomiphene citrate', 209, 'clomiphene citrate')]
PMC4258799	11/2014	S315-PMC4258799	['HOWEVER, smaller prospective studies SHOWED that oral Vitamin C supplementation in women, EITHER undergoing ivf-et treatment [123] or with Luteal phase defects [124], LEAD TO increased Pregnancy rates.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin C'), ('GO_0007565', 'female pregnancy', 139, 'luteal'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4289064	1/2015	S157-PMC4289064	['the pattern of results for Vitamin A also INDICATES that nutritional vulnerability to pollinator decline DEPENDS not ONLY on the specific sources of Nutrients in the diet and their pollinator DEPENDENCE, but also on the total amount of Nutrients being consumed.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('CHEBI_33284', 'nutrient', 149, 'nutrients'), ('CHEBI_33284', 'nutrient', 236, 'nutrients')]
PMC4289064	1/2015	S165-PMC4289064	['the wide DIFFERENCES we find among populations for Vitamin A (table 2) SUGGEST that global data on crop and Nutrient Production (e.g.,[10]) are INSUFFICIENT for predicting the EFFECTS of pollinator declines on Human health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 71), ('PROBLEM_COMPLICATION', 144), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('CHEBI_33284', 'nutrient', 108, 'nutrient'), ('GO_0007128', 'meiotic prophase I', 117, 'production'), ('NCBITaxon_9606', 'Homo sapiens', 210, 'human')]
PMC4302429	1/2015	S8-PMC4302429	['conclusion\nour OBSERVATIONS SUGGEST a DETRIMENTAL ROLE of Vitamin D deficiency in bacterial Central Nervous System infections.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 92, 'central nervous system')]
PMC4302429	1/2015	S166-PMC4302429	['TO ASSESS the ROLE of Vitamin D in an in-vivo experimental MODEL of bacterial Cns infection, we analyzed the INFLUENCE of the infection on the survival and Immune Response of Mice Fed a diet containing different amounts of Vitamin D3 after injection of E. Coli directly into the right Frontal Lobe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 78, 'CNS'), ('GO_0006955', 'immune response', 156, 'immune response'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'mice'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('CHEBI_33279', 'vitamin D5', 223, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 223, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'E. coli'), ('UBERON_0016525', 'frontal lobe', 285, 'frontal lobe')]
PMC4302429	1/2015	S186-PMC4302429	['PRESUMABLY, in addition to Cathelicidin, OTHER Immune Mediators are INVOLVED in the Vitamin D-dependent Immune pathways.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_3364', 'Canthiumine', 27, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 27, 'cathelicidin'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('CHEBI_35222', 'inhibitor', 54, 'mediators'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0002405', 'immune system', 104, 'immune')]
PMC4302429	1/2015	S206-PMC4302429	['conclusions\nour experiments IDENTIFIED for the FIRST TIME a DETRIMENTAL in-vivo EFFECT of Vitamin D deficiency on survival in experimental E. Coli meningoencephalitis.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 80)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'E. coli')]
PMC4302429	1/2015	S211-PMC4302429	['WHETHER high-dose Vitamin D has a PROTECTIVE EFFECT in combination with Antibiotics remains TO BE studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 92)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 72, 'antibiotics')]
PMC4303849	1/2015	S7-PMC4303849	['THIS REVIEW provides a current overview on the Regulation Of Vitamin D Metabolism, FOCUSING on Vitamin D deficiency during Gestation and its IMPACT on Pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 83), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('GO_0019216', 'regulation of lipid metabolic process', 47, 'regulation of vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'gestation'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC4329404	10/2014	S160-PMC4329404	['the same EFFECT was seen in a PREVIOUS STUDY that has investigated the EFFECTS of Vitamin D supplementation on allergic Airways disease in an ovalbumin MODEL using Adult Mice.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 120, 'airways'), ('UBERON_0007023', 'adult organism', 164, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice')]
PMC4329404	10/2014	S181-PMC4329404	['a PROMISING ROLE of Vitamin D supplementation in children with asthma is the POTENTIAL of minimizing the development of a very early feature of Airway Remodelling, increased thickness of the reticular basement membrane (41,42), which would incorporate a NOVEL therapeutic target in asthma.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 77), ('FULL_UNKNOWN', 254)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 144, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 144, 'airway')]
PMC4329745	10/2014	S88-PMC4329745	['ALTHOUGH in OUR STUDY the ASSOCIATION between age and Vitamin D deficiency is not substantially.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 26)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4377870	3/2015	S75-PMC4377870	['maternal intake of Vitamin E, Vitamin D, milk, cheese and calcium during Pregnancy are negatively ASSOCIATED, WHILE Vitamin C is positively ASSOCIATED, with wheezing in early childhood [57,58].']	[('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ANOMALY_CURIOUS_FINDING', 110), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin C')]
PMC4377870	3/2015	S76-PMC4377870	['antioxidants including Lycopene APPEAR to have positive INFLUENCES in Respiratory conditions, further detail is provided below on EVIDENCE for Vitamin C, Vitamin E and Flavonoids and their ROLE in the maternal diet, diets of children and Adults with asthma and Adults with copd.']	[('ANOMALY_CURIOUS_FINDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 189)]	4	[('CHEBI_15948', 'lycopene', 23, 'lycopene'), ('UBERON_0001004', 'respiratory system', 70, 'respiratory'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('CHEBI_72544', 'flavonoids', 168, 'flavonoids'), ('UBERON_0007023', 'adult organism', 238, 'adults'), ('UBERON_0007023', 'adult organism', 261, 'adults')]
PMC4377870	3/2015	S142-PMC4377870	['Vitamin D APPEARS to have a PROTECTIVE ROLE against the susceptibility to and severity of these infections [111], AS active Vitamin D (1,25 (Oh)2d) modifies Production Of Antimicrobial Cathelicidins and defensins that kill bacteria and induce wound Repair [112].']	[('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 114)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_76285', '(R)-vedaprofen', 136, ',25 (OH'), ('GO_0030154', 'cell differentiation', 157, 'production of ... cathelicidins'), ('CHEBI_65381', 'albizoside C', 171, 'antimicrobial'), ('GO_0006281', 'DNA repair', 249, 'repair')]
PMC4377870	3/2015	S157-PMC4377870	['experimental data SUGGEST that Vitamin D MAY BE IMPORTANT in copd for its EFFECT on normal Lung growth and Development, though Human data to support this is not available.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 91, 'lung ... development'), ('UBERON_0002048', 'lung', 91, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 127, 'human')]
PMC4377870	3/2015	S158-PMC4377870	['IT IS POSSIBLE that copd onset MAY also be IMPACTED by Cellular Responses to cigarette smoke exposure which inhibits the protective immunomodulatory EFFECTS of Vitamin D [126].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('GO_0006915', 'apoptotic process', 55, 'cellular responses'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4377870	3/2015	S160-PMC4377870	['in an OBSERVATIONAL study Single Nucleotide Polymorphisms in the Vitamin D Binding Protein (Vdbp) PREDICTED Vitamin D levels in copd patients and were FOUND TO BE a risk FACTOR for copd [123].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('SO_0000694', 'SNP', 26, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 65, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 92, 'VDBP'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4380518	9/2014	S10-PMC4380518	['our HYPOTHESIS was that lack of Prenatal vitamin (pnv) use WOULD BE ASSOCIATED with Vitamin D deficiency (DEFINED as <50 nmol/).']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_PREDICTION', 59), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 106)]	4	[('GO_0007565', 'female pregnancy', 32, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4380518	9/2014	S66-PMC4380518	['FUTURE ANALYSES of health EFFECTS of Vitamin D status in this population are PLANNED but beyond the scope of THIS analysis.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('FUTURE_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 109)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4383226	2/2015	S7-PMC4383226	['FUTURE STUDIES focusing on climate seasonality, Placental malaria and hiv ARE NEEDED to characterize better the ASSOCIATION between Vitamin A and malaria infection in DIFFERENT settings.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0001987', 'placenta', 48, 'placental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin A')]
PMC4383226	2/2015	S11-PMC4383226	["many also receive Vitamin A supplements, which HAVE BEEN LINKED not ONLY to the protection of a child's Vision, but also to a lower RISK of death and an improved ability to Fight off infections."]	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 132)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0007601', 'visual perception', 104, 'vision'), ('GO_0007631', 'feeding behavior', 173, 'fight')]
PMC4383226	2/2015	S15-PMC4383226	['it is LESS CLEAR WHETHER vaccines OR Vitamin A have antimalarial EFFECTS in Humans.']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans')]
PMC4383226	2/2015	S36-PMC4383226	['multiple clinical TRIALS in infants and young children have also IDENTIFIED PROTECTIVE EFFECTS from Vitamin A supplementation against illness (number and time to first clinical episode, risk of febrile illness, Spleen enlargement, and mean parasite density) (shankar et al., 1999;zeba et al., 2008) and death caused by malaria (fawzi et al., 1999;varandas et al., 2001;mwanga-amumpaire et al., 2012).']	[('FUTURE_WORK', 18), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('UBERON_0002106', 'spleen', 211, 'spleen')]
PMC4383226	2/2015	S44-PMC4383226	['BASED ON this evidence, the PURPOSE of THIS STUDY was TO DETERMINE the risk of plasmodium parasitemia and p. falciparum -specific antigenemia following Vitamin A supplementation and standard vaccination in children under 5 years of age in sub-saharan africa.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 54)]	4	[('CHEBI_27300', 'vitamin D', 152, 'vitamin A')]
PMC4383226	2/2015	S112-PMC4383226	['ADDITIONAL RESEARCH MAY BE WARRANTED on the IMPACT of Vitamin A supplementation in young children with known Prenatal exposure to malaria.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 109, 'prenatal')]
PMC4383226	2/2015	S148-PMC4383226	['FURTHER RESEARCH IS NEEDED to evaluate POTENTIAL INTERACTIONS between Vitamin A, hiv and malaria infection.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A')]
PMC4383575	1/2015	S147-PMC4383575	['several POTENTIAL modifiable FACTORS, such as higher maternal bmi, high dairy product intake, low Intake of healthy Food and fruits rich in Vitamin C, as well AS Delivery by cesarean section and country of Birth, were ASSOCIATED with higher adduct levels.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007631', 'feeding behavior', 98, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin C'), ('PR_000004900', 'complement C3', 148, 'C'), ('GO_0007567', 'parturition', 162, 'delivery'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC4396835	1/2015	S21-PMC4396835	['later, the negative IMPACT of Prenatal Vitamin D deficiency on Brain Development was POSTULATED by mcgrath [17], MAINLY BASED on epidemiological data.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 113), ('QUESTION_ANSWERED_BY_THIS_WORK', 120)]	4	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007420', 'brain development', 63, 'brain development'), ('UBERON_0000955', 'brain', 63, 'brain')]
PMC4396835	1/2015	S24-PMC4396835	['several epidemiological FINDINGS indirectly SUPPORT a POSSIBLE ROLE for Prenatal Vitamin D deficiency in autism.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('GO_0007565', 'female pregnancy', 72, 'prenatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4396835	1/2015	S30-PMC4396835	['season of Birth findings constitute another LINK between autism and Vitamin D. in europe a MAJOR proportion of the population have CONSIDERABLY lower 25(Oh)D in winter and spring compared TO summer and autumn [36,41].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 91), ('ANOMALY_CURIOUS_FINDING', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 188)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC4396835	1/2015	S31-PMC4396835	['a NUMBER OF STUDIES in sweden, denmark, uk and north-east usa on season of Birth HAVE SHOWN that more children with asd are Born in winter and spring [42,43], with highest relative rates in march [44,45] SUGGESTING that lower Vitamin D status in the mother during Pregnancy may constitute a risk FACTOR [46].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 296)]	4	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 124, 'born'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy')]
PMC4396835	1/2015	S141-PMC4396835	['ON THE OTHER HAND, a LINK between Genomic actions of Vitamin D and serotonergic deviations in asd HAS BEEN PROPOSED by patrick and ames [63].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107)]	4	[('SO_0001026', 'genome', 34, 'genomic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4396835	1/2015	S142-PMC4396835	['ACCORDING TO these authors, low levels of Vitamin D MAY simultaneously cause hypo-activity of the central serotonergic system and hyperactivity of the peripheral, causing hyperserotoninemia, one of the most REPLICATED BIOMARKERS in asd research [64].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 207), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4405493	4/2015	S1-PMC4405493	['the EFFECT of Vitamin D deficiency in Pregnancy is UNKNOWN, but HAS BEEN ASSOCIATED with adverse Pregnancy outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 51), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC4405493	4/2015	S2-PMC4405493	['the OBJECTIVE of THIS STUDY was TO ANALYZE the RELATIONSHIP between Vitamin D deficiency in the first trimester and subsequent clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 47)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4405493	4/2015	S19-PMC4405493	['HOWEVER, the EFFECT of less SEVERE Vitamin D deficiency and insufficiency on maternal and fetal outcomes during Pregnancy is LESS CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 28), ('FULL_UNKNOWN', 125)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4405493	4/2015	S117-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual Pregnancy complications.fig 1compares our study population with RECENTLY PUBLISHED cohort studies and randomized controlled trials (reviewed in christesen [2012] and wei [2013]) [13,39].10.1371/journal.pone.0123763.g001\n\ncaption (fig): fig 1\ncomparison of study parameters in recent Vitamin D OBSERVATIONAL and intervention studies.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 389)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D')]
PMC4405493	4/2015	S121-PMC4405493	['UNFORTUNATELY, the increasing use of multivitamins and Mineral dietary supplements in younger to older Adults DOES NOT APPEAR TO BE ASSOCIATED with a corresponding increase in Serum 25-oh Vitamin D concentrations [3,19,41].']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 110), ('ANOMALY_CURIOUS_FINDING', 119), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_46662', 'mineral', 55, 'mineral'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC4405493	4/2015	S150-PMC4405493	['maternal Vitamin D deficiency MAY also PREDISPOSE women to an increased inflammatory response that characterizes preeclampsia, ESPECIALLY SEVERE, early onset disease (reviewed in christesen [2012] and wei [2013]) [13,39].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 127), ('IMPORTANT_CONSIDERATION', 138)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4417995	4/2015	S3-PMC4417995	['in THIS PAPER, we review the EXISTING LITERATURE on the ASSOCIATION between ad and Vitamin D levels, FOCUSING on childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 101)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4417995	4/2015	S179-PMC4417995	['topical therapy\ncertain OBSERVATIONS FURTHER aimed at clarifying the ROLE of topical Vitamin D analogues.']	[('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 37), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4427001	4/2015	S1-PMC4427001	['the AIMS of the PRESENT STUDY were TO DETERMINE Midgestational and early Postpartum Vitamin D status in Pregnant women with and without gdm and to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of Glucose tolerance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('GO_0007507', 'heart development', 48, 'midgestational'), ('GO_0007565', 'female pregnancy', 73, 'postpartum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnant'), ('GO_0007507', 'heart development', 181, 'midgestational'), ('GO_0007565', 'female pregnancy', 200, 'postpartum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4427001	4/2015	S29-PMC4427001	["circulating Plasma concentration of 25(Oh)D IS CONSIDERED the MOST RELIABLE INDICATOR of Individual's Vitamin D status."]	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 62), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('UBERON_0001969', 'blood plasma', 12, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('NCBITaxon_1', 'root', 89, 'individual'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4438573	5/2015	S25-PMC4438573	['the ONLY STUDY to date that has assessed the EFFECTS of maternal Nutrient supplementation on malaria Antibody levels REPORTED that Vitamin A Prenatal supplements were ASSOCIATED with a reduction in Antibody responses to a Placental-binding isolate ej-24, but no significant changes in Antibody responses to non-Pregnancy related parasite Isolates were observed [22].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('CHEBI_33284', 'nutrient', 65, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('GO_0042571', 'immunoglobulin complex, circulating', 198, 'antibody'), ('UBERON_0001987', 'placenta', 222, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 285, 'antibody'), ('GO_0007565', 'female pregnancy', 311, 'pregnancy'), ('SO_0001040', 'integrated_plasmid', 338, 'isolates')]
PMC4438628	5/2015	S184-PMC4438628	['Human and/or experimental research SHOWS that acute and cumulative psychological stress (and ASSOCIATED MARKERS of Allostatic load) [273-276], environmental Pollutants [277-282], crowding [283], acoustic stress [284], heat stress [285], westernized dietary patterns [286], high Fructose and Sodium [287], dietary Age and Food Additives via processed foods [288,289], lack of colorful dietary Phytochemicals [290,291], magnesium deficiency [292], inadequate omega-3 [293], Antibiotic administration [294], excess Alcohol consumption [295,296], the Oral periodontopathogen p. gingivalis (when Swallowed) [297], tobacco exposure [298,299], sedentary behavior [300], Circadian disruptions [301], Sleep problems with functional constipation [302], and low levels of Vitamin D [303,304] are each individually ASSOCIATED with marked shifts in the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 803)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('GO_0007565', 'female pregnancy', 115, 'allostatic'), ('CHEBI_26199', 'polyprenol', 157, 'pollutants'), ('CHEBI_28757', 'fructose', 278, 'fructose'), ('CHEBI_52632', 'potassium-39 atom', 291, 'sodium'), ('CHEBI_80551', 'APC', 313, 'AGE'), ('CHEBI_77968', 'humectant', 321, 'food additives'), ('CHEBI_26254', 'prenylnaphthoquinone', 392, 'phytochemicals'), ('CHEBI_33282', 'antibacterial agent', 472, 'antibiotic'), ('CHEBI_30879', 'alcohol', 512, 'alcohol'), ('UBERON_0000165', 'mouth', 547, 'oral'), ('GO_0035196', 'production of miRNAs involved in gene silencing by miRNA', 591, 'swallowed'), ('GO_0051216', 'cartilage development', 663, 'circadian'), ('GO_0030431', 'sleep', 692, 'sleep'), ('CHEBI_27300', 'vitamin D', 761, 'vitamin D'), ('UBERON_0000160', 'intestine', 840, 'intestinal')]
PMC4448820	5/2015	S264-PMC4448820	['parenthetically, the IMPLICATIONS of the EFFECT of pem, Vitamin A, zinc, and Iron on Cd4+T Cell counts are IMPORTANT in the context of interpreting the IMPACT of nutritional interventions in conditions such as hiv in which Cd4+T Cell counts are used as a primary outcome.']	[('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 152)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('CHEBI_24870', 'ion', 77, 'iron'), ('CL_0000476', 'thyrotroph', 85, 'CD4 ...'), ('CL_0000084', 'T cell', 89, 'T cell'), ('CL_0000782', 'myeloid dendritic cell', 223, 'CD4+'), ('CL_0000084', 'T cell', 227, 'T cell')]
PMC4448820	5/2015	S354-PMC4448820	['EVIDENCE for EFFECTS of Vitamin A on epigenetic Regulation Of Immune Function is EMERGING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0002019', 'regulation of renal output by angiotensin', 48, 'regulation of immune function'), ('UBERON_0002405', 'immune system', 62, 'immune')]
PMC4448820	5/2015	S412-PMC4448820	['by using Pbmcs from healthy men who were treated with Lps, ANOTHER STUDY SHOWED that anti-inflammatory EFFECTS of Vitamin E supplementation (e.g., decreased Il-6 secretion) DEPENDS on having the gg genotype at position 313 of the Gstp1 Gene (236).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('CL_0002246', 'peripheral blood stem cell', 9, 'PBMCs'), ('CHEBI_16412', 'lipopolysaccharide', 54, 'LPS'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin E'), ('PR_000001470', 'interleukin-28B', 157, 'IL-6'), ('PR_000008294', 'glutathione S-transferase A1', 230, 'GSTP1'), ('SO_0000704', 'gene', 236, 'gene')]
PMC4448820	5/2015	S525-PMC4448820	['caption (boxed-text): text box 19\u2003\nwg 2 summary and conclusions\n\n● the review uses data on 3 Micronutrients (Vitamin A, zinc, and iron), anthropometrically defined undernutrition (stunting, wasting, and underweight), and obesity TO EVALUATE the EFFECT on the following:\n○ Immune function,\n○ recovery of immune function in response to nutritional interventions,\n○ RELATED health outcomes (e.g., risk of infection), and\n○ MARKERS of inflammation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('SUPERFICIAL_RELATIONSHIP', 245), ('SUPERFICIAL_RELATIONSHIP', 363), ('SUPERFICIAL_RELATIONSHIP', 420)]	4	[('CHEBI_33839', 'macromolecule', 93, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('UBERON_0002405', 'immune system', 272, 'immune')]
PMC4448820	5/2015	S1037-PMC4448820	['● observational studies IDENTIFIED an inverse ASSOCIATION between asthma risk and Vitamin A status, which MAY BE EXPLAINED by reduction in Serum Retinol due to inflammation.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin A'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_26536', 'retinoic acid', 145, 'retinol')]
PMC4448820	5/2015	S1106-PMC4448820	['studies USUALLY DESCRIBE HOW infection and inflammation are ASSOCIATED with nutritional deficiencies [e.g., iron, Vitamin B-12, Folate, and Vitamin D for bacterial vaginosis (637–639) and anemia or obesity for stillbirths (640)].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4448820	5/2015	S1193-PMC4448820	['THIS STUDY, which was followed by numerous others, HIGHLIGHTS an IMPORTANT and underappreciated ROLE for Vitamin D in Drug Metabolism through the induction of Gene Expression of key Drug-Metabolizing enzymes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_23888', 'drug', 118, 'drug'), ('GO_0042737', 'drug catabolic process', 118, 'drug metabolism'), ('GO_0010467', 'gene expression', 159, 'gene expression'), ('SO_0000704', 'gene', 159, 'gene'), ('CHEBI_23888', 'drug', 182, 'drug'), ('GO_0016540', 'protein autoprocessing', 182, 'drug-metabolizing')]
PMC4448820	5/2015	S1243-PMC4448820	['● the wg explored aspects of these INTERACTIONS on BIOMARKERS of specific Nutrients including iron, Vitamin A, hemoglobin, zinc, Iodine, Folate, and Vitamins b-6, b-12, c, and d.\n\nwg RECOMMENDATIONS:\n\none or more biomarkers of inflammation SHOULD BE measured in assessments of Micronutrient status in populations with a known or suspected moderate-to-high prevalence of inflammation.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 51), ('FUTURE_WORK', 183), ('FUTURE_WORK', 240)]	4	[('CHEBI_33284', 'nutrient', 74, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 129, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 137, 'folate'), ('CHEBI_33277', 'gamma-tocotrienol', 149, 'vitamins'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 277, 'micronutrient')]
PMC4448820	5/2015	S1453-PMC4448820	['○ BECAUSE it CORRELATES well with Retinol, rbp measurements CAN be used to ESTIMATE Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75)]	4	[('CHEBI_26536', 'retinoic acid', 34, 'retinol'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4448820	5/2015	S1474-PMC4448820	['the overall RELATION between inflammation, specific BIOMARKERS such as crp and Human-milk Vitamin A REMAINS UNRESOLVED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108)]	4	[('NCBITaxon_9606', 'Homo sapiens', 79, 'human'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin A')]
PMC4448820	5/2015	S1526-PMC4448820	['for many Nutrients (e.g., Vitamin D or Iodine), there APPEARS TO BE an ASSOCIATION between their BIOMARKERS and MARKERS of inflammation.']	[('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('CHEBI_33284', 'nutrient', 9, 'nutrients'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 39, 'iodine')]
PMC4452099	6/2015	S0-PMC4452099	['Gestational and early infancy exposure to margarine fortified with Vitamin D through a national danish programme and the risk of type 1 diabetes: the d-tect study\n\nabstract\nthe OBJECTIVE of the study was TO ASSESS WHETHER Gestational and early Infancy exposure to low dose Vitamin D from a mandatory Margarine fortification programme in denmark INFLUENCED the risk of developing type 1 diabetes (t1d) before age of 15 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('SUPERFICIAL_RELATIONSHIP', 345)]	4	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 67, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 67, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational'), ('UBERON_0000023', 'wing', 244, 'infancy'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_6784', 'mestranol', 300, 'margarine')]
PMC4452099	6/2015	S15-PMC4452099	['one HYPOTHESIS is that Vitamin D in Pregnant women is INVOLVED in the processes of Immunological Adaptation down-regulating the T Helper type 1 (th1) pro-inflammatory cytokine Responses, that POSSIBLY CONTRIBUTE to the Destruction Of Beta-Cells[10].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 201)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'pregnant'), ('GO_0002455', 'humoral immune response mediated by circulating immunoglobulin', 83, 'immunological adaptation'), ('CL_0002061', 'T-helper 9 cell', 128, 'T helper'), ('GO_0060033', 'anatomical structure regression', 176, 'responses'), ('GO_0048468', 'cell development', 219, 'destruction of ... cells'), ('CL_0000349', 'extraembryonic cell', 234, 'beta-cells')]
PMC4452099	6/2015	S92-PMC4452099	['AS the maternal Vitamin D fortification had EFFECT on babies´ Vitamin D levels via Breast feeding, Vitamin D intake during the first year of Life was LIKELY to HAVE BEEN lower than the maternal Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000310', 'breast', 83, 'breast'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000104', 'life cycle', 141, 'life'), ('GO_0007631', 'feeding behavior', 194, 'intake')]
PMC4466139	6/2015	S95-PMC4466139	['AS ALREADY KNOWN, Placental Transfer provides Vitamin D from mother to fetus, especially in the last trimester of Gestation [31] THUS neonatal and maternal 25Ohd levels are closely LINKED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 181)]	4	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0006412', 'translation', 28, 'transfer'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 156, '25OHD')]
PMC4466139	6/2015	S102-PMC4466139	['our results SHOW that few migrant mothers are supplemented with Vitamin D during Pregnancy, especially in the last month, SUGGESTING that more extensive PREVENTION and education programs SHOULD be adopted.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 153), ('FUTURE_WORK', 187)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4488777	5/2015	S11-PMC4488777	['in one of the publications, it was also FOUND that Vitamin D Binding Protein (Vdbp) has a molecular SIMILARITY to anti-Sperm Antibodies, and another one CONCLUDED that both low (<50 nmol/l) and high (>125 nmol/l) concentration of Vitamin D are ASSOCIATED with decreased number and quality of Spermatozoa in Semen.']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 244)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 78, 'VDBP'), ('CL_0000019', 'sperm', 119, 'sperm'), ('GO_0042571', 'immunoglobulin complex, circulating', 125, 'antibodies'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CL_0000019', 'sperm', 292, 'spermatozoa'), ('UBERON_0001968', 'semen', 307, 'semen')]
PMC4488777	5/2015	S111-PMC4488777	['authors STATE that the Proliferation Of Spermatogenic Cells was decreased with calcium-dependent down REGULATION of Cyclin E and Cdk2, and up REGULATION of P53 and P21 Expression, which is not a direct EFFECT of active Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0043277', 'apoptotic cell clearance', 23, 'proliferation of spermatogenic cells'), ('PR_000005344', 'centrosomal protein of 170 kDa', 116, 'cyclin E'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 129, 'CDK2'), ('PR_000003035', 'cellular tumor antigen p53', 156, 'p53'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 164, 'p21'), ('GO_0010467', 'gene expression', 168, 'expression'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4490503	6/2015	S298-PMC4490503	['FOUND that increased Parathyroid hormone, RATHER than Vitamin D deficiency was INDEPENDENTLY ASSOCIATED with dysglycaemia in Pregnancy in 524 women when tested in conjunction with the ogtt [124].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('UBERON_0001132', 'parathyroid gland', 21, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC4499946	7/2015	S2-PMC4499946	['IMPORTANTLY, LITTLE IS KNOWN about the EFFECT of maternal Vitamin D status on infant linear growth in communities in south asia where stunting is highly prevalent and maternal-infant Vitamin D status is commonly SUBOPTIMAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 13), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 212)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC4499946	7/2015	S27-PMC4499946	['because maternal Vitamin D status is the PREDOMINANT DETERMINANT of fetal and neonatal Vitamin D stores [18], Prenatal Vitamin D supplementation represents the OPTIMAL approach to testing the EFFECT of improving maternal-infant Vitamin D status on fetal-infant growth and other health outcomes.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'prenatal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4499946	7/2015	S37-PMC4499946	['HOWEVER, SOME Animal [27] and observational [21,28] studies have SUGGESTED an EFFECT of maternal Prenatal Vitamin D status on growth of the fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('GO_0007565', 'female pregnancy', 97, 'prenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4499946	7/2015	S38-PMC4499946	['there has BEEN considerable RECENT INTEREST in the ROLE of Vitamin D in maternal and infant health outcomes in low-income settings [29].']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 28), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4516377	6/2015	S33-PMC4516377	['studies that evaluated the ASSOCIATION between Calcium or Vitamin D and obesity in children, 2001-2014.authors/year of publicationcountrystudy designpopulation/samplemain resultscalciumcarruth & skinner12(2001)usalongitudinal (retrospective)caucasian children, followed from 2-96 months (n=53)higher mean intake of Calcium, and more daily servings of dairy products were ASSOCIATED with lower bfskinner et al.13(2005)usalongitudinalcaucasian children, followed from 2-96 months (n=52)Intake of calcium and polyunsaturated fat were negatively ASSOCIATED with bf%dixon et al.14(2005)usalongitudinalhc non-obese children and non-hcechildren aged 4 to 10 years (n=342)Calcium Intake was inversely ASSOCIATED with bmiasum of Skinfolds and Trunk sf in non-hc children aged 7 to 10 years.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 371), ('SUPERFICIAL_RELATIONSHIP', 542), ('SUPERFICIAL_RELATIONSHIP', 693)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 47, 'calcium'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 315, 'calcium'), ('GO_0007631', 'feeding behavior', 484, 'Intake'), ('CHEBI_31341', 'calcium dihydroxide', 664, 'Calcium'), ('GO_0007631', 'feeding behavior', 672, 'intake'), ('UBERON_0009007', 'superficial inguinal lymph node', 720, 'skinfolds'), ('UBERON_0002100', 'trunk', 734, 'trunk')]
PMC4516377	6/2015	S44-PMC4516377	['with multiple regression models, the authors FOUND an EFFECT of the fto increasing bmi over the years and the Vitamin D deficiency (<75 nmol/l in 32% of the sample in 2007) exacerbating this EFFECT, i.e., further increasing bmi.21in all these studies on Vitamin D, the authors made adjustments for POTENTIAL confounders.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 191), ('INCOMPLETE_EVIDENCE', 298)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 262, 'D')]
PMC4516377	6/2015	S52-PMC4516377	['moreover, Calcitriol inhibit s the Expression of Uncoupling Protein-2 (INVOLVED in the Regulation Of Metabolism, diet-induced Thermogenesis and body weight Control) through the classic Nuclear Vitamin D receptors in Adipocytes, thereby increasing energy efficiency.24,25additionally, the Regulation by Calcitriol of the Uncoupling Protein-2 and the levels of Intracellular calcium SEEMS to have an EFFECT on energy Metabolism by AFFECTING Adipocyte Apoptosis.24\n\n\ncaption (fig): figure 2.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('ANOMALY_CURIOUS_FINDING', 381), ('SUPERFICIAL_RELATIONSHIP', 398), ('SUPERFICIAL_RELATIONSHIP', 429)]	4	[('CHEBI_17823', 'calcitriol', 10, 'calcitriol'), ('GO_0010467', 'gene expression', 35, 'expression'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 49, 'uncoupling protein-2'), ('GO_0009894', 'regulation of catabolic process', 87, 'regulation of metabolism'), ('GO_0031649', 'heat generation', 126, 'thermogenesis'), ('GO_0065007', 'biological regulation', 156, 'control'), ('GO_0005634', 'nucleus', 185, 'nuclear'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CL_0000136', 'fat cell', 216, 'adipocytes'), ('GO_0065007', 'biological regulation', 288, 'regulation'), ('CHEBI_17823', 'calcitriol', 302, 'calcitriol'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 320, 'uncoupling protein-2'), ('GO_0005622', 'intracellular anatomical structure', 359, 'intracellular'), ('GO_0008152', 'metabolic process', 415, 'metabolism'), ('CL_0000136', 'fat cell', 439, 'adipocyte'), ('GO_0006915', 'apoptotic process', 449, 'apoptosis')]
PMC4516377	6/2015	S82-PMC4516377	['final CONSIDERATIONS\nthe ASSOCIATION between Calcium and Vitamin D with obesity is COMPLEX and much REMAINS TO BE ELUCIDATED.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 25), ('DIFFICULT_TASK', 83), ('FULL_UNKNOWN', 100)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 45, 'calcium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4516377	6/2015	S85-PMC4516377	['all SHOW an inverse ASSOCIATION between serum Vitamin D and obesity or measures of adiposity in children, with this ASSOCIATION being INFLUENCED by the seasons of the year and gender.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4586450	10/2015	S442-PMC4586450	['diet and growth in relation to biochemical outcomes\n\niron status\niron status was INVESTIGATED in RELATION to Food and Nutrient intakes at 1.5 years in the cif subsample (n = 796).60ferritin concentration (a measure of stored iron) was more sensitive to Nutrient intakes (energy-adjusted) than hemoglobin; calcium intake was negatively RELATED to ferritin ( r = −0.22; p< 0.001), and iron, Vitamin C, and fiber intakes were positively RELATED (all p< 0.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 335), ('SUPERFICIAL_RELATIONSHIP', 434)]	4	[('CHEBI_33290', 'food', 109, 'food'), ('CHEBI_33284', 'nutrient', 118, 'nutrient'), ('CHEBI_33284', 'nutrient', 253, 'nutrient'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin C')]
PMC4586450	10/2015	S443-PMC4586450	['the ONLY ROBUST RELATIONSHIP of Nutrients with hemoglobin was positive with Vitamin C intake ( r = 0.13; p = 0.001).']	[('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 16)]	4	[('CHEBI_33284', 'nutrient', 32, 'nutrients'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin C')]
PMC4586450	10/2015	S566-PMC4586450	['in the children at preschool ages, the RELATIONSHIP between diet and iron status was explored.60ferritin was negatively ASSOCIATED with calcium and Cows’ milk Intake and positively ASSOCIATED with iron intake, and hemoglobin was positively ASSOCIATED with Vitamin C and fruit and vegetable intake.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 120), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 240)]	4	[('NCBITaxon_33208', 'Metazoa', 148, 'cows'), ('GO_0007631', 'feeding behavior', 159, 'intake'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin C')]
PMC4586451	10/2015	S21-PMC4586451	['it is also POSSIBLE that fish Intake during Pregnancy INFLUENCES Neurodevelopment via a mechanism not related to its Fatty Acid content; OTHER active substances include its Vitamin D and Iodine content or its POSSIBLE contamination with mercury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007631', 'feeding behavior', 30, 'intake'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('GO_0007399', 'nervous system development', 65, 'neurodevelopment'), ('CHEBI_35366', 'fatty acid', 117, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 187, 'iodine')]
PMC4595656	10/2015	S19-PMC4595656	['the QUESTION of reduced Vitamin D concentrations on consequent neonatal, infant and child Development in RELATION to the hippocampus is THEREFORE HIGHLY PERTINENT.']	[('EXPLICIT_QUESTION', 4), ('SUPERFICIAL_RELATIONSHIP', 105), ('PROBABLE_UNDERSTANDING', 136), ('IMPORTANT_CONSIDERATION', 146)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0048513', 'animal organ development', 90, '... development')]
PMC4595656	10/2015	S30-PMC4595656	['a GROWING BODY of EVIDENCE also POINTS to a ROLE for Vitamin D in the Development Of the Cns.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0030324', 'lung development', 70, 'development of ... CNS'), ('UBERON_0001017', 'central nervous system', 89, 'CNS')]
PMC4598849	10/2015	S73-PMC4598849	['at Birth, there are POTENTIAL changes to levels of Vitamin D binding protein, 1,25(Oh)2D, the Cyp27 enzyme and Expression of Vitamin D receptors40, which MAY INFLUENCE the ASSOCIATION between 25(Oh)D and fetal growth41.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 172)]	4	[('GO_0007567', 'parturition', 3, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 80, '25(OH)2D'), ('PR_000006100', 'aromatase', 94, 'CYP27'), ('GO_0010467', 'gene expression', 111, 'expression'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D')]
PMC4600246	10/2015	S3-PMC4600246	['additionally, Vitamin K antagonists such as warfarin MAY cause DETRIMENTAL side EFFECTS, which MAY PARTLY be blunted through Vitamin K supplementation.']	[('INCOMPLETE_EVIDENCE', 53), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin K')]
PMC4600246	10/2015	S78-PMC4600246	['additionally, Vitamin K MAY EVEN play a VITAL ROLE in the stabilisation of inr control for patients on warfarin.']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K')]
PMC4624803	10/2015	S11-PMC4624803	['it HAS BEEN PROPOSED that Vitamin D deficiency COULD BE a risk FACTOR for developing attention deficit/hyperactivity disorder (adhd) [5,6].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4624803	10/2015	S13-PMC4624803	['results from two RECENT STUDIES on the ASSOCIATION between Vitamin D status and adhd diagnosis SHOWED an ASSOCIATION between low levels of D vitamin and an adhd diagnosis [5,6].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 139, 'D')]
PMC4624803	10/2015	S96-PMC4624803	['from a THEORETICAL POINT OF VIEW, in foetal Life and during early childhood, the immature Brain SHOULD BE more vulnerable to environmental INFLUENCES like Vitamin D deficiency [3,4].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0000955', 'brain', 90, 'brain'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4627942	10/2015	S61-PMC4627942	['a study in west kiang hdss, gambia, SHOWED that nutritional rickets, a disease caused largely by Vitamin D deficiency, the EFFECTS of which CAN include Cardiac failure and hypoglycaemic seizures, was more PREVALENT in infants whose mothers had poor Vitamin D status during Pregnancy (21).']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 205)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('UBERON_0000948', 'heart', 152, 'cardiac'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC4632418	10/2015	S8-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to elicit the clear EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4632418	10/2015	S22-PMC4632418	['the ROLE of Vitamin D on Gdm Development HAS been studied, and Vitamin D deficiency APPEARS TO BE ASSOCIATED with altered Glucose Homeostasis during Pregnancy [12,13].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 41), ('ANOMALY_CURIOUS_FINDING', 84), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 25, 'GDM development'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 122, 'glucose'), ('GO_0042593', 'glucose homeostasis', 122, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC4632418	10/2015	S25-PMC4632418	['THEREFORE, we CONDUCTED THIS meta-analysis to present the EFFECT of maternal Vitamin D level on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4632418	10/2015	S84-PMC4632418	['this result SHOWED Serum 25(Oh)D level was significant lower in participants with gdm than the control and also DEMONSTRATED that Vitamin D deficiency is significantly ASSOCIATED with an INCREASED RISK of gmd.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 187)]	4	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4632418	10/2015	S105-PMC4632418	['our sensitivity analyses SUGGESTED two studies [15,36] conducted in women with Vitamin D sufficiency PROBABLY CONTRIBUTED to the HETEROGENEITY.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 110), ('DIFFICULT_TASK', 129)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4632418	10/2015	S116-PMC4632418	['there are MAJOR causes behind Vitamin D deficiency during Pregnancy, such as INADEQUATE exposure to sunlight, low Vitamin D intake and more REQUIREMENTS for Vitamin D. Vitamin D supplementation during Pregnancy has beneficial EFFECTS on glycaemia, Insulin sensitivity [45], Insulin resistance [46] and Metabolic profiles [47].']	[('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 140), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 168, 'Vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('PR_000045358', 'insulin family protein', 248, 'insulin'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('GO_0008152', 'metabolic process', 302, 'metabolic')]
PMC4632418	10/2015	S134-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to determine the explicit EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 89), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4670104	12/2015	S145-PMC4670104	['about half of the proteins negatively CORRELATED with agp (i.e., that decline in relative abundance with inflammation) are also CONSIDERED Hepatic proteins released into the Bloodstream, but more INVOLVED in Transport and Metabolism Of Nutrients and Small Molecules (e.g., Rbp4 and ttr for Vitamin A; Apolipoproteins A1/A2/h/m for Lipid or Cholesterol Transport and Metabolism; and ahsg for Calcium And Phosphate Metabolism), sex Hormone and growth factor binding (e.g., Shbg and Igfals) or serine endopeptidase or proteinase inhibition in Regulating Blood Coagulation and complement cascades, among other ROLES.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 606)]	4	[('UBERON_0002107', 'liver', 139, 'hepatic'), ('UBERON_0001969', 'blood plasma', 174, 'bloodstream'), ('GO_0009294', 'DNA mediated transformation', 208, 'transport ...'), ('GO_0019503', 'stachydrine biosynthetic process', 222, 'metabolism of nutrients'), ('CHEBI_33284', 'nutrient', 236, 'nutrients'), ('GO_0044403', 'biological process involved in symbiotic interaction', 250, 'small molecules'), ('CHEBI_36357', 'polyatomic entity', 256, 'molecules'), ('PR_000013819', 'retinol-binding protein 2', 273, 'RBP4'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin A'), ('CHEBI_39015', 'apolipoprotein', 301, 'apolipoproteins'), ('PR_000004140', 'apolipoprotein A-I', 301, 'apolipoproteins A1'), ('PR_000004105', 'AP-3 complex subunit beta-2', 320, 'A2'), ('CHEBI_18059', 'lipid', 331, 'lipid'), ('GO_0006266', 'DNA ligation', 331, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 340, 'cholesterol'), ('GO_0030204', 'chondroitin sulfate metabolic process', 340, 'cholesterol transport ... metabolism'), ('CHEBI_77635', 'calcium phosphate', 391, 'calcium and phosphate'), ('GO_0019752', 'carboxylic acid metabolic process', 391, 'calcium ... metabolism'), ('CHEBI_33280', 'molecular messenger', 430, 'hormone'), ('PR_000014843', 'protein shisa-3', 471, 'SHBG'), ('PR_000008940', 'intraflagellar transport protein 88', 480, 'IGFALS'), ('GO_0065007', 'biological regulation', 540, 'regulating'), ('GO_0007596', 'blood coagulation', 551, 'blood coagulation'), ('UBERON_0000178', 'blood', 551, 'blood')]
PMC4673623	11/2015	S1-PMC4673623	['Folate, Choline, betaine and Vitamin B-12) during Pregnancy is ESSENTIAL for normal maternal and fetal Methionine Metabolism, and is CRITICAL for IMPORTANT Metabolic processes including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 63), ('IMPORTANT_CONSIDERATION', 133), ('IMPORTANT_CONSIDERATION', 146), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_15354', 'choline', 8, 'choline'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 29, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0006555', 'methionine metabolic process', 103, 'methionine metabolism'), ('GO_0008152', 'metabolic process', 156, 'metabolic')]
PMC4684854	12/2015	S2-PMC4684854	['THIS PAPER provides a brief review of POTENTIAL health outcomes RECENTLY LINKED to Gestational Vitamin D deficiency, including Preterm Birth, cesarean Delivery, and Gestational diabetes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('GO_0007565', 'female pregnancy', 83, 'gestational'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'preterm birth'), ('GO_0007567', 'parturition', 151, 'delivery'), ('GO_0007565', 'female pregnancy', 165, 'gestational')]
PMC4684854	12/2015	S38-PMC4684854	['with the EMERGING EVIDENCE that Vitamin D acts epigenetically in the Regulation of over 2700 different Genes [36], there HAS BEEN much RECENT RESEARCH exploring the widespread prevalence of Vitamin D deficiency through the continuum of Life, including the Gestational and Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 69, 'regulation'), ('SO_0000704', 'gene', 103, 'genes'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('UBERON_0007221', 'neonate stage', 272, 'neonatal period')]
PMC4684854	12/2015	S39-PMC4684854	['THIS PAPER is DESIGNED to review the literature FINDINGS about the enduring IMPACT of Gestational Vitamin D sufficiency on Maternal and pediatric health and Well-Being.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007618', 'mating', 123, 'maternal'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'well-being')]
PMC4684854	12/2015	S43-PMC4684854	['a primary OBSERVATION, HOWEVER, was that LIMITED scientific LITERATURE is available on the issue of Gestational Vitamin D insufficiency as it RELATES to long-term health outcomes.']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S51-PMC4684854	['with such widespread deficiency, it is VITAL to determine WHETHER OR NOT low Gestational levels of Vitamin D are a SIGNIFICANT DETERMINANT of Reproductive and pediatric health outcomes.']	[('IMPORTANT_CONSIDERATION', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 77, 'gestational'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0000003', 'reproduction', 142, 'reproductive')]
PMC4684854	12/2015	S64-PMC4684854	['many FACTORS MAY AFFECT the resultant status of Vitamin D in the body (AS reflected by measurement of 25(Oh)D levels) after Ingested supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 71)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('GO_0007631', 'feeding behavior', 124, 'ingested')]
PMC4684854	12/2015	S68-PMC4684854	['(i) there is wide HETEROGENEITY of studied populations with VARIATIONS in Vitamin D supplement dosing, geophysical location, social and dietary conditions, and OTHER FACTORS in studied groups [45].']	[('DIFFICULT_TASK', 18), ('DIFFICULT_TASK', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC4684854	12/2015	S87-PMC4684854	['escalating EVIDENCE in the literature CONFIRMS a PROTECTIVE ASSOCIATION between maternal Vitamin D sufficiency and the incidence of Preterm Birth [58–60].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'preterm birth')]
PMC4684854	12/2015	S111-PMC4684854	['it APPEARS that fetal Vitamin D levels MAY play a modulating ROLE in Immune functions INVOLVED in atopic disorders.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune')]
PMC4684854	12/2015	S115-PMC4684854	['furthermore, an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks of Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [93].']	[('ANOMALY_CURIOUS_FINDING', 16), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 150, 'gestational'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0030324', 'lung development', 212, 'lung development'), ('UBERON_0002048', 'lung', 212, 'lung'), ('GO_0050905', 'neuromuscular process', 254, 'neurocognitive'), ('GO_0051318', 'G1 phase', 311, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 331, 'adolescence')]
PMC4684854	12/2015	S116-PMC4684854	['the authors STATE that “Vitamin D MAY have an IMPORTANT, multifaceted ROLE in the Development Of fetal Lungs, Brain, and Bone” [93].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 82, 'development of ... lungs ... brain'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007567', 'parturition', 121, 'bone')]
PMC4684854	12/2015	S120-PMC4684854	['furthermore, current appraisals TEND to UNDERESTIMATE the extent of the REQUIRED resource utilization for specific conditions ASSOCIATED with Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4689556	12/2015	S13-PMC4689556	['conclusions\nwe FOUND NO EVIDENCE that Prenatal Vitamin D supplementation from 27 weeks Gestation to Delivery, at doses which FAILED to completely correct maternal Vitamin D deficiency, INFLUENCE overall healthcare utilisation in children in the first 3 years.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 21), ('DIFFICULT_TASK', 125), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('GO_0007567', 'parturition', 100, 'delivery'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4689556	12/2015	S153-PMC4689556	['first the EFFECT (or lack OF effect) of the specific timing and dose of Vitamin D used in our study CANNOT BE generalised to OTHER dosing and timing schedules.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ANOMALY_CURIOUS_FINDING', 26), ('DIFFICULT_TASK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4689556	12/2015	S180-PMC4689556	['HOWEVER, multivariate analysis of our data SHOWED that ALTHOUGH maternal ethnicity CORRELATED with 25(Oh) Vitamin D level there was no relationship between maternal ethnicity and our measures of healthcare utilization in this trial.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_30778', 'gallic acid', 99, '25(OH)'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4689556	12/2015	S186-PMC4689556	['in that context FURTHER DATA are AWAITED from two larger randomised controlled trials, vdarrt [53] and abcvitamind [54], to establish WHETHER higher dose daily Prenatal Vitamin D supplementation will IMPACT on child health outcomes.']	[('FUTURE_WORK', 16), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('SUPERFICIAL_RELATIONSHIP', 200)]	4	[('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4690051	12/2015	S167-PMC4690051	['we RECENTLY REPORTED [57] that Dna Methylation is jointly Modulated by ancestry and Gestational Vitamin D levels, observations which SUPPORT multidimensional FACTORS.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('GO_0006306', 'DNA methylation', 31, 'DNA methylation'), ('GO_0065007', 'biological regulation', 58, 'modulated'), ('GO_0007565', 'female pregnancy', 84, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4691762	12/2015	S73-PMC4691762	['we have established that composite maternal uvr dose (or 0.50 (95% ci 0.37 to 0.69) p<0.001) and maternal skin exposure index (or 0.81 (95% ci 0.66 to 0.98) p=0.03) were ASSOCIATED with breastfed infant Vitamin D status BUT infant time in the sun during the first year was NOT.15infant Feeding (amount of breastfeeding, Formula Feeding and type of formula, introduction of solid Foods) will also be recorded.']	[('SUPERFICIAL_RELATIONSHIP', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220), ('ANOMALY_CURIOUS_FINDING', 220), ('ANOMALY_CURIOUS_FINDING', 273)]	4	[('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0007631', 'feeding behavior', 286, 'feeding'), ('GO_0009057', 'macromolecule catabolic process', 320, 'formula'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_33290', 'food', 379, 'foods')]
PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]
PMC4719746	1/2016	S0-PMC4719746	['Vitamin D deficiency and supplementation in Pregnancy in a multiethnic population-based cohort\n\nabstract\n\nbackground\nTO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, assess RISK factors for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women with deficiency in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 250)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC4719746	1/2016	S15-PMC4719746	['there are FEW population-based STUDIES exploring Vitamin D deficiency in Pregnancy in today’s multiethnic europe, and LITTLE IS KNOWN about the IMPACT of socioeconomic status or the EFFECT of Vitamin D supplements [9,10].']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4719746	1/2016	S135-PMC4719746	['at high latitude, seasonal variance is an IMPORTANT EXPLANATORY FACTOR, AS the sun is not capable of producing Vitamin D by skin radiation during winter time [30].']	[('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 64), ('PROBABLE_UNDERSTANDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4719746	1/2016	S154-PMC4719746	['compared with no change or a small increase in 25(Oh)D concentrations in women with adequate levels or mild Vitamin D deficiency, this DIFFERENTIAL change may INDICATE a beneficial EFFECT of the RECOMMENDATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 181), ('FUTURE_WORK', 195)]	4	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4728621	1/2016	S193-PMC4728621	['finally, maternal trimester 2 Vitamin C intake was negatively ASSOCIATED with the sum of the 6 months old Triceps and Subscapular Skinfolds, a measure of overall adiposity, WHILE maternal trimester 3 Vitamin C intake was negatively ASSOCIATED with 6 months old Triceps-for-age skinfold thickness z-score.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173), ('ANOMALY_CURIOUS_FINDING', 173), ('SUPERFICIAL_RELATIONSHIP', 232)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 106, 'triceps'), ('UBERON_3010813', 'vent glands', 118, 'subscapular skinfolds'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 261, 'triceps')]
PMC4729160	1/2016	S0-PMC4729160	['prevalence and INFLUENCE FACTORS of Vitamin A deficiency of chinese Pregnant women\n\nabstract\n\nbackground\nvitamin a plays an IMPORTANT ROLE in the periods of rapid Cellular Growth and Differentiation, especially during Pregnancy, which is supplied by the mother to the fetus.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0001775', 'cell activation', 163, 'cellular growth ... differentiation'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
PMC4729160	1/2016	S25-PMC4729160	['a PREVIOUS STUDY [12] which BASED ON SMALL sample size FOUND that chinese Pregnant women’s Vitamin A concentration was 1.13\u2009±\u20090.37\xa0μmol/l, and 24 of 143 Pregnant women (16.80\xa0%) was Vitamin A deficiency, while another 52 Pregnant women (36.4\xa0%) was marginal Vitamin A deficiency.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 55)]	4	[('GO_0007565', 'female pregnancy', 74, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007565', 'female pregnancy', 153, 'pregnant'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin A'), ('GO_0007565', 'female pregnancy', 221, 'pregnant'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin A')]
PMC4764019	1/2016	S14-PMC4764019	['the RELATION to Vitamin D inadequacy SHOULD BE understood simply as just one of the conditions that, when met, together LEAD TO expression of the diseases CONCERNED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 155)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4765528	12/2015	S118-PMC4765528	['early work on methylation and Vitamin D Receptors and Placental calcium transporters SUGGESTS that epigenetic Regulation MIGHT explain HOW maternal Vitamin D levels AFFECT bone mineralization in the neonate [51].']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 121), ('EXPLICIT_QUESTION', 135), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 30, 'vitamin D receptors'), ('UBERON_0001987', 'placenta', 54, 'placental'), ('GO_0065007', 'biological regulation', 110, 'regulation'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4770602	1/2016	S0-PMC4770602	['EFFECT of Vitamin D supplementation in the reduce RISK of Preeclampsia in nulliparous women\n\nabstract\n\nbackground:\nthe exact ROLE of Vitamin D in the development and severity of Preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 58, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 178, 'preeclampsia')]
PMC4770602	1/2016	S1-PMC4770602	['the AIM of the PRESENT STUDY was TO INVESTIGATE the ASSOCIATION between Vitamin D supplement and Preeclampsia in Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 97, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 113, 'pregnant')]
PMC4770602	1/2016	S9-PMC4770602	['conclusion:\nIN SUMMARY, our results DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; DESPITE the non-significant ASSOCIATION between Vitamin D supplementation and preeclampsia, reduce the risk of preeclampsia.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 97, 'trimester'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4770602	1/2016	S16-PMC4770602	['[5] and an ASSOCIATION between low maternal Vitamin D and early-onset, SEVERE Preeclampsia is RECENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 78, 'preeclampsia')]
PMC4770602	1/2016	S19-PMC4770602	['[9] also, ASSOCIATION between Vitamin D deficiency and preeclampsia is REPORTED in a population based study on 23,423 women, which authors FOUND that a 27 percent reduction in the risk for Preeclampsia was ASSOCIATED with Vitamin D intake of 15-20 micrograms per day relative to less than 5 micrograms per day.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 189, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4770602	1/2016	S25-PMC4770602	['and FURTHER prospective longitudinal STUDIES or randomized controlled trials to assess the POTENTIAL EFFECT of Vitamin D supplementation on adverse Pregnancy outcomes are SUGGESTED.']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 171)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC4770602	1/2016	S80-PMC4770602	['and FURTHER TRIALS ARE NEEDED to FURTHER CLARIFY the EFFECT of calcium supplementation, Vitamin D supplementation, or both on reduce the incidence of Preeclampsia.']	[('FUTURE_WORK', 4), ('FUTURE_WORK', 12), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 150, 'preeclampsia')]
PMC4778858	3/2016	S110-PMC4778858	['mcleod and colleagues [33], who also conducted an ancillary study on Hapo participants, FOUND a WEAK, YET significant ASSOCIATION between 25-Ohd and fasting glucose in an australian Vitamin D replete population.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 102), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('CHEBI_17883', 'hydrogen chloride', 69, 'HAPO'), ('CHEBI_72765', 'verruculogen', 138, '25-OHD'), ('PR_000012086', 'homeobox protein OTX2', 141, 'OHD'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4785305	3/2016	S3-PMC4785305	['our HYPOTHESIS is that in middle eastern Pregnant women, a Vitamin D dose of 3000\u2005iu/day is REQUIRED to reach a DESIRABLE maternal 25-Hydroxyvitamin D [25(Oh)D] level, and to positively IMPACT infant bone Mineral content (bmc).']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 131, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D'), ('CHEBI_46662', 'mineral', 205, 'mineral')]
PMC4785305	3/2016	S16-PMC4785305	['caption (boxed-text)\nstrengths and limitations of this study\n\nTHIS is the FIRST randomised controlled trial (rct) in the middle east directly addressing the applicability of the institute of medicine RECOMMENDATIONS in this specific population, and assessing the EFFECT of Vitamin D supplementation on neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 200), ('SUPERFICIAL_RELATIONSHIP', 263)]	4	[('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_46662', 'mineral', 316, 'mineral')]
PMC4811107	3/2016	S12-PMC4811107	['the BEST EVIDENCE for the ROLE of Vitamin D in health is RELATED to its IMPORTANCE to bone health [1,2].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 72)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4811107	3/2016	S16-PMC4811107	['GIVEN the IMPORTANT ROLE of Vitamin D in health, there has BEEN much discussion about the best ways to prevent and treat Vitamin D deficiency [3,6].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 59)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4811107	3/2016	S94-PMC4811107	['REPORTED that neonatal Vitamin D had a positive CORRELATION with maternal Vitamin D levels ( r = 0.69, p< 0.001) in those mothers with normal Vitamin D levels BUT NOT in those with hypovitaminosis ( n = 123 maternal-child pairs) [29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 159), ('ANOMALY_CURIOUS_FINDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4811441	3/2016	S26-PMC4811441	['during the past decade, Vitamin D status has been ATTRIBUTED health BENEFITS beyond its RECOGNIZED EFFECTS on bone health.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4811441	3/2016	S137-PMC4811441	['our results SUGGEST that an increase of AT LEAST 30 nmol/l in 25(Oh)D concentration during Pregnancy is RELATED to lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 133)]	4	[('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4829940	5/2016	S8-PMC4829940	['in this large Genome wide assessment of the POTENTIAL INFLUENCE of maternal Vitamin D status on Dna Methylation, we DID NOT FIND any convincing ASSOCIATIONS in 1416 newborns.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('SO_0001026', 'genome', 14, 'genome'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0006306', 'DNA methylation', 96, 'DNA methylation')]
PMC4829940	5/2016	S14-PMC4829940	['low 25(Oh)D levels HAVE BEEN ASSOCIATED with a range of adverse conditions, from Pregnancy outcomes to childhood illnesses and chronic disease including osteoporosis, cancer and Cardiovascular disease in Adulthood[3], ALTHOUGH randomized controlled trials of Vitamin D supplements do NOT SUPPORT causality for Extra-Skeletal outcomes[4],[5].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	4	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 4, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 178, 'cardiovascular'), ('UBERON_0000113', 'post-juvenile adult stage', 204, 'adulthood'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 310, 'extra-skeletal')]
PMC4829940	5/2016	S26-PMC4829940	['a FEW smaller STUDIES have investigated Dna Methylation at SOME CANDIDATE loci in RELATION to Vitamin D[16].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 82)]	4	[('GO_0006306', 'DNA methylation', 40, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4829940	5/2016	S28-PMC4829940	['another STUDY explored epigenetic Regulation of Vitamin D converting enzymes[18], WHILE a third FOUND a RELATIONSHIP between methylation of the Genes Cyp24R1 and Cyp27A1 and variations in circulating 25(Oh)D levels[19].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('GO_0065007', 'biological regulation', 34, 'regulation'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('SO_0000704', 'gene', 144, 'genes'), ('PR_000006101', 'cytochrome P450 1A1', 150, 'CYP24R1'), ('PR_000006101', 'cytochrome P450 1A1', 162, 'CYP27A1'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 200, '25(OH ... D')]
PMC4829940	5/2016	S127-PMC4829940	['HOWEVER, a FEW other STUDIES have explored RELATIONSHIPS between Vitamin D supplementation or circulating 25(Oh)D and methylation at a few Cpg Sites in two to four candidate Genes in Adults[18],[46], and one Genome-wide Dna Methylation study explored ASSOCIATION with Vitamin D deficiency in african children[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D'), ('SO_0000036', 'matrix_attachment_site', 139, 'CpG sites'), ('SO_0000704', 'gene', 174, 'genes'), ('UBERON_0007023', 'adult organism', 183, 'adults'), ('SO_0001026', 'genome', 208, 'genome'), ('GO_0006306', 'DNA methylation', 220, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D')]
PMC4832516	10/2015	S0-PMC4832516	['season of Birth is ASSOCIATED with Birth weight, Pubertal timing, Adult body size and educational attainment: a uk biobank study\n\nabstract\nseason of Birth, a marker of in utero Vitamin D exposure, HAS BEEN ASSOCIATED with a WIDE RANGE of health outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('GO_0007567', 'parturition', 35, 'birth'), ('GO_0007567', 'parturition', 49, 'pubertal'), ('UBERON_0007023', 'adult organism', 66, 'adult'), ('GO_0007567', 'parturition', 149, 'birth'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC4832516	10/2015	S109-PMC4832516	['furthermore, recent Genetic studies have INDICATED POTENTIAL aetiological ROLES for the Vitamin D receptor (vdr) and RELATED Nuclear hormone receptors in Pubertal timing[14].']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0005634', 'nucleus', 125, 'nuclear'), ('GO_0007567', 'parturition', 154, 'pubertal')]
PMC4846845	4/2016	S173-PMC4846845	['ACCUMULATING DATA SUPPORT that Vitamin D deficiency plays a ROLE in DISPARITIES in Reproductive health outcomes [132,134].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 68)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0000003', 'reproduction', 83, 'reproductive')]
PMC4848664	4/2016	S15-PMC4848664	['the institute of medicine (iom) conducted a comprehensive review of Folic Acid SAFETY and CONCLUDED that progression of neuropathy among Vitamin B-12-deficient Individuals receiving Folic Acid doses ≥5000 µg/day was a POTENTIAL adverse EFFECT of Folic Acid.']	[('IMPORTANT_CONSIDERATION', 79), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 236)]	4	[('CHEBI_30751', 'formic acid', 68, 'folic acid'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 137, 'vitamin B-12'), ('NCBITaxon_1', 'root', 160, 'individuals'), ('CHEBI_30751', 'formic acid', 182, 'folic acid'), ('CHEBI_30751', 'formic acid', 246, 'folic acid')]
PMC4859539	5/2016	S16-PMC4859539	['a second AIM was TO DETERMINE IF the concentration of cathelicidin and Vitamin D CORRELATE with the number of infections a child experiences during childhood and as a function of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4889866	5/2016	S13-PMC4889866	['HENCE, AS a potent Immune modulator, Vitamin D WAS shown to be ASSOCIATED with childhood asthma and allergic diseases [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 7), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0002405', 'immune system', 19, 'immune'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4889866	5/2016	S20-PMC4889866	['furthermore, VERY FEW STUDIES address the IMPACT of Prenatal Vitamin D status on tlr-RELATED Innate Immune Response in neonatal infants.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0045087', 'innate immune response', 93, 'innate immune response'), ('UBERON_0002405', 'immune system', 100, 'immune')]
PMC4889866	5/2016	S88-PMC4889866	['discussion\nthe result from OUR STUDY SHOWED that maternal, BUT NOT Cord Blood Vitamin D level, was ASSOCIATED with Tlr-3 and Tlr7-8 triggered il-10 response.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 115, 'TLR-3'), ('PR_000001155', 'Toll-like receptor 4', 125, 'TLR7')]
PMC4889866	5/2016	S95-PMC4889866	['in the study of weisse et al., ALTHOUGH both maternal and Cord Blood Vitamin D levels were ASSOCIATED with clinical Food allergy, ONLY maternal 25(Oh)d3was ASSOCIATED with an increase in Allergen sensitization [19].']	[('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 156)]	4	[('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_30778', 'gallic acid', 144, '25(OH)'), ('CHEBI_50904', 'allergen', 187, 'allergen')]
PMC4889866	5/2016	S106-PMC4889866	['THUS, we SPECULATED that, with increasing Vitamin D level, the ability of tlr to trigger Il-10 Production is diminished when compared to lower concentration, THUS displaying a negative CORRELATION between Vitamin D level and Cytokine Response to Tlr Stimulation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 158), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 89, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 89, 'IL-10'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0008036', 'diuretic hormone receptor activity', 225, 'cytokine response'), ('GO_0031295', 'T cell costimulation', 246, 'TLR stimulation')]
PMC4889866	5/2016	S126-PMC4889866	['THUS, our data could NOT provide detailed mechanism on HOW maternal Vitamin D level AFFECTED neonatal tlr-triggered Il-10 Response.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('EXPLICIT_QUESTION', 55), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 116, 'IL-10'), ('GO_1990603', 'dark adaptation', 118, '- ... response')]
PMC4896250	4/2016	S2791-PMC4896250	['the GROWING DATA SUGGESTS that Vitamin D deficiency plays an IMPORTANT ROLE in the development of childhood asthma.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4896250	4/2016	S3018-PMC4896250	['FURTHER INVESTIGATIONS are NECESSARY to identify the RELATIONSHIPS between fia and Vitamin D.\n\nA210 TRIGGERING factors of atopic dermatitis by severity\n\nyoon ha hwang\n\nbusan st.mary’s hospital, south korea\nbackground : atopic dermatitis is exacerbated by several triggering factors, which are Allergens, stress, infections climates and so on.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('PR_000004050', 'ankyrin repeat domain-containing protein 6', 95, 'A210'), ('CHEBI_33663', 'cyclic hydrocarbon', 293, 'allergens')]
PMC4896250	4/2016	S4159-PMC4896250	['conclusions: our results DEMONSTRATE that low Vitamin D levels MAY LINK to high hdm sensitization in patients with the SEVERE ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4896250	4/2016	S4484-PMC4896250	['RECENTLY, epidemiologic studies HAVE SHOWN that the lack of Vitamin D levels MAY BE ASSOCIATED with high asthma prevalence.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4896250	4/2016	S4485-PMC4896250	['the PURPOSE of THIS STUDY was TO EXAMINE the ASSOCIATION of Serum Vitamin D levels with the prevalence of pediatric asthma in korea.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0001977', 'blood serum', 60, 'serum'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S4493-PMC4896250	['for PREVENTION and treatment of asthma, an intervention study in asthmatic children with low serum Vitamin D level, and a Vitamin D study ASSESSED the OPTIMAL delivery and safety of its supplementation IS NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('IMPORTANT_CONSIDERATION', 151), ('FUTURE_WORK', 202)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4896250	4/2016	S6120-PMC4896250	['SOME STUDIES had SUGGESTED a RELATIONSHIP between Vitamin D status and allergic rhinitis, and others DID NOT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4896250	4/2016	S7523-PMC4896250	['the AIM of THIS STUDY was TO INVESTIGATE the ASSOCIATION between concentration of Serum Vitamin D levels and recent symptoms of allergic diseases in elementary schoolchildren.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4896250	4/2016	S8291-PMC4896250	['in RECENT YEARS, SEVERAL STUDIES HAVE REPORTED an ASSOCIATION between Vitamin D levels, atopy, asthma and Respiratory Tract infections.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 50)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 106, 'respiratory tract')]
PMC4897157	5/2016	S91-PMC4897157	['in addition to its EFFECT on Calcium Homeostasis, Vitamin D has MAJOR EFFECTS on Innate and Adaptive Immunity, such that the INFLUENCE of Vitamin D on allergic diseases represents an area of significant interest.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('GO_0055073', 'cadmium ion homeostasis', 29, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007631', 'feeding behavior', 81, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 92, 'adaptive immunity'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4897157	5/2016	S117-PMC4897157	['in a Birth cohort study cord Blood 25(Oh)-Vitamin D deficiency was ASSOCIATED with INCREASED RISK of recurrent troublesome Lung symptoms till age 7 years, BUT SHOWED no association with Respiratory infection, asthma, or rhinitis21).']	[('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 83), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 159)]	4	[('GO_0007567', 'parturition', 5, 'birth'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_63056', 'zinc cation', 35, '25(OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 123, 'lung'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]
PMC4897157	5/2016	S135-PMC4897157	['HOWEVER, OTHER reports SUGGEST that the recent Vitamin D status is ASSOCIATED with Allergen sensitization32526).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_50904', 'allergen', 83, 'allergen')]
PMC4903143	5/2016	S97-PMC4903143	["an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency is ASSOCIATED with impaired Lung development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [34]."]	[('ANOMALY_CURIOUS_FINDING', 3), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0002048', 'lung', 196, 'lung'), ('GO_0050905', 'neuromuscular process', 238, 'neurocognitive'), ('GO_0051318', 'G1 phase', 295, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 315, 'adolescence')]
PMC4903143	5/2016	S99-PMC4903143	['with ABUNDANT EVIDENCE of myriad health sequelae ASSOCIATED with Gestational Vitamin D deficiency, there is POTENTIAL for CONSIDERABLE amelioration of maternal and fetal health outcomes by educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Gestation [76].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 122)]	4	[('GO_0007565', 'female pregnancy', 65, 'gestational'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'preconception'), ('GO_0007565', 'female pregnancy', 250, 'prenatal'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'gestation')]
PMC4908484	6/2016	S6-PMC4908484	['RECENTLY, a NUMBER OF Extraskeletal actions of Vitamin D HAVE BEEN REPORTED, including EFFECTS on Nitric Oxide Production, antioxidant activity, and Endothelial Proliferation and Migration (molinari et\xa0al.2011; uberti et\xa0al.2014; pittarella et\xa0al.2015).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('UBERON_0001431', 'distal carpal bone 2', 22, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_16480', 'nitric oxide', 98, 'nitric oxide'), ('GO_0070706', 'RNA nucleotide deletion', 98, 'nitric oxide production'), ('GO_0001714', 'endodermal cell fate specification', 149, 'endothelial proliferation ... migration'), ('UBERON_0001986', 'endothelium', 149, 'endothelial')]
PMC4908484	6/2016	S19-PMC4908484	['it HAS BEEN HYPOTHESIZED that Vitamin D exerts these EFFECTS by Modulation of Neuronal Ca2+Homeostasis, in particular through downregulation of l‐type voltage‐sensitive ca2+channels in Hippocampal Neurons against excitotoxic insults (tetich et\xa0al.2005), ACCOMPANIED by an increase in vdr density.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 254)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0065007', 'biological regulation', 64, 'modulation'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('CHEBI_29108', 'calcium(2+)', 87, 'Ca2+'), ('GO_0007608', 'sensory perception of smell', 90, '... +'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('CHEBI_29238', 'tritium atom', 172, '+'), ('CL_0002608', 'hippocampal neuron', 185, 'hippocampal neurons')]
PMC4908484	6/2016	S35-PMC4908484	['RECENTLY, a RELATIONSHIP between iron and Vitamin D HAS BEEN OBSERVED, especially in the context of iron deficiency and anemia (lee et\xa0al.2009).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 61)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4930210	7/2016	S14-PMC4930210	['the iom has RECOMMENDED a 25(Oh)D cut point of >50 nmol/l to define Vitamin D sufficiency, AS this level is ASSOCIATED with PREVENTION of the bone manifestations of Vitamin D deficiency (rickets and osteomalacia) for 97.5% of canadians and americans.']	[('FUTURE_WORK', 12), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC4930210	7/2016	S137-PMC4930210	['another RECENT american longitudinal STUDY of 193 Pregnant women from mid-Pregnancy to Birth SHOWED Consuming a Prenatal Vitamin D supplement (334 iu/day) did not PREVENT precipitous drops in maternal Plasma 25(Oh)D concentration [28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 163)]	4	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007567', 'parturition', 87, 'birth'), ('GO_0007631', 'feeding behavior', 100, 'consuming'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 201, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 208, '25(OH)D')]
PMC4930210	7/2016	S157-PMC4930210	['HOWEVER, given that Vitamin D from Foods in canada makes such a small overall CONTRIBUTION to Vitamin D dietary Intake (table 3), the accuracy of the 24-hour recalls is LESS CRITICAL in estimating women’s total Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 169), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007631', 'feeding behavior', 112, 'intake'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S160-PMC4930210	['STUDIES [34,35] HAVE SHOWN that ultraviolet radiation (uvr)-derived Vitamin D is an IMPORTANT FACTOR in 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 104, '25(OH)D3concentration'), ('PR_000006744', 'dual specificity protein phosphatase 18', 110, 'D3concentration')]
PMC4934634	11/2015	S8-PMC4934634	['introduction\nWHILE the beneficial EFFECTS of Vitamin D supplementation with respect to reducing the RISK of rickets HAS BEEN recognized for close to 100 years, there is increasing concern that rickets in young children is reemerging in numerous countries [1,2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 100), ('INCOMPLETE_EVIDENCE', 116)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S50-PMC4934634	['convincing data from Animal MODELS SHOW that Vitamin D deficiency or altered function CAN result in reduced liter size or loss of overall fertility in CONJUNCTION with an increase in maternal and offspring mortality [16,17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('NCBITaxon_33208', 'Metazoa', 21, 'animal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S85-PMC4934634	['ADDITIONAL clinical TRIALS in ethnically diverse populations with differing baseline Vitamin D levels ARE NEEDED to BETTER DELINEATE the EFFECT of Vitamin D status on Assisted Reproductive technology outcomes.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 102), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 167, 'assisted reproductive')]
PMC4934634	11/2015	S131-PMC4934634	['GIVEN the heightened response with co-supplementation, it SUGGESTS that the EFFECTS of Vitamin D on Gestational diabetes MIGHT be enhanced with the use of Calcium.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_22313', 'alkaline earth metal atom', 155, 'calcium')]
PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]
PMC4934634	11/2015	S156-PMC4934634	['the authors CONCLUDED that these LINKS are ONLY SUGGESTIVE since there was no difference in Pregnancy complication risk among the Vitamin D intervention groups.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 48)]	4	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4934634	11/2015	S171-PMC4934634	['Vitamin D supplementation is a low cost intervention strategy and ADDITIONAL clinical TRIALS powered to determine the EFFECTS of Vitamin D on Preeclampsia PREVENTION and treatment ARE clearly WARRANTED.']	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 155), ('FUTURE_WORK', 180)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 142, 'preeclampsia')]
PMC4934634	11/2015	S253-PMC4934634	['also, studies powered TO DETERMINE the EFFECT of separate ethnic groups’ varying baseline Vitamin D levels on 25(Oh)D levels after different Vitamin D supplementation doses will provide more concrete INFORMATION for individualized RECOMMENDATIONS during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 200), ('FUTURE_WORK', 231)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 112, '(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC4934634	11/2015	S288-PMC4934634	['also, loss of function mutations in 24-hydroylase was found to be a risk factor for idiopathic infantile hypercalcemia making those infants more susceptible to Vitamin D toxicity EVEN at lower Vitamin D supplementation doses [86], THUS genetics CAN play a ROLE in both Vitamin D deficiency and toxicity.']	[('ANOMALY_CURIOUS_FINDING', 179), ('PROBABLE_UNDERSTANDING', 231), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 256)]	4	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4969253	8/2016	S4-PMC4969253	['introduction: Retinoic Acid, a CRUCIAL signal for Formation Of the Embryonic Lung\nCLASSIC STUDIES in multiple species, including Hamsters, Rats, and Mice, HAVE SHOWN major pleiotropic EFFECTS of maternal dietary Vitamin A deprivation in Embryonic Development.']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_26536', 'retinoic acid', 14, 'retinoic acid'), ('GO_0001703', 'gastrulation with mouth forming first', 50, 'formation of ... lung'), ('UBERON_0000922', 'embryo', 67, 'embryonic'), ('UBERON_0002048', 'lung', 77, 'lung'), ('NCBITaxon_33208', 'Metazoa', 129, 'hamsters'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('GO_0009790', 'embryo development', 237, 'embryonic development'), ('UBERON_0000922', 'embryo', 237, 'embryonic')]
PMC4969253	8/2016	S59-PMC4969253	['premature infants were shown to have lower concentrations of Plasma Vitamin A, raising the POSSIBILITY that Vitamin A deficiency in preterm infants MAY CONTRIBUTE to INCREASED RISK of developing chronic Lung disease.']	[('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 152), ('IMPORTANT_CONSIDERATION', 166)]	4	[('UBERON_0001969', 'blood plasma', 61, 'plasma'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC4969253	8/2016	S60-PMC4969253	['a series of nine trials have BEEN RECENTLY reviewed to determine the IMPACT of Vitamin A supplementation in PREVENTING mortality and short- and long-term morbidities in very low Birth weight infants [21].']	[('ANOMALY_CURIOUS_FINDING', 29), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 108)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 178, 'birth')]
PMC4971719	8/2016	S1-PMC4971719	['we performed THIS STUDY TO EVALUATE WHETHER low maternal Vitamin D levels are ASSOCIATED with depressive symptoms in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4971719	8/2016	S22-PMC4971719	['one HYPOTHESIZED physiologic mechanism through which Vitamin D MAY act to AFFECT depressive symptoms has emerged with the understanding that Vitamin D acts as a neuroactive hormone, in addition to its ROLE as a fat-soluble Vitamin [15].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 201)]	4	[('CHEBI_28384', 'vitamin K', 53, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 223, 'vitamin')]
PMC4971719	8/2016	S24-PMC4971719	['DEMONSTRATED that Vitamin D receptors are broadly distributed throughout the Human Brain [16] and Animal studies have FOUND that Vitamin D deficiency or dietary manipulation/addition of Vitamin D alters Neurotransmitters that are KNOWN to be INVOLVED in depressive symptoms and depression [17–20].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 242)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('UBERON_0000955', 'brain', 83, 'brain'), ('NCBITaxon_33208', 'Metazoa', 98, 'animal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 203, 'neurotransmitters')]
PMC4971719	8/2016	S44-PMC4971719	['the primary AIM of this secondary analysis was TO DETERMINE WHETHER low Vitamin D during Pregnancy is ASSOCIATED with depressive symptoms as assessed by the beck depression inventory score at three time points during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy')]
PMC4971719	8/2016	S95-PMC4971719	['we used stepwise linear regression analyses to better define the RELATIONSHIP between “low Vitamin D” and bdi score while adjusting for POTENTIALLY CONFOUNDING EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 136), ('PROBLEM_COMPLICATION', 148), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4971719	8/2016	S138-PMC4971719	['in this adjusted model, “low Vitamin D”, at visit 1 (again, as a categorical variable) was ASSOCIATED with the bdi at 34–36 weeks’ Gestation ( p \u2009=\u20090.01), WHILE there was a TREND toward ASSOCIATION of low Dha ( p \u2009=\u20090.06) and low epa ( p \u2009=\u20090.09) with higher Bdi scores at that time point as well (r2for the model\u2009=\u20090.12).']	[('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 205, 'DHA'), ('PR_000004717', "transcription factor TFIIIB component B''", 259, 'BDI')]
PMC4971719	8/2016	S145-PMC4971719	['discussion\n\nmain findings\nTHIS STUDY presents EVIDENCE that low Vitamin D levels in early Pregnancy (12–20 weeks) are significantly ASSOCIATED with higher depression symptom scores at in early and late Pregnancy in a group of women AT RISK for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 132), ('IMPORTANT_CONSIDERATION', 232)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4971719	8/2016	S161-PMC4971719	['OUR STUDY FOUND an ASSOCIATION between low Vitamin D levels in early Pregnancy and depressive symptoms during Pregnancy BUT NOT Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 128, 'postpartum')]
PMC4971719	8/2016	S167-PMC4971719	['IF randomized studies SHOW a benefit for Vitamin D for PREVENTION or treatment of Perinatal depression, supplementation MAY benefit maternal fetal and neonatal health [49,50].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 120)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0036268', 'swimming', 82, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 82, 'perinatal')]
PMC4971719	8/2016	S171-PMC4971719	['such FUTURE RESEARCH SHOULD also explore any POTENTIAL INTERACTION between inflammatory cytokines and Vitamin D on depression symptoms.']	[('FUTURE_WORK', 5), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC4979151	8/2016	S0-PMC4979151	['Prenatal high-dose Vitamin D3Supplementation has balanced EFFECTS on Cord Blood th1 and th2 Responses\n\nabstract\n\nbackground\nantenatal Vitamin D3(vitd3) supplementation significantly increases maternal and neonatal 25-Hydroxyvitamin D3(25(Oh)D3) concentration, YET the EFFECT of an improvement in maternal-fetal Vitamin D status on the neonatal immune response is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 260), ('SUPERFICIAL_RELATIONSHIP', 268), ('FULL_UNKNOWN', 363)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_52915', 'phosphatediyl group', 19, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'vitamin D3supplementation'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0060033', 'anatomical structure regression', 92, 'responses'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_63991', '15-epi-lipoxin B4', 214, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 232, 'D3'), ('CHEBI_62946', 'ammonium sulfate', 235, '25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 241, 'D3'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D')]
PMC4979151	8/2016	S12-PMC4979151	['IN CONTRAST, no association [6,7] or negative EFFECTS of high Vitamin D intake in Pregnancy on the RISK of eczema, asthma and wheezing in the offspring HAVE also BEEN SHOWN [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC4989298	8/2016	S242-PMC4989298	['their results demonstrate a PROTECTIVE EFFECT of Vitamin C on the incidence of wheezing and a preventive EFFECT of the CONTRIBUTION of copper on the development of various allergic diseases.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 105), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin C')]
PMC4989298	8/2016	S373-PMC4989298	['the results REMAIN CONTROVERSIAL EVEN when CORRELATIONS between Vitamin D levels in maternal and Umbilical Cord Blood and allergic disease risk are measured directly.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 97, 'umbilical cord'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4990280	8/2016	S159-PMC4990280	['the positive ASSOCIATION between hb and Plasma concentration of ferritin, B12, hepcidin and Vitamin A MAINLY in fe60f group INDICATED a beneficial IMPACT of the higher dose of Antenatal iron on hb concentration in 9 years old children.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0001969', 'blood plasma', 40, 'plasma'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 74, 'B12'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('GO_0007567', 'parturition', 176, 'antenatal')]
PMC4992225	8/2016	S48-PMC4992225	['CONSIDERING the POSSIBLE CONNECTION between low Serum Vitamin D and depression, researchers studied the RELATIONSHIP between low Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0036268', 'swimming', 143, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 143, 'perinatal')]
PMC4992225	8/2016	S184-PMC4992225	['CONSIDERING the FACTORS AFFECTING Vitamin D Production such as clothing type, skin color and the time of day being exposed to the sun [48–50], these results are JUSTIFIABLE.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 161)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 34, 'vitamin D production')]
PMC4992225	8/2016	S245-PMC4992225	['IN CONTRAST, in ANOTHER STUDY 40,000\xa0iu Vitamin D per week was used for 6\xa0months, BUT Vitamin D was not EFFECTIVE in decreasing depression level compared to the control group [68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4992225	8/2016	S263-PMC4992225	['it was INTERESTING TO INVESTIGATE TREND of Vitamin D EFFECTIVENESS in the two primiparous and multiparous subgroups.']	[('ANOMALY_CURIOUS_FINDING', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4993554	8/2016	S113-PMC4993554	['Vitamins and other supplements in Pregnancy\nwomen’s awareness about the RECOMMENDATIONS for Supplements in Pregnancy was explored, including vitamins and other RECOMMENDED supplements (Folic Acid and Iodine), as well as those Vitamins for which there were DANGERS ASSOCIATED with excessive doses (Vitamin A, Vitamin D, and Vitamin B6).']	[('FUTURE_WORK', 72), ('FUTURE_WORK', 160), ('IMPORTANT_CONSIDERATION', 256), ('SUPERFICIAL_RELATIONSHIP', 264)]	4	[('CHEBI_28371', 'vitamin K epoxide', 0, 'Vitamins'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 92, 'supplements'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('CHEBI_30751', 'formic acid', 185, 'folic acid'), ('CHEBI_24859', 'iodine atom', 200, 'iodine'), ('CHEBI_33277', 'gamma-tocotrienol', 226, 'vitamins'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 305, 'A'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 323, 'vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 331, 'B6')]
PMC4996336	12/2015	S18-PMC4996336	['two of THESE STUDIES INVOLVED Calcium supplementation,16,17one INVOLVED supplementation with Calcium plus Vitamin D,18two INVOLVED supplementation with zinc,19,20and one included four intervention arms in females of Childbearing age (i.e.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 30, 'calcium'), ('CHEBI_22313', 'alkaline earth metal atom', 93, 'calcium'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 216, 'childbearing')]
PMC4997421	8/2016	S11-PMC4997421	['conclusion there APPEAR TO BE DISPARITIES in Serum Vitamin A levels in women of Childbearing age RELATED to income and race in the united states.']	[('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 80, 'childbearing')]
PMC4997421	8/2016	S14-PMC4997421	['maternal Vitamin A deficiency increases the RISK of COMPLICATIONS during Pregnancy and in the Postpartum Period and HAS BEEN positively ASSOCIATED with Preterm Delivery [3], maternal infections, night blindness, anemia [4], and Birth defects [5].']	[('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0007565', 'female pregnancy', 94, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 105, 'period'), ('GO_0007565', 'female pregnancy', 152, 'preterm'), ('GO_0007567', 'parturition', 160, 'delivery'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4997421	8/2016	S18-PMC4997421	['the united states has BEEN assumed to be free of Vitamin A deficiency BASED ON a high gross domestic product [12] and Vitamin A status has ONLY rarely BEEN investigated in the us population, especially in women of Childbearing age.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 139), ('ANOMALY_CURIOUS_FINDING', 151)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 214, 'childbearing')]
PMC4997421	8/2016	S123-PMC4997421	['we also INVESTIGATED the IMPACT of OTHER socioeconomic indicators on Vitamin A status that have not been WELL explored, including Food insecurity and Snap use.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('FUTURE_WORK', 105)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('CHEBI_33290', 'food', 130, 'food'), ('PR_000015329', 'stannin', 150, 'SNAP')]
PMC4997567	8/2016	S91-PMC4997567	['(2008) [19], and bakeit and megeid (2012) [13], who REVEALED that most of the rickets children were Breast-Fed which may LEAD TO decreased Vitamin D 25-Hydroxy Vitamin D(25-Ohd) intake from OTHER sources and thereby causing rickets.']	[('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	4	[('GO_0007567', 'parturition', 100, 'breast'), ('UBERON_0000310', 'breast', 100, 'breast'), ('GO_0007631', 'feeding behavior', 107, 'fed'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 149, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 170, '25-OHD')]
PMC4998950	4/2016	S23-PMC4998950	['lastly, we EVALUATED WHETHER lifetime maternal Vitamin D deficiency was DIFFERENTLY ASSOCIATED with asd among children with and without maternal histories of migration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5014971	8/2016	S34-PMC5014971	['results from a RECENT STUDY INDICATE that Vitamin D supplementation during Pregnancy with up to 4,000\u2009iu/day is SAFE and EFFECTIVE [26].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5017622	9/2016	S25-PMC5017622	['women of Reproductive age, ESPECIALLY Pregnant women, in low and middle income countries are AT RISK of several Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, which COULD adversely AFFECT the mother and Pregnancy outcome [13,14,15].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 244)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 112, 'micronutrient'), ('CHEBI_24870', 'ion', 148, 'iron'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('CHEBI_24859', 'iodine atom', 166, 'iodine'), ('CHEBI_27300', 'vitamin D', 180, 'vitamins A'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC5024513	9/2016	S157-PMC5024513	['it was NOT POSSIBLE to conduct analysis of Vitamin D status by ethnicity or exposure to sunlight, however, which are FACTORS KNOWN to have a significant IMPACT on Vitamin D status [51–53].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 153)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5029041	9/2016	S112-PMC5029041	['multiple Micronutrient supplements decrease lbw, fgr and stillbirths [69]; HOWEVER, WHETHER deficiencies of Micronutrients such as zinc, Calcium and Vitamin A INTERACT with malaria in Pregnancy REMAINS UNCLEAR [70].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 108, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5035678	4/2016	S23-PMC5035678	['a RECENT STUDY SHOWED that post-Parturition Vitamin D supplementation MAY PREVENT the progression of Insulin resistance in patients with a recent history of gdm (16).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('GO_0019230', 'proprioception', 32, 'parturition'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('PR_000045358', 'insulin family protein', 101, 'insulin')]
PMC5035678	4/2016	S26-PMC5035678	['objectives\nwe THEREFORE SOUGHT TO EXPLORE the EFFECT of Vitamin D supplementation in women with gdm and hypovitaminosis D, both on post-Partum Glucose levels and Insulin resistance, in a randomized clinical trial.']	[('PROBABLE_UNDERSTANDING', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('GO_0007567', 'parturition', 136, 'partum'), ('CHEBI_17234', 'glucose', 143, 'glucose'), ('PR_000045358', 'insulin family protein', 162, 'insulin')]
PMC5035678	4/2016	S113-PMC5035678	['several observational STUDIES INDICATE that Serum 25Ohd has an inverse RELATIONSHIP with Insulin resistance and incidence of gdm (22,23), and that Vitamin D deficiency is ASSOCIATED with type 2 diabetes (24).']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('UBERON_0001977', 'blood serum', 44, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 50, '25OHD'), ('PR_000045358', 'insulin family protein', 89, 'insulin'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC5035678	4/2016	S147-PMC5035678	['as PREVIOUSLY discussed, a LIMITED NUMBER OF STUDIES have evaluated the EFFECT of Vitamin D on Glucose Metabolism and Insulin resistance, especially during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('PR_000045358', 'insulin family protein', 118, 'insulin'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC5035678	4/2016	S158-PMC5035678	['regarding the predicted prevalence of 35%, the DETECTED incidence of dysglycemia (31%) MIGHT have led to an UNDERESTIMATION of the IMPACT of Vitamin D in our study.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 87), ('PROBLEM_COMPLICATION', 108), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5039809	10/2016	S0-PMC5039809	['maternal Serum Retinol and Β-Carotene concentrations and neonatal bone mineralization: results from the southampton women’s survey cohort\n\nabstract\nbackground: studies in older Adults and Animals have SUGGESTED CONTRASTING RELATIONS between bone health and DIFFERENT Vitamin A Compounds.']	[('INCOMPLETE_EVIDENCE', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('SUPERFICIAL_RELATIONSHIP', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	4	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_26536', 'retinoic acid', 15, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 27, 'β-carotene'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('NCBITaxon_33208', 'Metazoa', 188, 'animals'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A'), ('CHEBI_36357', 'polyatomic entity', 277, 'compounds')]
PMC5039809	10/2016	S115-PMC5039809	['the RELATIONS between Vitamin A nutrition, assessed by an ffq or Serum measurements, and fracture risk or bmd in Adults are INCONSISTENT (18), BUT in a RECENT meta-analysis wu et al.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('UBERON_0007023', 'adult organism', 113, 'adults')]
PMC5045784	10/2016	S58-PMC5045784	["our study is IN AGREEMENT with a study by onwuneme et al.16in which, in a cohort of 94 preterm infants (<32 weeks' Gestation), there was no association with bpd or other morbidities of Prematurity although the authors FOUND an ASSOCIATION between Vitamin D status and acute Respiratory morbidity (AS defined by differences in duration of positive pressure ventilation and highest oxygen concentration required in the delivery room and the odds of requiring assisted ventilation)."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 227), ('PROBABLE_UNDERSTANDING', 297)]	4	[('GO_0007565', 'female pregnancy', 115, 'gestation'), ('GO_0007565', 'female pregnancy', 185, 'prematurity'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 274, 'respiratory')]
PMC5045784	10/2016	S61-PMC5045784	['mandel et al.7REPORTED a PROTECTIVE ROLE for Vitamin D in a Rodent MODEL of neonatal Lung injury induced by in utero exposure to endotoxin.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 67)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 60, 'rodent'), ('UBERON_0002048', 'lung', 85, 'lung')]
PMC5051327	9/2016	S60-PMC5051327	['both Oestrogenic Compounds and Parathyroid Hormone upregulate 1,25-Dihydroxy Vitamin D in Vascular Smooth Muscle Cells.33thus, there are several Vitamin D-RELATED mechanisms that COULD AFFECT the strained fetal Heart during the CRITICAL time of Birth.']	[('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 185), ('IMPORTANT_CONSIDERATION', 228)]	4	[('CHEBI_33838', 'nucleoside', 5, 'oestrogenic compounds'), ('GO_0001896', 'autolysis', 5, 'oestrogenic'), ('UBERON_0001132', 'parathyroid gland', 31, 'parathyroid'), ('CHEBI_33280', 'molecular messenger', 43, 'hormone'), ('CHEBI_50341', '1-hydroxyethyl group', 62, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 90, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 90, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000948', 'heart', 211, 'heart'), ('GO_0007567', 'parturition', 245, 'birth')]
PMC5062906	10/2016	S48-PMC5062906	['to address the ROLE of maternal Vitamin D in determining offspring epigenetic state, we used a Mouse MODEL to characterize WHETHER depletion of maternal Vitamin D during Gestation and Lactation AFFECTS epigenetic and developmental outcomes of progeny.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('SUPERFICIAL_RELATIONSHIP', 194)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007595', 'lactation', 184, 'lactation')]
PMC5062906	10/2016	S313-PMC5062906	['STUDIES are ONGOING to characterize Genome-wide epigenetic EFFECTS of maternal Vitamin D depletion including the IMPACT of Genetic differences in determining epigenetic and phenotypic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('SO_0001026', 'genome', 36, 'genome'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('SO_0000704', 'gene', 123, 'genetic')]
PMC5064894	10/2016	S21-PMC5064894	['Vitamin D HAS BEEN SHOWN to Modulate the Innate Immune Response in Lung Epithelial Cells [6,7], and Antimicrobial peptides induced by Vitamin D MAY have antiviral EFFECTS BASED on observed activity against Herpes Simplex Virus-1 (Hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] and vaccinia [11].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 171)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0065007', 'biological regulation', 28, 'modulate'), ('GO_0045087', 'innate immune response', 41, 'innate immune response'), ('UBERON_0002405', 'immune system', 48, 'immune'), ('CL_0000082', 'epithelial cell of lung', 67, 'lung epithelial cells'), ('UBERON_0000115', 'lung epithelium', 67, 'lung epithelial'), ('CHEBI_65381', 'albizoside C', 100, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000008476', 'orexin', 206, 'herpes simplex virus'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 230, 'HSV-1')]
PMC5064894	10/2016	S37-PMC5064894	['first, THERE HAVE BEEN NO STUDIES examining the EFFECT of Prenatal Vitamin D supplementation on a primary outcome of laboratory-confirmed Viral Respiratory infections in the first 6\xa0months of Life, a high-risk period for both Vitamin D deficiency and Respiratory Tract infections.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('NCBITaxon_1', 'root', 138, 'viral'), ('UBERON_0001004', 'respiratory system', 144, 'respiratory'), ('UBERON_0000104', 'life cycle', 192, 'life'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 251, 'respiratory tract')]
PMC5084016	10/2016	S121-PMC5084016	['with Aging, the Synthesis Of Vitamin D in the Epidermis Layer becomes less efficient; also, diseases ASSOCIATED with Intestinal malabsorption, such as celiac disease, crohn’s disease, cystic fibrosis, ulcerative colitis, Liver and Kidney disorders and SOME Pharmacological treatments, MAY CONTRIBUTE to the development of Vitamin D deficiency [57].']	[('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 289)]	4	[('GO_0007568', 'aging', 5, 'aging'), ('GO_0030474', 'spindle pole body duplication', 16, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002027', 'stratum corneum of epidermis', 46, 'epidermis layer'), ('UBERON_0000160', 'intestine', 117, 'intestinal'), ('UBERON_0002107', 'liver', 221, 'liver'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('CHEBI_52217', 'pharmaceutical', 257, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5084016	10/2016	S128-PMC5084016	['HOWEVER, Vitamin D deficiency is very common during Pregnancy EVEN in countries with sunny climates and is ASSOCIATED with an INCREASED RISK of developing pre-eclampsia and Gestational diabetes mellitus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 126)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007565', 'female pregnancy', 173, 'gestational')]
PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5084041	10/2016	S18-PMC5084041	['POOR maternal Vitamin D status HAS also BEEN ASSOCIATED with Pregnancy COMPLICATIONS such as Preeclampsia [3], premature Birth [4] and infants Born small for Gestational age [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('PROBLEM_COMPLICATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 93, 'preeclampsia'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0007567', 'parturition', 143, 'born'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
PMC5084041	10/2016	S124-PMC5084041	['in OUR STUDY, the proportion of women using Vitamin D supplements was SIMILAR at t1 and t3, but IT IS POSSIBLE that supplement use CONTRIBUTED to the increase in 25(Oh)D if supplementation was initiated shortly before t1.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D')]
PMC5084041	10/2016	S138-PMC5084041	['moon et al SHOWED that Vitamin D supplementation is RELATED to changes in 25(Oh)D between the first and the third trimester, which SUPPORTS OUR FINDINGS [12].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 140)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D')]
PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]
PMC5085625	9/2016	S24-PMC5085625	['DEFICIENCY of Vitamin D is commonly diagnosed among Pregnant women worldwide, and WAS SHOWN to be ASSOCIATED with an INCREASED RISK of Pregnancy-related complications [1].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC5085625	9/2016	S62-PMC5085625	['DESPITE widespread deficiency of Vitamin D among Pregnant women worldwide, its ROLE in Pregnancy has LARGELY BEEN IGNORED [25,26,27].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5085625	9/2016	S68-PMC5085625	['taking into account INCONCLUSIVE results of cross-sectional and cohort studies analyzing the ASSOCIATION between Vitamin D status and occurrence of Pregnancy pathologies [28,29], the AIM of OUR STUDY was to asses 25(Oh)D status in women with Gestational hypertension (gh).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('GO_0007565', 'female pregnancy', 242, 'gestational')]
PMC5085625	9/2016	S72-PMC5085625	['the RELATIONSHIP between Vitamin D status and gh HAS also BEEN a subject of OTHER STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC5085625	9/2016	S84-PMC5085625	['HENCE, we POSTULATE to conduct a well-designed randomized study TO ASSESS the ROLE of Vitamin D in the etiopathogenesis of gh.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5085625	9/2016	S90-PMC5085625	['ACCORDING to barebring et al., AT LEAST a 30 nmol/l increase in Serum 25(Oh)D concentration is ASSOCIATED with lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy [13].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 129)]	4	[('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 70, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC5085625	9/2016	S99-PMC5085625	['preeclampsia in patients with Vitamin D insufficiency MAY BE LINKED to a low concentration of the Vascular Endothelial Growth Factor (Vegf) and high levels of inflammatory cytokines; expressions of these FACTORS are under a strong INFLUENCE of Vitamin D [35,36,37,38].']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 204), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 98, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 107, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 134, 'VEGF'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC5085625	9/2016	S125-PMC5085625	['CONSEQUENTLY, these authors RECOMMENDED to conduct a well-designed randomized controlled trial to examine the exact ROLE of Vitamin D supplementation in the PREVENTION of Gdm [49].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 157)]	4	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('GO_0070477', 'endospore core', 171, 'GDM')]
PMC5129897	10/2016	S12-PMC5129897	['the clinical trials listed FURTHER SUPPORT the ROLE of Vitamin D for SOME diseases.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 69)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5133057	10/2016	S128-PMC5133057	['moreover, considering the high prevalence of vad OBSERVED in THIS STUDY, as well as its IMPACT on the Pregnancy process, there is a NEED FOR regular assessment of the nutritional status of Prenatal Vitamin A in teens in order to achieve early diagnosis and proper management of this nutritional deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('SUPERFICIAL_RELATIONSHIP', 88), ('FUTURE_WORK', 132)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC5137891	12/2016	S138-PMC5137891	['other key FACTORS that MAY CONTRIBUTE to anemia include: OTHER Nutrient deficiencies (Folate, Vitamin B12, and Vitamin A), Genetic traits (including Sickle-Cell anemia and thalassaemia), malaria, schistosomiasis, hookworm and Trichuris infection, and hiv and some non-communicable diseases [1].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrient'), ('CHEBI_30863', '5-azaorotic acid', 86, 'folate'), ('CHEBI_33279', 'vitamin D5', 94, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 102, 'B12'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin A'), ('SO_0000704', 'gene', 123, 'genetic'), ('CL_0000429', 'imaginal disc cell', 149, 'sickle-cell'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'trichuris')]
PMC5146866	12/2016	S105-PMC5146866	['we would like to highlight the strengths of the PRESENT report that include: (i) prospective observation of a sufficient number and diverse population of mother-infant pairs, (ii) use of 95% confidence intervals to present the POTENTIAL variability in prevalence of Vitamin D deficiency/ insufficiency in cb, (iii) use of regression models for identifying maternal FACTORS that increase the risk for Vitamin D deficiency/insufficiency in infant at Birth, and (iv) reporting clinical characteristics of the neonates in ASSOCIATION with their Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 365), ('SUPERFICIAL_RELATIONSHIP', 518)]	4	[('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin D'), ('GO_0007567', 'parturition', 448, 'birth'), ('CHEBI_27300', 'vitamin D', 541, 'vitamin D'), ('GO_0007567', 'parturition', 561, 'birth')]
PMC5155676	12/2016	S23-PMC5155676	['clinically, understanding HOW Individuals respond COULD LEAD to individualized Antenatal counseling regarding Vitamin D supplementation to ensure Vitamin D repletion is achieved without increasing the RISK of Vitamin D toxicity.']	[('EXPLICIT_QUESTION', 26), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 201)]	4	[('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0007567', 'parturition', 79, 'antenatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5155676	12/2016	S24-PMC5155676	['we THEREFORE undertook THIS STUDY TO DETERMINE maternal characteristics ASSOCIATED with achieved 25(Oh)D after Antenatal Vitamin D supplementation in the context of a double-blind, randomized, placebo-controlled trial.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 103, 'D'), ('GO_0007567', 'parturition', 111, 'antenatal'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5223368	12/2016	S135-PMC5223368	['Pregnancy health is STRONGLY ASSOCIATED with Serum 25-Hydroxy Vitamin D [26], and the ROLE of Vitamin D in bone mineralization is WELL KNOWN [26,27].']	[('PROBABLE_UNDERSTANDING', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 130)]	4	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 51, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5223368	12/2016	S136-PMC5223368	['a study in london REPORTED that maternal Vitamin D insufficiency at Pregnancy as early as 19\xa0weeks CAN INFLUENCE Fetal Femoral Development, and SUGGESTED that maternal Vitamin D should be improved in early Pregnancy [14].']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 144)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007631', 'feeding behavior', 113, 'fetal'), ('GO_0009556', 'microsporogenesis', 119, 'femoral development'), ('UBERON_0000981', 'femur', 119, 'femoral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy')]
PMC5240436	1/2017	S120-PMC5240436	['FURTHER clinical TRIALS supplementing single Nutrients (efas, Vitamin A or zinc) MAY BE CRUCIAL in isolating the IMPACT of each Nutrient on maternal infections.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('CHEBI_33284', 'nutrient', 45, 'nutrients'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 128, 'nutrient')]
PMC5264377	7/2016	S18-PMC5264377	['the ROLE of Vitamin D in fertility and Ovarian function is STILL LARGELY UNEXPLORED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000992', 'ovary', 39, 'ovarian')]
PMC5310660	1/2017	S39-PMC5310660	['this latter plays a significant ROLE, SINCE increased Serum Vitamin D concentration is ASSOCIATED with a decreased risk of multiple sclerosis [10,11], and Vitamin D supplementation during the first year of Life is ASSOCIATED with a significantly decreased risk of type 1 diabetes [12].']	[('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('UBERON_0000104', 'life cycle', 206, 'life')]
PMC5310660	1/2017	S50-PMC5310660	['Genes ASSOCIATED with many Autoimmune diseases are enriched for Vitamin D receptor-Binding Sites [19-21], SUGGESTING that the combined EFFECT of Vitamin D deficiency, Genetic variation, and exposure to other environmental agents MAY concur in the pathogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 229)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('UBERON_0001442', 'skeleton of manus', 27, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('SO_0000409', 'binding_site', 83, 'binding sites'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('SO_0000704', 'gene', 167, 'genetic')]
PMC5310660	1/2017	S53-PMC5310660	['Vitamin D is INVOLVED in the pathogenesis of neovascular amd, and a significant CORRELATION HAS BEEN FOUND between reduced Plasma Vitamin D level and the prevalence of amd [25-28].']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5332602	3/2017	S180-PMC5332602	['in addition to decreased Serum protein, Albumin, and Glucose levels, we observed that protein malnutrition AFFECTED the Homeostatic Control of Selenium and Vitamins A and e, CONSISTENT with SIMILAR observations on secondary Micronutrient deficiencies ASSOCIATED with childhood malnourishment (1).']	[('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('PR_000005908', 'alpha-crystallin B chain', 40, 'albumin'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('GO_0042592', 'homeostatic process', 120, 'homeostatic'), ('GO_0065007', 'biological regulation', 132, 'control'), ('CHEBI_27568', 'selenium atom', 143, 'selenium'), ('GO_0007601', 'visual perception', 143, 'selenium'), ('CHEBI_27300', 'vitamin D', 156, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 156, 'vitamins A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 224, 'micronutrient')]
PMC5332602	3/2017	S181-PMC5332602	['THUS, UNLIKE in our MODEL of Prenatal Vitamin A deficiency (single-Micronutrient deficiency) (31), protein deficiency AFFECTED the levels or Homeostatic Control of multiple Macro- and Micronutrients, limiting the ability of neonatal Pigs to adapt/maintain Homeostasis through compensatory mechanisms.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('GO_0042592', 'homeostatic process', 141, 'homeostatic'), ('GO_0065007', 'biological regulation', 153, 'control'), ('CHEBI_34830', 'mefenacet', 173, 'macro'), ('CHEBI_33839', 'macromolecule', 184, 'micronutrients'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'pigs'), ('GO_0042592', 'homeostatic process', 256, 'homeostasis')]
PMC5340372	3/2017	S2-PMC5340372	['the AIM of THIS STUDY was TO INVESTIGATE the IMPACT of Perinatal Vitamin D levels on Respiratory function and disease outcome in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 85, 'respiratory')]
PMC5340372	3/2017	S10-PMC5340372	['conclusion\nalthough a high CORRELATION was FOUND between maternal and Cord Vitamin D levels, the EFFECT on Respiratory outcome was DIFFERENT.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131)]	4	[('UBERON_0002240', 'spinal cord', 70, 'cord'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory')]
PMC5340372	3/2017	S107-PMC5340372	['THEREFORE, drawing CONCLUSIONS about the EFFECTS of Perinatal and Postnatal Vitamin D status from these results can be DIFFICULT.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 119)]	4	[('GO_0036268', 'swimming', 52, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 52, 'perinatal'), ('GO_0007567', 'parturition', 66, 'postnatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5351212	3/2017	S30-PMC5351212	['in addition to its classical ROLE in calcium and Bone Homeostasis, Vitamin D has MAJOR immunomodulatory ROLES ASSOCIATED with inflammation [28].']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('GO_0055064', 'chloride ion homeostasis', 49, 'bone homeostasis'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5359891	3/2017	S7-PMC5359891	['the additional Micronutrients seek to address DEFICIENCIES of SOME b-group Vitamins and Vitamin D that are both common during Pregnancy and that HAVE BEEN ASSOCIATED with maternal dysglycaemia, epigenetic changes and greater offspring adiposity.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('CHEBI_33839', 'macromolecule', 15, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 75, 'vitamins'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC5368580	4/2017	S188-PMC5368580	['moreover, we FOUND that the acute EFFECTS of maternal supplementation REMAINED significant for riboflavin and Vitamin B-6 in the fasting Milk samples 24 h after supplementation compared with day 1, and that the Vitamins were not Secreted into Milk at the same rate throughout a day during maternal supplementation, resulting in a bolus dose of ≤35% of the adequate intake for Vitamin B-6 during a single Feeding, WHEREAS the bolus dose for riboflavin during a single Feeding only provided ∼11% of the adequate intake.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 110, 'vitamin B-6'), ('UBERON_0001913', 'milk', 137, 'milk'), ('CHEBI_33277', 'gamma-tocotrienol', 211, 'vitamins'), ('GO_0046903', 'secretion', 229, 'secreted'), ('UBERON_0001913', 'milk', 243, 'milk'), ('CHEBI_27300', 'vitamin D', 376, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 376, 'vitamin B-6'), ('GO_0007631', 'feeding behavior', 404, 'feeding'), ('GO_0007631', 'feeding behavior', 467, 'feeding')]
PMC5371920	3/2017	S126-PMC5371920	['the RECENT uk-based TRIAL of Vitamin D supplementation—maternal Vitamin D osteoporosis study (mavidos), tested the HYPOTHESIS that maternal Antenatal Vitamin D supplementation LEADS to increased offspring bone Mineral content.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 64, 'Vitamin D'), ('GO_0007567', 'parturition', 140, 'antenatal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_46662', 'mineral', 210, 'mineral')]
PMC5372327	3/2017	S6-PMC5372327	['discussion\nthe study ENABLES evaluation of short and long term EFFECTS of supplemental Vitamin D on growth, Immune functions and Skeletal and developmental parameters in infants, and the EFFECTS of Genetic FACTORS therein.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('UBERON_0004288', 'skeleton', 129, 'skeletal'), ('SO_0000704', 'gene', 198, 'genetic')]
PMC5372327	3/2017	S45-PMC5372327	['identification, treatment, and PREVENTION of Vitamin D deficiency in early childhood MAY THEREFORE have widespread health EFFECTS throughout childhood.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5372327	3/2017	S47-PMC5372327	['BASED ON epidemiological studies, low maternal Intake of Vitamin D at Pregnancy and low Cord Blood 25-Ohd concentration HAVE BEEN ASSOCIATED with a higher risk for asthma, allergic rhinitis and atopic eczema in the offspring, as assessed at 5\xa0years of age [35–38].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_72765', 'verruculogen', 99, '25-OHD')]
PMC5385921	4/2017	S7-PMC5385921	['because Gestational Vitamin D deficiency is readily preventable with SAFE, inexpensive and readily available supplementation, this RISK FACTOR WARRANTS CLOSER SCRUTINY.']	[('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 143), ('FUTURE_WORK', 152)]	4	[('GO_0007565', 'female pregnancy', 8, 'gestational'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5385921	4/2017	S18-PMC5385921	['we had the opportunity to explore the ASSOCIATION between developmental Vitamin D status and risk of asd, based on the same dutch Birth cohort in which we previously reported an ASSOCIATION between low mid-Gestational and neonatal Vitamin D concentrations and autistic traits.13within the cohort, we had access to an extensive set of POTENTIAL CONFOUNDING variables as well as the children’s individual-level Genome-wide genotype data.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 178), ('INCOMPLETE_EVIDENCE', 334), ('PROBLEM_COMPLICATION', 344)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('SO_0001026', 'genome', 409, 'genome')]
PMC5405075	4/2017	S1-PMC5405075	['abstract\nthe worldwide increase in asthma PREVALENCE during the last decades and the re-emergence of Vitamin D deficiency in many populations HINTED toward an UNDERLYING ASSOCIATION between these two conditions.']	[('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 159), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5405075	4/2017	S6-PMC5405075	['introduction\nepidemiological and experimental data on health IMPACT of “Multitasking” Vitamin D SUPPORT a PROTECTIVE EFFECT of Vitamin D over diseases such as cancer, Cardiovascular, Autoimmune, dementia, and diabetes (1,2).']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('GO_0007618', 'mating', 72, 'multitasking'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 167, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 183, 'autoimmune')]
PMC5405075	4/2017	S33-PMC5405075	['an immunodulatory ROLE of Vitamin D HAS also BEEN DESCRIBED in both Immune System and Lung Cell Maturation, which occurs MAINLY during fetal and early Extrauterine Life (40–42).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 121)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007566', 'embryo implantation', 68, 'immune system'), ('UBERON_0002405', 'immune system', 68, 'immune system'), ('CL_0000175', 'luteal cell', 86, 'lung cell'), ('GO_0060424', 'lung field specification', 86, 'lung cell maturation'), ('UBERON_0002048', 'lung', 86, 'lung'), ('UBERON_0005928', 'external naris', 151, 'extrauterine life')]
PMC5405075	4/2017	S46-PMC5405075	['moreover, both Animal and in vitro experiments have DEMONSTRATED a positive IMPACT of Prenatal Vitamin D exposure on aspects of Lung function and the process of inflammation, which are CONSIDERED to CONTRIBUTE to asthma pathogenesis (70–72).']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0002048', 'lung', 128, 'lung')]
PMC5418719	5/2017	S94-PMC5418719	['RECENT STUDIES DEMONSTRATED that low Vitamin D PREDISPOSE to increased RISK of rickets, Immune dysfunction, asthma, type 1 diabetes and Viral Respiratory Tract infections during infancy [14–17].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 88, 'immune'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0000065', 'respiratory tract', 142, 'respiratory tract')]
PMC5421133	5/2017	S0-PMC5421133	['marginal vitamin a deficiency EXACERBATES Memory deficits following aβ1-42injection in Rats\n\nabstract\n\nbackground:\nALTHOUGH clinical Vitamin A deficiency (vad), which is a PUBLIC HEALTH PROBLEM developing throughout the world, has been well controlled, marginal Vitamin A deficiency (mvad) is far more PREVALENT, especially among Pregnant women and preschool children in china.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ANOMALY_CURIOUS_FINDING', 115), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 302)]	4	[('GO_0007613', 'memory', 42, 'Memory'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'Rats'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A'), ('GO_0007565', 'female pregnancy', 330, 'pregnant')]
PMC5426325	4/2017	S151-PMC5426325	['IT IS POSSIBLE that this amount was too small to INFLUENCE fracture risk at the population level, EVEN when we CONFINED the analysis to those Pregnancies with habitually low Vitamin D during late trimesters, that is, those Giving Birth during winter months.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 111)]	4	[('GO_0007565', 'female pregnancy', 142, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0040007', 'growth', 223, 'giving'), ('GO_0007567', 'parturition', 230, 'birth')]
PMC5426325	4/2017	S162-PMC5426325	['conclusion\nthe study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from a mandatory fortification programme, adding1·25 µg Vitamin D/100 g Margarine, was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 189), ('INCOMPLETE_EVIDENCE', 240)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_6784', 'mestranol', 160, 'margarine'), ('GO_0007567', 'parturition', 264, 'birth')]
PMC5473979	6/2017	S118-PMC5473979	['various Micronutrients, such as Vitamin D, Selenium, zinc, Vitamin B12, Folates and OTHER b Vitamins, HAVE BEEN SUGGESTED as IMPORTANT for the PREVENTION of maternal depression [36].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 43, 'selenium'), ('CHEBI_33279', 'vitamin D5', 59, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 67, 'B12'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 72, 'folates'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins')]
PMC5474873	6/2017	S15-PMC5474873	['OF PARTICULAR INTEREST is ACCUMULATING EVIDENCE for the ROLE of Vitamin D in the Brain (5,6).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000955', 'brain', 81, 'brain')]
PMC5474873	6/2017	S32-PMC5474873	['THUS, the ASSOCIATION between Vitamin D, sun exposure, and psychosis REMAINS DEBATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5489519	6/2017	S94-PMC5489519	['SINCE there is no Trail toxicity demonstrated in vitro and in vivo treatment32,33, IT IS POSSIBLE that Trail Expression in the milk of mothers with Vitamin D deficiency COULD BE a compensatory mechanism to PROTECT infant health.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 18, 'TRAIL'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 103, 'TRAIL'), ('GO_0010467', 'gene expression', 109, 'expression'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5510234	7/2017	S72-PMC5510234	['(1994) FOUND a statistically significant CORRELATION between Vitamin A deficiency and mtct rates in 338 hiv-infected women in malawi, SPECULATING that Vitamin A deficiency MAY compromise the Epithelial integrity of Tissues in the Vaginal Mucosa and Mammary Glands.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000483', 'epithelium', 191, 'epithelial'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('UBERON_0004983', 'mucosa of vagina', 230, 'vaginal mucosa'), ('UBERON_0001911', 'mammary gland', 249, 'mammary glands')]
PMC5510234	7/2017	S73-PMC5510234	['this finding SUGGESTS then a LINK between Vitamin A deficiency and an INCREASED RISK of infant exposure to hiv during Vaginal Delivery.48,57later on, this was NOT CONFIRMED by other studies from the developped countries.61,62a cochrane review on Vitamin A supplementation and mtct of hiv was published in 2011, by wiysonge et al .']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('UBERON_0001987', 'placenta', 118, 'vaginal'), ('GO_0007567', 'parturition', 126, 'delivery'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin A')]
PMC5513133	7/2017	S2-PMC5513133	['evidence of the ROLE of Vitamin D status and supplementation in the etiology and PREVENTION of pe is reviewed in THIS ARTICLE along with identification of research gaps to inform FUTURE STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 113), ('FUTURE_WORK', 179)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5513133	7/2017	S204-PMC5513133	['residual CONFOUNDING and differences between groups MAY EXPLAIN the ASSOCIATION between Vitamin D deficiency and pe.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5513133	7/2017	S214-PMC5513133	['seasonality is also CONSIDERED a CONFOUNDER, particularly in studies RELATED to causal EFFECTS of Vitamin D on pe.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5513133	7/2017	S238-PMC5513133	['studies that find a ROLE early in Pregnancy, before the clinical onset of pe, SUGGEST that Vitamin D MAY play a ROLE in the Modulation of a pro-inflammatory response or Regulation of Angiogenic factors.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'modulation'), ('GO_0065007', 'biological regulation', 169, 'regulation'), ('GO_0001525', 'angiogenesis', 183, 'angiogenic')]
PMC5513133	7/2017	S239-PMC5513133	['IT IS POSSIBLE that BIOMARKERS for pe, such as Angiogenic factors Vegf and Pigf, MAY serve as mediators in the pathway LINKING Vitamin D Metabolites to pe.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('GO_0001525', 'angiogenesis', 47, 'angiogenic'), ('PR_000017279', 'testis-specific basic protein Y 1', 66, 'VEGF'), ('PR_000012702', 'GPI ethanolamine phosphate transferase 3', 75, 'PIGF'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_25212', 'metabolite', 137, 'metabolites')]
PMC5513133	7/2017	S249-PMC5513133	['SUGGESTS a POTENTIAL for a ROLE for the frequency and timing of Vitamin D supplementation and risk for pe, given that the total intake greater than 800\xa0iu/day did not reduce RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5513133	7/2017	S263-PMC5513133	['[25] SUGGEST that Vitamin D deficiency MAY BE a FACTOR in the DISPROPORTIONATE incidence of adverse Pregnancy outcomes in african american women since this group had the lowest Vitamin D levels among the populations they studied.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 62)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5521778	7/2017	S5-PMC5521778	['CONSEQUENTLY, we INVESTIGATED IF gcs counteract Retinoid EFFECTS in Alveolar Epithelial Cells by mechanisms involving Bco1-dependent local Vitamin A Metabolism.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26537', 'retinoid', 48, 'retinoid'), ('CL_0000322', 'pneumocyte', 68, 'alveolar epithelial cells'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 68, 'alveolar epithelial'), ('PR_000004693', 'Bcl-2-like protein 10', 118, 'BCO1'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 139, 'vitamin A metabolism')]
PMC5521778	7/2017	S137-PMC5521778	['suppression of Bco1 Expression and activity by Glucocorticoids\nsince Retinoids (Vitamin A) and Gcs play INTERACTIVE ROLES in Lung Development and Regeneration [40], we ASKED WHETHER gcs alter Carotenoid-to-Retinoid Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('EXPLICIT_QUESTION', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174)]	4	[('PR_000004693', 'Bcl-2-like protein 10', 15, 'BCO1'), ('GO_0010467', 'gene expression', 20, 'expression'), ('CHEBI_36597', 'phthalazine', 47, 'glucocorticoids'), ('CHEBI_26537', 'retinoid', 69, 'retinoids'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CL_0000740', 'retinal ganglion cell', 95, 'GCs'), ('GO_0060424', 'lung field specification', 125, 'lung development ... regeneration'), ('UBERON_0002048', 'lung', 125, 'lung'), ('CHEBI_23044', 'carotenoid', 192, 'carotenoid'), ('GO_0016116', 'carotenoid metabolic process', 192, 'carotenoid- ... metabolism'), ('CHEBI_26537', 'retinoid', 206, 'retinoid')]
PMC5524288	7/2017	S17-PMC5524288	['multiple epidemiologic STUDIES have FOUND an ASSOCIATION between higher maternal Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, the physiological measure of Vitamin D status, and lower ptb RISK [4–10].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 87, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5537904	7/2017	S14-PMC5537904	['Prenatal Vitamin D deficiency HAS BEEN ASSOCIATED with pre-term Birth [4,5], low birthweight [5,6], and small for Gestational age offspring [5,6,7], WHILE Prenatal Vitamin D supplementation HAS BEEN SHOWN to increase offspring Birth weight and length [8].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('INCOMPLETE_EVIDENCE', 190)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 227, 'birth')]
PMC5537904	7/2017	S16-PMC5537904	['current Human EVIDENCE SUPPORTING the ASSOCIATION between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity is MIXED.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5537904	7/2017	S20-PMC5537904	['there is also a notable LACK OF study on body composition during infancy, a time in which Postnatal exposures (infant Vitamin D supplementation, Vitamin D-fortified formula use) MAY also play a PIVOTAL ROLE in Adiposity Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 178), ('IMPORTANT_CONSIDERATION', 194), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0007567', 'parturition', 90, 'postnatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 210, 'adiposity development')]
PMC5537904	7/2017	S23-PMC5537904	['in addition, FEW STUDIES EXAMINED WHETHER Gestational weight gain OR body mass index (bmi) modify the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC5537904	7/2017	S179-PMC5537904	['we were ONLY able to use crude ESTIMATES of offspring Intake of Vitamin D Postnatally from formula or infant supplements, which MAY have prevented us from detecting ASSOCIATIONS between 25(Oh)D at Birth and 5-month body composition that varied by Postnatal Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('GO_0007631', 'feeding behavior', 54, 'intake'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'postnatally'), ('CHEBI_71657', 'versiconol acetate', 186, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 192, 'D'), ('GO_0007567', 'parturition', 197, 'birth'), ('GO_0007567', 'parturition', 247, 'postnatal'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D')]
PMC5539754	8/2017	S16-PMC5539754	['the presence of Vitamin D receptors and Expression of 1-α-hydroxylase enzyme in Pancreatic Beta Cells SUGGEST that Vitamin D MAY BE a modulator of Insulin secretion and THUS, INFLUENCE Glucose Homeostasis [6].']	[('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 169), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0010467', 'gene expression', 40, 'expression'), ('CL_0000169', 'type B pancreatic cell', 80, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 80, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000045358', 'insulin family protein', 147, 'insulin'), ('CHEBI_17234', 'glucose', 185, 'glucose'), ('GO_0042593', 'glucose homeostasis', 185, 'glucose homeostasis')]
PMC5539754	8/2017	S153-PMC5539754	['a recent meta-analysis of OBSERVATIONAL studies REPORTED that Vitamin D\xa0<\xa050\xa0nmol/l was ASSOCIATED with an INCREASED RISK (or\xa0=\xa01.53) of developing Gestational diabetes [9].']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5539754	8/2017	S176-PMC5539754	['WHILE no interaction effect was OBSERVED between season and Vitamin D with regards to Glucose Homeostasis, it is well RECOGNISED that 25Ohd declines in winter, and is a modifiable FACTOR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 118), ('SUPERFICIAL_RELATIONSHIP', 180)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0042593', 'glucose homeostasis', 86, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5546866	8/2017	S26-PMC5546866	['CONSIDERING this and the physiological changes to the Vitamin D pathway in Pregnancy, it is THEREFORE POSSIBLE that the Genetic variants ASSOCIATED with baseline Serum 25(Oh)d status and the response to supplementation also differ between the Pregnant and nonpregnant state.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 92), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('SO_0000704', 'gene', 120, 'genetic'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_30778', 'gallic acid', 168, '25(OH)'), ('GO_0007565', 'female pregnancy', 243, 'pregnant')]
PMC5546866	8/2017	S129-PMC5546866	['the Dhcr7 Gene encodes 7-Dhc reductase, which converts 7-Dhc back to Cholesterol, thereby reducing the availability of 7-Dhc for conversion to previtamin d. the ASSOCIATION of this Snp with only baseline 25(Oh)D is biologically CONSISTENT with the NOTION that the relative proportion of 25(Oh)D obtained from Vitamin D Biosynthesis in the skin AS OPPOSED TO dietary intake is lower following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 161), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344)]	4	[('PR_000006474', 'ATP-dependent RNA helicase A', 4, 'DHCR7'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 23, '7-DHC'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 55, '7-DHC'), ('CHEBI_16113', 'cholesterol', 69, 'cholesterol'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 119, '7-DHC'), ('SO_0000694', 'SNP', 181, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 204, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 287, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 293, 'D'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 309, 'vitamin D biosynthesis')]
PMC5546866	8/2017	S134-PMC5546866	['BECAUSE the g Allele at rs10741657, which was more frequent in our population, was ASSOCIATED with lower 25(Oh)D following supplementation, it COULD BE POSTULATED that this Allele previously conferred an evolutionary advantage to prevent Vitamin D toxicity.']	[('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('SO_0001023', 'allele', 14, 'allele'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('SO_0001023', 'allele', 173, 'allele'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5579643	8/2017	S64-PMC5579643	['HOWEVER, clinical trials on Vitamin D supplementation in children and the POSSIBLE ROLE in preventing Food allergy are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('FULL_UNKNOWN', 119)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_33290', 'food', 102, 'food')]
PMC5623264	9/2017	S108-PMC5623264	['vitamin a supplementation with other Micronutrients (Iron\xa0+\xa0Folate) compared with Micronutrient supplementation without Vitamin A had a positive EFFECT and reduced the risk of lbw by 33%.24HOWEVER, THESE FINDINGS are from a study involving only hiv-positive women and when comparing Vitamin A supplementation alone versus placebo or no treatment, a reduction of lbw could NOT be OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('INCOMPLETE_EVIDENCE', 198), ('FULL_UNKNOWN', 372)]	4	[('CHEBI_33839', 'macromolecule', 37, 'micronutrients'), ('CHEBI_24870', 'ion', 53, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 60, 'folate'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 82, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin A')]
PMC5634602	10/2017	S36-PMC5634602	['IMPORTANTLY, SEVERAL STUDIES have DOCUMENTED an ASSOCIATION with decreasing 25(Oh)D levels and lower Gestational age at Delivery allowing for a situation where preterm infants are a highly vulnerable population at Birth with regards to their Vitamin D status [15,28,30].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 82, 'D'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007567', 'parturition', 120, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC5634602	10/2017	S149-PMC5634602	['our results AGREE with PREVIOUS EVIDENCE that SUPPORTS an ASSOCIATION between Vitamin D status, Gestational age, and growth in premature infants.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'gestational')]
PMC5638722	8/2017	S0-PMC5638722	['EFFECTS of Cord Blood Vitamin D levels on the RISK of neonatal sepsis in premature infants\n\nabstract\n\npurpose\nVitamin D plays a KEY ROLE in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('UBERON_0002240', 'spinal cord', 11, 'cord'), ('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 110, 'Vitamin D'), ('UBERON_0002405', 'immune system', 140, 'immune')]
PMC5638722	8/2017	S1-PMC5638722	['Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections, and low levels of circulating Vitamin D are STRONGLY ASSOCIATED with infectious diseases.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5638722	8/2017	S2-PMC5638722	['in THIS STUDY, we AIMED TO EVALUATE the EFFECTS of low Vitamin D levels in Cord Blood on neonatal sepsis in preterm infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 40)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC5638722	8/2017	S11-PMC5638722	['the OBSERVATIONS of the ASSOCIATION between infections and Vitamin D deficiency were FIRST DESCRIBED more than a century ago2).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5638722	8/2017	S13-PMC5638722	['RECENT REPORTS have SUPPORTED a ROLE for Vitamin D in promoting normal function of the innate and Adaptive Immune Systems2).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0019825', 'oxygen binding', 98, 'adaptive immune'), ('UBERON_2000139', 'immature otolith', 107, 'immune systems2')]
PMC5638722	8/2017	S22-PMC5638722	['moreover, there is a MAJORITY of epidemiological EVIDENCE INDICATING that circulating Vitamin D concentrations from Cord Blood CORRELATE indirectly with increased susceptibility to infection in newborns7).']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 116, 'cord blood')]
PMC5638722	8/2017	S23-PMC5638722	['this FINDING has led to the common HYPOTHESIS that Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5638722	8/2017	S28-PMC5638722	['moreover, there is a preponderance of epidemiological EVIDENCE INDICATING that lower Vitamin D concentrations from Cord Blood CORRELATE with INCREASED susceptibility to infections in newborns11).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 141)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0009472', 'axilla', 115, 'cord blood')]
PMC5638722	8/2017	S89-PMC5638722	['the OBSERVATIONS of the ASSOCIATION between infections and Vitamin D deficiency were FIRST DESCRIBED more than a century ago15).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5638722	8/2017	S119-PMC5638722	['one of the factors ACCEPTED as a REGULATOR is Vitamin D. in A STUDY, small for Gestational age probability was FOUND TO BE 7.5 fold higher in the babies of the mothers with <15 ng/ml Vitamin D levels23).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 60), ('ANOMALY_CURIOUS_FINDING', 111)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'gestational'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5638722	8/2017	S120-PMC5638722	['BUT, ON THE OTHER HAND, there are also studies which DID NOT FIND a RELATIONSHIP between the Pregnancy Vitamin D levels and Birth weight and length.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth')]
PMC5638722	8/2017	S125-PMC5638722	['secondly, we also DO NOT HAVE data related to OTHER dietary factors which COULD BE INTERFERING with Vitamin D level.']	[('FULL_UNKNOWN', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5638722	8/2017	S131-PMC5638722	['and thirdly, with the consideration AS the POSSIBLE EFFECT of seasonal changes in Vitamin D levels on the results, we ONLY included the babies which are Born during the summer period.']	[('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007567', 'parturition', 153, 'born')]
PMC5659607	10/2017	S15-PMC5659607	['trial registration\ncopsac2010: clinicaltrials.govnct00856947; vdaart: clinicaltrials.govnct00920621\n\nintroduction\nthere are several REASONS to HYPOTHESIZE that low in utero Vitamin D exposure increases risk of childhood asthma/recurrent wheeze: (1) Genetic studies HAVE SHOWN that polymorphisms in the Vitamin D Receptor are ASSOCIATED with childhood asthma susceptibility[1].']	[('PROBABLE_UNDERSTANDING', 132), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 325)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('SO_0000704', 'gene', 249, 'Genetic'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 302, 'vitamin D receptor')]
PMC5659607	10/2017	S22-PMC5659607	['we THEREFORE conducted a combined analysis of the two trials including the primary end-point asthma/recurrent wheeze by age 3 years as well as the secondary end-points specific Ige, total Ige, eczema and Lower Respiratory Tract infections (lrti) and did 25(Oh)D level-based analyses to determine WHETHER nutritional status at entry to the trials INFLUENCED the EFFECT of Vitamin D.\n\nmethods\nvdaart: monitored by nhlbi and copsac: approved by the ethics committee for copenhagen.']	[('PROBABLE_UNDERSTANDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('SUPERFICIAL_RELATIONSHIP', 346), ('SUPERFICIAL_RELATIONSHIP', 361)]	4	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 177, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0004905', 'articulation', 204, 'lower respiratory tract'), ('CHEBI_71657', 'versiconol acetate', 254, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 254, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC5659607	10/2017	S139-PMC5659607	['HOWEVER, EMERGING EVIDENCE arising from Lung Gene Expression data from our own lab have SUBSEQUENTLY SHOWN that Vitamin D already has EFFECTS at the stage of Branching Morphogenesis of the fetal Lung occurring in the first Trimester of Pregnancy prior to randomization in both these trials[2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('UBERON_0002048', 'lung', 40, 'lung'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0001763', 'morphogenesis of a branching structure', 158, 'branching morphogenesis'), ('UBERON_0002048', 'lung', 195, 'lung'), ('GO_0009294', 'DNA mediated transformation', 223, 'trimester'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC5664622	9/2017	S65-PMC5664622	['other factors RELATED to Serum Vitamin D concentration\nmultivariate regression analysis REVEALED that, apart from the season of the year, Vitamin D concentration was AFFECTED by the following FACTORS: maternal use of Vitamin D supplements, weight gain in Pregnancy, Gestational diabetes mellitus (gdm), and—in case of Cord Blood—also with Maternal age.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 166), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('UBERON_0001977', 'blood serum', 25, 'Serum'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007565', 'female pregnancy', 266, 'gestational'), ('UBERON_0002240', 'spinal cord', 318, 'cord'), ('UBERON_0000178', 'blood', 323, 'blood'), ('GO_0007618', 'mating', 339, 'maternal')]
PMC5664622	9/2017	S83-PMC5664622	['reports from OTHER european countries also FOUND a TENDENCY for higher Vitamin D levels among Pregnant women during summer, e.g., in germany which is located at a similar latitude as poland [20], as well as countries with very DIFFERENT geographic location and sun exposure, such as greece [12], or norway [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant')]
PMC5664622	9/2017	S110-PMC5664622	['in OUR STUDY, we CONFIRMED DETRIMENTAL EFFECTS of excessive weight gain in Pregnancy which results in diminished Vitamin D concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5664622	9/2017	S128-PMC5664622	['we also DID NOT investigate pre-Pregnancy Vitamin D intake, which MAY have had SOME IMPACT on its concentration in the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5679631	11/2017	S89-PMC5679631	['use of multivitamin supplements containing Vitamin D and maternal obesity were ASSOCIATED with maternal 25(Oh)D level during both low and high seasons, WHILE recruitment group was significantly ASSOCIATED with 25(Oh)D concentration ONLY during the high season.10.1371/journal.pone.0188011.t002\n\ncaption (table-wrap): table 2\nmean maternal 25(Oh)D concentration according to season of Blood sampling and use of multivitamin supplements containing Vitamin D.Blood sampling in high season of cutaneous Vitamin D productionblood sampling in low season of cutaneous Vitamin D production maternal use of multivitamin supplement containing Vitamin Dmaternal Plasma 25(Oh)d nmol/lmaternal Plasma 25(Oh)D nmol/l no (mean (sd))45.2 (17.0)30.1 (13.5)yes (mean (sd))53.3 (17.8)40.9 (16.1)p value&p = 0.000p = 0.000model # beta (95% ci)beta (95% ci) constant52.7 (47.7, 57.7)34.6 (29.5, 39.7)maternal use of multivitamin supplement containing Vitamin D (yes vs .']	[('SUPERFICIAL_RELATIONSHIP', 79), ('ANOMALY_CURIOUS_FINDING', 152), ('SUPERFICIAL_RELATIONSHIP', 194), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 210, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 339, '25 ... OH ... D'), ('UBERON_0000178', 'blood', 384, 'blood'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('UBERON_0000178', 'blood', 456, 'Blood'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_61716', 'alpha-Kdo-CH2OH-(2->4)-alpha-Kdo', 633, 'vitamin DMaternal'), ('UBERON_0001969', 'blood plasma', 651, 'Plasma'), ('CHEBI_63056', 'zinc cation', 658, '25(OH'), ('UBERON_0001969', 'blood plasma', 681, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 688, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin D')]
PMC5679631	11/2017	S117-PMC5679631	['the abundance of several bacterial taxa in infant Fecal samples at one month after Birth was shown to be ASSOCIATED with pre- or Postnatal Vitamin D exposure, supporting the POSTULATION that Vitamin D CAN INFLUENCE the composition of the Intestinal microbiota.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 201), ('SUPERFICIAL_RELATIONSHIP', 205)]	4	[('UBERON_0000922', 'embryo', 50, 'fecal'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 129, 'postnatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000160', 'intestine', 238, 'intestinal')]
PMC5679631	11/2017	S122-PMC5679631	['the function of Vitamin D in Regulating Amp Production, THEREFORE, SUGGESTS that Vitamin D status COULD INFLUENCE the composition of the Intestinal microbiota.']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0065007', 'biological regulation', 29, 'regulating'), ('CHEBI_16027', "adenosine 5'-monophosphate", 40, 'AMP'), ('GO_0006754', 'ATP biosynthetic process', 40, 'AMP production'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000160', 'intestine', 137, 'intestinal')]
PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC5679631	11/2017	S131-PMC5679631	['investigations studying the EFFECT of Vitamin D status on the composition of the Intestinal microbiota are FEW; ONE STUDY was performed in Vitamin D deficient Mice and two investigations in Humans examined the ROLE of Vitamin D as secondary questions.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 210)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000160', 'intestine', 81, 'intestinal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 190, 'humans'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5679631	11/2017	S138-PMC5679631	['the INFLUENCE of direct Vitamin D supplementation of the child DIFFERED between the two recruitment groups SUGGESTING that lifestyle factors are Modulating the ASSOCIATION between Vitamin D and the Intestinal bacterial Taxa.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 145, 'modulating'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('UBERON_0000160', 'intestine', 198, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'taxa')]
PMC5679631	11/2017	S142-PMC5679631	['g ., health ISSUES leading to the choice of an alternative lifestyle, COULD BE modifying the EFFECT of Vitamin D on the Intestinal bacteria and, THEREFORE, recruitment group was adjusted for in the multivariable analyses.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 145)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000160', 'intestine', 120, 'intestinal')]
PMC5679631	11/2017	S161-PMC5679631	['the INFLUENCE of Postnatal Vitamin D supplementation MERITS to BE analyzed in a larger group of older infants and with extensive microbial profiling approach.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 53), ('ANOMALY_CURIOUS_FINDING', 63)]	4	[('GO_0007567', 'parturition', 17, 'postnatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5706533	11/2017	S96-PMC5706533	['higher regular dose regimens (≥2000 iu/day) LED TO a greater average increment in Maternal Delivery and Cord 25(Oh)D than lower doses (tables s1 and s2 in appendix 10); HOWEVER, the linear dose-response curves for maternal and Cord Blood INDICATED modest EFFECTS of increasing Vitamin D doses on the increment in 25(Oh)D concentrations (fig s2 and s4 in Appendix 10).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 238), ('SUPERFICIAL_RELATIONSHIP', 255)]	4	[('GO_0007618', 'mating', 82, 'maternal'), ('GO_0007567', 'parturition', 91, 'delivery'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('CHEBI_71657', 'versiconol acetate', 109, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 109, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 227, 'cord'), ('UBERON_0000178', 'blood', 232, 'blood'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('UBERON_0001154', 'vermiform appendix', 354, 'appendix')]
PMC5707701	11/2017	S166-PMC5707701	['SOME nutritional, obstetric, and socio-economic factors HAVE BEEN IMPLICATED as being ASSOCIATED with the Vitamin A and E concentrations in milk [36,39,60].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 106, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'E')]
PMC5707701	11/2017	S171-PMC5707701	['our results were SIMILAR with the PREVIOUS FINDING [37] that the percentage of body fat in the Lactating women was negatively ASSOCIATED to the concentration of Vitamin A in Breast Milk.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007594', 'puparial adhesion', 95, 'lactating'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 174, 'breast milk')]
PMC5707701	11/2017	S183-PMC5707701	['secondly, LITTLE IS KNOWN about the levels of Vitamins A and E in maternal Plasma ASSOCIATED with the corresponding Milk, which would be better than dietary Intake to assess maternal Nutrient status, DUE TO the IMPOSSIBILITY to collect such samples in our research.']	[('FULL_UNKNOWN', 10), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBLEM_COMPLICATION', 200), ('PROBLEM_COMPLICATION', 211)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 46, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 61, 'E'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('UBERON_0001913', 'milk', 116, 'milk'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('CHEBI_33284', 'nutrient', 183, 'nutrient')]
PMC5732505	12/2017	S2-PMC5732505	['our OBJECTIVE was to compare maternal 25-Hydroxy Vitamin D concentrations [25(Oh)D] between mothers with and without gdm, and TO INVESTIGATE IF an ASSOCIATION existed between maternal Vitamin D concentration and infant Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007567', 'parturition', 219, 'birth')]
PMC5732505	12/2017	S160-PMC5732505	['a POSSIBLE EXPLANATION for this MIGHT be a u-shaped ASSOCIATION between maternal Vitamin D concentration and fetal outcomes in a population with sufficient Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5732505	12/2017	S163-PMC5732505	['in MANY previous STUDIES, participants had various ethnic backgrounds which COULD AFFECT both Vitamin D status and their RISK of gdm [7,38].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 121)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5738092	12/2017	S123-PMC5738092	['OUR STUDY REVEALED that all the maternal variables EXAMINED, except Vitamin A and Β- Carotene supplement receipt during Pregnancy, were significantly ASSOCIATED with Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 82, 'β- carotene'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('GO_0007567', 'parturition', 166, 'birth')]
PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
PMC5758521	1/2018	S13-PMC5758521	['SURPRISINGLY, high-dose Vitamin E (Α-Tocopherol) supplementation HAS BEEN ASSOCIATED with increased risk of low Birth weight8– a condition LINKED to Insulin-Like Growth Factor I (Igf-I) insufficiency9.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin E'), ('CHEBI_27725', 'butin', 35, 'α-tocopherol'), ('GO_0007567', 'parturition', 112, 'birth'), ('PR_000045358', 'insulin family protein', 149, 'insulin'), ('PR_000009659', 'laminin subunit gamma-2', 157, 'like growth factor I'), ('PR_000008919', 'interferon alpha-6', 179, 'IGF-I')]
PMC5758521	1/2018	S131-PMC5758521	['a RECENT STUDY in Mice SUGGESTS that Vitamin A deficiency MAY AFFECT fetal Islet Development27.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 62)]	4	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('CL_0000214', 'synovial cell', 75, 'islet'), ('GO_0036165', 'invasive growth in response to heat', 75, 'islet development27'), ('UBERON_0002533', 'post-anal tail bud', 75, 'islet')]
PMC5784894	1/2018	S0-PMC5784894	['early Life Vitamin D depletion alters the Postnatal response to Skeletal loading in Growing and mature bone\n\nabstract\nthere is INCREASING EVIDENCE of persistent EFFECTS of early Life Vitamin D exposure on later Skeletal health; LINKING low levels in early Life to smaller bone size in childhood as well as increased fracture risk later in Adulthood, INDEPENDENTLY of later Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 350)]	4	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'postnatal'), ('UBERON_0004288', 'skeleton', 64, 'skeletal'), ('GO_0040007', 'growth', 84, 'growing'), ('UBERON_0000104', 'life cycle', 178, 'life'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0004288', 'skeleton', 211, 'skeletal'), ('UBERON_0000104', 'life cycle', 256, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 339, 'adulthood'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5784894	1/2018	S137-PMC5784894	['in THIS STUDY we HAVE SHOWN that early Life Vitamin D deficiency LEADS to decreased bone strength and negatively IMPACTS structure in the bone of Growing and mature female Mice.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('UBERON_0000104', 'life cycle', 39, 'life'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0040007', 'growth', 146, 'growing'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
PMC5812027	2/2018	S14-PMC5812027	['THUS, both higher Vitamin D status in late Pregnancy and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC5812027	2/2018	S24-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and neonatal Birth size is NOT CLEAR and WARRANTS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 88)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'birth')]
PMC5812027	2/2018	S28-PMC5812027	['lower Vitamin D status HAS also BEEN ASSOCIATED with a medical history of recurrent Miscarriage [12] BUT ONLY two prospective studies have INVESTIGATED this, without finding that lower 25Ohd concentrations increases the risk of Pregnancy Loss [5,13].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 139)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 84, 'miscarriage'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5812027	2/2018	S30-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and risk of Miscarriage NEEDS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 71), ('FUTURE_WORK', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 59, 'miscarriage')]
PMC5812027	2/2018	S115-PMC5812027	['THUS, preeclampsia does not SEEM to MEDIATE the ASSOCIATIONS between Vitamin D status trajectory and neonatal Birth size or Preterm Birth.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('GO_0007565', 'female pregnancy', 124, 'preterm birth')]
PMC5812027	2/2018	S131-PMC5812027	['we DID NOT SEE a u-shaped ASSOCIATION between early Pregnancy Vitamin D status and sga, as PREVIOUSLY INDICATED [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102)]	4	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5831579	3/2018	S104-PMC5831579	['fruits and vegetables, foods that require preparation, protein, Carbohydrate, Nutrients related to One-Carbon Metabolism pathway, Dha, Vitamin D, iron, sodium, Calcium and Caffeine were more strongly CORRELATED to the ‘seasoned vegetables and lean meats,’ which was the dietary pattern that COULD CONTRIBUTE MOST to a healthy pre-Pregnancy nutrition [9,17–20], followed by ‘lentils, whole grains and soups’ pattern.']	[('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 297), ('PROBABLE_UNDERSTANDING', 308)]	4	[('CHEBI_16730', 'chloramphenicol 3-acetate', 64, 'carbohydrate'), ('CHEBI_33284', 'nutrient', 78, 'nutrients'), ('GO_0006730', 'one-carbon metabolic process', 99, 'one-carbon metabolism'), ('CHEBI_17874', 'dihydrozeatin', 130, 'DHA'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 160, 'calcium'), ('CHEBI_27732', 'caffeine', 172, 'caffeine'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy')]
PMC5838372	3/2018	S1-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D concentrations after a support programme for Pregnant women was introduced.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant')]
PMC5838372	3/2018	S27-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D status, following the introduction of the support programme for pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5838372	3/2018	S115-PMC5838372	['as MIGHT BE EXPECTED PREVIOUS STUDIES HAVE SHOWN a strong CORRELATION between maternal and neonatal levels of Vitamin D (8,9).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5838372	3/2018	S118-PMC5838372	['SIMILARLY, we FOUND a strong positive CORRELATION between the mothers’ and their babies’ Vitamin D levels and low level of Vitamin D in mother was an important RISK FACTOR for deficiency in infants.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5838372	3/2018	S120-PMC5838372	['HOWEVER, mothers’ low Vitamin intake was FOUND AS a RISK FACTOR for the infants’ Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_33229', 'vitamin (role)', 22, 'vitamin'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5941617	5/2018	S2-PMC5941617	['indeed, RECENT DATA SUGGEST a POSSIBLE ROLE of Vitamin D in the pathogenesis of several pathological conditions, including infectious, allergic and Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 148, 'autoimmune')]
PMC5941617	5/2018	S141-PMC5941617	['in 2013 the aap RECOMMENDED a daily Vitamin D intake of 200–400\xa0iu for vlbw infants, AS their smaller size MAY LEAD TO a lower need for Vitamin D to ensure adequate Serum 25(Oh)D levels.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 111)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_71657', 'versiconol acetate', 171, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D')]
PMC5941617	5/2018	S174-PMC5941617	['following the publication of sacn review of the EVIDENCE on Vitamin D and health [25], public health england advised that uk children aged 1 to 4\xa0years should receive Vitamin D supplementation at 400\xa0iu/day, and older children and adolescents SHOULD take a daily supplement containing 400\xa0iu of Vitamin D in autumn and winter to PROTECT bone and muscle health because it is DIFFICULT to meet this intake from dietary sources.']	[('INCOMPLETE_EVIDENCE', 48), ('FUTURE_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 329), ('DIFFICULT_TASK', 374)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5941617	5/2018	S208-PMC5941617	['children of immigrants living in industrialized countries are at INCREASED RISK of rickets BECAUSE they USUALLY present several RISK FACTORS for Vitamin D deficiency such as prolonged breastfeeding without vitamin d supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 65), ('PROBABLE_UNDERSTANDING', 91), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5941617	5/2018	S264-PMC5941617	['HOWEVER, the EFFECT of supplementation became significant on total body bmc and Lumbar Spine bmd by dividing the sample into two groups, depending on Vitamin D status [25(Oh)D levels <\u200914\xa0ng/ml vs. ≥ 14\xa0ng/ml], SUGGESTING that Vitamin D supplementation MAY result in a clinically significant increase in bone mass in subjects with Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 253)]	4	[('UBERON_0006074', 'lumbar region of vertebral column', 80, 'lumbar spine'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC5941617	5/2018	S272-PMC5941617	['maternal Vitamin D status during Pregnancy MAY significantly INFLUENCE fetal and neonatal bone mass, as RECENTLY CONFIRMED by the sacn [25].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 113)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy')]
PMC5941617	5/2018	S275-PMC5941617	['these results CONFIRMED that maternal Vitamin D status MAY AFFECT bone Mineral accrual during the Intrauterine Period and INFLUENCE bone size [230].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_46662', 'mineral', 71, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 98, 'intrauterine period')]
PMC5941617	5/2018	S290-PMC5941617	['SOME authors also POSTULATED that the lower Vitamin D production in winter MIGHT CONTRIBUTE to the marked seasonality of epidemic influenza [251].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S291-PMC5941617	['OBVIOUSLY, the more ROBUST EVIDENCES on the ASSOCIATION between Vitamin D deficiency and Respiratory infections stem from prospective studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 89, 'respiratory')]
PMC5941617	5/2018	S297-PMC5941617	['OTHER STUDIES have FOUND an inverse ASSOCIATION between Vitamin D concentrations in Pregnancy and the RISK of Respiratory infections in newborns or children during the first 3\xa0years of life [253,254].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 102)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory')]
PMC5941617	5/2018	S317-PMC5941617	['in an usa study a SIMILAR ASSOCIATION was OBSERVED between skin or soft Tissue infections by staphylococcus aureus strains and Vitamin D levels [25(Oh)D\u2009<\u200930\xa0ng/ml] in 202 children [276].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 42)]	4	[('UBERON_0000479', 'tissue', 72, 'tissue'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D')]
PMC5941617	5/2018	S326-PMC5941617	['evaluated more than 900 infected children and OBSERVED that Vitamin D-RELATED host Genetic variants MAY alter the availability and activity of Vitamin D and are ASSOCIATED with risk of hiv disease progression in children [284].']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 83, 'genetic'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5941617	5/2018	S333-PMC5941617	['an italian rct was performed TO TEST WHETHER Vitamin D3Supplementation (oral 100000\xa0iu every 3\xa0months for 4 doses) COULD improve Vitamin D status and AFFECT the t-Cell phenotype in hiv-infected patients aged 8 to 26\xa0years with Serum 25(Oh) D\u2009<\u200930\xa0ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_52915', 'phosphatediyl group', 45, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CL_0000622', 'acinar cell', 162, '-cell'), ('UBERON_0001977', 'blood serum', 227, 'serum'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH) D')]
PMC5941617	5/2018	S341-PMC5941617	['significant ASSOCIATION between active tuberculosis and Vitamin D deficiency [25(Oh)D levels <\u200920\xa0ng/ml] HAS BEEN EVIDENCED in an australian study including 91 children with latent or active tuberculosis and 236 controls [296], SIMILARLY TO one uk study [297].']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 78, '25(OH)D')]
PMC5941617	5/2018	S357-PMC5941617	['SEVERAL STUDIES SHOWED that Vitamin D deficiency in utero and in early Life was ASSOCIATED with an increase in Th2 Lymphocyte Cells and a reduction in T Regulatory Cells and Production Of Interleukin (Il)-10, which subsequently MAY activate pro-inflammatory Cytokine Production through Macrophages and Dendritic Cells [306–308].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000546', 'T-helper 2 cell', 111, 'Th2 lymphocyte cells'), ('CL_0000902', 'induced T-regulatory cell', 151, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 153, 'regulatory'), ('GO_0030154', 'cell differentiation', 174, 'production of interleukin ... IL ... 10'), ('PR_000001470', 'interleukin-28B', 188, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 201, 'IL)-10'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 258, 'cytokine production'), ('CL_0000235', 'macrophage', 286, 'macrophages'), ('CL_0000451', 'dendritic cell', 302, 'dendritic cells')]
PMC5941617	5/2018	S359-PMC5941617	['furthermore, PREVIOUS STUDIES focused on the ASSOCIATION between Serum 25(Oh)D levels and the Expression of Genes INVOLVED in the Proliferation and Cells Differentiation, showing an anti-proliferative activity of Vitamin D with CONSEQUENTLY remodeling inhibition [309–312].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 228)]	4	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 77, 'D'), ('GO_0010467', 'gene expression', 94, 'expression'), ('SO_0000704', 'gene', 108, 'genes'), ('GO_0007565', 'female pregnancy', 130, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 148, 'cells differentiation'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5941617	5/2018	S366-PMC5941617	['OBSERVATIONAL studies on the RELATIONSHIP between Vitamin D in Pregnancy and wheezing, asthma, and allergies Development in early Life SHOWED UNCLEAR results.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 135), ('FULL_UNKNOWN', 142)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('GO_0048513', 'animal organ development', 109, '... development'), ('UBERON_0000104', 'life cycle', 130, 'life')]
PMC5941617	5/2018	S370-PMC5941617	['in 966 children DEMONSTRATED that Vitamin D deficiency [Serum 25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] was the MAJOR PREDICTIVE factor of asthma RISK [327], and gale et al.']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 91), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 125)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 62, '25(OH ... D')]
PMC5941617	5/2018	S378-PMC5941617	['RECENTLY, three studies SHOWED a positive CORRELATION between Vitamin D supplementation and the improvement of asthma Control [335–337], accordingly with two RECENT meta-analyses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 158)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0065007', 'biological regulation', 118, 'control')]
PMC5941617	5/2018	S397-PMC5941617	['in pediatric population there is SOME EVIDENCE about a favourable EFFECT of administration of Vitamin D on several aspects of ad, but results are STILL CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5941617	5/2018	S406-PMC5941617	['DATA from ongoing intervention trials ARE WARRANTED to establish the extent of Vitamin D POTENTIALLY preventive EFFECT, along with the best timing and dose of an intervention.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5941617	5/2018	S419-PMC5941617	['data on polymorphisms of OTHER Genes INVOLVED in Vitamin D Metabolism are still CONFLICTING or RELATED to small populations [373–376].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('SO_0000704', 'gene', 31, 'genes'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism')]
PMC5941617	5/2018	S485-PMC5941617	['THUS, several authors have SUGGESTED that Vitamin D deficiency COULD play a ROLE in worsening the comorbidities of pediatric obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S593-PMC5941617	['on the CONTRARY a stoss therapy (Oral single-dose of 10000\xa0iu/kg or 300000\xa0iu of Vitamin D3) HAS BEEN DEMONSTRATED EFFECTIVE and SAFE in the treatment of Vitamin D deficiency in older children (mean age 10.6\u2009±\u20094.4\xa0years) without rickets [523].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 115), ('IMPORTANT_CONSIDERATION', 129)]	4	[('UBERON_0000165', 'mouth', 33, 'oral'), ('CHEBI_33279', 'vitamin D5', 81, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 81, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5941617	5/2018	S649-PMC5941617	['Skeletal actions of Vitamin D\n\nnutritional rickets\n\nchildren of immigrants living in industrialized countries are at INCREASED RISK of nutritional rickets BECAUSE they USUALLY present several risk FACTORS for vitamin d deficiency such as prolonged breastfeeding without Vitamin D supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 197)]	4	[('UBERON_0004288', 'skeleton', 0, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC5956785	5/2018	S108-PMC5956785	['reviewsuggests severe jra has an INFLUENCE on bone mass POSSIBLY MEDIATED by a decrease in active Vitamin D Metabolites.study duration one year, controls ONLY measured at baseline 25(Oh)D 92\u2009±\u200917.5\xa0nmol/l n \u2009=\u200920huddinge, sweden johansson et al.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_25212', 'metabolite', 108, 'metabolites'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D')]
PMC5956785	5/2018	S123-PMC5956785	['age, ethnicity, season, bmi ASSOCIATED with 25(Oh)D BUT NOT Vitamin D deficiency.no association with whole sample; SMALL negative ASSOCIATION for new onset jia; mean time since onset 28\xa0months.helinski, finland markula-patjas et al.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 52), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 46, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC5956785	5/2018	S183-PMC5956785	['ONE STUDY (26.3%) SHOWED the OPPOSITE RELATIONSHIP; those with active disease had higher Vitamin D concentrations than those with inactive disease [34].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 38)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5956785	5/2018	S192-PMC5956785	['to date, the EVIDENCE TO SUPPORT a RELATIONSHIP between Vitamin D and disease activity with Autoimmune diseases in Humans is CORRELATIVE and not causative [71].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 92, 'autoimmune'), ('NCBITaxon_9606', 'Homo sapiens', 115, 'humans')]
PMC5956785	5/2018	S230-PMC5956785	['the ROLE of Vitamin D in MEDIATING bone health, especially in RELATION to Corticosteroids, HAS BEEN established [75].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 74, 'corticosteroids')]
PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]
PMC5956785	5/2018	S265-PMC5956785	['these variables CAN make it DIFFICULT to interpret the RELATIONSHIP between Vitamin D and disease activity in RELATION to both inflammation status and risk of relapse.']	[('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 28), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5956785	5/2018	S271-PMC5956785	['this review was UNABLE TO explore the RELATIONSHIP between Vitamin D status and ethnicity, Vitamin D receptor Genes or OTHER Genes that INFLUENCE Vitamin D Metabolism.']	[('DIFFICULT_TASK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('SO_0000704', 'gene', 110, 'genes'), ('SO_0000704', 'gene', 125, 'genes'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 146, 'vitamin D metabolism')]
PMC6011374	6/2018	S12-PMC6011374	['background\nwith an increasing prevalence of Vitamin D deficiency and insufficiency reported both in australia and new zealand, as well as worldwide [1], there is CONTINUING INTEREST in determining HOW Vitamin D deficiency MAY INFLUENCE health in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 162), ('EXPLICIT_QUESTION', 197), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S14-PMC6011374	['HOWEVER, INCONSISTENCIES between studies reflect UNCERTAINTY about the true EFFECT of Vitamin D deficiency on Pregnancy outcome [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FULL_UNKNOWN', 49), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC6043562	7/2018	S8-PMC6043562	['we IDENTIFIED a POTENTIAL synergistic INTERACTION (p\u2009=\u20090.02) between Vitamin E (Food\u2009+\u2009supplements) and Pm2.5; this exposure combination was ASSOCIATED with further increases in Feno levels.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CHEBI_33290', 'food', 80, 'food'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 104, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 178, 'FeNO')]
PMC6043562	7/2018	S225-PMC6043562	['we MODELLED all Nutrients in the same exposure group except Vitamin E and Β-Carotene, which DEMONSTRATED ASSOCIATIONS with Feno in the direction OPPOSITE to that observed for other Nutrients.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145)]	4	[('CHEBI_33284', 'nutrient', 16, 'nutrients'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('CHEBI_28660', '(-)-alpha-pinene', 74, 'β-Carotene'), ('CHEBI_32035', 'potassium hydroxide', 123, 'FeNO'), ('CHEBI_33284', 'nutrient', 181, 'nutrients')]
BMJ_2010_Apr_29_340_c1640	4/2010	S85-BMJ_2010_Apr_29_340_c1640	['this PROXY has some LIMITATIONS in that it DOES NOT take into account individual personal behaviour, concurrent dietary Vitamin D intake, or skin pigmentation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 43)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC1361787	12/2005	S11-PMC1361787	['maternal Intake of Carbohydrates and protein [3], Fatty Acids [4], and Micronutrients such as zinc [5-7], iron [2], magnesium [8-10], Calcium [11], riboflavin [4], and Vitamin C [12]MAY also have IMPORTANT EFFECTS on fetal growth and Perinatal outcomes.']	[('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 196), ('SUPERFICIAL_RELATIONSHIP', 206)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_16646', 'carbohydrate', 19, 'carbohydrates'), ('CHEBI_35366', 'fatty acid', 50, 'fatty acids'), ('CHEBI_33839', 'macromolecule', 71, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 134, 'calcium'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin C'), ('GO_0036268', 'swimming', 234, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 234, 'perinatal')]
PMC1533075	6/1998	S9-PMC1533075	['mothers also took individual Micronutrient supplements (e.g., Vitamin C tablets), but most mothers who took these also took multivitamins, making it IMPOSSIBLE to determine POTENTIAL independent EFFECTS of these Micronutrients.']	[('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 195)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 29, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('PR_000004900', 'complement C3', 70, 'C'), ('CHEBI_33839', 'macromolecule', 212, 'micronutrients')]
PMC2151954	10/2007	S173-PMC2151954	['secondly, a nonlinear exposure-risk RELATIONSHIP between maternal Vitamin D levels and neonatal anthropometry HAS BEEN FOUND [22].']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 119)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC2265059	3/2008	S37-PMC2265059	['for example, in australia,mcgrath and colleagues (2005b)SUGGESTED that Prenatal Vitamin D ASSOCIATED with maternal exposure to sunlight is ASSOCIATED with the seasonal variation in Birth weight.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC2290997	4/2008	S75-PMC2290997	['“SCIENTIFIC EVIDENCE on specific EFFECTS of Vitamin D in preventing ms or slowing its progression is not SUFFICIENT,” says alberto ascherio, a nutritional epidemiologist at the harvard school of public health.']	[('INCOMPLETE_EVIDENCE', 1), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 105)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2290997	4/2008	S192-PMC2290997	['in short, there is no real specificity for ambient uvr.”\nresearchers also ASSESS history of time in the sun at various ages, history of sunburns, dietary and supplemental Vitamin D intake, and OTHER PROXY measures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC2396486	6/2008	S97-PMC2396486	['discussion\ndevelopmental Vitamin D deficiency is ASSOCIATED with a subtle alteration in the Expression of protein INVOLVED in functions RELATED to calcium binding proteins, and Mitochondrial functioning.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010467', 'gene expression', 92, 'expression'), ('GO_0005739', 'mitochondrion', 177, 'mitochondrial')]
PMC2581757	11/2008	S13-PMC2581757	['HOWEVER, in a recent review, antioxidant therapy HAS BEEN SUGGESTED and that the prophylactic supplementation of Vitamins C and E to Pregnant women is ASSOCIATED with reduced incidence of preeclampsia and decreased Placental and Endothelial dysfunction [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 151)]	3	[('CHEBI_27300', 'vitamin D', 113, 'vitamins C'), ('PR_000004900', 'complement C3', 122, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 128, 'E'), ('GO_0007565', 'female pregnancy', 133, 'pregnant'), ('UBERON_0001987', 'placenta', 215, 'placental'), ('UBERON_0001986', 'endothelium', 229, 'endothelial')]
PMC2581757	11/2008	S18-PMC2581757	['the latter study does not SUPPORT the HYPOTHESIS of a causal RELATIONSHIP between decreased dietary Vitamin E consumption and Plasma levels and the development of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 126, 'plasma'), ('GO_0007128', 'meiotic prophase I', 163, 'preeclampsia')]
PMC2581757	11/2008	S45-PMC2581757	['group b initially consisted of a high number of patients who were viewed as being at an INCREASED RISK of preeclampsia BECAUSE of FACTORS such as preeclampsia in a preceding Pregnancy, hellp syndrome, or eclampsia in any past Pregnancy at any Gestational stage, and who were taking additional Vitamin supplement (1000\xa0mg Vitamin C plus 400\xa0iu Vitamin E per day) from the second Trimester of Pregnancy to Delivery as mentioned for the controls (placebo).']	[('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 119), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('GO_0007565', 'female pregnancy', 174, 'pregnancy'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('GO_0007565', 'female pregnancy', 243, 'gestational'), ('CHEBI_33229', 'vitamin (role)', 293, 'vitamin'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin E'), ('GO_0009294', 'DNA mediated transformation', 378, 'trimester'), ('GO_0007565', 'female pregnancy', 391, 'pregnancy'), ('GO_0007567', 'parturition', 404, 'delivery')]
PMC2581757	11/2008	S179-PMC2581757	['a comparison of these two groups REVEALED a significant difference (22–29%), which SHOWS that Vitamins C and E consumption PREVENTED the fall in Grx activity.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 94, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 109, 'E'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 145, 'GRx')]
PMC2582131	11/2008	S0-PMC2582131	['Maternal Plasma 25-Hydroxyvitamin D concentrations and the risk for Gestational diabetes mellitus\n\nabstract\n\nbackground\nEVIDENCE is ACCUMULATING for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 151)]	3	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001969', 'blood plasma', 9, 'Plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 16, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 68, 'Gestational'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_17234', 'glucose', 191, 'glucose'), ('GO_0042593', 'glucose homeostasis', 191, 'glucose homeostasis')]
PMC2582131	11/2008	S21-PMC2582131	['data on the ROLE of Vitamin D in Glucose Homeostasis during Pregnancy and the development of Gestational Diabetes Mellitus (gdm) are SCANT and findings are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('GO_0042593', 'glucose homeostasis', 33, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0035193', 'larval central nervous system remodeling', 93, 'gestational diabetes mellitus')]
PMC2582131	11/2008	S93-PMC2582131	['for instance, Endogenous Production Of Vitamin D In the Skin due to sun exposure is a MAJOR source of Plasma 25-[Oh] D. sun exposure could be positively CORRELATED with outdoor physical activity, a PROTECTIVE FACTOR for Insulin resistance and gdm[32]–[34].']	[('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('GO_0009790', 'embryo development', 14, 'endogenous'), ('GO_1902907', 'proteasome storage granule disassembly', 25, 'production of vitamin D in ... skin'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 109, '25-[OH] D'), ('PR_000045358', 'insulin family protein', 220, 'insulin')]
PMC2582131	11/2008	S121-PMC2582131	['such EVIDENCE is valuable in view of the LIMITED prospective DATA on the RELATION of circulating Vitamin D status to impaired Glucose tolerance in either Pregnant or non-Pregnant Individuals.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('NCBITaxon_1', 'root', 179, 'individuals')]
PMC2606998	6/2007	S12-PMC2606998	['in the industrialized countries, Intake of Folate, Vitamin\u2009D and iron, all with a SUGGESTED IMPACT on Pregnancy outcome, HAS BEEN REPORTED to be low in Pregnant women3–5.']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 121)]	3	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 43, 'folate'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 152, 'pregnant')]
PMC2671168	5/2009	S214-PMC2671168	['IN FACT, supplementation with some Micronutrients, such as Vitamins C and e, was ASSOCIATED with INCREASED RISK of low Birth weight[55].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_33839', 'macromolecule', 35, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 59, 'vitamins C'), ('PR_000004900', 'complement C3', 68, 'C'), ('GO_0007567', 'parturition', 119, 'birth')]
PMC2722583	1/2009	S117-PMC2722583	['iron deficiency is an IMPORTANT RISK FACTOR for increased maternal mortality, low Birth weight and Preterm Delivery (brabin et al 2001) and the availability of calcium, Iodine, Folate and Vitamins A and D MAY Modulate fetal development (bartley et al 2005).']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('CHEBI_24859', 'iodine atom', 169, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 177, 'folate'), ('CHEBI_27300', 'vitamin D', 188, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('GO_0065007', 'biological regulation', 209, 'modulate')]
PMC2798111	12/2010	S25-PMC2798111	['while the parent randomized clinical trial will not be completed until 2011, it is ESSENTIAL to report PRELIMINARY DATA on the EFFECTIVENESS of one drop per day dosing of Vitamin D to aid clinicians in their decision-making process concerning Vitamin D preparations for infants.']	[('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC2798111	12/2010	S105-PMC2798111	['WHILE prescription of a Vitamin or medication and changes in Blood levels of that vitamin or medication, in this case, Vitamin D does NOT prove direct causality, the change in circulating 25(Oh)D status was INDEPENDENT of season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 134), ('SUPERFICIAL_RELATIONSHIP', 207)]	3	[('CHEBI_33229', 'vitamin (role)', 24, 'vitamin'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
PMC2821652	2/2010	S125-PMC2821652	['our analytic technique, HOWEVER, is UNIQUE in that it utilizes the pharmacokinetics of Vitamin D Metabolism to PREDICT adherence, and the data are then compared to pill counts.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('ANOMALY_CURIOUS_FINDING', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 97, 'metabolism')]
PMC2841444	2/2010	S484-PMC2841444	['the RECENT lancet nutrition series IDENTIFIED neonatal Vitamin A supplementation in south asia were ASSOCIATED with a significant reduction in infant mortality at 6 months [245].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A')]
PMC2841444	2/2010	S500-PMC2841444	['EVIDENCE SUPPORTING the use of injectable Vitamin K (Phytomenadione) shortly after Birth to prevent hemorrhage-RELATED morbidity and mortality was accumulated before rcts were widely adopted, being based on observational studies.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin K'), ('CHEBI_71323', 'alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 53, 'phytomenadione'), ('GO_0007567', 'parturition', 83, 'birth')]
PMC2872349	4/2010	S94-PMC2872349	['in developing populations, OFTEN the Nutrient in short supply is Calcium RATHER than Vitamin D: children of mothers, in a mother-offspring cohort study in pune, india [42], who had a higher frequency of Intake of Calcium-rich Foods during Pregnancy had higher total and Lumbar Spine bmc and areal bmd, INDEPENDENT of parental size and bone composition.']	[('PROBABLE_UNDERSTANDING', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('SUPERFICIAL_RELATIONSHIP', 302)]	3	[('CHEBI_33284', 'nutrient', 37, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 65, 'calcium'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 203, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 213, 'calcium'), ('CHEBI_33290', 'food', 226, 'foods'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('UBERON_0006074', 'lumbar region of vertebral column', 270, 'lumbar spine')]
PMC2873552	4/2010	S131-PMC2873552	["second, in addition to mcgrace's list of diseases, Animal MODEL studies and epidemiological surveys have FURTHER LINKED Vitamin D insufficiency to Cardiovascular disease and Inflammatory Bowel disease [17,30,31], as well as abnormal Brain Development [31]."]	[('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 51, 'animal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 147, 'cardiovascular'), ('UBERON_0001782', 'pigmented layer of retina', 174, 'inflammatory bowel'), ('GO_0007420', 'brain development', 233, 'brain development'), ('UBERON_0000955', 'brain', 233, 'brain')]
PMC2889879	5/2010	S1-PMC2889879	['our AIM was TO EVALUATE the ASSOCIATION between the Intake of different fish species, Pufa and Vitamin D and the prevalence of psychotic-like symptoms in a population-based study among swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 28)]	3	[('GO_0007631', 'feeding behavior', 52, 'intake'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 86, 'PUFA'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC2889879	5/2010	S127-PMC2889879	['caption (table-wrap): table 4\n\nrelative risk of positive psychotic-like symptoms in relation to estimated dietary intake of vitamin Ddietary intake g/day·mjpositive psychotic-like symptomsamedianinterquintile rangelow level groupmiddle level grouphigh level group energy adjustedmultivariatebenergy adjustedmultivariatebvitamin dno.no.rr95% cirr95% cino.rr95% cirr95% ci 0.4(0.01-0.5)4132ref.36682400.6(0.5-0.6)447634620.870.82-0.930.88a0.82-0.931850.710.58-0.860.72a0.59-0.880.7(0.6-0.8)459033930.840.79-0.890.84a0.79-0.901710.640.53-0.790.65a0.52-0.800.9(0.8-4.0)462033430.830.78-0.880.82a0.77-0.881750.660.54-0.810.63a0.50-0.78\naadjusted for age, total energy intake, country of Birth, bmi and dietary intake of Vitamin B12\n\ndiscussion\nwe report HERE results from the FIRST STUDY that has evaluated the dietary Intake of Fish, Pufa and Vitamin D in RELATION to the experience of positive psychotic-like symptoms in a large cohort of over 30 000 swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 749), ('INCOMPLETE_EVIDENCE', 771), ('SUPERFICIAL_RELATIONSHIP', 852)]	3	[('GO_0051215', 'RNAi-mediated antiviral immunity against DNA virus', 132, 'DDietary'), ('GO_0007567', 'parturition', 682, 'birth'), ('CHEBI_33279', 'vitamin D5', 715, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 715, 'vitamin B12'), ('GO_0007631', 'feeding behavior', 814, 'intake'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 824, 'fish'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 830, 'PUFA'), ('CHEBI_27300', 'vitamin D', 839, 'vitamin D')]
PMC2889879	5/2010	S134-PMC2889879	['NO earlier STUDIES that we ARE AWARE OF have evaluated the RELATIONSHIP between Adult Vitamin D levels and psychotic symptoms.']	[('FULL_UNKNOWN', 0), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('UBERON_0007023', 'adult organism', 80, 'adult'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC2889879	5/2010	S137-PMC2889879	['results from the northern finland 1966 Birth cohort SHOWED that Vitamin D supplementation during the first year of Life was ASSOCIATED with a reduced risk of schizophrenia in males, BUT NOT in women [32].']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 124), ('FULL_UNKNOWN', 182)]	3	[('GO_0007567', 'parturition', 39, 'Birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 115, 'life')]
PMC2913107	8/2010	S0-PMC2913107	['on the aetiology of autism\ni have SUGGESTED that the primary environmental TRIGGER for autism is not vaccinations, Toxins or infections, BUT Gestational and early childhood Vitamin D deficiency (1,2).']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	3	[('CHEBI_27026', 'toxin', 115, 'toxins'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC2913107	8/2010	S45-PMC2913107	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]
PMC2913107	8/2010	S47-PMC2913107	['all that the current EPIDEMIC of maternal and early childhood Vitamin D deficiency does, with its resultant neural deficiency in the pluripotent Neurosteroid Calcitriol, is to ALLOW the Genetic TENDENCY for autism to Express itself.']	[('IMPORTANT_CONSIDERATION', 21), ('FUTURE_PREDICTION', 176), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_47838', 'nitrile oxide', 145, 'neurosteroid'), ('CHEBI_17823', 'calcitriol', 158, 'calcitriol'), ('SO_0000704', 'gene', 186, 'genetic'), ('GO_0010467', 'gene expression', 217, 'express')]
PMC2963768	10/2010	S15-PMC2963768	['low 25(Oh)D is SURPRISINGLY common in south asia, where systemic Vitamin D deficits would be expected to be PREVENTED by cutaneous Vitamin D Synthesis stimulated by exposure to sun at relatively low latitudes (3).']	[('ANOMALY_CURIOUS_FINDING', 15), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 108)]	3	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 139, 'D synthesis')]
PMC2963768	10/2010	S45-PMC2963768	['as a secondary exploratory analysis, observations relating to infant, maternal or household FACTORS that POTENTIALLY INFLUENCED Vitamin D status were drawn from the complete sample of 74 participants (cases and controls) in whom 25(Oh)D was measured.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 229, '25(OH)D')]
PMC2963768	10/2010	S51-PMC2963768	['given that the DETERMINANTS of Vitamin D status MAY DIFFER across age-groups, associational analyses were repeated among participants aged less than six months.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC2963768	10/2010	S103-PMC2963768	['THEREFORE, the representativeness of our data is LIMITED because they REFLECT Vitamin D status during the winter, when ultraviolet radiation exposure is at its nadir, and when cutaneous Vitamin D Synthesis would be expected to be relatively minimal (24).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 186, 'vitamin D synthesis')]
PMC2963768	10/2010	S120-PMC2963768	['hypothetical mechanisms that MAY CONTRIBUTE to risk of maternal-infant Vitamin D deficiency in south asiageneral mechanismexamples of specific HYPOTHESIZED mechanismsendogenous cutaneous Vitamin D Production\nconservative clothing practices (33)\nlimited time spent outdoors\ndark skin pigmentation (34)\ncloud-cover and outdoor air pollution (12)\ngeographic/Genetic/dietary factors that alter Epidermal 7-Dehydrocholesterol composition or concentrationdietary Vitamin D intake\ninadequate intake of Liver, eggs, fish, or fish oils, or fortified dairy products\ndiminished natural Vitamin d content of farmed fish (35)\nreduction in Vitamin D content of fish due to Cooking (e.g.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 143)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 187, 'vitamin D production'), ('PR_000006444', 'diacylglycerol kinase delta', 195, 'D'), ('SO_0000704', 'gene', 355, 'genetic'), ('UBERON_0007376', 'outer epithelium', 390, 'epidermal'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 400, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('UBERON_0002107', 'liver', 495, 'liver'), ('CHEBI_33229', 'vitamin (role)', 575, 'vitamin'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin D'), ('GO_0065007', 'biological regulation', 659, 'cooking')]
PMC2963768	10/2010	S126-PMC2963768	['the most WIDELY-accepted manifestation of SEVERE Vitamin D deficiency in infancy is rickets, the classical childhood Metabolic bone disease ASSOCIATED with Skeletal hypomineralization and deformities, muscle weakness, and growth impairment (1).']	[('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0008152', 'metabolic process', 117, 'metabolic'), ('UBERON_0004288', 'skeleton', 156, 'skeletal')]
PMC2996405	11/2010	S30-PMC2996405	['the clinal gradation of skin colouration is CORRELATED with uv radiation levels and represents a compromising Solution to the CONFLICTING physiological REQUIREMENTS of Photoprotection and Vitamin D uv-dependent synthesis [13].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 152)]	3	[('CHEBI_75958', 'solution', 110, 'solution'), ('GO_0006909', 'phagocytosis', 168, 'photoprotection'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC2996405	11/2010	S31-PMC2996405	['the latter is very IMPORTANT SINCE Vitamin D is INVOLVED in many health outcomes (e.g.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC2996405	11/2010	S50-PMC2996405	['AS most Individuals do not develop cancer until they are past their Reproductive age, from an evolutionary POINT OF VIEW, skin cancer REPRESENTS a less powerful selective force than Vitamin D availability in Serum [21].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('NCBITaxon_1', 'root', 8, 'individuals'), ('GO_0000003', 'reproduction', 68, 'reproductive'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001977', 'blood serum', 208, 'serum')]
PMC2996405	11/2010	S107-PMC2996405	["also the overlap of 70 Genes between vdr and schizophrenia RELATED Genes was significant (p-value 1.4 × 10-6, fisher's exact test; figure1and additional file3), CONFIRMING the ROLE of Vitamin D in schizophrenia pathogenesis."]	[('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 161), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('SO_0000704', 'gene', 23, 'genes'), ('SO_0000704', 'gene', 67, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC2996405	11/2010	S153-PMC2996405	['TO TEST this LINK at a Genomic level, we created a hand-curated list of Genes that, at different levels, are RELATED to Vitamin D (see results; additional file4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 109)]	3	[('SO_0001026', 'genome', 23, 'genomic'), ('SO_0000704', 'gene', 72, 'genes'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D')]
PMC2996405	11/2010	S157-PMC2996405	['Vitamin D receptors were FOUND in most Tissues OTHER than those classically INVOLVED in the Vitamin D action (bone, Gut, Kidney, etc.).']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 39, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 116, 'gut'), ('UBERON_0002113', 'kidney', 121, 'kidney')]
PMC2996405	11/2010	S158-PMC2996405	['in particular, receptors for Vitamin D are widely distributed in the Nervous System and Vitamin D HAS BEEN RECENTLY IMPLICATED in Brain function [51].']	[('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001016', 'nervous system', 69, 'nervous system'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000955', 'brain', 130, 'brain')]
PMC2996405	11/2010	S227-PMC2996405	['for example, we cannot exclude the presence of an UNKNOWN common FACTOR, different from Vitamin D, LINKING together schizophrenia and latitude.']	[('FULL_UNKNOWN', 50), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC2996405	11/2010	S249-PMC2996405	['conclusions\nwe FOUND that frequencies of Genetic variants INVOLVED in Brain Development, schizophrenia and Vitamin D-RELATED processes significantly vary with latitude.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('SO_0000704', 'gene', 41, 'genetic'), ('GO_0007420', 'brain development', 70, 'brain development'), ('UBERON_0000955', 'brain', 70, 'brain'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3004407	12/2010	S103-PMC3004407	['specifically, obesity and race DEMONSTRATED a significant ASSOCIATION with Vitamin D category, and obesity retained a significant RELATIONSHIP with Vitamin D category after controlling for race ( p = .01).']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3004407	12/2010	S131-PMC3004407	['WHILE there was a significant variation in 25(Oh)D concentrations between racial/ethnic categories, the deficiency did not APPEAR to change as a function of Gestational age; women in their later stages of Pregnancy had a SIMILAR risk of Vitamin D deficiency and insufficiency for a given race/ethnicity compared with women who had their 25(Oh)D concentrations measured earlier in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 123), ('SUPERFICIAL_RELATIONSHIP', 221)]	3	[('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 43, '25('), ('PR_000006444', 'diacylglycerol kinase delta', 49, 'D'), ('GO_0007565', 'female pregnancy', 157, 'gestational'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D'), ('GO_0007565', 'female pregnancy', 380, 'pregnancy')]
PMC3032617	5/2010	S3-PMC3032617	['the AIM of the study was TO INVESTIGATE, in a ugandan rural Pregnant women cohort, the preventive EFFECTS of Vitamin C supplementation on hospital admission.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C')]
PMC3032617	5/2010	S27-PMC3032617	['ON THE OTHER HAND, Oxalate is an end product of Ascorbate Catabolism and plays an IMPORTANT ROLE in Kidney Stone Formation, so excessive daily amounts of Vitamin C such as Intakes higher than 1g/day are shown to produce hyperoxaluria [1].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92)]	3	[('CHEBI_16162', 'o-orsellinate', 19, 'oxalate'), ('CHEBI_22651', 'ascorbate', 48, 'ascorbate'), ('GO_0009056', 'catabolic process', 58, 'catabolism'), ('GO_0016255', 'attachment of GPI anchor to protein', 100, 'kidney'), ('UBERON_0003460', 'arm bone', 100, 'kidney stone'), ('GO_0009057', 'macromolecule catabolic process', 113, 'formation'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin C'), ('GO_0007631', 'feeding behavior', 172, 'intakes')]
PMC3034879	12/2010	S185-PMC3034879	['the study SHOWS that fetal Vitamin D status, RATHER than Postnatal Vitamin D status, AFFECTS bone growth during the first year.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007567', 'parturition', 57, 'postnatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3034879	12/2010	S187-PMC3034879	['∆S-25-Ohd CORRELATED positively with ∆s-tracp and inversely with δbalp SUGGESTING that Vitamin D AFFECTS bone turnover [42].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_52260', 'rhod-2 dye', 1, 'S'), ('CHEBI_72765', 'verruculogen', 3, '25-OHD'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3039633	2/2011	S75-PMC3039633	['[30]302 children (australia)1,3(at 4 yrs)stanford-binet intelligence scale strengths and difficulties questionnaireiron vs. placebo20 weeks Gestation to Birth∅ 1,317/21\n1 = Cognitive Development\n2 = Motor Development\n3 = Behavioral Development\n4 = Visual Development\n5 = auditory development\n∅ = no effect of Nutrient(s) on development\n+ = positive EFFECT of Nutrient(s) on development\n- = negative EFFECT of Nutrient(s) on development\nmvm = multivitamin-Mineral\nHchp = high calorie, high protein\nlclp = low calorie, low protein\nmvm-a = multivitamin-Mineral without Vitamin a\nmvm+a = multivitamin-Mineral with Vitamin A\nld = lower dosage\ngiven the heterogeneity of methods and outcome measures in the studies reviewed, it was NOT FEASIBLE to compare effect sizes or to perform a meta-analysis.']	[('SUPERFICIAL_RELATIONSHIP', 349), ('SUPERFICIAL_RELATIONSHIP', 399), ('DIFFICULT_TASK', 726)]	3	[('GO_0007565', 'female pregnancy', 140, 'gestation'), ('GO_0007567', 'parturition', 153, 'birth'), ('GO_0007567', 'parturition', 158, '∅'), ('GO_0050787', 'detoxification of mercury ion', 173, 'cognitive development'), ('GO_0009653', 'anatomical structure morphogenesis', 199, 'motor development'), ('GO_0007420', 'brain development', 221, 'behavioral development'), ('GO_0007506', 'gonadal mesoderm development', 248, 'visual development'), ('CHEBI_33284', 'nutrient', 309, 'nutrient'), ('CHEBI_33284', 'nutrient', 359, 'nutrient'), ('CHEBI_33284', 'nutrient', 409, 'nutrient'), ('CHEBI_46662', 'mineral', 455, 'mineral'), ('CHEBI_17883', 'hydrogen chloride', 463, 'HCHP'), ('CHEBI_46662', 'mineral', 550, 'mineral'), ('CHEBI_33229', 'vitamin (role)', 566, 'vitamin'), ('CHEBI_46662', 'mineral', 597, 'mineral'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 618, 'A')]
PMC3061267	2/2011	S5-PMC3061267	['it is UNCLEAR WHETHER maternal Vitamin A supplementation will LEAD TO improved health outcomes for mother OR child.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A')]
PMC3061267	2/2011	S29-PMC3061267	['nutrient deficiencies LINKED to PUBLIC HEALTH PROBLEMS in women\n\nCalcium and Vitamin D\nCalcium (1,200 mg elemental Ca/d) was found to reduce all four Premenstrual syndrome symptoms examined in an older clinical trial [7].']	[('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_31341', 'calcium dihydroxide', 65, 'Calcium'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 87, 'Calcium'), ('CHEBI_32588', 'potassium chloride', 115, 'Ca'), ('GO_0007565', 'female pregnancy', 150, 'premenstrual')]
PMC3075531	7/2010	S57-PMC3075531	['furthermore, Genetic variations in Vitamin-D-related and other Genes MIGHT INFLUENCE the EFFECTS of Vitamin D on the Immune System.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('SO_0000704', 'gene', 13, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 35, 'vitamin-D'), ('SO_0000704', 'gene', 63, 'genes'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune system')]
PMC3235789	12/2011	S24-PMC3235789	['another us cohort study among nonpregnant women FOUND an ASSOCIATION between bv and the high total dietary intake of fat (aor 1.5, 95% ci: 1.1–2.4) and the low dietary Intake of Folate (aor 0.4, 95% ci: 0.2–0.8), Vitamin E (aor 0.4, 95% ci: 0.2–0.8), and Calcium (aor 0.4, 95% ci: 0.3–0.7), WHEREAS no relationship with dietary Vitamin D intake was observed [31].']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291)]	3	[('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 178, 'folate'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 255, 'calcium'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
PMC3235789	12/2011	S108-PMC3235789	['circulating levels of 25-Oh-D are a direct REFLECTION of total body Vitamin D status, which DEPENDS upon access to Vitamin D EITHER through exposure to sunlight or dietary intake.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 22, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3257641	3/2010	S0-PMC3257641	['Vitamin D status during Pregnancy and aspects of offspring health\n\nabstract\nlow maternal Vitamin D levels during Pregnancy HAVE BEEN LINKED to various health outcomes in the offspring, ranging from periconceptional EFFECTS to diseases of Adult onset.']	[('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('UBERON_0007023', 'adult organism', 238, 'adult')]
PMC3257641	3/2010	S41-PMC3257641	['for any uv-b level, Vitamin D synthesis is then DEPENDENT on the amount of skin exposed, skin pigmentation, use of sun protection such as shade, sunscreen and POSSIBLY other physical or host-related FACTORS [29,30].']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3257641	3/2010	S48-PMC3257641	['a NUMBER OF STUDIES within non-Pregnant Adult populations have examined 25(Oh)D levels in RELATION to DIFFERENT dosages, preparations or dosing intervals of oral Vitamin D (reviewed in[33]).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	3	[('GO_0007565', 'female pregnancy', 31, 'pregnant'), ('UBERON_0007023', 'adult organism', 40, 'adult'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3257641	3/2010	S75-PMC3257641	['ONGOING RESEARCH is examining the ROLE of 1,25(Oh)2D in decreasing the risk of infections during Pregnancy and WHETHER Vitamin D status alters the risk of developing adverse outcomes following such infections.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 42, '1,25(OH)2D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3257641	3/2010	S89-PMC3257641	['mode of Birth\nRECENT DATA SUGGEST an ASSOCIATION between Vitamin D deficiency and caesarean section.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37)]	3	[('GO_0007567', 'parturition', 8, 'Birth'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3257641	3/2010	S129-PMC3257641	['Genes of the Vitamin D pathway (25 Hydroxylase, 1Α Hydroxylase and 24 Hydroxylase) and vdr are Expressed in Rat Brain Cells [99] and the distribution of Vdr and 1Α hydroxylase IS THOUGHT TO be SIMILAR in Rat and Human Brains [100].']	[('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 32, '25 hydroxylase'), ('PR_000003753', 'adenylate cyclase type 2', 48, '1α hydroxylase'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 67, '24 hydroxylase'), ('GO_0010467', 'gene expression', 95, 'expressed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rat'), ('CL_0000312', 'keratinocyte', 112, 'brain cells'), ('UBERON_0000955', 'brain', 112, 'brain'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 153, 'VDR'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 161, '1α'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 204, 'rat'), ('NCBITaxon_9606', 'Homo sapiens', 212, 'human'), ('UBERON_0000955', 'brain', 218, 'brains')]
PMC3257641	3/2010	S143-PMC3257641	['in Adult ecological and observational studies there is considerable EVIDENCE that Vitamin D status MAY BE RELATED to risk or prognosis of a number of cancers, including of the Prostate [121] and Breast [122].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('UBERON_0007023', 'adult organism', 3, 'adult'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 176, 'prostate'), ('UBERON_0000310', 'breast', 195, 'breast')]
PMC3257641	3/2010	S144-PMC3257641	['one Animal STUDY HAS SHOWN that maternal Antenatal Vitamin D supplementation was ASSOCIATED with greater mean Prostatic weight and a histologically more differentiated Prostatic architecture in offspring in Adulthood [123].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('NCBITaxon_33208', 'Metazoa', 4, 'animal'), ('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0000054', 'macula', 110, 'prostatic'), ('UBERON_0000054', 'macula', 168, 'prostatic'), ('UBERON_0000113', 'post-juvenile adult stage', 207, 'adulthood')]
PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
PMC3271033	1/2012	S0-PMC3271033	['EFFECTS of ethnicity and Vitamin D supplementation on Vitamin D status and changes in bone Mineral content in infants\n\nabstract\n\nabstract\n\nbackground\nTO EVALUATE the EFFECTS on Serum 25(Oh)D and Bone mineralization of supplementation of Breast-Fed hispanic and non-hispanic caucasian infants with Vitamin D in infants in houston, texas.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 186, 'OH)D'), ('GO_0007567', 'parturition', 195, 'bone'), ('UBERON_0000310', 'breast', 237, 'breast'), ('GO_0007631', 'feeding behavior', 244, 'fed'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC3271033	1/2012	S6-PMC3271033	['daily Vitamin D intake of 400 iu during the first months of Life APPEARS adequate to increase Serum 25(Oh)D and SUPPORT bmc increases DESPITE low initial 25(Oh)D levels in some infants.']	[('ANOMALY_CURIOUS_FINDING', 65), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 134)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 102, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D')]
PMC3271033	1/2012	S16-PMC3271033	['ALTHOUGH Calcium and Phosphorus are transported transplacentally without Vitamin D, the EFFECTS of low Vitamin D in utero or shortly after Birth are UNCERTAIN [7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 9, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 21, 'phosphorus'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC3271033	1/2012	S113-PMC3271033	['the close RELATIONSHIPS between weight and length and initial bmc IMPLY that calcium transfer across the Placenta is closely RELATED to overall Nutrient transfer and not to Vitamin D status (7).']	[('SUPERFICIAL_RELATIONSHIP', 10), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('UBERON_0001987', 'placenta', 105, 'placenta'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3271033	1/2012	S147-PMC3271033	['the 30 ng/ml target is well above that LIKELY TO BE NEEDED for adequate Vitamin D status in the newborn BASED UPON the recent RECOMMENDATIONS of the institute of medicine [2].']	[('FUTURE_PREDICTION', 39), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 126)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3277098	12/2011	S38-PMC3277098	['Immune Cell Differentiation and Proliferation\nthe ROLE of Vitamin D in Regulation Of the Immune System was FIRST RECOGNIZED through the identification of Vitamin D receptors on Peripheral Blood Mononuclear cells (Lymphocytes) [2].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 107), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CL_0000902', 'induced T-regulatory cell', 0, 'Immune Cell'), ('GO_0002121', 'inter-male aggressive behavior', 0, 'Immune Cell Differentiation ... Proliferation'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007093', 'mitotic cell cycle checkpoint signaling', 71, 'regulation of ... immune system'), ('UBERON_0002405', 'immune system', 89, 'immune system'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('UBERON_0012101', 'perinatal stage', 177, 'peripheral blood'), ('CL_0000100', 'motor neuron', 194, 'mononuclear'), ('GO_0031097', 'medial cortex', 194, 'mononuclear'), ('CL_0000542', 'lymphocyte', 213, 'lymphocytes')]
PMC3277098	12/2011	S44-PMC3277098	['in Animal MODELS, an increased th2 response to Vitamin D HAS BEEN ACCOMPANIED by increase in anti-inflammatory Il-10 response [30].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10')]
PMC3277098	12/2011	S65-PMC3277098	['there is SOME SUPPORT for this in Human studies LINKING Vitamin D deficiency with reduced Lung function [3,5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0002048', 'lung', 90, 'lung')]
PMC3296991	2/2012	S17-PMC3296991	['bone BIOMARKERS including balp increase during Pregnancy REGARDLESS OF Vitamin D status and attain higher values in Umbilical Cord Blood than maternal Blood [14], POSSIBLY reflecting higher rates of bone turnover.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 163)]	3	[('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0000178', 'blood', 151, 'blood')]
PMC3296991	2/2012	S19-PMC3296991	['DEMONSTRATED that maternal Vitamin D status CAN INFLUENCE Fetal Femoral Development as early as 19 weeks Gestation [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007631', 'feeding behavior', 58, 'fetal'), ('GO_0009556', 'microsporogenesis', 64, 'femoral development'), ('UBERON_0000981', 'femur', 64, 'femoral'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC3296991	2/2012	S85-PMC3296991	['in the PRESENT STUDY, total maternal daily Vitamin D intake >600 iu/day was ASSOCIATED with significantly higher Cord, and a TREND towards higher maternal, Serum 25(Oh)D at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 125)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 162, '25(OH ... D'), ('GO_0007567', 'parturition', 173, 'delivery')]
PMC3309463	6/2011	S51-PMC3309463	['IF cryptic variation is exposed by environmental exposures, such as Vitamin D deficiency, stress or cannabis use, then Allelic EFFECTS should BE larger in populations where these exposures are prevalent.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 127), ('ANOMALY_CURIOUS_FINDING', 142)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0001023', 'allele', 119, 'allelic')]
PMC3347007	4/2012	S17-PMC3347007	['other STUDIES PROPOSE an ASSOCIATION between Vitamin D deficiency and pre-eclampsia [8].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347007	4/2012	S18-PMC3347007	['studies have also SUGGESTED that Vitamin D sufficiency has a PROTECTIVE EFFECT against pre-term Delivery and Gestational diabetes mellitus through its immunomodulatory and anti-inflammatory properties [9].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'delivery'), ('GO_0007565', 'female pregnancy', 109, 'gestational')]
PMC3347007	4/2012	S63-PMC3347007	['the following FACTORS were regarded as POTENTIAL DETERMINANTS of Vitamin D intake and included in the analyses: maternal age (<20, 20–25, 25–30, 30–35, 35–40, ≥40), pre-Pregnancy bmi (≤18.5, 18.5–25, 25–30, 30–35, 35–40, >40), energy intake, parity (0, 1, 2, 3+), civil status (single, coupled/married), socio-occupational status (high, medium, skilled, student, unskilled, unemployed), physical activity level (inactive, light, moderate, high), smoking during Pregnancy (non-smoker, occasional smoker, <15 cigarettes per day, ≥15 cigarettes per day), Alcohol Consumption during Pregnancy (yes, no), season of filling out the ffq, and planned Pregnancy (planned, partly planned, not planned).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'pregnancy'), ('CHEBI_30879', 'alcohol', 552, 'alcohol'), ('GO_0007631', 'feeding behavior', 560, 'consumption'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 643, 'pregnancy')]
PMC3347007	4/2012	S100-PMC3347007	['single women had lower odds ratio (or) for sufficient total Vitamin D intake than married/coupled women, HOWEVER, this RELATION was not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3347007	4/2012	S159-PMC3347007	['high socio-economic status and education was found TO BE directly ASSOCIATED with Vitamin D intake and supplement use in OTHER studies [17,18,27,28,29].']	[('ANOMALY_CURIOUS_FINDING', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3347007	4/2012	S163-PMC3347007	['we also FOUND civil status to be non-significantly ASSOCIATED with Vitamin D intake, with single women being less LIKELY to have sufficient total Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3347028	3/2012	S0-PMC3347028	['Vitamin D and its ROLE during Pregnancy in attaining optimal health of mother and fetus\n\nabstract\nDESPITE its discovery a hundred years ago, Vitamin D has emerged as one of the most CONTROVERSIAL Nutrients and prohormones of the 21st century.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33284', 'nutrient', 196, 'nutrients')]
PMC3347028	3/2012	S109-PMC3347028	['throughout Gestation, IF a woman is Vitamin D deficient, it APPEARS to IMPACT fetal bone health more than maternal [66,67,68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('GO_0007565', 'female pregnancy', 11, 'gestation'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3347028	3/2012	S177-PMC3347028	['in addition, WHAT amount of sunlight is sufficient to achieve optimal Vitamin D status varies DEPENDING ON a host of FACTORS such as the time of day, the time of year, the latitude, degree of skin pigmentation, type and extend of clothing, body surface area exposed and one’s body mass index (bmi) [146].']	[('EXPLICIT_QUESTION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3347028	3/2012	S224-PMC3347028	['it is INTERESTING that epidemiological studies involving Pregnant women with Preeclampsia—a clinical picture of inflammation and vasculitis—Vitamin D deficiency HAS BEEN IMPLICATED [152,153,154].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 77, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC3347028	3/2012	S228-PMC3347028	['IS it a constellation of FACTORS such as Vitamin D acting in concert with Vitamin A to create a healthful milieu?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('EXPLICIT_QUESTION', 112)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC3347028	3/2012	S230-PMC3347028	['ARE those at greatest risk for Vitamin D deficiency somehow PROTECTED by selective differences in Vitamin D binding protein affinities and in the Vitamin D receptor itself?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('EXPLICIT_QUESTION', 171)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3347028	3/2012	S232-PMC3347028	['WHAT about Vitamin D’s ROLE in maintaining Immune Homeostasis during Pregnancy?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 43, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 43, 'immune'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC3347028	3/2012	S237-PMC3347028	['conclusions\nthe ROLE of Vitamin D during Pregnancy and its EFFECT on maternal and fetal health is just BEGINNING TO BE understood.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 103)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy')]
PMC3348565	4/2012	S0-PMC3348565	['EFFECT on the incidence of pneumonia of Vitamin D supplementation by quarterly bolus dose to infants in kabul: a randomised controlled superiority trial\n\nabstractsummary\n\nbackground\nVitamin D has a ROLE in Regulating Immune function, and its deficiency is a SUGGESTED risk factor for childhood pneumonia.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 258)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 182, 'Vitamin D'), ('GO_0065007', 'biological regulation', 206, 'regulating'), ('UBERON_0002405', 'immune system', 217, 'immune')]
PMC3355895	1/2011	S4-PMC3355895	['THUS factors such as maternal lifestyle, diet, body build, physical activity, and Vitamin D status in Pregnancy all APPEAR to INFLUENCE offspring bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 116), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_46662', 'mineral', 151, 'mineral')]
PMC3355895	1/2011	S91-PMC3355895	['THUS, in populations in nutritional transition, where maternal sunlight exposure is sufficient to maintain adequate Vitamin D status, the availability of calcium becomes a more CRITICAL DETERMINANT of fetal and childhood bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_46662', 'mineral', 226, 'mineral')]
PMC3356951	4/2012	S56-PMC3356951	["[52] Vitamin D content of Human Milk is RELATED to the mother's Vitamin D status; THEREFORE mothers who supplement with high doses of Vitamin D MAY have high levels of Vitamin D in their milk."]	[('SUPERFICIAL_RELATIONSHIP', 40), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('UBERON_0001913', 'milk', 32, 'milk'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3356951	4/2012	S102-PMC3356951	['there is SOME EVIDENCE LINKING higher Vitamin D intake to a lower RISK for Breast cancer.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000310', 'breast', 75, 'breast')]
PMC3356951	4/2012	S112-PMC3356951	['levels of 25(Oh)D are inversely ASSOCIATED with bmi, waist circumference, and body fat BUT are positively ASSOCIATED with age, lean body mass, and Vitamin D intake.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('CHEBI_71657', 'versiconol acetate', 10, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 10, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3356951	4/2012	S116-PMC3356951	['[90] a CORRELATION between Vitamin D and the risk diabetes CAN be RULED in from the results.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3356951	4/2012	S124-PMC3356951	["a cohort study based on the mini-finland health survey DEMONSTRATED that low Vitamin D levels MAY PREDICT the development of parkinson's disease."]	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3395583	7/2012	S87-PMC3395583	['NOTABLY, Vitamin D Production is strictly DEPENDENT on uvb radiation and Vitamin D levels THEREFORE follow a seasonal distribution [23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 90)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 9, 'vitamin D production'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3395583	7/2012	S89-PMC3395583	['furthermore, in utero Vitamin D deficiency has a significant EFFECT on the developing Immune System and our group has RECENTLY SHOWN that Genes ASSOCIATED with ms, ra, cd, sle and t1d are significantly enriched for Vitamin D receptor Binding Sites [44-46].']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 223, 'D'), ('SO_0000409', 'binding_site', 234, 'binding sites')]
PMC3395583	7/2012	S91-PMC3395583	['it MAY BE that in utero Vitamin D deficiency, in conjunction with individual Genetic variation and subsequent exposure to other environmental agents, MAY then LEAD TO disease specificity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000704', 'gene', 77, 'genetic')]
PMC3407995	7/2012	S16-PMC3407995	['titles and abstracts were reviewed and reports were selected for inclusion in the review if they were systematic reviews, meta-analyses, randomised controlled trials, cohort studies, cross-sectional or case-control studies and IF they reported BENEFITS and/or harms ASSOCIATED with maternal supplementation with Dha, Vitamin D, Folic Acid or Iodine during Pregnancy and/or Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('IMPORTANT_CONSIDERATION', 244), ('SUPERFICIAL_RELATIONSHIP', 266)]	3	[('CHEBI_17874', 'dihydrozeatin', 312, 'DHA'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('CHEBI_30751', 'formic acid', 328, 'folic acid'), ('CHEBI_24859', 'iodine atom', 342, 'iodine'), ('GO_0007565', 'female pregnancy', 356, 'pregnancy'), ('GO_0007595', 'lactation', 373, 'lactation')]
PMC3407995	7/2012	S82-PMC3407995	['the MAJORITY of circulating Vitamin D, known as Serum 25-Hydroxyvitamin D [25(Oh)D] that is NECESSARY to maintain health and function of the Immune, Reproductive, Muscular, Skeletal and Integumentary System, originates from Vitamin D3 (Cholecalciferol) and REFLECTS endogenous synthesis from exposure to sunlight as well as Intake from the diet [46].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 92), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0002405', 'immune system', 141, 'immune ...'), ('GO_0000003', 'reproduction', 149, 'reproductive'), ('UBERON_0022230', 'retrohippocampal region', 149, 'reproductive ...'), ('UBERON_0004469', 'musculature of back', 163, 'muscular ...'), ('UBERON_0004288', 'skeleton', 173, 'skeletal'), ('UBERON_0002416', 'integumental system', 186, 'integumentary system'), ('CHEBI_33279', 'vitamin D5', 224, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 224, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 236, 'cholecalciferol'), ('GO_0007631', 'feeding behavior', 324, 'intake')]
PMC3407995	7/2012	S99-PMC3407995	['there is also evidence from observational studies SUGGESTING that adequate Vitamin D during early Life MAY PREVENT development of Immunological Diseases in the offspring later in Life such as type 1 diabetes [55], allergic diseases [53] and Lower Respiratory Tract infections, wheezing and asthma [56].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007567', 'parturition', 130, 'immunological diseases'), ('UBERON_0003222', 'flexor digitorum superficialis', 130, 'immunological'), ('UBERON_0000104', 'life cycle', 179, 'life'), ('UBERON_0004905', 'articulation', 241, 'lower respiratory tract')]
PMC3407995	7/2012	S293-PMC3407995	['THERE IS EVIDENCE that Vitamin D during Pregnancy is INVOLVED in foetal Brain Development and that maternal Vitamin D deficiency during Pregnancy CAN alter the structure and function of the Brain resulting in Life long behavioural changes in the offspring [146,147,148].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 146)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('UBERON_0000955', 'brain', 190, 'brain'), ('UBERON_0000104', 'life cycle', 209, 'life')]
PMC3424155	8/2012	S18-PMC3424155	['moreover, Vitamin D is ASSOCIATED with premature births, obesity and Renal dysfunction in Adulthood, making it more than an ESSENTIAL fat-soluble Vitamin RESPONSIBLE for calcium Metabolism[9],[10].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 124), ('PROBABLE_UNDERSTANDING', 154)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0000113', 'post-juvenile adult stage', 90, 'adulthood'), ('CHEBI_33229', 'vitamin (role)', 146, 'vitamin'), ('GO_0008152', 'metabolic process', 178, 'metabolism')]
PMC3424155	8/2012	S23-PMC3424155	['THIS STUDY investigates the EFFECTS of maternal Vitamin D deficiency on Glomerular Development in early Postnatal Life and its EFFECTS on Renal structure at maturity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0032835', 'glomerulus development', 72, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 72, 'glomerular'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('UBERON_0000104', 'life cycle', 114, 'life'), ('UBERON_0002113', 'kidney', 138, 'renal')]
PMC3424155	8/2012	S189-PMC3424155	['maternal Vitamin D deficiency MAY also have CONTRIBUTED to an increased number of Glomeruli, THUS producing smaller Glomeruli than in Animals Fed sc.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 82, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 116, 'glomeruli'), ('NCBITaxon_33208', 'Metazoa', 134, 'animals'), ('GO_0007631', 'feeding behavior', 142, 'fed')]
PMC3424155	8/2012	S211-PMC3424155	['in conclusion, the present FINDINGS provide INSIGHT into the RELATIONSHIP between maternal Vitamin D deficiency and the occurrence of a greater number of Glomeruli in offspring.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 154, 'glomeruli')]
PMC3427192	4/2012	S24-PMC3427192	['it is also IMPORTANT TO NOTE that ASSOCIATIONS between Prenatal Vitamin D exposure, wheezing and subsequent asthma have NOT BEEN CONSISTENT across studies.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	3	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3427192	4/2012	S57-PMC3427192	['in the FIRST KNOWN clinical TRIAL focused on the ROLE of Vitamin D in allergic disease, rappaport et al.85found that supplementation with 60,000 to 30,000 iu of Vitamin D2Per day resulted in significant relief of asthma and hay fever symptoms in more than 96% of patients suffering from asthma and seasonal allergies.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_63635', 'valganciclovir', 161, 'vitamin D2per'), ('PR_000001177', 'D(2) dopamine receptor', 169, 'D2per')]
PMC3427192	4/2012	S71-PMC3427192	['ultimately, randomized, double-blind, Placebo-controlled STUDIES ARE NEEDED in asthma populations to sort out causal RELATIONSHIPS between Vitamin D status and outcomes and to develop RECOMMENDATIONS for treatment.']	[('FUTURE_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 117), ('FUTURE_WORK', 184)]	3	[('CHEBI_26130', 'biological pigment', 38, 'placebo'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3427250	8/2012	S0-PMC3427250	['high prevalence of Vitamin D deficiency in Pregnant women: a national cross-sectional survey\n\nabstract\nan increasing NUMBER OF STUDIES SUGGEST that Vitamin D deficiency during Pregnancy is ASSOCIATED with multiple adverse health outcomes in mothers, neonates and children.']	[('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'Vitamin'), ('GO_0007565', 'female pregnancy', 43, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC3427250	8/2012	S17-PMC3427250	['in addition, an increasing NUMBER OF STUDIES SUGGEST that Vitamin D deficiency during Pregnancy is ASSOCIATED with multiple adverse health outcomes in mothers (Gestational diabetes and pre-eclampsia), in neonates (wheezing) and children (low bone Mineral density, type-1 diabetes, eczema)[16]–[22].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'gestational'), ('CHEBI_46662', 'mineral', 247, 'mineral')]
PMC3427250	8/2012	S102-PMC3427250	['the ASSOCIATION of Vitamin D status with bmi HAS BEEN ATTRIBUTED to an excessive Storage Of Vitamin D in fat Tissue decreasing thereby Serum concentrations[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 81, 'storage of vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0000479', 'tissue', 109, 'tissue'), ('UBERON_0001977', 'blood serum', 135, 'serum')]
PMC3427250	8/2012	S103-PMC3427250	['ethnicity was also a major DETERMINANT of Vitamin D status in the PRESENT STUDY, as PREVIOUSLY reported in the Adult population[32]and in Pregnant women[29],[48],[49].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 138, 'pregnant')]
PMC3427250	8/2012	S125-PMC3427250	['in addition, an increasing NUMBER OF STUDIES SUGGEST that Gestational Vitamin D deficiency is ASSOCIATED with multiple adverse health outcomes in mothers and children[16]–[22].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('GO_0007565', 'female pregnancy', 58, 'gestational'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3458940	9/2012	S10-PMC3458940	['such a catalogue will guide FURTHER STUDIES on molecular mediators of endogenous tra/rars during Kidney Development and in RELATION to Renal defects ASSOCIATED with Vitamin A deficiency.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('GO_0001822', 'kidney development', 97, 'kidney development'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002113', 'kidney', 135, 'renal'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin A')]
PMC3465343	10/2012	S40-PMC3465343	['ra is a derivative of Vitamin A and is REQUIRED for synchronous left-right Development Of Somites, either maternal vad during Pregnancy or an Embryonic defect in Metabolism from Vitamin A to ra MIGHT be ASSOCIATED with increased risk of Human vertebral defects.']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 194), ('SUPERFICIAL_RELATIONSHIP', 203)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0042461', 'photoreceptor cell development', 75, 'development of somites'), ('UBERON_0002329', 'somite', 90, 'somites'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0000922', 'embryo', 142, 'embryonic'), ('GO_0008152', 'metabolic process', 162, 'metabolism'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'human')]
PMC3470091	9/2012	S0-PMC3470091	['the EFFICACY and SAFETY of a high dose of Vitamin D in mothers with Gestational diabetes mellitus: a randomized controlled clinical TRIAL\n\nabstract\nbackground: during Pregnancy and Lactation outstanding changes occur in mother’s Vitamin D Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	3	[('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 42, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'Gestational'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('GO_0007595', 'lactation', 181, 'lactation'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 229, 'vitamin D metabolism')]
PMC3470091	9/2012	S16-PMC3470091	['SINCE, fetus and baby are both DEPENDENT upon mother for Blood and milk respectively, mother’s Vitamin D supplementation is highly VITAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 131)]	3	[('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3470091	9/2012	S78-PMC3470091	['this results in the increase of calcium absorption from the Intestine.27\nPREVIOUS STUDIES,17,27of intramuscular injection of 600,000 unit of Vitamin D was ASSOCIATED with significant increases of Serum Vitamin D at 1.5, 3, and 6 months, BUT NOT significant at 9 and 12 months later.']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('ANOMALY_CURIOUS_FINDING', 237)]	3	[('UBERON_0000160', 'intestine', 60, 'intestine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3470091	9/2012	S92-PMC3470091	['further STUDIES ARE NEEDED to evaluate the EFFECT of Postpartum supplementation of Vitamin D on antirachitic FACTOR of the mother’s Milk, and infant’s health indexes.']	[('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 109)]	3	[('GO_0007565', 'female pregnancy', 53, 'postpartum'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0001913', 'milk', 132, 'milk')]
PMC3471827	10/2012	S2-PMC3471827	['ttp and Vitamin E are ESSENTIAL for Productive Pregnancy in rodents, but their precise physiological ROLE in Embryogenesis is UNKNOWN.']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 101), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 36, 'productive'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0009790', 'embryo development', 109, 'embryogenesis')]
PMC3471827	10/2012	S135-PMC3471827	['NOTABLY, as morphologic outcomes from each study are ultimately due to Vitamin E deficiency, they LIKELY INVOLVE common mechanisms.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin E')]
PMC3472720	8/2012	S5-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC3472720	8/2012	S14-PMC3472720	['BASED ON findings from epidemiology, we predicted that offspring exposed to low Prenatal Vitamin D would be at INCREASED RISK of ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 111)]	3	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3472720	8/2012	S32-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC3472720	8/2012	S56-PMC3472720	['additionally, we SHOULD perform a transgenerational study in order to assess WHETHER the f2generation is positively AFFECTED by a high dose of Vitamin D delivered to the f0generation.']	[('FUTURE_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3475131	6/2012	S108-PMC3475131	['use of different Supplements (n\u2009=\u20097 reviews)\n\nlaboratory outcomes\nseven systematic reviews (four of high quality) investigated the EFFECTS of Micronutrients other than iron and Folic Acid [16,18-23] and FOUND NO EVIDENCE TO SUPPORT the use of Vitamin B12, Vitamin C, calcium or zinc to prevent anaemia during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 209)]	3	[('CHEBI_33341', 'titanium atom', 17, 'supplements'), ('CHEBI_33839', 'macromolecule', 142, 'micronutrients'), ('CHEBI_30751', 'formic acid', 177, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 243, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin C'), ('GO_0007565', 'female pregnancy', 309, 'pregnancy')]
PMC3476426	8/2012	S16-PMC3476426	['the main Metabolic EFFECT of 1, 25 Dihydroxy Vitamin D3, which is MEDIATED through the INTERACTION with Vitamin D receptors, is promoting the Intestinal absorption and Renal Resorption Of Calcium in order to increase its circulating levels.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 87)]	3	[('GO_0008152', 'metabolic process', 9, 'metabolic'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25 dihydroxy'), ('CHEBI_33279', 'vitamin D5', 45, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 45, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0000160', 'intestine', 142, 'intestinal'), ('UBERON_0002113', 'kidney', 168, 'renal'), ('GO_0051201', 'negative regulation of prosthetic group metabolic process', 174, 'resorption of calcium')]
PMC3476426	8/2012	S21-PMC3476426	['there is a GROWING BODY of LITERATURE LINKING Vitamin D to various Immune-related conditions, including allergy and autoimmunity [4].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune')]
PMC3476426	8/2012	S99-PMC3476426	['Genetic polymorphisms of Cytochrome P450 enzymes HAVE also BEEN LINKED to autism, specifically Cyp27B1 that is ESSENTIAL for proper Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64), ('IMPORTANT_CONSIDERATION', 111)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_38557', 'cytochrome c2', 25, 'cytochrome P450'), ('PR_000006101', 'cytochrome P450 1A1', 95, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 132, 'vitamin D metabolism')]
PMC3476426	8/2012	S104-PMC3476426	['Calcitriol, the active Vitamin D, AFFECTS numerous Neurotransmitters and neurotrophic factors, RELEVANT for mental disorders [34].']	[('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_17823', 'calcitriol', 0, 'Calcitriol'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 51, 'neurotransmitters')]
PMC3476426	8/2012	S105-PMC3476426	['in addition, Vitamin D plays IMPORTANT ROLES in Repairing Dna Damage and protecting against oxidative stress which is a KEY cause of dna damage.']	[('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 120)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0033197', 'response to vitamin E', 48, 'repairing DNA damage')]
PMC3476426	8/2012	S133-PMC3476426	['in Animal MODELS, an increased th2 response to Vitamin D HAS BEEN ACCOMPANIED by increase in anti-inflammatory Il-10 response [43].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10')]
PMC3476426	8/2012	S141-PMC3476426	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]
PMC3488410	10/2012	S113-PMC3488410	['the Vitamin D deficiency MODEL APPEARS TO BE useful to study the IMPACT of Brain disturbances during Embryonic/fetal Development [127,128].']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000955', 'brain', 75, 'brain'), ('GO_0009790', 'embryo development', 101, 'embryonic ... development'), ('UBERON_0000922', 'embryo', 101, 'embryonic')]
PMC3501517	11/2012	S15-PMC3501517	["Vitamin D3Is further hydrolyzed by the Liver to create 25-Hydroxyvitamin D3(25[Oh]D3), which REFLECTS the body's store of Vitamin D. additional conversion of 25[Oh]D3To the more biologically active 1α,25-Hydroxyvitamin D3(1α,25[Oh]D3) occurs primarily in the Kidney[5], BUT, is also observed in OTHER cell types such as Macrophages[6], Respiratory Epithelial Cells[7], and others[8],[9]."]	[('SUPERFICIAL_RELATIONSHIP', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	3	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3is'), ('UBERON_0002107', 'liver', 39, 'liver'), ('CHEBI_63991', '15-epi-lipoxin B4', 55, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 73, 'D3'), ('CHEBI_63218', 'pramipexole(2+)', 76, '25[OH]D3'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_86960', 'veratrone acetate', 158, '25[OH]D3to'), ('CHEBI_17996', 'chloride', 200, ','), ('CHEBI_63991', '15-epi-lipoxin B4', 201, '25-hydroxyvitamin D3'), ('CHEBI_63218', 'pramipexole(2+)', 225, '25[OH]D3'), ('UBERON_0002113', 'kidney', 259, 'kidney'), ('CL_0000235', 'macrophage', 320, 'macrophages'), ('CL_0002368', 'respiratory epithelial cell', 336, 'respiratory epithelial cells'), ('UBERON_0004802', 'respiratory tract epithelium', 336, 'respiratory epithelial')]
PMC3501517	11/2012	S16-PMC3501517	['the POTENTIAL ROLE of Vitamin D on Immune function HAS BEEN explored in the last decade.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 35, 'immune')]
PMC3501517	11/2012	S18-PMC3501517	["this is LARGELY THOUGHT TO be due to the EFFECTS of Vitamin D on T-Regulatory (Treg) Cell function and Vitamin D's ability to stimulate Treg populations and enhance tolerance[14],[15],[16]."]	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CL_0000098', 'sensory epithelial cell', 65, 'T-regulatory ...'), ('GO_0007265', 'Ras protein signal transduction', 65, 'T-regulatory'), ('CL_0000960', 'T3 B cell', 79, 'Treg ... cell'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 136, 'Treg')]
PMC3501517	11/2012	S24-PMC3501517	['RECENT STUDIES have also CORRELATED low Cord-Blood Vitamin D levels with infant wheezing[28]and RISK for Rsv infection[29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 96)]	3	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'RSV')]
PMC3509518	11/2012	S22-PMC3509518	['a LIMITED NUMBER OF Birth cohort STUDIES have SUGGESTED beneficial ASSOCIATIONS between higher maternal intakes of Antioxidants such as Vitamin E [9,10,11] and zinc [9] and the development of early childhood wheeze, and asthma [12].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 115, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3509518	11/2012	S93-PMC3509518	['SINCE many mothers did not meet the rdi for Vitamin E and Zinc [18], we INVESTIGATED ASSOCIATIONS between Vitamin E and zinc intakes dichotomized as exposure at the minimum rdi (yes/no) and allergic outcomes.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 58, 'Zinc'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin E')]
PMC3513049	2/2012	S4-PMC3513049	['methods\nTO INVESTIGATE POTENTIAL RELATIONSHIPS between household pet exposure and Cord Blood Vitamin D concentrations, we analyzed information from a large, geographically-based, general risk birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('UBERON_0002240', 'spinal cord', 82, 'cord'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC3515553	12/2012	S1-PMC3515553	['Brain Development occurs primarily in utero and early infancy, BUT the ROLE of maternal Vitamin B-12 status during Pregnancy on offspring Cognitive function is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 63), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 160)]	3	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0050890', 'cognition', 138, 'cognitive')]
PMC3515553	12/2012	S2-PMC3515553	['in THIS STUDY we ASSESSED the EFFECT of Vitamin B-12 status in well-nourished Pregnant women on the Cognitive ability of their offspring in a uk birth cohort (alspac).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('GO_0050890', 'cognition', 100, 'cognitive')]
PMC3515553	12/2012	S53-PMC3515553	['in the observational analyses of maternal dietary Vitamin B-12 in Pregnancy, we also EXAMINED POSSIBLE MEDIATION by Gestational age, Birth-weight and breastfeeding (obtained from repeat Postnatal maternal completed questionnaires and derived as no breastfeeding, breastfeeding for <3 months, for 3 to 5 months, for ≥6 months).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 50, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 116, 'gestational'), ('GO_0007567', 'parturition', 133, 'birth'), ('GO_0007567', 'parturition', 186, 'postnatal')]
PMC3515553	12/2012	S87-PMC3515553	['subsequent adjustment for POTENTIAL CONFOUNDERS attenuated the ASSOCIATION by 65% (model 2), such that in this model offspring iq was on average 0.7 (95%ci −0.04, 1.4; p\u200a=\u200a0.06) points greater per doubling of maternal Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 36), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('CHEBI_27300', 'vitamin D', 218, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 218, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 228, '12')]
PMC3515553	12/2012	S95-PMC3515553	['analysis of offspring genotypes and Cord Blood Vitamin B-12 REVEALED a strong ASSOCIATION with the Fut2 variant BUT no association with tcn2 rs1801198 and a marginal effect of tcn2 rs9606756 (table s3).']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 47, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 57, '12'), ('PR_000007719', 'frizzled-2', 99, 'FUT2')]
PMC3515553	12/2012	S96-PMC3515553	['Maternal rs9606756/rs1801198 Haplotypes carrying at least one PUTATIVE Vitamin B-12 increasing Allele showed higher Cord Blood Vitamin B-12 compared to the Haplotype carrying both Alleles PREVIOUSLY ASSOCIATED with elevated Hcy and lower Vitamin B-12 concentrations (ag, i.e.']	[('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('SO_0001024', 'haplotype', 29, 'haplotypes'), ('CHEBI_85855', 'diacylglycerol 46:7', 71, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 71, 'vitamin B-12'), ('SO_0001023', 'allele', 95, 'allele'), ('UBERON_0009472', 'axilla', 116, 'cord blood'), ('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('SO_0001024', 'haplotype', 156, 'haplotype'), ('SO_0001023', 'allele', 180, 'alleles'), ('CHEBI_37958', 'dye', 224, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 224, 'Hcy'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 238, 'vitamin B-12')]
PMC3515553	12/2012	S124-PMC3515553	['frequencies of the Vitamin B-12 Alleles were SIMILAR in the mothers and their offspring, and COMPARABLE to those FOUND in the hapmap european population (ceu) (rs492602 c Allele: 0.50 in alspac, 0.53 in ceu; rs1801198 c Allele: 0.55 in alspac, 0.55 in ceu; rs9606756 g Allele: 0.13 in alspac, 0.10 in ceu).']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 113)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 19, 'vitamin B-12'), ('SO_0001023', 'allele', 32, 'alleles'), ('SO_0001023', 'allele', 171, 'allele'), ('SO_0001023', 'allele', 220, 'allele'), ('SO_0001023', 'allele', 269, 'allele')]
PMC3515553	12/2012	S137-PMC3515553	['tcn2 rs9606756 is also a non-synonymous variant (i23v) that MAY facilitate the binding of cobalamin[30]and HAS BEEN ASSOCIATED with a higher proportion of Vitamin B-12 bound to transcobalamin[14], and lower Plasma total Hcy[15].']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 155, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 155, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 207, 'plasma'), ('CHEBI_37958', 'dye', 220, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 220, 'Hcy')]
PMC3515553	12/2012	S152-PMC3515553	['it is also LIKELY that we DID NOT have enough statistical power in our analysis to identify an EFFECT of Vitamin B-12 on iq in children.']	[('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 105, 'vitamin B-12')]
PMC3515553	12/2012	S181-PMC3515553	['caption (supplementary-material): table s5\n\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with offspring iq at age 8, stratified by Maternal Pregnancy RECOMMENDED daily amount (rda) of Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 85), ('FUTURE_WORK', 181)]	3	[('SO_0000694', 'SNP', 80, 'SNPs'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 96, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 96, 'vitamin B-12'), ('GO_0007618', 'mating', 162, 'maternal'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 215, 'vitamin B-12')]
PMC3521768	12/2012	S143-PMC3521768	['IN ORDER TO INVESTIGATE the POSSIBILITY of synergetic INTERACTION of the two deficiencies in causing lbw, the study subjects were categorized into four groups based on Vitamin A and zinc deficiency statuses and analyzed accordingly (table 3).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 168, 'vitamin A')]
PMC3521768	12/2012	S169-PMC3521768	['OBSERVATIONAL studies on the RELATIONSHIP between maternal Vitamin A and Birthweight in apparently health subjects concluded DIVERGENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 67, 'A'), ('GO_0007596', 'blood coagulation', 73, 'birthweight')]
PMC3552819	12/2012	S113-PMC3552819	['the Stillbirth and newborn deaths were explained by medical problems, and there was NO EVIDENCE that either was RELATED to the Vitamin D supplementation, given their timing (i.e., did not occur at peak [25(Oh)D]) and the absence of biochemical EVIDENCE of Vitamin D toxicity in the mother (table\u20093).']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 244)]	3	[('GO_0001966', 'thigmotaxis', 4, 'stillbirth'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC3586494	2/2013	S120-PMC3586494	['in comparing Vitamin levels in term and preterm infants, term babies had significantly higher levels of Vitamins A, C, and e. the authors concluded that for Vitamins A and E, neonatal levels are DEPENDENT on maternal levels and that preterm babies have fewer Lipid-soluble antioxidant Vitamins in their Serum compared to term infants THUS MAY BE more susceptible to oxidative stress [52].']	[('SUPERFICIAL_RELATIONSHIP', 195), ('PROBABLE_UNDERSTANDING', 334), ('INCOMPLETE_EVIDENCE', 339)]	3	[('CHEBI_33229', 'vitamin (role)', 13, 'vitamin'), ('CHEBI_27300', 'vitamin D', 104, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 104, 'vitamins A'), ('PR_000004900', 'complement C3', 116, 'C'), ('CHEBI_27300', 'vitamin D', 157, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 166, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 172, 'E'), ('CHEBI_18059', 'lipid', 259, 'lipid'), ('CHEBI_33277', 'gamma-tocotrienol', 285, 'vitamins'), ('UBERON_0001977', 'blood serum', 303, 'serum')]
PMC3599191	1/2013	S199-PMC3599191	['Intake Of Vitamin D during Pregnancy, EITHER through the diet OR through supplements, has a protective ROLE against asthma and atopic dermatitis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0060384', 'innervation', 0, 'Intake of'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC3613945	2/2013	S60-PMC3613945	['Vitamin D, dbp and Innate Immunity – an EMERGING theme\nthe ROLE of dbp in the biology of Vitamin D as it RELATES to the Endocrine status of bone and Mineral Metabolism is well established and the reader is referred to reviews47,48, monographs49and authoritative web sites50.']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0045087', 'innate immune response', 19, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0006397', 'mRNA processing', 120, 'endocrine'), ('CHEBI_46662', 'mineral', 149, 'mineral'), ('GO_0008152', 'metabolic process', 157, 'metabolism')]
PMC3613945	2/2013	S218-PMC3613945	['both THESE STUDIES ARGUE AGAINST a ROLE for gc-maf or Vitamin D in Breast cancer pathogenesis.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000310', 'breast', 67, 'breast')]
PMC3616124	4/2013	S186-PMC3616124	['first, Cardiovascular disease studies SUGGEST that Vitamin E alone has DIFFERENT EFFECTS from Vitamin C and E combined[18],[19],[27].']	[('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('UBERON_0004535', 'cardiovascular system', 7, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E')]
PMC3629265	4/2013	S12-PMC3629265	['HOWEVER, it was not until the early 1900s that Vitamin D deficiency was recognised as the UNDERLYING cause, and that the IMPORTANCE of sunlight to maintain adequate vitamin d levels was appreciated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3629265	4/2013	S78-PMC3629265	['these FACTORS CONTRIBUTE to Vitamin D deficiency in the mothers, and THEREFORE, poor Placental transfer to the infant (28).']	[('SUPERFICIAL_RELATIONSHIP', 6), ('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 69)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001987', 'placenta', 85, 'placental')]
PMC3629265	4/2013	S82-PMC3629265	['given the young age of the cases presented (mean age 30 days), maternal Vitamin D deficiency is LIKELY a MAJOR contributing FACTOR in all the cases presented.']	[('PROBABLE_UNDERSTANDING', 96), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 124)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3635901	4/2013	S33-PMC3635901	['it HAS BEEN SHOWN that a LINK exists between the mycobacterium, ads, and, SURPRISINGLY, another component of the puzzle, namely, Vitamin D [18].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3651971	5/2013	S11-PMC3651971	['caption (boxed-text)\narticle summary\n\narticle focus\nTHIS ARTICLE EXAMINES the EFFECTS of early Vitamin A supplementation on Cognitive and motor skills in school-aged children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 103, 'A'), ('GO_0050890', 'cognition', 124, 'cognitive')]
PMC3651971	5/2013	S73-PMC3651971	['an unpaired, two-sided test statistic that accounted for clustering was calculated using the formula described by moulton and hayes36:where cpis the number of clusters in the Placebo group, cvathe number of clusters in the Vitamin A group,36and s can be calculated as the square-root of the variance, s2:where xijis the jth cluster mean of the i group, and xithe mean of all six of the i group clusters.36a ci for the difference in means was computed using the formula:where tv,0.025is the 2.5% of a t distribution with v=cpl\u2009+\u2009cva\u2009−\u20092 degrees of freedom.36\na two-step variation of this technique was used to estimate the treatment effect in an adjusted model that controlled for INFLUENCES of POTENTIAL CONFOUNDERS that were unevenly distributed between the two groups.']	[('SUPERFICIAL_RELATIONSHIP', 680), ('INCOMPLETE_EVIDENCE', 694), ('PROBLEM_COMPLICATION', 704)]	3	[('CHEBI_26130', 'biological pigment', 175, 'placebo'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin A')]
PMC3651971	5/2013	S80-PMC3651971	["further, children whose mother's histories of Gestational night blindness during the trial were missing (n=31) were excluded from the sampling frame because night blindness is an INDICATOR of Vitamin A deficiency and was CONSIDERED an ESSENTIAL exposure of interest for other research questions in this study."]	[('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 235)]	3	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin A')]
PMC3659910	1/2013	S7-PMC3659910	['THEREFORE, PREVENTION of Vitamin D deficiency among Pregnant women is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 70)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant')]
PMC3659910	1/2013	S27-PMC3659910	['[5] the increasing PREVALENCE of disorders LINKED to Vitamin D deficiency is REFLECTED in the several hundred children with rickets treated each year.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3659910	1/2013	S36-PMC3659910	['BECAUSE of its Steroid structure and function, Vitamin D plays an IMPORTANT ROLE in priming cells for other hormones to do their action.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_35341', 'steroid', 15, 'steroid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3659910	1/2013	S70-PMC3659910	['pre-Pregnancy obesity is also ASSOCIATED with significant increases in the odds of maternal and neonatal Vitamin D deficiency, INDEPENDENT of other FACTORS such as ethnicity.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 148)]	3	[('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3659910	1/2013	S96-PMC3659910	['ROLE of Vitamin D in Pregnant women\nadequate Vitamin D intake is ESSENTIAL for maternal and fetal health during Pregnancy, and PREVENTION of adverse outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC3659910	1/2013	S106-PMC3659910	['induction of the 1α-hydroxylase in early Gestation MIGHT provide a mechanism by which environmental or dietary Vitamin D CAN INFLUENCE fetal-Placental Development.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0001890', 'placenta development', 141, 'placental development'), ('UBERON_0001987', 'placenta', 141, 'placental')]
PMC3659910	1/2013	S127-PMC3659910	['[27] weishaar and simpson[28] SHOWED that lengthy periods of Vitamin D deficiency in Rats are ASSOCIATED with PROFOUND changes in Cardiovascular function, including increases in Cardiac and vascular muscle Contractile function.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 110)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 85, 'rats'), ('UBERON_0004535', 'cardiovascular system', 130, 'cardiovascular'), ('UBERON_0000948', 'heart', 178, 'cardiac'), ('GO_0006936', 'muscle contraction', 206, 'contractile')]
PMC3659910	1/2013	S142-PMC3659910	['while Vitamin D supplementation in Pregnancy has PREVIOUSLY been ASSOCIATED with reduced RISK of wheezing and type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy')]
PMC3659910	1/2013	S160-PMC3659910	['[43] IF electing to test Vitamin D status, Serum 25-Hydroxyvitamin D is the ACCEPTED BIOMARKER to be offered early in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 49, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC3660281	5/2013	S27-PMC3660281	['regarding to Vitamin D, both an excess and a deficiency HAVE BEEN ASSOCIATED with an INCREASED RISK of asthma.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3668200	5/2013	S14-PMC3668200	['at high-latitude areas, conditions of low uv-b radiation EFFECTIVELY facilitate Vitamin D Production in Humans with light skin color, THEREBY PREVENTING Vitamin D deficiency7).']	[('IMPORTANT_CONSIDERATION', 57), ('PROBABLE_UNDERSTANDING', 134), ('SUPERFICIAL_RELATIONSHIP', 142)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 80, 'vitamin D production'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'humans'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3672018	5/2013	S0-PMC3672018	['the INFLUENCE of early exposure to Vitamin D for development of Diseases later in Life\n\nabstract\n\nbackground\nVitamin D deficiency is common among otherwise healthy Pregnant women and MAY have CONSEQUENCES for them as well as the early Development and long-term health Of their Children.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 183), ('IMPORTANT_CONSIDERATION', 192)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007586', 'digestion', 64, 'diseases'), ('UBERON_0000104', 'life cycle', 82, 'life'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0001709', 'cell fate determination', 235, 'development ... - ... of ... children')]
PMC3672018	5/2013	S4-PMC3672018	['apart from determining the INFLUENCES of exposure prior to Conception and during Prenatal Life, we will EXAMINE the IMPORTANCE of Vitamin D exposure during specific seasons and trimesters, by comparing disease incidence among Individuals Born before and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('IMPORTANT_CONSIDERATION', 116)]	3	[('GO_0007620', 'copulation', 59, 'conception'), ('GO_0007565', 'female pregnancy', 81, 'prenatal'), ('UBERON_0000104', 'life cycle', 90, 'life'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('NCBITaxon_1', 'root', 226, 'individuals'), ('GO_0007567', 'parturition', 238, 'born')]
PMC3672018	5/2013	S14-PMC3672018	['the discovery of high-affinity Vitamin D receptors (vdr) in many Organs and cell types has LED to an increasing focus on the ROLE of Vitamin D as a Steroid Hormone with significant INFLUENCES on Cell Metabolism and Proliferation.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 181)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000062', 'organ', 65, 'organs'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_26764', 'steroid hormone', 148, 'steroid hormone'), ('GO_0002028', 'regulation of sodium ion transport', 195, 'cell metabolism ... proliferation')]
PMC3672018	5/2013	S18-PMC3672018	['CONSEQUENTLY, low Vitamin D INFLUENCES bone health, body growth and composition, and also IMPACTS on immunity [3,4].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3672018	5/2013	S40-PMC3672018	['furthermore, a RECENT STUDY REPORTED that a low level of maternal Vitamin D during Pregnancy was RELATED to high fat and low muscle in offspring at ages 5–9 [15].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC3672018	5/2013	S45-PMC3672018	['furthermore, large-scale interventional STUDIES ARE NEEDED to examine HOW Vitamin D exposure during Pregnancy AFFECTS long-term health outcomes of offspring.']	[('FUTURE_WORK', 40), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 110)]	3	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC3672018	5/2013	S82-PMC3672018	['in the FUTURE, a third phase will be PLANNED and will examine ASSOCIATION between additional exposure to Vitamin D in fetal Life and later development of other Immunological disorders, including severe asthma, crohn’s disease, Inflammatory Bowel diseases, and juvenile idiopathic arthritis.']	[('FUTURE_WORK', 7), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life'), ('UBERON_0003222', 'flexor digitorum superficialis', 160, 'immunological'), ('UBERON_0001782', 'pigmented layer of retina', 227, 'inflammatory bowel')]
PMC3672018	5/2013	S178-PMC3672018	['it THUS allows examination of the EFFECTS of low Vitamin D during fetal Life in RELATION to later development of particular diseases.']	[('PROBABLE_UNDERSTANDING', 3), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
PMC3685533	6/2013	S106-PMC3685533	['the different skin colour INFLUENCES the Vitamin D levels with the CURRENTLY AVAILABLE DATA SUGGESTING that Plasma Vitamin D was lower in black neonates than white neonates [8-11].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 108, 'plasma'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3685533	6/2013	S132-PMC3685533	['moreover, Vitamin D is INFLUENCED by seasonability and the study was conducted in a single season; HOWEVER, the data was collected in summer when better Vitamin D levels are DEMONSTRATED by literature [1].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 174)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3691177	6/2013	S22-PMC3691177	['we assessed children whose mothers had taken part in a randomised controlled trial of Prenatal Vitamin D supplementation, TO DETERMINE WHETHER supplementation PREVENTED wheezing or allergic disease in the first 3 years of Life[19].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000104', 'life cycle', 222, 'life')]
PMC3691177	6/2013	S125-PMC3691177	['finally, we are also unable to exclude the POSSIBILITY that Vitamin D supplementation at a higher dose, MIGHT PROTECT against early childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 110)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3691177	6/2013	S132-PMC3691177	['the results of our randomised controlled trial do not SUPPORT a strong causal RELATIONSHIP between low Prenatal Vitamin D status within the deficient/insufficient range and INCREASED RISK of Allergic sensitization or wheezing in early childhood.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 173)]	3	[('GO_0007565', 'female pregnancy', 103, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0040011', 'locomotion', 191, 'allergic')]
PMC3691177	6/2013	S133-PMC3691177	['we are UNABLE TO confidently exclude a SIMILAR RELATIONSHIP in more Vitamin D sufficient populations[8].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC3695234	7/2013	S1-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3695234	7/2013	S11-PMC3695234	['conclusions\nthese results SUGGEST that Vitamin D deficiency is RELATED to the severity of ad ASSOCIATED with Food sensitization.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 93)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33290', 'food', 109, 'food')]
PMC3695234	7/2013	S12-PMC3695234	['THUS, these data SUGGEST a ROLE for Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 27)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S22-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3695234	7/2013	S55-PMC3695234	['there are several biologically PLAUSIBLE EXPLANATIONS for the inverse CORRELATION between Serum Vitamin D and the presence of ad.']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('UBERON_0001977', 'blood serum', 90, 'serum'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3702245	6/2013	S14-PMC3702245	['physiologically active 1,25(Oh)2D does not readily cross the Placenta.41MANY STUDIES HAVE SHOWN that the Vitamin D status of infants at Birth as measured by Cord Blood 25(Oh)D CORRELATES positively with maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 23, '1,25(OH)2D'), ('UBERON_0001987', 'placenta', 61, 'placenta'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 171, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3702245	6/2013	S41-PMC3702245	['a study from pittsburgh SHOWED an inverse RELATIONSHIP between Vitamin D status and the risk of pre-eclampsia.83the authors FOUND that the risk of pre-eclampsia was more than doubled (odds ratio 2.4; ci 1.1–5.4) for a 50 nmol/l decrease in maternal Serum 25(Oh)D concentration.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 249, 'serum'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D')]
PMC3702245	6/2013	S47-PMC3702245	['RECENT STUDIES have INDICATED a ROLE for Vitamin D in the Innate Immune Response.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0045087', 'innate immune response', 58, 'innate immune response'), ('UBERON_0002405', 'immune system', 65, 'immune')]
PMC3702245	6/2013	S48-PMC3702245	['Vitamin D HAS BEEN SHOWN to upregulate Endogenous Synthesis Of Cathelicidin, a potent Antimicrobial peptide, in response to Microbial Invasion, via activation of toll-like receptors on microphages and Monocytes.6,24given that Antimicrobial peptides provide rapid Defense against invading pathogens, it is PLAUSIBLE that Vitamin D plays a ROLE in host defense against infections in both mother and offspring.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 305), ('SUPERFICIAL_RELATIONSHIP', 338)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009790', 'embryo development', 39, 'endogenous'), ('GO_0007608', 'sensory perception of smell', 50, 'synthesis of ...'), ('CHEBI_3364', 'Canthiumine', 63, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 63, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 86, 'antimicrobial'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'microbial'), ('GO_0007586', 'digestion', 134, 'invasion'), ('CL_0000576', 'monocyte', 201, 'monocytes'), ('CHEBI_65381', 'albizoside C', 226, 'antimicrobial'), ('GO_0006952', 'defense response', 263, 'defense'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
PMC3702245	6/2013	S52-PMC3702245	['IMPACT on neonate and infant\nboth in vitro and observational studies have DEMONSTRATED that Vitamin D status during Pregnancy IMPACTS the Immune Response of the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0006955', 'immune response', 138, 'immune response'), ('UBERON_0002405', 'immune system', 138, 'immune')]
PMC3702245	6/2013	S69-PMC3702245	['the RECENT cochrane review of Vitamin D supplementation alone during Pregnancy79Considered five trials that compared the EFFECTS of supplementation with placebo or no supplementation.33,73,77,78,102the review CONCLUDED that Vitamin D supplementation increases Serum 25(Oh)D concentrations during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 209)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 69, 'pregnancy79considered'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('UBERON_0001977', 'blood serum', 260, 'serum'), ('CHEBI_71657', 'versiconol acetate', 266, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 266, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 296, 'pregnancy')]
PMC3702339	6/2013	S197-PMC3702339	['the ASSOCIATION CAN be secondary to the INFLUENCE of zinc on the Metabolism Of Vitamin A (42).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 40)]	3	[('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 65, 'metabolism of vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 87, 'A')]
PMC3705146	5/2013	S26-PMC3705146	['nowhere has lack of Photic input EXERTED more EFFECTS on Humans over time than in the high latitude country of ireland, where comparatively low dietary Vitamin D and the lack of sunlight-induced Vitamin D selected for the fairest skin type in the world, as REPORTED in dermatological surveys (gibson et al.,1997).']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 257)]	3	[('GO_0036367', 'light adaption', 20, 'photic'), ('NCBITaxon_9606', 'Homo sapiens', 57, 'humans'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC3705146	5/2013	S217-PMC3705146	['the need for Vitamin D MAY have played an IMPORTANT ROLE in selecting for polymorphisms in a variety of light-responsive Genes, including the melanotropins.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 121, 'genes')]
PMC3705146	5/2013	S221-PMC3705146	['in such a manner, certain polymorphisms in melanotropin Genes MAY have become more prevalent in low-light environments IF they positively AFFECTED the natural Synthesis Of Vitamin D by reducing the Synthesis and Sequestration Of Melanin (valverde et al.,1995).']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('SO_0000704', 'gene', 56, 'genes'), ('GO_0030474', 'spindle pole body duplication', 159, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 198, 'synthesis'), ('GO_0098725', 'symmetric cell division', 212, 'sequestration of melanin'), ('CHEBI_25179', 'melanins', 229, 'melanin')]
PMC3705320	3/2013	S14-PMC3705320	['HOWEVER, observational studies have SUGGESTED ASSOCIATIONS between Vitamin D status during Pregnancy and Postnatal infant health outcomes [3,4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'postnatal')]
PMC3710934	7/2013	S378-PMC3710934	['ON THE OTHER HAND, dietary Heme Iron Intake was positively ASSOCIATED with Lung cancer when subjects were stratified by Vitamin C supplements Intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_36084', 'dihydroxybenzoate', 27, 'heme iron'), ('GO_0007631', 'feeding behavior', 37, 'intake'), ('UBERON_0002048', 'lung', 75, 'lung'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin C'), ('GO_0007631', 'feeding behavior', 142, 'intake')]
PMC3710934	7/2013	S380-PMC3710934	['among current or ex-smokers, the ASSOCIATION was EVEN stronger (rr=20.38; 95% ci: 22.50–185.8) and reached statistical significance EVEN in the group having Vitamin C supplement Intake of >100 mg/day (rr=3.52; 95% ci: 1.24–8.97).']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 49), ('ANOMALY_CURIOUS_FINDING', 132)]	3	[('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('GO_0007631', 'feeding behavior', 178, 'intake')]
PMC3713405	7/2013	S85-PMC3713405	['gross brain anatomy, mitosis and apoptosis\nthe initial absence of Vitamin D also AFFECTS OTHER, more general, aspects of Brain Development that do not directly RELATE to Da Neurons.']	[('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain'), ('CL_0000589', 'cochlear inner hair cell', 170, 'DA neurons')]
PMC3713405	7/2013	S95-PMC3713405	['THUS at both the cellular and transcriptional levels, Vitamin D APPEARS fundamentally INVOLVED in the rate of Proliferation and Cell Death in the Brain.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 64), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0008283', 'cell proliferation', 110, 'proliferation'), ('GO_0008219', 'cell death', 128, 'cell death'), ('UBERON_0000955', 'brain', 146, 'brain')]
PMC3713405	7/2013	S126-PMC3713405	['Vitamin D deficiency in the later portion of Gestation is REQUIRED to elicit this behavioral sensitivity WHEREAS Vitamin D deficiency during the early portion of Gestation has no IMPACT (o’loan et al., 2007).']	[('IMPORTANT_CONSIDERATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 179)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 45, 'gestation'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'gestation')]
PMC3713405	7/2013	S150-PMC3713405	['CONSISTENT with the PREMISE that Vitamin D plays a ROLE in Dopaminergic Cell Development, Vdr Expression in the differentiating Field Of the Midbrain and Basal Ganglia can be observed by e15 (veenstra et al., 1998).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_18243', 'dopamine', 59, 'dopaminergic'), ('CL_0000700', 'dopaminergic neuron', 59, 'dopaminergic cell'), ('GO_0048569', 'post-embryonic animal organ development', 59, 'dopaminergic cell development'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 90, 'VDR'), ('GO_0010467', 'gene expression', 94, 'expression'), ('UBERON_0002615', 'ventral tegmental decussation', 128, 'field of ... midbrain'), ('UBERON_0002420', 'basal ganglion', 154, 'basal ganglia')]
PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]
PMC3717170	5/2013	S4-PMC3717170	['introduction\ntraditionally, Vitamin D HAS BEEN CONSIDERED almost exclusively in the context of its ROLE in Calcium Homeostasis.']	[('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 107, 'calcium homeostasis')]
PMC3717170	5/2013	S32-PMC3717170	['with permission from christakos.60\n\nVitamin D in Immune function and disease PREVENTION\nmartin hewison (the david geffen school of medicine, university of california) detailed one of the most prominent of the SO-called nonclassical EFFECTS of Vitamin D: its ability to act as a potent modulator of Human Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 232)]	3	[('CHEBI_28384', 'vitamin K', 36, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 36, 'Vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 298, 'human'), ('GO_0006955', 'immune response', 304, 'immune responses'), ('UBERON_0002405', 'immune system', 304, 'immune')]
PMC3717170	5/2013	S49-PMC3717170	['Vitamin D in the Heart and Vascular System\ndavid g. gardner (university of california, san francisco) expanded the discussion of nonclassical EFFECTS of Vitamin D to include EVIDENCE of a significant ROLE for Vitamin D in the Cardiovascular System.']	[('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 200)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000948', 'heart', 17, 'heart'), ('UBERON_0007798', 'vascular system', 27, 'vascular system'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 226, 'cardiovascular system')]
PMC3717170	5/2013	S115-PMC3717170	['IMPACT of Cholecalciferol repletion on Erythropoietin requirements in Hemodialysis patients\nlily li (cleveland clinic lerner college of medicine of case western reserve university and mount sinai school of medicine) presented pilot data from a randomized control trial investigating the IMPACT of Cholecalciferol repletion on Erythropoietin REQUIREMENTS in Vitamin D–deficient hemodialysis patients.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 287), ('IMPORTANT_CONSIDERATION', 341)]	3	[('CHEBI_52550', 'theopalauamide', 10, 'cholecalciferol'), ('CHEBI_24009', 'eumelanin', 39, 'erythropoietin'), ('GO_0030097', 'hemopoiesis', 70, 'hemodialysis'), ('CHEBI_52550', 'theopalauamide', 297, 'cholecalciferol'), ('CHEBI_24009', 'eumelanin', 326, 'erythropoietin'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D')]
PMC3717170	5/2013	S146-PMC3717170	['this is a topic of clinical significance BECAUSE myopathy characterized by proximal muscle weakness and atrophy is a common symptom in Vitamin D deficiency states.40the loss of muscular strength and a reduction in muscle mass increases the RISK of falls and LEADS to fractures.']	[('PROBABLE_UNDERSTANDING', 41), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 258)]	3	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D')]
PMC3717170	5/2013	S162-PMC3717170	['Vitamin D and physical and Cognitive function in older persons\nluigi ferrucci (national institute on Aging) DISCUSSED RECENT EVIDENCE LINKING Vitamin D deficiency to the pathogenesis and clinical Progression Of chronic Diseases highly prevalent in older Persons.']	[('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0050890', 'cognition', 27, 'cognitive'), ('GO_0007568', 'aging', 101, 'Aging'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'progression of ... diseases'), ('NCBITaxon_10088', 'Mus <genus>', 254, 'persons')]
PMC3717170	5/2013	S175-PMC3717170	['INTERESTINGLY, vdr Expression in Human muscle Tissue decreases with Aging, and Vitamin D level is STRONGLY CORRELATED with muscle quality and lower muscle fat infiltration.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('GO_0010467', 'gene expression', 19, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('UBERON_0000479', 'tissue', 46, 'tissue'), ('GO_0007568', 'aging', 68, 'aging'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3717170	5/2013	S177-PMC3717170	['a RECENT STUDY DEMONSTRATED that Vitamin D level CORRELATES with maximal oxygen consumption, and that supplementation of Vitamin D increases fitness in athletes.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3728489	7/2013	S23-PMC3728489	['we will highlight examples of three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 131)]	3	[('CHEBI_33839', 'macromolecule', 36, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 51, 'folate'), ('CHEBI_24859', 'iodine atom', 59, 'iodine'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007399', 'nervous system development', 142, 'neurodevelopmental')]
PMC3728489	7/2013	S339-PMC3728489	['in particular, maternal Micronutrient deficiencies in zinc, fat-soluble vitamins (e.g., Vitamins A, D, e) and nutritional factors RELATED to Single Carbon Metabolism (e.g., Choline, Vitamins B2, B6, B12 and Folate) HAVE BEEN SHOWN to play a ROLE in cell-mediated and Humoral Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 241)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 24, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 88, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 97, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('GO_0046505', 'sulfolipid metabolic process', 141, 'single carbon metabolism'), ('CHEBI_15354', 'choline', 173, 'choline'), ('CHEBI_33277', 'gamma-tocotrienol', 182, 'vitamins'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 182, 'vitamins B2'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 195, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 199, 'B12'), ('CHEBI_30863', '5-azaorotic acid', 207, 'folate'), ('GO_0002544', 'chronic inflammatory response', 267, 'humoral immune responses'), ('UBERON_0002405', 'immune system', 275, 'immune')]
PMC3739737	8/2013	S17-PMC3739737	['the HYPOTHESIS that low Vitamin D levels AFFECT the developing Brain is SUPPORTED by data from Prenatal Vitamin D deficiency in rodents, in which the foetus develops in utero in a Vitamin D-deficient but normocalcaemic dam[7],[8].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000955', 'brain', 63, 'brain'), ('GO_0007565', 'female pregnancy', 95, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC3760821	9/2013	S21-PMC3760821	['hypovitaminosis D is commonly SEEN in both Pregnant and non-Pregnant women worldwide[5]; with many FACTORS IMPACTING on Vitamin D status, including; exposure to sunlight, skin colour, season, latitude and obesity, among others[6].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3760821	9/2013	S36-PMC3760821	['additionally, there is EMERGING EVIDENCE DEMONSTRATING an ASSOCIATION between foetal and early childhood Vitamin D deficiency and later Adult disease processes, such as multiple sclerosis, cardiovascular disease, schizophrenia, certain cancers and other Autoimmune diseases such as t1dm and lupus[16].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 136, 'adult'), ('UBERON_0001442', 'skeleton of manus', 254, 'autoimmune')]
PMC3760821	9/2013	S134-PMC3760821	['a similar significant positive ASSOCIATION was SEEN between 25ohd at trimester 2 and trimester 3 in both groups.10.1371/journal.pone.0074068.t003\n\ncaption (table-wrap): table 3\nmaternal and Cord Vitamin D levels and their RELATIONSHIP with maternal and neonatal outcome variables.variablecontrol groupt1dm group rp value rp value maternal Vitamin D booking Vitamin D trimester 20.92<0.0010.46<0.001vitamin D trimester 30.76<0.0010.380.005hba1cbooking−0.160.49−0.380.004 maternal Vitamin D trimester 2 Vitamin D trimester 30.66<0.0010.64<0.001hba1cbooking−0.110.55−0.410.001hba1ctrimester 20.060.76−0.280.03birth weight (g)0.390.010.020.87neonatal bmi sds0.170.31−0.240.07birth height sds−0.060.730.230.08 maternal Vitamin D trimester 3 hba1cbooking−0.160.35−0.250.05hba1ctrimester 2−0.130.42−0.220.08neonatal bmi sds0.110.43−0.300.02birth height sds−0.0020.990.280.03 Cord Vitamin D neonatal measure\u2003neonatal bmi sds0.290.17−0.310.03\u2003Birth height sds−0.190.390.260.06maternal hba1c\u2003booking−0.140.57−0.440.001\u2003trimester 2−0.390.12−0.290.03\u2003trimester 3−0.230.29−0.220.12maternal Vitamin D\u2003booking0.390.260.330.02\u2003trimester 20.250.320.46<0.001\u2003trimester 30.73<0.0010.84<0.001\ncorrelations between continuous variables were assessed by pearson’s coefficients for correlations.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 222)]	3	[('UBERON_0002240', 'spinal cord', 190, 'cord'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 357, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 406, 'D'), ('CHEBI_28384', 'vitamin K', 479, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 501, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 714, 'Vitamin D'), ('UBERON_0000948', 'heart', 868, 'Cord'), ('CHEBI_28384', 'vitamin K', 873, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 873, 'Vitamin D'), ('GO_0007567', 'parturition', 934, 'Birth'), ('CHEBI_27300', 'vitamin D', 1077, 'vitamin D')]
PMC3760821	9/2013	S150-PMC3760821	['multiple linear regression analysis INDICATED that maternal Vitamin D at booking (b\u200a=\u200a−0.015; p \u200a=\u200a0.011) and obese bmi at booking (b\u200a=\u200a0.566; p \u200a=\u200a0.045), both had a significant INDEPENDENT IMPACT on hba1cat booking.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3760821	9/2013	S177-PMC3760821	['with respect to a causal LINK between Vitamin D repletion and improved Glucose Homeostasis, LIMITED STUDIES HAVE REPORTED substantial improvements in Glycaemic Control (hba1clevels) in t1dm patients who achieved higher circulating 25Ohd levels via supplementation[36],[37].']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 108)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_17234', 'glucose', 71, 'glucose'), ('GO_0042593', 'glucose homeostasis', 71, 'glucose homeostasis'), ('GO_0051162', 'L-arabitol metabolic process', 150, 'glycaemic control'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 231, '25OHD')]
PMC3773018	4/2013	S0-PMC3773018	['the longitudinal trajectory of Vitamin D status from Birth to early childhood on the development of Food sensitization\n\nabstract\n\nbackground\nINCREASING EVIDENCE SUPPORTS the immunomodulatory EFFECT of Vitamin D on Allergic diseases.']	[('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('GO_0007567', 'parturition', 53, 'Birth'), ('CHEBI_33290', 'food', 100, 'Food'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0040011', 'locomotion', 214, 'allergic')]
PMC3773018	4/2013	S1-PMC3773018	['the combined ROLE of Prenatal and Postnatal Vitamin D status in the development of Food Sensitization (fs) and Food Allergy REMAINS under-STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 137)]	3	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('GO_0007567', 'parturition', 34, 'postnatal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food'), ('GO_0031318', 'detection of folic acid', 83, 'food sensitization'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007631', 'feeding behavior', 111, 'food allergy')]
PMC3773018	4/2013	S7-PMC3773018	['conclusions\nPrenatal and early Postnatal Vitamin D levels, along with individual Genetic susceptibility, SHOULD BE CONSIDERED in assessing the ROLE of Vitamin D in the development of fs and Food allergy.']	[('FUTURE_WORK', 105), ('FUTURE_WORK', 115), ('SUPERFICIAL_RELATIONSHIP', 143)]	3	[('GO_0007565', 'female pregnancy', 12, 'Prenatal'), ('GO_0007567', 'parturition', 31, 'postnatal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('SO_0000704', 'gene', 81, 'genetic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_33290', 'food', 190, 'food')]
PMC3773018	4/2013	S17-PMC3773018	['(17) REPORTED that both higher (>40ng/ml) and lower (<20 ng/ml) Vitamin D levels were ASSOCIATED with high total Ige and detectable inhalant allergen-specific Ige; high Vitamin D was also ASSOCIATED with positive allergy skin tests.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 188)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 113, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 159, 'IgE'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3773018	4/2013	S22-PMC3773018	['HEREIN, we EXAMINED the INTERACTION of a Promoter polymorphism (rs2243250: c-590t) in the Il4 Gene and the longitudinal trajectory of Vitamin D status from Birth to early childhood on the risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('SO_0000167', 'promoter', 41, 'promoter'), ('PR_000008989', 'interleukin-1 family member 7', 90, 'IL4'), ('SO_0000704', 'gene', 94, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC3773018	4/2013	S57-PMC3773018	['finally, we OBSERVED an INTERACTION EFFECT between rs2243250 and persistently low Vitamin D status on the risk of fs (pinteraction= 0.02).']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3773018	4/2013	S87-PMC3773018	['for this subset study, we have ONLY presented findings for the Il4 Promoter polymorphism given that rs2243250 HAS BEEN commonly studied and has already been shown to have the most significant Gene-Vitamin D deficiency INTERACTION on fs (18).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 218)]	3	[('PR_000008989', 'interleukin-1 family member 7', 63, 'IL4'), ('SO_0000167', 'promoter', 67, 'promoter'), ('SO_0000704', 'gene', 192, 'gene'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC3798907	8/2013	S3-PMC3798907	['IN GENERAL, Vitamin E supplementation was ASSOCIATED with a TREND for reduced proliferative responses after stimulation with Antigens and house dust mite, and with increased Proliferation after stimulation with timothy grass allergen.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 60)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin E'), ('CHEBI_59132', 'antigen', 125, 'antigens'), ('GO_0008283', 'cell proliferation', 174, 'proliferation')]
PMC3798907	8/2013	S14-PMC3798907	['three Birth cohort studies HAVE REPORTED reduced maternal dietary Vitamin E intake during Pregnancy to be ASSOCIATED with an increased LIKELIHOOD of childhood wheezing [9,10] and asthma [11].']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 106), ('PROBABLE_UNDERSTANDING', 135)]	3	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC3798907	8/2013	S34-PMC3798907	['cell Cultures\nthe cell culture methodology was identical to that used in our PREVIOUS STUDY that DEMONSTRATED the ASSOCIATION between maternal Vitamin E intake and cbmc responses [12].']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	3	[('CL_0000010', 'cultured cell', 5, 'Cultures'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin E')]
PMC3798907	8/2013	S59-PMC3798907	['Vitamin E supplementation of cbmc\nthe addition of Vitamin E to 70 cbmc cultures REVEALED COMPLEX EFFECTS.']	[('INCOMPLETE_EVIDENCE', 80), ('DIFFICULT_TASK', 89), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E')]
PMC3798907	8/2013	S123-PMC3798907	['Vitamin E supplementation STUDIES in Colorectal cancer HAVE REPORTED a more pronounced stimulatory EFFECT by Vitamin E on naïve (Cd45Ra(+)) Th-Cells as compared with T Cells with a Memory/activated phenotype (Cd45Ro(+)) [4].']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('UBERON_0012652', 'colorectum', 37, 'colorectal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin E'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 129, 'CD45RA'), ('CL_0000545', 'T-helper 1 cell', 140, 'Th-cells'), ('CL_0000084', 'T cell', 166, 'T cells'), ('GO_0007613', 'memory', 181, 'memory'), ('PR_000005170', 'CD37 molecule', 209, 'CD45RO')]
PMC3798907	8/2013	S132-PMC3798907	['ONLY single doses of Mitogen and Allergens were used to stimulate the cbmc; HOWEVER these were identical to those used to identify the original ASSOCIATION between maternal Vitamin E Intake and cbmc responses in a general population [12].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_52290', 'mitogen', 21, 'mitogen'), ('CHEBI_33663', 'cyclic hydrocarbon', 33, 'allergens'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin E'), ('GO_0007631', 'feeding behavior', 183, 'intake')]
PMC3814422	10/2013	S0-PMC3814422	['maternal 25-Hydroxyvitamin D and its ASSOCIATION with childhood atopic outcomes and Lung function\n\nabstract\n\nbackground\nit HAS BEEN SUGGESTED that maternal Vitamin D status in Pregnancy INFLUENCES the risk of asthma and atopy in the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 9, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 84, 'lung'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC3814422	10/2013	S13-PMC3814422	['studies of maternal dietary Intake have MOSTLY REPORTED inverse RELATIONSHIPS between maternal Vitamin D intake in Pregnancy and early childhood wheeze, asthma, allergic rhinitis and eczema8–10.']	[('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('GO_0007631', 'feeding behavior', 28, 'intake'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC3814422	10/2013	S121-PMC3814422	['IT IS POSSIBLE that this is a POOR MARKER of Vitamin D levels over Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy')]
PMC3814422	10/2013	S139-PMC3814422	['in particular, we have not FOUND EVIDENCE to SUGGEST that higher Prenatal Vitamin D status in Pregnancy PROTECTS against the development of early childhood wheezing or later asthma.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC3827489	10/2013	S13-PMC3827489	['in the Liver, vitamin d3is converted to 25-Hydroxyvitamin D (25[Oh]D), the MAJOR circulating form and BEST INDICATOR of Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 40, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 61, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3827489	10/2013	S20-PMC3827489	['IN LIGHT OF the near universal Expression of the vdr across Tissues, Vitamin D would be expected to play a ROLE in diseases OTHER than those of bone.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	3	[('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3827489	10/2013	S40-PMC3827489	['a RECENT STUDY based on the knhanes iv 2008-2009 examining a total of 1,510 healthy adolescents aged 12-18 years (806 male subjects and 704 female subjects; mean age, 14.7 years) ASSESSED that the prevalence of Vitamin D deficiency (25[Oh]D<20.0 ng/ml) was 89.1% in spring, 53.7% in summer, 63.9% in autumn, and 90.5% in winter, and that independent PREDICTORS for low Vitamin D status were season (winter), higher education level, and a lack of Vitamin D supplementation22).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 350)]	3	[('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 233, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D')]
PMC3827489	10/2013	S64-PMC3827489	['in addition, Vitamin D HAS BEEN recognized as an anti-infective agent due TO its EFFECTS on Innate and Adaptive Immune Responses.']	[('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007631', 'feeding behavior', 92, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 103, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 112, 'immune')]
PMC3827489	10/2013	S80-PMC3827489	['the inverse ASSOCIATION between higher body fat and low Vitamin D concentrations MAY BE ASCRIBED to Sequestration Of the fat-soluble Vitamin D within Adipose Tissues57).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0051610', 'serotonin uptake', 100, 'sequestration of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0007149', 'inferior thyroid artery', 150, 'adipose tissues57')]
PMC3829803	11/2013	S30-PMC3829803	['in the last 2 decades, MANY STUDIES have DOCUMENTED the beneficial EFFECTS of Vitamin A supplements on general mortality and/or morbidity in young children in a wide range of developing countries.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin A')]
PMC3829803	11/2013	S174-PMC3829803	['using the paramyxovirus most closely RELATED to Measles, our group has DEMONSTRATED that canine distemper virus (cdv)-infected ferrets treated with Vitamin A develop less SEVERE disease [78].']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 171)]	3	[('NCBITaxon_33208', 'Metazoa', 48, 'measles'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin A')]
PMC3855580	10/2013	S153-PMC3855580	['we have PREVIOUSLY SHOWN that the ASSOCIATION between maternal Vitamin D deficiency [38] and Glucose intolerance [11,14] with offspring homa-ir was present at 9.5\xa0years of age, but NOT at 5\xa0years of age.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 181)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 93, 'glucose')]
PMC3873449	12/2013	S26-PMC3873449	['FURTHER INVESTIGATION IS NEEDED in order to confirm the EFFECT of Vitamin D deficiency during Pregnancy on various diseases in childhood.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC3873449	12/2013	S36-PMC3873449	['also, LITTLE IS KNOWN about maternal FACTORS INFLUENCING Vitamin D status in chinese Pregnant women.']	[('FULL_UNKNOWN', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC3873449	12/2013	S108-PMC3873449	['TO DETERMINE WHETHER education levels IMPACT Vitamin D status, women were grouped by better educated women (with associate degree or higher) and less educated women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3873449	12/2013	S162-PMC3873449	['in addition, pollution MAY BE also a FACTOR that AFFECTS uv-b reaching the skin and reducing endogenous Vitamin D Production in the skin.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 104, 'vitamin D production')]
PMC3873449	12/2013	S166-PMC3873449	['OTHER STUDIES have ALSO SHOWN that the air pollution has a significant INFLUENCE on Vitamin D status [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3873449	12/2013	S167-PMC3873449	['women in beijing can not produce enough Vitamin D through sunshine exposure in winter DUE TO multiple FACTORS.']	[('PROBABLE_UNDERSTANDING', 86), ('PROBLEM_COMPLICATION', 86), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3873449	12/2013	S170-PMC3873449	['a RECENT randomized clinical TRIAL in non-western immigrants in the netherlands (none asian) FOUND Vitamin D supplementation to be more EFFECTIVE than advised sunlight exposure for treating Vitamin D deficiency [37].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3873449	12/2013	S182-PMC3873449	['HOWEVER, in Pregnant women, a study evaluating Plasma Vitamin D status HAS SHOWN that Vitamin D supplementation of <2000 iu/day is not EFFECTIVE in achieving sufficiency [42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3873449	12/2013	S199-PMC3873449	['it HAS BEEN REPORTED that pre-gravid obese women had significantly lower Serum 25(Oh)D concentrations and dose-DEPENDENT RELATIONS between pre-Pregnancy bmi and maternal Vitamin D status [48].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	3	[('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 79, '25(OH)D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3882256	1/2014	S2-PMC3882256	['objective\nTO EXAMINE the RELATIONSHIP between Maternal Pregnancy dietary and supplement iron Intake and hemoglobin, with offspring’s Arterial stiffness (measured by Carotid-radial pulse wave velocity), Endothelial function (measured by Brachial Artery flow mediated dilatation), Blood pressure, and adiposity (measured by body mass index), test for mediation by cord ferritin, Birth weight, Gestational age, and child dietary iron intake, and for EFFECT modification by maternal Vitamin C intake and offspring sex.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 447)]	3	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007631', 'feeding behavior', 93, 'intake'), ('UBERON_0001637', 'artery', 133, 'arterial'), ('UBERON_0005396', 'carotid artery segment', 165, 'carotid'), ('UBERON_0001986', 'endothelium', 202, 'endothelial'), ('UBERON_0001398', 'brachial artery', 236, 'brachial artery'), ('UBERON_0000178', 'blood', 279, 'blood'), ('GO_0007567', 'parturition', 377, 'birth'), ('GO_0007565', 'female pregnancy', 391, 'gestational'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin C')]
PMC3888066	12/2012	S1-PMC3888066	['in 1995, rothman et al DEMONSTRATED an ASSOCIATION between excessive Vitamin A, >10,000 iu/day, during the first Trimester of Pregnancy and Teratogenic EFFECTS, particularly in the Central Nervous System.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('GO_0009294', 'DNA mediated transformation', 113, 'trimester'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('CHEBI_50905', 'teratogenic agent', 140, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 181, 'central nervous system')]
PMC3888066	12/2012	S41-PMC3888066	['the amount of Vitamin A in the Liver varies between species, but it is not a common Food in a regular diet and is, THEREFORE, UNLIKELY alone to be ASSOCIATED with Teratogenic Retinoic Acid levels.']	[('PROBABLE_UNDERSTANDING', 115), ('PROBABLE_UNDERSTANDING', 126), ('SUPERFICIAL_RELATIONSHIP', 147)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_33290', 'food', 84, 'food'), ('CHEBI_50905', 'teratogenic agent', 163, 'teratogenic'), ('GO_0031649', 'heat generation', 163, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 175, 'retinoic acid')]
PMC3901983	1/2013	S97-PMC3901983	['it HAS BEEN SUGGESTED that the Vitamin A status of Pregnant women CAN INFLUENCE Vitamin A stores in the fetus Liver [20].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('UBERON_0002107', 'liver', 110, 'liver')]
PMC3926113	1/2014	S2-PMC3926113	['in the PRESENT STUDY, we INVESTIGATED the developmental pattern and EFFECT of vitc deficiency on antioxidants, Vitamin E and Superoxide dismutase (sod), assessed oxidative damage by measuring Malondialdehyde (Mda), Hydroxynonenal (Hne) and Nitrotyrosine (Nt) and analysed Gene and protein Expression of Apoptosis marker Caspase-3 in the guinea pig foetal Brain at two Gestational (gd) time points, gd 45/pre-term and gd 56/near term following either a vitc sufficient (ctrl) or deficient (def) maternal dietary regime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_18421', 'superoxide', 125, 'superoxide'), ('CHEBI_16480', 'nitric oxide', 192, 'malondialdehyde'), ('CHEBI_34840', 'methyl methacrylate', 209, 'MDA'), ('CHEBI_5445', 'glyceraldehyde', 215, 'hydroxynonenal'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 231, 'HNE'), ('CHEBI_50654', 'but-2-enoate ester', 240, 'nitrotyrosine'), ('CHEBI_13389', 'NAD', 255, 'NT'), ('SO_0000704', 'gene', 272, 'gene'), ('GO_0010467', 'gene expression', 289, 'expression'), ('GO_0006915', 'apoptotic process', 303, 'apoptosis'), ('PR_000002319', 'catenin beta-1 isoform 1', 320, 'caspase-3'), ('UBERON_0000955', 'brain', 355, 'brain'), ('GO_0007565', 'female pregnancy', 368, 'gestational')]
PMC3991049	11/2013	S63-PMC3991049	["newborns' Vitamin D levels CORRELATED positively with maternal 25-Hydroxyvitamin D (p\xa0<\xa00.001).10in a study from china, jing wang et al., reported 57.1% of Pregnant women and 44.2% showed deficiency, and 97.4% of women and 96.1% of neonates SHOWED Vitamin D insufficiency.11\nbodnar et al.,12REPORTED the prevalence of Vitamin D deficiency and insufficiency in 200 caucasian and 200 african-american Pregnant women and in the Cord Blood samples of their neonates."]	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 289)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 63, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnant'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 399, 'pregnant'), ('UBERON_0002240', 'spinal cord', 425, 'cord'), ('UBERON_0000178', 'blood', 430, 'blood')]
PMC4018592	4/2014	S114-PMC4018592	['[43] in tanzania, when Micronutrient supplements providing amounts twice the RECOMMENDED dietary allowance (rda) for Vitamin E and 6-10 times for Vitamin C and several b Vitamins were administered, mean Birth weight increased by 67 g.[36] finally, the provision of multivitamin and multivitamin-Mineral supplements from two different Pharmaceutical companies MIGHT be INFLUENCED infants’ size.']	[('FUTURE_WORK', 77), ('INCOMPLETE_EVIDENCE', 359), ('SUPERFICIAL_RELATIONSHIP', 368)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 23, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin C'), ('CHEBI_33277', 'gamma-tocotrienol', 170, 'vitamins'), ('GO_0007567', 'parturition', 203, 'birth'), ('CHEBI_46662', 'mineral', 295, 'mineral'), ('CHEBI_52217', 'pharmaceutical', 334, 'pharmaceutical')]
PMC4034700	5/2014	S129-PMC4034700	['the ROLE of oxidative stress in mediating pe pathophysiology is SUPPORTED by REPORTS of significantly decreased levels of antioxidant Vitamins C, a, e, Β-Carotene, Glutathione levels, and iron-binding capacity in the maternal circulation of women with Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamins C'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 152, 'β-carotene'), ('CHEBI_16856', 'glutathione', 164, 'glutathione'), ('GO_0007128', 'meiotic prophase I', 252, 'preeclampsia')]
PMC4045304	2/2014	S272-PMC4045304	['POOR maternal Vitamin D status or early childhood Vitamin deficiency or low activity of various Vitamin D RELATED enzymes MAY result in deficient activity in the Vitamin D system crucial for Brain Development.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 50, 'vitamin'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007420', 'brain development', 191, 'brain development'), ('UBERON_0000955', 'brain', 191, 'brain')]
PMC4051754	6/2014	S244-PMC4051754	['parameters measured were: the indexes of Acute Phase Reaction, such as the positive Acute Phase protein haptoglobin and ceruloplasmin; the negative Acute Phase protein Albumin, paraoxonase and the other index RELATED to the negative Acute Phase Protein reaction such as Cholesterol, Β-Carotene, and Vitamin A; Bilirubin; the Liver enzymes aspartate aminotransferase (ast or got ) and γ- glutamyl transpeptidase ( ggt ); Minerals (Calcium, magnesium, zinc, and Phosphorous); creatinine; and Vitamin e. the concentration of total proteins was analyzed also previously[10]and the data were re-analyzed in the PRESENT STUDY in order to calculate accurately the concentration of globulins which are ESTIMATED by the difference between total proteins and albumin.']	[('SUPERFICIAL_RELATIONSHIP', 209), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('INCOMPLETE_EVIDENCE', 694)]	3	[('GO_0007354', 'zygotic determination of anterior/posterior axis, embryo', 41, 'acute phase reaction'), ('GO_0006953', 'acute-phase response', 84, 'acute phase'), ('GO_0006953', 'acute-phase response', 148, 'acute phase'), ('PR_000005908', 'alpha-crystallin B chain', 168, 'albumin'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 233, 'acute phase protein'), ('CHEBI_16113', 'cholesterol', 270, 'cholesterol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 283, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin A'), ('CHEBI_16990', 'bilirubin IXalpha', 310, 'bilirubin'), ('UBERON_0002107', 'liver', 325, 'liver'), ('CHEBI_46751', 'quinolizidine', 420, 'minerals'), ('CHEBI_22313', 'alkaline earth metal atom', 430, 'calcium'), ('CHEBI_30207', 'phosphorus(.)', 460, 'phosphorous'), ('CHEBI_33229', 'vitamin (role)', 490, 'vitamin')]
PMC4071151	6/2014	S69-PMC4071151	['Nutrients such as Vitamins A, b6, b12 and Folic Acid and zinc AFFECT Embryogenesis and a deficiency in any of these elements MAY BE RELATED to spontaneous abortion failure and to a spectrum of Neurodevelopmental disorders [16].']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 18, 'vitamins A'), ('CHEBI_30751', 'formic acid', 42, 'folic acid'), ('GO_0009790', 'embryo development', 69, 'embryogenesis'), ('GO_0007399', 'nervous system development', 193, 'neurodevelopmental')]
PMC4072587	6/2014	S24-PMC4072587	['the ROLE of Vitamin D deficiency during Pregnancy on longer term infant outcomes, PARTICULARLY with regard to early Childhood development is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 82), ('FULL_UNKNOWN', 141)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0013628', 'pollical pad', 116, 'childhood')]
PMC4072587	6/2014	S108-PMC4072587	['maternal Vitamin D and anthropometric measurements at six months of age\nan inverse ASSOCIATION between maternal 25-Ohd and infant length-for-age z scores at 6 months of age was DEMONSTRATED (md −0.09 per 25 nmol/l increase in Vitamin D concentration, 95% ci −0.12 to −0.02) (table 6).10.1371/journal.pone.0099005.t006\n\ncaption (table-wrap): table 6\ninfant anthropometric outcomes at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted modelinfant anthropometric outcomesmean [sd] ornumber(%)mean difference1,3or odds ratio2,3(95% ci)p valuemean difference1,4or odds ratio2,4(95% ci)p valuelength (cm)66.0 [2.28]−0.10 (−0.27 to 0.06)10.23−0.11 (−0.26 to 0.05)10.19weight (kg)7.71 [0.98]−0.02 (−0.09 to 0.05)10.61−0.03 (−0.10 to 0.04)10.45head circumference (cm)42.6 [1.43]0.003 (−0.10 to 0.11)10.95−0.01 (−0.10 to 0.11)10.95haz−0.57 [0.91]−0.09 (−0.15 to −0.02)1 0.02 −0.09 (−0.12 to −0.02)1 0.02 stunted55/891 (6.2)0.92 (0.68 to 1.26)20.620.89 (0.59 to 1.32)20.52\nvalues are estimated mean difference for each outcome associated with a 25 nmol/l increase in Vitamin D.\nconcentration (95% confidence interval).']	[('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 399)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 112, '25-OHD'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_72765', 'verruculogen', 430, '25-OHD'), ('GO_0007565', 'female pregnancy', 472, 'gestation'), ('CHEBI_27300', 'vitamin D', 1130, 'vitamin D')]
PMC4072587	6/2014	S113-PMC4072587	['OUR FINDINGS SHOW that low Vitamin D levels in late Pregnancy (<37.5 nmol/l) are ASSOCIATED with reduced infant Language Development at six months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 112, 'language development')]
PMC4072587	6/2014	S114-PMC4072587	['an ASSOCIATION between low maternal Vitamin D concentration and Language impairment has PREVIOUSLY been SUGGESTED by whitehouse et al.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 104)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0006266', 'DNA ligation', 64, 'language')]
PMC4072587	6/2014	S120-PMC4072587	['ALTHOUGH Vitamin D concentration was significantly higher in the twice weekly multiple Micronutrient group compared TO daily iron Folic Acid group, (mean [sd] of 76.3 [23.8] versus 67.8 [20.6] nmol/l), the prevalence of Vitamin D deficiency (<37.5 nmol/l) was SIMILAR (4.9% (16/326) versus 3.1% (9/293).']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 260)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 87, 'micronutrient'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4072587	6/2014	S131-PMC4072587	['a positive ASSOCIATION between maternal Vitamin D concentration and Gestational duration has PREVIOUSLY been DESCRIBED[41],[42], and morley et al.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 109)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'gestational')]
PMC4072587	6/2014	S135-PMC4072587	['the ASSOCIATION between Vitamin D concentration and Vaginal infection has PREVIOUSLY been DESCRIBED by several authors[45],[46],[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 52, 'vaginal')]
PMC4113768	7/2014	S11-PMC4113768	['the existence of a u-shaped RELATIONSHIP between Vitamin D status and RISK of certain health outcomes was ANOTHER area of discussion.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S101-PMC4113768	['Cyp2R1 and Cyp24A1 are capable of the 25-hydroxylation and 24-Hydroxylation, respectively, of Vitamin D. IT IS REPORTED that different Single Nucleotide Polymorphisms of Cyp2R1 and Cyp24A1 are ASSOCIATED with the 25(Oh)D status (wang, t.j., et al.']	[('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 11, 'CYP24A1'), ('GO_0006298', 'mismatch repair', 59, '24-hydroxylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000694', 'SNP', 135, 'single nucleotide polymorphisms'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 170, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 181, 'CYP24A1'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D')]
PMC4113768	7/2014	S118-PMC4113768	['background: PREVIOUS RESEARCH has FOUND an ASSOCIATION between Vitamin D status (25-Hydroxy Vitamin D, 25(Oh)D) and volumetric bone Mineral density (vbmd) in caucasians (pedone, c., et al.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('CHEBI_46662', 'mineral', 132, 'Mineral')]
PMC4113768	7/2014	S169-PMC4113768	['however, the RELATIONSHIP between Vitamin D RELATED measures and survival amongst Colorectal cancer patients REMAINS UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 44), ('FULL_UNKNOWN', 109)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0012652', 'colorectum', 82, 'colorectal')]
PMC4113768	7/2014	S178-PMC4113768	['conclusions: epidemiological EVIDENCE SUPPORTS an ASSOCIATION between increased Vitamin D status and improved survival amongst Colorectal cancer patients.']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0012652', 'colorectum', 127, 'colorectal')]
PMC4113768	7/2014	S213-PMC4113768	['Vitamin D HAS BEEN SHOWN to inhibit hiv-1 Replication in Macrophages, in vitro , while seasonal Vitamin D variation in europeans HAS BEEN ASSOCIATED with decreased Lymphocyte counts and enhanced pro-inflammatory responses in winter.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0006260', 'DNA replication', 42, 'replication'), ('CL_0000235', 'macrophage', 57, 'macrophages'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CL_0000542', 'lymphocyte', 164, 'lymphocyte')]
PMC4113768	7/2014	S273-PMC4113768	['the AIM was to find POSSIBLE clinical INDICATORS of Vitamin D deficiency in swedish and immigrant women at a primary Health care center in sweden.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000025', 'tube', 117, 'health')]
PMC4113768	7/2014	S407-PMC4113768	['jr.\nbackground: low Vitamin D (vd) status is common among patients with atopic dermatitis (ad) and SOME STUDIES SUGGEST an ASSOCIATION between vd deficiency and increased ad severity.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4113768	7/2014	S443-PMC4113768	['IF Vitamin D status does indeed IMPACT on Neurodevelopment, seasonal variation in Lateral Ventricular diameter MIGHT be expected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007399', 'nervous system development', 42, 'neurodevelopment'), ('UBERON_0004086', 'brain ventricle', 82, 'lateral ventricular')]
PMC4113768	7/2014	S457-PMC4113768	['our data do not THEREFORE SUPPORT a ROLE for Vitamin D in protection against foetal Lateral Ventriculomegaly.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001359', 'cerebrospinal fluid', 84, 'lateral ventriculomegaly')]
PMC4113768	7/2014	S579-PMC4113768	['background: SEVERAL STUDIES have investigated the ASSOCIATION between Vitamin D in Pregnancy and Birth weight, but the conclusion of the studies are NOT CLEAR.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 50), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S807-PMC4113768	['these transporters contain putative Vitamin D receptor response elements within their Promoters, SUGGESTING that amino acid transporters MAY BE Modulated by maternal Vitamin D status, a measure previously shown to RELATE to adiposity and bone health of the offspring.']	[('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 214)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000167', 'promoter', 86, 'promoters'), ('GO_0065007', 'biological regulation', 144, 'modulated'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC4113768	7/2014	S836-PMC4113768	['15% (3/20) women surveyed said they had RISK FACTORS for Vitamin D deficiency, BUT ONLY 2 were specifically asked about Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 83)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S870-PMC4113768	['IN CONTRAST TO observational studies that SHOW a beneficial EFFECT of Vitamin D on grip strength, there was no significant increase seen in grip strength in any of the included studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4113768	7/2014	S903-PMC4113768	['to WHAT degree does Vitamin D INFLUENCE Dental health in children?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 30), ('EXPLICIT_QUESTION', 65)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 40, 'dental')]
PMC4113768	7/2014	S963-PMC4113768	['logistic regression was used TO IDENTIFY environmental and Genetic factors independently ASSOCIATED with risk of Vitamin D deficiency DEFINED as Serum 25(Oh)D concentration <50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 134)]	3	[('SO_0000704', 'gene', 59, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 151, '25(OH ... D')]
PMC4113768	7/2014	S965-PMC4113768	['the following demographic factors were FOUND to INDEPENDENTLY ASSOCIATE with increased risk of Vitamin D deficiency: bmi > 30 kg/m2(or 1.87, p = 0.04); Blood draw during winter and spring seasons (or 3.00, p< 0.01; or 2.50, p< 0.01, respectively).']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC4113768	7/2014	S966-PMC4113768	['the following lifestyle factors were FOUND to INDEPENDENTLY ASSOCIATE with reduced risk of Vitamin D deficiency: Consumption of a Vitamin D supplement, 100–400 iu/day (or 0.42, p< 0.01); a sunny holiday abroad defined as: a trip to any location within a latitude 51 degrees north or south of the equator, during the local sunny season, 2 months prior to Blood draw, for a duration of ≥1 week (or 0.27, p = 0.02).']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007631', 'feeding behavior', 113, 'consumption'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0000178', 'blood', 354, 'blood')]
PMC4113768	7/2014	S971-PMC4113768	['Genetic variants in the Vitamin D pathway that HAVE PREVIOUSLY BEEN shown to ASSOCIATE with risk of Vitamin D deficiency in healthy Adult populations were not associated with deficiency in this patient group.']	[('IMPORTANT_CONSIDERATION', 47), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult')]
PMC4113768	7/2014	S995-PMC4113768	['our AIM was to EXPLORE ASSOCIATIONS between maternal and Cord 25(Oh)D concentrations and Vitamin D supplementation during Pregnancy and infancy and Gross Motor Development in infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 65, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0008406', 'gonad development', 148, 'gross motor development')]
PMC4113768	7/2014	S1026-PMC4113768	['maternal Vitamin D supplementation reduces the risk of infection and pre-term Birth: a population study on 36,181 Pregnancies\n\nhyppönen, e.; cavadino, a.; williams, d.; czeizel, e.\nbackground: adequate Vitamin D nutrition HAS BEEN SUGGESTED to be ESSENTIAL for the successful maintenance of Pregnancy, with increasing interest on its EFFECTS on Placental function, infection risk and inflammatory responses.']	[('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 247), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D'), ('GO_0007567', 'parturition', 78, 'Birth'), ('GO_0007565', 'female pregnancy', 114, 'Pregnancies'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnancy'), ('UBERON_0001987', 'placenta', 345, 'placental')]
PMC4113768	7/2014	S1037-PMC4113768	['conclusions: maternal Vitamin D supplementation during Pregnancy was ASSOCIATED with NOTABLE reductions in the risk of infections and pre-term Birth.']	[('SUPERFICIAL_RELATIONSHIP', 69), ('ANOMALY_CURIOUS_FINDING', 85), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4113768	7/2014	S1043-PMC4113768	['epidemiological studies in Adults SHOWED that bone Mineral density as well as bone turnover MARKERS are ASSOCIATED with Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S1051-PMC4113768	['for β-ctx ALONE no significant association with 25(Oh) Vitamin D was observed (−0.58 ng/l, p = 0.84), WHEREAS the β-ctx to Osteocalcin ratio was inversely ASSOCIATED with 25(Oh) Vitamin D levels (−1.1% change, p = 0.003).']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_30778', 'gallic acid', 48, '25(OH)'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 123, 'osteocalcin'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4113768	7/2014	S1172-PMC4113768	['studies FOUND INCONSISTENT results regarding the RELATIONSHIP of Vitamin D status and bone Mineral density (bmd) and quantitative ultrasound measurements (qus).']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral')]
PMC4113768	7/2014	S1178-PMC4113768	['low Vitamin D status (<25 nmol/l) was significantly ASSOCIATED with lower bua as COMPARED TO the reference group (≥50 nmol/l); this ASSOCIATION was modified by bmi ( p< 0.1).']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4113768	7/2014	S1190-PMC4113768	['there are an increasing NUMBER OF disorders THOUGHT TO be LINKED to Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S1348-PMC4113768	['in the absence of any known negative EFFECTS of Vitamin D supplementation and WHILE waiting for conclusive trials it COULD BE beneficial for many cancer patients to be tested and treated for Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4113768	7/2014	S1376-PMC4113768	['we AIMED TO EXAMINE the ASSOCIATION between Vitamin D concentration and Insulin resistance in healthy, non-diabetic, overweight Individuals at high risk of Cardiovascular disease using gold-standard techniques for assessment of both Vitamin D concentration and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('NCBITaxon_1', 'root', 128, 'individuals'), ('UBERON_0004535', 'cardiovascular system', 156, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('PR_000045358', 'insulin family protein', 261, 'insulin')]
PMC4113768	7/2014	S1444-PMC4113768	['background: epidemiological studies SUGGEST an ASSOCIATION between Vitamin D status and Cardiovascular disease (cvd) RISK.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 88, 'cardiovascular')]
PMC4113768	7/2014	S1559-PMC4113768	['HOWEVER, when the previously defined covariates (age, ethnicity, cosinor terms) were added to the linear regression model, Vitamin D CEASED to be a significant PREDICTOR of Cmv Antibody titre.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 173, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
PMC4113768	7/2014	S1597-PMC4113768	['SEVERAL STUDIES have FOUND an INTERACTION between Vitamin D status and Antiretroviral therapy on calcaemic outcomes such as 1,25(Oh)2D and pth levels.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 71, 'antiretroviral'), ('CHEBI_82784', 'PVP38-Ag NP', 124, '1,25(OH)2D')]
PMC4113768	7/2014	S1632-PMC4113768	['conclusions: standardization of 25(Oh)D measurements is IMPORTANT for accurate and consistent identification of INADEQUATE and/or deficient Vitamin D levels and RELATED health consequences in Individuals and populations.']	[('IMPORTANT_CONSIDERATION', 56), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 161)]	3	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 32, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
PMC4113768	7/2014	S1701-PMC4113768	['Life Style is a more significant FACTOR that CONTRIBUTES in Vitamin D insufficiency EVEN in a sun rich country like pakistan.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 84)]	3	[('UBERON_0000104', 'life cycle', 0, 'Life'), ('GO_0051320', 'S phase', 5, 'style'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4113768	7/2014	S1840-PMC4113768	['this is of particular IMPORTANCE DUE TO the seasonal DEPENDENCE on dietary sources of Vitamin D in denmark.']	[('IMPORTANT_CONSIDERATION', 22), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S1841-PMC4113768	['TO TEST the HYPOTHESIS of an ASSOCIATION between the Prenatal exposure to Vitamin D fortified Foods and the risk of the progeny developing schizophrenia later in Life, cox regression models were fit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29)]	3	[('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 94, 'foods'), ('UBERON_0000104', 'life cycle', 162, 'life')]
PMC4113768	7/2014	S1860-PMC4113768	['conclusions: DESPITE it supposedly being an inactive Metabolite of Vitamin D, 25(Oh)2D3, APPEARS TO have biologically relevant EFFECTS on cultured Huvecs.']	[('ANOMALY_CURIOUS_FINDING', 13), ('ANOMALY_CURIOUS_FINDING', 89), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_39382', 'flufenoxuron', 53, 'metabolite'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_73394', 'Ala-Ser', 78, '25(OH)2D3'), ('CL_0002674', 'H minus', 147, 'HUVECs')]
PMC4113768	7/2014	S1899-PMC4113768	[', pediatrics 2013, 131 , 739-753), SUGGESTING this COULD BE a more EFFECTIVE way of increasing and maintaining children’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4113768	7/2014	S2001-PMC4113768	['our AIM was TO EXAMINE the ASSOCIATION between Serum 25(Oh) Vitamin D and symptoms of depression and anxiety.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 27)]	3	[('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_30778', 'gallic acid', 53, '25(OH)'), ('PR_000036060', 'pro-caspase-8:fadd:rip1:ticam1:ticam2:activated TLR4 complex (human)', 53, '25 ... OH ... vitamin D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4113768	7/2014	S2024-PMC4113768	['HOWEVER, a causal RELATIONSHIP between Vitamin D status and cardiovascular disease (cvd) risk factors, such as hypertension or an atherogenic Lipid profile, has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('FULL_UNKNOWN', 161)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_18059', 'lipid', 142, 'lipid')]
PMC4113768	7/2014	S2144-PMC4113768	['in the PRESENT work we ASSESSED the INVOLVEMENT of these three Proteolytic systems in Vitamin D deficiency induced muscle wasting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('GO_0006508', 'proteolysis', 63, 'proteolytic'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S2147-PMC4113768	['Vitamin D deficient Rats were further subdivided into three groups: one group continued on deficient diet, second group was rescued with control diet to see for reversal of EFFECTS observed in d-deficiency, and the third group of Rats was supplemented with high calcium diet alone to delineate the ROLE of calcium per se on the muscle atrophy SEEN in Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 343)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 230, 'rats'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin D')]
PMC4113768	7/2014	S2252-PMC4113768	['a LACK OF association between the genotypes and 25-Hydroxy Vitamin D in patients SUGGESTS an absence of INFLUENCE of this polymorphism on circulating levels of Vitamin D.\n\n2.106.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_27844', "2',3'-cyclic AMP", 48, '25-Hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 67, 'D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 168, 'D')]
PMC4113768	7/2014	S2345-PMC4113768	['; al-othman, a.; yakout, s.; al-saleh, y.; fouda, m.; sabico, s.\nbackground: WHILE moderate to severe Vitamin D deficiency is prevalent in saudi arabia, Skeletal EFFECTS ASSOCIATED with this deficiency are not common in this population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0004288', 'skeleton', 153, 'skeletal')]
PMC4113768	7/2014	S2346-PMC4113768	['in THIS INTERVENTIONAL STUDY we measured the EFFECTS of improving Vitamin D status on bone biochemical MARKERS in overweight and obese Adult saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adult')]
PMC4113768	7/2014	S2414-PMC4113768	['we have PREVIOUSLY DEMONSTRATED that maternal lifestyle, body build, physical activity and Vitamin D status during Pregnancy are ASSOCIATED with offspring bone mass.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4113768	7/2014	S2547-PMC4113768	['we applied gee regression methods to quantify the ASSOCIATIONS of Vitamin D supplementation and 25(Oh)D with Serum Calcium, while considering the CONFOUNDING POTENTIAL of age, gender, and body weight status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('PROBLEM_COMPLICATION', 146), ('INCOMPLETE_EVIDENCE', 158)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium')]
PMC4113768	7/2014	S2560-PMC4113768	['background: SUBOPTIMAL Vitamin D status MAY BE ASSOCIATED with a variety of adverse health outcomes.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S2563-PMC4113768	['we AIMED TO EXAMINE the environmental and Genetic DETERMINANTS of change in 25 Hydroxy Vitamin D (25(Oh)D).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('SO_0000704', 'gene', 42, 'genetic'), ('CHEBI_45557', 'sec-butyl group', 76, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
PMC4113768	7/2014	S2692-PMC4113768	['there was a RELATIONSHIP between Vitamin D status and ethnicity for Serum and dbs samples ( p< 0.001 and p< 0.001 respectively) with caucasians more LIKELY to have an adequate status and asians more LIKELY to be severely deficient.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 199)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 68, 'serum')]
PMC4113768	7/2014	S2781-PMC4113768	['EVIDENCE from other Tissues INDICATES that local Synthesis Of active Vitamin D (1,25-Dihydroxy Vitamin D; 1,25(Oh)2D3) INFLUENCES Immune Responses and in particular Tlr Signalling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('UBERON_0000479', 'tissue', 20, 'tissues'), ('GO_0051610', 'serotonin uptake', 49, 'synthesis of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 80, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 107, ',25(OH)2D3'), ('GO_0006955', 'immune response', 130, 'immune responses'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0031929', 'TOR signaling', 165, 'TLR signalling')]
PMC4113768	7/2014	S2820-PMC4113768	['methods: a total of 49 apparently healthy Adults ( n = 23 males; n = 26 female) aged 18–65 years consented to take part in the current study, conducted between february and march 2013 to remove the CONFOUNDING EFFECT of sun exposure on circulating MARKERS of Vitamin D status.']	[('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 248)]	3	[('UBERON_0007023', 'adult organism', 42, 'adults'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4113768	7/2014	S2918-PMC4113768	['epidemiologic studies INDICATE that there is an inverse RELATIONSHIP between Vitamin D and the RISK and prognosis of Lung cancer.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 95)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0002048', 'lung', 117, 'lung')]
PMC4113768	7/2014	S3131-PMC4113768	['the very high prevalence of Vitamin D deficiency in this population and subsequent SMALL number of Vitamin D replete participants MAY have reduced the power of this study to detect a statistically significant ASSOCIATION between Vitamin D deficiency and hypersensitivity.']	[('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 209)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4113768	7/2014	S3145-PMC4113768	['this SUGGESTS fortification with moderate amounts of Vitamin D MAY have positive EFFECTS on bone health of populations.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S3177-PMC4113768	['intervention STUDIES ARE REQUIRED to more fully explore the EFFECTS on Vitamin D on Intestinal inflammation in cd.']	[('FUTURE_WORK', 13), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 84, 'intestinal')]
PMC4113768	7/2014	S3189-PMC4113768	['knowing that modernization is bringing about a change in Vitamin D CAN inform policy-makers in ethiopia and other tropical countries about the need to implement PUBLIC HEALTH measures to prevent escalation of Vitamin D deficiency and its ASSOCIATED health outcomes.']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 161), ('SUPERFICIAL_RELATIONSHIP', 238)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 65, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4113768	7/2014	S3209-PMC4113768	['25-Hydroxy Vitamin D3(25(Oh)D3) Modulates Innate Immunity and RECENT EVIDENCE HIGHLIGHTS ASSOCIATIONS between Vitamin D deficiency and several Respiratory illnesses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('CHEBI_43141', '3-hydroxypropoxy group', 0, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 22, '25(OH)D3'), ('GO_0065007', 'biological regulation', 32, 'modulates'), ('GO_0045087', 'innate immune response', 42, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 143, 'respiratory')]
PMC4113768	7/2014	S3241-PMC4113768	['these interim results SUGGEST an INDEPENDENT ROLE for Vitamin D in determining ari severity amongst nz children.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S3268-PMC4113768	['multi-centre trials of Vitamin D supplementation for PREVENTION of exacerbation and uri in patients with less SEVERE copd are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 110), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S3281-PMC4113768	['pre-specified sub-group analysis REVEALED a PROTECTIVE EFFECT of Vitamin D supplementation against moderate/severe exacerbations among participants who were Vitamin D deficient at baseline.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4113768	7/2014	S3300-PMC4113768	['there are many mechanisms whereby Vitamin D CAN reduce the RISK of cvd including reduced risk of diabetes mellitus and Metabolic syndrome, EFFECTS on Blood pressure, Cholesterol, cytokines, Endothelial disruption, Glucose Regulation, Insulin resistance, muscle strength, Respiratory infections, and vascular calcification.']	[('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_16113', 'cholesterol', 166, 'cholesterol'), ('UBERON_0001986', 'endothelium', 190, 'endothelial'), ('CHEBI_17234', 'glucose', 214, 'glucose'), ('GO_0006094', 'gluconeogenesis', 214, 'glucose regulation'), ('PR_000045358', 'insulin family protein', 234, 'insulin'), ('UBERON_0001004', 'respiratory system', 271, 'respiratory')]
PMC4113768	7/2014	S3331-PMC4113768	['1965; 58: 295–300) CAN be used to assess WHETHER Vitamin D is casually LINKED to reduced risk of the disease OR adverse health outcome.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S3333-PMC4113768	['when they are, they, too, will add to the UNDERSTANDING of the ROLE of Vitamin D in reducing the RISK of many types of disease and adverse health outcomes.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 63), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S3382-PMC4113768	['increased Dna Methylation in peripheral Leukocytes MAY BE one UNDERLYING mechanism by which Vitamin D exerts its anti-inflammatory EFFECTS.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 131)]	3	[('GO_0006306', 'DNA methylation', 10, 'DNA methylation'), ('CL_0000738', 'leukocyte', 40, 'leukocytes'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4129499	8/2014	S105-PMC4129499	['THESE FINDINGS encompass EITHER of two main disease-provoking mechanisms: a Cns disorder that is being detected peripherally [e.g., Serotonin and its Metabolites, Sulfate (54), low Platelet levels of Gamma-Aminobutyric Acid (Gaba) (55), low Oxytocin (which AFFECTS social affiliation) (56), and low Vitamin D levels (57,58)] or a systemic abnormality that has repercussions in the Brain (59).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('UBERON_0001017', 'central nervous system', 76, 'CNS'), ('CHEBI_28790', 'serotonin', 132, 'serotonin'), ('CHEBI_25212', 'metabolite', 150, 'metabolites'), ('CHEBI_16189', 'sulfate', 163, 'sulfate'), ('CL_0000233', 'platelet', 181, 'platelet'), ('CHEBI_16865', 'gamma-aminobutyric acid', 200, 'gamma-aminobutyric acid'), ('CHEBI_16865', 'gamma-aminobutyric acid', 225, 'GABA'), ('CHEBI_7872', 'oxytocin', 241, 'oxytocin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000955', 'brain', 381, 'brain')]
PMC4161853	8/2014	S214-PMC4161853	['HENCE, Vitamin A plays an IMPORTANT ROLE in the Intestinal Immune System as a source of Retinoic Acid (Ra), a Gut-homing factor for Iga Secreting cells in Intestinal Mucosa [117,118].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin A'), ('UBERON_0000160', 'intestine', 48, 'intestinal'), ('GO_0007566', 'embryo implantation', 59, 'immune'), ('UBERON_0002405', 'immune system', 59, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid'), ('CHEBI_36927', 'carbon-14 atom', 103, 'RA'), ('UBERON_0001555', 'digestive tract', 110, 'gut'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 132, 'IgA'), ('GO_0046903', 'secretion', 136, 'secreting'), ('UBERON_0001242', 'intestinal mucosa', 155, 'intestinal mucosa'), ('CL_0000187', 'muscle cell', 166, 'mucosa')]
PMC4161944	9/2014	S231-PMC4161944	['independent of nutrition or pathogen exposure, seasonality CAN also change diurnal exposure to sunlight and levels of circulating Vitamin D. in the united kingdom, Vitamin D status during Gestation and Birth month HAS BEEN ASSOCIATED with diseases with Immune involvement, including rheumatoid arthritis, irritable Bowel diseases, and multiple sclerosis (174).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 223)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0002405', 'immune system', 253, 'immune'), ('UBERON_0000160', 'intestine', 315, 'bowel')]
PMC4169453	9/2014	S25-PMC4169453	['further, in addition to the body composition indices (fat and lean mass) Vitamin D status SEEMS an INDEPENDENT CONTRIBUTOR to bone Mineral density in girls and women[24],[25].']	[('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_46662', 'mineral', 131, 'mineral')]
PMC4169453	9/2014	S27-PMC4169453	['TO THE BEST OF OUR KNOWLEDGE, bone mass and body composition have NOT BEEN EXAMINED in Lactating women and their offspring BASED ON the level of maternal Vitamin D Intake in randomized control trials.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 66), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('GO_0007594', 'puparial adhesion', 87, 'lactating'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake')]
PMC4169453	9/2014	S68-PMC4169453	['Serum 25(Oh)D <20 ng/ml DEFINED the Vitamin D deficiency state, WHEREAS ≥30 ng/ml REFLECTED Vitamin D sufficiency[7].']	[('PROBABLE_UNDERSTANDING', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4169453	9/2014	S124-PMC4169453	['Vitamin D status\nmaternal 25(Oh)D level was SIMILAR in both groups at baseline and after 3 months of Vitamin D supplementation, HOWEVER, at v6 significantly higher 25(Oh)D levels were NOTED in the 1200 iu/d group (fig.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 128), ('ANOMALY_CURIOUS_FINDING', 184)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 164, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 170, 'D')]
PMC4169453	9/2014	S218-PMC4169453	['our results INDICATE that the pth concentration SHOULD NOT BE considered a reliable functional MARKER of Vitamin D status in newborn infants.']	[('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4169453	9/2014	S229-PMC4169453	['Animal data demonstrate that, INSTEAD of Vitamin D, Calcitriol, or the Vitamin D receptor, the increase in Intestinal calcium absorption is LIKELY due to the Pregnancy-RELATED increase in Duodenal Expression of the calcium transporter Gene Trpv6 [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 140), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 52, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 107, 'intestinal'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('UBERON_0001245', 'anus', 188, 'duodenal'), ('GO_0010467', 'gene expression', 197, 'expression'), ('SO_0000704', 'gene', 235, 'gene'), ('PR_000016580', 'tropomyosin beta chain', 240, 'Trpv6')]
PMC4188019	1/2010	S20-PMC4188019	['in vitro studies have SUGGESTED a PROTECTIVE EFFECT of 25-Oh Vitamin D against malignancies such as Breastcancer and cancer of the Colon.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0000110', 'neurula stage', 100, 'breastcancer'), ('UBERON_0001155', 'colon', 131, 'colon')]
PMC4194375	10/2014	S126-PMC4194375	['there was SOME EVIDENCE to SUGGEST that the EFFECT of the intervention on Iodine, Vitamin E and Folate intake was modified by maternal bmi category (interaction p \u2009<\u20090.05 in all cases), with overall Intake significantly increased in obese but not overweight women randomised to the lifestyle advice group (data not shown).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_24859', 'iodine atom', 74, 'iodine'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 96, 'folate'), ('GO_0007631', 'feeding behavior', 199, 'intake')]
PMC4221707	11/2014	S23-PMC4221707	['low Folate levels are also SUGGESTED to be ASSOCIATED with other Birth defects, such as cleft lip and palate, Heart defects, and autism [11,12], and low levels of Vitamin D are ASSOCIATED with various adverse Pregnancy and Birth outcomes [13,14].']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 177)]	3	[('CHEBI_30863', '5-azaorotic acid', 4, 'folate'), ('GO_0007567', 'parturition', 65, 'birth'), ('UBERON_0000948', 'heart', 110, 'heart'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0007567', 'parturition', 223, 'birth')]
PMC4221707	11/2014	S134-PMC4221707	['mean daily Intake (amounts/day) of whole grain, Sucrose, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, Iodine, calcium, Vitamin D, Folate, and Vitamin B12 from Foods did not differ between the Pregnant and referent women REGARDLESS OF standardization by the residual method or not, WHEREAS iron Intake from Foods TENDED to be lower in the Pregnant women (table\xa02).']	[('INCOMPLETE_EVIDENCE', 243), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 304), ('SUPERFICIAL_RELATIONSHIP', 335)]	3	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_17992', 'sucrose', 48, 'sucrose'), ('CHEBI_24859', 'iodine atom', 125, 'iodine'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 153, 'folate'), ('CHEBI_33279', 'vitamin D5', 165, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 165, 'vitamin B12'), ('CHEBI_33290', 'food', 182, 'foods'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('GO_0007631', 'feeding behavior', 317, 'intake'), ('CHEBI_33290', 'food', 329, 'foods'), ('GO_0007565', 'female pregnancy', 361, 'pregnant')]
PMC4231606	10/2013	S30-PMC4231606	['it has a CRITICAL ROLE in Enamel, Dentin, and Oral Bone formation AS Ameloblasts and Odontoblasts are target cells for 1,25-Dihydroxyvitamin D, the active form of Vitamin D [17].']	[('IMPORTANT_CONSIDERATION', 9), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0001752', 'enamel', 26, 'enamel'), ('UBERON_0001751', 'dentine', 34, 'dentin'), ('UBERON_0000165', 'mouth', 46, 'oral'), ('GO_0007567', 'parturition', 51, 'bone'), ('CL_0000059', 'ameloblast', 69, 'ameloblasts'), ('CL_0000060', 'odontoblast', 85, 'odontoblasts'), ('CHEBI_67472', '15-epi-lupulin B', 119, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4231606	10/2013	S116-PMC4231606	['much of the EARLY RESEARCH in this field was conducted by may mellanby, who IDENTIFIED an ASSOCIATION between Vitamin D supplementation and reduced caries-risk [18,31].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4251419	12/2014	S79-PMC4251419	['additionally, WHILE increased sun exposure during childhood was inversely ASSOCIATED with risk of multiple sclerosis, there was no decreased risk associated with intake of Vitamin D supplements during childhood [40].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4251419	12/2014	S85-PMC4251419	['in the experimental Autoimmune encephalomyelitis Animal MODEL, Vitamin D supplementation in the Postnatal period delays the onset of the disease [52] but there is NO EVIDENCE that Antenatal Vitamin D supplementation has any EFFECT.']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 224)]	3	[('UBERON_0001442', 'skeleton of manus', 20, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 49, 'animal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'postnatal'), ('GO_0007567', 'parturition', 180, 'antenatal'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4251419	12/2014	S98-PMC4251419	['a PROPOSED network of INTERACTIONS between Vitamin D and the microbiome that MAY sway the Development Of Immune Tolerance or Tissue Inflammation\nActivation Of Immune Cells like Monocytes and Epithelial cells by bacterial-derived products (e.g.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0032253', 'dense core granule localization', 90, 'development of ... tolerance ... inflammation'), ('UBERON_0002405', 'immune system', 105, 'immune'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('GO_0006915', 'apoptotic process', 145, 'Activation of immune cells'), ('CL_0000738', 'leukocyte', 159, 'immune cells'), ('UBERON_0002405', 'immune system', 159, 'immune'), ('CL_0000576', 'monocyte', 177, 'monocytes'), ('CL_0000066', 'epithelial cell', 191, 'epithelial'), ('UBERON_0000483', 'epithelium', 191, 'epithelial')]
PMC4251419	12/2014	S139-PMC4251419	['Genetic variation in the physiological response to Vitamin D supplementation\na high degree of Individual VARIABILITY in the 25(Oh)D response to Vitamin D supplementation has been DESCRIBED that is the result of demographic, environmental and Genetic FACTORS [79].']	[('DIFFICULT_TASK', 105), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 250)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 94, 'individual'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('SO_0000704', 'gene', 242, 'genetic')]
PMC4251419	12/2014	S152-PMC4251419	['the study participants were not Vitamin D deficient at baseline\nif there is a causal ASSOCIATION between Vitamin D and disease risks, INCREASED risk occurs in ASSOCIATION with vitamin d deficiency [92].']	[('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 134), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4256222	12/2014	S0-PMC4256222	['maternal Vitamin D status and offspring bone fractures: prospective study over two decades in aarhus city, denmark\n\nabstract\n\nbackground\nstudies investigating the ASSOCIATION between maternal Vitamin D status and offspring bone mass measured by dual-energy x-ray absorptiometry (dxa) during childhood HAVE SHOWN CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 301), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4256222	12/2014	S21-PMC4256222	['TO OUR KNOWLEDGE, NO earlier STUDIES have focused on the INFLUENCE of Vitamin D status during Pregnancy on incident occurrences of offspring bone fractures during childhood.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC4256222	12/2014	S25-PMC4256222	['in a prospective cohort with follow up over two decades, we therefore EXAMINED WHETHER the risk of bone fractures during the first 18 years of Life was ASSOCIATED with the maternal status of Vitamin D in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('UBERON_0000104', 'life cycle', 143, 'life'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC4256222	12/2014	S97-PMC4256222	['HOWEVER, in sensitivity analyses we FOUND a borderline significant inverse ASSOCIATION (p\u200a=\u200a0.054) between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 151, 'forearm')]
PMC4256222	12/2014	S129-PMC4256222	['it would be OF great INTEREST to conduct similar analysis to investigate the ASSOCIATION between maternal status of Vitamin D and offspring Forearm fractures in a study population large enough to allow such subdivision of fractures and further stratification by Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 140, 'forearm'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
PMC4302429	1/2015	S25-PMC4302429	['Vitamin D HAS long BEEN KNOWN to play a ROLE in building the Skeletal System and in Calcium Homeostasis; Vitamin D deficiency is KNOWN to be a cause of rickets and osteomalacia and aggravates osteoporosis [12].']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 129)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001434', 'skeletal system', 61, 'skeletal system'), ('GO_0055073', 'cadmium ion homeostasis', 84, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4302429	1/2015	S27-PMC4302429	['cells of the Immune System possess Vitamin D receptors and are capable of Metabolizing the active form of Vitamin D (1,25(Oh)2D3) [15], SUGGESTING Vitamin D as an IMPORTANT FACTOR in the Immune Response to Infection [16].']	[('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 163), ('SUPERFICIAL_RELATIONSHIP', 173)]	3	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0008152', 'metabolic process', 74, 'metabolizing'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 117, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0006955', 'immune response', 187, 'immune response'), ('UBERON_0002405', 'immune system', 187, 'immune'), ('GO_0007586', 'digestion', 206, 'infection')]
PMC4302429	1/2015	S29-PMC4302429	['epidemiological studies have ESTABLISHED that Vitamin D deficiency plays an IMPORTANT ROLE in susceptibility to tuberculosis [18].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4302429	1/2015	S161-PMC4302429	['clinical and experimental observations SUPPORT the HYPOTHESIS that Vitamin D has an EFFECT on the Immune Response to infection and the ability to eliminate pathogens after entry Into the host.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0006955', 'immune response', 98, 'immune response'), ('UBERON_0002405', 'immune system', 98, 'immune'), ('GO_0007631', 'feeding behavior', 178, 'into')]
PMC4302429	1/2015	S205-PMC4302429	['in early infection (20\xa0h), low, BUT approximately equal Ifn-Γ levels were measured, SUGGESTING that Ifn-Γ was not INVOLVED in the protective action of an adequate Vitamin D supply.']	[('ANOMALY_CURIOUS_FINDING', 32), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 114)]	3	[('PR_000008920', 'interferon alpha-7', 56, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 100, 'IFN-γ'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4329404	10/2014	S15-PMC4329404	['an inverse ASSOCIATION between Serum Vitamin D and total Ige, Lung function and asthma exacerbations in physician diagnosed asthmatic children HAVE BEEN DESCRIBED (6–8).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 153)]	3	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 57, 'IgE'), ('UBERON_0002048', 'lung', 62, 'lung')]
PMC4329404	10/2014	S16-PMC4329404	['low Serum Vitamin D in childhood IS THOUGHT TO be PREDICTIVE of asthma in adolescent males (9).']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4329404	10/2014	S22-PMC4329404	['reduced maternal Vitamin D during Pregnancy HAS BEEN ASSOCIATED with an increase in early wheeze, but this ASSOCIATION does not extend to asthma at school age (14–16).']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy')]
PMC4329404	10/2014	S28-PMC4329404	['MULTIPLE STUDIES HAVE REPORTED a positive CORRELATION between Serum Vitamin D and Foxp3+Regulatory T-Cell numbers in both the periphery and Airways of Adults (24) and children (25,26).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000017653', 'zinc finger protein ZFPM2', 82, 'FoxP3'), ('CL_0000815', 'regulatory T cell', 88, 'regulatory T-cell'), ('GO_0065007', 'biological regulation', 88, 'regulatory'), ('GO_0005854', 'nascent polypeptide-associated complex', 100, '-'), ('UBERON_0001005', 'respiratory airway', 140, 'airways'), ('UBERON_0007023', 'adult organism', 151, 'adults')]
PMC4329404	10/2014	S102-PMC4329404	['supplementation with Vitamin D after in utero and early-Life insufficiency reduces Serum Ige in pups at 6\xa0weeks of age, BUT NOT th2 cytokines\nwe measured Serum total and hdm-specific Ige TO ASSESS whether early-Life Vitamin D insufficiency AFFECTED sensitization to Allergen (fig.4a).']	[('ANOMALY_CURIOUS_FINDING', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 240)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life'), ('UBERON_0001977', 'blood serum', 83, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 89, 'IgE'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 183, 'IgE'), ('UBERON_0000104', 'life cycle', 211, 'life'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_50904', 'allergen', 266, 'allergen')]
PMC4329404	10/2014	S122-PMC4329404	['the same reduction was still evident when Peri-Bronchiolar collagen was quantified (fig.5c,d), SUGGESTING Vitamin D supplementation MAY PROTECT from the development of Airway Remodelling.']	[('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('UBERON_0001789', 'outer nuclear layer of retina', 42, 'peri'), ('UBERON_0002186', 'bronchiole', 47, 'bronchiolar'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 168, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 168, 'airway')]
PMC4329404	10/2014	S139-PMC4329404	['we HAVE SHOWN EFFECTS on Immune phenotype after ONLY 4\xa0weeks of a Vitamin D-deficient diet in females.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 48)]	3	[('UBERON_0002405', 'immune system', 25, 'immune'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4329404	10/2014	S140-PMC4329404	['ours is the FIRST STUDY TO INVESTIGATE the IMPACT of maternal Vitamin D status on early-Life allergic inflammation.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 88, 'life')]
PMC4329404	10/2014	S141-PMC4329404	['a PREVIOUS STUDY has investigated the EFFECT of in utero and early-Life Vitamin D deficiency on aad, BUT Allergen challenge was commenced in Adult Mice, rather than during the Neonatal Period (32).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101)]	3	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_50904', 'allergen', 105, 'allergen'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('UBERON_0007221', 'neonate stage', 176, 'neonatal period')]
PMC4329404	10/2014	S154-PMC4329404	['an IMPORTANT finding from our data is the partial PROTECTION from disease severity SEEN in pups that were Born to mothers on a Vitamin D-deficient diet, but were weaned onto a Vitamin D-replete diet.']	[('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 106, 'born'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC4329404	10/2014	S169-PMC4329404	['it is INTERESTING that in OUR STUDY, dietary Vitamin D in utero was ASSOCIATED with the highest numbers of Il-10-secreting Tregs.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 107, 'IL-10'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 123, 'Tregs')]
PMC4329745	10/2014	S9-PMC4329745	['background\nthere is INCREASING EVIDENCE for the CRUCIAL ROLE of Vitamin D in maintaining Human health (1).']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 89, 'human')]
PMC4340999	3/2015	S95-PMC4340999	['low Vitamin D during the second or third Trimester of Pregnancy HAS BEEN SUGGESTED to be ASSOCIATED with Adult obesity.31,33in THE CURRENT STUDY, spring and early summer peaks and winter troughs for bmi and wc were evident.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 127)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 41, 'trimester'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
PMC4340999	3/2015	S99-PMC4340999	['FURTHER STUDIES ARE WARRANTED to test the ASSOCIATION between Prenatal Vitamin D status and Adult adiposity in an Adult population older than 35 years.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adult'), ('UBERON_0007023', 'adult organism', 114, 'adult')]
PMC4340999	3/2015	S101-PMC4340999	['month of Birth and three trimesters in relation to the calendar month of year, season, and the level of uvb radiation\nto OUR KNOWLEDGE, NO PREVIOUS STUDY has examined the RELATIONSHIP between Prenatal Vitamin D status and ll.']	[('PROBABLE_UNDERSTANDING', 121), ('FULL_UNKNOWN', 136), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('GO_0007567', 'parturition', 9, 'birth'), ('GO_0007565', 'female pregnancy', 192, 'prenatal'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4377870	3/2015	S80-PMC4377870	['anti-inflammatory and anti-asthmatic EFFECTS of Vitamin C supplementation in vivo , HAVE BEEN SHOWN through allergic Mouse MODELS of asthma.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin C'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mouse')]
PMC4377870	3/2015	S138-PMC4377870	['Vitamin D CAN be obtained from dietary sources or supplementation; HOWEVER sun exposure is the main CONTRIBUTOR to Vitamin D levels [108].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4377870	3/2015	S144-PMC4377870	['in vitro studies also SUPPORT the LINK between Vitamin D and Airway Remodelling AS active Vitamin D inhibits Airway Smooth Muscle (Asm) Cell Proliferation [114] and deficiency impairs normal Lung Development [115].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('PROBABLE_UNDERSTANDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 61, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 61, 'airway'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CL_0002633', 'respiratory basal cell', 109, 'airway smooth muscle ... cell'), ('UBERON_0001005', 'respiratory airway', 109, 'airway'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 116, 'smooth muscle'), ('UBERON_0001135', 'smooth muscle tissue', 116, 'smooth muscle'), ('UBERON_0001637', 'artery', 131, 'ASM'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030324', 'lung development', 191, 'lung development'), ('UBERON_0002048', 'lung', 191, 'lung')]
PMC4377870	3/2015	S150-PMC4377870	['several OBSERVATIONAL STUDIES SUPPORT the ROLE of Vitamin D for protection against Respiratory conditions in children.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 83, 'respiratory')]
PMC4377870	3/2015	S164-PMC4377870	['the extra-Skeletal EFFECTS of Vitamin D are WELL DOCUMENTED in both asthma and copd, and deficiency is ASSOCIATED with negative Respiratory and Immune outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('UBERON_0004288', 'skeleton', 10, 'skeletal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 128, 'respiratory'), ('UBERON_0002405', 'immune system', 144, 'immune')]
PMC4377879	3/2015	S178-PMC4377879	['for example, Folate MAY mask symptoms of megaloblastic anemia, which COULD BE an INDICATOR of Vitamin B-12 deficiency [68].']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_30863', '5-azaorotic acid', 13, 'folate'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 94, 'vitamin B-12')]
PMC4377888	3/2015	S25-PMC4377888	['for example, the EFFECTS of maternal dietary zinc, Vitamin A and protein restriction or maternal dietary fat excess all HAVE BEEN SHOWN to have a negative IMPACT on Kidney Development and later Renal disease in the offspring [16,17,18,19].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0001822', 'kidney development', 165, 'kidney development'), ('UBERON_0002113', 'kidney', 165, 'kidney'), ('UBERON_0002113', 'kidney', 194, 'renal')]
PMC4377888	3/2015	S68-PMC4377888	['the mechanism UNDERLYING this abnormal Kidney phenotype is MOST LIKELY the fact the Vitamin A is a key ligand for the cret receptor, which Controls the earliest processes of Kidney Development (seesection 2for full details).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('UBERON_0002113', 'kidney', 39, 'kidney'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'controls'), ('GO_0001822', 'kidney development', 174, 'kidney development'), ('UBERON_0002113', 'kidney', 174, 'kidney')]
PMC4380518	9/2014	S2-PMC4380518	['we used multivariable logistic regression to ANALYZE ASSOCIATIONS of pnv use and odds of Vitamin D deficiency DEFINED as 25(Oh)D levels < 50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 110)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 121, '25 ... OH ... D')]
PMC4380518	9/2014	S67-PMC4380518	['in conclusion, we FOUND that lack of pnv use during Pregnancy was ASSOCIATED with Vitamin D deficiency early in Pregnancy, BUT NOT among black women.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 123)]	3	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4383226	2/2015	S78-PMC4383226	['doi: http://dx.doi.org/10.7554/elife.03925.006\n\nIMPACT of Vitamin A supplementation on malaria infection\nvitamin a supplementation APPEARED PROTECTIVE against plasmodium parasitemia and p ƒhrp-2 antigenemia (table 2).']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('PR_000000164', 'BMP2', 192, '-2')]
PMC4383226	2/2015	S80-PMC4383226	['HOWEVER, for antigenemia, Vitamin A was moderately more PROTECTIVE in older children (ptrend<0.001), the more time passed since supplementation (ptrend<0.001) or if supplementation was given during the wet season (ptrend=0.04).table 3reveals that ASSOCIATIONS between Vitamin A and parasitemia were stronger among children 36–59 months of age or if their mother took an Antimalarial during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 247)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin A'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 370, 'antimalarial'), ('GO_0007565', 'female pregnancy', 390, 'pregnancy')]
PMC4383226	2/2015	S85-PMC4383226	['we had INSUFFICIENT data to identify cross-INTERACTIONS between vaccines and Vitamin A using an adjusted model, BUT in unadjusted models we found no significant interactions between vaccination and Vitamin A supplementation.10.7554/elife.03925.007\n\ncaption (table-wrap): table 3.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC4383226	2/2015	S94-PMC4383226	['discussion\nin THIS large, population-BASED STUDY within sub-saharan africa, Vitamin A supplementation was ASSOCIATED with a negative risk of plasmodium parasitemia and p ƒhrp-2 antigenemia among children aged 6–59 months.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin A')]
PMC4383226	2/2015	S120-PMC4383226	['the breadth and size of the study population enabled us TO EVALUATE the ASSOCIATION between malaria and childhood vaccines/Vitamin A DESPITE high vaccination coverage rates within most of the communities surveyed (desai et al., 2005).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 133)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin A')]
PMC4383575	1/2015	S129-PMC4383575	['HOWEVER, country of Birth, higher maternal bmi, Delivery by cesarean section, male infant sex (table 2), and low maternal intake of Fruits rich in Vitamin C and high intake of diary products as well as low adherence to healthy diet were ASSOCIATED with higher dna adduct levels in adjusted models (table 3).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 237)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('GO_0007567', 'parturition', 48, 'delivery'), ('CHEBI_33290', 'food', 132, 'fruits'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C'), ('PR_000004900', 'complement C3', 155, 'C')]
PMC4392553	3/2015	S389-PMC4392553	['[27] THUS, disruption of the shikimate pathway CONTRIBUTES to Vitamin K deficiency, which CAN lead to cholestasis.']	[('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin K')]
PMC4396835	1/2015	S20-PMC4396835	['stumpf and privette [16] first SUGGESTED that Vitamin D deficiency in Adults MIGHT CONTRIBUTE to the pathogenesis of certain psychiatric disorders, including depression.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 83)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0007023', 'adult organism', 70, 'adults')]
PMC4396835	1/2015	S22-PMC4396835	['FURTHER research HAS SHOWN that Vitamin D has a ROLE in Brain Development and function, including Neuronal differentiation, Axonal connectivity, Dopamine ontogeny, immunological modulation and transcriptional Control over a large number of Genes [18–21].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007420', 'brain development', 56, 'brain development'), ('UBERON_0000955', 'brain', 56, 'brain'), ('CL_0000540', 'neuron', 98, 'neuronal'), ('GO_0030424', 'axon', 124, 'axonal'), ('CHEBI_18243', 'dopamine', 145, 'dopamine'), ('GO_0065007', 'biological regulation', 209, 'control'), ('SO_0000704', 'gene', 240, 'genes')]
PMC4405493	4/2015	S18-PMC4405493	['during Pregnancy, severe maternal Vitamin D deficiency, AS defined as Serum 25-Hydroxyvitamin D (25-Oh Vitamin D) concentrations less than 5 ng/ml, HAS BEEN ASSOCIATED with disordered Skeletal Homeostasis, congenital rickets, and fractures of the newborn [4].']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 76, '25-hydroxyvitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 97, '25-OH'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0043276', 'anoikis', 184, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 184, 'skeletal')]
PMC4405493	4/2015	S138-PMC4405493	['as our study center is around 47 degrees latitude and 38% of our first Trimester Blood draws occurred in the winter, this CERTAINLY COULD CONTRIBUTE to the prevalence of Vitamin D deficiency in our population.']	[('ANOMALY_CURIOUS_FINDING', 122), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('GO_0009294', 'DNA mediated transformation', 71, 'trimester'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4405493	4/2015	S148-PMC4405493	['for example, there is SOME EVIDENCE Vitamin D AFFECTS transcription and function of Genes responsible for Trophoblast invasion and Angiogenesis, two factors CRITICAL for Placenta Development.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000704', 'gene', 84, 'genes'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblast'), ('GO_0001525', 'angiogenesis', 131, 'angiogenesis'), ('GO_0001890', 'placenta development', 170, 'placenta development'), ('UBERON_0001987', 'placenta', 170, 'placenta')]
PMC4417995	4/2015	S1-PMC4417995	['a wealth of STUDIES describing a beneficial EFFECT of Vitamin D on atopic dermatitis (ad) prevalence and severity are KNOWN.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 118)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4417995	4/2015	S45-PMC4417995	['GIVEN the above, Vitamin D deficiency MIGHT PREDISPOSE patients with ad to skin superinfection by staphylococcus aureus or its superantigens [24].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4417995	4/2015	S57-PMC4417995	['overall these data SEEM to INDICATE that Vitamin D deficiency is RELATED to the severity of ad.']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4417995	4/2015	S90-PMC4417995	['[41] DEMONSTRATED a negative CORRELATION between the scorad [42] and Serum Vitamin D levels in allergic sensitized Individuals, WHEREAS no correlation was noted in the group without sensitization.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	3	[('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('NCBITaxon_1', 'root', 115, 'individuals')]
PMC4417995	4/2015	S136-PMC4417995	['based on this RATIONALE and comforted by the data obtained from observational studies, the following clinical trials INVESTIGATED the therapeutic ROLE of Vitamin D supplementation in the treatment of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 146)]	3	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4417995	4/2015	S173-PMC4417995	['OF NOTE, a positive CORRELATION was EVIDENCED between the increase in Vitamin D levels and the decrease in the scorad index in march but not in january.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 36)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4417995	4/2015	S183-PMC4417995	['conclusions\nepidemiological and clinical EVIDENCES INDICATE a beneficial ROLE for Vitamin D in ad.']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4427001	4/2015	S0-PMC4427001	['Vitamin D status in women with Gestational diabetes mellitus during Pregnancy and Postpartum\n\nabstract\nof many Vitamin D Extraskeletal functions, its modulatory ROLE in Insulin secretion and action is ESPECIALLY RELEVANT for Gestational diabetes mellitus (gdm).']	[('SUPERFICIAL_RELATIONSHIP', 161), ('IMPORTANT_CONSIDERATION', 201), ('SUPERFICIAL_RELATIONSHIP', 212)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'Gestational'), ('GO_0007565', 'female pregnancy', 68, 'Pregnancy'), ('GO_0007567', 'parturition', 82, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 121, 'extraskeletal'), ('PR_000045358', 'insulin family protein', 169, 'insulin'), ('GO_0007565', 'female pregnancy', 225, 'gestational')]
PMC4427001	4/2015	S24-PMC4427001	['furthermore, Vitamin D has a strong immunomodulatory EFFECT; it inhibits Angiogenesis [8] and is also INVOLVED in the Regulation of Insulin secretion and POSSIBLY Insulin action [11,12].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0001525', 'angiogenesis', 73, 'angiogenesis'), ('GO_0065007', 'biological regulation', 118, 'regulation'), ('PR_000045358', 'insulin family protein', 132, 'insulin'), ('PR_000045358', 'insulin family protein', 163, 'insulin')]
PMC4427001	4/2015	S25-PMC4427001	['INTERESTINGLY Vitamin D also exerts renoprotective and antiproteinuric EFFECTS with several mechanisms INVOLVED including inhibition of Renin-angiotensin-aldosteron system (by decreasing Renin Expression), suppression of inflammation (by reducing accumulation of Inflammatory Cells), and restoration of Glomerular filtration barrier (by attenuating Podocyte damage) [13–15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('PR_000014368', 'RuvB-like 1', 136, 'renin'), ('PR_000014368', 'RuvB-like 1', 187, 'renin'), ('GO_0010467', 'gene expression', 193, 'expression'), ('CL_0000902', 'induced T-regulatory cell', 263, 'inflammatory cells'), ('UBERON_0000074', 'renal glomerulus', 303, 'glomerular'), ('CL_0000653', 'glomerular visceral epithelial cell', 349, 'podocyte')]
PMC4427001	4/2015	S33-PMC4427001	['a NUMBER OF STUDIES focused on PUTATIVE ROLE of Vitamin D deficiency in various Pregnancy pathologies including gdm [21–23].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 40)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4427001	4/2015	S34-PMC4427001	['OBSERVATIONAL studies REVEALED CORRELATION between low Vitamin D levels and preeclampsia or gdm [7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4427001	4/2015	S38-PMC4427001	['currently, LITTLE IS KNOWN about Postpartum Vitamin D status in women with history of gdm and POSSIBLE RELATIONSHIP between 25(Oh)D Plasma levels measured at the time of gdm diagnosis and the degree of Glucose (in)tolerance Postpartum.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0007565', 'female pregnancy', 33, 'postpartum'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 132, 'plasma'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('GO_0007565', 'female pregnancy', 224, 'postpartum')]
PMC4427001	4/2015	S92-PMC4427001	['the EFFECT of Vitamin D on Regulation Of Pancreatic Β Cell Function and Insulin secretion COULD BE MEDIATED through Intracellular changes in calcium pool.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_1904353', 'regulation of telomere capping', 27, 'regulation of ... cell function'), ('CL_0005019', 'pancreatic epsilon cell', 41, 'pancreatic β cell'), ('UBERON_0001264', 'pancreas', 41, 'pancreatic'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 116, 'intracellular')]
PMC4427001	4/2015	S143-PMC4427001	['rudnicki and mølsted-pedersen [45] reported that supplementation with an active form of Vitamin D (1,25(Oh)2D) was ASSOCIATED with significant decrease of plasma Glucose level and POSSIBLE EFFECT on Insulin sensitivity.']	[('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_37958', 'dye', 99, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D'), ('CHEBI_17234', 'glucose', 162, 'glucose'), ('PR_000045358', 'insulin family protein', 199, 'insulin')]
PMC4448820	5/2015	S154-PMC4448820	['● THIS REVIEW includes information on the ROLE of specific case study Nutrients (Vitamin A, Vitamin D, zinc, iron, Selenium, Folic Acid) in DEPENDENT pathways.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 115, 'selenium'), ('CHEBI_30751', 'formic acid', 125, 'folic acid')]
PMC4448820	5/2015	S194-PMC4448820	['in vivo data are EMERGING that SUPPORT Vitamin D–DEPENDENT induction of Cathelicidin in skin and peripheral Blood Monocytes by administration of large amounts of Vitamin D to Humans (115).']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 72, 'cathelicidin'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CL_0000576', 'monocyte', 114, 'monocytes'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 175, 'humans')]
PMC4448820	5/2015	S242-PMC4448820	['in addition to Vitamins A and D, OTHER Nutrients MAY AFFECT the induction of Tregs.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 30, 'D'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 77, 'Tregs')]
PMC4448820	5/2015	S249-PMC4448820	['● pem and deficiencies of Vitamin A, zinc, or iron have a ROBUST, ALBEIT variable EFFECT in reducing Antigen-Presenting Cell (Apc) function (150–160).']	[('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_59132', 'antigen', 101, 'antigen'), ('CL_0000593', 'androgen secreting cell', 101, 'antigen ... presenting cell'), ('PR_000004122', 'adenomatous polyposis coli protein', 126, 'APC')]
PMC4448820	5/2015	S281-PMC4448820	['most of the EFFECTS of Vitamin A on Immune or inflammatory Responses CAN be EXPLAINED via binding of the Vitamin A Metabolite, Atra, to 1 of 3 zinc-finger proteins containing members of the Nuclear receptor superfamily, Rar-Α, Rar-Β, and Rar-Γ (185).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0006955', 'immune response', 36, 'immune ... responses'), ('UBERON_0002405', 'immune system', 36, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 115, 'metabolite'), ('CHEBI_17033', 'biliverdin', 127, 'ATRA'), ('GO_0005634', 'nucleus', 190, 'nuclear'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 220, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 227, 'RAR-β'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 238, 'RAR-γ')]
PMC4448820	5/2015	S296-PMC4448820	['like Vitamin A, Vitamin D CAN AFFECT Immune function through this Genetic INTERACTION.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 37, 'immune'), ('SO_0000704', 'gene', 66, 'genetic')]
PMC4448820	5/2015	S375-PMC4448820	['Kdm6B/Jmjd3 Histone demethylase is induced by Vitamin D, but NOT Atra, in Human Colon cancer cells (217) and HAS BEEN IMPLICATED in the Regulation of Cyclin-Dependent Kinase Inhibitor 1A ( Cdkn1A ) /P21Cip1 by 1,25(Oh)2D in normal Prostate cells (218).']	[('ANOMALY_CURIOUS_FINDING', 61), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('PR_000009209', 'juxtaposed with another zinc finger protein 1', 0, 'KDM6B'), ('PR_000009211', 'lysine-specific demethylase 3A', 6, 'JMJD3'), ('CHEBI_15358', 'histone', 12, 'histone'), ('PR_000043452', 'core histone', 12, 'histone'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17033', 'biliverdin', 65, 'ATRA'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'human'), ('UBERON_0001155', 'colon', 80, 'colon'), ('GO_0065007', 'biological regulation', 136, 'regulation'), ('PR_000004910', 'complement component C8 gamma chain', 150, 'cyclin-dependent kinase inhibitor 1A'), ('CHEBI_35222', 'inhibitor', 174, 'inhibitor'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 189, 'CDKN1A'), ('PR_000014700', 'serpin B9', 199, 'p21CIP1'), ('CHEBI_37983', 'sulfur-35 atom', 210, '1'), ('CHEBI_17996', 'chloride', 211, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 212, '25(OH)2D'), ('CL_0002249', 'primitive cardiac myocyte', 231, 'prostate'), ('UBERON_0002367', 'prostate gland', 231, 'prostate')]
PMC4448820	5/2015	S380-PMC4448820	['there is OTHER EVIDENCE for a transgenerational EFFECT of Vitamin D on immunity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4448820	5/2015	S473-PMC4448820	['caption (boxed-text): text box 17\u2003\nPOSSIBLE mechanisms to EXPLAIN Vitamin A’s ROLE in Immune Response\n\n● vitamin A, via conversion to atra, can inhibit Nf-Κb Activation (118).']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0006955', 'immune response', 86, 'immune response'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('PR_000004370', 'asialoglycoprotein receptor 2', 113, 'A'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 152, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 152, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 152, 'NF-κB')]
PMC4448820	5/2015	S549-PMC4448820	['● a high infectious disease burden CAN lead to decreased appetite, decreased absorption, Liver or Kidney disease, and other FACTORS AFFECTING loss of Retinol Binding Protein (rbp), and depletion of body stores through excessive Metabolism and increased Excretion Of Vitamin A (325).']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('UBERON_0002107', 'liver', 89, 'liver'), ('UBERON_0002113', 'kidney', 98, 'kidney'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 150, 'retinol binding protein'), ('GO_0008152', 'metabolic process', 228, 'metabolism'), ('GO_0006881', 'extracellular sequestering of iron ion', 253, 'excretion of vitamin A'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin A')]
PMC4448820	5/2015	S571-PMC4448820	['SEVERAL Human STUDIES DOCUMENTED that vad is ASSOCIATED with increased Th1-Driven Delayed-type Hypersensitivity (dth) Responses and reduced th2-driven Antibody responses to vaccines; Vitamin A supplementation reverses these responses (104,105,326).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0044808', 'oncostatin M production', 71, 'Th1-driven'), ('GO_0001866', 'NK T cell proliferation', 82, 'delayed- ... hypersensitivity'), ('GO_0060033', 'anatomical structure regression', 118, 'responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin A')]
PMC4448820	5/2015	S584-PMC4448820	['for instance, neonatal Vitamin A supplementation had a DIFFERENT EFFECT on in vitro whole-Blood cytokine responses DEPENDING ON the sex and the vaccination status of the children (301).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC4448820	5/2015	S596-PMC4448820	['important EFFECT modifiers MAY BE population Vitamin A status, age, sex, vaccination status, season, pathogen prevalence, disease type, and disease BURDEN.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 148)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
PMC4448820	5/2015	S774-PMC4448820	['as discussed above, adverse outcomes were SEEN during Vitamin A and Iron supplementation programs, and the mechanisms underlying these adverse EFFECTS MAY involve altered host resistance.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 151)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_24870', 'ion', 68, 'iron')]
PMC4448820	5/2015	S1043-PMC4448820	['● EVIDENCE exists for a LINK between lower maternal Vitamin D intake and higher RISK of wheezing, allergic rhinitis, and eczema in childhood (591–595).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 24), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4448820	5/2015	S1147-PMC4448820	['Animal experiments clearly SHOW that changes in maternal methyl-donor supply (Choline, methionine, Folate, and Vitamin B-12) CAN INFLUENCE the offspring phenotype (664).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_15354', 'choline', 78, 'choline'), ('CHEBI_30863', '5-azaorotic acid', 99, 'folate'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 111, 'vitamin B-12')]
PMC4448820	5/2015	S1472-PMC4448820	['to date, LIMITED EVIDENCE SUGGESTS that Human-milk Vitamin A is not susceptible to the INFLUENCE of inflammation (775).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 87)]	3	[('NCBITaxon_9606', 'Homo sapiens', 40, 'human'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A')]
PMC4448820	5/2015	S1520-PMC4448820	['data on the INFLUENCE of inflammation on BIOMARKERS of Vitamin D status are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4452099	6/2015	S23-PMC4452099	['a RECENT danish fortification trial has PROVED that the Intake of fortified Food PREVENTED Vitamin D deficiency during winter [19].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('GO_0007631', 'feeding behavior', 56, 'intake'), ('CHEBI_33290', 'food', 76, 'food'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4452099	6/2015	S80-PMC4452099	['on the background of the great NEED of Vitamin D in finland due to its high latitude, this COULD have CONTRIBUTED to the recent levelling-off of the otherwise very high t1d incidence in 0–15 year old children [25].']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4452099	6/2015	S81-PMC4452099	['in the PRESENT STUDY, we INVESTIGATED Early Life exposure to fortification, and its ASSOCIATION with the later t1d risk, and utilized the fact that the mandatory danish Vitamin D fortification regimen was abandoned at a distinct time point.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('UBERON_0001847', 'lobule of pinna', 38, 'early life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4452099	6/2015	S84-PMC4452099	['one REASON for the absence of a detectable RELATIONSHIP between td risk and Early Life exposure to fortified Margarine COULD BE the actual dose of Vitamin D added to Margarine, and therefore the dose which Individuals were exposed to during Gestation and/or during the first year of Life.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 119)]	3	[('UBERON_0001847', 'lobule of pinna', 76, 'early life'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 166, 'margarine'), ('NCBITaxon_1', 'root', 206, 'individuals'), ('GO_0007565', 'female pregnancy', 241, 'gestation'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC4466139	6/2015	S83-PMC4466139	['a daily supplementation of 400 iu of Vitamin D LED TO 105 (37%) mothers (93 italian and 12 migrants) and 56 (20%) newborns (53 italian and 3 migrants) to have Blood 25Ohd values above the cut-off of sufficiency (fixed at 50 nmol/l) (table 5).10.1371/journal.pone.0129586.t005\n\ncaption (table-wrap): table 5\nnumber and percentage of subjects under Vitamin D supplementation (400 iu per day) SHOWING sufficient levels of Vitamin D (25Ohd≥50 nmol/l).subjectsall (283)italian (213)migrant (70)p value newborns 56 (20%)53 (24.9%)3 (4.3%)<0.001 mothers 105 (37%)93 (43.7%)12 (17.1%)<0.001\nno significant associations between maternal and neonatal 25Ohd levels and maternal weight gain in Pregnancy or Birth weight were FOUND.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 390), ('INCOMPLETE_EVIDENCE', 713)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000178', 'blood', 159, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 165, '25OHD'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 430, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 641, '25OHD'), ('GO_0007565', 'female pregnancy', 682, 'pregnancy'), ('GO_0007567', 'parturition', 695, 'birth')]
PMC4466139	6/2015	S106-PMC4466139	['these results SHOW a strong ROLE for supplementation in increasing 25Ohd levels and also that supplementation at 400 iu/die is INSUFFICIENT to provide an appropriate Vitamin D status in Pregnant women and their offsprings.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 28), ('PROBLEM_COMPLICATION', 127)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 67, '25OHD'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnant')]
PMC4466139	6/2015	S117-PMC4466139	['OUR FINDINGS also underline the IMPORTANCE of certain RISK FACTORS in causing Vitamin D deficiency such as immigration, dark skin, and lack of Vitamin D supplementation during the Third Trimester of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0042793', 'plastid transcription', 180, 'third trimester'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4476607	1/2015	S166-PMC4476607	['BASED ON their dietary habits, many children with fasd are not Consuming adequate or daily-RECOMMENDED amounts of Omega-3 Fatty Acids, Vitamin D, and Choline (figure 5a) (fuglestad et al 2013;werts et al.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('FUTURE_WORK', 91)]	3	[('GO_0007631', 'feeding behavior', 63, 'consuming'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 114, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_15354', 'choline', 150, 'choline')]
PMC4488777	5/2015	S9-PMC4488777	['high concentration of Vitamin D and its Metabolites in Decidua during the 1st trimester SUGGESTS its IMPORTANT ROLE in the Implantation process and a local immunological Embryo-protection.']	[('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 30, 'D'), ('CHEBI_25212', 'metabolite', 40, 'metabolites'), ('UBERON_0002450', 'decidua', 55, 'decidua'), ('GO_0007566', 'embryo implantation', 123, 'implantation'), ('UBERON_0000922', 'embryo', 170, 'embryo')]
PMC4488777	5/2015	S102-PMC4488777	['the direct EFFECT of Vitamin D on Amh level and follicle development was also CONFIRMED in a RECENTLY published in vitro experiment [45].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 93)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_16027', "adenosine 5'-monophosphate", 34, 'AMH')]
PMC4488777	5/2015	S104-PMC4488777	['the authors of the study SUGGEST a direct EFFECT of Vitamin D on Amh production, and THUS longer maintenance of Ovarian reserve in the patients with its higher concentration [46].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_16027', "adenosine 5'-monophosphate", 65, 'AMH'), ('UBERON_0000992', 'ovary', 112, 'ovarian')]
PMC4488777	5/2015	S115-PMC4488777	['earlier research SUGGESTED the adverse EFFECT of Vitamin D on fertility after a discovery of a molecular SIMILARITY of its transporting protein, the Vitamin D Binding Protein (Vdbp), to anti-Sperm Antibodies.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 149, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 176, 'VDBP'), ('CL_0000019', 'sperm', 191, 'sperm'), ('GO_0042571', 'immunoglobulin complex, circulating', 197, 'antibodies')]
PMC4499946	7/2015	S22-PMC4499946	['EFFECTS of improvements in Vitamin D status on linear growth in infants and children without rickets have not been widely studied; HOWEVER, in one TRIAL in india, weekly Vitamin D supplementation of low Birth weight infants reduced the risk of stunting in adjusted analyses [14].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007567', 'parturition', 203, 'birth')]
PMC4499946	7/2015	S26-PMC4499946	['THEREFORE, in bangladesh, we have OBSERVED that the period of greatest vulnerability with respect to Perinatal Vitamin D deficiency OVERLAPS with a critical period of fetal and early infant growth.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('GO_0036268', 'swimming', 101, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 101, 'perinatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4499946	7/2015	S28-PMC4499946	['OBSERVATIONAL studies of the ASSOCIATION between maternal Prenatal Vitamin D status and infant anthropometry have yielded CONFLICTING findings [19–23].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	3	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4499946	7/2015	S36-PMC4499946	['the EFFECT APPEARED TO BE attributable to a significantly accelerated increase in mean Laz from Birth to 1 month of age (change of 0.53 z-score in Vitamin D versus 0.19 z-score in placebo group; p = 0.004) RATHER than a significant difference in Birth length [26].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 206)]	3	[('PR_000009655', 'laminin subunit beta-2', 87, 'LAZ'), ('GO_0007567', 'parturition', 96, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 246, 'birth')]
PMC4499946	7/2015	S77-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D, we PLAN TO perform five primary between-group analyses, comprising each Vitamin D dose versus placebo (three comparisons) and comparisons between adjacent doses (two comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 47)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4499946	7/2015	S80-PMC4499946	['in our PRELIMINARY trial, we OBSERVED an increase in Laz of 0.44 at 1 year attributable to Prenatal Vitamin D supplementation, which CORRESPONDED to an increase of 1.1 cm (95 % ci, 0.06–2.0), adjusted for sex [26].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('PR_000009655', 'laminin subunit beta-2', 53, 'LAZ'), ('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4499946	7/2015	S218-PMC4499946	['our PRELIMINARY trial data REVEALED a discernible EFFECT of Prenatal Vitamin D supplementation on infant Laz at 1 year [26].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('GO_0007565', 'female pregnancy', 60, 'prenatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000009655', 'laminin subunit beta-2', 105, 'LAZ')]
PMC4499946	7/2015	S229-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D on mean Laz at 1 year of age, we PLAN TO perform five primary between-group analyses: each Prenatal Vitamin D dose versus placebo (three pairwise comparisons), as well as comparisons between all adjacent Vitamin D doses (two pairwise comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 76)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000009655', 'laminin subunit beta-2', 51, 'LAZ'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D')]
PMC4499946	7/2015	S295-PMC4499946	['the mdig trial will THEREFORE offer unique INSIGHTS into the EFFECT of improving maternal-infant Vitamin D status in a low-income setting where Vitamin D insufficiency is common and there is a high prevalence of infant linear growth faltering.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4514967	12/2014	S34-PMC4514967	['for example, subclinical Vitamin A deficiency is PREVALENT, AFFECTING an ESTIMATED one-third of children and 15% of Pregnant women,19and increases the risk of death from diarrhea (and measles).']	[('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 116, 'pregnant')]
PMC4516377	6/2015	S0-PMC4516377	['Calcium intake, Serum Vitamin D and obesity in children: IS there an ASSOCIATION?']	[('EXPLICIT_QUESTION', 57), ('SUPERFICIAL_RELATIONSHIP', 69), ('EXPLICIT_QUESTION', 80)]	3	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('UBERON_0001977', 'blood serum', 16, 'serum'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4516377	6/2015	S37-PMC4516377	['CONSIDERING the studies that assessed the ASSOCIATION between Vitamin D and obesity in children, two were cross-sectional18,20and one longitudinal21(table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4516377	6/2015	S76-PMC4516377	['that reduces its bioavailability and triggers the Hypothalamus to generate a cascade of reactions that leads to increased feelings of hunger and decreased energy expenditure, to compensate for the lack of the vitamin.37among these reactions is the increase in Parathyroid hormone (pth) levels, which promotes Lipogenesis38,39and CAN Modulate Adipogenesis by suppressing the Vitamin D receptor, which inhibits Compounds INVOLVED in Adipocyte differentiation and maturation.39,40in general, it can be OBSERVED that the increase in Bf can aggravate Vitamin D deficiency which, in turn, can further increase the accumulation of fat, creating a cycle (fig.']	[('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 419), ('INCOMPLETE_EVIDENCE', 499)]	3	[('UBERON_0001898', 'hypothalamus', 50, 'hypothalamus'), ('UBERON_0001132', 'parathyroid gland', 260, 'parathyroid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 309, 'lipogenesis38'), ('GO_0065007', 'biological regulation', 333, 'modulate'), ('GO_0060612', 'adipose tissue development', 342, 'adipogenesis'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 409, 'compounds'), ('CL_0000136', 'fat cell', 431, 'adipocyte'), ('UBERON_0002061', 'truncus arteriosus', 529, 'BF'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D')]
PMC4555116	7/2015	S25-PMC4555116	['ONE STUDY FOUND that after adjusting for energy intake, low maternal dietary intake of vegetable protein, fibre, Beta-Carotene, Vitamin C, Vitamin D, iron and magnesium were LINKED to an increased risk of orofacial clefts in newborns [13].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 174)]	3	[('CHEBI_17579', 'beta-carotene', 113, 'beta-carotene'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4581239	8/2015	S56-PMC4581239	['in a longitudinal cohort study researchers FOUND a dose-response RELATIONSHIP between Micronutrient nutrition deficiency (specifically deficiencies in zinc, iron, and Vitamin B) at 3 years of age, and Externalizing behavior PROBLEMS across childhood and into Adolescence [8].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 224)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 86, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('GO_0007530', 'sex determination', 201, 'externalizing'), ('GO_0048848', 'neurohypophysis morphogenesis', 259, 'adolescence')]
PMC4592566	10/2015	S330-PMC4592566	['the researchers FOUND that most women’s diets exceeded the upper limit for saturated fat intake and the majority of women’s diets were sub-optimal in RELATION to copper, iron, selenium, and ABOUT half were deficient in vitamin a, with smaller proportions deficient in various b Vitamins, Vitamin C and vitamin e [45].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 190)]	3	[('CHEBI_33277', 'gamma-tocotrienol', 278, 'vitamins'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin C')]
PMC4595656	10/2015	S6-PMC4595656	['FURTHER AVENUES OF FUTURE RESEARCH are outlined including Animal studies on the EFFECTS of Vitamin D deprivation and inadequacy on early hippocampal biochemistry and function, e.g., measurement of Bdnf levels, Gabaergic activity, long-term potentiation (ltp) and spatial Navigation.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('NCBITaxon_33208', 'Metazoa', 58, 'animal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('PR_000004716', 'brain-derived neurotrophic factor', 197, 'BDNF'), ('CHEBI_86629', 'G b H', 210, 'GABAergic'), ('GO_0009647', 'skotomorphogenesis', 271, 'navigation')]
PMC4595656	10/2015	S29-PMC4595656	['this was followed by SEVERAL functional STUDIES on physiological and cellular EFFECTS of Vitamin D on various aspects of Brain cellular function (for examples see ko et al.,2004; lin et al.,2005; taniura et al.,2006).']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 121, 'brain')]
PMC4595656	10/2015	S40-PMC4595656	['its overall CONTRIBUTION to healthy Brain Development renders also LIKELY a ROLE for Vitamin D in the developing hippocampus.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('GO_0007420', 'brain development', 36, 'brain development'), ('UBERON_0000955', 'brain', 36, 'brain'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4595656	10/2015	S56-PMC4595656	['the authors CONCLUDED that exposure to low Prenatal Vitamin D has a selective IMPACT on certain aspects of Memory ONLY, with disruption of latent inhibition, but no effect on Memory acquisition and Memory Retrieval.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 114)]	3	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007613', 'memory', 107, 'memory'), ('GO_0007613', 'memory', 175, 'memory'), ('GO_0030317', 'flagellated sperm motility', 198, 'memory retrieval')]
PMC4595656	10/2015	S93-PMC4595656	['apart from ELUCIDATING valuable data on the direct EFFECT of Vitamin D on Neurotransmitter levels within the hippocampus, such studies carried out on young Animals COULD also shed valuable light on Hippocampal Development when combined with behavioral testing.']	[('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 74, 'neurotransmitter'), ('NCBITaxon_33208', 'Metazoa', 156, 'animals'), ('GO_0003163', 'sinoatrial node development', 198, 'hippocampal development')]
PMC4595656	10/2015	S118-PMC4595656	['the antagonistic EFFECTS of Vitamin D on Glucocoticoid action was POSTULATED to have POTENTIAL significance in treatment of Cognitive impairments and major depression, both of which are accompanied by high amounts of circulating Corticosteroids (holsboer,2000).']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_24261', 'glucocorticoid', 41, 'glucocoticoid'), ('GO_0050890', 'cognition', 124, 'cognitive'), ('CHEBI_50850', 'etabonate ester', 229, 'corticosteroids')]
PMC4595656	10/2015	S141-PMC4595656	['this would shed the MOST valuable light POSSIBLE on the ROLE of Vitamin D in early Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
PMC4598849	10/2015	S76-PMC4598849	['HOWEVER, we were UNABLE TO assess the EFFECT of Vitamin D levels during early Pregnancy on fetal growth as these data are unavailable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 17), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC4624803	10/2015	S95-PMC4624803	['Human studies have INDICATED that Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing many diseases and disorders, like parkinson’s disease, epilepsy, depression, multiple sclerosis, schizophrenia, autism, and Autoimmune diseases like rheumatoid arthritis and type i diabetes mellitus [18–20].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 230, 'autoimmune')]
PMC4627942	10/2015	S180-PMC4627942	['compared with the 3-year period before the war, the authors REPORTED that children offered Vitamin A at home during the war had a 12% reduction in mortality, WHEREAS the overall IMPACT of the war was an 89% increase in mortality.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 178)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin A')]
PMC4632418	10/2015	S1-PMC4632418	['thus, we FOCUSED on EVALUATING the ASSOCIATION of Vitamin D deficiency with gdm by conducting a meta-analysis of observed studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4632418	10/2015	S15-PMC4632418	['the NON-CLASSICAL functions of Vitamin D are GAINING ATTENTION for its closer ASSOCIATIONS between Vitamin D deficiency and t2dm, Heart disease, Autoimmune diseases and certain types of cancers [4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000948', 'heart', 130, 'heart'), ('UBERON_0001442', 'skeleton of manus', 145, 'autoimmune')]
PMC4632418	10/2015	S74-PMC4632418	['main analysis\namong the 20 studies, ONLY six SHOWED a significant ASSOCIATION between Vitamin D deficiency (25(Oh)D levels below 50 nmol/l) and risk of gdm.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D')]
PMC4632418	10/2015	S96-PMC4632418	['discussion\nthere HAS BEEN a rapidly GROWING INTEREST in the ASSOCIATION between Vitamin D and risk of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'gestational')]
PMC4632418	10/2015	S107-PMC4632418	['for ONE STUDY, the majority of study participants were reported Consuming Prenatal multivitamins or taking Nutritional supplements, as well as living in a geographical location which MAY AFFECT the Vitamin D status [15].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 187)]	3	[('GO_0007631', 'feeding behavior', 64, 'consuming'), ('GO_0007565', 'female pregnancy', 74, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 107, 'nutritional'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC4632423	10/2015	S72-PMC4632423	['analysis of Serum levels of Micronutrients in the random subset of 25 very severely obese compared with 25 lean women CONFIRMED the significantly lower circulating levels of iron, vitamin b12, Folate, Vitamin A, copper, zinc and selenium with TRENDS for lower Vitamin E/Cholesterol and 25(Oh)D in very severely obese in early Pregnancy (table 3).']	[('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 243), ('SUPERFICIAL_RELATIONSHIP', 243)]	3	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 193, 'folate'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin A'), ('CHEBI_28384', 'vitamin K', 260, 'Vitamin E'), ('CHEBI_16113', 'cholesterol', 270, 'cholesterol'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy')]
PMC4632423	10/2015	S100-PMC4632423	['both Folate and Vitamin D deficiencies HAVE BEEN ASSOCIATED with INCREASED RISKS of pre-eclampsia, Preterm Delivery, low Birth weight and fetal growth restriction [26,27].']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('GO_0007567', 'parturition', 121, 'birth')]
PMC4645901	8/2014	S89-PMC4645901	['HOWEVER, many FACTORS would have CONTRIBUTED to the increase of Vitamin D uptake, including government advertising and better education for Health care professionals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000025', 'tube', 140, 'health')]
PMC4673623	11/2015	S23-PMC4673623	['Choline, betaine, Folate, and Vitamin B-12 have CRITICAL ROLES in Lipid Metabolism because they CONTRIBUTE to the Production Of Phosphatidylcholine (Pc) via the Phosphatidylethanolamine- n- methyltransferase (Pemt) pathway, which is necessary for the formation of very-low-density-lipoproteins (vldl) and the removal of Triglycerides (Tgs) from the Liver.']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 96)]	3	[('CHEBI_15354', 'choline', 0, 'Choline'), ('CHEBI_30863', '5-azaorotic acid', 18, 'folate'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 30, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 40, '12'), ('CHEBI_18059', 'lipid', 66, 'lipid'), ('GO_0006629', 'lipid metabolic process', 66, 'lipid metabolism'), ('GO_0070273', 'phosphatidylinositol-4-phosphate binding', 114, 'production of phosphatidylcholine'), ('CHEBI_36710', 'interferon inducer', 128, 'phosphatidylcholine'), ('CHEBI_16199', 'urea', 149, 'PC'), ('CHEBI_16038', 'phosphatidylethanolamine', 161, 'phosphatidylethanolamine'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 209, 'PEMT'), ('CHEBI_17855', 'triglyceride', 320, 'triglycerides'), ('CL_0002488', 'trophoblast giant cell', 335, 'TGs'), ('UBERON_0002107', 'liver', 349, 'liver')]
PMC4684854	12/2015	S71-PMC4684854	['(iii) DIFFERENT types of Vitamin D (Vitamin D2Versus Vitamin D3) have DIFFERENT physiological IMPACT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 36, 'vitamin D2versus'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 36, 'vitamin D2versus'), ('CHEBI_33279', 'vitamin D5', 53, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 53, 'vitamin D3')]
PMC4684854	12/2015	S77-PMC4684854	['early in Pregnancy, for example, an increased risk of First Trimester Miscarriage HAS BEEN LINKED to INADEQUATE maternal Vitamin D levels [49].']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 101)]	3	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 54, 'first trimester'), ('GO_0046660', 'female sex differentiation', 70, 'miscarriage'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4684854	12/2015	S79-PMC4684854	['this research FOUND that lower Vitamin D levels were ASSOCIATED with Immune Dysregulation in a NUMBER OF ways, including differences in indices involving Natural Killer Cells, various cytokines, and certain Regulatory proteins, when compared to those with sufficient Vitamin D levels [50].']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0001774', 'microglial cell activation', 69, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('CL_0000623', 'natural killer cell', 154, 'natural killer cells'), ('GO_0065007', 'biological regulation', 207, 'regulatory'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4684854	12/2015	S80-PMC4684854	['the authors of this study also NOTED that women with lower Vitamin D levels had higher degrees of various Autoantibodies including Antiphospholipid Antibody [50], a clinical state that HAS BEEN ASSOCIATED with fetal death, recurrent early Miscarriage, Preeclampsia, and Placental insufficiency [51].']	[('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0044308', 'axonal spine', 106, 'autoantibodies'), ('CHEBI_16240', 'hydrogen peroxide', 131, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 148, 'antibody'), ('GO_0046660', 'female sex differentiation', 239, 'miscarriage'), ('GO_0007128', 'meiotic prophase I', 252, 'preeclampsia'), ('UBERON_0001987', 'placenta', 270, 'placental')]
PMC4684854	12/2015	S85-PMC4684854	['NUMEROUS STUDIES have also CORRELATED low levels of Vitamin D with the development of Preeclampsia [52,53,55,56], PERHAPS through Immune mechanisms involving Antiphospholipid Antibody [51], and/or inflammatory mechanisms involving cytokines [56].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 86, 'preeclampsia'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('CHEBI_16240', 'hydrogen peroxide', 158, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibody')]
PMC4684854	12/2015	S91-PMC4684854	['other Gestational ISSUES also APPEAR TO BE INFLUENCED by maternal Vitamin D levels.']	[('IMPORTANT_CONSIDERATION', 18), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0007565', 'female pregnancy', 6, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4684854	12/2015	S113-PMC4684854	['maternal Vitamin D status during Gestation also APPEARS TO have INFLUENCE on many OTHER health indices in the future of the offspring.']	[('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'gestation')]
PMC4684854	12/2015	S139-PMC4684854	['with the recognition that Vitamin D plays an ESSENTIAL ROLE in myriad Genes that encode for health and Well-Being in the offspring, it behooves the medical and PUBLIC HEALTH community to endeavor to secure Vitamin D adequacy in the Gestational period.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 160)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 70, 'genes'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 103, 'well-being'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'gestational')]
PMC4689556	12/2015	S15-PMC4689556	['there is MIXED OBSERVATIONAL evidence with regards to the EFFECT of pre-Natal 25(Oh) Vitamin D status on child health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('GO_0007567', 'parturition', 72, 'natal'), ('CHEBI_30778', 'gallic acid', 78, '25(OH)'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4689556	12/2015	S173-PMC4689556	['overall the data SUGGEST that a clinically meaningful RELATIONSHIP between this regime of Vitamin D supplementation in Pregnancy in a deficient population, or these levels of Vitamin D in Cord-Blood or at three years of age, and healthcare utilization is UNLIKELY.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 54), ('PROBABLE_UNDERSTANDING', 255)]	3	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 188, 'cord'), ('UBERON_0000178', 'blood', 193, 'blood')]
PMC4689556	12/2015	S181-PMC4689556	['in conclusion we have FOUND NO EVIDENCE that supplementation of a Vitamin D deficient, urban mixed race population with either a single Oral bolus dose of 200,000 iu Cholecalciferol at 27 weeks or 800 iu Ergocalciferol daily from 27 weeks until Delivery had any EFFECT on child healthcare utilization in the first 3 years of Life.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 262)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000165', 'mouth', 136, 'oral'), ('CHEBI_52550', 'theopalauamide', 166, 'cholecalciferol'), ('CHEBI_4910', 'etomidate', 204, 'ergocalciferol'), ('GO_0007567', 'parturition', 245, 'delivery'), ('UBERON_0000104', 'life cycle', 325, 'life')]
PMC4690051	12/2015	S114-PMC4690051	['Animal studies provide biological PLAUSIBILITY for the HYPOTHESIS that in utero Vitamin D exposure AFFECTS Human Brain Development [39,40].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 107, 'human'), ('GO_0007420', 'brain development', 113, 'brain development'), ('UBERON_0000955', 'brain', 113, 'brain')]
PMC4690051	12/2015	S116-PMC4690051	['the presence of 1α-hydroxylase activity within numerous Brain Regions SUGGESTS that Brain Tissue can locally produce Metabolically active Vitamin D, further IMPLICATING a ROLE for Vitamin D in Brain Development.']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 157), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('UBERON_0002616', 'regional part of brain', 56, 'brain regions'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0008152', 'metabolic process', 117, 'metabolically'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007420', 'brain development', 193, 'brain development'), ('UBERON_0000955', 'brain', 193, 'brain')]
PMC4691762	12/2015	S0-PMC4691762	['vitality trial: protocol for a randomised controlled trial to establish the ROLE of Postnatal Vitamin D supplementation in infant Immune health\n\nabstract\n\nintroduction\nPostnatal Vitamin D supplementation MAY be ASSOCIATED with a reduction in Ige-mediated Food allergy, Lower Respiratory Tract infections and improved bone health.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 211)]	3	[('GO_0007567', 'parturition', 84, 'postnatal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0007567', 'parturition', 168, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007630', 'jump response', 242, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 242, 'IgE'), ('CHEBI_33290', 'food', 255, 'food'), ('GO_0007631', 'feeding behavior', 255, 'food'), ('UBERON_0004905', 'articulation', 269, 'lower respiratory tract')]
PMC4691762	12/2015	S111-PMC4691762	['furthermore we are uniquely placed internationally TO ASSESS the ROLE of Vitamin D in Early Life development since australia does not currently RECOMMEND universal infant Vitamin D supplementation and is one of the few countries where there is no routine fortification of the Food chain supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 86, 'early life'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_33290', 'food', 276, 'food')]
PMC4719746	1/2016	S17-PMC4719746	['studies provide INCONSISTENT and CONFLICTING evidence for adverse maternal and child health outcomes RELATED to Vitamin D deficiency [11–16].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 101)]	3	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4719746	1/2016	S161-PMC4719746	['this cost-effective, and easy-to-administer RECOMMENDATION LIKELY CONTRIBUTED the most to the improved Vitamin D status later in Pregnancy for these women.']	[('FUTURE_WORK', 44), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC4728621	1/2016	S7-PMC4728621	['maternal trimester three gi, trimester two Saturated Fats and trimester one and three Sodium intake were positively ASSOCIATED with offspring adiposity, WHILE trimester two and three Vitamin C Intake was negatively ASSOCIATED.']	[('SUPERFICIAL_RELATIONSHIP', 116), ('ANOMALY_CURIOUS_FINDING', 153), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_52261', 'rose bengal', 43, 'saturated fats'), ('CHEBI_52632', 'potassium-39 atom', 86, 'sodium'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin C'), ('GO_0007631', 'feeding behavior', 193, 'intake')]
PMC4729160	1/2016	S22-PMC4729160	['the MAJORITY of studies focus on vad of Pregnant women, it FOUND Vitamin A deficiency was strongly ASSOCIATED with Pregnancy and Birth outcomes.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC4729160	1/2016	S127-PMC4729160	['it is also LACK OF assessment of the participants’ physical behavior condition which INFLUENCES Vitamin A status of chinese Pregnant women.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007565', 'female pregnancy', 124, 'pregnant')]
PMC4729160	1/2016	S128-PMC4729160	['MORE STUDIES ARE NEEDED to understand the INFLUENCE FACTORS of Vitamin A status of chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant')]
PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
PMC4764019	1/2016	S25-PMC4764019	['Birth month, in itself, EXHIBITS precisely that RELATIONSHIP.7the UNDERLYING presumption is that the Intrauterine environment would have been relatively deprived of Vitamin D for Births occurring in late spring, and the same environment would have been richer in Vitamin D for births occurring in late fall.']	[('ANOMALY_CURIOUS_FINDING', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('UBERON_0022293', 'reproductive gland secretion', 101, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'births'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D')]
PMC4764019	1/2016	S55-PMC4764019	['THUS, the EFFECTS of Vitamin D inadequacy are as far-RANGING as the Tissues concerned, all of which require Vitamin D to gain access to information stored in their Genes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000479', 'tissue', 68, 'tissues'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000704', 'gene', 164, 'genes')]
PMC4765528	12/2015	S125-PMC4765528	['further work from that group also SUGGESTS that maternal Vitamin D stores CAN INFLUENCE Fetal Femoral Development at as early as 19 weeks Gestation [59].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007631', 'feeding behavior', 88, 'fetal'), ('GO_0009556', 'microsporogenesis', 94, 'femoral development'), ('UBERON_0000981', 'femur', 94, 'femoral'), ('GO_0007565', 'female pregnancy', 138, 'gestation')]
PMC4770602	1/2016	S14-PMC4770602	['[123] data from SOME STUDIES SUPPORTS ASSOCIATIONS of Vitamin D deficiency and Preterm Birth, decreased Birth weight, and hypertensive disease in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'preterm'), ('GO_0007567', 'parturition', 87, 'birth'), ('GO_0007567', 'parturition', 104, 'birth'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC4770602	1/2016	S59-PMC4770602	['[19] in the PRESENT STUDY, we ASSESSED the EFFECT of Vitamin D supplementation in reduction of risk of Preeclampsia in nulliparous women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 103, 'preeclampsia')]
PMC4770602	1/2016	S64-PMC4770602	['[3] in the norwegian mother and child cohort study, the ASSOCIATION between Intake of Vitamin D during Pregnancy and the risk of Preeclampsia in 23,423 Nulliparous Pregnant women was ESTIMATED and authors OBSERVED 27% reduction in risk of Preeclampsia after Vitamin D supplementation in these women.']	[('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007631', 'feeding behavior', 76, 'intake'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 129, 'preeclampsia'), ('GO_0046662', 'regulation of oviposition', 152, 'nulliparous'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 239, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4784858	3/2016	S166-PMC4784858	['HOWEVER, the risk of Neural Tube defects HAS also BEEN ASSOCIATED with a diet quality scoring that takes into account more Nutrients in addition to Folate (Calcium, iron, Vitamin B6 and Vitamin A, and percentage of calories from fat and from sweets) [43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('UBERON_0001049', 'neural tube', 21, 'neural tube'), ('CHEBI_33284', 'nutrient', 123, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 148, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 156, 'calcium'), ('CHEBI_33237', 'vitamin D4', 171, 'vitamin B6'), ('PR_000017255', 'Vang-like protein 1', 171, 'vitamin B6'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin A')]
PMC4785305	3/2016	S169-PMC4785305	['we will conduct this rct TO TEST the IMPACT of two different doses of Vitamin D replacement on clinically RELEVANT maternal and neonatal outcomes in middle eastern women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 106)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4811107	3/2016	S15-PMC4811107	['DESPITE its positive ROLE in health, Vitamin D deficiency is a pandemic [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4811107	3/2016	S18-PMC4811107	['PREVIOUS RESEARCH has DEMONSTRATED that the Vitamin D levels of women and their neonates are highly RELATED [7–11].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4811107	3/2016	S113-PMC4811107	["conclusions\nthe degree to which a newborn's Vitamin D [25(Oh)D] level is ASSOCIATED with their mother's Prenatal level varies by several INTERRELATED FACTORS including maternal race, Birth order, and the actual maternal level."]	[('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 150)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC4811441	3/2016	S2-PMC4811441	['the pathophysiology of the Development Of Hypertension In Pregnancy is UNKNOWN, but studies SUGGEST an ASSOCIATION with Vitamin D status, measured as 25-Hydroxyvitamin D (25(Oh)D).']	[('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0002234', 'detection of endoplasmic reticulum overloading', 27, 'development of hypertension in'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 150, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 173, '(OH)D')]
PMC4811441	3/2016	S12-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status in t1, was ASSOCIATED with a lower odds ratio for Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 173, 'preeclampsia')]
PMC4811441	3/2016	S34-PMC4811441	['this LIMITS the evaluation of the POTENTIAL ROLE of Vitamin D status during early Pregnancy in the development and progression Of Pe.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0001554', 'luteolysis', 127, 'of PE')]
PMC4811441	3/2016	S149-PMC4811441	['we FOUND a positive ASSOCIATION between Vitamin D status and bp trajectory, BUT non-significant for dbp after adjustment for baseline bp.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4811441	3/2016	S167-PMC4811441	['another STRENGTH is that Blood samples were taken in both early and late Pregnancy, enabling INVESTIGATION of changes in Vitamin D status in RELATION to pe and bp.']	[('IMPORTANT_CONSIDERATION', 8), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4811441	3/2016	S169-PMC4811441	['our results SHOW that an increment in 25(Oh)D concentration during Pregnancy is ASSOCIATED with lower odds of pe, REGARDLESS OF early Pregnancy Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4811441	3/2016	S171-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status at t1, was ASSOCIATED with a lower odds ratio for pe.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4843009	4/2016	S26-PMC4843009	['deletion of the Vitamin D Receptor (vdr) HAS SIMILARLY BEEN SHOWN to AFFECT Murine behavior34373839404142.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 69)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 16, 'vitamin D receptor'), ('NCBITaxon_39107', 'Murinae', 76, 'murine')]
PMC4843009	4/2016	S130-PMC4843009	['in wild type Animals, dietary Vitamin D does not necessarily INFLUENCE 1,25(Oh)2D3Concentration, AS 1Α-25-Hydroxyvitamin D hydroxylase and THUS 1,25(Oh)2D3Formation is under tight Regulation by Fgf23 and Klotho1.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 139)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animals'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_52815', 'cresyl violet', 71, '1,25(OH)2D3concentration'), ('CHEBI_67449', 'ananolignan L', 100, '1α-25-hydroxyvitamin D'), ('CHEBI_77734', 'dexverapamil', 146, '25(OH)2D3formation'), ('GO_0065007', 'biological regulation', 180, 'regulation'), ('PR_000007483', 'fibroblast growth factor 13', 194, 'FGF23'), ('PR_000009207', 'lysine-specific demethylase 5D', 204, 'klotho1')]
PMC4846845	4/2016	S168-PMC4846845	['the EFFECTS of maternal Vitamin D levels MAY INFLUENCE Perinatal and long-term outcomes through immune, antibacterial, and anti-inflammatory responses [99,129].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal')]
PMC4846845	4/2016	S169-PMC4846845	['a RECENT STUDY has FOUND ASSOCIATIONS between Vitamin D levels in maternal and Cord Blood and Immune Cell type proportions, as well as Placental Expression of Immune System related Genes [130].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CL_0000738', 'leukocyte', 94, 'immune cell'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0001987', 'placenta', 135, 'placental'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0002405', 'immune system', 159, 'immune system'), ('SO_0000704', 'gene', 181, 'genes')]
PMC4846845	4/2016	S170-PMC4846845	['INTERESTINGLY, Vitamin D deficiency was also ASSOCIATED with Downregulation Of the Expression Of Vitamin D receptor (vdr), Foxp3 (a transcription factor ASSOCIATED with Treg Cells), and Retinoic Acid Receptor (Rar).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 153)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0010629', 'negative regulation of gene expression', 61, 'downregulation of ... expression of ...'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000007620', 'forkhead box protein E3', 123, 'FOXP3'), ('CL_0000960', 'T3 B cell', 169, 'Treg cells'), ('CHEBI_26536', 'retinoic acid', 186, 'retinoic acid'), ('PR_000001245', 'rhodopsin', 186, 'retinoic acid receptor'), ('PR_000013644', 'Ras-related protein Rab-9A', 210, 'RAR')]
PMC4859539	5/2016	S47-PMC4859539	['four multivariable regressions were performed TO ASSESS WHETHER any significant ASSOCIATIONS existed between the natural logarithm of each subject’s cathelicidin concentration and each of the following Vitamin D measurements: (1) child’s current 25(Oh)D at time of follow-up, (2) child’s 25(Oh)d at Birth, (3) maternal 25(Oh)D throughout Pregnancy (visits 3 to 7 as area under the curve), and (4) maternal 25(Oh)D one month before Delivery; all analyses controlled for race/ethnicity, age, gender, and percent fat.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 246, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 246, '25(OH)D'), ('CHEBI_37972', 'phosphorus-32 atom', 288, '25'), ('CHEBI_17792', 'organohalogen compound', 291, 'OH'), ('GO_0007567', 'parturition', 299, 'birth'), ('CHEBI_71657', 'versiconol acetate', 319, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 319, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 338, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 406, '25(OH)D'), ('GO_0007567', 'parturition', 431, 'delivery')]
PMC4859539	5/2016	S124-PMC4859539	['lastly, total circulating Cathelicidin was measured RATHER than cell-specific mrna Expression of Cathelicidin or 1,25(Oh)2D3Concentration [17], which MAY BE more closely LINKED with Vitamin D status during Fetal and childhood Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('PR_000006009', 'alpha-catulin', 26, 'cathelicidin'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000006009', 'alpha-catulin', 97, 'cathelicidin'), ('CHEBI_52815', 'cresyl violet', 113, '1,25(OH)2D3concentration'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0030540', 'female genitalia development', 206, 'fetal ... development')]
PMC4864049	1/2016	S349-PMC4864049	['RECENT STUDIES SHOW that Vitamin D activates the Expression of Tryptophan hydroxylase, the enzyme ASSOCIATED with Serotonin Synthesis\xa0[159].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010467', 'gene expression', 49, 'expression'), ('PR_000001447', 'cadherin-1', 63, 'tryptophan'), ('CHEBI_28790', 'serotonin', 114, 'serotonin'), ('GO_0042427', 'serotonin biosynthetic process', 114, 'serotonin synthesis')]
PMC4889866	5/2016	S0-PMC4889866	['maternal Vitamin D level is ASSOCIATED with Viral toll-like receptor triggered Il-10 response but not the risk of infectious diseases in infancy\n\nabstract\nreports on the EFFECT of Prenatal Vitamin D status on fetal Immune Development and infectious diseases in childhood are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 275)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Viral'), ('PR_000001470', 'interleukin-28B', 79, 'IL-10'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0001822', 'kidney development', 215, 'immune development'), ('UBERON_0002405', 'immune system', 215, 'immune')]
PMC4889866	5/2016	S84-PMC4889866	['analysis was made to INVESTIGATE WHETHER maternal or Cord Blood Vitamin D status was ASSOCIATED with Lower Respiratory Tract infection (bronchiolitis, pneumonia, and croup), infectious enteritis, and Urinary Tract infection at 1 year of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0004905', 'articulation', 101, 'lower respiratory tract'), ('UBERON_0001553', 'medial tarsal artery', 200, 'urinary tract')]
PMC4889866	5/2016	S97-PMC4889866	['the RELATIONSHIP between Vitamin D and Il-10 HAS BEEN established CONSIDERABLY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 66)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 39, 'IL-10')]
PMC4896250	4/2016	S2806-PMC4896250	['FURTHER RESEARCH SHOULD BE focused on Vitamin D supplementation for the PREVENTION of childhood asthma.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC4896250	4/2016	S3549-PMC4896250	['the worldwide EPIDEMIC of Vitamin D deficiency in Pregnancy and the low content of Vitamin D in Breast Milk UNDERLIE the high RISK of deficiency in exclusively Breastfed infants.']	[('IMPORTANT_CONSIDERATION', 14), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 126)]	3	[('CHEBI_28384', 'vitamin K', 26, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 96, 'breast milk'), ('GO_0007567', 'parturition', 160, 'breastfed')]
PMC4896250	4/2016	S4148-PMC4896250	['a294 low Vitamin D levels are RELATED to high house dust mite sensitization in patients with severe atopic dermatitis\n\nyong hyun jang\n\nkyungpook national university school of medicine, south korea\nbackground: the RELATIONSHIP between atopic dermatitis (ad) and low Vitamin D levels HAS BEEN studied.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 213), ('INCOMPLETE_EVIDENCE', 282)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4896250	4/2016	S4150-PMC4896250	['HOWEVER, the EFFECT of Vitamin D on house dust Mite (hdm) sensitization in patients with ad has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_46662', 'mineral', 47, 'mite')]
PMC4896250	4/2016	S4151-PMC4896250	['we INVESTIGATED the ASSOCIATION between Vitamin D levels and hdm sensitization ACCORDING TO ad severity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4896250	4/2016	S4488-PMC4896250	['moreover, the RELATIONSHIP between Serum 25-Oh Vitamin D levels and Pulmonary function test and environmental FACTORS for sunshine were EXAMINED in asthmatic patients.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 136)]	3	[('UBERON_0001977', 'blood serum', 35, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 41, '25-OH'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 68, 'pulmonary')]
PMC4896250	4/2016	S4491-PMC4896250	['HOWEVER, there were no associations with Vitamin D level and Pulmonary function and sunshine related FACTORS, such as housing type, living floor, and indoor/outdoor activity time.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 101)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002048', 'lung', 61, 'pulmonary')]
PMC4896250	4/2016	S6211-PMC4896250	['a438 Vitamin D level and the CORRELATION with Ige in children with allergic Respiratory diseases in guangzhou china\n\nhuimin huang1, baoqing sun2, yun chen3, peiyan zheng2, nili wei1, wenting luo4\n\n1the first affiliated hospital of guangzhou medical university, china;2first affiliated hospital guangzhou medical university;3guangzhou yuexiu district maternal and child health care hospital;4first affiliated hospital of guangzhou medical university, guangzhou institute of respiratory diseases\n\ncorrespondence: huimin huang – the first affiliated hospital of guangzhou medical university, china\nobjective: TO EXPLORE the Vitamin D(vit D) level and analyse the CORRELATION with Immunoglobulin e (Ige) in children with allergic Respiratory diseases in guangzhou china.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('SUPERFICIAL_RELATIONSHIP', 660)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 46, 'IgE'), ('UBERON_0001004', 'respiratory system', 76, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 621, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 635, 'D'), ('GO_0019814', 'immunoglobulin complex', 677, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 695, 'IgE'), ('UBERON_0001004', 'respiratory system', 726, 'respiratory')]
PMC4896250	4/2016	S6538-PMC4896250	['conclusions: these results SUGGEST that Vitamin D MIGHT Modulate mediators INVOLVED in Immune Responses in crs.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 56, 'modulate'), ('GO_0006955', 'immune response', 87, 'immune responses'), ('UBERON_0002405', 'immune system', 87, 'immune')]
PMC4896250	4/2016	S6539-PMC4896250	['FURTHER STUDIES ARE NEEDED to clarify the clinical EFFICACY of Vitamin D in this disorder.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4896250	4/2016	S7049-PMC4896250	['a496 the EFFECT of Cord Serum 25-Hydroxyvitamin D (25(Oh)D) on the development of atopic dermatitis in first 3 years of Life : cocoa study\n\nhyun-ju cho1, youn ho shin2, eun lee3, young-ho kim3, darae lee3, mi-jin kang4, song-i yang5, kangmo ahn6, kyung won kim7, yoon hee kim7, hye-sung won3, soo hyun kim2, suk-joo choi6, young han kim7, jong kwan jun8, eun-jin kim9, jeom gyu lee9, so-yeon lee5, soo-jong hong1, dongin suh10\n\n1department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea;2cha medical center;3asan medical center;4asan institute for Life science, asan medical center;5hallym university sacred Heart hospital;6samsung medical center;7yonsei university college of medicine;8seoul national university college of medicine;9korea national institute of health;10seoul national university hospital\n\ncorrespondence: hyun-ju cho – department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea\nbackground: the ASSOCIATION between Serum Vitamin D deficiency at Birth and atopic dermatitis (ad) is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 1115), ('FULL_UNKNOWN', 1201)]	3	[('UBERON_0000948', 'heart', 19, 'Cord'), ('UBERON_0001977', 'blood serum', 24, 'Serum'), ('CHEBI_27844', "2',3'-cyclic AMP", 30, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('UBERON_0000104', 'life cycle', 120, 'Life'), ('UBERON_0000104', 'life cycle', 650, 'Life'), ('UBERON_0000948', 'heart', 710, 'Heart'), ('UBERON_0001977', 'blood serum', 1135, 'serum'), ('CHEBI_27300', 'vitamin D', 1141, 'vitamin D'), ('GO_0007567', 'parturition', 1165, 'birth')]
PMC4897157	5/2016	S87-PMC4897157	['discussion\nwe HYPOTHESIZED that there MAY BE an ASSOCIATION between the Perinatal Vitamin D status and the development of Allergic Diseases.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('GO_0036268', 'swimming', 72, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 72, 'perinatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 122, 'allergic diseases')]
PMC4897157	5/2016	S112-PMC4897157	['in ANOTHER STUDY, autumn Birth was ASSOCIATED with an increased risk of fa; this risk was greatest among those most LIKELY to experience seasonal variations in Vitamin D during infancy (caucasians) and in those at risk of skin barrier dysfunction (i.e., subjects with a history of eczema)18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 116)]	3	[('GO_0007567', 'parturition', 25, 'birth'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4897157	5/2016	S128-PMC4897157	['NUMEROUS STUDIES HAVE SHOWN that Vitamin D deficiency is ASSOCIATED with an increased incidence of allergic diseases2324).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4897157	5/2016	S149-PMC4897157	['finally, there is a LACK OF research on the EFFECT FACTOR for amount of sun exposure and Vitamin D status such as clothes and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4903143	5/2016	S92-PMC4903143	['THE literature has discussed that Vitamin D insufficiency MAY BE ASSOCIATED with first Trimester Pregnancy loss [85,86], Gestational diabetes [103,104], Preeclampsia [89,105], Preterm Birth [92,93], higher rates of primary and emergency caesarean Delivery [94,106], small for Gestational age infants [95], and maternal Postpartum depression [96].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 87, 'trimester'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('GO_0007565', 'female pregnancy', 121, 'gestational'), ('GO_0007128', 'meiotic prophase I', 153, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 176, 'preterm birth'), ('GO_0007567', 'parturition', 247, 'delivery'), ('GO_0007565', 'female pregnancy', 276, 'gestational'), ('GO_0007565', 'female pregnancy', 319, 'postpartum')]
PMC4908484	6/2016	S10-PMC4908484	['as regards the Cns, several RECENT STUDIES have POSTULATED anti‐inflammatory, immunomodulatory, and neuroprotective ROLES for Vitamin D (garcion et\xa0al.2002).']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('UBERON_0001017', 'central nervous system', 15, 'CNS'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4908484	6/2016	S13-PMC4908484	['MOUNTING EVIDENCE INDICATES that Vitamin D and its receptor have EFFECTS that include neuroprotection and Immunomodulation (aloia et\xa0al.2010).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 106, 'immunomodulation')]
PMC4908484	6/2016	S36-PMC4908484	['moreover, a neuroprotective EFFECT of Vitamin D against iron‐induced oxidative injury in locus coeruleus of Rat HAS BEEN REPORTED (chen et\xa0al.2003).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rat')]
PMC4908484	6/2016	S38-PMC4908484	['the PRESENT research was planned TO study the EFFECTS of Vitamin D on iron accumulation after 6\xa0days of stimulation in be(2)m17 neuroblastoma cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4930210	7/2016	S129-PMC4930210	['in northern countries such as canada, the latitude of the country further reduces the POTENTIAL CONTRIBUTION of dermal synthesis to the maintenance of appropriate Vitamin D concentrations, placing women at greater RISK for Vitamin D deficiency/ insufficiency [21,22].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 214)]	3	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
PMC4930210	7/2016	S138-PMC4930210	['IN FACT, randomized clinical trials of 2000 and 4000 iu/day Vitamin D during Pregnancy HAVE SHOWN that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥80 nmol/l of Vitamin D [9].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 153)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S154-PMC4930210	['the lower rate of Vitamin D insufficiency in OUR STUDY COULD BE RELATED to the cohort characteristics involving very educated, high socio-economic status Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC4934634	11/2015	S20-PMC4934634	['factors INFLUENCING Vitamin D status\nnumerous and diverse lifestyle choices, and environmental and Genetic FACTORS CAN alter Vitamin D status [6];figure 1.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_28384', 'vitamin K', 20, 'Vitamin D'), ('SO_0000704', 'gene', 99, 'genetic'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4934634	11/2015	S28-PMC4934634	['Genetic variations in Cyp2R1 and Vitamin D binding protein CAN reduce the subsequent increases of Serum Vitamin D after uvb exposure and Consumption of Vitamin D fortified foods, respectively, SUGGESTING genetics play a ROLE in determining Vitamin D status [7].']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 220)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 22, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007631', 'feeding behavior', 137, 'consumption'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4934634	11/2015	S39-PMC4934634	['today, Vitamin D IS THOUGHT TO have multiple functions beyond its ROLE(s) in bone health [13].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D')]
PMC4934634	11/2015	S45-PMC4934634	['circulating levels of Vitamin D are used as BIOMARKERS of exposure combining both production from uvb exposure and dietary Intake RATHER than as BIOMARKERS of effect.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130), ('SUPERFICIAL_RELATIONSHIP', 145)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007631', 'feeding behavior', 123, 'intake')]
PMC4934634	11/2015	S47-PMC4934634	['THE CURRENT REVIEW is FOCUSED on the EFFECTS of Vitamin D on numerous aspects of Reproduction including Male and Female Fertility, Pregnancy, and infant outcomes as well as childhood and Adult disease (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 37)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproduction'), ('GO_0007618', 'mating', 104, 'male ...'), ('GO_0007567', 'parturition', 113, 'female fertility'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4934634	11/2015	S57-PMC4934634	['supplementation with Estrogen was able to prevent the histological changes to vdr-null male Testis and normalize follicular stimulating hormone (fsh), and Luteinizing hormone (lh) levels, INDICATING Vitamin D MIGHT have a contributing ROLE in Spermatogenesis and Male Fertility.']	[('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 235)]	3	[('CHEBI_50114', 'estrogen', 21, 'estrogen'), ('UBERON_0000473', 'testis', 92, 'testis'), ('GO_0001905', 'activation of membrane attack complex', 155, 'luteinizing'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0007283', 'spermatogenesis', 243, 'spermatogenesis'), ('GO_0007141', 'male meiosis I', 263, 'male fertility')]
PMC4934634	11/2015	S118-PMC4934634	['ALTHOUGH positive EFFECTS were seen, 41.7% of the participants in the intervention group and 83% in the placebo group remained Vitamin D deficient (using the endocrine society cutoff; 20.8% and 54.2%, respectively using iom guidelines) DUE TO the low intervention dose.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 236)]	3	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4934634	11/2015	S145-PMC4934634	[', INVESTIGATED the ASSOCIATION of circulating maternal 1,25(Oh)2D levels on Preeclampsia and the EFFECT of Vitamin D supplementation on Placental Cytokine Production in Rats [57].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 55, '1,25(OH)2D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 146, 'cytokine production'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 169, 'rats')]
PMC4934634	11/2015	S149-PMC4934634	['TO INVESTIGATE the EFFECT of Vitamin D supplementation on Blood pressure and Circulating T Cells, the Rats induced by reduced Uterine perfusion pressure (rupp), a MODEL of preeclampsia, were administered Vitamin D2Or Vitamin D3On Gestation days 14–18 [57].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 163)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CL_0000080', 'circulating cell', 77, 'circulating'), ('CL_0000084', 'T cell', 89, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 102, 'rats'), ('UBERON_0000995', 'uterus', 126, 'uterine'), ('CHEBI_27329', 'xanthosine phosphate', 204, 'vitamin D2or'), ('PR_000017209', 'utrophin', 204, 'vitamin D2or'), ('CHEBI_63460', 'parkeol', 217, 'vitamin D3on'), ('PR_000017209', 'utrophin', 217, 'vitamin D3on'), ('GO_0007565', 'female pregnancy', 230, 'gestation')]
PMC4934634	11/2015	S176-PMC4934634	['it HAS BEEN PROPOSED that Vitamin D-induced epigenetic changes during development are INVOLVED in susceptibility to multiple morbidities ranging from allergies to cancer later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC4934634	11/2015	S179-PMC4934634	['NOT ONLY CAN seasonal variation IMPACT cutaneous production in the infant, BUT ALSO seasonal variation in maternal uvb exposure will IMPACT Breast Milk Vitamin D concentrations.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('UBERON_0001348', 'brown adipose tissue', 140, 'breast milk'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4934634	11/2015	S207-PMC4934634	['it is anticipated that THIS STUDY will provide valuable NEW information on the EFFECTS of maternal Vitamin D status and offspring allergy/asthma outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('FULL_UNKNOWN', 56), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4944244	7/2016	S0-PMC4944244	['risk factors for Antenatal hypovitaminosis d in an urban district in malaysia\n\nabstract\n\nbackground\nPregnant women form one of the HIGH RISK groups facing hypovitaminosis d. low level of Vitamin D will AFFECT directly OR indirectly both mother and fetus.']	[('IMPORTANT_CONSIDERATION', 131), ('SUPERFICIAL_RELATIONSHIP', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	3	[('GO_0007567', 'parturition', 17, 'antenatal'), ('GO_0007565', 'female pregnancy', 100, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4944244	7/2016	S40-PMC4944244	['these criteria were EXCLUDED AS it would INFLUENCE the Vitamin D level.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4944244	7/2016	S91-PMC4944244	['hypovitaminosis D is expected to be high AS PREVIOUS STUDIES RELATED to Vitamin D conducted in malaysia among children and malay women were also high.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4944244	7/2016	S106-PMC4944244	['ethnic chinese in THIS STUDY had better Vitamin D results COMPARED TO malays and indians which CONTRIBUTE to the decrease of the overall measure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4944244	7/2016	S116-PMC4944244	['in the second Trimester, there were two FACTORS that PREDICT INADEQUATE Vitamin D, namely not taking Antenatal Vitamins (or 4.28; 95\xa0% ci: 1.33–13.75; p \u2009<\u20090.05) and inadequate Serum Vitamin D levels in the first Trimester (or 5.10; 95\xa0% ci: 1.93–13.47; p \u2009<\u20090.01).']	[('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 61)]	3	[('GO_0009294', 'DNA mediated transformation', 14, 'trimester'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 111, 'vitamins'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 213, 'trimester')]
PMC4944244	7/2016	S173-PMC4944244	['[10] CLAIMED that work status (farmer versus non farmer) have significant IMPACT on Vitamin D levels, where farmers had higher levels of Serum 25(Oh)D COMPARED TO non-farmers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 146, 'OH)D')]
PMC4949006	7/2016	S143-PMC4949006	['Serum 25-Oh Vitamin D concentrations of 20 ng/ml (50 nmol/l) or greater are ASSOCIATED with bone health; values of 32 ng/ml (80 nmol/l) or greater are ASSOCIATED with appropriate BIOMARKER concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 179)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 6, '25-OH'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4969253	8/2016	S41-PMC4969253	['CONFIRMATION of this Ra-Sm Regulation in vivo was provided by EVIDENCE that restricting maternal Vitamin A dietary intake during initiation of Airway Development resulted in aberrant overly differentiated and ectopic distribution of sm in these Airways.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 62)]	3	[('PR_000013779', 'histone-binding protein RBBP7', 21, 'RA-SM'), ('GO_0065007', 'biological regulation', 27, 'regulation'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035904', 'aorta development', 143, 'airway development'), ('UBERON_0001005', 'respiratory airway', 143, 'airway'), ('UBERON_0001005', 'respiratory airway', 245, 'airways')]
PMC4969253	8/2016	S49-PMC4969253	['there HAVE BEEN multiple STUDIES LINKING low Serum Vitamin A levels to prevalence and severity of asthma.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A')]
PMC4969253	8/2016	S79-PMC4969253	['these EFFECTS CAN be PREVENTED or alleviated by proper Vitamin A supplementation during Gestation [25].']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('GO_0007565', 'female pregnancy', 88, 'gestation')]
PMC4971719	8/2016	S34-PMC4971719	['similarly, gur, et al., FOUND a significant ASSOCIATED between mid-Pregnancy Vitamin D levels and depression and depression screen scores measured longitudinally in the Postpartum period among healthy women who were not considered AT RISK for depression [27].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 231)]	3	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'postpartum')]
PMC4971719	8/2016	S39-PMC4971719	['this study DIFFERS from PREVIOUSLY-reported investigations in that our subjects were selected BASED ON predisposition to depression and both 25 [Oh] Vitamin D and depression scores were measured at several time points.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_74958', 'N-isovaleryl-L-homoserine lactone', 141, '25 [OH]'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4971719	8/2016	S93-PMC4971719	['NO threshold has been ESTABLISHED for prevention of other diseases HYPOTHESIZED to be RELATED to Vitamin D status [43,45–47].']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4971719	8/2016	S163-PMC4971719	['the main finding of OUR STUDY is that there exists a RELATIONSHIP between low early-Pregnancy Vitamin D levels and depression symptoms in early and late Pregnancy in women AT risk for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 172)]	3	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4971719	8/2016	S168-PMC4971719	['conclusions\nOUR FINDINGS SUGGEST that lower Vitamin D levels in early Pregnancy are ASSOCIATED with depressive symptoms in early and late Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC4973215	8/2016	S70-PMC4973215	["for white mothers, measurement of maternal Serum 25(Oh)D at <22 weeks' Gestation SHOWED a u-shaped RELATIONSHIP between Vitamin D status and risk of sga, where the highest risk for sga was SEEN with both low and high Vitamin D levels."]	[('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 189)]	3	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 71, 'gestation'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4973215	8/2016	S72-PMC4973215	['in a larger study, burris et al.14EXAMINED the RELATIONSHIP between second-Trimester Serum 25(Oh)D levels and sga in blacks and whites and FOUND a higher risk of sga in both Vitamin D-deficient black and white infants.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 139)]	3	[('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 91, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4973215	8/2016	S74-PMC4973215	['they FOUND that Vitamin D status was ASSOCIATED with risk of sga in white and nonobese women, BUT that there was no association between Vitamin D and sga in black or obese mothers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4973215	8/2016	S86-PMC4973215	[',39who FOUND that lack of Prenatal vitamin use was ASSOCIATED with Vitamin D deficiency in white BUT NOT black women.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	3	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4973215	8/2016	S97-PMC4973215	['first, we DID NOT have information regarding exact amounts of dietary maternal Vitamin D intake and sun exposure that MAY AFFECT maternal and Cord Blood Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 122)]	3	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 142, 'cord'), ('UBERON_0000178', 'blood', 147, 'blood'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4976416	7/2016	S31-PMC4976416	['[19] the CORRELATION between Vitamin E intake, Ige levels, and the clinical manifestations of atopy INDICATE that Vitamin E COULD BE a therapeutic tool for atopic dermatitis.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin E'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 47, 'IgE'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin E')]
PMC4979151	8/2016	S15-PMC4979151	['maternal Vitamin D status during Pregnancy MAY AFFECT the fetal Immune System and CONTRIBUTE to the risk of development of Immune-mediated diseases and infection in the offspring.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002405', 'immune system', 64, 'immune system'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC4979151	8/2016	S17-PMC4979151	['VARIOUS in vitro STUDIES of the EFFECTS of Vitamin D on the T-Cell phenotype HAVE SHOWN that active Vitamin D3(1,25(Oh)2D3) suppresses Production Of Th1 Cytokines and Il-17 [12,13] and promotes Th2 Responses [14,15] and T Regulatory Cells (Treg) to maintain a balance and prevent exacerbated Immune Responses [16,17].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CL_0000084', 'T cell', 60, 'T-cell'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 112, ',25(OH)2D3'), ('GO_0006915', 'apoptotic process', 135, 'production of Th1 cytokines'), ('PR_000001470', 'interleukin-28B', 167, 'IL-17'), ('GO_0007596', 'blood coagulation', 194, 'Th2 responses'), ('CL_0000902', 'induced T-regulatory cell', 220, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 220, 'T regulatory'), ('CL_0000901', 'Tr1 cell', 240, 'Treg'), ('GO_0006955', 'immune response', 292, 'immune responses'), ('UBERON_0002405', 'immune system', 292, 'immune')]
PMC4979151	8/2016	S117-PMC4979151	['there is a SCARCITY of in vivo data in Humans during Pregnancy SHOWING EFFECTS of Vitamin D supplementation on neonatal Immune function.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('NCBITaxon_9606', 'Homo sapiens', 39, 'humans'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune')]
PMC4979151	8/2016	S155-PMC4979151	['stimulation of cbmc with B Cell stimulant or tlr ligands such as Lps MIGHT have yielded a more COMPREHENSIVE picture of Vitamin D RELATED cytokine functions.']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CL_0000236', 'B cell', 25, 'B cell'), ('CHEBI_16412', 'lipopolysaccharide', 65, 'LPS'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4982007	8/2016	S39-PMC4982007	['THIS SYSTEMATIC REVIEW FOCUSSES on studies LINKING Cognitive function in children to the following indices of maternal nutritional status: a) anthropometry (body mass index (bmi), height and weight); b) status or Intake of selected single Micronutrients (Vitamins D, b1, b6, b12 and Folate) and iron and c) dietary Intake of Macronutrients (Carbohydrate, protein and fat).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0050890', 'cognition', 51, 'cognitive'), ('GO_0007631', 'feeding behavior', 213, 'intake'), ('CHEBI_33839', 'macromolecule', 239, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamins D'), ('CHEBI_30863', '5-azaorotic acid', 283, 'folate'), ('GO_0007631', 'feeding behavior', 315, 'intake'), ('CHEBI_33839', 'macromolecule', 325, 'macronutrients'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 341, 'carbohydrate')]
PMC4982007	8/2016	S75-PMC4982007	['m; 2010 \u2003n \u2009=\u20099983 14\xa0years \u2003n \u2009=\u200910474 16\xa0years\u2003finland\u2003prospective Birth cohort studyhb concentrations at 3rd 7th and 9th Gestational monthsanaemiaschool performance14\xa0years- self report16\xa0years- school report↑maternal hb at 9\xa0months-↑ total school performance score (β\u2009=\u20090.03) and theory score at 14\xa0years and total score at 16\xa0years offspring of mothers with anaemia –low school scores (or\u2009=\u2009-0.05 at 14\xa0years and (or\u2009=\u2009-0.06) at 16\xa0yearsconfounders adjusted for: the child’s sex, bwt, Pregnancy wanted or not, me, social class, parity, marital status, ms, maternal mental health status18 low40davidson pw; 2008 \u2003n \u2009=\u2009229\u2003age 5, 9, 25and 30\xa0months\u2003republic of seychelles\u2003longitudinal cohort studyiron- total body stores at 14-24 weeks of Gestation assessed before the start of iron supplementationbayley scales of infant development: mental development index (mdi) and psychomotor development index (pdi) (9 and 30\xa0months)infant Cognition (fagan infantest-novelty preference) and Visual expectation paradigm –Visual recognition Memory (9 and 25\xa0months)a-not-b and delayed spatial alternation: inhibition, Working Memory, Planning and attention (25\xa0months)no association between maternal iron stores and Cognitive function at any age.confounders adjusted for: the child’s sex, bwt, ma, ses, he, miq and both parents living with the child (yes/no)19 low41lewis sj; 2013 \u2003n \u2009=\u2009~3,500\u2003age 8\xa0years\u2003uk\u2003population based prospective birth cohorthb concentrationsbefore 18\xa0weekshb <11.0\xa0g/dl -8\xa0%after 28\xa0weekshb <11.0\xa0g/dl -30\xa0%wechsler intelligence scale for children-iii- full- scale iqno ASSOCIATION between maternal hb and child’s iqconfounders adjusted for: ga, me, the child’s genotype, Iron supplementation, population stratification15 medium42tran td; 2013 \u2003n \u2009=\u2009378\u2003age 6\xa0months\u2003vietnam\u2003population based prospective cohort studyiron deficiency anaemia (hb <11.0\xa0g/dl and Serum ferritin <15\xa0ng/ml) during 12-28 weeks of Gestation-16\xa0%bayley scales of infant and toddler development-iii edition-Cognitive scoreinfants of anaemic mothers scored 11.6 points (0.77sd) lower in bsid Cognitive scores compared to infants of non-anaemic mothers.confounders adjusted for: parity, ma, me, wealth index, the child’s Birth and current weight, family support, bf.18 low43zhou sj; 2006 \u2003n \u2009=\u2009302\u2003age 4\xa0years; australia\u2003double blind randomized controlled trialiron Supplements (20\xa0mg/day) or placebo from 20\xa0weeks Gestation until deliverycompliance-86\xa0%stanford binet intelligence scale – iq (Verbal Reasoning, Visual Reasoning, Quantitative Reasoning and Short-Term Memory)no difference between the children of supplement group and placebo group in the mean score of composite iq or any subscales iq or in the proportion of children whose iq fell 1 or 2 sd below the mean.confounders adjusted for: sex, Birth order, Gestational age, ma, me, pe, he, bf20 low44li q; 2009 \u2003n \u2009=\u20091305\u2003age 3, 6 and 12\xa0months\u2003double blind cluster randomized controlled trial\u2003china3 intervention groups (all received Folic Acid)Folic Acid alone400\xa0μg ( n \u2009=\u2009471)-controliron 60\xa0mg\u2009+\u2009Folic Acid400\xa0μg ( n \u2009=\u2009438)multiple Micronutrients ((b Vitamins (1,2,3 6 and 12), Vitamin A, d, c, e and minerals (zinc, Iodine, copper, Selenium)\u2009+\u2009iron 30\xa0mg\u2009+\u2009400\xa0μg Folic Acid)) ( n \u2009=\u2009396)daily supplementation from enrolment until Delivery; inadequate information about compliancebayley scales of Infant Development :mental (md) and Psychomotor Development (pd)no significant difference in infants md and pd score at 3 and 6\xa0months and pd score at 12\xa0months between Supplement groupsmean md score among children of multiple Micronutrient group increased by 1 to 1.22 points COMPARED to children of Folic Acid alone, or Folic Acid\u2009+\u2009Iron group at 12\xa0monthsconfounders adjusted for: infants age, sex, Gestational age, apgar score, bwt, infant health, maternal age and bmi, parental education, occupation, ses, number of tablets consumed19 low\nqs quality score , rb risk of bias , hb haemoglobin , ga Gestational age , ma maternal age , bwt birthweight , ses socio-economic status , me maternal education , pe paternal education , miq maternal intelligence , he home environment , ms maternal smoking , bf breast-feeding , bmi body mass index\n\ncaption (table-wrap): table 7\n\nsummary of the studies examining ASSOCIATIONS of maternal Carbohydrate/protein with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb45alderman h; 2014 \u2003n \u2009=\u20096774\u2003age 16-22 years\u2003double blind cluster randomized controlled trial\u2003gambiacarbohydrate/protein supplementsintervention group:2 biscuits daily (1015\xa0kcal Carbohydrate and 22\xa0g protein) from 20\xa0weeks of Gestation to Deliverycontrol group: same Supplements for 20\xa0weeks during Postpartum but not during Pregnancyno information about complianceraven’s progressive matrices- nonverbal reasoning abilitythe mill hill vocabulary testthe backward and forward digit-span testschooling achievement (questionnaire)no difference in any of the Cognitive test scores or schooling achievement between children whose mothers received thesupplements during Pregnancy and children whose mothers received Supplements during Postpartum.confounders adjusted for: the child’s sex, age, ga, me, pe, maternal height, parity, season of Birth, language and village allocation19 low\nqs quality score, rb risk of bias, ga Gestational age, me Maternal education, pe paternal education\n\nmaternal anthropometry (table\xa02)\nall were observational studies and from developed countries [8–19].']	[('SUPERFICIAL_RELATIONSHIP', 1587), ('ANOMALY_CURIOUS_FINDING', 3631), ('SUPERFICIAL_RELATIONSHIP', 4262)]	3	[('GO_0007567', 'parturition', 69, 'Birth'), ('GO_0007565', 'female pregnancy', 124, 'gestational'), ('GO_0007565', 'female pregnancy', 490, 'pregnancy'), ('GO_0007565', 'female pregnancy', 742, 'gestation'), ('GO_0050890', 'cognition', 933, 'cognition'), ('GO_0007601', 'visual perception', 984, 'Visual'), ('GO_0007601', 'visual perception', 1013, 'visual ...'), ('GO_0007613', 'memory', 1032, 'memory'), ('GO_0007631', 'feeding behavior', 1109, 'working memory'), ('GO_0006260', 'DNA replication', 1125, 'planning'), ('GO_0050890', 'cognition', 1207, 'cognitive'), ('CHEBI_24870', 'ion', 1689, 'iron'), ('UBERON_0001977', 'blood serum', 1876, 'serum'), ('GO_0007565', 'female pregnancy', 1924, 'gestation'), ('GO_0050890', 'cognition', 1998, 'cognitive'), ('GO_0050890', 'cognition', 2082, 'cognitive'), ('GO_0007567', 'parturition', 2210, 'birth'), ('CHEBI_33341', 'titanium atom', 2355, 'supplements'), ('GO_0007565', 'female pregnancy', 2404, 'gestation'), ('GO_0016055', 'Wnt signaling pathway', 2483, 'verbal reasoning'), ('GO_0007602', 'phototransduction', 2501, 'visual reasoning'), ('GO_0031028', 'septation initiation signaling', 2519, 'quantitative reasoning'), ('GO_0007608', 'sensory perception of smell', 2546, 'short-term memory'), ('GO_0007567', 'parturition', 2794, 'birth'), ('GO_0007565', 'female pregnancy', 2807, 'gestational'), ('CHEBI_30751', 'formic acid', 2985, 'folic acid'), ('CHEBI_30751', 'formic acid', 2996, 'Folic acid'), ('CHEBI_52727', 'ethyl nile blue A', 3051, 'folic acid400'), ('CHEBI_33839', 'macromolecule', 3088, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 3107, 'vitamins'), ('CHEBI_27300', 'vitamin D', 3134, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 3173, 'iodine'), ('CHEBI_27568', 'selenium atom', 3189, 'selenium'), ('CHEBI_30751', 'formic acid', 3221, 'folic acid'), ('GO_0007567', 'parturition', 3288, 'delivery'), ('GO_0060119', 'inner ear receptor cell development', 3354, 'Infant Development'), ('GO_0035210', 'prepupal development', 3390, 'Psychomotor development'), ('CHEBI_16158', 'steroid sulfate', 3523, 'supplement'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 3581, 'micronutrient'), ('CHEBI_30751', 'formic acid', 3655, 'folic acid'), ('CHEBI_30751', 'formic acid', 3676, 'folic acid'), ('CHEBI_24870', 'ion', 3689, 'iron'), ('GO_0007565', 'female pregnancy', 3756, 'gestational'), ('GO_0007565', 'female pregnancy', 3955, 'gestational'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4287, 'carbohydrate'), ('GO_0050890', 'cognition', 4323, 'cognitive'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4649, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 4697, 'gestation'), ('GO_0051607', 'defense response to virus', 4710, 'deliveryControl'), ('CHEBI_33341', 'titanium atom', 4738, 'supplements'), ('GO_0007565', 'female pregnancy', 4770, 'postpartum'), ('GO_0007605', 'sensory perception of sound', 4796, 'pregnancyNo'), ('GO_0050890', 'cognition', 5027, 'cognitive'), ('GO_0007565', 'female pregnancy', 5136, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 5182, 'supplements'), ('GO_0007565', 'female pregnancy', 5201, 'postpartum'), ('GO_0007567', 'parturition', 5307, 'birth'), ('GO_0007565', 'female pregnancy', 5390, 'gestational'), ('GO_0007618', 'mating', 5410, 'maternal')]
PMC4982007	8/2016	S269-PMC4982007	['maternal Vitamin D\ntwo of the three AVAILABLE STUDIES, all from developed populations, SHOWED an ASSOCIATION of higher maternal Vitamin D concentrations with better Cognitive function in the children [21,22].']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0050890', 'cognition', 165, 'cognitive')]
PMC4989298	8/2016	S348-PMC4989298	['state of knowledge\na recent meta-analysis INVESTIGATED the RELATIONSHIP between alterations of Vitamin D status and a number OF pathological conditions [121].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 59), ('ANOMALY_CURIOUS_FINDING', 125)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4989298	8/2016	S349-PMC4989298	['HISTORICALLY, Vitamin D HAS BEEN ASSOCIATED with Musculoskeletal diseases such as rachitism, osteoporosis, fractures and muscle weakness.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 49, 'musculoskeletal')]
PMC4989298	8/2016	S362-PMC4989298	['the study conclusions were that there was not SUFFICIENT evidence to establish a causal CONNECTION; there were also NO RANDOMISED clinical trial (rct) on the effect of supplementation of Vitamin D and risk of asthma.']	[('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 116)]	3	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4989298	8/2016	S365-PMC4989298	['one SHOWED no correlation and the other 5 FOUND an inverse RELATIONSHIP between Vitamin D intake (through diet or supplementation) or Vitamin D levels in Umbilical Cord blood and the incidence of asthma or wheezing at 1–3 or 5\xa0years of age.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 154, 'umbilical cord')]
PMC4989298	8/2016	S371-PMC4989298	['in particular, in addition to studies SHOWING an inverse RELATIONSHIP between Vitamin D and atopic dermatitis, STUDIES report that high Vitamin D levels in Umbilical Cord Blood determines a higher risk of Allergic Sensitisation and Food allergy [127,128].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 156, 'umbilical cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('GO_0046631', 'alpha-beta T cell activation', 205, 'allergic sensitisation'), ('CHEBI_33290', 'food', 232, 'food')]
PMC4990280	8/2016	S129-PMC4990280	['in the fe60f group BUT NOT others (fe30f and mm), hb was strongly positively ASSOCIATED with Plasma hepcidin and Vitamin A in all children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('UBERON_0001969', 'blood plasma', 93, 'plasma'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC4992225	8/2016	S37-PMC4992225	['Serum levels of 25-Hydroxyvitamin D REFLECTS the body’s Vitamin D reserves and this is a WELL-KNOWN INDICATOR for examining Vitamin D status [15].']	[('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 16, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4992225	8/2016	S42-PMC4992225	['THEREFORE, the Brain can regionally activate Vitamin D, which IMPLICATES Vitamin D’s ROLE in Brain function more prominent [22–25].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0000955', 'brain', 15, 'brain'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000955', 'brain', 93, 'brain')]
PMC4992225	8/2016	S232-PMC4992225	['the Vitamin D and control groups were SIMILAR regarding to general characteristics EXCEPT FOR two variables: unplanned Pregnancy and using other Supplements OUT OF THE STUDY’S PROTOCOL.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('PROBLEM_COMPLICATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 145, 'supplements')]
PMC4992225	8/2016	S239-PMC4992225	['HOWEVER in a cross-sectional study in japan, higher dietary Vitamin D intake was INDEPENDENTLY ASSOCIATED with a lower prevalence of depressive symptoms during Pregnancy [66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC4992225	8/2016	S240-PMC4992225	['ON THE OTHER HAND, the EFFECT of Vitamin D on depression in non-Pregnant People are NOT entirely CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'people')]
PMC4992225	8/2016	S241-PMC4992225	['SOME clinical trials in non-Pregnant People SHOWED that Vitamin D was EFFECTIVE in decreasing depression level.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'people'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4992225	8/2016	S251-PMC4992225	['its indirect EFFECTS are ATTRIBUTED to Vitamin D’s EFFECTS on improvement of muscle activities.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4992225	8/2016	S274-PMC4992225	['meaning that over time, depression scores decreased much more in the Vitamin D group in comparison to control group and this SHOWS the POSSIBLE EFFECTS of the Vitamin D3Supplementation.']	[('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_52915', 'phosphatediyl group', 159, 'vitamin D3supplementation')]
PMC4997567	8/2016	S103-PMC4997567	['several RISK FACTORS had IMPORTANT CONTRIBUTIONS, including low socio-economic status represented by low family income, low standard of education, poor housing conditions, lack of exposure to sunlight, nutritional status of mother, and prolonged Breast-Feeding without Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('GO_0007567', 'parturition', 246, 'breast-'), ('UBERON_0000310', 'breast', 246, 'breast'), ('GO_0007631', 'feeding behavior', 253, 'feeding'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4998950	4/2016	S11-PMC4998950	['we report HERE on the RELATIONSHIP between secondary care diagnosis of lifetime maternal Vitamin D deficiency and offspring risk of asd with and without intellectual disability, while addressing the INFLUENCE of ethnicity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4998950	4/2016	S28-PMC4998950	['diagnosed lifetime maternal Vitamin D deficiency was ASSOCIATED with risk of asd and, in particular, of asd with intellectual disability ( p for homogeneity 0.17) (table 2), ALTHOUGH there was SOME attenuation upon adjustment for parental characteristics.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 174), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5014971	8/2016	S16-PMC5014971	['POOR Vitamin D status is a RISK FACTOR for POOR Skeletal Development and fractures in newborns [3].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 43)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0001501', 'skeletal system development', 48, 'skeletal development'), ('UBERON_0004288', 'skeleton', 48, 'skeletal')]
PMC5014971	8/2016	S105-PMC5014971	['there is also a direct ASSOCIATION between circulating 25-Oh-D and 1,25-Oh2-D, which is not the case outside of Pregnancy, SUGGESTING both higher substrate (25-Oh-D) turnover and a greater EFFECT of 25-Oh-D levels on Vitamin D actions on physiology and Metabolism [2].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 55, '25-OH-D'), ('CHEBI_78731', '9(R)-HPETE', 69, '25-OH2-D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 157, '25-OH-D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 199, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 253, 'metabolism')]
PMC5035678	4/2016	S115-PMC5035678	['HOWEVER, there is SCARCE INFORMATION about the EFFECT of Vitamin D supplementation on Glucose Metabolism, especially during Pregnancy and after Delivery.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0006006', 'glucose metabolic process', 86, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC5035678	4/2016	S133-PMC5035678	['in OUR STUDY, over a median interval of 26 weeks between commencement of Vitamin D supplements and ogtt measurements, high dose Vitamin D LED TO maternal and neonatal 25Ohd level increases, but not to the predicted EFFECTS on Glucose level and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 167, '25OHD'), ('CHEBI_17234', 'glucose', 226, 'glucose'), ('PR_000045358', 'insulin family protein', 244, 'insulin')]
PMC5035678	4/2016	S134-PMC5035678	['this negative result was LIKELY caused by inadequate doses of Vitamin D3, time limitations, or the LACK OF a causal RELATION between Vitamin D and type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_33279', 'vitamin D5', 62, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 62, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5035678	4/2016	S135-PMC5035678	['as mentioned by yap, this result MAY INDICATE that it is actually dysglycemia that leads to defects in Liver Hydroxylation of Vitamin D.\nVitamin D supplementation has diverse EFFECTS on the non-Pregnant population.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 175)]	3	[('UBERON_0002107', 'liver', 103, 'liver'), ('GO_0044444', 'cytoplasmic part', 109, 'hydroxylation'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 137, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant')]
PMC5035678	4/2016	S150-PMC5035678	['the study was DESIGNED to detect any EFFECTS of Vitamin D on Insulin resistance by allowing for adequate time between the start of supplementation and the measurement of outcomes, and with the FEWEST number of patients lost to follow up.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000045358', 'insulin family protein', 61, 'insulin')]
PMC5039809	10/2016	S1-PMC5039809	['TO OUR KNOWLEDGE, the ASSOCIATIONS between maternal Vitamin A status and offspring Bone Development have NOT previously BEEN ELUCIDATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FULL_UNKNOWN', 105)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0048539', 'bone marrow development', 83, 'bone development')]
PMC5039809	10/2016	S21-PMC5039809	['FEW STUDIES to OUR KNOWLEDGE have RELATED maternal Vitamin A nutrition during Pregnancy to Offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 91, 'offspring'), ('GO_0048539', 'bone marrow development', 101, 'bone development')]
PMC5039809	10/2016	S89-PMC5039809	['Serum Vitamin A (Retinol and Β-Carotene) and neonatal bone indexes\nafter adjusting for maternal FACTORS, Gestational age, sex, and age at dxa scan, maternal Serum Retinol in late Pregnancy was significantly negatively ASSOCIATED with offspring total body bmc, ba, and Birth weight BUT NOT bmd or scbmc ( table 3 ).']	[('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 218), ('ANOMALY_CURIOUS_FINDING', 281)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 17, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 29, 'β-carotene'), ('GO_0007565', 'female pregnancy', 105, 'gestational'), ('UBERON_0001977', 'blood serum', 157, 'serum'), ('CHEBI_26536', 'retinoic acid', 163, 'retinol'), ('GO_0007565', 'female pregnancy', 179, 'pregnancy'), ('GO_0007567', 'parturition', 268, 'birth')]
PMC5039809	10/2016	S104-PMC5039809	['adjusting for Vitamin D status made little difference; the pattern of ASSOCIATIONS OBSERVED between Serum Retinol and Β-Carotene concentrations and neonatal bone indexes REMAINED the same (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 170)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_26536', 'retinoic acid', 106, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 118, 'β-carotene')]
PMC5039809	10/2016	S112-PMC5039809	['there are FEW STUDIES to OUR KNOWLEDGE that have RELATED maternal Vitamin A status to offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0048539', 'bone marrow development', 96, 'bone development')]
PMC5042197	9/2016	S0-PMC5042197	['prevalence and RISK FACTORS for low Vitamin D status among breastfeeding mother–infant dyads in an environment with abundant sunshine\n\nabstract\n\npurpose\nevaluation of Vitamin D (vd) status and RISK FACTORS for low vd among breastfeeding mother–infant dyads in a population at high RISK for vd deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 281)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5045784	10/2016	S71-PMC5045784	['in addition, large-SCALE Human studies MAY yield altered risk for bpd in ASSOCIATION with Vitamin D-Binding Protein and Vdr polymorphisms.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('NCBITaxon_9606', 'Homo sapiens', 25, 'human'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 90, 'vitamin D-binding protein'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 120, 'VDR')]
PMC5045784	10/2016	S79-PMC5045784	['HOWEVER, these studies DID NOT address the ROLE of Vitamin D status in bpd, wheezing and asthma among preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5051327	9/2016	S10-PMC5051327	['conclusions\nlow Vitamin D levels in early Pregnancy MAY BE ASSOCIATED with emergency caesarean section DUE TO suspected fetal distress and Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBLEM_COMPLICATION', 103)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC5062906	10/2016	S0-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation at Imprinted loci in multiple generations\n\nabstract\n\nbackground\nenvironmental perturbation of epigenetic mechanisms is LINKED to a GROWING NUMBER OF diseases.']	[('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 191)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 55, 'imprinted')]
PMC5062906	10/2016	S13-PMC5062906	['conclusions\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D status plays a ROLE in determining Dna Methylation state in the germline and Soma.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0006306', 'DNA methylation', 98, 'DNA methylation'), ('GO_0044297', 'cell body', 140, 'soma')]
PMC5062906	10/2016	S14-PMC5062906	['detection of methylation changes in the unexposed second-generation DEMONSTRATES that maternal Vitamin D depletion CAN have long-term EFFECTS on the epigenome of subsequent generations.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5062906	10/2016	S15-PMC5062906	['differences in Vitamin D-dependent epigenetic state between cell types and generations INDICATE perturbation of the epigenetic landscape RATHER than a targeted, locus-specific EFFECT.']	[('INCOMPLETE_EVIDENCE', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC5062906	10/2016	S269-PMC5062906	['the grandmaternal dietary INFLUENCE on g2phenotype and epigenetic outcome we report HERE DEMONSTRATES inheritance of Vitamin D-induced epigenetic perturbation.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('INCOMPLETE_EVIDENCE', 89)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5064894	10/2016	S20-PMC5064894	['higher rates of invasive pneumococcal disease HAVE BEEN ASSOCIATED with decreased ultraviolet light exposure through the POSTULATED mechanism of lower Vitamin D levels [5].']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC5064894	10/2016	S38-PMC5064894	['second, the ROLE of Prenatal Vitamin D as a DETERMINANT of susceptibility to specific Viral infections has NOT BEEN EXAMINED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 44), ('FULL_UNKNOWN', 107)]	3	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_1', 'root', 86, 'viral')]
PMC5084016	10/2016	S117-PMC5084016	['the circulating levels of Vitamin D are ONLY PARTLY AFFECTED by the dietary intakes.']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5084016	10/2016	S120-PMC5084016	['the Endogenous Synthesis Of Vitamin D requires exposure to ultraviolet radiation with a wavelength between 290 and 315 nm, and is INFLUENCED by several FACTORS, RELATED to both the Individual’s characteristics (such as sex and phenotype, weight), and environmental factors (the degree of physical activity, latitude, season, time of exposure to sunlight, pollution, use of sunscreens and supplements).']	[('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	3	[('GO_0009790', 'embryo development', 4, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 15, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 36, 'D'), ('NCBITaxon_1', 'root', 181, 'individual')]
PMC5084041	10/2016	S1-PMC5084041	['the AIM was TO STUDY the DETERMINANTS of change in Vitamin D status during Pregnancy and of Vitamin D deficiency (<30 nmol/l) in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC5084041	10/2016	S12-PMC5084041	['among them, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5084041	10/2016	S32-PMC5084041	['FEW STUDIES have investigated Vitamin D status longitudinally in a large cohort of Pregnant women, and knowledge of change in Vitamin D status during Pregnancy and its DETERMINANTS are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 168), ('FULL_UNKNOWN', 185)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC5084041	10/2016	S37-PMC5084041	['materials and methods\nthe gravid study was DESIGNED TO INVESTIGATE the ASSOCIATION of Vitamin D status during Pregnancy with Preeclampsia and Pregnancy-induced hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 125, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
PMC5084041	10/2016	S69-PMC5084041	['variables included in multivariate analyses were selected on the basis of biological PLAUSIBILITY; the POTENTIAL DETERMINANTS of Vitamin D deficiency at t1 were season, Clothing style, recent travel to <35° n, sun-seeking behaviour, Vitamin D supplement use (including multivitamin supplements containing Vitamin D), Vitamin D intake (from oily fish and Milk), origin, bmi at t1, tobacco use at t1 and age.']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_2002051', 'scale circulus', 169, 'clothing'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('UBERON_0001913', 'milk', 354, 'milk')]
PMC5084041	10/2016	S116-PMC5084041	['RISK FACTORS for Vitamin D deficiency (25(Oh)D <30 nmol/l) in early Pregnancy were IN LINE WITH PREVIOUS FINDINGS [13,17,27].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 39, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 45, 'D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5084041	10/2016	S136-PMC5084041	['we FOUND that DETERMINANTS of change in season-corrected Vitamin D status were RELATED to sun exposure (sun-Seeking behaviour, clothing style, and travel <35° n), Vitamin D intake (dietary and supplementary) and origin.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007568', 'aging', 107, '-seeking'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5084041	10/2016	S141-PMC5084041	['we FOUND that the ONLY DETERMINANT of change in the subgroup Born in africa and asia was Vitamin D supplement use.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('GO_0007567', 'parturition', 61, 'born'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5084041	10/2016	S156-PMC5084041	['among women Born in africa and asia, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 164)]	3	[('GO_0007567', 'parturition', 12, 'born'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5085625	9/2016	S71-PMC5085625	['[13] who DEMONSTRATED that Vitamin D status CORRELATES significantly with Blood pressure during the first trimester and Gestational systolic Blood pressure trajectory, BUT NOT with the prevalence of gh.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 168)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC5085625	9/2016	S75-PMC5085625	['moreover, the authors searched for a POTENTIAL mechanism EXPLAINING the ASSOCIATION between Vitamin D status and Pregnancy-related hypertensive disorders.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5085625	9/2016	S124-PMC5085625	['DEMONSTRATED that deficiency of Vitamin D MAY PREDISPOSE to gdm.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S126-PMC5085625	['to summarize, the LINK between Vitamin D and Glucose Metabolism REQUIRES FURTHER STUDIES on larger populations of Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('GO_0006006', 'glucose metabolic process', 45, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 114, 'pregnant')]
PMC5090877	11/2016	S76-PMC5090877	['ASSESSED the adequacy of nutrient Intake including proteins, energy, calcium, iron, Folate, and Vitamin C and IDENTIFIED the factors ASSOCIATED with nutrient intake in kenya [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('GO_0007631', 'feeding behavior', 34, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 84, 'folate'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin C')]
PMC5129897	10/2016	S4-PMC5129897	['we used 25(Oh)D concentration–health outcome RELATIONS for Breast cancer and Cardiovascular disease and results of clinical trials with Vitamin D for Respiratory infections and Musculoskeletal disorders to ESTIMATE the reductions in disease BURDEN for increased 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 206), ('IMPORTANT_CONSIDERATION', 241)]	3	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 14, 'D'), ('UBERON_0000310', 'breast', 59, 'breast'), ('UBERON_0004535', 'cardiovascular system', 77, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory'), ('UBERON_0002204', 'musculoskeletal system', 177, 'musculoskeletal'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D')]
PMC5129897	10/2016	S9-PMC5129897	['table\xa01outlines information SUPPORTING the ROLE of Vitamin D in reducing RISK of those diseases.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 73)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]
PMC5129897	10/2016	S102-PMC5129897	['other health outcomes\nVARIOUS STUDIES have REPORTED beneficial EFFECTS from Vitamin D for several other health outcomes.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5133057	10/2016	S0-PMC5133057	['Serum Retinol levels in Pregnant adolescents and their RELATIONSHIP with habitual Food intake, infection and obstetric, nutritional and socioeconomic variables\n\nabstract\nglobally, Vitamin A deficiency (vad) AFFECTS ABOUT 19.1 million Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 215)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27810', 'resorcinol', 6, 'Retinol'), ('GO_0007565', 'female pregnancy', 24, 'Pregnant'), ('CHEBI_33290', 'food', 82, 'Food'), ('GO_0007601', 'visual perception', 82, 'Food'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin A'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC5137891	12/2016	S143-PMC5137891	['Retinol Binding protein (rbp- a marker of Vitamin A status) was also directly ASSOCIATED with hb (0.27 mg/dl) and with ferritin (0.09 mg/dl), WHEREAS hookworm infection was indirectly ASSOCIATED with hb (-0.11) through rbp and ferritin.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('SUPERFICIAL_RELATIONSHIP', 184)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('PR_000014379', 'ryanodine receptor 3', 0, 'Retinol Binding'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin A')]
PMC5146866	12/2016	S9-PMC5146866	['conclusions\nthe LIKELIHOOD for an infant to be Born with Vitamin D deficiency/insufficiency is relatively high and is RELATED MAINLY to younger maternal age, gravidity, and non-white race/ethnicity.']	[('PROBABLE_UNDERSTANDING', 16), ('SUPERFICIAL_RELATIONSHIP', 118), ('PROBABLE_UNDERSTANDING', 126)]	3	[('GO_0007567', 'parturition', 47, 'born'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5146866	12/2016	S25-PMC5146866	['improved understanding of FACTORS ASSOCIATED with development of Vitamin D deficiency/ insufficiency will facilitate the creation and implementation of appropriate preventive STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 34), ('FUTURE_WORK', 175)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC5146866	12/2016	S67-PMC5146866	['inclusion of maternal race/ethnicity (white vs. non-white), age, and gravidity in the multiple regression models REVEALED INDEPENDENT ASSOCIATION of Vitamin D deficiency and insufficiency in the infant’s cb with non-white maternal race/ethnicity, younger age, and increased number of Pregnancies (table\xa01).']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 284, 'pregnancies')]
PMC5146866	12/2016	S70-PMC5146866	['a comparable magnitude of the INDEPENDENT EFFECT of maternal age and gravidity on Vitamin D status was IDENTIFIED in each race/ethnicity model (data not presented).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 103)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5146866	12/2016	S86-PMC5146866	['we FOUND that INDEPENDENTLY from the race/ethnicity, younger maternal age and increased number of Pregnancies were ASSOCIATED with Vitamin D deficiency and insufficiency in cb of the studied infants.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 98, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5146866	12/2016	S96-PMC5146866	['HOWEVER, there was a TENDENCY for a higher use of phototherapy in infants Born with Vitamin D deficiency as compared to those with Vitamin D sufficiency (5.3 vs. 1.1%, one-sided p \u2009=\u20090.053).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('GO_0007567', 'parturition', 74, 'born'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5146866	12/2016	S99-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, NO PRIOR STUDY has investigated the clinical status of neonates in ASSOCIATION with cb Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5146866	12/2016	S101-PMC5146866	['maternal data that MAY CORRELATE with neonatal Vitamin D levels at Birth, including the pre-Pregnancy weight [35], skin color [13], and sun exposure during Pregnancy [36] were NOT COLLECTED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 176)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 67, 'birth'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy')]
PMC5155676	12/2016	S19-PMC5155676	['RISK FACTORS for Vitamin D insufficiency are WELL DESCRIBED, and include ethnicity, extensive skin covering and liberal use of sun protection, overweight/obesity, low dietary Vitamin D intake, and smoking (1,10,11), in addition to the seasonal variation that is OBSERVED at temperate latitudes (11,12).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 262)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC5155676	12/2016	S100-PMC5155676	['HOWEVER, when Vitamin D replete status was considered as the outcome, ONLY non-white maternal ethnicity and Delivery in winter were significant PREDICTORS of Vitamin D nonreplete status after supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'delivery'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5155676	12/2016	S118-PMC5155676	['hollis et al SIMILARLY FOUND that EVEN with 4000 iu/d Vitamin D during Pregnancy, african-american women had lower 25(Oh)D in late Pregnancy than caucasian or hispanic women (10).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 34)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 121, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5155676	12/2016	S127-PMC5155676	['as baseline 25(Oh)D was ASSOCIATED with the LIKELIHOOD of achieving Vitamin D replete status, it is LIKELY that women with very low levels of 25(Oh)D at baseline will require a higher supplementation dose to achieve Vitamin D repletion.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 100)]	3	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 144, '(OH)D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC5264377	7/2016	S20-PMC5264377	['there is a direct ASSOCIATION between Vitamin D levels and Fertilization rates in DIFFERENT Animal MODELS (panda et al ., 2001;luk et al ., 2012).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0009566', 'fertilization', 59, 'fertilization'), ('NCBITaxon_33208', 'Metazoa', 92, 'animal')]
PMC5264377	7/2016	S21-PMC5264377	['in Humans, the ROLE of Vitamin D in Fertilization, Embryo quality and Implantation is STILL CONTROVERSIAL (terushkin et al ., 2010;aleyasin et al ., 2011;rudick et al ., 2012;aflatoonian et al ., 2014;paffoni et al ., 2014;polyzos et al ., 2014).']	[('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0009566', 'fertilization', 36, 'fertilization'), ('UBERON_0000922', 'embryo', 51, 'embryo'), ('GO_0007566', 'embryo implantation', 70, 'implantation')]
PMC5264377	7/2016	S36-PMC5264377	['EVEN THOUGH tian FOUND a positive ASSOCIATION between maternal Vitamin D levels and infant weight at Birth, Vitamin D supplementation for Pregnant women with low Serum levels of 25(Oh)D3 failed to improve Birth weight outcomes.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_32029', 'potassium acetate', 180, '(OH)D3'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 183, ')D3'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC5264377	7/2016	S37-PMC5264377	['IN FACT, the benefits ASSOCIATED with Gestational Vitamin D supplementation are debatable, and MORE RESEARCH IS WARRANTED (dalgard et al ., 2016;dressler et al ., 2016).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 95)]	3	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5310660	1/2017	S52-PMC5310660	['in Animal models, Gestational Vitamin D deficiency AFFECTS Brain Development [23], and the myelination process [24], and it COULD have an EFFECT on Retinal Cells.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('GO_0007565', 'female pregnancy', 18, 'gestational'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007420', 'brain development', 59, 'brain development'), ('UBERON_0000955', 'brain', 59, 'brain'), ('CL_0009004', 'retinal cell', 148, 'retinal cells'), ('UBERON_0000966', 'retina', 148, 'retinal')]
PMC5322422	2/2017	S121-PMC5322422	['our case also LED to an educational opportunity on the CRITICAL IMPORTANCE of Vitamin K prophylaxis at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 64)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin K'), ('GO_0007567', 'parturition', 103, 'birth')]
PMC5332602	3/2017	S182-PMC5332602	['this is IN AGREEMENT with the uniform suppression of the various innate Immune parameters evaluated in THIS STUDY and ASSOCIATED with protein deficiency versus concurrent up- or downregulation of those in Vitamin A-deficient Pigs (31).']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('UBERON_0002405', 'immune system', 72, 'immune'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 225, 'pigs')]
PMC5340372	3/2017	S0-PMC5340372	['low Cord-Serum 25-Hydroxyvitamin D levels are ASSOCIATED with poor Lung function performance and increased Respiratory infection in infancy\n\nabstract\n\nbackground\nPerinatal Vitamin D deficiency is ASSOCIATED with a higher RISK of wheezing in childhood.']	[('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 196), ('IMPORTANT_CONSIDERATION', 221)]	3	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 15, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 67, 'lung'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('GO_0036268', 'swimming', 162, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 162, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC5340372	3/2017	S1-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Lung function in infancy has NOT BEEN INVESTIGATED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002048', 'lung', 55, 'lung')]
PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
PMC5340372	3/2017	S25-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Respiratory function during infancy has NOT YET been clarified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 95)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 55, 'respiratory')]
PMC5340372	3/2017	S26-PMC5340372	['the primary PURPOSE of this study was TO INVESTIGATE the EFFECT of Perinatal Vitamin D levels on the performance of Respiratory function in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 116, 'respiratory')]
PMC5340372	3/2017	S130-PMC5340372	['HOWEVER, the exact ASSOCIATION between single Cord-Serum Vitamin D level and Postnatal immunity is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('FULL_UNKNOWN', 99)]	3	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'postnatal')]
PMC5351212	3/2017	S26-PMC5351212	['besides its ROLE in schizophrenia etiology, there is a GROWING body of EVIDENCE LINKING Vitamin D deficiency with autism [23].']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5351212	3/2017	S28-PMC5351212	['most RECENTLY, we HAVE SHOWN that low levels of Vitamin D at Birth are ASSOCIATED with increased incidence of autism in children [26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 61, 'birth')]
PMC5368580	4/2017	S30-PMC5368580	['samples were analyzed for Retinol (Vitamin A), Tocopherol (Vitamin E), Thiamin (Vitamin B-1), riboflavin (Vitamin B-2), Nicotinamide (Vitamin B-3), Vitamin B-6, and Vitamin B-12 to examine 1 ) within-Feeding variation, 2 ) Circadian variation and contributions DUE TO subject variability, 3 ) acute short-term EFFECTS of maternal supplementation on milk Vitamin concentrations, and 4 ) the OPTIMAL time for collection to determine which Milk samples best represented the daily median Vitamin concentrations in Milk.']	[('PROBLEM_COMPLICATION', 261), ('SUPERFICIAL_RELATIONSHIP', 310), ('IMPORTANT_CONSIDERATION', 390)]	3	[('CHEBI_26536', 'retinoic acid', 26, 'retinol'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_27013', 'tocopherol', 47, 'tocopherol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E'), ('CHEBI_26948', 'vitamin B1', 71, 'thiamin'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 88, 'B'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 90, '1'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin B'), ('CHEBI_17154', 'nicotinamide', 120, 'nicotinamide'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-3'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 148, 'vitamin B-6'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 200, 'feeding'), ('GO_0051216', 'cartilage development', 223, 'circadian'), ('CHEBI_33229', 'vitamin (role)', 354, 'vitamin'), ('UBERON_0001913', 'milk', 437, 'milk'), ('CHEBI_33229', 'vitamin (role)', 484, 'vitamin'), ('UBERON_0001913', 'milk', 510, 'milk')]
PMC5368580	4/2017	S185-PMC5368580	['the Regulation of fat-soluble Vitamins A and E APPEARS TO occur through a specific transport system independent from Lipid Transfer, but the mechanisms INVOLVED have not been revealed (36,37).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 47), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('CHEBI_27300', 'vitamin D', 30, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 30, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('CHEBI_18059', 'lipid', 117, 'lipid'), ('GO_0060986', 'endocrine hormone secretion', 117, 'lipid transfer')]
PMC5372327	3/2017	S52-PMC5372327	['Vitamin D trials are RARE and they have not been able to SUPPORT beneficial EFFECTS of Vitamin D supplementation on Cognitive functions among Adults [47,48].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0050890', 'cognition', 116, 'cognitive'), ('UBERON_0007023', 'adult organism', 142, 'adults')]
PMC5372327	3/2017	S59-PMC5372327	['Genome-wide association studies on Vitamin D insufficiency IDENTIFIED a number OF common Genetic variants that INFLUENCE 25-Ohd concentrations and the risk of insufficiency [54].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('SO_0001026', 'genome', 0, 'Genome'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_72765', 'verruculogen', 121, '25-OHD')]
PMC5372327	3/2017	S64-PMC5372327	['vdr polymorphisms together with Vitamin D supplementation AFFECT bone Mineral accrual SUGGESTING that Vitamin D supplementation COULD BE used to change the developmental trajectory and induce phenotype with lowered risk for chronic disease or disorder [59,60].']	[('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 128)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_46662', 'mineral', 70, 'mineral'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5372327	3/2017	S123-PMC5372327	['to date, epidemiological studies and randomised intervention trials have DEMONSTRATED CONFLICTING results on, for example, the EFFECT of Vitamin D supplementation on childhood infections and on Neurocognitive functioning.']	[('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 194, 'neurocognitive')]
PMC5372327	3/2017	S135-PMC5372327	['HOWEVER, DUE TO the randomised controlled study design our study will provide valuable data on the EFFECTS of Vitamin D substitution in populations with variable Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5372327	3/2017	S136-PMC5372327	['in addition, the study is designed to have control over the most common sources of Vitamin D.\nIF the results from the vidi-trial CONFIRM the connections between the increased dose of Vitamin D and the primary outcomes, the health benefits gained by a population-wide supplementation with higher Vitamin D dose — a simple and low-cost INTERVENTION — are obvious.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5385921	4/2017	S1-PMC5385921	['the ASSOCIATION between Vitamin D deficiency during Gestation, a CRITICAL period in Neurodevelopment, and asd is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 65), ('FULL_UNKNOWN', 113)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('GO_0007399', 'nervous system development', 84, 'neurodevelopment')]
PMC5385921	4/2017	S2-PMC5385921	['AIMS\nTO DETERMINE the ASSOCIATION between Gestational Vitamin D status and asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 22)]	3	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5385921	4/2017	S132-PMC5385921	['DEFINING the precise CRITICAL window during which developmental Vitamin D deficiency adversely AFFECTS Brain Development at this stage would be premature.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007420', 'brain development', 103, 'brain development'), ('UBERON_0000955', 'brain', 103, 'brain')]
PMC5405075	4/2017	S8-PMC5405075	['the PREVENTION of Asthma Development is one of the MANY POTENTIAL health benefits of Vitamin D (6).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	3	[('GO_0035801', 'adrenal cortex development', 18, 'asthma development'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5405075	4/2017	S28-PMC5405075	['AS a result, Vitamin D deficiency during Pregnancy exerts SIGNIFICANT IMPACT on Vitamin D status of newborns and subsequently on early Childhood (9,28).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0013628', 'pollical pad', 135, 'childhood')]
PMC5405075	4/2017	S34-PMC5405075	['maternal Vitamin D status and ASSOCIATIONS with asthma in early Life\nthe PUTATIVE EFFECT of Prenatal exposure to Vitamin D on asthmatic phenotypes in early Life has been initially investigated via observational studies based on either maternal dietary Intake of Vitamin D or 25(Oh)D levels in Venous maternal and/or Cord Blood [reviewed in ref.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 73), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'Life'), ('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life'), ('GO_0007631', 'feeding behavior', 252, 'intake'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 275, '25(OH)D'), ('UBERON_0001638', 'vein', 293, 'venous'), ('UBERON_0002240', 'spinal cord', 316, 'cord'), ('UBERON_0000178', 'blood', 321, 'blood')]
PMC5405075	4/2017	S36-PMC5405075	['mainly, the Food-approached studies have SUGGESTED a PROTECTIVE ROLE of Vitamin D Intake on the Development Of Wheezing and Asthma in offspring, with an attenuated effect after adjustment for multiple covariables (43–48).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_33290', 'food', 12, 'food'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007631', 'feeding behavior', 82, 'intake'), ('GO_0098789', 'pre-mRNA cleavage required for polyadenylation', 96, 'development of wheezing'), ('GO_0006953', 'acute-phase response', 124, 'asthma')]
PMC5410409	4/2017	S64-PMC5410409	['the CONFLICTING results MAY reflect Genetic variability in the general population in the Metabolism and allergy preventive EFFECTS of Vitamin D supplementation in the child [67].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('SO_0000704', 'gene', 36, 'genetic'), ('GO_0008152', 'metabolic process', 89, 'metabolism'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5418719	5/2017	S0-PMC5418719	['efficacy and SAFETY of early supplementation with 800\xa0iu of Vitamin D in very preterm infants followed by underlying levels of Vitamin D at Birth\n\nabstract\n\nbackground\nto determine the EFFICACY and SAFETY of early supplementation with 800\xa0iu of Vitamin D in very low Birth weight (vlbw) infants.']	[('IMPORTANT_CONSIDERATION', 13), ('SUPERFICIAL_RELATIONSHIP', 185), ('IMPORTANT_CONSIDERATION', 198)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007567', 'parturition', 140, 'birth'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth')]
PMC5418719	5/2017	S10-PMC5418719	['DUE TO the POTENTIAL IMPACT of Vitamin D on many developmental processes in preterm infants, jobe et al.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5418719	5/2017	S41-PMC5418719	['TO EVALUATE the EFFECT of the course of prematurity on Vitamin D status, we EVALUATED Respiratory Distress syndrome (rds), patent Ductus Arteriosus (pda), necrotizing enterocolitis (nec\u2009≥\u2009grade 2), sepsis (clinical or proven), bronchopulmonary dysplasia (bpd, ≥ moderate), retinopathy of prematurity, Intraventricular hemorrhage (ivh\u2009≥\u2009grade 2), type of infant formula, ventilation days, hospital days and total parenteral nutrition days.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0003495', 'respiratory system arteriole', 86, 'respiratory distress'), ('UBERON_0002254', 'thyroglossal duct', 130, 'ductus arteriosus'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 301, 'intraventricular')]
PMC5418719	5/2017	S96-PMC5418719	['moreover, INADEQUATE Vitamin D levels in Cord Blood are ASSOCIATED with Immune status and the prevalence of SEVERE Respiratory Tract infections in the first year of Life, as well as reduced bone density during childhood [18–20].']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0009472', 'axilla', 41, 'cord blood'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('UBERON_0000065', 'respiratory tract', 115, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC5418719	5/2017	S130-PMC5418719	['preterm infants with these diseases MAY more LIKELY to have low Vitamin D levels INVOLVED in impaired Vitamin D absorption or Metabolism during hospitalization.']	[('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0008152', 'metabolic process', 126, 'metabolism')]
PMC5426325	4/2017	S5-PMC5426325	['we ADDRESSED the POTENTIAL modification of the EFFECT of Vitamin D availability by season of Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 93, 'birth')]
PMC5426325	4/2017	S11-PMC5426325	['the study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from a mandatory fortification programme of 1·25 µg Vitamin D/100 g Margarine was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 224)]	3	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_6784', 'mestranol', 145, 'margarine'), ('GO_0007567', 'parturition', 248, 'birth')]
PMC5426325	4/2017	S117-PMC5426325	['the study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from fortification was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 165)]	3	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 189, 'birth')]
PMC5426325	4/2017	S135-PMC5426325	['the RELATIONSHIP between Vitamin D status during fetal Life and long-term bone health has not previously been widely examined, and results from earlier observational studies SHOWED EITHER no association or a direct association.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 55, 'life')]
PMC5426325	4/2017	S146-PMC5426325	['from systematic review and meta-analysis of randomised controlled trials, THERE IS EVIDENCE that Vitamin D-fortified Foods GENERALLY improve Vitamin D status among both children and Adults in a dose-DEPENDENT manner(57–59).']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 123), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0007023', 'adult organism', 182, 'adults')]
PMC5473979	6/2017	S20-PMC5473979	['several Micronutrients such as iron, zinc, Folate, Vitamin B-6, B-12, Calcium, Selenium, and N-3 Fatty Acids have BEEN LINKED to maternal mental health and wellbeing [9,10] HOWEVER, much of the work to date has focused on the Postpartum period.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 173)]	3	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 43, 'folate'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 51, 'vitamin B-6'), ('PR_000004770', 'Polycomb complex protein BMI-1', 64, 'B-12'), ('CHEBI_22313', 'alkaline earth metal atom', 70, 'calcium'), ('CHEBI_27568', 'selenium atom', 79, 'selenium'), ('CHEBI_30256', 'thiocarbonyl group', 93, 'n-3'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids'), ('GO_0007565', 'female pregnancy', 226, 'postpartum')]
PMC5474873	6/2017	S17-PMC5474873	['EVIDENCE now LINKS low Vitamin D levels with reduced Cognitive performance (8), INCREASED RISK for cancer, diabetes, Cardiovascular disease, and premature death (9,10).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0050890', 'cognition', 53, 'cognitive'), ('UBERON_0004535', 'cardiovascular system', 117, 'cardiovascular')]
PMC5474873	6/2017	S138-PMC5474873	['discussion\nin the nordic countries, as elsewhere, sun exposure is by far the most IMPORTANT source of Vitamin D. in a population-based cohort of over 30,000 women, we FOUND an ASSOCIATION between cumulative measures of sun exposure at ages 10–39\u2009years and positive pes later in Life.']	[('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000104', 'life cycle', 278, 'life')]
PMC5474873	6/2017	S140-PMC5474873	['the u-shaped ASSOCIATION is CONSISTENT with PREVIOUS STUDIES on Vitamin D and health outcomes (18).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5474873	6/2017	S172-PMC5474873	['FOUND that questionnaire-based reports of sun exposure was CONSIDERED a strong PREDICTOR of Vitamin D (51).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5474873	6/2017	S173-PMC5474873	['the same study FURTHER REPORTED that “staying at more southern latitudes during the previous summer was also positively ASSOCIATED with Vitamin D in the Blood” (51) (sun exposure self-reports included in the present study consist of questions related to time spent on sunny holidays in southern latitudes).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0000178', 'blood', 153, 'blood')]
PMC5485024	3/2017	S139-PMC5485024	['a cumulative EFFECT of Genetic susceptibility in Glutathione S‐Transferase Mu 1 ( Gstm1 ), Gstp1 and Nad(P)H dehydrogenase, Quinone 1 ( Nqo1 ) polymorphisms and low dietary Vitamin C intake HAS BEEN ASSOCIATED with decreased Lung function in asthmatic children28.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('SO_0000704', 'gene', 23, 'genetic'), ('CHEBI_16856', 'glutathione', 49, 'glutathione'), ('PR_000008320', 'general transcription factor IIH subunit 4', 49, 'glutathione S‐transferase mu 1'), ('PR_000008296', 'glutathione S-transferase A3', 82, 'GSTM1'), ('PR_000008294', 'glutathione S-transferase A1', 91, 'GSTP1'), ('CHEBI_13392', 'NAD(P)H', 101, 'NAD(P)H'), ('PR_000010999', 'N-acetyltransferase 14', 101, 'NAD ...'), ('3', 'A2MP1', 104, '(P'), ('PR_000004770', 'Polycomb complex protein BMI-1', 122, ', quinone 1'), ('CHEBI_36141', 'quinone', 124, 'quinone'), ('PR_000011339', 'RNA-binding protein Nova-1', 136, 'NQO1'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C'), ('UBERON_0002048', 'lung', 225, 'lung')]
PMC5489519	6/2017	S15-PMC5489519	['it HAS BEEN REPORTED that Vitamin D is INVOLVED in Mammary Gland Development and Lactation11.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0060611', 'mammary gland fat development', 51, 'mammary gland development'), ('UBERON_0001911', 'mammary gland', 51, 'mammary gland'), ('GO_0007595', 'lactation', 81, 'lactation11')]
PMC5489519	6/2017	S18-PMC5489519	['THEREFORE, Vitamin D deficient mothers are more LIKELY to have infants with Vitamin D deficiency which AFFECTS Immune and bone health16.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002405', 'immune system', 111, 'immune')]
PMC5489519	6/2017	S31-PMC5489519	['results\n\nVitamin D deficiency in mothers increases Trail Expression in Breast Milk\nphysiologic levels of Vitamin D HAS BEEN IMPLICATED as an IMPORTANT stimulant for Innate Immunity and Bone Remodeling.']	[('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 51, 'TRAIL'), ('GO_0010467', 'gene expression', 57, 'expression'), ('UBERON_0000310', 'breast', 71, 'breast'), ('UBERON_0001913', 'milk', 78, 'milk'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0045087', 'innate immune response', 165, 'innate immunity'), ('GO_0046849', 'bone remodeling', 185, 'bone remodeling')]
PMC5489519	6/2017	S87-PMC5489519	['THEREFORE, our results INDICATE that Trail\xa0is Expressed in Breast Milk as a FUNCTION of Vitamin D status in mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 37, 'TRAIL'), ('GO_0010467', 'gene expression', 46, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 59, 'breast milk'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5489519	6/2017	S99-PMC5489519	['THEREFORE, elevated levels of Trail Expression due to Vitamin D deficiency MAY have a significant IMPACT on both mother and infant bone Growth/Development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0040007', 'growth', 136, 'growth'), ('GO_0008289', 'lipid binding', 143, 'development')]
PMC5489519	6/2017	S106-PMC5489519	['this evidence SUGGESTS that Vitamin D and Trail Expression in Mammalian cells play a MAJOR ROLE in both mother and infant Immune health.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 85), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 42, 'TRAIL'), ('GO_0010467', 'gene expression', 48, 'expression'), ('NCBITaxon_40674', 'Mammalia', 62, 'mammalian'), ('UBERON_0002405', 'immune system', 122, 'immune')]
PMC5489519	6/2017	S112-PMC5489519	['THEREFORE, IT IS POSSIBLE that elevated levels of Trail INFLUENCE Vitamin D Metabolism in Mammary Epithelial Cells45.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 50, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 66, 'vitamin D metabolism'), ('CL_0002327', 'mammary gland epithelial cell', 90, 'mammary epithelial cells45'), ('UBERON_0006954', 'mammary gland myoepithelium', 90, 'mammary epithelial')]
PMC5513133	7/2017	S32-PMC5513133	['caption (table-wrap): table 1\n\nsummary of effects of increased Vitamin D on the pathogenesis of pre-eclampsia (pe)stage of pecharacteristic of pe↑ Vitamin dstage 1inflammation-linked abnormal Placental Implantation↓ predisposition to pro-inflammatory response [20]↑ Regulation of Genes associated with Placental invasion and normal Implantation [20]stage 2vascular Endothelial dysfunction↑ Vascular structure, elasticity and Intima-Media thickness↓ Blood pressure (Regulation of Renin-angiotension system) [63]↓oxidative stress [24]proteinuria mediated by Renal Vascular Endothelial Growth Factor (Vegf)↑ Vascular Smooth Muscle Cell Proliferation by increasing vegf Gene transcription [19]\n\nbiological PLAUSIBILITY of the ROLE of Vitamin D in pe\nVitamin D3, or Cholecalciferol, is formed endogenously when 7-Dehydrocholesterol in Keratinocytes is converted to a seco-Steroid pro-hormone upon irradiation by uv-b light.']	[('INCOMPLETE_EVIDENCE', 702), ('PROBABLE_UNDERSTANDING', 702), ('SUPERFICIAL_RELATIONSHIP', 722)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 147, 'Vitamin'), ('UBERON_0001987', 'placenta', 192, 'placental'), ('GO_0007566', 'embryo implantation', 202, 'implantation'), ('GO_0007567', 'parturition', 214, '↓'), ('GO_0065007', 'biological regulation', 266, 'Regulation'), ('SO_0000704', 'gene', 280, 'genes'), ('UBERON_0001987', 'placenta', 302, 'placental'), ('GO_0007566', 'embryo implantation', 332, 'implantation'), ('UBERON_0001986', 'endothelium', 365, 'Endothelial'), ('GO_0031674', 'I band', 390, 'Vascular'), ('GO_0005622', 'intracellular anatomical structure', 425, 'intima'), ('UBERON_0009472', 'axilla', 425, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 432, 'media'), ('UBERON_0000178', 'blood', 449, 'Blood'), ('GO_0065007', 'biological regulation', 465, 'regulation'), ('PR_000014368', 'RuvB-like 1', 479, 'renin'), ('UBERON_0002113', 'kidney', 556, 'renal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 562, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 571, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 598, 'VEGF'), ('CL_0000359', 'vascular associated smooth muscle cell', 605, 'Vascular smooth muscle cell'), ('UBERON_0006849', 'scapula', 605, 'Vascular'), ('UBERON_0001135', 'smooth muscle tissue', 614, 'smooth muscle'), ('GO_0007601', 'visual perception', 621, 'muscle'), ('GO_0008283', 'cell proliferation', 628, 'cell proliferation'), ('SO_0000704', 'gene', 666, 'gene'), ('CHEBI_27300', 'vitamin D', 730, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 746, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 746, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 761, 'cholecalciferol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 806, '7-dehydrocholesterol'), ('CL_0000312', 'keratinocyte', 830, 'keratinocytes'), ('CHEBI_35341', 'steroid', 867, 'steroid')]
PMC5513133	7/2017	S47-PMC5513133	['it is PLAUSIBLE that a deficiency in Vitamin D and its downstream products CAN play a ROLE in the etiology of pe.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5513133	7/2017	S53-PMC5513133	['role of Vitamin D as an Anti-Inflammatory Agent and Immune modulator\nVitamin D IS THOUGHT TO play a significant ROLE in pe as an Immune modulator [20,50].']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 112)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_67079', 'anti-inflammatory agent', 24, 'anti-inflammatory agent'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CHEBI_28384', 'vitamin K', 69, 'Vitamin D'), ('UBERON_0002405', 'immune system', 129, 'immune')]
PMC5513133	7/2017	S72-PMC5513133	['role of Vitamin D and Blood Pressure Regulation\nan inverse RELATIONSHIP between Plasma 1,25(Oh)2D and Plasma Renin activity HAS BEEN OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0060208', 'proestrus', 28, 'pressure'), ('GO_0065007', 'biological regulation', 37, 'regulation'), ('UBERON_0001969', 'blood plasma', 80, 'plasma'), ('CHEBI_82784', 'PVP38-Ag NP', 87, '1,25(OH)2D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('PR_000014368', 'RuvB-like 1', 109, 'renin')]
PMC5513133	7/2017	S87-PMC5513133	['it is also OBSERVED that calcium sufficiency MAY occur INDEPENDENTLY of Vitamin D sufficiency.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5513133	7/2017	S92-PMC5513133	['methods\n\nsearch strategy\nthe review protocol was designed a priori to answer the QUESTION, “WHAT are the EFFECTS of Vitamin D concentrations and supplementation during Pregnancy on pre-eclampsia in women?” we conducted a literature search using medline electronic databases (via pubmed) to identify published studies until february 2015.']	[('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy')]
PMC5513133	7/2017	S129-PMC5513133	['germany, 2–14 [85]case control20 – women with peat Delivery43 – healthy Pregnant controls\u2003mohaghegh et al., iran, 2015 [89]case control41 -- women with pe 50 – healthy Pregnant controlstime of labor\u2003powe, usa, 2010 [86]nested case control39 -- developed pe 131 – healthy Pregnant controls1st Trimester\u2003robinson et al., usa, 2010 [25]case control50 -- women with eospe29\xa0weeks Gestation100 – healthy Pregnant controls\u2003schneuer et al., australia, 2014 [114]nested case control5109 Pregnant women (223 with pe and 29/223 with eospe)10–14\xa0weeks Gestation\u2003singla et al., india, 2015 [87]case control74 -- nulliparous women with pe>30\xa0weeks Gestation100 -- healthy nulliparous controls\u2003ullah et al., bangladesh, 2013 [82]case control33 -- women with pe>20\xa0weeks Gestation79 – normal Pregnancy controls\u2003wetta et al., uk, 2013 [96]case control100 -women with pe15–21\xa0weeks Gestation200 – healthy Pregnant controls\u2003woodham et al., usa, 2011 [15]nested case control41 – women with severe pe2nd trimester121 – uncomplicated birth controls\u2003xu et al., usa, 2014 [53]case control100 – women with pe≤ 24\xa0weeks Gestation100 – uncomplicated Birth controls\u2003yu et al., uk, 2012 [115]case control60 –late pe11–13\xa0weeks Gestation30 –early pe1000 – healthy controlsretrospective cohort study\u2003alvarez-fernandez et al., spain, 2014 [90]retrospective cohort257 -- women attending obstetric triage with suspicion of pe1st trimester and 20\xa0weeks of Gestation\u2003scholl et al., usa, 2013 [78]retrospective cohort1141 -- low income and minority Pregnant womenentry to care (mean 13.7\xa0±\xa05.7\xa0weeks)prospective cohort studies\u2003burris et al., usa, 2014 [94]prospective cohort1591 -- Pregnant women16.4–36.9\xa0weeks Gestation\u2003haugen et al., norway, 2000 [77]prospective cohort23,423 -- Pregnant womenvitamin D intake at weeks 15, 22, and 30 Gestation\u2003shand et al., canada, 2010 [37]prospective cohort221 -- women at risk for pe10–20\xa0weeks Gestation\u2003wei et al., canda 2012 [60]prospective cohort697 -- Pregnant women receiving Vitamin C and e supplementation for the PREVENTION of pe12–18\xa0weeks Gestation, 24-26 weeks Gestation\u2003wei, canada, 2013 [14]prospective cohort697 -- Pregnant women receiving Vitamin C and e supplementation for the PREVENTION of pe24–26\xa0weeks Gestation\u2003zhou, china, 2014 [116]prospective cohort74 – women with pe16–20 weeks\xa0Gestation\n\ncaption (table-wrap): table 3\n\nASSOCIATION between Vitamin D and pre-eclampsia (pe) in observational studiesauthor, location, yearkey findingsresultsaugust et al., usa, 1992 [88]↓ 1,25Oh2D in women with pe vs chronic htn and normal women1,25 Oh2D levels:pe: 37.8 +/− 15\xa0pg/ml chronic htn: 75 +/− 15\xa0pg/ml ( p \xa0<\xa00.05); normal women: 65 +/− 10\xa0pg/ml ( p \xa0<\xa00.05)fernandez- alonzo et al., spain, 2012 [97]↔ Pe and 25(Oh)D levels25(Oh)D: <49.9\xa0nmol/l: 28.6% (2/7 women); 49.9–74.9\xa0nmol/l: 42.9% (3/7 women); ≥ 74.9\xa0nmol/l: 28.6% (2/7 women) ( p \xa0=\xa00.91)pena hr, et al.']	[('SUPERFICIAL_RELATIONSHIP', 2026), ('SUPERFICIAL_RELATIONSHIP', 2199), ('SUPERFICIAL_RELATIONSHIP', 2350)]	3	[('GO_0007567', 'parturition', 51, 'delivery43'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('GO_0007565', 'female pregnancy', 271, 'pregnant'), ('GO_0009294', 'DNA mediated transformation', 292, 'trimester'), ('GO_0007565', 'female pregnancy', 376, 'gestation100'), ('GO_0007565', 'female pregnancy', 399, 'pregnant'), ('GO_0007565', 'female pregnancy', 479, 'pregnant'), ('GO_0007565', 'female pregnancy', 541, 'gestation'), ('GO_0007565', 'female pregnancy', 635, 'gestation100'), ('GO_0007565', 'female pregnancy', 756, 'gestation79'), ('GO_0007565', 'female pregnancy', 777, 'pregnancy'), ('GO_0007565', 'female pregnancy', 865, 'gestation200'), ('GO_0007565', 'female pregnancy', 888, 'pregnant'), ('GO_0007565', 'female pregnancy', 1095, 'gestation100'), ('GO_0007567', 'parturition', 1124, 'birth'), ('GO_0007565', 'female pregnancy', 1199, 'gestation30'), ('GO_0007565', 'female pregnancy', 1422, 'gestation'), ('GO_0007565', 'female pregnancy', 1513, 'pregnant'), ('GO_0007565', 'female pregnancy', 1646, 'pregnant'), ('GO_0007565', 'female pregnancy', 1676, 'gestation'), ('GO_0007565', 'female pregnancy', 1746, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1768, 'D'), ('GO_0007565', 'female pregnancy', 1801, 'gestation'), ('GO_0007565', 'female pregnancy', 1899, 'gestation'), ('GO_0007565', 'female pregnancy', 1961, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1986, 'vitamin C'), ('GO_0007565', 'female pregnancy', 2054, 'gestation'), ('GO_0007565', 'female pregnancy', 2077, 'gestation'), ('GO_0007565', 'female pregnancy', 2134, 'pregnant'), ('CHEBI_27300', 'vitamin D', 2159, 'vitamin C'), ('GO_0007565', 'female pregnancy', 2227, 'gestation'), ('GO_0007565', 'female pregnancy', 2308, 'gestation'), ('CHEBI_27300', 'vitamin D', 2370, 'vitamin D'), ('CHEBI_72639', '13-HODE', 2501, '25OH2D'), ('CHEBI_72639', '13-HODE', 2558, '25 OH2D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2724, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2731, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 2747, '(OH)D')]
PMC5513133	7/2017	S138-PMC5513133	['OBSERVATIONAL studies which measured Vitamin D status after the onset of pe [53,82] near Delivery [83] or at Delivery [84,85] SUGGEST an inverse ASSOCIATION with pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 145)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'delivery'), ('GO_0007567', 'parturition', 109, 'delivery')]
PMC5513133	7/2017	S147-PMC5513133	['CORRELATION between low Serum Vitamin D in women with established pe was also FOUND in studies in which populations had specific RISK factors for Vitamin D deficiency such as race or seasonal sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5513133	7/2017	S157-PMC5513133	['two studies of Vitamin D in pe cases have evaluated the POSSIBLE RELATIONSHIP with Angiogenic FACTORS.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0001525', 'angiogenesis', 83, 'angiogenic')]
PMC5513133	7/2017	S165-PMC5513133	['there HAVE BEEN a SMALL NUMBER OF clinical trials studying ASSOCIATIONS between maternal Vitamin D and hypertensive disorders in Pregnancy (table4).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5513133	7/2017	S166-PMC5513133	['in a 50-year-old controlled trial of 5644 women, olsen & secher ASSESSED the PREVENTIVE EFFECT of a multi-Vitamin Mineral supplement, which included iron, Calcium, Iodine, manganese, copper, Vitamin B Complex, Vitamin C, and 260\xa0mg/day of calcium and halibut Liver oil containing 2500\xa0iu/g Vitamin D per day.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 88)]	3	[('CHEBI_46674', 'lizardite', 106, 'vitamin mineral'), ('CHEBI_22313', 'alkaline earth metal atom', 155, 'calcium'), ('CHEBI_24859', 'iodine atom', 164, 'iodine'), ('CHEBI_75427', 'deuterated fatty acid', 191, 'vitamin B complex'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin C'), ('UBERON_0002107', 'liver', 259, 'liver'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC5513133	7/2017	S177-PMC5513133	['RETROSPECTIVELY ANALYZED Vitamin D status and the risk of pe in 697 nulliparous women with singleton Pregnancies in a randomized, placebo-controlled trial of vitamin c and e supplementation for the PREVENTION of pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancies')]
PMC5513133	7/2017	S247-PMC5513133	['RECENTLY, participants in the Vitamin D for antenatal asthma (vdaart) randomized double-blind placebo controlled trial took a daily dose of 4000\xa0iu Vitamin D supplementation plus a multivitamin with 400\xa0iu Vitamin D or placebo (placebo pill plus a multi-Vitamin with 400\xa0iu Vitamin D daily) TO ASSESS the EFFECT of Vitamin D supplementation on the frequency of pe among Pregnant women with a high risk for atopic disease [110].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('SUPERFICIAL_RELATIONSHIP', 305)]	3	[('CHEBI_28384', 'vitamin K', 30, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 254, 'vitamin'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('GO_0007565', 'female pregnancy', 370, 'pregnant')]
PMC5521778	7/2017	S42-PMC5521778	['we HYPOTHESIZED that: ( a ) bco1 activity provides a local source for Pulmonary Retinoid Synthesis, and ( b ) gc alters Pulmonary EFFECTS of Vitamin A through Regulating Bco1 Expression.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('UBERON_0002048', 'lung', 70, 'pulmonary'), ('CHEBI_26537', 'retinoid', 80, 'retinoid'), ('GO_0016063', 'rhodopsin biosynthetic process', 80, 'retinoid synthesis'), ('UBERON_0002048', 'lung', 120, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 159, 'regulating'), ('PR_000004693', 'Bcl-2-like protein 10', 170, 'BCO1'), ('GO_0010467', 'gene expression', 175, 'expression')]
PMC5524288	7/2017	S112-PMC5524288	['IMPROVING the Vitamin D status of women with underlying conditions MAY AVERT the need for a medically indicated Preterm Delivery.']	[('FUTURE_WORK', 0), ('FUTURE_PREDICTION', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'preterm'), ('GO_0007567', 'parturition', 120, 'delivery')]
PMC5537904	7/2017	S5-PMC5537904	['non-hispanic white race, lower Pre-Pregnancy bmi, higher Prenatal Vitamin D intake, and summer Births were ASSOCIATED with higher Cord Blood 25(Oh)D. higher 25(Oh)D was ASSOCIATED with lower Birthweight ( β = –6.22, p = 0.02), but as maternal bmi increased, this ASSOCIATION became increasingly positive in direction and magnitude ( β = 1.05, p = 0.04).']	[('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 169), ('SUPERFICIAL_RELATIONSHIP', 263)]	3	[('GO_0007568', 'aging', 31, 'pre'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'prenatal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'births'), ('UBERON_0002240', 'spinal cord', 130, 'cord'), ('UBERON_0000178', 'blood', 135, 'blood'), ('CHEBI_63056', 'zinc cation', 141, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 147, 'D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 157, '25(OH ... D'), ('GO_0007596', 'blood coagulation', 191, 'birthweight')]
PMC5537904	7/2017	S8-PMC5537904	['our data CONFIRM the HYPOTHESIS that Vitamin D exposure in early Life is ASSOCIATED with neonatal body size and composition.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000104', 'life cycle', 65, 'life')]
PMC5537904	7/2017	S15-PMC5537904	['Prenatal Vitamin D exposure MAY also INFLUENCE offspring adiposity through reduced availability of the biologically active vitamin d metabolite, 1Α, 25-Dihydroxyvitamin D, which inhibits Parathyroid hormone and Intracellular calcium, thereby AFFECTING Lipogenesis and Lipolysis [9,10,11,12,13].']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 242)]	3	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 145, '1α, 25-dihydroxyvitamin D'), ('UBERON_0001132', 'parathyroid gland', 187, 'parathyroid'), ('GO_0005622', 'intracellular anatomical structure', 211, 'intracellular'), ('GO_0008610', 'lipid biosynthetic process', 252, 'lipogenesis'), ('GO_0016042', 'lipid catabolic process', 268, 'lipolysis')]
PMC5537904	7/2017	S143-PMC5537904	['AS EXPECTED, 25(Oh)D at Birth was PREDICTED by both modifiable (maternal bmi, Prenatal Vitamin D intake) and non-modifiable (race/ethnicity, season of Birth) FACTORS.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 158)]	3	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 19, 'D'), ('GO_0007567', 'parturition', 24, 'birth'), ('GO_0007565', 'female pregnancy', 78, 'prenatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 151, 'birth')]
PMC5546866	8/2017	S15-PMC5546866	['furthermore, ASSOCIATIONS between maternal Vitamin D status and obstetric COMPLICATIONS (4) and offspring Musculoskeletal Development (5–7) HAVE BEEN REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBLEM_COMPLICATION', 74), ('INCOMPLETE_EVIDENCE', 140)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0061375', 'mammillotectal axonal tract development', 106, 'musculoskeletal development'), ('UBERON_0002204', 'musculoskeletal system', 106, 'musculoskeletal')]
PMC5546866	8/2017	S125-PMC5546866	['(11) (15 to 18 nmol/l) than our cohort (9 to 10 nmol/l), BUT this COULD REFLECT the higher Cholecalciferol doses used in those studies and/or alterations in Vitamin D Metabolism and volume of distribution in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_52550', 'theopalauamide', 91, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 157, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
PMC5546866	8/2017	S137-PMC5546866	['we SIMILARLY FOUND that the c Allele was ASSOCIATED with lower achieved 25(Oh)D following Antenatal Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 75, 'OH ... D'), ('GO_0007567', 'parturition', 90, 'antenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5576167	8/2017	S87-PMC5576167	['with regards to OTHER Micronutrients, Vitamin D and Iodine deficiencies HAVE BEEN ASSOCIATED with various fetal and maternal abnormalities [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 52, 'iodine')]
PMC5579643	8/2017	S57-PMC5579643	['HOWEVER, over the last decade, the EFFECTS of Vitamin D on the innate and Adaptive Immune System HAVE BEEN investigated and expanded [20].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051866', 'general adaptation syndrome', 74, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 83, 'immune system')]
PMC5587553	9/2017	S66-PMC5587553	['ON THE OTHER HAND, Antenatal supplementation was FOUND EFFECTIVE when they had iron (n\u2009=\u200910, d 0.05, 95% ci 0.002–0.10, p\u2009=\u20090.04), Vitamins B1, B2, b3, B12(n\u2009=\u200910, d 0.05, 95% ci 0.01–0.10, p\u2009=\u20090.02), and Vitamin C (n\u2009=\u20099, d 0.07, 95% ci 0.02–0.12, p\u2009=\u20090.004).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('GO_0007567', 'parturition', 19, 'antenatal'), ('CHEBI_34993', 'talampicillin hydrochloride', 131, 'vitamins B1'), ('PR_000004693', 'Bcl-2-like protein 10', 140, 'B1'), ('PR_000004693', 'Bcl-2-like protein 10', 144, 'B2'), ('CHEBI_27778', 'abequose', 152, 'B12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC5623264	9/2017	S93-PMC5623264	['multiple Micronutrient supplementation\nthe EFFECT of mmn supplementation on lbw, ptb and sga was assessed in three reviews (see\xa0onlinesupplementary table 8).35–37mmn supplementation provided one RECOMMENDED daily nutrient intake of Vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, Vitamin B12, Folic Acid, Vitamin C, vitamin d, Vitamin E, copper, Selenium and Iodine with iron and zinc to Pregnant women.47a significant reduction of lbw in the range of 11%–14%\u2009and a significant reduction of sga in the range of 10%–17%\u2009could BE observed following mmn supplementation in all three reviews.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('FUTURE_WORK', 195), ('ANOMALY_CURIOUS_FINDING', 532)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin A'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 251, 'B1'), ('CHEBI_18245', 'carboxylato group', 263, 'B2'), ('CHEBI_51231', 'DAPI', 283, 'B6'), ('CHEBI_33279', 'vitamin D5', 287, 'vitamin B12'), ('CHEBI_30751', 'formic acid', 300, 'folic acid'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 353, 'selenium'), ('CHEBI_24859', 'iodine atom', 366, 'iodine'), ('GO_0007565', 'female pregnancy', 395, 'pregnant')]
PMC5623264	9/2017	S122-PMC5623264	['currently, there is NO EVIDENCE that magnesium or Vitamin C supplementation during Pregnancy positively or negatively AFFECT the RISK of ptb, lbw or sga.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin C'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC5634602	10/2017	S0-PMC5634602	['randomized trial of two doses of Vitamin D3In preterm infants <32 weeks: dose IMPACT on achieving desired Serum 25(Oh)D3In a nicu population\n\nabstract\n\nbackground\nRECOMMENDATIONS for Vitamin D supplementation for preterm infants span a WIDE range of doses.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('FUTURE_WORK', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236)]	3	[('CHEBI_33229', 'vitamin (role)', 33, 'vitamin D3in'), ('PR_000017209', 'utrophin', 33, 'vitamin D3in'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('PR_000001883', 'lysosome-associated membrane protein', 112, '25(OH)D3in'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]
PMC5634602	10/2017	S96-PMC5634602	['INITIAL STUDIES of and RECOMMENDATIONS for Vitamin D intake were designed to PREVENT rickets in term infants targeting a Serum 25(Oh)D level of >50 nmol/l [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 127, '25(OH)D')]
PMC5634602	10/2017	S97-PMC5634602	['the preterm population of patients is at high RISK for bone disease of prematurity, and improving Delivery of Vitamin D MAY have a positive IMPACT on bone health.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('GO_0007567', 'parturition', 98, 'delivery'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5634602	10/2017	S98-PMC5634602	['improving Vitamin D ALONE is not adequate to prevent POOR bone mineralization; this physiology is also DEPENDENT on delivery of appropriate amounts and ratios of Calcium and Phosphorus in the parenteral and enteral diet, as well as a patient’s over all nutrition status [21].']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 162, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 174, 'phosphorus')]
PMC5638722	8/2017	S24-PMC5638722	['there are a FEW STUDIES which REPORTED a LINK between Vitamin D deficiency and neonatal sepsis in term infants9).']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5638722	8/2017	S25-PMC5638722	['with the results of the FIRST STUDY, it IS SHOWN that maternal and neonatal Vitamin D is in RELATION with early-onset neonatal sepsis (eos).']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 92)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5638722	8/2017	S29-PMC5638722	['we SOUGHT TO EVALUATE the EFFECT of lower Vitamin D levels in Cord Blood on neonatal sepsis in preterm infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 26)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC5638722	8/2017	S92-PMC5638722	['moreover, there is a preponderance of epidemiological EVIDENCE INDICATING circulating Vitamin D concentrations from Cord Blood CORRELATE.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 116, 'cord'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC5638722	8/2017	S93-PMC5638722	['ONLY FEW STUDIES in the literature, regarding to the RELATIONSHIP between neonatal Vitamin D levels and early onset sepsis are present.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5659607	10/2017	S118-PMC5659607	['this resulted in more power to detect TRUE EFFECTS of the Vitamin D supplementation than the individual intent-to-treat analyses, illustrated by a similar overall effect estimate in the analyses, which now reached statistical SIGNIFICANCE.']	[('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 226)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5659607	10/2017	S130-PMC5659607	['furthermore, including a third trial of Vitamin D supplementation in the meta-analysis, which intervened at a later Pregnancy stage (week 27) and with a much lower dose (800 iu/day) [22] also SHOWED an overall PROTECTIVE EFFECT of Vitamin D on Development Of Asthma/recurrent Wheeze.']	[('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 221)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0009602', 'detection of symbiont', 244, 'development of asthma'), ('GO_0006386', 'termination of RNA polymerase III transcription', 276, 'wheeze')]
PMC5659607	10/2017	S138-PMC5659607	['when the two trials were initiated, IT WAS THOUGHT that the EFFECTS of Vitamin D were confined to the Alveolar stage of Lung Development, occurring in the third Trimester of Pregnancy[28].']	[('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0003215', 'alveolus', 102, 'alveolar'), ('GO_0030324', 'lung development', 120, 'lung development'), ('UBERON_0002048', 'lung', 120, 'lung'), ('GO_0009294', 'DNA mediated transformation', 161, 'trimester'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy')]
PMC5659607	10/2017	S140-PMC5659607	['THEREFORE, initiating the supplementation at 10–18 weeks’ Gestation in vdaart and in particular at 22–26 weeks’ Gestation in copsac2010was PRESUMABLY too late to achieve a maximal EFFECT of Vitamin D on fetal Lung Development.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 180)]	3	[('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007565', 'female pregnancy', 112, 'gestation'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0030324', 'lung development', 209, 'lung development'), ('UBERON_0002048', 'lung', 209, 'lung')]
PMC5664622	9/2017	S16-PMC5664622	['in CONSEQUENCE, season of the year, geographic location and lifestyle have become the KEY FACTORS as far as sources of Vitamin D are concerned.']	[('PROBABLE_UNDERSTANDING', 3), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5664622	9/2017	S126-PMC5664622	['it is CONSISTENT with the national studies, on a representative sample, which have determined the EFFECT of the geographic latitude on Serum Vitamin D concentration to be of minimal IMPORTANCE [37].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 182)]	3	[('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5679631	11/2017	S0-PMC5679631	['INFLUENCE of Vitamin D on key bacterial taxa in infant microbiota in the koala Birth cohort study\n\nabstract\nVitamin D has immunomodulatory properties giving it the POTENTIAL to AFFECT Microbial Colonization Of the Intestinal Tract.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 177)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'Birth'), ('CHEBI_28384', 'vitamin K', 108, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('GO_0042680', 'compound eye cone cell fate determination', 194, 'colonization of ... intestinal tract'), ('UBERON_0001555', 'digestive tract', 214, 'intestinal tract')]
PMC5679631	11/2017	S1-PMC5679631	['we INVESTIGATED WHETHER maternal Vitamin D supplemention, maternal Plasma 25-Hydroxyvitamin D concentration, OR direct supplementation of the infant INFLUENCES key bacterial taxa within microbiota of one month old infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 74, '25-hydroxyvitamin D')]
PMC5679631	11/2017	S69-PMC5679631	['due TO the study design, we tested for POSSIBLE INTERACTION between Vitamin D exposure and recruitment group (conventional/alternative).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5679631	11/2017	S146-PMC5679631	['in a FUTURE STUDY, it would be PREFERABLE to investigate the IMPACT of Postnatal Vitamin D supplementation in older infants whose 25(Oh)D concentrations have reached a steady state.']	[('FUTURE_WORK', 5), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('GO_0007567', 'parturition', 71, 'postnatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D')]
PMC5679631	11/2017	S151-PMC5679631	['the number of infants not administered Vitamin D supplementation was low because it is standard PRACTICE to supplement Breast Fed children with Vitamin D, and the lower prevalence of colonization with these bacteria also CONTRIBUTED to this LIMITATION.']	[('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 221), ('INCOMPLETE_EVIDENCE', 241)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 119, 'breast'), ('UBERON_0000310', 'breast', 119, 'breast'), ('GO_0007631', 'feeding behavior', 126, 'fed'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5682869	11/2017	S76-PMC5682869	['EARLY STUDIES concerning Vitamin D in Pregnancy SHOWED an ASSOCIATION with Preeclampsia and caesarean section but also Glucose tolerance, abnormal foetal Grown pattern, Preterm Birth and Reproductive failure.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 75, 'preeclampsia'), ('CHEBI_17234', 'glucose', 119, 'glucose'), ('GO_0040007', 'growth', 154, 'grown'), ('GO_0007565', 'female pregnancy', 169, 'preterm'), ('GO_0007567', 'parturition', 177, 'birth'), ('GO_0000003', 'reproduction', 187, 'reproductive')]
PMC5706533	11/2017	S115-PMC5706533	['caption (fig)\n\nfig 4 \xa0a: weighted mean differences (wmds) and b: cumulative wmds for effect of Prenatal Vitamin D supplementation on mean Birth weight (g), ESTIMATED with random effects meta-analysis, based on 37 intervention-control comparisons in 30 randomised controlled trials of regular or bolus regimen Vitamin D at any dose in studies published by september 2017\nCONSISTENT with the pooled EFFECT on mean Birth weight—but in a smaller subset of only seven comparisons—vitamin d reduced the risk of small for Gestational age (sga) (table 2; table s14 and fig s30 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 370), ('SUPERFICIAL_RELATIONSHIP', 397)]	3	[('GO_0007565', 'female pregnancy', 95, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0007567', 'parturition', 412, 'birth'), ('GO_0007565', 'female pregnancy', 515, 'gestational')]
PMC5706533	11/2017	S124-PMC5706533	['two studies REPORTED EFFECTS on neonatal bone Mineral content and bone Mineral density, for which the meta-analysis DID NOT support an effect of Vitamin D (table 3; tables s29-s30 and figs s56-s57 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_46662', 'mineral', 46, 'mineral'), ('CHEBI_46662', 'mineral', 71, 'mineral'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5706533	11/2017	S155-PMC5706533	['for example, Prenatal Vitamin D supplementation in deficient women modifies neonatal Calcium Homeostasis,31BUT clinical CORRELATES (such as symptomatic infant hypocalcaemia) were RARE and infrequently ascertained across trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 179)]	3	[('GO_0007565', 'female pregnancy', 13, 'prenatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 85, 'calcium homeostasis')]
PMC5707701	11/2017	S176-PMC5707701	['PREVIOUS STUDIES [36,37,66] SUGGESTED Vitamins A and e in Human milk were ASSOCIATED with maternal stores, dietary supplements, fortified foods, and dietary intake.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamins A'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'human')]
PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
PMC5716389	9/2017	S38-PMC5716389	['in fetal development, the ROLE of Vitamin A HAS BEEN RELATED to general Embryonic and fetal survival, Regulation Of Hematopoiesis and fetal growth.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007608', 'sensory perception of smell', 72, 'embryonic ...'), ('UBERON_0000922', 'embryo', 72, 'embryonic'), ('GO_1903706', 'regulation of hemopoiesis', 102, 'regulation of hematopoiesis')]
PMC5732505	12/2017	S19-PMC5732505	['HOWEVER, DUE TO recent changes in national health policies, intake of Vitamin D has increased RESULTING IN decreasing rates of Vitamin D deficiency [2–5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5732505	12/2017	S138-PMC5732505	['(2016) CONCLUDED in their meta-analysis that maternal Vitamin D insufficiency (< 50\xa0nmol/l or <75\xa0nmol/l) was ASSOCIATED with greater RISK of gdm [6].']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5732505	12/2017	S154-PMC5732505	['(2014) CONCLUDED that MODEST EVIDENCE exist for a positive RELATION between maternal Vitamin D status and Birth weight [31].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC5758521	1/2018	S0-PMC5758521	['vitamin a and e nutritional status in RELATION to leptin, adiponectin, Igf-I and Igf-Ii in early Life - a Birth cohort study\n\nabstract\nthe Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life are largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 156), ('FULL_UNKNOWN', 228)]	3	[('PR_000008919', 'interferon alpha-6', 71, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 81, 'IGF-II'), ('UBERON_0000104', 'life cycle', 97, 'Life'), ('GO_0007567', 'parturition', 106, 'Birth'), ('GO_0008152', 'metabolic process', 139, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 181, 'E'), ('UBERON_0000104', 'life cycle', 211, 'life')]
PMC5758521	1/2018	S22-PMC5758521	['we HYPOTHESIZED that Vitamin A and E nutritional status MAY AFFECT fetal circulating leptin, adiponectin, Igf-I and Igf-Ii levels.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 35, 'E'), ('PR_000008919', 'interferon alpha-6', 106, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 116, 'IGF-II')]
PMC5784894	1/2018	S18-PMC5784894	['[12] previous epidemiological work SUGGESTS a RELATIONSHIP between season of Birth, and HENCE maternal sunlight exposure and cutaneous Vitamin D Synthesis, and hip fracture risk in older people[13].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 46), ('PROBABLE_UNDERSTANDING', 88)]	3	[('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 135, 'vitamin D synthesis')]
PMC5784894	1/2018	S147-PMC5784894	['OUR FINDINGS SUGGEST a nutritional programming EFFECT of Vitamin D on Growing and Adult bone.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0040007', 'growth', 70, 'growing'), ('UBERON_0007023', 'adult organism', 82, 'adult')]
PMC5784894	1/2018	S148-PMC5784894	['THESE FINDINGS are CONSISTENT with multiple data sources that LINK early Life Vitamin D status to later bone size[4,8,9,25], structure[6,26], mass[8,9,26,27] and risk of fracture[9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('UBERON_0000104', 'life cycle', 73, 'life'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5784894	1/2018	S151-PMC5784894	['the EFFECT of maternal Vitamin D deficiency on bone (without loading) HAS BEEN studied in a range of Animal MODELS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 108)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 101, 'animal')]
PMC5784894	1/2018	S184-PMC5784894	['INSTEAD it SHOWS the EFFECT of Vitamin D response before or after Birth on the bone stiffness.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth')]
PMC5812027	2/2018	S0-PMC5812027	['trajectory of Vitamin D status during Pregnancy in RELATION to neonatal Birth size and fetal survival: a prospective cohort study\n\nabstract\n\nbackground\nwe INVESTIGATED the ASSOCIATIONS between Vitamin D status in early and late Pregnancy with neonatal small for Gestational age (sga), low Birth weight (lbw) and Preterm Delivery.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 155), ('SUPERFICIAL_RELATIONSHIP', 172)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007567', 'parturition', 72, 'birth'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0007565', 'female pregnancy', 262, 'gestational'), ('GO_0007567', 'parturition', 289, 'birth'), ('GO_0007565', 'female pregnancy', 312, 'preterm'), ('GO_0007567', 'parturition', 320, 'delivery')]
PMC5812027	2/2018	S20-PMC5812027	['ASSOCIATIONS HAVE also BEEN SHOWN between Vitamin D insufficiency (<\u200950\xa0nmol/l) and increased risk of infant small for Gestational age (sga) and low birth weight (lbw) [4].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'gestational')]
PMC5812027	2/2018	S108-PMC5812027	['discussion\nwe FOUND that higher Vitamin D status among women in late, BUT NOT early, Pregnancy was ASSOCIATED with lower probability of sga and lbw.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy')]
PMC5812027	2/2018	S137-PMC5812027	['TO OUR KNOWLEDGE, ours is one of the FIRST studies to find ASSOCIATIONS between Vitamin D status and Pregnancy loss.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5812027	2/2018	S160-PMC5812027	['INTERESTINGLY, Vitamin D status at t1- around the time the maternal Blood flow of the Placenta is fully developed- is ONLY RELATED to Pregnancy loss.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0001987', 'placenta', 86, 'placenta'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5812027	2/2018	S164-PMC5812027	['both higher late Pregnancy Vitamin D status and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'gestational'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5827025	2/2018	S117-PMC5827025	['RECENTLY, an Animal report INDICATES that Vitamin D inhibits Placental inflammation through reinforcing physical INTERACTION between Vitamin D Receptor (vdr) and Nf-Κb P65 Subunit17.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001987', 'placenta', 61, 'placental'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 133, 'vitamin D receptor'), ('GO_0071159', 'NF-kappaB complex', 162, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 162, 'NF-κB p65 subunit17')]
PMC5838372	3/2018	S2-PMC5838372	['a second AIM was TO IDENTIFY risk FACTORS for Vitamin D deficiency in a district of i̇stanbul.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5838372	3/2018	S28-PMC5838372	['a second AIM was TO IDENTIFY risk FACTORS for Vitamin D deficiency in the istanbul district of bağcılar, a low socio-economic neighborhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5838372	3/2018	S70-PMC5838372	['when the EFFECT of maternal RISK FACTORS on their infants’ Vitamin D levels was evaluated, there were no statistical differences, with the EXCEPTION of daily Vitamin D Intake.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 139)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007631', 'feeding behavior', 168, 'intake')]
PMC5838372	3/2018	S107-PMC5838372	['in PREVIOUS STUDIES in turkey, winter season, low socioeconomic status, low educational status and covered clothing style were REPORTED as RISK FACTORS for Vitamin D deficiency in mothers (31,34,35).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5838372	3/2018	S109-PMC5838372	['SIMILARLY, halicioglu et al (32) and çuhacı-çakır et al (36) REPORTED that covered clothing style was a RISK factor for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC5838372	3/2018	S116-PMC5838372	['ergur et al (31) SUGGESTED that maternal deficiency was the most IMPORTANT FACTOR for Vitamin D deficiency in newborns.']	[('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5941617	5/2018	S113-PMC5941617	['moreover, newborns from deficient mothers are at INCREASED RISK for Vitamin D deficiency AS Cord Blood and neonatal 25(Oh)D levels highly CORRELATE with maternal Vitamin d status during Gestation [92,93].']	[('IMPORTANT_CONSIDERATION', 49), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 162, 'vitamin'), ('GO_0007565', 'female pregnancy', 186, 'gestation')]
PMC5941617	5/2018	S134-PMC5941617	['Ketoconazole)• infants Born from mothers with multiple RISK FACTORS for Vitamin D deficiency, particularly in absence of Vitamin D supplementation during Pregnancy\n\npreterm\npreterm infants are AT RISK for Calcium-Phosphorus Metabolism alterations, with POSSIBLE development of osteopenia of prematurity [120].']	[('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 193), ('INCOMPLETE_EVIDENCE', 253)]	3	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('GO_0007567', 'parturition', 23, 'born'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_30272', 'arsonium', 205, 'calcium-phosphorus'), ('GO_0050655', 'dermatan sulfate proteoglycan metabolic process', 205, 'calcium-phosphorus metabolism')]
PMC5941617	5/2018	S147-PMC5941617	['SOME STUDIES evaluated the EFFECT of Vitamin D supplementation at DIFFERENT doses in preterm infants of various Gestational age and Birth weight [124,128–146].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'gestational'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5941617	5/2018	S198-PMC5941617	['we RECOMMEND against routine 25(Oh)D testing in children and adolescents, SUGGESTING to limit Serum 25(Oh)D levels evaluation in children and adolescents with multiple RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC5941617	5/2018	S242-PMC5941617	['the administration of 1α-Hydroxylated Metabolites of Vitamin D MAY BE CONSIDERED in nutritional rickets ASSOCIATED with acute hypocalcemia or hypocalcemic cardiomyopathy [9,183].']	[('INCOMPLETE_EVIDENCE', 63), ('FUTURE_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_24669', 'hydroxy carboxylic acid', 25, 'hydroxylated'), ('CHEBI_25212', 'metabolite', 38, 'metabolites'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5941617	5/2018	S268-PMC5941617	['particularly, 4 rcts PROVIDE EVIDENCE for a beneficial EFFECT of Vitamin D supplementation on bone Mineral accrual [148,166,216,224], mainly in subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 99, 'mineral'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5941617	5/2018	S270-PMC5941617	['INTERESTINGLY, a RECENT STUDY showed that the beneficial EFFECT of Vitamin D on Hip bone mass in lebanese adolescent girls persisted 1\xa0year after discontinuation of supplementation [226].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001464', 'hip', 80, 'hip')]
PMC5941617	5/2018	S285-PMC5941617	['a RELATIONSHIP between Vitamin D status and the incidence or the severity of Respiratory infections in children HAS BEEN FOUND in MANY observational STUDIES, most with a case-control or cross sectional design, both in developing and in westernized countries.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 77, 'respiratory')]
PMC5941617	5/2018	S312-PMC5941617	['THUS, the results of this study do not SUPPORT the routine use of high-dose Vitamin D supplementation in children for the PREVENTION of Viral Upper Respiratory Tract infections [271].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 122)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0001557', 'upper respiratory tract', 142, 'upper respiratory tract')]
PMC5941617	5/2018	S346-PMC5941617	['DID NOT FIND an ASSOCIATION between tubercular infection and Vitamin D status in a large population of internationally adopted children, although results DEMONSTRATED a high prevalence (about 75%) of hypovitaminosis d in this population [182].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5941617	5/2018	S348-PMC5941617	['the same authors had PREVIOUSLY DEMONSTRATED a RELATION between tubercular disease and Vitamin D status [301].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S354-PMC5941617	['RECENTLY, litonjua SHOWED that Vitamin D has both in utero and post-Natal EFFECTS on Lung Development and Immune System Development and function [304].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'natal'), ('GO_0030324', 'lung development', 85, 'lung development'), ('UBERON_0002048', 'lung', 85, 'lung'), ('GO_0002520', 'immune system development', 106, 'immune system development'), ('UBERON_0002405', 'immune system', 106, 'immune system')]
PMC5941617	5/2018	S382-PMC5941617	['about the EFFECTS of Vitamin D on Lung function, a RECENT meta-analysis DEMONSTRATED a difference of 0.54\xa0l/s in Forced Expiratory volume in the 1st second (fev1) values after the treatment with Vitamin D [334].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0002048', 'lung', 34, 'lung'), ('GO_0007629', 'flight behavior', 113, 'forced expiratory'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S403-PMC5941617	['the SO-called ecological studies SUGGEST the RELATIONSHIP between latitude, the consequent level of sun exposure, Vitamin D Production and subsequent Serum 25(Oh)D levels and the prevalence and severity of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 122, 'D production'), ('UBERON_0001977', 'blood serum', 150, 'serum'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC5941617	5/2018	S407-PMC5941617	['also in Food allergies the ROLE of Vitamin D REMAINS CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_33290', 'food', 8, 'food'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5941617	5/2018	S408-PMC5941617	['there are studies SUGGESTING that both lower and higher levels of Vitamin D are ASSOCIATED with elevated Ige concentrations, with a u-shaped RELATIONSHIP [354].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 105, 'IgE')]
PMC5941617	5/2018	S449-PMC5941617	['FOUND that two regimens of weekly Vitamin D3Administration (5000\xa0iu/10 kg/week, maximum weekly dose of 25000\xa0iu and maximum cumulative dose of 150000\xa0iu vs. 10000\xa0iu/10 kg/week, maximum weekly dose of 50000\xa0iu and maximum cumulative dose of 300000\xa0iu) for 6\xa0weeks were SAFE and EFFECTIVE in normalizing Vitamin D status in ibd children and adolescents with hypovitaminosis D [411].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	3	[('CHEBI_63455', 'tetronic acid derivative', 34, 'vitamin D3administration'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 34, 'vitamin D3administration'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 373, 'D')]
PMC5941617	5/2018	S450-PMC5941617	['finally, a single age DEPENDENT high-dose oral Vitamin D3(the SO-CALLED stoss therapy; <\u20093\xa0years: 200000\xa0iu; 4–12\xa0years 400000\xa0iu; >\u200912\xa0years 800000\xa0iu) was SAFE and efficacious in achieving and maintaining Serum 25(Oh)D levels >\u200920\xa0ng/ml during a 6-month period in ibd children with Vitamin D deficiency [412].']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_33279', 'vitamin D5', 47, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 47, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 213, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5941617	5/2018	S457-PMC5941617	['particularly, large rcts ARE NEEDED to BETTER investigate the ROLE of Vitamin D in disease remission and Control.']	[('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0065007', 'biological regulation', 105, 'control')]
PMC5941617	5/2018	S459-PMC5941617	['it HAS BEEN SUGGESTED that early-Life Vitamin D deficiency MAY CONTRIBUTE to the pathogenesis of childhood-onset cd by determining inappropriate Immune Responses, abnormal Intestinal Mucosal integrity and impaired local Defence against Microbial agents [413].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0006955', 'immune response', 145, 'immune responses'), ('UBERON_0002405', 'immune system', 145, 'immune'), ('UBERON_0001262', 'wall of intestine', 172, 'intestinal mucosal'), ('GO_0006952', 'defense response', 220, 'defence'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'microbial')]
PMC5941617	5/2018	S464-PMC5941617	['indeed, Small Intestinal Mucosal damage MAY AFFECT Intestinal absorption of Calcium and Vitamin D, and chronic Intestinal inflammation MAY lead to release of proinflammatory cytokines with subsequent increased bone loss [424].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 135)]	3	[('UBERON_0001206', 'serosa of small intestine', 8, 'small intestinal mucosal'), ('UBERON_0000160', 'intestine', 51, 'intestinal'), ('CHEBI_22313', 'alkaline earth metal atom', 76, 'calcium'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000160', 'intestine', 111, 'intestinal')]
PMC5941617	5/2018	S500-PMC5941617	['a RECENT italian rct SHOWED that supplementation with Vitamin D (800\xa0iu/day) plus Docosahexanoic Acid IMPROVED Insulin-resistance, Lipid profile, aminotransferases levels, and activity score in obese children with non alcoholic fatty Liver disease and Vitamin D deficiency [460].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_36006', 'icosapentaenoic acid', 82, 'docosahexanoic acid'), ('PR_000045358', 'insulin family protein', 111, 'insulin'), ('CHEBI_18059', 'lipid', 131, 'lipid'), ('UBERON_0002107', 'liver', 234, 'liver'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC5941617	5/2018	S501-PMC5941617	['finally, two RECENT meta-analyses SHOWED that Vitamin D supplementation had no significant effect on Glucose and Insulin Metabolism [461] and on changes in the concentrations of inflammatory BIOMARKERS (C-Reactive Protein, tumor necrosis factor alpha, Il-6) in obese and overweight adolescents and Adults [462].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17234', 'glucose', 101, 'glucose'), ('GO_0007369', 'gastrulation', 101, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 113, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 113, 'insulin'), ('PR_000005890', 'crooked neck-like protein 1', 203, 'C-reactive protein'), ('PR_000001470', 'interleukin-28B', 252, 'IL-6'), ('UBERON_0007023', 'adult organism', 298, 'adults')]
PMC5941617	5/2018	S525-PMC5941617	['NEVERTHELESS, a RECENT rct enrolled 42 children with autism spectrum disorders showing that Vitamin D supplementation (2000\xa0iu/day of Vitamin D3For 20\xa0weeks) had no EFFECT on the primary outcome (the stereotypic behaviour subscale from the aberrant behaviour checklist) in comparison with placebo [485].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 165)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27364', 'zinc molecular entity', 134, 'vitamin D3for')]
PMC5941617	5/2018	S536-PMC5941617	['meta-analyses assessing the EFFECT of Vitamin D supplementation in depressed Adults FOUNDED CONFLICTING results [495–497].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults')]
PMC5941617	5/2018	S545-PMC5941617	['during Pregnancy Vitamin D Metabolism changes so that maternal Serum 1,25(Oh)2D levels significantly rise to meet increased calcium REQUIREMENTS for Fetal Skeleton mineralization, WHEREAS fetal Vitamin D stores are exclusively DEPENDENT on maternal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('SUPERFICIAL_RELATIONSHIP', 227)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 17, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_37958', 'dye', 69, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 71, '25(OH)2D'), ('UBERON_0000922', 'embryo', 149, 'fetal'), ('UBERON_0004288', 'skeleton', 155, 'skeleton'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC5941617	5/2018	S548-PMC5941617	['in addition, Vitamin D plays a KEY ROLE in the Immunological Adaptation NEEDED for the onset and maintenance of a normal Pregnancy [500].']	[('IMPORTANT_CONSIDERATION', 31), ('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 72)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0002455', 'humoral immune response mediated by circulating immunoglobulin', 47, 'immunological adaptation'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy')]
PMC5941617	5/2018	S551-PMC5941617	['moreover, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED risk of several obstetrics diseases (spontaneous Pregnancy Loss, Preterm and/or small-for-Gestational age Birth, Gestational diabetes pre-eclampsia) [502–506].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0006508', 'proteolysis', 124, 'pregnancy loss'), ('GO_0007565', 'female pregnancy', 140, 'preterm'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 181, 'birth'), ('GO_0007565', 'female pregnancy', 188, 'gestational')]
PMC5941617	5/2018	S552-PMC5941617	['in addition, Vitamin D deficiency during Pregnancy MAY negatively AFFECT long-term offspring Extraskeletal health outcomes, with INCREASED risk of infant Respiratory Tract infections, asthma, wheeze, and eczema [273,380,507,508].']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 93, 'extraskeletal'), ('UBERON_0000065', 'respiratory tract', 154, 'respiratory tract')]
PMC5941617	5/2018	S609-PMC5941617	['moreover, the RECENTLY SUGGESTED ROLE of Vitamin D in the development of other non-Skeletal diseases reinforced the interest in the promotion of an adequate Vitamin D status during pediatric age.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5941617	5/2018	S619-PMC5941617	['adolescents are PARTICULARLY AT RISK of hypovitaminosis d.\nVitamin D status of newborns is INFLUENCED by ethnicity, season of Birth, and maternal Vitamin D status during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_28384', 'vitamin K', 59, 'Vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC5941617	5/2018	S660-PMC5941617	['AVAILABLE EVIDENCE SUGGESTS a positive EFFECT of Vitamin D supplementation on bone mass acquisition in children and adolescents with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5941617	5/2018	S661-PMC5941617	['RECENT STUDIES SUGGEST a RELATIONSHIP between maternal Vitamin D status during Pregnancy and bone mass of the fetus and the newborn.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy')]
PMC5941617	5/2018	S663-PMC5941617	['Extraskeletal actions of Vitamin D\n\nrespiratory infections\n\nRECENT STUDIES SUGGEST an ASSOCIATION between Vitamin D deficiency and the severity or the incidence of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('UBERON_0001431', 'distal carpal bone 2', 0, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory')]
PMC5941617	5/2018	S665-PMC5941617	['NO DEFINITIVE EVIDENCE exists to RECOMMEND Vitamin D supplementation for PREVENTION of Respiratory infections (non-associated with wheezing) or recurrent Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory')]
PMC5941617	5/2018	S684-PMC5941617	['in pediatric population there is LIMITED EVIDENCE regarding a POSSIBLE favourable EFFECT of Vitamin D supplementation on several aspects of ad.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5941617	5/2018	S701-PMC5941617	['RECOMMENDATIONS for treatment of Vitamin D deficiency in patients with newly diagnosed cd are equivalent to those for ibds patients, AS both these conditions are ASSOCIATED with Intestinal malabsorption.']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 133), ('SUPERFICIAL_RELATIONSHIP', 162)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000160', 'intestine', 178, 'intestinal')]
PMC5941617	5/2018	S704-PMC5941617	['obesity is the cause and not the EFFECT of this ASSOCIATION BECAUSE of the deposition of Vitamin D in Adipose Tissue with consequent reduction in Serum 25(Oh)d levels.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 102, 'adipose tissue'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_30778', 'gallic acid', 152, '25(OH)')]
PMC5952272	5/2018	S11-PMC5952272	['SIMILAR TREND was FOUND with respect to Vitamins E, d, a, and Folic Acid.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 18)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamins E'), ('CHEBI_30751', 'formic acid', 62, 'folic acid')]
PMC5956785	5/2018	S4-PMC5956785	['further, we geo-mapped the results of the studies TO IDENTIFY the PATTERNS of the ASSOCIATION between Vitamin D and chronic childhood arthritis across the globe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5956785	5/2018	S31-PMC5956785	['2) WHAT is the RELATIONSHIP between Vitamin D status and childhood arthritis activity?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 85)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S32-PMC5956785	['3) WHAT is the RELATIONSHIP between Vitamin D status in jia and medication use?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S33-PMC5956785	['4) WHAT is the RELATIONSHIP between Vitamin D status and geographic and demographic characteristics in children with jia?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 120)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5956785	5/2018	S71-PMC5956785	['results of scoping review and discussion\nconsiderations when evaluating the ROLE of Vitamin D in jia include Vitamin D REQUIREMENTS for this population and the ROLE that Vitamin D plays in disease activity.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('IMPORTANT_CONSIDERATION', 119), ('SUPERFICIAL_RELATIONSHIP', 160)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5956785	5/2018	S156-PMC5956785	['INTERESTINGLY, the RELATIONSHIP between reduced Vitamin D status and increased disease activity also APPEARS TO BE present and follow a north-south gradient (fig.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ANOMALY_CURIOUS_FINDING', 101)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5956785	5/2018	S185-PMC5956785	['except for one STUDY conducted in turkey [21], all other studies conducted in europe that explored disease activity REPORTED an inverse ASSOCIATION between Vitamin D and disease activity.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5956785	5/2018	S193-PMC5956785	['long-term, adequately powered randomized studies which control for CONFOUNDING variables (sun exposure, season, and Vitamin D intake) are REQUIRED to confirm a causative RELATIONSHIP between Vitamin D and disease activity.']	[('PROBLEM_COMPLICATION', 67), ('IMPORTANT_CONSIDERATION', 138), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC5956785	5/2018	S205-PMC5956785	['REPORTED SIMILAR intake of Vitamin D and higher 25(Oh)D in controls, and in the study REPORTED by dey et al.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D')]
PMC5956785	5/2018	S209-PMC5956785	['understanding this RELATIONSHIP will be IMPORTANT in the use of Vitamin D as a POTENTIAL adjunct therapy.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 79)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5956785	5/2018	S211-PMC5956785	['by exploring the factors that INFLUENCE Vitamin D status (genetics, environment, and nutrition), we will be BETTER able to discern an ASSOCIATION between Vitamin D and jia.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5956785	5/2018	S244-PMC5956785	['season of Birth MAY BE a MARKER for Vitamin D status in utero with children Born in the non-Vitamin D synthesizing periods being exposed to less Vitamin D during their time in utero THAN those who are Born during the Vitamin D synthesizing seasons.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'born'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0007567', 'parturition', 201, 'born'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC5956785	5/2018	S256-PMC5956785	['also HOW they IMPACT the biological Response involving Vitamin D and inflammation REMAINS UNCLEAR.']	[('EXPLICIT_QUESTION', 5), ('SUPERFICIAL_RELATIONSHIP', 14), ('FULL_UNKNOWN', 82)]	3	[('GO_0060033', 'anatomical structure regression', 36, 'response'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5956785	5/2018	S272-PMC5956785	['conclusion\nTHIS is the FIRST scoping review to summarize research RELATING to Vitamin D and jia in the context of Vitamin D status, latitude, disease activity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5956785	5/2018	S279-PMC5956785	['thus far, we KNOW that there is a ROLE for Vitamin D in the inflammatory pathways, a high prevalence of 25(Oh)D insufficiency among children with jia, and an established LINK of Vitamin D with other Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 199, 'autoimmune')]
PMC5995352	6/2018	S28-PMC5995352	['this leaves the infant more SUSCEPTIBLE to developing Vitamin D deficiency rickets if not receiving adequate Vitamin D supplementation, AS the lower inborn Vitamin D stores will decrease to severely insufficient levels sooner IN ACCORDANCE WITH the half-life of 25Ohd.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 226)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD')]
PMC5995352	6/2018	S34-PMC5995352	['ALTHOUGH maternal Vitamin D status during Pregnancy has no impact on foetal Bone mineralisation IF Calcium supply is adequate, observational studies have LINKED low maternal Vitamin D levels with smaller child bone mass and impaired linear growth in the first 12 months of Life [18–20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('SUPERFICIAL_RELATIONSHIP', 154)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'bone'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000104', 'life cycle', 273, 'life')]
PMC5995352	6/2018	S39-PMC5995352	['on this background we AIMED TO INVESTIGATE the RELATIONSHIP between early Life Vitamin D exposure and linear growth in children up to three years of age in the large, danish, population-based odense child cohort (occ).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('UBERON_0000104', 'life cycle', 74, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC6011374	6/2018	S1-PMC6011374	['hence, there is CONTINUING INTEREST in determining HOW Vitamin D INFLUENCES Pregnancy health.']	[('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 51), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC6011374	6/2018	S2-PMC6011374	['we AIMED to compare Vitamin D status in two distinct populations of Pregnant women in australia and new zealand and TO INVESTIGATE the RELATIONSHIP between Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC6011374	6/2018	S13-PMC6011374	['evidence SUGGESTS that Vitamin D deficiency is ASSOCIATED with a number of Pregnancy COMPLICATIONS including Preeclampsia (pe), Gestational diabetes mellitus (gdm) and spontaneous Preterm Birth (Sptb) [2–4].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBLEM_COMPLICATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 109, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 128, 'gestational'), ('GO_0007565', 'female pregnancy', 180, 'preterm birth'), ('PR_000015390', 'sterol O-acyltransferase 2', 195, 'sPTB')]
PMC6011374	6/2018	S64-PMC6011374	['caption (table-wrap): table 1\n\nparticipant characteristics and comparison of characteristics between women recruited at the adelaide and auckland scope centresall women (n = 2800)adelaide (n = 1156)auckland (n = 1644) p value*age yrs , mean (sd)28 (6)23.73 (5.11)30.44 (4.82)<0.0001bmi kg/m2, mean (sd)25.8 (5.44)27.04 (6.56)24.88 (4.26)<0.0001ethnicity<0.0001\u2003caucasian2449 (87)1060 (92)1389 (84)\u2003non caucasian351 (13)96 (8)255 (16)smoking status, n (%)<0.0001\u2003no2152 (77)704 (61)1448 (88)\u2003quit during Pregnancy306 (11)175 (15)131 (8)\u2003smoking342 (12)277 (24)65 (4)Alcohol consumption, n (%)<0.0001\u2003no1480 (53)708 (61)772 (47)\u2003stopped during pregnancy1185 (42)397 (34)788 (48)\u2003consuming Alcohol135 (5)51 (4)84 (5)fruit intake, n (%)<0.0001\u2003≥1x per day2032 (73)586 (51)1446 (88)\u20033-6x per week405 (14)272 (24)133 (8)\u20031-2x per week223 (8)181 (16)42 (3)\u20031-3x per month or less140 (5)117 (10)23 (1)recreational walking<0.0001\u2003never428 (15)265 (23)163 (10)\u20031-3 times/week1773 (63)668 (58)1105 (68)\u2003≥4 times/week590 (22)221 (19)369 (23)time watching tv<0.0001\u2003<5 hours per day2404 (86)901 (78)1503 (92)\u2003≥5 hours per day387 (14)253 (22)134 (8)season Serum was sampled0.3213\u2003summer636 (23)278 (24)358 (22)\u2003autumn705 (25)273 (24)432 (26)\u2003winter727 (26)300 (26)427 (26)\u2003spring732 (26)305 (26)427 (26)Serum 25(Oh)D nmol/l , mean (sd)68.09 (27.14)60.06 (23.68)73.74 (27.99)<0.0001vitamin D status<0.0001\u2003<25 nmol/l99 (4)48 (4)51 (3)\u200325-50 nmol/l673 (24)375 (32)298 (18)\u200350-75 nmol/l928 (33)422 (37)506 (31)\u2003>75 nmol/l1098 (39)311 (27)787 (48)\n* p values for continuous variables were determined using a welch’s t-test and categorical variables a fisher’s exact test comparing adelaide and auckland women\n\nstandardising Serum 25(Oh)D based on seasonal variation\nAS EXPECTED, there was a seasonal INFLUENCE on Serum 25(Oh)D and THUS, “standardised” Vitamin D concentrations were calculated to account for the month of Serum collection.']	[('INCOMPLETE_EVIDENCE', 1748), ('SUPERFICIAL_RELATIONSHIP', 1782), ('PROBABLE_UNDERSTANDING', 1813)]	3	[('GO_0007602', 'phototransduction', 503, 'pregnancy306'), ('CHEBI_30879', 'alcohol', 565, 'Alcohol'), ('CHEBI_78635', 'fatty alcohol 16:1', 687, 'alcohol135'), ('UBERON_0001977', 'blood serum', 1142, 'serum'), ('UBERON_0001977', 'blood serum', 1289, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1295, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1375, 'D'), ('UBERON_0001977', 'blood serum', 1706, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1712, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1712, '25(OH)D'), ('UBERON_0001977', 'blood serum', 1795, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1801, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1801, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1834, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1903, 'serum')]
PMC6011374	6/2018	S94-PMC6011374	['PREVIOUS STUDIES HAVE SHOWN a positive ASSOCIATION between socioeconomic status and Vitamin D in both Pregnant and non-Pregnant women [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnant'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC6011374	6/2018	S101-PMC6011374	['THEREFORE, the protective ROLE of high 25(Oh)D 15\u2009±\u20091\xa0weeks’ Gestation against gdm, as seen with a decreased risk of gdm in women within the ‘high’ quartile of standardised Vitamin D compared to moderate-high, is CONSISTENT with knowledge about Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 213)]	3	[('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('GO_0007565', 'female pregnancy', 61, 'gestation'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC6011374	6/2018	S102-PMC6011374	['this is also CONSISTENT with another study that observed an increased risk of gdm with Vitamin D deficiency in early Pregnancy (aor: 3.40; 95% ci: 2.03–4.98 [17]) and offers POTENTIAL physiological CONNECTIONS between Vitamin D status and the progression of Insulin resistance in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007565', 'female pregnancy', 280, 'pregnant')]
PMC6011374	6/2018	S107-PMC6011374	['in THIS STUDY, we observed marginal sex-specific DIFFERENCES between early Pregnancy Vitamin D status and Pregnancy outcome where by high Vitamin D status and carrying a male fetus was moderately ASSOCIATED with decreasing the risk of having any Pregnancy complication.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('SUPERFICIAL_RELATIONSHIP', 196)]	3	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S109-PMC6011374	['indeed, for the risk of gdm an OPPOSITE EFFECT of Vitamin D status in early Pregnancy was observed DEPENDING ON fetal sex.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC6011374	6/2018	S110-PMC6011374	['this is similar to that which has PREVIOUSLY been shown in the RELATIONSHIP between Vitamin D status at ≤26\xa0weeks’ Gestation and Placental pathology in Pregnancy [51] SUGGESTING that male and female fetuses respond differently to maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 167)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('UBERON_0001987', 'placenta', 129, 'placental'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC6039335	7/2018	S260-PMC6039335	['the appropriate age for, and duration of, Vitamin A deple tion or supplementation have been SUGGESTED as IMPORTANT factors that AFFECT ms. oka et al [134] reported that restricting Vitamin A in 15-month-old cattle until the final finishing phase (29 months of age) increased ms, but not in 23-month-old cattle prior to finishing.']	[('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 128)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin A')]
PMC6039335	7/2018	S261-PMC6039335	['they SUGGESTED that Serum Vitamin A level AFFECTS the Lm ms during the early fattening stage and that restricting Vitamin A during the later stages of growth AFFECTS growth rate.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 158)]	3	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('UBERON_0016551', 'subdivision of spinal cord ventral column', 54, 'LM'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin A')]
PMC6039335	7/2018	S281-PMC6039335	['FEW in vivo STUDIES HAVE BEEN performed on the EFFECT of Vitamin D on beef marbling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC6039335	7/2018	S283-PMC6039335	['FURTHER STUDY IS NEEDED to clarify the EFFECTS of dietary Vitamin D on ms and qg in beef cattle.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC6039335	7/2018	S294-PMC6039335	['FURTHER STUDY is NECESSARY to clarify the EFFECTS of dietary Vitamin C on ms and qg in other breeds of beef cattle.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
BMJ_2008_Nov_7_337_a2001	11/2008	S180-BMJ_2008_Nov_7_337_a2001	['the Vitamin C in the multiple Micronutrient supplements MIGHT have enhanced the absorption of iron and also CONTRIBUTED TO reducing the difference in the absolute amount of iron absorbed.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin C'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 30, 'micronutrient')]
PMC1448690	4/2006	S296-PMC1448690	['the dietary factors INVOLVED include Eating at fast food outlets, as well as lower intake of milk, vegetables, fibre and Foods rich in Vitamin E. dietary Vitamin E was REPORTED to inhibit Ige responses to allergic stimuli in a random sample of 2633 Adults [174].']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 168)]	2	[('GO_0051318', 'G1 phase', 37, 'eating'), ('CHEBI_33290', 'food', 121, 'foods'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('GO_0007630', 'jump response', 188, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0007023', 'adult organism', 249, 'adults')]
PMC2151954	10/2007	S176-PMC2151954	['FUTURE STUDIES would ideally examine the RELATIONSHIP between maternal Vitamin D status and neonatal anthropometry across time (e.g.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 41)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC2290997	4/2008	S77-PMC2290997	['a swedish epidemiologic study published in the december 2006 issue of diabetologia FOUND that sufficient Vitamin D status in early Life was ASSOCIATED with a lower risk of developing type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC2581757	11/2008	S15-PMC2581757	['in addition, there was a RELATIONSHIP FOUND between the extent of Vitamin E deficiency and increased Lipid Peroxidation with enhanced diastolic Blood pressure [12].']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('CHEBI_18059', 'lipid', 101, 'lipid'), ('GO_0032622', 'interleukin-19 production', 101, 'lipid peroxidation'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC2581757	11/2008	S170-PMC2581757	['from our results we INFER the positive EFFECT of Vitamins C and E on retaining sod activity during Preeclampsia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 64, 'E'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia')]
PMC2581757	11/2008	S188-PMC2581757	['they INFERRED a CORRELATION between the Pai-1/Pai-2 (Plasminogen Activator Inhibitor) ratio with Vitamins C and e levels.']	[('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('PR_000014702', 'plasminogen activator inhibitor 1', 40, 'PAI-1'), ('PR_000014700', 'serpin B9', 46, 'PAI-2'), ('PR_000014700', 'serpin B9', 53, 'plasminogen activator inhibitor'), ('CHEBI_35222', 'inhibitor', 75, 'inhibitor'), ('CHEBI_27300', 'vitamin D', 97, 'vitamins C')]
PMC2582131	11/2008	S17-PMC2582131	['moreover, a significant and strong ASSOCIATION between Vitamin D deficiency and Ss-Cell dysfunction HAS BEEN REPORTED in healthy, non-diabetic, or diabetic populations[13]–[15].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 99)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CL_0000623', 'natural killer cell', 80, 'ß-cell')]
PMC2582131	11/2008	S18-PMC2582131	['furthermore, circulating concentrations of 25-Hydroxyvitamin D (25-[Oh] D), the primary circulating form of Vitamin D, were significantly and inversely RELATED to the risk for type 2 diabetes[15]and RELATED phenotypes in epidemiological studies[9],[16]–[19].']	[('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 199)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 43, '25-hydroxyvitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 64, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC2582131	11/2008	S86-PMC2582131	['it has become increasingly CLEAR that Vitamin D has physiological functions beyond bone health[6]; Vitamin D receptors were Expressed in a large number of other Tissues including those INVOLVED in the Regulation Of Glucose Metabolism, such as Muscle and Pancreatic Β Cells[1].']	[('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0010467', 'gene expression', 124, 'expressed'), ('UBERON_0000479', 'tissue', 161, 'tissues'), ('GO_0010906', 'regulation of glucose metabolic process', 201, 'regulation of glucose metabolism'), ('CHEBI_17234', 'glucose', 215, 'glucose'), ('CL_0000187', 'muscle cell', 243, 'muscle ...'), ('CL_0000173', 'pancreatic D cell', 254, 'pancreatic β cells'), ('UBERON_0001264', 'pancreas', 254, 'pancreatic')]
PMC2582131	11/2008	S110-PMC2582131	['first, determination of 25-[Oh] D concentrations using Plasma collected in early Pregnancy served to define the temporal RELATIONSHIP between maternal Vitamin D deficiency and subsequent risk of gdm BECAUSE, in general, Pregnant women develop Gestational diabetes during the late 2ndor 3rdtrimester.']	[('SUPERFICIAL_RELATIONSHIP', 121), ('PROBABLE_UNDERSTANDING', 199)]	2	[('CHEBI_34300', '2-naphthoyl-CoA', 24, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 55, 'plasma'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 220, 'pregnant'), ('GO_0007565', 'female pregnancy', 243, 'gestational')]
PMC2679409	5/2009	S488-PMC2679409	['[87] yielded SIMILAR FINDINGS on the risk of stillbirth ASSOCIATED with Vitamin A supplementation (rr = 1.26, 95% ci: 0.53, 3.01) [loe: 1++] (additional file13).']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A')]
PMC2685863	5/2009	S6-PMC2685863	['“this is the FIRST DIRECT EVIDENCE that Vitamin D Regulates the Gene,” says ebers.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'regulates'), ('SO_0000704', 'gene', 64, 'gene')]
PMC2798111	12/2010	S1-PMC2798111	['TO EXAMINE the EFFECTIVENESS of oral Vitamin D3(400\u2009iu) supplementation on the nutritional Vitamin D status of breastfeeding infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_33279', 'vitamin D5', 37, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 37, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC2798111	12/2010	S116-PMC2798111	['clearly, the 400\u2009iu/day group of infants (presented HERE) had improved Vitamin D status BASED ON their therapy that was not seen in the 2400\u2009iu group of infants, who were receiving placebo and whose only source of Vitamin D was maternal Breast Milk that has significantly lower levels than that of the 6400 iu group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 237, 'breast milk')]
PMC2821652	2/2010	S57-PMC2821652	['at each study visit, AS a MARKER of Vitamin D status, circulating levels of 25(Oh)D and Vitamin D3Were measured in patient Serum.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 26)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_73706', 'bromosuccinate', 88, 'vitamin D3were'), ('UBERON_0001977', 'blood serum', 123, 'serum')]
PMC2841444	2/2010	S491-PMC2841444	['antenatal and Postnatal Vitamin K supplementation in preterm infants\nVitamin K is a fat-soluble Vitamin CRUCIAL to the Production Of many Proteins INVOLVED with the Coagulation Process.']	[('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 147)]	2	[('GO_0007567', 'parturition', 14, 'postnatal'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 69, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 96, 'vitamin'), ('GO_0006412', 'translation', 119, 'production of ... proteins'), ('GO_0050817', 'coagulation', 165, 'coagulation process')]
PMC2872349	4/2010	S29-PMC2872349	['the Proliferation Of the Chondrocytes HAS BEEN SHOWN to be INFLUENCED by Parathyroid Hormone Related peptide (pthrp) [14], cytokines of the igf axis [15], activated Vitamin D [16] and Triodothryronine [17].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0002901', 'mature B cell apoptotic process', 4, 'proliferation of ... chondrocytes'), ('CL_0000138', 'chondrocyte', 25, 'chondrocytes'), ('PR_000013393', 'proteasome activator complex subunit 2', 73, 'parathyroid hormone related'), ('UBERON_0001132', 'parathyroid gland', 73, 'parathyroid'), ('CHEBI_33280', 'molecular messenger', 85, 'hormone'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_26982', 'threo-3-methylmalic acid', 184, 'triodothryronine')]
PMC2872349	4/2010	S34-PMC2872349	['rickets has served as a longstanding example of an adverse Early Life environment, in the form of Vitamin D deficiency, disrupting the process of Bone Development and untreated CAN LEAD TO persistent changes in the child’s bone structure.']	[('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('UBERON_0001847', 'lobule of pinna', 59, 'early life'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0048539', 'bone marrow development', 146, 'bone development')]
PMC2872349	4/2010	S118-PMC2872349	['a further example of a dynamic INTERACTION between Genetic and environmental INFLUENCES of bone mass was shown in the analysis of the Vitamin D Receptor (vdr) genotype and Adult bmd in participants of the hertfordshire cohort study.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('SO_0000704', 'gene', 51, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0007023', 'adult organism', 172, 'adult')]
PMC2872349	4/2010	S124-PMC2872349	['in summary Maternal behavior, in the form of activities such as smoking, dietary choices including Calcium and Vitamin D intake, and alterations in the Endocrine pathways especially in early Life, HAVE BEEN SHOWN to CORRELATE with offspring bone health [48,50,54,55].']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216)]	2	[('GO_0007618', 'mating', 11, 'maternal'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0006397', 'mRNA processing', 152, 'endocrine'), ('UBERON_0000104', 'life cycle', 191, 'life')]
PMC2874518	6/2010	S113-PMC2874518	[',23in a case–control study of offspring with congenital Heart disease, FOUND that periconceptual use of Vitamin E supplements with high dietary intake of the same Vitamin was ASSOCIATED with up to nine-fold increase in the risk of congenital Heart disease.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 175)]	2	[('UBERON_0000948', 'heart', 56, 'heart'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('UBERON_0000948', 'heart', 242, 'heart')]
PMC2874518	6/2010	S115-PMC2874518	['in a randomised controlled trial TO ASSESS the EFFECT of Vitamin E and C supplementation during Pregnancy on the incidence of pre-eclampsia, poston et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 71, 'C'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC2889879	5/2010	S0-PMC2889879	['dietary Intake of fish, Omega-3, Omega-6 polyunsaturated Fatty Acids and Vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population\n\nabstract\n\nbackground\nlow intake of fish, polyunsaturated Fatty Acids (pufa) and Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 287), ('SUPERFICIAL_RELATIONSHIP', 316)]	2	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_79370', 'ibho#10', 24, 'omega-3'), ('CHEBI_79370', 'ibho#10', 33, 'omega-6'), ('CHEBI_35366', 'fatty acid', 57, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 243, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D')]
PMC2889879	5/2010	S26-PMC2889879	['fatty fish is a rich dietary source of essential Fatty Acids and Vitamin D, both of which COULD BE IMPLICATED in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_35366', 'fatty acid', 49, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC2889879	5/2010	S177-PMC2889879	['in terms of GENERALISABILITY of our results it is RELEVANT TO compare the levels of dietary Intake of Pufas and Vitamin D in our cohort to other populations.']	[('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('GO_0007631', 'feeding behavior', 92, 'intake'), ('CHEBI_86926', 'S a S b S', 102, 'PUFAs'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC2898025	5/2010	S106-PMC2898025	['maternal Serum Vitamin D levels TEND to be closely CORRELATED with infant Cord Serum levels [146,147].']	[('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 74, 'cord'), ('UBERON_0001977', 'blood serum', 79, 'serum')]
PMC2913107	8/2010	S25-PMC2913107	['toxins delivered by Water or air pollution APPEAR to DAMAGE the Genome of the Vitamin D deficient (14).']	[('ANOMALY_CURIOUS_FINDING', 43), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_15377', 'water', 20, 'water'), ('SO_0001026', 'genome', 64, 'genome'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC2963768	10/2010	S7-PMC2963768	['within a larger group of 74 infants and toddlers aged 1-17 months (cases and controls recruited for the pneumonia study), young age was the ONLY significant RISK FACTOR for Vitamin D deficiency [25(Oh)D <25 nmol/l].']	[('ANOMALY_CURIOUS_FINDING', 140), ('SUPERFICIAL_RELATIONSHIP', 157)]	2	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2963768	10/2010	S148-PMC2963768	['aside from these caveats, the community-based sampling was LIKELY random with respect to most DETERMINANTS of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 94)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2996405	11/2010	S10-PMC2996405	['conclusions\nour results SUGGEST a latitude-driven adaptation for both schizophrenia and Vitamin D RELATED Genes.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('SO_0000704', 'gene', 106, 'genes')]
PMC2996405	11/2010	S159-PMC2996405	['there is GROWING EVIDENCE that low Vitamin D levels adversely IMPACT on Brain Development [52].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain')]
PMC2996405	11/2010	S160-PMC2996405	['in Mice, it HAS BEEN SUGGESTED that changes in Brain Development induced by Prenatal Vitamin D deficiency LEAD TO specific functional alterations in hippocampal Synaptic plasticity [53].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('GO_0007420', 'brain development', 47, 'brain development'), ('UBERON_0000955', 'brain', 47, 'brain'), ('GO_0007565', 'female pregnancy', 76, 'prenatal'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0045202', 'synapse', 161, 'synaptic')]
PMC2996405	11/2010	S161-PMC2996405	['also in Humans, maternal Vitamin D insufficiency HAS BEEN ASSOCIATED with childhood rickets and longer term problems including schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('NCBITaxon_9606', 'Homo sapiens', 8, 'humans'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC2996405	11/2010	S164-PMC2996405	['we FOUND a significant overlap of 70 Genes between schizophrenia and Vitamin D RELATED Genes (figure1and additional file3).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('SO_0000704', 'gene', 37, 'genes'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('SO_0000704', 'gene', 87, 'genes')]
PMC3004407	12/2010	S16-PMC3004407	['RATHER, Vitamin D is now seen as a preprohormone whose active Metabolites act not only to ensure Calcium Homeostasis and bone health [5] but also act as mediators of Immune function in general [6,7], and specific to Pregnancy, play a ROLE in Immune tolerance, Insulin resistance, and Preeclampsia [8–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 234)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites'), ('GO_0055073', 'cadmium ion homeostasis', 97, 'calcium homeostasis'), ('UBERON_0002405', 'immune system', 166, 'immune'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0002405', 'immune system', 242, 'immune'), ('PR_000045358', 'insulin family protein', 260, 'insulin'), ('GO_0007128', 'meiotic prophase I', 284, 'preeclampsia')]
PMC3004407	12/2010	S86-PMC3004407	['a small percentage (5.2%) of the women reported dietary restrictions that MAY have INFLUENCED their Vitamin D status; 3% reported such restrictions for health reasons such as type 2 diabetes, 0.9% for religious reasons (vegetarian), and 1.3% gave no reason.']	[('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3004407	12/2010	S101-PMC3004407	['multinomial logistic regression models for the three Vitamin D categories (deficient, insufficient, and sufficient) were constructed TO EVALUATE the ASSOCIATION between Vitamin D status and age, gravidity, race, and season of measurement.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3004407	12/2010	S147-PMC3004407	['this is concerning in that the EFFECTS of Vitamin D deficiency among Pregnancy women are not limited to the women: IF a mother has Vitamin D insufficiency, or worse, deficiency, her fetus is developing in a hypovitaminotic state.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3032617	5/2010	S5-PMC3032617	['the primary outcome measure of this study was TO ASSESS the PREVENTION of hospitalization during Pregnancy in the group of women supplemented with Vitamin C compared to the controls.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C')]
PMC3032617	5/2010	S37-PMC3032617	['all this considerations led us TO INVESTIGATE, in an open-label cohort randomized study, the preventive EFFECTS of regular Vitamin C supplementation on overall hospitalization rate in the Pregnant women population attending a ugandan rural health centre for Antenatal assessment.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 104)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin C'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('GO_0007567', 'parturition', 258, 'antenatal')]
PMC3032617	5/2010	S38-PMC3032617	['the primary outcome measure of this study was TO ASSESS the PREVENTION of hospitalization during Pregnancy in the group of women supplemented with Vitamin C compared to the controls, and the secondary outcome measures were to compare the overall mother-to-child health benefits in the two groups, such as: overall hospitalization rate, weight gain during Pregnancy (normal <16kg), term Pregnancy (≥37 Gestational weeks), Preterm Delivery, Miscarriage (<24 Gestational weeks) and child low Birth weight (<2500g) and Gestational systolic Blood pressure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0007565', 'female pregnancy', 386, 'pregnancy'), ('GO_0007565', 'female pregnancy', 401, 'gestational'), ('GO_0007565', 'female pregnancy', 421, 'preterm'), ('GO_0007567', 'parturition', 429, 'delivery'), ('GO_0046660', 'female sex differentiation', 439, 'miscarriage'), ('GO_0007565', 'female pregnancy', 456, 'gestational'), ('GO_0007567', 'parturition', 489, 'birth'), ('GO_0007565', 'female pregnancy', 515, 'gestational'), ('UBERON_0000178', 'blood', 536, 'blood')]
PMC3032617	5/2010	S88-PMC3032617	['seemingly, in both groups a linear CORRELATION was FOUND between the hospitalization rate and the Delivery body mass index (Vitamin C group (r=0.59), cl 0.49-0.68; control group (r=0.43), cl 0.3-0.54; p=0.0001).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 51)]	2	[('GO_0007567', 'parturition', 98, 'delivery'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C')]
PMC3034879	12/2010	S3-PMC3034879	['we EVALUATED the ROLE of Prenatal and Postnatal Vitamin D status on bone parameters in early infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 17)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('GO_0007567', 'parturition', 38, 'postnatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3034879	12/2010	S98-PMC3034879	['caption (table-wrap): table\xa01\n\nbackground characteristics and changes in them from baseline value given as mean (sd)low dhigh dindependent samples t -test n 4443age, months14.9 (0.5)14.8 (0.5)0.336males, %58550.842aanthropometric and growth variables \xa0weight, kg10.8 (1.3)10.8 (1.3)0.997\xa0relative weight−1.2 (8.1)0.2 (6.7)0.382\xa0∆weight, kg7.1 (1.1)7.2 (1.0)0.624\xa0weight velocity, g/month475 (72)488 (67)0.446\xa0height, cm79.0 (2.8)78.4 (3.5)0.386\xa0height z-score0.25 (1.0)0.03 (1.2)0.378\xa0∆height, cm27.9 (2.0)27.7 (2.9)0.732\xa0height velocity, cm/month1.88 (0.12)1.87 (0.19)0.951 history of Breast feeding and dietary intakes \xa0duration of exclusive breastfeeding, months4.2 (1.9)4.3 (2.0)0.755\xa0currently Breastfed, n (%)11 (26.8)7 (16.6)0.196a\xa0energy intake, kcal/day920 (220)930 (180)0.770\xa0fat intake, g/day28.6 (7.9)28.0 (6.9)0.698\xa0protein Intake, g/day43 (13)42 (10)0.481\xa0Calcium intake, mg/day820 (320)840 (260)0.863\xa0total intake of Vitamin D, μg/day12.4 (3.1)12.2 (2.9)0.782 motor and language skills \xa0age when learnt to crawl, months8.0 (1.8)8.2 (1.8)0.690\xa0age when Learnt to stand, months8.4 (1.7)8.5 (1.6)0.668\xa0age when learnt to walk with support, months8.8 (1.6)10.1 (1.5)0.001\xa0age when Learnt to walk without support, months11.9 (1.6)12.1 (1.5)0.458\xa0number of words in use5.7 (6.2)6.8 (7.7)0.490\napearson chi square\nDESPITE lower Vitamin D concentration during Pregnancy and at Birth in low d than in high d (means 35.7 vs. 54.2\xa0nmol/l, and in the Cord 40.5 and 59.3\xa0nmol/l, independent samples t -test; p \u2009<\u20090.001, respectively), the 25-Ohd concentrations in the two groups at 14\xa0months were SIMILAR (63 vs. 66\xa0nmol/l, p \u2009=\u20090.58).']	[('ANOMALY_CURIOUS_FINDING', 1322), ('SUPERFICIAL_RELATIONSHIP', 1599)]	2	[('UBERON_0000310', 'breast', 586, 'breast'), ('GO_0007567', 'parturition', 699, 'breastfed'), ('GO_0007631', 'feeding behavior', 837, 'intake'), ('CHEBI_31341', 'calcium dihydroxide', 870, 'Calcium'), ('CHEBI_27300', 'vitamin D', 932, 'vitamin D'), ('GO_0007612', 'learning', 1067, 'learnt'), ('GO_0007612', 'learning', 1192, 'learnt'), ('CHEBI_27300', 'vitamin D', 1336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1367, 'pregnancy'), ('GO_0007567', 'parturition', 1384, 'birth'), ('UBERON_0002240', 'spinal cord', 1454, 'cord'), ('CHEBI_72765', 'verruculogen', 1541, '25-OHD')]
PMC3034879	12/2010	S167-PMC3034879	['SOME STUDIES have witnessed that insufficient Vitamin D status during Pregnancy is RELATED to lower bone Mineral status in the newborn [9,10,28].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_46662', 'mineral', 105, 'mineral')]
PMC3034879	12/2010	S189-PMC3034879	['there was a positive ASSOCIATION between total intake of Vitamin D and 25-Ohd in the entire group and in high d, but NOT among those infants in low D whose Vitamin D status during Pregnancy was worse.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 117)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 71, '25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy')]
PMC3075531	7/2010	S0-PMC3075531	['a comparative study of 25 (Oh) Vitamin D Serum levels in patients with multiple sclerosis and control group in isfahan, iran\n\nabstract\n\nobjectives:\nthere is NO STUDY about CORRELATION between Vitamin D Serum level and multiple sclerosis (ms) in iran.']	[('FULL_UNKNOWN', 157), ('SUPERFICIAL_RELATIONSHIP', 172)]	2	[('CHEBI_30778', 'gallic acid', 23, '25 (OH)'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 41, 'Serum'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('UBERON_0001977', 'blood serum', 202, 'serum')]
PMC3075531	7/2010	S35-PMC3075531	['this study SHOWED a significant RELATIONSHIP between Serum levels of Vitamin D between the two groups (p=0.021).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0001977', 'blood serum', 53, 'serum'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3120197	7/2011	S78-PMC3120197	['AS EXPECTED, higher nonheme iron intake was ASSOCIATED with higher intake of fruits, vegetables, fiber, and Vitamin C.\n\ncaption (table-wrap): table 1\n\nparticipants’ characteristics according to quartiles of dietary Heme and nonheme iron intake, seattle and tacoma, wa, omega cohort studycharacteristicdietary Heme iron (mg per day)dietary nonheme iron (mg per day)cohortquintile 1quintile 2quintile 3quintile 4 p for trendquintile 1quintile 2quintile 3quintile 4 p for trend n 3,158806765793794787790791790interval—<0.480.48–0.750.76–1.11≥1.12<9.109.10–12.1612.17–15.97≥12.98median—0.300.610.931.43<0.0017.1610.6513.8119.60<0.001maternal age (years)32.732.632.732.633.00.1032.432.932.932.70.11prepregnancy bmi (kg/m2)23.522.623.223.524.6<0.00123.623.623.423.20.04non-hispanic white (%)87.787.689.588.884.80.0880.987.689.992.2<0.001<12 years of education (%)3.13.72.23.43.00.723.63.03.22.70.35not married (%)10.011.08.19.311.50.6211.49.98.410.30.30nullipara (%)62.267.063.562.256.1<0.00160.261.863.663.20.17smoked during Pregnancy (%)5.45.14.45.46.70.117.14.74.85.10.10prenatal Vitamin use (%)97.697.897.398.197.40.8797.598.497.197.60.72iron deficiency anemia (%)2.33.12.41.81.80.0512.32.01.63.00.43physically inactive in Pregnancy (%)12.111.811.113.112.50.4411.913.911.511.10.35history of hypertension (%)4.23.53.73.56.20.024.35.14.33.20.19family history of hypertension (%)49.245.949.248.952.80.0152.548.248.347.70.08family history of diabetes (%)13.512.313.713.614.40.2614.613.812.812.80.23total energy intake (kcal)1,7171,4201,5631,7862,096<0.0011,1851,6061,8572,216<0.001calories from Carbohydrate (%)53.057.154.452.048.4<0.00151.352.253.555.0<0.001calories from protein (%)17.415.917.117.818.8<0.00117.517.317.517.20.28calories from total fat (%)31.529.330.532.034.1<0.00132.732.331.029.9<0.001calories from Saturated fat (%)11.210.610.911.412.0<0.00111.711.511.110.6<0.001calories from trans fat (%)1.110.971.051.151.25<0.0011.161.141.081.05<0.001calories from polyunsaturated fat (%)6.56.26.36.56.9<0.0016.76.66.46.3<0.001calories from N-3 Fatty Acids (%)0.760.710.750.770.82<0.0010.820.780.730.71<0.001dietary Cholesterol (mg)*271222247269315<0.001298287274249<0.001dietary Vitamin C (mg)*136148142138123<0.001118129129151<0.001dietary Vitamin E (mg)*15.716.416.215.615.00.0019.311.413.722.2<0.001total dietary fiber (g)*20.922.721.820.919.2<0.00116.719.220.923.4<0.001dietary calcium (g)*1.411.541.491.421.27<0.0011.321.321.381.51<0.001dietary total iron (mg)*16.216.716.616.116.00.0029.312.415.222.0<0.001fruits and vegetables (servings per day)4.44.14.24.64.9<0.0013.24.34.75.5<0.001whole grains (servings per day)0.630.580.590.670.68<0.0010.400.530.710.88<0.001red and processed meats (servings per day)0.660.190.470.731.24<0.0010.500.650.720.76<0.001poultry meats (servings per day)0.230.090.190.260.37<0.0010.180.220.240.27<0.001fish meats (servings per day)0.200.110.180.220.28<0.0010.150.180.200.25<0.001\ndata are means or percentages.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 108, 'vitamin C'), ('CHEBI_30413', 'heme', 215, 'heme'), ('CHEBI_30413', 'heme', 309, 'heme'), ('GO_0007565', 'female pregnancy', 1020, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 1077, 'vitamin'), ('GO_0007565', 'female pregnancy', 1221, 'pregnancy'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 1589, 'carbohydrate'), ('CHEBI_51247', 'texas red', 1813, 'saturated'), ('CHEBI_30256', 'thiocarbonyl group', 2043, 'n-3'), ('CHEBI_35366', 'fatty acid', 2047, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 2118, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 2182, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin E')]
PMC3235789	12/2011	S1-PMC3235789	['TO INVESTIGATE ASSOCIATIONS among Serum 25-Hydroxy-Vitamin D (25-Oh-D), Folate, Omega-6/Omega-3 Fatty Acid ratio and bacterial vaginosis (bv) during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_70487', '(-)-sanguinolignan C', 40, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 62, '25-OH-D'), ('CHEBI_30863', '5-azaorotic acid', 72, 'folate'), ('CHEBI_79370', 'ibho#10', 80, 'omega-6'), ('CHEBI_79370', 'ibho#10', 88, 'omega-3'), ('CHEBI_35366', 'fatty acid', 96, 'fatty acid'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC3235789	12/2011	S23-PMC3235789	['national health and nutrition examination survey (nhanes) data from 2001–2004 REVEAL that Vitamin D deficiency is ASSOCIATED with bv in Pregnant, but not nonpregnant, women (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant')]
PMC3235789	12/2011	S129-PMC3235789	['conclusions\nthis case-control study FOUND a significant ASSOCIATION between maternal Plasma 25-Hydroxy-Vitamin D <12\u2009ng/ml and Folate <5\u2009ug/ml and bv during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('UBERON_0001969', 'blood plasma', 85, 'plasma'), ('CHEBI_70487', '(-)-sanguinolignan C', 92, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 127, 'folate'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy')]
PMC3257641	3/2010	S8-PMC3257641	['caption (fig): figure 1\n\nmanifestation of reviewed POSSIBLE major outcomes RELATED to Vitamin D status at different Life Stages.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 116, 'life stages')]
PMC3257641	3/2010	S85-PMC3257641	['Immunomodulation\nearly Life Immunomodulation is LIKELY to also be AFFECTED by Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 0, 'Immunomodulation'), ('UBERON_0000104', 'life cycle', 23, 'life'), ('GO_0050900', 'leukocyte migration', 28, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3257641	3/2010	S96-PMC3257641	['thus within the offspring of Vitamin D deficient mothers, there was lower Birth weight in those having the ff or ff genotype (where the f Allele is associated with increased Vitamin D Receptor activity [65]), but not in offspring with the ff genotype ( p -value for INTERACTION after adjustment for potential CONFOUNDING FACTORS = 0.02) [66].']	[('SUPERFICIAL_RELATIONSHIP', 266), ('PROBLEM_COMPLICATION', 309)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('SO_0001023', 'allele', 138, 'allele'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 174, 'vitamin D receptor')]
PMC3257641	3/2010	S102-PMC3257641	['in Rats, maternal Vitamin D deficiency was ASSOCIATED with an increase in Nephron number, BUT lower Renal Corpuscle size [68].']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 90)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0001285', 'nephron', 74, 'nephron'), ('UBERON_0001229', 'renal corpuscle', 100, 'renal corpuscle')]
PMC3257641	3/2010	S118-PMC3257641	['the diabetes autoimmunity study in the young (daisy) cohort has OBSERVED that Maternal Intake of Vitamin D via Food, recorded at Birth, was significantly ASSOCIATED with a decreased risk of Islet autoimmunity in offspring during the first four years of Life [88].']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 154)]	2	[('GO_0007618', 'mating', 78, 'maternal'), ('GO_0007631', 'feeding behavior', 87, 'intake'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007567', 'parturition', 129, 'birth'), ('CL_0000214', 'synovial cell', 190, 'islet'), ('UBERON_0002533', 'post-anal tail bud', 190, 'islet'), ('UBERON_0000104', 'life cycle', 253, 'life')]
PMC3257641	3/2010	S136-PMC3257641	['using Prenatal ambient uvr levels as an instrumental variable for Vitamin D levels in Pregnancy [113], an inverse ASSOCIATION between maternal ambient uvr exposure during the late first trimester and ms risk was OBSERVED [110].']	[('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 212)]	2	[('GO_0007565', 'female pregnancy', 6, 'prenatal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC3271033	1/2012	S15-PMC3271033	['neonatal Serum 25(Oh)D levels REFLECT a range of in utero FACTORS, most significant of these being the maternal Vitamin D status [6].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 15, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3277098	12/2011	S2-PMC3277098	['it has since been RECOGNIZED that the active form of Vitamin D, 1α,25(Oh)2D3, has direct AFFECTS on Naïve and Activated Helper T cells, Regulatory T Cells, Activated B Cells and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_73394', 'Ala-Ser', 67, '25(OH)2D3'), ('CL_0000540', 'neuron', 100, 'naïve ...'), ('CL_0002627', 'mature astrocyte', 110, 'activated'), ('CL_0000545', 'T-helper 1 cell', 120, 'helper T'), ('CL_0000815', 'regulatory T cell', 136, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 136, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 156, 'activated B cells'), ('CL_0000451', 'dendritic cell', 178, 'dendritic cells')]
PMC3277098	12/2011	S63-PMC3277098	['[4] FOUND that Vitamin D deficiency in Mice is significantly ASSOCIATED with decreased Lung volume, Tissue volume and increased Airway resistance.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 39, 'mice'), ('UBERON_0002048', 'lung', 87, 'lung'), ('UBERON_0000479', 'tissue', 100, 'tissue'), ('UBERON_0001005', 'respiratory airway', 128, 'airway')]
PMC3277098	12/2011	S118-PMC3277098	['for each 2.5 µg/day (100 iu) incremental increase in Vitamin D intake the authors FOUND a 10% decrease risk of wheeze and 13% decrease risk of recurrent wheeze at 2 years (or 0.90; 95% ci, 0.83–0.97 and or 0.87; 95% ci, 0.77–0.97, respectively) and SIMILAR risk of recurrent wheeze at 3 years of age (or 0.80; 95% ci 0.72–0.90), adjusted for multiple factors.']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 249)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3277098	12/2011	S119-PMC3277098	['the ASSOCIATION REMAINED significant after adjusting for several predisposing risk factors and dietary components such as Calcium, Vitamin E, fish and vegetable intake.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 122, 'calcium'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin E')]
PMC3277098	12/2011	S133-PMC3277098	['in this cohort 6.5% of women took a Vitamin D-containing Supplement, a FACTOR that was borderline significant for Vitamin D status, and only 3 women met the uk dietary RECOMMENDATION of 10 µg/day.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('FUTURE_WORK', 168)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 57, 'supplement'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC3277098	12/2011	S187-PMC3277098	['[74] reported that supplementation with 50 µg Vitamin D/day (2000 iu) in the first year of Life was ASSOCIATED with a higher RISK of allergic rhinitis (or 1.66; 95% ci 1.1–1.6, p< 0.001) and atopy (or 1.46; 95% ci 1.4–2.0, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life')]
PMC3319623	4/2012	S61-PMC3319623	['furthermore, neonatal Vitamin D levels are significantly ASSOCIATED with RISK of schizophrenia later in Life[26].']	[('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 104, 'life')]
PMC3347007	4/2012	S14-PMC3347007	['this SUGGESTS that Vitamin D deficiency in Pregnancy will LEAD TO more children being Born deficient [5].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007567', 'parturition', 86, 'born')]
PMC3347007	4/2012	S15-PMC3347007	['in the unborn child, Vitamin D is IMPORTANT for fetal Bone Development through its ROLE in Regulating Calcium Homeostasis [6,7].']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0048539', 'bone marrow development', 54, 'bone development'), ('GO_0065007', 'biological regulation', 91, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 102, 'calcium homeostasis')]
PMC3347007	4/2012	S99-PMC3347007	['inclusion of the above-mentioned covariates in the analyses made the ASSOCIATION between sufficient total Vitamin D intake and number of children stronger, but had no effect on the ASSOCIATION between sufficient total Vitamin D intake and number of smoked cigarettes during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('GO_0007565', 'female pregnancy', 274, 'pregnancy')]
PMC3347007	4/2012	S154-PMC3347007	['we FOUND that smoking was inversely ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347007	4/2012	S187-PMC3347007	['we FOUND supplements to CONTRIBUTE substantially to Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347028	3/2012	S31-PMC3347028	['without this reaction, Humans are DEPENDENT on dietary Intake of Vitamin D, which MAY BE in the form of either Vitamin D2Or D3.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 82)]	2	[('NCBITaxon_9606', 'Homo sapiens', 23, 'humans'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27329', 'xanthosine phosphate', 111, 'vitamin D2or'), ('PR_000017050', 'UDP-glucuronosyltransferase 1A3', 111, 'vitamin D2or D3')]
PMC3347028	3/2012	S38-PMC3347028	['dietary and endogenous Vitamin D APPEAR TO act SIMILARLY with half-life between 12 and 24 h, the length of time depending on how quickly the Liver converts Vitamin D to 25-Hydroxy-Vitamin D (also known as Calcidiol).']	[('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0002107', 'liver', 141, 'liver'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_70487', '(-)-sanguinolignan C', 169, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_17933', 'calcidiol', 205, 'calcidiol')]
PMC3347028	3/2012	S43-PMC3347028	['the half-life of 25(Oh)D is 2–3 weeks, making it a much better INDICATOR of the body’s Vitamin D status than Vitamin D. OF NOTE, 25(Oh)D can be expressed as ng/ml or nmol/l.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('ANOMALY_CURIOUS_FINDING', 120)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D')]
PMC3347028	3/2012	S65-PMC3347028	['significant SUPPORT for the ROLE of Vitamin D in Immune Processes and function came in 2006 when liu et al.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0002252', 'immune effector process', 49, 'immune processes'), ('UBERON_0002405', 'immune system', 49, 'immune')]
PMC3347028	3/2012	S79-PMC3347028	['additionally, the ROLE of Vitamin D in Immune function intensifies the NEED to establish Vitamin D sufficiency during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 71)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 39, 'immune'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC3347028	3/2012	S83-PMC3347028	['THUS, pth levels are RELATED to Vitamin D status as well: pth upregulates 1-α-hydroxylase, the enzyme responsible for 1-α-hydroxylation of 25(Oh)D, converting 25(Oh)D to 1,25(Oh)2D.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 139, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 159, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 172, '25(OH)2D')]
PMC3347028	3/2012	S144-PMC3347028	['there is a strong RELATIONSHIP between maternal and fetal (Cord Blood) circulating 25(Oh)D levels [92,93,94,95] such that maternal Vitamin D deficiency is MIRRORED by neonatal Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 155)]	2	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 83, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC3347028	3/2012	S149-PMC3347028	['[100], comparing growth parameters in newborn infants with the maternal Intakes of milk and Vitamin D during Pregnancy, FOUND an ASSOCIATION between Vitamin D intake during Pregnancy and Birth weight.']	[('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 129)]	2	[('GO_0007631', 'feeding behavior', 72, 'intakes'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('GO_0007567', 'parturition', 187, 'birth')]
PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]
PMC3348565	4/2012	S22-PMC3348565	['there is DEBATE between investigators regarding concentrations that RELATE to optimum stores of Vitamin D in the body.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3348565	4/2012	S128-PMC3348565	['the optimum concentrations of Vitamin D for Adults and children6are BASED ON non-immunological and, MOSTLY, bone outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 100)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0007023', 'adult organism', 44, 'adults')]
PMC3355895	1/2011	S3-PMC3355895	['physiological systems include Vitamin D, Parathyroid hormone, leptin, gh/Igf-1; finally the POTENTIAL ROLE of epigenetic processes in the underlying mechanisms will be explored.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 102)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 41, 'parathyroid'), ('PR_000008929', 'interferon-related developmental regulator 1', 73, 'IGF-1')]
PMC3356951	4/2012	S10-PMC3356951	['a meta-analysis published in 2007 SHOWED that Vitamin D supplementation was ASSOCIATED with significantly reduced mortality.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3356951	4/2012	S18-PMC3356951	['[6] a meta-analysis published in 2007 SHOWED that Vitamin D supplementation was ASSOCIATED with significantly reduced mortality.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3356951	4/2012	S89-PMC3356951	['Vitamin D crosses the Blood–Brain barrier and the receptors for Vitamin D are found across the Brain, but its precise ROLE is STILL NOT KNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 118), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000955', 'brain', 28, 'brain'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000955', 'brain', 95, 'brain')]
PMC3356951	4/2012	S142-PMC3356951	['age-related Macular Regeneration\nhigh Vitamin D Blood levels APPEAR TO BE ASSOCIATED with a decreased risk for the development of early age-related Macular degeneration (amd) among women younger than 75 years.']	[('ANOMALY_CURIOUS_FINDING', 61), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('UBERON_0000054', 'macula', 12, 'macular'), ('GO_0031099', 'regeneration', 20, 'regeneration'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0000054', 'macula', 148, 'macular')]
PMC3395583	7/2012	S6-PMC3395583	["the risk of id was inversely CORRELATED with PREDICTED second Trimester uvb exposure (spearman's rho = -0.49, p = 0.00005) and third Trimester Vitamin D status (spearman's rho = -0.44, p = 0.0003)."]	[('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0009294', 'DNA mediated transformation', 62, 'trimester'), ('GO_0009294', 'DNA mediated transformation', 133, 'trimester'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3395583	7/2012	S8-PMC3395583	['Gestational uvb and Vitamin D exposure MAY BE IMPLICATED in the aetiology of id.']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3395583	7/2012	S59-PMC3395583	['figure3shows the direct RELATION between uvb radiation and Vitamin D status and the amount of time required for a change in uvb to IMPACT on Vitamin D Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 131)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 141, 'vitamin D metabolism')]
PMC3407995	7/2012	S94-PMC3407995	['Vitamin D insufficiency HAS BEEN ASSOCIATED with reduction in bone Mineral content of the offspring [51] and Perinatal growth restriction [52].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('CHEBI_46662', 'mineral', 67, 'mineral'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
PMC3407995	7/2012	S257-PMC3407995	['differences in latitude HAVE also BEEN SHOWN to INFLUENCE the concentration of Vitamin D in a majority of Pregnant women [140].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnant')]
PMC3407995	7/2012	S260-PMC3407995	['Miscarriages CAN also result from an increased rate of bacterial vaginosis in the 1st Trimester of Pregnancy that is ASSOCIATED with low Vitamin D status [49].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('GO_0042700', 'luteinizing hormone signaling pathway', 0, 'Miscarriages'), ('GO_0009294', 'DNA mediated transformation', 86, 'trimester'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3407995	7/2012	S287-PMC3407995	['in addition, there was an increase in late (5–10 days of age) and late-late (2–12 weeks of age) neonatal hypocalcaemia presenting predominantly with seizures, DEMONSTRATING the INVOLVEMENT of Vitamin D in Brain function [50].']	[('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 177)]	2	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('UBERON_0000955', 'brain', 205, 'brain')]
PMC3407995	7/2012	S306-PMC3407995	['studies SHOWING CORRELATION between maternal and foetal Vitamin D status\nfive hundred and six Pregnant women were given 400 iu (10μg) of Vitamin D per day from about the 12th week of Pregnancy until Delivery [150].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('CHEBI_28384', 'vitamin K', 56, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007567', 'parturition', 199, 'delivery')]
PMC3424155	8/2012	S22-PMC3424155	['therefore, the adverse EFFECTS of Vitamin D restriction during Kidney Development NEED FURTHER exploration.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0001822', 'kidney development', 63, 'kidney development'), ('UBERON_0002113', 'kidney', 63, 'kidney')]
PMC3424155	8/2012	S167-PMC3424155	['in the PRESENT STUDY, maternal Vitamin D deficiency in Mice LED TO significant changes in Kidney Development in the offspring, such as retardation of Glomerular Maturation and an increase in the number of Glomeruli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 150, 'glomerular'), ('GO_0007618', 'mating', 161, 'maturation'), ('UBERON_0000074', 'renal glomerulus', 205, 'glomeruli')]
PMC3424155	8/2012	S169-PMC3424155	['furthermore, NOT ONLY the f1 generation BUT ALSO the f2 generation was AFFECTED by the Gestational Vitamin D deficiency of the f0 generation Mice.']	[('ANOMALY_CURIOUS_FINDING', 13), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('GO_0007565', 'female pregnancy', 87, 'gestational'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'mice')]
PMC3424155	8/2012	S188-PMC3424155	['ALTHOUGH the vitd- offspring in the present study did not show a reduction in Wt1 Expression, maternal Vitamin D deficiency did alter the ratio of immature-to-mature Glomeruli at Birth by EXTENDING the period of Glomerular maturation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 188)]	2	[('PR_000017450', 'protein Wnt-8a', 78, 'WT1'), ('GO_0010467', 'gene expression', 82, 'expression'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 166, 'glomeruli'), ('GO_0007567', 'parturition', 179, 'birth'), ('UBERON_0000074', 'renal glomerulus', 212, 'glomerular')]
PMC3424155	8/2012	S212-PMC3424155	['maternal Vitamin D deficiency is ACCOMPANIED by changes in the Renal Expression of Podocin, Renin and at1 receptors, and it delays the maturity of the Glomeruli, by EXTENDING Nephrogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002113', 'kidney', 63, 'renal'), ('GO_0010467', 'gene expression', 69, 'expression'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 83, 'podocin'), ('PR_000014368', 'RuvB-like 1', 92, 'renin'), ('UBERON_0000074', 'renal glomerulus', 151, 'glomeruli'), ('GO_0001822', 'kidney development', 175, 'nephrogenesis')]
PMC3427192	4/2012	S14-PMC3427192	['Vitamin D overview\nVitamin D, a fat-soluble Nutrient, is a Secosteroid Hormone which is widely recognized as a modulator of calcium absorption and bone health and further Regulates Neuromuscular function, Cellular Differentiation, Insulin secretion, and Blood pressure.25,26vitamin D also plays an IMPORTANT ROLE in Immune Regulation through interactions between 1,25-Dihydroxyvitamin D and Vitamin D receptors ( vdrs ) .']	[('IMPORTANT_CONSIDERATION', 298), ('SUPERFICIAL_RELATIONSHIP', 308)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 44, 'nutrient'), ('CHEBI_26661', 'shidasterone', 59, 'secosteroid hormone'), ('GO_0065007', 'biological regulation', 171, 'regulates'), ('UBERON_0001016', 'nervous system', 181, 'neuromuscular'), ('GO_0030154', 'cell differentiation', 205, 'cellular differentiation'), ('PR_000045358', 'insulin family protein', 231, 'insulin'), ('UBERON_0000178', 'blood', 254, 'blood'), ('PR_000006444', 'diacylglycerol kinase delta', 282, 'D'), ('UBERON_0002405', 'immune system', 316, 'immune'), ('GO_0065007', 'biological regulation', 323, 'regulation'), ('CHEBI_67472', '15-epi-lupulin B', 363, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D')]
PMC3427192	4/2012	S25-PMC3427192	['WHEREAS devereux et al.61did observe a negative ASSOCIATION between Vitamin D intake and wheezing in preschool children, no associations between Vitamin D intake and asthma were noted in children 5 y of age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3427192	4/2012	S56-PMC3427192	['ultimately, randomized controlled trials of Vitamin D ARE NEEDED in Adults with asthma to determine the causal ASSOCIATIONS between Vitamin D and asthma and to develop an evidence base for treatment.']	[('FUTURE_WORK', 54), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0007023', 'adult organism', 68, 'adults'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3427192	4/2012	S67-PMC3427192	['conclusion\nthere is a GROWING INTEREST in the ROLE of Vitamin D in asthma and Respiratory disorders across the Lifespan.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 78, 'respiratory'), ('UBERON_0000104', 'life cycle', 111, 'lifespan')]
PMC3427250	8/2012	S101-PMC3427250	['the variations of 25-(Oh)D concentration with seasons REFLECT the changes in uvb exposure, one of the main DETERMINANTS of Vitamin D status in many european countries.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_72657', '19,20-DiHDPA', 18, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3427250	8/2012	S121-PMC3427250	['this ASSUMPTION is based on the fact that the main risk factors ASSOCIATED with Vitamin D deficiency (sun exposure and/or ethnicity) are common to many european countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3458940	9/2012	S11-PMC3458940	['introduction\nAll- Trans Retinoic Acid (Tra) is the primary Bioactive form of endogenous Retinoids derived from dietary Vitamin A and plays IMPORTANT ROLES in Regulating a myriad of physiological events[1].']	[('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_80638', '3-Oxovalproic acid', 13, 'All- trans retinoic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 39, 'tRA'), ('CHEBI_51870', 'boryl group', 59, 'bioactive'), ('CHEBI_26537', 'retinoid', 88, 'retinoids'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('GO_0065007', 'biological regulation', 158, 'regulating')]
PMC3458940	9/2012	S159-PMC3458940	['moreover, post-Natal Vitamin A deficiency HAS BEEN ASSOCIATED with Renal anomalies, including increased incidence of pyelonephritis, Kidney inflammation and fibrosis, polyuria and Dysregulated Urinary Ion/solute content, urolithiasis, and delayed Tissue Repair[7],[41],[42],[43],[44].']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('GO_0007567', 'parturition', 15, 'natal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('UBERON_0002113', 'kidney', 67, 'renal'), ('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0060203', 'clathrin-sculpted glutamate transport vesicle membrane', 180, 'dysregulated'), ('UBERON_0001088', 'urine', 193, 'urinary'), ('CHEBI_24870', 'ion', 201, 'ion'), ('UBERON_0000479', 'tissue', 247, 'tissue'), ('GO_0006281', 'DNA repair', 254, 'repair')]
PMC3465343	10/2012	S28-PMC3465343	['ra, an active form of Vitamin A, plays ESSENTIAL ROLES in many physiological functions, including Vision, Immunity, and Cell Differentiation[15]–[17].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0007601', 'visual perception', 98, 'vision'), ('GO_0007566', 'embryo implantation', 106, 'immunity'), ('GO_0030154', 'cell differentiation', 120, 'cell differentiation')]
PMC3465343	10/2012	S129-PMC3465343	['HOWEVER, the RELATIONSHIP between the congenital Spinal deformities and Vitamin A deficiency has been poorly understood.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('UBERON_0001130', 'vertebral column', 49, 'spinal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A')]
PMC3465343	10/2012	S154-PMC3465343	['ra is the active form of Vitamin A and plays a CRUCIAL ROLE in stimulating Nuclear receptor signaling during development.']	[('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0005634', 'nucleus', 75, 'nuclear')]
PMC3470091	9/2012	S73-PMC3470091	['they SHOWED that supplementation with an oral dose of 300,000 iu of Vitamin D and 500-1000 mg daily of Calcium LED TO an increase in the concentration of Serum Vitamin D from 15 to 81.4 nmol/l.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 103, 'calcium'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC3470091	9/2012	S75-PMC3470091	['the mechanism of pth reduction is that an increased Serum Vitamin D LEADS to a decrease in pth Gene Translation, and THUS pth secretion.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 117)]	2	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('SO_0000704', 'gene', 95, 'gene'), ('GO_0006412', 'translation', 100, 'translation')]
PMC3470091	9/2012	S80-PMC3470091	['in ANOTHER STUDY,15administration of 600,000 iu of Vitamin D was ASSOCIATED with a significant increase in Serum Vitamin D, a significant decrease in Serum pth, and hypercalcemia occurring in 4% of the subjects during 4 and 12 months of intervention.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 150, 'serum')]
PMC3470091	9/2012	S88-PMC3470091	['THEREFORE, a single dose of 300,000 iu dose employed in this study is of higher EFFECTIVENESS compared with an Oral dose, especially in People suffering from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('UBERON_0000165', 'mouth', 111, 'oral'), ('NCBITaxon_10088', 'Mus <genus>', 136, 'people'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3471827	10/2012	S130-PMC3471827	['the malformations ASSOCIATED with ttp knockdown are DIFFERENT from those caused by parental diet-induced Vitamin E deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin E')]
PMC3472720	8/2012	S22-PMC3472720	['we wondered IF the second generation (f2) had any persisting alterations in Immune function RELATED to the Vitamin D status of the Pregnant f0female Mice.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('UBERON_0002405', 'immune system', 76, 'immune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice')]
PMC3475131	6/2012	S110-PMC3475131	['four of the seven systematic reviews assessed the ROLE of Vitamin A [16,17,20,21], although ONLY one was of high quality.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A')]
PMC3476426	8/2012	S20-PMC3476426	['it has since been RECOGNIZED that the active form of Vitamin D has direct AFFECTS on Naïve and Activated Helper T Cells, Regulatory T Cells, Activated B Cells, and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CL_0000540', 'neuron', 85, 'naïve ...'), ('CL_0002131', 'regular ventricular cardiac myocyte', 95, 'activated helper T cells'), ('CL_0000815', 'regulatory T cell', 121, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 121, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 141, 'activated B cells'), ('CL_0000451', 'dendritic cell', 164, 'dendritic cells')]
PMC3476426	8/2012	S143-PMC3476426	['maternal and early childhood Vitamin D deficiency MAY allow the Genetic TENDENCY for autism to Express itself.']	[('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genetic'), ('GO_0010467', 'gene expression', 95, 'express')]
PMC3485340	10/2012	S147-PMC3485340	['these results INDICATE that Prenatal vitc deficiency negatively AFFECTS the Migration Of newborn Cells into the Gl.10.1371/journal.pone.0048488.g004\n\ncaption (fig): figure 4\nPrenatal Vitamin C deficiency causes sustained reduction in Postnatal Migration Of newborn Cells into the granule layer.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('GO_0016477', 'cell migration', 76, 'migration of ... cells'), ('UBERON_0001792', 'ganglionic layer of retina', 112, 'GL'), ('GO_0007565', 'female pregnancy', 174, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin C'), ('GO_0007567', 'parturition', 234, 'postnatal'), ('GO_0016477', 'cell migration', 244, 'migration of ... cells')]
PMC3485340	10/2012	S165-PMC3485340	['by up-regulating Expression of the Vitamin C transporter Svct2 protein or OTHER PROTECTIVE mechanisms, to increase Postnatal Vitc uptake and retention in the Brain ensuring a rapid repletion once an adequate vitc supply is provided.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('GO_0010467', 'gene expression', 17, 'expression'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin C'), ('PR_000004900', 'complement C3', 43, 'C'), ('PR_000015393', 'suppressor of cytokine signaling 2', 57, 'SVCT2'), ('GO_0007567', 'parturition', 115, 'postnatal'), ('GO_0007601', 'visual perception', 125, 'VitC'), ('UBERON_0000955', 'brain', 158, 'brain')]
PMC3485340	10/2012	S205-PMC3485340	['marginal Vitamin C deficiency is far from uncommon in Humans, and MAY AFFECT large subpopulations including mothers-to-be and young children[52].']	[('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'humans')]
PMC3501517	11/2012	S17-PMC3501517	['Autoimmune diseases such as type 1 diabetes[10], multiple sclerosis[11]and asthma[12],[13]HAVE BEEN ASSOCIATED with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('UBERON_0005445', 'segment of pes', 0, 'Autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3501517	11/2012	S21-PMC3501517	['Neutrophils also Express the Vitamin D receptor[21]; HOWEVER, beyond the fact that patients with rickets have impaired Neutrophil Chemotaxis[22], little else is known about Vitamin D Regulation Of Neutrophil Function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 183)]	2	[('CL_0000775', 'neutrophil', 0, 'Neutrophils'), ('GO_0010467', 'gene expression', 17, 'express'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 37, 'D'), ('CL_0000775', 'neutrophil', 119, 'neutrophil'), ('GO_0007567', 'parturition', 119, 'neutrophil'), ('GO_0006935', 'chemotaxis', 130, 'chemotaxis'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_1902530', 'positive regulation of protein linear polyubiquitination', 183, 'regulation of neutrophil function'), ('CL_0000775', 'neutrophil', 197, 'neutrophil')]
PMC3501517	11/2012	S29-PMC3501517	['we HYPOTHESIZED that Vitamin D level would INFLUENCE Lps-induced Lung inflammation and injury, and its resolution.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 53, 'LPS'), ('UBERON_0002048', 'lung', 65, 'lung')]
PMC3501517	11/2012	S153-PMC3501517	['Lung inflammation and injury 10 days after Lps\nTO INVESTIGATE the EFFECT of Vitamin D deficiency on resolution of Lung injury, we evaluated Mice at day 10 after Lps or pbs instillation[34].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 43, 'LPS'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002048', 'lung', 114, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 140, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 161, 'LPS')]
PMC3501517	11/2012	S181-PMC3501517	['the PRIMARY findings of this study are that Vitamin D level has minimal IMPACT on acute inflammation and injury following Lps and on subsequent resolution of inflammation and injury.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 122, 'LPS')]
PMC3501517	11/2012	S211-PMC3501517	['these data INDICATE that chronic Vitamin D deficiency has minimal IMPACT on the acute inflammatory response to Lps or in resolution of Lps-induced Lung injury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 111, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 135, 'LPS'), ('UBERON_0002048', 'lung', 147, 'lung')]
PMC3501517	11/2012	S216-PMC3501517	['epidemiological data SUGGEST that Vitamin D level is ASSOCIATED with severity of illness with community-acquired pneumonia[42],[43].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC3501517	11/2012	S229-PMC3501517	['IN SUMMARY, Vitamin D deficiency, established through dietary restriction, has minimal IMPACT on the acute inflammatory response to Lps in the Lung or resolution of inflammation.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 132, 'LPS'), ('UBERON_0002048', 'lung', 143, 'lung')]
PMC3509518	11/2012	S1-PMC3509518	['we INVESTIGATED ASSOCIATIONS between maternal intakes of Β-Carotene, Vitamin C, Vitamin E, copper and zinc, and infant allergic outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 57, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin E')]
PMC3509518	11/2012	S3-PMC3509518	['the main RELATIONSHIPS with allergic outcomes were SEEN with dietary Vitamin C and copper.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 51)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin C')]
PMC3509518	11/2012	S84-PMC3509518	['for “any allergic disease” higher maternal dietary Vitamin C intake was ASSOCIATED with a reduced risk of diagnosed allergic disease at 1 year for the highest versus the lowest quartile (the crude odds ratio [or] = 0.48, 95% ci 0.25–0.93), ALTHOUGH the inverse linear trend and the adjusted or were not statistically significant (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 240)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin C')]
PMC3509518	11/2012	S87-PMC3509518	['there were also RELATIONSHIPS between Vitamin C intake and both Food allergy ( ptrend= 0.07) and sensitisation ( ptrend= 0.07) ALTHOUGH neither of these was statistically significant.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 127)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C'), ('CHEBI_33290', 'food', 64, 'food')]
PMC3509518	11/2012	S105-PMC3509518	['furthermore, maternal dietary Vitamin C intake in Pregnancy APPEARED PROTECTIVE against Development Of Wheeze in the first year of Life.']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0060041', 'retina development in camera-type eye', 88, 'development of wheeze'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC3509518	11/2012	S128-PMC3509518	['there is a PAUCITY of intervention studies with Vitamin C in Pregnancy for PREVENTION of allergic disease.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin C'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC3515553	12/2012	S3-PMC3515553	['we then examined the ASSOCIATION of Snps in maternal Genes Fut2 (rs492602) and tcn2 (rs1801198, rs9606756) that are RELATED to Plasma Vitamin B-12, with offspring iq.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('SO_0000694', 'SNP', 36, 'SNPs'), ('SO_0000704', 'gene', 53, 'genes'), ('PR_000007719', 'frizzled-2', 59, 'FUT2'), ('UBERON_0001969', 'blood plasma', 127, 'plasma'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-12')]
PMC3515553	12/2012	S4-PMC3515553	['observationally, there was a positive ASSOCIATION between maternal Vitamin B-12 intake and child’s iq that was markedly attenuated after adjustment for potential CONFOUNDERS (mean difference in offspring iq score per doubling of maternal B-12 Intake, before adjustment: 2.0 (95% ci 1.3, 2.8); after adjustment: 0.7 (95% ci −0.04, 1.4)).']	[('SUPERFICIAL_RELATIONSHIP', 38), ('PROBLEM_COMPLICATION', 162)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 67, 'vitamin B-12'), ('PR_000004770', 'Polycomb complex protein BMI-1', 238, 'B-12'), ('GO_0007631', 'feeding behavior', 243, 'intake')]
PMC3515553	12/2012	S68-PMC3515553	['the ASSOCIATION of Cord Blood Vitamin B-12 and offspring iq was SIMILARLY adjusted for covariates and mediators.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 30, 'vitamin B-12')]
PMC3515553	12/2012	S69-PMC3515553	['in these analyses, we log transformed Vitamin B-12 to base 2 so that results are INTERPRETED as a mean difference in iq per doubling of Vitamin B-12 intake or status.10.1371/journal.pone.0051084.t002\n\ncaption (table-wrap): table 2\nASSOCIATION of maternal dietary vitamin b-12 Intake during Pregnancy with offspring iq at age 8.']	[('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 231)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 38, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('GO_0007631', 'feeding behavior', 276, 'intake'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC3515553	12/2012	S89-PMC3515553	['Cord Blood Vitamin B-12 was also positively ASSOCIATED, by a SIMILAR magnitude, with iq (mean age and sex adjusted difference in offspring iq per doubling of Cord Vitamin B-12∶2.9, 95% ci −0.1, 5.8, p\u200a=\u200a0.06).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 11, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 158, 'cord'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017260', 'tubulinyl-Tyr carboxypeptidase 1', 163, 'vitamin B-12∶'), ('CHEBI_37983', 'sulfur-35 atom', 173, '12'), ('CHEBI_24870', 'ion', 175, '∶')]
PMC3515553	12/2012	S93-PMC3515553	['Vitamin B-12 status RELATED Snps, maternal dietary intake of Vitamin B-12 and Cord Blood Vitamin B-12\nneither of the maternal Snps was associated with maternal dietary Intake of Vitamin B-12 during Pregnancy in a linear model, ALTHOUGH tcn2 rs1801198 heterozygotes showed higher Vitamin B-12 intake than either homozygote group (p\u200a=\u200a0.02).']	[('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('SO_0000694', 'SNP', 28, 'SNPs'), ('PR_000017269', 'ventral anterior homeobox 2', 61, 'Vitamin B-12'), ('UBERON_0000948', 'heart', 78, 'Cord'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('PR_000017269', 'ventral anterior homeobox 2', 89, 'Vitamin B-12'), ('SO_0000694', 'SNP', 126, 'SNPs'), ('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 178, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 279, 'vitamin B-12')]
PMC3515553	12/2012	S99-PMC3515553	['offspring Haplotypes were not associated with Cord Blood Vitamin B-12 (data not shown).10.1371/journal.pone.0051084.t003\n\ncaption (table-wrap): table 3\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with maternal dietary intake at 32 weeks Pregnant and Vitamin B-12 Cord Blood concentration.Snpgenotypenamedian (iqr) of maternal Vitaminb-12 dietary intake (µg/day)nmedian (iqr) of Vitamin B-12 Cord Blood (pmol/l) Fut2 rs492602tt16424.2 (3.0, 6.1)62291 (183, 397)tc31874.2 (3.0, 6.1)128300 (196, 424)cc16484.3 (3.0, 6.2)50294 (214, 534)ratio of geometric means perc Allele (95% ci)64771.00 (0.98, 1.02)2401.08 (0.97, 1.19)p-valuea0.82/0.960.15/0.31 tcn2 rs1801198gg12764.1 (3.0, 5.9)41276 (173, 369)cg32214.3 (3.2, 6.2)125279 (196, 417)cc20024.1 (3.0, 6.1)68318 (226, 436)ratio of geometric meansper c Allele (95% ci)64991.01 (0.99, 1.03)2341.13 (1.02–1.25)p-valuea0.44/0.020.02/0.07 tcn2 rs9606756aa54834.3 (3.1, 6.2)193288 (205, 397)ag16504.3 (3.0, 6.1)58298 (206, 484)gg1204.0 (2.9, 6.1)2238 (82, 394)ratio of geometric meansper G Allele (95% ci)72530.99 (0.96, 1.01)2531.03 (0.89, 1.18)p-valuea0.23/0.460.73/0.31\nn reflects the number of mothers with genotype and dietary Intake or offspring Cord Blood Vitamin B-12 data, regardless of whether there was offspring iq data available for them as well.']	[('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('SO_0001024', 'haplotype', 10, 'haplotypes'), ('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('SO_0000694', 'SNP', 188, 'SNPs'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 204, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 204, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 269, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin B'), ('UBERON_0002240', 'spinal cord', 295, 'cord'), ('UBERON_0000178', 'blood', 300, 'blood'), ('SO_0001744', 'UPD', 320, 'SNPgenotypeNamedian'), ('CHEBI_27300', 'vitamin D', 358, 'vitaminB'), ('PR_000017269', 'ventral anterior homeobox 2', 358, 'vitaminB-12'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin B'), ('UBERON_0002240', 'spinal cord', 423, 'cord'), ('UBERON_0000178', 'blood', 428, 'blood'), ('PR_000007719', 'frizzled-2', 443, 'FUT2'), ('SO_0001023', 'allele', 595, 'allele'), ('SO_0001023', 'allele', 831, 'allele'), ('SO_0001434', 'cassette_pseudogene', 1061, 'G'), ('SO_0001023', 'allele', 1063, 'allele'), ('GO_0007631', 'feeding behavior', 1205, 'intake'), ('UBERON_0002240', 'spinal cord', 1225, 'cord'), ('UBERON_0000178', 'blood', 1230, 'blood'), ('CHEBI_27300', 'vitamin D', 1236, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 1236, 'vitamin B-12')]
PMC3515553	12/2012	S113-PMC3515553	['the expected EFFECTS of maternal Vitamin B-12 on offspring iq, based on the EFFECT of each genotype on Cord Blood Vitamin B-12 and on child’s iq, were 0.6, 1.1 and 1.6 additional iq points per doubling of Vitamin B-12 in Cord Blood when using tcn2 rs1801198, rs9606756, and Fut2 , respectively as proxies.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 33, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 43, '12'), ('UBERON_0002240', 'spinal cord', 103, 'cord'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 221, 'cord'), ('UBERON_0000178', 'blood', 226, 'blood'), ('PR_000007719', 'frizzled-2', 274, 'FUT2')]
PMC3515553	12/2012	S114-PMC3515553	['all EFFECT estimates were included within the 95% ci of the observed effect of Cord Blood Vitamin B-12 on iq scores (2.9; 95% ci -0.1, 5.8), and were compatible with a negative, null and largely positive ASSOCIATION of Vitamin B-12 levels with offspring iq.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 204)]	2	[('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 90, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 100, '12'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 219, 'vitamin B-12')]
PMC3515553	12/2012	S167-PMC3515553	['because we used smaller subsets of samples from the original alspac study to assess ASSOCIATIONS of Snps with Cord Blood Vitamin B-12 and iq, there is always the POSSIBILITY of these subsets not being representative of the population under study.']	[('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 162)]	2	[('SO_0000694', 'SNP', 100, 'SNPs'), ('UBERON_0009472', 'axilla', 110, 'cord blood'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 121, 'vitamin B-12')]
PMC3515553	12/2012	S177-PMC3515553	['caption (supplementary-material): table s3\n\nASSOCIATION of offspring genotype at Snps RELATED to Vitamin B-12 Metabolism with Vitamin B-12 Cord Blood concentration.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('SO_0000694', 'SNP', 81, 'SNPs'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 97, 'vitamin B-'), ('GO_0000010', 'trans-hexaprenyltranstransferase activity', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC3586494	2/2013	S118-PMC3586494	['maternal Vitamin A and e levels were higher than cord values, YET there was a positive CORRELATION between maternal and cord levels of these two Vitamins.']	[('ANOMALY_CURIOUS_FINDING', 62), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 145, 'vitamins')]
PMC3613945	2/2013	S74-PMC3613945	['ASSOCIATION between common Genetic variants of the Vitamin D Binding Protein Gene (gc) and various diseases.sample size ( n )diseasereferencecasescontrolscountryethnicitygc polymorphisms studiedfindings cancer Breast cancerabbas et al.16014022608germanycaucasianagc1f, gc1s, gc2genotype Gc2-2 was ASSOCIATED with decreased risk of Postmenopausal Breast cancer, [or\u2009=\u20090.72 (ci\u2009=\u20090.54–0.96, p \u2009=\u20090.04)], when compared to the most frequently observed genotype, gc1s-1s.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 297)]	2	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'vitamin D binding protein'), ('SO_0000704', 'gene', 77, 'gene'), ('UBERON_0000310', 'breast', 210, 'Breast'), ('PR_000008010', 'glycerol kinase', 287, 'Gc2-2'), ('GO_0007595', 'lactation', 331, 'postmenopausal'), ('UBERON_0000310', 'breast', 346, 'breast')]
PMC3613945	2/2013	S142-PMC3613945	['the primary clinical MARKER of osteoporosis, lower bone Mineral density (bmd), is ASSOCIATED with Vitamin D insufficiency78–80.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_46662', 'mineral', 56, 'mineral'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3629265	4/2013	S0-PMC3629265	['SEVERE Vitamin D deficiency in 6 canadian first nation formula-Fed infants\n\nabstract\n\nbackground\nrickets was first described in the 17th century and Vitamin D deficiency was recognized as the UNDERLYING cause in the early 1900s.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 192)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007631', 'feeding behavior', 63, 'fed'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3629265	4/2013	S47-PMC3629265	['all had multiple RISK FACTORS for Vitamin D deficiency including darker skin pigmentation, limited cutaneous sun exposure, residence at a northern latitude of 54°, and confirmed or SUSPECTED Vitamin D deficiency in their mothers.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 181)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3629265	4/2013	S49-PMC3629265	['in the 2 youngest infants in our series, it is LIKELY that profound maternal Vitamin D deficiency was the most significant FACTOR leading to the early presentation of these infants.']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 123)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3629265	4/2013	S93-PMC3629265	['attention also NEEDS to be focused on the PREVENTION of maternal Vitamin D deficiency.']	[('FUTURE_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3641012	4/2013	S55-PMC3641012	['Serum aliquots were frozen at −20°c and shipped at ambient temperature from bangladesh to toronto for measurement of Serum 25(Oh)D concentration, a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [17].']	[('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3641012	4/2013	S200-PMC3641012	['in particular, the overall proportion of encounters in which there was at least one symptom POSSIBLY suggestive of hypercalcemia was SIMILAR for the Placebo and Vitamin D groups (54% vs. 53%, p \u2009=\u20090.71; analysis accounted for repeated events within the same participants).']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 133)]	2	[('CHEBI_26130', 'biological pigment', 149, 'placebo'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC3651971	5/2013	S0-PMC3651971	['cognitive and motor skills in school-aged children following maternal Vitamin A supplementation during Pregnancy in rural nepal: a follow-up of a placebo-controlled, randomised cohort\n\nabstract\n\nobjective\nTO DETERMINE the EFFECTS of maternal Vitamin A supplementation from Preconception through Postpartum on Cognitive and Motor Development of children at 10–13\u2005years of age in rural nepal.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('SUPERFICIAL_RELATIONSHIP', 222)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin A'), ('GO_0007565', 'female pregnancy', 273, 'preconception'), ('GO_0007565', 'female pregnancy', 295, 'postpartum'), ('GO_0050890', 'cognition', 309, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 323, 'motor development')]
PMC3651971	5/2013	S161-PMC3651971	['in conclusion, in this Vitamin A deficient setting, where maternal Vitamin A supplementation reduced maternal night blindness and mortality, no long-term EFFECTS have BEEN observed on the Cognitive and motor skill development of Prepubescent offspring.']	[('SUPERFICIAL_RELATIONSHIP', 154), ('ANOMALY_CURIOUS_FINDING', 167)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('GO_0050890', 'cognition', 188, 'cognitive ...'), ('GO_0048633', 'positive regulation of skeletal muscle tissue growth', 229, 'prepubescent')]
PMC3659910	1/2013	S38-PMC3659910	['[8] the active form of Vitamin D (1,25-Dihydroxyvitamin D3, 1,25[Oh] 2D3) has WELL-ESTABLISHED EFFECTS on bone Metabolism and Mineral Homeostasis.']	[('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 34, '1,25-dihydroxyvitamin D3'), ('CHEBI_64115', '(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin hydrochloride', 62, '25[OH] 2D3'), ('GO_0008152', 'metabolic process', 111, 'metabolism'), ('CHEBI_46662', 'mineral', 126, 'mineral'), ('GO_0055085', 'transmembrane transport', 126, 'mineral homeostasis')]
PMC3659910	1/2013	S118-PMC3659910	['nutritional Vitamin D status has very RECENTLY been LINKED to the Human innate Immune System and its ability to contain mycobacterium tuberculosis.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('GO_0007566', 'embryo implantation', 79, 'immune'), ('UBERON_0002405', 'immune system', 79, 'immune system')]
PMC3659910	1/2013	S139-PMC3659910	['[32]\n\nROLE of Vitamin D in newborn and infant\nadequate maternal Vitamin D levels are also IMPORTANT for fetal and child health.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3668200	5/2013	S2-PMC3668200	['many Genetic, dietary, and environmental FACTORS AFFECT the body concentration of Vitamin D, Calcium, Phosphorus, and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('SO_0000704', 'gene', 5, 'genetic'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 93, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 102, 'phosphorus'), ('GO_0007567', 'parturition', 118, 'bone'), ('GO_0008152', 'metabolic process', 123, 'metabolism')]
PMC3672018	5/2013	S2-PMC3672018	['the PRESENT STUDY includes an in-depth examination of the INFLUENCE of exposure to Vitamin D early in Life for development of fractures of the Wrist, Arm and Clavicle; obesity, and type 1 diabetes (t1d) during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life'), ('UBERON_0004452', 'carpal region', 143, 'wrist'), ('UBERON_0001460', 'arm', 150, 'arm'), ('UBERON_0001105', 'clavicle bone', 158, 'clavicle'), ('UBERON_0000113', 'post-juvenile adult stage', 221, 'adulthood')]
PMC3672018	5/2013	S15-PMC3672018	['widely distributed in body Tissues, a vdr, once bound to a Vitamin D ligand, travels to the Nucleus where it binds to sites within the Human Genome and CONSEQUENTLY INFLUENCES the activity, or Expression, of individual Genes.']	[('PROBABLE_UNDERSTANDING', 152), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0000479', 'tissue', 27, 'tissues'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0005634', 'nucleus', 92, 'nucleus'), ('NCBITaxon_9606', 'Homo sapiens', 135, 'human'), ('SO_0001026', 'genome', 141, 'genome'), ('GO_0010467', 'gene expression', 193, 'expression'), ('SO_0000704', 'gene', 219, 'genes')]
PMC3672018	5/2013	S16-PMC3672018	['a RECENT STUDY reported identification of as many as 2,776 sites of Vitamin D receptor binding and 229 Genes whose Expression was directly LINKED to changes in Vitamin d levels [2].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0000704', 'gene', 103, 'genes'), ('GO_0010467', 'gene expression', 115, 'expression'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin')]
PMC3672018	5/2013	S50-PMC3672018	['this allows for the examination of the EFFECTS of exposure to additional Vitamin D via fortified Foods during fetal Life in RELATION to later development of particular diseases.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 97, 'foods'), ('UBERON_0000104', 'life cycle', 116, 'life')]
PMC3672018	5/2013	S51-PMC3672018	['initially the PRESENT STUDY will include an in-depth examination of the INFLUENCE of exposure to Vitamin D during Pregnancy for development of fractures of the Wrist, forearm, upper Arm and Shoulder, as well as fractures of Ankle; development of obesity; and development of t1d during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('UBERON_0004452', 'carpal region', 160, 'wrist'), ('UBERON_0001460', 'arm', 182, 'arm'), ('UBERON_0001467', 'shoulder', 190, 'shoulder'), ('UBERON_0004454', 'tarsal region', 224, 'ankle'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
PMC3672018	5/2013	S52-PMC3672018	['furthermore, the large number of subjects that will be followed will ensure that the EFFECTS of Vitamin D exposure in RELATION to the timing of the seasons of Gestational development also can be examined.']	[('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 118)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'gestational')]
PMC3672018	5/2013	S65-PMC3672018	['databases\nin a first effort, we will EXAMINE INFLUENCE of additional early exposure to Vitamin D on subsequent development of fractures, obesity, and t1d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3672018	5/2013	S96-PMC3672018	['LIKEWISE, Individuals Born 1–2\u2009years after mandatory fortification terminated in 1985, and who were unexposed to Vitamin D both during Fetal Development and subsequently, will have a higher risk of later developing the diseases COMPARED TO those exposed during fetal Life.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	2	[('NCBITaxon_1', 'root', 10, 'individuals'), ('GO_0007567', 'parturition', 22, 'born'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 135, 'fetal development'), ('UBERON_0000104', 'life cycle', 267, 'life')]
PMC3672018	5/2013	S142-PMC3672018	['the comprehensive linkage of different datasets makes it possible to study the mediation, CONFOUNDING or modification of EFFECTS of Vitamin D for selected conditions through the development of sophisticated models in which Individuals can be followed for periods of up to 50\u2009years.']	[('PROBLEM_COMPLICATION', 90), ('SUPERFICIAL_RELATIONSHIP', 121)]	2	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('NCBITaxon_1', 'root', 223, 'individuals')]
PMC3672018	5/2013	S143-PMC3672018	['moreover, the large number of subjects that will be followed ensures that the EFFECTS of Vitamin D exposure in RELATION to the timing of the seasons and Gestational Development can also be examined.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007536', 'activation of recombination (HML)', 153, 'gestational development')]
PMC3672018	5/2013	S153-PMC3672018	['in CONTRARY, the Individuals in the database are unselected in RELATION to Vitamin D exposure as well as to later disease occurrence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('NCBITaxon_1', 'root', 17, 'individuals'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3672018	5/2013	S164-PMC3672018	['finally, the uncertainties RELATED to lack of knowledge about real Vitamin D status in mother and offspring MAY BE eliminated by assessing the measurement of infant Blood Vitamin D levels in those developing the three disease entities and comparing to time and gender-matched controls to examine actual exposure differences at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 108)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000178', 'blood', 165, 'blood'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007567', 'parturition', 327, 'birth')]
PMC3672018	5/2013	S173-PMC3672018	['Human intervention studies to determine the level of Vitamin D supplementation NECESSARY to reduce susceptibility to diseases later in Life and concomitant basic research exploring the biological mechanisms that may be INVOLVED.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('NCBITaxon_9606', 'Homo sapiens', 0, 'human'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC3685533	6/2013	S29-PMC3685533	['country of origin, Genetic traits and cultural behaviour are IMPORTANT FACTORS in determining Vitamin D levels [17].']	[('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('SO_0000704', 'gene', 19, 'genetic'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3685533	6/2013	S30-PMC3685533	['currently, the literature SHOWS that neonatal Vitamin D status at Birth is highly CORRELATED with maternal Vitamin storage.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
PMC3685533	6/2013	S32-PMC3685533	['DISCORDANT data are present with respect to the ROLE of Vitamin D supplementation during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy')]
PMC3685533	6/2013	S98-PMC3685533	['multiple regression analysis REVEALED that Vitamin D levels in Cord Blood were PREDICTED (r2: 0.670; p\u2009<\u20090.0001) by neonatal Vitamin D values (standardized β: 0.818), when corrected for Vitamin D supplementation and Gestational age.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_28384', 'vitamin K', 125, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'gestational')]
PMC3685533	6/2013	S104-PMC3685533	['lob had lower Serum levels with respect to Mbb, SUGGESTING a particular ROLE for different skin colour in Metabolism and in Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('UBERON_0001977', 'blood serum', 14, 'serum'), ('PR_000010211', 'protein max', 43, 'MBB'), ('GO_0008152', 'metabolic process', 106, 'metabolism'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3685533	6/2013	S117-PMC3685533	['moreover, we OBSERVED higher Vitamin D levels in Cord Blood than in neonate Serum with a strong CORRELATION to each other.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0001977', 'blood serum', 76, 'serum')]
PMC3685533	6/2013	S119-PMC3685533	['we have also INVESTIGATED the ROLE of supplementation in Pregnancy on Vitamin D Cord Blood and Serum levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood'), ('UBERON_0001977', 'blood serum', 95, 'serum')]
PMC3685533	6/2013	S137-PMC3685533	['identifying Vitamin D deficiency at Birth is ESSENTIAL for the development of public policy for PREVENTION and supplementation.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007567', 'parturition', 36, 'birth')]
PMC3691177	6/2013	S1-PMC3691177	['we EXAMINED the EFFECT of Prenatal Vitamin D on childhood wheezing in an interventional study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC3695234	7/2013	S53-PMC3695234	['this Molecule is subsequently Metabolized in the Kidney to its active form, 1,25(Oh)2D3, which plays a key ROLE in Skeletal and Extraskeletal functions, including immunity and Glucose Metabolism.8since it is absorbed via the skin, the IMPACT of Vitamin D levels on allergic skin diseases is of particular interest.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 235)]	2	[('CHEBI_36357', 'polyatomic entity', 5, 'molecule'), ('GO_0008152', 'metabolic process', 30, 'metabolized'), ('UBERON_0002113', 'kidney', 49, 'kidney'), ('CHEBI_37983', 'sulfur-35 atom', 76, '1'), ('CHEBI_17996', 'chloride', 77, ','), ('CHEBI_73394', 'Ala-Ser', 78, '25(OH)2D3'), ('UBERON_0004288', 'skeleton', 115, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 128, 'extraskeletal'), ('CHEBI_17234', 'glucose', 176, 'glucose'), ('GO_0006006', 'glucose metabolic process', 176, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3695234	7/2013	S64-PMC3695234	['chi et al.16ASSESSED the INFLUENCE of Prenatal Vitamin D status on Immune function at Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune'), ('GO_0007567', 'parturition', 86, 'birth')]
PMC3702245	6/2013	S25-PMC3702245	['there is CONTROVERSY concerning the EFFECT of maternal Vitamin D deficiency on Skeletal Development Of the Fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0000901', 'translation repressor activity, non-nucleic acid binding', 79, 'skeletal development of ... fetus'), ('UBERON_0004288', 'skeleton', 79, 'skeletal')]
PMC3702245	6/2013	S36-PMC3702245	['intervention trials and observational studies have also FOUND an ASSOCIATION between risk of small-for-Gestational age infants and maternal Vitamin D nutrition during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy')]
PMC3702245	6/2013	S50-PMC3702245	['in another large study from new york in the us,89bacterial vaginosis was ONLY ASSOCIATED with Vitamin D deficiency (Serum 25(Oh)D < 75 nmol/l) in Pregnant women (adjusted odds ratio 2.87; ci 1.13–7.28).']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 122, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant')]
PMC3702245	6/2013	S79-PMC3702245	['Vitamin D status was monitored in the mother during Pregnancy and in Cord Blood AS a SURROGATE marker of infant Vitamin D status at Birth.']	[('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 85)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC3702339	6/2013	S198-PMC3702339	['a study in Pregnant rhesus monkeys CONCLUDED that, in the zinc-deficient groups, zinc AFFECTS Vitamin A Metabolism by altering the formation or release of holo-Retinol-Binding Protein (43).']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('GO_0007565', 'female pregnancy', 11, 'pregnant'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 94, 'vitamin A metabolism'), ('CHEBI_26536', 'retinoic acid', 160, 'retinol'), ('PR_000013779', 'histone-binding protein RBBP7', 160, 'retinol-binding protein')]
PMC3702339	6/2013	S199-PMC3702339	['Zinc supplementation trial in Pregnant nepalese women also SUGGESTED that Zinc potentiates the EFFECT of Vitamin A in restoring night-Vision among night-blind Pregnant women with low initial Serum zinc concentrations (44).']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 0, 'Zinc'), ('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('CHEBI_33340', 'zinc group element atom', 74, 'zinc'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('GO_0007601', 'visual perception', 134, 'vision'), ('GO_0007565', 'female pregnancy', 159, 'pregnant'), ('UBERON_0001977', 'blood serum', 191, 'serum')]
PMC3705146	5/2013	S224-PMC3705146	['an INTERACTION between Vitamin D and the melanotropin system during development HAS BEEN DEMONSTRATED by eyles et al.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 80)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC3705146	5/2013	S225-PMC3705146	['(2007) who FOUND that Prenatal Vitamin D deficiency in rodents LEADS to elevations in the functional antagonist of alpha-msh , the melanotropic peptide mch .']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007565', 'female pregnancy', 22, 'prenatal'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3705146	5/2013	S239-PMC3705146	['OBVIOUSLY, two of the major light-responsive physiological systems that would be strongly AFFECTED in afro-caribbean immigrants to the u.k. would be uv-induced Vitamin D and the melanotropins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC3705320	3/2013	S206-PMC3705320	['FUTURE TRIALS in dhaka will address the dose-dependency of the EFFECTS of Prenatal Vitamin D supplementation on infant growth and morbidity.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007565', 'female pregnancy', 74, 'prenatal'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3713405	7/2013	S4-PMC3713405	['to address this we created an Animal MODEL of one such RISK FACTOR, developmental Vitamin D (Dvd) deficiency.']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('NCBITaxon_33208', 'Metazoa', 30, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 93, 'DVD')]
PMC3713405	7/2013	S125-PMC3713405	['IMPORTANTLY, this behavioral sensitivity is heavily DEPENDENT on the timing of Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3713405	7/2013	S163-PMC3713405	['the interactions between, and functions of, the vdr and rxr APPEAR TO BE extremely DEPENDENT on the presence of Vitamin D. for example, the vdr-rxr heterodimer with no ligand acts as a weak transcriptional repressor (tagami et al., 1998).']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3717170	5/2013	S87-PMC3717170	['2; unpublished data) and improved MARKERS of adiposity and Vitamin D status (Plasma concentrations of Glucose, Insulin, adiponectin, 25(Oh)D3, 1,25(Oh)2D3, and pth), BUT an increased Plasma Ca2+.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 77, 'plasma'), ('CHEBI_17234', 'glucose', 102, 'glucose'), ('PR_000045358', 'insulin family protein', 111, 'insulin'), ('CHEBI_62946', 'ammonium sulfate', 133, '25(OH)D3'), ('CHEBI_73394', 'Ala-Ser', 145, '25(OH)2D3'), ('UBERON_0001969', 'blood plasma', 183, 'plasma'), ('CHEBI_29108', 'calcium(2+)', 190, 'Ca2+.')]
PMC3717170	5/2013	S108-PMC3717170	['pearson correlation coefficient SHOWED significant CORRELATIONS between Plasma Vitamin D concentration and fev1 ( r = 0.31, p< 0.01), fvc ( r = 0.29, p< 0.01) and dlco ( r = 0.20, p = 0.01).']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3717170	5/2013	S129-PMC3717170	['li and colleagues have isolated Monocytes from patients and examined Expression of a number OF Genes RELATED to Vitamin D Metabolism and Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 101)]	2	[('CL_0000576', 'monocyte', 32, 'monocytes'), ('GO_0010467', 'gene expression', 69, 'expression'), ('SO_0000704', 'gene', 95, 'genes'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 112, 'vitamin D metabolism'), ('GO_0006955', 'immune response', 137, 'immune responses'), ('UBERON_0002405', 'immune system', 137, 'immune')]
PMC3717170	5/2013	S145-PMC3717170	['molecular aspects of the ROLE of Vitamin D in muscle\nricardo boland (universidad nacional del sur, argentina) discussed molecular aspects of the ROLE of Vitamin D in Skeletal muscle health and function.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 145)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal')]
PMC3717170	5/2013	S180-PMC3717170	['the ROLE of Vitamin D in Neurologic function and pathology HAS BEEN studied from multiple perspectives.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 59)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001016', 'nervous system', 25, 'neurologic')]
PMC3717170	5/2013	S183-PMC3717170	['overall, Vitamin D APPEARS TO BE IMPLICATED in many of the physiological and pathological changes that occur with Aging.']	[('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007568', 'aging', 114, 'aging')]
PMC3728489	7/2013	S164-PMC3728489	['fat-soluble Vitamins A and D play IMPORTANT ROLES in both Cell-Mediated and humoral Immune Responses (wintergerst et al.,2007).']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 27, 'D'), ('GO_0000911', 'cytokinesis by cell plate formation', 58, 'cell-mediated ... immune responses'), ('UBERON_0002405', 'immune system', 84, 'immune')]
PMC3728489	7/2013	S340-PMC3728489	['they also HAVE BEEN ASSOCIATED with increased offspring risk for Respiratory infections (Vitamin D), Intestinal inflammation and diarrhea (Folate and Vitamin A), allergy and asthma (Vitamin E and Folate) and Neurodevelopmental disorders (Folate).']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0001004', 'respiratory system', 65, 'respiratory'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000160', 'intestine', 101, 'intestinal'), ('CHEBI_30863', '5-azaorotic acid', 139, 'folate'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 196, 'folate'), ('GO_0007399', 'nervous system development', 208, 'neurodevelopmental'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
PMC3739737	8/2013	S15-PMC3739737	['several systematic reviews and meta-analyses HAVE BEEN undertaken, based on cross-sectional and prospective studies, that lend weight to hypotheses LINKING low Vitamin D with (a) adverse Cognitive outcomes and dementia[4],[5]and (b) depression[6].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	2	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0050890', 'cognition', 187, 'cognitive')]
PMC3739737	8/2013	S155-PMC3739737	['exploring a longer period of Vitamin D deficiency, or subsequent insults MAY have a greater IMPACT on Brain function and behaviour.']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000955', 'brain', 102, 'brain')]
PMC3760821	9/2013	S115-PMC3760821	['also, when compared within season, levels of Vitamin D were SIMILAR between the two groups, with a significant difference between the two groups ONLY apparent in autumn [control group vs. t1dm group (nmol/l±sd); 31.76±18.41 vs. 39.12±17.34, p \u200a=\u200a0.031].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 145)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3760821	9/2013	S146-PMC3760821	['multiple linear regression analysis INDICATED that maternal trimester 3 Vitamin D, (b\u200a=\u200a0.462; p<0.001) and obese bmi at booking (b\u200a=\u200a−5.132; p \u200a=\u200a0.013) significantly IMPACTED on Cord 25Ohd levels.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 180, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD')]
PMC3760821	9/2013	S151-PMC3760821	['also, maternal trimester 2 Vitamin D (b\u200a=\u200a−0.01; p \u200a=\u200a0.017) INDEPENDENTLY IMPACTED on hba1cat trimester 2.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3760821	9/2013	S153-PMC3760821	['in addition, the study findings INDICATE that Cord Blood Vitamin D levels CORRELATE with those of the mother, and are significantly lower in obese women than in their normal weight counterparts.']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3760821	9/2013	S168-PMC3760821	['when the IMPACT of maternal bmi at booking on maternal and cord Vitamin D levels in t1dm women was examined, maternal levels of 25Ohd in women with t1dm classified as obese at booking displayed a TREND for being lower.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 196)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 128, '25OHD')]
PMC3760821	9/2013	S178-PMC3760821	['the results of a recent systematic review SUGGEST a weak EFFECT of Vitamin D supplementation in reducing fasting Glucose and improving Insulin resistance in patients with t2dm or impaired glucose tolerance[38].']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_17234', 'glucose', 113, 'glucose'), ('PR_000045358', 'insulin family protein', 135, 'insulin')]
PMC3773018	4/2013	S13-PMC3773018	['to date, ONLY three birth cohort studies have examined the EFFECT of Prenatal Vitamin D exposure on allergic phenotypes using Cord Blood 25(Oh)D concentrations, an objective measure of Vitamin D status reflecting both dietary intake and sun exposure.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 69, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 126, 'cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 137, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3773018	4/2013	S38-PMC3773018	['we also conducted the above regression analyses stratified by the genotypes of rs2243250, and then EXAMINED the statistical significance for the multiplicative INTERACTION between low Vitamin D status and rs2243250.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 160)]	2	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC3773018	4/2013	S62-PMC3773018	['we FOUND that persistently low Vitamin D status from Birth to early childhood was ASSOCIATED with fs in the bbc.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 53, 'birth')]
PMC3773018	4/2013	S72-PMC3773018	['we PREVIOUSLY reported the qualitative INTERACTIONS between Vitamin D deficiency, assessed from Cord Blood and a Genetic variant in the Gene Il4 (rs2243250), and fs in the same birth cohort (18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood'), ('SO_0000704', 'gene', 113, 'genetic'), ('SO_0000704', 'gene', 136, 'gene'), ('PR_000008989', 'interleukin-1 family member 7', 141, 'IL4')]
PMC3773018	4/2013	S99-PMC3773018	['the biological mechanisms UNDERPINNING the ASSOCIATIONS between persistently low Vitamin D and the development of fs and then Food allergy include excessive exposure to abundant Food Allergens caused by increased Gastrointestinal Barrier permeability and decreased Immune tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_33290', 'food', 126, 'food'), ('CHEBI_33290', 'food', 178, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 183, 'allergens'), ('UBERON_0010172', 'bulb of aorta', 213, 'gastrointestinal barrier'), ('UBERON_0002405', 'immune system', 265, 'immune')]
PMC3798907	8/2013	S20-PMC3798907	['secondly, ALTHOUGH cbmc responses are ASSOCIATED with maternal dietary Vitamin E intake during Pregnancy, there is no association with maternal or Cord Blood Α-Tocopherol [12].']	[('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin E'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 147, 'cord'), ('UBERON_0000178', 'blood', 152, 'blood'), ('CHEBI_27725', 'butin', 158, 'α-tocopherol')]
PMC3798907	8/2013	S38-PMC3798907	['antioxidant supplementation was at final concentrations of 6.5 μmol/l for Α-Tocopherol and 44.11 μmol/l for Ascorbic Acid, corresponding to the Cord Blood 95th centile concentrations measured in the original general population study that REPORTED an ASSOCIATION between maternal Vitamin E intake and cbmc responses [18].']	[('INCOMPLETE_EVIDENCE', 238), ('SUPERFICIAL_RELATIONSHIP', 250)]	2	[('CHEBI_27725', 'butin', 74, 'α-tocopherol'), ('CHEBI_22652', 'ascorbic acid', 108, 'ascorbic acid'), ('UBERON_0009472', 'axilla', 144, 'cord blood'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin E')]
PMC3798907	8/2013	S68-PMC3798907	['Vitamin E supplementation of Adult pbmc\nwhen the EFFECTS of Vitamin E supplementation were tested on pbmc responses, UNLIKE the results for cbmc, there were no consistent trends or significant differences in Proliferation induced by the set of T-Cell stimuli (figure 2andtable 1).']	[('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('UBERON_0007023', 'adult organism', 29, 'Adult'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('GO_0008283', 'cell proliferation', 208, 'proliferation'), ('CL_0000084', 'T cell', 244, 'T-cell')]
PMC3798907	8/2013	S69-PMC3798907	['LIKEWISE, there were no consistent trends in the EFFECTS of Vitamin E supplementation on cytokine responses by pbmc.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin E')]
PMC3798907	8/2013	S94-PMC3798907	['IN CONTRAST, the pattern of EFFECTS of Vitamin E supplementation on pbmc responses was typified by increases in both th Effector and Regulatory cytokine responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_35224', 'effector', 120, 'effector'), ('GO_0065007', 'biological regulation', 133, 'regulatory')]
PMC3798907	8/2013	S103-PMC3798907	['vitamin c was included as a control comparator GIVEN the absence of epidemiological evidence of an ASSOCIATION between Maternal Vitamin C intake during Pregnancy and cbmc responses and childhood asthma [9,10,11].']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('GO_0007618', 'mating', 119, 'maternal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3809191	1/2013	S0-PMC3809191	['frequency of Vitamin D deficiency in Pregnant diabetics at baskent university hospital, istanbul\n\nabstract\nobjective: TO FIND out the frequency of Vitamin D deficiency and its RELATION with Glucose parameters and the incidence of Gestational diabetes (gdm).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('SUPERFICIAL_RELATIONSHIP', 176)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_17234', 'glucose', 190, 'glucose'), ('GO_0007565', 'female pregnancy', 230, 'gestational')]
PMC3827489	10/2013	S53-PMC3827489	['the MAJOR ROLE of Vitamin D in maintaining bone health is to ensure normal calcium and phosphate levels in the Blood.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 10)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000178', 'blood', 111, 'blood')]
PMC3827489	10/2013	S75-PMC3827489	['these observational and clinical studies INDICATE a beneficial EFFECT of Vitamin D supplementation in Vitamin D deficient children with asthma or acute or chronic Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 163, 'respiratory')]
PMC3829803	11/2013	S33-PMC3829803	['the mechanism UNDERLYING the positive EFFECTS of Vitamin A supplements and treatment in measles are not well understood [13].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A')]
PMC3873449	12/2013	S12-PMC3873449	['duration of sun exposure and the use of multivitamin were the most IMPORTANT DETERMINANTS for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3873449	12/2013	S18-PMC3873449	['there is GROWING concern about the functional IMPACTS of maternal Vitamin D on their offspring.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3873449	12/2013	S25-PMC3873449	['there is LITTLE EVIDENCE concerning the ROLE of maternal Vitamin D in Pregnancy in their child Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 95, 'autoimmune')]
PMC3873449	12/2013	S130-PMC3873449	['this SUGGESTS that sun exposure plays a ROLE in maintaining Vitamin D levels in chinese Pregnant women in winter.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'pregnant')]
PMC3873449	12/2013	S203-PMC3873449	['THEREFORE, there were no enough subjects who were over weight or obese for analysis of the IMPACT of this factor on Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 91)]	2	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3873449	12/2013	S211-PMC3873449	['this design allowed us TO ASSESS the IMPACT of these factors on Vitamin D status in chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnant')]
PMC3873449	12/2013	S212-PMC3873449	['the EFFECT of prolonging the duration of sun exposure on maintaining appropriate Vitamin D levels is LIMITED in Pregnant women residing in beijing in winter.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC3882256	1/2014	S74-PMC3882256	['the POSSIBILITIES that offspring sex or maternal adequate intake of Vitamin C (≤ versus >50 mg/day) modified the ASSOCIATION of maternal exposures with offspring outcomes were assessed by examining stratified (by sex and maternal adequate Vitamin C intake) analyses and by including an interaction term in the confounder adjusted models.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 113)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin C'), ('PR_000004900', 'complement C3', 247, 'C')]
PMC3901983	1/2013	S104-PMC3901983	['the excessive vomiting or fat malabsorbtion, AFFECTING Pregnant women after bariatric surgery, MAY lead to a higher risk of Vitamin K-deficient bleeding disorders of the neonates of these mothers.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 95)]	2	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin K')]
PMC3930526	2/2014	S150-PMC3930526	['Prenatal Selenium[62]and Vitamin A[63]COULD also play a ROLE in Postnatal growth.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27568', 'selenium atom', 9, 'selenium'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007567', 'parturition', 64, 'postnatal')]
PMC3933171	3/2014	S0-PMC3933171	['Vitamin D status of early preterm infants and the EFFECTS of Vitamin D intake during hospital stay\n\nabstract\n\nobjectives\nTO EVALUATE Vitamin D (vitd) status in early preterm infants (eptis) at Birth and during Birth hospitalisation on current vitd intake.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 121)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 193, 'birth'), ('GO_0007567', 'parturition', 210, 'birth')]
PMC3970319	5/2013	S23-PMC3970319	['multiple-Micronutrient supplements (mmss) provided in Pregnancy compared with Iron and Folate supplements were marginally ASSOCIATED with lower offspring systolic, BUT NOT diastolic, Blood pressure at 2 y of age in one nepalese study (10) but were unrelated to offspring Blood pressure at 6–8 y in a separate nepalese trial where mmss were compared with Vitamin A supplementation (11).']	[('SUPERFICIAL_RELATIONSHIP', 122), ('ANOMALY_CURIOUS_FINDING', 164)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_24870', 'ion', 78, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 87, 'folate'), ('UBERON_0000178', 'blood', 183, 'blood'), ('UBERON_0000178', 'blood', 271, 'blood'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin A')]
PMC3991049	11/2013	S19-PMC3991049	['Vitamin D receptors can be found in most Tissues and cells in the body, and the IMPACT of a Vitamin D deficiency on the developing fetus and maternal health is of significant CONCERN.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 175)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 41, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4045304	2/2014	S187-PMC4045304	['grant and soles [72] used epidemiological data for seasonal variation of Birth rates and prevalence of infantile autism disease (iad) to examine WHETHER maternal Vitamin D deficiency was a RISK factor for iad for cohorts Born before 1985.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 189)]	2	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'born')]
PMC4051754	6/2014	S44-PMC4051754	['the numerical difference between the two groups in Prepartum concentrations of Vitamin A, and partly, Vitamin E, are LIKELY RELATED with the dry matter intake which was higher in of vs. re Prepartum (see[10]for Feed Intake).']	[('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('GO_0007565', 'female pregnancy', 51, 'prepartum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin E'), ('GO_0007565', 'female pregnancy', 189, 'prepartum'), ('GO_0007631', 'feeding behavior', 211, 'feed intake')]
PMC4051754	6/2014	S45-PMC4051754	['the concentration of Vitamin E TENDED to be lower after +14 days relative to Parturition ( d ) in of vs. re DESPITE the lack of difference in Feed Intake Postpartum[10](figure 1).']	[('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 108)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin E'), ('GO_0019230', 'proprioception', 77, 'parturition'), ('GO_0007631', 'feeding behavior', 142, 'feed intake'), ('GO_0007565', 'female pregnancy', 154, 'postpartum')]
PMC4071151	6/2014	S72-PMC4071151	['in particular, Folic Acid, Vitamin B12 and Vitamin A and its biologically active Metabolite Retinoic Acid are THOUGHT TO be INVOLVED in Neurulation and subsequent Neural Tube growth and patterning [20].']	[('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('CHEBI_30751', 'formic acid', 15, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 27, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 81, 'metabolite'), ('CHEBI_26536', 'retinoic acid', 92, 'retinoic acid'), ('GO_0000293', 'ferric-chelate reductase activity', 136, 'neurulation'), ('UBERON_0001049', 'neural tube', 163, 'neural tube')]
PMC4072587	6/2014	S15-PMC4072587	['dietary intake makes ONLY a small CONTRIBUTION to Vitamin D status[3],[7].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4072587	6/2014	S77-PMC4072587	['multivariable linear regression was performed to derive estimates of mean differences (95% confidence intervals (ci)) of the continuous outcome data (developmental composite scores of the infant at 6 months, Gestational age and anthropometric measurements) ASSOCIATED with maternal Vitamin D concentrations at 32 weeks, and multivariable logistic regression was used to assess the ASSOCIATIONS between maternal Vitamin D concentrations and the binary outcomes (Preterm Delivery, low Birth weight, small for Gestational age and infant stunting).']	[('SUPERFICIAL_RELATIONSHIP', 257), ('SUPERFICIAL_RELATIONSHIP', 381)]	2	[('GO_0007565', 'female pregnancy', 208, 'gestational'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('GO_0007565', 'female pregnancy', 461, 'preterm'), ('GO_0007567', 'parturition', 469, 'delivery'), ('GO_0007567', 'parturition', 483, 'birth'), ('GO_0007565', 'female pregnancy', 507, 'gestational')]
PMC4072587	6/2014	S82-PMC4072587	['to further investigate the presence of a POTENTIAL threshold EFFECT of Vitamin D concentration on infant developmental outcomes[24], secondary statistical analyses were performed on maternal Vitamin D concentration categorized as deficient (<37.5 nmol/l), insufficient(≥37.5 nmol/l and <75 nmol/l) or replete (≥75 nmol/l).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4072587	6/2014	S90-PMC4072587	['a TREND towards an ASSOCIATION with Preterm Delivery (odds ratio (or) 0.77 per 25 nmol/l increase in Vitamin D concentration, 95% ci 0.57 to 1.05) and small for Gestational age (odds ratio (or) 1.37 per 25 nmol/l increase in Vitamin D concentration, 95% ci 0.98 to 1.91) was observed.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('GO_0007565', 'female pregnancy', 36, 'preterm'), ('GO_0007567', 'parturition', 44, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4072587	6/2014	S123-PMC4072587	['there HAS also BEEN interest in the LINK between autism and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4099383	7/2014	S61-PMC4099383	['the PROTECTIVE elements within these diets are LIKELY to include selenium, zinc, Folate, Vitamin E, and other antioxidants.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 47)]	2	[('CHEBI_30863', '5-azaorotic acid', 81, 'folate'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E')]
PMC4106226	7/2014	S4-PMC4106226	['mechanistic studies SUGGESTED a ROLE for Vitamin D deficiency in asthma and type 1 diabetes and for reactivation of varicella-zoster virus in aseptic meningitis.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S84-PMC4113768	['background: Serum 25-Hydroxy Vitamin D (25(Oh)D) is the ESTABLISHED BIOMARKER of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('UBERON_0001977', 'blood serum', 12, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S133-PMC4113768	['discussion: overall, in caucasians Vitamin D status APPEARS TO BE positively CORRELATED with radial and Tibial bone mass and size.']	[('ANOMALY_CURIOUS_FINDING', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002101', 'limb', 104, 'tibial')]
PMC4113768	7/2014	S134-PMC4113768	['in south asians, Vitamin D status APPEARS TO BE positively CORRELATED with distal radial Trabecular density.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002363', 'dura mater', 89, 'trabecular')]
PMC4113768	7/2014	S174-PMC4113768	['higher Vitamin D status (per 25 nmol/l increase in Serum/Plasma 25(Oh)D) was ASSOCIATED with IMPROVED Colorectal cancer specific survival (adjusted hr = 0.92 (95% ci: 0.86–0.98, p< 0.001) and overall survival (pooled adjusted hr = 0.87 (95% ci: 0.79–0.95, p< 0.001) in pooled estimates of 5 prospective studies.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 93)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 64, '25(OH ... D'), ('UBERON_0012652', 'colorectum', 102, 'colorectal')]
PMC4113768	7/2014	S176-PMC4113768	['high Vitamin D receptor Expression in tumour cells relative to normal cells was ASSOCIATED with improved disease-free survival in one prospective STUDY.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 146)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0010467', 'gene expression', 24, 'expression')]
PMC4113768	7/2014	S233-PMC4113768	['to account for seasonal variation in Vitamin D levels, as well as seasonality of infections, we EXAMINED the ASSOCIATION within different season strata.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 109)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4113768	7/2014	S280-PMC4113768	['conclusion: pain in Muscles and Joints as well as balance problems MAY BE clinical INDICATORS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('UBERON_0005090', 'muscle structure', 20, 'muscles'), ('UBERON_0004905', 'articulation', 32, 'joints'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S385-PMC4113768	['conclusion: we DID NOT FIND EVIDENCE of a Vitamin D sparing EFFECT of high Calcium intake.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 75, 'calcium')]
PMC4113768	7/2014	S471-PMC4113768	['high dose Retinol PREVENTS toxic EFFECTS, including death, in Vitamin D poisoning, experimentally.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_26536', 'retinoic acid', 10, 'retinol'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S512-PMC4113768	['randomised controlled trials of Vitamin D supplementation in children with asthma for PREVENTION of exacerbation and uri HAVE REPORTED positive results; such trials have not previously been conducted in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 121)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0007023', 'adult organism', 203, 'adults')]
PMC4113768	7/2014	S528-PMC4113768	['a multicenter randomized, controlled trial\n\nahmed, b.; kashif, w.; iqbal, r.; habib, a.; nasir, k.; mehmood, a.; sarwar, s.\nbackground: we INVESTIGATED the ROLE of Vitamin D (vd) and targeted physical activity in improving Musculoskeletal health among chronic Kidney diseases (ckd) patients.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 223, 'musculoskeletal'), ('UBERON_0002113', 'kidney', 260, 'kidney')]
PMC4113768	7/2014	S582-PMC4113768	['the INFLUENCE of Vitamin D exposure during Prenatal Life on Birth weight was INVESTIGATED among 59,411 danish children by comparing Birth weight among Individuals Born before, during, and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 77)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('GO_0007567', 'parturition', 60, 'birth'), ('GO_0007567', 'parturition', 132, 'birth'), ('NCBITaxon_1', 'root', 151, 'individuals'), ('GO_0007567', 'parturition', 163, 'born')]
PMC4113768	7/2014	S587-PMC4113768	['conclusion: exposure to Vitamin D from fortified Margarine and milk during Prenatal Life altered Birth weight, but the ASSOCIATIONS were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_6784', 'mestranol', 49, 'margarine'), ('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S588-PMC4113768	['we SPECULATE that the EFFECT of Vitamin D exposure in Pregnancy is modified by the exposure prior to Conception.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 22)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('GO_0007620', 'copulation', 101, 'conception')]
PMC4113768	7/2014	S602-PMC4113768	['the current analysis, based on two large cohort studies, EXAMINED the ASSOCIATION between peri-Pregnancy Vitamin D status in mothers, season of Birth of their offspring, and the risk of incident Peanut/Tree Nut (p/tn) allergy during childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 195, 'peanut'), ('NCBITaxon_33208', 'Metazoa', 202, 'tree nut')]
PMC4113768	7/2014	S635-PMC4113768	['to date, LITTLE IS KNOWN about the EFFECT of low Vitamin D status at Birth on body composition during the Neonatal Period.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('UBERON_0007221', 'neonate stage', 106, 'neonatal period')]
PMC4113768	7/2014	S690-PMC4113768	['methods: as part of a study examining the IMPACT of the introduction of the london low emission zone on children’s Respiratory health, we ASSESSED the feasibility and acceptability of a Finger prick dried Blood spot method for assessing Vitamin D status (pro-diagnostics, london, uk).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	2	[('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('UBERON_0002389', 'manual digit', 186, 'finger'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4113768	7/2014	S874-PMC4113768	['they ATTRIBUTED this improvement to an increase in both jumping velocity and height, SUGGESTING greater flexibility and muscular co-ordination after Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 85)]	2	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4113768	7/2014	S876-PMC4113768	['DESPITE Vitamin D deficiency primarily AFFECTING proximal muscle function, the three studies that met the inclusion criteria all looked predominantly at distal muscle function (Hand grip or pinch grip strength.)']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002398', 'manus', 177, 'hand')]
PMC4113768	7/2014	S878-PMC4113768	['well-designed rcts that include assessments of proximal muscle function ARE NEEDED to clearly determine the EFFECT of Vitamin D on muscle function in young People.']	[('FUTURE_WORK', 72), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'people')]
PMC4113768	7/2014	S904-PMC4113768	['objective: to ascertain WHETHER Vitamin D deficiency is LINKED to Dental health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 66, 'dental')]
PMC4113768	7/2014	S958-PMC4113768	['studies investigating the prevalence and DETERMINANTS of Vitamin D deficiency among copd patients in the uk are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('FULL_UNKNOWN', 112)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4113768	7/2014	S978-PMC4113768	['; kiely, m.\nbackground: persistence of the INFLUENCE of Vitamin D status at Birth into Infancy HAS RECENTLY BEEN SHOWN (við streym, s., et al .']	[('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 95)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'birth'), ('UBERON_0000023', 'wing', 87, 'infancy')]
PMC4113768	7/2014	S986-PMC4113768	['ASSOCIATIONS between low circulating 25-Hydroxy Vitamin D (25(Oh)D), the BIOMARKER of Vitamin D status, and muscle weakness in older Adults (bischoff-ferrari, h.a., et al .']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0007023', 'adult organism', 133, 'adults')]
PMC4113768	7/2014	S1035-PMC4113768	['risk of premature Birth was NOTABLY lower for mothers who took Vitamin D supplementation during Pregnancy (0.53, 0.43–0.66 for multivitamin; 0.44, 0.40–0.49 for single preparation), with the ASSOCIATION remaining unaffected by adjustment for infections.']	[('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 191)]	2	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC4113768	7/2014	S1045-PMC4113768	['HOWEVER randomized controlled trials in children and adolescents did not show significant EFFECTS on total body bone Mineral density after Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_46662', 'mineral', 117, 'mineral'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4113768	7/2014	S1057-PMC4113768	['; van schoor, n.; de jongh, r.t.; visser, m.; lips, p.\nbackground: physical activity (pa) MAY have an IMPACT on Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102)]	2	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1072-PMC4113768	['methods: we determined concentrations of Serum 25 Hydroxy-Vitamin D in RELATION to several other Metabolic BIOMARKERS including total Cholesterol, low-density lipoprotein Cholesterol (ldl-c), high density lipoprotein-Cholesterol (Hdl-C), Triglycerides, atherogenic index, Glucose, C-Reactive Protein (crp), measures of adiposity, and Blood pressure values in a cross-sectional analysis in 180 saudi Postmenopausal women aged 48 to 88 years.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_67778', '(E)-Adrienyne, [rel(threo)]-', 47, '25 hydroxy-'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0008152', 'metabolic process', 97, 'metabolic'), ('CHEBI_16113', 'cholesterol', 134, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 171, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 217, 'cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 230, 'HDL-C'), ('CHEBI_17855', 'triglyceride', 238, 'triglycerides'), ('CHEBI_17234', 'glucose', 272, 'glucose'), ('PR_000005890', 'crooked neck-like protein 1', 281, 'C-reactive protein'), ('UBERON_0000178', 'blood', 334, 'blood'), ('GO_0007595', 'lactation', 399, 'postmenopausal')]
PMC4113768	7/2014	S1079-PMC4113768	['there APPEARED TO BE NO significant impact of hypovitaminosis D on the inflammatory marker crp, levels of which were SIMILAR among Vitamin D sufficient and deficient subjects.']	[('ANOMALY_CURIOUS_FINDING', 6), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 62, 'D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4113768	7/2014	S1183-PMC4113768	['conclusion: the ASSOCIATION between Vitamin D status and bua was modified by bmi in the older cohorts, with the strongest EFFECT in Person with low-to-normal bmi (<26.5 kg/m2).']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'person')]
PMC4113768	7/2014	S1283-PMC4113768	['; filteau, s.; trilok, kumar, g.\nbackground: Vitamin D status or parent-selected Vitamin D supplementation in infancy HAVE BEEN ASSOCIATED with better bone growth and mineralization in later childhood.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('CHEBI_28384', 'vitamin K', 45, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1374-PMC4113768	['low Vitamin D concentrations are ASSOCIATED with an INCREASED RISK of type 2 diabetes mellitus (dm), as shown in longitudinal and cross-sectional studies.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4113768	7/2014	S1392-PMC4113768	['there is NO INFORMATION about Vitamin D: s EFFECT on Brain Steroidogenesis.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000955', 'brain', 53, 'brain'), ('GO_0001501', 'skeletal system development', 59, 'steroidogenesis')]
PMC4113768	7/2014	S1402-PMC4113768	['FUTURE STUDIES will be directed to analysis of EFFECTS of Vitamin D on enzyme activities.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S1466-PMC4113768	['; brenner, h.; schirmer, h.; jorde, r.; power, c.; llewellyn, d.; hyppönen, e.\nbackground: recent epidemiological and EXPERIMENTAL STUDIES have LINKED Vitamin D deficiency to a range of non-Skeletal conditions including reduced Cognitive function.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	2	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('UBERON_0004288', 'skeleton', 190, 'skeletal'), ('GO_0050890', 'cognition', 228, 'cognitive')]
PMC4113768	7/2014	S1522-PMC4113768	['the participants were genotyped for 25 Snps in the Vitamin D pathway and two common Single Nucleotide Polymorphisms (Snps) in the Cyp2R1 Gene (rs10741657 and rs10766197) and two common Snps in the gc Gene (rs4588 and rs842999) were FOUND to PREDICT baseline S-25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 241)]	2	[('SO_0000694', 'SNP', 39, 'SNPs'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007601', 'visual perception', 51, 'vitamin D'), ('SO_0000694', 'SNP', 84, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 117, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 130, 'CYP2R1'), ('SO_0000704', 'gene', 137, 'gene'), ('SO_0000694', 'SNP', 185, 'SNPs'), ('SO_0000704', 'gene', 200, 'gene'), ('PR_000015800', 'syntaxin-8', 258, 's-25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 260, '25(OH)D')]
PMC4113768	7/2014	S1529-PMC4113768	['we FOUND a significant positive linear RELATIONSHIP between carrying 0–2, 3, 4 or 5 risk Alleles, total Vitamin D intake and the increase in s-25(Oh)D concentrations ( p = 0.0012, 0.0001, 0.0118 and 0.0029), respectively.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('SO_0001023', 'allele', 89, 'alleles'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D')]
PMC4113768	7/2014	S1603-PMC4113768	['INTERACTION EFFECTS between Vitamin D deficiency (<50 nmol/l) and Antiretroviral therapy were explored.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 12)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 66, 'antiretroviral')]
PMC4113768	7/2014	S1611-PMC4113768	['baseline covariates significantly ASSOCIATED with lower Hip bmd adjusting for age were previous tdf use, BUT ONLY in those with Vitamin D sufficiency (mean difference −0.07 g/cm3 95% confidence interval (ci) −0.01 to −0.13; p = 0.02), lean body mass (7 gram increase in lean body mass for every 1 g/cm3 increase in bmd, 95% ci 4.28,9.84; p< 0.001), Vitamin D deficiency (mean difference −0.04 g/cm3 95% ci −0.009 to 0.09; p = 0.03), Vitamin D deficiency in those not on tdf (mean difference between Vitamin D sufficiency and insufficiency in those not on tdf-0.09 g/cm3 95% ci −0.15 to −0.01; p = 0.006), and white ethnicity (−0.07, 95% ci −0.007 to −0.13).']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 105)]	2	[('UBERON_0001464', 'hip', 56, 'hip'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC4113768	7/2014	S1613-PMC4113768	['conclusions: tdf has the PREDOMINANT EFFECT on bmd irrespective of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S1709-PMC4113768	['data on the prevalence of Vitamin D deficiency and its clinical CORRELATES among asthma patients in the uk are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 64), ('FULL_UNKNOWN', 111)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4113768	7/2014	S1718-PMC4113768	['the MAJOR DETERMINANTS of Vitamin D status were season of sampling, sun-seeking behaviour, use of Vitamin D supplements and bmi.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 10)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4113768	7/2014	S1842-PMC4113768	['cox regression models were also used to test the HYPOTHESIS of INTERACTIONS between season of Birth and exposure to Vitamin D fortified Foods.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007567', 'parturition', 94, 'birth'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_33290', 'food', 136, 'foods')]
PMC4113768	7/2014	S1843-PMC4113768	['results: the results of the cox regression analysis INDICATED that there was a significant INTERACTION between the season of Birth and exposure to Vitamin D fortified Margarine amongst children Born between 1983 and 1987.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 91)]	2	[('GO_0007567', 'parturition', 125, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 167, 'margarine'), ('GO_0007567', 'parturition', 194, 'born')]
PMC4113768	7/2014	S1906-PMC4113768	['results: in both SCENARIOS and subgroups, replacing Cows’ Milk with gum LED TO a significant increase in Vitamin D intakes (+278% to +356%).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('NCBITaxon_33208', 'Metazoa', 52, 'cows'), ('UBERON_0001913', 'milk', 58, 'milk'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1909-PMC4113768	['conclusion: the ROLE of Vitamin D fortified Foods in the uk, especially in young children, COULD BE a useful mechanism for increasing the nutritional intake of this essential Nutrient.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_33290', 'food', 44, 'foods'), ('CHEBI_33284', 'nutrient', 175, 'nutrient')]
PMC4113768	7/2014	S2023-PMC4113768	['; lanham-new, s.; tripkovic, l.\nbackground: epidemiological research HAS SHOWN a close ASSOCIATION between Vitamin D deficiency (25Ohd < 25 nmol/l) and Cardiovascular mortality and morbidity.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 129, '25OHD'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular')]
PMC4113768	7/2014	S2041-PMC4113768	['despite these INTERVENTIONS, a substantial portion of our population is AT-RISK of suboptimal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('IMPORTANT_CONSIDERATION', 72)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4113768	7/2014	S2115-PMC4113768	['2008, 62 , 1079-1089) provides representative data TO ASSESS the current Vitamin D status of Adults in germany according to latitude of residence and to identify additional DETERMINANTS of Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC4113768	7/2014	S2143-PMC4113768	['the ROLE of these pathways in Vitamin D deficiency induced muscle wasting has NOT BEEN STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 78)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4113768	7/2014	S2219-PMC4113768	['randomized, double-blind, placebo-controlled trial of Vitamin D supplement in parkinson’s disease\n\nurashima, m.; suzuki, m.; yoshioka, m.; hashimoto, m.; murakami, m.; noya, m.; takahashi, d.\nbackground: in our PREVIOUS STUDY, higher Serum 25-Hydroxy Vitamin D (25Ohd) levels and the Vitamin D receptor (vdr) fokicc genotype were ASSOCIATED with milder parkinson’s disease (pd).']	[('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 330)]	2	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 234, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 240, '25-hydroxy vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 259, 'D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC4113768	7/2014	S2294-PMC4113768	['conclusion: nearly 4 out of 5 Premenopausal saudi women shoppers harbor Vitamin D deficiency and this is INFLUENCED not by sun exposure, BUT by age and Milk consumption.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	2	[('GO_0043277', 'apoptotic cell clearance', 30, 'premenopausal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001913', 'milk', 152, 'milk')]
PMC4113768	7/2014	S2351-PMC4113768	['conclusion: the results SUGGEST that a modest increase in Vitamin D levels among overweight and obese subjects through the promotion of lifestyle changes for one year have marginal EFFECTS in bone turnover markers as well as obesity itself.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S2404-PMC4113768	['conclusions: there was MODEST EVIDENCE TO SUPPORT ASSOCIATIONS between maternal 25(oh)-Vitamin D status and offspring Serum Calcium concentrations, Birth weight and bone mass.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0007567', 'parturition', 148, 'birth')]
PMC4113768	7/2014	S2463-PMC4113768	['as participants with higher Pigmented skin require a longer period of sunlight exposure to synthesise the same amount of Vitamin D as lighter skins, the former group will have produced less Vitamin D. diet provided 70–90 iu Vitamin D per day (median) across the seasons and sunlight exposure was the MAJOR CONTRIBUTOR (accounting for 70%) to total Vitamin D in summer as shown below (median (iqr)).']	[('IMPORTANT_CONSIDERATION', 300), ('SUPERFICIAL_RELATIONSHIP', 306)]	2	[('CHEBI_26130', 'biological pigment', 28, 'pigmented'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D')]
PMC4113768	7/2014	S2475-PMC4113768	['a questionnaire was administered to explore variables POTENTIALLY RELATED to tb and Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4113768	7/2014	S2498-PMC4113768	['KEY modifiable DETERMINANTS of achievement of peak bone mass are calcium intake, physical activity and Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4113768	7/2014	S2521-PMC4113768	['background: understanding of the EFFECT of Vitamin D supplementation on Plasma 25(Oh)D levels is ESSENTIAL to optimizing nutritional status and health.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 79, '25 ... OH ... D')]
PMC4113768	7/2014	S2602-PMC4113768	['conclusions: TO ASSESS the IMPACT of exposure to Vitamin D during Gestation for later t1d risk we studied seasonality of month of Birth in a specific context of Food fortification practices in denmark.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'gestation'), ('GO_0007567', 'parturition', 130, 'birth'), ('CHEBI_33290', 'food', 161, 'food')]
PMC4113768	7/2014	S2616-PMC4113768	['we INVESTIGATED the EFFECT of Vitamin D supplementation on the Metabolic status of Individuals at increased risk of developing t2d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0008152', 'metabolic process', 63, 'metabolic'), ('NCBITaxon_1', 'root', 83, 'individuals')]
PMC4113768	7/2014	S2631-PMC4113768	['placebo is SUGGESTIVE of a beneficial EFFECT of Vitamin D supplementation on Arterial stiffness.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001637', 'artery', 77, 'arterial')]
PMC4113768	7/2014	S2637-PMC4113768	['; inskip, h.m.; cooper, c.; harvey, n.c.\nbackground: maternal 25-Hydroxy-Vitamin D (25(Oh)d) status in Pregnancy HAS BEEN ASSOCIATED with offspring Bone Development and adiposity.']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_70487', '(-)-sanguinolignan C', 62, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 84, '25(OH'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0048539', 'bone marrow development', 148, 'bone development')]
PMC4113768	7/2014	S2664-PMC4113768	['this uncertainty can ONLY be resolved by well-designed randomized controlled trials (rcts) to determine the EFFECT of Vitamin D supplementation on bp.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4113768	7/2014	S2753-PMC4113768	['this MAY LINK in with the increased availability or awareness of Vitamin D supplementation through the healthy start scheme, launched in 2006, and other initiatives.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S2772-PMC4113768	['these RELATIONS were almost exclusively SEEN in subjects not using Vitamin D and/or Calcium supplements.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 84, 'calcium')]
PMC4113768	7/2014	S2813-PMC4113768	['as OTHER FACTORS in today’s modern lifestyles (e.g., sunscreen/Cosmetic use, indoor occupations, lack of outdoor activities) further limit such synthesis during the summer months, the general population is becoming increasingly reliant on dietary sources of Vitamin D to maintain adequate Vitamin D status (gillie, o. mol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('GO_0007620', 'copulation', 63, 'cosmetic'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC4113768	7/2014	S2836-PMC4113768	['CORRELATIONS between Vitamin D Serum levels, Nailfold microangiopathy and clinical features in systemic sclerosis patients\n\npaolino, s.; pizzorni, c.; smith, v.; decuman, s.; sulli, a.; seriolo, b.; cutolo, m.\nbackground: Vitamin D (25-Hydroxy Vitamin D) [25(Oh)D3] and its active Metabolite [1,25(Oh)D3] are INVOLVED in the Regulation Of both Innate and Adaptive Immunity (cutolo, m., et al.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 309)]	2	[('CHEBI_28384', 'vitamin K', 21, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 21, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 31, 'Serum'), ('UBERON_0009073', 'dorsobronchus', 45, 'Nailfold'), ('CHEBI_28384', 'vitamin K', 222, 'Vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 233, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 256, '25(OH)'), ('CHEBI_29238', 'tritium atom', 262, 'D3'), ('PR_000001177', 'D(2) dopamine receptor', 262, 'D3'), ('CHEBI_39382', 'flufenoxuron', 281, 'metabolite'), ('CHEBI_17996', 'chloride', 294, ','), ('CHEBI_62946', 'ammonium sulfate', 295, '25(OH)D3'), ('GO_0002222', 'stimulatory killer cell immunoglobulin-like receptor signaling pathway', 325, 'regulation of ... innate ... adaptive immunity')]
PMC4113768	7/2014	S3080-PMC4113768	['we EXAMINED the EFFECT of Prenatal Vitamin D on childhood wheezing in an interventional study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4113768	7/2014	S3112-PMC4113768	['adjusting for hiv status, season, site, sex, weight-for age z score, breastfeeding, type of house, mother with previous tb diagnosis, age at Vitamin D determination, and inh/placebo treatment arm, vdid was INDEPENDENTLY ASSOCIATED with any tb (ahr 1.75, 95% ci 1.01–3.05; p = 0.046) as well as any tb or death (ahr 1.76, 95% ci 1.03–3.00; p = 0.038).']	[('SUPERFICIAL_RELATIONSHIP', 206), ('SUPERFICIAL_RELATIONSHIP', 220)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC4113768	7/2014	S3125-PMC4113768	['the EFFECT of Vitamin D deficiency on risk of Sensitisation to various common Allergens was ASSESSED using multiple logistic regression analysis.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 46, 'sensitisation'), ('CHEBI_33663', 'cyclic hydrocarbon', 78, 'allergens')]
PMC4113768	7/2014	S3181-PMC4113768	['purpose: TO DETERMINE Vitamin D status and its PREDICTORS among school children aged 11–18 years in ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4113768	7/2014	S3249-PMC4113768	['to date, there is NO STUDY investigating the EFFECT of maternal Vitamin D deficiency on the Human fetus.']	[('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 92, 'human')]
PMC4113768	7/2014	S3279-PMC4113768	['sub-group analysis REVEALED that Vitamin D supplementation was PROTECTIVE against moderate/severe exacerbation among the 148 participants who were Vitamin D deficient at baseline (ahr 0.57, 95% ci 0.35 to 0.92, p = 0.02), but not among the 92 participants with baseline Serum 25(Oh)D ≥ 50 nmol/l (ahr 1.45, 95% ci 0.81 to 2.62, p = 0.21; p for interaction = 0.02).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001977', 'blood serum', 270, 'serum'), ('CHEBI_33010', 'chromide(1-)', 278, '(OH)D')]
PMC4113768	7/2014	S3349-PMC4113768	['and the Vitamin D status in Pregnant women is significantly INFLUENCED by air temperature which is RELATED to the exposure of ultraviolet rays.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnant')]
PMC4113768	7/2014	S3366-PMC4113768	['background: Peripheral Leukocytes, which Express Vitamin D receptor (vdr) and are capable of locally yielding active Vitamin D, play an IMPORTANT ROLE in inflammatory responses.']	[('IMPORTANT_CONSIDERATION', 136), ('SUPERFICIAL_RELATIONSHIP', 146)]	2	[('CL_0002481', 'peritubular myoid cell', 12, 'Peripheral leukocytes'), ('GO_0010467', 'gene expression', 41, 'express'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4142706	7/2014	S71-PMC4142706	['(2013b)SHOWED that Vitamin C caused dna breaks in Nucleoids (substrate) when trying to carry out the comet-based in vitro Repair assay to study the EFFECT of Vitamin C on Ber of caco-2 cells.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 148)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin C'), ('GO_0005730', 'nucleolus', 50, 'nucleoids'), ('GO_0006281', 'DNA repair', 122, 'repair'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin C'), ('UBERON_0000063', 'organ subunit', 171, 'BER')]
PMC4169453	9/2014	S103-PMC4169453	['the itt approach ASSESSES the EFFECTIVENESS of improving Vitamin D status via different oral Vitamin D supplementation, regardless of whether the subject adhered to the dosing regimen.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4169453	9/2014	S150-PMC4169453	['HOWEVER, when Cord Blood was controlled for, the CORRELATION was not significant (r\u200a=\u200a0.001, p\u200a=\u200a0.99 ).10.1371/journal.pone.0107708.t004\n\ncaption (table-wrap): table 4\nSerum ipth and calcium concentrations, and Urinary Ca/cr ratio during 6 months of Vitamin D supplementation.parametertime400 iu/d group1200 iu/d group p -value between groups mothers n\u200a=\u200a67n\u200a=\u200a70ipth, pg/mlbaseline30.4 (20.2–43.5)28.6 (20–42)0.54δipth, pg/mlbaseline to 3 months−8.7±18.2−9.0±15.90.703 to 6 months4.1±10.43.5±10.30.75serum Ca, mmol/l3 months2.43 (2.36–2.49)2.44 (2.38–2.52)0.546 months2.37 (2.33–2.43)2.40 (2.36–2.47)0.13Uca/cr ratio, mmol/mmol3 months0.22 (0.12–0.38)0.3 (0.16–0.43)0.176 months0.19 (0.08–0.34)0.23 (0.11–0.41)0.27 infants n\u200a=\u200a67n\u200a=\u200a70ipth, pg/mlbaseline4.8 (3.7–7.1) (n\u200a=\u200a61)4.5 (3.8–5.8) (n\u200a=\u200a60)0.69δipth, pg/mlbaseline to 3 months10.7±10.011.5±6.30.803 to 6 months5.1±8.43.0±6.40.08serum ca, mmol/l3 months2.66 (2.61–2.73)2.67 (2.62–2.74)0.766 months2.62 (2.57–2.68)2.65 (2.62–2.7)0.009uca/cr ratio, mmol/mmol3 month1.58 (1.02–2.40)1.51 (0.89–2.47)0.556 months1.26 (0.87–1.81)1.47 (0.86–2.27)0.17\ndata presented as median (interquartile range: q1–q3) or mean ± sd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('UBERON_0002240', 'spinal cord', 14, 'cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 169, 'Serum'), ('UBERON_0001088', 'urine', 212, 'urinary'), ('CHEBI_32588', 'potassium chloride', 220, 'Ca'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_32588', 'potassium chloride', 508, 'Ca'), ('CHEBI_73165', 'elf18', 604, '13UCa')]
PMC4169453	9/2014	S162-PMC4169453	['HOWEVER, maternal total body fat mass was comparable between groups, significant negative CORRELATIONS were noted between maternal 25(Oh)D level and maternal fat mass (r\u200a=\u200a−0.49, p \u200a=\u200a0.00001), Android fat mass (r\u200a=\u200a−0.53, p \u200a=\u200a0.00001), and gynoid fat mass (r\u200a=\u200a−0.43, p \u200a=\u200a0.00001) after 6 months of Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_71657', 'versiconol acetate', 131, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 131, '25(OH)D'), ('UBERON_0001428', 'intermedium', 194, 'android'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4169453	9/2014	S190-PMC4169453	['from a clinical POINT OF VIEW, the IMPACT of 1200 iu/d Vitamin D dose on the maternal 25(Oh)D concentration was very subtle.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D')]
PMC4169453	9/2014	S194-PMC4169453	['HOWEVER, when the prevalence of Vitamin D deficiency in intervention groups was considered, the clinical EFFECT of the higher dose was much more distinct.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 105)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4171568	9/2014	S138-PMC4171568	['in a large-scale Birth cohort study of 9,114 people in finland, the use of Vitamin D supplements in the first year of Life was ASSOCIATED with a reduced risk of developing schizophrenia at 31\xa0years of age, with higher doses SEEN as more beneficial than lower amounts [110].']	[('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 224)]	2	[('GO_0007567', 'parturition', 17, 'birth'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC4188019	1/2010	S1-PMC4188019	['LITTLE IS KNOWN on Vitamin D deficiency in Pregnant women in belgium, non on the IMPACT of wearing Head and/or body cover.']	[('FULL_UNKNOWN', 0), ('SUPERFICIAL_RELATIONSHIP', 81)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('UBERON_0000033', 'head', 99, 'head')]
PMC4188019	1/2010	S17-PMC4188019	['25-Oh Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing preeclampsia (bodnar et al., 2007; haugen et al., 2009), multiple sclerosis (hayes et al., 1997; pierrot-deseilligny, 2009) and schizophrenia (mcgrath, 1999; mcgrath et al., 2003).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 0, '25-OH'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4192458	9/2014	S22-PMC4192458	['furthermore, Serum Nutrient levels (such as elevated polyunsaturated Fatty Acids, and decreased Vitamins C and E, zinc, and iron) HAVE BEEN ASSOCIATED with increased inflammation, oxidative stress, and dyslipidemia [9,10].']	[('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_33284', 'nutrient', 19, 'nutrient'), ('CHEBI_35366', 'fatty acid', 69, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 96, 'vitamins C'), ('PR_000004900', 'complement C3', 105, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 111, 'E')]
PMC4192458	9/2014	S23-PMC4192458	['Nutrient status HAS also BEEN directly LINKED with increased risk of pre-eclampsia, including increased Serum Triglyceride and Fatty Acids, and reduced levels of Serum calcium, Vitamin D, magnesium, and zinc [9].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_17855', 'triglyceride', 110, 'triglyceride'), ('CHEBI_35366', 'fatty acid', 127, 'fatty acids'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC4192458	9/2014	S201-PMC4192458	['fruit and vegetables are low in fat and calories, and are IMPORTANT sources of Nutrients RELATED to hypertension in non-Pregnant populations including dietary fiber, calcium, Magnesium, Potassium, and Vitamins C [67].']	[('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_33284', 'nutrient', 79, 'nutrients'), ('GO_0007565', 'female pregnancy', 120, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 175, 'magnesium'), ('CHEBI_22314', 'alkali metal atom', 186, 'potassium'), ('CHEBI_27300', 'vitamin D', 201, 'vitamins C')]
PMC4221707	11/2014	S7-PMC4221707	['intake of Folate and Vitamin D supplements was GENERALLY high in the Pregnant group and LED TO significantly higher total estimated Intake of Vitamin D and Folate in the pregnant group.']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_30863', '5-azaorotic acid', 10, 'folate'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('GO_0007631', 'feeding behavior', 132, 'intake'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 156, 'folate')]
PMC4221707	11/2014	S192-PMC4221707	['inadequate Intake of either Calcium or Vitamin D CAN LEAD TO disturbances in mineralized Tissues of the foetus [13].']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 28, 'calcium'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000479', 'tissue', 89, 'tissues')]
PMC4231606	10/2013	S107-PMC4231606	['s-ecc, infrequent milk Intake, and winter season were ASSOCIATED with lower 25(Oh)D levels, BUT NOT household income or Vitamin D drop use.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('ANOMALY_CURIOUS_FINDING', 92)]	2	[('GO_0007631', 'feeding behavior', 23, 'intake'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4231606	10/2013	S108-PMC4231606	['logistic regression for caries status was also performed, REVEALING that lower household income, poorer ratings of children’s general health, and lower Vitamin D levels were significantly ASSOCIATED with s-ecc (table\xa04).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 188)]	2	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4251419	12/2014	S68-PMC4251419	['multiple sclerosis: a case study\none of the earliest INDICATIONS of an ASSOCIATION between Vitamin D and disorders of Human Immune function was the geographical variation in prevalence of multiple sclerosis, as first described in 1922 [36].']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0002405', 'immune system', 124, 'immune')]
PMC4251419	12/2014	S105-PMC4251419	['OTHER STUDIES have LINKED Vitamin D with specific changes to the composition of the bacterial flora in the Gut microbiome.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 107, 'gut')]
PMC4251419	12/2014	S110-PMC4251419	['collectively, these studies SUGGEST that Vitamin D is instrumental in Regulating the microbiome of the Lungs and Gut, and is ENTWINED with the maintenance of Immune tolerance.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0065007', 'biological regulation', 70, 'regulating'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0001555', 'digestive tract', 113, 'gut'), ('UBERON_0002405', 'immune system', 158, 'immune')]
PMC4256222	12/2014	S76-PMC4256222	['total Vitamin D status was significantly ASSOCIATED with parity (p\u200a=\u200a0.004), with parous women being more LIKELY to be in deficient or insufficient state.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('PROBABLE_UNDERSTANDING', 106)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4256222	12/2014	S108-PMC4256222	['[5]SHOWED a direct ASSOCIATION between maternal Vitamin D status during Pregnancy and bmc and bmd in 160 offspring at 9 years of age.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC4256222	12/2014	S126-PMC4256222	['we FOUND a borderline significant inverse ASSOCIATION between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 106, 'forearm')]
PMC4275593	9/2014	S45-PMC4275593	['the supply of free or cheap Vitamin A and D tablets, milk, orange juice and cod Liver oil to expectant mothers and children through the wartime vitamin welfare scheme, with their perceived ROLE in the decline of maternal mortality, consolidated the IMPORTANCE of dietary supplements in Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 249)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 42, 'D'), ('UBERON_0002107', 'liver', 80, 'liver'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy')]
PMC4277121	12/2015	S255-PMC4277121	['CONVERSELY, when treatments with Minocycline and Vitamin E were started at earlier ages – 7 months and 4 months, respectively – and maintained for several months, both PREVENTED neurodegeneration at 10 months.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_50694', 'minocycline', 33, 'minocycline'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin E')]
PMC4289064	1/2015	S178-PMC4289064	['we tested the EFFECTS of this uncertainty[8]on a subset of our results for Vitamin A and FOUND no qualitative change in our results.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin A')]
PMC4302429	1/2015	S28-PMC4302429	['studies of the Innate Immune Response to pathogens such as mycobacterium tuberculosis HAVE SHOWN that pathogen-recognition receptor (prr)-mediated activation of localized Vitamin D Metabolism and signaling is a key event ASSOCIATED with resistance to infection [17].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 221)]	2	[('GO_0045087', 'innate immune response', 15, 'innate immune response'), ('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 171, 'vitamin D metabolism')]
PMC4302429	1/2015	S85-PMC4302429	['results\n\nVitamin D3 Serum concentrations DEPENDED on dietary Vitamin D3 content\nthe analysis of the Vitamin D3 Metabolite 25-Oh-D3 in Serum samples obtained after six weeks of experimental diet REVEALED that the Vitamin D3 content in the diet determined the Vitamin D Serum concentrations of the Mice.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 194)]	2	[('CHEBI_33237', 'vitamin D4', 9, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D3'), ('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_33279', 'vitamin D5', 61, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 61, 'vitamin D3'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 100, 'vitamin D3'), ('CHEBI_39382', 'flufenoxuron', 111, 'metabolite'), ('CHEBI_86945', 'syringaldehyde acetate', 122, '25-OH-D3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25-OH-D3'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_33279', 'vitamin D5', 212, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 212, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001977', 'blood serum', 268, 'serum'), ('NCBITaxon_10088', 'Mus <genus>', 296, 'mice')]
PMC4302429	1/2015	S89-PMC4302429	['at 24\xa0hours after infection, Vitamin D-deficient Mice had a TENDENCY towards a greater weight loss ( p \u2009=\u20090.22; figure\xa01b), the difference failing to reach statistical significance BECAUSE of high interindividual variation.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('PROBLEM_COMPLICATION', 181)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 49, 'mice')]
PMC4302429	1/2015	S163-PMC4302429	['a central feature of many of these NON-CLASSICAL actions of Vitamin D is RELATED to the synthesis of active 1,25(Oh)2D in a cell-specific manner: enzyme 25Ohd-1α-hydroxylase (encoded by the Gene Cyp27B1 ) is Expressed by many Extrarenal Tissues, including the Immune System [14,34].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 108, '1,25(OH)2D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 153, '25OHD'), ('SO_0000704', 'gene', 190, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 195, 'CYP27B1'), ('GO_0010467', 'gene expression', 208, 'expressed'), ('UBERON_0005292', 'extraembryonic tissue', 226, 'extrarenal tissues'), ('UBERON_0002405', 'immune system', 260, 'immune system')]
PMC4302429	1/2015	S173-PMC4302429	['in-vivo studies in Mice and Rats also SHOWED beneficial EFFECTS of Vitamin D in Lipopolysaccharide-induced sepsis [20,39], and antenatal Vitamin D therapy improved survival in newborn Rat pups and enhanced their Lung structure after exposure to endotoxin [40].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('NCBITaxon_10088', 'Mus <genus>', 19, 'mice'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 28, 'rats'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 80, 'lipopolysaccharide'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 184, 'rat'), ('UBERON_0002048', 'lung', 212, 'lung')]
PMC4302429	1/2015	S174-PMC4302429	['the INFLUENCE of Vitamin D on the course of Cns infections is NOT KNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 44, 'CNS')]
PMC4302429	1/2015	S190-PMC4302429	['a study on the Immune Response to an allergic stimulus in Mice in vivo SUGGESTED that Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection) given after the initial period of sensitization prevented high levels of Eosinophils ASSOCIATED with a reduced local inflammatory response in Bronchoalveolar Lavage Fluid and Lung Tissue.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 227)]	2	[('GO_0006955', 'immune response', 15, 'immune response'), ('UBERON_0002405', 'immune system', 15, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 120, '1,25(OH)2D'), ('CL_0000771', 'eosinophil', 215, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 284, 'bronchoalveolar lavage fluid'), ('UBERON_0002048', 'lung', 317, 'lung tissue')]
PMC4303849	1/2015	S13-PMC4303849	['Calcidiol is the major Vitamin D Metabolite present in the circulation and the BEST INDICATOR of vd nutritional status.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_17933', 'calcidiol', 0, 'Calcidiol'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 33, 'metabolite')]
PMC4329404	10/2014	S1-PMC4329404	['we INVESTIGATED the EFFECT of early-Life Vitamin D deficiency on the development of Murine neonatal allergic Airways disease (aad).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0000104', 'life cycle', 36, 'life'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 84, 'murine'), ('UBERON_0001005', 'respiratory airway', 109, 'airways')]
PMC4329404	10/2014	S8-PMC4329404	['conclusion\nperi-natal Vitamin D deficiency ALONE has immunomodulatory EFFECTS including th2 skewing and reduced Il-10-Secreting T Regulatory Cells, exaggerated with additional Allergen exposure.']	[('ANOMALY_CURIOUS_FINDING', 43), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 112, 'IL-10'), ('CL_0000595', 'enucleate erythrocyte', 118, 'secreting'), ('GO_0046903', 'secretion', 118, 'secreting'), ('CL_0000902', 'induced T-regulatory cell', 128, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 130, 'regulatory'), ('CHEBI_50904', 'allergen', 176, 'allergen')]
PMC4329404	10/2014	S19-PMC4329404	['Serum Vitamin D levels HAVE BEEN ASSOCIATED with disease severity in children and were reduced in severe compared to moderate asthmatics (12).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4329404	10/2014	S26-PMC4329404	['the ROLE of Vitamin D as an immunomodulator is BETTER DEFINED, with Vitamin D skewing the Immune System towards Regulation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 90, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation')]
PMC4329404	10/2014	S30-PMC4329404	['Pregnant females were Fed a Vitamin D-deficient diet starting from day-16 Gestation (last trimester) to FOCUS on Immune-mediated mechanisms of disease development in offspring and to limit any EFFECTS of in utero Vitamin D deficiency on foetal Lung growth and Development (27).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007631', 'feeding behavior', 22, 'fed'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('UBERON_0002405', 'immune system', 113, 'immune'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0030324', 'lung development', 244, 'lung ... development'), ('UBERON_0002048', 'lung', 244, 'lung')]
PMC4329404	10/2014	S87-PMC4329404	['Vitamin D insufficiency in utero and in early Life promotes Pulmonary th2 skewing and reduced Il-10+T Regulatory Cells\nto DETERMINE the ROLE of Vitamin D in T-Cell Differentiation, we analysed Th2 Cells and Il-10+T Regulatory Cells in the Lungs of pups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 46, 'life'), ('UBERON_0002048', 'lung', 60, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 94, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 100, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 102, 'regulatory'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CL_0000084', 'T cell', 157, 'T-cell'), ('GO_0030217', 'T cell differentiation', 157, 'T-cell differentiation'), ('CL_0000546', 'T-helper 2 cell', 193, 'Th2 cells'), ('PR_000001470', 'interleukin-28B', 207, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 213, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 215, 'regulatory'), ('UBERON_0002048', 'lung', 239, 'lungs')]
PMC4329404	10/2014	S151-PMC4329404	['data from Adult studies SHOW an ASSOCIATION between Vitamin D status and Steroid response (23).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_35341', 'steroid', 73, 'steroid')]
PMC4329404	10/2014	S159-PMC4329404	['SIMILARLY, Serum Ige levels were lowest in Mice that were supplemented with Vitamin D at weaning, EVEN lower than those that were always Vitamin D sufficient (fig.4a).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 98)]	2	[('UBERON_0001977', 'blood serum', 11, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 17, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4329404	10/2014	S184-PMC4329404	['our data SUGGEST Vitamin D deficiency in utero and early Life CONTRIBUTES to worse Eosinophilic inflammation and that Vitamin D supplementation after weaning reduces the development of both Pulmonary Eosinophilia and remodelling.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('CL_0000771', 'eosinophil', 83, 'eosinophilic'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'pulmonary'), ('CL_0000771', 'eosinophil', 200, 'eosinophilia')]
PMC4329745	10/2014	S65-PMC4329745	['Serum 25-Ohd level is the BEST INDICATOR of Vitamin D status in Individuals (7).']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_72765', 'verruculogen', 6, '25-OHD'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('NCBITaxon_1', 'root', 64, 'individuals')]
PMC4329745	10/2014	S69-PMC4329745	['DEMONSTRATED that low early-Pregnancy Vitamin D status was ASSOCIATED with more depressive symptoms in Pregnancy (11).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC4329745	10/2014	S70-PMC4329745	['as well, the RELATIONSHIP between schizophrenia in Adult men and Vitamin D supply during the first year of Life was SHOWN in a study conducted by mcgrath et al.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 116)]	2	[('UBERON_0007023', 'adult organism', 51, 'adult'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000104', 'life cycle', 107, 'life')]
PMC4340999	3/2015	S13-PMC4340999	['low exposure to ultraviolet b radiation and subsequent reduced levels of Vitamin D during the late second and early third Trimesters MAY BE INVOLVED in these phenomena.']	[('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0002298', 'brainstem', 122, 'trimesters')]
PMC4340999	3/2015	S107-PMC4340999	['besides significant seasonal variation in sunshine, peak and trough windows are also SUPPOSED to last long enough to INFLUENCE Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4377870	3/2015	S111-PMC4377870	['evidence from observational studies also SUGGESTS that reduced maternal dietary intake of Vitamin E is RELATED to an increased risk of childhood asthma and wheeze [90,91,92] and increased in vitro proliferative responses in Cord Blood Mononuclear Cells (Cbmc) [93].']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 103)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin E'), ('CL_0000752', 'cone retinal bipolar cell', 224, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 224, 'cord'), ('UBERON_0000178', 'blood', 229, 'blood'), ('GO_0031097', 'medial cortex', 235, 'mononuclear'), ('CL_0002062', 'type I pneumocyte', 254, 'CBMC')]
PMC4377870	3/2015	S140-PMC4377870	['the review by foong and zosky [111] presents the CURRENT EVIDENCE for the ROLE of Vitamin D deficiency in disease onset, progression and exacerbation in Respiratory infections, asthma and copd.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 153, 'respiratory')]
PMC4377870	3/2015	S149-PMC4377870	['other OBSERVATIONAL STUDIES report that in children, low levels of Vitamin D are ASSOCIATED with asthma exacerbation [118].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 81)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4377870	3/2015	S152-PMC4377870	['[119] FOUND that Vitamin D deficiency at 18 weeks Gestation was ASSOCIATED with lower Lung function and current wheeze in children 6 years of age and an increased risk of asthma in boys.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'gestation'), ('UBERON_0002048', 'lung', 86, 'lung')]
PMC4377870	3/2015	S156-PMC4377870	['Blood Vitamin D levels HAVE also BEEN CORRELATED with Lung function in copd patients [124,125].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung')]
PMC4377870	3/2015	S159-PMC4377870	['there is research SUGGESTING a Genetic LINK between Vitamin D and copd pathogenesis.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4377870	3/2015	S162-PMC4377870	['copd progression MAY also be AFFECTED by Vitamin D status through absence of the Vitamin D receptor and Parenchyma degradation [128].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000353', 'parenchyma', 104, 'parenchyma')]
PMC4377879	3/2015	S97-PMC4377879	['INTERACTIONS among Micronutrients\nINTERACTIONS between Micronutrient-dependent physiological and biological actions can be both positive, e.g., zinc and Vitamin A, and negative, as e.g., with zinc or copper and iron [43].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_34850', 'milrinone lactate', 19, 'Micronutrients'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 55, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin A')]
PMC4380518	9/2014	S36-PMC4380518	['in other words, early pnv use was ASSOCIATED with Vitamin D sufficiency earlier in Pregnancy BUT NOT later in Pregnancy (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC4380518	9/2014	S48-PMC4380518	['both overweight/obesity as well as darker skin pigmentation are both WELL-ESTABLISHED RISK FACTORS for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 69), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4383226	2/2015	S79-PMC4383226	['these EFFECTS REMAINED after weighting.figure 2illustrates that the association between Vitamin A and plasmodium parasitemia was not impacted by season, age or time since supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S128-PMC4383226	['we have chosen to present data in this paper that includes mozambique because these results provide more conservative ESTIMATES of Vitamin A EFFECTS when using Blood films.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 141)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin A'), ('UBERON_0000178', 'blood', 160, 'blood')]
PMC4383575	1/2015	S63-PMC4383575	['subgroups of Food items known to be sources of either higher levels of adduct-forming exposures (e.g., processed meat, meats, and leafy green vegetables), or higher levels of POTENTIAL PROTECTIVE components (e.g., fruits rich in Vitamin C, as well as their parent Food groups), were evaluated separately and as a dietary score.']	[('INCOMPLETE_EVIDENCE', 175), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_33290', 'food', 13, 'food'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin C'), ('CHEBI_33290', 'food', 264, 'food')]
PMC4392531	3/2015	S130-PMC4392531	['bread and cereals play an ESSENTIAL ROLE in the supplying calories for women and are rich in Vitamin B, iron, zinc, and fiber.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin B')]
PMC4392553	3/2015	S438-PMC4392553	['[36]\nosteoarthritis is another pathology LIKELY RELATED to Mn deficiency, impaired Chondroitin Sulfate Synthesis and impaired Vitamin D activation.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('PR_000010460', 'carbohydrate-responsive element-binding protein', 59, 'Mn'), ('CHEBI_37397', 'chondroitin sulfate', 83, 'chondroitin sulfate'), ('GO_0030206', 'chondroitin sulfate biosynthetic process', 83, 'chondroitin sulfate synthesis'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4396835	1/2015	S17-PMC4396835	['low Vitamin D availability has attracted increasing INTEREST as an aetiological FACTOR in disorders of the Central Nervous System.']	[('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 107, 'central nervous system')]
PMC4405493	4/2015	S118-PMC4405493	['RISK FACTORS for Vitamin D deficiency include INADEQUATE sun or uv light exposure, physiologic factors (such as dark skin pigmentation, obesity, Pregnancy, certain medical problems), and low Vitamin D intake [2–3].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4405493	4/2015	S124-PMC4405493	['other RISK FACTORS for Vitamin D deficiency include ethnicity, AS darker skinned Individuals have decreased Vitamin D3 Synthesis in response to ultraviolet light.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('PROBABLE_UNDERSTANDING', 63)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('NCBITaxon_1', 'root', 81, 'individuals'), ('CHEBI_33279', 'vitamin D5', 108, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 108, 'vitamin D3'), ('GO_0009057', 'macromolecule catabolic process', 119, 'synthesis')]
PMC4405493	4/2015	S162-PMC4405493	['obesity is also a KNOWN RISK FACTOR for Vitamin D deficiency[73].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4405493	4/2015	S163-PMC4405493	['we reviewed the bmi of our study participants to see IF there was any ASSOCIATION between Vitamin D deficiency classification and bmi.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4405493	4/2015	S175-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual complications of Pregnancy.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC4417995	4/2015	S24-PMC4417995	['data in Adults SUGGESTS that Vitamin D levels less than approximately 30\u2009ng/ml are ASSOCIATED with changes in Parathyroid hormone levels, as well as Intestinal calcium transport [13].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('UBERON_0007023', 'adult organism', 8, 'adults'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 110, 'parathyroid'), ('UBERON_0000160', 'intestine', 149, 'intestinal')]
PMC4417995	4/2015	S61-PMC4417995	['[30] OBSERVED that higher intake of Vitamin D during the first year of Life was CORRELATED with increased risk of eczema at age six.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life')]
PMC4417995	4/2015	S70-PMC4417995	['[33], who PROPOSED a bimodal and/or gender specific RELATIONSHIP between Vitamin D and allergic skin diseases.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4417995	4/2015	S106-PMC4417995	['[50] DEMONSTRATED an inverse ASSOCIATION between Cord Plasma Vitamin D levels and T-Regulatory Cells number.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 82, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 84, 'regulatory')]
PMC4417995	4/2015	S169-PMC4417995	['heliotherapy\ndifferent studies FOCUSED on the EFFECT of heliotherapy on both Vitamin D levels and ad severity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4427001	4/2015	S20-PMC4427001	['Vitamin D—via its binding to the Vitamin D receptor (vdr)—Regulates Expression of hundreds of Genes (directly OR indirectly) including those that Control key processes AFFECTING cell fate [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0065007', 'biological regulation', 58, 'regulates'), ('GO_0010467', 'gene expression', 68, 'expression'), ('SO_0000704', 'gene', 94, 'genes'), ('GO_0065007', 'biological regulation', 146, 'control')]
PMC4427001	4/2015	S120-PMC4427001	['[28] reported that prevalence of Vitamin D deficiency is higher among women with impaired Glucose tolerance or gdm in 204 iranian women but they DID NOT FIND CORRELATION with bmi or fpg.']	[('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 158)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_17234', 'glucose', 90, 'glucose')]
PMC4427001	4/2015	S142-PMC4427001	['[44] assessed the EFFECT of Calcium and Vitamin D cosupplementation on gdm in a randomised placebo-controlled study (56 iranian women with gdm) and they OBSERVED a significant reduction in fpg, serum Insulin levels, and homa-ir and increase in quicki compared with placebo, and also an increase in Glutathione and a reduction in Serum ldl-Cholesterol and total Cholesterol and a significant elevation in hdl-Cholesterol were common.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 153)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 28, 'calcium'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('PR_000045358', 'insulin family protein', 200, 'insulin'), ('CHEBI_16856', 'glutathione', 298, 'glutathione'), ('UBERON_0001977', 'blood serum', 329, 'serum'), ('CHEBI_16113', 'cholesterol', 339, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 361, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 408, 'cholesterol')]
PMC4448820	5/2015	S255-PMC4448820	['in particular, Nk T Cell Development in Mice is CRITICALLY DEPENDENT on Vitamin D (173).']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CL_0000213', 'lining cell', 15, 'NK T cell'), ('GO_0001822', 'kidney development', 15, 'NK T cell development'), ('GO_0005634', 'nucleus', 15, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4448820	5/2015	S273-PMC4448820	['for the PURPOSE of this overview, the general molecular actions of 4 Micronutrients (Vitamins A and d, zinc, Folic Acid) will be the primary focus, including their specific points of convergence on the Regulation of 2 major regulators of inflammation: Nf-Κb activity and the induction, and maintenance, of Treg cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 202)]	2	[('CHEBI_33839', 'macromolecule', 69, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 85, 'vitamins A'), ('CHEBI_30751', 'formic acid', 109, 'folic acid'), ('GO_0065007', 'biological regulation', 202, 'regulation'), ('GO_0005883', 'neurofilament', 252, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 252, 'NF-κB'), ('CL_0000901', 'Tr1 cell', 306, 'Treg')]
PMC4448820	5/2015	S274-PMC4448820	['caption (boxed-text): text box 9\u2003\npotential pathways of intersection for Micronutrients\n\n● Myelomonocytic Cell Differentiation (Vitamins A and D)\n● Macrophage polarization (Vitamins a and d, zinc, Folic Acid)\n● B and T Cell Proliferation (zinc, Iron, Folic Acid, others)\n● T Cell Apoptosis (zinc, iron, Vitamin A, Vitamin E, others)\n● Regulation of Nf-Κb activity (Vitamins A, d, and e; zinc; iron; many others)\n● induction, and maintenance, of Treg Cells (Vitamins A and D, zinc, Folic Acid)\n● Regulation Of Gene Expression and/or activity of Protein Kinase C, cyclins, and cyclin-dependent kinases (e.g., as seen with iron): such defects in one or more of these factors MAY AFFECT or Modulate Lymphocyte Responses to stimuli\n\niv.']	[('INCOMPLETE_EVIDENCE', 672), ('SUPERFICIAL_RELATIONSHIP', 676)]	2	[('CHEBI_33839', 'macromolecule', 73, 'micronutrients'), ('CL_0000763', 'myeloid cell', 91, 'Myelomonocytic cell'), ('GO_0002270', 'plasmacytoid dendritic cell activation', 91, 'Myelomonocytic'), ('GO_0030154', 'cell differentiation', 106, 'cell differentiation'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 137, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 143, 'D'), ('CL_0000235', 'macrophage', 148, 'Macrophage'), ('CHEBI_33277', 'gamma-tocotrienol', 173, 'vitamins'), ('CHEBI_30751', 'formic acid', 197, 'folic acid'), ('CL_0000969', 'regulatory B cell', 211, 'B ...'), ('CL_0000084', 'T cell', 217, 'T cell'), ('GO_0008283', 'cell proliferation', 219, 'cell proliferation'), ('CHEBI_24870', 'ion', 245, 'iron'), ('CHEBI_30751', 'formic acid', 251, 'folic acid'), ('CL_0000084', 'T cell', 273, 'T cell'), ('GO_0006915', 'apoptotic process', 275, 'cell apoptosis'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin E'), ('GO_0065007', 'biological regulation', 335, 'Regulation'), ('GO_0035773', 'insulin secretion involved in cellular response to glucose stimulus', 349, 'NF-κB'), ('GO_0071159', 'NF-kappaB complex', 349, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 349, 'NF-κB'), ('CHEBI_27300', 'vitamin D', 365, 'vitamins A'), ('CL_0000960', 'T3 B cell', 445, 'Treg cells'), ('CHEBI_27300', 'vitamin D', 457, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 472, 'D'), ('CHEBI_30751', 'formic acid', 481, 'folic acid'), ('GO_0010468', 'regulation of gene expression', 495, 'Regulation of gene expression'), ('SO_0000704', 'gene', 509, 'gene'), ('PR_000013390', '26S proteasome non-ATPase regulatory subunit 8', 544, 'protein kinase C'), ('GO_0065007', 'biological regulation', 686, 'modulate'), ('CL_0000542', 'lymphocyte', 695, 'lymphocyte'), ('GO_0060033', 'anatomical structure regression', 706, 'responses')]
PMC4448820	5/2015	S297-PMC4448820	['because Vitamins A and D share a Nuclear receptor (rxr), compete for coactivators and corepressors, and reciprocally Regulate the Expression of their receptors, a wide variety of combined EFFECTS on Gene Regulation LIKELY occurs (190–192).']	[('SUPERFICIAL_RELATIONSHIP', 188), ('PROBABLE_UNDERSTANDING', 215)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 23, 'D'), ('GO_0005634', 'nucleus', 33, 'nuclear'), ('GO_0065007', 'biological regulation', 117, 'regulate'), ('GO_0010467', 'gene expression', 130, 'expression'), ('SO_0000704', 'gene', 199, 'gene'), ('GO_0065007', 'biological regulation', 204, 'regulation')]
PMC4448820	5/2015	S405-PMC4448820	['v. Vitamin E.\npolymorphisms at cytokine Genes MAY determine the EFFECT of Vitamin E on Cytokine Production in the elderly (232).']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_28384', 'vitamin K', 3, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 3, 'Vitamin E'), ('SO_0000704', 'gene', 40, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin E'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 87, 'cytokine production')]
PMC4448820	5/2015	S476-PMC4448820	['confirmation of Vitamin A’s ROLE is provided by 4 types of observations:\n● elimination of infections SOMETIMES leads to a relatively rapid rebound in Plasma Retinol without nutritional intervention (23).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('UBERON_0001969', 'blood plasma', 150, 'plasma'), ('CHEBI_26536', 'retinoic acid', 157, 'retinol')]
PMC4448820	5/2015	S552-PMC4448820	['● Serum Retinol and rbp also CORRELATE with Liver Vitamin A stores in subjects with or AT RISK of clinical deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 87)]	2	[('UBERON_0001977', 'blood serum', 2, 'Serum'), ('CHEBI_26536', 'retinoic acid', 8, 'retinol'), ('UBERON_0002107', 'liver', 44, 'liver'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin A')]
PMC4448820	5/2015	S1044-PMC4448820	['● in a multicenter study in the united states, Vitamin D insufficiency (<30 μg/l) was PREDICTIVE of SEVERE asthma exacerbations (586).']	[('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 100)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4448820	5/2015	S1045-PMC4448820	['● no randomized trials HAVE BEEN published on the EFFECTS of Vitamin D supplementation to prevent asthma or to reduce morbidity.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4448820	5/2015	S1195-PMC4448820	['several of these types of INTERACTIONS, including a similar enzyme-Nutrient INTERACTION involving Vitamin A, were highlighted by wg 1.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_33284', 'nutrient', 67, 'nutrient'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin A')]
PMC4448820	5/2015	S1457-PMC4448820	['● Retinol isotope dilution: ALTHOUGH not widely used clinically or programmatically, this is the most sensitive BIOMARKER of Vitamin A status to Liver reserves of Vitamin A.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 112)]	2	[('CHEBI_27810', 'resorcinol', 2, 'Retinol'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'liver'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin A')]
PMC4448820	5/2015	S1503-PMC4448820	['the available BIOMARKERS of Vitamin B-12 were also RECENTLY reviewed (785) and are summarized in the text box 50 .']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 51)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 28, 'vitamin B-12')]
PMC4448820	5/2015	S1504-PMC4448820	['caption (boxed-text): text box 50\u2003\ncurrently available Vitamin B-12 BIOMARKERS/indicators\n\n● Serum/Plasma total Vitamin B-12\n● Serum holotranscobalamin\n● Serum/Plasma Methylmalonic Acid (Mma)\n● Plasma total Homocysteine\n\nINFLUENCE of inflammation on Vitamin B-12 assessment.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 221)]	2	[('CHEBI_85855', 'diacylglycerol 46:7', 55, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 55, 'vitamin B-12'), ('UBERON_0001977', 'blood serum', 93, 'Serum'), ('UBERON_0001969', 'blood plasma', 99, 'plasma'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 112, 'vitamin B-12'), ('UBERON_0001977', 'blood serum', 127, 'Serum'), ('UBERON_0001977', 'blood serum', 154, 'Serum'), ('UBERON_0001969', 'blood plasma', 160, 'plasma'), ('CHEBI_30860', 'methylmalonic acid', 167, 'methylmalonic acid'), ('CHEBI_34840', 'methyl methacrylate', 187, 'MMA'), ('UBERON_0001969', 'blood plasma', 194, 'Plasma'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 207, 'homocysteine'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 250, 'vitamin B-12')]
PMC4448820	5/2015	S1525-PMC4448820	['the IMPACT of inflammation on Nutrient BIOMARKERS is well described for several key Nutrients, such as iron and Vitamin A.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_33284', 'nutrient', 30, 'nutrient'), ('CHEBI_33284', 'nutrient', 84, 'nutrients'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin A')]
PMC4448820	5/2015	S1535-PMC4448820	['caption (table-wrap): table 12\n\nsummary of key Nutrient biomarkers1nutrientcommonly used biomarker/indicatorsmagnitude and direction of inflammation effectsettings where usednotesironferritin+++clinical, research, populationstfr+research, populationstfr assays are not yet standardized and compare poorlyhemoglobinclinicalbody Iron+research, populationratio of tfr:ferritin+researchtfr index+research, clinicalzpp+clinical, populationhepcidin0researchvitamin Aretinol−clinical, research, populationrbp−research, populationbreast-milk Retinolresearchretinol dose response testresearchzincserum/Plasma zinc−clinical, populationnot reliable in clinical settings if patient inflamedfolateerythrocyte Folate+clinical, populationplasma or Serum Folate−clinical, populationvitamin B-12serum/Plasma total cobalamin0clinical, populationserum holotranscobalaminresearchsuperior diagnostic performance of holotranscobalamin is controversialplasma/Urine mma0clinical, populationmma assay is more expensiveplasma total Homocysteine+clinicalelevated in both Folate and Vitamin B-12 deficiencyiodineurinary Iodine0Populationno known ASSOCIATION with inflammationvitamin D25(Oh)D−clinical, populationvitamin B-6plasma Pyridoxal 5-Phosphate−research, populationvitamin cserum Ascorbic Acid−research, populationfreshly prepared Serum NEEDS to be promptly Acidified with Meta-Phosphoric Acid and frozen to stabilize Ascorbic Acid\nMma, Methylmalonic Acid; Rbp, Retinol Binding Protein; Stfr, soluble Transferrin Receptor; tfr, Transferrin Receptor; zpp, Zinc Protoporphyrin; 0, no change; 25(Oh)D, 25-Hydroxyvitamin D; −, decrease; +, increase; +++, major increase.']	[('SUPERFICIAL_RELATIONSHIP', 1118), ('FUTURE_WORK', 1316)]	2	[('CHEBI_33284', 'nutrient', 47, 'nutrient'), ('CHEBI_24870', 'ion', 327, 'iron'), ('CHEBI_80843', 'Leonurine', 459, 'ARetinol'), ('CHEBI_67264', 'geranic acid', 534, 'retinolResearchRetinol'), ('UBERON_0001969', 'blood plasma', 593, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 696, 'folate'), ('UBERON_0001977', 'blood serum', 733, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 739, 'folate'), ('PR_000000037', 'BMP receptor type-2', 774, 'B'), ('UBERON_0001969', 'blood plasma', 784, 'plasma'), ('UBERON_0001088', 'urine', 936, 'urine'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 1006, 'homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 1044, 'folate'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 1055, 'vitamin B-12'), ('CHEBI_30593', 'disilanyl', 1092, 'iodine0PopulationNo'), ('PR_000001177', 'D(2) dopamine receptor', 1155, 'D25'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1159, 'OH)D'), ('PR_000000037', 'BMP receptor type-2', 1192, 'B'), ('CHEBI_18335', "pyridoxamine 5'-phosphate", 1202, 'pyridoxal 5-phosphate'), ('CHEBI_22652', 'ascorbic acid', 1259, 'ascorbic acid'), ('UBERON_0001977', 'blood serum', 1310, 'serum'), ('CHEBI_34520', 'acephate', 1337, 'acidified'), ('CHEBI_25286', 'methylbutanoyl-CoA', 1352, 'meta-phosphoric acid'), ('CHEBI_22652', 'ascorbic acid', 1397, 'ascorbic acid'), ('CHEBI_34840', 'methyl methacrylate', 1411, 'MMA'), ('CHEBI_30860', 'methylmalonic acid', 1416, 'methylmalonic acid'), ('PR_000013830', 'calcipressin-2', 1436, 'RBP'), ('CHEBI_26536', 'retinoic acid', 1441, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 1441, 'retinol binding protein'), ('PR_000015619', 'sorcin', 1466, 'sTfR'), ('PR_000001679', 'trace amine-associated receptor 5', 1480, 'transferrin receptor'), ('PR_000001679', 'trace amine-associated receptor 5', 1507, 'transferrin receptor'), ('CHEBI_28783', 'zinc protoporphyrin', 1534, 'zinc protoporphyrin'), ('CHEBI_71657', 'versiconol acetate', 1569, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 1578, '25-hydroxyvitamin D')]
PMC4452099	6/2015	S3-PMC4452099	['we further MODELLED birth cohort EFFECTS in children developing t1d as a linear spline, and compared the slopes between the birth cohorts with various Prenatal and infancy exposures to Vitamin D fortification.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('GO_0007565', 'female pregnancy', 151, 'prenatal'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4452099	6/2015	S13-PMC4452099	['a variety of environmental t1d risk and PROTECTIVE FACTORS, including Vitamin D supplementation during Gestation and in early infancy, HAVE BEEN investigated [5–9].']	[('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 135)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'gestation')]
PMC4452099	6/2015	S17-PMC4452099	['Animal studies DEMONSTRATED that in Mice, Prenatal Vitamin D supplementation PREVENTED the development of t1d [13,14].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4466139	6/2015	S0-PMC4466139	['high prevalence of Vitamin D deficiency in native versus migrant mothers and newborns in the north of italy: a CALL TO act with a stronger prevention program\n\nabstract\n\nbackground\nVitamin D status during Pregnancy is RELATED to neonatal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 180, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4466139	6/2015	S84-PMC4466139	['multivariate adjusted regression model analysis (r-square: 0.302), adjusted for maternal age and education SHOWED a LINK between maternal 25Ohd level and season (p<0.0001), country of origin (north africa, p<0.0001; africa, p = 0.0052; asia, p = 0.0003; south america, p = 0.0002) and Vitamin D supplementation in Pregnancy (p<0.0001), while Vitamin D Intake from diet was non-significant (p = 0.944).']	[('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 138, '25OHD'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('GO_0007565', 'female pregnancy', 314, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('GO_0007631', 'feeding behavior', 352, 'intake')]
PMC4466139	6/2015	S103-PMC4466139	['furthermore, when we analyzed the ROLE of diet and supplementation in Pregnancy and their EFFECTS on mothers and newborns, Vitamin D intake through diet was (136 iu on average) under 400 iu (recommended minimum), with an Intake slightly higher in migrants than italian mothers.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007631', 'feeding behavior', 221, 'intake')]
PMC4488777	5/2015	S81-PMC4488777	['up to this moment, researchers were FOCUSED on immunomodulating EFFECT of Vitamin D on Endometriosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0010230', 'eyeball of camera-type eye', 87, 'endometriosis')]
PMC4488777	5/2015	S159-PMC4488777	['the immunomodulating ROLE of Vitamin D was also CONFIRMED by Stimulation Of Nk Cells (natural killer Cd56+ve) isolated from the 1sttrimester Decidua.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 48)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0048870', 'cell motility', 61, 'stimulation of NK cells'), ('CL_0000623', 'natural killer cell', 76, 'NK cells'), ('GO_0005634', 'nucleus', 76, 'NK'), ('PR_000001309', 'CD70 molecule', 101, 'CD56'), ('UBERON_0002450', 'decidua', 141, 'decidua')]
PMC4490503	6/2015	S293-PMC4490503	['Vitamin D\nlow Vitamin D HAS BEEN IMPLICATED in the aetiology of obesity, Insulin resistance and t2dm [121].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('PR_000045358', 'insulin family protein', 73, 'insulin')]
PMC4490503	6/2015	S296-PMC4490503	['early Pregnancy Vitamin D status HAS BEEN inversely ASSOCIATED with gdm risk [123].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('GO_0007565', 'female pregnancy', 6, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4490503	6/2015	S300-PMC4490503	['[122] FOUND lower first trimester 25-Hydroxyvitamin D (25-Ohd) levels were ASSOCIATED with higher risk of gdm after adjustment for Vitamin D confounders and gdm risk factors.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 34, '25-hydroxyvitamin D'), ('CHEBI_72765', 'verruculogen', 55, '25-OHD'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4499266	4/2015	S43-PMC4499266	['the lack of Gestational Vitamin A HAS BEEN SUGGESTED to CONTRIBUTE to Hearing loss development in developing countries [7].']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('GO_0007565', 'female pregnancy', 12, 'gestational'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0007605', 'sensory perception of sound', 70, 'hearing')]
PMC4499946	7/2015	S9-PMC4499946	['discussion\nthe ROLE of Vitamin D in maternal and infant health remains UNRESOLVED.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4499946	7/2015	S34-PMC4499946	['analyses of the EFFECT of Prenatal Vitamin D supplementation on infant length among 134 infants followed up to 1 year of age REVEALED that infants Born to women in the Vitamin D group had mean length for age z-scores (lazs) at 1 year that were significantly greater than infants in the placebo group (mean = 0.44 z-score units higher; 95% confidence interval [ci], 0.06–0.82) [26].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 125)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4499946	7/2015	S46-PMC4499946	['objectives\nthe primary AIMS of the trial are to estimate (1) the effect of maternal Prenatal oral Vitamind3Supplementation (4200 iu/wk, 16,800 iu/wk, or 28,000 iu/wk administered as weekly doses) versus placebo on infant length at 1 year of age in dhaka, bangladesh; and (2) the EFFECT of maternal Postpartum oral Vitamin D3Supplementation (28,000 iu/wk) versus placebo on length at 1 year of age among infants Born to women who received Vitamin D 28,000 iu/wk during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 279)]	2	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 98, 'vitaminD3supplementation'), ('GO_0007565', 'female pregnancy', 298, 'postpartum'), ('CHEBI_52915', 'phosphatediyl group', 314, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 314, 'vitamin D3supplementation'), ('GO_0007567', 'parturition', 411, 'born'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D'), ('GO_0007565', 'female pregnancy', 468, 'pregnancy')]
PMC4499946	7/2015	S94-PMC4499946	['interventions and control\n\nVitamin D doses\nthe primary OBJECTIVE of the mdig trial is to establish evidence of a causal RELATIONSHIP between maternal-infant Vitamin D status and infant stature.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 120)]	2	[('CHEBI_28384', 'vitamin K', 27, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4499946	7/2015	S205-PMC4499946	['Genomic dna will be subjected to Bisulfite modification, and amplified Pcr Products will be analyzed by quantitative pyrosequencing to assess Dna Methylation at several consecutive Cpg Sites within an APPROXIMATELY 150-Bp region at the Promoters of two Genes INVOLVED in Vitamin D Metabolism ( Cyp27B1 and Cyp24A1 ).']	[('INCOMPLETE_EVIDENCE', 201), ('SUPERFICIAL_RELATIONSHIP', 259)]	2	[('SO_0001026', 'genome', 0, 'Genomic'), ('CHEBI_29874', 'bromine dioxide', 33, 'bisulfite'), ('SO_0000006', 'PCR_product', 71, 'PCR products'), ('GO_0006306', 'DNA methylation', 142, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 181, 'CpG sites'), ('SO_0000028', 'base_pair', 219, 'bp'), ('SO_0000167', 'promoter', 236, 'promoters'), ('SO_0000704', 'gene', 253, 'genes'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 271, 'vitamin D metabolism'), ('PR_000006101', 'cytochrome P450 1A1', 294, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 306, 'CYP24A1')]
PMC4499946	7/2015	S257-PMC4499946	['Serum Calcium is the best available BIOMARKER of Vitamin D toxicity [57,58]; THEREFORE, hypercalcemia is the primary biochemical safety outcome.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 77)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_22313', 'alkaline earth metal atom', 6, 'calcium'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4514967	12/2014	S68-PMC4514967	['the predominant EFFECTS of Vitamin A on the Immune System are THOUGHT TO be mediated by Retinoic Acid (ra).']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 62)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('UBERON_0002405', 'immune system', 44, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid')]
PMC4516377	6/2015	S1-PMC4516377	['abstract\n\nobjective:\nTO EVALUATE the ASSOCIATION between Calcium intake and Serum Vitamin D levels and childhood obesity by an integrative review.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 57, 'calcium'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4516377	6/2015	S9-PMC4516377	['conclusions:\nthe studies reviewed SHOWED an ASSOCIATION between Calcium and Vitamin D with childhood obesity.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 64, 'calcium'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4516377	6/2015	S68-PMC4516377	['suggested mechanisms to EXPLAIN the cyclical ASSOCIATION between Vitamin D deficiency and increased body fat deposition.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4586450	10/2015	S246-PMC4586450	['the CONTRIBUTION to energy of these Foods rose from 19.1% to 26.3% ( p< 0.001), with very little CONTRIBUTION to Vitamin A intake.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_33290', 'food', 36, 'foods'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 121, 'A')]
PMC4586451	10/2015	S190-PMC4586451	['a weak ASSOCIATION was FOUND between maternal dietary iron and magnesium Intake and height, particularly sitting height; it was greatly attenuated on full adjustment.19\n\ncaption (table-wrap): table 3\n\nassociations of maternal dietary intakes, iron supplement use, anemia, and Vitamin D status during Pregnancy with measures of offspring growth, Blood pressure, and Bone developmentmeasure in childdietary factoradjustments appliedminimally adjusted resultsfully adjusted resultscommentsheight at 7.5 y, n = 6663 singletons19\niron\nmagnesium\nvitamin c\nminimal: child sex, age at measurement, Pregnancy energy Intake\nfull: plus maternal age, bmi, height, smoking, seb, parity, breastfeeding\nβ = 0.08 (95% ci, 0.05–0.12), p< 0.001\nβ = 0.10 (95% ci, 0.07–0.14), p< 0.001\nβ = 0.05 (95% ci, 0.03–0.08), p< 0.001\nβ = 0.04 (95% ci, 0.01–0.08), p = 0.02\nβ = 0.05 (95% ci, 0.01–0.08), p = 0.04\nβ = 0.02 (95% ci, −0.01 to 0.04), p = 0.2\nregression analysis using standard deviation scores.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 23)]	2	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnancy'), ('UBERON_0000178', 'blood', 345, 'blood'), ('GO_0007567', 'parturition', 365, 'bone'), ('GO_0007565', 'female pregnancy', 590, 'pregnancy'), ('GO_0007631', 'feeding behavior', 607, 'intake')]
PMC4595656	10/2015	S47-PMC4595656	['THEREFORE they are germane to an overall understanding of the ROLE of Vitamin D in Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
PMC4595656	10/2015	S70-PMC4595656	['one STUDY to date has investigated the EFFECTS of Vitamin D deprivation over time on this reflex in Rats (burne et al.,2004).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 100, 'rats')]
PMC4595656	10/2015	S124-PMC4595656	['IT IS POSSIBLE that there are temporal variations in the EFFECTS of Vitamin D such that particular time points along the spectrum of hippocampal Development are more sensitive to its absence or its supply, than are others.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0008289', 'lipid binding', 145, 'development')]
PMC4598849	10/2015	S51-PMC4598849	['currently, there is LIMITED INFORMATION on the ASSOCIATION between fetal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4600246	10/2015	S41-PMC4600246	['IN SUMMARY, Vitamin K1Along with Vitamin D has beneficial EFFECTS on Arterial elasticity.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_33229', 'vitamin (role)', 12, 'vitamin'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 20, 'K1along'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001637', 'artery', 69, 'arterial')]
PMC4624803	10/2015	S4-PMC4624803	['in a logistic regression analysis, attention deficit/hyperactivity disorder SHOWED a significant ASSOCIATION with maternal age (odds ratio: 0.96, 95% confidence interval: 0.92–0.99) but not with Vitamin D levels (odds ratio: 0.99, 95% confidence interval: 0.97–1.02).']	[('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC4624803	10/2015	S6-PMC4624803	['HOWEVER, the statistical power of the study was too weak to detect an eventual small to medium size ASSOCIATION between Vitamin D levels and attention deficit/hyperactivity disorder.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4624803	10/2015	S8-PMC4624803	['ALTHOUGH exposure of the skin to sunlight LEADS to Vitamin D Production From Cholesterol, Vitamin D deficiency is common, also in areas rich in sunshine [1,2].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 59, 'D production from cholesterol'), ('CHEBI_16113', 'cholesterol', 77, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4624803	10/2015	S61-PMC4624803	['the POSSIBLE ASSOCIATIONS between Vitamin D levels below the thresholds and adhd were tested using conditional logistic regression.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4624803	10/2015	S78-PMC4624803	['maternal age (or: 0.95; 95% ci: 0.91–0.99) and season of Birth july to september (or: 2.30; 95% ci: 1.27–4.16) SHOWED a significant ASSOCIATION with adhd (or: 0.96; 95% ci: 0.92–0.99), but not smoking (or: 1.17; 95% ci: 0.89–1.53), season of Birth january to march (or: 1.45; 95% ci: 0.79–2.65) or Vitamin D levels (or: 0.98; 95% ci: 0.95–1.01).10.1371/journal.pone.0140164.g001\n\ncaption (fig): fig 1\nVitamin D concentrations in Individuals with adhd and controls.']	[('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('GO_0007567', 'parturition', 57, 'birth'), ('GO_0007567', 'parturition', 242, 'birth'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 401, 'Vitamin D'), ('NCBITaxon_1', 'root', 429, 'individuals')]
PMC4624803	10/2015	S101-PMC4624803	['WHILE strøm et al have analysed the levels of D Vitamin in the Serum from the mothers at Pregnancy, we have analysed D Vitamin levels in the Serum collected from the child at Birth, which should REFLECT the Prenatal Vitamin D status of the child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 195)]	2	[('CHEBI_28748', 'doxorubicin', 46, 'D vitamin'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_28748', 'doxorubicin', 117, 'D vitamin'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0007567', 'parturition', 175, 'birth'), ('GO_0007565', 'female pregnancy', 207, 'prenatal'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4632418	10/2015	S0-PMC4632418	['Vitamin D deficiency increases the risk of Gestational diabetes mellitus: a meta-analysis of observational studies\n\nabstract\nthe results investigating the RELATIONSHIP between Vitamin D levels and Gestational diabetes mellitus (gdm) are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 237)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'Gestational'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'gestational')]
PMC4632418	10/2015	S34-PMC4632418	['study selection\noriginal research evaluating the ASSOCIATIONS between Vitamin D status and Pregnancy outcomes were scrutinized and subsequently selected if they fulfilled the following inclusion criteria: a. study population was Pregnant women without pre-existing chronic disease; b. gdm as outcome and the control were women with normal Glucose tolerance (ngt); c. contained RELEVANT data to calculate the effect size and corresponding 95% confidence intervals (ci); d. met the predefined methodological quality assessment criteria for observational studies (supplementary data box 1) [18]; e. only studies published in english were considered.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 377)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007565', 'female pregnancy', 229, 'pregnant'), ('CHEBI_17234', 'glucose', 339, 'glucose')]
PMC4632423	10/2015	S74-PMC4632423	['there were SIMILAR PATTERNS in late Pregnancy other than for iron, Vitamin A, zinc and Selenium which were no longer significantly different between groups.nutrients-07-05403-t002_table 2\n\ncaption (table-wrap): table 2\n\nreported daily Nutrient intakes in lean and very severely obese women in early and late Pregnancy.Nutrientearly Pregnancylate Pregnancylean n = 93obese n = 148lean n = 87obese n = 146medianc25–c75medianc25–c75ppadjmedianc25–c75medianc25–c75ppadjenergy (kcal)2349(1995–2846)2435(1975–3040)*2354(1957–2876)2173(1747–2672)*protein (g)94.1(75–114)98.6(73–125)*90.5(76–117)87.7(69–113)*fat (g)91.6(75–118)95.6(73–122)*91.8(73–124)87.9(65–108)Carbohydrate (g)302.1(252–355)309.8(249–387)*304.1(258–361)278.8(227–346)*sfa (g)34.6(28–28)38.5(28–51)*36.2(29–50)35.1(25–44)mufa (g)32.1(26–42)33.2(25–43)*31.9(25–42)30.1(22–37)*Pufa (mg)15.9(13–20)16(12–22)**15.2(13–20)14.1(11–19)*Cholesterol (g)277(191–353)290.5(202–390)255(189–365)271.5(197–376)Sugars (g)134.9(109–176)150.3(113–195)*142(110–179)132.7(99–174)**Starch (g)150(130–196)156(121–191)*158(121–183)136(107–175)*fibre (g)22.8(20–29)20.6(16–26)***23.3(18–27)19(14–24)***Sodium (mg)3200(2375–3969)3389(2551–4065)*3239(2638–3896)2926(2298–3595)potassium (mg)3876(3262–4679)39533036–5017)*3813(3265–4769)34762845–4648*Calcium (mg)1233(1006–1496)1195.5(945–1603)**1268(1015–1579)1077(837–1415)*magnesium (mg)426(375–519)399.5(327–487)***417(355–527)359(289–452)***Phosphorus (mg)1791(1483–2106)1779.5(1423–2311)*1753(1476–2215)1652(1276–2097)**Iron (mg)16.5(14–20)14.5(11–19)***16.1(13–20)13(10–17)***copper (mg)3.2(2–4)2.9(2–4)*3.1(2.7–4)2.6(2.1–3.4)**Zinc (mg)12.1(9–15)12.1(9–15)**11.8(9–15)10.9(8–14)*Chloride (mg)4786(3899–6097)4998(3873–6273)*4871(3992–5900)4428.5(3552–5523)Manganese (mg)4.6(4–6)3.6(3–5)***4.5(3–6)3.2(2.6–4.3)***Selenium (µg)64(51–80)61(44–84)***63(51–80)58(41–77)**Iodine (µg)233(186–307)246.5(173–313)249(189–331)221.5(157–290)**Retinol (µg)320(228–436)319(220–466)316(221–504)290.5(200–423)Β–Carotene (µg)4362(3081–6848)4109(2361–6127)*4082(2594–6533)3340(2245–5023)Vitamin D (µg)3.8(2.8–5.7)3.1(2–4.6)*4(2.7–5.7)2.8(1.9–4.4)*Vitamin E (mg)12(9.8–15)11.4(8.3–13.4)**12(9–15.6)10.2(7–13)***Thiamine (mg)2(1.7–2.3)2(1.6–2.5)*2(1.6–2.4)1.8(1.5–2.3)*riboflavin (mg)2.1(1.8–2.7)2.2(1.5–2.8)***2.2(1.8–2.9)1.9(1.4–2.6)***niacin (mg)23.2(19–28)24.5(18–31)**22.5(18–28)22.6(16–29)*potential niacin (mg)20.9(16–25)20.5(15–27)*19.4(16–26)18.4(14–24)**Vitamin B6 (mg)2.5(2–3)2.7(2–3.3)*2.5(2.1–3.2)2.5(1.8–3.1)*Vitamin B12 (mg)6.2(4.6–8.8)6.2(4.2–8.6)6(4.9–9)5.7(3.9–7.7)Folate (µg)350(282–439)310.5(225–387)***362(268–436)276(202–353)***pa (mg)6.2(5.1–7.7)6.5(4.8–8.1)*6.2(5.1–7.9)5.7(4.5–7.7)*Biotin (µg)45.4(37–56)41.8(31–52)***44.1(37–59)37.2(27–50)****vitamin c (mg)160(120–204)160(110–227)**151(111–102)147(86–199)**Vitamin K (mg)69.9(43–137)34(22–68)**57.3(39–132)32.6(17–67)**\nc25: 25th percentile, c75: 75th percentile; p : ln-transformed crude intakes; padj: ln-transformed crude intakes adjusted for total energy intake, age, parity, ethnicity & depcat; * p< 0.05; ** p< 0.001.nutrients-07-05403-t003_table 3\n\ncaption (table-Wrap): table 3\n\nSerum levels of essential Micronutrients in early and late Pregnancy.early Pregnancy (16 weeks)late Pregnancy (28 weeks)obese n = 25lean n = 25 p *obese n = 25lean n = 25 p *iron (μmol/l)15.7 (4.7)23.4 (5.9)<0.000112.5 (5.3)14.7 (7.1)0.24vitamin B12 (ng/l)239.6 (87.7)389.1 (138.4)<0.0001202.1 (56.2)262.4 (96.4)0.02folate (μg/l)7.9 (4.2)15.0 (2.7)<0.00013.9 (2.8)10.6 (5.7)<0.0001vitamin A (μmol/l)1.2 (0.26)1.36 (0.28)0.0461.0 (0.24)1.1 (0.31)0.38vitamin e (μmol/l)29.6 (6.74)28.9 (5.78)0.69231.9 (8.46)38.1 (7.21)0.009cholesterol (mmol/l)5.67 (0.82)5.00 (0.85)0.0075.8 (0.79)6.6 (0.94)0.011vite/Chol5.26 (1.04)5.82 (0.91)0.0545.5 (1.06)5.9 (0.86)0.135copper (μmol/l)32.9 (4.5)26.1 (4.9)<0.000134.4 (4.1)28.2 (3.9)<0.0001copper+(μmol/l)33.1 (4.4)33.1 (5.3)<0.000134.5 (4.3)28.0 (3.7)<0.0001zinc (umol/l)9.7 (1.17)10.7 (1.30)0.0089.1 (0.92)9.3 (0.94)0.413zinc/albumin0.32 (0.04)0.31 (0.03)0.1720.32 (0.02)0.32 (0.03)0.958selenium (μmol/l)0.85 (0.13)1.02 (0.16)<0.00010.79 (0.11)0.89 (0.14)0.009selenium+(μmol/l)0.89 (0.14)1.00 (0.16)0.0500.85 (0.11)0.87 (0.14)0.437total 25Ohd (nmol/l)++51.1 (16.89)68.1 (29.91)0.07045.5 (32.54)68.7 (27.34)0.093crp (mg/l)12.0 (8.48)3.7 (3.35)<0.000113.4 (8.1)4.7 (5.6)0.001albumin (g/l)30.1 (1.98)34.5 (2.97)<0.000128.1 (1.2)29.3 (2.0)0.034\ndata are means (sd).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('CHEBI_27568', 'selenium atom', 87, 'selenium'), ('CHEBI_33284', 'nutrient', 235, 'nutrient'), ('GO_0007565', 'female pregnancy', 308, 'pregnancy'), ('CHEBI_36823', 'pseudohalo group', 318, 'NutrientEarly'), ('GO_0006412', 'translation', 332, 'pregnancyLate'), ('GO_0006562', 'proline catabolic process', 346, 'pregnancyLean'), ('CHEBI_16646', 'carbohydrate', 657, 'Carbohydrate'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 837, 'PUFA'), ('CHEBI_16113', 'cholesterol', 891, 'Cholesterol'), ('CHEBI_86939', 's perillic acid', 958, 'Sugars'), ('CHEBI_28017', 'starch', 1024, 'Starch'), ('CHEBI_33314', 'radon atom', 1141, 'Sodium'), ('CHEBI_31341', 'calcium dihydroxide', 1286, 'Calcium'), ('CHEBI_30207', 'phosphorus(.)', 1431, 'Phosphorus'), ('CHEBI_24870', 'ion', 1511, 'Iron'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 1620, 'Zinc'), ('CHEBI_17996', 'chloride', 1672, 'Chloride'), ('CHEBI_33309', 'noble gas atom', 1748, 'Manganese'), ('CHEBI_27568', 'selenium atom', 1804, 'Selenium'), ('CHEBI_31719', 'ipriflavone', 1858, 'Iodine'), ('CHEBI_27810', 'resorcinol', 1923, 'Retinol'), ('CHEBI_35193', 'tetraterpene', 1985, 'β–carotene'), ('CHEBI_28384', 'vitamin K', 2061, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2061, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 2121, 'Vitamin E'), ('CHEBI_32215', 'thiamphenicol', 2184, 'Thiamine'), ('CHEBI_27306', 'vitamin B6', 2436, 'Vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 2444, 'B6'), ('CHEBI_28334', 'malonamoyl-CoA', 2495, 'Vitamin B12'), ('PR_000017279', 'testis-specific basic protein Y 1', 2495, 'Vitamin B12'), ('CHEBI_81245', 'Vulpecholate', 2555, 'Folate'), ('CHEBI_15956', 'biotin', 2679, 'Biotin'), ('CHEBI_28384', 'vitamin K', 2806, 'Vitamin K'), ('PR_000017453', 'protein Wnt-9b', 3120, 'WRAP'), ('UBERON_0001977', 'blood serum', 3136, 'Serum'), ('CHEBI_33839', 'macromolecule', 3162, 'micronutrients'), ('GO_0007565', 'female pregnancy', 3195, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3211, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3236, 'pregnancy'), ('CHEBI_27778', 'abequose', 3382, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 3382, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 3525, 'A'), ('CHEBI_30799', 'dioxosuccinic acid', 3734, 'Chol5'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 4208, '25OHD')]
PMC4632423	10/2015	S106-PMC4632423	['increased adiposity itself is ASSOCIATED with lower Serum levels of some fat-soluble Nutrients, such as Vitamin D, and this PREDICTS poor status of this Nutrient during Pregnancy [27].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_33284', 'nutrient', 85, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_33284', 'nutrient', 153, 'nutrient'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC4645901	8/2014	S2-PMC4645901	['prior to our newly designed INTERVENTION, those babies with low Vitamin D levels would be given a letter to ENCOURAGE collection of supplementation from their gp.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 108)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4645901	8/2014	S36-PMC4645901	['[4]\nthose AT RISK of Vitamin D deficiency include: Pregnant mothers, babies who are exclusively Breastfed, those who have darker skin, those who cover up most of their body when outside, and patients with certain medical conditions AFFECTING Gut absorption or who suffer from long term Liver and Kidney disease.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 232)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('GO_0007567', 'parturition', 96, 'breastfed'), ('UBERON_0001555', 'digestive tract', 242, 'gut'), ('UBERON_0002107', 'liver', 286, 'liver'), ('UBERON_0002113', 'kidney', 296, 'kidney')]
PMC4645901	8/2014	S88-PMC4645901	['conclusion\ndesigning a leaflet to ENCOURAGE patients and clinicians to increase uptake of Vitamin D had a positive IMPACT on the number of babies having correct supplementation.']	[('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4673623	11/2015	S15-PMC4673623	['Folate, Vitamin B-12, Choline, and betaine) to several IMPORTANT Metabolic Processes (kalhan and marczewski2012) including those INVOLVED in developmental programming.']	[('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 129)]	2	[('CHEBI_30863', '5-azaorotic acid', 0, 'folate'), ('CHEBI_27300', 'vitamin D', 8, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 8, 'vitamin B-12'), ('CHEBI_15354', 'choline', 22, 'choline'), ('GO_0008152', 'metabolic process', 65, 'metabolic processes')]
PMC4673623	11/2015	S116-PMC4673623	['the Vitamin B-12 deficiency that led to the Metabolic trapping of Folate in the hf-hed group MAY BE RELATED to the caloric/Lipid load (mccurdy2009) and increased use of Vitamin B-12 as a lipotrope.']	[('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 4, 'vitamin B-12'), ('GO_0008152', 'metabolic process', 44, 'metabolic'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('CHEBI_18059', 'lipid', 123, 'lipid'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 169, 'vitamin B-12')]
PMC4684854	12/2015	S48-PMC4684854	['clinical relevance of Vitamin D sufficiency in Reproductive healthcare\nthe widespread clinical IMPORTANCE of determining the CORRELATION between Vitamin D levels and Reproductive outcomes is evident.']	[('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('GO_0000003', 'reproduction', 47, 'Reproductive'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0000003', 'reproduction', 166, 'reproductive')]
PMC4684854	12/2015	S93-PMC4684854	['as well as individual studies, systematic reviews exploring ASSOCIATION between Vitamin D sufficiency and health outcomes HAVE also BEEN illuminating.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 122)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4684854	12/2015	S95-PMC4684854	['another systematic review and meta-analysis published in the british medical journal also LINKED Vitamin D insufficiency with an INCREASED RISK of Gestational diabetes, Preeclampsia, and small for Gestational age infants [65].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 129)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational'), ('GO_0007128', 'meiotic prophase I', 169, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 197, 'gestational')]
PMC4684854	12/2015	S101-PMC4684854	['Gestational Vitamin D status also APPEARS to INFLUENCE outcomes beyond the Pregnancy and Delivery.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007567', 'parturition', 89, 'delivery')]
PMC4684854	12/2015	S114-PMC4684854	['for example, Gestational Vitamin D status DIRECTLY CORRELATES with subsequent Whole-Body and Lumbar Spine bone Mineral content in progeny at 9 years of age [92].']	[('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 78, 'whole-body'), ('UBERON_0006074', 'lumbar region of vertebral column', 93, 'lumbar spine'), ('CHEBI_46662', 'mineral', 111, 'mineral')]
PMC4684854	12/2015	S141-PMC4684854	['it is time for maternity health providers to be apprised of the POTENTIAL for improved and enduring health and well-Being ASSOCIATED with inexpensive measures to secure Vitamin D nutritional adequacy during Gestation, the most vulnerable time in the Life Cycle of the developing child.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('GO_0016441', 'posttranscriptional gene silencing', 115, '-being'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'gestation'), ('UBERON_0000104', 'life cycle', 250, 'life cycle')]
PMC4689556	12/2015	S166-PMC4689556	['the RELATIONSHIP between Prenatal Vitamin D status and child health outcomes MAY not be linear.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 77)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4690051	12/2015	S0-PMC4690051	['Gestational vitamin 25(oh)d status as a risk factor for Receptive Language Development: a 24-month, longitudinal, observational study\n\nabstract\nemerging data suggest that Vitamin D status during childhood and Adolescence CAN AFFECT Neurocognitive Development.']	[('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 225)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('GO_0000003', 'reproduction', 56, 'Receptive'), ('GO_0008584', 'male gonad development', 66, 'Language Development'), ('UBERON_0003215', 'alveolus', 66, 'Language'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 209, 'adolescence'), ('GO_0007399', 'nervous system development', 232, 'neurocognitive development')]
PMC4690051	12/2015	S15-PMC4690051	['biologically, higher Melanin Pigment in Dermis of Individuals with african ancestry CONTRIBUTES to lower production of 25(Oh)D, YET higher bioavailable 1,25(Oh)2-D circulates due to lower levels of Vitamin D Binding Protein (Vdbp) [10].']	[('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 128)]	2	[('CHEBI_25179', 'melanins', 21, 'melanin'), ('CHEBI_26130', 'biological pigment', 29, 'pigment'), ('UBERON_0002067', 'dermis', 40, 'dermis'), ('NCBITaxon_1', 'root', 50, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('CHEBI_34890', '2-nitrofuran', 157, 'OH)2-D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 225, 'VDBP')]
PMC4690051	12/2015	S117-PMC4690051	['Murine dams maintained on Vitamin D deficient diets before and during Pregnancy display alterations in Murine Brain morphology that COULD CONTRIBUTE to deficits in Memory, Learning, and attention processing [39].']	[('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 138)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Murine'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('NCBITaxon_39107', 'Murinae', 103, 'murine'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007613', 'memory', 164, 'memory'), ('GO_0007612', 'learning', 172, 'learning')]
PMC4691762	12/2015	S31-PMC4691762	['mothers who receive Antenatal Vitamin D supplementation will not be excluded BECAUSE in our setting, this has not been shown to be PROTECTIVE against Postnatal infant Vitamin D deficiency.15\n\nrandomisation\nrandomisation will be undertaken using a web-based randomisation system set up within the trial database (redcap).']	[('PROBLEM_COMPLICATION', 77), ('SUPERFICIAL_RELATIONSHIP', 131)]	2	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 150, 'postnatal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4691762	12/2015	S94-PMC4691762	['a 30% reduction in the prevalence of Food allergy ATTRIBUTED to Vitamin D supplementation represents a clinically IMPORTANT reduction on a population level.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 114)]	2	[('CHEBI_33290', 'food', 37, 'food'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4691762	12/2015	S108-PMC4691762	['this will be the FIRST population-based trial of Postnatal infant Vitamin D supplementation sufficiently powered to address the IMPACT on any disease outcome including allergic disease, lris and bone health.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('GO_0007567', 'parturition', 49, 'postnatal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4691762	12/2015	S114-PMC4691762	['there are several PLAUSIBLE biological mechanisms for the ROLE of Vitamin D in early infant, Immune health.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4719746	1/2016	S7-PMC4719746	['ethnicity, education, season and intake of Vitamin D were independently ASSOCIATED with 25(Oh)D. at gw 28, the mean 25(Oh)d had increased from 23 (sd:7.8) to 47 (27) nmol/l ( p \u2009<\u20090.01) in women who were RECOMMENDED Vitamin D supplementation, with small or no change in women with sufficient Vitamin D levels at baseline.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('FUTURE_WORK', 204)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('CHEBI_51686', 'haematoxylin', 118, '(OH'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin D')]
PMC4719746	1/2016	S16-PMC4719746	['also studies of multiethnic populations in australia have uncovered maternal country of Birth in asia and africa AS RISK FACTOR of Vitamin D deficiency in Pregnancy [11].']	[('PROBABLE_UNDERSTANDING', 113), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy')]
PMC4719746	1/2016	S90-PMC4719746	['in addition, education, Intake of Vitamin D supplements and season were INDEPENDENTLY ASSOCIATED with 25(Oh)D concentrations at inclusion.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('GO_0007631', 'feeding behavior', 24, 'intake'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 102, '25(OH ... D')]
PMC4719746	1/2016	S159-PMC4719746	['ethnic minority background, low intake of Supplements, low education and winter season were INDEPENDENT RISK FACTORS for Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 104)]	2	[('CHEBI_33341', 'titanium atom', 42, 'supplements'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4728621	1/2016	S139-PMC4728621	['maternal trimester 3 Vitamin C intake was negatively ASSOCIATED with 6 months old Triceps-for-age skinfold thickness z-score (b = −0.005, p = 0.035) and, finally, trimester 2 Vitamin C was negatively ASSOCIATED with the sum of the 6 months old Triceps and Subscapular Skinfolds (b = −0.015, p = 0.007).']	[('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 200)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 82, 'triceps'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 244, 'triceps'), ('UBERON_3010813', 'vent glands', 256, 'subscapular skinfolds')]
PMC4728621	1/2016	S148-PMC4728621	['finally, maternal trimester 3 Vitamin C intake was negatively ASSOCIATED with 6 months old Triceps-for-age skinfold thickness z-score and, finally, trimester 2 Vitamin C was negatively ASSOCIATED with the sum of the 6 months old Triceps and Subscapular Skinfolds.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 91, 'triceps'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin C'), ('UBERON_0001509', 'triceps brachii', 229, 'triceps'), ('UBERON_3010813', 'vent glands', 241, 'subscapular skinfolds')]
PMC4729160	1/2016	S94-PMC4729160	['in THE CURRENT STUDY, Pregnant women age and va status were negatively ASSOCIATED and the level of Vitamin A decreased with age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A')]
PMC4764019	1/2016	S9-PMC4764019	['i defer until the end of this review consideration of the actual, numerical range of Vitamin D status values that APPEARS to permit avoidance of the barker EFFECT if it is present.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4764019	1/2016	S37-PMC4764019	['schizophrenia\nmcgrath et al9have EVALUATED the ASSOCIATION between Vitamin D status at Birth and the development of schizophrenia later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 87, 'birth'), ('UBERON_0000104', 'life cycle', 139, 'life')]
PMC4770602	1/2016	S15-PMC4770602	['[45678] another data SUGGESTING an ASSOCIATION between Vitamin D deficiency and preeclampsia is now developing.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4770602	1/2016	S69-PMC4770602	['indirectly, during the Gestation Vitamin D consumption MAY AFFECT infant Birth weight.']	[('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 23, 'gestation'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 73, 'birth')]
PMC4778858	3/2016	S22-PMC4778858	['frank maternal Vitamin D deficiency, using levels ranging from less than 12–15.5 ng/ml, HAS BEEN ASSOCIATED with low Birth weight [13], increased rates of small for Gestational age Births [13,14], and gdm [15].']	[('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'birth'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 181, 'births')]
PMC4778858	3/2016	S112-PMC4778858	['INTERESTINGLY, Insulin sensitivity was significantly ASSOCIATED with maternal Serum Vitamin D level in univariate analysis.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('PR_000045358', 'insulin family protein', 15, 'insulin'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4785305	3/2016	S0-PMC4785305	['EFFECT of Vitamin D replacement on maternal and neonatal outcomes: a randomised controlled trial in Pregnant women with hypovitaminosis D. a protocol\n\nabstract\n\nintroduction\nthe Vitamin D RECOMMENDED doses during Pregnancy differ between societies.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('FUTURE_WORK', 188)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy')]
PMC4785305	3/2016	S35-PMC4785305	['these latter studies AIM at assessing the EFFECT of Vitamin D supplementation on offspring calcium status, maternal and infant Vitamin D status and bone status (by quantitative ultrasound) at 1\u2005year.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4785305	3/2016	S38-PMC4785305	['they ASSESSED the EFFECT of various doses of Vitamin D on the 25(Oh)D level, Immune function and Periodontal disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('UBERON_0002405', 'immune system', 77, 'immune'), ('UBERON_0001758', 'periodontium', 97, 'periodontal')]
PMC4785305	3/2016	S42-PMC4785305	['the secondary OBJECTIVES are to compare the EFFECT of high-dose versus low-dose Vitamin D on:\nmaternal outcomes:\nmean maternal 25(Oh)D level at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000011594', 'inositol polyphosphate 5-phosphatase OCRL', 130, 'OH ...'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC4811441	3/2016	S30-PMC4811441	['cross sectional and cohort studies investigating the ASSOCIATION between Vitamin D status and pe show CONFLICTING results [11–14].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4811441	3/2016	S39-PMC4811441	['the primary outcome of the study was TO INVESTIGATE the ASSOCIATION between Vitamin D status and hypertensive disorders in Pregnancy and pe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
PMC4829940	5/2016	S27-PMC4829940	['one RECENT STUDY examined the ASSOCIATION between Vitamin D deficiency and Genome wide Dna Methylation in african children[17].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('SO_0001026', 'genome', 75, 'genome'), ('GO_0006306', 'DNA methylation', 87, 'DNA methylation')]
PMC4832516	10/2015	S19-PMC4832516	['marked seasonal changes HAVE BEEN REPORTED in maternal circulating 25-Hydroxyvitamin D levels (25(Oh)D)[11], which reflect sunshine exposure and directly INFLUENCE fetal Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 154)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 67, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 95, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4832516	10/2015	S22-PMC4832516	['Age At Menarche is a well-recalled measure of Pubertal timing in girls and HAS BEEN LINKED to Vitamin D status in prospective[13]and Genetic[14]studies.']	[('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('GO_0007568', 'aging', 0, 'Age at'), ('GO_0042696', 'menarche', 7, 'menarche'), ('GO_0007567', 'parturition', 46, 'pubertal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000704', 'gene', 133, 'genetic')]
PMC4859539	5/2016	S0-PMC4859539	['circulating Cathelicidin concentrations in a cohort of healthy children: INFLUENCE of age, body composition, gender and Vitamin D status\n\nabstract\nCathelicidin is an Antimicrobial peptide whose circulating levels are RELATED to Vitamin D status in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_3461', 'Casuarictin', 12, 'Cathelicidin'), ('PR_000004907', 'complement component C7', 12, 'Cathelicidin'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('PR_000004907', 'complement component C7', 147, 'Cathelicidin'), ('CHEBI_65381', 'albizoside C', 166, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0007023', 'adult organism', 248, 'adults')]
PMC4859539	5/2016	S105-PMC4859539	['Adipose Tissue is also BELIEVED to be ASSOCIATED with Vitamin D [26–29].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4864049	1/2016	S348-PMC4864049	['the number of asd diagnoses in regions with low sun exposure in the usa is increased and HAS also BEEN LINKED to Vitamin D insufficiency\xa0[159].']	[('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 103)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4889866	5/2016	S12-PMC4889866	['in vitro studies have DEMONSTRATED Vitamin D to CORRELATE with alterations of several cytokines such as Il-4, Il-5, Il-6, Il-10, Il-13, and Interferon Γ [1–3].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 104, 'IL-4'), ('PR_000001470', 'interleukin-28B', 110, 'IL-5'), ('PR_000001470', 'interleukin-28B', 116, 'IL-6'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 122, 'IL'), ('PR_000001470', 'interleukin-28B', 129, 'IL-13'), ('PR_000008918', 'interferon alpha-5', 140, 'interferon γ')]
PMC4889866	5/2016	S98-PMC4889866	['our result had OBSERVED a negative CORRELATION between maternal Vitamin D concentration and tlr-induced Il-10 response.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 104, 'IL-10')]
PMC4889866	5/2016	S107-PMC4889866	['in addition, studies have DEMONSTRATED higher Vitamin D levels at Birth to be ASSOCIATED with lower number of T Regulatory (Treg) Cells in the Cord Blood [2,16].']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth'), ('CL_0000902', 'induced T-regulatory cell', 110, 'T regulatory ...'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 110, 'T regulatory'), ('CL_0000960', 'T3 B cell', 124, 'Treg ... cells'), ('UBERON_0002240', 'spinal cord', 143, 'cord'), ('UBERON_0000178', 'blood', 148, 'blood')]
PMC4896250	4/2016	S394-PMC4896250	['a28 tgfβ1 level is ASSOCIATED with vdr Gene polymorphism in children with allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute of nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova – institute of nutrition, russia\nbackground: Vitamin D Receptor (Vdr) is Intracellulary located on the cells Of the Immune System and is INVOLVED in the Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 412)]	2	[('SO_0000704', 'gene', 39, 'gene'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 320, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 340, 'VDR'), ('GO_0005622', 'intracellular anatomical structure', 348, 'intracellulary'), ('CL_0000024', 'oogonial cell', 384, 'of'), ('UBERON_0002405', 'immune system', 391, 'immune system'), ('CL_0000034', 'stem cell', 398, 'system'), ('GO_0006955', 'immune response', 428, 'immune response'), ('UBERON_0002405', 'immune system', 428, 'immune')]
PMC4896250	4/2016	S420-PMC4896250	['after adjustment for CONFOUNDING FACTORS, including age, smoking, alcohol drinking, exercise, and Vitamin D levels, high bmi (≥30 kg/m2) (or = 4.241, 95% ci: 1.60–11.24), high wc (≥80 cm) (or = 2.062, 95% ci: 1.08–3.94), and high bf percentage (q4) (or = 2.073, 95% ci: 1.22–3.52) were shown to be significantly ASSOCIATED with ad in young Adult women.']	[('PROBLEM_COMPLICATION', 21), ('SUPERFICIAL_RELATIONSHIP', 312)]	2	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0007023', 'adult organism', 340, 'adult')]
PMC4896250	4/2016	S1046-PMC4896250	['data on the RELATION of Vitamin D status and allergy are CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4896250	4/2016	S3003-PMC4896250	['a209 regional differences of Vitamin D and Food-induced anaphylaxis in korea\n\nsi-heon kim1, gil-soon choi2, su-chin kim1, ji hye kim1, ga young ban1, yoo seob shin1, hae-sim park1, young min ye1\n\n1ajou university school of medicine south korea;2kosin university gospel hospital\n\ncorrespondence: si-heon kim – ajou university school of medicine, south korea\nbackground: it HAS BEEN SUGGESTED that Vitamin D deficiency has an INFLUENCE on increase in the prevalence of allergic disease.']	[('INCOMPLETE_EVIDENCE', 372), ('SUPERFICIAL_RELATIONSHIP', 424)]	2	[('CHEBI_28384', 'vitamin K', 29, 'Vitamin D'), ('CHEBI_33290', 'food', 43, 'Food'), ('CHEBI_27300', 'vitamin D', 396, 'vitamin D')]
PMC4896250	4/2016	S3562-PMC4896250	['a policy on Vitamin D supplementation is RECOMMENDED in this population to mitigate the IMPACT of Vitamin D deficiency especially on chronic non-communicable diseases.']	[('FUTURE_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4896250	4/2016	S4157-PMC4896250	['in addition, a significant negative CORRELATION was FOUND between Vitamin D levels and hdm sensitization in the severe ad group.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 52)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S4492-PMC4896250	['conclusion: these results SUGGEST that Serum Vitamin D levels were ASSOCIATED with pediatric asthma in korea.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0001977', 'blood serum', 39, 'serum'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4896250	4/2016	S5531-PMC4896250	['in the medical professional institute metylovice located 410 meters above sea level found in štramberk highlands during a 4-week stay for treatment with Vitamin D, we INVESTIGATED the EFFECT of climate on the parameters of bronchial asthma and changes of physical parameters by modified cooperœ test in asthmatic children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	2	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4896250	4/2016	S5537-PMC4896250	['c) results\nthe object was TO EVALUATE the EFFECTIVENESS and benefits of long term stay for asthmatic children after the continuous treatment with Vitamin D and physical exercises.the evaluation was done by the comparison of laboratory examination of Blood and physical parameters in the beginning of the stay and in the end of the stay.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0000178', 'blood', 250, 'blood')]
PMC4896250	4/2016	S6216-PMC4896250	['in experimental group, levels of total and dp specific Ige were negatively CORRELATED with Serum concentration of Vitamin D (rs=-0.579, p =0.001; rs=-0.334, p =0.035, respectively), level of Cow’s Milk specific Ige was positively CORRELATED with serum concentration of Vitamin D (rs=0.544, p =0.000).']	[('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 230)]	2	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 55, 'IgE'), ('UBERON_0001977', 'blood serum', 91, 'serum'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 191, 'cow'), ('UBERON_0001913', 'milk', 197, 'milk'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 211, 'IgE'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4896250	4/2016	S6217-PMC4896250	['using multivariate linear regression analysis after adjusted with sex and age,there is significant ASSOCIATION between the total Ige and Serum Vitamin D (b -4.386, 95%ci -8.488- -0.285, p =0.037) in 40 children with allergic Respiratory diseases, and also significant ASSOCIATION between both total and dp specific Ige and Serum Vitamin D (b -9.56, 95%ci -15.405- -3.715, p =0.003; b -0.857, 95%ci -1.561- -0.153, p =0.02, respectively) in 21 children with dp sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 268)]	2	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 225, 'respiratory'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 315, 'IgE'), ('UBERON_0001977', 'blood serum', 323, 'serum'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D')]
PMC4896250	4/2016	S8303-PMC4896250	['conclusions\nwe FOUND that Vitamin D insufficiency in patients with asthma CORRELATES with allergic sensitization.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4897157	5/2016	S17-PMC4897157	['the increased prevalence of Vitamin D deficiency MAY in turn be ASSOCIATED with the increased prevalence of allergic diseases in korea.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4897157	5/2016	S136-PMC4897157	['in ONE STUDY, Vitamin D deficiency in children and adolescents was reportedly ASSOCIATED with an increased prevalence of Allergen sensitization24).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_50904', 'allergen', 121, 'allergen')]
PMC4908484	6/2016	S14-PMC4908484	['moreover, Vitamin D is a regulator of Brain Cell Proliferation and Differentiation, and has an ESSENTIAL ROLE in the Brain Development (chopp et\xa0al.2007; stewart et\xa0al.2010) and Neurotransmitter Synthesis (tetich et\xa0al.2004).']	[('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 38, 'brain cell'), ('UBERON_0000955', 'brain', 38, 'brain'), ('GO_0030154', 'cell differentiation', 44, 'cell proliferation ... differentiation'), ('GO_0007420', 'brain development', 117, 'brain development'), ('UBERON_0000955', 'brain', 117, 'brain'), ('CHEBI_25512', 'neurotransmitter', 178, 'neurotransmitter'), ('GO_0042136', 'neurotransmitter biosynthetic process', 178, 'neurotransmitter synthesis')]
PMC4908484	6/2016	S22-PMC4908484	["early Vitamin D deficiency MAY BE a RISK FACTOR for a number of disorders including schizophrenia, autism (thompson et\xa0al.1998; pilz et\xa0al.2011; chowdhury et\xa0al.2012), multiple sclerosis, parkinson's disease, and stroke (sun et\xa0al.2012)."]	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4924183	6/2016	S42-PMC4924183	['grieger and clifton, provide updated EVIDENCE from epidemiological and rcts on the IMPACT of dietary and supplemental intakes of Omega-3 Long-Chain polyunsaturated Fatty Acids, zinc, Folate, iron, Calcium, and Vitamin D, as well as dietary patterns, on infant Birth weight [16].']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_76261', '1-nitropropane', 129, 'omega-3 long-chain'), ('CHEBI_35366', 'fatty acid', 164, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 260, 'birth')]
PMC4930210	7/2016	S18-PMC4930210	['HOWEVER, the daily use of Vitamin D supplements CONTRIBUTED to a better 25-Hydroxycholecalciferol (25(Oh)D) status [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_50545', 'trans-isoeugenol', 72, '25-hydroxycholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D')]
PMC4930210	7/2016	S23-PMC4930210	['the BEST clinical laboratory INDICATOR of Vitamin D status is the Blood concentration of 25(Oh)D [4].']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 95, 'D')]
PMC4930210	7/2016	S119-PMC4930210	['Plasma 3-Epi-25(Oh)D3Was significantly ASSOCIATED with reported Vitamin D intake from supplements BUT not diet (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 98)]	2	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_73839', 'D-Leu-D-Leu', 7, '3-epi-25(OH)D3was'), ('PR_000008528', 'hairy/enhancer-of-split related with YRPW motif protein 1', 13, '25(OH ... D3was'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4930210	7/2016	S127-PMC4930210	['using lc-ms/ms, we separated epimer from estimation of Vitamin D status and were able to ACCURATELY ESTIMATE the prevalence of Vitamin D insufficiency in our Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnant')]
PMC4930210	7/2016	S134-PMC4930210	['we SHOWED Consuming lower doses of Vitamin D (< than the current dri) is ASSOCIATED with a higher rate of Vitamin D insufficiency (>75nmol/l).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('GO_0007631', 'feeding behavior', 10, 'consuming'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4930210	7/2016	S140-PMC4930210	['in addition, we DEMONSTRATED the presence of 3-Epi-25(Oh)D3In all our Pregnant women’s Plasma samples across Pregnancy (second trimester), and that including this epimer in the measurement of Vitamin D status significantly INFLUENCED the classification of prevalence of Vitamin D sufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 223)]	2	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 45, '3-epi-25(OH)D3in'), ('PR_000011622', 'S-acyl fatty acid synthase thioesterase, medium chain', 54, 'OH ... D3in'), ('GO_0007565', 'female pregnancy', 70, 'pregnant'), ('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
PMC4930210	7/2016	S155-PMC4930210	['still, we FOUND a wide distribution of Vitamin D intake and status, which allowed us to study the ASSOCIATION between maternal reported Vitamin D intake and maternal Vitamin d concentrations.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]
PMC4934634	11/2015	S6-PMC4934634	['the EFFECT of Vitamin D supplementation during Pregnancy and early Life on maternal and infant outcomes will be of particular FOCUS in this review.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('UBERON_0000104', 'life cycle', 67, 'life')]
PMC4934634	11/2015	S75-PMC4934634	['MANY observational STUDIES have LINKED higher maternal Vitamin D status to an increase in rates of both clinical Pregnancy (sonographic presence of a heartbeat following ivf) and live Birth [29,30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC4934634	11/2015	S110-PMC4934634	['low Vitamin D HAS BEEN ASSOCIATED with Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 23)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('PR_000045358', 'insulin family protein', 39, 'insulin')]
PMC4934634	11/2015	S124-PMC4934634	['these data SUGGEST a positive EFFECT of Vitamin D supplementation on Pregnancy outcomes in women with Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 102, 'gestational')]
PMC4934634	11/2015	S126-PMC4934634	[', INVESTIGATED the EFFECTS of Vitamin D co-supplemented with Calcium on Metabolic parameters in women diagnosed with Gestational diabetes starting in their 24th–28th week of Gestation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 61, 'calcium'), ('GO_0008152', 'metabolic process', 72, 'metabolic'), ('GO_0007565', 'female pregnancy', 117, 'gestational'), ('GO_0007565', 'female pregnancy', 174, 'gestation')]
PMC4934634	11/2015	S136-PMC4934634	['Serum Calcium was SIMILAR among the groups further SUGGESTING no adverse side effects with the Vitamin D dosages tested.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 51)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_22313', 'alkaline earth metal atom', 6, 'calcium'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4934634	11/2015	S143-PMC4934634	['anti-inflammatory and Immune modulating properties of Vitamin D are POSTULATED to CONTRIBUTE to the protective mechanism against Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 129, 'preeclampsia')]
PMC4934634	11/2015	S182-PMC4934634	['Respiratory health and allergic disease in children\nover the last decade, there is CONFLICTING data on the ROLE of maternal Vitamin D on offspring allergic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('UBERON_0001004', 'respiratory system', 0, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4934634	11/2015	S183-PMC4934634	['higher maternal Vitamin D intake during Pregnancy was FOUND TO BE inversely ASSOCIATED with asthma [68], allergic rhinitis [68], wheezing [69], and eczema in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy')]
PMC4934634	11/2015	S192-PMC4934634	['one randomized controlled trial INVESTIGATED the EFFECTS of Prenatal Vitamin D supplementation on Respiratory outcomes in children at three years of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'prenatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 98, 'respiratory')]
PMC4934634	11/2015	S203-PMC4934634	['in an on-GOING TRIAL (Vitamin D antenatal asthma reduction trial, vdaart) the INFLUENCE of Vitamin D supplementation beginning in the second Trimester on different infant allergic disease risk at three years of age is being explored [76].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 141, 'trimester')]
PMC4934634	11/2015	S237-PMC4934634	['as mentioned earlier, genetics CAN play a ROLE in determining an Individual’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('NCBITaxon_1', 'root', 65, 'individual'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4934634	11/2015	S262-PMC4934634	['a one-time, Oral bolus of Vitamin D is an EFFECTIVE way to treat Vitamin D deficiency AS 25(Oh)D levels quickly rise following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 86)]	2	[('UBERON_0000165', 'mouth', 12, 'oral'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D')]
PMC4934640	11/2015	S34-PMC4934640	['this includes EFFECTS of iron deficiency, low Vitamin D, as well as oxidative stress and chronic inflammation ASSOCIATED with poor diet [28,29].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 110)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4944244	7/2016	S15-PMC4944244	['lack of Vitamin D MAY have an adverse health EFFECTS including death, cancer, Cardiovascular disease, impaired Immune function and Glucose Metabolism [4].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 78, 'cardiovascular'), ('UBERON_0002405', 'immune system', 111, 'immune'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('GO_0006006', 'glucose metabolic process', 131, 'glucose metabolism')]
PMC4944244	7/2016	S94-PMC4944244	['this high prevalence of hypovitaminosis D was DUE TO age, Abdominal obesity and Metabolic syndrome AFFECTING Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 40, 'D'), ('UBERON_0000916', 'abdomen', 58, 'abdominal'), ('GO_0008152', 'metabolic process', 80, 'metabolic'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4944244	7/2016	S200-PMC4944244	['[36] claimed that increased skin pigmentation CAN reduce the transmission of ultraviolet rays to synthesize Vitamin D3 and this LEADS TO a high risk of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('CHEBI_33279', 'vitamin D5', 108, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 108, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4944244	7/2016	S227-PMC4944244	['Calcium supplement with Vitamin D SHOULD BE given earlier to those who do not Consume adequate milk during Pregnancy to prevent adverse health EFFECTS to the mother and fetus.']	[('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 143)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 78, 'consume'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
PMC4969253	8/2016	S2-PMC4969253	['disruption in ra signaling or Vitamin A deficiency (vad) HAS BEEN LINKED to aberrant Development Of the Lung including alterations in the Airway Smooth Muscle (sm) differentiation, development, and function.']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0008053', 'mitochondrial fusion', 85, 'development of ... lung'), ('UBERON_0002048', 'lung', 104, 'lung'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001135', 'smooth muscle tissue', 145, 'smooth muscle')]
PMC4969253	8/2016	S48-PMC4969253	['vitamin a-ra and Postnatal Airway disease\na NUMBER OF epidemiological STUDIES in children and Adult subjects have LINKED Vitamin A status with chronic Airway diseases.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('GO_0007567', 'parturition', 17, 'postnatal'), ('UBERON_0001005', 'respiratory airway', 27, 'airway'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 151, 'airway')]
PMC4969253	8/2016	S78-PMC4969253	['a study in a population with chronic Vitamin A deficiency SHOWED that maternal Vitamin A deficiency has a negative IMPACT in Postnatal Lung function of the offspring with reduced fev1, fvc in childhood.']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 125, 'postnatal'), ('UBERON_0002048', 'lung', 135, 'lung')]
PMC4971719	8/2016	S7-PMC4971719	['using regression analyses, we EVALUATED the RELATIONSHIP between Vitamin D levels with bdi scores as well as with mini diagnoses of major depressive disorder and generalized anxiety disorder.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4971719	8/2016	S9-PMC4971719	['results\nwe FOUND that Vitamin D levels at 12–20 weeks were inversely ASSOCIATED with bdi scores both at 12—20 and at 34–36 weeks’ Gestation ( p \u2009<\u20090.05, both).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'gestation')]
PMC4971719	8/2016	S12-PMC4971719	['conclusions\nin women AT RISK for depression, early Pregnancy low Vitamin D levels are ASSOCIATED with higher depressive symptom scores in early and late Pregnancy.']	[('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4971719	8/2016	S19-PMC4971719	['for instance, a systematic review and meta-analysis of observational studies involving 31,424 non-Pregnant Adults FOUND low Vitamin D levels to be significantly ASSOCIATED with clinical diagnoses of depression [13].']	[('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 161)]	2	[('GO_0007565', 'female pregnancy', 98, 'pregnant'), ('UBERON_0007023', 'adult organism', 107, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4971719	8/2016	S28-PMC4971719	['in a follow-up study of a subset of this cohort, the authors also DEMONSTRATED an ASSOCIATION of low early Pregnancy Vitamin D levels with Postpartum depressive symptoms [23].']	[('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'postpartum')]
PMC4971719	8/2016	S30-PMC4971719	['FOUND an ASSOCIATION between low early Pregnancy Vitamin D levels and depressive symptoms measured at 16\xa0weeks Gestation [24].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'gestation')]
PMC4971719	8/2016	S32-PMC4971719	['SEVERAL STUDIES have evaluated the ASSOCIATION of Vitamin D levels with Postpartum symptoms of depression.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'postpartum')]
PMC4971719	8/2016	S33-PMC4971719	['robinson, et al., in an unselected australian cohort of caucasian women, FOUND Vitamin D levels at 18\xa0weeks’ Gestation to be ASSOCIATED with Postnatal depressive symptoms measured at 3\xa0days Postpartum [26].']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('GO_0007567', 'parturition', 141, 'postnatal'), ('GO_0007565', 'female pregnancy', 190, 'postpartum')]
PMC4971719	8/2016	S36-PMC4971719	['FOUND an ASSOCIATION between Vitamin D levels <32\xa0ng/ml measured monthly for 7\xa0months Postpartum and depression symptom scores at these same time points [28].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'postpartum')]
PMC4971719	8/2016	S41-PMC4971719	['we HYPOTHESIZED that lower Vitamin D levels during Pregnancy would be ASSOCIATED with higher depression symptom scores during Pregnancy and at 6–8 weeks Postpartum.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007565', 'female pregnancy', 153, 'postpartum')]
PMC4971719	8/2016	S118-PMC4971719	['Vitamin D levels at 12–20 weeks were STRONGLY CORRELATED with Vitamin D levels at 34–36 weeks (pearson’s ρ \u2009=\u20090.60, p \u2009<\u2009.0001).']	[('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4971719	8/2016	S127-PMC4971719	['standard deviation\nfor our primary outcome, we EVALUATED the RELATIONSHIP between Vitamin D levels at two time points and bdi scores at 12–20 weeks, 34–36 weeks and 6–8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 175, 'postpartum')]
PMC4971719	8/2016	S128-PMC4971719	['using analysis of covariance (ancova), and adjusting for season, (winter/non-winter), we FOUND that Vitamin D at 12–20 weeks was a significant PREDICTOR of the Bdi score at 12–20 ( p \u2009<\u20090.05) weeks and at 34–36 weeks Gestation ( p \u2009<\u20090.05).']	[('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 143)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('PR_000004717', "transcription factor TFIIIB component B''", 160, 'BDI'), ('GO_0007565', 'female pregnancy', 217, 'gestation')]
PMC4971719	8/2016	S133-PMC4971719	['there was a non-significant TREND towards ASSOCIATION of the most recent Vitamin D level with the bdi score ( p \u2009=\u20090.07).']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4971719	8/2016	S136-PMC4971719	['HOWEVER, “low Vitamin D” at enrollment was significantly ASSOCIATED with higher bdi score at 34–36 weeks Gestation ( p \u2009=\u20090.05).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC4971719	8/2016	S142-PMC4971719	['we FOUND that 12\xa0% of the variance in the bdi score at 34–36 weeks was PREDICTED by low Vitamin D levels, low epa, and low Dha at 12–20 weeks.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_17874', 'dihydrozeatin', 123, 'DHA')]
PMC4971719	8/2016	S164-PMC4971719	['our regression model SUGGESTED that 12\xa0% of the variance in bdi score at 34–36 weeks was PREDICTED by a combination of low Vitamin D, low epa and low Dha levels in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_17874', 'dihydrozeatin', 150, 'DHA'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4973215	8/2016	S16-PMC4973215	['in particular, we wanted TO EVALUATE the additive EFFECTS of race and maternal characteristics such as obesity on Vitamin D deficiency and sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4973215	8/2016	S100-PMC4973215	['this WOULD have allowed for a more expansive definition of the RELATIONSHIP between maternal Vitamin D status and Perinatal outcomes.']	[('FUTURE_PREDICTION', 5), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0036268', 'swimming', 114, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 114, 'perinatal')]
PMC4973215	8/2016	S103-PMC4973215	['furthermore, black race and Vitamin D deficiency were ASSOCIATED with an INCREASED RISK of sga.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4976416	7/2016	S10-PMC4976416	['[3]\nthere are eight types of Vitamin E (α-,β-,Γ-, and Σ-Tocopherols and their RELATED corresponding Tocotrienols), Γ-Tocopherol being the most abundant Tocopherol in diet, WHEREAS Α-Tocopherol (α-Toc) is the most abundant Vitamin E Derivative in Human Tissues and Sera.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin E'), ('CHEBI_66498', 'Ys-IV', 46, 'γ-,'), ('CHEBI_52029', 'dilC18(3) dye', 54, 'σ-'), ('CHEBI_27013', 'tocopherol', 56, 'tocopherols'), ('CHEBI_33257', 'secondary amide', 100, 'tocotrienols'), ('CHEBI_27725', 'butin', 115, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 152, 'tocopherol'), ('CHEBI_27725', 'butin', 180, 'α-tocopherol'), ('CHEBI_27021', 'toluate', 196, 'Toc'), ('CHEBI_84790', 'trans-3-hexenoyl-CoA(4-)', 222, 'vitamin E derivative'), ('NCBITaxon_9606', 'Homo sapiens', 246, 'human'), ('UBERON_0000479', 'tissue', 252, 'tissues'), ('UBERON_0001977', 'blood serum', 264, 'sera')]
PMC4976416	7/2016	S68-PMC4976416	['[45]\n\ndermatological indications for which there are ANECDOTAL reports of beneficial EFFECTS of Vitamin E\nchronic cutaneous lupus erythematosus[46]\nkeratosis follicularis[47]\npostherpetic neuralgia[48]\npseudoxanthoma elasticum[49]\nporphyria cutanea tarda.']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 85)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin E')]
PMC4979151	8/2016	S6-PMC4979151	['HOWEVER, Pha stimulation significantly induced the Expression of Genes encoding th1 and th2 cytokines and down-regulated a number of Genes INVOLVED in T-Cell Development, Proliferation and Differentiation Of B Cells, signal transduction pathway, transcriptional Regulation and pattern recognition receptors (prrs) in the Vitamin D group (vitd group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_34926', 'Pitrazepin', 9, 'PHA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('SO_0000704', 'gene', 65, 'genes'), ('SO_0000704', 'gene', 133, 'genes'), ('CL_0000084', 'T cell', 151, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 151, 'T-cell development'), ('GO_0007565', 'female pregnancy', 171, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 189, 'differentiation of B cells'), ('CL_0000236', 'B cell', 208, 'B cells'), ('GO_0065007', 'biological regulation', 262, 'regulation'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]
PMC4982007	8/2016	S128-PMC4982007	['it also FOUND a positive ASSOCIATION between maternal Vitamin D concentrations and offspring Mental and Psychomotor Development scores (0.8-0.9 score points (~0.06 sd) per 25\xa0nmol/l increase).']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007613', 'memory', 93, 'mental ...'), ('GO_0030324', 'lung development', 104, 'psychomotor development')]
PMC4988030	8/2016	S93-PMC4988030	['these Nutrients (total and saturated fat, Cholesterol, sodium, calcium, fiber, Folate, iron, Vitamins C and d, and Choline) were chosen BASED ON their importance to an overall healthy diet and increased Nutrient needs during Pregnancy [33–37].']	[('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_33284', 'nutrient', 6, 'nutrients'), ('CHEBI_16113', 'cholesterol', 42, 'cholesterol'), ('CHEBI_30863', '5-azaorotic acid', 79, 'folate'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('CHEBI_15354', 'choline', 115, 'choline'), ('CHEBI_33284', 'nutrient', 203, 'nutrient'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy')]
PMC4988030	8/2016	S142-PMC4988030	['LIKEWISE, clinically meaningful increases in percentages of pat participants meeting recommendations for Cholesterol and Vitamin C intakes between gm 4 and gm 8 were OBSERVED (65 to 84\xa0% and 86 to 97\xa0%, respectively).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 166)]	2	[('CHEBI_16113', 'cholesterol', 105, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin C')]
PMC4989298	8/2016	S351-PMC4989298	['the results of this meta-analysis SUPPORTS a CORRELATION between low Vitamin D status and diseases such as hypertension, rachitism in children, vaginosis in Pregnancy, the level of activity of rheumatoid arthritis, Colorectal cancer and falls in the elderly.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy'), ('UBERON_0012652', 'colorectum', 215, 'colorectal')]
PMC4989298	8/2016	S367-PMC4989298	['in the cohort studied by rothers and colleagues, high and low Vitamin D levels are ASSOCIATED with an INCREASED RISK of Sensitisation [123].']	[('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 102)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 120, 'sensitisation')]
PMC4989298	8/2016	S372-PMC4989298	['the RELATIONSHIP between Vitamin D and PREVENTION of allergic diseases is strong when epidemiological and ecological studies are considered.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC4990268	8/2016	S224-PMC4990268	['multi-Micronutrient supplementation\nvarious Micronutrients HAVE BEEN investigated for their ROLE in Pregnancy outcomes (Iron, Folic Acid, Calcium, magnesium, zinc, Vitamin A/ B-Carotene, Vitamin D3, Iodine, Omega-3 Fatty Acids, and others).']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('CHEBI_6956', 'Mitragynine', 6, 'Micronutrient'), ('CHEBI_33839', 'macromolecule', 44, 'micronutrients'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_24870', 'ion', 120, 'iron'), ('CHEBI_30751', 'formic acid', 126, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_27793', 'beta-carotene 5,6-epoxide', 175, 'B-carotene'), ('CHEBI_33279', 'vitamin D5', 187, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 187, 'vitamin D3'), ('CHEBI_24859', 'iodine atom', 199, 'iodine'), ('CHEBI_79370', 'ibho#10', 207, 'omega-3'), ('CHEBI_35366', 'fatty acid', 215, 'fatty acids')]
PMC4990268	8/2016	S299-PMC4990268	['that said, there is also EVIDENCE that Vitamin A deficiency INTERFERES with proper fetal development[103].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A')]
PMC4990268	8/2016	S354-PMC4990268	['among hiv positive women in zimbabwe, there was NO EVIDENCE for IMPACT of Vitamin A supplementation for mothers and/or their newborns on mortality[127].']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4990280	8/2016	S130-PMC4990280	['when these ASSOCIATIONS were stratified by sex, hb was ASSOCIATED with Vitamin A in boys and with hepcidin in girls (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A')]
PMC4992225	8/2016	S177-PMC4992225	['caption (table-wrap): table 4\n\n25(Oh)D concentrations and depression scores in nulliparous and multiparous subgroupsvariables mean (sd)nulliparousmultiparousvitamin D groupcontrol groupn p -valuevitamin D groupcontrol groupn p -value*25(Oh)D at baseline (ng/ml)13.13(6.91)13.25 (6.55)41/510.9312.49 (9.08)9.31 (5.34)34/270.1525(Oh)D at Delivery (ng/ml)18.40 (11.38)12.49 (6.29)33/430.0116.58 (8.54)11.36 (5.47)28/250.02depression score at baseline8.41(3.52)8.73 (3.57)41/510.678.47 (4.35)8.48 (4.30)34/270.99depression score at 38-40w Gestation6.47(3.43)7.98 (3.74)38/460.065.80 (3.62)7.44 (4.28)30/270.12depression score at Postpartum (4w)4.59(3.24)7.27 (4.04)34/450.0024.60 (3.40)7.52 (4.70)30/270.01depression score at Postpartum (8w)4.18(3.79)7.24 (3.79)34/450.0014.20 (3.79)7.07 (4.37)30/270.01\n*mann–whitney u test\nwe EXAMINED the CORRELATION between change in Vitamin D concentrations and change in depression scores at 38–40 weeks of Gestation, 4 and 8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 824), ('SUPERFICIAL_RELATIONSHIP', 837)]	2	[('CHEBI_71657', 'versiconol acetate', 31, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 31, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_71657', 'versiconol acetate', 234, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 240, 'D'), ('CHEBI_33010', 'chromide(1-)', 327, '(OH)D'), ('GO_0007567', 'parturition', 336, 'delivery'), ('GO_0007565', 'female pregnancy', 535, 'gestation6'), ('GO_0007565', 'female pregnancy', 625, 'postpartum'), ('GO_0007565', 'female pregnancy', 722, 'postpartum'), ('CHEBI_27300', 'vitamin D', 867, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'gestation'), ('GO_0007565', 'female pregnancy', 967, 'postpartum')]
PMC4992225	8/2016	S182-PMC4992225	['they were suffering from Vitamin D deficiency BASED ON NEW perspective towards normal Serum Vitamin D concentration [46].']	[('SUPERFICIAL_RELATIONSHIP', 46), ('FULL_UNKNOWN', 55)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4992225	8/2016	S223-PMC4992225	['there was an inverse RELATIONSHIP between the Vitamin D logarithm and depression scores, AS by adding one unit to the Vitamin D concentration logarithm, equal to 2.72\xa0ng/ml, a 46\xa0% reduction in the depression scores occurred [63].']	[('SUPERFICIAL_RELATIONSHIP', 21), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4997421	8/2016	S15-PMC4997421	['maternal Vitamin A deficiency also has SERIOUS repercussions for the newborn and is ASSOCIATED with depressed Immune function and higher morbidity and mortality due to infections [1], low Birth weight [6], Diaphragmatic hernia [7], bronchopulmonary dysplasia and other Respiratory disease [8,9,10].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0002405', 'immune system', 110, 'immune'), ('GO_0007567', 'parturition', 188, 'birth'), ('UBERON_0001103', 'diaphragm', 206, 'diaphragmatic'), ('UBERON_0001004', 'respiratory system', 269, 'respiratory')]
PMC4997421	8/2016	S20-PMC4997421	['signs of Vitamin A deficiency MAY not be observed in the mother, but the rapidly developing fetus is more vulnerable to these EFFECTS [13].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC4997567	8/2016	S6-PMC4997567	['the RISK FACTORS were low socioeconomic status, insufficient family income, poor housing conditions, lack of exposure to sunlight DUE TO cultural practices, sole Breast feeding, and inadequate supplementation of Vitamin D to the children and the Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBLEM_COMPLICATION', 130)]	2	[('UBERON_0000310', 'breast', 162, 'breast'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnant')]
PMC4997567	8/2016	S78-PMC4997567	['maternally, repeated Pregnancies more than 3 gravida (70%), shortened Pregnancy free intervals to less than 2 years (56%), lack OF adequate sunlight exposure to less than half an hour (80%), and inadequate maternal Gestational supplementation of Calcium and Vitamin D (62%) were contributing RISK FACTORS.']	[('ANOMALY_CURIOUS_FINDING', 128), ('SUPERFICIAL_RELATIONSHIP', 292)]	2	[('GO_0007565', 'female pregnancy', 21, 'pregnancies'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'gestational'), ('CHEBI_22313', 'alkaline earth metal atom', 246, 'calcium'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4998950	4/2016	S1-PMC4998950	['AIMS\nto clarify the RELATIONSHIP between maternal Vitamin D deficiency and offspring risk of asd with and without intellectual disability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5000726	8/2016	S232-PMC5000726	['low maternal Calcium and Vitamin D intake during late Pregnancy HAS BEEN ASSOCIATED with reduced bone Mineral content.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 13, 'calcium'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_46662', 'mineral', 102, 'mineral')]
PMC5014971	8/2016	S27-PMC5014971	['low to moderate quality evidence exists for a PROTECTIVE EFFECT of Vitamin D supplementation during Pregnancy for a number of Pregnancy outcomes, including Preeclampsia, being small for Gestational age, and Preterm labor [20].']	[('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 156, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 186, 'gestational'), ('GO_0007565', 'female pregnancy', 207, 'preterm')]
PMC5014971	8/2016	S124-PMC5014971	['dark skin pigmentation, AS OPPOSED TO african heritage per se, is a RISK FACTOR for poor Vitamin D status, especially in higher latitudes where sun intensity decreases outside of the summer months.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5028238	10/2016	S80-PMC5028238	['this would PROTECT Individuals from developing rickets (a Vitamin D deficiency condition that results in bone softening and malformations) and osteomalacia (an Adult form of rickets).17\ncertain Dhcr7 variants were found to be evolutionarily favored in northern climates, including europe and asia28suggesting a selective pressure and a PLAUSIBLE heterozygote advantage for those variants.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 336)]	2	[('NCBITaxon_1', 'root', 19, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 160, 'adult'), ('PR_000006474', 'ATP-dependent RNA helicase A', 194, 'DHCR7')]
PMC5028238	10/2016	S87-PMC5028238	["biological mechanism: Dhcr7's EFFECT on Vitamin D and Cholesterol Synthesis\nthe biological mechanism that CONNECTS Dhcr7 mutations (slos carriers) and northern climate involves Regulation of 7-Dehydrocholesterol, Vitamin D and Cholesterol."]	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('PR_000006474', 'ATP-dependent RNA helicase A', 22, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 54, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 54, 'cholesterol synthesis'), ('PR_000006474', 'ATP-dependent RNA helicase A', 115, 'DHCR7'), ('GO_0065007', 'biological regulation', 177, 'regulation'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 191, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 227, 'cholesterol')]
PMC5028238	10/2016	S91-PMC5028238	['an indirect negative feedback LOOP, established in laboratory studies, allows Vitamin D levels to Regulate Dhcr7 activity and PREVENT hypervitaminosis D (that is, toxically high Vitamin d levels).54slos patients have high 7-Dehydrocholesterol levels.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0065007', 'biological regulation', 98, 'regulate'), ('PR_000006474', 'ATP-dependent RNA helicase A', 107, 'DHCR7'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 151, 'D'), ('CHEBI_33229', 'vitamin (role)', 178, 'vitamin'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 222, '7-dehydrocholesterol')]
PMC5035678	4/2016	S1-PMC5035678	['objectives\nwe report the FIRST STUDY of the IMPACT of Prenatal Vitamin D supplementation on Postpartum dysglycemia in gdm patients in a randomized clinical trial.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('GO_0007565', 'female pregnancy', 54, 'prenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'postpartum')]
PMC5035678	4/2016	S19-PMC5035678	['an inverse RELATIONSHIP between serum Vitamin D levels and Glucose Metabolism in women with gdm HAS BEEN REPORTED in several observational studies (8-11).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_17234', 'glucose', 59, 'glucose'), ('GO_0006006', 'glucose metabolic process', 59, 'glucose metabolism')]
PMC5035678	4/2016	S117-PMC5035678	['(26) REVEALED a positive EFFECT of co-supplementation with Vitamin D and Calcium on Insulin resistance during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 73, 'calcium'), ('PR_000045358', 'insulin family protein', 84, 'insulin'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC5035678	4/2016	S144-PMC5035678	['in THIS STUDY, application of a proper dose and duration of Vitamin D supplementation LED TO a rapid increase in 25Ohd, up to near 70 ng/ml, which was maintained for the duration of the study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 113, '25OHD')]
PMC5039809	10/2016	S92-PMC5039809	['including Birth weight as a covariate markedly attenuated ASSOCIATIONS between measures of maternal Vitamin A and offspring ba and bmc, and there was no evidence of any nonlinearity in the ASSOCIATIONS between Vitamin A measures and offspring Birth weight or bone indexes.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 189)]	2	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin A'), ('GO_0007567', 'parturition', 243, 'birth')]
PMC5045784	10/2016	S14-PMC5045784	['camargo et al.4DEMONSTRATED that lower maternal Intake of Vitamin D during Pregnancy is ASSOCIATED with recurrent wheezing and asthma in their offspring during early childhood.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5051327	9/2016	S45-PMC5051327	['TO STUDY the EFFECT of Vitamin D levels in early Pregnancy and the risk for Birth asphyxia, we divided the study population into two groups: those with vitamin d deficiency (25-Oh Vitamin D <50\u2005nmol/l, n=95) and those who were non-deficient (25-Oh Vitamin d ≥50\u2005nmol/l, n=78) (table 2).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'birth'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 174, '25-OH'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_82341', 'Methylazoxymethanol acetate', 242, '25-OH vitamin')]
PMC5062906	10/2016	S38-PMC5062906	['VERY LITTLE IS KNOWN about the ROLE of Vitamin D in epigenetic mechanisms.']	[('FULL_UNKNOWN', 0), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5062906	10/2016	S59-PMC5062906	['we utilized reciprocal crosses between cc001/unc and cc011/unc (cross 1: cc001 female\u2009×\u2009cc011 male and cross 2: cc011 female\u2009×\u2009cc001 male) TO ASSESS the presence of parent of origin EFFECTS on phenotypic and epigenetic response to Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 182)]	2	[('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5062906	10/2016	S68-PMC5062906	['the INFLUENCE of grandmaternal Vitamin D status on phenotypic and epigenetic outcomes DEMONSTRATES inheritance of perturbed epigenetic landscapes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5062906	10/2016	S71-PMC5062906	['results\n\ndietary depletion of circulating Plasma 25(Oh)D is DEPENDENT on Genetic background\nTO DETERMINE the extent of Vitamin D depletion in g0dams Fed diet lacking Vitamin d (lvd) compared with dams on control diet (con) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('SO_0000704', 'gene', 73, 'genetic'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007631', 'feeding behavior', 149, 'fed'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]
PMC5062906	10/2016	S78-PMC5062906	['1c) DEMONSTRATING a Genetic INFLUENCE on response to dietary Vitamin D depletion.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5062906	10/2016	S297-PMC5062906	['when Vitamin D-dependent methylation profiles are compared between cell types, the Soma was SEEMINGLY more susceptible to perturbation with more loci AFFECTED and to a greater extent compared with Germ Cells (Sperm, fig.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0044297', 'cell body', 83, 'soma'), ('CL_0000586', 'germ cell', 197, 'germ cells'), ('CL_0000019', 'sperm', 209, 'sperm')]
PMC5064894	10/2016	S44-PMC5064894	['if a significantly decreased incidence of microbiologically confirmed ari is FOUND, we will further assess for EFFECT of lower doses of Prenatal maternal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5064894	10/2016	S45-PMC5064894	['we AIM to quantify the EFFECT of maternal Vitamin D supplementation on the relative incidence of, a) microbiologically confirmed ari (primary outcome); b) ari due to influenza (a&b) and Rsv; c) clinical ari; and, d) s. pneumococcus nasal carriage density.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 23)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'RSV')]
PMC5064894	10/2016	S160-PMC5064894	['we anticipate that the EFFECT of maternal Vitamin D supplementation will be incremental with increasing dose, such that the greatest EFFECT size (vs. placebo) will be observed in the highest dose Vitamin D group with Postpartum continuation (group e in fig.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 133)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007565', 'female pregnancy', 217, 'postpartum')]
PMC5064894	10/2016	S185-PMC5064894	['a specific pairwise comparison between the 28,000\xa0iu/week Prenatal\u2009+\u2009Postpartum group (group e) will be compared to 28,000\xa0iu/week without Postpartum supplementation (group d) TO IDENTIFY the IMPACT of continuing Vitamin D supplementation in the Postpartum period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('SUPERFICIAL_RELATIONSHIP', 192)]	2	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('GO_0007565', 'female pregnancy', 69, 'postpartum'), ('GO_0007565', 'female pregnancy', 139, 'postpartum'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'postpartum')]
PMC5084016	10/2016	S119-PMC5084016	['the hydroxylation into 1,25-Hydroxy-Vitamin D in the Proximal Renal Tubules is closely Regulated by feedback mechanisms and PRIMARILY DEPENDS on the requirement for calcium and Phosphorus [57].']	[('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	2	[('CHEBI_67771', 'Xestoproxamine C, (rel)-', 23, '1,25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001092', 'vertebral bone 1', 53, 'proximal'), ('UBERON_0009773', 'renal tubule', 62, 'renal tubules'), ('GO_0065007', 'biological regulation', 87, 'regulated'), ('CHEBI_35885', 'secondary phosphine', 177, 'phosphorus')]
PMC5084016	10/2016	S137-PMC5084016	['Breastmilk, IN FACT, contains amounts of Vitamin D (<80 iu/l) that are insufficient for deficit PREVENTION in the first year of Life [63].']	[('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breastmilk'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 128, 'life')]
PMC5084016	10/2016	S185-PMC5084016	['in cases of post-surgery Conception, specific nutritional deficiencies CAN AFFECT Visual Acuity (Vitamin A) and the Development Of the Nervous System (Vitamin B12) and Neural Tube (folates) [87,88].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('GO_0007620', 'copulation', 25, 'conception'), ('GO_0019042', 'viral latency', 82, 'visual acuity'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035882', 'defecation rhythm', 116, 'development of ... nervous system'), ('UBERON_0001016', 'nervous system', 135, 'nervous system'), ('CHEBI_33279', 'vitamin D5', 151, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 151, 'vitamin B12'), ('UBERON_0001049', 'neural tube', 168, 'neural tube')]
PMC5084028	10/2016	S151-PMC5084028	['this is because Nutrients CAN INTERACT with each other in both a positive (e.g., Vitamin A and zinc [127]) and negative manner (e.g., calcium or iron and zinc [128,129]).']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_33284', 'nutrient', 16, 'nutrients'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A')]
PMC5084041	10/2016	S0-PMC5084041	['Vitamin D status during Pregnancy in a multi-ethnic population-representative swedish cohort\n\nabstract\nthere is currently LITTLE INFORMATION on changes in Vitamin D status during Pregnancy and its PREDICTORS.']	[('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 197)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 179, 'pregnancy')]
PMC5084041	10/2016	S17-PMC5084041	['POOR maternal Vitamin D status during Pregnancy is ASSOCIATED with lower bone Mineral density and muscle strength in the infant [2].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('CHEBI_46662', 'mineral', 78, 'mineral')]
PMC5084041	10/2016	S23-PMC5084041	['such analyses of 25(Oh)D concentrations during Pregnancy SHOW that Vitamin D status between early and late Pregnancy tracks moderately and that change DEPENDS ON supplement use, Gestational weight gain and physical activity [12].']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 151)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'gestational')]
PMC5084041	10/2016	S106-PMC5084041	['a season-corrected analysis of change in 25(Oh)D SHOWED that the DETERMINANTS of change in 25(Oh)D during Pregnancy were origin, sun-Seeking behaviour, clothing style, dietary Vitamin D intake at t3, Vitamin D supplementation at t3 and having travelled to <35° n in the past six months (adjusted r2= 0.186) (table 3).']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_71657', 'versiconol acetate', 41, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 47, 'D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0007601', 'visual perception', 133, 'seeking'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5085625	9/2016	S74-PMC5085625	['ANALYZED ASSOCIATIONS between Vitamin D status, Blood pressure at the onset of Pregnancy and occurrence of a mid-Pregnancy decrease in the latter parameters.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5085625	9/2016	S96-PMC5085625	['the mechanism through which a low concentration of Vitamin D CONTRIBUTES to preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('FULL_UNKNOWN', 92)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5085625	9/2016	S110-PMC5085625	['owing the POTENTIAL CONTRIBUTION of an altered Vitamin D Metabolism to diabetes mellitus, we compared Serum concentrations of 25(Oh)D in patients with type 1 and 2 gdm (gdm g1 and gdm g2) and healthy controls.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 47, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC5085625	9/2016	S121-PMC5085625	['furthermore, a direct LINK between Glucose Metabolism and Vitamin D pathways HAS BEEN identified.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	2	[('CHEBI_17234', 'glucose', 35, 'glucose'), ('GO_0006006', 'glucose metabolic process', 35, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5095257	11/2016	S9-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period, coupled with Vitamin D deficiency, COULD lead to dysregulation of innate immunity AFFECTING the risk of developing aad.']	[('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 145)]	2	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5118763	12/2016	S160-PMC5118763	['a positive EFFECT of mmn supplementation on maternal Plasma Vitamin B-12 HAS also BEEN observed among Pregnant women in nepal (17).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 73)]	2	[('UBERON_0001969', 'blood plasma', 53, 'plasma'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 60, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 102, 'pregnant')]
PMC5118763	12/2016	S173-PMC5118763	['FURTHER FOLLOW-up of this cohort will be helpful to evaluate the EFFECT of high Folate and low Vitamin B-12 status of mothers on their offspring.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 95, 'vitamin B-12')]
PMC5129285	11/2016	S276-PMC5129285	['other dysbiotic INFLUENCES which are MORE COMMON along ses disadvantaged lines include sedentary behavior, Circadian disruptions, Sleep problems with functional constipation, and low levels of Vitamin D [249].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37)]	2	[('GO_0051216', 'cartilage development', 107, 'circadian'), ('GO_0030431', 'sleep', 130, 'sleep'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC5129897	10/2016	S21-PMC5129897	["hill's criteria HAVE BEEN used to evaluate the beneficial EFFECTS of Vitamin D for cancer,6,7cvd,8and ms.9\n\ncaption (table-Wrap): table 1."]	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000017453', 'protein Wnt-9b', 123, 'WRAP')]
PMC5129897	10/2016	S24-PMC5129897	['the EVIDENCE for the ROLE of Vitamin D for diseases considered in 2010 has increased.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5129897	10/2016	S99-PMC5129897	['Vitamin D supplementation CAN improve osteoporosis and reduce fractures.26the classical ROLE of Vitamin D is to help with calcium absorption and Metabolism, leading to strong Bones.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0008152', 'metabolic process', 145, 'metabolism'), ('UBERON_0001474', 'bone element', 175, 'bones')]
PMC5133057	10/2016	S19-PMC5133057	['furthermore, TO OUR KNOWLEDGE, no research concomitantly evaluated the ASSOCIATION of diet, C-Reactive Protein levels, and social, nutritional, and Gestational variables with the Vitamin A status of this population.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_59147', '3-[(4-methoxyphenylsulfonyloxy)methyl]-5,5-dimethylbutyrolactone', 92, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 92, 'C-reactive protein'), ('GO_0007565', 'female pregnancy', 148, 'gestational'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin A')]
PMC5133057	10/2016	S119-PMC5133057	['the results SHOWED a significant linear CORRELATION between Maternal Intake of Vitamin A obtained by 24hr and Serum Retinol.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('GO_0007618', 'mating', 60, 'maternal'), ('GO_0007631', 'feeding behavior', 69, 'intake'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol')]
PMC5146866	12/2016	S3-PMC5146866	['we used descriptive statistics and multiple regression models TO IDENTIFY the rate and factors associated with Vitamin D deficiency/insufficiency and RELATED outcomes in the enrolled mother-infant pairs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC5155676	12/2016	S0-PMC5155676	['DETERMINANTS of the maternal 25-Hydroxyvitamin D response to Vitamin D supplementation during Pregnancy\n\nabstract\n\ncontext:\ncurrent approaches to Antenatal Vitamin D supplementation do NOT ACCOUNT for interindividual differences in 25-Hydroxyvitamin D (25(Oh)D) response.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 185)]	2	[('CHEBI_27844', "2',3'-cyclic AMP", 29, '25-Hydroxyvitamin D'), ('CHEBI_28384', 'vitamin K', 61, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 61, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'Pregnancy'), ('GO_0007567', 'parturition', 146, 'antenatal'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 232, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 253, '25(OH)D')]
PMC5155676	12/2016	S21-PMC5155676	['in nonpregnant Adults, baseline 25(Oh)D concentration, body weight/adiposity and age are IMPORTANT DETERMINANTS of the incremental rise in 25(Oh)D after Vitamin D supplementation (13,14).']	[('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('UBERON_0007023', 'adult organism', 15, 'adults'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_30778', 'gallic acid', 139, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 145, 'D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5155676	12/2016	S84-PMC5155676	['when achievement of Vitamin D replete status at 34 weeks of Gestation was considered INSTEAD of absolute 25(Oh)D concentration, in multivariate analyses, Delivery in summer (relative risk [rr] = 1.20; 95%ci 1.09, 1.33; p< .001), white ethnicity (rr = 1.27; 95%ci 1.17, 1.37; p< .001), greater compliance with Medication (%) (rr = 1.01; 95%ci 1.00, 1.02; p = .03), and greater early Pregnancy 25(Oh)D concentration (nmol/l) (rr = 1.003; 95%ci 1.001, 1.006; p = .007) were significantly ASSOCIATED with achieving 25(Oh)D >50 nmol/l in the women randomized to Cholecalciferol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 485)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('GO_0007567', 'parturition', 154, 'delivery'), ('CHEBI_60211', 'compound Z', 309, 'medication'), ('GO_0007565', 'female pregnancy', 382, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 511, '25(OH)D'), ('CHEBI_52550', 'theopalauamide', 557, 'cholecalciferol')]
PMC5155676	12/2016	S95-PMC5155676	['the maternal characteristics ASSOCIATED with 25(Oh)D at 34 weeks of Gestation and achieving Vitamin D replete status were SIMILAR TO those observed in the whole cohort.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 122)]	2	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('GO_0007565', 'female pregnancy', 68, 'gestation'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5155676	12/2016	S97-PMC5155676	['this dose achieved Vitamin D repletion in over 80% of women, without leading to 25(Oh)D levels POTENTIALLY ASSOCIATED with Vitamin D toxicity (at least within the included baseline of 25–100 nmol/l 25(Oh)D).']	[('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 198, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 198, '25(OH ... D')]
PMC5155676	12/2016	S98-PMC5155676	['however, gaining less weight during Pregnancy, having a higher 25(Oh)D in early Pregnancy, Delivering in summer and having higher compliance with supplementation were INDEPENDENTLY ASSOCIATED with achieving a greater 25(Oh)D concentration in late Pregnancy among women randomized to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 167), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 63, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0006900', 'vesicle budding from membrane', 91, 'delivering'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC5155676	12/2016	S123-PMC5155676	['data from healthy and hospitalized Adults have SIMILARLY SHOWN that older Individuals achieve a higher 25(Oh)D after Vitamin D supplementation (13,32).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('NCBITaxon_1', 'root', 74, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 105, '('), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5264377	7/2016	S14-PMC5264377	['Humans obtain their daily levels of Vitamin D MAINLY by Endogenous Biosynthesis induced by exposure to ultraviolet b (uvb) radiation, in concert with a small CONTRIBUTION from the Intake of different Food sources.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 158)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Humans'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0009790', 'embryo development', 56, 'endogenous'), ('GO_0009057', 'macromolecule catabolic process', 67, 'biosynthesis'), ('GO_0007631', 'feeding behavior', 180, 'intake'), ('CHEBI_33290', 'food', 200, 'food')]
PMC5273824	1/2017	S0-PMC5273824	['investigation of the Vitamin D nutritional status in women with Gestational diabetes mellitus in beijing\n\nabstract\n\nbackground\nVitamin D deficiency is a common ISSUE, which has RELATION with gdm, during the Pregnant period.']	[('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 177)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_28384', 'vitamin K', 127, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'pregnant')]
PMC5310660	1/2017	S37-PMC5310660	['the peak of Births for those who developed one of these diseases occurred in april and a trough in october, and the risk CORRELATED inversely with PREDICTED second-trimester uvb exposure and third-trimester Vitamin D status [7].']	[('SUPERFICIAL_RELATIONSHIP', 121), ('SUPERFICIAL_RELATIONSHIP', 147)]	2	[('GO_0007567', 'parturition', 12, 'births'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5318550	2/2017	S5-PMC5318550	['we EXPLORED how adjusting for socioeconomic status and maternal iq, Childbirth outcomes, Pregnancy Vitamin D status, nutritional intake, exposure to infections, and child age relative to peers in class changed the RELATION between season of Birth and child iq.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 214)]	2	[('GO_0007623', 'circadian rhythm', 68, 'childbirth'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007567', 'parturition', 241, 'birth')]
PMC5318550	2/2017	S103-PMC5318550	['as shown in the correlation matrix (see onlinesupplementary table s1), child spring Birth negatively CORRELATED with nulliparity (r=−0.03, p=0.008), maternal mid-Pregnancy and Cord Blood Vitamin D Plasma concentrations (r=−0.11, p=0.01 and r=−0.12, p<0.001), child relative age compared with peers in school (r=−0.17, p<0.001) and positively CORRELATED with maternal crp concentrations (r=0.05, p=0.001) and presence of fever in mid-Pregnancy (r=0.06, p=0.001).10.1136/bmjopen-2016-012406.supp3\n\nnext, we tested the change of the association between season of Birth and iq with addition of possible covariates to the basic model, each in a separate model (see onlinesupplementary table s2).']	[('SUPERFICIAL_RELATIONSHIP', 101), ('SUPERFICIAL_RELATIONSHIP', 342)]	2	[('GO_0007567', 'parturition', 84, 'birth'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 176, 'cord'), ('UBERON_0000178', 'blood', 181, 'blood'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 197, 'plasma'), ('GO_0007565', 'female pregnancy', 433, 'pregnancy'), ('GO_0007567', 'parturition', 560, 'birth')]
PMC5318550	2/2017	S157-PMC5318550	['moreover, certain VARIABLES have MISSING values of over 20%, for example, maternal nutrition and Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC5322422	2/2017	S10-PMC5322422	['THEREFORE, infants who accumulate inactive Vitamin K-dependent Coagulation factors have an increased bleeding TENDENCY [2].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 110)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin K'), ('GO_0050817', 'coagulation', 63, 'coagulation')]
PMC5322422	2/2017	S63-PMC5322422	['this form nearly always occurs in exclusively Breast-Fed infants and is OFTEN ASSOCIATED with undiagnosed Hepatobiliary dysfunction impairing absorption of Vitamin K [1].']	[('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('GO_0007567', 'parturition', 46, 'breast'), ('UBERON_0000310', 'breast', 46, 'breast'), ('GO_0007631', 'feeding behavior', 53, 'fed'), ('UBERON_0002423', 'hepatobiliary system', 106, 'hepatobiliary'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin K')]
PMC5322422	2/2017	S87-PMC5322422	['WHILE the differential diagnosis included spontaneous hemorrhage into normal Thymic Tissue, malignancy or Vitamin K ASSOCIATED bleeding into benign or malignant Tissue could not be ruled out.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('UBERON_0002370', 'thymus', 77, 'thymic tissue'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin K'), ('UBERON_0000479', 'tissue', 161, 'tissue')]
PMC5340372	3/2017	S15-PMC5340372	['REPORTED an inverse CORRELATION between Prenatal Vitamin D intake and recurrent wheezing of offspring [5].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5340372	3/2017	S16-PMC5340372	['measurements of Vitamin D Serum level 25-Hydroxyvitamin D [25(Oh)D] have yielded CONFLICTING results regarding the RELATIONSHIP between maternal- or Cord-Blood levels and subsequent Asthma Development [6–15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0035801', 'adrenal cortex development', 182, 'asthma development')]
PMC5351212	3/2017	S27-PMC5351212	['Birth cohort studies have provided EVIDENCE that maternal Vitamin D deficiency is ASSOCIATED with a range of later autism-related outcomes including impaired Language Development [24] and Cognitive Development in offspring [25].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 158, 'language development'), ('GO_0050787', 'detoxification of mercury ion', 188, 'cognitive development')]
PMC5351212	3/2017	S192-PMC5351212	['4a), SUGGESTING that Vitamin D blocked the EFFECTS of mia on Emotional Learning.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0050959', 'echolocation', 61, 'emotional learning')]
PMC5351212	3/2017	S197-PMC5351212	['this mia-induced reduction in fear acquisition was not evident when vitdwas co-administered SUGGESTING that Vitamin D blocked the EFFECTS of Mia on Emotional Learning.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 130)]	2	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_34840', 'methyl methacrylate', 141, 'MIA'), ('GO_0050959', 'echolocation', 148, 'emotional learning')]
PMC5368580	4/2017	S11-PMC5368580	['acute supplementation EFFECTS were FOUND for Thiamin, riboflavin, and Vitamins B-6 and a at 2–4 h postdosing, with 0.1–6.17% passing into Milk.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 35)]	2	[('CHEBI_26948', 'vitamin B1', 45, 'thiamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamins B'), ('UBERON_0001913', 'milk', 138, 'milk')]
PMC5368580	4/2017	S106-PMC5368580	['however, the CONTRIBUTION of the Circadian variation to the total variance was <10% for all Vitamins, but increased CONSIDERABLY with maternal supplementation for riboflavin (36%) and Vitamin B-6 (23%) ( table 2 , supplemental table 2 ).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 116)]	2	[('GO_0051216', 'cartilage development', 33, 'circadian'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 184, 'vitamin B-6')]
PMC5368580	4/2017	S175-PMC5368580	['without supplementation, the morning hours (0900–0959) and early afternoon hours (1500–1559) were also acceptable for sample collection based on their lower variation in Vitamin concentrations, WHEREAS increases in the concentration of riboflavin and Vitamin B-6 in milk during the early afternoon on days 2 and 3 reflected acute EFFECTS of maternal supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 330)]	2	[('CHEBI_33229', 'vitamin (role)', 170, 'vitamin'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 251, 'vitamin B-6')]
PMC5368580	4/2017	S184-PMC5368580	['the transport mechanisms INVOLVED with niacin and Vitamin B-6 are UNKNOWN (11,35).']	[('SUPERFICIAL_RELATIONSHIP', 25), ('FULL_UNKNOWN', 66)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 50, 'vitamin B-6')]
PMC5372327	3/2017	S30-PMC5372327	['in healthy children aged 8–17 years with S-25-Ohd levels above 50\xa0nmol/l, no effect of Vitamin D supplementation on bmd is seen [14], and the RELATIONSHIP between bmd and s-25-Ohd is INCONSISTENT in infants and young children [15].']	[('SUPERFICIAL_RELATIONSHIP', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	2	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 41, 'S-25-OHD'), ('PR_000000036', 'BMP receptor type-1B', 42, '-25'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 173, '25-OHD')]
PMC5372327	3/2017	S31-PMC5372327	['in infants, severe Vitamin D deficiency (<25\xa0nmol/l) ASSOCIATES with poor linear growth and delayed motor development POSSIBLY due to muscle weakness [16,17].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 118)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5372327	3/2017	S53-PMC5372327	['LITTLE EVIDENCE exists on the EFFECTS of Vitamin D on the Cognitive Development among children and adolescents.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 58, 'cognitive development')]
PMC5372327	3/2017	S61-PMC5372327	['we have studied gc polymorphisms in RELATION to Vitamin D Metabolism and bone strength in children [55] and OBSERVED differences in s-25-Ohd and pth concentrations between gc genotypes and that variation exists in bmd and bone strength index as well.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 108)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 48, 'vitamin D metabolism'), ('CHEBI_72765', 'verruculogen', 134, '25-OHD')]
PMC5372327	3/2017	S128-PMC5372327	['by analysis of the IMPACT of Gene polymorphisms on the concentration and efficacy of the given Vitamin D substitution it MAY create the basis for individualised dosage guidelines.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 121)]	2	[('SO_0000704', 'gene', 29, 'gene'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5385921	4/2017	S0-PMC5385921	['Gestational Vitamin D deficiency and autism spectrum disorder\n\nabstract\n\nbackground\nthere is GROWING INTEREST in LINKING Vitamin D deficiency with autism spectrum disorders (asds).']	[('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 113)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5385921	4/2017	S6-PMC5385921	['conclusions\nmid-Gestational Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of asd.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 72)]	2	[('GO_0007565', 'female pregnancy', 16, 'gestational'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5385921	4/2017	S125-PMC5385921	['for example, the active form of Vitamin D (1,25Ohd) IS KNOWN to AFFECT the function of voltage-gated calcium channels.38variants in Genes coding for subunits of these same calcium channels (e.g.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 45, '25OHD'), ('SO_0000704', 'gene', 132, 'genes')]
PMC5405075	4/2017	S53-PMC5405075	['besides, a POSSIBLE EFFECT of Vitamin D was depicted on primary care visits, where asthma was diagnosed by physicians (74).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5405075	4/2017	S85-PMC5405075	['additionally, Vitamin D is a marker of uv exposure, which CAN Modulate Immunity via non-Vitamin D RELATED pathways (80,81).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulate'), ('GO_0007566', 'embryo implantation', 71, 'immunity'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5410409	4/2017	S63-PMC5410409	['in more RECENT observation STUDIES, high-dose Maternal Intake of Vitamin D was ASSOCIATED with increased atopic diseases such as atopic dermatitis and/or allergic rhinitis [14].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC5410409	4/2017	S194-PMC5410409	['in 1 large Birth cohort STUDY, regular Vitamin D supplementation was ASSOCIATED with the risk of developing atopy (odds ratio [or], 1.66) and allergic rhinitis (or, 1.46) than those who received it irregularly or none at all [75].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('GO_0007567', 'parturition', 11, 'birth'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5418719	5/2017	S110-PMC5418719	['a randomized controlled trial in 100 infants with Gestational age between 23 and 27\xa0weeks DEMONSTRATED that the 800\xa0iu/d dose of Vitamin D supplementation PREVENTED Vitamin D deficiency, without toxicity, with concentrations above the desired 25(Oh)D range of 20–60\xa0ng/ml in the majority of infants on day 28 [2].']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 155)]	2	[('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC5418719	5/2017	S117-PMC5418719	['in addition, circulating 25(Oh)D levels are INFLUENCED by ethnicity, Genetic factors and maternal FACTORS such as Prenatal Vitamin D intake and Gestational diabetes mellitus [27,28].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('SO_0000704', 'gene', 69, 'genetic'), ('GO_0007565', 'female pregnancy', 114, 'prenatal'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 144, 'gestational')]
PMC5418719	5/2017	S126-PMC5418719	['these results SUGGEST Vitamin D deficiency is RELATED to impaired Glucose tolerance and Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('PR_000045358', 'insulin family protein', 88, 'insulin')]
PMC5418719	5/2017	S131-PMC5418719	['INTERESTINGLY, preterm morbidities INFLUENCING Vitamin D status had no significant differences between the groups in our patients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5426325	4/2017	S17-PMC5426325	['we used this historical change in fortification legislation TO EXAMINE the INFLUENCE of extra Prenatal Vitamin D exposure from fortified Margarine on the risk of fractures during Pubertal-related Growth Spurts, which has the highest fracture incidence(4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_6784', 'mestranol', 137, 'margarine'), ('GO_0007567', 'parturition', 179, 'pubertal'), ('UBERON_0002445', 'ulnare', 196, 'growth spurts')]
PMC5426325	4/2017	S24-PMC5426325	['in addition, it was HYPOTHESISED that the Vitamin D fortification during sun-deprived months of Gestation would be ASSOCIATED with the greatest risk reduction of offspring childhood fractures.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'gestation')]
PMC5426325	4/2017	S65-PMC5426325	['in a third series of models, we addressed the POTENTIAL modification of the EFFECT of Vitamin D availability by season of Birth, with winter defined as Births in november, december or january.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007567', 'parturition', 122, 'birth'), ('GO_0007567', 'parturition', 152, 'births')]
PMC5426325	4/2017	S136-PMC5426325	['in the avon longitudinal study of parents and children (alspac) study, uv-b-exposure during the third Trimester of Pregnancy was used as a PROXY for Vitamin D status, and the exposure was directly ASSOCIATED with bone Mineral content (bmc), bone area and bmd among 6955 children at age 9·9 years(8).']	[('SUPERFICIAL_RELATIONSHIP', 139), ('SUPERFICIAL_RELATIONSHIP', 197)]	2	[('GO_0009294', 'DNA mediated transformation', 102, 'trimester'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_46662', 'mineral', 218, 'mineral')]
PMC5445675	6/2017	S135-PMC5445675	['the positive IMPACT on sga in 2004 was ASSOCIATED with significant increases (>50%) in Vitamin A, Thiamin, Nicotinamide, riboflavin, Vitamin C, iron, and Calcium, and a small reduction in Folic Acid (supplemental table 1).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 98, 'thiamin'), ('CHEBI_17154', 'nicotinamide', 107, 'nicotinamide'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin C'), ('CHEBI_22313', 'alkaline earth metal atom', 154, 'calcium'), ('CHEBI_30751', 'formic acid', 188, 'folic acid')]
PMC5474873	6/2017	S16-PMC5474873	['Animal studies HAVE SHOWN that deficiency of Prenatal Vitamin D is ASSOCIATED with persistent changes in Adult Brain structure, neurochemistry, and behavior (5,7).']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 45, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('UBERON_0000955', 'brain', 111, 'brain')]
PMC5474873	6/2017	S144-PMC5474873	['using the same cohort of women SHOWED that Vitamin D intake from the diet was statistically significantly ASSOCIATED with a decreased relative risk of both medium and high levels of psychotic symptoms (50).']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5474873	6/2017	S151-PMC5474873	['SHOWED a j-shaped ASSOCIATION, with reduced risk for an intermediate Intake of Vitamin D (fish intake) (13).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('GO_0007631', 'feeding behavior', 69, 'intake'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5489519	6/2017	S0-PMC5489519	['Vitamin D MODULATION of Trail expression in Human Milk and Mammary Epithelial Cells\n\nabstract\nthe Vitamin D levels in mothers AFFECT the health status of both the mother and breastfeeding infant.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 24, 'TRAIL'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Human'), ('UBERON_0001913', 'milk', 50, 'Milk'), ('CL_0002458', 'langerin-positive dermal dendritic cell', 59, 'Mammary Epithelial Cells'), ('UBERON_0006918', 'parakeratinized epithelium of tongue', 59, 'Mammary Epithelial'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5489519	6/2017	S6-PMC5489519	['IN CONTRAST, Vitamin D at 20\u2009nm concentration SUPPRESSED the Expression of both Trail Α and β proteins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0010467', 'gene expression', 61, 'expression'), ('PR_000001683', 'vasopressin V2 receptor', 80, 'TRAIL α')]
PMC5489519	6/2017	S7-PMC5489519	['CONSISTENTLY, Vitamin D Regulated Trail mrna Expression in hme-1 cells.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 24, 'regulated'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 34, 'TRAIL'), ('GO_0010467', 'gene expression', 45, 'expression')]
PMC5489519	6/2017	S11-PMC5489519	['in addition, Vitamin D is IMPLICATED in the Regulation of T-Lymphocytes, Monocytes and Macrophages Of the Immune System3–5.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'regulation'), ('CL_0000084', 'T cell', 58, 'T-lymphocytes'), ('CL_0000576', 'monocyte', 73, 'monocytes'), ('CL_0000091', 'Kupffer cell', 87, 'macrophages of ... immune system3'), ('UBERON_0002405', 'immune system', 106, 'immune system3')]
PMC5489519	6/2017	S16-PMC5489519	['studies have SUGGESTED that the Vitamin D status of mother DETERMINES the Vitamin D levels of breastfeeding infant12–14.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5489519	6/2017	S17-PMC5489519	['evidently, randomized controlled clinical trials INDICATED the beneficial ROLE of maternal Vitamin D supplementation on the Vitamin D status of breastfed infants14,15.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5489519	6/2017	S27-PMC5489519	['HOWEVER, the ASSOCIATION between the levels of Vitamin D in the maternal Blood and Trail Expression in Human Milk has not been previously described.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0000178', 'blood', 73, 'blood'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 83, 'TRAIL'), ('GO_0010467', 'gene expression', 89, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 103, 'human'), ('UBERON_0001913', 'milk', 109, 'milk')]
PMC5489519	6/2017	S95-PMC5489519	['the functional ROLE of Vitamin D in fetus and infant’s Bone Development has been PREVIOUSLY demonstrated.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 81)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0048539', 'bone marrow development', 55, 'bone development')]
PMC5489519	6/2017	S97-PMC5489519	['mother-offspring group studies HAVE SHOWN that maternal Vitamin D insufficiency LEADS to reduced bone mass during childhood35,36.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5513133	7/2017	S42-PMC5513133	['RISK FACTORS that AFFECT Vitamin D status include season, time of the day, latitude, clothing and skin color [32].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC5513133	7/2017	S57-PMC5513133	['in a study conducted on 100 normotensive and 100 pre-eclamptic women, both Plasma Vitamin D deficiency (or 4.2, 95% ci: 1.4–12.8, p \xa0=\xa00.04) and Interleukin-6 elevation (or 4.4, 95% ci: 1.8–10.8, p \xa0<\xa00.01) were INDEPENDENTLY ASSOCIATED with pe.']	[('SUPERFICIAL_RELATIONSHIP', 212), ('SUPERFICIAL_RELATIONSHIP', 226)]	2	[('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 145, 'interleukin-6')]
PMC5513133	7/2017	S120-PMC5513133	['a LIMITATION of this study was that it was unable to adjust for Intake of Long Chain N-3 Fatty Acids, which CORRELATED with Vitamin D intake in a norwegian diet.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('GO_0007631', 'feeding behavior', 64, 'intake'), ('CHEBI_25098', 'lyxoside', 74, 'long chain n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5513133	7/2017	S143-PMC5513133	['SIMILAR Vitamin D levels were FOUND in women with mild and severe pe [87].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
PMC5513133	7/2017	S148-PMC5513133	['a nested case control study SHOWED an ASSOCIATION between eospe and Vitamin D deficiency after the diagnosis of eospe.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S209-PMC5513133	['smoking HAS also BEEN LINKED to lower Vitamin D concentrations [37].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 22)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5513133	7/2017	S213-PMC5513133	['individuals receive the MAJORITY of their Vitamin D from sunlight, LINKING seasonality to the development of pe.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5513133	7/2017	S223-PMC5513133	['the use of cod Liver oil as a Food supplement in some diets presents a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation.']	[('DIFFICULT_TASK', 71), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('UBERON_0002107', 'liver', 15, 'liver'), ('CHEBI_33290', 'food', 30, 'food'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5513133	7/2017	S261-PMC5513133	['replication of findings using a uniform set of definitions for pe and clinical subtypes CAN inform the use of Vitamin D supplementation for the PREVENTION of pe.']	[('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 144)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5513133	7/2017	S266-PMC5513133	['conclusion\nthere is CONSISTENT EVIDENCE of an ASSOCIATION between low Vitamin D concentrations and adverse pih outcomes.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5513133	7/2017	S267-PMC5513133	['results from Vitamin D supplementation during Pregnancy did not show a statistically significant independent EFFECT of Vitamin D on the RISK of pe and pih.']	[('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 136)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5523023	7/2017	S82-PMC5523023	['it WAS SHOWN that ba and Airflow limitation are ASSOCIATED with deficiency of various antioxidants, such as Carotenoids, Retinol, coenzyme q10, and Vitamin C, d, and e (17,40–45).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('UBERON_0001005', 'respiratory airway', 25, 'airflow'), ('CHEBI_50815', 'norgestimate', 108, 'carotenoids'), ('CHEBI_26536', 'retinoic acid', 121, 'retinol'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin C')]
PMC5523023	7/2017	S85-PMC5523023	['in SEVERAL STUDIES, the supplementation with a Nutraceutical of Antioxidants and Anti-Inflammatory Compounds (e.g., Curcumin, zinc, Selenium, Vitamin D) was ASSOCIATED with reduction of Airway inflammation, as documented by a decrease in fractional exhaled Nitric Oxide (feno) (48) or prolonged time to exacerbation (49).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 157)]	2	[('CHEBI_50733', 'nutraceutical', 47, 'nutraceutical'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 64, 'antioxidants'), ('CHEBI_22485', 'glucosamine oligosaccharide', 81, 'anti-inflammatory compounds'), ('CHEBI_3962', 'curcumin', 116, 'curcumin'), ('CHEBI_27568', 'selenium atom', 132, 'selenium'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 186, 'airway'), ('CHEBI_16480', 'nitric oxide', 257, 'nitric oxide')]
PMC5523023	7/2017	S97-PMC5523023	['Prenatal supplementation of Vitamin C and E improved Pulmonary functions of newborns of smoking mothers (59), BUT in a large placebo-controlled study, this EFFECT was not confirmed (60).']	[('ANOMALY_CURIOUS_FINDING', 110), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'E'), ('UBERON_0002048', 'lung', 53, 'pulmonary')]
PMC5524288	7/2017	S18-PMC5524288	['Serum 25(Oh)D concentration captures the EFFECT of multiple Vitamin D input sources (Supplement, sun, and Food) and makes provision for inter-individual VARIABILITY in dose response [11].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 153)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 6, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 85, 'supplement'), ('CHEBI_33290', 'food', 106, 'food')]
PMC5537904	7/2017	S1-PMC5537904	['we EXAMINED ASSOCIATIONS between Prenatal Vitamin D intake, 25-Hydroxyvitamin D (25(Oh)D) in Cord Blood, and offspring size and body composition at Birth and 5 months.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 12)]	2	[('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 60, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('GO_0007567', 'parturition', 148, 'birth')]
PMC5537904	7/2017	S61-PMC5537904	['this variable was used as PROXY for offspring Vitamin D intake from Food, given that Breastmilk contains little-to-no Vitamin D and all infant formulas in the united states are REQUIRED to contain at least 400 iu/l [40].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('IMPORTANT_CONSIDERATION', 177)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_33290', 'food', 68, 'food'), ('UBERON_0001348', 'brown adipose tissue', 85, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5537904	7/2017	S102-PMC5537904	['the FIRST analysis evaluated the ASSOCIATION of maternal oral Intake of Vitamin D during Pregnancy with Cord Blood 25(Oh)D. this model was adjusted for season of Birth, maternal age, pre-Pregnancy bmi, race/ethnicity, household income, gwg, and Gestational age at Birth and considered the following interaction terms: Vitamin D intake × bmi, Vitamin D intake × gwg, Vitamin D intake × race/ethnicity, season × bmi, season × gwg, and season × race/ethnicity.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('GO_0007631', 'feeding behavior', 62, 'intake'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('UBERON_0000178', 'blood', 109, 'blood'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 115, '25(OH ... D'), ('GO_0007567', 'parturition', 162, 'birth'), ('GO_0007565', 'female pregnancy', 187, 'pregnancy'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('GO_0007567', 'parturition', 264, 'birth'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D')]
PMC5539754	8/2017	S23-PMC5539754	['epidemiological data SUGGEST that seasonality in sunlight and Vitamin D are RELATED to mortality and infection rates [18].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5539754	8/2017	S104-PMC5539754	['additionally, those at risk of Vitamin D deficiency in early Pregnancy are more LIKELY to have increased fasting Glucose in late Pregnancy, INDEPENDENT of season.']	[('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_17234', 'glucose', 113, 'glucose'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5546866	8/2017	S12-PMC5546866	['abstract:teaser\nASSOCIATIONS between Snps in the Vitamin D Metabolism pathway and 25(Oh)D were ASSESSED before and after Antenatal Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	2	[('SO_0000694', 'SNP', 37, 'SNPs'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 57, 'D'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('GO_0007567', 'parturition', 121, 'antenatal'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5546866	8/2017	S16-PMC5546866	['RISK FACTORS for Vitamin D deficiency, in addition to geographic and seasonal variation, are WELL ESTABLISHED.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5546866	8/2017	S21-PMC5546866	['several of these Snps have been ASSOCIATED with the Serum 25(Oh)D increase in response to Vitamin D supplementation in SMALL STUDIES (9–11).']	[('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 119)]	2	[('SO_0000694', 'SNP', 17, 'SNPs'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5546866	8/2017	S130-PMC5546866	['Cyp2R1 encodes a 25-hydroxylase, a KEY enzyme INVOLVED in the conversion of Vitamin D to 25(Oh)D (23).']	[('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D')]
PMC5579643	8/2017	S24-PMC5579643	['Nutrients, such as zinc and Vitamin D and nutritional factors, such as pre- and Probiotics, CAN INFLUENCE the nature of an Immune Response and are important in ensuring appropriate functioning of the Immune System, as described in the paragraphs below.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_26346', 'prostaglandins J', 80, 'probiotics'), ('GO_0006955', 'immune response', 123, 'immune response'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('UBERON_0002405', 'immune system', 200, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 207, 'system')]
PMC5623264	9/2017	S8-PMC5623264	['six interventions were ASSOCIATED with a decreased RISK of lbw: oral supplementation with (1) Vitamin A, (2) low-dose Calcium, (3) zinc, (4) multiple Micronutrients (mmn), nutritional education and provision of preventive Antimalarials.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 51)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 118, 'calcium'), ('CHEBI_33839', 'macromolecule', 150, 'micronutrients'), ('CHEBI_22580', 'anthraquinone', 222, 'antimalarials')]
PMC5634602	10/2017	S1-PMC5634602	['response to Vitamin D supplementation and IMPACT on outcomes in preterm infants is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 83)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC5634602	10/2017	S28-PMC5634602	['another trial evaluating placebo, 200 iu and 800 iu daily Vitamin D supplement evaluated levels at 36 weeks and days of Respiratory support, SHOWING PREVENTION of Vitamin D deficiency with the 800 iu dose, and an improvement in Serum levels with the 200 iu dose as compared to placebo, but no difference in days alive or in Respiratory support [11].']	[('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('UBERON_0001004', 'respiratory system', 324, 'respiratory')]
PMC5634602	10/2017	S66-PMC5634602	['Gestational age, Birth anthropometrics and in hospital growth are presented intable 2.10.1371/journal.pone.0185950.t002\n\ncaption (table-wrap): table 2\nGestational age, Birth anthropometrics and in hospital growth by Vitamin D3Supplementation group.variable400 iu800 iup-valuenmedianiqrnmedianiqr Birth weight, grams 161405.5270161392.56321.00 Birth weight %ile 1633301639.5390.33 Gestational age at delivery 163121630.355.350.75 Birth length, cm 16395.51639.510.10.94 Birth length %ile 1615241624.536.50.36 Birth Head circumference, cm 1627.521627.54.150.66 Birth hc %ile 162051163940.50.71 weight at 36 weeks, grams 142378.5393122542472.50.23 weight %ile 36 weeks 1418201227.5310.14 length at 36 weeks, cm 14432.21245.753.650.09 length %ile 36 weeks 1411151228450.06 hc at 36 weeks, cm 1432.13.51233.252.050.75 hc %ile 36 weeks 1430.562124429.50.52\n\n25Ohd changes by Vitamin D dose\nCord Blood 25(Oh)D3Levels were significantly CORRELATED with Gestational age (r = 0.40, p = 0.04), but had no CORRELATION with sex or race.']	[('SUPERFICIAL_RELATIONSHIP', 928), ('SUPERFICIAL_RELATIONSHIP', 993)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('GO_0007567', 'parturition', 17, 'birth'), ('GO_0007565', 'female pregnancy', 151, 'Gestational'), ('GO_0007567', 'parturition', 168, 'birth'), ('CHEBI_52915', 'phosphatediyl group', 216, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 216, 'vitamin D3supplementation'), ('GO_0007567', 'parturition', 296, 'Birth'), ('GO_0007567', 'parturition', 343, 'Birth'), ('GO_0007565', 'female pregnancy', 380, 'Gestational'), ('GO_0007567', 'parturition', 429, 'Birth'), ('GO_0007567', 'parturition', 468, 'Birth'), ('GO_0007567', 'parturition', 507, 'Birth'), ('UBERON_0000033', 'head', 513, 'head'), ('GO_0007567', 'parturition', 558, 'Birth'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 851, '25OHD'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('UBERON_0000948', 'heart', 883, 'Cord'), ('UBERON_0000178', 'blood', 888, 'blood'), ('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 894, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 900, 'D3levels'), ('GO_0007565', 'female pregnancy', 944, 'gestational')]
PMC5634602	10/2017	S95-PMC5634602	['bone health HAS long BEEN the primary ASSOCIATION with Vitamin D in infants and children.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5634602	10/2017	S116-PMC5634602	['reports of clinical EFFECTS from Vitamin D overdose in infants and children are quite RARE.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5634602	10/2017	S132-PMC5634602	['our dexa scan evaluation of these infants at term corrected age is an IMPORTANT INDICATOR of both short term and long-term benefits of improvement in Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC5638722	8/2017	S27-PMC5638722	['TO THE BEST OF OUR KNOWLEDGE, no study evaluated the ASSOCIATION between neonatal sepsis and Cord Blood Vitamin D levels in preterm infants910).']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5638722	8/2017	S94-PMC5638722	['cetinkaya et al.10)HAS SHOWN that, low maternal and neonatal Vitamin D levels are RELATED to eos of the newborn.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5638722	8/2017	S95-PMC5638722	['cizmeci at al.91011), SIMILARLY, EMPHASIZED that the maternal and Cord Blood Vitamin D levels are significantly low in the babies who have eos.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 33)]	2	[('UBERON_0002240', 'spinal cord', 66, 'cord'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5638722	8/2017	S96-PMC5638722	['we concluded that Vitamin D deficiency detected via the Blood taken from the Umbilical Cord MAY BE RELATED to increased rates of neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord')]
PMC5638722	8/2017	S130-PMC5638722	['but the maternal Vitamin D intake was FOUND to the SIMILAR in all 3 groups.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5659607	10/2017	S121-PMC5659607	['furthermore, taking advantage of these DIFFERENCES in the combined analysis by utilizing the measured 25(Oh)D levels at study entry, unmasked the most pronounced protective EFFECT of the Vitamin D intervention in women with 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 224, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 230, 'D')]
PMC5659607	10/2017	S150-PMC5659607	['it has already been shown that maternal Vitamin D status is ASSOCIATED with OTHER Immune-mediated diseases such as pre-eclampsia[34] and type i diabetes in the offspring[35].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC5664622	9/2017	S68-PMC5664622	['excessive weight gain was negatively CORRELATED with Vitamin D concentration in Venous and Cord Blood, and was lower by APPROXIMATELY 4.0 ng/ml (95% ci = [−7.96, −0.02]) in the mothers and by 5.7 ng/ml (95% ci = [−11.02, −0.41]) in their neonates as compared to normal weight gain ( p< 0.05).']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001638', 'vein', 80, 'venous'), ('UBERON_0009472', 'axilla', 91, 'cord blood')]
PMC5664622	9/2017	S80-PMC5664622	['who also CONFIRMED season-DEPENDENT variability in Vitamin D levels, with the highest values in summer and the lowest in winter [3,17].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 26)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5664622	9/2017	S115-PMC5664622	['THUS, we were unable to evaluate the RELATIONSHIP between Vitamin D levels and the development Of Gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0044477', 'envenomation resulting in negative regulation of platelet aggregation in other organism', 95, 'of GDM')]
PMC5664622	9/2017	S136-PMC5664622	['HOWEVER, that level does not apply to the overall EFFECT of Vitamin D on the course of Pregnancy and maternal health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5679631	11/2017	S12-PMC5679631	['difficile were ASSOCIATED with Vitamin D supplementation of Breast Fed infants whose mothers were more LIKELY to adhere to an alternative lifestyle in terms of, e .']	[('SUPERFICIAL_RELATIONSHIP', 15), ('PROBABLE_UNDERSTANDING', 103)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000310', 'breast', 60, 'breast'), ('GO_0007631', 'feeding behavior', 67, 'fed')]
PMC5679631	11/2017	S14-PMC5679631	['these data SUGGEST that Vitamin D INFLUENCES the abundance of several key bacterial taxa within the infant microbiota.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5679631	11/2017	S22-PMC5679631	['in addition, a study of sepsis patients DEMONSTRATED a positive ASSOCIATION between Vitamin D status and Plasma Cathelicidin concentrations [10].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('CHEBI_3364', 'Canthiumine', 112, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 112, 'cathelicidin')]
PMC5679631	11/2017	S84-PMC5679631	['the characteristics of the Breast Fed children were fairly SIMILAR between the children receiving Vitamin D supplementation and those who did not, except that mothers who were recruited in the conventional recruitment group were more LIKELY to give their child Vitamin D supplementation than those in the alternative recruitment group.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 234)]	2	[('GO_0007567', 'parturition', 27, 'breast fed'), ('UBERON_0000310', 'breast', 27, 'breast'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D')]
PMC5679631	11/2017	S135-PMC5679631	['in a cross sectional analysis of 98 Adults examining enterotype partitioning in RELATION to Nutrient Consumption (Food frequency questionnaire), Vitamin D supplement use and Vitamin D from dairy sources were found to be ASSOCIATED with enterotypes.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 220)]	2	[('UBERON_0007023', 'adult organism', 36, 'adults'), ('CHEBI_33284', 'nutrient', 92, 'nutrient'), ('GO_0007631', 'feeding behavior', 101, 'consumption'), ('CHEBI_33290', 'food', 114, 'food'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC5679631	11/2017	S137-PMC5679631	['HERE we report on an ASSOCIATION between Prenatal Vitamin D exposure and the abundance of several key bacterial taxa in the infant Intestinal microbiota.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('GO_0007565', 'female pregnancy', 41, 'prenatal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000160', 'intestine', 131, 'intestinal')]
PMC5697969	12/2017	S21-PMC5697969	['the IMPACTS of Micronutrient supplements, such as Iron and Folic Acid (ifa) (7), calcium (8), Vitamin A (9), and zinc (10), on maternal and child health outcomes are well DOCUMENTED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 171)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 15, 'micronutrient'), ('CHEBI_24870', 'ion', 50, 'iron'), ('CHEBI_30751', 'formic acid', 59, 'folic acid'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A')]
PMC5716389	9/2017	S43-PMC5716389	['there is NO INFORMATION on the ASSOCIATION between maternal Vitamin A status during Pregnancy and infant Immune Response.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0006955', 'immune response', 105, 'immune response'), ('UBERON_0002405', 'immune system', 105, 'immune')]
PMC5716389	9/2017	S46-PMC5716389	['fetal Vitamin D stores HAVE BEEN FOUND to be highly DEPENDENT on maternal nutritional levels [32].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC5732505	12/2017	S13-PMC5732505	['conclusions\nmaternal Vitamin D concentration was SIMILAR in mothers with and without gdm in a MOSTLY Vitamin D sufficient population.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 94)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5732505	12/2017	S14-PMC5732505	['ASSOCIATIONS between maternal Vitamin D status and Birth size were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 51, 'birth')]
PMC5732505	12/2017	S117-PMC5732505	['the PREVALENCE of Vitamin D deficiency [25(Oh)D\u2009<\u200950\xa0nmol/l] during Pregnancy was SIMILAR between mothers with or without gdm [4.9% (4/81) vs 3.3% (21/642), p \u2009=\u20090.51].']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5732505	12/2017	S140-PMC5732505	['in OUR STUDY, maternal Vitamin D concentrations were SIMILAR in non-gdm and gdm mothers, and there was no linear association between Vitamin D concentrations and ogtt results.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5732505	12/2017	S173-PMC5732505	['conclusion\nIN SUMMARY, maternal Vitamin D concentration was SIMILAR in mothers with and without gdm in a Vitamin D sufficient population.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC5736940	12/2017	S111-PMC5736940	['the EFFECTS of a healthy dietary pattern on reducing risk of gdm MAY BE due to a lower dietary energy density and Glycemic load and higher amount of fruits and vegetables rich in antioxidants and Phytochemicals, dietary fiber, and Micronutrients such as magnesium and Vitamin C [22,30].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65)]	2	[('GO_0006096', 'glycolytic process', 114, 'glycemic'), ('CHEBI_26254', 'prenylnaphthoquinone', 196, 'phytochemicals'), ('CHEBI_33839', 'macromolecule', 231, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin C')]
PMC5738092	12/2017	S14-PMC5738092	['in THIS PAPER, we illustrate the use of partial least squares (pls) regression analysis to quantify ASSOCIATIONS between materno-infant and household socioeconomic characteristics and multiple measures of newborn size, drawing on a large population cohort of infants whose mothers participated in a maternal Vitamin A and Beta-Carotene supplementation in rural, northern bangladesh [6].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 308, 'vitamin A'), ('CHEBI_17579', 'beta-carotene', 322, 'beta-carotene')]
PMC5738092	12/2017	S93-PMC5738092	['all the PREDICTORS except Vitamin A and Β-Carotene supplementation were significantly (p<0.05) CORRELATED with all the Birth size variables.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 40, 'β-carotene'), ('GO_0007567', 'parturition', 119, 'birth')]
PMC5758521	1/2018	S9-PMC5758521	['however, the Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life remain largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('FULL_UNKNOWN', 105)]	2	[('GO_0008152', 'metabolic process', 13, 'metabolic'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 55, 'E'), ('UBERON_0000104', 'life cycle', 85, 'life')]
PMC5758521	1/2018	S15-PMC5758521	['circulating Vitamin A and E concentrations HAVE BEEN inversely CORRELATED to adiposity and Insulin sensitivity in children11.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 20, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 26, 'E'), ('PR_000045358', 'insulin family protein', 91, 'insulin')]
PMC5784894	1/2018	S116-PMC5784894	['thus at greater age, the EFFECTS of antenatal Vitamin D depletion on response to loading were evident in Cortical bone ONLY, with bone volume fraction increasing approximately twice as much in the replete dams’ offspring.10.1371/journal.pone.0190675.g004\n\ncaption (fig): fig 4\n\nthe effect of diet and mechanical loading on Cortical (a) bone fraction, (b) bone volume and (c) and Marrow area at 18 weeks age.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 119)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001851', 'cortex', 105, 'cortical'), ('UBERON_0001851', 'cortex', 323, 'cortical'), ('UBERON_0002371', 'bone marrow', 379, 'marrow')]
PMC5812027	2/2018	S19-PMC5812027	['we have PREVIOUSLY SHOWN that higher Vitamin D status in late Pregnancy and larger increase in Vitamin D status during Pregnancy is ASSOCIATED with lower risk of Preeclampsia [3].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 162, 'preeclampsia')]
PMC5812027	2/2018	S33-PMC5812027	['our OBJECTIVES were to study the ASSOCIATIONS between Vitamin D status in both early and late Pregnancy, as well as change in Vitamin D status during Pregnancy with neonatal sga, lbw and Preterm Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 187, 'preterm'), ('GO_0007567', 'parturition', 195, 'delivery')]
PMC5812027	2/2018	S34-PMC5812027	['ASSOCIATIONS between Vitamin D status in early Pregnancy and Pregnancy loss WERE also STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC5812027	2/2018	S65-PMC5812027	['these groups were chosen to study WHETHER Vitamin D insufficiency (30–50\xa0nmol/l), sufficiency (≥\u200950\xa0nmol/l) or high status (≥\u200975 or ≥\u2009100\xa0nmol/l) was ASSOCIATED with the outcomes studied, COMPARED to Vitamin D deficiency (<\u200930\xa0nmol/l).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5812027	2/2018	S111-PMC5812027	['we also FOUND that lower Vitamin D status in early Pregnancy was RELATED to Pregnancy loss.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5812027	2/2018	S116-PMC5812027	['we have PREVIOUSLY SHOWN that the DETERMINANTS of season-corrected change in 25Ohd during Pregnancy include origin, sun-exposure and dietary as well as supplementary Vitamin D Intake [18].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 77, '25OHD'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007631', 'feeding behavior', 176, 'intake')]
PMC5812027	2/2018	S141-PMC5812027	['one earlier study, from denmark, FOUND that lower Vitamin D status in early Pregnancy was ASSOCIATED with Pregnancy loss in the first trimester [24].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC5812027	2/2018	S162-PMC5812027	['high Vitamin D status in late, BUT NOT early, Pregnancy was ASSOCIATED with lower odds of sga and lbw.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC5827025	2/2018	S9-PMC5827025	['in conclusion, pre-Pregnancy bmi, seasonality and multivitamin use are INFLUENT FACTORS of Gestational Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0007565', 'female pregnancy', 91, 'gestational'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5827025	2/2018	S78-PMC5827025	['a report DEMONSTRATED that socio-economic status INFLUENCES Gestational Vitamin D status26.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5827025	2/2018	S104-PMC5827025	['the PRESENT STUDY analyzed the ASSOCIATION between Vitamin D status during first- and second-Trimester and Preterm Delivery in chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 93, 'trimester'), ('GO_0007565', 'female pregnancy', 107, 'preterm'), ('GO_0007567', 'parturition', 115, 'delivery')]
PMC5838372	3/2018	S106-PMC5838372	['limited sun exposure, regular use of sunscreens, living in northern latitudes, dark skin, obesity, extensive clothing cover, Aging, poor nutritional status, malabsorption syndromes and Medications HAVE BEEN REPORTED as RISK FACTORS for Vitamin D deficiency (1,19).']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('GO_0007568', 'aging', 125, 'aging'), ('CHEBI_25441', 'mycothiols', 185, 'medications'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC5838372	3/2018	S119-PMC5838372	['when we evaluated the RELATIONSHIP between the infants’ Vitamin D level and their mothers’ clothing style, together with daily Vitamin D intake, we FOUND that there were no significant differences with respect to the mothers’ clothing style.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5941617	5/2018	S28-PMC5941617	['it is the BEST MARKER to monitor for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5941617	5/2018	S71-PMC5941617	['caption (table-wrap): table 4\n\nprevalence of hypovitaminosis d in healthy children and adolescents living in italystudyperiod of enrolmentnumberm (%)age (range or as specified)city/region (latitude)% overweight% obese% receiving Vitamin D% not caucasian25(Oh)D assaysevere deficiency, % [25(Oh)D\u2009<\u200910\xa0ng/ml]deficiency, % [25(Oh)D\u2009<\u200920\xa0ng/ml]insufficiency, % [25(Oh)D: 20–29.9\xa0ng/ml]hypovitaminosis D, % [25(Oh)D\u2009<\u200930\xa0ng/ml]FACTORS for ASSOCIATED with Serum 25(Oh)D levelslippi g et al.']	[('SUPERFICIAL_RELATIONSHIP', 423), ('SUPERFICIAL_RELATIONSHIP', 435)]	2	[('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 255, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 288, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 322, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 359, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 398, 'D'), ('CHEBI_71657', 'versiconol acetate', 404, '25(OH)D'), ('UBERON_0001977', 'blood serum', 451, 'serum'), ('CHEBI_71657', 'versiconol acetate', 457, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 457, '25 ... OH ... D')]
PMC5941617	5/2018	S115-PMC5941617	['SOME STUDIES evaluated the EFFECT of daily Vitamin D supplementation at variable dosages (ranging from 200 to 1600\xa0iu/day) on Vitamin D status in children during the first year of Life [52,62,97–107].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC5941617	5/2018	S128-PMC5941617	['infants Born at term without risk factors for Vitamin D deficiency SHOULD receive 400\xa0iu/day of Vitamin D, while in the presence of RISK factors for vitamin d deficiency (table\xa06) up to 1000\xa0iu/day of Vitamin D can be administered.']	[('FUTURE_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('GO_0007567', 'parturition', 8, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC5941617	5/2018	S139-PMC5941617	['in addition to optimize bone mineralization during fetal Life, Vitamin D status HAS BEEN ASSOCIATED with acute Respiratory morbidity in preterm infants Born <\u200932\xa0weeks Gestation [124].']	[('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('UBERON_0000104', 'life cycle', 57, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 111, 'respiratory'), ('GO_0007567', 'parturition', 152, 'born'), ('GO_0007565', 'female pregnancy', 168, 'gestation')]
PMC5941617	5/2018	S169-PMC5941617	['several international societies RECOMMENDED Vitamin D supplementation in children older than 1\xa0year and adolescents with RISK FACTORS for Vitamin D, such as reduced sun exposure or dark skin pigmentation [8,9,11,18,19,23,28,30,114].']	[('FUTURE_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 121)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC5941617	5/2018	S170-PMC5941617	['particularly, the espghan reinforced that first of all a healthy lifestyle ASSOCIATED with a normal body mass index and including a healthy diet with Vitamin D-containing foods and adequate outdoor activities SHOULD BE promoted in healthy children and adolescents [19].']	[('SUPERFICIAL_RELATIONSHIP', 75), ('FUTURE_WORK', 209)]	2	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC5941617	5/2018	S177-PMC5941617	['variation of sunlight efficacy in promoting skin Vitamin D Synthesis (DEPENDING ON season and latitude) and local factors RELATED to sunlight exposure (i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 49, 'vitamin D synthesis')]
PMC5941617	5/2018	S182-PMC5941617	['these data SUGGEST that wintry Vitamin D status DEPENDS ON the amount of Vitamin D produced and stored during the previous summer [181].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5941617	5/2018	S184-PMC5941617	['in the present consensus we RECOMMEND Vitamin D supplementation in children and adolescents with RISK FACTORS for Vitamin D deficiency (table\xa07), at doses ranging from 600\xa0iu/day (i.e.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5941617	5/2018	S189-PMC5941617	['continuous supplementation SHOULD BE reserved to children with permanent RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5941617	5/2018	S243-PMC5941617	['bone health\nbone mass acquisition is INFLUENCED by both genetics and lifestyle-related FACTORS, such as Vitamin D status, physical activity and Calcium intake [23,53].']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 144, 'calcium')]
PMC5941617	5/2018	S250-PMC5941617	['a FEW STUDIES evaluated the RELATIONSHIP between Vitamin D status and bone mass during this period of Life [52,62,97,104,201–203].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life')]
PMC5941617	5/2018	S254-PMC5941617	['INTERESTINGLY, higher Vitamin D status from infancy through to 3\xa0years of age was ASSOCIATED with leaner body composition [205].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC5941617	5/2018	S261-PMC5941617	['moreover, Vitamin D status was DEMONSTRATED to be a significant DETERMINANT of pbm in young Adults [214,215].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adults')]
PMC5941617	5/2018	S263-PMC5941617	['overall, meta-analysis SHOWED a non-significant EFFECT of Vitamin D supplementation on bmd at any site.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5941617	5/2018	S277-PMC5941617	['RECENTLY an english rct (mavidos) failed to demonstrate an EFFECT of maternal Vitamin D supplementation (1000\xa0iu/day from 14\xa0week of Gestation until Delivery) on offspring bone mass assessed within 2\xa0weeks of Birth by dxa.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'gestation'), ('GO_0007567', 'parturition', 149, 'delivery'), ('GO_0007567', 'parturition', 209, 'birth')]
PMC5941617	5/2018	S280-PMC5941617	['another smaller rct on 50 newborns FAILED TO demonstrate an EFFECT of Vitamin D supplementation during Pregnancy (2000\xa0iu/day from 26 to 28\xa0weeks until Childbirth) on infant bone mass measured at 23\u2009±\u200910\xa0days by dxa [234].']	[('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007623', 'circadian rhythm', 152, 'childbirth')]
PMC5941617	5/2018	S287-PMC5941617	['the LINK between SEVERE Vitamin D deficiency and susceptibility to Respiratory infections is prototypically represented by the high Respiratory morbidity in children with rickets [243,244].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 67, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5941617	5/2018	S294-PMC5941617	['also DEMONSTRATED that Cord Blood Vitamin D levels <\u200920\xa0ng/ml were ASSOCIATED with a sixfold (95% ci: 1.6–24.9) increased risk of Respiratory syncytial Virus lower Respiratory Tract infections in the first year of Life as compared with concentrations ≥30\xa0ng/ml [249].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('NCBITaxon_1', 'root', 152, 'virus'), ('UBERON_0000065', 'respiratory tract', 164, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 214, 'life')]
PMC5941617	5/2018	S322-PMC5941617	['in a large randomized study in afghanistan involving 3000 children with acute diarrhea Vitamin D supplementation HAS BEEN ASSOCIATED with improvement in clinical parameters [283].']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S324-PMC5941617	['the Vitamin D status CAN be INFLUENCED by the infection itself but also by Antiretroviral therapy.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 75, 'antiretroviral')]
PMC5941617	5/2018	S361-PMC5941617	['about the ROLE of Vitamin D in the immunopathogenesis of allergic skin diseases, Vitamin D induces the production of Antimicrobial Peptides, as Beta-Defensin and Cathelicidin, causing a reduction of the bacterial infections that MAY exacerbate asthma and atopic dermatitis (ad) [316,317].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 229)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 117, 'antimicrobial'), ('GO_0007565', 'female pregnancy', 131, 'peptides'), ('PR_000006033', 'cathepsin S', 144, 'beta-defensin'), ('PR_000006009', 'alpha-catulin', 162, 'cathelicidin')]
PMC5941617	5/2018	S362-PMC5941617	['not YET FULLY UNDERSTOOD is the ROLE of Vitamin D on Eosinophilic Airway inflammation.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CL_0000771', 'eosinophil', 53, 'eosinophilic'), ('UBERON_0001005', 'respiratory airway', 66, 'airway')]
PMC5941617	5/2018	S377-PMC5941617	['a meta-analysis SHOWED a significant ASSOCIATION between Vitamin D supplementation and reduction of asthma exacerbations (17% vs. 46%, p \u2009<\u20090.029) [334].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5941617	5/2018	S413-PMC5941617	['type 1 diabetes mellitus\nseveral epidemiological studies SUGGESTED that type 1 diabetes mellitus (t1dm) is ASSOCIATED with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5941617	5/2018	S435-PMC5941617	['a recent meta-analysis SHOWED that patients with crohn’s disease ( n \u2009=\u2009129808, age 11–48\xa0years) had lower Serum 25(Oh)D concentrations compared with healthy controls, with an overall prevalence of Vitamin D deficiency [25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] of 57.7% and an inverse CORRELATION between Serum 25(Oh)D levels and the severity of disease [399].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 265)]	2	[('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_63056', 'zinc cation', 113, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 119, 'D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('UBERON_0001977', 'blood serum', 285, 'serum'), ('CHEBI_71657', 'versiconol acetate', 291, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 291, '25(OH ... D')]
PMC5941617	5/2018	S456-PMC5941617	['the ROLE of Vitamin D as a therapeutic agent in ibd is still UNDER investigation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 61)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC5941617	5/2018	S480-PMC5941617	['two meta-analyses CONFIRMED that Vitamin D deficiency was ASSOCIATED with obesity in children, adolescents and Adults irrespective of age, latitude, and cut-offs used to define deficiency [439,440].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adults')]
PMC5941617	5/2018	S484-PMC5941617	['Animal models and in vitro studies report that Vitamin D MAY INFLUENCE both Pancreatic Insulin secretion and Insulin sensitivity in Skeletal muscle [446,447].']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001264', 'pancreas', 76, 'pancreatic'), ('PR_000045358', 'insulin family protein', 87, 'insulin'), ('PR_000045358', 'insulin family protein', 109, 'insulin'), ('UBERON_0004288', 'skeleton', 132, 'skeletal')]
PMC5941617	5/2018	S494-PMC5941617	['further, CONTRASTING results came from the studies investigating the ASSOCIATION between Vitamin D deficiency and non-alcoholic fatty Liver disease [451–453].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002107', 'liver', 134, 'liver')]
PMC5941617	5/2018	S515-PMC5941617	['MORE rcts ARE NEEDED to evaluate the INFLUENCE of Vitamin D supplementation on Controlling Metabolic syndrome.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0065007', 'biological regulation', 79, 'controlling'), ('GO_0008152', 'metabolic process', 91, 'metabolic')]
PMC5941617	5/2018	S521-PMC5941617	['several OBSERVATIONAL STUDIES have LINKED autism spectrum disorders and low Serum 25(Oh)D levels during Pregnancy because of Vitamin D pleiotropic activity [469–476].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5941617	5/2018	S533-PMC5941617	['FOUND no differences in Vitamin D status and bone density among adolescents AFFECTED by major depression and healthy controls [493].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S566-PMC5941617	['veiled women) and/or constant use of sunscreens• Malabsorption syndromes• chronic therapies AFFECTING Vitamin D Metabolism• obesity• risk of pre-eclampsia• Alcohol abuse• bone pain• hypocalcemia• a previous child with rickets• Pregnant adolescents\nin the present consensus we RECOMMEND Vitamin D supplementation in all Pregnant and breastfeeding women since the beginning of Pregnancy at a dose of 600\xa0iu/day.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 276)]	2	[('GO_0046661', 'male sex differentiation', 49, 'Malabsorption'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 102, 'vitamin D metabolism'), ('CHEBI_30879', 'alcohol', 156, 'Alcohol'), ('GO_0007565', 'female pregnancy', 227, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('GO_0007565', 'female pregnancy', 375, 'pregnancy')]
PMC5941617	5/2018	S567-PMC5941617	['women with RISK FACTORS for Vitamin D deficiency SHOULD receive higher dosages (1000–2000\xa0iu/day).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('FUTURE_WORK', 49)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5941617	5/2018	S612-PMC5941617	['supplementation SHOULD BE subsequently individualized in terms of regimen and duration on the basis of the presence of RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 119)]	2	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5941617	5/2018	S624-PMC5941617	['infants Born at term without risk factors for Vitamin D deficiency SHOULD receive 400\xa0iu/day of Vitamin D.\nin the presence of RISK FACTORS for Vitamin D deficiency (table\xa06) up to 1000\xa0iu/day of Vitamin D can be given.']	[('FUTURE_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('GO_0007567', 'parturition', 8, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S628-PMC5941617	['we SUGGEST to measure Serum 25(Oh)D levels in infants with multiple RISK FACTORS for Vitamin D deficiency (table\xa06).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 34, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5941617	5/2018	S633-PMC5941617	['1–18\xa0years\n\nwe RECOMMEND Vitamin D supplementation in children and adolescents with RISK FACTORS for Vitamin D deficiency (table\xa07).']	[('FUTURE_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5941617	5/2018	S641-PMC5941617	['we SUGGEST continuous Vitamin D supplementation in cases of permanent RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S647-PMC5941617	['we SUGGEST to measure Serum 25(Oh)D levels in presence of multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 28, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5941617	5/2018	S713-PMC5941617	['autism\n\nautistic Individuals frequently develop nutritional deficiencies, especially in presence of Food selectivity; causal RELATIONSHIP with Vitamin D deficiency is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 167)]	2	[('NCBITaxon_1', 'root', 17, 'individuals'), ('CHEBI_33290', 'food', 100, 'food'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5941617	5/2018	S716-PMC5941617	['depression\n\nepidemiological studies that evaluated an ASSOCIATION between Vitamin D deficiency and depression are lacking at PRESENT.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 125)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S722-PMC5941617	['women with RISK FACTORS for Vitamin D deficiency SHOULD receive higher dosages (1000–2000\xa0iu/day).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('FUTURE_WORK', 49)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5956785	5/2018	S15-PMC5956785	['AS an Immune and inflammatory Mediator, Vitamin D is IMPLICATED in the pathogenesis of Autoimmune diseases including, as examples, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, crohn’s disease, and chronic childhood arthritis [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002405', 'immune system', 6, 'immune'), ('CHEBI_35222', 'inhibitor', 30, 'mediator'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 87, 'autoimmune')]
PMC5956785	5/2018	S22-PMC5956785	['reports of RELATIONSHIPS between Vitamin D and chronic childhood arthritis are derived from studies having DIFFERENT methodologic approaches, originating from multiple geographic regions, and comprising demographically disparate populations.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5956785	5/2018	S63-PMC5956785	['these values are based on the institute of medicine (iom) review of published research focused on determining the OPTIMAL Vitamin D concentration for maximal calcium absorption, prevention of rickets, reduction of fracture risk and PREVENTION of osteomalacia in healthy populations [19].']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 232)]	2	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5956785	5/2018	S106-PMC5956785	['(1994) 37°n [47]jra n \u2009=\u200944 (28)11.8\u2009±\u20093.866.6\u2009±\u200926.7lower bone Mineral content and bone BIOMARKERS in jra patients that controls BUT higher Vitamin D in jra.n\u2009=\u200937 controls 25(Oh)D 53.2\u2009±\u200918.7\xa0nmol/l.milano, italy bianchi et al.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('ANOMALY_CURIOUS_FINDING', 130)]	2	[('CHEBI_46662', 'mineral', 64, 'mineral'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 174, '25(OH ... D')]
PMC5956785	5/2018	S188-PMC5956785	['active disease or frequent relapse was ASSOCIATED with reduced Vitamin D status COMPARED TO patients with no active disease or frequent flare-ups.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5956785	5/2018	S277-PMC5956785	['further, the RELATIONSHIP between Vitamin D status and disease activity in children with jia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC5956785	5/2018	S282-PMC5956785	['the RELATIONSHIP between Vitamin D status and jia over time in newly diagnosed Individuals has YET to be investigated.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 95)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_1', 'root', 79, 'individuals')]
PMC5995352	6/2018	S145-PMC5995352	['covariates\nCord 25Ohd was RELATED with season of Birth, maternal ethnicity, pre-Gestational bmi, parity, maternal Vitamin D supplementation and smoking in Pregnancy, which is CONSISTENT with the literature [33–35].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 175)]	2	[('UBERON_0000948', 'heart', 11, 'Cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 16, '25OHD'), ('GO_0007567', 'parturition', 49, 'birth'), ('GO_0007565', 'female pregnancy', 80, 'gestational'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy')]
PMC5995352	6/2018	S148-PMC5995352	['IN KEEPING WITH our results, longitudinal growth trajectories at age seven months were SIMILAR in Breast vs. formula Fed infants in an american cohort studying maternal Vitamin D supplementation during Lactation [37].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('UBERON_0000310', 'breast', 98, 'breast'), ('GO_0007631', 'feeding behavior', 117, 'fed'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007595', 'lactation', 202, 'lactation')]
PMC6011374	6/2018	S0-PMC6011374	['Vitamin D levels in an australian and new zealand cohort and the ASSOCIATION with Pregnancy outcome\n\nabstract\n\nbackground\nPregnant women are at INCREASED SUSCEPTIBILITY to Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 144)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007565', 'female pregnancy', 122, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC6011374	6/2018	S22-PMC6011374	['there are numerous studies which HAVE SHOWN that Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes (most recent: [14–17]), particularly in populations that reside at higher latitudes.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC6011374	6/2018	S50-PMC6011374	['given that the month in which the Serum was sampled heavily INFLUENCES Vitamin D status, “standardised” Serum 25(Oh)D concentrations were calculated as previously described [34] in order to normalise against seasonal VARIATION.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('DIFFICULT_TASK', 217)]	2	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
PMC6011374	6/2018	S89-PMC6011374	['this was independent of diet and lifestyles factors including bmi and sei and highlights the DIFFICULTY in understanding the ROLE of Vitamin D in Pregnancy in Human cohort studies.']	[('DIFFICULT_TASK', 93), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC6011374	6/2018	S90-PMC6011374	['HOWEVER, there was a protective ASSOCIATION of having high Vitamin D at 15\u2009±\u20091\xa0weeks’ Gestation and gdm once standardised based on month Serum was sampled.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('UBERON_0001977', 'blood serum', 137, 'serum')]
PMC6011374	6/2018	S112-PMC6011374	['indeed many of the studies that have assessed the ASSOCIATION between Vitamin D status and adverse Pregnancy outcome that have reported statistically significant differences HAVE BEEN in populations with higher rates of Vitamin D deficiency [2,4].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 174)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC6039335	7/2018	S156-PMC6039335	['nutritional factors\nseveral nutritional factors including Fat Metabolism, fat Digestion and absorption, Glucose/Starch availability, roughage vs. concentrate ratio, dietary energy and protein levels, Vitamins A, d, and c levels, fetal nutritional programming, and stage-specific Feeding systems CAN AFFECT imf deposition.']	[('INCOMPLETE_EVIDENCE', 295), ('SUPERFICIAL_RELATIONSHIP', 299)]	2	[('GO_0006631', 'fatty acid metabolic process', 58, 'fat metabolism'), ('GO_0007586', 'digestion', 78, 'digestion'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('CHEBI_28017', 'starch', 112, 'starch'), ('CHEBI_27300', 'vitamin D', 200, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 209, 'A'), ('GO_0007631', 'feeding behavior', 279, 'feeding')]
PMC6039335	7/2018	S262-PMC6039335	['oka et al [134] RECOMMENDED selective restriction of dietary Vitamin A from 14 to 22 or 25 months of age to improve ms and qg without adverse health effects (blindness, arthritis, and muscular edema), given the EFFECT of Vitamin A restriction from 23 months of age in improving ms is minimal.']	[('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 211)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A')]
PMC6039335	7/2018	S275-PMC6039335	['they concluded that the tt genotype of adh1c c.-64t>c is RELATED to greater imf than the cc genotype when Vitamin A is restricted, and adh1c c.-64t>c COULD BE a Genetic marker for enhancing marbling in feedlot steers.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 150)]	2	[('CHEBI_27300', 'vitamin D', 106, 'vitamin A'), ('SO_0000704', 'gene', 161, 'genetic')]
PMC6039335	7/2018	S282-PMC6039335	['WHILE Vitamin A restriction improves marbling, but Vitamin D restriction did not significantly AFFECT marbling in angus crossbred steers [133].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC6043562	7/2018	S117-PMC6043562	['two other Prenatal Nutrients with immunomodulatory potential, N-3 polyunsaturated Fatty Acids and Vitamin D, were also ASSOCIATED with lower Feno levels in OUR STUDY.']	[('SUPERFICIAL_RELATIONSHIP', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	2	[('GO_0007565', 'female pregnancy', 10, 'prenatal'), ('CHEBI_33284', 'nutrient', 19, 'nutrients'), ('CHEBI_30256', 'thiocarbonyl group', 62, 'n-3'), ('CHEBI_35366', 'fatty acid', 82, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
PMC1448690	4/2006	S297-PMC1448690	['in a study of Adult-onset wheeze in aberdeen, intakes of Vitamin E and Plasma levels of Ascorbate (a measure of vitamin c) were inversely RELATED to Adult wheeze in the manual social class and among current smokers [175].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('UBERON_0007023', 'adult organism', 14, 'adult'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 71, 'plasma'), ('CHEBI_22651', 'ascorbate', 88, 'ascorbate'), ('UBERON_0007023', 'adult organism', 149, 'adult')]
PMC1448690	4/2006	S302-PMC1448690	['in a separate study, the lowest intake of Vitamin E was ASSOCIATED with a fivefold increase in Adult-onset wheezy illness, while the lowest intake of vitamin c doubled the risk.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
PMC2396486	6/2008	S10-PMC2396486	['conclusions\ndevelopmental Vitamin D deficiency was ASSOCIATED with subtle changes in protein Expression in the nucleus accumbens.']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0010467', 'gene expression', 93, 'expression')]
PMC2396486	6/2008	S131-PMC2396486	['in conclusion, developmental Vitamin D deficiency is ASSOCIATED with subtle changes in a range of proteins in the nucleus accumbens.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC2581757	11/2008	S0-PMC2581757	['ROLE of Vitamins C and e in Regulating antioxidant and pro-oxidant markers in Preeclampsia\n\nabstract\nwe compared three groups of Pregnant women: placebo with normotensive women, group a which included preeclamptics, and group b which comprised preeclamptics who were supplemented their diets with Vitamins C and e. Mda increased from 6.22\xa0±\xa02.8 (Placebo) to 8.48\xa0±\xa01.2 (a) and 8.02\xa0±\xa01.8\xa0nmol/ghb (b).']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27306', 'vitamin B6', 8, 'Vitamins C'), ('PR_000027594', 'histone H3', 8, 'Vitamins C'), ('GO_0065007', 'biological regulation', 28, 'Regulating'), ('GO_0007128', 'meiotic prophase I', 78, 'Preeclampsia'), ('GO_0007565', 'female pregnancy', 129, 'pregnant'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('CHEBI_34840', 'methyl methacrylate', 315, 'MDA'), ('CHEBI_26130', 'biological pigment', 346, 'placebo')]
PMC2581757	11/2008	S8-PMC2581757	['the Vitamin C content in both mild and severe preeclamptics was found to decrease significantly [3] in ASSOCIATION with enhanced peroxidation [4] and lowered Thiol levels [5].']	[('SUPERFICIAL_RELATIONSHIP', 103)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin C'), ('CHEBI_29917', 'thiol group', 158, 'thiol')]
PMC2582131	11/2008	S9-PMC2582131	['after adjustment for the aforementioned covariates including bmi, Vitamin D deficiency was ASSOCIATED with a 2.66-fold (or (95% ci): 2.66 (1.01–7.02)) increased gdm risk.']	[('SUPERFICIAL_RELATIONSHIP', 91)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC2582131	11/2008	S15-PMC2582131	['for instance, in both Animal and Human studies, Vitamin D depletion was significantly RELATED to Insulin resistance and impaired Insulin secretion.']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('NCBITaxon_33208', 'Metazoa', 22, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000045358', 'insulin family protein', 97, 'insulin'), ('PR_000045358', 'insulin family protein', 129, 'insulin')]
PMC2679409	5/2009	S491-PMC2679409	['3 rcts included.assessed the IMPACT on Pregnancy outcomes of Vitamin A supplementation +/- multivitamins (intervention #1), compared to supplementation with placebo +/- multivitamins (controls).']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin A')]
PMC2679409	5/2009	S492-PMC2679409	['also assessed the IMPACT of Vitamin A + iron + Folate (intervention #2) vs. iron + Folate (controls).sbr: rr = 1.04 (95% ci: 0.60–1.79) [ns] in those supplemented with Vitamin A (+/- multivitamins) vs. those supplemented with Placebo (+/- multivitamins)[1 rct, n = 11723 women]sbr: rr = 1.26 (95% ci: 0.53–3.01) [ns] in those supplemented with Vitamin A + iron + Folate vs. those supplemented with Iron + Folate [2 rcts, n = 940 women]van den broek et al.']	[('SUPERFICIAL_RELATIONSHIP', 18)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 47, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 83, 'folate'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin A'), ('CHEBI_26130', 'biological pigment', 226, 'placebo'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 363, 'folate'), ('CHEBI_24870', 'ion', 398, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 405, 'folate')]
PMC2679409	5/2009	S494-PMC2679409	['1 rct included.assessed the IMPACT on Pregnancy outcomes of Vitamin A (intervention #1) and/or Β-Carotene (intervention #2) supplementation vs. placebo (controls).Fetal death: rr = 1.04 (95% ci: 0.92–1.17) [ns] in women receiving Vitamin A vs. controls, respectively.Fetal death: rr = 1.03 (95% ci: 0.91–1.16) [ns] in women receiving Β-Carotene vs. controls, respectively.wiysonge et al.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 95, 'β-carotene'), ('GO_0008618', '7-methylguanosine metabolic process', 163, 'Fetal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin A'), ('GO_0008618', '7-methylguanosine metabolic process', 267, 'Fetal'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 334, 'β-carotene')]
PMC2679409	5/2009	S496-PMC2679409	['4 rcts included.compared the IMPACT on Pregnancy outcomes of Vitamin A supplementation (intervention) vs. no Vitamin A supplementation (controls).sbr: or = 0.99 (95% ci: 0.67–1.46) [ns] .']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A')]
PMC2679409	5/2009	S697-PMC2679409	['2005 meta-analysis: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 20)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 59, 'stillbirth'), ('GO_0036268', 'swimming', 74, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 74, 'perinatal')]
PMC2679409	5/2009	S702-PMC2679409	['2002 review: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 52, 'stillbirth'), ('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal')]
PMC2679409	5/2009	S707-PMC2679409	['2005 meta-analysis: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 20)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 59, 'stillbirth'), ('GO_0036268', 'swimming', 74, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 74, 'perinatal')]
PMC2841444	2/2010	S333-PMC2841444	['Preterm Birth\na systematic review of four rcts comparing the use of Vitamin A with Placebo in hiv-positive Pregnant women did not show significant EFFECTS on maternal-to-Child hiv Transmission (or 1.06; 95% ci 0.89-1.26) or Preterm Birth (rr 0.88, 95% ci 0.65-1.19).']	[('SUPERFICIAL_RELATIONSHIP', 147)]	1	[('GO_0007565', 'female pregnancy', 0, 'Preterm birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_26130', 'biological pigment', 83, 'placebo'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('GO_0021863', 'forebrain neuroblast differentiation', 169, '-child ... transmission'), ('GO_0007565', 'female pregnancy', 224, 'preterm birth')]
PMC2841444	2/2010	S487-PMC2841444	['neonatal Vitamin A supplementation among preterm infants was ASSOCIATED with a nonsignificant reduction in infant mortality at 6 months of age (rr 0.87; 95% ci 0.65, 1.17).']	[('SUPERFICIAL_RELATIONSHIP', 61)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC2841444	2/2010	S496-PMC2841444	['antenatal Vitamin K was ASSOCIATED with a nonsignificant reduction in all grades of pvh (rr 0.82, 95% confidence interval (ci) 0.67-1.00) and in severe pvh (grades 3 and 4) (rr 0.75, 95% ci 0.45-1.25) for babies receiving Prenatal Vitamin K compared with control babies.']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin K'), ('GO_0007565', 'female pregnancy', 222, 'prenatal'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin K')]
PMC2872349	4/2010	S3-PMC2872349	['maternal lifestyle, body build and 25(Oh) Vitamin D status PREDICT offspring bone mass.']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('CHEBI_30778', 'gallic acid', 35, '25(OH)'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC2872349	4/2010	S90-PMC2872349	['lower concentrations of Serum 25(Oh) Vitamin D in mothers during late Pregnancy were also ASSOCIATED with reduced Whole-body and Lumbar Spine bmc in children at age 9 years [40].']	[('SUPERFICIAL_RELATIONSHIP', 90)]	1	[('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_30778', 'gallic acid', 30, '25(OH)'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0007688', 'anlage', 114, 'whole'), ('UBERON_0006074', 'lumbar region of vertebral column', 129, 'lumbar spine')]
PMC2872349	4/2010	S91-PMC2872349	['maternal Vitamin D status was statistically significantly ASSOCIATED with childhood bone area, and areal bmd.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC2872349	4/2010	S92-PMC2872349	['estimated exposure to ultraviolet b radiation during late Pregnancy (p < 0.0001) and the maternal use of Vitamin D supplements (p = 0.01) both PREDICTED maternal 25(Oh) Vitamin D concentration, and childhood bone mass (p = 0.03).']	[('SUPERFICIAL_RELATIONSHIP', 143)]	1	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 162, '25(OH)'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC2889879	5/2010	S96-PMC2889879	['additionally, there is a high CORRELATION between Vitamin D and Omega-3 Fatty Acids (correlation = 0.77).']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 64, 'omega-3 fatty acids')]
PMC2898025	5/2010	S108-PMC2898025	['levels of Vitamin D are known to fluctuate depending on sunlight exposure, which is highest in the summer for the northern hemisphere and TENDS to increase for latitudes nearer the equator [145,148–150].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 18, 'D')]
PMC2963768	10/2010	S124-PMC2963768	['Vitamin A (41)\nGenetic polymorphisms in Genes encoding proteins INVOLVED in Vitamin D Metabolism, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamin A'), ('SO_0000704', 'gene', 15, 'Genetic'), ('SO_0000704', 'gene', 40, 'genes'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 76, 'vitamin D metabolism')]
PMC2996405	11/2010	S108-PMC2996405	['finally, we found 9 Genes ( Smarca2, Mitf , Dlgap1 , Magi1 , Il4R , Ntrk3 , Runx1 , Ppp3Ca , and Inpp4B ) in common among those ones RELATED to latitude, Vitamin D and schizophrenia (figure1).']	[('SUPERFICIAL_RELATIONSHIP', 133)]	1	[('SO_0000704', 'gene', 20, 'genes'), ('PR_000000364', 'smad2', 28, 'SMARCA2'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 37, 'MITF'), ('PR_000006560', 'dynein heavy chain 14, axonemal', 44, 'DLGAP1'), ('PR_000010068', 'melanoma-associated antigen B3', 53, 'MAGI1'), ('PR_000001470', 'interleukin-28B', 61, 'IL4R'), ('PR_000011459', 'neurotrophin-3', 68, 'NTRK3'), ('PR_000014339', 'radial spoke head 14 homolog', 76, 'RUNX1'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 84, 'PPP3CA'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 97, 'INPP4B'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2996405	11/2010	S148-PMC2996405	['the cutaneous Synthesis Of Vitamin D is a function of skin pigmentation and of the Solar Zenith angle which, in turn, DEPENDS ON latitude, season, and time of day [49].']	[('SUPERFICIAL_RELATIONSHIP', 118)]	1	[('GO_0030474', 'spindle pole body duplication', 14, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0003655', 'molar tooth', 83, 'solar zenith')]
PMC2996405	11/2010	S190-PMC2996405	['Swi/Snf Components and Dna Replication-related factors form, in turn, a Human multiprotein Complex (winac) that directly INTERACTS with Vitamin D receptor [69].']	[('SUPERFICIAL_RELATIONSHIP', 121)]	1	[('GO_0070603', 'SWI/SNF superfamily-type complex', 0, 'SWI/SNF components'), ('GO_0006260', 'DNA replication', 23, 'DNA replication'), ('NCBITaxon_9606', 'Homo sapiens', 72, 'human'), ('GO_0032991', 'protein-containing complex', 91, 'complex'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC2996405	11/2010	S266-PMC2996405	['the list of Vitamin D related Genes was manually created by merging three different lists of Genes RELATED in different ways to Vitamin D (additional file4).']	[('SUPERFICIAL_RELATIONSHIP', 99)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('SO_0000704', 'gene', 30, 'genes'), ('SO_0000704', 'gene', 93, 'genes'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3004407	12/2010	S61-PMC3004407	["participants were categorized as Vitamin D deficient, insufficient, or sufficient as described above; the associations between Vitamin D category and PREDICTIVE factors were evaluated using the chi-square test or fisher's exact test (categorical predictors) and logistic regression (continuous predictors and/or multivariable models)."]	[('SUPERFICIAL_RELATIONSHIP', 150)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC3032617	5/2010	S25-PMC3032617	['intakes of 2-3g/day of Vitamin C produce unpleasant diarrhea from the osmotic EFFECTS of the unabsorbed Vitamin in the Intestinal lumen in most People [13].']	[('SUPERFICIAL_RELATIONSHIP', 78)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 104, 'vitamin'), ('UBERON_0000160', 'intestine', 119, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 144, 'people')]
PMC3034879	12/2010	S0-PMC3034879	['maternal Vitamin D status AFFECTS bone growth in early childhood—a prospective cohort study\n\nabstract\n\nsummary\nin this prospective study, 87 children were followed up from Birth to 14\xa0months with data on maternal Vitamin D status during the Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy')]
PMC3034879	12/2010	S19-PMC3034879	['low maternal Vitamin D status or inadequate dietary Vitamin D intake during Pregnancy PREDISPOSES children to asthma and allergic rhinitis [6], diabetes [7], acute lower respiratory infection [8], and impaired bone mass accrual.']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC3034879	12/2010	S100-PMC3034879	['the total intake of Vitamin D CORRELATED positively with 25-Ohd concentration in the whole cohort ( r \u2009=\u20090.301, p \u2009=\u20090.005) and in high d ( r \u2009=\u20090.505, p \u2009<\u20090.001), but not in low d ( r \u2009=\u20090.219, p \u2009=\u20090.168) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 57, '25-OHD')]
PMC3034879	12/2010	S104-PMC3034879	['higher dietary intake of Vitamin D and use of d3supplements were RELATED to improved Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 65)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3034879	12/2010	S106-PMC3034879	['1\n\ntotal intake of Vitamin D CORRELATED positively with Serum 25-Ohd in high D ( r \u2009=\u20090.505, p \u2009<\u20090.001), but not in low d ( r \u2009=\u20090.219, p \u2009=\u20090.168).']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_72765', 'verruculogen', 62, '25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 77, 'D')]
PMC3099599	5/2011	S156-PMC3099599	['protracted labor, Pelvic dystocia, the use of Oxytocin, prematurity, macrosomy, forceps or vacuum extraction Delivery, and Vitamin D deficiency (discussed below) are significant RISK FACTORS for excess compression of the Skull, deformation and Dural damage and sdh.']	[('SUPERFICIAL_RELATIONSHIP', 178)]	1	[('UBERON_0002108', 'small intestine', 18, 'pelvic'), ('CHEBI_7872', 'oxytocin', 46, 'oxytocin'), ('GO_0007567', 'parturition', 109, 'delivery'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0003129', 'skull', 221, 'skull'), ('UBERON_0002364', 'tympanic membrane', 244, 'dural')]
PMC3103150	3/2011	S15-PMC3103150	['Vitamin D in Breast Milk RELATES to mothers’ Vitamin D intake, skin pigmentation and sunlight exposure3.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 13, 'breast milk'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3103150	3/2011	S20-PMC3103150	['the seasonal difference in Vitamin D concentration in infants and Lactating mothers, prevalence of radiological rickets among those infants with biochemical Vitamin D deficiency and FACTORS that can predict the Vitamin D concentration in infants have not been reported from india.']	[('SUPERFICIAL_RELATIONSHIP', 182)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 66, 'lactating'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC3103150	3/2011	S75-PMC3103150	['the prevalence of the biochemical MARKERS of Vitamin D deficiency in infants and mothers is presented intable ii.']	[('SUPERFICIAL_RELATIONSHIP', 34)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3103150	3/2011	S130-PMC3103150	['maternal Vitamin D status, intake of Vitamin supplement by infant and exposure to sunlight were positively CORRELATED with infants’ 25Ohd concentration.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 37, 'vitamin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 132, '25OHD')]
PMC3120197	7/2011	S76-PMC3120197	['Heme iron intake was positively ASSOCIATED with saturated fat, trans fat, red and processed meats, poultry meat, fruits, vegetables, and Vitamin C intake.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_46756', 'HEPES', 0, 'Heme'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin C')]
PMC3171895	9/2011	S143-PMC3171895	['Vitamin E ( Α -Tocopherol) is a Lipid-soluble Vitamin acting with the Lipid Membrane and with synergistic INTERACTIONS with Vitamin C [128] (figure 3).']	[('SUPERFICIAL_RELATIONSHIP', 106)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('CHEBI_27725', 'butin', 12, 'α -tocopherol'), ('CHEBI_18059', 'lipid', 32, 'lipid'), ('CHEBI_33229', 'vitamin (role)', 46, 'vitamin'), ('CHEBI_18059', 'lipid', 70, 'lipid'), ('GO_0097232', 'lamellar body membrane', 70, 'lipid membrane'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C')]
PMC3257641	3/2010	S39-PMC3257641	['the prevalence of low Vitamin D status during Pregnancy\nas noted above, Vitamin D adequacy DEPENDS on both endogenous, uv-induced synthesis, and exogenous sources, i.e., diet and Supplements.']	[('SUPERFICIAL_RELATIONSHIP', 91)]	1	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 179, 'supplements')]
PMC3257641	3/2010	S81-PMC3257641	['there was a positive CORRELATION between the maternal 25(Oh)D level and the Fetal Metaphyseal cross-sectional area, with the latter 5% and 14% greater in fetuses of mothers who were Vitamin D insufficient (Serum 25(Oh)D 25-50 nmol/l) and Vitamin D deficient (Serum 25(Oh)D < 25 nmol/l) compared to Vitamin D sufficient mothers (Serum 25(Oh)D > 50 nmol/l) [56].']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('UBERON_0000922', 'embryo', 76, 'fetal'), ('UBERON_0001438', 'metaphysis', 82, 'metaphyseal'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 218, 'D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0001977', 'blood serum', 259, 'serum'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 265, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D'), ('UBERON_0001977', 'blood serum', 328, 'serum'), ('CHEBI_71657', 'versiconol acetate', 334, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 334, '25(OH)D')]
PMC3257641	3/2010	S111-PMC3257641	['bone health\nmaternal Vitamin D status INFLUENCES bone health in the offspring [76].']	[('SUPERFICIAL_RELATIONSHIP', 38)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC3257641	3/2010	S133-PMC3257641	['in a finnish Birth cohort study, regular Vitamin D supplementation (maternal self-report) during the first year of offspring Life was ASSOCIATED with a reduced risk of schizophrenia in males (but not females) (rr = 0.08, 95% ci 0.01–0.95) [106].']	[('SUPERFICIAL_RELATIONSHIP', 134)]	1	[('GO_0007567', 'parturition', 13, 'birth'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 125, 'life')]
PMC3257641	3/2010	S149-PMC3257641	['insufficient trials have occurred for Vitamin D supplementation in RELATION to specific clinical outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 67)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3271033	1/2012	S109-PMC3271033	['supplementation with 400 iu/day of Vitamin D to these infants LED TO a relatively greater increase in those who were Born with the lowest Vitamin D status and there was no suggestion of any bone Mineral outcome deficits at one week or three months of age in infants with low Cord 25(Oh)D levels.']	[('SUPERFICIAL_RELATIONSHIP', 62)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002240', 'spinal cord', 275, 'cord'), ('CHEBI_71657', 'versiconol acetate', 280, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 280, '25(OH)D')]
PMC3276895	11/2011	S14-PMC3276895	['[1]\nFolic Acid (Fa) is a Water-soluble Vitamin B which serves as a Cofactor in many enzymatic reactions RELATED to growth and development, Neuronal function, and Blood Cell production.']	[('SUPERFICIAL_RELATIONSHIP', 104)]	1	[('CHEBI_30751', 'formic acid', 4, 'Folic acid'), ('CHEBI_30751', 'formic acid', 16, 'FA'), ('CHEBI_15377', 'water', 25, 'water'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin B'), ('CHEBI_23357', 'cofactor', 67, 'cofactor'), ('CL_0000540', 'neuron', 139, 'neuronal'), ('CL_0000081', 'blood cell', 162, 'blood cell'), ('UBERON_0000178', 'blood', 162, 'blood')]
PMC3277098	12/2011	S7-PMC3277098	['within the body Vitamin D acts as a hormone and is well recognized for its ROLE in Calcium and Phosphorus Homeostasis and Skeletal health.']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 83, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 95, 'phosphorus'), ('GO_0042592', 'homeostatic process', 106, 'homeostasis'), ('UBERON_0004288', 'skeleton', 122, 'skeletal')]
PMC3277098	12/2011	S28-PMC3277098	['lifestyle patterns and environments that do not facilitate adequate sun exposure (indoor occupation, “screen time” and active sun avoidance) PREDISPOSE to inadequate Vitamin D synthesis and status.']	[('SUPERFICIAL_RELATIONSHIP', 141)]	1	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC3277098	12/2011	S33-PMC3277098	['the developing foetus depends entirely on its mother for supply of 25(Oh)D and poor maternal Vitamin D status is REFLECTED in the infant at Birth [23].']	[('SUPERFICIAL_RELATIONSHIP', 113)]	1	[('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0007567', 'parturition', 140, 'birth')]
PMC3277098	12/2011	S34-PMC3277098	['in non-supplemented infants serum 25(Oh)D status TENDS to decrease over the first few months of Life until sun exposure is increased and Vitamin D-containing Foods introduced into the diet.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('UBERON_0000104', 'life cycle', 96, 'life'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_33290', 'food', 158, 'foods')]
PMC3277098	12/2011	S90-PMC3277098	['in addition to transporting Vitamin D in circulation, Vdbp has anti-inflammatory and immunomodulatory functions including EFFECTS on Macrophage Activation.']	[('SUPERFICIAL_RELATIONSHIP', 122)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000017279', 'testis-specific basic protein Y 1', 54, 'VDBP'), ('CL_0000235', 'macrophage', 133, 'macrophage'), ('GO_0042116', 'macrophage activation', 133, 'macrophage activation')]
PMC3277098	12/2011	S107-PMC3277098	['maternal Vitamin D intake during Pregnancy (assessed by Food frequency questionnaires), is reported to be inversely ASSOCIATED with wheeze [49,50,51], allergic rhinitis and asthma [6].']	[('SUPERFICIAL_RELATIONSHIP', 116)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_33290', 'food', 56, 'food')]
PMC3277098	12/2011	S117-PMC3277098	['basing their “recurrent wheeze” classification on the asthma predictive index, the authors report a significant inverse ASSOCIATION between Antenatal dietary and supplemental Vitamin D intake and the risk of ever having wheeze or having recurrent wheeze symptoms.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007567', 'parturition', 140, 'antenatal'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC3277098	12/2011	S190-PMC3277098	['the increase in relative risk of atopic dermatitis (ad) was 18% per 1 µg/day increase in Vitamin D intake, and a high Vitamin D Intake was a stronger PREDICTOR of ad than was family history of atopy.']	[('SUPERFICIAL_RELATIONSHIP', 150)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007631', 'feeding behavior', 128, 'intake')]
PMC3296991	2/2012	S9-PMC3296991	['in teens and Adults, Parathyroid hormone (pth) and bone specific alkaline phosphatase (balp) are elevated in Vitamin D deficiency and are ASSOCIATED with enhanced bone turnover [2,3].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('UBERON_0007023', 'adult organism', 13, 'adults'), ('UBERON_0001132', 'parathyroid gland', 21, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3296991	2/2012	S48-PMC3296991	['statistical analysis\nmeasurement of infant wbbmc by dxa in the present study was conducted as a secondary outcome in a comprehensive study estimating prevalence, PREDICTORS, and consequences of Vitamin D status during Pregnancy [18].']	[('SUPERFICIAL_RELATIONSHIP', 162)]	1	[('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
PMC3313761	3/2012	S23-PMC3313761	['higher Prenatal Vitamin D levels are shown to have a protective ROLE against wheezing in young children in epidemiological studies.']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('GO_0007565', 'female pregnancy', 7, 'prenatal'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC3313761	3/2012	S24-PMC3313761	['[5] the above observations highlight the fact that Vitamin D has a key ROLE to play in the pathogenesis of wheezing/asthma.']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3347007	4/2012	S12-PMC3347007	['during Pregnancy, Vitamin D is transported from mother to fetus through the Placenta in the form of 25(Oh)D which is also the established MARKER of Vitamin D status [1,3,4].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0001987', 'placenta', 76, 'placenta'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3347007	4/2012	S13-PMC3347007	['at Birth, there is a CORRELATION between maternal and child Vitamin D concentrations, where the concentration in the Umbilical Cord Blood is around 80% of maternal Blood concentration [4,5].']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('GO_0007567', 'parturition', 3, 'birth'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 117, 'umbilical cord'), ('UBERON_0000178', 'blood', 132, 'blood'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC3347007	4/2012	S96-PMC3347007	['a statistically-significant direct ASSOCIATION was seen between sufficient total Vitamin D intake and maternal age.']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC3347007	4/2012	S97-PMC3347007	['adjustment for pre-Pregnancy bmi, parity, civil status, socio-occupational status, physical activity level, season of filling out the ffq, smoking and alcohol use during Pregnancy, total energy intake, and Planning Of Pregnancy made the direct ASSOCIATION between maternal age and sufficient total Vitamin D intake stronger.']	[('SUPERFICIAL_RELATIONSHIP', 244)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy'), ('GO_0006915', 'apoptotic process', 206, 'planning of pregnancy'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC3347007	4/2012	S98-PMC3347007	['a statistically-significant inverse ASSOCIATION was seen between sufficient total Vitamin D intake and parity and number of cigarettes daily.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3347007	4/2012	S103-PMC3347007	['this ASSOCIATION was weakened a little by adjustment for relevant covariates.nutrients-04-00259-t004_table 4\n\ncaption (table-wrap): table 4\n\ndeterminants of sufficient total Vitamin D intake (≥10 µg per day) vs. insufficient total Vitamin D intake (<10 µg per day) ( n = 58,763) *.sufficient total Vitamin D intake n or (95% ci) crudeor (95% ci) adjusted ** p *** age<0.0001age < 208290.8 (0.7, 0.9)0.7 (0.6, 0.8)20 ≤ age < 2510,2371.0 (1.0, 1.1)0.9 (0.9, 1.0)25 ≤ age < 3026,5181.0 (ref.']	[('SUPERFICIAL_RELATIONSHIP', 5)]	1	[('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC3347007	4/2012	S165-PMC3347007	['we found a significant ASSOCIATION between season and Vitamin D intake of at least 10 µg per day where filling out the ffq during summer or fall had higher ors than filling out the ffq during spring or winter.']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC3347028	3/2012	S150-PMC3347028	['they reported with every additional 40 iu (1 μg) of maternal Vitamin D intake, there was an ASSOCIATED 11-g increase in Birth weight.']	[('SUPERFICIAL_RELATIONSHIP', 92)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007567', 'parturition', 120, 'birth')]
PMC3348565	4/2012	S16-PMC3348565	['our systematic review identified one randomised placebo controlled trial3RELATING pneumonia or Lower Respiratory infections to Vitamin D deficiency supplementation in young children.']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('UBERON_0009567', 'nail of pedal digit', 95, 'lower'), ('UBERON_0001004', 'respiratory system', 101, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC3355895	1/2011	S84-PMC3355895	['lower concentrations of Serum 25(oh)-Vitamin D in mothers during late Pregnancy were ASSOCIATED with reduced Whole body bmc and bmd in children at age 9 years (javaid et al.,2006a).']	[('SUPERFICIAL_RELATIONSHIP', 85)]	1	[('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0007688', 'anlage', 109, 'whole')]
PMC3355895	1/2011	S85-PMC3355895	['estimated exposure to ultraviolet b radiation during late Pregnancy ( p \u2009<\u20090.0001) and the maternal use of Vitamin D supplements ( p \u2009=\u20090.01) both PREDICTED maternal 25(oh)-Vitamin D concentration, and childhood bmc ( p \u2009=\u20090.03).']	[('SUPERFICIAL_RELATIONSHIP', 147)]	1	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3356951	4/2012	S98-PMC3356951	['[70]\n\nclinical benefits of Vitamin D\n\ncancer\nVitamin D decreases Cell Proliferation and increases Cell Differentiation, stops the growth of new Blood Vessels, and has significant anti-inflammatory EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 197)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 45, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 98, 'cell differentiation'), ('UBERON_0001981', 'blood vessel', 144, 'blood vessels')]
PMC3356951	4/2012	S108-PMC3356951	['age-ASSOCIATED increase in systolic Blood pressure was significantly lower in Individuals with Vitamin D sufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('UBERON_0000178', 'blood', 36, 'blood'), ('NCBITaxon_1', 'root', 78, 'individuals'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3356951	4/2012	S118-PMC3356951	['[91] the result determines a CORRELATION between Vitamin D and the risk of depression.']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3356951	4/2012	S119-PMC3356951	['Cognitive impairment\nin the invecchiare in chianti (inchianti) italian population-based study, low levels of Vitamin D were ASSOCIATED with substantial Cognitive decline in the elderly population studied during a 6-year period.']	[('SUPERFICIAL_RELATIONSHIP', 124)]	1	[('GO_0050890', 'cognition', 0, 'Cognitive'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0050890', 'cognition', 152, 'cognitive')]
PMC3365381	3/2011	S115-PMC3365381	['Imprinting with receptor level acting Vitamins A and D INFLUENCED the Brain biogenic amine levels of f1 progenies (tekes et al.2009a,b,c) as well as the hormone Production Of Immune Cells (csaba et al.2007).']	[('SUPERFICIAL_RELATIONSHIP', 55)]	1	[('GO_0071514', 'genetic imprinting', 0, 'Imprinting'), ('CHEBI_27300', 'vitamin D', 38, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 47, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 53, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('UBERON_0000955', 'brain', 70, 'brain'), ('GO_0002001', 'renin secretion into blood stream', 161, 'production of immune cells'), ('CL_0000738', 'leukocyte', 175, 'immune cells'), ('UBERON_0002405', 'immune system', 175, 'immune')]
PMC3395583	7/2012	S3-PMC3395583	["predicted uvb radiation and Vitamin D status in different time windows during Pregnancy were calculated for each month of Birth and CORRELATED with risk of id using the spearman's correlation coefficient."]	[('SUPERFICIAL_RELATIONSHIP', 132)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC3395583	7/2012	S36-PMC3395583	['average monthly 25-Oh-D levels were collected from a large cohort of Adult scottish and english women (n = 3,787) as previously described [28] and used as a PROXY for the seasonal variation in Gestational Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 157)]	1	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 16, '25-OH-D'), ('UBERON_0007023', 'adult organism', 69, 'adult'), ('GO_0007565', 'female pregnancy', 193, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC3395583	7/2012	S88-PMC3395583	['this is also the case among Pregnant women, whose Vitamin D status largely DEPENDS on season and follows the same distribution as the levels of the general population [28,42,43].']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3403156	7/2012	S33-PMC3403156	['antioxidant administration of Melatonin or Vitamin C to Pregnant Sheep increased Umbilical vascular [5] and fetal Femoral Artery conductance [4], respectively, by mechanisms ASSOCIATED with increased Nitric Oxide (No) bioavailability following decreased Superoxide Anion levels.']	[('SUPERFICIAL_RELATIONSHIP', 174)]	1	[('CHEBI_25179', 'melanins', 30, 'melatonin'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin C'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'sheep'), ('UBERON_0007118', 'umbilicus', 81, 'umbilical'), ('UBERON_0002060', 'femoral artery', 114, 'femoral artery'), ('CHEBI_16480', 'nitric oxide', 200, 'nitric oxide'), ('CHEBI_16382', 'iodide', 214, 'NO'), ('CHEBI_62945', 'thromboxane anion', 254, 'superoxide anion')]
PMC3403156	7/2012	S97-PMC3403156	['Prenatal Vitamin C inhibited the hypoxia-induced increase in fetal Cardiac Hsp70 Expression and Adult Myocardial contractility ASSOCIATED with Β 1 Adrenoceptor stimulation in Rat offspring [36].']	[('SUPERFICIAL_RELATIONSHIP', 127)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('UBERON_0000948', 'heart', 67, 'cardiac'), ('PR_000008794', 'heat shock factor protein 5', 75, 'HSP70'), ('GO_0010467', 'gene expression', 81, 'expression'), ('UBERON_0007023', 'adult organism', 96, 'adult'), ('UBERON_0002349', 'myocardium', 102, 'myocardial'), ('PR_000001595', 'leukotriene B4 receptor 2', 143, 'β 1 adrenoceptor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 175, 'rat')]
PMC3407995	7/2012	S97-PMC3407995	['these Vitamin D induced immunological changes in the mother PREVENT Miscarriage [45,53].']	[('SUPERFICIAL_RELATIONSHIP', 60)]	1	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 68, 'miscarriage')]
PMC3407995	7/2012	S281-PMC3407995	['there was a positive CORRELATION between the Vitamin D levels in maternal and Cord Blood ( r = 0.03; p< 0.003).']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 78, 'cord'), ('UBERON_0000178', 'blood', 83, 'blood')]
PMC3407995	7/2012	S282-PMC3407995	['maternal Vitamin D levels were significantly AFFECTED by sunlight exposure ( p< 0.007) and quality of diet ( p< 0.01).']	[('SUPERFICIAL_RELATIONSHIP', 45)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3427250	8/2012	S16-PMC3427250	['adequate Vitamin D intake is ASSOCIATED with a lower risk of cancer[7],[8],[9],[10],[11], Cardiovascular diseases[12], Autoimmune diseases[13], Neurological disorders[14]and diabetes[15].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 90, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 119, 'autoimmune'), ('UBERON_0001016', 'nervous system', 144, 'neurological')]
PMC3427250	8/2012	S66-PMC3427250	['of all women included, 15% Smoked during Pregnancy and 12% reported having drunk Alcohol during Pregnancy (table 2).10.1371/journal.pone.0043868.t002\n\ncaption (table-wrap): table 2\ncharacteristics of the Pregnant women included in the study (n\u200a=\u200a1311) (belgian national survey on Vitamin D status in Pregnant women, 2010–2011).characteristicnmean age28.5±5.11305mean bmi*(kg/m2)24.4±5.11290% underweight5.6673% healthy weight59.20763% overweight22.09285% obese13.10169 ethnicity % white/caucasian73.61965% asiatic2.5233% african (black)4.8864% north african13.42176% hispanic0.9212% not known4.6561 education level % secondary education or lower54.54715% higher education27.23357% university or higher14.87195% other education0.233% no diploma0.699% not known2.4432 smoking % yes16.78220% of which during past 4 wks15.41202% no82.911087% not known0.314 Drinking Alcohol % yes20.37267% of which during past 4 wks11.51151% no78.491029% not known1.1415\nfirst trimester bmi used as a PROXY for Prepregnancy bmi.']	[('SUPERFICIAL_RELATIONSHIP', 980)]	1	[('GO_0007601', 'visual perception', 27, 'smoked'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_30879', 'alcohol', 81, 'alcohol'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'pregnant'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnant'), ('GO_0006307', 'DNA dealkylation involved in DNA repair', 853, 'Drinking'), ('CHEBI_30879', 'alcohol', 862, 'alcohol'), ('GO_0007565', 'female pregnancy', 990, 'prepregnancy')]
PMC3427250	8/2012	S85-PMC3427250	['in addition the risk of Vitamin D deficiency was significantly lower in summer, spring and autumn compared to winter (table 4).10.1371/journal.pone.0043868.t004\n\ncaption (table-wrap): table 4\nrisk of Vitamin D deficiency during Pregnancy in belgium (25-(Oh)D <20 ng/ml) (n\u200a=\u200a1100), results of multiple logistic regressions.n of subjectsn of deficient casesor[95% conf interval]p season winter4702781.000spring3841270.2340.1650.332<0.001summer93120.1000.0490.203<0.001autumn3511660.5500.3910.7750.001bmi*1.0511.0221.080<0.001 smoking yes2191181.000no10784650.7010.4801.0250.067 use of multivitamins containing Vitamin D no4893171.000yes8092660.2240.1680.300<0.001 ethnicity caucasian, white9553691.000asiatic33192.8231.2356.4540.014african (black)64341.3090.6942.4680.406north african1741306.0483.8139.595<0.001hispanic1275.3051.54918.1670.008 education level secondary education or less7194131.000high school3531080.4880.3490.681<0.001university195520.5090.3310.7830.002 frequency of fish Consumption (non-fatty fish) never2261171.000less than once a month225900.5640.3540.8970.0161–3 days a month5052160.8390.5641.2480.3861 day per week2701240.7940.5061.2480.3182–4 days a week or more frequent69350.5620.2891.0950.090 sometimes going on holidays to sunny climates yes8823661.000no4082151.7031.2482.3240.001\nfirst Trimester bmi used as a PROXY for Prepregnancy bmi.']	[('SUPERFICIAL_RELATIONSHIP', 1339)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('CHEBI_72657', '19,20-DiHDPA', 250, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 609, 'vitamin D'), ('GO_0007631', 'feeding behavior', 989, 'consumption'), ('GO_0009294', 'DNA mediated transformation', 1315, 'trimester'), ('UBERON_0002371', 'bone marrow', 1315, 'trimester'), ('GO_0007565', 'female pregnancy', 1349, 'prepregnancy')]
PMC3427250	8/2012	S105-PMC3427250	['in addition education level was ASSOCIATED with Vitamin D status in our Pregnant women population.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant')]
PMC3437304	8/2012	S22-PMC3437304	['Prenatal exposure to Pets, Vitamin D supplement, or antioxidants such as mediterranean diet is shown to be PROTECTIVE from the development of asthma.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('NCBITaxon_10088', 'Mus <genus>', 21, 'pets'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3458940	9/2012	S166-PMC3458940	['Dhrs3 is INVOLVED in converting Retinaldehyde back to Vitamin A to reduce tra biosynthesis[30].']	[('SUPERFICIAL_RELATIONSHIP', 9)]	1	[('PR_000006602', 'dynamin-1-like protein', 0, 'Dhrs3'), ('CHEBI_17173', 'D-ribulose', 32, 'retinaldehyde'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin A')]
PMC3465343	10/2012	S46-PMC3465343	['results\n\neffect of Vitamin A-free diet on maternal Rats and Embryonic survival\nthe body weight of vad and control females before Mating were SIMILAR (weight gain vs. n\u200a=\u200a24 and 8, respectively).']	[('SUPERFICIAL_RELATIONSHIP', 141)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 51, 'rats'), ('UBERON_0000922', 'embryo', 60, 'embryonic'), ('GO_0007618', 'mating', 129, 'mating')]
PMC3465343	10/2012	S127-PMC3465343	['Teratogenic EFFECTS of Vitamin A deficiency and excess both involve Skeletal Morphogenesis, and these abnormalities include hypoplastic Cranial Bones, defects of the Thyroid, Cricoid and Tracheal Cartilages as well as agenesis of the Neural Arch of Cervical Vertebrae 1 and ectopic bone in the dorsal regions of C1, malformation of the Sternal and Pelvic Regions[29].']	[('SUPERFICIAL_RELATIONSHIP', 12)]	1	[('CHEBI_73676', '3-deoxychenodeoxycholic acid', 0, 'Teratogenic'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0001501', 'skeletal system development', 68, 'skeletal morphogenesis'), ('UBERON_0004288', 'skeleton', 68, 'skeletal'), ('UBERON_0004766', 'cranial bone', 136, 'cranial bones'), ('UBERON_0002046', 'thyroid gland', 166, 'thyroid'), ('UBERON_0001566', 'cricothyroid muscle', 175, 'cricoid'), ('UBERON_0000310', 'breast', 187, 'tracheal cartilages'), ('UBERON_0003861', 'neural arch', 234, 'neural arch'), ('UBERON_0002413', 'cervical vertebra', 249, 'cervical vertebrae'), ('UBERON_0003124', 'chorion', 312, 'C1'), ('UBERON_0001905', 'pineal body', 336, 'sternal ...'), ('UBERON_0002401', 'visceral pleura', 348, 'pelvic regions')]
PMC3476426	8/2012	S9-PMC3476426	['Serum 25-Hydroxy Vitamin D levels had significant negative CORRELATIONS with Serum levels of anti-mag auto-Antibodies ( p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 6, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001977', 'blood serum', 77, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibodies')]
PMC3476426	8/2012	S40-PMC3476426	['in addition, all subjects were studied during summer (april to september) to avoid the EFFECT of seasonal variation on Serum 25 Hydroxy Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 87)]	1	[('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_45557', 'sec-butyl group', 125, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC3476426	8/2012	S72-PMC3476426	['the horizontal line inside the box represents the median and the whiskers represent the non-outlier (between 1.5 and 3 iqr) or extreme (more than 3 iqr) maximum and minimum values of Serum 25-Hydroxy Vitamin D.\n\ncaption (table-wrap): table 1\n\nbasic clinical data and Vitamin D status of the studied childrenclinical dataautistic children (\u2009 n \u2009= 50)control children (\u2009 n \u2009= 30) age ( years)8.24 ± 2.378.63 ± 2.65sex (male/female)39/1124/6the duration of sun exposure (hours/week)6.48 ± 1.296.23 ± 1.41vitamin D deficiency (<10 ng/ml)40% (20/50)0vitamin D insufficiency (10 to 30 ng/ml)48% (24/50)20% (6/30)Vitamin D sufficiency (>30 ng/ml)12% (6/50)80% (24/30)\nSerum 25-Hydroxy Vitamin D had significant negative CORRELATIONS with cars (r = −0.84, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 713)]	1	[('UBERON_0001977', 'blood serum', 183, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 189, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 509, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 553, 'D'), ('CHEBI_28384', 'vitamin K', 606, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 661, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 667, '25-hydroxy vitamin D')]
PMC3476426	8/2012	S114-PMC3476426	['in addition, all subjects were studied during summer (april to september) to avoid the EFFECT of seasonal variation on Serum 25 Hydroxy Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 87)]	1	[('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_45557', 'sec-butyl group', 125, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC3476426	8/2012	S130-PMC3476426	['Serum 25-Hydroxy Vitamin D levels had significant negative CORRELATIONS with Serum levels of anti-mag auto-Antibodies ( p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 6, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001977', 'blood serum', 77, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibodies')]
PMC3501517	11/2012	S96-PMC3501517	['additionally, Blood total Leukocyte and Neutrophil counts were SIMILAR between groups (table 1).10.1371/journal.pone.0049076.t001\n\ncaption (table-wrap): table 1\nSerum and whole Blood measurements.vdsamean (sd)vddbmean (sd)p-value25(Oh)Vitamin D3 (ng/ml)14.6 (2.6)not detected0.0006calcium (mg/dl)8.8 (0.8)8.6 (0.5)0.15phosphate (mg/dl)7.6 (1.2)7.4 (1.1)0.81alkaline phosphatase (u/l)105.2 (14.3)150.7 (35.7)0.03leukocyte (×103/µl)4.35 (1.5)4.21 (1.7)0.88absolute Neutrophil count (×103/µl)0.395 (0.183)0.375 (0.253)0.88\nVitamin D sufficient Mice;\nVitamin D deficient Mice.']	[('SUPERFICIAL_RELATIONSHIP', 63)]	1	[('UBERON_0000178', 'blood', 14, 'blood'), ('CL_0000738', 'leukocyte', 26, 'leukocyte'), ('CL_0000775', 'neutrophil', 40, 'neutrophil'), ('UBERON_0001977', 'blood serum', 161, 'Serum'), ('UBERON_0000178', 'blood', 177, 'blood'), ('CHEBI_51686', 'haematoxylin', 231, '(OH'), ('CHEBI_33237', 'vitamin D4', 235, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 235, 'Vitamin D3'), ('CL_0000775', 'neutrophil', 463, 'neutrophil'), ('CHEBI_27300', 'vitamin D', 520, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 541, 'mice'), ('CHEBI_27300', 'vitamin D', 547, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 567, 'mice')]
PMC3501517	11/2012	S191-PMC3501517	['using a Rat model of radiation-induced pneumonitis, yazici and co-authors examined the EFFECT of Vitamin D supplementation on Lung injury and remodeling 8 and 12 weeks after Thoracic irradiation[32].']	[('SUPERFICIAL_RELATIONSHIP', 87)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 8, 'rat'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('UBERON_0002048', 'lung', 126, 'lung'), ('UBERON_0000915', 'thoracic segment of trunk', 174, 'thoracic')]
PMC3509518	11/2012	S4-PMC3509518	['specifically, higher maternal dietary Vitamin C intake was ASSOCIATED with a reduced risk of any diagnosed infant allergic disease and wheeze.']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C')]
PMC3509518	11/2012	S6-PMC3509518	['there was also an inverse linear RELATIONSHIP between Vitamin C and Food allergy.']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin C'), ('CHEBI_33290', 'food', 68, 'food')]
PMC3509518	11/2012	S85-PMC3509518	['higher maternal dietary Vitamin C intake was also ASSOCIATED with a reduced risk of wheeze (highest versus the lowest quartile crude or 0.40; 95% ci 0.18–0.87), with the inverse linear trend approaching significance ( ptrend= 0.06).']	[('SUPERFICIAL_RELATIONSHIP', 50)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin C')]
PMC3509518	11/2012	S119-PMC3509518	['there is a sigmoidal ASSOCIATION between Vitamin C intake and Plasma concentration of Vitamin C. levine et al.']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin C'), ('UBERON_0001969', 'blood plasma', 62, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C')]
PMC3509518	11/2012	S125-PMC3509518	['[11] reported an inverse RELATIONSHIP between Maternal Intake of citrus fruits, rich in Vitamin C, and reduced risk of wheeze at 2 years.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin C')]
PMC3513049	2/2012	S8-PMC3513049	['for whites, but not african americans, having no pet compared to 1 or >1 pet during Pregnancy was ASSOCIATED with lower Cord Blood Vitamin D concentrations (37.7, 45.2, 47.0 nmol/l, respectively, p = 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 98)]	1	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0009472', 'axilla', 120, 'cord blood'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3515553	12/2012	S13-PMC3515553	['Vitamin B-12 concentration in Breast Milk and Vitamin B-12 status of the infant are ASSOCIATED with Vitamin B-12 concentration in maternal Blood[4].']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('UBERON_0001348', 'brown adipose tissue', 30, 'breast milk'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 100, 'vitamin B-12'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC3515553	12/2012	S76-PMC3515553	['we used an additive Genetic model taking as baseline the genotype ASSOCIATED with the lowest Vitamin B-12 and/or highest thcy concentrations (tt for Fut2 rs492602, gg for tcn2 rs1801198 and aa for tcn2 rs9606756).']	[('SUPERFICIAL_RELATIONSHIP', 66)]	1	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 93, 'vitamin B-12'), ('PR_000007719', 'frizzled-2', 149, 'FUT2')]
PMC3515553	12/2012	S78-PMC3515553	['the calculation of linkage disequilibrium (ld), Haplotype construction and Haplotype ASSOCIATION with Cord Blood Vitamin B-12 and offspring iq were carried out with the program plink v1.07[28].']	[('SUPERFICIAL_RELATIONSHIP', 85)]	1	[('SO_0001024', 'haplotype', 48, 'haplotype'), ('SO_0001024', 'haplotype', 75, 'haplotype'), ('UBERON_0002240', 'spinal cord', 102, 'cord'), ('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 113, 'vitamin B-12')]
PMC3515553	12/2012	S86-PMC3515553	['dietary maternal Vitamin B-12 intake, Cord Blood Vitamin B-12 and offspring iq\nmother’s dietary intake of Vitamin B-12 during Pregnancy was ASSOCIATED with offspring iq in simple age, sex and energy Intake adjusted analyses (model 1), with offspring iq being on average 2.0 (95%ci 1.3, 2.8; p<0.001) points greater per doubling of maternal dietary Vitamin B-12 intake (table 2).']	[('SUPERFICIAL_RELATIONSHIP', 140)]	1	[('PR_000027594', 'histone H3', 17, 'Vitamin B'), ('UBERON_0000948', 'heart', 38, 'Cord'), ('UBERON_0000178', 'blood', 43, 'Blood'), ('PR_000027594', 'histone H3', 49, 'Vitamin B'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 114, 'B'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007631', 'feeding behavior', 199, 'intake'), ('CHEBI_85855', 'diacylglycerol 46:7', 348, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 348, 'vitamin B-12')]
PMC3515553	12/2012	S90-PMC3515553	['additional adjustment by confounders and mediators (mean difference in offspring iq per doubling of Cord Vitamin B-12∶1.3, 95% ci −1.5, 4.1, p\u200a=\u200a0.36) in the subsample of 222 children with these data reduced the EFFECT by ∼55%.']	[('SUPERFICIAL_RELATIONSHIP', 212)]	1	[('UBERON_0002240', 'spinal cord', 100, 'cord'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017260', 'tubulinyl-Tyr carboxypeptidase 1', 105, 'vitamin B-12∶'), ('CHEBI_37972', 'phosphorus-32 atom', 115, '12∶')]
PMC3515553	12/2012	S100-PMC3515553	['additive test/any effect test.10.1371/journal.pone.0051084.t004\n\ncaption (table-wrap): table 4\nassociation of maternal tcn2 Haplotypes with Vitamin B-12 Cord Blood levels and offspring iq at age 8.rs9606756-rs1801198 Haplotypehaplotype frequencycord Blood geometricmean (95% ci)p-valueaiq mean (95% ci)p-valueaac0.46298 (274, 324)0.11104.4 (103.7, 105.1)0.35ag0.41278 (255, 304)0.02104.1 (103.4, 104.7)0.03gc0.10317 (257, 391)0.23104.7 (103.4, 105.9)0.38gg0.03279 (78, 995)0.85108.6 (105.4, 111.8)0.01 p-value b0.140.01 n c58642023429\np-value for testing the EFFECT of each Haplotype vs all others.']	[('SUPERFICIAL_RELATIONSHIP', 559)]	1	[('SO_0001024', 'haplotype', 124, 'haplotypes'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 140, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 153, 'cord'), ('UBERON_0000178', 'blood', 158, 'blood'), ('SO_0001024', 'haplotype', 217, 'haplotypehaplotype'), ('UBERON_0000178', 'blood', 250, 'blood'), ('SO_0001024', 'haplotype', 574, 'haplotype')]
PMC3515553	12/2012	S132-PMC3515553	['in alspac, child iq was weakly ASSOCIATED with maternal Vitamin B-12-elevating Alleles at Fut2 and tcn2 .']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 56, 'vitamin B-12'), ('SO_0001023', 'allele', 79, 'alleles'), ('PR_000007719', 'frizzled-2', 90, 'FUT2')]
PMC3515553	12/2012	S162-PMC3515553	['in terms of Vitamin B-12 Plasma measurements, we lacked maternal data to verify the ASSOCIATION with Fut2 and tcn2 genotypes and undertake a formal instrumental variable analysis[10].']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 12, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 25, 'plasma'), ('PR_000007719', 'frizzled-2', 101, 'FUT2')]
PMC3544621	11/2012	S76-PMC3544621	['[21]5 (1999-2006)provision of advice regarding Vitamin A supplementation in hiv infected womenrisk of Mother-To-Child Transmission (mtct) of hiv,Birth weight, stillbirth rate and ptdno evidence of an EFFECT on the risk of Prenatal or Postnatal mtct of hiv (rr 1.06, 95% ci 0.89-1.26).']	[('SUPERFICIAL_RELATIONSHIP', 200)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('GO_0060126', 'somatotropin secreting cell differentiation', 102, 'Mother-to-Child Transmission'), ('GO_0007567', 'parturition', 145, 'birth'), ('GO_0007565', 'female pregnancy', 222, 'prenatal'), ('GO_0007567', 'parturition', 234, 'postnatal')]
PMC3599191	1/2013	S198-PMC3599191	['furthermore, levels of maternal Vitamin E AFFECT the development of fetal biometrics (Crown-Rump length, Femur length and biparietal diameter) and Lung Development: for every millimeter of increase in fetus length, there is an increase of up to 5 ml of fev1and 6 ml of fvc [107].']	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('UBERON_0002283', 'nail matrix', 86, 'crown-rump'), ('UBERON_0000981', 'femur', 105, 'femur'), ('GO_0030324', 'lung development', 147, 'lung development'), ('UBERON_0002048', 'lung', 147, 'lung')]
PMC3613945	2/2013	S307-PMC3613945	['in comparison to Gc-2 (436\u2009k) types, non- Gc-2 polymorphisms are ASSOCIATED with increased Macrophage activity and elevated Vitamin D Serum levels required for downstream upregulation of Antimicrobial peptides220.']	[('SUPERFICIAL_RELATIONSHIP', 65)]	1	[('PR_000007760', 'gamma-aminobutyric acid receptor-associated protein-like 3', 17, 'Gc-2'), ('PR_000007760', 'gamma-aminobutyric acid receptor-associated protein-like 3', 42, 'Gc-2'), ('CL_0000235', 'macrophage', 91, 'macrophage'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_65381', 'albizoside C', 187, 'antimicrobial')]
PMC3629265	4/2013	S73-PMC3629265	['adequate transfer of stores DEPENDS ON the Vitamin D status of the mother.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3635901	4/2013	S3-PMC3635901	['within the environmental FACTORS generating autoimmunity are now included unsuspected Molecules such as Vitamin D and aluminum.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_36357', 'polyatomic entity', 86, 'molecules'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3641012	4/2013	S5-PMC3641012	['results\nmean maternal 25(Oh)D concentration was SIMILAR in the Vitamin D and placebo groups at baseline (45 vs. 44\xa0nmol/l; p\u2009=\u20090.66), but was significantly higher in the Vitamin D group vs. placebo group among mothers at Delivery (134 vs. 38\xa0nmol/l; p\u2009<\u20090.001) and newborns (Cord Blood: 103 vs. 39; p\u2009<\u20090.001).']	[('SUPERFICIAL_RELATIONSHIP', 48)]	1	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 24, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'delivery'), ('UBERON_0002240', 'spinal cord', 275, 'cord'), ('UBERON_0000178', 'blood', 280, 'blood')]
PMC3641012	4/2013	S110-PMC3641012	['maternal characteristics and 25(Oh)D at baseline were SIMILAR in the placebo and Vitamin D groups (tables\xa01and2).']	[('SUPERFICIAL_RELATIONSHIP', 54)]	1	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC3641012	4/2013	S122-PMC3641012	['adherence for participants for whom Delivery specimens were available was SIMILAR: mean of 99.1% in the placebo group (n\u2009=\u200963) and 99.3% in the Vitamin D group (n\u2009=\u200967).']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('GO_0007567', 'parturition', 36, 'delivery'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC3641012	4/2013	S125-PMC3641012	['proportions in the subgroup of participants for whom Delivery specimens were available were SIMILAR: 90.5% in the Placebo group (n\u2009=\u200963) and 94.0% in the Vitamin D group (n\u2009=\u200967).']	[('SUPERFICIAL_RELATIONSHIP', 92)]	1	[('GO_0007567', 'parturition', 53, 'delivery'), ('CHEBI_26130', 'biological pigment', 114, 'placebo'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3641012	4/2013	S128-PMC3641012	['Vitamin D supplementation had a substantial, statistically significant EFFECT on maternal and neonatal Vitamin D status at the time of Delivery, as reflected in the overall 25(Oh)D distributions (figure\xa02; table\xa04) as well as the proportion of participants considered to have low 25(Oh)D using cut-offs (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'delivery'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 176, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 179, 'D'), ('CHEBI_71657', 'versiconol acetate', 280, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 280, '25(OH)D')]
PMC3641012	4/2013	S198-PMC3641012	['Vitamin D supplementation had a significant suppressive EFFECT on maternal pth concentration, such that the rise in pth observed in the placebo group was completely attenuated in the vitamin D group (figure\xa04), and the average pth concentration was lower in the Vitamin D group at Delivery (figure\xa02; table\xa04).']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 191, 'D'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('GO_0007567', 'parturition', 281, 'delivery')]
PMC3651971	5/2013	S134-PMC3651971	['caption (table-wrap): table\xa04\n\nthe average cluster-summarised unit and mabc scores among children who repeated a grade (n=76), and those who never repeated a grade (n=272)Vitamin aplaceboeffect estimate*95% cip valuerepeaters\u2003number of clusters56\u2003number of participants3244\u2003√(mabc+1) mean of cluster means2.582.73−0.15(−0.60 to 0.31)0.49\u2003unit mean of cluster means77.4381.09−3.65(−14.07 to 6.77)0.45non-repeaters\u2003number of clusters66\u2003number of participants159113\u2003√(mabc+1) mean of cluster means†2.592.230.36(0.05 to 0.67)0.03\u2003unit mean of cluster means85.3382.85−2.48(−14.19, 9.23)0.64never attended school\u2003number of clusters64\u2003number of participants1817\u2003√(mabc+1) mean of cluster means‡3.273.52−0.25(−0.99 to 0.50)0.47\u2003unit mean of cluster means41.7240.721.00(−24.25 to 26.25)0.93\n*the EFFECT estimate is the difference in scores or adjusted residuals comparing Vitamin A with placebo.']	[('SUPERFICIAL_RELATIONSHIP', 787)]	1	[('CHEBI_33229', 'vitamin (role)', 171, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 863, 'vitamin A')]
PMC3659910	1/2013	S80-PMC3659910	['w\nepidemiological analyses IMPLICATED high dietary Vitamin D intake during Pregnancy results in Birth of syndromic babies.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007567', 'parturition', 96, 'birth')]
PMC3659910	1/2013	S144-PMC3659910	['lower maternal Vitamin D status was ASSOCIATED with lower bone Mineral concentration and impaired Glucose Homeostasis in newborn infants.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_46662', 'mineral', 63, 'mineral'), ('CHEBI_17234', 'glucose', 98, 'glucose'), ('GO_0042593', 'glucose homeostasis', 98, 'glucose homeostasis')]
PMC3659910	1/2013	S145-PMC3659910	['[35] maternal Vitamin D deficiency also has been ASSOCIATED with craniotabes,[35] a softening of Skull Bones that is one of the earliest signs of vitamin d deficiency, in a case study with neonatal seizures of a hypocalcemic infant and with impaired Skeletal Development in utero.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0003215', 'alveolus', 97, 'skull bones'), ('GO_0001501', 'skeletal system development', 250, 'skeletal development'), ('UBERON_0004288', 'skeleton', 250, 'skeletal')]
PMC3672018	5/2013	S5-PMC3672018	['the danish national databases assure that there are a sufficient number of Individuals to verify any Vitamin D EFFECTS during different Gestation phases.']	[('SUPERFICIAL_RELATIONSHIP', 111)]	1	[('NCBITaxon_1', 'root', 75, 'individuals'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'gestation')]
PMC3672018	5/2013	S36-PMC3672018	['to date, the RELATIONSHIP between Vitamin D status during fetal Life and long-term health has not been widely examined, and interventions are generally lacking.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'life')]
PMC3672018	5/2013	S58-PMC3672018	['the figure provides examples of designs for examining the EFFECTS of Vitamin D fortification on Development Of Diseases for a follow-up period of up to 50ὕyears.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 96, 'development of diseases')]
PMC3672018	5/2013	S92-PMC3672018	['exposure assessment\nfour main analyses of exposure related to initiation and termination of Vitamin D fortification will be considered for each of the disease outcomes:\n1. Perinatal exposure to Vitamin D for offspring;\n2. seasonal variation in Vitamin D exposure in different Pregnancy trimesters;\n3. exposure to Vitamin D adjusted for Genetic and common environmental INFLUENCES;\n4. levels of Vitamin D (25(Oh)D3) measured in infant Blood from dbs cards.']	[('SUPERFICIAL_RELATIONSHIP', 369)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('SO_0000704', 'gene', 336, 'genetic'), ('CHEBI_27300', 'vitamin D', 394, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 405, '25(OH)D3'), ('UBERON_0000178', 'blood', 434, 'blood')]
PMC3672018	5/2013	S97-PMC3672018	['similar comparisons of disease development can be made in RELATION to higher exposure to Vitamin D from 1972–1976, when fortified low fat Milk was permitted.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001913', 'milk', 138, 'milk')]
PMC3672018	5/2013	S139-PMC3672018	['discussion\n\nstrengths and limitations\nthe study takes advantage of a Vitamin D fortification policy implemented in denmark almost fifty years ago, and nests this “societal experiment” in a setting where the EFFECT of conditions from Conception (and before) for development of certain Diseases can be followed among Individuals from Birth through Adulthood.']	[('SUPERFICIAL_RELATIONSHIP', 207)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007620', 'copulation', 233, 'conception'), ('GO_0007586', 'digestion', 284, 'diseases'), ('NCBITaxon_1', 'root', 315, 'individuals'), ('GO_0007567', 'parturition', 332, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 346, 'adulthood')]
PMC3685533	6/2013	S0-PMC3685533	['Vitamin D status in Cord Blood and newborns: ethnic differences\n\nabstract\n\nbackground\na deficiency in Vitamin D (25Ohd) is common throughout the world in both Adults and children, being RELATED to skin pigmentation, sun exposure, dietary intake and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 186)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 113, '25OHD'), ('UBERON_0007023', 'adult organism', 159, 'adults')]
PMC3685533	6/2013	S19-PMC3685533	['RISK FACTORS for Vitamin D deficiency and rickets in early Life include Breast-Feeding without Vitamin D supplementation, dark skin pigmentation, season, latitude and maternal Vitamin d deficiency [1].']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 59, 'life'), ('GO_0007567', 'parturition', 72, 'breast'), ('GO_0007631', 'feeding behavior', 79, 'feeding'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 176, 'vitamin')]
PMC3685533	6/2013	S99-PMC3685533	['likewise neonatal Vitamin D levels were PREDICTED (r2: 0.670; p\u2009<\u20090.0001) by Vitamin D values on Cord Blood (standardized β: 0.818), when corrected for Vitamin D supplementation and Gestational age.']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 77, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'gestational')]
PMC3691177	6/2013	S12-PMC3691177	['conclusion\nPrenatal Vitamin D supplementation in late Pregnancy that had a modest EFFECT on Cord Blood Vitamin D level, was not associated with decreased wheezing in offspring at age three years.']	[('SUPERFICIAL_RELATIONSHIP', 82)]	1	[('GO_0007565', 'female pregnancy', 11, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3691177	6/2013	S128-PMC3691177	['two on-going trials, the Vitamin D Prenatal asthma reduction trial (nct00920621), and abcvitamind (nct00856947) are specifically exploring the EFFECTS of earlier and higher dose Prenatal Vitamin D supplementation on child health.']	[('SUPERFICIAL_RELATIONSHIP', 143)]	1	[('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'Prenatal'), ('GO_0007565', 'female pregnancy', 178, 'prenatal'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3695234	7/2013	S56-PMC3695234	['for example, Vitamin D IMPACTS the Innate Immune System by stimulating the Production Of Cathelicidin, which is an anti-Microbial peptide activated through toll-like receptors (tlrs).']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007449', 'proximal/distal pattern formation, imaginal disc', 35, 'innate immune system'), ('UBERON_0002405', 'immune system', 42, 'immune system'), ('GO_1902430', 'negative regulation of amyloid-beta formation', 75, 'production of cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'microbial')]
PMC3695234	7/2013	S66-PMC3695234	['another prospective Birth cohort study investigated Vitamin D deficiency and Food sensitization, and genotyped 11 Genes INVOLVED in Regulating Ige and 25(Oh)D3Concentration.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33290', 'food', 77, 'food'), ('SO_0000704', 'gene', 114, 'genes'), ('GO_0065007', 'biological regulation', 132, 'regulating'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 143, 'IgE'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 151, '25(OH)D3concentration'), ('PR_000010888', 'deubiquitinase MYSM1', 151, '25 ... OH ... D3concentration')]
PMC3702339	6/2013	S112-PMC3702339	['correlates of Vitamin A deficiency\n\nsociodemographic factors\nmaternal age was negatively ASSOCIATED with vad.']	[('SUPERFICIAL_RELATIONSHIP', 89)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A')]
PMC3705146	5/2013	S29-PMC3705146	['the RELATIONSHIP between a diet rich in fatty fish and Serum levels of Vitamin D is clear (burgaz et al.,2007).']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3705320	3/2013	S25-PMC3705320	['reasons for exclusion were: preexisting medical condition; current Vitamin D supplement use; Anti-convulsant or anti-Mycobacterial medications; severe anemia (hemoglobin concentration <70 g/l); hypertension at enrollment (systolic Blood pressure ≥140 mmhg or diastolic Blood pressure ≥90 mmhg on at least two measurements); major risk FACTORS for Preterm Delivery or Pregnancy complications; or previous delivery of an infant with a congenital anomaly or Perinatal death.']	[('SUPERFICIAL_RELATIONSHIP', 335)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_59132', 'antigen', 93, 'anti'), ('CHEBI_52217', 'pharmaceutical', 117, 'mycobacterial'), ('UBERON_0000178', 'blood', 231, 'blood'), ('UBERON_0000178', 'blood', 269, 'blood'), ('GO_0007565', 'female pregnancy', 347, 'preterm'), ('GO_0007567', 'parturition', 355, 'delivery'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy'), ('GO_0036268', 'swimming', 455, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 455, 'perinatal')]
PMC3717170	5/2013	S11-PMC3717170	['discovery of the vdr and Cyp27B1 in these Tissues led to exploration of the ROLES and mechanisms of Vitamin D function in each.']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('PR_000006101', 'cytochrome P450 1A1', 25, 'CYP27B1'), ('UBERON_0000479', 'tissue', 42, 'tissues'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3717170	5/2013	S38-PMC3717170	['in Macrophages and Monocytes, Cellular Sensing Of Pathogens, such as mycobacterium tuberculosis , by pattern recognition receptors, such as toll-like receptors, enhances Expression of Cyp27B1 and the vdr, thereby increasing Intracrine Synthesis and activity of 1,25(Oh)2D3.4the resulting EFFECTS, including enhanced Expression of the antibacterial proteins Cathelicidin and Β-Defensin 2, and enhanced Formation Of Autophagosomes, facilitate improved bacterial Killing in a Vitamin D–dependent fashion.']	[('SUPERFICIAL_RELATIONSHIP', 288)]	1	[('CL_0000235', 'macrophage', 3, 'macrophages'), ('CL_0000576', 'monocyte', 19, 'monocytes'), ('GO_0048870', 'cell motility', 30, 'cellular sensing of pathogens'), ('GO_0010467', 'gene expression', 170, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 184, 'CYP27B1'), ('GO_0045112', 'integrin biosynthetic process', 224, 'intracrine synthesis'), ('CHEBI_72779', '11-trans-LTE4', 261, '1,25(OH)2D3'), ('GO_0010467', 'gene expression', 316, 'expression'), ('PR_000006009', 'alpha-catulin', 357, 'cathelicidin'), ('PR_000001017', 'receptor-type tyrosine-protein phosphatase C isoform CD45RO', 374, 'β-defensin 2'), ('GO_0007416', 'synapse assembly', 401, 'formation of autophagosomes'), ('GO_0005776', 'autophagosome', 414, 'autophagosomes'), ('GO_0007601', 'visual perception', 460, 'killing'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3717170	5/2013	S42-PMC3717170	['the Immunomodulatory EFFECTS of Vitamin D also involve the adaptive Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('GO_0007566', 'embryo implantation', 4, 'immunomodulatory'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0002405', 'immune system', 68, 'immune system')]
PMC3717170	5/2013	S98-PMC3717170	['Vitamin D and Lung function in patients with chronic obstructive Pulmonary disease\nerica rutten (ciro+, centre of expertise for chronic Organ failure, netherlands) discussed her work investigating the ASSOCIATION between Plasma Vitamin D levels and Lung function in chronic obstructive Pulmonary disease (copd) patients.']	[('SUPERFICIAL_RELATIONSHIP', 201)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0002048', 'lung', 65, 'pulmonary'), ('UBERON_0000033', 'head', 136, 'Organ'), ('UBERON_0001969', 'blood plasma', 221, 'plasma'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0002048', 'lung', 249, 'lung'), ('UBERON_0002048', 'lung', 286, 'pulmonary')]
PMC3717170	5/2013	S190-PMC3717170	['there is considerable variation among Individuals with regard to the Serum level of 25(Oh)D3Achieved with a given dose of oral Vitamin D, and it is the Serum level that counts with respect to biologic EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 201)]	1	[('NCBITaxon_1', 'root', 38, 'individuals'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_77716', 'oxymetazoline(1+)', 84, '25(OH)D3achieved'), ('PR_000000364', 'smad2', 84, '25(OH)D3achieved'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0001977', 'blood serum', 152, 'serum')]
PMC3739737	8/2013	S167-PMC3739737	['in addition, Vitamin D has a direct neuroprotective action against excitotoxic insults by down regulating l-type calcium channels[38]and pre-treatment with Vitamin d attenuates the EFFECTS of various stressors including 6-Hydroxydopamine-induced neurotoxicity[39].']	[('SUPERFICIAL_RELATIONSHIP', 181)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 156, 'vitamin'), ('CHEBI_28921', '7-methyladenine', 220, '6-hydroxydopamine')]
PMC3760821	9/2013	S14-PMC3760821	['Cord Blood Vitamin D levels CORRELATE with those of the mother, and are significantly lower in obese women than in their normal weight counterparts.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC3760821	9/2013	S27-PMC3760821	['increased Synthesis Of the active Vitamin D Form is due to the enhanced production of 1α-hydroxylase in the Decidua and Placenta, as well as an Oestrogen-DEPENDENT increase in Vitamin D binding protein[7].']	[('SUPERFICIAL_RELATIONSHIP', 154)]	1	[('GO_0009057', 'macromolecule catabolic process', 10, 'synthesis of ... form'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002450', 'decidua', 108, 'decidua'), ('UBERON_0001987', 'placenta', 120, 'placenta'), ('CHEBI_50114', 'estrogen', 144, 'oestrogen'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC3760821	9/2013	S125-PMC3760821	['furthermore, within spring, winter and autumn, post-Delivery 25Ohd levels were significantly greater than Cord Blood levels.10.1371/journal.pone.0074068.g001\n\ncaption (fig): figure 1\nIMPACT of maternal Vitamin D status and bmi on neonatal Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 183)]	1	[('GO_0007567', 'parturition', 52, 'delivery'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 61, '25OHD'), ('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC3760821	9/2013	S139-PMC3760821	['correlations between Cord Blood Vitamin D levels and maternal and neonatal outcomes\nmaternal 25ohd CORRELATED positively with Cord 25ohd at all 3 trimesters in the t1dm group ( table 3 ) and at Trimester 3 in the control group.']	[('SUPERFICIAL_RELATIONSHIP', 99)]	1	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 126, 'cord'), ('GO_0009294', 'DNA mediated transformation', 194, 'trimester')]
PMC3760821	9/2013	S176-PMC3760821	['low Vitamin D levels are ASSOCIATED with Insulin resistance in t2dm and its co-morbidities[35].']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('PR_000045358', 'insulin family protein', 41, 'insulin')]
PMC3773018	4/2013	S20-PMC3773018	['in an earlier report, we examined a single time point Gene-Cord Blood Vitamin D INTERACTION on fs in the boston Birth cohort (16).']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('SO_0000704', 'gene', 54, 'gene'), ('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'Birth')]
PMC3773018	4/2013	S37-PMC3773018	['multiple logistic regression was used to test the ASSOCIATION between persistently low Vitamin D and fs after adjustment for maternal age (<20, 20–25, 25–30, 30–35, ≥35), Postnatal exposure to maternal smoking, household income, child’s gender, history of breastfeeding, and ancestry proportion estimated based on 144 ancestry informative markers (aims) as previously detailed (18).']	[('SUPERFICIAL_RELATIONSHIP', 50)]	1	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 171, 'postnatal')]
PMC3773018	4/2013	S58-PMC3773018	['among children carrying the c Allele of rs2243250 (~65% of the study subjects), persistently low Vitamin D status was ASSOCIATED with an over 3-fold increased risk of fs (or = 3.23, 95%ci: 1.37–7.60) compared to those with sufficient Vitamin D at both time points.']	[('SUPERFICIAL_RELATIONSHIP', 118)]	1	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC3798907	8/2013	S96-PMC3798907	['caption (fig): figure 5\n\nsummary of differential EFFECTS of Vitamin E or C supplementation on cbmc or pbmc responses to Allergen.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 73, 'C'), ('CHEBI_50904', 'allergen', 120, 'allergen')]
PMC3798907	8/2013	S115-PMC3798907	['the EFFECTS of Vitamin E supplementation of cbmc cultures on cytokine responses were also not straightforward.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin E')]
PMC3798907	8/2013	S121-PMC3798907	['this study followed on from our observation of an ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc proliferative Responses [12].']	[('SUPERFICIAL_RELATIONSHIP', 50)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin E'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0060033', 'anatomical structure regression', 136, 'responses')]
PMC3827489	10/2013	S4-PMC3827489	['the RISK FACTORS for Vitamin D insufficiency or deficiency in the pediatric population are season (winter), insufficient time spent outdoors, ethnicity (non-white), older age, more advanced stage of puberty, obesity, low milk Consumption, low socioeconomic status, and female gender.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 226, 'consumption')]
PMC3829803	11/2013	S172-PMC3829803	['both Vitamin A supplementation and treatment have either no or negative EFFECTS on Respiratory Tract infections including the Common paramyxovirus, Respiratory syncytial virus (Rsv) [72]–[74].']	[('SUPERFICIAL_RELATIONSHIP', 72)]	1	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('UBERON_0000065', 'respiratory tract', 83, 'respiratory tract'), ('NCBITaxon_33208', 'Metazoa', 126, 'common'), ('UBERON_0001004', 'respiratory system', 148, 'respiratory'), ('NCBITaxon_10088', 'Mus <genus>', 177, 'RSV')]
PMC3873449	12/2013	S49-PMC3873449	['women with a history of any disease including Renal, bone and Gastrointestinal disorders and Medications INFLUENCING Calcium or Vitamin D Metabolism were excluded.']	[('SUPERFICIAL_RELATIONSHIP', 105)]	1	[('UBERON_0002113', 'kidney', 46, 'renal'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 62, 'gastrointestinal'), ('CHEBI_25441', 'mycothiols', 93, 'medications'), ('CHEBI_22313', 'alkaline earth metal atom', 117, 'calcium'), ('GO_0019752', 'carboxylic acid metabolic process', 117, 'calcium ... D metabolism'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3873449	12/2013	S96-PMC3873449	['degree or higher (n, %)38 (67.9)59 (85.5)p = 0.019income (rmb thousand yuan/month/Person, sd)5.10 (2.69)4.62 (2.28)p = 0.289multivitamin users (n, %)13 (23.2)45 (65.2)p < 0.001sun exposure (h/day, sd)0.76 (0.71)1.08 (0.68)p = 0.014computer usage ((h/day, sd)3.96 (2.56)3.64 (2.46)p = 0.494walking (min/day, sd)137.5 (94.47)133.3 (83.18)p = 0.796\n\nthe INFLUENCE of maternal factors on Vitamin D status\nforty eight women (38.4%) had sun exposure time ≤ 0.5 h/day.']	[('SUPERFICIAL_RELATIONSHIP', 351)]	1	[('NCBITaxon_10088', 'Mus <genus>', 82, 'person'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
PMC3873449	12/2013	S198-PMC3873449	['obesity is a RISK FACTOR for Vitamin D deficiency [47].']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC3882256	1/2014	S22-PMC3882256	['furthermore, since Vitamin C is a key enhancer of iron absorption[24],[25], the RELATIONSHIP between Maternal iron intake and Perinatal or longer term outcomes may be stronger with adequate intake of Vitamin C[26].']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin C'), ('GO_0007618', 'mating', 101, 'maternal'), ('GO_0036268', 'swimming', 126, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 126, 'perinatal'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin C')]
PMC3882256	1/2014	S107-PMC3882256	['there was also no evidence of effect modification by maternal Vitamin C intake or child sex on any of the RELATIONSHIPS (table 5).']	[('SUPERFICIAL_RELATIONSHIP', 106)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C')]
PMC3882256	1/2014	S110-PMC3882256	['interaction p value, testing the null hypotheses that ASSOCIATIONS do not differ by maternal Vitamin C level or by sex of participants.']	[('SUPERFICIAL_RELATIONSHIP', 54)]	1	[('CHEBI_27300', 'vitamin D', 93, 'vitamin C')]
PMC3926113	1/2014	S6-PMC3926113	['abstract:graphicalgraphical abstract\n\nabstract:author-highlightshighlights\n\nmaternal Vitamin C deficiency AFFECTS redox balance in the foetal Brain.']	[('SUPERFICIAL_RELATIONSHIP', 106)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin C'), ('UBERON_0000955', 'brain', 142, 'brain')]
PMC3991049	11/2013	S15-PMC3991049	["conclusion: weekly doses of 50,000 Vitamin D during Pregnancy maintains acceptable Vitamin D level during Pregnancy and the newborn's Vitamin D level CORRELATES with the mother's levels."]	[('SUPERFICIAL_RELATIONSHIP', 150)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3991049	11/2013	S56-PMC3991049	['the mean Parathyroid hormone level was within normal range (n: 15–65\xa0ng/ml) during all Trimesters except for one woman who had a high Parathyroid hormone level; the level CORRELATED with very low Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 171)]	1	[('UBERON_0001132', 'parathyroid gland', 9, 'parathyroid'), ('GO_0043033', 'isoamylase complex', 87, 'trimesters'), ('UBERON_0001132', 'parathyroid gland', 134, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3991049	11/2013	S58-PMC3991049	["the level of Vitamin D in newborns CORRELATED with the mothers' 3rdtrimester level with significant p value (tables 1 and 2).table 3shows the level of vitamin d level in subjects who were on multivitamin supplement and those who were not on it before being recruited for the study."]	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3991049	11/2013	S76-PMC3991049	["newborns' Vitamin D levels CORRELATE with the Vitamin D level of their mothers."]	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3994635	8/2010	S128-PMC3994635	['the EFFECTS of the Pregnancy Supplement were superimposed on the changes in biochemistry from 20 wk of Pregnancy to 13 wk Postpartum as experienced by both groups of women (ie, significant reductions in Urinary Calcium Excretion and Plasma concentrations of Vitamin D Metabolites plus increases in Plasma concentrations of pth and bone turnover markers) (table 5).']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 29, 'supplement'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007565', 'female pregnancy', 122, 'postpartum'), ('GO_0060073', 'micturition', 203, 'urinary'), ('UBERON_0001088', 'urine', 203, 'urinary'), ('GO_0036161', 'calcitonin secretion', 211, 'calcium excretion'), ('UBERON_0001969', 'blood plasma', 233, 'plasma'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_25212', 'metabolite', 268, 'metabolites'), ('UBERON_0001969', 'blood plasma', 298, 'plasma')]
PMC4017421	7/2011	S42-PMC4017421	['the questionnaire included Foods with high content of Nutrients and Antinutrients, previously LINKED to ppd: N-3 Fatty Acids, b Vitamins, Fe, zn, Vitamin C, Ca, Se as well as foods rich in compounds antagonistic to the above: N-6, Saturated and trans Fatty Acids, Phytic Acid, Caffeine & Tannin, Sucrose, casein and Foods with high glycaemic index values.']	[('SUPERFICIAL_RELATIONSHIP', 94)]	1	[('CHEBI_33290', 'food', 27, 'foods'), ('CHEBI_33284', 'nutrient', 54, 'nutrients'), ('CHEBI_33282', 'antibacterial agent', 68, 'antinutrients'), ('CHEBI_30256', 'thiocarbonyl group', 109, 'n-3'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acids'), ('CHEBI_33277', 'gamma-tocotrienol', 128, 'vitamins'), ('CHEBI_33290', 'food', 138, 'Fe'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin C'), ('CHEBI_32588', 'potassium chloride', 157, 'Ca'), ('CHEBI_37972', 'phosphorus-32 atom', 161, 'Se'), ('CHEBI_18320', '1,4-dithiothreitol', 226, 'n-6'), ('CHEBI_51247', 'texas red', 231, 'saturated'), ('CHEBI_35366', 'fatty acid', 251, 'fatty acids'), ('CHEBI_16666', 'prephenic acid', 264, 'phytic acid'), ('CHEBI_27732', 'caffeine', 277, 'caffeine'), ('CHEBI_26848', 'tannin', 288, 'tannin'), ('CHEBI_17992', 'sucrose', 296, 'sucrose'), ('CHEBI_33290', 'food', 316, 'foods')]
PMC4045304	2/2014	S183-PMC4045304	['the main source of Vitamin D is the solar ultraviolet b radiation RELATED conversion of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of vitamin d from Food [73,74].']	[('SUPERFICIAL_RELATIONSHIP', 66)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 88, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 112, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 123, 'D3'), ('CHEBI_33290', 'food', 176, 'food')]
PMC4072587	6/2014	S13-PMC4072587	['maternal Vitamin D readily crosses the Placenta, and maternal levels strongly CORRELATE with infant Vitamin D concentration at Birth[6].']	[('SUPERFICIAL_RELATIONSHIP', 78)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0001987', 'placenta', 39, 'placenta'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC4072587	6/2014	S89-PMC4072587	['maternal Vitamin D and Birth outcomes\ntable 3summarizes Birth outcomes RELATED to maternal Vitamin D in late Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 23, 'birth'), ('GO_0007567', 'parturition', 56, 'birth'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy')]
PMC4072587	6/2014	S91-PMC4072587	['for the 49.5% of infants with a measurement of Head circumference, there was an inverse RELATIONSHIP between infant Head circumference at Birth and maternal 25-ohd (md of −0.35 cm per 25 nmol/l increase in Vitamin D concentration, 95% ci −0.62 to −0.09).10.1371/journal.pone.0099005.t003\n\ncaption (table-wrap): table 3\nBirth outcomes associated with maternal Serum 25-ohd concentration (nmol/l) at 32 weeks Gestation (unadjusted and adjusted models).unadjusted modeladjusted model 1adjusted model 2birth outcomesmean [sd] or no.']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('UBERON_0000033', 'head', 47, 'head'), ('UBERON_0000033', 'head', 116, 'head'), ('GO_0007567', 'parturition', 138, 'birth'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007567', 'parturition', 319, 'Birth'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('GO_0007565', 'female pregnancy', 407, 'gestation')]
PMC4106226	7/2014	S35-PMC4106226	['decreased Vitamin D levels were ASSOCIATED with difficult-to-control asthma, increased number of emergency unit admissions, number of hospitalizations, severity of asthma.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4106226	7/2014	S42-PMC4106226	['[5] assessed Vitamin D status in egyptian children and adolescents with t1dm in order to clarify the prevalence of Vitamin D deficiency and its ROLE in the pathogenesis of t1dm.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4113768	7/2014	S355-PMC4113768	['this resulted in a research project within our practice, where we identified and treated Vitamin D deficiency in Pregnancy to try and PREVENT rickets in our community.']	[('SUPERFICIAL_RELATIONSHIP', 134)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC4113768	7/2014	S435-PMC4113768	['upcoming work with this group of patients will include 25Ohd testing, and a randomized, double-blind, placebo-controlled trial that will test the EFFECT of weekly Vitamin D supplementation on ad severity in children.']	[('SUPERFICIAL_RELATIONSHIP', 146)]	1	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 55, '25OHD'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4113768	7/2014	S622-PMC4113768	['conclusions: peri-Pregnancy Vitamin D status of mothers had a u-shaped ASSOCIATION with risk of p/tn allergy in offspring, with lowest risk for mothers with predicted 25Ohd between 80–85 nmol/l.']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('GO_0007565', 'female pregnancy', 18, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 167, '25OHD')]
PMC4113768	7/2014	S633-PMC4113768	["maternal Vitamin D status in Pregnancy is ASSOCIATED with adiposity in the offspring: findings from the southampton women's survey."]	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy')]
PMC4113768	7/2014	S664-PMC4113768	['we will continue to examine LINKS between Vitamin D status throughout early childhood and body composition.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4113768	7/2014	S886-PMC4113768	['results were LINKED to biochemistry, haematology and Vitamin D measures in the patients.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S893-PMC4113768	['6 other patients had SIMILARLY deficient levels of Vitamin D, but they did not have frequent admissions, or lower levels of haemolysis.']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4113768	7/2014	S960-PMC4113768	['participants completed a questionnaire detailing potential demographic and lifestyle DETERMINANTS of Vitamin D status, and gave a Blood sample for analysis of Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration and dna extraction.']	[('SUPERFICIAL_RELATIONSHIP', 85)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0000178', 'blood', 130, 'blood'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 165, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D')]
PMC4113768	7/2014	S962-PMC4113768	['thirty-seven Single Nucleotide Polymorphisms (Snps) in 13 Genes (dbp, Dhcr7, Cubn, Lrp2, Crtam, Lta4H, Cyp2R1, Cyp3A4, Cyp27A1, Cyp27B1, Cyp24A1, vdr, rxra), INVOLVED with Vitamin D Transport, Metabolism and Signalling were typed using taqman Allelic discrimination assays.']	[('SUPERFICIAL_RELATIONSHIP', 158)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 58, 'genes'), ('PR_000006474', 'ATP-dependent RNA helicase A', 70, 'DHCR7'), ('PR_000006022', 'lysosomal protective protein', 77, 'CUBN'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 83, 'LRP2'), ('PR_000005866', 'cAMP-responsive element modulator', 89, 'CRTAM'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 96, 'LTA4H'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 103, 'CYP2R1'), ('PR_000006131', 'cytochrome P450 3A43', 111, 'CYP3A4'), ('PR_000006101', 'cytochrome P450 1A1', 119, 'CYP27A1'), ('PR_000006101', 'cytochrome P450 1A1', 128, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 137, 'CYP24A1'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0007601', 'visual perception', 172, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 182, 'transport ...'), ('GO_0009554', 'megasporogenesis', 193, 'metabolism ... signalling'), ('SO_0001023', 'allele', 243, 'allelic')]
PMC4113768	7/2014	S970-PMC4113768	['recent travel to a sunny country and Consumption of Vitamin D supplements were PROTECTIVE.']	[('SUPERFICIAL_RELATIONSHIP', 79)]	1	[('GO_0007631', 'feeding behavior', 37, 'consumption'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4113768	7/2014	S1050-PMC4113768	['results: a 10 nmol/l increase in season-adjusted 25(Oh) Vitamin D was significantly ASSOCIATED with a 0.14 nmol/l increase ( p = 0.01) in Osteocalcin after adjustment for study, city, fasting status, daytime of Blood draw, personal characteristics (age, sex, bmi, detectable sex hormones, total physical activity level) and socioeconomic factors (parental education, single parent status and income).']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('CHEBI_30778', 'gallic acid', 49, '25(OH)'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 64, 'D'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 138, 'osteocalcin'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC4113768	7/2014	S1054-PMC4113768	['higher levels of 25(Oh) Vitamin D were ASSOCIATED with slightly increased bone formation, and a decreased Bone Resorption to bone formation ratio.']	[('SUPERFICIAL_RELATIONSHIP', 39)]	1	[('CHEBI_30778', 'gallic acid', 17, '25(OH)'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0045453', 'bone resorption', 106, 'bone resorption')]
PMC4113768	7/2014	S1081-PMC4113768	['the precise nature of this ASSOCIATION and the optimum levels of Vitamin D for Cardiovascular health remain to be elucidated.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 79, 'cardiovascular')]
PMC4113768	7/2014	S1399-PMC4113768	['the strongest suppressive EFFECT was seen on Cyp11A1, 3Β-Hsd and Cyp19A1 where the Vitamin D treatment decreased the Gene Expression to 30% compared to control.']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 45, 'CYP11A1'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '3β-HSD'), ('PR_000006101', 'cytochrome P450 1A1', 65, 'CYP19A1'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0010467', 'gene expression', 117, 'gene expression'), ('SO_0000704', 'gene', 117, 'gene')]
PMC4113768	7/2014	S1558-PMC4113768	['when examined via linear regression, there was a weak but significant negative CORRELATION between Vitamin D and Cmv Antibody titre ( r = 0.102, p = 0.005).']	[('SUPERFICIAL_RELATIONSHIP', 79)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 113, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 117, 'antibody')]
PMC4113768	7/2014	S1584-PMC4113768	['generalised estimating equations will be used to examine the RELATIONSHIP between Vitamin D status and changes in absolute cd4+ cell count and cd4% over time.']	[('SUPERFICIAL_RELATIONSHIP', 61)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4113768	7/2014	S1686-PMC4113768	['when level of Vitamin D was compared with Sputum smear conversion time high significant p -value (0.00) indicates that level of Vitamin D has a significant ASSOCIATION with early Sputum Conversion in Pulmonary tb patients.']	[('SUPERFICIAL_RELATIONSHIP', 156)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0007311', 'sputum', 42, 'sputum'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0035041', 'sperm chromatin decondensation', 179, 'sputum conversion'), ('UBERON_0007311', 'sputum', 179, 'sputum'), ('UBERON_0002048', 'lung', 200, 'pulmonary')]
PMC4113768	7/2014	S1688-PMC4113768	['further we are also working on to see the ROLE of Vitamin D Receptor polymorphism in these patients.']	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 50, 'vitamin D receptor')]
PMC4113768	7/2014	S1698-PMC4113768	['Serum Calcium and Phosphorus was done as a BIOMARKER of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_31341', 'calcium dihydroxide', 6, 'Calcium'), ('CHEBI_30207', 'phosphorus(.)', 18, 'Phosphorus'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4113768	7/2014	S1792-PMC4113768	['background: within the lina cohort study maternal as well as newborn Vitamin D levels were shown to be positively ASSOCIATED with Allergic Sensitisation and Food Allergy Development within the first two years of Life.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0046631', 'alpha-beta T cell activation', 130, 'allergic sensitisation'), ('CHEBI_33290', 'food', 157, 'food'), ('GO_0048467', 'gynoecium development', 157, 'food allergy development'), ('UBERON_0000104', 'life cycle', 212, 'life')]
PMC4113768	7/2014	S1834-PMC4113768	['during this period, the danish government mandated the fortification of Margarine with Vitamin D, 1.25 mg/100 g. in this talk we will analyze and discuss the benefits ASSOCIATED with Prenatal Consumption of Vitamin D fortified Foods in terms of the development of schizophrenia amongst the progeny later in Life.']	[('SUPERFICIAL_RELATIONSHIP', 167)]	1	[('CHEBI_6784', 'mestranol', 72, 'margarine'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'prenatal'), ('GO_0007631', 'feeding behavior', 192, 'consumption'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'foods'), ('UBERON_0000104', 'life cycle', 307, 'life')]
PMC4113768	7/2014	S1975-PMC4113768	['there was a positive CORRELATION between the total amount of Vitamin D obtained from Food and the Serum 25(Oh)D concentration ( r = 0.218, p = 0.004).']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_33290', 'food', 85, 'food'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 104, '25(OH)D')]
PMC4113768	7/2014	S1978-PMC4113768	['conclusion: in the absence of Vitamin D Synthesis by sunlight, Vitamin D obtained from Food has a significant INFLUENCE on the Serum 25(Oh)D concentration in children.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 40, 'synthesis'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33290', 'food', 87, 'food'), ('UBERON_0001977', 'blood serum', 127, 'serum'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D')]
PMC4113768	7/2014	S2046-PMC4113768	['season had a distinct EFFECT on Vitamin D status during Pregnancy but not on Cord Blood.']	[('SUPERFICIAL_RELATIONSHIP', 22)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('UBERON_0009472', 'axilla', 77, 'cord blood')]
PMC4113768	7/2014	S2132-PMC4113768	['in multivariate analyses, sunnier season, lower latitude, higher Vitamin D intake index, Vitamin D supplement use, higher physical activity, lower bmi, and marital status were significantly ASSOCIATED with higher Serum 25(Oh)D levels in both sexes.']	[('SUPERFICIAL_RELATIONSHIP', 190)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_71657', 'versiconol acetate', 219, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 219, '25 ... OH ... D')]
PMC4113768	7/2014	S2189-PMC4113768	['treatment with Vitamin D did not reduce 24 h Ambulatory Blood pressure (adjusted treatment effects: systolic +3 mmhg, 95% ci −4 to +11, p = 0.33; diastolic −2 mmhg, 95% ci −6 to +2, p = 0.29); SIMILAR results were seen for office Blood pressure.']	[('SUPERFICIAL_RELATIONSHIP', 193)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0040011', 'locomotion', 45, 'ambulatory'), ('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0000178', 'blood', 230, 'blood')]
PMC4113768	7/2014	S2292-PMC4113768	['age and milk Consumption were the significant PREDICTORS of Vitamin D status, with 33.9% of variance perceived ( p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('GO_0007631', 'feeding behavior', 13, 'consumption'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4113768	7/2014	S2293-PMC4113768	['increased bmi, being married and the presence of muscle pain were all significantly ASSOCIATED with Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4113768	7/2014	S2309-PMC4113768	['Ft3 was inversely ASSOCIATED with circulating 25(Oh) Vitamin D ( r = −0.25; p = 0.01).']	[('SUPERFICIAL_RELATIONSHIP', 18)]	1	[('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 0, 'FT3'), ('CHEBI_30778', 'gallic acid', 46, '25(OH)'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S2420-PMC4113768	['maternal free 25(oh)-Vitamin D index was negatively ASSOCIATED with methylation at one of these rxra Cpg Sites (β = −3.3 sd/unit, p = 0.03).']	[('SUPERFICIAL_RELATIONSHIP', 52)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('SO_0000036', 'matrix_attachment_site', 101, 'CpG sites')]
PMC4113768	7/2014	S2546-PMC4113768	['methods: the examination of the INFLUENCE of Vitamin D supplementation and 25(Oh)D on Serum calcium levels was based on 8906 baseline and follow-up assessments of Vitamin D supplementation, Serum 25(Oh)D and calcium of healthy participants of the pure north wellness program.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('UBERON_0001977', 'blood serum', 190, 'serum'), ('CHEBI_71657', 'versiconol acetate', 196, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 196, '25 ... OH ... D')]
PMC4113768	7/2014	S2566-PMC4113768	['eighty-eight Single Nucleotide Polymorphisms (Snps) in 41 candidate Genes RELATED to Vitamin D status were genotyped using sequenom massarray technology.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 68, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4113768	7/2014	S2584-PMC4113768	['to date, the INFLUENCE of Vitamin D status during Gestation on long-term risk of t1d has not been widely studied.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'gestation')]
PMC4113768	7/2014	S2592-PMC4113768	['later, geographical latitude with its INFLUENCE on Vitamin D Synthesis was listed among the reasons.']	[('SUPERFICIAL_RELATIONSHIP', 38)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 51, 'vitamin D synthesis')]
PMC4113768	7/2014	S2671-PMC4113768	['mean bp was SIMILAR for the Vitamin D and placebo groups at baseline (123.4/76.3 vs. 122.6/75.6 mmhg; respectively).']	[('SUPERFICIAL_RELATIONSHIP', 12)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S2674-PMC4113768	['conclusions: long-term monthly Vitamin D supplementation, which increased mean 25(Oh)D concentration above 100 nmol/l for 18 months, had no EFFECT on systolic or diastolic bp in predominantly white, healthy Adults without severe Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 140)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 79, '25(OH ... D'), ('UBERON_0007023', 'adult organism', 207, 'adults'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4113768	7/2014	S2780-PMC4113768	['development of Bladder cancer is ASSOCIATED with low levels of Vitamin D. both Urinary Tract infections and 90% of Bladder cancers involve the transitional epithelium, which lines the Urinary Bladder.']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('UBERON_0018707', 'bladder organ', 15, 'bladder'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001553', 'medial tarsal artery', 79, 'urinary tract'), ('UBERON_0018707', 'bladder organ', 115, 'bladder'), ('UBERON_0001255', 'urinary bladder', 184, 'urinary bladder')]
PMC4113768	7/2014	S2920-PMC4113768	['methods: the EFFECT of Vitamin D on cancer progression was tested in the ntcu model, using dietary Vitamin D3(0 or 2000 iu/kg) alone and in combination with Intraperitoneal injections of the active Metabolite of Vitamin D, Calcitriol (80 µg/kg).']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('UBERON_2001932', 'sensory canal tubular ossicle', 157, 'intraperitoneal'), ('CHEBI_39382', 'flufenoxuron', 198, 'metabolite'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 223, 'calcitriol')]
PMC4113768	7/2014	S2929-PMC4113768	['moreover, Vitamin D deficiency was ASSOCIATED with an increased systemic and local inflammation marked by a 3-fold increase in Circulating White Blood Cells (Wbcs) ( p< 0.05), a 20% increase in Il-6 levels ( p< 0.05) and a 4 -fold increase in wbcs in bronchial lavages ( p< 0.05) in the dn group.']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CL_0000080', 'circulating cell', 127, 'circulating'), ('CL_0000738', 'leukocyte', 139, 'white blood cells'), ('UBERON_0000178', 'blood', 145, 'blood'), ('CL_0000784', 'plasmacytoid dendritic cell', 158, 'WBCs'), ('PR_000001470', 'interleukin-28B', 194, 'IL-6')]
PMC4113768	7/2014	S3047-PMC4113768	['the main DETERMINANTS of Cord 25(Oh)D [adjusted mean difference in nmol/l (95% ci)] were summer season of sampling [19.2 (17.4, 20.9), p < 0.0001], maternal 25(Oh)D concentrations at 15 weeks [0.3 (0.26, 0.34), p < 0.0001] and the maternal use of a Vitamin D containing supplement at 15 weeks [2.5 (0.6, 4.42), p = 0.011].']	[('SUPERFICIAL_RELATIONSHIP', 9)]	1	[('UBERON_0002240', 'spinal cord', 25, 'cord'), ('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 30, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 157, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4113768	7/2014	S3091-PMC4113768	['conclusion: Prenatal Vitamin D supplementation in late Pregnancy that had a modest EFFECT on Cord Blood Vitamin D level, was not associated with decreased wheezing in offspring at age three years.']	[('SUPERFICIAL_RELATIONSHIP', 83)]	1	[('GO_0007565', 'female pregnancy', 12, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S3200-PMC4113768	['use of Vitamin D supplements, living in an institution and season of Blood sampling were significant independent predictors of 25(Oh)D concentrations using linear regression models, while non-use of Vitamin D containing supplements, season and low physical activity PREDICTED Vitamin D deficiency using logistic regression models.']	[('SUPERFICIAL_RELATIONSHIP', 266)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 127, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC4113768	7/2014	S3280-PMC4113768	['conclusions: in the study population as a whole, intermittent bolus-dose Vitamin D supplementation did not influence time to exacerbation or time to uri, but it was ASSOCIATED with a modest reduction in severity of exacerbation symptoms.']	[('SUPERFICIAL_RELATIONSHIP', 165)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4113768	7/2014	S3346-PMC4113768	['meanwhile, the Vitamin D level was CORRELATED with air temperature and its partial correlation coefficient was 0.306 ( n = 3278, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4160835	9/2014	S19-PMC4160835	['Vitamin C and E, for the PREVENTION of pre-eclampsia.19\norganic agriculture is a production system that relies on ecological processes, biodiversity and cycles adapted to local conditions, aiming at sustaining the health of soils, ecosystems and People.20organically produced Food is produced without the application of synthetic Pesticides, synthetic fertilisers or Genetically modified Organisms.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamin C'), ('PR_000004900', 'complement C3', 8, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 14, 'E'), ('NCBITaxon_10088', 'Mus <genus>', 246, 'people'), ('CHEBI_33290', 'food', 276, 'food'), ('CHEBI_35392', 'glucarate(1-)', 330, 'pesticides'), ('SO_0000704', 'gene', 367, 'genetically'), ('NCBITaxon_1', 'root', 388, 'organisms')]
PMC4169453	9/2014	S117-PMC4169453	['the EFFECTS of group (maternal Vitamin D dose) × time interaction, group (maternal Vitamin D dose) and time on maternal and infants’ Serum 25(Oh)D levels were obtained from a two-factor repeated-measures anova.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('CHEBI_33010', 'chromide(1-)', 141, '(OH)D')]
PMC4169453	9/2014	S215-PMC4169453	['during Vitamin D supplementation in our infants, an increasing infants’ 25(Oh)D level COINCIDED with an increase in ipth.']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D')]
PMC4171568	9/2014	S84-PMC4171568	['these levels increased significantly at 4-month follow-up after Omega-3 Epufa supplementation combined with Vitamin C and E and were ASSOCIATED with improvements in psychopathology and quality Of Life.']	[('SUPERFICIAL_RELATIONSHIP', 133)]	1	[('CHEBI_82678', '3beta-hydroxy-7-oxo-5beta-cholan-24-oic acid', 64, 'omega-3 EPUFA'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 122, 'E'), ('GO_0007608', 'sensory perception of smell', 193, 'of life')]
PMC4188019	1/2010	S39-PMC4188019	['linear regression was used to analyse wether Vitamin D level is INFLUENCED by Gestational age, maternal age, parity, gravidity, sun exposure, intake of Supplements and/or date of Blood sample .']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'gestational'), ('CHEBI_33341', 'titanium atom', 152, 'supplements'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC4188019	1/2010	S53-PMC4188019	['there was a significant EFFECT of degree of body covering on Vitamin D level (linear regression, p\u2008<\u20080,001).']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4251419	12/2014	S22-PMC4251419	['in case-control studies, participants with one of these Autoimmune diseases TEND to report lower past sun exposure, and/or have lower Vitamin D status (measured as the Blood concentration of the intermediary Metabolite, 25(Oh)D, seefigure 1), than healthy controls (see for example recent reviews [12,13]).']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('UBERON_0001442', 'skeleton of manus', 56, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('UBERON_0000178', 'blood', 168, 'blood'), ('CHEBI_39382', 'flufenoxuron', 208, 'metabolite'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
PMC4251419	12/2014	S25-PMC4251419	['this is a stronger study design because the direction of causality is established, that is, the low Vitamin D status PRECEDES the onset of the health outcome.']	[('SUPERFICIAL_RELATIONSHIP', 117)]	1	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4251419	12/2014	S104-PMC4251419	['Vitamin D deficiency increased the severity of colitis and bacterial numbers in the Colons of Mice [66] and, in male Mice with allergic Airway disease (modelling allergic asthma), Vitamin D deficiency increased Lung inflammation and bacterial numbers [65]; these EFFECTS were reversed by Vitamin D supplementation [65].']	[('SUPERFICIAL_RELATIONSHIP', 263)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001155', 'colon', 84, 'colons'), ('NCBITaxon_10088', 'Mus <genus>', 94, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mice'), ('UBERON_0001005', 'respiratory airway', 136, 'airway'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('UBERON_0002048', 'lung', 211, 'lung'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D')]
PMC4251419	12/2014	S140-PMC4251419	['the EFFECT of these factors on the physiological, or disease-relevant, response to Vitamin D supplementation has not been explored.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4256222	12/2014	S1-PMC4256222	['purpose\nwe used occurrence of bone fractures up to the age of 18 as a measure reflecting offspring bone mass and RELATED that to maternal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 113)]	1	[('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4256222	12/2014	S64-PMC4256222	['furthermore, we analyzed the ASSOCIATION between maternal Vitamin D status and offspring Forearm fractures and performed sensitivity analyses where we excluded all fractures related to traffic accidents.']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 89, 'forearm')]
PMC4256222	12/2014	S78-PMC4256222	['maternal Vitamin D status was INDEPENDENT of maternal age, occupational status and sex of the child.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4256222	12/2014	S79-PMC4256222	['season for Blood sampling was highly RELATED to the status of Vitamin D (p<0.001).10.1371/journal.pone.0114334.t001\n\ncaption (table-wrap): table 1\nbackground characteristics of participants in the dafo88 cohort according to offspring bone fracture (yes/no) and maternal vitamin d status (nmol/l) around Gestational week 30 (n\u200a=\u200a850) in aarhus city, denmark.fracturevitamin d status (%)missing %yes n\u200a=\u200a294no n\u200a=\u200a556 p value<50 n\u200a=\u200a21750–74.9 n\u200a=\u200a19975–125 n\u200a=\u200a321>125 n\u200a=\u200a113 p valuematernalage (mean)29.129.00.72a28.829.329.128.90.62abmi (mean)3.621.321.50.26a21.921.221.421.10.10aeducationstatus (%)unskilled14.012.70.85b17.110.712.313.00.59bskilled25.426.424.627.324.929.6university39.036.435.835.337.941.7higheracademic14.316.914.419.816.710.2other7.37.58.06.98.25.6smokingnever (%)5.357.461.20.30b55.856.062.567.00.12bparity (%)nulliparous58.857.00.26b46.157.864.261.10.004b1 child28.933.440.533.225.930.12+children12.29.513.49.010.08.8sex, boy (%)57.149.80.04b48.455.851.755.70.41bseason of blood draw (%)mar/apr/may14.011.90.26b12.414.616.24.4<0.001bjun/jul/aug30.825.88.818.134.372.6sep/oct/nov34.237.452.135.729.917.7dec/jan/feb21.024.826.731.719.65.3\ntwo-sided anova for measure of association.']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('UBERON_0000178', 'blood', 11, 'blood'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 303, 'gestational')]
PMC4258799	11/2014	S301-PMC4258799	['the in vitro EFFECTS of Vitamin E on normal and abnormal Spermatozoa during cryopreservation are improved post-thaw motility [57,58] and dna integrity [57], while addition during incubation improved motility and viability of abnormal Spermatozoa [59].']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin E'), ('CL_0000019', 'sperm', 57, 'spermatozoa'), ('CL_0000019', 'sperm', 234, 'spermatozoa')]
PMC4258799	11/2014	S304-PMC4258799	['moslemi and tavanbakhsh studied the EFFECTS of Vitamin E and Selenium therapy for 14\xa0weeks in 690 asthenoteratozoospermic infertile men from couples with male factor infertility.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 61, 'selenium')]
PMC4289064	1/2015	S117-PMC4289064	["sixty-nine percent or more of the Vitamin A in children's diets came from fruits and vegetables, many of which DEPEND strongly on pollinators (fig."]	[('SUPERFICIAL_RELATIONSHIP', 111)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A')]
PMC4302429	1/2015	S87-PMC4302429	['Vitamin D3 deficiency LED TO higher mortality of E. Coli meningoencephalitis\nafter Intracerebral infection with 4,000\xa0cfus, 15 of 17 Vitamin D-deficient Mice (l-vitd), 10 of 21 Mice Fed a s-vitd diet, and 8 of 15 Mice Fed a h-vitd diet died ( p \u2009=\u20090.002\xa0l-vitd versus h-vitd, p \u2009=\u20090.003\xa0l-vitd versus s-vitd, log-rank test, figure\xa01a).']	[('SUPERFICIAL_RELATIONSHIP', 22)]	1	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 49, 'E. coli'), ('UBERON_0001093', 'vertebral bone 2', 83, 'intracerebral'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 153, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 177, 'mice'), ('GO_0007631', 'feeding behavior', 182, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 213, 'mice'), ('GO_0007631', 'feeding behavior', 218, 'fed')]
PMC4302429	1/2015	S165-PMC4302429	['the concentration of the biologically active form of Vitamin D, 1,25(Oh)2D, is DEPENDENT on the Serum Vitamin D (25(Oh)d) concentration, the substrate for Cyp27B1 [13,37].']	[('SUPERFICIAL_RELATIONSHIP', 79)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 66, '25(OH)2D'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 113, '25(OH'), ('PR_000006101', 'cytochrome P450 1A1', 155, 'CYP27B1')]
PMC4329404	10/2014	S20-PMC4329404	['additionally, lower Serum Vitamin D was ASSOCIATED with poorer Lung function and increased sensitization to aeroallergens (12,13).']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002048', 'lung', 63, 'lung')]
PMC4346113	3/2015	S89-PMC4346113	['low maternal Protein Consumption or poor Vitamin B and methionine status are ASSOCIATED with behavioral and Cardiovascular abnormalities, and sex-specific changes in Hepatic Gene Expression in Rat fetuses and changes in Imprinted Gene Expression in the Rat Embryo-fetal axis [40,74-76].']	[('SUPERFICIAL_RELATIONSHIP', 77)]	1	[('GO_0006412', 'translation', 13, 'protein consumption'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('UBERON_0004535', 'cardiovascular system', 108, 'cardiovascular'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('GO_0010467', 'gene expression', 174, 'gene expression'), ('SO_0000704', 'gene', 174, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('GO_0071514', 'genetic imprinting', 220, 'imprinted'), ('GO_0010467', 'gene expression', 230, 'gene expression'), ('SO_0000704', 'gene', 230, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat'), ('UBERON_0000922', 'embryo', 257, 'embryo')]
PMC4352710	2/2015	S21-PMC4352710	['investigated the ROLE of supplemental Folate, zinc and antioxidants (Vitamins C, e, and Β-Carotene) on Spermatocyte aneuploidy.']	[('SUPERFICIAL_RELATIONSHIP', 17)]	1	[('CHEBI_30863', '5-azaorotic acid', 38, 'folate'), ('CHEBI_27300', 'vitamin D', 69, 'vitamins C'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 88, 'β-carotene'), ('CL_0000017', 'spermatocyte', 103, 'spermatocyte')]
PMC4377870	3/2015	S113-PMC4377870	['[94] examined the EFFECT of Α-Tocopherol and Vitamin C on cbmc and maternal Peripheral Blood Mononuclear Cells (Pbmc).']	[('SUPERFICIAL_RELATIONSHIP', 18)]	1	[('CHEBI_27725', 'butin', 28, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CL_0000111', 'peripheral neuron', 76, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 76, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 93, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 93, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 112, 'PBMC')]
PMC4377870	3/2015	S147-PMC4377870	['in children, low circulating Vitamin D was RELATED to lower Lung function, increased Corticosteroid use and exacerbation frequency [117].']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002048', 'lung', 60, 'lung'), ('CHEBI_36916', 'cation', 85, 'corticosteroid')]
PMC4377870	3/2015	S148-PMC4377870	['also in children with Steroid resistant asthma, low Vitamin D was RELATED to increased asm thickness [117].']	[('SUPERFICIAL_RELATIONSHIP', 66)]	1	[('CHEBI_35341', 'steroid', 22, 'steroid'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4377879	3/2015	S179-PMC4377879	['indicators of low Vitamin B-12 are ASSOCIATED with adverse Pregnancy outcomes, anaemia, low birthweight, and Intrauterine retardation [9].']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 18, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 109, 'intrauterine')]
PMC4383226	2/2015	S2-PMC4383226	['parasitemia (n=8390) and plasmodium falciparum Hrp-2 ( pf Hrp-2)-RELATED antigenemia (n=6121) following Vitamin A supplementation and standard vaccination.']	[('SUPERFICIAL_RELATIONSHIP', 65)]	1	[('PR_000008820', 'heat shock protein beta-8', 47, 'HRP-2'), ('PR_000008820', 'heat shock protein beta-8', 58, 'HRP-2'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A')]
PMC4383226	2/2015	S83-PMC4383226	['the ASSOCIATION between Vitamin A and P ƒhrp-2 was stronger among children tested during the dry season or who lived in communities with a longer rainy season, and in communities with a lower annual mean for enhanced vegetation index (evi).']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('PR_000012567', 'peroxisome assembly factor 2', 38, 'P'), ('PR_000000164', 'BMP2', 44, '-2')]
PMC4383226	2/2015	S84-PMC4383226	['ASSOCIATIONS between Vitamin A and parasitemia were stronger among communities with a higher mean predicted Sickle Cell hemoglobin (hbs) Allele frequency or median predicted Glucose-6-Phosphate dehydrogenase deficiency (g6pdd) Allele frequency.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CL_0000129', 'microglial cell', 108, 'sickle cell'), ('SO_0001023', 'allele', 137, 'allele'), ('CHEBI_17234', 'glucose', 174, 'glucose'), ('CHEBI_18367', 'phosphate(3-)', 184, 'phosphate'), ('SO_0001023', 'allele', 227, 'allele')]
PMC4383226	2/2015	S86-PMC4383226	['modifiers of the ASSOCIATION between Vitamin A supplementation and malaria infection among children 6–59 months of age\ndoi: http://dx.doi.org/10.7554/elife.03925.007characteristics at Blood testinglevel in the model plasmodium species (parasitemia)* plasmodium falciparum (antigenemia)†no.']	[('SUPERFICIAL_RELATIONSHIP', 17)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('UBERON_0000178', 'blood', 184, 'blood')]
PMC4383575	1/2015	S7-PMC4383575	['residence in southern european countries, higher maternal body mass index, Delivery by cesarean section, male infant sex, low maternal intake of Fruits rich in Vitamin C, high Intake of Dairy Products, and low adherence to healthy diet score were statistically significantly ASSOCIATED with higher adduct levels in adjusted models.']	[('SUPERFICIAL_RELATIONSHIP', 275)]	1	[('GO_0007567', 'parturition', 75, 'delivery'), ('CHEBI_33290', 'food', 145, 'fruits'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin C'), ('GO_0007631', 'feeding behavior', 176, 'intake'), ('CHEBI_4682', 'dolasetron', 186, 'dairy products')]
PMC4392553	3/2015	S386-PMC4392553	['[7]\none final factor in cholestasis is Vitamin K deficiency, which is ASSOCIATED with cholestatic Liver disease.']	[('SUPERFICIAL_RELATIONSHIP', 70)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin K'), ('UBERON_0002107', 'liver', 98, 'liver')]
PMC4396835	1/2015	S110-PMC4396835	['25-Hydroxyvitamin D in children with asd RELATED to iq\nthere was no relation between iq and Vitamin D level, that is, the group with intellectual disability did not display lower 25(Oh)D levels compared to those without.']	[('SUPERFICIAL_RELATIONSHIP', 41)]	1	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 0, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 179, '25(OH)D')]
PMC4417995	4/2015	S14-PMC4417995	['two independent pathways LEAD TO Vitamin D Synthesis: the photochemical action of solar ultraviolet b (uvb) light in the skin and specific dietary sources.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 33, 'vitamin D synthesis')]
PMC4417995	4/2015	S127-PMC4417995	['[55] reported a Genetic association study in which a Vitamin D-related Gene polymorphism rs4674343 on Cyp27A1 was found to be PROTECTIVE against atopic eczema.']	[('SUPERFICIAL_RELATIONSHIP', 126)]	1	[('SO_0000704', 'gene', 16, 'genetic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('SO_0000704', 'gene', 71, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 102, 'CYP27A1')]
PMC4448820	5/2015	S221-PMC4448820	['ROLE of Vitamin A in Treg activity.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin A'), ('CL_0000901', 'Tr1 cell', 21, 'Treg')]
PMC4448820	5/2015	S234-PMC4448820	['ROLE of Vitamin D in Treg activity.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 21, 'Treg')]
PMC4448820	5/2015	S250-PMC4448820	['● pem and Vitamin A, zinc, and iron deficiencies exert their greatest EFFECT on reducing Cd4+T Cell function (79,161,162).']	[('SUPERFICIAL_RELATIONSHIP', 70)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin A'), ('CL_0000782', 'myeloid dendritic cell', 89, 'CD4+'), ('CL_0000084', 'T cell', 93, 'T cell')]
PMC4448820	5/2015	S259-PMC4448820	['● pem and Vitamin A and zinc deficiencies have their largest EFFECT in reducing Cd4+T Cell function (98).']	[('SUPERFICIAL_RELATIONSHIP', 61)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin A'), ('CL_0000782', 'myeloid dendritic cell', 80, 'CD4+'), ('CL_0000084', 'T cell', 84, 'T cell')]
PMC4448820	5/2015	S280-PMC4448820	['a. mechanisms of Vitamin A EFFECT on the Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('UBERON_0002405', 'immune system', 41, 'immune system')]
PMC4448820	5/2015	S290-PMC4448820	['b. mechanisms of Vitamin D EFFECT on the Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune system')]
PMC4448820	5/2015	S300-PMC4448820	['more than 10% of this proteome encodes enzymes, including Alcohol and Aldehyde dehydrogenases, INVOLVED in Vitamin A Metabolism (193).']	[('SUPERFICIAL_RELATIONSHIP', 95)]	1	[('CHEBI_30879', 'alcohol', 58, 'alcohol'), ('CHEBI_17478', 'aldehyde', 70, 'aldehyde'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 107, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 115, 'A')]
PMC4448820	5/2015	S346-PMC4448820	['ROLE of Vitamin A in epigenetic processes and the genetics of Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin A'), ('UBERON_0002405', 'immune system', 62, 'immune')]
PMC4448820	5/2015	S372-PMC4448820	['ROLE of Vitamin D in epigenetic processes and the genetics of Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002405', 'immune system', 62, 'immune')]
PMC4448820	5/2015	S568-PMC4448820	['EFFECTS of vad/Vitamin A supplementation on Immune function and disease risk.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('UBERON_0002405', 'immune system', 44, 'immune')]
PMC4448820	5/2015	S569-PMC4448820	['as discussed by wg 1, Vad and Vitamin A supplementation AFFECT a range of innate and Adaptive Immune functions.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_16695', "uridine 5'-monophosphate", 22, 'VAD'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0019825', 'oxygen binding', 85, 'adaptive immune'), ('UBERON_0002405', 'immune system', 94, 'immune')]
PMC4448820	5/2015	S871-PMC4448820	['to explore this aspect of the inflammation/nutrition RELATION, 6 specific Nutrients—iron, zinc, Vitamin A, Folate, Vitamin B-12, and Vitamin D—are examined.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_33284', 'nutrient', 74, 'nutrients'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 107, 'folate'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 123, 'B'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4448820	5/2015	S1458-PMC4448820	['INFLUENCE of inflammation on Vitamin A assessment.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin A')]
PMC4448820	5/2015	S1502-PMC4448820	['the ROLE of Vitamin B-12 in health and disease was previously reviewed (785,786).']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 12, 'vitamin B-12')]
PMC4452099	6/2015	S68-PMC4452099	['the size of the study population in various Gestational period groups is presented in tables1and2.10.1371/journal.pone.0128631.t001\n\ncaption (table-wrap): table 1\nstudied population by periods of various Gestational exposures to Vitamin D fortification, t1d onset age, and sex.n (%)Birth period in RELATION to exposure to Vitamin D fortification during Gestationexposure: jan 1983-may 1985*washout: jun 1985-aug 1986*non-exposure: sep 1986-dec 1988*total127,20769,667134,749\xa0\xa0\xa0\xa0males (% from total)65,266 (51.3)35,729 (51.3)69,436 (51.5)t1d until 15 (% from total)298 (0.23)184 (0.26)404 (0.30)\xa0\xa0\xa0\xa0in males (% from above)157 (52.7)99 (53.8)224 (55.4)t1d at 0–4 (% from total)32 (0.02)28 (0.04)54 (0.04)\xa0\xa0\xa0\xa0in males (% from above)21 (65.6)11 (39.3)35 (64.8)t1d at 5–9 (% from total)83 (0.07)55 (0.08)131 (0.10)\xa0\xa0\xa0\xa0in males (% from above)38 (45.8)29 (52.7)75 (57.3)t1d at 10–15 (% from total)183 (0.14)101 (0.14)219 (0.16)\xa0\xa0\xa0\xa0in males (% from above)98 (53.6)59 (58.4)114 (52.1)\n* including the starting and ending months.10.1371/journal.pone.0128631.t002\n\ncaption (table-wrap): table 2\nstudied population by periods of various first Postnatal year exposures to Vitamin D fortification, t1d onset age, and sex.n (%)Birth period in relation to exposure to Vitamin D fortification during first year of Postnatal Lifeexposure: jan 1983-may 1984*washout: jun 1984-aug 1986*non-exposure: sep 1986-dec 1988*total73,986122,888134,749males (% from total)37,977 (51.3)63,018 (51.3)69,436 (51.5)t1d until 15 (% from total)156 (0.23)326 (0.26)404 (0.30)in males (% from above)82 (52.6)174 (53.4)224 (55.4)t1d at 0–4 (% from total)15 (0.02)45 (0.04)54 (0.04)in males (% from above)7 (46.7)25 (55.6)35 (64.8)t1d at 5–9 (% from total)49 (0.07)89 (0.08)131 (0.10)in males (% from above)19 (38.8)48 (53.9)75 (57.3)t1d at 10–15 (% from total)92 (0.14)192 (0.14)219 (0.16)in males (% from above)56 (60.9)101 (52.6)114 (52.1)\n* including the starting and ending months.']	[('SUPERFICIAL_RELATIONSHIP', 298)]	1	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'gestational'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0007567', 'parturition', 282, 'Birth'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007530', 'sex determination', 353, 'gestationExposure'), ('GO_0007567', 'parturition', 1131, 'postnatal'), ('CHEBI_27300', 'vitamin D', 1159, 'vitamin D'), ('GO_0007567', 'parturition', 1212, 'Birth'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1260, 'D'), ('GO_0007567', 'parturition', 1297, 'postnatal'), ('UBERON_0002004', 'trunk of sciatic nerve', 1307, 'lifeExposure')]
PMC4452099	6/2015	S89-PMC4452099	['the Intake of Vitamin D among Pregnant and Lactating women CORRELATES well with the Vitamin D Serum levels [28].']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('GO_0007631', 'feeding behavior', 4, 'intake'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('GO_0007594', 'puparial adhesion', 43, 'lactating'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001977', 'blood serum', 94, 'serum')]
PMC4452099	6/2015	S109-PMC4452099	['conclusions\nwe did not find that Gestational or early Infancy exposure to small extra doses of Vitamin D coming from the danish mandatory Margarine fortification programme INFLUENCED the risk of developing t1d later in Life.']	[('SUPERFICIAL_RELATIONSHIP', 172)]	1	[('GO_0007565', 'female pregnancy', 33, 'gestational'), ('UBERON_0000023', 'wing', 54, 'infancy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 138, 'margarine'), ('UBERON_0000104', 'life cycle', 219, 'life')]
PMC4466139	6/2015	S44-PMC4466139	['nbs values measured by lc-ms and maternal values measured by immunoassay methods were COMPARABLE after reconverted neonatal Vitamin D levels to Serum concentration (nmol/l) using the same algorithm [16,18–21].']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 144, 'serum')]
PMC4466139	6/2015	S121-PMC4466139	['in conclusion, Vitamin D insufficiency in Pregnancy is widely present in piedmont and it is RELATED to Vitamin D status in newborns.']	[('SUPERFICIAL_RELATIONSHIP', 92)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4488777	5/2015	S100-PMC4488777	['in linear regression analysis Serum, Vitamin D level positively CORRELATED with total Testosterone ( p< 0.001) and free Androgen index ( p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_17347', 'testosterone', 86, 'testosterone'), ('CHEBI_50113', 'androgen', 120, 'androgen')]
PMC4499946	7/2015	S29-PMC4499946	['the EFFECTS of Prenatal Vitamin D supplementation on infant length have not been widely studied in controlled trials.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('GO_0007565', 'female pregnancy', 15, 'prenatal'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4499946	7/2015	S113-PMC4499946	['Tablets may be Consumed with or without Food, which has a negligible IMPACT on Vitamin D absorption [44].']	[('SUPERFICIAL_RELATIONSHIP', 69)]	1	[('CHEBI_33288', 'rodenticide', 0, 'Tablets'), ('GO_0007631', 'feeding behavior', 15, 'consumed'), ('CHEBI_33290', 'food', 40, 'food'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4499946	7/2015	S245-PMC4499946	['two secondary approaches will be used to examine the EFFECTS of Vitamin D on linear growth.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4516377	6/2015	S3-PMC4516377	["we used the combined terms in english: ''children'' and ''calcium'' or ''children'' and ''Vitamin D'' ASSOCIATED with the descriptors: ''obesity'', ''adiposity'' or ''body fat'' for all bases."]	[('SUPERFICIAL_RELATIONSHIP', 102)]	1	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4516377	6/2015	S6-PMC4516377	['data synthesis:\neight articles were part of this review, five of which were RELATED to calcium and three to Vitamin D. most studies had a longitudinal design.']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4516377	6/2015	S28-PMC4516377	['among the included articles, five13-17were RELATED to Calcium and three18,20,21to Vitamin D.figure 1shows the process flowchart until the selection of the studies included in this review.']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4516377	6/2015	S38-PMC4516377	['in a study with children aged seven to nine years in korea, lee et al.18found an inverse ASSOCIATION between Vitamin D concentrations and bmi, body fat percentage (bf%), waist circumference, mid-Arm circumference and Triceps Skinfold.']	[('SUPERFICIAL_RELATIONSHIP', 89)]	1	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001460', 'arm', 195, 'arm'), ('UBERON_0005299', 'prepuce of clitoris', 217, 'triceps skinfold')]
PMC4516377	6/2015	S71-PMC4516377	['this fact is RELATED to a higher incidence of sunlight in tropical areas, increasing the Conversion Of Vitamin D into its active form, which is measured.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('GO_0006936', 'muscle contraction', 89, 'conversion of'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D')]
PMC4516377	6/2015	S88-PMC4516377	['Calcium and Vitamin D, both assessed by dietary intake and by biochemical markers, were ASSOCIATED with obesity.']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4595656	10/2015	S33-PMC4595656	['the offspring of Vitamin D deficient Rats have larger Lateral Ventricles (eyles et al.,2003; féron et al.,2005), a thinner Cortex (eyles et al.,2003) diminished levels of Nerve Growth Factor (Ngf; eyles et al.,2003; féron et al.,2005), and reduced Expression of a number of Genes INVOLVED in Neuronal structure and Neurotransmission (féron et al.,2005).']	[('SUPERFICIAL_RELATIONSHIP', 280)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 37, 'rats'), ('UBERON_0002285', 'telencephalic ventricle', 54, 'lateral ventricles'), ('UBERON_0001851', 'cortex', 123, 'cortex'), ('PR_000011193', 'ephexin-1', 171, 'nerve growth factor'), ('UBERON_0001021', 'nerve', 171, 'nerve'), ('PR_000011159', 'nexilin', 192, 'NGF'), ('GO_0010467', 'gene expression', 248, 'expression'), ('SO_0000704', 'gene', 274, 'genes'), ('CL_0000540', 'neuron', 292, 'neuronal'), ('GO_0007266', 'Rho protein signal transduction', 315, 'neurotransmission')]
PMC4595656	10/2015	S115-PMC4595656	['one in vitro study has investigated the INTERACTION of Glucocorticoids with Vitamin D in isolated Hippocampal Cells (obradovic et al.,2006).']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('CHEBI_36597', 'phthalazine', 55, 'glucocorticoids'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CL_0002608', 'hippocampal neuron', 98, 'hippocampal cells')]
PMC4595656	10/2015	S116-PMC4595656	['pre-treatment with 1 μmol Vitamin D for 24 h substantially reduced the degree of Dexamethasone—induced Apoptosis and induced the activation of the P42/P44 mapk Complex which is INVOLVED in Cellular Differentiation.']	[('SUPERFICIAL_RELATIONSHIP', 177)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_41879', 'dexamethasone', 81, 'dexamethasone'), ('GO_0006915', 'apoptotic process', 103, 'apoptosis'), ('PR_000001245', 'rhodopsin', 147, 'p42'), ('PR_000001245', 'rhodopsin', 151, 'p44'), ('GO_0032991', 'protein-containing complex', 160, 'complex'), ('GO_0030154', 'cell differentiation', 189, 'cellular differentiation')]
PMC4600246	10/2015	S26-PMC4600246	['gla-containing proteins (Mgp and Osteocalcin) Regulate many Anticalcification and Bone-Forming processes in the body, which are DEPENDENT on Vitamin K in order to be produced.']	[('SUPERFICIAL_RELATIONSHIP', 128)]	1	[('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 25, 'MGP'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 33, 'osteocalcin'), ('GO_0065007', 'biological regulation', 46, 'regulate'), ('GO_0009948', 'anterior/posterior axis specification', 60, 'anticalcification'), ('GO_0071714', 'icosanoid transmembrane transporter activity', 82, 'bone-forming'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin K')]
PMC4624803	10/2015	S74-PMC4624803	['the ASSOCIATION between Vitamin D values in the lower quartile among the swedish controls (<10.4 ng/ml) and adhd was also analysed, but was not statistically significant (or: 1.10; 95% ci: 0.71–1.71).']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4627942	10/2015	S197-PMC4627942	['in ghana, Vitamin A supplementation was found to increase Liver reserves of mothers during the Postpartum period, with the EFFECTS persisting for at least five months (72).']	[('SUPERFICIAL_RELATIONSHIP', 123)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin A'), ('UBERON_0002107', 'liver', 58, 'liver'), ('GO_0007565', 'female pregnancy', 95, 'postpartum')]
PMC4632418	10/2015	S127-PMC4632418	['taking bmi for example, increased bmi in Pregnancy is ASSOCIATED with higher risk of gdm [49], as well as increased risk of Vitamin D deficiency [5].']	[('SUPERFICIAL_RELATIONSHIP', 54)]	1	[('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4632423	10/2015	S101-PMC4632423	['low Vitamin D status is also ASSOCIATED with physical anomalies including osteomalacia and Skeletal malformations [27].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0004288', 'skeleton', 91, 'skeletal')]
PMC4670104	12/2015	S7-PMC4670104	['negatively associated proteins exhibited distinct differences in abundance between secretory Hepatic proteins involved in transporting or binding Lipids, Micronutrients (Vitamin A and Calcium), growth factors and sex hormones, and proteins of largely extra-Hepatic origin INVOLVED in the Formation and Metabolic Regulation Of Extracellular Matrix.']	[('SUPERFICIAL_RELATIONSHIP', 272)]	1	[('UBERON_0002107', 'liver', 93, 'hepatic'), ('CHEBI_18059', 'lipid', 146, 'lipids'), ('CHEBI_33839', 'macromolecule', 154, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 184, 'calcium'), ('UBERON_0002107', 'liver', 257, 'hepatic'), ('GO_0007631', 'feeding behavior', 288, 'formation ...'), ('GO_0008152', 'metabolic process', 302, 'metabolic'), ('GO_0010524', 'positive regulation of calcium ion transport into cytosol', 312, 'regulation of ... matrix'), ('GO_0031012', 'extracellular matrix', 326, 'extracellular matrix')]
PMC4684854	12/2015	S65-PMC4684854	['dosing of Supplements, body weight, levels of various Toxicants, and individual Metabolism can all be FACTORS in consequent Vitamin D indices after supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 102)]	1	[('CHEBI_33341', 'titanium atom', 10, 'supplements'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 54, 'toxicants'), ('GO_0008152', 'metabolic process', 80, 'metabolism'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4684854	12/2015	S76-PMC4684854	['Gestational Vitamin D status and obstetrical outcomes\nthe list of adverse Gestational outcomes in Pregnancy ASSOCIATED with Vitamin D insufficiency continues to mount.']	[('SUPERFICIAL_RELATIONSHIP', 108)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestational'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4689556	12/2015	S91-PMC4689556	['secondary analysis included bolus and daily Vitamin D groups combined (combined Vitamin D) compared with the control group and the RELATIONSHIP between 25(Oh)D levels measured in Cord Blood at Delivery and in the child at age three years.']	[('SUPERFICIAL_RELATIONSHIP', 131)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 179, 'cord'), ('UBERON_0000178', 'blood', 184, 'blood'), ('GO_0007567', 'parturition', 193, 'delivery')]
PMC4691762	12/2015	S19-PMC4691762	['furthermore as one of the few countries that does not routinely fortify the Food chain supply, australia is uniquely placed internationally to assess the ROLE of Vitamin D in Early Life development.']	[('SUPERFICIAL_RELATIONSHIP', 154)]	1	[('CHEBI_33290', 'food', 76, 'food'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 175, 'early life')]
PMC4691762	12/2015	S29-PMC4691762	['infants of mothers who intend to continue predominantly breastfeeding until 6\u2005months will be recruited since Formula Feeding is a SURROGATE form of partial Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 130)]	1	[('GO_0009057', 'macromolecule catabolic process', 109, 'formula'), ('GO_0007631', 'feeding behavior', 117, 'feeding'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4719746	1/2016	S95-PMC4719746	['=\u20090.24independent variabler2adj.b95\xa0% cib95\xa0% cir2adj.b95\xa0% cib95\xa0% cilowerupperlowerupperlowerupperloweruppergestational week at inclusion (<15 ref)−0.0010.01ᅟ≥15−0.56−4.43.3 −6.4−10−2.3**−4.6−8.3−0.92* age at inclusion0.03 0.940.551.3** 0.14−0.210.490.03 1.10.641.5**0.700.261.1** parity (para 0 ref)0.020.01ᅟpara1−1.2−5.43.10.24−3.13.6−2.8−7.41.8 −4.4−8.7−0.22* ᅟpara ≥2 −11−17−6.3** −3.2−7.61.3 −9.3−15−3.8** −5.4−110.25geographic region (western europe ref)0.380.16ᅟsouth asia −37−40−33**−28−33−23**−26−31−21**−17−23−11** ᅟmiddle east −34−39−30**−24−29−18**−21−26−15**−9.5−16−2.9** ᅟsub-saharan africa −31−37−25**−20−27−13**−26−34−19**−12−20−3.1** ᅟeast asia −17−24−10**−11−18−3.9**−19−28−11**−11−20−1.6* ᅟother −13−19−6.4**−7.6−14−0.90*−9.0−17−1.3* −1.4−9.66.9season (summer ref)0.030.01ᅟwinter −9.9−14−6.1**−5.2−8.9−1.4**−5.7−9.8−1.6** −1.3−6.13.4geographic region*seasona−11−16−4.8**−15−22−7.4** education level (>12 y ref)0.110.08ᅟ10-12 year −14−18−10**−3.7−7.1−0.30*−11−15−6.8** −1.8−6.12.5ᅟ<10\xa0year −23−28−17**−5.2−10−0.31*−23−29−17**−8.6−15−2.5** Vitamin D supplements (≥10μgbref)0.080.02ᅟno or <10\xa0μg −15−19−11**−11−14−7.7**−8.2−13−3.8**−9.8−14−5.8** pre-Pregnancy bmi (<25\xa0kg/m2ref)−0.001−0.001ᅟ≥25\xa0kg/m2−0.76−4.73.2−0.11−4.44.2\nathe EFFECT of season on 25(Oh)d differed by ethnicity: the interaction term is "1" for records with both non-western and winter and "0" for western and summer (ref)\nbintake of ≥10\xa0μg Vitamin D daily past two weeks\nbold numbers indicate p \u2009<\u20090.05 (* p \u2009<\u20090.05, ** p \u2009<\u20090.01)\n\nVitamin D status at Gestational week 28\nat the beginning of the third trimester, the prevalence of 25(Oh)D <50\xa0nmol/l among the largest ethnic minority groups was lower than at study inclusion: south asia: 62\xa0%, the middle east: 58\xa0% and sub-saharan africa: 63\xa0%.']	[('SUPERFICIAL_RELATIONSHIP', 1248)]	1	[('CHEBI_28384', 'vitamin K', 1059, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1168, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 1268, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1268, '25(OH'), ('CHEBI_27300', 'vitamin D', 1427, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1435, 'D'), ('CHEBI_28384', 'vitamin K', 1519, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1539, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 1618, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 1618, '25 ... OH ... D')]
PMC4719746	1/2016	S99-PMC4719746	['in addition, age, parity, education, intake of Vitamin D supplementation and Gestational week at inclusion were independently ASSOCIATED with 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 126)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 148, 'D')]
PMC4728621	1/2016	S126-PMC4728621	['no association between change in maternal weight from late Pregnancy to 6 months Postpartum and any measure of offspring anthropometry was observed.nutrients-08-00007-t003_table 3\n\ncaption (table-wrap): table 3\n\nmaternal and paternal characteristics and maternal Nutrient intakes associated with 6 months old offspring adiposity-adjusted analysis *.model variabletotal model bseb p -value r2adjp -value weight for length z-score 0.0790.001trimester 1 sodium0.00030.00010.003 weight for age z-score 0.141<0.001trimester 2 Saturated Fatty (%Te)0.0750.0270.005 length for age z-score 0.186<0.001trimester 1 Carotene9.63e−050.000040.013trimester 1 Pufa (%te)0.1590.0490.002 bmi for age z-score 0.0710.002trimester 1 sodium0.00030.00010.003 muac-for-age z-score 0.1820.001trimester 3 sodium0.00030.00010.009gestational weight gain (kg)0.0590.0180.002 Triceps skinfold-for-age z-score 0.0880.003trimester 3 Vitamin C−0.0050.0030.035trimester 3 glycaemic index0.0530.0230.023 Subscapular Skinfold-for-age z-score 0.0710.045moderate pa baseline (number of 20 min intervals/day)0.1150.0450.013 thigh circumference 0.0990.001trimester 1 sodium0.0010.00030.013trimester 1 Carotene0.00020.000080.038trimester 3 Carbohydrate (%te)−0.0810.0340.019 Biceps Skinfold 0.1090.003trimester 1 Thiamine0.6030.2070.004baseline minutes sitting/weekday0.0020.0010.064trimester 3 glycaemic index0.1210.040.003 sum of Triceps and Subscapular Skinfolds 0.0670.015trimester 2 Vitamin C−0.0150.0050.007 waist:hip circumference ratio 0.163<0.001trimester 1 Vitamin B6−0.0280.0120.019trimester 3 potassium3.01e−058.39e−06<0.001trimester 1 Glycaemic index−0.0040.0010.004trimester 2 Saturated Fat (%te)0.0060.002<0.001\nbackwards stepwise multiple linear regression was used for this analysis * adjusted for well-established INFLUENCES on neonatal size.']	[('SUPERFICIAL_RELATIONSHIP', 1791)]	1	[('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('GO_0007565', 'female pregnancy', 81, 'postpartum'), ('CHEBI_33284', 'nutrient', 263, 'nutrient'), ('CHEBI_26710', 'sodium chloride', 521, 'saturated fatty'), ('CHEBI_87158', 'SU1498', 539, 'TE'), ('CHEBI_23042', 'carotene', 604, 'carotene9'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 644, 'PUFA'), ('UBERON_0001509', 'triceps brachii', 846, 'Triceps'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin C'), ('UBERON_0012295', "Guérin's valve", 969, 'Subscapular skinfold'), ('CHEBI_87207', 'pyrimidine fungicide', 1161, 'carotene0'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 1199, 'carbohydrate'), ('UBERON_0001530', 'common carotid artery plus branches', 1234, 'Biceps'), ('UBERON_0009007', 'superficial inguinal lymph node', 1241, 'skinfold'), ('CHEBI_48466', 'glutaredoxin disulfide', 1272, 'thiamine0'), ('UBERON_0001509', 'triceps brachii', 1391, 'triceps'), ('UBERON_3010813', 'vent glands', 1403, 'subscapular skinfolds'), ('CHEBI_27300', 'vitamin D', 1447, 'vitamin C'), ('CHEBI_33237', 'vitamin D4', 1526, 'vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 1534, 'B6'), ('CHEBI_24400', 'glycoside', 1607, 'glycaemic'), ('CHEBI_26710', 'sodium chloride', 1650, 'saturated fat')]
PMC4729160	1/2016	S24-PMC4729160	['vitamin a status is assessed by the Serum concentration of Retinol, but there was little about its value as a MARKER of Vitamin A status during Pregnancy in china.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_26536', 'retinoic acid', 59, 'retinol'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy')]
PMC4730270	12/2015	S30-PMC4730270	['risks AFFECTING early-Life bp of offspring examined in these cohorts include smoking, low Vitamin D intake, Gestational hypertension, maternal obesity, short-term breastfeeding, excessive Postnatal weight gain, and undernutrition [10,11,12,13,14,15,16,17,18,19,20].']	[('SUPERFICIAL_RELATIONSHIP', 6)]	1	[('UBERON_0000104', 'life cycle', 22, 'life'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'gestational'), ('GO_0007567', 'parturition', 188, 'postnatal')]
PMC4764019	1/2016	S38-PMC4764019	['denmark has a long-standing practice of storing Cord Blood samples on all newborns, making it possible to explore ASSOCIATIONS between late-Life–onset diseases and Vitamin D status at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000104', 'life cycle', 140, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC4778858	3/2016	S96-PMC4778858	['as we expected, Cord Blood levels of Vitamin D were found to be strongly ASSOCIATED with Birth season.']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('UBERON_0002240', 'spinal cord', 16, 'cord'), ('UBERON_0000178', 'blood', 21, 'blood'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'birth')]
PMC4785305	3/2016	S151-PMC4785305	['subgroup analysis based on the season will be also performed to check for INTERACTION between the Vitamin D dose and the season of Pregnant women enrolment.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant')]
PMC4811107	3/2016	S55-PMC4811107	['maternal atopic status was included because the primary goal of the cohort was to study allergic outcomes in the children and Prenatal and early Life Vitamin D levels have been investigated for their ROLE in allergic disease development [22,24–27].']	[('SUPERFICIAL_RELATIONSHIP', 200)]	1	[('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('UBERON_0000104', 'life cycle', 145, 'life'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4811441	3/2016	S87-PMC4811441	['Vitamin D status was used as time-varying in model 1, where the mean of the 25(Oh)D concentration in t1 and t3 was used as a PROXY for Vitamin D status at Gestational week 25 and the concentration at week 32 (t3) was duplicated for week 37.']	[('SUPERFICIAL_RELATIONSHIP', 125)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'gestational')]
PMC4829940	5/2016	S2-PMC4829940	['SIMILARLY for offspring health outcomes and Vitamin D, no convincing associations.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4843009	4/2016	S25-PMC4843009	['Prenatal Vitamin D deficiency INFLUENCES Murine self-grooming behavior36.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 41, 'murine')]
PMC4843009	4/2016	S27-PMC4843009	['in Humans Vitamin D deficiency PREDISPOSES to several psychiatric disorders, such as depression, bipolar disorder and schizophrenia32434445.']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4846845	4/2016	S157-PMC4846845	['maternal Vitamin D levels during Pregnancy also PREDICT long-term outcomes for the child including congenital rickets, smaller Arm muscle and higher Insulin resistance, autism spectrum disorders, and asthma in childhood.']	[('SUPERFICIAL_RELATIONSHIP', 48)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0001460', 'arm', 127, 'arm'), ('PR_000045358', 'insulin family protein', 149, 'insulin')]
PMC4846845	4/2016	S158-PMC4846845	['higher levels of Vitamin D is ASSOCIATED with higher fasting Insulin, Cholesterol, and Triglyceride concentrations in Adults [120,121,122,123,124].']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('PR_000045358', 'insulin family protein', 61, 'insulin'), ('CHEBI_16113', 'cholesterol', 70, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 87, 'triglyceride'), ('UBERON_0007023', 'adult organism', 118, 'adults')]
PMC4846845	4/2016	S159-PMC4846845	['the largest PREDICTOR of circulating Vitamin D levels in neonates is the circulating Vitamin D levels of their mothers [125].']	[('SUPERFICIAL_RELATIONSHIP', 12)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4846845	4/2016	S162-PMC4846845	['1,25(Oh)2D then binds the Vitamin D receptor, which can subsequently act as a transcription factor by targeting the Vitamin D response element (vdre) motif within the Promoter of the target Gene to AFFECT Gene Expression [126].']	[('SUPERFICIAL_RELATIONSHIP', 198)]	1	[('CHEBI_37983', 'sulfur-35 atom', 0, '1'), ('CHEBI_17996', 'chloride', 1, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('SO_0000167', 'promoter', 167, 'promoter'), ('SO_0000704', 'gene', 190, 'gene'), ('GO_0010467', 'gene expression', 205, 'gene expression'), ('SO_0000704', 'gene', 205, 'gene')]
PMC4889866	5/2016	S6-PMC4889866	['maternal Vitamin D level was inversely CORRELATED with Il-10 response to Tlr3 ( p = 0.004) and Tlr7-8 stimulation ( p = 0.006).']	[('SUPERFICIAL_RELATIONSHIP', 39)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 55, 'IL-10'), ('PR_000001155', 'Toll-like receptor 4', 73, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 95, 'TLR7')]
PMC4891833	6/2016	S164-PMC4891833	['Iron and Vitamin A BIOMARKERS will be adjusted for inflammation using the method described by thurnham et al.']	[('SUPERFICIAL_RELATIONSHIP', 19)]	1	[('CHEBI_24870', 'ion', 0, 'Iron'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC4896250	4/2016	S6534-PMC4896250	['Cathelicidin, Human B-Defensin and Autophagy Related Protein Light Chain 3 Alpha (Lc3A, a Molecule INVOLVED in Autophagy) were upregulated after Vitamin D administration in pbmcs with similar results observed in necs.']	[('SUPERFICIAL_RELATIONSHIP', 99)]	1	[('CHEBI_3461', 'Casuarictin', 0, 'Cathelicidin'), ('PR_000004907', 'complement component C7', 0, 'Cathelicidin'), ('NCBITaxon_9606', 'Homo sapiens', 14, 'human'), ('PR_000002199', 'cytochrome c protein', 20, 'b-defensin'), ('GO_0006914', 'autophagy', 35, 'autophagy'), ('PR_000003681', 'actin, gamma-enteric smooth muscle', 35, 'autophagy related protein light chain 3 alpha'), ('PR_000009691', 'protein LBH', 82, 'LC3A'), ('CHEBI_36357', 'polyatomic entity', 90, 'molecule'), ('GO_0006914', 'autophagy', 111, 'autophagy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4897157	5/2016	S18-PMC4897157	['Synthesis in the skin represents the major natural source of Vitamin D; such dermal synthesis is DEPENDENT on sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 97)]	1	[('GO_0009057', 'macromolecule catabolic process', 0, 'Synthesis'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4908484	6/2016	S2-PMC4908484	['this research was planned to study the ROLE of Vitamin D to prevent iron damage in neuroblastomabe(2)m17 cells.']	[('SUPERFICIAL_RELATIONSHIP', 39)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4908484	6/2016	S18-PMC4908484	['moreover, Vitamin D can PROTECT Neurons against nmda, glutamate, 6‐Hydroxydopamine, and Reactive Oxygen Species (brewer et\xa0al.2001; ibi et\xa0al.2001).']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CL_0000540', 'neuron', 32, 'neurons'), ('CHEBI_65941', '6-O-galloyl-beta-D-glucose', 65, '6‐hydroxydopamine'), ('CHEBI_26523', 'reactive oxygen species', 88, 'reactive oxygen species')]
PMC4930210	7/2016	S7-PMC4930210	['there was a significant RELATIONSHIP between maternal reported dietary Vitamin D intake (diet and supplement) and 25(Oh)D and 3-Epi-25(Oh)D3Concentrations in an adjusted linear regression model.']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('CHEBI_34304', 'fenobucarb', 126, '3-epi-25'), ('CHEBI_73735', 'gadoterate', 135, 'OH)D3concentrations')]
PMC4930210	7/2016	S73-PMC4930210	['a multiple linear regression analysis was used to examine the ASSOCIATION between women’s Plasma 25(Oh)D (D2+ D3) concentration and their reported dietary Vitamin D intake in supplements and diet adjusted for the potential covariates of maternal age, maternal bmi at second trimester, season (summer from may 01-oct 31 and winter from nov 01-apr 30), and race (caucasian vs .']	[('SUPERFICIAL_RELATIONSHIP', 62)]	1	[('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 97, '25(OH ... D'), ('CHEBI_29108', 'calcium(2+)', 106, 'D2+'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 106, 'D2'), ('PR_000001177', 'D(2) dopamine receptor', 110, 'D3'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4930210	7/2016	S109-PMC4930210	['ASSOCIATION between women’s Plasma 25(Oh)D and 3-Epi-25(Oh)D3Concentration and maternal reported Vitamin D intake .']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('UBERON_0001969', 'blood plasma', 28, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 35, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 41, 'D'), ('CHEBI_58090', 'L-cysteate(1-)', 47, '3-epi-25(OH)D3concentration'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4930210	7/2016	S111-PMC4930210	['there was a significant ASSOCIATION between maternal Plasma 25(Oh)D and total reported Vitamin D intake during the second Trimester of Pregnancy (β: 0.09, 95% ci: 0.06 to 0.13) in an adjusted linear regression model.']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('UBERON_0001969', 'blood plasma', 53, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 60, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 122, 'trimester'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC4930210	7/2016	S112-PMC4930210	['season of sampling and race were also significantly ASSOCIATED with 25(Oh)D concentration (table 4).10.1371/journal.pone.0157262.g002\n\ncaption (fig): fig 2\nabsolute concentrations of (a) Plasma 25(Oh)D, and (b) Plasma 3-Epi-25(Oh)D3Versus maternal Vitamin D intake (iu/day) in a longitudinal cohort of Pregnant women and their infants in alberta, canada.']	[('SUPERFICIAL_RELATIONSHIP', 52)]	1	[('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 68, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 187, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 211, 'plasma'), ('CHEBI_34304', 'fenobucarb', 218, '3-epi-25'), ('CHEBI_51048', '(R,R)-diepoxybutane', 226, '(OH)D3versus'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 302, 'pregnant')]
PMC4930210	7/2016	S118-PMC4930210	['in addition, the ASSOCIATION between maternal Plasma 3-epi-25(oh)d3and total reported Vitamin D intake during the second trimester was significant (β: 0.13, 95% ci: 0.07 to 0.18), as well as maternal bmi at second Trimester and race in an adjusted linear regression model (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 17)]	1	[('UBERON_0001969', 'blood plasma', 46, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 214, 'trimester')]
PMC4930210	7/2016	S124-PMC4930210	['≥ 75 nmol/l in a multiple logistic regression model, higher reported intake of Vitamin D was ASSOCIATED with greater odds of Vitamin D sufficiency during the second trimester within both ranges (or: 2.17, 95% ci: 1.48 to 3.16 for ≥75 nmol/l and or: 3.21, 95% ci: 1.17 to 8.83 for ≥50 nmol/l).']	[('SUPERFICIAL_RELATIONSHIP', 93)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4933662	4/2016	S157-PMC4933662	['lower Transcript Expression of\xa0Vitamin D Receptor and Interferon Gamma in Skeletal muscle Tissue was ASSOCIATED with higher lean mass and lower Gene Expression of Interleukin 6 (il‐6), Tumour Necrosis Factor‐alpha (Tnf‐Α) and Interleukin‐1 Receptor (Il1R1) in community‐dwelling older men (patel et\xa0al .,2014).']	[('SUPERFICIAL_RELATIONSHIP', 101)]	1	[('SO_0000673', 'transcript', 6, 'transcript'), ('GO_0010467', 'gene expression', 17, 'expression'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 31, 'vitamin D receptor'), ('PR_000002050', 'interferon regulatory factor 8', 54, 'interferon gamma'), ('CHEBI_37958', 'dye', 65, 'gamma'), ('UBERON_0004288', 'skeleton', 74, 'skeletal'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0010467', 'gene expression', 144, 'gene expression'), ('SO_0000704', 'gene', 144, 'gene'), ('PR_000008988', 'interleukin-1 family member 5', 163, 'interleukin 6'), ('PR_000016589', 'tumor protein p63-regulated gene 1 protein', 185, 'tumour necrosis factor'), ('PR_000000134', 'tumor necrosis factor alpha', 215, 'TNF‐α'), ('PR_000001364', 'interleukin-1 receptor type II', 226, 'interleukin‐1 receptor'), ('PR_000001385', 'interleukin-27 subunit alpha', 250, 'IL1R1')]
PMC4934634	11/2015	S25-PMC4934634	['caption (fig): figure 1\n\nmodifying factors that can AFFECT Vitamin D status throughout the Life Cycle.']	[('SUPERFICIAL_RELATIONSHIP', 52)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life cycle'), ('GO_0007049', 'cell cycle', 96, 'cycle')]
PMC4934634	11/2015	S67-PMC4934634	['compared to women with Serum levels ≥30 ng/ml, women with low Vitamin D status had higher circulating Antiphospholipid Antibodies ASSOCIATED with poor Reproductive outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 130)]	1	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_16240', 'hydrogen peroxide', 102, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 119, 'antibodies'), ('GO_0000003', 'reproduction', 151, 'reproductive')]
PMC4934634	11/2015	S116-PMC4934634	['the EFFECTS of Vitamin D supplementation (400 iu /day Vitamin D3) on Insulin and Glucose Metabolism were observed in healthy, Pregnant women in their 25th week of Gestation [45].']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 54, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 54, 'vitamin D3'), ('GO_0007631', 'feeding behavior', 69, 'insulin ...'), ('PR_000045358', 'insulin family protein', 69, 'insulin'), ('CHEBI_17234', 'glucose', 81, 'glucose'), ('GO_0006006', 'glucose metabolic process', 81, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 126, 'pregnant'), ('GO_0007565', 'female pregnancy', 163, 'gestation')]
PMC4934634	11/2015	S133-PMC4934634	['to test the dose response EFFECT of Vitamin D on Glucose Metabolism, doses of 200 iu/day, 50,000 iu/monthly, or 50,000 iu/biweekly Vitamin D3Were chosen to supplement healthy (non-Gestational diabetes), Pregnant women with severe Vitamin D deficiency (7.6 ± 6.3 ng/ml) from the 12th week of Gestation to Delivery [49].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_17234', 'glucose', 49, 'glucose'), ('GO_0006006', 'glucose metabolic process', 49, 'glucose metabolism'), ('CHEBI_73706', 'bromosuccinate', 131, 'vitamin D3were'), ('PR_000017209', 'utrophin', 131, 'vitamin D3were'), ('GO_0007565', 'female pregnancy', 180, 'gestational'), ('GO_0007565', 'female pregnancy', 203, 'pregnant'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'gestation'), ('GO_0007567', 'parturition', 304, 'delivery')]
PMC4934634	11/2015	S175-PMC4934634	['through vdr, Vitamin D is INVOLVED in Modulation Of Histone Acetylation and Methylation resulting in the activation or silencing of Genes [63,64,65].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0061724', 'lipophagy', 38, 'modulation of'), ('CHEBI_15358', 'histone', 52, 'histone'), ('GO_0034729', 'histone H3-K79 methylation', 52, 'histone acetylation ... methylation'), ('PR_000043452', 'core histone', 52, 'histone'), ('SO_0000704', 'gene', 132, 'genes')]
PMC4934634	11/2015	S201-PMC4934634	['children will be followed for three years for Respiratory health outcomes and the data will provide a better look into the EFFECTS of a higher dose Vitamin D supplement on allergic outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 123)]	1	[('UBERON_0001004', 'respiratory system', 46, 'respiratory'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4934640	11/2015	S102-PMC4934640	['as mentioned above, smoking in Pregnancy is LINKED to depressive symptoms, more frequent use of Psychotropic Medications and other prescribed Medications, [13] poor maternal nutrition, iron deficiency and low Vitamin D [29].']	[('SUPERFICIAL_RELATIONSHIP', 44)]	1	[('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_18170', 'selenic acid', 96, 'psychotropic'), ('CHEBI_25441', 'mycothiols', 109, 'medications'), ('CHEBI_25441', 'mycothiols', 142, 'medications'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4944244	7/2016	S75-PMC4944244	['caption (table-wrap): table 1\n\nsocio-demographic, Antenatal, skin characteristics and Vitamin D intake of first trimester Pregnant women ( n \u2009=\u2009396)independent variablesnpercentmean\u2009±\u2009sd /\xa0median (iqr 25\xa0%, 75\xa0%)a) socio-demographic factors\u2003age (year)28.06\u2009±\u20094.09 (min\u2009=\u200918, max\u2009=\u200940)\u2003ethnic groups\u2003\u2003malay30777.5\u2003\u2003chinese4411.2\u2003\u2003indian358.8\u2003\u2003others102.5\u2003educational status\u2003\u2003primary school164.0\u2003\u2003secondary school14937.6\u2003\u2003tertiary school23158.4\u2003working status\u2003\u2003working30176.0\u2003\u2003not working9524.0\u2003household members3 (2,4) (min\u2009=\u20092, max\u2009=\u200912)\u2003household income per monthrm3500 (2800,5000) (min\u2009=\u2009rm900, max\u2009=\u2009rm20 000)b) factors related to Antenatal\u2003Week Of Pregnancy10 (8,12) (min\u2009=\u20094, max\u2009=\u200912)\u2003gravidity2 (1,3) (min\u2009=\u20091, max\u2009=\u20099)\u2003parity0 (0,1) (min\u2009=\u20090, max\u2009=\u20096)\u2003smoking status\u2003\u2003yes30.8\u2003\u2003no39399.2\u2003last child Birth\u2003\u2003≤ 2\xa0years12461.1\u2003\u2003>2\xa0years7938.9\u2003\u2003not applicable (first Pregnancy)193\u2003still breastfeeding\u2003\u2003yes4122.9\u2003\u2003no13879.1\u2003\u2003not applicable (no child)217\u2003body mass index (bmi) before Pregnancy(kg/m2)22.69 (19.95, 26.36) (min\u2009=\u200914.29, max\u2009=\u200953.90)\u2003weight at first Antenatal visit (kg)57.70 (49.60,68.00) (min\u2009=\u200933.00, max\u2009=\u2009148.70)c) factors related to skin\u2003fitzpatrick skin classification\u2003\u2003skin type i -ii10326.0\u2003\u2003skin type iii17343.7\u2003\u2003skin type iv-vi12030.3\u2003Melanin indices (using mexameter 18) (0-999.000)302.17 (245.00, 302.17) (min\u2009=\u2009133.33, max\u2009=\u2009949.33)\u2003sun protection score (0-8)5 (4,5) (min\u2009=\u20090, max\u2009=\u20097)\u2003the length of time exposed to sunlight (minutes per week)37.50 (0,150) (min\u2009=\u20090, max\u2009=\u20091680)d) factors related to Vitamin D intake\u2003intake of Vitamin D in Food (iu/day)202.16 (124.94, 334.62) (min\u2009=\u200913.50, max\u2009=\u20091523.12)\u2003the number of respondents taking Antenatal Supplements\u2003\u2003taking Supplements containing Vitamin D4411.1\u2003\u2003taking supplements without Vitamin D intake61.5\u2003\u2003not taking supplement34687.4\u2003Calcium and Vitamin D supplement\u2003\u2003no38697.5\u2003\u2003yes102.5\u2003intake of Vitamin D from Food and supplements (iu/day)220.04 (137.88, 376.45) (min\u2009=\u200915.10, max\u2009=\u20091523.12)\u2003the level of Vitamin D taken from Food and supplements (iu/day)\u2003\u2003<200\xa0iu/day17844.90\u2003\u2003≥200\xa0iu/day21855.10\n\ncaption (table-wrap): table 2\n\nSerum Vitamin D (25(Oh)D) concentrations among first Trimester Pregnant women ( n \u2009=\u2009396)Serum Vitamin dnpercentmedian (iqr 25\xa0%, 75\xa0%)Serum concentration of 25 (Oh)D nmol/l27.11 (19.87,36.99) (min\u2009=\u20097.50, max\u2009=\u2009121.43)Serum concentration of 25 (Oh) D nmol/l (categorized)\u2003<25.00\xa0nmol/l17443.9\u200325-49.99\xa0nmol/l18446.5\u200350-74.99\xa0nmol/l338.3\u2003≥75\xa0nmol/l51.3serum concentration of 25 (Oh) D nmol/l (categorized)\u2003<50\xa0nmol/l35890.4\u2003≥50\xa0nmol/l389.6\ntable\xa03shows the association between each independent variable with hypovitaminosis d. age, ethnicity, education level, fitzpatrick classification, Melanin indices, sun protection score and Intake of Vitamin D from Food have ASSOCIATION with hypovitaminosis D ( p \u2009<\u20090.05).']	[('SUPERFICIAL_RELATIONSHIP', 2779)]	1	[('GO_0007567', 'parturition', 50, 'antenatal'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0003410', 'anterior rotation of the optic cup', 634, 'antenatal Week of pregnancy10'), ('GO_0007567', 'parturition', 806, 'Birth'), ('GO_0007565', 'female pregnancy', 869, 'pregnancy'), ('GO_0007565', 'female pregnancy', 984, 'pregnancy'), ('GO_0007567', 'parturition', 1064, 'antenatal'), ('CHEBI_25179', 'melanins', 1260, 'Melanin'), ('CHEBI_27300', 'vitamin D', 1528, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1555, 'vitamin D'), ('CHEBI_33290', 'food', 1568, 'food'), ('GO_0007567', 'parturition', 1667, 'antenatal'), ('CHEBI_33341', 'titanium atom', 1677, 'supplements'), ('CHEBI_33341', 'titanium atom', 1697, 'supplements'), ('CHEBI_72741', '2-arachidonyl-sn-glycero-3-phosphoethanolamine', 1720, 'vitamin D4411'), ('CHEBI_27300', 'vitamin D', 1764, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 1815, 'Calcium'), ('CHEBI_27300', 'vitamin D', 1827, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1879, 'vitamin D'), ('CHEBI_33290', 'food', 1894, 'food'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D'), ('CHEBI_33290', 'food', 2010, 'food'), ('UBERON_0001977', 'blood serum', 2114, 'Serum'), ('CHEBI_27300', 'vitamin D', 2120, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2131, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 2131, '25 ... OH ... D'), ('GO_0009294', 'DNA mediated transformation', 2167, 'trimester'), ('GO_0007565', 'female pregnancy', 2177, 'pregnant'), ('UBERON_0001977', 'blood serum', 2203, 'Serum'), ('CHEBI_33229', 'vitamin (role)', 2209, 'vitamin'), ('UBERON_0001977', 'blood serum', 2249, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2272, '25 (OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 2272, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 2279, 'D'), ('UBERON_0001977', 'blood serum', 2333, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2356, '25 (OH) D'), ('CHEBI_71657', 'versiconol acetate', 2489, '25 (OH) D'), ('CHEBI_25179', 'melanins', 2702, 'melanin'), ('GO_0007631', 'feeding behavior', 2744, 'intake'), ('CHEBI_27300', 'vitamin D', 2754, 'vitamin D'), ('CHEBI_33290', 'food', 2769, 'food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2812, 'D')]
PMC4949006	7/2016	S132-PMC4949006	['supplementation does prevent and cure this condition.93–95all studies to date fail to show any significant EFFECTS of Vitamin A supplementation on Pregnancy outcomes for mother or fetus.96more than 10,000 iu of Vitamin A supplementation per day (4 times the recommended daily allowance) increases the risk of cleft lip or palate, Hydrocephalus, and Heart defects.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	[('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('UBERON_4100114', 'anterior distal condyle of femur', 330, 'hydrocephalus'), ('UBERON_0000948', 'heart', 349, 'heart')]
PMC4949006	7/2016	S150-PMC4949006	['Calcium and/or Vitamin D deficiency LEADS TO porous, weak Bones and to rickets.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001474', 'bone element', 58, 'bones')]
PMC4958285	7/2016	S70-PMC4958285	[')39351008.55\n\nHerbals, homeopathic and dietary medications\nwith respect to herbals, homeopathic and dietary medications, there were a total of 4462 calls, with the majority of these inquiries being unspecified ( n \u2009=\u2009492), this was closely followed by inquires RELATED to Caffeine Consumption ( n \u2009=\u2009415), zinc ( n \u2009=\u2009246), and Vitamin C ( n \u2009=\u2009205) supplements.']	[('SUPERFICIAL_RELATIONSHIP', 261)]	1	[('CHEBI_35581', 'indole', 14, 'Herbals'), ('CHEBI_27732', 'caffeine', 272, 'caffeine'), ('GO_0007631', 'feeding behavior', 281, 'consumption'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin C')]
PMC4969253	8/2016	S33-PMC4969253	['[14,15]\n\nPrenatal Vitamin A-ra Signaling INFLUENCES the program of Smooth Muscle differentiation in developing Airways\nthe developing Lung Mesenchyme gives rise to a number of derivatives including Endothelium, cartilage rings, Interstitial Fibroblasts, and vascular and Airway Smooth Muscle.']	[('SUPERFICIAL_RELATIONSHIP', 41)]	1	[('GO_0007565', 'female pregnancy', 9, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 26, 'A'), ('GO_0023051', 'regulation of signaling', 31, 'signaling'), ('UBERON_0001135', 'smooth muscle tissue', 67, 'smooth muscle'), ('UBERON_0001005', 'respiratory airway', 111, 'airways'), ('UBERON_0004883', 'lung mesenchyme', 134, 'lung mesenchyme'), ('UBERON_0001986', 'endothelium', 198, 'endothelium'), ('UBERON_0005169', 'interstitial tissue', 228, 'interstitial'), ('CL_0000057', 'fibroblast', 241, 'fibroblasts'), ('UBERON_0004230', 'urinary bladder neck smooth muscle', 271, 'airway smooth muscle')]
PMC4969253	8/2016	S51-PMC4969253	['on multivariate analysis, severity of disease was highly CORRELATED with Serum Vitamin A levels.']	[('SUPERFICIAL_RELATIONSHIP', 57)]	1	[('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
PMC4969253	8/2016	S52-PMC4969253	['studies have also LINKED severity of Vitamin A deficiency with severity of wheezing in infants [17].']	[('SUPERFICIAL_RELATIONSHIP', 18)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A')]
PMC4971719	8/2016	S8-PMC4971719	['our primary outcome measure was the ASSOCIATION of maternal Vitamin D levels with bdi scores during early and late Pregnancy and Postpartum.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0007565', 'female pregnancy', 129, 'postpartum')]
PMC4971719	8/2016	S85-PMC4971719	['statistical analysis\nwe evaluated mean Vitamin D levels and standard deviations at 12–20 weeks and at 34–36 weeks and used pearson’s correlation to evaluate the RELATIONSHIP between time points.']	[('SUPERFICIAL_RELATIONSHIP', 161)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4973215	8/2016	S3-PMC4973215	['results:\nblack race, medicaid status, mean body mass index at Delivery and lack of Prenatal vitamin use were ASSOCIATED with Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 109)]	1	[('GO_0007567', 'parturition', 62, 'delivery'), ('GO_0007565', 'female pregnancy', 83, 'prenatal'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4973215	8/2016	S43-PMC4973215	['race, medicaid status, higher bmi at Delivery and lack of Prenatal vitamin use were all ASSOCIATED with Vitamin D deficiency (25(Oh)D <50\u2009nmol\u2009l−1; p<0.01).']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('GO_0007567', 'parturition', 37, 'delivery'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4973215	8/2016	S69-PMC4973215	['bodnar et al.8conducted a case–control study to examine the ASSOCIATION between Vitamin D levels, race and sga.']	[('SUPERFICIAL_RELATIONSHIP', 60)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4976416	7/2016	S13-PMC4976416	['[7]\n\nstability of vitamin e\nstability of Vitamin E DEPENDS ON its form, dl-α-toc acetate being the most stable.']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin E')]
PMC4979151	8/2016	S21-PMC4979151	['in a sub-set in the same trial cohort, we studied the IMPACT of Vitamin D status on the Expression profile of cytokines by Stimulated T Lymphocytes and on T Cell Activation pathway as a key component of Adaptive Immunity.']	[('SUPERFICIAL_RELATIONSHIP', 54)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0010467', 'gene expression', 88, 'expression'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 123, 'stimulated'), ('CL_0000084', 'T cell', 134, 'T lymphocytes'), ('CL_0000084', 'T cell', 155, 'T cell'), ('GO_0042110', 'T cell activation', 155, 'T cell activation'), ('GO_0051866', 'general adaptation syndrome', 203, 'adaptive immunity')]
PMC4988030	8/2016	S114-PMC4988030	['the remaining five diet outcome variables (Cholesterol, dietary fiber, iron, Vitamin C, and Choline) were modeled using quantile regression on the median to test for significant treatment, time and treatment by time EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 216)]	1	[('CHEBI_16113', 'cholesterol', 43, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin C'), ('CHEBI_15354', 'choline', 92, 'choline')]
PMC4989298	8/2016	S241-PMC4989298	['evaluate the EFFECT of the administration of antioxidants (Β-Carotene, Vitamin C, Vitamin E, copper and zinc) on the development of allergic disease in children [93].']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 59, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin E')]
PMC4990280	8/2016	S121-PMC4990280	['hb was also positively ASSOCIATED with Vitamin A in all children (table 4).']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A')]
PMC4990280	8/2016	S161-PMC4990280	['iron status IMPACTS Plasma and Liver levels of Vitamin A [42].']	[('SUPERFICIAL_RELATIONSHIP', 12)]	1	[('UBERON_0001969', 'blood plasma', 20, 'plasma'), ('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin A')]
PMC4992225	8/2016	S242-PMC4992225	['in a study by mozafari- khosravi et al., 300,000 and 150,000\xa0iu Vitamin D were administered by injection to the two groups who suffered depression and the third group did not receive Vitamin D. high doses of Vitamin D were EFFECTIVE in decreasing depression levels after 3\xa0months [30].']	[('SUPERFICIAL_RELATIONSHIP', 223)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC4992225	8/2016	S249-PMC4992225	['the existence of receptors for the active form of Vitamin D (1, 25(Oh)2D) in the Brain induces a direct EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 104)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_17996', 'chloride', 62, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 64, '25(OH)2D'), ('UBERON_0000955', 'brain', 81, 'brain')]
PMC4992225	8/2016	S266-PMC4992225	['staying on Vitamin D consumption until Childbirth resulted in higher Serum 25-Hydroxyvitamin D concentration that induced the EFFECT on Postnatal depression exceeding than Prenatal depression.']	[('SUPERFICIAL_RELATIONSHIP', 126)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 39, 'childbirth'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 75, '25-hydroxyvitamin D'), ('GO_0007567', 'parturition', 136, 'postnatal'), ('GO_0007565', 'female pregnancy', 172, 'prenatal')]
PMC4993554	8/2016	S115-PMC4993554	['the women were asked to identify Micronutrients for which there was a risk ASSOCIATED with excessive intake, from a list including zinc, Vitamin A, magnesium, vitamin D, and Vitamin B6.']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('CHEBI_33839', 'macromolecule', 33, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 167, 'D'), ('CHEBI_33237', 'vitamin D4', 174, 'vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 182, 'B6')]
PMC4993554	8/2016	S174-PMC4993554	['the low level of knowledge RELATING to Food that is a rich source of Vitamin A (Liver) is concerning, especially during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_33290', 'food', 39, 'food'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('UBERON_0002107', 'liver', 80, 'liver'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy')]
PMC4997421	8/2016	S8-PMC4997421	['results: the poverty score and race were significantly ASSOCIATED with Vitamin A status after adjustment for confounders.']	[('SUPERFICIAL_RELATIONSHIP', 55)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A')]
PMC4997567	8/2016	S101-PMC4997567	['the RISK FACTORS included low socioeconomic status, nutritionally Vitamin D deficient mothers, and prolonged Breast Feeding without Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 109, 'breast'), ('GO_0007631', 'feeding behavior', 116, 'feeding'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4998950	4/2016	S2-PMC4998950	['method\nusing a register-based total population study ( n =509 639), we calculated adjusted odds ratios (aors) and 95% confidence intervals (cis) of asd with and without intellectual disability in RELATION to lifetime diagnoses of maternal Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 196)]	1	[('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC4998950	4/2016	S18-PMC4998950	['we first calculated frequencies and means of case status and other characteristics ACCORDING to lifetime maternal Vitamin D deficiency, with pearson’s chi-square tests to compute the difference between proportions and t -tests to test the difference between means.']	[('SUPERFICIAL_RELATIONSHIP', 83)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5014971	8/2016	S18-PMC5014971	['fetal and neonatal Vitamin D status is largely DEPENDENT upon maternal status [11], and maternal Vitamin D deficiency/insufficiency is distressingly prevalent in the united states.']	[('SUPERFICIAL_RELATIONSHIP', 47)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC5028238	10/2016	S11-PMC5028238	['these mutations AFFECT a pathway involving Vitamin D and Cholesterol Production.']	[('SUPERFICIAL_RELATIONSHIP', 16)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 57, 'cholesterol'), ('GO_0002510', 'central B cell tolerance induction', 57, 'cholesterol production')]
PMC5054480	9/2016	S70-PMC5054480	['caption (table-wrap): table 2\n\nchanges in Calcium Homeostasis during Pregnancy and Lactationmeasured levelspregnant womanplacentafetuslactating womanserum Catotal Ca ↓Ionized Ca↔Intestinal Absorption twofold ↑active transfer DEPENDENT on Pthrp+ passive transferhigher than maternal levels; Regulated by fetal pthrpionized Ca slightly ↑Bone Resorption ↑Urinary Ca↑unknown↔pth↓↔no transferlowlowpthrpprogressively ↑ secretion by Decidua and Breastsno transfer; Placental and amniotic secretionhigher than in mothersecretion by the Umbilical Cord and Fetal Parathyroid Glands as early as 10 weeks↑↑: secretion by breasts25‐Vitamin D↔transfer; Placental hydroxylationrenal hydroxylation↔1,25‐dihydroxyvitamin dprogressive ↑ by 100%; Calbindin‐D9K ↑no transferlow↔1 α ‐hydroxylase activity↑stimulated by Estradiol, prolactin, Placental Lactogen, pthrppresentpresent in the Kidney↔Calcitonin↑ by 20%secretion by Thyroid and breastsno transfer; Placental secretion↑ in the first 6 weeks\nca, calcium level; Pthrp, Parathyroid Hormone‐Related Protein; Calbindin‐D9K, Vitamin D‐dependent calcium‐binding protein.']	[('SUPERFICIAL_RELATIONSHIP', 225)]	1	[('GO_0055073', 'cadmium ion homeostasis', 42, 'calcium homeostasis'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0001764', 'neuron migration', 83, 'lactationMeasured'), ('CHEBI_17793', 'calycosin', 155, 'CaTotal'), ('CHEBI_32588', 'potassium chloride', 163, 'Ca'), ('CHEBI_24870', 'ion', 166, '↓'), ('CHEBI_5893', 'indapamide', 167, 'Ionized'), ('GO_0070481', 'nuclear-transcribed mRNA catabolic process, non-stop decay', 167, 'Ionized'), ('CHEBI_32588', 'potassium chloride', 175, 'Ca'), ('GO_0050892', 'intestinal absorption', 178, 'Intestinal absorption'), ('UBERON_0000160', 'intestine', 178, 'Intestinal'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 238, 'PTHrP'), ('GO_0065007', 'biological regulation', 290, 'regulated'), ('CHEBI_32588', 'potassium chloride', 322, 'Ca'), ('GO_0097578', 'sequestering of copper ion', 335, 'Bone resorption'), ('UBERON_0001088', 'urine', 352, 'Urinary'), ('CHEBI_32588', 'potassium chloride', 360, 'Ca'), ('UBERON_0002450', 'decidua', 427, 'decidua'), ('UBERON_0000310', 'breast', 439, 'breastsNo'), ('UBERON_0001987', 'placenta', 459, 'placental'), ('UBERON_0002331', 'umbilical cord', 529, 'umbilical cord'), ('UBERON_0000922', 'embryo', 548, 'fetal'), ('UBERON_0001132', 'parathyroid gland', 554, 'parathyroid glands'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D'), ('UBERON_0001987', 'placenta', 640, 'placental'), ('PR_000004968', 'calretinin', 729, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 739, 'D9k'), ('CHEBI_23965', 'estradiol', 799, 'estradiol'), ('CHEBI_81588', 'Placental lactogen', 821, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 821, 'placental lactogen'), ('UBERON_0001987', 'placenta', 821, 'placental'), ('UBERON_0002113', 'kidney', 868, 'kidney'), ('CHEBI_17793', 'calycosin', 875, 'Calcitonin'), ('UBERON_0002046', 'thyroid gland', 906, 'thyroid'), ('UBERON_0001987', 'placenta', 938, 'placental'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 999, 'PTHrP'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1006, 'parathyroid hormone'), ('UBERON_0001132', 'parathyroid gland', 1006, 'parathyroid'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 1026, 'related protein'), ('PR_000004968', 'calretinin', 1043, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 1053, 'D9k'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin D')]
PMC5062906	10/2016	S4-PMC5062906	['methods\nwe used collaborative cross (cc) inbred Mice to characterize the EFFECT of maternal Vitamin D depletion on offspring phenotypic and epigenetic outcomes at Imprinted domains ( h19/igf2 , snrpn , Dlk1/Gtl2 , and Grb10 ) in the Soma (Liver) and germline (Sperm).']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('NCBITaxon_10088', 'Mus <genus>', 48, 'mice'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0071514', 'genetic imprinting', 163, 'imprinted'), ('PR_000006549', 'doublesex- and mab-3-related transcription factor C2', 202, 'Dlk1'), ('PR_000007939', 'glial fibrillary acidic protein', 207, 'Gtl2'), ('PR_000008210', 'glutathione peroxidase 1', 218, 'Grb10'), ('GO_0044297', 'cell body', 233, 'soma'), ('UBERON_0002107', 'liver', 239, 'liver'), ('CL_0000019', 'sperm', 260, 'sperm')]
PMC5062906	10/2016	S7-PMC5062906	['results\nmaternal Vitamin D deficiency LED TO altered body weight and Dna Methylation in two generations of offspring.']	[('SUPERFICIAL_RELATIONSHIP', 38)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0006306', 'DNA methylation', 69, 'DNA methylation')]
PMC5062906	10/2016	S115-PMC5062906	['2\n\nmaternal (g0) Vitamin D deficiency is LINKED to (g1) offspring developmental outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 41)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5062906	10/2016	S136-PMC5062906	['3\n\nGrandmaternal (g0) Vitamin D deficiency is LINKED to g2offspring developmental outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('GO_0000050', 'urea cycle', 3, 'Grandmaternal'), ('UBERON_0001225', 'cortex of kidney', 3, 'Grandmaternal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC5062906	10/2016	S240-PMC5062906	['in both generations, maternal and grandmaternal Vitamin D-dependent epigenetic changes COINCIDE with differences in offspring body weight, body composition, and Testes weight.']	[('SUPERFICIAL_RELATIONSHIP', 87)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000473', 'testis', 161, 'testes')]
PMC5084016	10/2016	S126-PMC5084016	['in the first stage of Pregnancy, Vitamin D (mainly Vitamin D3, the predominant form in the maternal Blood) is INVOLVED in the Regulation Of Cytokine Metabolism and in the Modulation Of the Immune System, thereby contributing to the Embryo Implantation and Regulating the secretion of several hormones.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 51, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'Vitamin D3'), ('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 126, 'regulation of'), ('GO_0009690', 'cytokinin metabolic process', 140, 'cytokine metabolism'), ('GO_0002022', 'detection of dietary excess', 171, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 189, 'immune system'), ('GO_0007601', 'visual perception', 232, 'embryo'), ('UBERON_0000922', 'embryo', 232, 'embryo'), ('GO_0007566', 'embryo implantation', 239, 'implantation'), ('GO_0065007', 'biological regulation', 256, 'regulating')]
PMC5084016	10/2016	S129-PMC5084016	['the season of Birth, ethnicity, and maternal prophylaxis during Pregnancy AFFECT the Vitamin D status of infants.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('GO_0007567', 'parturition', 14, 'birth'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5084041	10/2016	S96-PMC5084041	['in a multivariable logistic regression analysis, DETERMINANTS relating to odds of 25(Oh)D concentrations <30 nmol/l at t1 were of non-north european origin, sampling in spring, never exposing skin when sunny, no Vitamin D supplementation, lower dietary Vitamin D intake and lower age (table 2).']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5084041	10/2016	S97-PMC5084041	['among the subgroup ( n = 316) of women Born in africa and asia, DETERMINANTS of 25(Oh)D concentrations <30 nmol/l were not taking Vitamin D supplements, never exposing skin when sunny and lower age (table 2).']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('GO_0007567', 'parturition', 39, 'born'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5084041	10/2016	S107-PMC5084041	['Gestational weight gain, bmi and age were not significantly associated with change in 25(Oh)D. in the subgroup of women Born in africa and asia, only Vitamin D supplementation at t3 was a DETERMINANT of season-corrected change in Vitamin D status during Pregnancy (adjusted r2= 0.115) (table 3).']	[('SUPERFICIAL_RELATIONSHIP', 188)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007567', 'parturition', 120, 'born'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC5085625	9/2016	S19-PMC5085625	['Blood concentration of 25(Oh)D REFLECTS actual content of Vitamin D in the Human body [7].']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human')]
PMC5118763	12/2016	S10-PMC5118763	['conclusion: compared with fe60f, Mmns produced higher maternal Vitamin B-12 and SIMILAR ferritin and Folate concentrations in bangladeshi women.']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('UBERON_0002544', 'digit', 33, 'MMNs'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 63, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 101, 'folate')]
PMC5133057	10/2016	S36-PMC5133057	['we evaluated the intake of Vitamin A (µg), zinc (mg/day), and iron (mg/day), with the latter two predicted to be INVOLVED in Vitamin A bioavailability [24].']	[('SUPERFICIAL_RELATIONSHIP', 113)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin A')]
PMC5146866	12/2016	S6-PMC5146866	['deficient cb Vitamin D levels in infants were ASSOCIATED with maternal black, hispanic, or asian race/ethnicity, younger age, and increased number of Pregnancies.']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancies')]
PMC5146866	12/2016	S45-PMC5146866	['variables with significant between-group variability ( p value of less than 0.05) were classified for inclusion into the multiple regression models to estimate their independent ROLE in the development of Vitamin D deficiency and insufficiency in cb as compared to those with sufficient levels of Vitamin D. in addition multiple regression models were stratified by race/ethnicity defined as white, black, hispanic, and asian.']	[('SUPERFICIAL_RELATIONSHIP', 178)]	1	[('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5146866	12/2016	S81-PMC5146866	['because the main source of Vitamin D is Vitamin D3That is synthesized in the skin through a Photolytic Reaction, the level of Vitamin D DEPENDS ON skin pigmentation, use of sunscreens, coverage of sun-exposed skin, seasonal factors, and geographic latitude [25–27].']	[('SUPERFICIAL_RELATIONSHIP', 136)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_85160', '3-hydroxylubimin', 40, 'vitamin D3that'), ('GO_0043631', 'RNA polyadenylation', 92, 'photolytic reaction'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5146866	12/2016	S88-PMC5146866	['[13] reported an ASSOCIATION between younger maternal age and diagnosis of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 17)]	1	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5155676	12/2016	S53-PMC5155676	['additionally, maternal factors ASSOCIATED with achieving a Vitamin D replete status (>50 nmol/l) were determined using poisson regression with robust standard errors (21).']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5155676	12/2016	S75-PMC5155676	['percentage of women achieving Vitamin D replete status (>50 nmol/l) according to randomization group and season of Deliveryseason of Deliveryplacebo1000 iu/d Cholecalciferol p comparing randomization groupswinter (december–may)13.975.0<.001summer (june–november)54.290.1<.001 p comparing seasons<.001<.001\n\ndeterminants of maternal 25(Oh)D at 34 weeks of Gestation\nin univariate analysis, maternal age, baseline 25(Oh)D, season of Delivery and compliance with study Medication were significantly ASSOCIATED with 34 week 25(Oh)D in both the Placebo and Vitamin D supplementation groups (table 3).']	[('SUPERFICIAL_RELATIONSHIP', 496)]	1	[('CHEBI_28384', 'vitamin K', 30, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 30, 'Vitamin D'), ('GO_0006260', 'DNA replication', 115, 'DeliverySeason'), ('GO_0006260', 'DNA replication', 133, 'DeliveryPlacebo1000'), ('CHEBI_16113', 'cholesterol', 158, 'Cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 332, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 355, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 412, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 415, 'OH ... D'), ('GO_0007567', 'parturition', 431, 'delivery'), ('CHEBI_60211', 'compound Z', 466, 'medication'), ('CHEBI_71657', 'versiconol acetate', 520, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 520, '25(OH)D'), ('CHEBI_26130', 'biological pigment', 540, 'placebo'), ('CHEBI_27300', 'vitamin D', 552, 'vitamin D')]
PMC5155676	12/2016	S82-PMC5155676	['in multiple linear regression analysis, maternal factors significantly ASSOCIATED with greater 25(Oh)D at 34 weeks of Gestation in the Vitamin D supplementation group were lower Pregnancy weight gain (kg) (β = −0.81; 95% confidence interval [ci] −1.39, −0.22; p = .007), higher compliance (%) (β = 0.28; 95%ci 0.072, 0.48; p = .008), higher early Pregnancy 25(Oh)D (nmol/l) (β = 0.28; 95%ci 0.16, 0.40; p< .001), and summer Delivery (summer vs winter) (β = 10.51; 95%ci 6.40, 14.63; p< .001) (figure 2a).']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_71657', 'versiconol acetate', 95, '25(OH)D'), ('GO_0007565', 'female pregnancy', 118, 'gestation'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('GO_0007565', 'female pregnancy', 347, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 357, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 357, '25(OH)D'), ('GO_0007567', 'parturition', 424, 'delivery')]
PMC5155676	12/2016	S117-PMC5155676	['similarly, non-white ethnicity was ASSOCIATED with a higher risk of not achieving Vitamin D replete status in the supplemented women.']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5155676	12/2016	S120-PMC5155676	['maternal age was also positively ASSOCIATED in univariate analyses with 25(Oh)D achieved at 34 weeks of Gestation in women who received Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('GO_0007565', 'female pregnancy', 104, 'gestation'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5322422	2/2017	S34-PMC5322422	['based on the severely abnormal Coagulation studies, the patient was treated acutely for suspected Vitamin K deficiency RELATED bleeding.']	[('SUPERFICIAL_RELATIONSHIP', 119)]	1	[('GO_0050817', 'coagulation', 31, 'coagulation'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin K')]
PMC5340372	3/2017	S118-PMC5340372	['the fetal Vitamin D status is DEPENDENT on the Placental-fetal circulation.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental')]
PMC5351212	3/2017	S25-PMC5351212	['another epidemiologically valid developmental RISK FACTOR for later psychiatric disease is developmental Vitamin D (Dvd) deficiency [22].']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 116, 'DVD')]
PMC5368580	4/2017	S8-PMC5368580	['circadian variance was significant except for fat-adjusted Vitamins A and E, with a higher CONTRIBUTION to total variance with supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 91)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 59, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'E')]
PMC5371920	3/2017	S70-PMC5371920	['for example, maternal 25(oh)-Vitamin D [25(Oh)D] status INFLUENCES offspring bone mass at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007567', 'parturition', 90, 'birth')]
PMC5371920	3/2017	S131-PMC5371920	['thus, in a pre-specified analysis, amongst winter births, neonates Delivered to mothers allocated Vitamin D supplements had more than 0.5 sd greater whole body bmc than did neonates Born to placebo mothers ( p = 0.004); the INTERACTION between season and treatment was also statistically significant ( p = 0.04) [44].']	[('SUPERFICIAL_RELATIONSHIP', 224)]	1	[('GO_0007567', 'parturition', 67, 'delivered'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'born')]
PMC5372327	3/2017	S11-PMC5372327	['it is bound to Vitamin D Binding Protein (Dbp) and transported to the Liver for conversion to 25-Hydroxy-Vitamin D (25-Ohd), the most abundant circulating Metabolite of Vitamin D. in the Kidney, 25-Ohd is further hydroxylated to the active form Calcitriol, 1,25-oh2d, that CONTRIBUTES to Calcium Metabolism [1].']	[('SUPERFICIAL_RELATIONSHIP', 273)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 15, 'vitamin D binding protein'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 42, 'DBP'), ('UBERON_0002107', 'liver', 70, 'liver'), ('CHEBI_70487', '(-)-sanguinolignan C', 94, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 116, '25-OHD'), ('CHEBI_39382', 'flufenoxuron', 155, 'metabolite'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0002113', 'kidney', 187, 'kidney'), ('CHEBI_72765', 'verruculogen', 195, '25-OHD'), ('CHEBI_17823', 'calcitriol', 245, 'calcitriol'), ('GO_0018884', 'carbazole metabolic process', 288, 'calcium metabolism')]
PMC5372327	3/2017	S17-PMC5372327	['both cutaneously synthesised and dietary Vitamin D CONTRIBUTE to the circulating 25-Ohd concentration.']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 81, '25-OHD')]
PMC5372327	3/2017	S25-PMC5372327	['ROLE of Vitamin D in health and disease\n\ngrowth and bone mineralisation\nSerum calcium and Phosphate concentrations are tightly Regulated by Parathyroid hormone (pth) and 1,25-oh2d by negative feedback.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0001977', 'blood serum', 72, 'Serum'), ('CHEBI_18367', 'phosphate(3-)', 90, 'phosphate'), ('GO_0065007', 'biological regulation', 127, 'regulated'), ('UBERON_0001132', 'parathyroid gland', 140, 'parathyroid')]
PMC5372327	3/2017	S32-PMC5372327	['in Vitamin D deficient children, Vitamin D supplementation improved growth velocity and PREVENTED stunted growth [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5372327	3/2017	S44-PMC5372327	['in addition, Vitamin D deficiency is ASSOCIATED with Upper Respiratory Tract, Gastrointestinal and Ear infections in children [32,33].']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0001557', 'upper respiratory tract', 53, 'upper respiratory tract'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 78, 'gastrointestinal'), ('UBERON_0001690', 'ear', 99, 'ear')]
PMC5372327	3/2017	S60-PMC5372327	['these included Single Nucleotide Polymorphisms in the gc Gene encoding Vitamin D Binding Protein, locus near the 7-Dehydrocholesterol reductase INVOLVED in Vitamin D Synthesis in the skin, and Cyp2R1 coding Cytochrome P450 responsible for 25-Hydroxylation.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('SO_0000694', 'SNP', 15, 'single nucleotide polymorphisms'), ('SO_0000704', 'gene', 57, 'gene'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 71, 'vitamin D binding protein'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 113, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 156, 'vitamin D synthesis'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 193, 'CYP2R1'), ('CHEBI_38557', 'cytochrome c2', 207, 'cytochrome P450'), ('PR_000006100', 'aromatase', 207, 'cytochrome P450'), ('CHEBI_52846', 'cycloalkane ring', 239, '25-hydroxylation')]
PMC5372327	3/2017	S63-PMC5372327	['polymorphisms of the Vitamin D Receptor Gene Vdr ASSOCIATE with growth pattern in infancy [56,57] and with bone strength [58].']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'VDR')]
PMC5385921	4/2017	S67-PMC5385921	['statistical analyses\nto estimate the EFFECT of Vitamin D deficiency on asd, variations of linear models were fitted to the data.']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5385921	4/2017	S69-PMC5385921	['main analyses\nlogistic regression analyses were applied to test the EFFECT of Vitamin D deficiency status on asd.']	[('SUPERFICIAL_RELATIONSHIP', 68)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5385921	4/2017	S85-PMC5385921	['third, we fitted a model on the full sample replacing the categorical Vitamin D predictor with a continuous measure of Vitamin D and tested the ASSOCIATION between 25ohd and asd.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5385921	4/2017	S140-PMC5385921	['developmental Vitamin D deficiency at mid-Gestation was ASSOCIATED with a twofold increased risk of asd.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'gestation')]
PMC5405075	4/2017	S15-PMC5405075	['Vitamin D levels during Pregnancy\nthe main ROLE of Vitamin D during Pregnancy is to maintain Serum calcium levels by promoting calcium absorption in the Intestine and allowing proper function of Parathyroid hormone.']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('UBERON_0001977', 'blood serum', 93, 'serum'), ('UBERON_0000160', 'intestine', 153, 'intestine'), ('UBERON_0001132', 'parathyroid gland', 195, 'parathyroid')]
PMC5405075	4/2017	S30-PMC5405075	['Gestational Vitamin D has now been LINKED to a variety of diseases such as osteoporosis, Autoimmune disorders, altered Brain Development and Adult mental health, Food allergies, and asthma (17,29,31–33).']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('GO_0007420', 'brain development', 119, 'brain development'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('CHEBI_33290', 'food', 162, 'food')]
PMC5410409	4/2017	S192-PMC5410409	['there are no rcts done on Vitamin D supplementation in allergy PREVENTION.']	[('SUPERFICIAL_RELATIONSHIP', 63)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5418719	5/2017	S77-PMC5418719	['caption (table-wrap): table 2\n\nVitamin D statusvariablecord 25(Oh)D concentrations <10\xa0ng/mlcord 25(Oh)D concentrations ≥10\xa0ng/ml p at Birth\u2003n2029\u2003Serum 25(Oh)D levels8.3\u2009±\u20091.921.4\u2009±\u20098.5<0.001\u2003Vitamin D sufficiency (>30\xa0ng/ml)0 (0%)5 (17%)0.0732\u2009±\u20091\xa0weeks Postmenstrual age\u2003n1318\u2003Serum 25(Oh)d levels15.3\u2009±\u200910.124.1\u2009±\u20099.30.05\u2003Vitamin D sufficiency (>30\xa0ng/ml)3 (23%)4 (22%)1.0036\u2009±\u20091\xa0weeks Postmenstrual age\u2003n1726\u2003Serum 25(Oh)D levels43.1\u2009±\u200920.357.7\u2009±\u200921.90.03\u2003Vitamin D sufficiency (>30\xa0ng/ml)11 (65%)23 (88%)0.12\ndata are presented as n (%), median (range), or mean\u2009±\u2009sd\ntable\xa03presents the levels of Serum calcium, Phosphorous, alkaline phosphatase level at Birth, 32\u2009±\u20091\xa0weeks pma, and 36\u2009±\u20091\xa0weeks pma as MARKERS of Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 710)]	1	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('GO_0007567', 'parturition', 135, 'birth'), ('UBERON_0001977', 'blood serum', 147, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 153, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 153, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 193, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 256, 'postmenstrual'), ('UBERON_0001977', 'blood serum', 280, 'Serum'), ('CHEBI_63056', 'zinc cation', 286, '25(OH'), ('CHEBI_28384', 'vitamin K', 326, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 390, 'postmenstrual'), ('UBERON_0001977', 'blood serum', 414, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 420, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 461, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 603, 'serum'), ('CHEBI_30207', 'phosphorus(.)', 618, 'phosphorous'), ('GO_0007567', 'parturition', 661, 'birth'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D')]
PMC5418719	5/2017	S91-PMC5418719	['the response to Vitamin D supplementation was DEPENDENT on the baseline Vitamin D stores at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 92, 'birth')]
PMC5418719	5/2017	S135-PMC5418719	['in one infant in our study, nephrocalcinosis was ASSOCIATED with hypercalciuria and excessive Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5426325	4/2017	S120-PMC5426325	['also, in the danish national Birth cohort, mid-Pregnancy maternal supplementation with >10 µg Vitamin D/d was ASSOCIATED with a 30 % higher risk of offspring Forearm fractures(37).']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007567', 'parturition', 29, 'Birth'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 158, 'forearm')]
PMC5426325	4/2017	S150-PMC5426325	['margarine consumption CONTRIBUTED to 13 % of this Vitamin D intake, which is equivalent to 0·36 µg(61).']	[('SUPERFICIAL_RELATIONSHIP', 22)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5489519	6/2017	S62-PMC5489519	['effect of Vitamin D on Trail Expression in Human Breast Epithelial Cells\nsince the Expression of Trail is elevated in Vitamin D deficient mothers’ Breast Milk, we next examined the direct EFFECT of Vitamin D on normal Human Breast Epithelial Cells to analyze the Trail Expression.']	[('SUPERFICIAL_RELATIONSHIP', 188)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 23, 'TRAIL'), ('GO_0010467', 'gene expression', 29, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 43, 'human'), ('CL_0002327', 'mammary gland epithelial cell', 49, 'breast epithelial cells'), ('UBERON_0008367', 'breast epithelium', 49, 'breast epithelial'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 97, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0000310', 'breast', 147, 'breast'), ('UBERON_0001913', 'milk', 154, 'milk'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 218, 'human'), ('CL_0002327', 'mammary gland epithelial cell', 224, 'breast epithelial cells'), ('UBERON_0008367', 'breast epithelium', 224, 'breast epithelial'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 263, 'TRAIL'), ('GO_0010467', 'gene expression', 269, 'expression')]
PMC5513133	7/2017	S31-PMC5513133	['these include Vitamin D’s ROLE in Modulating pro-inflammatory responses and decreasing oxidative stress in pe, promoting Angiogenesis through Vegf and Gene modulation, and decreasing Blood Pressure through the Renin-angiotensin system (ras) [19–25].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 34, 'modulating'), ('GO_0001525', 'angiogenesis', 121, 'angiogenesis'), ('PR_000017279', 'testis-specific basic protein Y 1', 142, 'VEGF'), ('SO_0000704', 'gene', 151, 'gene'), ('UBERON_0000178', 'blood', 183, 'blood'), ('GO_0060208', 'proestrus', 189, 'pressure'), ('PR_000014368', 'RuvB-like 1', 210, 'renin')]
PMC5513133	7/2017	S82-PMC5513133	['role of Vitamin D and Vitamin D Receptor (vdr) in Calcium Homeostasis\nthe EFFECTS of Calcium supplementation on Pregnancy-induced hypertensive disorders are well characterized.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 22, 'vitamin D receptor'), ('GO_0050817', 'coagulation', 50, 'calcium'), ('GO_0042592', 'homeostatic process', 58, 'homeostasis'), ('CHEBI_22313', 'alkaline earth metal atom', 85, 'calcium'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC5513133	7/2017	S101-PMC5513133	['the inclusion criteria for this review were availability of an abstract, clinical data on Vitamin D concentrations and/or supplementation in ASSOCIATION with pih outcomes in any global setting, and subjects that included Pregnant participants aged 18\xa0years and above without other medical co-morbidities.']	[('SUPERFICIAL_RELATIONSHIP', 141)]	1	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnant')]
PMC5513133	7/2017	S156-PMC5513133	['there was a significant RELATIONSHIP between Vitamin D levels in pre-eclamptic women with levels in their neonates ( r \xa0=\xa00.901, p \xa0=\xa00.0001) [89].']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5513133	7/2017	S222-PMC5513133	['oily fish and cod Liver oil (N-3 Fatty Acids) are a rich source of Vitamin D. in the norwegian diet, intake of Vitamin D is CORRELATED with Intake of Long Chain N-3 Fatty Acids [77].']	[('SUPERFICIAL_RELATIONSHIP', 124)]	1	[('UBERON_0002107', 'liver', 18, 'liver'), ('CHEBI_35418', 'N-acetylneuraminate', 29, 'n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007631', 'feeding behavior', 140, 'intake'), ('CHEBI_25098', 'lyxoside', 150, 'long chain n-3 fatty acids')]
PMC5513133	7/2017	S226-PMC5513133	['in their secondary analysis with Intake of Long Chain N-3 Fatty Acids and Vitamin D, a weaker ASSOCIATION with the incidence of pe was observed [77].']	[('SUPERFICIAL_RELATIONSHIP', 94)]	1	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_25098', 'lyxoside', 43, 'long chain n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5513133	7/2017	S232-PMC5513133	['in the rcts reviewed, no conclusions can be made regarding the independent EFFECTS of Vitamin D in preventing or treating pe.']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5521778	7/2017	S4-PMC5521778	['alterations in this balance, including Vitamin A deficiency and gc excess, CONTRIBUTE to the development of chronic Lung disorders.']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('UBERON_0002048', 'lung', 116, 'lung')]
PMC5521778	7/2017	S19-PMC5521778	['SIMILARLY, Vitamin A deficiency impairs Alveolar maintenance in the Adult Lung [11].']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0003215', 'alveolus', 40, 'alveolar'), ('UBERON_0007023', 'adult organism', 68, 'adult'), ('UBERON_0002048', 'lung', 74, 'lung')]
PMC5521778	7/2017	S40-PMC5521778	['moreover, maternal gc treatment is ASSOCIATED with decreased fetal Lung Vitamin A stores [33].']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('UBERON_0002048', 'lung', 67, 'lung'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A')]
PMC5537904	7/2017	S117-PMC5537904	['every 100 iu/day increase in oral Vitamin D was ASSOCIATED with a 0.6 (0.2) nmol/l increase in Cord Blood 25(Oh)D ( p = 0.01).']	[('SUPERFICIAL_RELATIONSHIP', 48)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 95, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_33010', 'chromide(1-)', 108, '(OH)D')]
PMC5539754	8/2017	S14-PMC5539754	['background\nVitamin D status and season are intrinsically LINKED; upon exposure to natural ultraviolet solar radiation, endogenous skin Production Of Vitamin D occurs.']	[('SUPERFICIAL_RELATIONSHIP', 57)]	1	[('CHEBI_28384', 'vitamin K', 11, 'Vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 135, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5594587	9/2017	S166-PMC5594587	['periconceptional restriction of maternal Vitamin B and methionine supply LED to altered methylation at Cpg islands in the foetal Sheep Liver and with increased Adult body weight and fatness of the offspring [78].']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('SO_0001334', 'hydroxywybutosine', 103, 'CpG'), ('NCBITaxon_10088', 'Mus <genus>', 129, 'sheep'), ('UBERON_0002107', 'liver', 135, 'liver'), ('UBERON_0007023', 'adult organism', 160, 'adult')]
PMC5623264	9/2017	S74-PMC5623264	['Vitamin A\na review including 19 rcts, quasi-rcts and cluster-rcts randomising over 310\u2009000 Pregnant women living in areas with endemic Vitamin A deficiency or in areas with adequate Intake assessed the EFFECT of Vitamin A supplementation or one of its derivatives alone or in combination with other supplements on lbw and ptb.24vitamin a alone compared with placebo or no treatment did not reduce lbw or ptb.']	[('SUPERFICIAL_RELATIONSHIP', 202)]	1	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('GO_0007631', 'feeding behavior', 182, 'intake'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A')]
PMC5638722	8/2017	S17-PMC5638722	['Cord Blood low Plasma concentrations of Vitamin D were also found to CORRELATE with diminished tlr induction of Cathelicidin, which encodes for an Antimicrobial peptide5).']	[('SUPERFICIAL_RELATIONSHIP', 69)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001969', 'blood plasma', 15, 'plasma'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 112, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 147, 'antimicrobial')]
PMC5638722	8/2017	S19-PMC5638722	['current studies investigate the RELATIONSHIP between Cord Blood Vitamin D status and in vitro measures of Human Monocyte function.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('UBERON_0009472', 'axilla', 53, 'cord blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 106, 'human'), ('CL_0000576', 'monocyte', 112, 'monocyte')]
PMC5638722	8/2017	S20-PMC5638722	['Cord Blood Vitamin D deficiency, by its EFFECTS on tlr-induced Antimicrobial Production, causes alteration in vitro Monocyte responses4).']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 63, 'antimicrobial'), ('GO_0002775', 'antimicrobial peptide production', 63, 'antimicrobial production'), ('CL_0000576', 'monocyte', 116, 'monocyte')]
PMC5638722	8/2017	S21-PMC5638722	['Cord Blood Vitamin D deficiency, by its IMPACT on the tlr-induced Antimicrobial Production, altered in vitro Monocyte responses4).']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 66, 'antimicrobial'), ('GO_0002775', 'antimicrobial peptide production', 66, 'antimicrobial production'), ('CL_0000576', 'monocyte', 109, 'monocyte')]
PMC5659607	10/2017	S63-PMC5659607	['for the primary end-point asthma/recurrent wheeze at age 0–3 years, we first analysed the EFFECT of the intervention (Vitamin D vs. placebo).']	[('SUPERFICIAL_RELATIONSHIP', 90)]	1	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5664622	9/2017	S46-PMC5664622	['Maternal Venous Blood by season\nmean maternal Vitamin D concentration was 19.3 ± 7.9 ng/ml, and was closely CONNECTED with the season of the year, with 16.5 ± 8.2 ng/ml for the winter and 22.2 ± 6.5 ng/ml ( p< 0.001) for the summer group.']	[('SUPERFICIAL_RELATIONSHIP', 108)]	1	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001638', 'vein', 9, 'Venous'), ('UBERON_0000178', 'blood', 16, 'Blood'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5664622	9/2017	S48-PMC5664622	['the season was also significantly ASSOCIATED with the distribution structure for Vitamin D concentration (pr = 0.005).']	[('SUPERFICIAL_RELATIONSHIP', 34)]	1	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5679631	11/2017	S85-PMC5679631	['there was also a minor difference in that parents with more children TENDED not to supplement their infant with Vitamin D. in terms of use of multivitamin supplements containing Vitamin D, by the mother, those in the conventional group were more represented in the none and highest categories of supplementation with approximately equal representation of recruitment groups occuring in the < 10 μg category.']	[('SUPERFICIAL_RELATIONSHIP', 69)]	1	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5679631	11/2017	S105-PMC5679631	['600 (reference)0 (reference)quintile 2680.01 (-0.21, 0.24)0.01 (-0.21, 0.22)quintile 349-0.11 (-0.35, 0.14)-0.18 (-0.41, 0.06)quintile 4510.02 (-0.22, 0.26)0.04 (-0.20, 0.28)quintile 558-0.06 (-0.30, 0.17)0.08 (-0.17, 0.33)p for linear trendp = 0.459\n&number of children colonized;\n#adjusted for: place and mode of Delivery, number of siblings, recruitment group, total bacterial counts, sex, vaginitis during the last month of Pregnancy, mode of infant nutrition and season of Blood sampling; quintile 5 is the highest quintile;\n* remained statistically significant after correction with fdr (q < 0.05)\n\nVitamin D supplementation of the infant\nthere was no influence of Vitamin D supplementation of the infant during the first month of Life on the prevalence of any of the bacterial species or groups (data not shown).table 5shows the ASSOCIATION between Vitamin D supplementation of the infant in the first month of Life and the log10cfus of the different bacteria in children colonized with the respective bacterial group or species (for a visualisation of the data in univariable boxplots see alsos3 fig).10.1371/journal.pone.0188011.t005\n\ncaption (table-wrap): table 5\nassociation between Vitamin D supplementation of the infant and log10colony forming units/g Feces of bacterial species or groups in Breast Fed infants (n = 616) colonized with the respective bacteria.Vitamin D supplement use of Breast feeding infantsvitamin D supplementationbacteria&nunadjusted b (95% ci)#adjusted b (95% ci)no use bifidobacterium spp.']	[('SUPERFICIAL_RELATIONSHIP', 836)]	1	[('GO_0007567', 'parturition', 315, 'delivery'), ('GO_0007565', 'female pregnancy', 428, 'pregnancy'), ('UBERON_0000178', 'blood', 478, 'blood'), ('CHEBI_28384', 'vitamin K', 605, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 671, 'vitamin D'), ('UBERON_0000104', 'life cycle', 737, 'life'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('UBERON_0000104', 'life cycle', 918, 'life'), ('CHEBI_27300', 'vitamin D', 1194, 'vitamin D'), ('UBERON_0001988', 'feces', 1266, 'feces'), ('GO_0007567', 'parturition', 1306, 'breast'), ('UBERON_0000310', 'breast', 1306, 'breast'), ('GO_0007631', 'feeding behavior', 1313, 'fed'), ('CHEBI_28384', 'vitamin K', 1374, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1374, 'Vitamin'), ('UBERON_0000310', 'breast', 1402, 'Breast'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1432, 'D')]
PMC5679631	11/2017	S114-PMC5679631	['difficile were ASSOCIATED with Vitamin D supplementation in the alternative group (b = -1.45 log10cfu/g Feces; 95% ci: -2.63, -0.28) with no association found in the conventional group (b = 0.49; 95% ci: -0.71, 1.69).']	[('SUPERFICIAL_RELATIONSHIP', 15)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001988', 'feces', 104, 'feces')]
PMC5679631	11/2017	S123-PMC5679631	['active Vitamin D INFLUENCES tolerance by inhibiting Dendritic Cell Maturation and Differentiation.']	[('SUPERFICIAL_RELATIONSHIP', 17)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CL_0000451', 'dendritic cell', 52, 'dendritic cell'), ('GO_0048774', 'cyanophore differentiation', 62, 'cell maturation ... differentiation')]
PMC5679631	11/2017	S163-PMC5679631	['in infants colonized with the respective bacteria in RELATION to maternal multivitamin supplementation containing Vitamin D.\n(docx)\n\ncaption (media)\n\nclick here for additional data file.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5679631	11/2017	S168-PMC5679631	['in infants colonized with the respective bacteria in RELATION to Vitamin D supplement use of breastfed infants.']	[('SUPERFICIAL_RELATIONSHIP', 53)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC5697969	12/2017	S144-PMC5697969	['the nutrition-focused mnch program had significant EFFECTS on daily Intakes of protein and fats (effects: 27 and 34 g, respectively) and on most Micronutrients studied (effects: 356 mg for calcium, 6.4 mg for iron, 3.3 mg for zinc, 156 g for Vitamin C, 291 μg for Folate, 1.7 μg for Vitamin B-12 and 706 μg for Vitamin A) ( table 5 ).']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('GO_0007631', 'feeding behavior', 68, 'intakes'), ('CHEBI_33839', 'macromolecule', 145, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 264, 'folate'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 283, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin A')]
PMC5706533	11/2017	S93-PMC5706533	['estimated mean change in effective Vitamin D dose for every 20 nmol/l increase in baseline mean 25(Oh)D concentration was increase of 208 iu/day (p=0.54)\n\nEFFECTS on maternal and Cord Blood 25-Hydroxyvitamin D concentrations\nwe performed meta-analyses for 11 maternal and 27 neonatal/infant outcomes (tables 2 and 3).']	[('SUPERFICIAL_RELATIONSHIP', 155)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 96, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 179, 'cord'), ('UBERON_0000178', 'blood', 184, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 190, '25-hydroxyvitamin D')]
PMC5706533	11/2017	S98-PMC5706533	['caption (table-wrap): table 2\n\npooled risk ratios from primary meta-analyses of EFFECTS of Vitamin D supplementation during Pregnancy on maternal and neonatal/infant outcomesoutcomestrials reporting eligible outcometrials included*intervention-control comparisons included*participants included*risk ratio (95% ci)i2(%) maternal pre-eclampsia3337061.09 (0.43 to 2.76)67†Gestational hypertension2225641.69 (0.73 to 3.92)0gestational diabetes55510300.65 (0.39 to 1.08)45stillbirth16161946060.75 (0.51 to 1.13)0caesarean section17161832401.02 (0.93 to 1.12)0preterm labor4447760.52 (0.26 to 1.05)51hypercalcaemia4111753.11 (0.87 to 11.08)—hypercalciuria2111603.00 (0.12 to 72.56)—hypocalcaemia2112000.05†(0.01 to 0.18)—admission to hospital55517760.97 (0.69 to 1.35)0 neonatal/infant Preterm Birth14131537571.00 (0.77 to 1.30)0low Birth weight87711560.74 (0.47 to 1.16)47small for Gestational age5577410.60†(0.40 to 0.90)0congenital malformations54425090.93 (0.61 to 1.42)0neonatal death53412020.48 (0.16 to 1.49)0.0hypercalcaemia111730.97 (0.31 to 3.08)—hypocalcaemia2111260.10 (0.01 to 1.83)—admission to Neonatal Intensive Care unit55619970.92 (0.66 to 1.28)21respiratory infections (general)1122230.97 (0.77 to 1.23)0upper Respiratory Tract infections2243890.91 (0.77 to 1.06)0lower Respiratory Tract infections44617690.97 (0.84 to 1.12)0asthma or recurrent/persistent wheeze by age 3 years22213870.81†(0.67 to 0.98)0\n*intervention-control group comparisons with zero events in both groups excluded from primary meta-analyses.']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007565', 'female pregnancy', 370, 'Gestational'), ('GO_0007128', 'meiotic prophase I', 781, 'Preterm'), ('GO_0043174', 'nucleoside salvage', 789, 'birth14131537571'), ('GO_0007567', 'parturition', 828, 'birth'), ('GO_0007565', 'female pregnancy', 878, 'gestational'), ('UBERON_0001759', 'vagus nerve', 1104, 'neonatal'), ('UBERON_0001007', 'digestive system', 1113, 'intensive care'), ('UBERON_0000065', 'respiratory tract', 1224, 'respiratory tract'), ('UBERON_0000065', 'respiratory tract', 1284, 'respiratory tract')]
PMC5706533	11/2017	S114-PMC5706533	['in a post hoc analysis of the EFFECT on Birth weight that took into account both effective dose and baseline Vitamin D status, there was a significant dose-response effect in trials in which mean baseline 25(Oh)D was 30-50 nmol/l but no association in trials with mean 25(Oh)d <30 nmol/l (fig s29 in appendix 10).']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 269, '25(OH')]
PMC5732382	12/2017	S21-PMC5732382	['children under five years are particularly AFFECTED by deficiencies in Vitamin A (84% of children), iron (73.4%), and zinc (51%).']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A')]
PMC5738092	12/2017	S100-PMC5738092	['except the Prenatal supplementation of Vitamin A and Β-Carotene, all the variables had significant (p <0.001) ASSOCIATION with infant’s size at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 11, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 53, 'β-carotene'), ('GO_0007567', 'parturition', 144, 'birth')]
PMC5784894	1/2018	S6-PMC5784894	['early Life Vitamin D depletion LED TO reduced bone strength and altered bone biomechanical properties.']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC5784894	1/2018	S15-PMC5784894	['in addition, lower maternal Vitamin D status is ASSOCIATED with reduced bone Mineral content and area persisting into childhood[8] and young Adulthood[9].']	[('SUPERFICIAL_RELATIONSHIP', 48)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_46662', 'mineral', 77, 'mineral'), ('UBERON_0000113', 'post-juvenile adult stage', 141, 'adulthood')]
PMC5784894	1/2018	S89-PMC5784894	['results\n\na lack of dietary Vitamin D LEADS to Vitamin D deficiency\ncontrol dams had Vitamin D3Levels of 96.1±10.9nm; deficient dams 0.9±0.2nm.']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_24834', 'inorganic anion', 84, 'Vitamin D3levels')]
PMC5784894	1/2018	S112-PMC5784894	['at age 18 weeks, parameters for both Cortical and Trabecular Bone were SIMILAR between the offspring of Vitamin D-deplete and replete dams without loading.']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('UBERON_0001851', 'cortex', 37, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 50, 'trabecular bone'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5812027	2/2018	S1-PMC5812027	['furthermore, ASSOCIATIONS between Vitamin D status and Pregnancy loss were studied.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC5812027	2/2018	S9-PMC5812027	['t3 25Ohd ≥\u2009100\xa0nmol/l (equal to 40\xa0ng/ml) was ASSOCIATED with lower odds of sga (or 0.3, p \u2009=\u20090.031) and lbw (or 0.2, p \u2009=\u20090.046), compared to Vitamin D deficiency (25Ohd <\u200930\xa0nmol/l, or 12\xa0ng/ml).']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 3, '25OHD'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 165, '25OHD')]
PMC5827025	2/2018	S35-PMC5827025	['influence of demographic characteristics on Gestational Serum 25(Oh)D concentration\nthe demographic characteristics for INFLUENCING Gestational Vitamin D status were analyzed.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 132, 'gestational'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5831579	3/2018	S10-PMC5831579	['dietary Intake of fruits and vegetables, foods that require preparation, Nutrients from One-Carbon Metabolism, protein, iron, Calcium and Vitamin D were CORRELATED with the ‘seasoned vegetables and lean meats’.']	[('SUPERFICIAL_RELATIONSHIP', 153)]	1	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_33284', 'nutrient', 73, 'nutrients'), ('GO_0007608', 'sensory perception of smell', 88, 'one-carbon'), ('GO_0008152', 'metabolic process', 99, 'metabolism'), ('CHEBI_22313', 'alkaline earth metal atom', 126, 'calcium'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC5831579	3/2018	S96-PMC5831579	['in descending order of CORRELATION, these Nutrients were natural Folate (rs\u2009=\u20090.51), Vitamin B6 (0.41), iron (0.41), Choline (0.38), dfe (0.38), protein (0.37), Sodium (0.36), methionine (0.35), Calcium (0.34), Vitamin B12 (0.31), Carbohydrate (0.30), Vitamin D (0.28) and Caffeine (0.20).']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_33284', 'nutrient', 42, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 65, 'folate'), ('CHEBI_33237', 'vitamin D4', 85, 'vitamin B6'), ('CHEBI_15354', 'choline', 117, 'choline'), ('CHEBI_52632', 'potassium-39 atom', 161, 'sodium'), ('CHEBI_22313', 'alkaline earth metal atom', 195, 'calcium'), ('CHEBI_33279', 'vitamin D5', 211, 'vitamin B12'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 231, 'carbohydrate'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27732', 'caffeine', 273, 'caffeine')]
PMC5838372	3/2018	S46-PMC5838372	['participants were divided into three groups as deficient, insufficient or sufficient ACCORDING TO their Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 85)]	1	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5838372	3/2018	S113-PMC5838372	['when we evaluated the infants ACCORDING to the Vitamin D levels of their mothers, we found no difference between groups in terms of gender, Gestational age, birth weight, Delivery route and the levels of ca, p and alp.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'gestational'), ('GO_0007567', 'parturition', 171, 'delivery')]
PMC5941617	5/2018	S17-PMC5941617	['when dietary Calcium intakes are inadequate, Calcitriol INTERACTS with the Vitamin D Receptor (Vdr) Expressed on Osteoblasts, bringing Osteoclasts precursors to maturation and promoting calcium and Phosphorus absorption by Bone Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 13, 'calcium'), ('CHEBI_17823', 'calcitriol', 45, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 75, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 95, 'VDR'), ('GO_0010467', 'gene expression', 100, 'expressed'), ('CL_0000062', 'osteoblast', 113, 'osteoblasts'), ('CL_0000092', 'osteoclast', 135, 'osteoclasts'), ('CHEBI_35885', 'secondary phosphine', 198, 'phosphorus'), ('GO_0046903', 'secretion', 198, 'phosphorus'), ('UBERON_0001474', 'bone element', 223, 'bone'), ('UBERON_0000479', 'tissue', 228, 'tissue')]
PMC5941617	5/2018	S88-PMC5941617	['[84]oct 201310810011–14\xa0yearssalerno (40°n)45.4 (overweight or obese)0aclaaa83.3bmi\ncl chemiluminescence, ria radioimmunoassay, tm tandem mass, bmi body mass index\nadata not reported\nbi 25(Oh)D3Tertile: 11.5\u2009±\u20094.2\xa0years; ii 25(oh)d3tertile 11.2\u2009±\u20094.3\xa0years; iii 25(Oh)d3tertile 11.0\u2009±\u20094.0\xa0years (median\u2009±\u2009interquartile range)\ncmean\u2009±\u2009standard error of mean\ndchildren AFFECTED by growth hormone deficiency\n\nsources of Vitamin D and dietary reference values\nmost of the Vitamin D we synthesize (90%) starts with skin exposure to ultraviolet b radiation from the sun.']	[('SUPERFICIAL_RELATIONSHIP', 367)]	1	[('CHEBI_52182', 'meso-bromoporphyrin', 186, '25(OH)D3tertile'), ('CHEBI_63056', 'zinc cation', 262, '25(OH'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 468, 'vitamin D')]
PMC5941617	5/2018	S186-PMC5941617	['in presence of multiple RISK FACTORS for Vitamin D deficiency).']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5941617	5/2018	S437-PMC5941617	['besides RISK factors common to general population (seasonality, reduced sun exposure, low dietary Vitamin D intake, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 8)]	1	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5941617	5/2018	S577-PMC5941617	['daily administration of 2000\xa0iu of Vitamin D3For 16\xa0weeks was EFFECTIVE in increasing Serum 25(Oh)D levels >\u200930\xa0ng/ml also in black adolescents (14–18\xa0years) with Vitamin D deficiency [151].']	[('SUPERFICIAL_RELATIONSHIP', 62)]	1	[('CHEBI_27364', 'zinc molecular entity', 35, 'vitamin D3for'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5941617	5/2018	S638-PMC5941617	['in presence of multiple RISK FACTORS for Vitamin D deficiency).']	[('SUPERFICIAL_RELATIONSHIP', 24)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5941617	5/2018	S681-PMC5941617	['indeed, a pathogenetic ROLE of Vitamin D in ad has yet to be demonstrated.']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5956785	5/2018	S7-PMC5956785	['further, the ASSOCIATION between low Vitamin D and increased arthritis activity follow a north-south geographical gradient.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5956785	5/2018	S94-PMC5956785	['2014 28°n [31]jian\u2009=\u2009353–1622.0\u2009±\u200918.0decreased dietary intake of Vitamin D and Calcium, decreased weight bearing physical activity and sunlight exposure were the major FACTORS for low bmd.']	[('SUPERFICIAL_RELATIONSHIP', 169)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 80, 'calcium')]
PMC5956785	5/2018	S105-PMC5956785	['1994 39°n [50]jcan\u2009=\u200935 (14)8.8\u2009±\u20094.139.8\u2009±\u200920.5disease activity of jca appears to be ASSOCIATED with lower Vitamin D.mean disease duration 3.4\xa0years control n \u2009=\u200915 25(Oh)D 68.1\u2009±\u200915.5\xa0nmol/l control group taking Corticosteroids n\u2009=\u20094 25(Oh)D 51.4\u2009±\u200924.5\xa0nmol/l.missouri, usa hillman et al.']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('CHEBI_50850', 'etabonate ester', 214, 'corticosteroids'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 242, 'D')]
PMC5956785	5/2018	S116-PMC5956785	['there was a significant negative CORRELATION between Vitamin D concentration and disease activity ( p \u2009=\u20090.01, r \u2009=\u2009−\u20090,37).salé, morocco bouaddi et al.']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5956785	5/2018	S125-PMC5956785	['2009 52°n [59]pediatric arthralgia n \u2009=\u2009730 25(Oh)D n \u2009=\u200973<\u20091859.9significantly more reported fall and winter as season of onset – more referrals from northern sk 40%\u2009<\u200950\xa0nmol/l 42% 50–75\xa0nmol/l ASSOCIATION between psychological stress, school absenteeism Vitamin D insufficiency and arthralgia.helinski, finland valta et al.']	[('SUPERFICIAL_RELATIONSHIP', 197)]	1	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5956785	5/2018	S180-PMC5956785	['fifteen of the 38 studies comprising this present review (39.5%) evaluated the RELATIONSHIP between Vitamin D and disease activity (fig.']	[('SUPERFICIAL_RELATIONSHIP', 79)]	1	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5956785	5/2018	S201-PMC5956785	['Vitamin D intake and status was SIMILAR for two jia patient groups [23,26], and lower intake resulted in lower Vitamin D status in the third group [31].']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC5956785	5/2018	S219-PMC5956785	['Corticosteroids promote the breakdown of both 25(Oh)D and 1,25(Oh)D and also counteract EFFECTS of Vitamin D on bone formation [74,75].']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('CHEBI_36961', 'chalcocarbonic acid', 0, 'Corticosteroids'), ('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('CHEBI_17996', 'chloride', 59, ','), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5956785	5/2018	S232-PMC5956785	['the ROLE and an appropriate amount of Vitamin D intake or 25(Oh)D target for inflammation or disease activity have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D')]
PMC5956785	5/2018	S255-PMC5956785	['the ROLE of Genes in the Vitamin D pathway on both disease development and disease activity are still in the early stages of investigation.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('SO_0000704', 'gene', 12, 'genes'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC5956785	5/2018	S266-PMC5956785	['of the studies that investigated the RELATIONSHIP between Vitamin D and function or disease activity, various measures were used.']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5996965	6/2018	S17-PMC5996965	['these include anaemia due to iron deficiency and risk of child mortality ASSOCIATED with clinical Vitamin A deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('CHEBI_27300', 'vitamin D', 98, 'vitamin A')]
PMC6011374	6/2018	S17-PMC6011374	['in australia and new zealand, the deficiency cut-offs are based on the ROLE of Vitamin D in bone health where Serum 25(Oh)D\u2009≥\u200950\xa0nmol/l at the end of winter is required for optimal Musculoskeletal health [1].']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 116, '25(OH ... D'), ('UBERON_0002204', 'musculoskeletal system', 181, 'musculoskeletal')]
PMC6011374	6/2018	S27-PMC6011374	['in the case of Preterm Delivery, Vitamin D status measured closer to the Delivery date was more significantly ASSOCIATED with Preterm Delivery than earlier measures [26].']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 15, 'preterm'), ('GO_0007567', 'parturition', 23, 'delivery'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 73, 'delivery'), ('GO_0007565', 'female pregnancy', 126, 'preterm'), ('GO_0007567', 'parturition', 134, 'delivery')]
PMC6011374	6/2018	S62-PMC6011374	['given that all these factors significantly INFLUENCED Serum 25(Oh)D in the linear regression model, it was unsurprising that Vitamin D status of the women was significantly different between the two recruitment sites.']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 60, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC6011374	6/2018	S113-PMC6011374	['high dose (>\u20092000\xa0iu) Vitamin D supplementation is ASSOCIATED with decreasing risk of Pregnancy complications [23–25].']	[('SUPERFICIAL_RELATIONSHIP', 51)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC6011374	6/2018	S120-PMC6011374	['conclusions\nin conclusion, once standardised against month of sampling, we demonstrate a protective EFFECT of high Vitamin D with gdm.']	[('SUPERFICIAL_RELATIONSHIP', 100)]	1	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC6039335	7/2018	S23-PMC6039335	['factors AFFECTING imf deposition can be sub-categorized into Genetic (breed and sex differences, heritability), management (weaning age, castration, slaughter weight and age, and environment), and nutritional factors (Fat Metabolism, Fat Digestion and absorption, Glucose/Starch availability, roughage vs concentrate ratio, dietary energy and protein levels, Vitamins A, d, and c levels, fetal and neonatal nutritional programming, and stage-specific Feeding systems).']	[('SUPERFICIAL_RELATIONSHIP', 8)]	1	[('SO_0000704', 'gene', 61, 'genetic'), ('GO_0006631', 'fatty acid metabolic process', 218, 'fat metabolism'), ('GO_0009566', 'fertilization', 234, 'fat digestion'), ('CHEBI_17234', 'glucose', 264, 'glucose'), ('CHEBI_28017', 'starch', 272, 'starch'), ('CHEBI_27300', 'vitamin D', 359, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 368, 'A'), ('GO_0007631', 'feeding behavior', 451, 'feeding')]
PMC6039335	7/2018	S272-PMC6039335	['a significant INTERACTION was detected between adh1c c.-64t>c genotype and Vitamin A supplementation for imf content in the lm.']	[('SUPERFICIAL_RELATIONSHIP', 14)]	1	[('CHEBI_27300', 'vitamin D', 75, 'vitamin A')]
